{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "bcf2895a",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_huggingface.embeddings import HuggingFaceEmbeddings\n",
    "from langchain_community.vectorstores import FAISS\n",
    "from langchain_community.docstore.in_memory import InMemoryDocstore\n",
    "import torch\n",
    "import faiss\n",
    "import os\n",
    "from tqdm import tqdm\n",
    "from glob import glob\n",
    "\n",
    "if torch.cuda.is_available():\n",
    "    device = \"cuda\"\n",
    "elif torch.backends.mps.is_available():\n",
    "    device = \"mps\"\n",
    "else:\n",
    "    device = \"cpu\"\n",
    "\n",
    "embeddings = HuggingFaceEmbeddings(\n",
    "    model_name=\"sentence-transformers/all-MiniLM-L6-v2\",\n",
    "    model_kwargs={\"device\": device},\n",
    "    cache_folder=\"cache\",\n",
    ")\n",
    "\n",
    "\n",
    "folder_path = \"/Users/ha/Downloads/mirrulations/specific/\"\n",
    "folders = os.listdir(folder_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "25a0c87f",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in CMS-2019-0039:   0%|          | 0/4 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 84 issue 42 (monday, march 4, 2019)</title>\n",
      "</head>\n",
      "<body><pre>\n",
      "[federal register volume 84, number 42 (monday, march 4, 2019)]\n",
      "[proposed rules]\n",
      "[pages 7610-7680]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2019-02200]\n",
      "\n",
      "\n",
      "\n",
      "\u0000\u0000federal register / vol. 84 , no. 42 / monday, march 4, 2019 / \n",
      "proposed rules\u0000\u0000\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of health and human services\n",
      "\n",
      "centers for medicare & medicaid services\n",
      "\n",
      "42 cfr parts 406, 407, 422, 423, 431, 438, 457, 482, and 485\n",
      "\n",
      "office of the secretary\n",
      "\n",
      "45 cfr part 156\n",
      "\n",
      "[cms-9115-p]\n",
      "rin 0938-at79\n",
      "\n",
      "\n",
      "medicare and medicaid programs; patient protection and affordable \n",
      "care act; interoperability and patient access for medicare advantage \n",
      "organization and medicaid managed care plans, state medicaid agencies, \n",
      "chip agencies and chip managed care entities, issuers of qualified \n",
      "health plans in the federally-facilitated exchanges and health care \n",
      "providers\n",
      "\n",
      "agency: centers for medicare & medicaid services (cms), hhs.\n",
      "\n",
      "action: proposed rule.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: this proposed rule is intended to move the health care \n",
      "ecosystem in the direction of interoperability, and to signal our \n",
      "commitment to the vision set out in the 21st century cures act and \n",
      "executive order 13813 to improve access to, and the quality of, \n",
      "information that americans need to make informed health care decisions, \n",
      "including data about health care prices and outcomes, while minimizing \n",
      "reporting burdens on affected plans, health care providers, or payers.\n",
      "\n",
      "dates: to be assured consideration, comments must be received at one of \n",
      "the addresses provided below, no later than 5 p.m. on may 3, 2019.\n",
      "\n",
      "addresses: in commenting, please refer to file code cms-9115-p. because \n",
      "of staff and resource limitations, we cannot accept comments by \n",
      "facsimile (fax) transmission.\n",
      "    comments, including mass comment submissions, must be submitted in \n",
      "one of the following three ways (please choose only one of the ways \n",
      "listed):\n",
      "    1. electronically. you may submit electronic comments on this \n",
      "regulation to <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a>. follow the ``submit a \n",
      "comment'' instructions.\n",
      "    2. by regular mail. you may mail written comments to the following \n",
      "address only: centers for medicare & medicaid services, department of \n",
      "health and human services, attention: cms-9115-p, p.o. box 8016, \n",
      "baltimore, md 21244-8016.\n",
      "    please allow sufficient time for mailed comments to be received \n",
      "before the close of the comment period.\n",
      "    3. by express or overnight mail. you may send written comments to \n",
      "the following address only: centers for medicare & medicaid services, \n",
      "department of health and human services, attention: cms-9115-p, mail \n",
      "stop c4-26-05, 7500 security boulevard, baltimore, md 21244-1850.\n",
      "    for information on viewing public comments, see the beginning of \n",
      "the supplementary information section.\n",
      "\n",
      "for further information contact: \n",
      "    alexandra mugge, (410) 786-4457, for issues related to \n",
      "interoperability, cms health it strategy, technical standards and \n",
      "patient matching.\n",
      "    natalie albright, (410) 786-1671, for issues related to medicare \n",
      "advantage.\n",
      "    john giles, (410) 786-1255, for issues related to medicaid.\n",
      "    emily pedneau, (301) 492-4448, for issues related to qualified \n",
      "health plans.\n",
      "    meg barry, (410) 786-1536, for issues related to chip.\n",
      "    thomas novak, (202) 322-7235, for issues related to trust exchange \n",
      "networks and payer to payer coordination.\n",
      "    sharon donovan, (410) 786-9187, for issues related to federal-state \n",
      "data exchange.\n",
      "    daniel riner, (410) 786-0237, for issues related to physician \n",
      "compare.\n",
      "    ashley hain, (410) 786-7603, for issues related to hospital public \n",
      "reporting.\n",
      "    melissa singer, (410) 786-0365, for issues related to provider \n",
      "directories.\n",
      "    capt scott cooper, usphs, (410) 786-9465, for issues related to \n",
      "hospital and critical access hospital conditions of participation.\n",
      "    lisa bari, (410) 786-0087, for issues related to advancing \n",
      "interoperability in innovative models.\n",
      "    russell hendel, (410) 786-0329, for issues related to the \n",
      "collection of information or the regulation impact analysis sections.\n",
      "\n",
      "supplementary information: \n",
      "    inspection of public comments: all comments received before the \n",
      "close of the comment period are available for viewing by the public, \n",
      "including any personally identifiable or confidential business \n",
      "information that is included in a comment. we post all comments \n",
      "received before the close of the comment period on the following \n",
      "website as soon as possible after they have been received: <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a>. follow the search instructions on that website to \n",
      "view public comments.\n",
      "\n",
      "[[page 7611]]\n",
      "\n",
      "i. background and summary of provisions\n",
      "\n",
      "a. purpose\n",
      "\n",
      "    this proposed rule is the first phase of proposed policies \n",
      "centrally focused on advancing interoperability and patient access to \n",
      "health information using the authority available to the centers for \n",
      "medicare & medicaid services (cms). we believe this is an important \n",
      "step in advancing interoperability, putting patients at the center of \n",
      "their health care and ensuring they have access to their health \n",
      "information. we are committed to solving the issue of interoperability \n",
      "and achieving complete access to health information for patients in the \n",
      "united states (u.s.) health care system, and are taking an active \n",
      "approach to move participants in the health care market toward \n",
      "interoperability and the secure and timely exchange of health \n",
      "information by proposing and adopting policies for the medicare and \n",
      "medicaid programs, the children's health insurance program (chip), and \n",
      "issuers of qualified health plans (qhps).\n",
      "    throughout this proposed rule, we refer to terms such as patient, \n",
      "consumer, beneficiary, enrollee, and individual. we note that every \n",
      "reader of this proposed rule is a patient and has or will receive \n",
      "medical care at some point in their life. in this proposed rule, we use \n",
      "the term ``patient'' as an inclusive term, but because we have \n",
      "historically referred to patients using other terms in our regulations, \n",
      "we use specific terms as applicable in sections of this proposed rule \n",
      "to refer to individuals covered under the health care programs that cms \n",
      "administers and regulates. we also use terms such as payer, plan, and \n",
      "issuer in this proposed rule. certain portions of this proposed rule \n",
      "are applicable to the medicare fee-for-service (ffs) program, the \n",
      "medicaid ffs program, the chip ffs program, medicare advantage (ma) \n",
      "organizations, medicaid managed care plans (managed care organizations \n",
      "(mcos), prepaid inpatient health plans (pihps) and prepaid ambulatory \n",
      "health plans (pahps)), chip managed care entities (mcos, pihps, and \n",
      "pahps), and qhp issuers in federally-facilitated exchanges (ffes). we \n",
      "use the term ``payer'' as an inclusive term, but we use specific terms \n",
      "as applicable in sections of this proposed rule.\n",
      "\n",
      "b. overview\n",
      "\n",
      "    we are dedicated to enhancing and protecting the health and well-\n",
      "being of all americans. one critical issue in the u.s. health care \n",
      "system is that people cannot easily access their complete health \n",
      "information in interoperable forms. patients and the health care \n",
      "providers caring for them are often presented with an incomplete \n",
      "picture of their health and care as pieces of their information are \n",
      "stored in various, unconnected systems and do not accompany the patient \n",
      "to every care setting.\n",
      "    we believe patients should have the ability to move from health \n",
      "plan to health plan, provider to provider, and have both their clinical \n",
      "and administrative information travel with them throughout their \n",
      "journey. when a patient receives care from a new provider, a complete \n",
      "record of their health information should be readily available to that \n",
      "care provider, regardless of where or by who care was previously \n",
      "provided. when a patient is discharged from a hospital to a post-acute \n",
      "care (pac) setting there should be no question as to how, when, or \n",
      "where their data will be exchanged. likewise, when an enrollee changes \n",
      "health plans or ages into medicare, the enrollee should be able to have \n",
      "their claims history and encounter data follow so that information is \n",
      "not lost.\n",
      "    for providers in clinical settings, health information technology \n",
      "(health it) should be a resource, designed to make it faster and easier \n",
      "for providers to deliver high quality care, creating efficiencies and \n",
      "allowing them to access all available data for their patients. health \n",
      "it should not detract from the clinician-patient relationship, from the \n",
      "patient's experience of care, or from the quality of work life for \n",
      "physicians, nurses, and other health care professionals. through \n",
      "standards-based interoperability and exchange, health it has the \n",
      "potential to be a resource and facilitator for efficient, safe, high-\n",
      "quality care for individuals and populations.\n",
      "    all payers, including health plans, should have the ability to \n",
      "exchange data seamlessly with other payers for timely benefits \n",
      "coordination or transitions, and with providers to facilitate more \n",
      "coordinated and efficient care. health plans are in a unique position \n",
      "to provide enrollees a complete picture of their claims and encounter \n",
      "data, allowing patients to piece together their own information that \n",
      "might otherwise be lost in disparate systems. this information can \n",
      "contribute to better informed decision making, helping to inform the \n",
      "patient's choice of coverage options and care providers to more \n",
      "effectively manage their own health, care, and costs.\n",
      "    we are committed to solving the issue of interoperability and \n",
      "patient access in the u.s. health care system while reducing \n",
      "administrative burdens on providers and are taking an active approach \n",
      "using all available policy levers and authorities to move participants \n",
      "in the health care market toward interoperability and the secure and \n",
      "timely exchange of health care information.\n",
      "\n",
      "c. executive order and myhealthedata\n",
      "\n",
      "    on october 12, 2017, president trump issued executive order 13813 \n",
      "to promote healthcare choice and competition across the united states. \n",
      "section 1(c)(iii) of executive order 13813 states that the \n",
      "administration will improve access to, and the quality of, information \n",
      "that americans need to make informed health care decisions, including \n",
      "information about health care prices and outcomes, while minimizing \n",
      "reporting burdens on affected plans, providers, and payers.\n",
      "    in support of executive order 13813, the administration launched \n",
      "the myhealthedata initiative. this government-wide initiative aims to \n",
      "empower patients by ensuring that they have full access to their own \n",
      "health information and the ability to decide how their data will be \n",
      "used, while keeping that information safe and secure. myhealthedata \n",
      "aims to break down the barriers that prevent patients from gaining \n",
      "electronic access to their health information from the device or \n",
      "application of their choice, empowering patients and taking a critical \n",
      "step toward interoperability and patient data exchange.\n",
      "    in march 2018, the white house office of american innovation and \n",
      "the cms administrator announced the launch of myhealthedata, and cms's \n",
      "direct, hands-on role in improving patient access and advancing \n",
      "interoperability. as part of the myhealthedata initiative, we are \n",
      "taking a patient-centered approach to health information access and \n",
      "moving to a system in which patients have immediate access to their \n",
      "computable health information and can be assured that their health \n",
      "information will follow them as they move throughout the health care \n",
      "system from provider to provider, payer to payer. to accomplish this, \n",
      "we have launched several initiatives related to data sharing and \n",
      "interoperability to empower patients and encourage plan and provider \n",
      "competition. in this proposed rule, we continue to advance the policies \n",
      "and goals of the myhealthedata initiative through various proposals as \n",
      "outlined in the following sections.\n",
      "    our proposals are wide-reaching and would have an impact on all \n",
      "facets of the health care system. several key\n",
      "\n",
      "[[page 7612]]\n",
      "\n",
      "touch points of the proposals in this rule include:\n",
      "    <bullet> patients: enabling patients to access their health \n",
      "information electronically without special effort by requiring the \n",
      "payers subject to this proposed rule to make the data available through \n",
      "an application programming interface (api) to which third party \n",
      "software applications connect to make the data available to patients. \n",
      "this encourages them to take charge of and better manage their health \n",
      "care, and thus these initiatives are imperative to improving a \n",
      "patient's long-term health outcomes.\n",
      "    <bullet> clinicians and hospitals: ensuring that health care \n",
      "providers have ready access to health information about their patients, \n",
      "regardless of where the patient may have previously received care. we \n",
      "are also proposing policies to prevent health care providers from \n",
      "inappropriately restricting the flow of information to other health \n",
      "care providers and payers. finally, we are working to ensure that \n",
      "better interoperability reduces the burden on health care providers.\n",
      "    <bullet> payers: proposing requirements to ensure that payers (that \n",
      "is, entities and organizations that pay for health care), such as ma \n",
      "plans and medicaid and chip programs, make enrollee electronic health \n",
      "information held by the plan available through an api such that, with \n",
      "use of software we expect payers and third parties to develop, the \n",
      "information becomes easily accessible to the enrollee, and that the \n",
      "data flows seamlessly with the enrollee as they change providers, \n",
      "plans, and issuers. additionally, our proposals would ensure that \n",
      "payers make it easy for current and prospective enrollees to identify \n",
      "which providers are within a given plan's network in a way that is \n",
      "simple and easy for enrollees to access and understand, and thus find \n",
      "the providers that are right for them.\n",
      "    under our proposals to standardize data and technical approaches to \n",
      "advance interoperability, we believe health care providers and their \n",
      "patients, as well as other key participants within the health care \n",
      "ecosystem such as plans and payers, will have appropriate access to the \n",
      "information necessary to coordinate individual care, analyze population \n",
      "health trends, outcomes, and costs, and manage benefits and the health \n",
      "of populations, while tracking progress through quality improvement \n",
      "initiatives. we are working with other federal partners including the \n",
      "office of the national coordinator for health information technology \n",
      "(onc) on this effort with the clear objective to improve patient access \n",
      "and care, alleviate provider burden, and reduce overall health care \n",
      "costs.\n",
      "\n",
      "d. past efforts\n",
      "\n",
      "    the department of health and human services (hhs) has been working \n",
      "to advance the interoperability of electronic health information since \n",
      "2004, when the onc was initially created via executive order 13335. \n",
      "from 2004 to 2009, onc worked with a variety of federal and private \n",
      "sector stakeholders to coordinate private and public actions, began \n",
      "harmonizing data standards, and worked to advance nationwide health \n",
      "information exchange. in 2009, the national coordinator position, \n",
      "office, and statutory duties were codified by the health information \n",
      "technology for economic and clinical health act (hitech act), enacted \n",
      "as part of the american recovery and reinvestment act of 2009 (pub. l. \n",
      "111-5, enacted february 17, 2009), at title 42--health information \n",
      "technology and quality (42 u.s.c. 300jj et seq.) of the public health \n",
      "service act (phsa). under section 3001(c)(5) of the phsa, onc \n",
      "established a voluntary certification program to certify that health it \n",
      "met standards, implementation specifications, and certification \n",
      "criteria adopted by the secretary. onc is organizationally located \n",
      "within hhs' office of the secretary and is the principal federal entity \n",
      "charged with coordination of nationwide efforts to implement and use \n",
      "the most advanced health it and the electronic exchange of health \n",
      "information.\n",
      "    the hitech act provided the opportunity to move interoperability \n",
      "forward in many additional meaningful ways. a few are particularly \n",
      "worth noting in relation to this proposed rule. for instance, hitech \n",
      "also amended the social security act (the act), authorizing cms to make \n",
      "incentive payments (and in later years, make downward adjustments to \n",
      "medicare payments) to eligible professionals, eligible hospitals and \n",
      "critical access hospitals (cahs), and ma organizations to promote the \n",
      "adoption and meaningful use of certified electronic health record \n",
      "technology (cehrt). in 2010, through rulemaking, we established \n",
      "criteria for the medicare and medicaid electronic health record (ehr) \n",
      "incentive programs to encourage eligible professionals, eligible \n",
      "hospitals, and cahs to adopt, implement, upgrade, and demonstrate the \n",
      "meaningful use of cehrt. the programs were implemented in three stages:\n",
      "\n",
      "    <bullet> stage 1 set the foundation for the ehr incentive \n",
      "programs by establishing requirements for the electronic capture of \n",
      "clinical data, including providing patients with electronic copies \n",
      "of health information.\n",
      "    <bullet> stage 2 expanded upon the stage 1 criteria with a focus \n",
      "on advancing clinical processes and ensuring that the meaningful use \n",
      "of ehrs supported the aims and priorities of the national quality \n",
      "strategy. stage 2 criteria encouraged the use of cehrt for \n",
      "continuous quality improvement at the point of care and the exchange \n",
      "of information in the most structured format possible.\n",
      "    <bullet> stage 3 focuses on using cehrt to improve health \n",
      "outcomes.\n",
      "\n",
      "    the federal government has spent over $35 billion under the ehr \n",
      "incentive programs to incentivize the adoption and meaningful use of \n",
      "ehr systems by eligible professionals, eligible hospitals, and cahs; \n",
      "however, despite the fact that 78 percent of physicians \\1\\ and 96 \n",
      "percent of hospitals \\2\\ now use a certified ehr system, progress on \n",
      "system-wide data sharing has been limited.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\1\\ onc, health it dashboard, ``office-based physician health it \n",
      "adoption: state rates of physician ehr adoption, health information \n",
      "exchange & interoperability, and patient engagement (2015),'' \n",
      "<a href=\"https://dashboard.healthit.gov/apps/physician-health-it-adoption.php\">https://dashboard.healthit.gov/apps/physician-health-it-adoption.php</a> \n",
      "(last accessed july 9, 2018).\n",
      "    \\2\\ onc, health it dashboard, ``non-federal acute care hospital \n",
      "health it adoption and use: state rates of non-federal acute care \n",
      "hospital ehr adoption, health information exchange and \n",
      "interoperability, and patient engagement (2015),'' <a href=\"https://dashboard.healthit.gov/apps/hospital-health-it-adoption.php\">https://dashboard.healthit.gov/apps/hospital-health-it-adoption.php</a> (last \n",
      "accessed july 9, 2018).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in 2010, under the hitech act, onc adopted an initial set of \n",
      "standards, implementation specifications, and certification criteria, \n",
      "and established the temporary certification program for health \n",
      "information technology, under which health it developers could begin to \n",
      "obtain certification of the ehr technology that eligible professionals, \n",
      "eligible hospitals, and cahs would need to adopt and use to satisfy cms \n",
      "stage 1 requirements for demonstration of meaningful use of cehrt. in \n",
      "january 2011, onc replaced the temporary certification program with the \n",
      "permanent certification program for health information technology (45 \n",
      "cfr part 170). the secretary has adopted iterative editions of the set \n",
      "of standards, implementation specifications, and certification criteria \n",
      "included in the programs to keep pace with advances in standards, \n",
      "health information exchange, and the health it market. in addition, \n",
      "this helps to maintain alignment with the needs of health care \n",
      "providers seeking to succeed within health it-linked federal programs.\n",
      "    in april 2015, congress passed the medicare access and chip \n",
      "reauthorization act of 2015 (macra) (pub. l. 114-10, enacted april 16, \n",
      "2015), which declared it a national\n",
      "\n",
      "[[page 7613]]\n",
      "\n",
      "objective to achieve widespread exchange of health information through \n",
      "interoperable cehrt nationwide. section 106(b)(1)(b)(ii) of macra \n",
      "defines ``interoperability'' as the ability of two or more health \n",
      "information systems or components to exchange clinical and other \n",
      "information and to use the information that has been exchanged using \n",
      "common standards as to provide access to longitudinal information for \n",
      "health care providers in order to facilitate coordinated care and \n",
      "improved patient outcomes. the macra charges the secretary to establish \n",
      "metrics to be used to determine if widespread interoperability had been \n",
      "achieved, and the heading of section 106(b)(2) of the macra refers to \n",
      "``preventing blocking the sharing of information.'' specifically, \n",
      "section 106(b)(2) of the macra amended section 1848(o)(2)(a)(ii) of the \n",
      "act for eligible professionals and section 1886(n)(3)(a)(ii) of the act \n",
      "for eligible hospitals and cahs to require that the professional or \n",
      "hospital demonstrate that they have not knowingly and willfully taken \n",
      "action to limit or restrict the compatibility or interoperability of \n",
      "cehrt. for a discussion of the attestation requirements that we \n",
      "established and codified to support the prevention of information \n",
      "blocking, we refer readers to the cy 2017 quality payment program final \n",
      "rule (81 fr 77028 through 77035).\n",
      "    in april 2018, we renamed the ehr incentive programs and the mips \n",
      "advancing care information performance category to the promoting \n",
      "interoperability (pi) programs and promoting interoperability \n",
      "performance category, respectively (83 fr 41635). this refocusing and \n",
      "rebranding of the initiatives is just one part of the cms strategic \n",
      "shift in focus to advancing health it and interoperability.\n",
      "    cms appreciates the pathways congress opened for action on \n",
      "interoperability, as will be discussed in more detail throughout this \n",
      "proposed rule and has been working diligently with onc to support \n",
      "implementation. in addition, in order to make sure we have as much \n",
      "stakeholder feedback on all the options cms specifically has available \n",
      "to best take advantage of this new opportunity to promote \n",
      "interoperability, over a span of several months in 2018, we released \n",
      "interoperability requests for information (rfis) in several medicare \n",
      "payment rules, including in the fy 2019 inpatient prospective payment \n",
      "system (ipps) proposed rule (83 fr 20164). while the interoperability \n",
      "rfi in the fy 2019 ipps proposed rule was focused primarily on how and \n",
      "whether changes to hospital conditions of participation and other like \n",
      "program requirements could impact or contribute to advancing \n",
      "interoperability, stakeholders provided additional input that we are \n",
      "taking under advisement for the purposes of advancing interoperability \n",
      "generally in this proposed rule. for example, some commenters \n",
      "recommended aligning existing standards and adopting common standards \n",
      "and/or data elements across the health care industry as a whole (not \n",
      "just focusing on providers), incentivizing the use of standards, and \n",
      "removing barriers as possible ways to address gaps in interoperability. \n",
      "commenters also expressed support for the use of open apis but \n",
      "cautioned cms to consider the need to ensure health information \n",
      "security. support was also expressed for enhancing applications that \n",
      "are designed for patient, or consumer use, such as blue button 2.0 \n",
      "(cms' medicare ffs open api for patient access to health information), \n",
      "and the development of patient-facing consumer applications that \n",
      "aggregate various longitudinal health information for the patient into \n",
      "one location. we plan to continue to review the public comments we \n",
      "receive to help identify opportunities for cms to advance \n",
      "interoperability in future rulemaking and subregulatory guidance.\n",
      "    cms is also working with partners in the private sector to promote \n",
      "interoperability. in 2018, cms began participating in the da vinci \n",
      "project, a private-sector initiative led by health level 7 (hl7), a \n",
      "standards development organization. for one of the use cases under this \n",
      "project--called ``coverage requirements and documentation rules \n",
      "discovery''--the da vinci project developed a draft fast healthcare \n",
      "interoperability resources (fhir) standard during the summer and fall \n",
      "of 2018. in june 2018, in support of the da vinci project, the cms \n",
      "medicare ffs program began: (1) developing a prototype documentation \n",
      "requirement lookup service for the medicare ffs program; (2) populating \n",
      "it with the list of items/services for which prior authorization is \n",
      "required by the medicare ffs program; and (3) populating it with the \n",
      "documentation rules for oxygen and continuous positive airway pressure \n",
      "(cpap) devices. more information about the ffs medicare program's \n",
      "efforts to support these da vinci use cases are available at \n",
      "<a href=\"http://go.cms.gov/medicarerequirementslookup\">go.cms.gov/medicarerequirementslookup</a>.\n",
      "    we encourage all payers, including but not limited to ma \n",
      "organizations, medicaid managed care plans and chip managed care \n",
      "entities, and qhp issuers in ffes to follow cms's example and align \n",
      "with the da vinci project to: (1) develop a similar lookup service; (2) \n",
      "populate it with their list of items/services for which prior \n",
      "authorization is required; and (3) populate it with the documentation \n",
      "rules for at least oxygen and cpap. by taking this step, health plans \n",
      "can join cms in helping to build an ecosystem that will allow providers \n",
      "to connect their ehrs or practice management systems and efficient work \n",
      "flows with up-to-date information on which items and services require \n",
      "prior authorization and what the documentation requirements are for \n",
      "various items and services under that patient's current plan \n",
      "enrollment.\n",
      "    in the 8 years since the first hhs rulemakings to implement hitech, \n",
      "significant progress has been made in the adoption of ehrs by hospitals \n",
      "and clinicians; however, progress on interoperability needs to be \n",
      "accelerated.\n",
      "    in section 106(b) of macra, congress declared it a national \n",
      "objective to achieve widespread exchange of health information through \n",
      "interoperable certified ehr technology nationwide by december 31, 2018. \n",
      "not later than july 1, 2016, the secretary was to establish metrics to \n",
      "be used to determine if and to the extent this objective was achieved. \n",
      "if the objective is not achieved by december 31, 2018, the secretary \n",
      "must submit a report not later than december 31, 2019, that identifies \n",
      "barriers to the objective and recommends actions that the federal \n",
      "government can take to achieve the objective. in april 2016, onc \n",
      "published the ``office of the national coordinator for health \n",
      "information technology; medicare access and chip reauthorization act of \n",
      "2015; request for information regarding assessing interoperability for \n",
      "macra'' rfi (81 fr 20651). based on stakeholder input received in \n",
      "response to the rfi, onc subsequently identified the following two \n",
      "metrics for interoperability (see <a href=\"https://www.healthit.gov/sites/default/files/fulfilling_section_106b1c_of_the_medicare_access_and_chip_reauthorization_act_of_2015_06.30.16.pdf\">https://www.healthit.gov/sites/default/files/fulfilling_section_106b1c_of_the_medicare_access_and_chip_reauthorization_act_of_2015_06.30.16.pdf</a>):\n",
      "    <bullet> measure #1: proportion of health care providers who are \n",
      "electronically engaging in the following core domains of interoperable \n",
      "exchange of health information: sending, receiving, finding (querying), \n",
      "and integrating information received from outside sources.\n",
      "    <bullet> measure #2: proportion of health care providers who report \n",
      "using the information they electronically receive from outside \n",
      "providers and sources for clinical decision-making.\n",
      "    onc recently provided an update on these metrics in its 2018 report \n",
      "to\n",
      "\n",
      "[[page 7614]]\n",
      "\n",
      "congress--annual update on the adoption of a nationwide system for the \n",
      "electronic use and exchange of health information (see <a href=\"https://www.healthit.gov/sites/default/files/page/2018-12/2018-hitech-report-to-congress.pdf\">https://www.healthit.gov/sites/default/files/page/2018-12/2018-hitech-report-to-congress.pdf</a>). onc will continue to evaluate nationwide performance \n",
      "according to the identified metrics, and believes current developments, \n",
      "such as policy changes being implemented under the 21st century cures \n",
      "act (cures act) (pub. l. 114-255, enacted december 13, 2016) will \n",
      "contribute to increasingly improved performance under these metrics.\n",
      "    in addition, the cures act included provisions to advance \n",
      "interoperability and health information exchange, including, for \n",
      "example, enhancements to onc's health it certification program and a \n",
      "definition of ``information blocking'' (as discussed further in section \n",
      "viii. of this proposed rule). these provisions have been addressed in \n",
      "depth in onc's proposed rule ``21st century cures act: \n",
      "interoperability, information blocking, and the onc health it \n",
      "certification program'' (published elsewhere in this issue of the \n",
      "federal register).\n",
      "    section 4003 of the cures act added a definition of \n",
      "``interoperability'' as paragraph 10 of section 3000 of the phsa (42 \n",
      "u.s.c. 300jj (9)) (as amended). under section 3000 of the phsa, \n",
      "`interoperability', with respect to health it, means technology that \n",
      "enables the secure exchange of electronic health information with, and \n",
      "use of electronic health information from, other health it without \n",
      "special effort on the part of the user. it also allows for complete \n",
      "access, exchange, and use of all electronically accessible health \n",
      "information for authorized use under applicable state or federal law \n",
      "and does not constitute information blocking as defined in section \n",
      "3022(a) of the phsa.\n",
      "    this definition aligns with the definition under macra and the hhs \n",
      "vision and strategy for achieving a health information ecosystem within \n",
      "which all individuals and their health care providers are able to send, \n",
      "receive, find, and use electronic health information in a manner that \n",
      "is appropriate, secure, timely, and reliable to support the health and \n",
      "wellness of individuals through informed shared decision-making, as \n",
      "well as through patient choice of health plans and providers. \n",
      "accordingly, except where we further or otherwise specify for a \n",
      "specific policy or purpose, when we use the term ``interoperability'' \n",
      "within this proposed rule we are referring to the definition in section \n",
      "3000 of the phsa.\n",
      "\n",
      "e. challenges and barriers to interoperability\n",
      "\n",
      "    through significant stakeholder feedback, we understand that there \n",
      "are many barriers to interoperability which have obstructed progress \n",
      "over the years. we have conducted stakeholder meetings and roundtables; \n",
      "solicited comments via rfis; and received additional feedback through \n",
      "letters and rulemaking. all of this input together has contributed to \n",
      "our proposals in this proposed rule. some of the main barriers shared \n",
      "with us are addressed in the following sections. while we have made \n",
      "efforts to address some of these barriers in this proposed rule and \n",
      "through prior rules and actions, we believe there is still considerable \n",
      "work to be done to overcome some of these considerable challenges \n",
      "toward achieving interoperability.\n",
      "1. patient identifier and interoperability\n",
      "    in the interoperability rfi in the fy 2019 ipps proposed rule (83 \n",
      "fr 20550), we solicited feedback on positive solutions to better \n",
      "achieve interoperability or the sharing of health care information \n",
      "between providers. a number of commenters noted that the lack of a \n",
      "unique patient identifier (upi) inhibited interoperability efforts \n",
      "because, without a unique identifier for each patient, the safe and \n",
      "secure electronic exchange of health information is constrained because \n",
      "it is difficult to ensure that the relevant records are all for the \n",
      "same patient.\n",
      "    as part of efforts to reduce the administrative costs of providing \n",
      "and paying for health care, the health insurance portability and \n",
      "accountability act of 1996 (hipaa) (pub. l. 104-191, enacted august 21, \n",
      "1996) required the adoption of a ``unique individual identifier for \n",
      "healthcare purposes,'' commonly referred to as a upi. at the time hipaa \n",
      "was enacted, hhs began to consider what information would be needed to \n",
      "develop a rule to adopt a upi standard. an initial notice of intent to \n",
      "issue a proposed rule on requirements for a unique health identifier \n",
      "for individuals was published in the november 2, 1998 federal register \n",
      "(63 fr 61773-61774).\n",
      "    such an identifier has the potential to facilitate the accurate \n",
      "portability of health information by allowing correct patient matching \n",
      "because the universal identifier allows for accurate and timely patient \n",
      "record linking between providers across the care continuum and it \n",
      "allows a patient's complete record to easily move with them from \n",
      "provider to provider. however, stakeholders immediately raised \n",
      "significant concerns regarding the impact of this upi on health \n",
      "information security and privacy. stakeholders were concerned that if \n",
      "there was a single identifier used across systems, it would be easier \n",
      "for that information to be compromised, exposing protected health \n",
      "information (phi) more easily than in the current medical record \n",
      "environment that generally requires linking several pieces of \n",
      "personally identifying information to link health records.\n",
      "    the national committee on vital health statistics (ncvhs), the \n",
      "statutory public advisory body to the secretary of health and human \n",
      "services (the secretary) for health data, statistics, privacy, and \n",
      "national health information policy and hipaa, conducted extensive \n",
      "hearings in the first year after hipaa was enacted to evaluate this and \n",
      "other hipaa-related implementation issues. the ncvhs first annual \n",
      "report to the congress on the implementation of the administrative \n",
      "simplification provisions of the health insurance portability and \n",
      "accountability act, february 3, 1998, outlines the ncvhs' efforts to \n",
      "obtain feedback on the upi (<a href=\"https://ncvhs.hhs.gov/wp-content/uploads/2018/03/yr1-rpt-508.pdf\">https://ncvhs.hhs.gov/wp-content/uploads/2018/03/yr1-rpt-508.pdf</a>). through this process, ncvhs found a lack of \n",
      "consensus on how best to define a upi and controversy around the use of \n",
      "a upi due to privacy and data security concerns. those in favor of \n",
      "adopting a upi believe a upi is the most efficient way to foster \n",
      "information sharing and accurate patient record linking, where those \n",
      "against it are concerned about patient privacy and data security. ncvhs \n",
      "found these privacy and data security concerns outweighed the benefits \n",
      "of a upi.\n",
      "    the ncvhs recommended that the secretary not move forward with a \n",
      "proposed rule on a patient identifier until further discussions could \n",
      "be had to fully understand the privacy and data security concerns, as \n",
      "well as the full breadth of options beyond a single identifier. ncvhs \n",
      "suggested the secretary work to maximize public participation in \n",
      "soliciting a variety of options for establishing an identifier or an \n",
      "alternative approach for identifying individuals and linking health \n",
      "information of individuals for health purposes.\n",
      "    appreciating the significant concerns raised by stakeholders \n",
      "regarding implementing a upi, congress included language in the omnibus \n",
      "consolidated and emergency supplemental appropriations act of 1999 \n",
      "(pub. l. 105-277, enacted october 21, 1998) and in each subsequent \n",
      "appropriations bill, stating ``none of the funds made available in this \n",
      "act may be used to\n",
      "\n",
      "[[page 7615]]\n",
      "\n",
      "promulgate or adopt any final standard under section 1173(b) of the act \n",
      "(42 u.s.c. 1320d-2(b)) providing for, or providing for the assignment \n",
      "of, a unique health identifier for an individual (except in an \n",
      "individual's capacity as an employer or a health care provider), until \n",
      "legislation is enacted specifically approving the standard.'' this \n",
      "language has effectively prohibited hhs from engaging in rulemaking to \n",
      "adopt a upi standard. consequently, the secretary withdrew the notice \n",
      "of intent to pursue rulemaking on this issue on august 9, 2000 (<a href=\"https://www.reginfo.gov/public/do/eagendaviewrule?pubid=200010&rin=0938-ai91\">https://www.reginfo.gov/public/do/eagendaviewrule?pubid=200010&rin=0938-ai91</a>).\n",
      "    in recent years, concerns regarding the privacy and security of \n",
      "information have only increased. for example, in the first quarter \n",
      "through third quarter of fy 2018 (october 1, 2017 through june 30, \n",
      "2018), 276 breach incidents were reported to the hhs office of civil \n",
      "rights (ocr) affecting 4,341,595 individuals (<a href=\"https://ocrportal.hhs.gov/ocr/breach/breach_report.jsf\">https://ocrportal.hhs.gov/ocr/breach/breach_report.jsf</a>).\n",
      "    although the appropriations language regarding the upi standard has \n",
      "remained unchanged, in the report accompanying the 2017 appropriations \n",
      "bill, congress additionally stated, ``although the committee continues \n",
      "to carry a prohibition against hhs using funds to promulgate or adopt \n",
      "any final standard providing for the assignment of a unique health \n",
      "identifier for an individual until such activity is authorized, the \n",
      "committee notes that this limitation does not prohibit hhs from \n",
      "examining the issues around patient matching. accordingly, the \n",
      "committee encouraged the secretary, acting through onc and cms, to \n",
      "provide technical assistance to private-sector led initiatives to \n",
      "develop a coordinated national strategy that will promote patient \n",
      "safety by accurately identifying patients to their health \n",
      "information.'' (h.r. rep. no. 114-699, p. 110, <a href=\"https://www.gpo.gov/fdsys/pkg/crpt-114hrpt699/pdf/crpt-114hrpt699.pdf\">https://www.gpo.gov/fdsys/pkg/crpt-114hrpt699/pdf/crpt-114hrpt699.pdf</a>). congress has \n",
      "repeated this guidance for 2018 and 2019. this guidance directed hhs to \n",
      "focus on examining issues around patient matching and to provide \n",
      "technical assistance to private sector-led initiatives focusing on a \n",
      "patient matching solution.\n",
      "    unlike a upi, which assigns a unique identifier--either numerical \n",
      "or otherwise--to each patient, patient matching is a process by which \n",
      "health information from multiple sources is compared to identify common \n",
      "elements, with the goal of identifying records representing a single \n",
      "patient. this is generally done by using multiple demographic data \n",
      "fields such as name, birth date, gender, and address. the goal of \n",
      "patient matching is to link one patient's data across multiple \n",
      "databases within and across health care providers in order to obtain a \n",
      "comprehensive view of that patient's health care information.\n",
      "    onc has stated that patient matching is critically important to \n",
      "interoperability and the nation's health it infrastructure as health \n",
      "care providers must be able to share patient health information and \n",
      "accurately match a patient to his or her data from a different provider \n",
      "in order for many anticipated interoperability benefits to be realized.\n",
      "    patient matching can be less precise than a upi due to the reliance \n",
      "on demographic attributes (such as name and date of birth) which are \n",
      "not unique traits to a particular patient; further, patient matching is \n",
      "often dependent on manual data entry and data maintained in varying \n",
      "formats. matching mistakes can contribute to adverse events, \n",
      "compromised safety and privacy, and increased health care costs (see \n",
      "<a href=\"https://www.healthit.gov/sites/default/files/hie-interoperability/nationwide-interoperability-roadmap-final-version-1.0.pdf\">https://www.healthit.gov/sites/default/files/hie-interoperability/nationwide-interoperability-roadmap-final-version-1.0.pdf</a>). however, a \n",
      "wide range of strategies and best practices currently being deployed \n",
      "across the industry have been shown to improve patient matching rates, \n",
      "suggesting that patient matching approaches can be an effective \n",
      "solution when appropriately implemented (see <a href=\"https://www.healthit.gov/sites/default/files/patient_identification_matching_final_report.pdf\">https://www.healthit.gov/sites/default/files/patient_identification_matching_final_report.pdf</a>).\n",
      "    many stakeholders commenting on the interoperability rfis included \n",
      "in the 2019 proposed payment rules indicated that patient matching is a \n",
      "``core functionality'' of patient identification and necessary to \n",
      "ensure care coordination and the best patient outcomes. commenters also \n",
      "noted that a consistently used matching strategy could accomplish the \n",
      "original goals of a upi with a diminished risk to individual privacy \n",
      "and health information security.\n",
      "    several commenters noted that the lack of a upi impacted \n",
      "interoperability, but finding a suitable and consistent matching \n",
      "strategy could address this issue. these commenters often specifically \n",
      "supported congress' guidance to have onc and cms provide technical \n",
      "assistance to the private sector to identify this strategy. to help \n",
      "jump start the process of finding a solution to patient matching, onc \n",
      "launched the patient matching algorithm challenge in 2017, awarding six \n",
      "winners $75,000 in grants in late 2017 (<a href=\"https://www.patientmatchingchallenge.com/challenge-information/challenge-details\">https://www.patientmatchingchallenge.com/challenge-information/challenge-details</a>). the goal of the patient matching algorithm challenge was to \n",
      "bring about greater transparency and data on the performance of \n",
      "existing patient matching algorithms, spur the adoption of performance \n",
      "metrics for patient data matching algorithm vendors, and positively \n",
      "impact other aspects of patient matching such as deduplication and \n",
      "linking to clinical data.\n",
      "    we continue to support onc's work promoting the development of \n",
      "patient matching initiatives. per congress' guidance, onc is looking at \n",
      "innovative ways to provide technical assistance to private sector-led \n",
      "initiatives to further develop accurate patient matching solutions in \n",
      "order to promote interoperability without requiring a upi.\n",
      "    we understand the significant health information privacy and \n",
      "security concerns raised around the development of a upi standard and \n",
      "the current prohibition against using hhs funds to adopt a upi \n",
      "standard. recognizing congress' statement regarding patient matching \n",
      "and stakeholder comments stating that a patient matching solution would \n",
      "accomplish the goals of a upi, we seek comment for future consideration \n",
      "on ways for onc and cms to continue to facilitate private sector \n",
      "efforts on a workable and scalable patient matching strategy so that \n",
      "the lack of a specific upi does not impede the free flow of \n",
      "information. we also seek comment on how we may leverage our program \n",
      "authority to provide support to those working to improve patient \n",
      "matching. in addition, we intend to use comments for the development of \n",
      "policy and future rulemaking.\n",
      "2. lack of standardization\n",
      "    lack of standardization inhibits the successful exchange of health \n",
      "information without additional effort on the part of the end user. to \n",
      "achieve secure exchange of health information across health it products \n",
      "and systems that can be readily used without special effort by the \n",
      "user, both the interface technology and the underlying data must be \n",
      "standardized, so all systems are ``speaking the same language.'' \n",
      "consistent use of modern computing standards and applicable content \n",
      "standards (such as clinical vocabularies) are fundamental to achieving \n",
      "full-scale technical interoperability (systems can connect and exchange \n",
      "data unaltered) and semantic interoperability (systems can interpret \n",
      "and use the information that has been exchanged). lack of such \n",
      "standards creates a barrier to\n",
      "\n",
      "[[page 7616]]\n",
      "\n",
      "interoperability. where specific standards are not consistently used, \n",
      "particularly to structure exchange interfaces such as apis, the \n",
      "exchange is more difficult and expensive than it needs to be and the \n",
      "recipient of exchanged data must often undertake substantial special \n",
      "effort to make sense of the information.\n",
      "    in this proposed rule, similar to cms' blue button 2.0 approach for \n",
      "medicare ffs,\\3\\ we propose to require that all ma organizations, \n",
      "medicaid managed care plans, chip managed care entities, medicaid state \n",
      "agencies, chip agencies that operate ffs systems, and issuers of qhps \n",
      "in the ffes, deploy standardized, open apis to make certain information \n",
      "available to enrollees as discussed in section iii. of this proposed \n",
      "rule.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\3\\ we refer readers to <a href=\"https://bluebutton.cms.gov\">https://bluebutton.cms.gov</a> for more \n",
      "information related to the cms blue button initiative.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the lack of a sufficiently mature api functionality technical \n",
      "standard has posed a challenge and impediment to advancing \n",
      "interoperability. in 2015, onc finalized an api functionality \n",
      "certification criterion in the ``2015 edition health information \n",
      "technology (health it) certification criteria, 2015 edition base \n",
      "electronic health record (ehr) definition, and onc health it \n",
      "certification program modifications'' final rule (2015 edition final \n",
      "rule) (80 fr 62602). however, while a consensus technical standard \n",
      "specific to the api technical functionality was in development, it had \n",
      "not yet matured enough for inclusion in the 2015 edition final rule, \n",
      "which does not identify a specific standard for api functionality.\n",
      "    as discussed in greater detail in section ii of this proposed rule, \n",
      "we believe that a specific foundational standard for api functionality \n",
      "has matured sufficiently enough for onc to propose it for hhs adoption \n",
      "(published elsewhere in this issue of the federal register). to take \n",
      "full advantage of this proposed standard, as well as already adopted \n",
      "standards applicable to content exchanged via apis, we propose in \n",
      "sections ii. and iii. of this proposed rule to require that ma \n",
      "organizations, medicaid managed care plans, medicaid state agencies, \n",
      "chip managed care entities, chip agencies that operate ffs systems, and \n",
      "qhp issuers in ffes comply with the onc-proposed regulations for this \n",
      "standard. those proposed regulations would require deployment of api \n",
      "technologies conformant with the api technical standard proposed by onc \n",
      "for hhs adoption at 45 cfr 170.215 and other applicable standards such \n",
      "as content and vocabulary standards adopted at 45 cfr part 162 and 42 \n",
      "cfr 423.160, and proposed by onc for hhs adoption at 45 cfr 170.213 \n",
      "(published elsewhere in this issue of the federal register). \n",
      "furthermore, we note that we intend to continue to work with \n",
      "stakeholders to develop standards that will advance interoperability.\n",
      "3. information blocking\n",
      "    as explained above, information blocking is defined in section \n",
      "3022(a) of the phsa. understanding this definition, information \n",
      "blocking could be considered to include the practice of withholding \n",
      "data, or intentionally taking action to limit or restrict the \n",
      "compatibility or interoperability of health it. through stakeholder \n",
      "outreach, roundtables, and letters we have received, we understand that \n",
      "health care providers may limit or prevent data exchange in an effort \n",
      "to retain patients. by withholding a patient's health information from \n",
      "competing health care providers, a health care provider can effectively \n",
      "inhibit a patient from freely moving within the health care market \n",
      "because that patient would not otherwise have access to their complete \n",
      "health information.\n",
      "    we additionally understand from stakeholder feedback that in \n",
      "certain cases a health it vendor has prohibited the movement of data \n",
      "from one health it system to another in an effort to maintain their \n",
      "customer base.\n",
      "    information blocking is a significant threat to interoperability \n",
      "and can limit the ability for providers to coordinate care and treat a \n",
      "patient based on the most comprehensive information available. in \n",
      "sections viii.b. and c. of this proposed rule we propose to publicly \n",
      "report the names of clinicians and hospitals who submit a ``no'' \n",
      "response to certain attestation statements related to the prevention of \n",
      "information blocking in order to deter health care providers from \n",
      "engaging in conduct that could be considered information blocking.\n",
      "    preventing and avoiding information blocking is important to \n",
      "advancing interoperability. we believe this proposal would help \n",
      "discourage health care providers from information blocking and clearly \n",
      "indicates cms's commitment to preventing such practices.\n",
      "4. lack of adoption/use of certified health it among post-acute care \n",
      "(pac) providers\n",
      "    pac facilities are critical in the care of patients' post-hospital \n",
      "discharge, and can be a determining step in the health progress for \n",
      "those patients.\\4\\ interoperable health it can improve the ability of \n",
      "these facilities to coordinate and provide care; however, long-term \n",
      "care and pac providers, such as nursing homes, home health agencies \n",
      "(hhas), long-term care providers, and others, were not eligible for the \n",
      "ehr incentive programs under the hitech act. based on the information \n",
      "we have, we understand that this was a contributing factor to these \n",
      "providers not adopting cehrt at the same rate as eligible hospitals and \n",
      "physicians, who were able to adopt cehrt using the financial incentives \n",
      "provided under the programs.<sup>5 6</sup>\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\4\\ <a href=\"https://www.healthit.gov/sites/default/files/electronic-health-record-adoption-and-interoperability-among-u.s.-skilled-nursing-facilities-in-2016.pdf\">https://www.healthit.gov/sites/default/files/electronic-health-record-adoption-and-interoperability-among-u.s.-skilled-nursing-facilities-in-2016.pdf</a>.\n",
      "    \\5\\ <a href=\"https://aspe.hhs.gov/report/opportunities-engaging-long-term-and-post-acute-care-providers-health-information-exchange-activities-exchanging-interoperable-patient-assessment-information/hit-and-ehr-certification-ltpac\">https://aspe.hhs.gov/report/opportunities-engaging-long-term-and-post-acute-care-providers-health-information-exchange-activities-exchanging-interoperable-patient-assessment-information/hit-and-ehr-certification-ltpac</a>.\n",
      "    \\6\\ <a href=\"https://www.healthit.gov/sites/default/files/pdf/hit_ltpac_issuebrief031513.pdf\">https://www.healthit.gov/sites/default/files/pdf/hit_ltpac_issuebrief031513.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while a majority of skilled nursing facilities (snfs) used an ehr \n",
      "in 2016 (64 percent), there is considerable work to be done to increase \n",
      "adoption and the exchange of data in this provider population. in that \n",
      "same year, only three out of 10 snfs electronically exchanged (that is, \n",
      "sent or received) key clinical health information, and only 7 percent \n",
      "had the ability to electronically send, receive, find, and integrate \n",
      "patient health information. in 2017, an onc survey found that more hha) \n",
      "(78 percent) adopted ehrs than snfs (66 percent), but integration of \n",
      "received information continued to lag behind for both hhas (36 percent) \n",
      "and snfs (18 percent). while both onc surveys focused on snfs, it is \n",
      "important to note the large provider overlap between snfs and other \n",
      "nursing facilities. in 2014, 14,409 out of 15,640 (92 percent) of \n",
      "nursing homes were certified for both medicare and medicaid.\\7\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\7\\ <a href=\"https://www.cms.gov/medicare/provider-enrollment-and-certification/certificationandcomplianc/downloads/nursinghomedatacompendium_508-2015.pdf\">https://www.cms.gov/medicare/provider-enrollment-and-certification/certificationandcomplianc/downloads/nursinghomedatacompendium_508-2015.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    long-term hospitals, inpatient rehabilitation facilities (irfs), \n",
      "snfs, and hhas are required to submit to cms standardized patient \n",
      "assessment data described in section 1899b(b)(1) of the act (as added \n",
      "by section 2(a) of the improving medicare post-acute care \n",
      "transformation act of 2014 (impact act) (pub. l. 113-185, enacted \n",
      "october 6, 2014)). we have defined the term ``standardized patient \n",
      "assessment data'' (or ``standardized resident assessment data'' for \n",
      "purposes of snfs) as patient or resident assessment questions and\n",
      "\n",
      "[[page 7617]]\n",
      "\n",
      "response options that are identical in all four pac assessment \n",
      "instruments, and to which identical standards and definitions apply. \n",
      "section 1899b(b)(1)(b) of the act states that the categories for which \n",
      "standardized patient or resident assessment data must be submitted \n",
      "include, at a minimum, functional status; cognitive function; medical \n",
      "conditions and co-morbidities; special services, treatments and \n",
      "interventions; and impairments. section 1899b(b)(1)(a) of the act \n",
      "requires that such data must be submitted through the applicable \n",
      "reporting provision that applies to each pac provider type using the \n",
      "pac assessment instrument that applies to the pac provider. section \n",
      "1899b(a)(1)(b) of the act additionally requires that these data be \n",
      "standardized and interoperable so as to allow for their exchange among \n",
      "health care providers, including pac providers, to ensure coordinated \n",
      "care and improved medicare beneficiary outcomes as these patients \n",
      "transition throughout the care continuum. to enable the interoperable \n",
      "exchange of such information, we have adopted certain patient \n",
      "assessment data elements as standardized patient or resident assessment \n",
      "data and mapped them to appropriate health it standards which can \n",
      "support the exchange of this information. for more information, we \n",
      "refer the reader to the cms website at <a href=\"https://del.cms.gov/delweb/pubhome\">https://del.cms.gov/delweb/pubhome</a>.\n",
      "5. privacy concerns and hipaa\n",
      "    the privacy, security, and breach notification rules under hipaa \n",
      "(45 cfr parts 160 and 164) support interoperability by providing \n",
      "assurance to the public that phi as defined in 45 cfr 160.103 is \n",
      "maintained securely and shared only for appropriate purposes or with \n",
      "express authorization of the individual. for more than a decade, the \n",
      "hipaa rules have provided a strong privacy and security foundation for \n",
      "the health care system. however, we have heard that lack of \n",
      "harmonization between federal and state privacy and security standards \n",
      "can create uncertainty or confusion for hipaa covered entities that \n",
      "want to exchange health information. resources about how the hipaa rule \n",
      "permits health care providers and health plans to share health \n",
      "information using health it for purposes like treatment or care \n",
      "coordination is available on the hhs ocr website. see <a href=\"https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/permitted-uses/index.html\">https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/permitted-uses/index.html</a>.\n",
      "    although barriers to interoperability do exist, hhs and private \n",
      "industry are actively working to address them. on june 6, 2018, the hhs \n",
      "deputy secretary initiated the regulatory sprint to coordinated care \n",
      "(rs2cc). in support of this effort, the hhs office of inspector general \n",
      "(oig) released an rfi on barriers to coordinated care or value-based \n",
      "care, which was out for public comment through october 26, 2018 (83 fr \n",
      "43607). together, cms and onc are working to address information \n",
      "blocking via rulemaking. we are actively working to improve data \n",
      "standardization, particularly through the use of apis. and, we are \n",
      "using available policy levers to encourage greater adoption of ehr \n",
      "technology and interoperability among pac providers. we provide \n",
      "resources to help providers see how hipaa and interoperability work \n",
      "together. and, we are leveraging private sector relationships to find \n",
      "patient matching solutions in lieu of a patient identifier.\n",
      "\n",
      "f. summary of major provisions\n",
      "\n",
      "    to empower beneficiaries of medicaid and chip ffs programs and \n",
      "enrollees in ma organizations, medicaid and chip managed care entities, \n",
      "and qhp issuers in the ffes (when mentioned throughout this proposed \n",
      "rule, this includes qhps certified by ffes regardless of whether \n",
      "enrollees enroll through the ffe or off the ffe), we are proposing \n",
      "several initiatives to break down the barriers that impede patients' \n",
      "ease of access to their electronic health care information; we propose \n",
      "to create and implement new mechanisms for them to access to their own \n",
      "health care information, as well as the ability to decide how, when, \n",
      "and with whom to share their information. we are proposing to require \n",
      "that a variety of information be made accessible to these impacted \n",
      "patients via ``openly published'' (or simply ``open'') apis- that is, \n",
      "apis for which the technical and other information required for a \n",
      "third-party application to connect to them is publicly available. this \n",
      "will provide these patients with convenient access to their health care \n",
      "information in accordance with the hipaa privacy rule access standard \n",
      "at 45 cfr 164.524, and an increase in their choice of applications with \n",
      "which to access and use their own electronic health information, as \n",
      "discussed above, and other information relevant to managing their \n",
      "health, enabling open apis to improve competition and choice as they \n",
      "have in other industries. we propose to require ma organizations, \n",
      "medicaid state agencies, state chip agencies, medicaid managed care \n",
      "plans, chip managed care entities, and qhp issuers in ffes (by \n",
      "requiring them to comply with the proposed onc standard) to implement \n",
      "open apis consistent with the api technical standards proposed by onc \n",
      "for adoption by hhs and to use content and vocabulary standards adopted \n",
      "by hhs at 45 cfr part 162 and 42 cfr 423.160, and proposed by onc for \n",
      "adoption by hhs at 45 cfr 170.213 (published elsewhere in this issue of \n",
      "the federal register).\n",
      "    effective coordination and appropriate sharing of enrollee \n",
      "information between health plans can reduce the need for providers to \n",
      "write duplicative letters of medical necessity, or it could reduce \n",
      "instances of subjecting beneficiaries to unnecessary repetition of step \n",
      "therapy, or repeated utilization reviews, risk screenings and \n",
      "assessments. it could also help to streamline prior authorization \n",
      "procedures or reduce instances where the clinician might need to \n",
      "intervene personally with a payer to ensure his or her patient received \n",
      "the treatment necessary. we are proposing to require payers to support \n",
      "beneficiaries in coordinating their own care via payer to payer care \n",
      "coordination. in addition to existing care coordination efforts between \n",
      "plans, we propose that a plan must, if asked by the beneficiary, \n",
      "forward his or her information to a new plan or other entity designated \n",
      "by the beneficiary for up to 5 years after the beneficiary has \n",
      "disenrolled with the plan. such transactions would be made in \n",
      "compliance with applicable laws. we are proposing a requirement for ma \n",
      "plans, medicaid and chip managed care entities (mcos, pihps, pahps), \n",
      "and qhp issuers in ffes to coordinate care between plans by exchanging, \n",
      "at a minimum, the data elements in the united states core data for \n",
      "interoperability (uscdi) standard \\8\\ at enrollee request at specified \n",
      "times.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\8\\ for more information on the uscdi, see <a href=\"https://www.healthit.gov/uscdi\">https://www.healthit.gov/uscdi</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we believe that payers' ability to share enrollee claims, encounter \n",
      "data, utilization history, and clinical health information they may \n",
      "have for their enrollees with one another, as well as their ability to \n",
      "share that information with patients and health care providers, when \n",
      "approved by the patient and appropriate under applicable law, using \n",
      "interoperable electronic means will considerably improve patient access \n",
      "to information, reduce provider burden, and reduce redundant and \n",
      "otherwise unnecessary data-related policies and procedures. we are \n",
      "proposing to require that all ma organizations, medicaid and chip \n",
      "managed care entities (mcos, pihps, and pahps), and qhp issuers in ffes \n",
      "(with the exception of stand-alone dental plans (sadps)) must \n",
      "participate in a trusted health information exchange network meeting \n",
      "criteria for\n",
      "\n",
      "[[page 7618]]\n",
      "\n",
      "interoperability. further, we discuss an approach to payer-to-payer and \n",
      "payer-to-provider interoperability which leverages such existing trusts \n",
      "networks.\n",
      "    states and cms routinely exchange data to support the \n",
      "administration of benefits to medicare-medicaid dually eligible \n",
      "beneficiaries. this includes ``buy-in'' data on who is enrolled in \n",
      "medicare, and who is liable for paying the dual eligible beneficiary's \n",
      "part a and b premiums. buy-in data exchanges support state, cms, and \n",
      "social security administration (ssa) premium accounting, collections, \n",
      "and enrollment functions. this also includes ``mma'' data on dual \n",
      "eligibility status (called the ``mma file'' after the medicare \n",
      "prescription drug, improvement and modernization act of 2003 (mma) \n",
      "(pub. l. 108-173, enacted december 8, 2003)), which are used in all \n",
      "four parts of medicare. we are proposing to establish frequency \n",
      "requirements to require all states to participate in daily exchange of \n",
      "buy-in data with cms by april 1, 2022, and to update frequency \n",
      "requirements to require all states to submit mma file data to cms daily \n",
      "by april 1, 2022.\n",
      "    we are actively working with our partners throughout hhs to deter \n",
      "the practice of information blocking. we believe it would benefit \n",
      "patients to know if their health care providers attested negatively to \n",
      "any of the prevention of information blocking attestation statements \n",
      "under the quality payment program (qpp) or the medicare ffs promoting \n",
      "interoperability program. in previous testing with patients and \n",
      "caregivers, we have learned that effective use of cehrt is important to \n",
      "them when making informed health care decisions. to address this issue, \n",
      "we are proposing to publicly post information about negative \n",
      "attestations on appropriate cms websites.\n",
      "    section 4003 of the cures act recognized the importance of making \n",
      "provider digital contact information available through a common \n",
      "directory. to facilitate this, cms has updated the national plan and \n",
      "provider enumeration system (nppes) to be able to capture this digital \n",
      "contact information. now that the systems are in place, we seek to \n",
      "increase the number of clinicians with valid and current digital \n",
      "contact information available through nppes. we are proposing to \n",
      "publicly identify those clinicians who have not submitted digital \n",
      "contact information in nppes. further, we are proposing to align \n",
      "program requirements for ma organizations, medicaid state agencies, \n",
      "medicaid managed care plans, chip agencies that operate ffs systems, \n",
      "chip managed care entities, and qhp issuers in ffes (with the exception \n",
      "of issuers of sadps) such that each payer/plan issuer would make \n",
      "provider directory information publicly available via an api.\n",
      "    electronic patient event notifications from hospitals, or clinical \n",
      "event notifications, are widely recognized as an effective tool for \n",
      "improving care coordination across settings, especially for patients at \n",
      "admission, discharge, and transfer. we are proposing to revise the \n",
      "conditions of participation for hospitals (including short-term acute \n",
      "care hospitals, long-term care hospitals (ltchs), rehabilitation \n",
      "hospitals, psychiatric hospitals, children's hospitals, and cancer \n",
      "hospitals) and cahs to require that these entities send patient event \n",
      "notifications to another health care facility or to another community \n",
      "provider. we propose to limit this requirement to only those medicare- \n",
      "and medicaid-participating hospitals and cahs that possess ehrs systems \n",
      "with the technical capacity to generate information for electronic \n",
      "patient event notifications.\n",
      "    we also plan to test ways to promote interoperability across the \n",
      "health care spectrum through models tested by the center for medicare \n",
      "and medicaid innovation (``innovation center''). innovation center \n",
      "models offer a unique opportunity to engage with health care providers \n",
      "and other entities in innovative ways and to test concepts that have \n",
      "the ability to accelerate change in the u.s. health care system, \n",
      "including to promote interoperability. as such, we are soliciting \n",
      "public comment on general principles around interoperability within \n",
      "innovation center models for integration into new models, through \n",
      "provisions in model participation agreements or other governing \n",
      "documents. in applying these general principles, we intend to be \n",
      "sensitive to the details of individual model design, and the \n",
      "characteristics and capacities of the participants in each specific \n",
      "model.\n",
      "    one of the many proposals we considered but did not include in this \n",
      "proposed rule was a proposal to make updates to the promoting \n",
      "interoperability program (formerly the medicare and medicaid ehr \n",
      "incentive programs) to encourage eligible hospitals and cahs to engage \n",
      "in certain activities focused on interoperability. this concept was \n",
      "initially introduced in a request for public comment in the fy 2019 \n",
      "ipps/ltch pps proposed rule (83 fr 20537 through 20538). we discussed a \n",
      "possible future strategy in which we would create a set of priority \n",
      "health it or ``interoperability'' activities that would serve as \n",
      "alternatives to measures in the promoting interoperability program. we \n",
      "discussed creating a set of priority health it activities with a focus \n",
      "on interoperability and simplification to reduce health care provider \n",
      "burden while allowing flexibility to pursue innovative applications of \n",
      "health it to improve care delivery. we offered three different examples \n",
      "of activities which might be included under such an approach, \n",
      "including:\n",
      "    <bullet> participation in, or serving as, a health information \n",
      "network which is part of the trusted exchange framework and common \n",
      "agreement (tefca);\n",
      "    <bullet> maintaining an open api which allows persistent access to \n",
      "third parties which enables patients to access their health \n",
      "information; and\n",
      "    <bullet> participating in piloting and testing of new standards \n",
      "that support emerging interoperability use cases.\n",
      "    while we are not proposing this here, we expect to introduce a \n",
      "proposal for establishing ``interoperability activities'' in the fy \n",
      "2020 ipps/ltch pps rulemaking in conjunction with other updates to the \n",
      "promoting interoperability program. to help inform future rulemaking, \n",
      "we invite comments on the concepts discussed above, as well as other \n",
      "ideas for ``interoperability activities'' for which eligible hospitals \n",
      "and cahs could receive credit in lieu of reporting on program measures.\n",
      "    finally, we include two rfis. one related to interoperability and \n",
      "health it adoption in pac settings, and one related to the role of \n",
      "patient matching in interoperability and improved patient care.\n",
      "\n",
      "ii. technical standards related to interoperability\n",
      "\n",
      "a. technical approach and standards\n",
      "\n",
      "1. use of fhir for apis\n",
      "    the macra defines interoperability as the ability of two or more \n",
      "health information systems or components to exchange clinical and other \n",
      "information and to use the information that has been exchanged using \n",
      "common standards such as to provide access to longitudinal information \n",
      "for health care providers in order to facilitate coordinated care and \n",
      "improved patient outcomes. interoperability is also defined in section \n",
      "3000 of the public health service act (phsa) (42 u.s.c. 300jj), as \n",
      "amended by section 4003 of the cures act. under that definition, \n",
      "``interoperability'', with respect to health it, means such health it \n",
      "that enables the secure exchange of electronic health information with, \n",
      "and use of electronic health information from, other health it without \n",
      "special\n",
      "\n",
      "[[page 7619]]\n",
      "\n",
      "effort on the part of the user; allows for complete access, exchange, \n",
      "and use of all electronically accessible health information for \n",
      "authorized use under applicable state or federal law; and does not \n",
      "constitute information blocking as defined in section 3022(a) of the \n",
      "phsa, which was added by section 4004 of the cures act. we believe the \n",
      "phsa definition is consistent with the macra definition of \n",
      "interoperability. as noted at the outset of this proposed rule, for the \n",
      "purposes of this proposed rule and this specific section, we will use \n",
      "the phsa definition.\n",
      "    we believe the phsa definition of interoperability is useful as a \n",
      "foundational reference for our approach to advancing interoperability \n",
      "and exchange of electronic health information for individuals \n",
      "throughout the united states, and across the entire spectrum of \n",
      "provider types and care settings with which health plan issuers and \n",
      "administrators need to efficiently exchange multiple types of relevant \n",
      "data. we note the phsa definition of interoperability is not applied \n",
      "only to a specific program or initiative but to all activities under \n",
      "the title of the phsa that establishes onc's responsibilities to \n",
      "support and shape the health information ecosystem, including exchange \n",
      "infrastructure for the united states health care system as a whole. the \n",
      "phsa definition of interoperability is also consistent with hhs's \n",
      "vision and strategies for achieving a health information ecosystem \n",
      "within which all individuals, their families, and health care providers \n",
      "are able to send, receive, find, and use electronic health information \n",
      "in a manner that is appropriate, secure, timely, and reliable to \n",
      "support the health and wellness of individuals through informed, shared \n",
      "decision-making,\\9\\ as well as to support consumer choice of health \n",
      "plans and providers.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\9\\ see, for example, onc ``connecting health and care for the \n",
      "nation: a shared nationwide interoperability roadmap'' final version \n",
      "1.0 (2015): <a href=\"https://www.healthit.gov/sites/default/files/hie-interoperability/nationwide-interoperability-roadmap-final-version-1nor.0.pdf\">https://www.healthit.gov/sites/default/files/hie-interoperability/nationwide-interoperability-roadmap-final-version-1nor.0.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    a core policy principle we aim to support across all proposals in \n",
      "this proposed rule is that every american should be able, without \n",
      "special effort or advanced technical skills, to see, obtain, and use \n",
      "all electronically available information that is relevant to their \n",
      "health, care, and choices--of plans, providers, and specific treatment \n",
      "options. this includes two types of information: information \n",
      "specifically about the individual that requires appropriate diligence \n",
      "to protect the individual's privacy, such as their current and past \n",
      "medical conditions and care received, as well as information that is of \n",
      "general interest and should be widely available, such as plan provider \n",
      "networks, the plan's formulary, and coverage policies.\n",
      "    while many consumers today can often access their own electronic \n",
      "health information through patient/enrollee portals and proprietary \n",
      "applications made available by various providers and health plans, they \n",
      "must typically go through separate processes to obtain access to each \n",
      "system, and often need to manually aggregate information that is \n",
      "delivered in various, often non-standardized, formats. the complex \n",
      "tasks of accessing and piecing together this information can be \n",
      "burdensome and frustrating to consumers.\n",
      "    in contrast, consider the ease with which consumers can choose and \n",
      "use a navigation application which integrates information on their \n",
      "current location, preferences, and real-time traffic conditions to \n",
      "choose the best route to a chosen destination. consumers do not have to \n",
      "log into a different ``location'' portal to learn their current \n",
      "geographic coordinates, write them down, and then log into a separate \n",
      "``map'' portal to enter their current coordinates to request directions \n",
      "to their destination.\n",
      "    an api can be thought of as a set of commands, functions, \n",
      "protocols, or tools published by one software developer (``a'') that \n",
      "enable other software developers to create programs (applications or \n",
      "``apps'') that can interact with a's software without needing to know \n",
      "the internal workings of a's software, all while maintaining consumer \n",
      "privacy data standards. this is how api technology enables the seamless \n",
      "user experiences associated with applications familiar from other \n",
      "aspects of many consumers' daily lives, such as travel and personal \n",
      "finance. standardized, transparent, and pro-competitive api technology \n",
      "can enable similar benefits to consumers of health care services.\\10\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\10\\ onc has made available a succinct, non-technical overview \n",
      "of apis in context of consumers' access to their own medical \n",
      "information across multiple providers' ehr systems, which is \n",
      "available at the <a href=\"http://healthit.gov\">healthit.gov</a> website at <a href=\"https://www.healthit.gov/api-education-module/story_html5.html\">https://www.healthit.gov/api-education-module/story_html5.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while acknowledging the limits of our authority to require use of \n",
      "apis to address our goals for interoperability and data access, we are \n",
      "proposing in this rule to use our programmatic authority in medicare, \n",
      "medicaid, chip, and over qhps in ffes to advance these goals. \n",
      "therefore, we are proposing to require that a variety of data be made \n",
      "accessible to ma enrollees, medicaid beneficiaries, chip enrollees, and \n",
      "enrollees in qhps in ffes, by requiring that ma organizations, medicaid \n",
      "state agencies, medicaid managed care plans, chip agencies, chip \n",
      "managed care entities, and qhps in ffes, adopt and implement ``openly \n",
      "published'' (or simply ``open'') apis. having certain data available \n",
      "through open apis would allow these enrollees to use the application of \n",
      "their choice to access and use their own electronic health information \n",
      "and other information relevant to managing their health.\n",
      "    much like our efforts under the medicare blue button 2.0 and \n",
      "myhealthedata initiatives, which made parts a, b, and d claims data \n",
      "available to medicare beneficiaries, our proposal would result in \n",
      "claims and coverage information being accessible for the vast majority \n",
      "of medicare beneficiaries by requiring ma organizations to take new \n",
      "steps--by implementing the api described in this proposed rule--to make \n",
      "claims data available to their enrollees. we expect that our proposal \n",
      "would also benefit all medicaid beneficiaries because our proposal \n",
      "applies to medicaid state agencies (which administer medicaid ffs \n",
      "programs), and all types of medicaid managed care plans (mcos, pihps, \n",
      "and pahps), and chip agencies (which administer chip ffs) and chip \n",
      "managed care entities (mcos, pihps, and pahps). finally, while our \n",
      "proposal is only applicable to qhps in ffes, we hope that states \n",
      "operating exchanges might consider adopting similar requirements for \n",
      "qhps in state-based exchanges (sbes), and that other payers in the \n",
      "private sector might consider voluntarily offering data accessibility \n",
      "of the type included in this proposal so that even more patients across \n",
      "the american health care system can easily have and use such \n",
      "information to advance their choice and participation in their health \n",
      "care. we hope that the example being set by cms will raise consumers' \n",
      "expectations and encourage other payers in the market to take similar \n",
      "steps to advance patient access and empowerment outside the scope of \n",
      "our proposed requirements.\n",
      "    an ``open api,'' for purposes of this proposed rule, is simply one \n",
      "for which the technical and other information required for a third-\n",
      "party application to connect to it is openly published. open api does \n",
      "not imply any and all applications or application developers would have \n",
      "unfettered access to people's personal or sensitive information. \n",
      "rather, an open api's published technical and other information \n",
      "specifically includes what an application developer would need to\n",
      "\n",
      "[[page 7620]]\n",
      "\n",
      "know to connect to and obtain data available through the api.\n",
      "    we recommend reviewing the discussion of the standardized api \n",
      "criterion and associated policy principles and technical standards \n",
      "included in onc's proposed rule ``21st century cures act: \n",
      "interoperability, information blocking, and the onc health it \n",
      "certification program'' (published elsewhere in this issue of the \n",
      "federal register) for those seeking more detailed information on api \n",
      "functionality and interoperability standards relevant to electronic \n",
      "health information. while that discussion is specific to health it \n",
      "certified under onc's health it certification program rather than the \n",
      "information systems generally used by payers and plan issuers for \n",
      "claims, encounters, or other administrative or plan operational data, \n",
      "it includes information applicable to interoperability standards, as \n",
      "well as considerations relevant to establishing reasonable and non-\n",
      "discriminatory terms of service for applications seeking to connect to \n",
      "the open api. however, it is important to reiterate that we are not \n",
      "proposing to require health plan issuers to use health it modules \n",
      "certified under onc's program to make administrative data such as \n",
      "claims history or provider directory information available to \n",
      "enrollees.\n",
      "    in developing this proposed rule, we considered how to advance the \n",
      "sort of interoperability and innovation in the health system supported \n",
      "by open apis in other industries. we have also collaborated with onc to \n",
      "align with and leverage relevant api policies onc has proposed to \n",
      "implement cures act requirements. in general, we believe three \n",
      "attributes of open apis are particularly important to achieve the goal \n",
      "of offering individuals convenient access, through applications they \n",
      "choose, to available and relevant electronic health information. the \n",
      "three api attributes are:\n",
      "    <bullet> the api technologies themselves, not just the data \n",
      "accessible through them, are standardized;\n",
      "    <bullet> the apis are technically transparent; and\n",
      "    <bullet> the apis are implemented in a pro-competitive manner.\n",
      "    in this section, we discuss these concepts generally and how they \n",
      "are applicable in the health care context for all payers, as well as \n",
      "explain how these are relevant to our specific proposals, which are \n",
      "discussed in detail in section iii. of this proposed rule.\n",
      "a. standardized\n",
      "    technical consistency and implementation predictability are \n",
      "fundamental to scale api-enabled interoperability and reduce the level \n",
      "and costs of custom development otherwise necessary to access, \n",
      "exchange, and use health information. from an industry standpoint, a \n",
      "consistent and predictable set of api functions, as well as content and \n",
      "formatting standards, provide the health it ecosystem with known \n",
      "technical requirements against which application developers can build \n",
      "applications (including but not limited to ``mobile apps'') and other \n",
      "innovative services which users can select to access and manage the \n",
      "data they need. therefore, to achieve interoperability consistent with \n",
      "the phsa definition, the proposals in section iii. of this proposed \n",
      "rule would effectively require that api technologies deployed by health \n",
      "plans subject to this rule use modern computing standards (such as \n",
      "restful interfaces \\11\\ and xml/json), and present the requested \n",
      "information using widely recognized content standards (such as \n",
      "standardized vocabularies of clinical terms), where applicable.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\11\\ ``restful interfaces'' are those that are consistent with \n",
      "representational state transfer (rest) architectural style and \n",
      "communications approaches to web services development.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "b. transparent\n",
      "    transparency and openness around api documentation is commonplace \n",
      "in many other industries and has fueled innovation, growth, and \n",
      "competition. documentation associated with apis deployed by health care \n",
      "providers, health plans, and other entities engaged in exchanging \n",
      "electronic health information typically addresses the information that \n",
      "would be material to persons and entities that use or create software \n",
      "applications that interact with the api (api users). information \n",
      "material to api users includes, but is not necessarily limited to, all \n",
      "terms and conditions for use of the api, including terms of service, \n",
      "restrictions, limitations, obligations, registration process \n",
      "requirements, or other similar requirements that would be needed to:\n",
      "    <bullet> develop software applications to interact with the api;\n",
      "    <bullet> connect software applications to the api to access \n",
      "electronic health information through the api;\n",
      "    <bullet> use any electronic health information obtained by means of \n",
      "the api technology; and\n",
      "    <bullet> register software applications to connect with the api.\n",
      "    as discussed in section iii. of this proposed rule, we are \n",
      "proposing that certain entities (ma organizations, state medicaid \n",
      "agencies, medicaid managed care plan, state chip agencies, chip managed \n",
      "care entities, and qhps in ffes), supported by the suppliers of their \n",
      "api technology, and for the api technology they use to comply with the \n",
      "requirements we propose in this proposed rule, be required to make \n",
      "freely and publicly accessible the specific business and technical \n",
      "documentation necessary to interact with these apis. thus, we propose \n",
      "to require that these entities comply with the requirements that onc \n",
      "has proposed that the secretary adopt for developers and users of \n",
      "health it certified to the api criteria at 45 cfr 170.315 (published \n",
      "elsewhere in this issue of the federal register).\n",
      "c. pro-competitive\n",
      "    pro-competitive practices in selecting, configuring, and \n",
      "maintaining apis are those business practices that promote the \n",
      "efficient access to, exchange of, and use of electronic health \n",
      "information to support a competitive marketplace that enhances consumer \n",
      "value and choice of direct-to-consumer technology, health coverage, and \n",
      "care. we believe that an ultimate goal of all participants in the \n",
      "health care ecosystem is that individuals should be able to use an \n",
      "application they choose to connect and access, without special effort, \n",
      "their electronic health information held by health care providers, \n",
      "health plans, or any health information networks, within practical and \n",
      "prudent limits that do not needlessly hinder their ability to connect \n",
      "to the api in a persistent manner.\n",
      "    such acceptable limits include technical compatibility and ensuring \n",
      "the application does not pose an unacceptable level of risk to a system \n",
      "when connecting to an api offered by that system, consistent with the \n",
      "hipaa privacy and security rules and guidance issued by the hhs \n",
      "ocr,\\12\\ to which the secretary delegated the authority to enforce \n",
      "hipaa privacy and security requirements. organizational policies and \n",
      "procedures needed to comply with any additional requirements under \n",
      "state laws that would apply in a given situation would also be viewed \n",
      "as necessary and not anti-competitive. examples of practices\n",
      "\n",
      "[[page 7621]]\n",
      "\n",
      "we would view as pro-competitive might include proactively advising \n",
      "enrollees they are not required to use only the organization's own or \n",
      "preferred applications to access, use, and share their health \n",
      "information. such advice would be publicly available and include \n",
      "information relevant to the enrollee about how they could request \n",
      "access to their information through a third-party application of their \n",
      "choosing.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\12\\ ocr enforces federal civil rights laws, conscience and \n",
      "religious freedom laws, the health insurance portability and \n",
      "accountability act of 1996 (hipaa) privacy, security, and breach \n",
      "notification rules, and provisions of the patient safety and quality \n",
      "improvement act of 2005 (psqia) and the patient safety rule \n",
      "(codified at 42 cfr part 3 (73 fr 70732)) protecting the \n",
      "confidentiality and privilege of patient safety work product as \n",
      "defined in psqia and 42 cfr part 3. thus, within hhs, ocr has lead \n",
      "responsibility for interpreting, administering, and enforcing hipaa \n",
      "regulations and developing guidance.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we recognize that organizations subject to the open api \n",
      "requirements proposed in section iii. of this proposed rule need to \n",
      "take reasonable and necessary steps to fulfill the organizations' \n",
      "duties under all applicable laws and regulations to protect the privacy \n",
      "and security of personally identifiable information (pii), including \n",
      "but not limited to phi under hipaa as defined at 45 cfr 160.103; those \n",
      "privacy and security protection obligations remain applicable even in \n",
      "the context of complying with our proposal. however, we do not believe \n",
      "it is appropriate to use security and privacy concerns as an \n",
      "opportunity to engage in anti-competitive practices. anti-competitive \n",
      "practices might include declining to assess the technical compatibility \n",
      "or security risk of an application provided to prospective enrollees by \n",
      "a competing plan, despite an enrollee request to disclose their phi to \n",
      "that application through the api.\n",
      "2. privacy and security concerns in the context of apis\n",
      "    we have received a wide range of stakeholder feedback on privacy \n",
      "and security issues in response to prior proposals \\13\\ about policies \n",
      "related to apis that would allow consumers to use any app of their \n",
      "choosing to access phi held by a hipaa covered entity. this feedback \n",
      "includes concerns about potential security risks to phi created by an \n",
      "api connecting to third-party applications.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\13\\ for instance, see discussion of stakeholder comments in the \n",
      "2015 edition final rule at 80 fr 62676.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we appreciate these concerns. deploying api technology that offers \n",
      "consumers the opportunity to access their electronic health information \n",
      "that is held by a covered entity (which includes but is not limited to \n",
      "ma organizations, the medicare part a and b programs, the medicaid \n",
      "program, chip, qhp issuers on the ffe, and other health plan issuers) \n",
      "does not lessen the covered entity's duties under hipaa and other law \n",
      "to protect the privacy and security of information it holds, including \n",
      "but not limited to phi. a covered entity implementing an api to enable \n",
      "individuals to access their health information must take reasonable \n",
      "steps to ensure an individual's information is only disclosed as \n",
      "permitted or required by applicable law. the entity must take greater \n",
      "care in configuring and maintaining the security functionalities of the \n",
      "api and the covered entities' electronic information systems to which \n",
      "it connects than would be needed if it was implementing an api simply \n",
      "to allow easier access to widely available public information.\n",
      "    hipaa covered entities and their business associates continue to be \n",
      "responsible for compliance with the hipaa rules, the federal trade \n",
      "commission act (ftc act), and all other laws applicable to their \n",
      "business activities including but not limited to their handling of \n",
      "enrollees' phi and other data. as we state repeatedly throughout this \n",
      "proposed rule, nothing in this proposed rule is intended to alter or \n",
      "should be construed as altering existing responsibilities to protect \n",
      "phi under the hipaa rules and requirements.\n",
      "    however, we note that a number of stakeholders may believe that \n",
      "they are responsible for determining whether an application to which an \n",
      "individual directs their phi be disclosed applies appropriate \n",
      "safeguards for the information it receives. based on the ocr guidance \n",
      "discussed below, covered entities are not responsible under the hipaa \n",
      "rules for the security of phi once it has been received by a third-\n",
      "party application chosen by an individual.\n",
      "    under the hipaa privacy rule,\\14\\ individuals have the right of \n",
      "access to inspect and receive a copy of a defined set of their phi as \n",
      "detailed at 45 cfr 164.501. specifically, as ocr has indicated in \n",
      "regulations and guidance, an individual can exercise their right of \n",
      "access to direct a covered entity to send their information to a third \n",
      "party. when responding to an access request, ``the same requirements \n",
      "for providing the phi to the individual, such as the timeliness \n",
      "requirements, fee limitations, prohibition on imposing unreasonable \n",
      "measures, and form and format requirements, apply when an individual \n",
      "directs that the phi be sent to another person or entity.'' \\15\\ \n",
      "moreover, a covered entity may not impose unreasonable measures on an \n",
      "individual requesting access that serve as barriers to or unreasonably \n",
      "delay the individual from obtaining access to their phi.\\16\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\14\\ more information on the privacy rule, including related \n",
      "rulemaking actions and additional interpretive guidance, is \n",
      "available at <a href=\"https://www.hhs.gov/hipaa/for-professionals/privacy/index.html\">https://www.hhs.gov/hipaa/for-professionals/privacy/index.html</a>.\n",
      "    \\15\\ see sec.  164.524(c)(2) and (3), and 164.308(a)(1), ocr \n",
      "hipaa guidance/faq-2036: <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2036/can-an-individual-through-the-hipaa-right/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2036/can-an-individual-through-the-hipaa-right/index.html</a>, and ocr hipaa guidance/faq-2037: <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2037/are-there-any-limits-or-exceptions-to-the-individuals-right/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2037/are-there-any-limits-or-exceptions-to-the-individuals-right/index.html</a>.\n",
      "    \\16\\ see, generally, the ``unreasonable measures'' heading of \n",
      "ocr hipaa for professionals information web page at <a href=\"https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\">https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html</a>. see also faq 2039--<a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2039/what-is-the-liability-of-a-covered-entity-in-responding/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2039/what-is-the-liability-of-a-covered-entity-in-responding/index.html</a>; faq 2060: <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2060/do-individuals-have-the-right-under-hipaa-to-have/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2060/do-individuals-have-the-right-under-hipaa-to-have/index.html</a>; faq 2040: <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2040/what-is-a-covered-entitys-obligation-under/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2040/what-is-a-covered-entitys-obligation-under/index.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we refer readers to further ocr guidance on related issues, \n",
      "including: the liability of a covered entity in responding to an \n",
      "individual's access request to send the individual's phi to a third \n",
      "party (faq 2039); \\17\\ individuals' rights under hipaa to have copies \n",
      "of their phi transferred or transmitted to them in the manner they \n",
      "request, even if the requested mode of transfer or transmission is \n",
      "unsecure (faq 2060); \\18\\ and, a covered entity's obligation under the \n",
      "hipaa breach notification rule if it transmits an individual's phi to a \n",
      "third party designated by the individual in an access request, and the \n",
      "entity discovers the information was breached in transit (faq \n",
      "2040).\\19\\ under the hipaa privacy rule, as explained in ocr's \n",
      "interpretive guidance, ``individuals have the right under hipaa to have \n",
      "copies of their phi transferred or transmitted to them in the manner \n",
      "they request . . . as long as the phi is `readily producible' in the \n",
      "manner requested, based on the capabilities of the covered entity and \n",
      "transmission or transfer in such a manner would not present an \n",
      "unacceptable level of security risk to the phi on the covered entity's \n",
      "systems, such as risks that may be presented by connecting an outside \n",
      "system, application, or device directly to a covered entity's systems \n",
      "(as opposed to security risks to phi once it has left the systems)'' \n",
      "(hipaa faq 2060).\\20\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\17\\ <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2039/what-is-the-liability-of-a-covered-entity-in-responding/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2039/what-is-the-liability-of-a-covered-entity-in-responding/index.html</a>.\n",
      "    \\18\\ <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2060/do-individuals-have-the-right-under-hipaa-to-have/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2060/do-individuals-have-the-right-under-hipaa-to-have/index.html</a>.\n",
      "    \\19\\ <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2040/what-is-a-covered-entitys-obligation-under/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2040/what-is-a-covered-entitys-obligation-under/index.html</a>.\n",
      "    \\20\\ <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2060/do-individuals-have-the-right-under-hipaa-to-have/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2060/do-individuals-have-the-right-under-hipaa-to-have/index.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we have also noted stakeholder concerns about protections which \n",
      "apply to non-covered entities such as direct-\n",
      "\n",
      "[[page 7622]]\n",
      "\n",
      "to-consumer applications. stakeholders, as well as covered entities who \n",
      "may be required to send phi to these applications, have noted concerns \n",
      "that unscrupulous actors could deploy direct-to-consumer applications \n",
      "specifically in order to profit from obtaining, using, or disclosing \n",
      "individuals' phi (and potentially other information) in ways the \n",
      "individual either did not authorize or to which the individual would \n",
      "not knowingly consent.\n",
      "    when a non-hipaa-covered entity discloses an individual's \n",
      "confidential information in a manner or for a purpose not consistent \n",
      "with the privacy notice and terms of use to which the individual \n",
      "agreed, the ftc has authority under the ftc act to investigate and take \n",
      "action against unfair or deceptive trade practices. the ftc has applied \n",
      "this authority to a wide variety of entities. the ftc also enforces the \n",
      "ftc health breach notification rule, which applies to certain types of \n",
      "entities that fall outside of the scope of hipaa, and therefore, are \n",
      "not subject to the hipaa breach notification rule.\\21\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\21\\ <a href=\"https://www.healthit.gov/sites/default/files/non-covered_entities_report_june_17_2016.pdf\">https://www.healthit.gov/sites/default/files/non-covered_entities_report_june_17_2016.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we recognize that this is a complex landscape for patients, who we \n",
      "anticipate will want to exercise due diligence on their own behalf in \n",
      "reviewing the terms of service and other information about the \n",
      "applications they consider selecting. therefore, we propose in section \n",
      "iii. of this proposed rule specific requirements on the payers subject \n",
      "to these proposed regulations to ensure enrollees have the opportunity \n",
      "to become more informed about how to protect their phi, important \n",
      "things to consider in selecting an application, and where they can \n",
      "lodge a complaint if they believe a hipaa covered entity or business \n",
      "associate may have breached their duties under hipaa or if they believe \n",
      "they have been subjected to unfair or deceptive actions or practices \n",
      "related to a direct-to-consumer application's privacy practices or \n",
      "terms of use.\n",
      "    in some circumstances, information that would be required to be \n",
      "made available through an api per an enrollee's information request \n",
      "under this proposed rule--which we view as consistent with the \n",
      "enrollee's right of access from a covered entity under the privacy \n",
      "rule--may not be readily transferable through the api. for instance, \n",
      "the covered entity may not hold certain information electronically. \n",
      "however, such a scenario would in no way limit or alter \n",
      "responsibilities and requirements under other law (including though not \n",
      "limited to hipaa privacy, security, and breach notification rules) that \n",
      "apply to the organizations that would be subject to our proposed \n",
      "regulations. even if the open api access requirements proposed in \n",
      "section iii.c. of this proposed rule were to be finalized and \n",
      "implemented, the organization may still be called upon to respond to \n",
      "individuals' request for information not available through the api, or \n",
      "for all of their information through means other than the api. we \n",
      "encourage hipaa covered entities or business associates to review the \n",
      "ocr website for resources on the individual access standard at <a href=\"https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\">https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html</a> \n",
      "to ensure they understand their responsibilities.\n",
      "3. specific technical approach and standards\n",
      "    achieving interoperability throughout the health system is \n",
      "essential to achieving an effective, value-conscious health system \n",
      "within which consumers are able to choose from an array of health plans \n",
      "and providers. an interoperable system should ensure that consumers can \n",
      "both easily access their electronic health information held by plans \n",
      "and routinely expect that their claims, encounter, and other relevant \n",
      "health history information will follow them smoothly from plan to plan \n",
      "and provider to provider without burdensome requirements for them or \n",
      "their providers to reassemble or re-document the information. ready \n",
      "availability of health information can be especially helpful when an \n",
      "individual cannot access their usual source of care, for instance if \n",
      "care is needed outside their regular provider's business hours, while \n",
      "traveling, or in the wake of a natural disaster.\n",
      "    the specific proposals within this rule as described in section \n",
      "iii.c.2. would impose new requirements on ma organizations, state \n",
      "medicaid and chip ffs programs, medicaid managed care plans, chip \n",
      "managed care entities, and qhp issuers in ffes (excluding issuers of \n",
      "sadps) to implement standardized, transparent apis. using the api, \n",
      "these entities would be required to provide current and former \n",
      "enrollees with certain claims and encounter data and certain specific \n",
      "clinical information. these entities would also be required to make \n",
      "available through the api information already required to be widely \n",
      "available, such as provider directory and plan coverage information. in \n",
      "developing our proposal delineating the information that must be \n",
      "available through an api consistent with the proposed technical \n",
      "requirements, we were guided by an intent to have available through the \n",
      "api all of the individual's electronic health information held by the \n",
      "plan in electronic format that is compatible with the api or that can, \n",
      "through automated means, be accurately rendered compatible with \n",
      "representation through the api. we were also guided by an intent to \n",
      "make available through standardized, transparent api technology all of \n",
      "the provider directory and plan coverage information that is held in \n",
      "formats readily compatible with the api.\n",
      "    both the api technology itself and the data it makes available must \n",
      "be standardized to support true interoperability. therefore, we propose \n",
      "in section iii.c.2.b. of this proposed rule to require compliance with \n",
      "both (1) onc's 21st century cures act proposed regulations regarding \n",
      "content and vocabulary standards for representing electronic health \n",
      "information and (2) technical standards for an api by which the \n",
      "electronic health information must be made available. for the proposals \n",
      "described in section iii.c.2.b. of this proposed rule (which include \n",
      "purposes other than a hipaa transaction, which is required to comply \n",
      "with standards adopted at 45 cfr part 162), we are proposing these \n",
      "requirements to comply with interoperability standards proposed for hhs \n",
      "adoption in onc's 21st century cures act proposed rule (published \n",
      "elsewhere in this issue of the federal register).\n",
      "    in proposing to require that regulated entities comply with onc-\n",
      "proposed regulations (published elsewhere in this issue of the federal \n",
      "register), and therefore, use specified standards, we intend to \n",
      "preclude regulated entities from implementing api technology using \n",
      "alternative technical standards to those onc proposes for hhs adoption \n",
      "at 45 cfr 170.215, including but not limited to those not widely used \n",
      "to exchange electronic health information in the u.s. health system. we \n",
      "further intend to preclude entities from using earlier versions of the \n",
      "technical standards adopted at 45 cfr 170.215 by requiring compliance \n",
      "with only specified provisions of 45 cfr part 170 and deliberately \n",
      "excluding others. likewise, by proposing to require use of the content \n",
      "and vocabulary standards by requiring compliance with 42 cfr 423.160 \n",
      "and 45 cfr part 162, and proposed at 45 cfr 170.213, we intend to \n",
      "prohibit use of alternative technical standards that could potentially \n",
      "be used for these same data classes and elements, as well as earlier \n",
      "versions of the adopted standards named in 42 cfr\n",
      "\n",
      "[[page 7623]]\n",
      "\n",
      "423.160, 45 cfr part 162 and proposed at 45 cfr 170.213.\n",
      "    while we intend to preclude regulated entities from using content \n",
      "and vocabulary standards other than those described in 42 cfr 423.160, \n",
      "45 cfr part 162, or proposed 45 cfr 170.213 and 170.215, we recognize \n",
      "there may be circumstances which render the use of other content and \n",
      "vocabulary alternatives necessary. as discussed below, we propose to \n",
      "allow the use of other alternatives in two circumstances. first, where \n",
      "other content or vocabulary standards are expressly mandated by \n",
      "applicable law, we would allow for use of those other mandated \n",
      "standards. second, where no appropriate content or vocabulary standard \n",
      "exists within 45 cfr part 162, 42 cfr 423.160, or proposed 45 cfr \n",
      "170.213 and 170.215, we would allow for use of any suitable gap-filling \n",
      "options, as may be applicable to the specific situation.\n",
      "    we are using two separate rulemakings because onc's 21st century \n",
      "cures act proposed rule, which includes api interoperability standards \n",
      "proposed for hhs adoption, would have broader reach than the scope of \n",
      "this proposed rule. at the same time, we wish to assure stakeholders \n",
      "that the api standards required of ma organizations, state medicaid \n",
      "agencies, state chip agencies, medicaid managed care plans, chip \n",
      "managed care entities, and qhp issuers in ffes under this proposal \n",
      "would be consistent with the api standards proposed by onc for hhs \n",
      "adoption because we would require that the regulated entities follow \n",
      "specified, applicable provisions of the onc-proposed requirements.\n",
      "    requiring that regulated entities comply with the regulations \n",
      "regarding standards in onc's 21st century cures act proposed rule will \n",
      "support greater interoperability across the health care system, as \n",
      "health it products and applications that will be developed for \n",
      "different settings and use cases would be developed according to a \n",
      "consistent base of standards that supports more seamless exchange of \n",
      "information. we welcome public comment on the proposed required \n",
      "compliance with regulations regarding standards in this proposed rule \n",
      "to those proposed for adoption by hhs through onc' 21st century cures \n",
      "act proposed rule, as well as on the best method to provide support in \n",
      "identifying and implementing the applicable content and vocabulary \n",
      "standards for a given data element.\n",
      "    finally, while we believe that the proposed required compliance \n",
      "with regulations regarding standards requirements in this proposed rule \n",
      "to those proposed by onc for hhs adoption is the best approach, we seek \n",
      "public comment on an alternative by which cms would separately adopt \n",
      "the proposed onc standards identified throughout this proposed rule, as \n",
      "well as future interoperability, content and vocabulary standards. we \n",
      "anticipate that any such alternative would include incorporating by \n",
      "reference the fhir and oauth technical standards and the uscdi content \n",
      "and vocabulary standard (described in sections ii.a.3.b. and ii.a.3.a. \n",
      "of this proposed rule, respectively) in cms regulation, and replacing \n",
      "references to onc regulations at 45 cfr 170.215, 170.213, and 170.205, \n",
      "respectively. however, we specifically seek comment on whether this \n",
      "alternative would present an unacceptable risk of creating multiple \n",
      "regulations requiring standards or versions of standards across hhs' \n",
      "programs, and an assessment of the benefits or burdens of separately \n",
      "adopting new standards and incorporating updated versions of standards \n",
      "in cfr text on a program by program basis. furthermore, we seek comment \n",
      "on: how such an option might impact health it development timelines; \n",
      "how potentially creating multiple regulations regarding standards over \n",
      "time across hhs might impact system implementation; and other factors \n",
      "related to the technical aspect of implementing these requirements.\n",
      "\n",
      "b. content and vocabulary standards\n",
      "\n",
      "    the hhs-adopted content and vocabulary standards applicable to the \n",
      "data provided through the api will vary by use case and within a use \n",
      "case. for instance, content and vocabulary standards supporting \n",
      "consumer access vary according to what specific data elements ma \n",
      "organizations, state medicaid and chip ffs programs, medicaid managed \n",
      "care plans, chip managed care entities, and qhp's in ffes have \n",
      "available electronically. where another law does not require use of a \n",
      "specific standard, we are proposing to require use of, in effect, a \n",
      "catalogue of content and vocabulary standards from which the regulated \n",
      "entities may choose in order to satisfy the proposed requirements in 42 \n",
      "cfr 422.119, 431.60, 457.730, 438.252, and 457.1233, and 45 cfr \n",
      "156.221.\n",
      "    we propose in section iii.c.2.b. of this proposed rule that the \n",
      "applicable entity must comply with regulations regarding certain \n",
      "content and vocabulary standards for data available through the api, \n",
      "where applicable to the data type or data element, unless an alternate \n",
      "standard is required by other applicable law. specifically, we propose \n",
      "the applicable entity must use:\n",
      "    <bullet> content and vocabulary standard onc proposes for hhs \n",
      "adoption at 45 cfr 170.213 (uscdi version 1) where such standards are \n",
      "the only available standards for the data type or element;\n",
      "    <bullet> hipaa administrative simplification transaction standards \n",
      "under 45 cfr part 162 or the part d e-prescribing transaction standards \n",
      "at 42 cfr 423.160 where required by other applicable law, or where such \n",
      "standards are the only available standards for the data type or \n",
      "element; or\n",
      "    <bullet> where a specific data type or element might be encoded or \n",
      "formatted using either a 45 cfr part 162 or 42 cfr 423.160 standard or \n",
      "the uscdi version 1 standard at 45 cfr 170.213, the applicable entity \n",
      "may use any of these content and vocabulary standards as determined \n",
      "appropriate for the data type or element. we describe these proposals \n",
      "in more detail below.\n",
      "    first, we propose in section iii.c.2.b. of this proposed rule to \n",
      "require compliance with the onc-proposed regulations regarding the \n",
      "content and vocabulary standard at 45 cfr 170.213 as applicable to the \n",
      "data type or data element. this is the uscdi version 1 set of data \n",
      "classes that can be supported by commonly used standards, and \n",
      "establishes a minimum set of data classes that would be required to be \n",
      "interoperable nationwide.\\22\\ the uscdi is designed to be expanded in \n",
      "an iterative and predictable way over time. on behalf of hhs, onc has \n",
      "proposed to adopt the uscdi as a standard in its 21st century cures act \n",
      "proposed rule (published elsewhere in this issue of the federal \n",
      "register). the uscdi version 1 data sets proposed by onc for hhs \n",
      "adoption at 45 cfr 170.213 also includes the standards that are \n",
      "referenced by certification criteria that are also adopted in 45 cfr \n",
      "part 170, to which health it, such as health it modules presented for \n",
      "certification under onc's health it certification program, must \n",
      "conform. developers of applications are already familiar with and \n",
      "commonly using these standards in products that interact with onc-\n",
      "certified health it. the payer and purchaser communities are also aware \n",
      "of and commonly using the 45 cfr part 170 standards, and many members \n",
      "of these communities actively participate in health-data-focused \n",
      "standards development organizations responsible for the creation of \n",
      "these standards. as a result, we believe that compliance with \n",
      "regulations requiring these standards for\n",
      "\n",
      "[[page 7624]]\n",
      "\n",
      "cms' programs should not add new burdens to the industry. all standards \n",
      "adopted within 45 cfr part 170, including the uscdi standard onc \n",
      "proposes for hhs adoption at 45 cfr 170.213, are, or are proposed by \n",
      "onc to be incorporated by reference by hhs, at 45 cfr 170.299 \n",
      "(published elsewhere in this issue of the federal register).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\22\\ for more information on the uscdi, see <a href=\"https://www.healthit.gov/uscdi\">https://www.healthit.gov/uscdi</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    second, we propose to require that entities use standards specified \n",
      "at 45 cfr part 162 for hipaa transactions as required by applicable \n",
      "law, as well as the standards specified at 42 cfr 423.160 for part d e-\n",
      "prescribing transactions, as required by applicable law. we reiterate \n",
      "that this proposed rule would not alter these other regulations, and \n",
      "should not be construed as altering any organization's compliance \n",
      "requirements for these other regulations. the standards proposed in \n",
      "this regulation are intended for instances where other statutes and \n",
      "regulations do not dictate the standard by which regulated parties are \n",
      "to convey or otherwise make available electronic information.\n",
      "    where there is no legally mandated standard applicable to a \n",
      "specific data type or data element in a particular exchange context, \n",
      "and the hipaa administrative simplification transaction standards under \n",
      "45 cfr part 162 or the part d e-prescribing transaction standards at 42 \n",
      "cfr 423.160 are the only standards available for a specific data \n",
      "element or type, we propose to require entities subject to these \n",
      "proposals to use these hipaa standards when making data available \n",
      "through the api. we further clarify that, for purposes of formatting, \n",
      "making available, and sending electronic data under this proposed rule, \n",
      "we would require compliance with: (1) the content and vocabulary \n",
      "standards identified in 45 cfr part 162 regardless of whether the \n",
      "entities are covered entities, and (2) the part d e-prescribing \n",
      "standards in 42 cfr 423.160 to exchange e-prescribing and related data \n",
      "(such as drug formulary and preferred drug list data) regardless of \n",
      "whether they are conducting a part d e-prescribing transaction.\n",
      "    third, in information exchanges where applicable law does not \n",
      "mandate a certain standard and where a specific data type or element \n",
      "might be encoded or formatted using the 45 cfr part 162 or 42 cfr \n",
      "423.160 standard, or the uscdi version 1 standard at 45 cfr 170.213, we \n",
      "propose in section iii.c.2.b. of this proposed rule that the regulated \n",
      "entities subject to our proposal would have the freedom to provide data \n",
      "through the api that complies with any of these format or encoding \n",
      "standards. specifically, we believe payers should use standards that \n",
      "are most efficient and effective based on their existing systems, data \n",
      "mapping considerations, or those standards that best meets enrollees' \n",
      "needs, while remaining technically practicable for use in conjunction \n",
      "with api technology conformant to the 45 cfr 170.215 proposed standards \n",
      "(published elsewhere in this issue of the federal register), and so \n",
      "long as such action is in accordance with applicable laws. for example, \n",
      "for data types for which 45 cfr part 162 standards are the only ones \n",
      "widely used throughout the payer community, and for specific content \n",
      "that payers typically only receive according to these hipaa standards, \n",
      "we believe use of the 45 cfr part 162 content standards to represent \n",
      "the information is appropriate and efficient at this juncture. we note \n",
      "that for data made available through the api, entities subject to this \n",
      "proposal would be required to use the standards identified in this \n",
      "proposal even if the exact information to be exchanged through the api \n",
      "is also required to be available through other mechanisms.\n",
      "    finally, we encourage payers or plans to implement additional, \n",
      "widely used, consensus-based standards identified by other means--such \n",
      "as by hhs for other purposes or through a consensus standards \n",
      "development organization--for additional data in their information \n",
      "systems for which no standard is adopted at 45 cfr part 162, 42 cfr \n",
      "423.160, or 45 cfr 170.213 to the extent feasible, while maintaining \n",
      "compatibility with the required api technical standards. we also \n",
      "encourage entities to pilot emerging standards identified by hhs, or by \n",
      "a consensus standards development organization through development or \n",
      "approval for trial use, where such a pilot maintains compatibility with \n",
      "the proposed api technical standards. however, ma organizations, state \n",
      "medicaid and chip agencies, medicaid managed care plans, chip managed \n",
      "care entities, and qhps in ffes that choose to make non-standardized \n",
      "data available through their apis would be required to ensure that \n",
      "their api documentation provides sufficient information to an \n",
      "application developer for their applications to handle this information \n",
      "accurately and automatically. we welcome public comment on these \n",
      "proposals.\n",
      "\n",
      "c. api standard\n",
      "\n",
      "    in section iii.c.2.b. of this proposed rule, we propose to require \n",
      "compliance with the api technical standard proposed by onc for hhs \n",
      "adoption at 45 cfr 170.215 (published elsewhere in this issue of the \n",
      "federal register). by requiring compliance with 45 cfr 170.215, we are \n",
      "proposing in section iii.c.2.b. of this proposed rule to require use of \n",
      "the foundational health level 7 (hl7[supreg]) \\23\\ fast healthcare \n",
      "interoperability resources (fhir[supreg]) standard,\\24\\ several \n",
      "implementation specifications specific to fhir, and complementary \n",
      "security and app registration protocols (oauth 2.0 and openid connect \n",
      "core).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\23\\ health level seven international (hl7[supreg]) is a not-\n",
      "for-profit, ansi-accredited standards development organization (sdo) \n",
      "focused on developing consensus standards for the exchange, \n",
      "integration, sharing, and retrieval of electronic health information \n",
      "that supports clinical practice and the management, delivery and \n",
      "evaluation of health services. learn more at ``about hl7'' web page, \n",
      "last accessed 06/27/2018.)\n",
      "    \\24\\ <a href=\"https://www.hl7.org/fhir/overview.html\">https://www.hl7.org/fhir/overview.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the fhir standard holds great potential for supporting \n",
      "interoperability and enabling new entrants and competition throughout \n",
      "the health care industry. fhir leverages modern computing techniques to \n",
      "enable users to access health care ``resources'' over the internet via \n",
      "a standardized restful api. developers can create tools that interact \n",
      "with fhir apis to provide actionable data to their stakeholders. in the \n",
      "short time since fhir was first created, the health care industry has \n",
      "rapidly embraced the standard through substantial investments in \n",
      "industry pilots, specification development, and the deployment of fhir \n",
      "apis supporting a variety of business needs. with the exception of the \n",
      "api resource collection in health (arch) (proposed by onc for hhs \n",
      "adoption at 45 cfr 170.215(a)(2)), the api technology standards and \n",
      "implementation specifications proposed at 45 cfr 170.215 (published \n",
      "elsewhere in this issue of the federal register) are consensus \n",
      "technical standards that, under the national technology transfer & \n",
      "advancement act of 1995 (pub. l. 104-113, enacted march 7, 1996) and \n",
      "omb circular no. a-119, are, where available and their use not \n",
      "impracticable, preferred for use in government programs over both \n",
      "government-unique standards and standards developed using less rigorous \n",
      "consensus processes.\n",
      "    we note that while all apis that would be used by software \n",
      "applications to provide consumers access to their electronic health \n",
      "information would be required to adhere to the foundational fhir \n",
      "standard, and other essential standards such as security protocols \n",
      "applicable to the data exchanged, we do not anticipate that all of the \n",
      "standards, implementation specifications, and\n",
      "\n",
      "[[page 7625]]\n",
      "\n",
      "protocols proposed at 45 cfr 170.215 will be directly relevant to every \n",
      "use case reflected within the policies proposed in this rule. for \n",
      "example, authenticating end users' identities may not be needed where \n",
      "the information requested and released to an application through the \n",
      "api is limited to information otherwise published, such as provider \n",
      "directory information otherwise required by the programs' regulations \n",
      "to be made widely available.\n",
      "    we note that an api implemented by regulated entities described in \n",
      "section iii.c. of this proposed rule is not required to be certified by \n",
      "onc under the onc health it certification program for the related \n",
      "certification criteria. furthermore, because the data required to be \n",
      "made available by an api as proposed in section iii.c. of this proposed \n",
      "rule includes information beyond the uscdi version 1 data set (proposed \n",
      "by onc for hhs adoption at 45 cfr 170.213), certification to the onc \n",
      "certification criteria at 45 cfr 170.215 would not alone be sufficient \n",
      "to ensure the api's capacity to support the full range of data elements \n",
      "required under the proposal in section iii.c. of this proposed rule.\n",
      "    finally, we are aware that the implementation specifications \n",
      "currently proposed by onc for hhs adoption at 45 cfr 170.215 (published \n",
      "elsewhere in this issue of the federal register), in complement to the \n",
      "base fhir foundational standards, leave substantial work to be done by \n",
      "health it developers and their customers to build and deploy technology \n",
      "to support the proposals described in section iii.c.2.b. of this \n",
      "proposed rule. supplemental technical resources to support efficient \n",
      "and successful implementation of the foundational fhir standard can be \n",
      "developed by a variety of organizations. however, we recognize that \n",
      "there may be fewer applicable resources to support the development \n",
      "required under this rule. thus, hhs expects to provide organizations \n",
      "subject to the policies proposed in this proposed rule with technical \n",
      "assistance and subregulatory guidance that incorporates feedback from \n",
      "industry. we recommend readers review onc's 21st century cures act \n",
      "proposed rule to fully understand the scope and detail of the api \n",
      "standard and content and vocabulary standards proposed by onc for hhs \n",
      "adoption which apply to the proposals included in this proposed rule. \n",
      "we further recommend readers review the publicly available resources \n",
      "available on the hl7 fhir standard (<a href=\"https://www.hl7.org/fhir/overview.html\">https://www.hl7.org/fhir/overview.html</a>) and the uscdi version 1 standard (<a href=\"https://www.healthit.gov/uscdi\">https://www.healthit.gov/uscdi</a>), respectively. these publicly available \n",
      "materials will inform readers understanding of the requirements under \n",
      "this proposed rule and, we expect, will also assist stakeholders in \n",
      "drafting comments submitted within this rulemaking proceeding.\n",
      "    as noted in our proposal in section iii.c.2.b. of this proposed \n",
      "rule, we have determined to align our proposal to the types of data, \n",
      "technology use, and available standards that are consistent with an \n",
      "overall hhs approach to support interoperability while mitigating \n",
      "provider and developer burden by requiring compliance with applicable \n",
      "hhs regulations. we hope to see continued innovation and advancement in \n",
      "standards development for identified gaps in health information data \n",
      "classes and data elements, as well as improved bi-directional patient \n",
      "engagement functionalities. for example, we are not proposing to \n",
      "require that organizations subject to the requirements proposed in \n",
      "section iii.c. of this proposed rule offer patients or providers the \n",
      "ability through the api to write information directly to patient \n",
      "records held by the organization. however, we hope that organizations \n",
      "and their health it developers build on the api technology we do \n",
      "propose to require and accelerate innovation responsive to providers' \n",
      "and patients' calls for api write functionality at the fastest pace \n",
      "practicable given the maturity of needed standards. we believe this \n",
      "innovation may be fostered by the concrete steps forward in data \n",
      "exchange and api capabilities we are proposing to require across the \n",
      "significant segment of payers subject to this proposed rule.\n",
      "\n",
      "d. updates to standards\n",
      "\n",
      "    in addition to our efforts to align standards across hhs, we \n",
      "recognize that while we must codify in regulation a specific version of \n",
      "each standard, the need for continually evolving standards development \n",
      "has historically outpaced our ability to amend regulatory text. in \n",
      "order to address how standards development can outpace our rulemaking \n",
      "schedule, we propose in section iii.c.2.b. of this proposed rule that \n",
      "regulated entities may use updated versions of required standards if \n",
      "use of the updated version is required by other applicable law.\n",
      "    in addition, under certain circumstances, we propose to allow use \n",
      "of an updated version of a standard if the standard is not prohibited \n",
      "under other applicable law. where a single standard is updated more \n",
      "than once in a brief period of time and upon review of the standard hhs \n",
      "determines that--to reduce fragmentation and preserve efficacy--only \n",
      "the latest of the updated versions should be used. we will publish \n",
      "subregulatory guidance to that effect.\n",
      "    for content and vocabulary standards at 45 cfr part 162 or 42 cfr \n",
      "423.160, we propose to allow the use of an updated version of the \n",
      "content or vocabulary standard adopted under this rulemaking, unless \n",
      "the use of the updated version of the standard is prohibited for \n",
      "entities regulated by that part or the program under that section, or \n",
      "prohibited by the secretary for purposes of these policies or for use \n",
      "in onc's health it certification program, or is precluded by other \n",
      "applicable law.\n",
      "    for the content and vocabulary standards proposed by onc for hhs \n",
      "adoption at 45 cfr 170.213 (uscdi version 1),\\25\\ as well as for api \n",
      "interoperability standards proposed by onc for hhs adoption at 45 cfr \n",
      "170.215 (including hl7 fhir and other standards discussed above),\\26\\ \n",
      "we propose to allow the use of an updated version of a standard adopted \n",
      "by hhs, provided such updated version has been approved by the national \n",
      "coordinator through the standards version advancement process described \n",
      "in onc's 21st century cures act proposed rule (published elsewhere in \n",
      "this issue of the federal register).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\25\\ for more information on the uscdi, see <a href=\"https://www.healthit.gov/uscdi\">https://www.healthit.gov/uscdi</a>.\n",
      "    \\26\\ for more information on fhir, see <a href=\"https://www.hl7.org/fhir/overview.html\">https://www.hl7.org/fhir/overview.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    as described in the onc 21st century cures act proposed rule, under \n",
      "the proposed onc standards version advancement process, onc would allow \n",
      "health it developers participating in the onc health it certification \n",
      "program to voluntarily use updated versions of adopted standards in \n",
      "their certified health it modules, so long as certain conditions are \n",
      "met. the proposed standards version advancement process flexibility \n",
      "gives health it developers the option to avoid unnecessary costs and is \n",
      "expected to help reduce market confusion by enabling certified health \n",
      "it modules to keep pace with standards advancement and market needs. \n",
      "once a standard has been adopted for use in onc's health it \n",
      "certification program through notice and comment rulemaking, onc would \n",
      "undertake an annual, open and transparent process, including \n",
      "opportunity for public comment, to timely ascertain whether a more \n",
      "recent version of that standard or implementation specification should \n",
      "be approved for developers' voluntary use. onc expects to use an \n",
      "expanded section\n",
      "\n",
      "[[page 7626]]\n",
      "\n",
      "of the interoperability standards advisory (isa) web platform to \n",
      "facilitate the public transparency and engagement process, and to \n",
      "publish each year's final list of national coordinator-approved \n",
      "advanced versions that health it developers could elect to use \n",
      "consistent with the standards version advancement process. (for more \n",
      "detail, please see section viii.b.5. of onc's 21st century cures act \n",
      "proposed rule (published elsewhere in this issue of the federal \n",
      "register).) we believe that permitting the use of updates to standards \n",
      "at 45 cfr 170.213 and 170.215 consistent with the onc standards version \n",
      "advancement process will enhance alignment and foster improved \n",
      "interoperability across the health system.\n",
      "    in providing flexibility to the plans and payers that will be \n",
      "required to implement apis that use the content and vocabulary \n",
      "standards identified in this proposed rule, we also believe it is \n",
      "important to maintain compatibility and avoid a disruption or reduction \n",
      "in data availability to the end user. entities subject to the proposed \n",
      "regulations seeking to use an updated version of a standard must \n",
      "consider factors such as the impact of differences between standards \n",
      "versions and the potential burden on developers and end users to \n",
      "support transitioning between versions. we expect that these practical \n",
      "considerations to maintain compatibility and avoid disruption will \n",
      "discourage premature use of new versions of a standard.\n",
      "    therefore, we propose in section iii.c.2.b. of this proposed rule \n",
      "that an entity may use an updated version of a required standard so \n",
      "long as use of the updated version does not disrupt an end user's \n",
      "ability to access the data available through the api proposed in \n",
      "section iii. of this proposed rule. entities that would be required to \n",
      "implement an open api under this rulemaking would be free to upgrade to \n",
      "newer versions of the required standards, subject only to those \n",
      "limiting conditions noted here, at any pace they wish. however, they \n",
      "must continue to support connectivity, and make the same data \n",
      "available, for end users using applications that have been built to \n",
      "support only the hhs-adopted version(s) of the api standards.\n",
      "    we welcome public comment on this proposed approach to allow \n",
      "voluntary use of updated versions of these standards.\n",
      "\n",
      "iii. patient access through apis\n",
      "\n",
      "a. background on medicare blue button\n",
      "\n",
      "    we are committed to advancing interoperability, putting patients at \n",
      "the center of their health care, and ensuring they have simple and easy \n",
      "access, without special effort, to their health information. with the \n",
      "establishment of the initial medicare blue button[supreg] service in \n",
      "2010, medicare beneficiaries became able to download their part a, part \n",
      "b, and part d health care claims data through <a href=\"http://mymedicare.gov\">mymedicare.gov</a> in either \n",
      "pdf or text format. while the original blue button effort was a first \n",
      "step towards liberating patient health information, we recognize that \n",
      "significant opportunities remain to modernize access to that health \n",
      "information and the ability to share health information across the \n",
      "health ecosystem. we believe that moving to a system in which patients \n",
      "have access to and use of their health information will empower them to \n",
      "make better informed decisions about their health care. additionally, \n",
      "interoperability, and the ability for health information systems and \n",
      "software applications to communicate, exchange, and interpret health \n",
      "information in a usable and readable format, is vital to improving \n",
      "health care. allowing access to health information only through pdf and \n",
      "text format limits the utility and sharing of the health information.\n",
      "    medicare blue button 2.0 is a new, modernized version of the \n",
      "original blue button service. it enables beneficiaries to access their \n",
      "medicare parts a, b, and d claims data and share that electronic health \n",
      "information through an application program interface (api) with \n",
      "applications, services, and research programs they select. as discussed \n",
      "in more detail in section ii.a. of this proposed rule, api technology \n",
      "allows software from different developers to connect with one another \n",
      "and exchange electronic health information in electronic formats that \n",
      "can be more easily compiled and leveraged by patients and their \n",
      "caregivers. beneficiaries may also select third-party applications to \n",
      "compile and leverage their electronic health information to help them \n",
      "manage their health and engage in a more fully informed way in their \n",
      "health care.\n",
      "    medicare blue button 2.0 is expected to foster increased \n",
      "competition among technology innovators who serve medicare patients and \n",
      "their caregivers, such as through finding better ways to use claims \n",
      "data to address their health needs. patients should have the ability to \n",
      "access their health information, in a format of their choosing, to \n",
      "receive a full picture of their health records. api technology can be \n",
      "an effective way to share data because health information from various \n",
      "sources can be retrieved through these secure interfaces and \n",
      "consolidated by a single tool, such as a third-party application chosen \n",
      "by, in the case of medicare, the beneficiary or their caregiver.\n",
      "    the medicare blue button 2.0 api is also expected to improve the \n",
      "medicare beneficiary experience by providing beneficiaries secure \n",
      "access to their claims data in a standardized, computable format. we \n",
      "recognize that data security is of the utmost importance and are \n",
      "dedicated to safeguarding patient health information so that only the \n",
      "beneficiary and their authorized personal representative would have the \n",
      "ability to authorize release of their health information through \n",
      "medicare blue button 2.0 to a third-party software application.\n",
      "    medicare blue button 2.0 will provide beneficiaries with a \n",
      "longitudinal view of their medicare claims data, which can then be \n",
      "combined with other health information within third party applications. \n",
      "one benefit of making records available via an api is that it enables a \n",
      "beneficiary to pull medicare health information along with other heath \n",
      "information into a single application not dictated by any specific \n",
      "health plan, provider, or portal. apis allow health information to move \n",
      "through the health ecosystem with the patient and ensure comprehensive \n",
      "and timely information is accessible even if the patient changes health \n",
      "plans, providers, or both over time, facilitating continuity of care.\n",
      "\n",
      "b. expanding the availability of health information\n",
      "\n",
      "1. benefits of information access\n",
      "    we believe there are numerous benefits associated with individuals \n",
      "having simple and easy access to their health care data under a \n",
      "standard that is widely used. claims and encounter data, used in \n",
      "conjunction with ehr data, can offer a broader and more holistic \n",
      "understanding of an individual's interactions with the health care \n",
      "system than ehr data alone. for example, inconsistent benefit \n",
      "utilization patterns in an individual's claims data, such as a failure \n",
      "to fill a prescription or receive recommended therapies, can indicate \n",
      "that the individual has had difficulty adhering to a treatment regimen \n",
      "and may require less expensive prescription drugs or therapies, \n",
      "additional explanation about the severity of their condition, or other \n",
      "types of assistance. identifying and\n",
      "\n",
      "[[page 7627]]\n",
      "\n",
      "finding opportunities to address the individual's non-adherence to a \n",
      "care plan are critical to keeping people with chronic conditions \n",
      "healthy and engaged so they can avoid hospitalizations. while a health \n",
      "plan can use claims and encounter data to help it identify which \n",
      "enrollees could benefit from an assessment of why they are not filling \n",
      "their prescriptions or who might be at risk for particular problems, \n",
      "putting this information into the hands of the individual's chosen care \n",
      "provider--such as the doctor or nurse practitioner prescribing the \n",
      "medications or the pharmacist who fills the prescriptions--helps them \n",
      "to engage the patient in shared decision making that can help address \n",
      "some of the reasons the individual might not be willing or able to take \n",
      "medications as prescribed. by authorizing their providers to access the \n",
      "same information through the open api, individuals can further \n",
      "facilitate communication with their care teams. enabling the provider \n",
      "to integrate claims and encounter information with ehr data gives the \n",
      "provider the ability to use the combined information, with relevant \n",
      "clinical decision support tools, as part of normal care delivery in a \n",
      "less burdensome way, leading to improved care. this may be particularly \n",
      "important during times of system surge, for example, in the event of an \n",
      "event that generates a large and sudden demand for health services, \n",
      "when access to such information may help to inform patient triage, \n",
      "transfer, and care decisions.\n",
      "    further, consumers who have immediate electronic access to their \n",
      "health information are empowered to make more informed decisions when \n",
      "discussing their health needs with providers, or when considering \n",
      "changing to a different health plan. in many cases, claims and \n",
      "encounter data can provide a more holistic and comprehensive view of a \n",
      "patient's care history than ehr data alone. whereas ehr data is \n",
      "frequently locked in closed, disparate health systems, care and \n",
      "treatment information in the form of claims and encounter data is \n",
      "comprehensively combined in a patient's claims and billing history. \n",
      "currently, not all beneficiaries enrolled in ma plans have immediate \n",
      "electronic access to their claims and encounter data and those who do \n",
      "have it, cannot easily share it with providers or others. the same is \n",
      "true of medicaid beneficiaries and chip enrollees, whether enrolled in \n",
      "ffs or managed care programs, and enrollees in qhps in ffes. as \n",
      "industries outside of health care continue to integrate multiple \n",
      "sources of data to understand and predict their consumers' needs, we \n",
      "believe it is important to position ma organizations, medicaid and chip \n",
      "managed care entities, and qhp issuers in ffes to do the same to \n",
      "encourage competition, innovation, and value. further, we believe that \n",
      "beneficiaries in medicaid ffs programs administered by state medicaid \n",
      "agencies and chip enrollees in both ffs and managed care should benefit \n",
      "from similar advances and the benefits of innovation and value.\n",
      "    cms has programmatic authority over ma organizations, medicaid \n",
      "programs (both ffs and managed care), chip (including ffs and managed \n",
      "care), and qhp issuers in ffes. this proposed rule seeks to leverage \n",
      "that cms authority to make claims and encounter data available to \n",
      "patients in these programs along with other plan data (such as provider \n",
      "directory data) as detailed in sections iii.c. and iv. of this proposed \n",
      "rule. we propose that regulated entities make this data available in a \n",
      "standardized format and through a specific technological means so that \n",
      "third parties can develop and make available applications that make the \n",
      "data available for patient use in a convenient and timely manner. our \n",
      "proposal would require compliance with specific regulations regarding \n",
      "interoperability standards adopted by the secretary in implementing and \n",
      "complying with the proposed requirement to use an api to make this data \n",
      "available. we are proposing to require compliance with 45 cfr 170.215 \n",
      "to require the api technical standards that onc is proposing for hhs \n",
      "adoption in its 21st century cures act proposed rule (published \n",
      "elsewhere in this issue of the federal register). we are also proposing \n",
      "to require that the data elements made available through the proposed \n",
      "api technology must be formatted and presented in accordance with \n",
      "applicable content and vocabulary standards as described in section ii. \n",
      "of this proposed rule. this means that the software receiving and using \n",
      "the data can readily consume the data to support consumer-friendly \n",
      "display and other functionalities.\n",
      "    ultimately, the goal of this proposal is to require that patient \n",
      "data be made available in a standardized format through an api, so that \n",
      "third parties can develop and offer applications that make the data \n",
      "available in a convenient and timely manner for enrollees and \n",
      "beneficiaries in ma plans, medicaid and chip ffs and managed care \n",
      "delivery systems, and ffes that are specified in our proposal as \n",
      "detailed below.\n",
      "2. alignment with the hipaa right of access\n",
      "    the hipaa privacy rule, at 45 cfr 164.524, provides that \n",
      "individuals have a right of access to inspect and obtain a copy of phi, \n",
      "defined at 45 cfr 160.103, about them that is maintained by a health \n",
      "plan or covered health care provider in a designated record set, \n",
      "defined at 45 cfr 164.501. the right of access also provides \n",
      "individuals with the right to initiate disclosures to third parties.\n",
      "    software applications using the api proposed in 42 cfr 422.119, \n",
      "431.60, 438.242(b)(6), 457.730, 457.1233(d)(2), and 45 cfr 156.221 \n",
      "would provide an additional mechanism through which the individuals in \n",
      "that coverage who so choose can exercise the hipaa right of access to \n",
      "their phi, by giving them a simple and easy electronic way to request, \n",
      "receive, and share data that they want and need, including with a \n",
      "designated third party. however, as discussed in section ii of this \n",
      "proposed rule, due to limitations in current availability of \n",
      "interoperability standards for some types of data and patient's rights \n",
      "to be granted access in the form and manner of their own choosing, the \n",
      "api requirement may not be sufficient to support access to all of the \n",
      "health information subject to the hipaa right of access because it may \n",
      "not all be transferable through the api.\n",
      "\n",
      "c. open api proposal for ma, medicaid, chip, and qhp issuers in ffes\n",
      "\n",
      "1. introduction\n",
      "    we are proposing to add new provisions at 42 cfr 422.119, 431.60, \n",
      "438.242(b)(6), 457.730, 457.1233(d) and 45 cfr 156.221, that would, \n",
      "respectively, require ma organizations, state medicaid ffs programs, \n",
      "medicaid managed care plans, chip ffs programs, chip managed care \n",
      "entities, and qhp issuers in ffes (excluding issuers of sadps) to \n",
      "implement, test, and monitor an openly-published api that is accessible \n",
      "to third-party applications and developers. we note that states with \n",
      "chips are not required to operate ffs systems and that some states' \n",
      "chips are exclusively operated by managed care entities. we do not \n",
      "intend to require chips that do not operate a ffs program to establish \n",
      "an api; rather, these states may rely on their contracted plans, \n",
      "referred to throughout this proposed rule as chip managed care \n",
      "entities, to set up such a system.\n",
      "    the api would allow enrollees and beneficiaries of ma \n",
      "organizations, medicaid and chip ffs programs, medicaid managed care \n",
      "plans, chip\n",
      "\n",
      "[[page 7628]]\n",
      "\n",
      "managed care entities, and qhp issuers in ffes to exercise \n",
      "electronically their hipaa right of access to certain health \n",
      "information specific to their plan, through the use of common \n",
      "technologies and without special effort. common technologies, for \n",
      "purposes of our proposal, are those that are widely used and readily \n",
      "available, such as computers, smartphones or tablets.\n",
      "    we are proposing that the api would be required to meet certain \n",
      "interoperability standards, consistent with the api technical standards \n",
      "proposed by onc for hhs adoption in its proposed rule (published \n",
      "elsewhere in this issue of the federal register), as well as to require \n",
      "the use of content and vocabulary standards adopted by hhs and that the \n",
      "use of these standards would be applicable across the specific entities \n",
      "subject to proposed 42 cfr 422.119, 431.60, 438.242(b)(6), 457.730, and \n",
      "457.1233(d), and 45 cfr 156.221. in this context, these standards are \n",
      "critical to ensure that enrollees of those plans and programs have \n",
      "electronic access to their health information in interoperable form and \n",
      "that access to their health information and information about their \n",
      "coverage are not obstructed by, or confined to, certain propriety \n",
      "systems.\n",
      "    under our proposal, the scope and volume of the information to be \n",
      "provided or made accessible through the open api would include: \n",
      "adjudicated claims (including cost); encounters with capitated \n",
      "providers; provider remittances; enrollee cost-sharing; and clinical \n",
      "data, including laboratory results (where available). we propose that \n",
      "these programs and organizations, with the exception of the qhp issuers \n",
      "in ffes, would also be required to make information regarding provider \n",
      "directories and formularies available through the open api. sections \n",
      "1852(c), 1932(a)(5), and 2103(f)(3) of the act require that ma \n",
      "organizations and medicaid mcos, and chip managed care entities provide \n",
      "basic information to their enrollees on how to get covered benefits in \n",
      "the plan and to facilitate decision making about plan choice, \n",
      "providers, and benefits. these statutory provisions indicate \n",
      "information enrollees could use to make decisions about their health \n",
      "care. the api proposals at 42 cfr 422.119(a), 438.242(b)(6), and \n",
      "457.1233(d) support and complement existing implementation of these \n",
      "provisions in a robust and modern way. we believe the health \n",
      "information that would be available through the proposed api would \n",
      "greatly supplement the benefit, provider directory, and, if applicable, \n",
      "formulary information from states and managed care plans by providing \n",
      "important details and context, thus enabling enrollees to make more \n",
      "informed, proactive decisions.\n",
      "    additionally, we believe that since most of the information \n",
      "required to be provided by these statutory sections of the act, such as \n",
      "the provider directory, is currently accessible to enrollees and \n",
      "potential enrollees electronically online, making such standardized \n",
      "health information available through the proposed api could allow easy \n",
      "integration for use by more enrollees. further, the proposal would \n",
      "enable these enrollees to more easily share their information with \n",
      "providers, family, caregivers, and others. as a general matter, \n",
      "providing important details and context to patients gives them more \n",
      "visibility into their treatment record through adjudicated claims, \n",
      "allowing them to be true partners in their health care. this goal is \n",
      "related to the disclosure requirements in sections 1852, 1932 and 2103 \n",
      "of the act and our proposal furthers each.\n",
      "    we also believe the proposed api allows for the administration of \n",
      "more efficient and effective medicaid and chip programs by taking \n",
      "advantage of commonly used methods of information sharing and data \n",
      "standardization. consumers routinely perform many daily tasks on their \n",
      "mobile phones--banking, shopping, paying bills, scheduling--using \n",
      "secure applications. we believe that obtaining their health information \n",
      "should be just as easy, convenient, and user-friendly. our proposal is \n",
      "a step toward that vision for enrollees in ma plans, medicaid ffs and \n",
      "managed care programs, chip ffs programs and managed care entities, and \n",
      "qhps in ffes. finally, our proposal includes a number of parameters and \n",
      "standards for the api and for adopting, implementing, testing, and \n",
      "monitoring the api; the specific pieces of our proposal are addressed \n",
      "in turn in sections iii.c.2 of this proposed rule.\n",
      "2. the open api proposal\n",
      "    this section outlines the components of the open api proposal. \n",
      "specifically, this section will discuss:\n",
      "    <bullet> authority to require implementation of an open api;\n",
      "    <bullet> the api technical standard and content and vocabulary \n",
      "standards;\n",
      "    <bullet> data required to be available through the open api & \n",
      "timeframes for data availability;\n",
      "    <bullet> documentation requirements for apis;\n",
      "    <bullet> routine testing and monitoring of open apis;\n",
      "    <bullet> compliance with existing privacy and security \n",
      "requirements;\n",
      "    <bullet> denial or discontinuation of access to the api;\n",
      "    <bullet> enrollee and beneficiary resources regarding privacy and \n",
      "security;\n",
      "    <bullet> exceptions or provisions specific to certain programs or \n",
      "sub-programs;\n",
      "    <bullet> applicability and timing; and\n",
      "    <bullet> request for information on information sharing between \n",
      "payers and providers through apis.\n",
      "    we are proposing nearly identical language for the regulations \n",
      "requiring open apis at 42 cfr 422.119; 431.60, and 457.730 and 45 cfr \n",
      "156.221 for ma organizations, medicaid state agencies, state chip \n",
      "agencies, and qhps in ffes; medicaid managed care plans would be \n",
      "required at 42 cfr 438.242(b)(6), to comply with the requirement at 42 \n",
      "cfr 431.60, and chip managed care entities would be required by 42 cfr \n",
      "457.1233(d)(2) to comply with the requirement at 42 cfr 457.730. as \n",
      "discussed in detail in this proposed rule, we are proposing similar if \n",
      "not identical requirements for these various entities to establish and \n",
      "maintain an open api, make specified data available through that api, \n",
      "disclose api documentation, provide access to the api, and make \n",
      "resources available to enrollees. we believe that such nearly identical \n",
      "text is appropriate here as the reasons and need for the proposal and \n",
      "the associated requirements are the same across these programs. except \n",
      "as noted below with regard to specific proposals, we intend to \n",
      "interpret and apply the regulations proposed in this section, iii.c. of \n",
      "this proposed rule, similarly and starting with similar text is an \n",
      "important step to communicate that to the applicable entities that \n",
      "would be required to comply.\n",
      "    in paragraph (a) of each of the proposed regulations, we propose \n",
      "that the regulated entity (that is, the ma organization, the state \n",
      "medicaid or chip agency, the medicaid managed care plan, the chip \n",
      "managed care entity or the qhp in an ffe, as applicable) would be \n",
      "required to implement and maintain an open api that permits third-party \n",
      "applications to retrieve, with the approval and at the direction of the \n",
      "individual beneficiary, data specified in paragraph (b) of each \n",
      "regulation through the use of common technologies and without special \n",
      "effort from the beneficiary. by ``common technologies and without \n",
      "special effort'' by the enrollee, we mean use of common consumer \n",
      "technologies, like smart phones, home computers, laptops or tablets, to \n",
      "request, receive, use and approve transfer of the data that would be \n",
      "available through the open api technology. by ``without special \n",
      "effort,'' we codify our expectation that third-\n",
      "\n",
      "[[page 7629]]\n",
      "\n",
      "party software, as well as proprietary applications and web portals \n",
      "operated by the payer could be used to connect to the api and provide \n",
      "access to the data to the enrollee. in our proposed regulations, we \n",
      "address the data that must be made available through the api in \n",
      "paragraph (b); the regulation regarding the technical standards for the \n",
      "api and the data it contains in paragraph (c); the documentation \n",
      "requirements for the api in paragraph (d); explicit authority for the \n",
      "payer regulated under each regulation to deny or discontinue access to \n",
      "the api in paragraph (e); and requirements for posting information \n",
      "about resources on security and privacy for beneficiaries in paragraphs \n",
      "(f) or (g). additional requirements specific to each program, discussed \n",
      "in sections iv. and v. of this proposed rule, are also included in some \n",
      "of the regulations that address the api.\n",
      "    we solicit comment on our use of virtually identical language in \n",
      "these regulations and our overall proposal to require implementation \n",
      "and maintenance of an open api.\n",
      "a. authority to require implementation of an open api\n",
      "    our proposal would apply to ma organizations, medicaid state \n",
      "agencies and managed care plans, state chip agencies and managed care \n",
      "entities, and qhp issuers in ffes. we note that our proposal for \n",
      "medicaid managed care plans, at 42 cfr 438.242(b)(6), would require \n",
      "mcos, pihps, and pahps to comply with the regulation that we are \n",
      "proposing for medicaid state agencies at 42 cfr 431.60 as if that \n",
      "regulation applied to the medicaid managed care plan. similarly, we \n",
      "intend for chip managed care entities to comply with the requirements \n",
      "we propose at 42 cfr 457.730 via the regulations proposed at 42 cfr \n",
      "457.1233(d)(2). we propose to structure the regulations this way to \n",
      "avoid ambiguity and to ensure that this api proposal would result in \n",
      "consistent access to information for medicaid beneficiaries and chip \n",
      "enrollees, regardless of whether they are in a ffs delivery system \n",
      "administered by the state or in a managed care delivery system. chip \n",
      "currently adopts the medicaid requirements at 42 cfr 438.242 in whole. \n",
      "we propose revisions to 42 cfr 457.1233(d)(1) to indicate chip's \n",
      "continued adoption of 42 cfr 438.242(a), (b)(1) through (5), (c), (d), \n",
      "and (e), while proposing specific text for chip managed care entities \n",
      "to comply with the regulations proposed at 42 cfr 457.1233(d)(2) in \n",
      "lieu of the proposed medicaid revision, which would add 42 cfr \n",
      "438.242(b)(6). in our discussion of the specifics of this proposal and \n",
      "how we propose to codify it at 42 cfr 422.119, 431.60, 457.730, and 45 \n",
      "cfr 156.221, we refer only generally to 42 cfr 438.242(b)(6) and \n",
      "457.1233(d)(2) for this reason.\n",
      "(1) medicare advantage\n",
      "    sections 1856(b) and 1857(e) of the act provide cms with the \n",
      "authority to add standards and requirements for ma organizations that \n",
      "the secretary finds necessary and appropriate and not inconsistent with \n",
      "part c of the medicare statute; section 1852(c) of the act requires \n",
      "disclosure by ma organizations of specific information about the plan, \n",
      "covered benefits, and the network of providers; section 1852(h) of the \n",
      "act requires ma organizations to provide their enrollees with timely \n",
      "access to medical records and health information insofar as ma \n",
      "organizations maintain such information. as technology evolves to allow \n",
      "for faster, more efficient methods of information transfer, so do \n",
      "expectations as to what is generally considered ``timely.'' currently, \n",
      "consumers across public and private sectors have become increasingly \n",
      "accustomed to accessing a broad range of personal records, such as bank \n",
      "statements, credit scores, and voter registrations, immediately through \n",
      "electronic means and with updates received in near real time. thus, we \n",
      "believe that in order to align our standards with 21st century demands, \n",
      "we must take steps for ma enrollees to have immediate, electronic \n",
      "access to their health information and plan information. the proposed \n",
      "requirements in this rule are intended to achieve this goal.\n",
      "    we believe that the scope of the information that would be made \n",
      "available through an api under this proposal (described in section iii. \n",
      "of this proposed rule) is consistent with the access and disclosure \n",
      "requirements in section 1852 of the act, and we rely on our authority \n",
      "in sections 1856(b) and 1857(e) of the act, which provide cms with the \n",
      "authority to add standards and requirements for ma organizations, to \n",
      "require ma organizations to make specific types of information, at \n",
      "minimum, accessible through an open api and require timeframes for \n",
      "update cycles. throughout this section iii.c. of this proposed rule, we \n",
      "explain how and why the open api proposal is necessary and appropriate \n",
      "for ma organizations and the ma program; the goals and purposes of \n",
      "achieving interoperability for the health care system as a whole are \n",
      "equally applicable to ma organizations and their enrollees; thus, the \n",
      "discussion in section ii of this proposed rule serves to provide \n",
      "further explanation as to how an open api proposal is necessary and \n",
      "appropriate in the ma program. further, having easy access to their \n",
      "claims, encounter, and other health information would also facilitate \n",
      "beneficiaries' ability to detect and report fraud, waste, and abuse--a \n",
      "critical component of an effective program.\n",
      "    to the extent necessary, we also rely on section 1860d-12(b)(3) of \n",
      "the act to add provisions specific to the part d benefit offered by \n",
      "certain ma organizations. for ma organizations that offer ma \n",
      "prescription drug plans, we are proposing requirements in 42 cfr \n",
      "422.119(b)(2) regarding electronic health information for part d \n",
      "coverage. that aspect of our proposal is also supported by the \n",
      "disclosure requirements imposed under section 1860d-4(a) of the act, \n",
      "which requires part d claims information, pharmacy directory \n",
      "information, and formulary information to be disclosed to enrollees.\n",
      "(2) medicaid and chip\n",
      "    we are proposing new provisions at 42 cfr 431.60(a), 457.730, \n",
      "438.242(b)(6), and 457.1233(d)(2) that would require states \n",
      "administering medicaid ffs or chip ffs, medicaid managed care plans, \n",
      "and chip managed care entities to implement an open api that permits \n",
      "third-party applications authorized by the beneficiary or enrollee to \n",
      "retrieve certain standardized data. this proposed requirement would \n",
      "provide medicaid beneficiaries' and chip enrollees simple and easy \n",
      "access to their information through common technologies, such as \n",
      "smartphones, tablets, or laptop computers, and without special effort \n",
      "on the part of the user.\n",
      "    for medicaid, we are proposing these new requirements under the \n",
      "authority in section 1902(a)(4) of the act, which requires that a state \n",
      "medicaid plan for medical assistance provide such methods of \n",
      "administration as are found by the secretary to be necessary for the \n",
      "proper and efficient operation of the plan and section 1902(a)(19) of \n",
      "the act, which requires that care and services be provided in a manner \n",
      "consistent with simplicity of administration and the best interests of \n",
      "the recipients. for chip, we propose these requirements under the \n",
      "authority in section 2101(a) of the act, which sets forth that the \n",
      "purpose of title xxi is to provide funds to states to provide child \n",
      "health assistance to uninsured, low-income children in an effective and \n",
      "efficient manner that is coordinated with other sources of health \n",
      "benefits coverage. together these provide us with authority (in \n",
      "conjunction with our\n",
      "\n",
      "[[page 7630]]\n",
      "\n",
      "delegation of authority from the secretary) to adopt requirements for \n",
      "medicaid and chip that are necessary to ensure the provision of quality \n",
      "care in an efficient and cost-effective way, consistent with simplicity \n",
      "of administration and the best interest of the beneficiary.\n",
      "    we believe that requiring state medicaid and chip agencies and \n",
      "managed care plans/entities to take steps to make medicaid \n",
      "beneficiaries' and chip enrollees' claims, encounters, and other health \n",
      "information available through interoperable technology will ultimately \n",
      "lead to these enrollees accessing that information in a convenient, \n",
      "timely, and portable way, which is essential for these programs to be \n",
      "effectively and efficiently administered in the best interests of \n",
      "beneficiaries. further, as noted in this proposed rule, there are \n",
      "independent statutory provisions that require the disclosure and \n",
      "delivery of information to medicaid beneficiaries and chip enrollees; \n",
      "this proposal assists in the implementation of those requirements in a \n",
      "way that is appropriate and necessary in the 21st century. we believe \n",
      "making this information available in this format would result in better \n",
      "health outcomes and patient satisfaction and improve the cost \n",
      "effectiveness of the entire health care system, including medicaid and \n",
      "chip. having easy access to their claims, encounter, and other health \n",
      "information would also facilitate beneficiaries' ability to detect and \n",
      "report fraud, waste, and abuse--a critical component of an effective \n",
      "program.\n",
      "    as technology has advanced, we have encouraged states, health \n",
      "plans, and providers to adopt various forms of technology to improve \n",
      "the accurate and timely exchange of standardized health care \n",
      "information. this proposal would move medicaid and chip programs in the \n",
      "direction of enabling better information access by medicaid \n",
      "beneficiaries and chip enrollees, which would make them active partners \n",
      "in their health care through the exchange of electronic health \n",
      "information by easily monitoring and sharing their data. by requiring \n",
      "that certain information be available in and through standardized \n",
      "formats and technologies, our proposal moves these programs toward \n",
      "interoperability, which is key for data sharing and access, and \n",
      "ultimately, improved health outcomes. as an additional note, states \n",
      "will be expected to implement the chip provisions using chip \n",
      "administrative funding, which is limited under section 2105(a)(1)(d)(v) \n",
      "and 2105(c)(2)(a) of the act to 10 percent of a state's total annual \n",
      "chip expenditures.\n",
      "(3) qualified health plan issuers in federally-facilitated exchanges\n",
      "    we propose a new qhp minimum certification standard at 45 cfr \n",
      "156.221(a) that would require qhp issuers in ffes, not including sadps, \n",
      "to implement an open api that permits third-party applications, with \n",
      "the approval and at the direction of the individual enrollee, to \n",
      "retrieve standardized data concerning adjudicated claims (including \n",
      "cost), encounters with capitated providers, and provider remittances, \n",
      "enrollee cost-sharing, and clinical data, including laboratory results \n",
      "(where available). we are also proposing to require that the data be \n",
      "made available to qhp enrollees through common technologies, such as \n",
      "smartphones or tablets, and without special effort from enrollees.\n",
      "    we are proposing these new requirements under our authority in \n",
      "section 1311(e)(1)(b) of the patient protection and affordable care \n",
      "act, as amended by the health care and education reconciliation act of \n",
      "2010 (pub. l. 111-148, enacted march 23, 2010, and pub. l. 111-152, \n",
      "enacted march 30, 2010, respectively) (collectively referred to as the \n",
      "affordable care act), which affords the exchanges the discretion to \n",
      "certify qhps that are in the best interests of qualified individuals \n",
      "and qualified employers. specifically, section 1311(e) of the \n",
      "affordable care act authorizes exchanges to certify qhps that meet the \n",
      "qhp certification standards established by the secretary, and if the \n",
      "exchange determines that making available such health plan through such \n",
      "exchange is in the interests of qualified individuals and qualified \n",
      "employers in the state or states in which such exchange operates.\n",
      "    we believe there are numerous benefits associated with individuals \n",
      "having access to their health plan data that is built upon widely used \n",
      "standards. the ability to easily obtain, use, and share claims, \n",
      "encounter, and other health data enables enrollees to more effectively \n",
      "and easily use the health care system. for example, by being able to \n",
      "easily access a comprehensive list of their adjudicated claims, the \n",
      "plan enrollee can ensure their providers know what services have \n",
      "already been received, avoid receiving duplicate services; and verify \n",
      "when prescriptions were filled. we believe these types of activities \n",
      "would result in better health outcomes and enrollee satisfaction and \n",
      "improve the cost effectiveness of the entire health care system. having \n",
      "simple and easy access, without special effort, to their health \n",
      "information, including cost and payment information, also facilitates \n",
      "enrollees' ability to detect and report fraud, waste, and abuse--a \n",
      "critical component of an effective program. existing and emerging \n",
      "technologies provide a path to make information and resources for \n",
      "health and health care management universal, integrated, equitable, \n",
      "accessible to all, and personally relevant. therefore, we believe \n",
      "generally certifying only health plans that make enrollees' health \n",
      "information available to them in a convenient, timely, and portable way \n",
      "is in the interests of qualified individuals and qualified employers in \n",
      "the state or states in which an ffe operates. we encourage sbes to \n",
      "consider whether a similar requirement should be applicable to qhp \n",
      "issuers participating in their exchange.\n",
      "b. api technical standard and content and vocabulary standards\n",
      "    we propose to require compliance with proposed 45 cfr 170.215 at 42 \n",
      "cfr 422.119(a) and (c), 431.60(a) and (c) and 457.730(a) and (c), \n",
      "438.242(b)(6) and 457.1233(d)(2), and 45 cfr 156.221(a) and (c), so \n",
      "that ma organizations, medicaid and chip ffs programs, medicaid managed \n",
      "care plans, chip managed care entities, and qhp issuers in ffes \n",
      "implement open api technology conformant with the proposed api \n",
      "technical standards (published elsewhere in this issue of the federal \n",
      "register) (see also section ii.a.3. of this proposed rule). we further \n",
      "propose to require compliance with the regulations regarding the \n",
      "following content and vocabulary standards for data available through \n",
      "the api, where applicable to the data type or data element, unless an \n",
      "alternate standard is required by other applicable law: standards \n",
      "adopted at 45 cfr part 162 and 42 cfr 423.160; and standards proposed \n",
      "by onc for adoption by hhs at 45 cfr 170.213 (uscdi version 1). see \n",
      "section ii.a.3. of this proposed rule for further information about our \n",
      "proposals regarding how entities subject to this rule would be required \n",
      "to utilize these standards. we are proposing that both the api \n",
      "technical standard and the content and vocabulary standards would be \n",
      "required across the ma program, medicaid program, and chip, and by qhp \n",
      "issuers in ffes (not including issuers of sadps).\n",
      "    further, with the new proposed requirements to implement and \n",
      "maintain an api at 42 cfr 422.119(a), 431.60(a), and 457.730(a), we are \n",
      "proposing corresponding requirements at proposed 42 cfr 422.119(c) for \n",
      "ma\n",
      "\n",
      "[[page 7631]]\n",
      "\n",
      "plans, 431.60(c) for medicaid ffs programs, and 457.730(c) for chip ffs \n",
      "programs implementing the proposed api technology. in proposed \n",
      "paragraphs 42 cfr 422.119(c), 431.60(c), 457.730(c), ma plans and the \n",
      "state medicaid or chip (for chip agencies that operate ffs systems) \n",
      "agency would be required to implement api technology conformant with \n",
      "the standards proposed by onc for hhs adoption at 45 cfr 170.215; for \n",
      "data available through the api, to use content and vocabulary standards \n",
      "adopted at 45 cfr part 162 and 42 cfr 423.160, and proposed for \n",
      "adoption at 45 cfr 170.213; and to maintain and use the technology in \n",
      "compliance with applicable law, including but not limited to 45 cfr \n",
      "parts 162, 42 cfr part 2, and the hipaa privacy and security rules.\n",
      "    we similarly propose at 45 cfr 156.221(c) that qhp issuers in ffes \n",
      "must implement api technology conformant with the api technical \n",
      "standards proposed by onc for hhs adoption at 45 cfr 170.215; for data \n",
      "available through the api, use content and vocabulary standards adopted \n",
      "at 45 cfr part 162 and 42 cfr 423.160, and proposed for adoption at 45 \n",
      "cfr 170.213; and maintain and use the technology in compliance with \n",
      "applicable law, including but not limited to 45 cfr part 162, 42 cfr \n",
      "part 2, and the hipaa privacy and security rules.\n",
      "    we believe that these proposals would serve to create a health care \n",
      "information ecosystem that allows and encourages the health care market \n",
      "to tailor products and services to better serve and compete for \n",
      "patients, thereby increasing quality, decreasing costs, and empowering \n",
      "patients with information that helps them live better, healthier lives. \n",
      "additionally, under these proposals, clinicians would be able to review \n",
      "information on their patient's current prescriptions and services \n",
      "received by the enrollee on the enrollee's smartphone. also, the \n",
      "enrollee could allow clinicians to access such information by sharing \n",
      "data received through the api with the clinician's ehr system--by \n",
      "forwarding the information once the enrollee receives it or by \n",
      "authorizing release of the data through the api directly to the \n",
      "clinician's ehr system.\n",
      "    we also encourage payers to consider using the proposed api \n",
      "infrastructure as a means to exchange phi for other health care \n",
      "purposes, such as to health care providers for treatment purposes. \n",
      "sharing interoperable information directly with the enrollee's health \n",
      "care provider's ehr in advance of a patient visit would save time \n",
      "during appointments and ultimately improve the quality of care \n",
      "delivered to patients. most clinicians and patients have access to the \n",
      "internet, providing many access points for viewing health information \n",
      "over secure connections. we believe that these proposed requirements \n",
      "would significantly improve patients' experiences by providing a \n",
      "mechanism through which they can access their data in a standardized, \n",
      "computable, and digital format in alignment with other public and \n",
      "private health care entities. we also believe that these proposals are \n",
      "designed to empower patients to have simple and easy access to their \n",
      "data in a usable digital format, and therefore, can empower them to \n",
      "decide how their health information is going to be used. however, we \n",
      "remind payers that this proposed regulation regarding the api would not \n",
      "lower or change their obligations as hipaa covered entities to comply \n",
      "with regulations regarding standard transactions in 45 cfr part 162.\n",
      "    as discussed in section ii.a.3. of this proposed rule, we recognize \n",
      "that while we must codify in regulation a specific version of each \n",
      "standard, the need for continually evolving standards development has \n",
      "historically outpaced our ability to amend regulations. to address how \n",
      "standards development can outpace our rulemaking schedule, we offer \n",
      "several proposals. we propose that regulated entities may use an \n",
      "updated version of a standard where required by other applicable law. \n",
      "we also propose that regulated entities may use an updated version of \n",
      "the standard where not prohibited by other applicable law, under \n",
      "certain circumstances. first, we propose to allow the use of an updated \n",
      "version of content or vocabulary standards adopted at 45 cfr part 162 \n",
      "or 42 cfr 423.160, unless the use of the updated version of the \n",
      "standard is prohibited for entities regulated by that part or the \n",
      "program under that section, is prohibited by the secretary for purposes \n",
      "of these policies, is prohibited for use in onc's health it \n",
      "certification program, or is prohibited by other applicable law.\n",
      "    second, for the content and vocabulary standards proposed by onc \n",
      "for hhs adoption at 45 cfr 170.213 (uscdi version 1), as well as for \n",
      "api interoperability standards proposed by onc for hhs adoption at 45 \n",
      "cfr 170.215 (including hl7 fhir and other standards discussed above), \n",
      "we propose to allow the use of an updated version, provided such \n",
      "updated version has been approved by the national coordinator through \n",
      "the standards version advancement process described in onc's 21st \n",
      "century cures act proposed rule (published elsewhere in this issue of \n",
      "the federal register).\n",
      "    finally, we propose that use of an updated standard by a payer that \n",
      "is subject to these proposed regulations must not disrupt an end user's \n",
      "ability to access the data available through the api proposed in \n",
      "section iii. of this proposed rule using an application that was \n",
      "designed to work with an api that conforms to the api standard proposed \n",
      "under onc's 21st century cures act proposed rule (published elsewhere \n",
      "in this issue of the federal register). entities that would be required \n",
      "to implement an open api under this rulemaking would be free to upgrade \n",
      "to newer versions of the required standards, subject only to those \n",
      "limiting conditions noted here, and at any pace they wish. however, \n",
      "they must continue to support connectivity and make the same data \n",
      "available to applications that have been built to support only the \n",
      "adopted version(s) of the api standards. for further discussion of \n",
      "these proposals, see section ii.a.3.d. of this proposed rule.\n",
      "c. data required to be available through the open api & timeframes for \n",
      "data availability\n",
      "    we propose the content that must be accessible for each enrollee of \n",
      "an entity subject to our open api proposal as set out at paragraph (b) \n",
      "of 42 cfr 422.119, 431.60, and 457.730 and 45 cfr 156.221; as noted \n",
      "previously, the regulations for medicaid managed care plans and chip \n",
      "managed care entities cross-reference and incorporate the regulations \n",
      "we propose for medicaid and chip programs. we note that the types of \n",
      "content proposed here would represent the minimum threshold for \n",
      "compliance; at their discretion, ma organizations, state medicaid and \n",
      "chip ffs programs, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers in ffes would have the option to use the api \n",
      "required by this proposed rule to make additional types of health \n",
      "information or plan information available, exceeding these minimum \n",
      "requirements.\n",
      "    we request comment on the data proposed to be made available as \n",
      "detailed in the subsections below, the appropriateness of the proposed \n",
      "timeframes, and suggestions for alternative timeframes that consider \n",
      "the utility to the beneficiary, as well as challenges that the proposed \n",
      "timeframe may create for the entities that would have to comply.\n",
      "\n",
      "[[page 7632]]\n",
      "\n",
      "(1) patient claims and encounter data\n",
      "    we propose that ma organizations, medicaid and chip ffs programs, \n",
      "medicaid managed care plans, chip managed care entities, and qhp \n",
      "issuers in ffes, permit third-party applications to retrieve, with the \n",
      "approval of an enrollee, certain specific data: adjudicated claims \n",
      "data, including provider remittances and beneficiary or enrollee cost-\n",
      "sharing data; encounters from capitated providers; and clinical data, \n",
      "including laboratory results (but only if managed by the payer). \n",
      "adjudicated claims data would include on approved and denied claims; \n",
      "under this proposal, adjudicated claims data includes that for which \n",
      "the plan has made an initial payment decision even when the period \n",
      "during which an enrollee can file an appeal is still in effect, or when \n",
      "the enrollee has filed an appeal and is awaiting a reconsideration \n",
      "decision. we specifically request comments from plans regarding the \n",
      "feasibility of including such claims data, including any possible \n",
      "timing issues. in addition, the open apis required for these entities \n",
      "must make available formulary information (for ma-pd plans) or \n",
      "information about covered outpatient drugs and preferred drug lists \n",
      "(for state medicaid and chip agencies, medicaid managed care plans and \n",
      "chip managed care entities).\n",
      "    our proposal includes timeframe requirements for making these \n",
      "various categories of data available through the open api. for ma \n",
      "organizations, proposed 42 cfr 422.119(b)(1)(i), (1)(ii), and (2)(i) \n",
      "would require open api access to all claims activity pertaining to \n",
      "adjudicated claims (including cost) and encounter data for benefits \n",
      "covered by the plan (that is, medicare part a and part b items and \n",
      "services, part d prescription drugs if covered by the ma plan, and any \n",
      "supplemental benefits) no later than one (1) business day after a claim \n",
      "is adjudicated or the encounter data is received by the ma \n",
      "organization. for clinical data, including laboratory results, ma \n",
      "organizations that manage such data would be required under 42 cfr \n",
      "422.119(b)(1)(iv) to provide access through the open api to that data \n",
      "no later than one business day after it is received by the ma plan. for \n",
      "medicaid state agencies and managed care plans, claims data, encounter \n",
      "data, and clinical data, including laboratory results (if available) \n",
      "would be required (specifically at 42 cfr 431.60(b)(1),(2), and (4)) \n",
      "through the api no later than one business day after the claim is \n",
      "processed or the data is received. for state medicaid agencies in \n",
      "connection with the ffs program, the api would have to include all \n",
      "claims data concerning adjudicated claims and standardized encounter \n",
      "data from providers (other than mcos, pihps or pahps) that are paid \n",
      "using capitated payments. the requirement for medicaid managed care \n",
      "plans to provide encounter data is specified at 42 cfr \n",
      "438.242(b)(6)(i); encounter data would include any data from \n",
      "subcontractors and providers compensated by the managed care plan on \n",
      "the basis of capitation payments, such as behavioral health \n",
      "organizations, dental management organizations, and pharmacy benefit \n",
      "managers. the api of medicaid managed care plans would have to include \n",
      "all claims and encounter data would be included regardless if it is \n",
      "adjudicated or generated by the managed care plan itself, \n",
      "subcontractor, or provider compensated on the basis of capitation \n",
      "payments. all data would need to be obtained in a timely manner to \n",
      "comply with these proposed requirements.\n",
      "    for chip agencies and managed care entities, claims data, encounter \n",
      "data, and reports of lab test results (if available) would be required \n",
      "(specifically at 42 cfr 457.730(b)(1),(2), and (4)) through the api as \n",
      "soon as possible but no later than one business day. the proposal for \n",
      "chip state agencies (regarding ffs programs) and chip managed care \n",
      "entities is identical to the proposal for medicaid state agencies \n",
      "(regarding ffs programs) and medicaid managed care plans. for qhp \n",
      "issuers in ffes, our proposed regulation at 45 cfr 156.221(b) would \n",
      "require claims, encounter, and lab data to be available within one \n",
      "business day of adjudication and receipt, respectively.\n",
      "    these proposed timeframes would ensure that data provided through \n",
      "the api would be the most current data available, which may be critical \n",
      "if the data is provided by an enrollee to his or her health care \n",
      "provider to use in making clinical decisions. under our proposal, the \n",
      "claims and encounter data to be disclosed should include information \n",
      "such as enrollee identifiers, dates of service, payment information \n",
      "(provider remittance if applicable and available), and enrollee cost-\n",
      "sharing. the ability for enrollees--created and facilitated by the api \n",
      "required under our proposal--to access this information electronically \n",
      "would make it easier for them to take it with them as they move from \n",
      "payer to payer or among providers across the care continuum.\n",
      "    regarding the provision of standardized encounter data through the \n",
      "api within one (1) business day of the receiving the data, we note that \n",
      "this proposal would mean that a payer must rely on capitated providers \n",
      "submitting their encounter data in a timely manner to ensure that \n",
      "patients receive a timely and complete set of data. to the extent \n",
      "providers do not submit in a timely manner, there would be a delay in \n",
      "patients having access to their data. we recommend that ma \n",
      "organizations, medicaid managed care plans, chip managed care entities, \n",
      "and qhp issuers in ffes that would need this information in order to \n",
      "meet the proposed api requirements should consider whether their \n",
      "contracts with network providers should include timing requirements for \n",
      "the submission of encounter data and claims so that the payer can \n",
      "comply with the api requirements. for medicaid and chip ffs programs, \n",
      "we encourage states to consider other means to ensure that necessary \n",
      "encounter data from providers is also provided on a timely basis.\n",
      "    we note that the data for claims and remittances that would be \n",
      "available through the api is much of the same data that is required for \n",
      "the asc x12 837, asc x12 835, and asc x12 863 standards which are \n",
      "required for certain transactions between certain entities under 45 cfr \n",
      "162.1102, 162.1602 and 162.1603, as well as the part d erx transaction \n",
      "standards that use for conveying prescription and prescription-related \n",
      "information between part d plans, providers, and pharmacies as \n",
      "specified in 42 cfr 423.160. as most claims are submitted to payers \n",
      "electronically utilizing these industry standard transaction types, we \n",
      "believe this maximizes efficiency and reduces programming burden. as \n",
      "noted previously, our proposed regulation for medicaid managed care \n",
      "plans at 42 cfr 438.242(b)(6) and for chip managed care entities at 42 \n",
      "cfr 457.1233(d)(2) would require mcos, pihps, and pahps to comply with \n",
      "the same standard transaction types.\n",
      "    specifically regarding qhp issuers in ffes, in 45 cfr \n",
      "156.221(b)(1)(i) and (ii), we propose to require that qhp issuers \n",
      "participating in an ffe make available through the api standardized \n",
      "data concerning adjudicated claims (including cost) and encounters with \n",
      "capitated providers. under proposed paragraph (b)(1)(i), qhp issuers in \n",
      "ffes would be required to make available standardized adjudicated \n",
      "claim, provider remittance, and enrollee cost-sharing data through the \n",
      "api within one (1) business day after the claim is processed. under \n",
      "proposed paragraph (b)(1)(ii), qhp issuers in ffes would be required to \n",
      "provide standardized encounter data through the api within one (1) \n",
      "business day of the issuer receiving the data.\n",
      "\n",
      "[[page 7633]]\n",
      "\n",
      "    we are also considering requiring the encounter data to be \n",
      "available through the api within a certain period after the encounter, \n",
      "within one (1) business day after the encounter data is received. we \n",
      "seek comment on what a reasonable period from the encounter date would \n",
      "be for us to consider as part of future rulemaking. in addition, we \n",
      "solicit comment on our authority to require ma organizations, states \n",
      "(for ffs medicaid programs and chip), medicaid and chip managed care \n",
      "plans, and qhps in the ffes to require submission of such data on a \n",
      "particular timeframe.\n",
      "(2) provider directory data\n",
      "    we are also proposing at 42 cfr 422.119(b)(1)(iii), 431.60(b)(3), \n",
      "438.242(b)(6)(ii), 457.730(b)(3), and 457.1233(d)(2)(ii) that the \n",
      "required api make available provider directory data, including updates \n",
      "to such data. our proposal at 45 cfr 156.221 would not require qhp \n",
      "issuers to permit third-party retrieval of provider directory and \n",
      "preferred drug list information because such information is already \n",
      "required to be provided by qhps in ffes.\n",
      "    for ma organizations, at proposed 42 cfr 422.119(b)(1)(iii), we \n",
      "propose to specify that ma organizations make specific provider \n",
      "directory information for their network of contracted providers \n",
      "accessible through their apis: the names of providers; addresses; phone \n",
      "numbers; and specialty. this information is the same information ma \n",
      "organizations are already required to disclose to their enrollees under \n",
      "42 cfr 422.111(b)(3) and make available online under 42 cfr \n",
      "422.111(h)(2)(ii). ma organizations would be required to ensure the \n",
      "availability of this information through their apis for all ma plans. \n",
      "including this information in an open api allows non- ma third-party \n",
      "applications to consume, aggregate, and display plan data in different \n",
      "contexts, allowing patients to understand and compare plan information \n",
      "in a way that can best serve their individual needs. ma plans would be \n",
      "required to update provider directory information available through the \n",
      "api no later than 30 calendar days after changes to the provider \n",
      "directory are made. in addition, we are adding a new ma contract \n",
      "requirement at 42 cfr 422.504(a)(18) specifying that ma organizations \n",
      "must comply with the requirement for access to health data and plan \n",
      "information under 42 cfr 422.119.\n",
      "    under proposed 42 cfr 431.60(b)(3) and 457.730(b)(3), state \n",
      "medicaid and chip agencies respectively would be required to make \n",
      "provider directory information available through the api, including \n",
      "updated provider information no later than 30 calendar days after the \n",
      "state receives updated provider information. as noted previously, our \n",
      "proposed regulation for medicaid managed care plans at 42 cfr \n",
      "438.242(b)(6) and for chip managed care entities at 42 cfr \n",
      "457.1233(d)(2) would require mcos, pihps, and pahps to comply with the \n",
      "same standard, with the addition of specific provider directory \n",
      "information as noted in 42 cfr 438.242(b)(6)(ii) and \n",
      "457.1233(d)(2)(ii). for medicaid managed care plans and chip managed \n",
      "care entities, the provider directory information available through the \n",
      "api must include all information that is specified in 42 cfr \n",
      "438.10(h)(1) for disclosure to managed care enrollees. we note that we \n",
      "have proposed that the api be updated with new provider directory \n",
      "information within 30 calendar days from when the updated information \n",
      "is received by the state (or the managed care plan under 42 cfr \n",
      "438.242(b)(6) and 457.1233(d)(2)) to be consistent with existing \n",
      "medicaid managed care rules at 42 cfr 438.10(h)(3). we propose that the \n",
      "api implemented by the state medicaid agency would include the data \n",
      "elements specified for disclosure by medicaid state agencies in section \n",
      "1902(a)(83) of the act; we propose in 42 cfr 438.242(b)(6)(ii) that the \n",
      "api implemented by medicaid managed care plans would have the data \n",
      "elements specified for disclosure at 42 cfr 438.10(h)(1). for chip \n",
      "agencies that operate ffs systems and chip managed care entities at 42 \n",
      "cfr 457.730(b)(3) and 457.1233(d)(2)(ii), respectively, we have also \n",
      "proposed 30 calendar days.\n",
      "    we are not proposing a similar requirement for qhp issuers in ffes. \n",
      "these issuers are already required, under 45 cfr 156.230(c) and \n",
      "implementing guidance, to make provider directory information \n",
      "accessible in a machine-readable format. because this information is \n",
      "already highly accessible in this format, we do not believe the \n",
      "benefits of making it also available through an open api outweigh the \n",
      "burden for qhp issuers in ffes. however, we seek comment as to whether \n",
      "this same requirement should apply to qhp issuers, or if such a \n",
      "requirement would be overly burdensome for them.\n",
      "    we request comment on these proposals.\n",
      "(3) clinical data including laboratory results\n",
      "    regarding the provision of clinical data, including laboratory \n",
      "results, we propose at 42 cfr 422.119(b)(1)(iv) that ma organizations \n",
      "make clinical data, such as laboratory test results available through \n",
      "the api if the ma organization manages such data. because we propose in \n",
      "paragraph (c) that the uscdi standard, proposed by onc for hhs adoption \n",
      "at 45 cfr 170.213, be used as the content and vocabulary standard for \n",
      "this clinical data as provided in the api, we intend our proposal to \n",
      "mean that the data required under paragraph (b)(1)(iv) be the same as \n",
      "the data that is specified in that content and vocabulary standard. in \n",
      "effect, we are proposing any clinical data included in the uscdi \n",
      "standard, proposed by onc for hhs adoption at 45 cfr 170.213, be \n",
      "available through the api if such data is managed by the ma \n",
      "organization. we recognize that some ma organizations receive this \n",
      "information regularly or as a part of their contracted arrangements for \n",
      "health services, but that not all ma organizations do. therefore, this \n",
      "proposed requirement applies to ma organizations, regardless of the \n",
      "type of ma plan offered by the ma organization, but only under \n",
      "circumstances when the ma organization receives and maintains this data \n",
      "as a part of its normal operations. this proposed requirement aligns \n",
      "with existing regulations at 42 cfr 422.118, which require ma \n",
      "organizations to disclose to individual enrollees any medical records \n",
      "or other health or enrollment information the ma organizations maintain \n",
      "with respect to their enrollees. we propose that this data be available \n",
      "in the api no later than 1 business day from its receipt by the ma \n",
      "organization.\n",
      "    similarly, the proposed regulations for medicaid and chip ffs \n",
      "programs and managed care plans (proposed 42 cfr 431.60(b)(4) and \n",
      "457.730(b)(4)), require provision of standardized data for clinical \n",
      "data, including laboratory results, through the api, if available, no \n",
      "later than one (1) business day after a claim is adjudicated or the \n",
      "data is received (by the state or the managed care plan/entity). this \n",
      "would ensure that data provided through the api would be the most \n",
      "current data available, which may be critical if the data is being \n",
      "shared by an enrollee with a health care provider who is basing \n",
      "clinical decisions on the data. like proposed 42 cfr 422.119(c), these \n",
      "medicaid and chip regulations propose compliance with the regulations \n",
      "regarding the uscdi standard, proposed by onc for hhs adoption at 45 \n",
      "cfr 170.213, as the content and vocabulary standard for the clinical \n",
      "data available through the api; therefore, we are, in\n",
      "\n",
      "[[page 7634]]\n",
      "\n",
      "effect, proposing any clinical data included in the uscdi standard, \n",
      "proposed by onc for hhs adoption at 45 cfr 170.213, be available \n",
      "through the api. for state agencies managing medicaid or chip ffs \n",
      "programs, such data must be included through the api under our proposal \n",
      "only if the state manages clinical data. our proposed regulation for \n",
      "medicaid managed care plans at 42 cfr 438.242(b)(6) and chip managed \n",
      "care entities at 42 cfr 457.1233(d)(2) would require mcos, pihps, and \n",
      "pahps to comply with the same standard in terms of the scope of \n",
      "information and the timing of its availability through the api; the \n",
      "limitation about the availability of clinical data through the api \n",
      "would carry through to managed care plans and entities under our \n",
      "proposal.\n",
      "    proposed 45 cfr 156.221(b)(3) requires qhp issuers in ffes to also \n",
      "make available, with the approval of the enrollee, clinical data, \n",
      "including laboratory results, if the qhp maintains such data.\n",
      "    we recognize not all of the entities subject to this requirement \n",
      "have uniform access to this type of data and seek comment on what \n",
      "barriers exist that would discourage them from obtaining, maintaining, \n",
      "and sharing this data. we request comment on these proposals.\n",
      "(4) drug benefit data, including pharmacy directory, and formulary data\n",
      "    we are also proposing that drug benefit data, including pharmacy \n",
      "directory information and formulary or preferred drug list data, also \n",
      "be available through the api at proposed 42 cfr 422.119(b)(2)(ii) and \n",
      "(iii), 431.60(b)(5), and 457.730(b)(5). as previously discussed, \n",
      "medicaid managed care plans would be required by 42 cfr 438.242(b)(6) \n",
      "to comply with the requirement at 42 cfr 431.60(b)(5), and chip managed \n",
      "care entities would be required by 42 cfr 457.1233(d)(2) to comply with \n",
      "the requirement at 42 cfr 457.730(b)(5).\n",
      "    we propose at 42 cfr 422.119(b)(2)(ii) and (iii) that ma \n",
      "organizations offering ma-pd plans make available pharmacy directory \n",
      "data, including the number, mix, and addresses of pharmacies in the \n",
      "plan network, as well as formulary data including covered part d drugs \n",
      "and any tiered formulary structure or utilization management procedure \n",
      "which pertains to those drugs. the pharmacy directory information is \n",
      "the same information that ma-pd plans--like all part d plans--must \n",
      "provide on their websites under 42 cfr 423.128(b)(5) and (d)(2). while \n",
      "prescription drug claims would have to be made available through the \n",
      "api no later than 1 business day of the ma-pd plan's receipt of that \n",
      "information, we are not proposing a specific timeframe for pharmacy \n",
      "directory or formulary information to be available (or updated) through \n",
      "the api. we intend that the requirements in 42 cfr part 423 requiring \n",
      "when and how information related to pharmacy directories be updated \n",
      "will apply to the provision of this information through the api; we \n",
      "solicit comment specifically whether we should address this in the \n",
      "regulation text or otherwise impose a time-frame for this information \n",
      "to be made available through the api.\n",
      "    at proposed 42 cfr 431.60(b)(5), for medicaid ffs programs, and at \n",
      "42 cfr 457.730(b)(5) for chip ffs programs, states would be required to \n",
      "include and update covered outpatient drug lists (including, where \n",
      "applicable, preferred drug lists) through the api no later than one (1) \n",
      "business day after the effective date of the information or any \n",
      "changes. we are proposing to set this timeframe at one (1) business day \n",
      "because we believe that it is critical for beneficiaries and \n",
      "prescribers to have this information as soon as the information is \n",
      "applicable to coverage or in near real time since this information \n",
      "could improve care and health outcomes. having timely data is \n",
      "particularly important during urgent or emergency situations. medicaid \n",
      "managed care plans and chip managed care entities would be required to \n",
      "comply with these requirements as well under proposed 42 cfr \n",
      "438.242(b)(6) and 457.1233(d)(2). we also note that adjudicated claims \n",
      "and encounter data referenced in 42 cfr 431.60(b)(1) and (2), \n",
      "438.242(b)(6), and 457.730(b)(1) and (2) include claims and encounter \n",
      "data for covered outpatient drugs. to the extent that a state or \n",
      "managed care plan utilizes a pharmacy benefit manager (pbm), we \n",
      "anticipate that, as a practical matter, the state or managed care plan \n",
      "would need to obtain the data from the pbm in a timely manner to comply \n",
      "with these proposed requirements.\n",
      "    we request comment on these proposals.\n",
      "d. documentation requirements for apis\n",
      "    we are proposing that the specific business and technical \n",
      "documentation necessary to interact with the proposed apis be made \n",
      "freely and publicly accessible. as discussed in section ii.a.1 of this \n",
      "proposed rule, we believe transparency about api technology is needed \n",
      "to ensure that any interested third-party application developer can \n",
      "easily obtain the information needed to develop applications \n",
      "technically compatible with the organization's api. transparency is \n",
      "also needed so that third-parties can understand how to successfully \n",
      "interact with an organization's api, including by satisfying any \n",
      "requirements the organization may establish for verification of \n",
      "developers' identity and their applications' authenticity, consistent \n",
      "with its security risk analysis and related organizational policies and \n",
      "procedures to ensure it maintains an appropriate level of privacy and \n",
      "security protection for data on its systems.\n",
      "    specifically, at 42 cfr 422.119(d), 431.60(d), 457.730(d), and 45 \n",
      "cfr 156.221(d), we propose virtually identical text to require \n",
      "publication of complete accompanying documentation regarding the api by \n",
      "posting this documentation directly on the applicable entity's website \n",
      "or via a publicly accessible hyperlink. as previously discussed, \n",
      "medicaid managed care plans would be required by 42 cfr 438.242(b)(6) \n",
      "to comply with the requirement at 42 cfr 431.60(d), and chip managed \n",
      "care entities would be required by 42 cfr 457.1233(d)(2) to comply with \n",
      "the requirement at 42 cfr 457.730(d). in requiring that this \n",
      "documentation is ``publicly accessible,'' we expect that any person \n",
      "using commonly available technology to browse the internet could access \n",
      "the information without any preconditions or additional steps beyond \n",
      "downloading and using a third-party application to access data through \n",
      "the api. this is not intended to preclude use of links the user would \n",
      "click to review the full text of lengthy documents or access sources of \n",
      "additional information, such as if the technology's supplier prefers to \n",
      "host technical documentation at a centralized location. rather, we mean \n",
      "``additional steps'' to include actions such as: collecting a fee for \n",
      "access to the documentation; requiring the reader to receive a copy of \n",
      "the material via email; or requiring the user to read promotional \n",
      "material or agree to receive future communications from the \n",
      "organization making the documentation available. we specifically \n",
      "solicit comments on these points.\n",
      "    we propose that the publicly accessible documentation would be \n",
      "required to include, at a minimum, the following information:\n",
      "    <bullet> api syntax, function names, required and optional \n",
      "parameters supported and their data types, return variables and their \n",
      "types/structures, exceptions and exception handling methods and their \n",
      "returns.\n",
      "    <bullet> the software components and configurations an application \n",
      "must use\n",
      "\n",
      "[[page 7635]]\n",
      "\n",
      "in order to successfully interact with the api (for example, to connect \n",
      "and receive data through the api) and process its response(s).\n",
      "    <bullet> all applicable technical requirements and attributes \n",
      "necessary for an application to be registered with any authorization \n",
      "server(s) deployed in conjunction with the api.\n",
      "    we note that these information requirements are similar to those \n",
      "onc has proposed for adoption by hhs for developers and users of health \n",
      "it certified to the api criteria proposed at 45 cfr 170.315 (published \n",
      "elsewhere in this issue of the federal register), but are proposed here \n",
      "to apply specifically to the api technology deployed by organizations \n",
      "subject to the api requirements proposed in section iii. of this \n",
      "proposed rule. we request comments on this proposal.\n",
      "e. routine testing and monitoring of open apis\n",
      "    at 42 cfr 422.119(c)(2), 431.60(c)(2), 457.730(c)(2), and 45 cfr \n",
      "156.221(c)(2) for ma organizations, state medicaid and chip ffs \n",
      "programs, and qhp issuers in ffes, respectively, we are proposing that \n",
      "the api be routinely tested and monitored to ensure it is functioning \n",
      "properly, including assessments to verify that the api is fully and \n",
      "successfully implementing privacy and security features such as but not \n",
      "limited to those minimally required to comply with the hipaa privacy \n",
      "and security requirements in 45 cfr part 164, 42 cfr parts 2 and 3, and \n",
      "other applicable law protecting privacy and security of individually \n",
      "identifiable health information. medicaid managed care plans would be \n",
      "required by 42 cfr 438.242(b)(6) to comply with the requirement at 42 \n",
      "cfr 431.60(c), and chip managed care entities would be required by 42 \n",
      "cfr 457.1233(d)(2) to comply with the requirement at 42 cfr 457.730(c).\n",
      "    additionally, we note that while federal laws that regulate ma \n",
      "organizations and ma plans supersede any state law except where noted \n",
      "under section 1856(b)(3) of the act, some state, local, or tribal laws \n",
      "that pertain to privacy and security of individually identifiable \n",
      "information generally and are not specific to health insurance may also \n",
      "apply to ma organizations and ma plans in the context of our proposal. \n",
      "for the other entities regulated under our proposals in these various \n",
      "programs, we also intend the phrase ``other applicable law'' to include \n",
      "federal, state, tribal or local laws that apply to the entity.\n",
      "    we propose this requirement to establish and maintain processes to \n",
      "routinely test and monitor the open apis to ensure they are functioning \n",
      "properly, especially with respect to their privacy and security \n",
      "features. under our proposal, ma organizations, medicaid and chip ffs \n",
      "programs, medicaid managed care plans, chip managed care entities, and \n",
      "qhp issuers in ffes would have to implement, properly maintain, update \n",
      "(as appropriate), and routinely test authentication features that will \n",
      "be used to verify the identity of individual enrollees who seek to \n",
      "access their claims and encounter data and other phi through the api. \n",
      "similarly, compliance with our proposed requirements would mean that \n",
      "these entities must implement, maintain, update (as appropriate), and \n",
      "routinely test authorization features to ensure an individual enrollee \n",
      "or their personal representative can only access claims and encounter \n",
      "data or other phi that belongs to that enrollee. as is the case under \n",
      "existing hipaa requirements, where an enrollee is also a properly \n",
      "designated personal representative of another enrollee, the hipaa \n",
      "covered entity must provide for appropriate access to the information \n",
      "of the enrollee that has designated the personal representative, just \n",
      "as they would if the personal representative were an enrollee of the \n",
      "same plan.\n",
      "    similarly, at proposed 45 cfr 156.221(c)(2), qhp issuers in ffes \n",
      "would be required to routinely test and monitor their api to confirm \n",
      "that it is functioning properly.\n",
      "    we request comment on these proposals.\n",
      "f. compliance with existing privacy and security requirements\n",
      "    in the hands of a hipaa covered entity or its business associate, \n",
      "individually identifiable patient claims, encounter data, and other \n",
      "health information are phi as defined at 45 cfr 160.103. ensuring the \n",
      "privacy and security of the claims, encounter, and other health \n",
      "information when it is transmitted through the api is of critical \n",
      "importance. therefore, we remind ma organizations, state medicaid and \n",
      "chip ffs programs, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers in ffes that mechanisms and practices to \n",
      "release phi, including but not limited to authorization and \n",
      "authentication protocols and practices must provide protection \n",
      "sufficient to comply with hipaa privacy and security regulations at 45 \n",
      "cfr part 164 and other law (whether federal, state, tribal or local) \n",
      "that may apply based on the specific circumstances. under this \n",
      "proposal, the entities subject to these requirements would need to \n",
      "continuously ensure that all authorization and authentication \n",
      "mechanisms provide sufficient protections to enrollee phi and that they \n",
      "function as intended. we specifically request public comment on whether \n",
      "existing privacy and security standards, including but not limited to \n",
      "those in 45 cfr part 164, are sufficient with respect to these \n",
      "proposals, or whether additional privacy and security standards should \n",
      "be required by cms as part of this proposal.\n",
      "g. issues related to denial or discontinuation of access to the api\n",
      "    as discussed in section ii.a of this proposed rule, hipaa covered \n",
      "entities must comply with patients' requests to receive their data \n",
      "under the hipaa right of access, including having to transmit patient \n",
      "data to a third party. as noted in guidance from ocr, disagreement with \n",
      "the individual about the worthiness of the third party as a recipient \n",
      "of phi, or even concerns about what the third party might do with the \n",
      "phi, are not grounds for denying a request.\\27\\ however, a covered \n",
      "entity is not expected to tolerate unacceptable levels of risk to the \n",
      "phi held by the covered entity in its systems, as determined by its own \n",
      "risk analysis.\\28\\ accordingly, it may be appropriate for an \n",
      "organization to deny or terminate specific applications' connection to \n",
      "its api under certain circumstances in which the application poses an \n",
      "unacceptable risk to the phi on its systems or otherwise violates the \n",
      "terms of use of the api technology.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\27\\ <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2037/are-there-any-limits-or-exceptions-to-the-individuals-right/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2037/are-there-any-limits-or-exceptions-to-the-individuals-right/index.html</a>.\n",
      "    \\28\\ see 45 cfr 164.524(c)(2) and (3), and 164.308(a)(1), ocr \n",
      "hipaa guidance/faq-2036: <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2036/can-an-individual-through-the-hipaa-right/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2036/can-an-individual-through-the-hipaa-right/index.html</a>, and ocr hipaa guidance/faq-2037: <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2037/are-there-any-limits-or-exceptions-to-the-individuals-right/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2037/are-there-any-limits-or-exceptions-to-the-individuals-right/index.html</a> (faqs last accessed at these \n",
      "urls july 30, 2018).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    at 42 cfr 422.119(e), 431.60(e), 438.242(b)(6), 457.730(e), \n",
      "457.1233(d)(2) and 45 cfr 156.221(e) for ma organizations, state \n",
      "medicaid and chip ffs programs, medicaid managed care plans, chip \n",
      "managed care entities, and qhp issuers in ffes, we are proposing to \n",
      "specify the circumstances under which these regulated entities, which \n",
      "are all hipaa-covered entities subject to hipaa privacy and security \n",
      "requirements, may decline to establish or may terminate a third-party \n",
      "application's connection to the covered entity's api while remaining in \n",
      "compliance with our proposed requirement to offer patients access \n",
      "through open apis. we intend for this\n",
      "\n",
      "[[page 7636]]\n",
      "\n",
      "proposal to be consistent with the hipaa rules, and we note that these \n",
      "circumstances apply to specific applications, rather than the third \n",
      "party itself. for instance, were the individual to request that the \n",
      "hipaa covered entity provide the individual's information through other \n",
      "means than through an api to the same third party that would have \n",
      "received it on the individual's behalf through an application which has \n",
      "been denied access, the covered entity would be required to approach \n",
      "that request as if the application's api request or connection had not \n",
      "occurred.\n",
      "    specifically, we propose that an ma organization, state medicaid \n",
      "and chip ffs program, medicaid managed care plan, chip managed care \n",
      "entity, or qhp issuer in an ffe, may, in accordance with hipaa, deny \n",
      "access to the api if the entity reasonably determines that allowing \n",
      "that application to connect or remain connected to the api would \n",
      "present an unacceptable level of risk to the security of phi on the \n",
      "organization's systems. we further propose that this determination must \n",
      "be based on objective, verifiable criteria that are applied fairly and \n",
      "consistently across all applications through which enrollees seek to \n",
      "access their electronic health information as defined at 45 cfr \n",
      "171.102, including but not limited to criteria that may rely on \n",
      "automated monitoring and risk mitigation tools.\n",
      "    where we propose to require access through open apis to otherwise \n",
      "publicly available information, such as provider directories, the \n",
      "entities subject to our proposal may also deny or terminate an \n",
      "application's connection to the api when it makes a similar \n",
      "determination about risk to its systems. however, depending on how the \n",
      "organization's systems are designed and configured, we recognize that \n",
      "the criteria and tolerable risk levels appropriate to assessing an \n",
      "application for connection to an api for access to publicly available \n",
      "information may differ from those required for api access to non-\n",
      "published pii.\n",
      "    we also anticipate that, where an application's connection has been \n",
      "terminated under these circumstances, it might be feasible in some \n",
      "instances for the organization to allow the application to re-connect \n",
      "to the api if and when the flaw or compromise of the application has \n",
      "been addressed sufficiently that the organization can no longer fairly \n",
      "say the application's api connection continues to pose an unacceptable \n",
      "risk.\n",
      "    we request comment on these proposals.\n",
      "h. enrollee and beneficiary resources regarding privacy and security\n",
      "    as discussed in section ii.a. of this proposed rule, we are \n",
      "committed to maximizing enrollees' access to and control over their \n",
      "health information. we believe this calls for providing enrollees that \n",
      "would access data under our proposal with essential information about \n",
      "the privacy and security of their information, and what to do if they \n",
      "believe they have been misled or deceived about an application's terms \n",
      "of use or privacy policy.\n",
      "    at 42 cfr 422.119(g), 431.60(f), and 457.730(f), and 45 cfr \n",
      "156.221(g), we propose to require ma organizations, state medicaid and \n",
      "chip ffs programs, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers in ffes, to make available to their current \n",
      "and former enrollees certain information about: factors to consider in \n",
      "selecting a health information management application, practical \n",
      "strategies to help them safeguard the privacy and security of their \n",
      "data, and how to submit complaints to ocr or ftc. these proposed \n",
      "obligations are proposed to apply to medicaid managed care plans and \n",
      "chip managed care entities through cross-references proposed in 42 cfr \n",
      "438.242(b)(6) and 457.1233(d)(2).\n",
      "    the general information about the steps individuals can take to \n",
      "help protect the privacy and security of their health information \n",
      "should not be limited to, but should specifically include and emphasize \n",
      "the importance of understanding the privacy and security practices of \n",
      "any application to which they entrust their data. information about \n",
      "submitting complaints should include both specific contact information \n",
      "for the ocr and ftc complaints processes and a brief overview, in \n",
      "simple and easy-to-understand language, of: what organizations are \n",
      "hipaa covered entities, ocr's responsibility to oversee compliance with \n",
      "hipaa, and ftc's complementary responsibility to oversee unfair and \n",
      "deceptive practices, including by non-covered entities that may offer \n",
      "direct-to-consumer health information management applications.\n",
      "    we propose that this information must be made available on the \n",
      "website of the organization subject to this proposed requirement, and \n",
      "through other appropriate mechanisms through which the organization \n",
      "ordinarily communicates with enrollees. this could include customer \n",
      "portals, online customer service help desks, and other locations, such \n",
      "as any portals through which enrollees and former enrollees might \n",
      "request disclosure of their data to a third-party application through \n",
      "the organization's api. we are also proposing that the entity must make \n",
      "this information available in non-technical, consumer-friendly \n",
      "language.\n",
      "    we anticipate that organizations could meet the requirement to \n",
      "provide information to current and former enrollees in whole or in part \n",
      "using materials designed for consumer audiences that are available on \n",
      "the hhs website (for example, content and materials such as those \n",
      "available at <a href=\"https://www.hhs.gov/hipaa/for-individuals/right-to-access/index.html\">https://www.hhs.gov/hipaa/for-individuals/right-to-access/index.html</a>) and ftc website (for example, content and materials such as \n",
      "those available at <a href=\"https://www.consumer.ftc.gov/topics/online-security\">https://www.consumer.ftc.gov/topics/online-security</a>). however, we note that whether the organization chooses to \n",
      "draft its own resource materials to provide the required information or \n",
      "to rely on governmental or other sources for such materials, the \n",
      "organization will be responsible for ensuring that the content of the \n",
      "materials remains current as relevant law and policy may evolve over \n",
      "time. we seek comment on this proposal, and we invite additional \n",
      "comments on what specific information resources in addition to those \n",
      "already available on the websites noted above would be most useful to \n",
      "entities in meeting this requirement. we anticipate using this feedback \n",
      "to help inform hhs planning and prioritization of informational \n",
      "resource development work in addition to making a decision on the final \n",
      "rule regarding this proposal.\n",
      "i. exceptions or provisions specific to certain programs or sub-\n",
      "programs\n",
      "    we are proposing certain exceptions or specific additional \n",
      "provisions as part of this proposed rule for certain qhps in ffes and \n",
      "certain types of ma plans, respectively. under sections 1856, 1857, and \n",
      "1860d-12(b)(3) of the act, we proposed at 42 cfr 422.119(b)(2) to \n",
      "include additional requirements that would apply specifically to ma \n",
      "organizations that offer medicare advantage-prescription drug (ma-pd) \n",
      "plans. the organizations offering these ma-pd plans must comply with ma \n",
      "requirements in 42 cfr part 422 for part a, part b and non-drug \n",
      "supplemental benefits; they must comply with part d requirements in 42 \n",
      "cfr part 423 for the part d prescription drug benefit. these additional \n",
      "requirements would ensure that enrollees of ma-pd plans can easily \n",
      "access the information they need in order to adhere to their care \n",
      "plans. including this information in an open api allows non- ma third-\n",
      "party applications to properly use, aggregate, and display plan data in \n",
      "different\n",
      "\n",
      "[[page 7637]]\n",
      "\n",
      "contexts, enabling another means of accessing information for patients \n",
      "and more options for comparing and understanding plan information in a \n",
      "way that can best serve their individual needs.\n",
      "    specifically, at 42 cfr 422.119 (b)(2)(i), we propose to require ma \n",
      "organizations make standardized data concerning adjudicated part d \n",
      "claims, including remittances and enrollee cost-sharing, available \n",
      "through the api to enrollees covered under a ma-pd plan. we propose to \n",
      "require that this information be made available no later than one (1) \n",
      "business day after a claim is adjudicated. this would ensure that data \n",
      "provided through the api would be the most current data available, \n",
      "which may be critical if the data is being used by a provider who is \n",
      "basing clinical decisions on the data. to the extent that an ma \n",
      "organization offering ma-pd plans utilizes a pbm, the ma organization \n",
      "would be required to obtain the data from the pbm in order to comply \n",
      "with these requirements.\n",
      "    related to qhp issuers, we propose two exceptions to this proposed \n",
      "rule. first, we propose that the requirements proposed in 45 cfr \n",
      "156.221(a) not apply to issuers of sadps in the ffes. in contrast to \n",
      "qhp issuers of medical plans, issuers of sadps offer enrollees access \n",
      "to a unique and specialized form of medical care. we believe the \n",
      "proposed standards and health it investment would be overly burdensome \n",
      "for sadp issuers as related to their current enrollment and premium \n",
      "intake and could result in sadp issuers no longer participating in \n",
      "ffes, which would not be in the best interest of enrollees. \n",
      "additionally, we believe much of the benefit to enrollees from \n",
      "requiring issuers of qhps to make patient data more easily available \n",
      "through a standard format depends upon deployment of open api \n",
      "technology that conforms to standards proposed by onc for hhs adoption \n",
      "at 45 cfr 170.215 (published elsewhere in this issue of the federal \n",
      "register) and a corresponding energetic response by the developer \n",
      "community in developing innovative, useful, usable, and affordable \n",
      "consumer-facing applications through which plan enrollees can \n",
      "conveniently access, use, and share their information as they choose. \n",
      "through our proposals in this section to require implementation of open \n",
      "api technology in the medicare, medicaid and chip programs, as well as \n",
      "by qhp issuers in ffes, we would anticipate significantly expanding the \n",
      "implementation of open apis by medical plans. however, we do not \n",
      "anticipate similar widespread usage with respect to sadps. therefore, \n",
      "we believe that the utility of access to issuers' data is less \n",
      "applicable to dental coverage, and do not believe it would be in the \n",
      "interest of qualified individuals and qualified employers in the state \n",
      "in which an ffe operates to not certify sadps because they do not \n",
      "provide patient access to their data through an openly-published api. \n",
      "we seek comment on whether we should apply this policy to sadp issuers \n",
      "in the future.\n",
      "    we also propose to provide an exceptions process through which an \n",
      "ffe may certify health plans that do not provide patient access through \n",
      "an openly-published api, but otherwise meet the requirements for qhp \n",
      "certification. we propose in 45 cfr 156.221(h)(1) that if a plan \n",
      "applying for qhp certification to be offered through an ffe does not \n",
      "provide patient access to their data through an open api, the issuer \n",
      "must include as part of its qhp application a narrative justification \n",
      "outlining the reasons why the plan cannot reasonably satisfy the \n",
      "requirements in proposed 45 cfr 156.221(a),(b), or (c), the impact of \n",
      "non-compliance upon enrollees, the current or proposed means of \n",
      "providing health information to enrollees, and proposed solutions and \n",
      "timeline to achieve api compliance. in 45 cfr 156.221(h)(2), we propose \n",
      "that an ffe may grant an exception to the requirement to provide \n",
      "enrollees access to data through open api technology if the ffe \n",
      "determines that making available such health plan is in the interest of \n",
      "qualified individuals and qualified employers in the state in which the \n",
      "ffe operates. we anticipate that this exception would be provided in \n",
      "limited situations. for example, we would consider providing an \n",
      "exception for small issuers, issuers who are only in the individual or \n",
      "small group market, financially vulnerable issuers, or new entrants to \n",
      "the market who demonstrate that deploying open api technology \n",
      "consistent with the required interoperability standards would pose a \n",
      "significant barrier to the issuer's ability to provide coverage to \n",
      "consumers, and not certifying the issuer's qhp or qhps would result in \n",
      "consumers having few or no plan options in certain areas. we seek \n",
      "comment on other circumstances in which the ffe should consider \n",
      "providing an exception.\n",
      "j. applicability and timing\n",
      "    at 42 cfr 422.119(h) and 45 cfr 156.221(i), we are proposing \n",
      "specific provisions regarding applicability and timing for ma \n",
      "organizations and qhp issuers in ffes that would be subject to our \n",
      "proposal. we are not proposing specific regulation text for 42 cfr \n",
      "431.60 or 438.242 because we intend to make the regulation text \n",
      "effective on the applicable date discussed below. we expect that state \n",
      "medicaid and chip agencies will be aware of upcoming new regulations \n",
      "and planning for compliance with them when they are effective and \n",
      "applicable, even if the new regulation is not yet codified in the cfr; \n",
      "we similarly expect that such agencies will ensure that their managed \n",
      "care plans/entities will be prepared for compliance. unlike medicaid \n",
      "state agencies and managed care plans and state chip agencies and \n",
      "managed care entities, ma organizations and qhp issuers in ffes \n",
      "generally are subject to rules regarding bid and application \n",
      "submissions to cms in advance of the coverage period; for example, ma \n",
      "organizations must submit bids to cms by the first monday in june of \n",
      "the year before coverage starts in order to be awarded an ma contract. \n",
      "in order to ensure that these requirements for ma organizations and qhp \n",
      "issuers in ffes are enforceable and reflected in the bids and \n",
      "applications these entities submit to us in advance of when the actual \n",
      "requirements must be met, we propose to codify the actual compliance \n",
      "and applicability dates of these requirements. we solicit comment on \n",
      "this approach.\n",
      "    for ma organizations, under 42 cfr 422.119(h), we are proposing \n",
      "that the requirements would be effective beginning january 1, 2020. \n",
      "under this proposal, the requirements we propose for 42 cfr 422.119 \n",
      "would be applicable for all ma organizations with contracts to offer \n",
      "any ma plan on that date and thereafter. we request feedback about this \n",
      "proposed timing from the industry. in particular, we are interested in \n",
      "information and request comment from ma organizations about their \n",
      "current capability to implement an api consistent with this proposal \n",
      "and the costs associated with compliance by january 1, 2020, versus \n",
      "compliance by a future date.\n",
      "    for medicaid ffs at 42 cfr 431.60, chip agencies that operate ffs \n",
      "systems at 42 cfr 457.730, medicaid managed care plans at 42 cfr \n",
      "438.242(b)(6), and chip managed care entities at 42 cfr 457.1233(d)(2), \n",
      "we are proposing that the api requirements would be effective beginning \n",
      "july 1, 2020, regardless of when the managed care contract started. \n",
      "given the expected date of publication of this proposed rule and \n",
      "potential final rule, we believe july 1, 2020, would provide state \n",
      "medicaid agencies and chip agencies that operate ffs systems, medicaid \n",
      "managed care plans, and chip managed care entities sufficient time to \n",
      "implement. we solicit comment on this\n",
      "\n",
      "[[page 7638]]\n",
      "\n",
      "proposal and whether additional flexibility would be necessary to take \n",
      "into account the contract terms that states use for their medicaid \n",
      "managed care plans.\n",
      "    for chip, we are aware that some states do not provide any benefits \n",
      "on a ffs basis, and we do not intend for those states to implement an \n",
      "api outside their managed care plans. therefore, we also propose in 42 \n",
      "cfr 457.700(c) that separate chip agencies that provide benefits \n",
      "exclusively through managed care entities may meet the requirements of \n",
      "42 cfr 457.730 by requiring the managed care entities to meet the \n",
      "requirements of 42 cfr 457.1233(d)(2) beginning july 1, 2020.\n",
      "    for qhp issuers in ffes, we propose in 45 cfr 156.221(i) that these \n",
      "requirements would be applicable for plan years beginning on or after \n",
      "january 1, 2020. we seek comment on the timing of these requirements, \n",
      "and on how long issuers, particularly smaller issuers, anticipate it \n",
      "would take to come into compliance with these requirements.\n",
      "    we believe that these proposals would help to create a health care \n",
      "information ecosystem that allows and encourages the health care market \n",
      "to tailor products and services to compete for patients, thereby \n",
      "increasing quality, decreasing costs, and helping them live better, \n",
      "healthier lives. additionally, under these proposals, physicians would \n",
      "be able to access information on their patient's current prescriptions \n",
      "and services by reviewing the information with the patient on the \n",
      "patient's personal device or by the patient sharing data with the \n",
      "provider's ehr system, which would save time during appointments and \n",
      "ultimately improve the quality of care delivered to beneficiaries. most \n",
      "health care professionals and consumers have widespread access to the \n",
      "internet, providing many access points for viewing health care data \n",
      "over secure connections. we believe that these proposed requirements \n",
      "would significantly improve beneficiaries' experiences by providing a \n",
      "secure mechanism through which they can access their data in a \n",
      "standardized, computable format.\n",
      "    these proposals are designed to empower patients by making sure \n",
      "that they have access to health information about themselves in a \n",
      "usable digital format and can make decisions about how, with whom, and \n",
      "for what uses they will share it. by making claims data readily \n",
      "available and portable to the enrollee, these initiatives support \n",
      "efforts to move our health care system away from a ffs payment system \n",
      "that pays for volume and toward a payment system that pays for value \n",
      "and quality by reducing duplication of services, adding efficiency to \n",
      "patient visits to providers; and, facilitating identification of fraud, \n",
      "waste, and abuse. data interoperability is critical to the success of \n",
      "new payment models and approaches that incentivize high quality, \n",
      "efficient care. all of the health care providers for a patient need to \n",
      "coordinate their care for a value-based system to work, and that \n",
      "requires information to be securely shareable in standardized, \n",
      "computable formats. moreover, patients need to understand and be \n",
      "actively involved in their care under a value-based framework. we are \n",
      "committed to supporting requirements that focus on these goals, and we \n",
      "believe that these specific proposals in this proposed rule support \n",
      "these efforts.\n",
      "k. request for information on information sharing between payers and \n",
      "providers through apis\n",
      "    this proposed rule requires the implementation of open apis for \n",
      "making accessible data that a third-party could use to create \n",
      "applications for patients to access data in order to coordinate and \n",
      "better participate in their medical treatment. while in some instances, \n",
      "direct provider to health plan transmission of health information may \n",
      "be more appropriate than sharing data through an open api, in other \n",
      "instances a patient may wish to send a provider a copy of their health \n",
      "information via another health care provider's api. in such cases, \n",
      "patients could direct the payer to transmit the health information to a \n",
      "third party application (for example, an application offered by a \n",
      "health care provider to obtain patient claims and encounter data, as \n",
      "well as lab test results (if applicable) on a one-off and as-needed \n",
      "basis. to the extent a hipaa covered entity uses a third party \n",
      "application to offer patients access to their records, another hipaa \n",
      "covered entity may be able to obtain an individual's health information \n",
      "from the app for treatment, payment, or certain health care operations, \n",
      "if it could do so in accordance with hipaa without need of an \n",
      "individual's authorization. (see 45 cfr 164.506.) under other laws, \n",
      "providers may need to obtain specific individual consent to obtain \n",
      "health information related to care provided by a behavioral health \n",
      "provider, treatment received at a substance use disorder treatment \n",
      "facility, certain 42 cfr part 2-covered diagnoses or other claims-\n",
      "related information, or labs that suggest a part 2 diagnosis. we do not \n",
      "intend to expand any scope of authority to access patient data nor to \n",
      "contravene existing requirements related to disclosure of phi under the \n",
      "hipaa rules and other legal standards, but instead specify a new and \n",
      "additional mechanism by which to share health information as directed \n",
      "by the individual, through the use of api technology in compliance with \n",
      "all existing federal, state, local, and tribal privacy and security \n",
      "laws.\n",
      "    in the future, we anticipate payers and providers may seek to \n",
      "coordinate care and share information in such a way as to request data \n",
      "on providers' or a plan's patient/insured overlapping population(s) in \n",
      "one transaction. effective care coordination between plans and \n",
      "providers can inform health care providers about where their patients \n",
      "are receiving care to better understand the totality of their \n",
      "healthcare needs and manage their care. we have heard that being aware \n",
      "of urgent care or emergency department visits allows clinicians to \n",
      "arrange appropriate follow-up, modify treatments, and update records if \n",
      "services are provided (for example, tetanus boosters given with a \n",
      "laceration treated in urgent care). the accompanying proposals in \n",
      "section x. of this proposed rule, to amend the conditions of \n",
      "participation regarding notification of patient discharge, further \n",
      "support the ability of clinicians to arrange and affirm such \n",
      "appropriate follow-up care. having a complete record of tests done at \n",
      "specialists' offices can reduce duplicate testing. having a complete \n",
      "list of clinicians caring for a patient facilitates appropriate \n",
      "notification if treatments are changed or procedures are planned that \n",
      "may impact the other clinicians' treatment plan. we have heard from \n",
      "participants in our accountable care programs and models that \n",
      "organizations taking risk for their patient populations need to have a \n",
      "complete picture of the patients' needs to better budget for \n",
      "appropriate resources. this may be particularly relevant during \n",
      "disasters or public health emergencies when patients are not able to \n",
      "access their normal sources of care and/or health care facilities are \n",
      "overwhelmed due to patient surge.\n",
      "    we believe there are a variety of transmission solutions that may \n",
      "be employed to share data regarding a provider's and plan's overlapping \n",
      "patient populations. for instance, some geographic areas might have \n",
      "regional health information exchanges that could coordinate such \n",
      "transmissions. elsewhere, direct provider-to-provider and plan-to-plan \n",
      "exchange might be more appropriate. plans could participate in direct \n",
      "exchange through existing trusted networks, or beneficiary-facing third \n",
      "party\n",
      "\n",
      "[[page 7639]]\n",
      "\n",
      "applications could meet this potential future requirement.\n",
      "    we seek comment for possible consideration in future rulemaking on \n",
      "the feasibility of providers being able to request a download on a \n",
      "shared patient population, and whether such a process could leverage \n",
      "the apis described in sections ii.a.3. and iii.c. of this proposed \n",
      "rule. we seek comment on requirements for patient notice and consent, \n",
      "and applicable legal and regulatory requirements, and whether or how \n",
      "this data transfer could be cumulative over time and between various \n",
      "providers. we seek input on the utility to providers of obtaining all \n",
      "of their patients' utilization history in a timely and comprehensive \n",
      "fashion. we also seek input on potential unintended consequences that \n",
      "could result from allowing a provider to access or download information \n",
      "about a shared patient population from payers through an open api. \n",
      "finally, we seek comment on the associated burden on plans to exchange \n",
      "this data, as well as the identification other potential statutory or \n",
      "regulatory barriers to exchanging this data.\n",
      "\n",
      "iv. api access to published provider directory data\n",
      "\n",
      "a. interoperability background and use cases\n",
      "\n",
      "    the proposals described in section iii of this proposed rule \n",
      "primarily focus on patient access to their data through a standardized, \n",
      "transparent api; however, we have also proposed that entities subject \n",
      "to these proposals make available certain plan-level data through the \n",
      "api. in this section, we provide additional context for the proposal \n",
      "related to making provider directory information available through the \n",
      "api, including ways in which this proposal may differ from our other \n",
      "proposals related to accessibility of patient data.\n",
      "    provider directories make key information about health care \n",
      "professionals and organizations available to help consumers identify a \n",
      "provider when they enroll in an insurance plan or as new health needs \n",
      "arise. for example, such information might include hours of operation, \n",
      "languages spoken, specialty/services, availability for new patients. \n",
      "provider directories also function as a resource used by the provider \n",
      "community to discover contact information of other providers to \n",
      "facilitate referrals, transitions of care, and care coordination for \n",
      "enrollees.\n",
      "    the current applicable regulations for ma plans (42 cfr 422.111) \n",
      "and medicaid and chip managed care plans (42 cfr 438.10(e)(2)(vi) and \n",
      "(h) and 457.1207, respectively) require that provider directories be \n",
      "made available to enrollees and potential enrollees in hard copy and on \n",
      "the plan's website. section 1902(a)(83) of the act requires state \n",
      "medicaid agencies to publish a directory of certain physicians on the \n",
      "public website of the state agency. a regulation for qhps in ffes (45 \n",
      "cfr 156.230(b)) requires public access to the qhp's provider directory \n",
      "in addition to distribution and access for enrollees. in addition to \n",
      "directing that this information be accessible, the current regulations \n",
      "also address the content of such directories and the format and manner \n",
      "in which ma plans, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers in ffes make the information available.\n",
      "    making this required provider directory information available to \n",
      "enrollees and prospective enrollees through an api could support \n",
      "development of applications (whether standalone or integrated with \n",
      "providers' ehr technology) that would pull in current information about \n",
      "available providers to meet enrollees' current needs. for instance, as \n",
      "part of a referral lookup use case, api access to a provider directory \n",
      "could allow for a referring provider's health it to enable either the \n",
      "enrollee or the provider to easily identify up-to-date contact \n",
      "information obtained from the directory through an api, and securely \n",
      "send the receiving health care provider the patient information needed \n",
      "to provide safe, high-quality care sensitive to the patient's \n",
      "preferences. broad availability of provider directory data through \n",
      "interoperable api technology would also allow for innovation in \n",
      "applications or other services that help enrollees and prospective \n",
      "enrollees to more easily compare provider networks while they are \n",
      "considering their options for changing health plans. finally, a \n",
      "consistent, fhir-based api-driven approach to making provider directory \n",
      "data accessible could reduce provider burden by enabling payers/plans \n",
      "to share more widely basic information about the providers in their \n",
      "networks, such as provider type, specialty, contact information, and \n",
      "whether or not they are accepting new patients.\n",
      "\n",
      "b. broad api access to provider directory data\n",
      "\n",
      "    in sections ii.a.3. and iii.c. of this proposed rule, we propose to \n",
      "require ma organizations, state medicaid and chip ffs programs, \n",
      "medicaid managed care plans, and chip managed care entities to make \n",
      "standardized information about their provider networks available \n",
      "through api technology, so that third party software could access and \n",
      "publish that information. such availability would be for current \n",
      "enrollees, prospective enrollees and possibly the general public to the \n",
      "extent existing regulations require that information to be disclosed \n",
      "beyond current enrollees. we propose to require that the api technology \n",
      "conform to the api standards proposed by onc for hhs adoption at 45 cfr \n",
      "170.215 (published elsewhere in this issue of the federal register). at \n",
      "this time, because qhp issuers in ffes are already required to make \n",
      "provider directory information available in a specified, machine-\n",
      "readable format,\\29\\ we do not propose these as requirements for qhp \n",
      "issuers. however, we seek comment as to whether this same requirement \n",
      "should apply to qhp issuers, or if such a requirement would be overly \n",
      "burdensome for them.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\29\\ available at <a href=\"https://github.com/cmsgov/qhp-provider-formulary-apis/blob/master/readme.md\">https://github.com/cmsgov/qhp-provider-formulary-apis/blob/master/readme.md</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we note that, since the provider directory information we are \n",
      "proposing to require be available through the api is already available \n",
      "and accessible to enrollees without cost to them, this information \n",
      "should be as accessible through the api as it is required to be when \n",
      "posted on the organization's websites. therefore, the security \n",
      "protocols proposed at 45 cfr 170.215 that are specific to \n",
      "authenticating users and confirming individuals' authorization or \n",
      "request to disclose their personal information to a specific \n",
      "application would not apply to public access to provider directory \n",
      "information through apis. while we are aware the organization will \n",
      "nevertheless need to take appropriate steps to mitigate the potential \n",
      "security risks of allowing any application to connect to the api \n",
      "through which it offers provider directory access, we emphasize that \n",
      "these steps should be appropriate to the level of risk associated with \n",
      "the specific use case of accessing otherwise public information through \n",
      "api technology. those wishing to access this data should not be unduly \n",
      "burdened by security protocols that are not necessary to provide the \n",
      "appropriate degree of protection for the organization's systems and \n",
      "data.\n",
      "    as referenced in sections ii. and iii. of this proposed rule, we \n",
      "intend to develop additional guidance, incorporating feedback from \n",
      "industry that provides implementation best practices relevant to fhir-\n",
      "conformant open apis to help organizations subject to the requirements \n",
      "proposed in this rulemaking. to that end, we solicit\n",
      "\n",
      "[[page 7640]]\n",
      "\n",
      "comment on what specific resources would be most helpful to \n",
      "organizations implementing apis under requirements proposed in this \n",
      "proposed rule.\n",
      "\n",
      "v. health information exchange and care coordination across payers: \n",
      "establishing a coordination of care transaction to communicate between \n",
      "plans\n",
      "\n",
      "    we are proposing a new requirement for medicare advantage (ma) \n",
      "plans, medicaid managed care plans, chip managed care entities, and \n",
      "qhps in the ffes to require these plans to maintain a process to \n",
      "coordinate care between plans by exchanging, at a minimum, the uscdi at \n",
      "enrollee request at the specific times specified in the proposed \n",
      "regulation text. understanding that this information could already be \n",
      "available for exchange between plans, this proposal is specifically \n",
      "requiring this information sharing not only occur when initiated by an \n",
      "enrollee request, but that the information requested, in the form of \n",
      "the uscdi data set, would then be incorporated into the recipient \n",
      "plan's systems. the uscdi (version 1) data set would have to be sent to \n",
      "another plan that covers the enrollee or a recipient identified by the \n",
      "enrollee at any time during coverage or up to 5 years after coverage \n",
      "ends, and the plan would have to receive the uscdi (version 1) data set \n",
      "from any health plan that covered the enrollee within the preceding 5 \n",
      "years. under our proposal we are supporting patient directed \n",
      "coordination of care and each of the plans subject to the requirement \n",
      "would, upon an enrollee's request: (1) accept the data set from another \n",
      "plan that had covered the enrollee within the previous 5 years; (2) \n",
      "send the data set at any time during an enrollee's enrollment and up to \n",
      "5 years later, to another plan that currently covers the enrollee; and \n",
      "(3) send the data set at any time during enrollment or up to 5 years \n",
      "after enrollment has ended to a recipient identified by the enrollee.\n",
      "    as we discussed in section iii.c.2. of this proposed rule, this \n",
      "proposal is based on our authority under sections 1856(b) and 1857(e) \n",
      "of the act to adopt standards and contract terms for ma plans; section \n",
      "1902(a)(4) of the act to adopt methods of administration for state \n",
      "medicaid plans, including requirements for medicaid managed care plans \n",
      "(mcos, pihps, and pahps); section 2101(a) of the act for chip managed \n",
      "care entities (mcos, pihps, and pahps); and section 1311(e)(1)(b) of \n",
      "the aca for qhp issuers in an ffe (not including sadp issuers). we \n",
      "believe that our proposal will help to reduce provider burden and \n",
      "improve patient access to their health information through coordination \n",
      "of care between health plans. we also note that the chip regulations \n",
      "incorporate and apply, through an existing cross-reference at 42 cfr \n",
      "457.1216, the medicaid managed care plan requirements codified at 42 \n",
      "cfr 438.62(b)(1)(vi). therefore, the proposal for medicaid managed care \n",
      "plans described above will also apply to chip managed care entities \n",
      "without new regulation text in part 457. we are proposing that this new \n",
      "requirement would be effective starting january 1, 2020 for ma plans, \n",
      "medicaid managed care plans, chip managed care entities, and qhp \n",
      "issuers in ffes. among other topics related to this proposal, we \n",
      "solicit comments on this proposed effective date.\n",
      "    we propose to codify this new requirement at 42 cfr 422.119(f)(1) \n",
      "for ma organizations; at 42 cfr 438.62(b)(1)(vi) for medicaid managed \n",
      "care plans (and by extension under existing rules in part 457, to chip \n",
      "managed care entities); and at 45 cfr 156.221(c) for qhps in ffes. this \n",
      "proposed new requirement is virtually identical for ma plans, medicaid \n",
      "managed care plans, chip managed care entities, and qhp issuers in \n",
      "ffes, with modifications in the proposal necessary for specific plans \n",
      "types to account for the program needs of the ma program, medicaid and \n",
      "chip managed care programs, and qhp program. our proposed regulation \n",
      "text references the content standard adopted at 45 cfr 170.213, which \n",
      "onc is proposing as the uscdi version 1 data set (published elsewhere \n",
      "in this issue of the federal register). we believe that exchanging this \n",
      "minimum data would help both plan enrollees and health care providers \n",
      "coordinate care and reduce administrative burden to ensure that plans \n",
      "provide coordinated high-quality care in an efficient and cost-\n",
      "effective way that protects program integrity.\n",
      "    leveraging interoperability to facilitate care coordination among \n",
      "plans can, with thoughtful execution, significantly reduce unnecessary \n",
      "care, as well as ensure that health care providers are able to spend \n",
      "their time providing care rather than performing unnecessary \n",
      "administrative tasks. we believe that use of the uscdi to exchange \n",
      "information furthers care coordination. for instance, effective \n",
      "information exchange between plans could improve care coordination by \n",
      "reducing the need for health care providers to write unneeded letters \n",
      "of medical necessity; by reducing instances of inappropriate step \n",
      "therapy; and by reducing repeated utilization reviews, risk screenings, \n",
      "and assessments. it can also streamline prior authorization processes \n",
      "and reduce instances where an enrollee's health care provider needs to \n",
      "intervene personally with the enrollee's ma plan, medicaid managed care \n",
      "plan, chip managed care entity, or qhp in the ffe to ensure his or her \n",
      "patient received the necessary treatment. this addresses concerns \n",
      "stakeholders have previously raised with cms and onc regarding such \n",
      "administrative burdens, as the uscdi standard contains many of the data \n",
      "points required to more effectively coordinate care.\n",
      "    in addition to the benefits for care coordination at the plan level \n",
      "and reduced provider burden, we note that once the combined health \n",
      "information, specified by the uscdi standard, from a prior plan is \n",
      "available to the patient's current plan, the enrollee would also have \n",
      "access to multiple years of their health information through the \n",
      "proposed patient access api discussed in section iii of this proposed \n",
      "rule. the uscdi (version 1) data set includes laboratory results and \n",
      "tests, medications, health concerns, assessment and plan of treatment, \n",
      "care teams, clinical notes, and other data points essential for care \n",
      "coordination. this would provide the patient with a more comprehensive \n",
      "history of their medical care, helping them to make better informed \n",
      "health care decisions. we seek comments on how plans might combine \n",
      "records and address error reconciliation or other factors in \n",
      "establishing a more longitudinal record for each patient.\n",
      "    we propose to allow multiple methods for electronic exchange of the \n",
      "information, including use of the apis proposed in section iii. of this \n",
      "proposed rule, to allow for patient-mediated exchange of payer \n",
      "information or direct payer-to-payer communication, subject to hipaa \n",
      "requirements, 42 cfr part 2, and other applicable laws. we considered \n",
      "requiring the use of the fhir-based api discussed in section iii. of \n",
      "this proposed rule for the information exchange; however, we understand \n",
      "that some geographic areas might have a regional health information \n",
      "exchange that could coordinate such transitions for the ma plans, \n",
      "medicaid managed care plans, chip managed care entities, and qhps in \n",
      "the ffes that are subject to this proposal. we seek comment on whether \n",
      "it would be beneficial to interoperability and patient care \n",
      "coordination for us to require the use of the fhir-based api discussed \n",
      "in section iii. of this proposed rule, and whether this should be the \n",
      "only mechanism allowed for this exchange, or whether\n",
      "\n",
      "[[page 7641]]\n",
      "\n",
      "multiple methods for electronic exchange of the information should be \n",
      "allowed under this proposed policy.\n",
      "    we also propose that a patient should be able to request his or her \n",
      "information from their prior plan up to 5 years after dis-enrollment, \n",
      "which is considerably less than existing data retention policies for \n",
      "some of the plans.\\30\\ further, if a plan has access to multiple years \n",
      "of health information for a patient, either due to the fact that the \n",
      "patient has been enrolled with the plan for multiple years, or because \n",
      "the enrollee has requested transfer of the health information from \n",
      "prior plans which previously covered the enrollee, we propose that the \n",
      "health information would be incorporated into the it and data systems \n",
      "of each plan that receives the uscdi data set under this proposed \n",
      "requirement, such that the enrollee's data would be cumulative and move \n",
      "with the enrollee as he or she changes enrollment. for example, if a \n",
      "patient is enrolled in plan 1 in 2020 and plan 2 in 2021, then requests \n",
      "the data from plan 1 to be sent to plan 2, plan 2 would have at least 2 \n",
      "years (2020 and 2021) of health information for that patient. if the \n",
      "patient moves to plan 3 in 2022, plan 3 should receive both 2020 and \n",
      "2021 data from plan 2 at the patient's request. while our proposal is \n",
      "to require compliance (and thus exchange of these data sets) only by ma \n",
      "plans, medicaid managed care plans, chip managed care entities, and \n",
      "qhps in the ffes, we hope that compliance by these plans could be the \n",
      "first step toward adoption and implementation of these standards on a \n",
      "voluntary basis by other health plans and health issuers throughout the \n",
      "health care system.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\30\\ under 42 cfr 422.504(d) and 438.3(u), ma organizations and \n",
      "medicaid managed care plans and chip plans must retain records for \n",
      "at least 10 years. under 45 cfr 156.705; 45 cfr 155.1210(b)(2), (3) \n",
      "and (5) qhps in the ffes must also retain records for 10 years.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    research indicates that the completeness of a patient record and \n",
      "the availability of up-to-date and relevant health information at the \n",
      "point of care can have a significant impact on patient outcomes.\\31\\ \n",
      "our proposal here for ma plans, medicaid managed care plans, chip \n",
      "managed care entities, and qhps in the ffes to exchange a minimum data \n",
      "set in particular scenarios would support improvement in care \n",
      "coordination by allowing for sharing of key patient health information \n",
      "when an enrollee requests it. the uscdi (version 1) data set would have \n",
      "to be sent to another plan that covers the enrollee or a recipient \n",
      "identified by the enrollee at any time during coverage or up to 5 years \n",
      "after coverage ends and the plan would have to receive the uscdi \n",
      "(version 1) data set from any health plan that covered the enrollee \n",
      "within the preceding 5 years.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\31\\ <a href=\"https://www.healthit.gov/topic/health-it-basics/improved-diagnostics-patient-outcomes\">https://www.healthit.gov/topic/health-it-basics/improved-diagnostics-patient-outcomes</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we propose that the plans subject to this new requirement would be \n",
      "required to exchange, at a minimum, the uscdi version 1 data set. on \n",
      "behalf of hhs, onc has proposed to adopt the uscdi as a standard \n",
      "(published elsewhere in this issue of the federal register), to be \n",
      "codified at 45 cfr 170.213, and our proposed regulation text cross-\n",
      "references this regulation. these data exchanges would provide the \n",
      "enrollee's new plan with a core set of data that can be used to support \n",
      "better care coordination and improved outcomes for the enrollee. we \n",
      "considered requiring plans to exchange all the data that we proposed be \n",
      "available through an api (see section iii. of this proposed rule) but \n",
      "we understand that ingesting data and reconciling errors has challenges \n",
      "and proposed this more limited data set to address those concerns. we \n",
      "are seeking comment on whether the uscdi data set is comprehensive \n",
      "enough to facilitate the type of care coordination and patient access \n",
      "described in this proposal, or whether additional data fields and data \n",
      "elements that would be available under our api proposal in section iii \n",
      "of this proposed rule, should also be required.\n",
      "    many key attributes of the uscdi make it suitable for the purpose \n",
      "outlined in our proposal. the uscdi includes data classes that can be \n",
      "supported by commonly used standards, including the health level seven \n",
      "(hl7[supreg]) consolidated clinical data architecture (c-cda) version \n",
      "2.1 and the fast healthcare interoperability resources (fhir[supreg]) \n",
      "standards for essential patient health information like vital signs, \n",
      "lab results, medications and medication allergies. the uscdi \n",
      "establishes a minimum set of data elements that would be required to be \n",
      "interoperable nationwide and is designed to be expanded in an iterative \n",
      "and predictable way over time. the uscdi, at a minimum, transferred for \n",
      "each enrollee moving among the plans subject to our proposal would \n",
      "greatly improve each plan's coordination of care efforts and spotlight \n",
      "areas of urgent need. having this information would allow the new ma \n",
      "plan, medicaid managed care plan, chip managed care entity or a qhp in \n",
      "the ffe to evaluate and review an enrollee's utilization history in a \n",
      "timely and comprehensive fashion and thus assist each enrollee to \n",
      "transition to the new plan with minimal disruption to care. by being \n",
      "able to perform timely outreach to enrollees based on past and current \n",
      "utilization, these plans could take steps to prevent unnecessary \n",
      "emergency room visits and lapses in medication and ongoing care; \n",
      "further, they could proactively address any network deficiencies that \n",
      "may impact the enrollee. we believe that having an enrollee's \n",
      "utilization history in a timely and comprehensive fashion would \n",
      "facilitate outreach and coordination efforts in ways heretofore \n",
      "unavailable on a broad basis. in all, this ability would mean that \n",
      "these plans could help new enrollees transition to new coverage rules \n",
      "and a new network with minimal disruptions to care.\n",
      "    while our proposal is to require, at a minimum, exchange of the \n",
      "uscdi version 1 data set, we reiterate that we do not propose to \n",
      "specify the means of exchanging this data at this time. while we \n",
      "anticipate that plans may opt to use apis (such as those described in \n",
      "section iii of this proposed rule) as the means to exchange this data, \n",
      "we intend to not be overly prescriptive as to how uscdi data set \n",
      "information for applicable enrollees is exchanged as we expect there \n",
      "are a variety of transmission solutions that may be employed. for \n",
      "instance, some geographic areas might have a regional health \n",
      "information exchange that could coordinate such transitions for the ma \n",
      "plans, medicaid managed care plans, chip managed care entities, and \n",
      "qhps in the ffes that are subject to this proposal. elsewhere, direct \n",
      "plan-to-plan exchange might be more appropriate, or beneficiary-facing \n",
      "third party applications could be used by ma plans, medicaid managed \n",
      "care plans, chip managed care entities, and qhps in the ffes to meet \n",
      "this proposed requirement. we also expect there may be instances where \n",
      "these plans may leverage their connections to health information \n",
      "exchanges to engage in the information exchanges necessary to comply \n",
      "with this proposed rule. we expect enrolled beneficiaries to have \n",
      "constant access to requesting an exchange of data as our proposal would \n",
      "require exchange of the uscdi data set whenever an enrollee makes such \n",
      "a request, which may occur at times other than enrollment or \n",
      "disenrollment. we request comments on other means that the applicable \n",
      "plans may prefer to use for meeting this requirement and whether cms \n",
      "might be able to leverage its program authority to facilitate the data \n",
      "exchanges contemplated by this proposal. we acknowledge that in some \n",
      "cases plans subject to this proposed requirement may be exchanging \n",
      "patient health information with other plans that are not similarly \n",
      "required to exchange\n",
      "\n",
      "[[page 7642]]\n",
      "\n",
      "uscdi data sets for enrollees, and we request comment on how to support \n",
      "patients and providers in those situations.\n",
      "    we believe that this proposed requirement would also support dual \n",
      "eligible individuals who are concurrently enrolled in ma plans and \n",
      "medicaid managed care plans. under our proposal, both of the dual \n",
      "eligible individual's plans would be subject to the requirement to \n",
      "exchange that individual's data in the uscdi version 1, which should \n",
      "improve the ability of both plans to coordinate care based on that \n",
      "data. for example, when an enrollee is initially eligible for only one \n",
      "program (that is, only for medicare and enrolled in a ma plan, or only \n",
      "for medicaid and enrolled in a medicaid mco) and then becomes dually \n",
      "eligible for a second program, the sharing of data between the existing \n",
      "plan and the new plan reduces the burden on the new plan, on the \n",
      "enrollee, and on health care providers in the new plan regarding \n",
      "collecting information about prior utilization or health information. \n",
      "rather than completing a lengthy health assessment, the enrollee in \n",
      "this example would benefit from having similar (or possibly the same) \n",
      "information transferred directly between the ma plan and the medicaid \n",
      "managed care plan under our proposal. we seek comment on how plans \n",
      "should coordinate care and exchange information in those situations. we \n",
      "also seek comment on the associated burden on plans to exchange the \n",
      "uscdi data set under our proposal. in addition, we are interested in \n",
      "comments about potential legal barriers to exchanging the uscdi data \n",
      "set as would be required under our proposal; for example, are there \n",
      "federal, state, local and tribal laws governing privacy for specific \n",
      "use cases (such as in the care of minors or for certain behavioral \n",
      "health treatments) that raise additional considerations we should \n",
      "address in this regulation or guidance.\n",
      "    we believe that activities related to this proposal may qualify as \n",
      "a quality improvement activity (qia) meeting the criteria described in \n",
      "section 2718(a)(2) of the phsa for purposes of the medical loss ratio \n",
      "(mlr) requirements for qhp issuers in an ffe (excluding sadp \n",
      "issuers),\\32\\ and similar standards for treatment of quality \n",
      "improvement standards applicable to medicaid managed care plans (mcos, \n",
      "pihps, and pahps) under 42 cfr 438.8, chip managed care entities under \n",
      "42 cfr 457.1203(f), and ma plans under 42 cfr 422.2400 through \n",
      "422.2490. we request comments related to this assumption and its \n",
      "implications.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\32\\ while this rulemaking is specific to qhp issuers \n",
      "participating in ffes, we note that to the extent other commercial \n",
      "market issuers incur similar costs for coverage sold in the \n",
      "individual or group markets, those expenses may similarly qualify as \n",
      "qia.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "vi. care coordination through trusted exchange networks: trust exchange \n",
      "network requirements for ma plans, medicaid managed care plans, chip \n",
      "managed care entities, and qhps in the ffes\n",
      "\n",
      "    we are proposing to require ma plans, medicaid managed care plans, \n",
      "chip managed care entities, and qhps in the ffes (excluding sadp \n",
      "issuers) to participate in trust networks in order to improve \n",
      "interoperability in these programs. we would codify this requirement \n",
      "in, respectively, 42 cfr 422.119(f)(2), 438.242(b)(5), and 457.1233(d) \n",
      "(which cross-references the requirements in 42 cfr 438.242(b)(5)) and \n",
      "45 cfr 156.221. in general, payers and patients' ability to communicate \n",
      "between themselves and with health care providers could considerably \n",
      "improve patient access to data, reduce provider burden, and reduce \n",
      "redundant and unnecessary procedures. trusted exchange networks allow \n",
      "for broader interoperability beyond one health system or point to point \n",
      "connections among payers, patients, and providers. such networks \n",
      "establish rules of the road for interoperability, and with maturing \n",
      "technology, such networks are scaling interoperability and gathering \n",
      "momentum with participants, including several federal agencies, ehr \n",
      "vendors, retail pharmacy chains, large provider associations, and \n",
      "others.\n",
      "    the importance of a trusted exchange framework to such \n",
      "interoperability is reflected in section 4003(b) of the cures act, as \n",
      "discussed in more detail in section i.d. of this proposed rule. a \n",
      "trusted exchange framework allows for the secure exchange of electronic \n",
      "health information with, and use of electronic health information from, \n",
      "other health it without special effort on the part of the user. \n",
      "widespread payer participation in such a framework might allow for more \n",
      "complete access and exchange of all electronically accessible health \n",
      "information for authorized use under applicable state or federal law, \n",
      "which we believe would lead to better use of such data. while we cannot \n",
      "require widespread payer participation in trust networks, we are \n",
      "proposing here to use our program authority in the ma program, medicaid \n",
      "managed care program, chip managed care program, and qhp certification \n",
      "program for the ffes to increase participation in trust networks and to \n",
      "bring the benefits of such participation to those programs.\n",
      "    we are proposing to require, effective beginning january 1, 2020, \n",
      "that ma plans, medicaid managed care plans, chip managed care entities \n",
      "and qhps in the ffes (excluding not stand alone sadps) participate in a \n",
      "trusted exchange network. this proposal is based on our authority \n",
      "under: sections 1856(b) and 1857(e) of the act to adopt standards and \n",
      "contract terms for ma plans; section 1902(a)(4) of the act to adopt \n",
      "methods of administration for the administration state medicaid plans, \n",
      "including requirements for medicaid managed care plans (mcos, pihps, \n",
      "and pahps); section 2101(a) for chip managed care entities (mcos, \n",
      "pihps, and pahps); and section 3001(c)(9)(f)(iii) of the public health \n",
      "service act and section 1311(e)(1)(b) of the affordable care act for \n",
      "qhp issuers in an ffe. under our proposal, participation would be \n",
      "required in a trusted exchange framework that meets the following \n",
      "criteria:\n",
      "    (1) the trusted exchange network must be able to exchange phi, \n",
      "defined in 45 cfr 160.103, in compliance with all applicable state and \n",
      "federal laws across jurisdictions.\n",
      "    (2) the trusted exchange network must be capable of connecting both \n",
      "inpatient ehrs and ambulatory ehrs.\n",
      "    (3) the trusted exchange network must support secure messaging or \n",
      "electronic querying by and between patients, providers and payers.\n",
      "    we propose to codify these requirements for these plans at 42 cfr \n",
      "422.119(f)(2) for ma organizations, 438.242(b)(5) for medicaid managed \n",
      "care plans, 457.1233(d)(2) for chip managed care entities, and 45 cfr \n",
      "156.221(d) for qhps in the ffes.\n",
      "    on january 5, 2018, onc released the draft trusted exchange \n",
      "framework for public comment. commenters to the draft framework, \n",
      "particularly payers providing comments, requested that existing trust \n",
      "networks operating successfully be leveraged in further advancing \n",
      "interoperability; thus, we are considering proposing in the future an \n",
      "approach to payer to payer and payer to provider interoperability that \n",
      "leverages existing trust networks to support care coordination and \n",
      "improve patient access to their data. we request comments on this \n",
      "approach and how it might be aligned in the future with section 4003(b) \n",
      "of the cures act. we also request comments on the effective date we \n",
      "have proposed for this requirement and what benefits and challenges the \n",
      "plans (ma organization, medicare managed care plans, chip managed care \n",
      "entities and qhps in the ffe) may face meeting this requirement for \n",
      "additional consideration in future rulemaking.\n",
      "\n",
      "[[page 7643]]\n",
      "\n",
      "    we believe that activities related to this proposal may qualify as \n",
      "a qia meeting the criteria described in section 2718(a)(2) of the phsa \n",
      "for purposes of the mlr requirements for qhp issuers in an ffe \n",
      "(excluding sadp issuers),\\33\\ and similar standards for treatment of \n",
      "quality improvement standards applicable to medicaid managed care plans \n",
      "(mcos, pihps, and pahps) under 42 cfr 438.8, chip managed care entities \n",
      "under 42 cfr 457.1203(f), and ma plans under 42 cfr 422.2400 through \n",
      "422.2490. we request comments related to this assumption and its \n",
      "implications.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\33\\ as noted above, to the extent other commercial market \n",
      "issuers incur similar costs for coverage sold in the individual or \n",
      "group markets outside of an ffe, those expenses may similarly \n",
      "qualify as qia.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "vii. improving the medicare-medicaid dually eligible experience by \n",
      "increasing the frequency of federal-state data exchanges\n",
      "\n",
      "a. increasing the frequency of federal-state data exchanges for dually \n",
      "eligible individuals\n",
      "\n",
      "1. background\n",
      "    the medicare and medicaid programs were originally created as \n",
      "distinct programs with different purposes. the programs have different \n",
      "rules for eligibility, covered benefits, and payment, and the programs \n",
      "have operated as separate and distinct systems despite a growing number \n",
      "of people who depend on both programs for their health care. there is \n",
      "an increasing need to align these programs--and the data and systems \n",
      "that support them--to improve care delivery and the beneficiary \n",
      "experience for dually eligible beneficiaries, while reducing \n",
      "administrative burden for providers, health plans, and states. the \n",
      "interoperability of state and cms eligibility systems is a critical \n",
      "part of modernizing the programs and improving beneficiary and provider \n",
      "experiences. improving the accuracy of data on dual eligibility status \n",
      "by increasing the frequency of federal-state data exchanges is a strong \n",
      "first step in improving how these systems work together.\n",
      "2. data exchanges to support state buy-in for medicare parts a and b\n",
      "    states and cms routinely exchange data on who is enrolled in \n",
      "medicare, and which parties are liable for paying that beneficiary's \n",
      "parts a and b premiums. these data exchanges support state, cms, and \n",
      "ssa premium accounting, collections, and enrollment functions. section \n",
      "1843 of the act permits states to enter into an agreement with the \n",
      "secretary to facilitate state ``buy-in,'' that is, payment of medicare \n",
      "premiums, in this case part b premiums, on behalf of certain \n",
      "individuals. for those beneficiaries covered under the agreement, the \n",
      "state pays the beneficiary's monthly part b premium. section 1818(g) of \n",
      "the act establishes the option for states to amend their buy-in \n",
      "agreement to include enrollment and payment of the part a premium for \n",
      "certain specified individuals. all states and the district of columbia \n",
      "have a part b buy-in agreement; 36 states and the district of columbia \n",
      "have a part a buy-in agreement.\n",
      "    to effectuate the state payment of medicare part a or part b \n",
      "premiums, a state submits data on a buy-in file to cms via an \n",
      "electronic file transfer (eft) exchange setup. the state's input file \n",
      "includes a record for each medicare beneficiary for whom the state is \n",
      "adding or deleting coverage, or changing buy-in status. in response, \n",
      "cms returns an updated transaction record that provides data \n",
      "identifying, for each transaction on the state file, whether cms \n",
      "accepted, modified, or rejected it, as well a part a or part b billing \n",
      "record showing the state's premium responsibility. in addition, the cms \n",
      "file may ``push'' new updates obtained from ssa to the state, for \n",
      "example, changes to the medicare beneficiary identifier number or a \n",
      "change of address.\n",
      "    we have issued regulations for certain details of the state buy-in \n",
      "processes. for medicare part a, 42 cfr 407.40 describes the option for \n",
      "states to amend the buy-in agreement to cover part a premiums for \n",
      "qualified medicare beneficiaries (qmbs). for medicare part b, 42 cfr \n",
      "406.26 codifies the process for modifying the buy-in agreement to \n",
      "identify the eligibility groups covered. cms subregulatory guidance, \n",
      "specifically chapter 3 of the state buy-in manual,\\34\\ specifies that \n",
      "states should exchange buy-in data with cms at least monthly, but \n",
      "describes the option for states to exchange buy-in data with cms daily \n",
      "or weekly. likewise, states can choose to receive the cms response data \n",
      "file daily or monthly. we note that 31 states and the district of \n",
      "columbia are now submitting buy-in data to cms daily; 28 states and the \n",
      "district of columbia are now receiving buy-in response files from cms \n",
      "daily.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\34\\ cms, ``state buy-in manual chapter 3--data exchange,'' \n",
      "<a href=\"https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/buyin_c03.pdf\">https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/buyin_c03.pdf</a>. (last accessed september 26, 2018).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while many states submit and receive buy-in files daily, some \n",
      "continue to only do so on a monthly basis. we have become increasingly \n",
      "concerned about the limitations of monthly buy-in data exchanges with \n",
      "states. the relatively long lag in updating buy-in data means that the \n",
      "state is not able to terminate or activate buy-in coverage sooner, so \n",
      "the state or beneficiary may be paying premiums for longer than \n",
      "appropriate. in most cases, funds must be recouped and redistributed--a \n",
      "burdensome administrative process involving debits and payments between \n",
      "the beneficiary, state, cms, and ssa. additionally, transaction errors \n",
      "do occur in the current data exchange processes. in a monthly exchange, \n",
      "it can take multiple months to correct and resubmit an improperly \n",
      "processed transaction, exacerbating the delays in appropriately \n",
      "assigning premium liability, leading to larger mispayment, recoupment, \n",
      "and redistribution of premiums.\n",
      "    exchanging the buy-in data with greater frequency supports more \n",
      "timely access to coverage. all states' systems already have the \n",
      "capacity to exchange buy-in data. we acknowledge that states who do not \n",
      "already exchange data daily will need an initial, one-time systems \n",
      "change to do so. however, moving to a daily data exchange would result \n",
      "in a net reduction of burden for states, and further, reduce \n",
      "administrative complexity for beneficiaries and providers. more \n",
      "frequent submission of updates to individuals' buy-in status positively \n",
      "impacts all involved. based on our experience with the states currently \n",
      "exchanging buy-in data daily, we have found:\n",
      "    <bullet> states can terminate buy-in coverage sooner and lower the \n",
      "risk of paying part a or part b premiums for individuals once they no \n",
      "longer qualify. enrollees for whom the buy-in is ending have less risk \n",
      "of a retroactive deduction from their social security check due to \n",
      "delayed part b buy-in terminations (while 42 cfr 407.48(c) limits \n",
      "retroactive recoupments to a maximum of 2 months, an unexpected \n",
      "deduction of up to $268 [2 months of part b premiums in 2018] is \n",
      "significant for those with incomes low enough to be dually eligible);\n",
      "    <bullet> states can detect and fix errors sooner, limiting the \n",
      "impact of such errors;\n",
      "    <bullet> state staff can spread the workload of resolving rejected \n",
      "records across the whole month rather than a spike when they receive \n",
      "the monthly cms response file;\n",
      "    <bullet> states can effectuate an earlier shift to medicare as \n",
      "primary payer for many health care services, for those already covered \n",
      "by medicaid;\n",
      "    <bullet> beneficiaries newly eligible for buy-in who had been \n",
      "paying premiums themselves can stop having the part b\n",
      "\n",
      "[[page 7644]]\n",
      "\n",
      "premium deducted from their social security check sooner; and,\n",
      "    <bullet> beneficiaries newly eligible for buy-in who could not \n",
      "afford medicare premiums can access medicare parts a and b services and \n",
      "providers can be assured of coverage sooner.\n",
      "    while there exist opportunities to modernize the platform for buy-\n",
      "in data exchange, we believe that an important first step is to promote \n",
      "the exchange of the most current available data. section 1843(f) of the \n",
      "act specifies that part b buy-in agreements shall contain such \n",
      "provisions as will facilitate the financial transactions of the state \n",
      "and the carrier with respect to deductions, coinsurance, and otherwise, \n",
      "and as will lead to economy and efficiency of operation. further, \n",
      "section 1818(g)(2)(a) of the act on part a buy-in identifies this \n",
      "section 1843(f) requirement as applicable to part a buy-in. while the \n",
      "regulations governing buy-in agreements (see 42 cfr 406.26 and 407.40) \n",
      "are silent on the frequency of buy-in data exchanges, current guidance \n",
      "articulates that the required buy-in data may be submitted daily, \n",
      "weekly, or monthly. we are proposing to establish frequency \n",
      "requirements in the regulations at 42 cfr 406.26(a)(1) and 407.40(c) to \n",
      "require all states to participate in daily exchange of buy-in data to \n",
      "cms, with ``daily'' meaning every business day, but that if no new \n",
      "transactions are available to transmit, data would not need to be \n",
      "submitted on a given business day. we believe these requirements will \n",
      "improve the economy and efficiency of operation of the ``buy-in'' \n",
      "process. we propose that states would be required to begin \n",
      "participating in daily exchange of buy-in data with cms by april 1, \n",
      "2022. we believe this effective date will allow states to phase in any \n",
      "necessary operational changes or bundle this required change with any \n",
      "new systems implementation. there are 19 states that we anticipate will \n",
      "need to make a system change to send buy-in data to cms daily, and 22 \n",
      "states that we anticipate will need to make a system change to receive \n",
      "buy-in data from cms daily. we estimate the one-time cost to be a \n",
      "little less than $80,000 per state, per change. so a state that needs \n",
      "to make systems updates to both send buy-in data daily, and receive \n",
      "buy-in data daily would have a one-time cost of just under $160,000. we \n",
      "seek comment on these proposals.\n",
      "3. exchange of state mma data files\n",
      "    states submit data on files at least monthly to cms to identify all \n",
      "dually eligible individuals, including full-benefit and partial-benefit \n",
      "dually eligible beneficiaries (that is, those who get medicaid help \n",
      "with medicare premiums, and often for cost-sharing). the file is called \n",
      "the ``mma file,'' but is occasionally referred to as the ``state \n",
      "phasedown file.'' the mma file was originally developed to meet the \n",
      "need to timely identify dually eligible beneficiaries for the then-new \n",
      "medicare part d prescription drug benefit. the medicare modernization \n",
      "act (mma) established that beginning january 1, 2006, medicare would be \n",
      "primarily responsible for prescription drug coverage for full-benefit \n",
      "dually eligible individuals; established auto-enrollment of full-\n",
      "benefit dually eligible beneficiaries into medicare prescription drug \n",
      "plans (with regulations further establishing facilitated enrollment \n",
      "into prescription drug plans for partial-benefit dually eligible \n",
      "beneficiaries), provided that dually eligible beneficiaries are treated \n",
      "as eligible for the medicare part d low income subsidy (lis), sometimes \n",
      "called extra help; defined phased down state contributions to partly \n",
      "finance part d costs for dually eligible beneficiaries; and required \n",
      "risk-adjusting capitation payments for low-income subsidy (which \n",
      "include dually eligible) enrollees of part d plans. to support these \n",
      "new requirements, we issued 42 cfr 423.910, establishing monthly \n",
      "reporting by states, in which states would submit, at least monthly, a \n",
      "data file identifying dually eligible individuals in their state. over \n",
      "time, we used these files' data on dual eligibility status to support \n",
      "part c capitation risk-adjustment, and most recently, to feed dual \n",
      "eligibility status to part a and b eligibility and claims processing \n",
      "systems so providers, suppliers, and beneficiaries have accurate \n",
      "information on beneficiary cost-sharing obligations.\n",
      "    it is required at 42 cfr 423.910 that states to submit at least one \n",
      "mma file each month. however, states have the option to submit multiple \n",
      "mma files throughout the month (up to one per day). most states submit \n",
      "mma data files at least weekly; however, only 13 states submit mma data \n",
      "files daily. as cms now leverages mma data on dual eligibility status \n",
      "into systems supporting all four parts of the medicare program, it is \n",
      "becoming even more essential that dual eligibility status is accurate \n",
      "and up-to-date. dual eligibility status can change at any time in a \n",
      "month. waiting up to a month for status updates can negatively impact \n",
      "access to the correct level of benefit at the correct level of payment. \n",
      "based on our experience with states that exchange data daily, more \n",
      "frequent mma file submissions benefit states, beneficiaries, and \n",
      "providers, in a number of ways including:\n",
      "    <bullet> enabling an earlier transition to medicare coverage for \n",
      "prescription drugs, which reduces the number of claims the state pays \n",
      "erroneously and has to recoup from pharmacists (that then have the \n",
      "burden of reaching out to reconcile with the new part d plan);\n",
      "    <bullet> effectuating an earlier shift to medicare as primary payer \n",
      "for many health care services;\n",
      "    <bullet> aiding timely error identification and resolution, \n",
      "mitigating the payment and other implications of the error;\n",
      "    <bullet> supporting states that promote enrollment in integrated \n",
      "care by expediting the enrollment into medicare, since beneficiaries \n",
      "must have medicare parts a and b, as well as medicaid to be eligible \n",
      "for integrated products such as dual-eligible special needs plans, \n",
      "medicare-medicaid plans, and the programs for all-inclusive care for \n",
      "the elderly (pace);\n",
      "    <bullet> supporting beneficiaries to obtain access to medicare part \n",
      "d benefits and related subsidies sooner, as dual eligibility status on \n",
      "the mma file prompts cms to deem individuals automatically eligible for \n",
      "the medicare part d lis and make changes to lis status (for example, \n",
      "reducing copayments to $0 when data indicate a move to a nursing \n",
      "facility or use of home and community based long term care services) \n",
      "and auto-enroll them into medicare prescription drug coverage back to \n",
      "the start of dual eligibility status; and,\n",
      "    <bullet> promoting protections for qmbs by improving the accuracy \n",
      "of data for providers and qmbs on zero cost-sharing liability for \n",
      "services under medicare parts a and b.\n",
      "    as noted, current regulation requires that the mma files be \n",
      "submitted at least monthly. we have implemented ``work-arounds'' for \n",
      "lags in dual eligibility status for part d, including the ``best \n",
      "available evidence'' policy (see 42 cfr 423.800(d)), as well as the \n",
      "limited income newly eligible transition demonstration, which provides \n",
      "short term drug coverage for dually eligible beneficiaries with no part \n",
      "d plan enrollment in a given month (see medicare prescription drug \n",
      "benefit manual, chapter 3, section 40.1.4).\\35\\ while these work-\n",
      "arounds provide needed protections, more frequent data\n",
      "\n",
      "[[page 7645]]\n",
      "\n",
      "exchanges would mitigate the need for them.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\35\\ cms, ``medicare prescription drug benefit manual: chapter \n",
      "3--eligibility, enrollment and disenrollment (2017),'' <a href=\"https://www.cms.gov/medicare/eligibility-and-enrollment/medicarepresdrugeligenrol/downloads/cy_2018_pdp_enrollment_and_disenrollment_guidance_6-15-17.pdf\">https://www.cms.gov/medicare/eligibility-and-enrollment/medicarepresdrugeligenrol/downloads/cy_2018_pdp_enrollment_and_disenrollment_guidance_6-15-17.pdf</a> (last \n",
      "accessed september 26, 2018).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    ensuring information on dual eligibility status is accurate and up-\n",
      "to-date by increasing the frequency of federal-state data exchange is \n",
      "an important step in the path to interoperability. as a result, we are \n",
      "proposing to update the frequency requirements in 42 cfr 423.910(d) to \n",
      "require that starting april 1, 2022, all states submit the required mma \n",
      "file data to cms daily, and to make conforming edits to 42 cfr \n",
      "423.910(b)(1). daily would mean every business day, but that if no new \n",
      "transactions are available to transmit, data would not need to be \n",
      "submitted on a given business day. we propose that states will be \n",
      "required to begin submitting these data daily to cms by april 1, 2022, \n",
      "because we believe this effective date will allow states to phase in \n",
      "any necessary operational changes or bundle this required change with \n",
      "any new systems implementation. there are 37 states and the district of \n",
      "columbia that we anticipate will need to make a system change to send \n",
      "mma data to cms daily. we estimate the one-time cost for a state to be \n",
      "a little less than $80,000 for this mma data systems change. for a \n",
      "detailed discussion of the costs associated with these requirements we \n",
      "refer readers to section xvi. of this proposed rule. we seek comment on \n",
      "these proposals.\n",
      "\n",
      "b. request for stakeholder input\n",
      "\n",
      "    in addition to the proposals recommended above, we seek public \n",
      "comment for consideration in future rulemaking on how we can achieve \n",
      "greater interoperability of federal-state data for dually eligible \n",
      "beneficiaries, including in the areas of program integrity and care \n",
      "coordination, coordination of benefits and crossover claims, \n",
      "beneficiary eligibility and enrollment, and their underlying data \n",
      "infrastructure. specifically, we seek comment on:\n",
      "    <bullet> whether existing regulations, as well as those proposed \n",
      "here, sufficiently support interoperability among those serving dually \n",
      "eligible beneficiaries, and if not, what additional steps would advance \n",
      "interoperability.\n",
      "    <bullet> how to enhance the interoperability of existing cms \n",
      "processes to share medicare data with states for care coordination and \n",
      "program integrity.\n",
      "    <bullet> how to improve the cms and state data infrastructure to \n",
      "support interoperability (for example, more frequent data exchanges, \n",
      "common data environment, etc.).\n",
      "    <bullet> for eligibility, how interoperability can provide timely, \n",
      "integrated eligibility and enrollment status across medicare, medicaid, \n",
      "and related agencies (for example, ssa), and reduce the need for \n",
      "persons to provide, and states to collect/process, the same demographic \n",
      "information (for example, address, income).\n",
      "    <bullet> for provider enrollment in both medicaid and medicare, how \n",
      "interoperability can streamline provider enrollment and reduce provider \n",
      "and state burden to increase systems accuracy and beneficiary \n",
      "utilization of provider enrollment data (for example, disability \n",
      "competence, hours of service, types of insurance accepted, etc.).\n",
      "    <bullet> for coordination of benefits, including crossover claims, \n",
      "the underlying changes that would need to be made to support \n",
      "interoperability (for example, coding, file formats, provider/\n",
      "beneficiary identifier, and encounter versus ffs data).\n",
      "    please include specific examples when possible while avoiding the \n",
      "transmission of protected information. please also include a point of \n",
      "contact who can provide additional information upon request.\n",
      "\n",
      "viii. information blocking background and public reporting\n",
      "\n",
      "a. information blocking background\n",
      "\n",
      "1. legislative background and policy considerations\n",
      "    the nature and extent of information blocking has come into focus \n",
      "in recent years. in 2015, at the request of the congress, onc submitted \n",
      "a report on health information blocking \\36\\ (hereinafter referred to \n",
      "as the ``information blocking congressional report''), in which onc \n",
      "commented on the then current state of technology, health it, and \n",
      "health care markets. notably, onc observed that prevailing market \n",
      "conditions create incentives for some individuals and entities to \n",
      "exercise their control over electronic health information in ways that \n",
      "limit its availability and use. since that time, onc and other \n",
      "divisions of hhs have continued to receive feedback regarding practices \n",
      "which may constitute information blocking from patients, clinicians, \n",
      "health care executives, payers, app developers and other technology \n",
      "companies, registries and health information exchanges, professional \n",
      "and trade associations, and many other stakeholders. despite \n",
      "significant public and private sector efforts to improve \n",
      "interoperability and data liquidity, engagement with stakeholders \n",
      "confirms that adverse incentives remain and continue to undermine \n",
      "progress toward a more connected health system.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\36\\ onc, report to congress on health information blocking \n",
      "(apr. 2015), <a href=\"https://www.healthit.gov/sites/default/files/reports/info_blocking_040915.pdf\">https://www.healthit.gov/sites/default/files/reports/info_blocking_040915.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    based on these economic realities and first-hand experience working \n",
      "with the health it industry and stakeholders, onc concluded in the \n",
      "information blocking congressional report that information blocking is \n",
      "a serious problem and recommended that the congress prohibit \n",
      "information blocking and provide penalties and enforcement mechanisms \n",
      "to deter these harmful practices.\n",
      "    macra became law in the same month that the information blocking \n",
      "congressional report was published. section 106(b)(2)(a) of macra \n",
      "amended section 1848(o)(2)(a)(ii) of the act to require that an \n",
      "eligible professional must demonstrate that he or she has not knowingly \n",
      "and willfully taken action (such as to disable functionality) to limit \n",
      "or restrict the compatibility or interoperability of certified ehr \n",
      "technology, as part of being a meaningful ehr user. section \n",
      "106(b)(2)(b) of macra made corresponding amendments to section \n",
      "1886(n)(3)(a)(ii) of the act for eligible hospitals and, by extension, \n",
      "under section 1814(l)(3) of the act for cahs. sections 106(b)(2)(a) and \n",
      "(b) of macra provide that the manner of this demonstration is to be \n",
      "through a process specified by the secretary, such as the use of an \n",
      "attestation. to implement these provisions, as discussed further below, \n",
      "we established and codified attestation requirements to support the \n",
      "prevention of information blocking, which consist of three statements \n",
      "containing specific representations about a health care provider's \n",
      "implementation and use of cehrt. to review our discussion of these \n",
      "requirements, we refer readers to the cy 2017 quality payment program \n",
      "final rule (81 fr 77028 through 77035).\n",
      "    recent empirical and economic research further underscores the \n",
      "complexity of the information blocking problem and its harmful effects. \n",
      "in a national survey of health information organizations, half of \n",
      "respondents reported that ehr developers routinely engage in \n",
      "information blocking, and a quarter of respondents reported that \n",
      "hospitals and health systems routinely do so.\\37\\ perceived motivations \n",
      "for\n",
      "\n",
      "[[page 7646]]\n",
      "\n",
      "information blocking described by respondents included, for ehr \n",
      "vendors, maximizing short term revenue and competing for new clients, \n",
      "and for hospitals and health systems, strengthening their competitive \n",
      "position relative to other hospitals and health systems. other research \n",
      "suggests that these practices weaken competition among health care \n",
      "providers by limiting patient mobility, encouraging consolidation, and \n",
      "creating barriers to entry for developers of new and innovative \n",
      "applications and technologies that enable more effective uses of \n",
      "clinical data to improve population health and the patient \n",
      "experience.\\38\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\37\\ see, for example, julia adler-milstein and eric pfeifer, \n",
      "information blocking: is it occurring and what policy strategies can \n",
      "address it?, 95 milbank quarterly 117, 124-25 (mar. 2017), available \n",
      "at <a href=\"http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12247/full\">http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12247/full</a>.\n",
      "    \\38\\ see, for example, martin gaynor, farzad mostashari, and \n",
      "paul b. ginsberg, making health care markets work: competition \n",
      "policy for health care, 16-17 (apr. 2017), available at <a href=\"http://heinz.cmu.edu/news/news-detail/index.aspx?nid=3930\">http://heinz.cmu.edu/news/news-detail/index.aspx?nid=3930</a>; see also diego \n",
      "a. martinez et al., a strategic gaming model for health information \n",
      "exchange markets, health care mgmt. science (sept. 2016). niam \n",
      "yaraghi, a sustainable business model for health information \n",
      "exchange platforms: the solution to interoperability in healthcare \n",
      "it (2015), available at <a href=\"http://www.brookings.edu/research/papers/2015/01/30-sustainable-business-model-health-information-exchange-yaraghi\">http://www.brookings.edu/research/papers/2015/01/30-sustainable-business-model-health-information-exchange-yaraghi</a>; thomas c. tsai & ashish k. jha, hospital consolidation, \n",
      "competition, and quality: is bigger necessarily better?, 312 j. am. \n",
      "med. assoc. 29, 29 (2014).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in december 2016, section 4004 of the cures act added section 3022 \n",
      "of the phsa (the ``phsa information blocking provision''), which \n",
      "defines conduct by health care providers, health it developers, and \n",
      "health information exchanges and networks, that constitutes information \n",
      "blocking. the phsa information blocking provision was enacted in \n",
      "response to ongoing concerns that some individuals and entities are \n",
      "engaging in practices that unreasonably limit the availability and use \n",
      "of electronic health information for authorized and permitted purposes \n",
      "(see the definition of electronic health information proposed by onc \n",
      "for hhs adoption at 45 cfr 171.102 (published elsewhere in this issue \n",
      "of the federal register)). these practices undermine public and private \n",
      "sector investments in the nation's health it infrastructure and \n",
      "frustrate efforts to use modern technologies to improve health care \n",
      "quality and efficiency, accelerate research and innovation, and provide \n",
      "greater value and choice to health care consumers.\n",
      "    the information blocking provision added to phsa defines and \n",
      "creates possible penalties and disincentives for information blocking \n",
      "in broad terms, working to deter the entire spectrum of practices \n",
      "likely to interfere with, prevent, or materially discourage access, \n",
      "exchange, or use of electronic health information. the phsa information \n",
      "blocking provision applies to health care providers, health it \n",
      "developers, exchanges, and networks. the information blocking provision \n",
      "added to phsa by the cures act also provides that the ``secretary, \n",
      "through rulemaking, shall identify reasonable and necessary activities \n",
      "that do not constitute information blocking for purposes of the \n",
      "definition at section 3022(a)(1) of the phsa.'' onc has taken the lead \n",
      "on this rulemaking effort, and in addition to the attestation discussed \n",
      "in this section, all health care providers would also be subject to the \n",
      "separate information blocking regulations proposed by onc for hhs \n",
      "adoption at 45 cfr part 171 (published elsewhere in this issue of the \n",
      "federal register).\n",
      "    we propose to publicly report certain information about eligible \n",
      "clinicians' attestations under the qpp on physician compare and \n",
      "eligible hospitals' and cahs' attestations under the medicare ffs \n",
      "promoting interoperability program (previously known as the medicare \n",
      "ehr incentive program) on a cms website. as discussed below, although \n",
      "we have already implemented what is required by sections 106(b)(2)(a) \n",
      "and (b) of macra through the attestation requirements we have \n",
      "established in prior rulemaking (81 fr 77028 through 77035), we believe \n",
      "publishing information on which eligible clinicians, eligible \n",
      "hospitals, and cahs have negatively attested that they have not \n",
      "knowingly and willfully taken action to limit or restrict the \n",
      "compatibility or interoperability of certified ehr technology would \n",
      "serve to discourage knowing and willful behavior that limits \n",
      "interoperability and prevents the sharing of information discussed in \n",
      "both macra and the cures act.\n",
      "\n",
      "b. public reporting and prevention of information blocking on physician \n",
      "compare\n",
      "\n",
      "    physician compare (<a href=\"http://www.medicare.gov/physiciancompare\">http://www.medicare.gov/physiciancompare</a>) draws \n",
      "its operating authority from section 10331(a)(1) of the affordable care \n",
      "act. consistent with section 10331(a)(2) of the affordable care act, \n",
      "physician compare initiated a phased approach to publicly reporting \n",
      "performance scores that provide comparable information on quality and \n",
      "patient experience measures. a complete history of public reporting on \n",
      "physician compare is detailed in the cy 2016 physician fee schedule \n",
      "(pfs) final rule with comment period (80 fr 71117 through 71122). more \n",
      "information about physician compare, including the history of public \n",
      "reporting and regular updates about what information is currently \n",
      "available, can also be accessed on the physician compare initiative \n",
      "website at <a href=\"https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/physician-compare-initiative/\">https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/physician-compare-initiative/</a>.\n",
      "    as discussed in the cy 2018 quality payment program final rule (82 \n",
      "fr 53820), physician compare has continued to pursue a phased approach \n",
      "to public reporting under macra in accordance with section 1848(q)(9) \n",
      "of the act. specifically, subparagraphs (a) and (d) of section \n",
      "1848(q)(9) of the act facilitate the continuation of the phased \n",
      "approach to public reporting by requiring the secretary to make \n",
      "available on the physician compare website, in an easily understandable \n",
      "format, individual mips eligible clinician and group performance \n",
      "information, including: the mips eligible clinician's final score; the \n",
      "mips eligible clinician's performance under each mips performance \n",
      "category (quality, cost, improvement activities, and promoting \n",
      "interoperability); names of eligible clinicians in advanced apms and, \n",
      "to the extent feasible, the names of such advanced apms and the \n",
      "performance of such models; and, aggregate information on the mips, \n",
      "posted periodically, including the range of final scores for all mips \n",
      "eligible clinicians and the range of the performance of all mips \n",
      "eligible clinicians for each performance category.\n",
      "    in the cy 2018 quality payment program final rule (82 fr 53827), we \n",
      "finalized a policy to include an indicator on physician compare, as \n",
      "technically feasible, for any eligible clinician or group who \n",
      "successfully meets the promoting interoperability performance category. \n",
      "we also finalized a policy to include, as technically feasible, \n",
      "additional information on physician compare, either on the profile \n",
      "pages or in the downloadable database, including, but not limited to \n",
      "objectives, activities, or measures specified in the cy 2018 quality \n",
      "payment program final rule (82 fr 53827; see 82 fr 53663 through 53688) \n",
      "with respect to the promoting interoperability performance category.\n",
      "    generally, all data available for public reporting on physician \n",
      "compare must meet our established public reporting standards under 42 \n",
      "cfr 414.1395(b). in addition, for each program year, cms provides a 30-\n",
      "day preview period for any clinician or group with qpp data being \n",
      "publicly reported on physician compare under 42 cfr 414.1395(d). all \n",
      "data available for public reporting--\n",
      "\n",
      "[[page 7647]]\n",
      "\n",
      "such as final scores--are available for review and correction during \n",
      "the targeted review process as finalized in the cy 2017 quality payment \n",
      "program final rule (81 fr 77392).\n",
      "    building upon the continuation of our phased approach to public \n",
      "reporting and understanding the importance of preventing information \n",
      "blocking, promoting interoperability and the sharing of information, we \n",
      "propose to make certain data about the attestation statements on the \n",
      "prevention of information blocking referenced earlier in section \n",
      "viii.a. of this proposed rule available for public reporting on \n",
      "physician compare, drawing upon our authority under section 10331(a)(2) \n",
      "of affordable care act, which requires us to make publicly available on \n",
      "physician compare information on physician performance that provides \n",
      "comparable information for the public on quality and patient experience \n",
      "measures. section 10331(a)(2) of the affordable care act provides that \n",
      "to the extent scientifically sound measures that are developed \n",
      "consistent with the requirements of section 10331 of the affordable \n",
      "care act are available, such information shall include, to the extent \n",
      "practicable, an assessment of the coordination of care and other \n",
      "information as determined appropriate by the secretary. we believe \n",
      "section 10331(a)(2) of the affordable care act provides the statutory \n",
      "authority to publicly report certain data about the prevention of \n",
      "information blocking attestation statements as an assessment of care \n",
      "coordination and as other information determined appropriate by the \n",
      "secretary. furthermore, the prevention of information blocking \n",
      "attestation statements are required for a clinician to earn a promoting \n",
      "interoperability performance category score, which is then incorporated \n",
      "into the final score for mips, and we are required to publicly report \n",
      "both of these scores under section 1848(q)(9)(a) of the act. publicly \n",
      "posting this information as an indicator is consistent with our \n",
      "finalized policy to publicly report, either on the profile pages or in \n",
      "the downloadable database, other aspects of the promoting \n",
      "interoperability performance category, such as objectives, activities, \n",
      "or measures specified in the cy 2018 quality payment program final \n",
      "rule.\n",
      "    there are three prevention of information blocking attestation \n",
      "statements under 42 cfr 414.1375(b)(3)(ii)(a) through (c) to which \n",
      "eligible clinicians reporting on the promoting interoperability \n",
      "performance category of mips must attest. to report successfully on the \n",
      "promoting interoperability performance category, in addition to \n",
      "satisfying other requirements, an eligible clinician must submit an \n",
      "attestation response of ``yes'' for each of these statements. for more \n",
      "information about these statements, we refer readers to the preamble \n",
      "discussion in the cy 2017 quality payment program final rule (81 fr \n",
      "77028 through 81 fr 77035).\n",
      "    we believe it would benefit the public to know if eligible \n",
      "clinicians have attested negatively to the statements under 42 cfr \n",
      "414.1375(b)(3)(ii) as this may assist the patient in selecting a \n",
      "clinician or group who collaborates with other clinicians, groups, or \n",
      "other types of health care providers by sharing information \n",
      "electronically, and does not withhold information that may result in \n",
      "better care. therefore, we are proposing to include an indicator on \n",
      "physician compare for the eligible clinicians and groups that submit a \n",
      "``no'' response to any of the three statements under 42 cfr \n",
      "414.1375(b)(3)(ii)(a) through (c). in the event that these statements \n",
      "are left blank, that is, a ``yes'' or a ``no'' response is not \n",
      "submitted, the attestations would be considered incomplete, and we \n",
      "would not include an indicator on physician compare. we also propose to \n",
      "post this indicator on physician compare, either on the profile pages \n",
      "or the downloadable database, as feasible and appropriate, starting \n",
      "with the 2019 performance period data available for public reporting \n",
      "starting in late 2020.\n",
      "    under 42 cfr 414.1395(b), these data must meet our established \n",
      "public reporting standards, including that to be included on the public \n",
      "facing profile pages, the data must resonate with website users, as \n",
      "determined by cms. in previous testing with patients and caregivers, we \n",
      "have learned that effective use of cehrt is important to them when \n",
      "making informed health care decisions. to determine how to best display \n",
      "and meaningfully communicate the indicator on the physician compare \n",
      "website, the exact wording and, if applicable, profile page indicator \n",
      "would be determined after user testing and shared with stakeholders \n",
      "through the physician compare initiative page, listservs, webinars, and \n",
      "other available communication channels. we note this proposal is \n",
      "contingent upon the availability of and technical feasibility to use \n",
      "these data for public reporting. we request comment on this proposal.\n",
      "\n",
      "c. public reporting and prevention of information blocking for eligible \n",
      "hospitals and critical access hospitals (cahs)\n",
      "\n",
      "    section 1886(n)(4)(b) of the act requires the secretary to post in \n",
      "an easily understandable format a list of the names and other relevant \n",
      "data, as determined appropriate by the secretary, of eligible hospitals \n",
      "and cahs who are meaningful ehr users under the medicare ffs program, \n",
      "on a cms website. in addition, that section requires the secretary to \n",
      "ensure that an eligible hospital or cah has the opportunity to review \n",
      "the other relevant data that are to be made public with respect to the \n",
      "eligible hospital or cah prior to such data being made public. we \n",
      "believe certain information related to the prevention of information \n",
      "blocking attestation statements under 42 cfr 495.40(b)(2)(i)(i)(1) \n",
      "through (3) would constitute other relevant data under section \n",
      "1886(n)(4)(b) of the act. specifically, we are referring to the three \n",
      "prevention of information blocking attestation statements under 42 cfr \n",
      "495.40(b)(2)(i)(i)(1) through (3) to which eligible hospitals and cahs \n",
      "must attest for purposes of the promoting interoperability program. as \n",
      "part of successfully demonstrating that an eligible hospital or cah is \n",
      "a meaningful ehr user for purposes of the promoting interoperability \n",
      "program, the eligible hospital or cah must submit an attestation \n",
      "response of ``yes'' for each of these statements. for more information \n",
      "about these statements, we refer readers to the preamble discussion in \n",
      "the cy 2017 quality payment program final rule (81 fr 77028 through 81 \n",
      "fr 77035).\n",
      "    we believe it would be relevant to the public to know if eligible \n",
      "hospitals and cahs have attested negatively to the statements under 42 \n",
      "cfr 495.40(b)(2)(i)(i)(1) through (3) as it could indicate that they \n",
      "are knowingly and unreasonably interfering with the exchange or use of \n",
      "electronic health information in ways that limit its availability and \n",
      "use to improve health care. as we stated in the cy 2017 quality payment \n",
      "program final rule, we believe that addressing issues related to \n",
      "information blocking would require additional and more comprehensive \n",
      "measures (81 fr 77029). in addition, publicly posting this information \n",
      "would reinforce our commitment to focus on increased interoperability \n",
      "and the appropriate exchange of health information. we propose to post \n",
      "information on a cms website available to the public indicating that an \n",
      "eligible hospital or cah attesting under the medicare ffs promoting\n",
      "\n",
      "[[page 7648]]\n",
      "\n",
      "interoperability program submitted a ``no'' response to any of the \n",
      "three statements under 42 cfr 495.40(b)(2)(i)(i)(1) through (3). in the \n",
      "event that these statements are left blank, that is, a ``yes'' or a \n",
      "``no'' response is not submitted, the attestations would be considered \n",
      "incomplete, and we would not post any information related to these \n",
      "attestation statements for that hospital or cah. we propose to post \n",
      "this information starting with the attestations for the ehr reporting \n",
      "period in 2019, and we expect the information would be posted in late \n",
      "2020. in accordance with section 1886(n)(4)(b) of the act, we propose \n",
      "to establish a process for each eligible hospital and cah to review the \n",
      "information related to their specific prevention of information \n",
      "blocking attestation statements before it is publicly posted on a cms \n",
      "website. specifically, for each program year, we propose a 30-day \n",
      "preview period for an eligible hospital or cah to review this \n",
      "information before it is publicly posted. during the 30-day preview \n",
      "period, we propose that all of the information that we would publicly \n",
      "post would be available for the eligible hospital or cah to review, and \n",
      "we would consider making changes to the information on a case-by-case \n",
      "basis (for example, in the event the eligible hospital or cah \n",
      "identifies an error, and we subsequently determine that the information \n",
      "is not accurate). additional information on the review process will be \n",
      "provided outside of the rulemaking process through the usual \n",
      "communication channels for the program. we invite comments on this \n",
      "proposal.\n",
      "\n",
      "ix. provider digital contact information\n",
      "\n",
      "a. background\n",
      "\n",
      "    congress required the secretary to create a provider digital \n",
      "contact information index in section 4003 of the cures act. this index \n",
      "must include all individual health care providers and health care \n",
      "facilities, or practices, in order to facilitate a comprehensive and \n",
      "open exchange of patient health information. congress gave the \n",
      "secretary the authority to use an existing index or to facilitate the \n",
      "creation of a new index. in comments received on the fy 2019 ipps \n",
      "proposed rule rfi, there was strong support for a single, public \n",
      "directory of provider digital contact information. commenters noted \n",
      "that digital communication could improve interoperability by \n",
      "facilitating efficient exchange of patient records, eliminating the \n",
      "burden of working with scanned paper documents, and ultimately \n",
      "enhancing care coordination.\n",
      "    to ensure the index is accessible to all clinicians and facilities, \n",
      "we have updated the nppes \\39\\ to be able to capture digital contact \n",
      "information for both individuals and facilities. nppes currently \n",
      "supplies national provider identifier (npi) numbers to health care \n",
      "providers (both individuals and facilities), maintains their npi \n",
      "record, and publishes the records online.\\40\\ the secretary adopted the \n",
      "npi as the hipaa administrative simplification standard identifier for \n",
      "health care providers (69 fr 3434). hipaa covered entities, including \n",
      "health care providers, health plans, and health care clearinghouses, \n",
      "must use the npi in hipaa transactions. all health care providers that \n",
      "transmit health information in electronic form in connection with a \n",
      "hipaa transaction must obtain an npi.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\39\\ the nppes website is available at <a href=\"https://nppes.cms.hhs.gov/\">https://nppes.cms.hhs.gov/</a>.\n",
      "    \\40\\ see <a href=\"https://nppes.cms.hhs.gov/\">https://nppes.cms.hhs.gov/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    health care providers are required to communicate to the nppes any \n",
      "information that has changed within 30 days of the change (45 cfr \n",
      "162.410(a)(4)). cms reviews nppes to ensure a provider has a valid npi \n",
      "as part of the medicare enrollment process, as well as the revalidation \n",
      "process, which occurs every 3 to 5 years depending on the provider or \n",
      "supplier type.\n",
      "    information in nppes is publicly accessible via both an online \n",
      "search option and a downloadable database option. as a result, adding \n",
      "digital contact information to this existing index is an efficient and \n",
      "effective way to meet the congressional requirement to establish a \n",
      "digital contact information index and to promote the sharing of \n",
      "information.\n",
      "    as of june 2018, nppes has been updated to include the capability \n",
      "to capture one or more pieces of digital contact information that can \n",
      "be used to facilitate secure sharing of health information. for \n",
      "instance, providers can submit a direct address, which functions \n",
      "similar to a regular email address, but includes additional security \n",
      "measures to ensure that messages are only accessible to the intended \n",
      "recipient in order to keep the information confidential and secure. \n",
      "``direct'' is a technical standard for exchanging health information. \n",
      "direct addresses are available from a variety of sources, including ehr \n",
      "vendors, state health information exchange entities, regional and local \n",
      "health information exchange entities, as well as private service \n",
      "providers offering direct exchange capabilities called health \n",
      "information service providers (hisps) (<a href=\"https://www.healthit.gov/sites/default/files/directbasicsforprovidersqa_05092014.pdf\">https://www.healthit.gov/sites/default/files/directbasicsforprovidersqa_05092014.pdf</a>). nppes can also \n",
      "capture information about a wide range of other types of endpoints that \n",
      "providers can use to facilitate secure exchange of health information, \n",
      "for instance a fhir server url or query endpoint associated with a \n",
      "health information exchange.\n",
      "    in addition, nppes can now maintain information about the type of \n",
      "contact information providers and organizations are associated with, \n",
      "along with the preferred uses for each address. each provider in nppes \n",
      "can maintain their own unique information or associate themselves with \n",
      "information shared among a group of providers. finally, nppes has also \n",
      "added a public api which can be used to obtain contact information \n",
      "stored in the database. although nppes is now better equipped to \n",
      "maintain provider digital contact information, many providers have not \n",
      "submitted this information. in the 2015 final rule, ``medicare and \n",
      "medicaid programs; electronic health record incentive program-stage 3 \n",
      "and modifications to meaningful use in 2015 through 2017'' (80 fr \n",
      "62901), we finalized a policy to collect information in nppes about the \n",
      "electronic addresses of participants in the ehr incentive program \n",
      "(specifically, a direct address and/or other ``electronic service \n",
      "information'' as available). however, this policy was not fully \n",
      "implemented at the time, in part due to the limitations of the nppes \n",
      "system which have since been addressed. as a result, many providers \n",
      "have not yet added their digital contact information to nppes and \n",
      "digital contact information is frequently out of date.\n",
      "    in light of these updates to the nppes system, all individual \n",
      "health care providers and facilities can take immediate action to \n",
      "update their nppes record online to add digital contact information. \n",
      "this simple step will significantly improve interoperability by making \n",
      "valuable contact information easily accessible. for those providers who \n",
      "continue to rely on the use of cumbersome, fax-based modes of sharing \n",
      "information, we hope that greater availability of digital contact \n",
      "information will help to reduce barriers to electronic communication \n",
      "with a wider set of providers with whom they share patients. \n",
      "ubiquitous, public availability of digital contact information for all \n",
      "providers is a crucial step towards eliminating the use of fax machines \n",
      "for the exchange of health information. we urge all providers to take \n",
      "advantage of this resource to implement congress' requirement that\n",
      "\n",
      "[[page 7649]]\n",
      "\n",
      "the secretary establish a digital contact information index.\n",
      "\n",
      "b. proposed public reporting of missing digital contact information\n",
      "\n",
      "    entities seeking to engage in electronic health information \n",
      "exchange need accurate information about the electronic addresses (for \n",
      "example, direct address, fhir server url, query endpoint, or other \n",
      "digital contact information) of potential exchange partners. a common \n",
      "directory of the electronic addresses of health care providers and \n",
      "organizations could enhance interoperability and information exchange \n",
      "by providing a resource where users can obtain information about how to \n",
      "securely transmit electronic health information to a provider.\n",
      "    we propose to increase the number of providers with valid and \n",
      "current digital contact information available through nppes by publicly \n",
      "reporting the names and npis of those providers who do not have digital \n",
      "contact information included in the nppes system. we propose to begin \n",
      "this public reporting in the second half of 2020, to allow individuals \n",
      "and facilities time to review their records in nppes and update the \n",
      "system with appropriate digital contact information. we are also \n",
      "requesting comment from stakeholders on the most appropriate way to \n",
      "pursue this public reporting initiative, including where these names \n",
      "should be posted, with what frequency, and any other information \n",
      "stakeholders believe would be helpful.\n",
      "    we believe this information is extremely valuable to facilitate \n",
      "interoperability, and we appreciate congress' leadership in requiring \n",
      "the establishment of this directory. we are interested in stakeholder \n",
      "comment on additional possible enforcement authorities to ensure that \n",
      "individuals and facilities make their digital contact information \n",
      "publicly available through nppes. for example, should medicare \n",
      "reporting programs, such as mips, require eligible clinicians to update \n",
      "their nppes data with their digital contact information? should cms \n",
      "require this information to be included as part of the medicare \n",
      "enrollment and revalidation process? how can cms work with states to \n",
      "promote adding information to the directory through state medicaid \n",
      "programs and chip? should cms require providers to submit digital \n",
      "contact information as part of program integrity processes related to \n",
      "prior authorization and submission of medical record documentation? we \n",
      "will review comments for possible consideration in future rulemaking on \n",
      "these questions.\n",
      "\n",
      "x. revisions to the conditions of participation for hospitals and \n",
      "critical access hospitals (cahs)\n",
      "\n",
      "a. background\n",
      "\n",
      "    as noted earlier in this proposed rule, cms appreciates the \n",
      "pathways congress has created for action on interoperability and has \n",
      "been working diligently with onc to implement them. in order to ensure \n",
      "broad stakeholder input to inform our proposals, we published a request \n",
      "for information (rfi) on interoperability in several recently published \n",
      "proposed rules, including the fy 2019 ipps proposed rule (83 fr 20550). \n",
      "specifically, we published the rfi entitled, ``promoting \n",
      "interoperability and electronic healthcare information exchange through \n",
      "possible revisions to the cms patient health and safety requirements \n",
      "for hospitals and other medicare- and medicaid-participating providers \n",
      "and suppliers.'' we requested stakeholders' input on how we could use \n",
      "the cms health and safety standards that are required for providers and \n",
      "suppliers participating in the medicare and medicaid programs (that is, \n",
      "the conditions of participation (cops), conditions for coverage (cfcs), \n",
      "and requirements for participation (rfps) for long term care \n",
      "facilities) to further advance electronic exchange of information that \n",
      "supports safe, effective transitions of care between hospitals and \n",
      "community providers. specifically, we asked for comment on revisions to \n",
      "the current cms cops for hospitals such as: requiring that hospitals \n",
      "transferring medically necessary information to another facility upon a \n",
      "patient transfer or discharge do so electronically; requiring that \n",
      "hospitals electronically send required discharge information to a \n",
      "community provider via electronic means if possible and if a community \n",
      "provider can be identified; and, requiring that hospitals make certain \n",
      "information available to patients or a specified third-party \n",
      "application (for example, required discharge instructions) via \n",
      "electronic means if requested.\n",
      "    the rfi discussed several steps we have taken in recent years to \n",
      "update and modernize the cops and other health and safety standards to \n",
      "reflect current best practices for clinical care, especially in the \n",
      "area of care coordination and discharge planning. on november 3, 2015, \n",
      "we published a proposed rule, ``medicare and medicaid programs; \n",
      "revisions to requirements for discharge planning for hospitals, \n",
      "critical access hospitals, and home health agencies'' (80 fr 68126), to \n",
      "implement the discharge planning requirements of the impact act and to \n",
      "revise the discharge planning cop requirements that hospitals \n",
      "(including short-term acute care hospitals, ltchs, rehabilitation \n",
      "hospitals, psychiatric hospitals, children's hospitals, and cancer \n",
      "hospitals), cahs, and hhas must meet in order to participate in the \n",
      "medicare and medicaid programs. the final rule in response to public \n",
      "comment on our proposed new requirements for discharge planning for \n",
      "hospitals, cahs, and hhas is under development while we review and \n",
      "respond to public comments (our deadline to finalize this rule is \n",
      "november 3, 2019). several of the proposed requirements from the 2015 \n",
      "discharge planning proposed rule directly addressed the issue of \n",
      "communication between providers and between providers and patients, as \n",
      "well as the issue of interoperability:\n",
      "\n",
      "    <bullet> hospitals and cahs would be required to transfer \n",
      "certain necessary medical information and a copy of the discharge \n",
      "instructions and discharge summary to the patient's practitioner, if \n",
      "the practitioner is known and has been clearly identified;\n",
      "    <bullet> hospitals and cahs would be required to send certain \n",
      "necessary medical information to the receiving facility/pac \n",
      "providers, at the time of discharge; and,\n",
      "    <bullet> hospitals, cahs, and hhas would need to comply with the \n",
      "impact act requirements that would require hospitals, cahs, and \n",
      "certain pac providers to use data on quality measures and data on \n",
      "resource use measures to assist patients during the discharge \n",
      "planning process, while taking into account the patient's goals of \n",
      "care and treatment preferences.\n",
      "\n",
      "    we also published the ``medicare and medicaid programs; hospital \n",
      "and critical access hospital changes to promote innovation, flexibility \n",
      "and improvement in patient care'' proposed rule (81 fr 39448) on june \n",
      "16, 2016, which is under development while we review and respond to \n",
      "public comments (our deadline to finalize this rule is june 15, 2019). \n",
      "in that rule, we proposed updating a number of cop requirements that \n",
      "hospitals and cahs would have to meet to participate in the medicare \n",
      "and medicaid programs. one of the proposed hospital cop revisions \n",
      "directly addressed the issues of communication between providers and \n",
      "patients, patient access to their medical records, and \n",
      "interoperability. we proposed that patients have the right to access \n",
      "their medical records, including current medical records, upon an oral \n",
      "or written request, in the form and format requested by such patients, \n",
      "if the information is readily producible in\n",
      "\n",
      "[[page 7650]]\n",
      "\n",
      "such form and format (including in an electronic form or format when \n",
      "such medical records are maintained electronically); or, if not, in a \n",
      "readable hard copy form or such other form and format as agreed to by \n",
      "the facility and the individual, and within a reasonable timeframe. \n",
      "under the proposal, a hospital could not frustrate the legitimate \n",
      "efforts of individuals to gain access to their own medical records and \n",
      "would be required to meet these patient requests as quickly as record \n",
      "keeping systems permit.\n",
      "    in response to the recent rfi in the fy 2019 ipps proposed rule, \n",
      "many stakeholders supported our goals of increasing interoperability \n",
      "and acknowledged the important role that hospital settings play in \n",
      "supporting care coordination. stakeholders agreed that use of \n",
      "electronic technology was an important factor in ensuring safe \n",
      "transitions. at the same time, many stakeholders expressed concerns \n",
      "about implementing policy changes within the cops, which may increase \n",
      "the compliance burden on hospitals.\n",
      "    given responses to the recent rfi, as well as previous rulemaking \n",
      "activities, we are seeking to further expand cms requirements for \n",
      "interoperability within the hospital and cah cops as part of this \n",
      "proposed rulemaking by focusing on electronic patient event \n",
      "notifications. in addition, we are committed to taking further steps to \n",
      "ensure that facilities that are electronically capturing information \n",
      "are electronically exchanging that information with providers who have \n",
      "the capacity to accept it. we expect that this will be required through \n",
      "rulemaking at a future point in time, with one option being alignment \n",
      "with the tefca described in section 4003 of the cures act. we will also \n",
      "continue to consider the rfi responses as we pursue this goal in future \n",
      "rulemaking.\n",
      "    infrastructure supporting the exchange of electronic health \n",
      "information across settings has matured substantially in recent years. \n",
      "research studies have increasingly found that health information \n",
      "exchange interventions can effect positive outcomes in health care \n",
      "quality and public health, in addition to more longstanding findings \n",
      "around reductions in utilization and costs. a recent review of how \n",
      "health information exchange interventions can improve cost and quality \n",
      "outcomes identified a growing body of high-quality studies showing that \n",
      "these interventions are associated with beneficial results.\\41\\ the \n",
      "authors identified a number of studies demonstrating positive effects \n",
      "on outcomes associated with better care coordination, such as \n",
      "reductions in 30-day readmissions,<sup>42 43 44</sup>  and medication \n",
      "reconciliation.\\45\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\41\\ menachemi n, rahurkar s, harle ca, vest jr, the benefits of \n",
      "health information exchange: an updated systematic review, j am med \n",
      "inform assoc. 2018 apr 28, accessed at <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29718258\">https://www.ncbi.nlm.nih.gov/pubmed/29718258</a>.\n",
      "    \\42\\ yeaman b, ko kj, alvarez del castillo r. care ransitions in \n",
      "long-term care and acute care: health information exchange and \n",
      "readmission rates. online j issues nurs 2015;20(3):5. accessed at \n",
      "<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/26882514\">https://www.ncbi.nlm.nih.gov/pubmed/26882514</a>.\n",
      "    \\43\\ vest jr, kern lm, silver md, kaushal r, investigators h. \n",
      "the potential for community-based health information exchange \n",
      "systems to reduce hospital readmissions. j am med inform assoc, 2015 \n",
      "march, accessed at <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25100447\">https://www.ncbi.nlm.nih.gov/pubmed/25100447</a>.\n",
      "    \\44\\ unruh ma, jung hy, kaushal r, vest jr, hospitalization \n",
      "event notifications and reductions in readmissions of medicare ffs \n",
      "beneficiaries in the bronx, new york. j am med inform assoc, 2017 \n",
      "apr 1, accessed at <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28395059\">https://www.ncbi.nlm.nih.gov/pubmed/28395059</a>.\n",
      "    \\45\\ boockvar ks, ho w, pruskowski j, et al. effect of health \n",
      "information exchange on recognition of medication discrepancies is \n",
      "interrupted when data charges are introduced: results of a cluster-\n",
      "randomized controlled trial. j am med inform assoc 2017, accessed at \n",
      "<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28505367\">https://www.ncbi.nlm.nih.gov/pubmed/28505367</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    electronic patient event notifications from hospitals, or clinical \n",
      "event notifications, are one type of health information exchange \n",
      "intervention that has been increasingly recognized as an effective and \n",
      "scalable tool for improving care coordination across settings, \n",
      "especially for patients at discharge. this approach has been identified \n",
      "with a reduction in readmissions following implementation.\\46\\ we note \n",
      "that the evidence cited in this section to support the use of \n",
      "innovative health information exchange interventions and approaches, \n",
      "such as the patient event notifications that we are proposing to \n",
      "require in this rule, can be applied to various types of hospitals, \n",
      "including psychiatric hospitals, as well as to cahs, as discussed \n",
      "below.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\46\\ unruh ma, jung hy, kaushal r, vest jr, hospitalization \n",
      "event notifications and reductions in readmissions of medicare ffs \n",
      "beneficiaries in the bronx, new york. j am med inform assoc, 2017 \n",
      "apr 1, accessed at <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28395059\">https://www.ncbi.nlm.nih.gov/pubmed/28395059</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    patient event notifications are automated, electronic \n",
      "communications from the discharging provider to another facility, or to \n",
      "another community provider as identified by the patient, which alerts \n",
      "the receiving provider that the patient has received care at a \n",
      "different setting. depending on the implementation, information \n",
      "included with these notifications can range from conveying the \n",
      "patient's name, other basic demographic information, and the sending \n",
      "institution to a richer set of clinical data on the patient. regardless \n",
      "of the information included, these notifications can help ensure that a \n",
      "receiving provider is aware that the patient has received care \n",
      "elsewhere. the notification triggers a receiving provider to reach out \n",
      "to the patient and deliver appropriate follow-up care in a timely \n",
      "manner. by notifying the physician, care manager, or care management \n",
      "team, the notification can help to improve post-discharge transitions \n",
      "and reduce the likelihood that a patient would face complications from \n",
      "inadequate follow-up care.\n",
      "    in addition to their effectiveness in supporting care coordination, \n",
      "virtually all ehr systems generate the basic messages commonly used to \n",
      "support electronic patient event notifications. these notifications are \n",
      "based on admission, discharge, and transfer (adt) messages, a standard \n",
      "message used within an ehr as the vehicle for communicating information \n",
      "about key changes in a patient's status as they are tracked by the \n",
      "system (more information about the current standard supporting these \n",
      "messages is available at <a href=\"http://www.hl7.org/implement/standards/product_brief.cfm?product_id=144\">http://www.hl7.org/implement/standards/product_brief.cfm?product_id=144</a>). as noted in the isa published by \n",
      "onc, this messaging standard has been widely adopted across the health \n",
      "care system (see <a href=\"https://www.healthit.gov/isa/sending-a-notification-a-patients-admission-discharge-andor-transfer-status-other-providers\">https://www.healthit.gov/isa/sending-a-notification-a-patients-admission-discharge-andor-transfer-status-other-providers</a>).\n",
      "    adt messages provide each patient's personal or demographic \n",
      "information (such as the patient's name, insurance, next of kin, and \n",
      "attending physician), when that information has been updated, and also \n",
      "indicate when an adt status has changed. to create an electronic \n",
      "patient event notification, a system can use the change in adt status \n",
      "to trigger a message to a receiving provider or to a health information \n",
      "exchange system that can then route the message to the appropriate \n",
      "provider. in addition to the basic demographic information contained in \n",
      "the adt message, some patient event notification implementations attach \n",
      "more detailed information to the message regarding the patient's \n",
      "clinical status and care received from the sending provider.\n",
      "\n",
      "b. proposal for hospitals (proposed 42 cfr 482.24(d))\n",
      "\n",
      "    we propose to revise the cops for medicare- and medicaid-\n",
      "participating hospitals at 42 cfr 482.24 by adding a new standard at \n",
      "paragraph (d), ``electronic notifications,'' that would require \n",
      "hospitals to send electronic patient event notifications of a patient's \n",
      "admission, discharge, and/or transfer to another health care facility \n",
      "or to another community provider. as noted in the\n",
      "\n",
      "[[page 7651]]\n",
      "\n",
      "discussion above, we would require hospitals to convey, at a minimum, \n",
      "the patient's basic personal or demographic information, as well as the \n",
      "name of the sending institution (that is, the hospital), and, if not \n",
      "prohibited by other applicable law, diagnosis. we would also encourage \n",
      "hospitals, as their systems and those of the receiving providers allow, \n",
      "to work with patients and their practitioners to offer more robust \n",
      "patient information and clinical data upon request in accordance with \n",
      "applicable law.\n",
      "    for a hospital that currently possesses an ehr system with the \n",
      "capacity to generate the basic patient personal or demographic \n",
      "information for electronic patient event (adt) notifications, \n",
      "compliance with this proposed standard within the medical records \n",
      "services cop (42 cfr 482.24) would be determined by the hospital \n",
      "demonstrating that its system: (1) is fully operational and that it \n",
      "operates in accordance with all state and federal statutes and \n",
      "regulations regarding the exchange of patient health information; (2) \n",
      "utilizes the content exchange standard incorporated by reference at 45 \n",
      "cfr 170.299(f)(2); (3) sends notifications that must include the \n",
      "minimum patient health information (which must be patient name, \n",
      "treating practitioner name, sending institution name, and, if not \n",
      "prohibited by other applicable law, patient diagnosis); and (4) sends \n",
      "notifications directly, or through an intermediary that facilitates \n",
      "exchange of health information, and at the time of the patient's \n",
      "admission to the hospital and either immediately prior to or at the \n",
      "time of the patient's discharge and/or transfer from the hospital. we \n",
      "recognize that some existing adt messages might not include diagnosis \n",
      "and therefore seek comment on the technical feasibility of including \n",
      "this information as well as the challenges in appropriately segmenting \n",
      "this information in instances where the diagnosis may not be permitted \n",
      "for disclosure under other applicable laws.\n",
      "    we propose to limit this requirement to only those hospitals which \n",
      "currently possess ehr systems with the technical capacity to generate \n",
      "information for electronic patient event notifications as discussed \n",
      "below, recognizing that not all medicare- and medicaid-participating \n",
      "hospitals have been eligible for past programs promoting adoption of \n",
      "ehr systems. our goal with this proposed requirement is to ensure that \n",
      "hospital ehr systems have a basic capacity to generate messages that \n",
      "can be utilized for notifications by a wide range of receiving \n",
      "providers, enabled by common standards. we believe that a system that \n",
      "utilizes the adt messaging standard, which is widely used as the basis \n",
      "for implementing these notifications and other similar use cases, would \n",
      "meet this goal by supporting the availability of information that can \n",
      "be used to generate information for patient event notifications. \n",
      "specifically, we propose that the system utilize the adt messaging \n",
      "standard incorporated by reference at 45 cfr 170.299(f)(2).\\47\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\47\\ health level seven messaging standard version 2.5.1 (hl7 \n",
      "2.5.1), an application protocol for electronic data exchange in \n",
      "healthcare environments, february 21, 2007.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while there is no criterion under the onc health it certification \n",
      "program which certifies health it to create and send electronic patient \n",
      "event notifications, this standard is referenced by other certification \n",
      "criteria under the program. specifically, this standard supports \n",
      "certification criteria related to transferring information to \n",
      "immunization registries, as well as transmission of laboratory results \n",
      "to public health agencies as described at 45 cfr 170.315(f) under the \n",
      "2015 edition certification criteria, and at 45 cfr 170.314(f) under the \n",
      "2014 edition. thus, we expect systems that include health it modules \n",
      "certified to meet criteria which reference this standard will possess \n",
      "the basic capacity to generate information for notification messages. \n",
      "we further note that adopting certified health it that meets these \n",
      "criteria has been required for any hospital seeking to qualify for the \n",
      "promoting interoperability programs (formerly the ehr incentive \n",
      "programs).\n",
      "    we recognize that there is currently significant variation in how \n",
      "hospitals have utilized the adt messages to support implementation of \n",
      "patient event notifications. we also recognize that many hospitals, \n",
      "which have already implemented notifications, may be delivering \n",
      "additional information beyond the basic information included in the adt \n",
      "message (both automatically when a patient's status changes and then \n",
      "upon request from receiving providers) to receiving practitioners, \n",
      "patient care team members, and post-acute care services providers and \n",
      "suppliers with whom they have established patient care relationships \n",
      "and agreements for patient health information exchange as allowed by \n",
      "law. we believe consensus standards for adt-based notifications may \n",
      "become more widely adopted in the future (we refer readers to onc's isa \n",
      "\\48\\ for more information about standards under consideration). \n",
      "however, at this time, we do not wish to restrict hospitals from \n",
      "pursuing more advanced content as part of patient notifications, nor to \n",
      "create redundant requirements where hospitals already have a suitable \n",
      "notification system in place. accordingly, while we are requiring that \n",
      "hospitals subject to this proposal possess a system utilizing this \n",
      "standard, hospitals may utilize other standards or features to support \n",
      "their notification systems. we request comment on this proposal, and \n",
      "whether this requirement would achieve the goal of setting a baseline \n",
      "for hospitals' capacity to generate information for electronic \n",
      "notifications, while still allowing for innovative approaches that \n",
      "would potentially increase the effectiveness of these notifications \n",
      "toward improving patient outcomes and safety during transitions in \n",
      "care.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\48\\ <a href=\"https://www.healthit.gov/isa/admission-discharge-and-transfer\">https://www.healthit.gov/isa/admission-discharge-and-transfer</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we further propose that the hospital would need to demonstrate that \n",
      "the system's notification capacity is fully operational, that it \n",
      "operates in accordance with all state and federal statutes and \n",
      "regulations regarding the exchange of patient health information. we \n",
      "intend for these notifications to be required, at minimum, for \n",
      "inpatients admitted to, and discharged and/or transferred from the \n",
      "hospital. however, we also note that patient event notifications are an \n",
      "effective tool for coordinating care across a wider set of patients \n",
      "that may be cared for by a hospital. for instance, a patient event \n",
      "notification could ensure a primary care physician is aware that their \n",
      "patient has received care at the emergency room, and initiate outreach \n",
      "to the patient to ensure that appropriate follow-up for the emergency \n",
      "visit is pursued. while we encourage hospitals to extend the coverage \n",
      "of their notification systems to serve additional patients, outside of \n",
      "those admitted and seen as inpatients, we also seek comment on whether \n",
      "we should identify a broader set of patients to whom this requirement \n",
      "would apply, and if so, how we should implement such a requirement in a \n",
      "way that minimizes administrative burden on hospitals.\n",
      "    additionally, we are proposing that the hospital must demonstrate \n",
      "that its system sends notifications that must include the minimum \n",
      "patient health information (which must be patient name, treating \n",
      "practitioner name, sending institution name, and, if not prohibited by \n",
      "other applicable law, patient diagnosis). the hospital would also need \n",
      "to demonstrate that the system sends notifications directly, or through \n",
      "an intermediary that facilitates exchange of health information, and at \n",
      "the time of the patient's admission to the hospital, to licensed and \n",
      "qualified practitioners, other patient care team members, and\n",
      "\n",
      "[[page 7652]]\n",
      "\n",
      "pac services providers and suppliers that: (1) receive the notification \n",
      "for treatment, care coordination, or quality improvement purposes; (2) \n",
      "have an established care relationship with the patient relevant to his \n",
      "or her care; and (3) for whom the hospital has a reasonable certainty \n",
      "of receipt of notifications. similarly, we are also proposing that the \n",
      "hospital would need to demonstrate the transmission of these \n",
      "notifications either directly, or through an intermediary that \n",
      "facilitates the exchange of health information, and either immediately \n",
      "prior to or at the time of the patient's discharge or transfer from the \n",
      "hospital, to licensed and qualified practitioners, other patient care \n",
      "team members, and pac services providers and suppliers that: (1) \n",
      "receive the notification for treatment, care coordination, or quality \n",
      "improvement purposes; (2) have an established care relationship with \n",
      "the patient relevant to his or her care; and (3) for whom the hospital \n",
      "has a reasonable certainty of receipt of notifications. we believe this \n",
      "proposal will allow for a diverse set of strategies that hospitals \n",
      "might use when implementing patient event notifications.\n",
      "    through these provisions, we are seeking to allow for different \n",
      "ways that a hospital might identify those practitioners, other patient \n",
      "care team members, and pac services providers and suppliers that are \n",
      "most relevant to both the pre-admission and post-discharge care of a \n",
      "patient. we are proposing that hospitals should send notifications to \n",
      "those practitioners or providers that have an established care \n",
      "relationship with the patient relevant to his or her care. we recognize \n",
      "that hospitals and their partners may identify appropriate recipients \n",
      "through various methods. for instance, hospitals might identify \n",
      "appropriate practitioners by requesting this information from patients \n",
      "or caregivers upon arrival, or by obtaining information about care team \n",
      "members from the patient's record. we expect hospitals might develop or \n",
      "optimize processes to capture information about established care \n",
      "relationships directly, or work with an intermediary that maintains \n",
      "information about care relationships. in other cases, hospitals may, \n",
      "directly or through an intermediary, identify appropriate notification \n",
      "recipients through the analysis of care patterns or other attribution \n",
      "methods that seek to determine the provider most likely to be able to \n",
      "effectively coordinate care post-discharge for a specific patient. the \n",
      "hospital or intermediary might also develop processes to allow a \n",
      "provider to specifically request notifications for a given patient for \n",
      "whom they are responsible for care coordination as confirmed through \n",
      "conversations with the patient.\n",
      "    additionally, we would expect hospitals, psychiatric hospitals, and \n",
      "cahs to comply with the health insurance portability and accountability \n",
      "act (hipaa) privacy rules set out at 45 cfr parts 160 and 164 when \n",
      "these proposed cop requirements for patient event notifications are \n",
      "finalized. as required at 42 cfr 482.11 for hospitals and psychiatric \n",
      "hospitals and at 42 cfr 485.608 for cahs, these providers must comply \n",
      "with all pertinent currently existing federal laws, including the hipaa \n",
      "privacy rule. the patient event notifications and other exchanges of \n",
      "patient information would be permitted as disclosures for treatment \n",
      "purposes under 45 cfr part 164.\n",
      "    we also recognize that factors outside of the hospital's control \n",
      "may determine whether or not a notification is successfully received \n",
      "and utilized by a practitioner. accordingly, we have proposed that a \n",
      "hospital would only need to send notifications to those practitioners \n",
      "for whom the hospital has reasonable certainty of receipt. while we \n",
      "expect hospitals will, to the best of their ability, seek to ensure \n",
      "that notification recipients are able to receive notifications (for \n",
      "instance, by obtaining a recipient's direct address), we understand \n",
      "that technical issues beyond the hospital's control may prevent \n",
      "successful receipt and use of a notification.\n",
      "    finally, we note that hospitals have an existing responsibility \n",
      "under the cops at 42 cfr 482.43(d) to ``transfer or refer patients, \n",
      "along with necessary medical information, to appropriate facilities, \n",
      "agencies, or outpatient services, as needed, for follow-up or ancillary \n",
      "care.'' we wish to emphasize that our proposal regarding patient event \n",
      "notifications would be separate from the requirement regarding \n",
      "necessary medical information at 42 cfr 482.43(d). we recognize that \n",
      "processes to implement this proposal, if finalized, may intersect with \n",
      "the hospital's discharge planning process. we note that nothing in this \n",
      "proposal would affect the hospital's responsibilities under 42 cfr \n",
      "482.43(d). however, if this proposal is finalized, hospitals may wish \n",
      "to consider ways to fulfill these requirements in ways that reduce \n",
      "redundancy while still remaining compliant with existing requirements. \n",
      "for instance, where appropriate and allowed by law, hospitals may seek \n",
      "to include required necessary medical information within the same \n",
      "message as a patient event notification.\n",
      "    as previously stated, we are committed to continuing to identify \n",
      "further steps we can take to ensure that facilities that are \n",
      "electronically capturing information are exchanging that information \n",
      "electronically with providers that have the capacity to accept it. we \n",
      "expect that this will be required through rulemaking at a future point \n",
      "in time with one option being alignment with the tefca described in the \n",
      "cures act.\n",
      "\n",
      "c. proposal for psychiatric hospitals (proposed 42 cfr 482.61(f))\n",
      "\n",
      "    medicare- and medicaid-participating psychiatric hospitals must \n",
      "comply with all of the hospital cops at 42 cfr 482.1 through 482.23 and \n",
      "at 42 cfr 482.25 through 482.57. they also must adhere to special \n",
      "provisions regarding medical records at 42 cfr 482.61 and staffing \n",
      "requirements at 42 cfr 482.62. since the medical records requirements \n",
      "are different for psychiatric hospitals, and since these hospitals do \n",
      "not have to comply with our regulations at 42 cfr 482.24, we are \n",
      "proposing a new electronic notification standard at 42 cfr 482.61(f) \n",
      "within the special provisions for psychiatric hospitals in this \n",
      "section.\n",
      "    similar to our proposal for hospitals at 42 cfr 482.24(d), we are \n",
      "proposing a new standard at 42 cfr 482.61(f), ``electronic \n",
      "notifications,'' that would require psychiatric hospitals to send \n",
      "electronic patient event notifications of a patient's admission, \n",
      "discharge, and/or transfer to another health care facility or to \n",
      "another community provider.\n",
      "    as we have proposed for hospitals, we propose to limit this \n",
      "requirement to only those psychiatric hospitals which currently possess \n",
      "ehr systems with the technical capacity to generate information for \n",
      "electronic patient event notifications, defined as systems that utilize \n",
      "the content exchange standard incorporated by reference at 45 cfr \n",
      "170.299(f)(2). we propose that for a psychiatric hospital that \n",
      "currently possesses an ehr system with the capacity to generate the \n",
      "basic patient personal or demographic information for electronic \n",
      "patient event (adt) notifications, compliance with this proposed \n",
      "standard within the special medical records requirements for \n",
      "psychiatric hospitals cop (42 cfr 482.61) would be determined by the \n",
      "hospital demonstrating that its system: (1) is fully operational and \n",
      "that it operates in accordance with all state and federal statutes and \n",
      "regulations regarding the exchange of patient health\n",
      "\n",
      "[[page 7653]]\n",
      "\n",
      "information; (2) utilizes the content exchange standard incorporated by \n",
      "reference at 45 cfr 170.299(f)(2); (3) sends notifications that must \n",
      "include the minimum patient health information (which must be patient \n",
      "name, treating practitioner name, sending institution name, and, if not \n",
      "prohibited by other applicable law, patient diagnosis); and (4) sends \n",
      "notifications directly, or through an intermediary that facilitates \n",
      "exchange of health information, and at the time of the patient's \n",
      "admission to the hospital and either immediately prior to or at the \n",
      "time of the patient's discharge and/or transfer from the hospital. \n",
      "please note that we are requesting comment on this policy as part of \n",
      "this hospital proposal in section x.b. of this proposed rule above. \n",
      "please see additional discussion in the proposal for hospitals above.\n",
      "    additionally, we are proposing that the hospital would need to \n",
      "demonstrate that the system sends notifications directly, or through an \n",
      "intermediary that facilitates exchange of health information, and at \n",
      "the time of the patient's admission to the hospital, to licensed and \n",
      "qualified practitioners, other patient care team members, and pac \n",
      "services providers and suppliers that: (1) receive the notification for \n",
      "treatment, care coordination, or quality improvement purposes; (2) have \n",
      "an established care relationship with the patient relevant to his or \n",
      "her care; and (3) for whom the hospital has a reasonable certainty of \n",
      "receipt of notifications. similarly, we are also proposing that the \n",
      "hospital would need to demonstrate the transmission of these \n",
      "notifications either directly, or through an intermediary that \n",
      "facilitates the exchange of health information, and either immediately \n",
      "prior to or at the time of the patient's discharge or transfer from the \n",
      "hospital, to licensed and qualified practitioners, other patient care \n",
      "team members, and pac services providers and suppliers that: (1) \n",
      "receive the notification for treatment, care coordination, or quality \n",
      "improvement purposes; (2) have an established care relationship with \n",
      "the patient relevant to his or her care; and (3) for whom the hospital \n",
      "has a reasonable certainty of receipt of notifications.\n",
      "    we refer readers to the extended discussion of these proposals in \n",
      "sections x.a. and b. of this proposed rule. we seek comment on these \n",
      "proposals.\n",
      "\n",
      "d. proposal for cahs\n",
      "\n",
      "    we believe implementation of patient event notifications are also \n",
      "important for cahs to support improved care coordination from these \n",
      "facilities to other providers in their communities. therefore, similar \n",
      "to our proposals for the hospital and psychiatric hospital medical \n",
      "records requirements as discussed in the preceding sections, we would \n",
      "revise 42 cfr 485.638, by adding a new standard to the cah clinical \n",
      "records cop at paragraph (d), ``electronic notifications.'' this \n",
      "proposed standard would require cahs to send electronic patient event \n",
      "notifications of a patient's admission, discharge, and/or transfer to \n",
      "another health care facility or to another community provider.\n",
      "    we propose to limit this requirement to only those cahs which \n",
      "currently possess ehr systems with the technical capacity to generate \n",
      "information for electronic patient event notifications, defined as \n",
      "systems that utilize the content exchange standard incorporated by \n",
      "reference at 45 cfr 170.299(f)(2). we propose that for a cah that \n",
      "currently possesses an ehr system with the capacity to generate the \n",
      "basic patient personal or demographic information for electronic \n",
      "patient event (adt) notifications, compliance with this proposed \n",
      "standard within the clinical records services cop (42 cfr 485.638) \n",
      "would be determined by the cah demonstrating that its system: (1) is \n",
      "fully operational and that it operates in accordance with all state and \n",
      "federal statutes and regulations regarding the exchange of patient \n",
      "health information; (2) utilizes the content exchange standard \n",
      "incorporated by reference at 45 cfr 170.299(f)(2); (3) sends \n",
      "notifications that must include the minimum patient health information \n",
      "(which must be patient name, treating practitioner name, sending \n",
      "institution name, and, if not prohibited by other applicable law, \n",
      "patient diagnosis); and (4) sends notifications directly, or through an \n",
      "intermediary that facilitates exchange of health information, and at \n",
      "the time of the patient's admission to the cah and either immediately \n",
      "prior to or at the time of the patient's discharge and/or transfer from \n",
      "the cah. please note that we are requesting comment on this policy as \n",
      "part of the hospital proposal above in section x.b. of this proposed \n",
      "rule. please see additional discussion in the proposal for hospitals \n",
      "above.\n",
      "    additionally, we are proposing that the cah would need to \n",
      "demonstrate that the system sends notifications directly, or through an \n",
      "intermediary that facilitates exchange of health information, and at \n",
      "the time of the patient's admission to the cah, to licensed and \n",
      "qualified practitioners, other patient care team members, and pac \n",
      "services providers and suppliers that: (1) receive the notification for \n",
      "treatment, care coordination, or quality improvement purposes; (2) have \n",
      "an established care relationship with the patient relevant to his or \n",
      "her care; and (3) for whom the cah has a reasonable certainty of \n",
      "receipt of notifications. similarly, we are also proposing that the cah \n",
      "would need to demonstrate the transmission of these notifications \n",
      "either directly, or through an intermediary that facilitates the \n",
      "exchange of health information, and either immediately prior to or at \n",
      "the time of the patient's discharge or transfer from the cah, to \n",
      "licensed and qualified practitioners, other patient care team members, \n",
      "and pac services providers and suppliers that: (1) receive the \n",
      "notification for treatment, care coordination, or quality improvement \n",
      "purposes; (2) have an established care relationship with the patient \n",
      "relevant to his or her care; and (3) for whom the cah has a reasonable \n",
      "certainty of receipt of notifications.\n",
      "    we request comments on all of these proposals. we are especially \n",
      "interested in stakeholder feedback about how these proposals should be \n",
      "operationalized. additionally, we seek comment on how cms should \n",
      "implement these proposals as part of survey and certification guidance \n",
      "in a manner that minimizes compliance burden on hospitals, psychiatric \n",
      "hospitals, and cahs while ensuring adherence with the standards. we are \n",
      "also interested in stakeholder input about a reasonable timeframe for \n",
      "implementation of these proposals for hospitals, psychiatric hospitals, \n",
      "and cahs, respectively.\n",
      "\n",
      "xi. request for information on advancing interoperability across the \n",
      "care continuum\n",
      "\n",
      "a. background\n",
      "\n",
      "    transitions across care settings have been characterized as common, \n",
      "complicated, costly, and potentially hazardous for individuals with \n",
      "complex health needs. yet despite the need for functionality to support \n",
      "better care coordination, discharge planning, and timely transfer of \n",
      "essential health information, interoperability by certain health care \n",
      "providers such as long term and pac, behavioral health, and home and \n",
      "community-based services continues to lag behind acute care providers. \n",
      "research from the assistant secretary for planning and evaluation \n",
      "(aspe) and cms, showed that in 2014, 44 percent of patients discharged \n",
      "from an acute care hospitalization received post-acute services, such \n",
      "as an admission to a snfs, an irf or a ltch, or received hha services. \n",
      "specifically, of the 1,260,958 patients that received\n",
      "\n",
      "[[page 7654]]\n",
      "\n",
      "post-acute services following an acute care hospitalization, ``. . . \n",
      "47.8 percent were discharged to a hha, 42.1 percent to a snf, 8.4 \n",
      "percent to an irf, 1.0 percent to a ltch and .7 percent to ltch-site \n",
      "neutral.'' \\49\\ in addition to the frequency of patients discharged \n",
      "from acute care to pac, a remarkable number of patients discharged from \n",
      "pac services receive subsequent care by another pac provider. for \n",
      "instance, while more current analysis is being finalized, we note that \n",
      "2012 data from the post-acute care reform demonstration (pac prd) \n",
      "found, ``67 percent of those discharged to snfs continued on to \n",
      "additional services. almost a quarter of them were readmitted to the \n",
      "acute hospital (23.1 percent). another third (32.7 percent) were \n",
      "discharged from the snf to a hha.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\49\\ ongoing work under contract: hhsp23320095651wc with rti \n",
      "international.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in patients with the acute-snf-hha pattern, almost 20 percent (19.9 \n",
      "percent) returned to the acute care hospital within 30 days of \n",
      "discharge from the hha. hospital patients discharged to ltchs and irfs \n",
      "were also likely to use multiple types of pac services and a \n",
      "substantial share of these cases were readmitted within 30 days of \n",
      "discharge, ranging from 15.9 percent (ltch-to-irf cases) to 42.8 \n",
      "percent (ltch to snf cases).'' \\50\\ in examining the home health \n",
      "patterns, it is important to keep in mind that a significant number of \n",
      "the home health population does not come through an acute admission or \n",
      "as part of a post-acute trajectory of care but instead are directly \n",
      "admitted to the hha from the community. the percentages of pac use and \n",
      "patterns of multiple transitions reinforce the need for safeguards \n",
      "around transitions of care. these findings also speak to the importance \n",
      "of the interoperable exchange of information necessary to ensure \n",
      "continuity of care, and mitigate the risks of unintended events, such \n",
      "as those associated with medication errors, that can result from \n",
      "inadequate and untimely exchange of information.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\50\\ gage bj, morley ma, smith lm, ingber mj, deutsch a, kline \n",
      "tl, dever ja, abbate jh, miller rd, lyda-mcdonald b, kelleher ca, \n",
      "garfinkel db, manning jr, murtaugh cm, stineman mg, mallinson t. \n",
      "(march, 2012). post-acute care payment reform demonstration: final \n",
      "report volume 2. prepared for the centers for medicare and medicaid \n",
      "services. available at <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reports/downloads/pac-prd_finalrpt_vol2of4.pdf\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reports/downloads/pac-prd_finalrpt_vol2of4.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    poor patient outcomes, resulting from poor communication and lack \n",
      "of information, have been found to contribute to hospital readmissions, \n",
      "emergency department (ed) visits, and adverse outcomes. a well-\n",
      "documented contributor to this problem is incomplete and missing \n",
      "information for patients with frequent transitions across care \n",
      "settings. while interoperable, bidirectional exchange of essential \n",
      "health information can improve these transitions, many long-term and \n",
      "pac, behavioral health, and home and community-based service providers \n",
      "have not adopted health it at the same rate as acute care hospitals. \n",
      "one major contributing factor to this difference in adoption rates can \n",
      "be attributed to the fact that pac providers were not eligible for the \n",
      "medicare and medicaid ehr incentive programs (now known as the \n",
      "promoting interoperability programs), which slowed adoption of ehrs and \n",
      "other forms of interoperable health it for these providers.\n",
      "    national data on ehr adoption and interoperability by these \n",
      "providers is limited. for pac facilities that do possess ehrs, vendor \n",
      "adoption of interoperable functionality has been slow and uneven. a \n",
      "national survey of snfs found that 64 percent of facilities used an ehr \n",
      "in 2016, 29 percent of snfs could send or receive health information, \n",
      "but only 7 percent could send, find, receive, and integrate such \n",
      "information.\\51\\ according to the 2015 national electronic health \n",
      "records survey (nehrs), 61.3 percent of psychiatrists were using an \n",
      "ehr, of which 40.8 percent were certified systems.\\52\\ a cdc survey \n",
      "found that 26 percent of residential care communities used ehrs in \n",
      "2016.\\53\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\51\\ alvarado c, zook k, henry j. electronic health record \n",
      "adoption and interoperability among u.s. skilled nursing facilities \n",
      "in 2016, washington, dc, office of the national coordinator for \n",
      "health information technology, u.s. department of health and human \n",
      "services, september 2017. accessed at <a href=\"https://www.healthit.gov/sites/default/files/electronic-health-record-adoption-and-interoperability-among-u.s.-skilled-nursing-facilities-in-2016.pdf\">https://www.healthit.gov/sites/default/files/electronic-health-record-adoption-and-interoperability-among-u.s.-skilled-nursing-facilities-in-2016.pdf</a>.\n",
      "    \\52\\ yang n, hing e. table of electronic health record adoption \n",
      "and use among office-based physicians in the u.s., by specialty: \n",
      "2015 national electronic health records survey. 2017. accessed at \n",
      "<a href=\"https://www.cdc.gov/nchs/data/ahcd/nehrs/2015_nehrs_ehr_by_specialty.pdf\">https://www.cdc.gov/nchs/data/ahcd/nehrs/2015_nehrs_ehr_by_specialty.pdf</a>.\n",
      "    \\53\\ quickstats: percentage of residential care communities that \n",
      "use electronic health records, by community bed size--united states, \n",
      "2016. mmwr morb mortal wkly rep 2018;67:138. doi: <a href=\"https://www.cdc.gov/mmwr/volumes/67/wr/mm6704a8.htm?s_cid=mm6704a8_w\">https://www.cdc.gov/mmwr/volumes/67/wr/mm6704a8.htm?s_cid=mm6704a8_w</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "b. solicitation of comments\n",
      "\n",
      "    we are soliciting comment on several potential strategies for \n",
      "advancing interoperability across care settings to inform future \n",
      "rulemaking activity in this area.\n",
      "    as discussed above, health it adoption has lagged in care settings \n",
      "that were not part of the ehr incentive programs. we are seeking input \n",
      "on how hhs can more broadly incentivize the adoption of interoperable \n",
      "health it systems and use of interoperable data across settings such as \n",
      "long-term and pac, behavioral health, and those settings serving \n",
      "individuals who are dually eligible for medicare and medicaid and/or \n",
      "receiving home and community-based services. we invite comment on \n",
      "specific policy strategies hhs could adopt to deliver financial support \n",
      "for technology adoption and use in these settings.\n",
      "    we also recognize that an ongoing challenge to advancing and \n",
      "incentivizing interoperability is the lack of agreed-upon measure \n",
      "concepts with which to gauge how well providers are routinely and \n",
      "effectively engaging in exchange of information across settings. to \n",
      "date, the measurement of interoperability has largely focused on the \n",
      "use of certified technology and the percentage of information \n",
      "exchanged. expanding the scope of interoperability measurement beyond \n",
      "settings that were eligible for the ehr incentive programs is critical \n",
      "as efforts are being made to enable health it and exchange capabilities \n",
      "across a broader range of care settings. in light of the interest by \n",
      "the stakeholder community to enable interoperability across all \n",
      "providers, hhs is seeking public comment on measure concepts that \n",
      "assess interoperability, including measure concepts that address pac, \n",
      "behavioral health, home and community-based services, and other \n",
      "provider settings.\n",
      "    a national quality forum report on quality in home and community-\n",
      "based services to support community living: addressing gaps in \n",
      "performance measurement suggested that new types of measure concepts \n",
      "that assess quality across the continuum of care are needed. \n",
      "specifically, nqf cited the domain of ``service delivery and \n",
      "effectiveness,'' which encompasses the level to which individuals who \n",
      "use home and community based services (hcbs) receive services and \n",
      "supports sufficient to meet their needs, as well as the domain of \n",
      "``person-centered planning and coordination,'' which includes a focus \n",
      "on the level to which services and supports across the health and \n",
      "social service systems are coordinated for individuals who receive \n",
      "hcbs. we seek comment on needed measure development work and quality \n",
      "improvement efforts focused on assuring individuals receive sufficient \n",
      "needed services across the care continuum and that their services are\n",
      "\n",
      "[[page 7655]]\n",
      "\n",
      "coordinated.\\54\\ we are also interested in comments on the \n",
      "applicability and feasibility of measure concepts for pac, behavioral \n",
      "health, home and community-based services as identified in previous \n",
      "aspe reports \\55\\ \\56\\ and the report, a measurement framework to \n",
      "assess nationwide progress related to interoperable health information \n",
      "exchange to support the national quality strategy, published by the \n",
      "national quality forum.\\57\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\54\\ quality in home and community-based services to support \n",
      "community living: <a href=\"https://www.qualityforum.org/publications/2016/09/quality_in_home_and_community-based_services_to_support_community_living__addressing_gaps_in_performance_measurement.aspx\">https://www.qualityforum.org/publications/2016/09/quality_in_home_and_community-based_services_to_support_community_living__addressing_gaps_in_performance_measurement.aspx</a>.\n",
      "    \\55\\ measurement of interoperable electronic health care records \n",
      "utilization final report: <a href=\"https://aspe.hhs.gov/system/files/pdf/255526/ehrutilizationreport.pdf\">https://aspe.hhs.gov/system/files/pdf/255526/ehrutilizationreport.pdf</a>.\n",
      "    \\56\\ analyzing the public benefit attributable to interoperable \n",
      "health information exchange: <a href=\"https://aspe.hhs.gov/system/files/pdf/258851/analyzingthepublicbenefitattributabletointeroperablehealth.pdf\">https://aspe.hhs.gov/system/files/pdf/258851/analyzingthepublicbenefitattributabletointeroperablehealth.pdf</a>.\n",
      "    \\57\\ a measurement framework to assess nationwide progress \n",
      "related to interoperable health information exchange to support the \n",
      "national quality strategy: <a href=\"https://www.qualityforum.org/projects/i-m/interoperability_2016-2017/final_report.aspx\">https://www.qualityforum.org/projects/i-m/interoperability_2016-2017/final_report.aspx</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    as part of its work under the impact act, which requires, in part, \n",
      "that certain patient assessment data be standardized and interoperable \n",
      "to allow for exchange of the data among pac providers and other \n",
      "providers, cms has defined certain standardized patient assessment data \n",
      "elements \\58\\ and their associated health it vocabularies across pac \n",
      "settings. implementation of these standardized data elements is \n",
      "designed to support more seamless and effective assessment of quality \n",
      "across pac settings, while also presenting a significant improvement in \n",
      "the ability of these settings to potentially share structured \n",
      "electronic data with other providers across the care continuum.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\58\\ for more information on the data element library see \n",
      "<a href=\"https://del.cms.gov/delweb/pubhome\">https://del.cms.gov/delweb/pubhome</a>, as well as the data element \n",
      "library training and faq at <a href=\"https://del.cms.gov/delweb/pubtrainfaq\">https://del.cms.gov/delweb/pubtrainfaq</a>. \n",
      "cms also provides information and training on the various assessment \n",
      "instruments through which post-acute care providers must submit \n",
      "data. training on the oasis instrument can be found on the hh qrp \n",
      "website at <a href=\"https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/homehealthqualityinits/home-health-quality-reporting-training.html\">https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/homehealthqualityinits/home-health-quality-reporting-training.html</a>; information related to the training on the \n",
      "irf pai is available on the irf qrp website at <a href=\"https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/irf-quality-reporting/irf-quality-reporting-training.html\">https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/irf-quality-reporting/irf-quality-reporting-training.html</a>; information \n",
      "related to the training on the ltch care data set is available on \n",
      "the ltch qrp website at <a href=\"https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/ltch-quality-reporting/ltch-quality-reporting-training.html\">https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/ltch-quality-reporting/ltch-quality-reporting-training.html</a>; and information related to the \n",
      "training on the mds is available on the snf qrp website at <a href=\"https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/nursinghomequalityinits/skilled-nursing-facility-quality-reporting-program/snf-quality-reporting-program-training.html\">https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/nursinghomequalityinits/skilled-nursing-facility-quality-reporting-program/snf-quality-reporting-program-training.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    to enable the bidirectional exchange of this health information, we \n",
      "are seeking public comment on whether hospitals and physicians should \n",
      "adopt the capability to collect and electronically exchange a subset of \n",
      "the same pac standardized patient assessment data elements (for \n",
      "example, functional status, pressure ulcers/injuries) in their ehrs. as \n",
      "these health care providers have generally been eligible for the ehr \n",
      "incentive programs (now known as promoting interoperability programs), \n",
      "many of them would have adopted certified ehr technology and health it \n",
      "systems, which are required to capture and exchange certain data \n",
      "elements under the onc health it certification program. the set of data \n",
      "which systems must include under the certification program is set to \n",
      "expand in coming years under the uscdi version 1 onc has proposed for \n",
      "hhs adoption at 45 cfr 170.213, which would establish a minimum set of \n",
      "data classes that would be required to be interoperable nationwide (see \n",
      "the onc proposed rule published elsewhere in this issue of the federal \n",
      "register). the uscdi is designed to be expanded in an iterative and \n",
      "predictable way over time.\n",
      "    we are seeking comment on whether to move toward the adoption of \n",
      "pac standardized data elements through the expansion of the uscdi \n",
      "process. we are interested in whether the standardized patient \n",
      "assessment data elements that are implemented in cms pac assessment \n",
      "instruments in satisfaction of the impact act would be appropriate. if \n",
      "the full set of such standardized patient assessment data elements is \n",
      "not appropriate, we are seeking comment on whether a subset of these \n",
      "standardized items would be appropriate, and input on which data \n",
      "elements should be prioritized as part of a subset. we are also seeking \n",
      "information on what implementation timeline would be most appropriate \n",
      "for requiring adoption of these data elements in provider and hospital \n",
      "systems under the onc health it certification program. we are also \n",
      "seeking comment on the administrative, development, and implementation \n",
      "burden that may be associated with adopting these data elements.\n",
      "\n",
      "xii. advancing interoperability in innovative models\n",
      "\n",
      "a. promoting interoperability\n",
      "\n",
      "    cms plans to utilize center for medicare and medicaid innovation \n",
      "(``innovation center'') authority under section 1115a of the act to \n",
      "test ways to promote interoperability across the health care spectrum. \n",
      "section 1115a of the act authorizes the innovation center to test \n",
      "innovative payment and service delivery models expected to reduce \n",
      "program expenditures, while preserving or enhancing the quality of care \n",
      "furnished to medicare and medicaid beneficiaries and chip enrollees. \n",
      "interoperability and health data sharing are critical to the success of \n",
      "new payment and service delivery models that incentivize high quality, \n",
      "efficient care.\n",
      "    innovation center models can include multiple types of health care \n",
      "providers and other entities such as physician group practices, \n",
      "hospitals, pac facilities, community-based organizations providing \n",
      "community-based long-term care services and supports or non-medical \n",
      "services, and dialysis centers. these types of health care providers \n",
      "furnish care to patients in different care settings, have different \n",
      "health it systems, and have varied levels of experience with, and \n",
      "access to, ehr technology. the historically disparate and inadequate \n",
      "use of health it among these providers and other entities has posed \n",
      "challenges to interoperability. additionally, many of these types of \n",
      "health care providers are not eligible for the promoting \n",
      "interoperability programs (previously known as the medicare and \n",
      "medicaid ehr incentive programs) and the associated financial \n",
      "incentives for ehr adoption and meaningful use.\n",
      "    we believe innovation center models (<a href=\"https://innovation.cms.gov/\">https://innovation.cms.gov/</a>) \n",
      "provide an important lever to advance progress toward interoperability. \n",
      "these models offer unique opportunities to engage with health care \n",
      "providers and other entities in innovative ways and to test concepts \n",
      "that have the ability to accelerate change in the u.s. health care \n",
      "system, including to promote interoperability. one example of cms's use \n",
      "of innovation center models to promote interoperability is found in the \n",
      "innovation center's state innovation models (sim) initiative (<a href=\"https://innovation.cms.gov/initiatives/state-innovations/\">https://innovation.cms.gov/initiatives/state-innovations/</a>), under which several \n",
      "awards to states are focused on health information exchanges and health \n",
      "it investment. another example of this work is found in the \n",
      "comprehensive primary care plus (cpc+) model\n",
      "\n",
      "[[page 7656]]\n",
      "\n",
      "(<a href=\"https://innovation.cms.gov/initiatives/comprehensive-primary-care-plus\">https://innovation.cms.gov/initiatives/comprehensive-primary-care-plus</a>), in which primary care practices use health it to strengthen \n",
      "their ability to deliver care, with some practices partnering with \n",
      "health it vendors to implement advanced health it functionality in \n",
      "their practices, including functionality that promotes interoperability \n",
      "and sharing of electronic health information.\n",
      "\n",
      "b. examples of interoperability-related areas of focus for new model \n",
      "development\n",
      "\n",
      "    examples of how we may focus on interoperability related-issues in \n",
      "future model development may include: models that incorporate piloting \n",
      "emerging standards; models leveraging non-traditional data in model \n",
      "design (for example, data from schools, data regarding housing and data \n",
      "on food insecurity); and models leveraging technology-enabled patient \n",
      "engagement platforms. the innovation center has incorporated non-\n",
      "clinical data in prior models, but anticipates addressing additional \n",
      "uses and types of non-clinical data in future models.\n",
      "    we are now requesting public comment on the following general \n",
      "principles around interoperability within innovation center models for \n",
      "integration into new models, through provisions in model participation \n",
      "agreements or other governing documents. in applying these general \n",
      "principles, we intend to be sensitive to the details of individual \n",
      "model design, and the characteristics and capacities of the \n",
      "participants in each specific model.\n",
      "\n",
      "c. establishing principles for promoting interoperability in innovative \n",
      "model tests\n",
      "\n",
      "1. provide patients access to their own electronic health information\n",
      "    the myhealthedata and medicare blue button 2.0 initiatives aim to \n",
      "empower patients by ensuring that they have access to their health care \n",
      "data and can decide how their data is going to be used, all while \n",
      "keeping their data safe and secure. certain innovation center models \n",
      "already require that participants with direct patient interactions \n",
      "provide their patients with electronic access to their health \n",
      "information within 24 hours of any encounter. new innovation center \n",
      "models may also require that providers and other health care entities \n",
      "with direct patient interactions provide patients access to their own \n",
      "electronic health information and, upon the patient's authorization, to \n",
      "third party developers via apis.\n",
      "2. promote trusted health information exchange\n",
      "    innovation center model participants may, where appropriate, be \n",
      "required to participate in a trusted exchange network that meets the \n",
      "following criteria:\n",
      "    <bullet> the trusted exchange network must be able to exchange phi \n",
      "in compliance with all applicable state and federal laws across \n",
      "jurisdictions.\n",
      "    <bullet> the trusted exchange network must connect both inpatient \n",
      "ehrs and ambulatory ehrs.\n",
      "    <bullet> the trusted exchange network must support secure messaging \n",
      "or electronic querying by and between patients, providers and payers.\n",
      "    additionally, model participants may be required to participate in \n",
      "electronic alerting via one of the standards described in the isa, ii-\n",
      "a: admission, discharge, and transfer published and updated by onc.\n",
      "3. adopt leading health it standards and pilot emerging standards\n",
      "    emerging health data standards present new opportunities to \n",
      "exchange more types of health care data between health care providers. \n",
      "innovation center model participants, along with their health it \n",
      "vendors, may pilot new fhir standards and advance adoption of new data \n",
      "classes in uscdi (for example, psychosocial data) to improve \n",
      "interoperability for care management, quality reporting or other \n",
      "priority use cases. as part of the design and testing of innovative \n",
      "payment and service delivery models, the innovation center anticipates \n",
      "taking on a leadership role in developing new or less mature fhir and \n",
      "supporting more innovative interventions undertaken by states, whenever \n",
      "possible.\n",
      "\n",
      "d. request for stakeholder input\n",
      "\n",
      "    the innovation center seeks public comment on the principles for \n",
      "promoting interoperability in innovative payment and service delivery \n",
      "models described above. additionally, the innovation center is \n",
      "requesting public comment on other ways in which the innovation center \n",
      "may further promote interoperability among model participants and other \n",
      "health care providers as part of the design and testing of innovative \n",
      "payment and service delivery models.\n",
      "\n",
      "xiii. request for information on policies to improve patient matching\n",
      "\n",
      "a. background\n",
      "\n",
      "    through stakeholder feedback such as roundtables, stakeholder \n",
      "meetings, and rulemaking, we have received considerable feedback that \n",
      "the lack of a upi inhibits interoperability efforts because, without a \n",
      "unique identifier for each patient, the safe and secure electronic \n",
      "exchange of health information is constrained as it is difficult to \n",
      "ensure that the relevant records are all for the same patient. hipaa \n",
      "required the adoption of a ``unique individual identifier for \n",
      "healthcare purposes,'' commonly referred to as a upi. at the time hipaa \n",
      "was enacted, hhs began to consider what information would be needed to \n",
      "develop a rule to adopt a upi standard. an initial notice of intent to \n",
      "issue a proposed rule on requirements for a unique health identifier \n",
      "for individuals was published in the november 2, 1998 federal register \n",
      "(63 fr 61773 through 61774).\n",
      "    appreciating the significant privacy and security concerns raised \n",
      "by stakeholders regarding implementing a upi, congress included \n",
      "language in the omnibus consolidated and emergency supplemental \n",
      "appropriations act of 1999 (pub. l. 105-277, enacted october 21, 1998) \n",
      "and in each subsequent appropriations bill, stating none of the funds \n",
      "made available in this act may be used to promulgate or adopt any final \n",
      "standard under section 1173(b) of the act (42 u.s.c. 1320d-2(b)) \n",
      "providing for, or providing for the assignment of, a unique health \n",
      "identifier for an individual (except in an individual's capacity as an \n",
      "employer or a health care provider), until legislation is enacted \n",
      "specifically approving the standard. this language has effectively \n",
      "prohibited hhs from engaging in rulemaking to adopt a upi standard. \n",
      "consequently, the secretary withdrew the notice of intent to pursue \n",
      "rulemaking on this issue on august 9, 2000 (<a href=\"https://www.reginfo.gov/public/do/eagendaviewrule?pubid=200010&rin=0938-ai91\">https://www.reginfo.gov/public/do/eagendaviewrule?pubid=200010&rin=0938-ai91</a>).\n",
      "    although the appropriations language regarding the upi standard has \n",
      "remained unchanged, in the report accompanying the 2017 appropriations \n",
      "bill, congress additionally stated, although the committee continues to \n",
      "carry a prohibition against hhs using funds to promulgate or adopt any \n",
      "final standard providing for the assignment of a unique health \n",
      "identifier for an individual until such activity is authorized, the \n",
      "committee notes that this limitation does not prohibit hhs from \n",
      "examining the issues around patient matching. accordingly, the \n",
      "committee encouraged the secretary, acting through onc and cms, to \n",
      "provide technical assistance to private-sector led initiatives to \n",
      "develop a coordinated national strategy that will\n",
      "\n",
      "[[page 7657]]\n",
      "\n",
      "promote patient safety by accurately identifying patients to their \n",
      "health information. (h.r. rep. no. 114-699, p. 110, <a href=\"https://www.gpo.gov/fdsys/pkg/crpt-114hrpt699/pdf/crpt-114hrpt699.pdf\">https://www.gpo.gov/fdsys/pkg/crpt-114hrpt699/pdf/crpt-114hrpt699.pdf</a>). \n",
      "congress has repeated this guidance for 2018 and 2019. this guidance \n",
      "directed hhs to focus on examining issues around patient matching and \n",
      "to provide technical assistance to private sector-led initiatives \n",
      "focusing on a patient matching solution.\n",
      "    in conjunction with onc, we are posing a request for information \n",
      "regarding how cms could leverage our program authority to improve \n",
      "patient identification to facilitate improved patient safety, enable \n",
      "better care coordination, and advance interoperability. inaccurate \n",
      "patient matching can lead to adverse events, compromised safety and \n",
      "privacy, inappropriate and unnecessary care, increased health care \n",
      "costs, and poor oversight of fraud and abuse. we consider this a \n",
      "quality of care and patient safety issue and seek stakeholder input on \n",
      "ways we can incent improvements.\n",
      "    in section 4007 of the 21st century cures act, the government \n",
      "accountability office (gao) was directed to conduct a study to \n",
      "determine whether onc and other stakeholders could improve patient \n",
      "matching through various mechanisms, to survey ongoing efforts related \n",
      "to the policies and activities and the effectiveness of such efforts \n",
      "occurring in the private sector, and to evaluate current methods used \n",
      "in certified ehrs for patient matching. the gao was also tasked with \n",
      "submitting to congress a report concerning the findings of the study. \n",
      "this report was released in january 2019.\\59\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\59\\ <a href=\"https://www.gao.gov/assets/700/696426.pdf\">https://www.gao.gov/assets/700/696426.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in section i of this proposed rule, we discuss further how patient \n",
      "identification and matching pose challenges to interoperability. we \n",
      "look forward to working with onc as we review the responses to this rfi \n",
      "in concert with the gao report to help inform potential appropriate \n",
      "methods to scale best practices and leverage program authority to \n",
      "improve patient matching.\n",
      "\n",
      "b. solicitation of comments\n",
      "\n",
      "    we are soliciting comment on potential strategies to address \n",
      "patient matching. many stakeholders commenting on the interoperability \n",
      "rfis included in the various 2019 proposed payment rules, including the \n",
      "fy 2019 ipps proposed rule (83 fr 20550), indicated that patient \n",
      "matching is a ``core functionality'' of patient identification and \n",
      "necessary to ensure care coordination and the best patient outcomes. \n",
      "commenters also noted that a consistently used matching strategy could \n",
      "accomplish the original goals of a upi with a diminished risk to \n",
      "individual privacy and health information security. we solicit comment \n",
      "on how and in what way patient matching does or does not present the \n",
      "same security and privacy risks as a upi.\n",
      "    we understand the significant health information privacy and \n",
      "security concerns raised around the development of a upi standard and \n",
      "the current prohibition against using hhs funds to adopt a upi \n",
      "standard. recognizing congress' statement regarding patient matching \n",
      "and stakeholder comments stating that a patient matching solution would \n",
      "accomplish the goals of a upi, we seek comment on ways for us to \n",
      "continue to facilitate private sector work on a workable and scalable \n",
      "patient matching strategy so that the lack of a specific upi does not \n",
      "impede the free flow of information for future consideration.\n",
      "    we are also seeking comment on how we may leverage our program \n",
      "authority to provide support to those working to improve patient \n",
      "matching. we specifically seek input on the following questions and the \n",
      "potential authority for the requirement:\n",
      "    1. should cms require medicare ffs, ma plans, medicaid ffs, \n",
      "medicaid managed care plans (mcos, pihps, and pahps), chip ffs, chip \n",
      "managed care entities, and qhp issuers in ffes (not including sadp \n",
      "issuers), use a patient matching algorithm with a proven success rate \n",
      "of a certain percentage where the algorithm and real world processes \n",
      "associated with the algorithm used are validated by hhs or a 3rd party?\n",
      "    2. should cms require medicare ffs, the ma plans, medicaid ffs, \n",
      "medicaid managed care plans, chip ffs, chip managed care entities, and \n",
      "qhp issuers in ffes to use a particular patient matching software \n",
      "solution with a proven success rate of a certain percentage validated \n",
      "by hhs or a 3rd party?\n",
      "    3. should cms expand the recent medicare id card efforts by \n",
      "requiring a cms-wide identifier which is used for all beneficiaries and \n",
      "enrollees in health care programs under cms administration and \n",
      "authority, specifically by requiring any or all of the following:\n",
      "    <bullet> that ma organizations, part d prescription drug plan \n",
      "sponsors, entities offering cost plans under section 1876 of the act, \n",
      "and other medicare health plans use the medicare id in their plan \n",
      "administration.\n",
      "    <bullet> that state medicaid and chip agencies in their ffs or \n",
      "managed care programs use the medicare id for dual eligible individuals \n",
      "when feasible.\n",
      "    <bullet> that qhp issuers in ffes use the medicare id for their \n",
      "enrollees in the administration of their plans.\n",
      "    4. should cms advance more standardized data elements across all \n",
      "appropriate programs for matching purposes, perhaps leveraging the \n",
      "uscdi proposed by onc for hhs adoption at 45 cfr 170.213.\n",
      "    5. should cms complement cms data and plan data in medicaid managed \n",
      "care plans (mcos, pihps, and pahps), chip managed care entities, ma \n",
      "plans, and qhp issuers in an ffe (not including sadp issuers) with one \n",
      "or more verifying data sources for identity proofing? what potential \n",
      "data source should be considered? what are possible restrictions or \n",
      "limitations to accessing such information?\n",
      "    6. should cms support connecting ehrs to other complementary \n",
      "verifying data sources for identity proofing? what potential data \n",
      "source should be considered? what are possible restrictions or \n",
      "limitations to accessing such information?\n",
      "    7. to what extent should patient-generated data complement the \n",
      "patient-matching efforts?\n",
      "\n",
      "xiv. collection of information requirements\n",
      "\n",
      "    under the paperwork reduction act of 1995, we are required to \n",
      "provide 60-day notice in the federal register and solicit public \n",
      "comment before a collection of information requirement is submitted to \n",
      "the office of management and budget (omb) for review and approval. in \n",
      "order to fairly evaluate whether an information collection should be \n",
      "approved by omb, section 3506(c)(2)(a) of the paperwork reduction act \n",
      "of 1995 requires that we solicit comment on the following issues:\n",
      "    <bullet> the need for the information collection and its usefulness \n",
      "in carrying out the proper functions of our agency.\n",
      "    <bullet> the accuracy of our estimate of the information collection \n",
      "burden.\n",
      "    <bullet> the quality, utility, and clarity of the information to be \n",
      "collected.\n",
      "    <bullet> recommendations to minimize the information collection \n",
      "burden on the affected public, including automated collection \n",
      "techniques.\n",
      "    we are soliciting public comment on each of these issues for the \n",
      "following sections of this document that contain information collection \n",
      "requirements (icrs):\n",
      "\n",
      "[[page 7658]]\n",
      "\n",
      "a. background\n",
      "\n",
      "    health plans should have the ability to exchange data instantly \n",
      "with other payers for care and payment coordination or transitions, and \n",
      "with providers to facilitate more efficient care. health plans are in a \n",
      "unique position to provide enrollees a complete picture of their claims \n",
      "and encounter data, allowing patients to piece together their own \n",
      "information that might otherwise be lost in disparate systems. to \n",
      "advance our commitment to interoperability, we are proposing new \n",
      "requirements to implement apis for ma organizations at 42 cfr 422.119, \n",
      "medicaid ffs at 42 cfr 431.60, chip ffs at 42 cfr 457.730, medicaid \n",
      "managed care at 42 cfr 438.242, chip managed care at 42 cfr \n",
      "457.1233(d), and qhp issuers in ffes, excluding sadps at 45 cfr \n",
      "156.221. these openly published apis will permit third-party \n",
      "applications to retrieve standardized data for adjudicated claims, \n",
      "encounters with capitated and subcapitated providers, provider \n",
      "remittances, beneficiary cost-sharing, reports of lab test results \n",
      "(depending on whether the plan manages such data), provider \n",
      "directories, and, as applicable, preferred drug lists. we believe that \n",
      "these proposals are designed to empower patients by making sure that \n",
      "they can access their healthcare data, through the use of common \n",
      "technologies, without special effort and in an easily usable digital \n",
      "format. we also expect our api proposals to enable the enrollees in the \n",
      "plans that are subject to our proposal to share their healthcare data. \n",
      "by making claims data readily available and portable to the patient, \n",
      "these initiatives support moving our healthcare system away from a ffs \n",
      "payment system that pays for volume and toward a payment system that \n",
      "pays for value and quality by reducing duplication of services; adding \n",
      "efficiency to provider visits; and, facilitating identification of \n",
      "fraud, waste, and abuse.\n",
      "\n",
      "b. wage estimates\n",
      "\n",
      "    to derive average costs, we used data from the u.s. bureau of labor \n",
      "statistics' may 2017 national occupational employment and wage \n",
      "estimates for direct health and medical insurance carriers (naics \n",
      "524114) (<a href=\"https://www.bls.gov/oes/current/naics5_524114.htm\">https://www.bls.gov/oes/current/naics5_524114.htm</a>). table 1 \n",
      "presents the mean hourly wage, the cost of fringe benefits (calculated \n",
      "at 100 percent of salary), and the adjusted hourly wage.\n",
      "\n",
      "                                    table 1--occupation titles and wage rates\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                                                     adjusted\n",
      "                occupation title                    occupation      mean hourly   fringe benefit  hourly wage (/\n",
      "                                                       code         wage (/hr)         (/hr)            hr)\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "administrators and network architects...........         15-1140          $46.35          $46.35          $92.70\n",
      "security engineer...............................         17-2199           50.66           50.66          101.32\n",
      "computer and information analysts...............         15-1120           41.98           41.98           83.96\n",
      "general operations mgr..........................         11-1021           72.51           72.51          145.02\n",
      "operations research analysts....................         15-2031           37.33           37.33           74.66\n",
      "software developers, applications...............         15-1132           45.57           45.57           91.14\n",
      "computer and information systems managers.......         11-3021           71.10           71.10          142.20\n",
      "general and operations mgr......................         11-1021           72.51           72.51          145.02\n",
      "designers.......................................         27-1020           29.32           29.32           58.64\n",
      "technical writer................................         27-3042           32.68           32.68           65.36\n",
      "computer systems analysts.......................         15-1121           41.59           41.59           83.18\n",
      "network and computer systems administrators.....         15-1142           43.64           43.64           87.28\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    as indicated, we are adjusting our employee hourly wage estimates \n",
      "by a factor of 100 percent. this is necessarily a rough adjustment, \n",
      "both because fringe benefits and overhead costs vary significantly from \n",
      "employer to employer, and because methods of estimating these costs \n",
      "vary widely from study to study. nonetheless, there is no practical \n",
      "alternative and we believe that doubling the hourly wage to estimate \n",
      "total cost is a reasonable accurate estimation method.\n",
      "\n",
      "c. information collection requirements (icrs)\n",
      "\n",
      "1. icrs regarding mma file requirements (42 cfr 423.910)\n",
      "    states submit data on files at least monthly to cms to identify all \n",
      "dually eligible individuals, including full-benefit and partial-benefit \n",
      "dually eligible beneficiaries (that is, those who get medicaid help \n",
      "with medicare premiums, and often for cost-sharing). the file is called \n",
      "the mma file, but is occasionally referred to as the ``state phasedown \n",
      "file.'' section 423.910(d) requires states to submit at least one mma \n",
      "file each month. however, states have the option to submit multiple mma \n",
      "files throughout the month (up to one per day). most states submit at \n",
      "least weekly. this information collection activity is currently \n",
      "approved under omb control number 0938-0958.\n",
      "    ensuring information on dual eligibility status is accurate and up-\n",
      "to-date by increasing the frequency of federal-state data exchange is \n",
      "an important step toward interoperability. as a result, we are \n",
      "proposing to update the frequency requirements in 42 cfr 423.910(d) to \n",
      "require that starting april 1, 2022, all states submit the required mma \n",
      "file data to cms daily, and to make conforming edits to 42 cfr \n",
      "423.910(b)(1). daily would mean every business day, but that if no new \n",
      "transactions are available to transmit, data would not need to be \n",
      "submitted on a given business day. we estimate it would take a computer \n",
      "systems analyst about 6 months (approximately 960 hours) to complete \n",
      "the systems updates necessary to process and submit the mma data daily. \n",
      "as only 13 states currently submit mma data daily, we estimate a one-\n",
      "time burden for 37 states and the district of columbia complying with \n",
      "submission of daily mma data at 3,034,406 (38 states (and dc) x 960 \n",
      "hours x 83.18 per hour for a computer system analyst). we will be \n",
      "revising the information collection request currently approved under \n",
      "0938-0958 to include the requirements discussed in this section.\n",
      "2. icrs regarding api proposals (42 cfr 422.119, 431.60, and 438.242, \n",
      "and 45 cfr 156.221)\n",
      "    to promote our commitment to interoperability, we are proposing new \n",
      "requirements for apis for ma organizations at 42 cfr 422.119, medicaid \n",
      "ffs at 42 cfr 431.60, chip ffs at 42 cfr 457.730, medicaid managed care \n",
      "at 42 cfr 438.242, chip managed care at 42 cfr 457.1233(d), and qhp \n",
      "issuers in ffes at 45 cfr\n",
      "\n",
      "[[page 7659]]\n",
      "\n",
      "156.221. these openly published apis will permit third-party \n",
      "applications to retrieve standardized data for adjudicated claims, \n",
      "encounters with capitated and subcapitated providers, provider \n",
      "remittances, beneficiary cost-sharing, reports of lab test results, \n",
      "provider directories, and preferred drug lists. to implement the new \n",
      "requirements for apis, we estimate that plans and states will conduct \n",
      "three major work phases: initial design; development and testing; and \n",
      "long-term support and maintenance.\n",
      "    in the initial design phase, we believe tasks would include: \n",
      "determining available resources (personnel, hardware, cloud space, \n",
      "etc.); assessing whether to use in-house resources to facilitate an api \n",
      "connection or contract the work to a third party; convening a team to \n",
      "scope, build, test, and maintain the api; performing a data \n",
      "availability scan to determine any gaps between internal data models \n",
      "and the data required for the necessary fhir resources; and, mitigating \n",
      "any gaps discovered in the available data.\n",
      "    during the development and testing phase, we believe plans and \n",
      "states would need to conduct the following: map existing data to fhir, \n",
      "which would constitute the bulk of the work required for \n",
      "implementation; allocate hardware for the necessary environments \n",
      "(development, testing, production); build a new fhir server or leverage \n",
      "existing fhir servers; determine the frequency and method by which \n",
      "internal data is populated on the fhir server; build connections \n",
      "between the databases and fhir server; perform capability and security \n",
      "testing; and vetting third-party applications.\n",
      "    after the completion of the api development, we believe that plans \n",
      "and states would need to conduct the following on an annual basis: \n",
      "allocate resources to maintain the fhir server, and perform capability \n",
      "and security testing.\n",
      "    the burden estimate related to the new requirements for apis \n",
      "reflects the time and effort needed to collect the information \n",
      "described above and disclose this information. we estimate an initial \n",
      "set one-time costs associated with the implementing the api \n",
      "requirements. we presume that it will take administrators and network \n",
      "architects 1440 hours (at 92.70 an hour), security engineers 960 hours \n",
      "(at 101.32 an hour), computer and information analysts 480 hours (at \n",
      "83.96 an hour), operations research analysts 960 hours (at 74.66 an \n",
      "hour), software developers 960 hours (at 91.14 an hour), computer and \n",
      "information systems managers 720 hours (at 142.20 an hour), general and \n",
      "operations managers 720 hours (at 145.02 an hour), designers 960 hours \n",
      "(at 58.64 an hour), technical writers 240 hours (at 65.36 an hour), and \n",
      "computer systems analysts 960 hours (at 83.18 an hour). we estimate a \n",
      "one-time burden assessment of 8,400 (1440hrs + 960hrs + 480hrs + 960hrs \n",
      "+ 960hrs + 720hrs + 720hrs + 960hrs + 240hrs + 960hrs) hours per \n",
      "organization or state and a total of 3,898,000 (8,400hrs x 345 \n",
      "organizations) hours across all organizations or states. the one-time \n",
      "cost to implement api requirements is 789,356.00 per organization or \n",
      "state per implementation and 275,432,820 across all organizations or \n",
      "states to complete the task described above.\n",
      "    once the api is established, we believe that there would be an \n",
      "annual cost for performing necessary capability and security testing, \n",
      "performing necessary upgrades and vetting of third-party applications. \n",
      "we presume that it would take administrators and network architects 180 \n",
      "hours (at 92.70 an hour), network and computer systems administrators \n",
      "420 hours (at 87.28 an hour), security engineers 240 hours (at 101.32 \n",
      "an hour), computer and information analysts 60 hours (at 83.96 an \n",
      "hour), operations research analysts 120 hours (at 74.66 an hour), \n",
      "software developers 240 hours (at 91.14 an hour), computer and \n",
      "information systems managers 90 hours (at 142.20 an hour), general and \n",
      "operations managers 90 hours (at 145.02 an hour), designers 120 hours \n",
      "(at 58.64 an hour), technical writers 30 hours (at 65.36 an hour), and \n",
      "computer systems analysts 120 hours (at 83.96 an hour). we estimate the \n",
      "total annual burden to be 1,710 hours (180hrs + 420hrs + 60hrs + 120hrs \n",
      "+ 240hrs + 90hrs + 120hrs + 30hrs + 120hrs) per organization or state, \n",
      "and 589,950 hours (1,710hrs x 345 organizations) across all \n",
      "organizations and states. thus, the total annual cost to maintain the \n",
      "api requirements is 158,359.80 per organization or state and 54,634,131 \n",
      "across all organizations and states.\n",
      "3. summary of information collection burdens\n",
      "\n",
      "                                                   table 2--summary of information collection burdens\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                                                          hourly\n",
      "                                                                                    burden     total      labor    total labor     total\n",
      "       regulation section(s)         omb control number    number of   number of     per       annual    cost of     cost of      capital/    total cost\n",
      "                                                          respondents  responses   response    burden   reporting   reporting   maintenance      ($)\n",
      "                                                                                   (hours)    (hours)      ($)         ($)       costs ($)\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "sec.   423.910....................  0938-0958 *.........          38          38         20        960      83.18    3,034,406           0     3,034,406\n",
      "sec.   422.119, sec.   431.60,      0938-new............         345         345        840  2,889,600  .........  275,432,820           0   275,432,820\n",
      " sec.   457.730, sec.   438.242,\n",
      " sec.   457.1233 and sec.\n",
      " 156.221.\n",
      "sec.   422.119, sec.   431.60,      0938-new............         345         345      1,710    588,240  .........   54,634,131           0    54,634,131\n",
      " sec.   457.730, sec.   438.242,\n",
      " sec.   457.1233, and sec.\n",
      " 156.221.\n",
      "                                   ---------------------------------------------------------------------------------------------------------------------\n",
      "    total.........................  ....................         344         344      2,570  3,478,800  .........  333,101,357  ...........  333,101,357\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "* this currently approved icr will be revised to include the burden discussed in this rule.\n",
      "\n",
      "    if you comment on these information collections, that is, \n",
      "reporting, recordkeeping or third-party disclosure requirements, please \n",
      "submit your comments electronically as specified in the addresses \n",
      "section of this proposed rule.\n",
      "    comments must be received on/by may 3, 2019.\n",
      "\n",
      "d. exempt icrs\n",
      "\n",
      "1. usual and customary business practices\n",
      "    while the requirements under 42 cfr 482.24(d), 482.61(f) and \n",
      "485.638 are subject to the pra, we believe the burden associated with \n",
      "those requirements is exempt from the pra in accordance with 5 cfr \n",
      "1320.3(b)(2). we believe that the time, effort, and financial resources \n",
      "necessary to comply with these requirements would be incurred by \n",
      "persons during the normal course of their activities, and therefore, \n",
      "should be considered usual and customary business practices.\n",
      "    we are proposing to further expand cms requirements for \n",
      "interoperability within the hospital, psychiatric hospital, and cah \n",
      "cops by focusing on electronic patient event notifications.\n",
      "\n",
      "[[page 7660]]\n",
      "\n",
      "for hospitals, psychiatric hospitals, and cahs, we are proposing \n",
      "similar requirements to revise the cops for medicare- and medicaid-\n",
      "participating hospitals, psychiatric hospitals, and cahs by adding a \n",
      "new standard, ``electronic notifications,'' that would require \n",
      "hospitals, psychiatric hospitals, and cahs to send electronic patient \n",
      "event notifications of a patient's admission, discharge, and/or \n",
      "transfer to another health care facility or to another community \n",
      "provider. we propose to limit this requirement to only those hospitals, \n",
      "psychiatric hospitals, and cahs which currently possess ehr systems \n",
      "with the technical capacity to generate information for electronic \n",
      "patient event notifications, recognizing that not all medicare- and \n",
      "medicaid-participating hospitals and psychiatric hospitals have been \n",
      "eligible for past programs promoting adoption of ehr systems. we intend \n",
      "for these notifications to be required, at minimum, for inpatients \n",
      "admitted to, and discharged and/or transferred from the hospital, \n",
      "psychiatric hospital, or cah. these requirements would help support \n",
      "coordination of a patient's care between settings or with services \n",
      "received through different care settings. these sections would require \n",
      "updates to discharge planning processes, which has been a long-standing \n",
      "industry practice. electronic patient event notifications from these \n",
      "care settings, or clinical event notifications, are one type of health \n",
      "information exchange intervention that has been increasingly recognized \n",
      "as an effective and scalable tool for improving care coordination \n",
      "across settings. these notifications are typically automated, \n",
      "electronic communications from the admitting or discharging provider to \n",
      "a receiving facility or to another community provider that alert the \n",
      "receiving provider that a patient is receiving, or has received, care \n",
      "at a different setting.\n",
      "    these notifications are based on ``admission, discharge, and \n",
      "transfer'' (adt) messages, a standard message used within an ehr as the \n",
      "vehicle for communicating information about key changes in a patient's \n",
      "status as they are tracked by the system (more information about the \n",
      "current standard supporting these messages is available at <a href=\"http://www.hl7.org/implement/standards/product_brief.cfm?product_id=144\">http://www.hl7.org/implement/standards/product_brief.cfm?product_id=144</a>). as \n",
      "noted in the isa published by onc, this messaging standard has been \n",
      "widely adopted across the health care system (see <a href=\"https://www.healthit.gov/isa/sending-a-notification-a-patients-admission-discharge-andor-transfer-status-other-providers\">https://www.healthit.gov/isa/sending-a-notification-a-patients-admission-discharge-andor-transfer-status-other-providers</a>).\n",
      "    we note that hospitals have an existing responsibility under the \n",
      "cops at 42 cfr 482.43(d) to transfer or refer patients, along with \n",
      "necessary medical information, to appropriate facilities, agencies, or \n",
      "outpatient services, as needed, for follow-up or ancillary care. we \n",
      "wish to emphasize that the proposal in this proposed rule around \n",
      "patient event notifications is independent of the requirement regarding \n",
      "necessary medical information at 42 cfr 482.43(d). as these processes \n",
      "are already required, and as many ehr systems already have an \n",
      "electronic notification system in place, we do not anticipate a \n",
      "significant increase in burden on hospitals, psychiatric hospitals, and \n",
      "cahs with the adoption of this proposal. however, we recognize that \n",
      "processes to implement this proposal, if finalized, might intersect \n",
      "with the hospital's discharge planning process. we note that nothing in \n",
      "this proposal would affect the hospital's responsibilities under 42 cfr \n",
      "482.43(d). however, if this proposal is finalized, hospitals might wish \n",
      "to consider ways to fulfill these requirements in ways that reduce \n",
      "redundancy while still fully meeting the provisions of each. for \n",
      "instance, where appropriate, hospitals might seek to include required \n",
      "necessary medical information within the same message as a patient \n",
      "event notification.\n",
      "\n",
      "xv. response to comments\n",
      "\n",
      "    because of the large number of public comments we normally receive \n",
      "on federal register documents, we are not able to acknowledge or \n",
      "respond to them individually. we will consider all comments we receive \n",
      "by the date and time specified in the dates section of this preamble, \n",
      "and, when we proceed with a subsequent document, we will respond to the \n",
      "comments in the preamble to that document.\n",
      "\n",
      "xvi. regulatory impact analysis\n",
      "\n",
      "a. statement of need\n",
      "\n",
      "    as described in detail in section iii. of this proposed rule, the \n",
      "changes to 42 cfr parts 422, 431, 438, 457 and 45 cfr part 156 are part \n",
      "of the agency's broader efforts to empower patients by ensuring that \n",
      "they have full access to their own health care data, through common \n",
      "technologies and without special effort, while keeping that information \n",
      "safe and secure. interoperability and the capability for health \n",
      "information systems and software applications to communicate, exchange, \n",
      "and interpret data in a usable and readable format, such as pdf or \n",
      "text, is vital, but allowing access to health care data through pdf and \n",
      "text format also limits the utility and sharing of the data. moving to \n",
      "a system in which patients have access of their health care data will \n",
      "help empower them to make informed decisions about their health care, \n",
      "as well as share their data with providers who can assist these \n",
      "patients with their health care. our proposals here are designed to \n",
      "move the medicare, ma, medicaid, chip and qhp programs further to that \n",
      "ultimate goal of empowering their enrollees. as technology has \n",
      "advanced, we have encouraged states, health plans, and providers to \n",
      "adopt various forms of technology to improve the accurate and timely \n",
      "exchange of standardized health care information; these proposals would \n",
      "enable beneficiaries and enrollees to be active partners in the \n",
      "exchange of electronic health care data by easily monitoring or sharing \n",
      "their data.\n",
      "    states and cms routinely exchange data on who is enrolled in \n",
      "medicare, and which parties are liable for paying that beneficiary's \n",
      "parts a and b premiums. these ``buy-in'' data exchanges support state, \n",
      "cms, and ssa premium accounting, collections, and enrollment functions. \n",
      "we have become increasingly concerned about the limitations of monthly \n",
      "buy-in data exchanges with states. the relatively long lag in updating \n",
      "buy-in data means that the state is not able to terminate or activate \n",
      "buy-in coverage sooner, so the state or beneficiary may be paying \n",
      "premiums for longer than appropriate. we note that once the data catch \n",
      "up, states and cms reconcile the premiums by recouping and re-billing, \n",
      "so premiums collected are ultimately accurate, but only with--an \n",
      "administratively burdensome process involving debits and payments \n",
      "between the beneficiary, state, cms, ssa, and potentially providers. \n",
      "daily buy-in data exchange would reduce this administrative burden. as \n",
      "described in detail in section vii. of this proposed rule, the changes \n",
      "to 42 cfr parts 406, 407, and 423 establish frequency requirements that \n",
      "necessitate all states to participate in daily exchange of buy-in data, \n",
      "and updates frequency requirements to require all states to participate \n",
      "in daily exchange of mma file data, with cms by april 1, 2022.\n",
      "    states submit data on files at least monthly to cms to identify all \n",
      "dually eligible individuals, including full-benefit and partial-benefit \n",
      "dually eligible beneficiaries (that is, those who get medicaid help \n",
      "with medicare premiums, and often for cost-sharing). the mma file was \n",
      "originally developed to meet the need to timely identify dually \n",
      "eligible beneficiaries for the then-\n",
      "\n",
      "[[page 7661]]\n",
      "\n",
      "new medicare part d prescription drug benefit. over time, we used these \n",
      "files' data on dual eligibility status to support part c capitation \n",
      "risk-adjustment, and most recently, feeding dual eligibility status to \n",
      "part a and b eligibility and claims processing systems so providers, \n",
      "suppliers, and beneficiaries have accurate information on beneficiary \n",
      "cost-sharing obligations. as cms now utilizes mma data on dual \n",
      "eligibility status in systems supporting all four parts of the medicare \n",
      "program, it is becoming even more essential that dual eligibility \n",
      "status is accurate and up-to-date. dual eligibility status can change \n",
      "at any time in a month. waiting up to a month for status updates can \n",
      "negatively impact access to the correct level of benefit at the correct \n",
      "level of payment.\n",
      "\n",
      "b. overall impact\n",
      "\n",
      "    we have examined the impacts of this proposed rule as required by \n",
      "executive order 12866 on regulatory planning and review (september 30, \n",
      "1993), executive order 13563 on improving regulation and regulatory \n",
      "review (january 18, 2011), the regulatory flexibility act (rfa) \n",
      "(september 19, 1980, pub. l. 96-354), section 1102(b) of the social \n",
      "security act, section 202 of the unfunded mandates reform act of 1995 \n",
      "(march 22, 1995; pub. l. 104-4), executive order 13132 on federalism \n",
      "(august 4, 1999), the congressional review act (5 u.s.c. 804(2)), and \n",
      "executive order 13771 on reducing regulation and controlling regulatory \n",
      "costs (january 30, 2017).\n",
      "    executive orders 12866 and 13563 direct agencies to assess all \n",
      "costs and benefits of available regulatory alternatives and, if \n",
      "regulation is necessary, to select regulatory approaches that maximize \n",
      "net benefits (including potential economic, environmental, public \n",
      "health and safety effects, distributive impacts, and equity). section \n",
      "3(f) of executive order 12866 defines a ``significant regulatory \n",
      "action'' as an action that is likely to result in a rule: (1) having an \n",
      "annual effect on the economy of $100 million or more in any 1 year, or \n",
      "adversely and materially affecting a sector of the economy, \n",
      "productivity, competition, jobs, the environment, public health or \n",
      "safety, or state, local or tribal governments or communities (also \n",
      "referred to as ``economically significant''); (2) creating a serious \n",
      "inconsistency or otherwise interfering with an action taken or planned \n",
      "by another agency; (3) materially altering the budgetary impacts of \n",
      "entitlement grants, user fees, or loan programs or the rights and \n",
      "obligations of recipients thereof; or (4) raising novel legal or policy \n",
      "issues arising out of legal mandates, the president's priorities, or \n",
      "the principles set forth in the executive order.\n",
      "    a regulatory impact analysis (ria) must be prepared for major rules \n",
      "with economically significant effects ($100 million or more in any 1 \n",
      "year). we estimate that this rulemaking is ``economically significant'' \n",
      "as measured by the $100 million threshold, and hence also a major rule \n",
      "under the congressional review act. accordingly, we have prepared an \n",
      "ria that to the best of our ability presents the costs and benefits of \n",
      "the rulemaking. table 3 summarizes the estimated costs presented in the \n",
      "collection of information section of this proposed rule. we note that \n",
      "estimates below do not account for enrollment growth or higher costs \n",
      "associated with medical care. this is because the cost of requirements \n",
      "to implement patient access through apis and for states to comply with \n",
      "data exchange requirements are not impacted by enrollment growth or \n",
      "higher costs associated with medical care. per omb guidelines, the \n",
      "projected estimates for future years do not take into account ordinary \n",
      "inflation.\n",
      "\n",
      "                                        table 3--estimated aggregate costs to the health care sector by provision\n",
      "                                                                 [cys 2020 through 2024]\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                                   calendar year ($ in millions)                          total cy 2020-\n",
      "             provision                   regulation      --------------------------------------------------------------------------------   2024 ($ in\n",
      "                                         section(s)            2020            2021            2022            2023            2024         millions) *\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "requirements to patient access      sec.   422.119, sec.           275.4            54.7            54.7            54.7            54.7           494.0\n",
      " through apis.                         431.60, sec.\n",
      "                                     438.242, sec.\n",
      "                                     457.730, sec.\n",
      "                                     457.1233, sec.\n",
      "                                     156.221.\n",
      "dual eligible care coordination...  sec.   406.26, sec.              0.7             2.2             2.2             1.2               0             6.3\n",
      "                                      407.40, sec.\n",
      "                                     423.910.\n",
      "                                   ---------------------------------------------------------------------------------------------------------------------\n",
      "    total cost....................  ....................           276.1            56.9            56.9            55.9            54.7           500.3\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "* total may not equal sum of parts due to rounding.\n",
      "\n",
      "    allocation of cost impact by program: as stated in the collection \n",
      "of information section of this proposed rule, cost estimates have been \n",
      "aggregated at the parent organization level because we believe that an \n",
      "organization that offers commercial, medicare, medicaid, and chip \n",
      "products would create one system that would be used by all ``plans'' it \n",
      "offers. we note that due to the implementation of apis across multiple \n",
      "business lines, there is no straightforward method to immediately \n",
      "estimate parent organization expenditures on how much of the cost is \n",
      "born by each program.\n",
      "    preliminary estimates: later in this ria section, we provide \n",
      "several detailed estimates of cost by program where we account for \n",
      "federal matching for medicaid and payments by the trust fund for \n",
      "medicare advantage organizations. however, these estimates are \n",
      "approximate as explained in detail below. therefore, the purpose of \n",
      "this preliminary estimate section, is to observe that the costs of this \n",
      "proposed rule are negligible relative to the costs of the various \n",
      "programs it impacts.\n",
      "    for purposes of clarification we use the metric of ``costs per \n",
      "enrollee.'' the ``costs per enrollee'' whether for medicaid or \n",
      "medicare, does not refer to actual costs paid by the enrollee but \n",
      "rather is a metric, it is the quotient of total program expenditures \n",
      "divided by total enrollees. the cost per enrollee metric facilitates \n",
      "comparison of costs. since program expenditures for both medicaid and \n",
      "ma are typically\n",
      "\n",
      "[[page 7662]]\n",
      "\n",
      "hundreds of millions (or billions) of dollars, concepts like \n",
      "negligibility do not have intuitive meaning. contrastively, the costs \n",
      "per enrollee are more manageable and understandable. the 2018 medicare \n",
      "trust fund \\60\\ states that costs per enrollee are projected to be \n",
      "roughly $12,000-$14,000 for contract years 2020-2023 (table iv.c3). the \n",
      "costs per enrollee for the medicaid program are similarly several \n",
      "thousand dollars. we estimate 169 million enrollees will be affected by \n",
      "these provisions since. currently there are 76, 66,\\61\\ 20,\\62\\ and \n",
      "7\\2\\ million enrollees in the commercial, medicaid, ma and separate \n",
      "chip programs respectively.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\60\\ <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2018.pdf\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2018.pdf</a>.\n",
      "    \\61\\ <a href=\"https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html\">https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html</a>.\n",
      "    \\62\\ <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/monthly-contract-and-enrollment-summary-report-items/contract-summary-2018-08.html?dlpage=1&dlentries=10&dlsort=1&dlsortdir=descending\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/monthly-contract-and-enrollment-summary-report-items/contract-summary-2018-08.html?dlpage=1&dlentries=10&dlsort=1&dlsortdir=descending</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the total first year (implementation) cost per enrollee is $1.63 \n",
      "($276.1 million cost (table 3) divided by 169 million enrollees); \n",
      "maintenance cost per enrollee in the following years are 34 cents \n",
      "($56.9 million total cost (table 3) divided by 169 million enrollees). \n",
      "the assertion that $1.63 and $0.34 is negligible compared to the \n",
      "$12,000-$14,000 cost per enrollee for the ma program or the several \n",
      "thousand-dollar cost per enrollee for the medicaid program has \n",
      "intuitive appeal. however, these are very rough preliminary estimates. \n",
      "in the remainder of this ria, we provide, subject to the limitations \n",
      "noted, more detailed impact by program.\n",
      "    data sources for cost by program: to obtain allocation of cost by \n",
      "program we used the cms public use files for mlr data, for \n",
      "2016.<sup>63 64</sup> the mlr data sets are for private insurance plans \n",
      "but the issuers of that private (commercial) insurance in many cases \n",
      "also have contracts to provide ma, medicaid and chip managed care plans \n",
      "and report revenue, expense, and enrollment data for these plans on the \n",
      "commercial mlr reporting form.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\63\\ <a href=\"https://www.cms.gov/cciio/resources/data-resources/mlr.html\">https://www.cms.gov/cciio/resources/data-resources/mlr.html</a>.\n",
      "    \\64\\ although the 2017 mlr data recently became available, using \n",
      "them would not change the bottom line of the analysis. the 2016 data \n",
      "gives $113 billion, $157 billion and $370 billion enrollees for \n",
      "commercial, ma, and medicaid plans respectively resulting in revenue \n",
      "proportions of 57.81 percent, 24.53 percent, 17.68 percent. the 2017 \n",
      "data gives $119.5, $170.3 and $381.5 billion for commercial ma, and \n",
      "medicaid plans resulting in proportions of 56.8 percent, 25.36 \n",
      "percent, and 17.79 percent. the 76 million commercial enrollees from \n",
      "the 2016 data decreased to 73.5 million in 2017. using these \n",
      "alternate proportions and numbers would not change significantly our \n",
      "dollar-per-enrollee estimates of impacts.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    thus, these mlr data sets omit organizations that only have \n",
      "medicare or medicaid. the data from the cms mlr files also omits: (1) \n",
      "the chip program; and (2) medicaid state agencies. we now discuss these \n",
      "omissions to assess the accuracy of using these mlr files.\n",
      "    chip: 85 percent of the 194 chip managed care plans also offer \n",
      "medicaid and hence are covered by the parent entity. we believe it \n",
      "reasonable that the remaining chip plans also have commercial offerings \n",
      "since it would be inefficient to operate a chip-only plan as the total \n",
      "national chip enrollment is currently only about 7 million. similarly, \n",
      "except for one state, chip programs are run through the state medicaid \n",
      "agency; again, there would be one interoperability cost for the one \n",
      "state agency since the resulting software would be used both by \n",
      "medicaid and chip. thus, while we are leaving out chip programs in this \n",
      "analysis since they are not in the cms mlr files, we do not believe \n",
      "this materially alters the overall picture.\n",
      "    medicare advantage: we compared the cms mlr files with the cms \n",
      "trustee report.\\65\\ according to the trustee report (table iv.c2), \n",
      "total ma revenue for 2016 was $189.1 billion. thus, the reported amount \n",
      "in the cms mlr files of $157 billion for ma represents 83 percent (157/\n",
      "189.1) of all ma activity reflected in the trustee report. therefore, \n",
      "we believe the proportions obtained from these mlr files are accurate.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\65\\ <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2018.pdf\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2018.pdf</a> \n",
      "table iv.c2.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    medicaid: for the year for which these mlr files provide data, \n",
      "2016, about 70 percent of medicaid enrollees were enrolled in medicaid \n",
      "managed care.\\66\\ thus although the mlr files omit state agencies, we \n",
      "believe that the 70 percent medicaid enrollees enrolled in medicaid \n",
      "managed care provides a good approximation.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\66\\ <a href=\"https://www.cms.gov/newsroom/press-releases/cms-proposes-changes-streamline-and-strengthen-medicaid-and-chip-managed-care-regulations\">https://www.cms.gov/newsroom/press-releases/cms-proposes-changes-streamline-and-strengthen-medicaid-and-chip-managed-care-regulations</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    finally, as noted in the section ``preliminary estimates'', \n",
      "independent of these omissions, the average cost per enrollee is capped \n",
      "at $1.63 and $0.34 in first and follow up years.\n",
      "    best estimates of impact per program: we present two methods to \n",
      "obtain an estimate of cost by program both for purposes of assessing \n",
      "impact on small entities, as well as for purposes of assessing impacts \n",
      "of the provision on the federal government, programs, and enrollees: we \n",
      "could assume costs proportional to current enrollment, or \n",
      "alternatively, we could assume costs proportional to total premium. for \n",
      "purposes of analyzing impact on small entities and impacts of the \n",
      "provision on the federal government, programs, and enrollees we are \n",
      "using the method of assuming costs proportional to total premium (the \n",
      "method of assuming costs proportional to current enrollment will be \n",
      "used below to assess impact on transfers to enrollees).\n",
      "    among issuers with products in both commercial and ma or commercial \n",
      "and medicaid, the 2016 cms mlr files show $370 billion reported in \n",
      "premium for commercial plans, $157 billion reported for ma, and $113 \n",
      "billion reported for medicaid. consequently, the proportion of \n",
      "interoperability cost for each of the programs is 57.81 percent (370/\n",
      "(370+157+113)), 24.53 percent (157/(370+157+113)), and 17.66 percent \n",
      "(113/(370+157+113)) for commercial, ma, and medicaid respectively.\n",
      "    using these proportions, table 4 breaks out the top row in table 3, \n",
      "the total cost by year of implementing and maintaining the api, by \n",
      "program.\n",
      "\n",
      "                                                  table 4--api costs (in millions) by year and program\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                          year                                 2020            2021            2022            2023            2024            total\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "full implementation and maintenance costs (table 3, row            275.4            54.7            54.7            54.7            54.7           494.0\n",
      " 1).....................................................\n",
      "commercial programs (57.81%)............................           159.2            31.6            31.6            31.6            31.6           285.6\n",
      "medicaid and chip programs (17.66%).....................            48.6             9.7             9.7             9.7             9.7            87.2\n",
      "medicare advantage programs (24.53%)....................            67.6            13.4            13.4            13.4            13.4           121.2\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "[[page 7663]]\n",
      "\n",
      "    methods of bearing cost by program: commercial plans have the \n",
      "options to deal with increased costs by either temporarily absorbing \n",
      "them (for purposes of market competitiveness), increasing premiums to \n",
      "enrollees, or reducing benefits.\n",
      "    to the extent that issuers increase premiums for plans in the ffe, \n",
      "there would be federal premium tax credit (ptc) impacts. however, the \n",
      "ptc formula is highly individual-specific, that is, it is the result of \n",
      "the relationship between the premium of the second lowest-cost silver \n",
      "plan applicable to a specific consumer in a specific month, the cost of \n",
      "the actual plan purchased by that consumer for that month, and that \n",
      "consumer's income. consequently, it would not be possible to estimate \n",
      "the magnitude of the ptc impact with a reliable degree of accuracy, \n",
      "since we cannot predict: (1) what proportion of costs would be passed \n",
      "on to enrollees as increased premiums; (2) to what extent commercial \n",
      "issuers may recoup investment costs through raising premiums on the \n",
      "second-lowest cost silver plans or on other plans; and (3) whether or \n",
      "in what ways such premium increases may impact the ptc calculation or \n",
      "eligibility with respect to various consumers,\n",
      "    to deal with this uncertainty, we list the possible federal ptc \n",
      "impacts as a qualitative impact. most importantly, we assume the \n",
      "unlikely worst case scenario that all cost is passed on as premium to \n",
      "the enrollee without subsidization; we then show that the net impact \n",
      "per enrollee per month is extremely small (see table 7).\n",
      "    medicare advantage: medicare advantage organizations (maos) pass \n",
      "increased costs back to the trust fund. for those (most) maos whose bid \n",
      "amount is below the benchmark, the trust fund provides total \n",
      "expenditures to the maos consisting of: (1) full payment of the bid \n",
      "amount; and (2) the rebate, a portion of the difference between the \n",
      "benchmark and the bid amount. since maos are increasing their bid \n",
      "amounts to reflect the costs of this proposed rule, it follows that the \n",
      "rebate, equaling the difference between the benchmark and bid, is \n",
      "decreased, resulting in less rebates paid to the maos. based on our \n",
      "historical and projected experience, the rebate is estimated as 34 \n",
      "percent of the difference between benchmark and bid. thus, although the \n",
      "trust fund pays the bid in full, nevertheless, 66 percent of the \n",
      "increased bid costs arising from this proposed rule, are reduced from \n",
      "the rebates. the mao in its submitted bid, can address this reduction \n",
      "of rebates by either: (1) temporarily, for marketing purposes, \n",
      "absorbing the loss, and reducing its profit margin; (2) reduce the \n",
      "additional benefits it provides the enrollee paid for by the rebate; or \n",
      "(3) raise enrollee premiums.\n",
      "    medicaid: state medicaid agencies may be allowed to allocate the \n",
      "costs of state information retrieval systems between the costs \n",
      "attributable to design, development, installation, or enhancement of \n",
      "the system--at a 90 percent federal match--and for ongoing operations \n",
      "of the system--at a 75 percent federal match.\n",
      "    for medicaid managed care entities, we assume an mco, pihp, and \n",
      "pahp cost for implementing the open api provisions would be built into \n",
      "the capitation rates and matched at the state's medical assistance \n",
      "match rate. for purposes of these estimates we use the weighted fmap, \n",
      "58.44.\n",
      "    chip: most states operate medicaid and chip from the same state \n",
      "agency. one state is a notable exception in that it has a separate \n",
      "medicaid and chip agency. the federal government pays an enhanced \n",
      "federal medical assistance percentage (efmap) to states for all costs \n",
      "associated with chip, including systems costs (this is unlike medicaid \n",
      "where there are different fmaps for different types of costs). for \n",
      "federal fy 2019 the efmaps will range from 88 to 100 percent. for \n",
      "federal fy 2020 the efmaps will range from approximately 76.5 to 93 \n",
      "percent. after federal fy 2020, the efmaps will range from \n",
      "approximately 65 to 81.5 percent. since the chip program federal rebate \n",
      "ranges include the 90 percent and 75 percent federal matching \n",
      "proportions of the medicaid program, we are applying the 90 percent and \n",
      "75 percent from medicaid to the chip programs. since the chip program \n",
      "is small relative to the medicaid program, we believe this approach \n",
      "reasonable.\n",
      "    table 5 uses these proportions to estimate the impact of the api on \n",
      "the federal government. for example, the $28.4 million cost to the \n",
      "federal government for medicaid/chip for 2020, the implementation year \n",
      "of the api, is obtained by multiplying the state agency medical \n",
      "assistance average match rate to medicaid managed care plans, 58.44%, \n",
      "by the $48.6 million total cost to medicaid for 2020 listed in table 4.\n",
      "\n",
      "                                     table 5--costs (in millions) incurred by federal government by program and year\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                          year                                 2020            2021            2022            2023            2024            total\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "for commercial programs.................................             0.0             0.0             0.0             0.0             0.0             0.0\n",
      "for medicaid/chip programs (58.44%, average state agency            28.4             5.6             5.6             5.6             5.6            51.0\n",
      " medical assistance match rate).........................\n",
      "for medicare/advantage programs (the bid increase in                23.0             4.6             4.6             4.6             4.6            41.2\n",
      " spending due to this proposed rule reduces the\n",
      " difference between the benchmark and the bid. the trust\n",
      " fund incurs 34% of this reduction while plans incur 66%\n",
      " of this reduction in the form of smaller rebates than\n",
      " would have been received had the cost of this provision\n",
      " not been included in the bid)..........................\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    by taking the difference between the respective cells in tables 4 \n",
      "and 5 we obtain the remaining costs for the api. to this amount must be \n",
      "added the coordination cost for the dual eligibles (row 2 of table 3). \n",
      "for example, medicaid/chip has a remaining cost of $20.3 million ($48.6 \n",
      "million total cost for 2020 (table 4)-$28.4 million matched by medicaid \n",
      "state agencies (table 5) + $0.7 million total cost for coordination of \n",
      "dual eligibles (table 3) * 17.66 percent (proportion of total costs \n",
      "incurred by medicaid/chip (table 4)). (there are minor differences due \n",
      "to\n",
      "\n",
      "[[page 7664]]\n",
      "\n",
      "rounding). the results are summarized in table 6.\n",
      "\n",
      "                                           table 6--remaining costs (in millions) for api by year and program\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                               2020            2021            2022            2023            2024            total\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "commercial..............................................           159.6            32.9            32.9            32.3            31.6           289.2\n",
      "medicaid/chip...........................................            20.3             4.4             4.4             4.2             4.0            37.4\n",
      "medicare advantage......................................            44.8             9.4             9.4             9.1             8.8            81.5\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    the further discussion of bearing these costs, is clarified, if we \n",
      "reformulate the costs in terms of costs per enrollee. to do this we use \n",
      "enrollments by program. for commercial enrollment we use the 2016 mlr \n",
      "data, for ma enrollment we use the august 2018 data, and for medicaid \n",
      "and chip we use september 2018 data. these enrollment numbers are 76, \n",
      "66,\\67\\ 20,\\68\\ and 7\\4\\ million enrollees in the commercial, medicaid, \n",
      "ma and separate chip programs respectively. thus, for purposes of this \n",
      "analysis, we use a total of 169 million (76+67+20+6) enrollees in all \n",
      "programs. table 7 presents cost per enrollee by program and year. for \n",
      "example, there is a 28-cent cost to medicaid/chip state agencies in \n",
      "2020 (20.3 million remaining cost (table 6) divided by 73 million (66 \n",
      "million medicaid + 7 million chip)).\\69\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\67\\ <a href=\"https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html\">https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html</a>.\n",
      "    \\68\\ <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/monthly-contract-and-enrollment-summary-report-items/contract-summary-2018-08.html?dlpage=1&dlentries=10&dlsort=1&dlsortdir=descending\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/monthly-contract-and-enrollment-summary-report-items/contract-summary-2018-08.html?dlpage=1&dlentries=10&dlsort=1&dlsortdir=descending</a>.\n",
      "    \\69\\ to give an idea of how the per enrollee per year numbers \n",
      "would change had we used updated enrollment, we note that the latest \n",
      "ma enrollment (as of january 2019) is for january 2019 and is 22 \n",
      "million, the latest medicaid enrollment is for oct 2018 and is still \n",
      "73 million, and the latest commercial enrollment is for 2017 and is \n",
      "73.5. the resulting per-enrollee-per-year cost impacts would be \n",
      "$2.17, 0.28, and $2.04 versus the numbers in table 7 which are \n",
      "$2.10, 0.28, and $2.24. these changes per enrollee per year would \n",
      "not affect any of our conclusions about negligibility relative to \n",
      "the 4 and 5 digit per enrollee per year expenses for medicare, \n",
      "medicaid and the federally funded exchange.\n",
      "\n",
      "                                           table 7--cost per enrollee per year (dollars and cents) by program\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                              current\n",
      "                                            enrollment\n",
      "                                           (millions) by       2020            2021            2022            2023            2024            total\n",
      "                                              program\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "commercial..............................              76            2.10            0.43            0.43            0.42            0.42            3.81\n",
      "medicaid/chip...........................              73            0.28            0.06            0.06            0.06            0.05            0.51\n",
      "medicare advantage......................              20            2.24            0.47            0.47            0.46            0.44            4.08\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    using table 7 we can assess the approximate impact of the remaining \n",
      "cost.\n",
      "    commercial: as pointed out above, the commercial program has the \n",
      "options of absorbing costs or passing costs to enrollees either in the \n",
      "form of premiums or reduced benefits. the cost per enrollee in 2021 \n",
      "through 2024 is under a half dollar and could comfortably be passed on \n",
      "to enrollees. for purposes of market competitiveness, it is very likely \n",
      "that some of the 2020 cost of $2.10 per enrollee will be absorbed by \n",
      "each qhp in an ffe.\n",
      "    medicaid: medicaid state agencies are adding a cost under 30 cents \n",
      "per enrollee for 2020-2024. since total costs per enrollee for the \n",
      "medicaid program are several thousand dollars we do not believe this \n",
      "additional 30 cents per enrollee cost to be a significant burden.\n",
      "    medicare advantage: medicare advantage plans in their june-\n",
      "submitted bids would address the reduced rebates (arising from \n",
      "increased bid costs due to the increased costs of this proposed rule \n",
      "being included in the bid) by either: (1) temporarily absorbing costs \n",
      "by reducing profit margins; (2) reducing additional benefits paid for \n",
      "by the rebates; or (3) raising enrollee cost sharing (however, many \n",
      "plans for competitive reasons would choose to remain zero premium and \n",
      "either absorb losses for one year or reduce additional, rebate-funded \n",
      "benefits in the amount per enrollee shown in table 7).\n",
      "    table 8 summarizes these methods of bearing the remaining costs.\n",
      "\n",
      "           table 8--how programs would defray remaining costs\n",
      "------------------------------------------------------------------------\n",
      " \n",
      "------------------------------------------------------------------------\n",
      "commercial........................  commercial plans have the options of\n",
      "                                     absorbing costs (for example, in\n",
      "                                     2020 for reasons of market\n",
      "                                     competitiveness), increasing\n",
      "                                     premiums to enrollees, or reducing\n",
      "                                     benefits.\n",
      "medicaid/chip.....................  medicaid managed care plan would\n",
      "                                     bear the cost (under a dime per\n",
      "                                     enrollee) which is negligible\n",
      "                                     compared to current costs per\n",
      "                                     enrollee.\n",
      "medicare advantage (ma)...........  ma plans in their june-submitted\n",
      "                                     bids would address the reduced\n",
      "                                     rebates (arising from increased bid\n",
      "                                     costs due to the increased costs of\n",
      "                                     this proposed rule being included\n",
      "                                     in the bid) by either: (1)\n",
      "                                     temporarily absorbing costs by\n",
      "                                     reducing profit margins; (2)\n",
      "                                     reducing additional benefits paid\n",
      "                                     for by the rebates; or (3) raising\n",
      "                                     enrollee cost sharing (however,\n",
      "                                     many plans for competitive reasons\n",
      "                                     would chose to remain zero premium\n",
      "                                     and either absorb losses for one\n",
      "                                     year or reduce additional, rebate-\n",
      "                                     funded benefits in the amount per\n",
      "                                     enrollee shown in table 8).\n",
      "------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "[[page 7665]]\n",
      "\n",
      "c. anticipated effects\n",
      "\n",
      "    the rfa, as amended, requires agencies to analyze options for \n",
      "regulatory relief of small businesses, if a rule has a significant \n",
      "impact on a substantial number of small entities. for purposes of the \n",
      "rfa, small entities include small businesses, nonprofit organizations, \n",
      "and small governmental jurisdictions.\n",
      "    this proposed rule affects (1) commercial issuers (2) ma plans, \n",
      "including those that are also part d sponsors of ma-pd plans, as well \n",
      "as (3) medicaid mcos with a minimum threshold for small business size \n",
      "of $38.5 million (<a href=\"https://www.sba.gov/federal-contracting/contracting-guide/size-standards\">https://www.sba.gov/federal-contracting/contracting-guide/size-standards</a>).\n",
      "    assessment of impact is complicated by the fact that costs have \n",
      "been aggregated at the parent organization level. a typical parent \n",
      "organization might have products with the commercial, ma, or medicaid/\n",
      "chip programs. we have no way of directly assessing the size of parent \n",
      "organizations. therefore, as a proxy, we analyze each program \n",
      "separately.\n",
      "    medicare advantage: we first assess the impact on ma plans. to \n",
      "clarify the flow of payments between these entities and the federal \n",
      "government, we note that maos submit proposed plan designs and \n",
      "estimates of the amount of revenue necessary to cover the cost of those \n",
      "plan designs (called bids) by the first monday in june of the year \n",
      "preceding the coverage year. regulations governing this process are in \n",
      "42 cfr part 422, subpart f. these bids must be broken down in the \n",
      "following:\n",
      "    (1) the revenue requirements for providing medicare part a and part \n",
      "b benefits with actuarially equivalent cost sharing (this is the \n",
      "``basic benefit bid'');\n",
      "    (2) the revenue requirements for providing supplemental benefits; \n",
      "and\n",
      "    (3) a part d bid consistent with part d regulations in 42 cfr part \n",
      "423.\n",
      "\n",
      "these bids project payments to hospitals, providers and staff, as well \n",
      "as the cost of administration and profits. because the api requirements \n",
      "proposed in this rule will apply to every ma plan and each ma plan must \n",
      "furnish at least the medicare part a and part b benefits, the cost of \n",
      "the api will be built into the administrative component of the basic \n",
      "benefit bid. these bids in turn determine one component of the payments \n",
      "of the medicare trust fund to the maos who reimburse providers and \n",
      "other stakeholders for their services. a second component of the trust \n",
      "fund payment to maos are the rebates, which are a portion of the \n",
      "difference between the basic benefit bid compared to an \n",
      "administratively-set benchmark for the ma plan's service area \n",
      "(currently, based on our past and projected experience, rebates are \n",
      "approximately 66 percent). benchmarks are based on a formula using an \n",
      "estimate of the medicare ffe per capita cost for the geographic area, \n",
      "which are adjusted to reflect the per capita cost of each county in the \n",
      "united states and its territories. payments from the medicare trust \n",
      "funds for monthly capitation are capped at the benchmark; for basic \n",
      "benefit bids under the benchmark, a portion, currently 66 percent, of \n",
      "the difference between the bid and benchmark is made available to the \n",
      "ma organization to either: (1) pay the premium for supplemental \n",
      "benefits; (2) include reductions in cost sharing; (3) provide \n",
      "additional non-medicare covered benefits; or (4) provide buy-downs of \n",
      "part b or part d premiums. basic benefit bids that are at or above the \n",
      "benchmark receive payment from the trust funds of the benchmark amount, \n",
      "with any excess charged to the enrollee as a premium.\n",
      "    maos are made aware of the benchmark through the annual cms \n",
      "publication, ``medicare advantage capitation rates and medicare \n",
      "advantage and part d payment policies and final call letter,'' which, \n",
      "consistent with section 1853 of the act, is released prior to mao \n",
      "submission of bids. therefore, the bids of most maos are below the \n",
      "benchmark and consequently most maos receive from the trust fund a \n",
      "total expenditure equaling payment for the bid plus the rebate.\n",
      "    because of these proposed api provisions, maos would be raising the \n",
      "june-submitted bid amount to reflect additional costs. while the trust \n",
      "fund pays these bid amounts in full, the rebate goes down: that is, \n",
      "since the bid amount goes up, the rebate, equaling the difference \n",
      "between the benchmark and bid, decreases and results in less rebate \n",
      "payment to the mao. the mao has several options of dealing with these \n",
      "increased bid costs and reduced rebates: the mao might decide to: (1) \n",
      "temporarily absorb the loss by reducing its profit margin (so as to \n",
      "reduce the bid amount and thereby increase the rebates); (2) reduce \n",
      "additional benefits paid to the enrollee from the rebates; or (3) raise \n",
      "enrollee premiums so as to compensate for the reduction of enrollee \n",
      "premium that would have happened if the bid had not been increased \n",
      "(note: for marketing purposes, many plans operate at zero premium, and \n",
      "we do not consider this a likely possibility). in this ria we have \n",
      "referred to options (2) and (3) reduction of additional benefits and \n",
      "raising of enrollee premiums as ``passing the costs to the enrollee'' \n",
      "the intent being that the ``effect'' of reduced rebates is less \n",
      "additional benefits or higher enrollee premiums than would have \n",
      "happened had the cost of the provisions of this proposed rule not been \n",
      "included in the bid.\n",
      "    there are various types of medicare health plans, including ma \n",
      "hmos, pos plans, and ppos; demonstration plans; cost plans; \n",
      "prescription drug plans (pdp); and programs of all-inclusive care for \n",
      "the elderly (pace) organizations. this proposed rule affects ma hmos, \n",
      "ma pos plans, and ma ppos but does not affect cost plans, prescription \n",
      "drug plans nor pace organizations.\n",
      "    there are a variety of ways to assess whether maos meet the $38.5 \n",
      "million threshold for small businesses. the assessment can be done by \n",
      "examining net worth, net income, cash flow from operations and \n",
      "projected claims as indicated in their bids. using projected monetary \n",
      "requirements and projected enrollment for 2018 from submitted bids, 32 \n",
      "percent of the maos fell below the $38.5 million threshold for small \n",
      "businesses. additionally, an analysis of 2016 data, the most recent \n",
      "year for which we have actual data on mao net worth, shows that 33 \n",
      "percent of all maos fall below the minimum threshold for small \n",
      "businesses.\n",
      "    medicaid: we next assess the impact on medicaid mcos. the society \n",
      "of actuaries (soa) published ``medicaid managed care organizations: \n",
      "considerations in calculating margin in rate setting'' in 2017.\\70\\ the \n",
      "report provided an ms excel spreadsheet of medicaid mcos using data \n",
      "from 2013-2015. that report noted that ``[n]ot every state requires \n",
      "medicaid mcos to submit annual statements, so not every mco is \n",
      "represented. mcos in california and arizona are shown with a limited \n",
      "set of metrics, based on what was available and provided by hma [health \n",
      "management associates].'' of the 231 mcos listed in the 2015 worksheet, \n",
      "196 provided data that are adequate to identify mcos with annual \n",
      "``revenue'' less than $38.5 million. (note: since total revenue is \n",
      "reported at the company level, which includes revenue from non-medicaid \n",
      "sources, we used ``direct premium written'' in the medicaid portion of \n",
      "the worksheet as a proxy for annual revenue on the individual plan \n",
      "level.) of the 196 medicaid mcos, only\n",
      "\n",
      "[[page 7666]]\n",
      "\n",
      "15 mcos or 7.7 percent had ``revenue'' less than $38.5 million in 2015.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\70\\ society of actuaries, medicaid managed care organizations: \n",
      "considerations in calculating margin in rate setting. accessed at \n",
      "<a href=\"https://www.soa.org/research-reports/2017/medicaid-margins/\">https://www.soa.org/research-reports/2017/medicaid-margins/</a>, pg. 49.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    commercial: based on the 2016 cms mlr data, approximately 85 out of \n",
      "494, or 17 percent of companies (that either had only commercial \n",
      "business, or had commercial plus medicare and/or medicaid business) had \n",
      "total premium revenue of less than $38,500,000. in other words, for ma, \n",
      "medicaid, and commercial, a significant number of small plans are \n",
      "affected. the rfa requires us to assess whether the rule has a \n",
      "significant impact on the plans which we do next.\n",
      "    if a proposed rule has a substantial impact on a substantial number \n",
      "of small entities, the proposed rule must discuss steps taken, \n",
      "including alternatives, to minimize burden on small entities. while a \n",
      "significant number (more than 5 percent) of not-for-profit \n",
      "organizations and small businesses are affected by this final rule, the \n",
      "impact is not significant. to assess impact, we use the data in table 3 \n",
      "of this section which shows that the total raw (not discounted) net \n",
      "effect of this final rule over 5 years is 500 million dollars.\n",
      "    medicare advantage: we first assess impact on ma plans. comparing \n",
      "the 500 million dollar number to the total monetary amounts projected \n",
      "to be needed just for 2018, the most recent year on which we have \n",
      "finalized plan submitted bid data (and which is expected to be less \n",
      "than the need in future years including 2019), we find that that the \n",
      "impact of this proposed rule is significantly below the 3 percent-5 \n",
      "percent threshold for significant impact for ma plans.\n",
      "    medicaid: we next assess impact on medicaid managed care plans. the \n",
      "total projected capitation payment and premiums for 2019 is projected \n",
      "to be $337.6 billion.\\71\\ hence, the total cost of this proposed rule \n",
      "over 5 years, $500 million, is significantly below the 3 percent-5 \n",
      "percent threshold for significant impact to medicaid managed care \n",
      "plans.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\71\\ table 17 of appendix d, ``capitation payments and \n",
      "premiums'', in the cms report, ``2016 actuarial report on the \n",
      "financial outlook for medicaid,'' accessible at url <a href=\"https://www.medicaid.gov/medicaid/finance/downloads/medicaid-actuarial-report-2016.pdf\">https://www.medicaid.gov/medicaid/finance/downloads/medicaid-actuarial-report-2016.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    commercial: as discussed prior to table 4, based on data in the \n",
      "public, cms mlr files, commercial plans had a revenue of at least $370 \n",
      "billion in 2016. we say at least, because this only includes \n",
      "organizations with either: (1) only commercial; (2) both commercial and \n",
      "ma; or (3) both commercial and medicaid. had all organizations been \n",
      "included in the cms mlr files (including those that only offer ma and/\n",
      "or medicaid) the amount would be greater than $370 billion. therefore, \n",
      "the aggregate raw cost of this proposed rule over 5 years, $500 \n",
      "million, is significantly below the 3 percent-5 percent threshold for \n",
      "significant impact to commercial plans.\n",
      "    we conclude, that although a significant number of small plans in \n",
      "all programs are affected by this rule, this impact is not significant.\n",
      "    besides the fact that the impact is not significant, we are not \n",
      "concerned that small plans will have a burden in implementing these \n",
      "requirements since as indicated above, without considering any rebates \n",
      "or federal matching funds, the cost of this provision is $1.63 per \n",
      "enrollee per year in the first implementation year, and $0.34 in the \n",
      "following years for maintenance, these per enrollee costs are \n",
      "negligible when compared to the typical costs per enrollee (several \n",
      "thousand dollars).\n",
      "    consequently, the secretary has determined that this proposed rule \n",
      "will not have a significant economic impact on a substantial number of \n",
      "small entities and the requirements of the rfa have been met. please \n",
      "see our detailed analysis of apportionment of costs per program and \n",
      "plan in tables 4 through 8 and section xvi.h. of this proposed rule for \n",
      "further details.\n",
      "    in addition, section 1102(b) of the act requires cms to prepare an \n",
      "ria if a rule may have a significant impact on the operations of a \n",
      "substantial number of small rural hospitals. this analysis must conform \n",
      "to the provisions of section 603 of the rfa. for purposes of section \n",
      "1102(b) of the act, we define a small rural hospital as a hospital that \n",
      "is located outside a metropolitan statistical area and has fewer than \n",
      "100 beds. we are not preparing an analysis for section 1102(b) of the \n",
      "act because we have determined, and the secretary certifies, that this \n",
      "proposed rule would not have a significant impact on the operations of \n",
      "a substantial number of small rural hospitals.\n",
      "    section 202 of the unfunded mandates reform act of 1995 (umra) \n",
      "(pub. l. 104-04, enacted march 22, 1995) also requires that agencies \n",
      "assess anticipated costs and benefits before issuing any rule whose \n",
      "mandates require spending in any 1 year of $100 million in 1995 \n",
      "dollars, updated annually for inflation. in 2018, that is approximately \n",
      "$150 million. the apportionment of total cost between the ma, medicaid, \n",
      "commercial and chip programs is detailed in both section xvi.b. (tables \n",
      "4 through 8) and section xvi.h of this ria showing that costs for both \n",
      "enrollees and the states are small. executive order 13132 establishes \n",
      "certain requirements that an agency must meet when it promulgates a \n",
      "proposed rule (and subsequent final rule) that imposes substantial \n",
      "direct requirement costs on state and local governments, preempts state \n",
      "law, or otherwise has federalism implications. this rule will not have \n",
      "a substantial direct effect on state or local governments, preempt \n",
      "state law, or otherwise have a federalism implication. therefore, the \n",
      "requirements of executive order 13132 are not applicable.\n",
      "    if regulations impose administrative costs, such as the time needed \n",
      "to read and interpret this proposed rule, we should estimate the cost \n",
      "associated with regulatory review. there are currently 288 \n",
      "organizations and 56 states and territories. we assume each \n",
      "organization will have one designated staff member who will read the \n",
      "entire rule.\n",
      "    using the wage information from the bls for medical and health \n",
      "service managers (code 11-9111), we estimate that the cost of reviewing \n",
      "this rule is $139.14 per hour, including overhead and fringe benefits \n",
      "(<a href=\"https://www.bls.gov/oes/current/naics5_524114.htm\">https://www.bls.gov/oes/current/naics5_524114.htm</a>). assuming an \n",
      "average reading speed, we estimate that it would take approximately 6 \n",
      "hours for each person to review this proposed rule. for each plan and \n",
      "state that reviews the rule, the estimated cost is $834.84 (6 hours x \n",
      "$139.14). therefore, we estimate that the total cost of reviewing this \n",
      "regulation is $288,020 ($834.84 x 345 reviewers).\n",
      "1. requirements for patient access through apis\n",
      "    to promote our commitment to interoperability, we are proposing new \n",
      "requirements in section iii. of this proposed rule for ma organizations \n",
      "at 42 cfr 422.119, medicaid ffs at 42 cfr 431.60, medicaid managed care \n",
      "at 42 cfr 438.242, chip ffs at 42 cfr 457.730, chip managed care at 42 \n",
      "cfr 457.1233, and qhp issuers, excluding sadp issuers, that offer plans \n",
      "through the ffe at 45 cfr 156.221 to implement open apis for making \n",
      "certain data available to enrollees and the public. these openly \n",
      "published apis will permit third-party applications to retrieve \n",
      "standardized data for adjudicated claims, encounters with capitated and \n",
      "subcapitated providers, provider remittances, beneficiary cost-sharing, \n",
      "reports of lab test results, provider directories, and preferred drug \n",
      "lists. we believe that these proposals are designed to empower patients \n",
      "by mandating that entities subject to our api proposal take steps--by \n",
      "implementing the api--to enable\n",
      "\n",
      "[[page 7667]]\n",
      "\n",
      "enrollees to have access to their data in a usable digital format and \n",
      "have (potentially) easier means to share that data. by making these \n",
      "data readily available and portable to the patient, these initiatives \n",
      "support moving our healthcare system away from a ffs payment system \n",
      "that pays for volume and toward a payment system that pays for value \n",
      "and quality by reducing duplication of services, adding efficiency to \n",
      "provider visits, and facilitating identification of fraud, waste, and \n",
      "abuse.\n",
      "    to estimate the number of impacted issuers, we reviewed parent \n",
      "organizations of health plans across ma, medicaid mcos, and qhps in \n",
      "ffes to remove organizations that would not be subject to our proposal, \n",
      "such as sadps; transportation plans and brokers such as non-emergency \n",
      "medical transportation (nemts) brokers; pace; visiting nurse and home \n",
      "health care organizations; senior organizations such as area agencies \n",
      "on aging; and other organizations such as community action programs. \n",
      "after removing these organizations, we then reviewed the remaining \n",
      "names of parent organizations and health plans in the national \n",
      "association of insurance commissioners (naic) consumer information \n",
      "support (cis) system to determine the legal name of the entity and \n",
      "whether the entity was registered with the naic. we also used the 2018 \n",
      "naic listing of companies to determine whether various health plans had \n",
      "associated parent organizations using the naic's group coding and \n",
      "numbering system. if the health plan or parent organization did not \n",
      "appear in the naic cis or in the 2018 naic listing of companies, we \n",
      "then reviewed the name of the entity in the securities and exchange \n",
      "online edgar system to locate the entity's form 10-k filing, which \n",
      "includes an exhibit (exhibit 21) that requires the entity to list its \n",
      "subsidiaries. if the health plan or organization did not appear in \n",
      "these online systems or listings, an online internet search using \n",
      "google search engine was conducted. after review, we have determined \n",
      "that 288 issuers and 56 states, territories, and u.s. commonwealths, \n",
      "which operate ffs programs, will be subject to the api provisions for \n",
      "medicare, medicaid, and the commercial market. to this we add the one \n",
      "state that operates its chip and medicaid separately. thus, we have a \n",
      "total of 345 parent entities (288+56+1). we note that although 42 \n",
      "states have some lower-income children in an expansion of medicaid, and \n",
      "some higher-income children or pregnant women in a separate chip, all \n",
      "but one of these programs are operated out of the same agency. although \n",
      "the chip programs may be distinct, we believe they will use the same \n",
      "infrastructure built for medicaid. thus, the addition of 1 parent \n",
      "entity for chip is reasonable and plausible.\n",
      "    as noted in section xiii.c.3. of this proposed rule, to implement \n",
      "the new requirements for apis, we estimate that organizations and \n",
      "states would conduct three major work phases: initial design; \n",
      "development and testing; and long-term support and maintenance. (for a \n",
      "detailed description of these phases, see section xiii.c.3. of this \n",
      "proposed rule.)\n",
      "    as part of our research into the regulatory impact, we reviewed a \n",
      "sample of health plan organizations offering ma plans to determine \n",
      "whether any currently offer patient portal functionality with the ma \n",
      "plan. if yes, we reviewed whether they offered the opportunity to \n",
      "connect to medicare's blue button 2.0. health plan organizations \n",
      "offering ma plans were identified from june 2018 data and statistics \n",
      "compiled at <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/index.html\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/index.html</a>. we \n",
      "initially reviewed the functionality offered by three organizations \n",
      "which together enroll over half of ma members through review of \n",
      "publicly-available information such as press releases and website \n",
      "informational materials. we found from this review that these \n",
      "organizations not only offered patient portals primarily focused on \n",
      "claims and user-entered data on their website, but that all three also \n",
      "offered enrollees the opportunity to connect to blue button. we then \n",
      "identified a selection of other health plan organizations at random and \n",
      "conducted the same evaluation. results indicate that the majority of \n",
      "the health plan organizations we reviewed offer patients a way to \n",
      "access claims data and other information via their websites and \n",
      "sometimes via applications. regarding blue button access, results were \n",
      "either negative or unclear.\n",
      "    we also cross-referenced health plan organizations offering ma \n",
      "plans with health plan organizations that offer plans in the federal \n",
      "employee health benefit (fehb) program because a percentage of those \n",
      "organizations offer plans with patient portal access and blue button \n",
      "functionality. the fehb, administered by the office of personnel \n",
      "management (opm), reported in 2014 that 90 percent of its participating \n",
      "plans offered enrollees access to a personal health record on the \n",
      "organization's website. in addition, opm reported that over half of the \n",
      "fehb participating plans expected to offer blue button functionality by \n",
      "january 1, 2016. we sought to learn whether there was any overlap \n",
      "between these two lists of organizations to gauge whether additional \n",
      "organizations may already have the capability to offer either patient \n",
      "portals or blue button, albeit in a different business arm, as having \n",
      "internal capability may assuage some of the cost of building out a new \n",
      "api to support patient access to claims data. while we found \n",
      "significant overlap between unitedhealthcare and the blue cross blue \n",
      "shield affiliates, we also were able to identify other organizations \n",
      "that offer both ma plans and plans included in the fehb. while not \n",
      "definitive, this data allows us to draw the conclusion that a number of \n",
      "health plan organizations have the technology in place to offer patient \n",
      "portals to ma enrollees and, further, also have the ability to offer ma \n",
      "enrollees blue button functionality.\n",
      "    as detailed in the collection of information section of this \n",
      "proposed rule and summarized in table 3, given the current state of \n",
      "interoperability, we estimate the burden related to the new \n",
      "requirements for apis to have an initial set one-time costs of $798,356 \n",
      "per implementation or an aggregate cost of $275,432,820 ($798,356 x 345 \n",
      "parent entities). for a detailed discussion of the one-time costs \n",
      "associated with implementing the api requirements we refer readers to \n",
      "section xiii.c.3. of this proposed rule. once the api is established we \n",
      "believe that there will be an annual cost for performing necessary \n",
      "capability and security testing, performing necessary upgrades and \n",
      "vetting of third party applications. we estimate the burden related to \n",
      "the requirements for apis to have an annual cost of $158,406 per \n",
      "implementation or an aggregate cost of $54,650,070 (345 parent entities \n",
      "x $158,406). for a detailed discussion of the annual costs associated \n",
      "with implementing the api requirements, we refer readers to section \n",
      "xiii.c.3. of this proposed rule.\n",
      "    we are committed to fulfilling our role in promoting \n",
      "interoperability, putting patients first and ensuring they have access \n",
      "to their health care data. we recognize that there are significant \n",
      "opportunities to modernize access to patient data and its ability to \n",
      "share across the health ecosystem. we realize the importance of \n",
      "interoperability and the capability for health information systems and \n",
      "software applications to communicate, exchange, and interpret data in a \n",
      "usable and readable format. although allowing access to healthcare data \n",
      "through pdf and text format is vital,\n",
      "\n",
      "[[page 7668]]\n",
      "\n",
      "it limits the utility of the data, and its ability to be easily \n",
      "accessed and shared. additionally, we realize that moving to a system \n",
      "in which patients have access to their healthcare data will ultimately \n",
      "empower them to make informed decisions about their healthcare. our \n",
      "proposals here do not go as far as our goals for how patients will be \n",
      "ultimately empowered but take steps in that direction.\n",
      "    we note that the federal government has spent over $35 billion \n",
      "under the ehr incentive programs \\72\\ to incentivize the adoption of \n",
      "ehr systems; however, despite the fact that 78 percent of physicians \n",
      "and 96 percent of hospitals now use an ehr system,\\73\\ progress on \n",
      "system-wide data sharing has been limited. previous attempts to advance \n",
      "interoperability have made incremental progress but have failed to \n",
      "align the necessary stakeholders to drive momentum in a single \n",
      "direction. recently, the administration launched the myhealthedata \n",
      "initiative.\\74\\ this government-wide initiative aims to empower \n",
      "patients by ensuring that they have full access to their own healthcare \n",
      "data and the ability to decide how their data will be used, while \n",
      "keeping that information safe and secure. myhealthedata aims to break \n",
      "down the barriers that prevent patients from gaining electronic access \n",
      "to their healthcare data and allow them to access that data from the \n",
      "device or application of their choice that will connect to a plan's \n",
      "api, empowering patients and taking a critical step toward \n",
      "interoperability and patient data exchange.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\72\\ may 2018, ehr incentive program, payment summary report, \n",
      "accessed at <a href=\"https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/may2018_summaryreport.pdf\">https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/may2018_summaryreport.pdf</a>.\n",
      "    \\73\\ onc, health it dashboard, ``office-based physician health \n",
      "it adoption: state rates of physician ehr adoption, health \n",
      "information exchange & interoperability, and patient engagement \n",
      "(2015),'' <a href=\"https://dashboard.healthit.gov/apps/physician-health-it-adoption.php\">https://dashboard.healthit.gov/apps/physician-health-it-adoption.php</a> (last accessed july 9, 2018).\n",
      "    \\74\\ <a href=\"https://www.cms.gov/newsroom/mediareleasedatabase/press-releases/2018-press-releases-items/2018-03-06.html\">https://www.cms.gov/newsroom/mediareleasedatabase/press-releases/2018-press-releases-items/2018-03-06.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    health plans should have the ability to exchange data instantly \n",
      "with other payers for care coordination or transitions, and with \n",
      "providers to facilitate more efficient care. health plans are in a \n",
      "unique position to provide enrollees a complete picture of their claims \n",
      "and encounter data, allowing patients to piece together their own \n",
      "information that might otherwise be lost in disparate systems. we are \n",
      "committed to solving the issue of interoperability and achieving \n",
      "complete patient access in the u.s. health care system and are taking \n",
      "an active approach using all available policy levers and authorities \n",
      "available to move all participants in the health care market toward \n",
      "interoperability and the secure exchange of health care data. the \n",
      "modern internet app economy thrives on an open api software \n",
      "environment. part of the health care api evolution is incorporating \n",
      "many of the current protocols from leading standards development \n",
      "organizations with the newer fast healthcare interoperability resources \n",
      "(fhir) web developer-friendly way of representing clinical data.\n",
      "2. increasing the frequency of federal-state data exchanges for dually \n",
      "eligible individuals\n",
      "    we routinely exchange data with states on who is enrolled in \n",
      "medicare, and which parties are liable for paying that beneficiary's \n",
      "part a and b premiums. these buy-in data exchanges support state, cms, \n",
      "and ssa premium accounting, collections, and enrollment functions. cms \n",
      "subregulatory guidance, specifically chapter 3 of the state buy-in \n",
      "manual, specifies that states should exchange buy-in data with cms at \n",
      "least monthly, but provides the option for states to exchange buy-in \n",
      "data with cms daily or weekly. likewise, states can choose to receive \n",
      "the cms response data on a file daily or monthly. currently, 31 states \n",
      "and the district of columbia now submit buy-in data to cms, daily and \n",
      "28 states and the district of columbia receive buy-in response files \n",
      "from cms daily.\n",
      "    we are proposing to establish the frequency requirements in the \n",
      "regulation itself to require all states to participate in daily \n",
      "exchange of buy-in data to cms, with ``daily'' meaning every business \n",
      "day, but that if no new transactions are available to transmit, data \n",
      "would not need to be submitted on a given business day. we propose that \n",
      "states would be required to begin participating in daily exchange of \n",
      "buy-in data with cms by april 1, 2022.\n",
      "    we estimate the cost for states to comply with these new \n",
      "requirements to be one-time costs associated with state systems \n",
      "updates, totaling $3,273,965 across impacted states and over the 3-year \n",
      "implementation period. we first identified those states already \n",
      "exchanging data daily, and then determined there are 19 states that we \n",
      "anticipate will need to make a systems change to send buy-in data to \n",
      "cms daily, and 22 states that we anticipate will need to make a systems \n",
      "change to receive buy-in data from cms daily. we then estimated that \n",
      "each change would involve 960 hours of computer analyst time at $83.18 \n",
      "per hour, for a one-time cost to be a little less than $80,000 per \n",
      "state, per change. so, a state that needs to make systems updates to \n",
      "both send buy-in data daily, and receive buy-in data daily would have a \n",
      "one-time cost of just under $160,000. we did not estimate any savings \n",
      "related to exchanging buy-in data with greater frequency, as data lags \n",
      "only delay when states are billed for premium costs; delays do not \n",
      "impact the effective date and total costs. while we did not estimate \n",
      "premium savings (since premium collection is ultimately correct), we \n",
      "anticipate that states may experience longer term reduction in \n",
      "administrative burden of making those corrections.\n",
      "    states submit data on mma files at least monthly to cms to identify \n",
      "all dually eligible individuals, including full-benefit and partial-\n",
      "benefit dually eligible beneficiaries (that is, those who get medicaid \n",
      "help with medicare premiums, and often cost-sharing). while 42 cfr \n",
      "423.910(d) requires states to submit at least one mma file each month, \n",
      "states have the option to submit multiple mma files throughout the \n",
      "month (up to one per day). as cms now utilizes mma data on dual \n",
      "eligibility status in systems supporting all four parts of the medicare \n",
      "program, it is becoming even more essential that dual eligibility \n",
      "status is accurate and up-to-date.\n",
      "    we are proposing to update the frequency requirements in 42 cfr \n",
      "423.910(d) to require that starting april 1, 2022, all states submit \n",
      "the required mma file data to cms daily, and to make conforming edits \n",
      "to 42 cfr 423.910(b)(1). daily would mean every business day, but that \n",
      "if no new transactions are available to transmit, data would not need \n",
      "to be submitted on a given business day. we estimate the cost for \n",
      "states to comply with these new requirements to be a one-time cost \n",
      "associated with state systems updates, totaling $3,034,406 across \n",
      "impacted states, and across the 3 years which states have to implement \n",
      "the requirement. there are 37 states and the district of columbia that \n",
      "we anticipate will need to make a systems change to send mma data to \n",
      "cms daily. we estimate the one-time cost for a state to be a little \n",
      "less than $80,000 for this mma data systems change. for a detailed \n",
      "discussion of the costs associated with these requirements we refer \n",
      "readers to section xiii.c. of this proposed rule. we did not estimate \n",
      "any savings related to submitting mma files daily, as data lags only \n",
      "delay when data are sent; delays do not impact the\n",
      "\n",
      "[[page 7669]]\n",
      "\n",
      "effective date and total costs. while we did not estimate savings, we \n",
      "anticipate that states may experience longer term reduction in \n",
      "administrative burden.\n",
      "    if these proposals are finalized as proposed, we anticipate that \n",
      "states would have approximately 3 years to implement daily exchange of \n",
      "buy-in and mma data. for each state there would be a one-time cost to \n",
      "make needed systems changes, and thereafter, no new on-going costs. \n",
      "states will have the ability to choose, in consultation with cms, when \n",
      "in the 3-year implementation period they want to make this change, with \n",
      "numerous factors impacting in which year they would do so. for the \n",
      "purposes of this impact analysis, we estimated an even distribution \n",
      "beginning in may 2019 and ending in april 2022. the total cost impact \n",
      "over the 3-year implementation period for this provision is $6,308,371 \n",
      "($3,273,965 + $3,034,406), comprising $0.7 million in fy 2019, $2.2 \n",
      "million in fy 2020, $2.2 million in fy 2021, and $1.2 million in fy \n",
      "2022. since the proposed effective date is april 1, 2022, we estimate \n",
      "no costs for fy 2023.\n",
      "3. revisions to the conditions of participation for hospitals and \n",
      "critical access hospitals (cahs)\n",
      "    we are seeking to further expand cms requirements for \n",
      "interoperability within the hospital and cah cops by focusing on \n",
      "electronic patient event notifications. we are proposing new \n",
      "requirements in section x. of this proposed rule for hospitals at 42 \n",
      "cfr 482.24(d)), for psychiatric hospitals at 42 cfr 482.61(f), and for \n",
      "cahs at 42 cfr 485.638. specifically, for hospitals, psychiatric \n",
      "hospitals and cahs, we are proposing similar requirements to revise the \n",
      "cops for medicare- and medicaid-participating hospitals, psychiatric \n",
      "hospitals, and cahs by adding a new standard, ``electronic \n",
      "notifications,'' that would require hospitals, psychiatric hospitals, \n",
      "and cahs to make electronic patient event notifications available to \n",
      "another healthcare facility or to another community provider. we \n",
      "propose to limit this requirement to only those hospitals, psychiatric \n",
      "hospitals, and cahs which currently possess ehr systems with the \n",
      "technical capacity to generate information for electronic patient event \n",
      "notifications, recognizing that not all medicare- and medicaid-\n",
      "participating hospitals have been eligible for past programs promoting \n",
      "adoption of ehr systems. we propose that these notifications would need \n",
      "to be sent at admission and either immediately prior to or at the time \n",
      "of the patient's discharge or transfer to licensed and qualified \n",
      "practitioners, other patient care team members, and pac services \n",
      "providers and suppliers that: (1) receive the notification for \n",
      "treatment, care coordination, or quality improvement purposes; (2) have \n",
      "an established care relationship with the patient relevant to his or \n",
      "her care; and (3) for whom the hospital, psychiatric hospital, or cah \n",
      "has a reasonable certainty of receipt of notifications. as we noted, \n",
      "infrastructure supporting the exchange of electronic health information \n",
      "across settings has matured substantially in recent years. research \n",
      "studies have increasingly found that health information exchange \n",
      "interventions can effectuate positive outcomes in health care quality \n",
      "and public health outcomes, in addition to more longstanding findings \n",
      "around reductions in utilization and costs. electronic patient event \n",
      "notifications from hospitals, or clinical event notifications, are one \n",
      "type of health information exchange intervention that has been \n",
      "increasingly recognized as an effective and scalable tool for improving \n",
      "care coordination across settings, especially for patients at \n",
      "discharge. this approach has been identified with a reduction in \n",
      "readmissions following implementation.\\75\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\75\\ unruh ma, jung hy, kaushal r, vest jr, hospitalization \n",
      "event notifications and reductions in readmissions of medicare ffs \n",
      "beneficiaries in the bronx, new york. j am med inform assoc, 2017 \n",
      "apr 1, accessed at <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/28395059\">https://www.ncbi.nlm.nih.gov/pubmed/28395059</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    these notifications are automated, electronic communications from \n",
      "the provider to another facility or another community provider \n",
      "identified by the patient. these automated communications alert the \n",
      "receiving provider that the patient has received care at a different \n",
      "setting. information included with these notifications can range from \n",
      "simply conveying the patient's name, basic demographic information, and \n",
      "the sending institution, to a richer set of clinical data depending \n",
      "upon the level of technical implementation. however, regardless of the \n",
      "information included these alerts can help ensure that a receiving \n",
      "provider is aware that the patient has received care elsewhere. the \n",
      "notification triggers a receiving provider to reach out to the patient \n",
      "to deliver appropriate follow-up care in a timely manner. by providing \n",
      "timely notifications, the alert may improve post-discharge transitions \n",
      "and reduce the likelihood of complications resulting from inadequate \n",
      "follow-up care.\n",
      "    virtually all ehr systems generate the basic messages commonly used \n",
      "to support electronic patient event notifications. we believe that care \n",
      "coordination can have a significant positive impact on the quality of \n",
      "life, consumer experience, and health outcomes for patients. however, \n",
      "we acknowledge that though such activities can have positive impact, \n",
      "they will likely generate some costs. we believe it is difficult to \n",
      "quantify the impact of this proposed change because ehr implementation \n",
      "across care settings varies in maturity rates, leading to potential \n",
      "variance in cost and impact across such settings. we believe that this \n",
      "proposal would impose minimal additional costs on hospitals. the cost \n",
      "of implementing these proposed changes would largely be limited to the \n",
      "one-time cost related initial implementation of the notification \n",
      "system, and to the revision of a policies and procedures as they relate \n",
      "to discharge planning. there also may be some minimal cost associated \n",
      "with communicating these changes to affected staff. however, we believe \n",
      "that these costs would be offset by the benefits derived from positive \n",
      "outcomes in health care quality and public health outcomes. therefore, \n",
      "while this proposal would impose a minimal burden on hospitals, we \n",
      "believe that, in sum, the changes proposed would greatly benefit \n",
      "patients overall.\n",
      "4. effects of other proposed policy changes\n",
      "    in addition to those proposed policy changes discussed previously \n",
      "that we are able to model, we are proposing to make various other \n",
      "changes in this proposed rule. generally, we have limited or no \n",
      "specific data available with which to estimate the impacts of these \n",
      "proposed changes. our estimates of the likely impacts associated with \n",
      "these other proposed changes are discussed in this section.\n",
      "a. care coordination across payers\n",
      "    in section v. of this proposed rule, we are proposing a new \n",
      "requirement for ma plans, medicaid managed care plans, chip managed \n",
      "care entities, and qhp issuers in ffes to require these plans to \n",
      "maintain a process to exchange, at a minimum, the uscdi data set upon \n",
      "an enrollee's request. under our proposal, each of these plans subject \n",
      "to the requirement would, upon an enrollee's request: (1) accept the \n",
      "data set from another plan that had covered the enrollee within the \n",
      "previous 5 years; (2) send the data set at any time during an \n",
      "enrollee's enrollment and up to 5 years later, to another plan that \n",
      "currently covers the enrollee; and (3) send the data set at any time \n",
      "during enrollment or up to 5 years after\n",
      "\n",
      "[[page 7670]]\n",
      "\n",
      "enrollment has ended to a recipient identified by the enrollee.\n",
      "    such transactions would be made in compliance with applicable laws.\n",
      "    we believe that sending and receiving this minimum data would help \n",
      "both plan enrollees and health care providers in coordinating care and \n",
      "reducing administrative burden. we believe that this entails utilizing \n",
      "all tools available to us to ensure that plans provide coordinated \n",
      "high-quality care in an efficient and cost-effective way that protects \n",
      "program integrity.\n",
      "    we believe that this proposal would impose minimal additional costs \n",
      "on plans. we note that we do not specify a transport standard in the \n",
      "proposal and anticipate that plans may opt to use apis, such as the api \n",
      "that this proposed rule would also require. we also anticipate that \n",
      "plans may choose to utilize a regional health information exchange. we \n",
      "believe it is difficult to quantify the impact of this proposed change \n",
      "because plans will likely implement different transport methods, and we \n",
      "cannot predict the selected method plans will choose.\n",
      "b. care coordination through trusted exchange networks\n",
      "    in section vi. of this proposed rule, we are proposing to require \n",
      "ma plans, medicaid managed care plans, chip managed care entities and \n",
      "qhp issuers in ffes to participate in trust networks in order to \n",
      "improve interoperability in these programs. we believe that payers and \n",
      "patients' ability to communicate between themselves and with health \n",
      "care providers could considerably improve patient access to data, \n",
      "reduce provider burden, and reduce redundant and unnecessary \n",
      "procedures. a trusted exchange framework allows for the secure exchange \n",
      "of electronic health information with, and use of electronic health \n",
      "information from, other health it without special effort on the part of \n",
      "the user. widespread payer participation in such a framework might also \n",
      "allow for more complete access, exchange, and use of all electronically \n",
      "accessible health information for authorized use under applicable state \n",
      "or federal law. under our proposal, participation would be required in \n",
      "a trusted exchange framework that meets the following criteria:\n",
      "    <bullet> the trusted exchange network must be able to exchange phi, \n",
      "defined in 45 cfr 160.103, in compliance with all applicable state and \n",
      "federal laws across jurisdictions.\n",
      "    <bullet> the trusted exchange network must connect both inpatient \n",
      "ehrs and ambulatory ehrs.\n",
      "    <bullet> the trusted exchange network must support secure messaging \n",
      "or electronic querying by and between patients, providers and payers.\n",
      "    we believe that this proposal would impose minimal additional costs \n",
      "on plans.\n",
      "\n",
      "d. alternatives considered\n",
      "\n",
      "    this proposed rule contains a range of proposed and potential \n",
      "future policies. it provides descriptions of the statutory provisions \n",
      "that are addressed, identifies the proposed policies, and presents \n",
      "rationales for our decisions and, where relevant, alternatives that \n",
      "were considered. we carefully considered the alternatives to this \n",
      "proposed rule but concluded that none would adequately and immediately \n",
      "begin to address the critical issue of the lack of patient access and \n",
      "interoperability, or exchange of health care data within the health \n",
      "care system.\n",
      "    the critical policy decision was how broadly or narrowly to \n",
      "classify the standards required to implement interoperability. overly \n",
      "prescriptive standards may stifle innovation and, in turn, increase \n",
      "costs. on the other side, broad language surrounding standards risked \n",
      "leaving too much open to interpretation and continuing the uncertainty \n",
      "about which standards would be the most practical and cost-effective to \n",
      "implement. we determined it was most appropriate to propose a technical \n",
      "and standards framework that strikes a balance between these two ends \n",
      "of the spectrum, and to establish that we expect the standards \n",
      "framework to expand and mature as interoperability increases.\n",
      "    a second decision was how broadly or narrowly to apply the proposed \n",
      "policies and requirements. for example, alternatives to requiring \n",
      "health plans to provide claims data to patients via an open api could \n",
      "have been altered in a number of ways, such as requiring more or less \n",
      "information to be provided to patients or, simultaneously, to require \n",
      "additional information beyond that already accessible through existing \n",
      "apis be provided to patients by providers. ultimately, we opted to \n",
      "continue to consider most matters pertaining to providers in separate \n",
      "rfis, such as that in the fy 2019 ipps proposed rule seeking \n",
      "information about program participation conditions and requirements, \n",
      "and to maintain the policies proposed in this rule as policies that \n",
      "will further enhance and secure the foundation of future \n",
      "interoperability, including through inclusion of payers, through care \n",
      "coordination, and through matters of security and identity \n",
      "confirmation.\n",
      "    as we recognize that advancing interoperability is no small or \n",
      "simple matter, we continue to explore alternatives and potential other \n",
      "policies. we have requested comment for consideration in future \n",
      "rulemaking or subregulatory guidance on a number of alternatives \n",
      "related to whether additional policies or requirements, beyond those \n",
      "proposed herein, should be imposed to promote interoperability. for \n",
      "example, the innovation center is seeking comment on general principles \n",
      "around promoting interoperability within innovation center models for \n",
      "integration into new models as part of the design and testing of \n",
      "innovative payment and service delivery models. additionally, we are \n",
      "seeking comment on how we may leverage our program authority to provide \n",
      "support to those working on improving patient matching. for example, we \n",
      "are requesting comment on whether cms should require, in medicare ffs, \n",
      "the ma program, medicaid ffs, chip ffs, medicaid managed care programs, \n",
      "chip managed care entities, and the ffes, use of a particular patient \n",
      "matching software solution with a proven success rate of a certain \n",
      "percentage validated by hhs or a 3rd party. we also continue to \n",
      "consider feedback received from rfis issued in various rules over the \n",
      "course of the past year and to incorporate those suggestions into our \n",
      "strategy.\n",
      "\n",
      "e. accounting statement and table\n",
      "\n",
      "    in accordance with omb circular a- 4, table 9 depicts an accounting \n",
      "statement summarizing the assessment of the benefits, costs, and \n",
      "transfers associated with this regulatory action.\n",
      "\n",
      "[[page 7671]]\n",
      "\n",
      "\n",
      "\n",
      "                                          table 9--accounting statement\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                                       units\n",
      "                                                      primary    -----------------------------------------------\n",
      "                    category                         estimate                      discount rate\n",
      "                                                                   year dollars         (%)       period covered\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "benefits:\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "    qualitative.................................  <bullet> api requirements will alleviative the burden for\n",
      "                                                  beneficiaries and enrollees to go through separate processes\n",
      "                                                  to obtain access to each system, and the need to manually\n",
      "                                                  aggregate information that is delivered in various, often non-\n",
      "                                                  standardized, formats.\n",
      "                                                  <bullet> api requirement allows for the administration of a\n",
      "                                                  more efficient and effective medicaid program by taking\n",
      "                                                  advantage of commonly used methods of information sharing and\n",
      "                                                  data standardization.\n",
      "                                                  <bullet> api requirements would help to create a healthcare\n",
      "                                                  information ecosystem that allows and encourages the\n",
      "                                                  healthcare market to tailor products and services to compete\n",
      "                                                  for patients, thereby increasing quality, decreasing costs,\n",
      "                                                  and helping them live better, healthier lives.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "costs:\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "    annualized monetized $ millions/year........          106.26            2020               7       2020-2024\n",
      "                                                          102.73            2020               3       2020-2024\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    the preceding discussion was an actual cost impact (not a transfer) \n",
      "since goods and computer services are being paid for. plans have the \n",
      "option of transferring their expenses to enrollees. in practice, \n",
      "because of market competitive forces a plan may decide to operate at a \n",
      "(partial) loss and not transfer the entire cost. it is important to \n",
      "estimate the maximum the transfer could be. some costs are transferred \n",
      "to the states (for medicaid and chip) and ultimately to the federal \n",
      "government (for medicare, medicaid, and chip), mitigating the amount \n",
      "transferred to enrollees. one approach to estimate impact on enrollees \n",
      "was made in section xvi.b. of this ria. however, this analysis did not \n",
      "take into account transfers.\n",
      "    we now re-estimate the potential full transfer. as noted in section \n",
      "tables 4 through 8 of xvi.b. of this ria, we have in 2021 through 2024 \n",
      "under a dollar increase in premium as the worst case scenario, and we \n",
      "used actual costs per year. in this alternate analysis we use actual \n",
      "amounts for each of 2021 through 2024 with the initial 1-year cost \n",
      "amortized over 5 years. in other words, we assume a cost of $110 \n",
      "(275.4/5 + 54.7)\n",
      "    we point out that this premium increase should be counterbalanced \n",
      "by projected savings arising from the provisions in this proposed rule. \n",
      "more specifically, we expect the availability of portable electronic \n",
      "transfer of medical data proposed by this rule to increase prevention \n",
      "of future medical illnesses due to better data accessibility. the \n",
      "savings from avoiding one illness or one cheaper procedure would offset \n",
      "the under one-dollar impact. however, we have no way, at this point, of \n",
      "estimating this aspect of the future savings of the rule.\n",
      "    we present two estimates. first, we estimate using the enrollment \n",
      "figures used in table 7 of this ria. table 7 shows that we have 169 \n",
      "million (76+73+20) in programs that will be spending about $110 million \n",
      "per year. ignoring federal subsidies, and assuming that all costs will \n",
      "be passed on to enrollees (which is contrary to our experience), the \n",
      "169 million enrollees would each incur an extra 65 cents (110/169) a \n",
      "year to achieve the $110 million goal. we next estimate using premium \n",
      "versus enrollment as was done in section xvi.b. of this ria.\n",
      "    prior to discussing potential transfers to enrollees, we discuss \n",
      "how this proposed rule may affect commercial enrollees not in the ma, \n",
      "medicaid, chip, or ffe programs. technically, plans are only required \n",
      "to provide interoperability for enrollees in the ma, medicaid, chip, \n",
      "and ffe programs. however, it is both possible and likely, that a \n",
      "parent organization providing interoperability for its ffe and other \n",
      "program enrollees as required, may choose to offer this to commercial \n",
      "enrollees. consequently, it is possible that to cover the cost of \n",
      "offering interoperability to commercial enrollees outside the ma, \n",
      "medicaid, chip and ffe programs, the parent organizations, raise \n",
      "premiums to both their commercial enrollees as well as the ma, \n",
      "medicaid, chip or ffe enrollees. thus it is possible (and we argue \n",
      "likely) that this proposed rule will affect commercial enrollees even \n",
      "though there is no requirement to provide them interoperability. \n",
      "therefore, we believe we are obligated in this ria to calculate the \n",
      "cost impact per enrollee should the parent organizations offer \n",
      "interoperability (and should they pass on the cost of interoperability \n",
      "in terms of commercial premium). the rest of the discussion below \n",
      "explores this possibility.\\76\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\76\\ note that our analysis in tables 5,6,7,8 also assume that \n",
      "costs are incurred by commercial enrollees even though there is no \n",
      "requirement to provide them with interoperability. we believe this \n",
      "the most likely scenario. however, if we are restrictive in our \n",
      "impact analysis and only assume ma, medicaid, chip and ffe enrollees \n",
      "are bearing the cost the results of tables 5-8 would not change the \n",
      "negligibility conclusion as the following justifications show: we \n",
      "have assumed 20 million, 73 million and 76 million enrollees in the \n",
      "ma, medicaid and commercial programs (table 7). the 20 million and \n",
      "73 million remain accurate. the 76 million (commercial enrollees) \n",
      "must be replaced by ffe enrollees. for this purpose we use qhp data. \n",
      "based on internal data (some of which has not yet been published), \n",
      "for 2017 there were 9,757,747 enrollees with $55,109,210,072 total \n",
      "premium resulting in a $5600 per enrollee per year cost, and for \n",
      "2018, there were 9,925,382 enrollees with $70,738,585,845 total \n",
      "premium resulting in a $7100 per enrollee per year cost. to \n",
      "illustrate how this changes the table 7 impact, the $2.10 per \n",
      "enrollee per year cost for 2020 commercial must be replaced by \n",
      "$15.96 to account for a division by 10 million versus 76 million. \n",
      "although this is a big increase, $15.96 is still only about one \n",
      "third a percent of the per-enrollee-per-year costs of the ffe. thus \n",
      "the cost is still negligible. furthermore, a parent organization \n",
      "actuary reviewing these numbers would probably seriously recommend \n",
      "that all enrollees including commercial be offered the \n",
      "interoperability since that significantly reduces the per enrollee \n",
      "per year cost.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    commercial: rebates are required under section 2718(b)(1)(a) of the \n",
      "phsa and the implementing regulations at 45 cfr part 158 when an issuer \n",
      "does not meet the applicable threshold. the\n",
      "\n",
      "[[page 7672]]\n",
      "\n",
      "commercial market mlr is generally calculated as the percent of each \n",
      "dollar of after-tax premium revenue spent by the issuer on medical \n",
      "products and services, and activities that improve the quality of \n",
      "health care. if the issuer mlr for a state market is below the \n",
      "applicable threshold, then the issuer must return the difference to \n",
      "policyholders. it follows, that if interoperability costs raise plan \n",
      "costs, and if additionally, the issuers pass on the full cost in the \n",
      "form of premium and/or are able to treat these costs as qias, then \n",
      "premiums and rebates will change. the following two highly simplified \n",
      "examples are illustrative.\n",
      "    suppose the mlr threshold is 85 percent (in practice it can vary by \n",
      "state market), but the issuer's mlr is below the threshold at 75 \n",
      "percent. then the issuer would have to return the 10 percent as a \n",
      "rebate. if the interoperability costs for an issuer are on average 6 \n",
      "percent of premium and the issuer treats these expenses as qia, the \n",
      "issuer will now have to rebate only 4 percent instead of 10 percent \n",
      "(that is, the issuer's mlr would be 81 percent rather than 75 percent). \n",
      "similarly, if both the applicable threshold and issuer mlr are 85 \n",
      "percent, then the issuer would not owe a rebate.\n",
      "    there are two effects of recognizing these costs as qia: (1) for \n",
      "issuers below the applicable mlr threshold, the rebate from issuers to \n",
      "policyholders would go down by some amount between $0 and the \n",
      "interoperability cost; and (2) for issuers at or above the mlr \n",
      "standards, the premium transfers from enrollees to issuers will go up \n",
      "by some amount between $0 and the interoperability cost.\n",
      "    to estimate these amounts, we used the public use 2016 mlr files on \n",
      "the cms website that were used for tables 4 through 7 of this ria. the \n",
      "total 2016 premium revenue on the commercial side was approximately \n",
      "$370 billion. of the $370 billion, the total 2016 premium revenue of \n",
      "issuers that were below the commercial mlr standard (80 or 85 percent, \n",
      "depending on the market) was approximately $19.4 billion and that \n",
      "subset of issuers paid a total of $455 million in rebates.\n",
      "    as mentioned earlier, to proceed further we use the estimates of \n",
      "the interoperability costs which are $110 million per year. this cost \n",
      "is for all parent organizations with each parent organization possibly \n",
      "dealing with up to four lines of business subject to mlr requirements: \n",
      "ma (including part d sponsors); medicaid; chip; and commercial. thus, \n",
      "of the $110 million level annual cost of interoperability, we estimate \n",
      "$64 million (57.81 percent commercial proportion x $110 million level \n",
      "annual interoperability cost) to be the cost for the commercial market.\n",
      "    in estimating the transfers to policyholders in the commercial \n",
      "market, we must distinguish between the $19.4 billion of premium \n",
      "revenues of issuers whose mlr was below the applicable threshold and \n",
      "the $350.6 billion of premium revenues ($370 billion total revenue-\n",
      "$19.4 billion) of issuers whose mlr was at or above the applicable \n",
      "threshold. we can now calculate the estimated aggregate transfer in the \n",
      "commercial market from the policyholders to the issuers whether through \n",
      "premium or rebates as follows:\n",
      "    <bullet> interoperability cost = 0.017 percent of revenue premium \n",
      "($64 million cost/$370 billion total revenue).\n",
      "    <bullet> reduced mlr rebates = $3.3 million (0.017 percent x $19.4 \n",
      "billion premium from issuers below the applicable mlr threshold).\n",
      "    <bullet> increased premiums = up to $60.0 million (0.017 percent x \n",
      "($370 billion total revenue-$19.4 billion premium from issuers below \n",
      "the applicable mlr threshold)).\n",
      "    <bullet> total transfer from enrollees = up to $63.3 million ($60.0 \n",
      "million increased premium + $3.3 million reduced rebate).\n",
      "    <bullet> transfer per enrollee = 83 cents ($63.3 million/76 million \n",
      "commercial enrollee).\n",
      "    we note that the 83 cents (under a dollar per enrollee) is \n",
      "consistent with the results obtained in tables 4 through 8 (with exact \n",
      "raw amounts by year without amortization of a large first year \n",
      "expense). these calculations are summarized in table 10.\n",
      "    these calculations are summarized in table 10.\n",
      "\n",
      "                        table 10--transfers to enrollee resulting from the proposed rule\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      " \n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                      level annual cost of interoperability\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(a)...................  first year cost of                275.4  estimated in this        in millions.\n",
      "                         interoperability.                        proposed rule.\n",
      "(b)...................  first year cost                   55.08  (a)/5..................  in millions.\n",
      "                         amortized over 5 years.\n",
      "(c)...................  continuation year cost             54.7  estimated in this        in millions.\n",
      "                         of interoperability.                     proposed rule.\n",
      "(d)...................  level interoperability           109.78  (b) + (c)..............  in millions.\n",
      "                         cost per year.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                     commercial percent of premium revenues\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(e)...................  total premium revenues              640  sum of (f) (g) and (h)   in billions.\n",
      "                         in commercial,                           below.\n",
      "                         medicaid and medicare.\n",
      "(f)...................  commercial premium                  370  58%....................  2016 cms mlr files (in\n",
      "                         revenues (dollar                                                  billions); percentage\n",
      "                         amount and percent).                                              obtained by dividing\n",
      "                                                                                           by column e.\n",
      "(g)...................  medicare advantage                  157  25%....................  2016 cms mlr files (in\n",
      "                         premium revenues                                                  billions); percentage\n",
      "                         (dollar amount and                                                obtained by dividing\n",
      "                         percent).                                                         by column e.\n",
      "(h)...................  medicaid premium                    113  18%....................  2016 cms mlr files (in\n",
      "                         revenues (dollar                                                  billions); percentage\n",
      "                         amount and percent).                                              obtained by dividing\n",
      "                                                                                           by column e.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                    annual interoperability cost as a percent of commercial premium revenues\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(i)...................  annualized level                 109.78  (d)....................  in millions.\n",
      "                         interoperability cost.\n",
      "(j)...................  percent of total                    58%  (f)....................  ......................\n",
      "                         revenues related to\n",
      "                         commercial market.\n",
      "(k)...................  interoperability cost             63.67  (i) x (j)..............  in millions.\n",
      "                         for commercial issuers.\n",
      "(l)...................  commercial premium              370,000  (f)....................  in millions.\n",
      "                         revenues.\n",
      "\n",
      "[[page 7673]]\n",
      "\n",
      " \n",
      "(m)...................  interoperability cost            0.017%  (k)/(l)................  ......................\n",
      "                         as a percent of total\n",
      "                         commercial revenue.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "            commercial revenue broken out by whether above or below mlr threshold (requiring rebate)\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(n)...................  total commercial                370,000  (f)....................  in millions.\n",
      "                         revenue.\n",
      "(o)...................  revenues of commercial           19,400  2016 cms mlr files (in   ......................\n",
      "                         market issuers whose                     millions).\n",
      "                         mlr is below threshold.\n",
      "(p)...................  revenues of commercial          350,600  (n)-(o)................  in millions.\n",
      "                         market issuers whose\n",
      "                         mlr is at or above the\n",
      "                         threshold.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                 transfer to enrollee per enrollee from decreased rebates and increased premium\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(q)...................  reduction in commercial             3.3  (m) x (o)..............  in millions.\n",
      "                         market rebates from\n",
      "                         interoperability for\n",
      "                         those issuers paying\n",
      "                         rebates.\n",
      "(r)...................  premium increase from              60.0  (m) x (p)..............  in millions.\n",
      "                         interoperability for\n",
      "                         those commercial\n",
      "                         market issuers not\n",
      "                         paying rebates.\n",
      "(s)...................  total increase to                  63.3  (q) + (r)..............  in millions.\n",
      "                         commercial enrollees\n",
      "                         from interoperability.\n",
      "(t)...................  number commercial                    76  2016 cms mlr files (in   ......................\n",
      "                         enrollees.                               millions).\n",
      "(u)...................  dollar increase in                $0.83  (s)/(t)................  ......................\n",
      "                         premium per enrollee.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "f. regulatory reform analysis under e.o. 13771\n",
      "\n",
      "    executive order 13771, titled reducing regulation and controlling \n",
      "regulatory costs, was issued on january 30, 2017 and requires that the \n",
      "costs associated with significant new regulations ``shall, to the \n",
      "extent permitted by law, be offset by the elimination of existing costs \n",
      "associated with at least two prior regulations.'' this proposed rule is \n",
      "considered an e.o. 13771 regulatory action. we estimate that this rule \n",
      "generates $56.7 million in annualized costs, discounted at 7 percent \n",
      "relative to year 2016, over an infinite time horizon. details on the \n",
      "estimated costs of this proposed rule can be found in the preceding \n",
      "analysis.\n",
      "\n",
      "g. conclusion\n",
      "\n",
      "    the analysis above, together with the preceding preamble, provides \n",
      "an ria.\n",
      "    in accordance with the provisions of executive order 12866, this \n",
      "regulation was reviewed by the office of management and budget.\n",
      "\n",
      "list of subjects\n",
      "\n",
      "42 cfr part 406\n",
      "\n",
      "    health facilities, diseases, medicare.\n",
      "\n",
      "42 cfr part 407\n",
      "\n",
      "    medicare.\n",
      "\n",
      "42 cfr part 422\n",
      "\n",
      "    administrative practice and procedure, health facilities, health \n",
      "maintenance organizations (hmo), medicare, penalties, privacy, \n",
      "reporting and recordkeeping requirements.\n",
      "\n",
      "42 cfr part 423\n",
      "\n",
      "    administrative practice and procedure, emergency medical services, \n",
      "health facilities, health maintenance organizations (hmo), medicare, \n",
      "penalties, privacy, reporting and recordkeeping requirements.\n",
      "\n",
      "42 cfr part 431\n",
      "\n",
      "    grant programs--health, health facilities, medicaid, privacy, \n",
      "reporting and recordkeeping requirements.\n",
      "\n",
      "42 cfr part 438\n",
      "\n",
      "    grant programs--health, medicaid, reporting and recordkeeping \n",
      "requirements.\n",
      "\n",
      "42 cfr part 457\n",
      "\n",
      "    administrative practice and procedure, grant programs--health, \n",
      "health insurance, reporting and recordkeeping requirements.\n",
      "\n",
      "42 cfr part 482\n",
      "\n",
      "    grant programs--health, hospitals, medicaid, medicare, reporting \n",
      "and recordkeeping requirements.\n",
      "\n",
      "42 cfr part 485\n",
      "\n",
      "    grant programs--health, health facilities, medicaid, privacy, \n",
      "reporting and recordkeeping requirements.\n",
      "\n",
      "45 cfr part 156\n",
      "\n",
      "    administrative practice and procedure, advertising, advisory \n",
      "committees, brokers, conflict of interests, consumer protection, grant \n",
      "programs--health, grants administration, health care, health insurance, \n",
      "health maintenance organization (hmo), health records, hospitals, \n",
      "indians, individuals with disabilities, loan programs--health, \n",
      "medicaid, organization and functions (government agencies), public \n",
      "assistance programs, reporting and recordkeeping requirements, state \n",
      "and local governments, sunshine act, technical assistance, women, \n",
      "youth.\n",
      "\n",
      "    for the reasons set forth in the preamble, the centers for medicare \n",
      "& medicaid services (cms) proposes to amend 42 cfr chapter iv and the \n",
      "office of the secretary (hhs) proposes to further amend 45 cfr subtitle \n",
      "a, subchapter b (as proposed to be amended in onc's proposed rule \n",
      "``21st century cures act: interoperability, information blocking, and \n",
      "the onc health it certification program'' published elsewhere in this \n",
      "issue of this federal register), as set forth below:\n",
      "\n",
      "title 42--public health\n",
      "\n",
      "chapter iv--centers for medicare & medicaid services, department of \n",
      "health and human services\n",
      "\n",
      "part 406--hospital insurance eligibliity and entitlement\n",
      "\n",
      "0\n",
      "1. the authority citation for part 406 is revised to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c 1302 and 1395hh.\n",
      "\n",
      "0\n",
      "2. section 406.26 is amended by adding paragraph (a)(1)(i) and adding \n",
      "and reserving paragraph (a)(1)(ii) to read as follows:\n",
      "\n",
      "\n",
      "sec.  406.26  enrollment under state buy-in.\n",
      "\n",
      "    (a) * * *\n",
      "    (1) * * *\n",
      "    (i) any state that has a buy-in agreement in effect must \n",
      "participate in\n",
      "\n",
      "[[page 7674]]\n",
      "\n",
      "daily exchanges of enrollment data with cms.\n",
      "    (ii) [reserved]\n",
      "* * * * *\n",
      "\n",
      "part 407--supplementary medical insurance (smi) enrollment and \n",
      "entitlement\n",
      "\n",
      "0\n",
      "3. the authority citation for part 407 is revised to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c 1302 and 1395hh.\n",
      "\n",
      "0\n",
      "4. section 407.40 is amended by adding paragraph (c)(4) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  407.40  enrollment under a state buy-in agreement.\n",
      "\n",
      "* * * * *\n",
      "    (c) * * *\n",
      "    (4) any state that has a buy-in agreement in effect must \n",
      "participate in daily exchanges of enrollment data with cms.\n",
      "\n",
      "part 422--medicare advantage program\n",
      "\n",
      "0\n",
      "5. the authority citation for part 422 is revised to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c 1395w26 and 1395w-27.\n",
      "\n",
      "0\n",
      "6. section 422.119 is added to read as follows:\n",
      "\n",
      "\n",
      "sec.  422.119  access to and exchange of health data and plan \n",
      "information.\n",
      "\n",
      "    (a) application programming interface to support ma enrollees. a \n",
      "medicare advantage (ma) organization must implement and maintain an \n",
      "open application programming interface (api) that permits third-party \n",
      "applications to retrieve, with the approval and at the direction of an \n",
      "individual ma enrollee, data specified in paragraph (b) of this section \n",
      "through the use of common technologies and without special effort from \n",
      "the enrollee.\n",
      "    (b) accessible content. (1) an ma organization must make the \n",
      "following information accessible to its enrollees through the api \n",
      "described in paragraph (a) of this section:\n",
      "    (i) standardized data concerning adjudicated claims, including \n",
      "claims data for payment decisions that may be appealed, were appealed, \n",
      "or are in the process of appeal, and provider remittances and enrollee \n",
      "cost-sharing pertaining to such claims, no later than one (1) business \n",
      "day after a claim is processed;\n",
      "    (ii) standardized encounter data, no later than one (1) business \n",
      "day after data concerning the encounter is received by the ma \n",
      "organization;\n",
      "    (iii) provider directory data on the ma organization's network of \n",
      "contracted providers, including names, addresses, phone numbers, and \n",
      "specialties, updated no later than 30 business days after changes are \n",
      "made to the provider directory; and\n",
      "    (iv) clinical data, including laboratory results, if the ma \n",
      "organization manages any such data, no later than one (1) business day \n",
      "after the data is received by the ma organization.\n",
      "    (2) in addition to the information specified in paragraph (b)(1) of \n",
      "this section, an ma organization that offers an ma-pd plan must make \n",
      "the following information accessible to its enrollees through the api \n",
      "described in paragraph (a) of this section:\n",
      "    (i) standardized data concerning adjudicated claims for covered \n",
      "part d drugs, including remittances and enrollee cost-sharing, no later \n",
      "than 1 business day after a claim is adjudicated;\n",
      "    (ii) pharmacy directory data, including the number, mix, and \n",
      "addresses of network pharmacies; and\n",
      "    (iii) formulary data that includes covered part d drugs, and any \n",
      "tiered formulary structure or utilization management procedure which \n",
      "pertains to those drugs.\n",
      "    (c) technical requirements. an ma organization:\n",
      "    (1) must implement, maintain, and use api technology conformant \n",
      "with 45 cfr 170.215;\n",
      "    (2) must conduct routine testing and monitoring to ensure the api \n",
      "functions properly, including assessments to verify that the api is \n",
      "fully and successfully implementing privacy and security features such \n",
      "as, but not limited to, those minimally required to comply with hipaa \n",
      "privacy and security requirements in 45 cfr part 164, 42 cfr parts 2 \n",
      "and 3, and other applicable law protecting the privacy and security of \n",
      "individually identifiable data;\n",
      "    (3) must comply with the following regulations regarding content \n",
      "and vocabulary standards for data available through the api, where \n",
      "applicable to the data type or data element, unless alternate standards \n",
      "are required by other applicable law:\n",
      "    (i) content and vocabulary standards at 45 cfr 170.213 where such \n",
      "standards are the only available standards for the data type or \n",
      "element;\n",
      "    (ii) content and vocabulary standards at 45 cfr part 162 and 42 cfr \n",
      "423.160 where required by law or where such standards are the only \n",
      "available standards for the data type or element; or\n",
      "    (iii) the content and vocabulary standards in either paragraph \n",
      "(c)(3) (i) or (ii) of this section as determined appropriate for the \n",
      "data type or element, where a specific data type or element may be \n",
      "encoded or formatted using content and vocabulary standards in either \n",
      "paragraph (c)(3)(i) or (ii) of this section.\n",
      "    (4) may use an updated version of any standard or all standards \n",
      "required under paragraph (c)(1) or (3) of this section, where:\n",
      "    (i) use of the updated version of the standard is required by other \n",
      "applicable law, or\n",
      "    (ii) use of the updated version of the standard is not prohibited \n",
      "under other applicable law, provided that:\n",
      "    (a) for content and vocabulary standards other than those at 45 cfr \n",
      "170.213, the secretary has not prohibited use of the updated version of \n",
      "a standard for purposes of this section or 45 cfr part 170;\n",
      "    (b) for standards at 45 cfr 170.213 and 45 cfr 170.215, the \n",
      "national coordinator has approved the updated version for use in the \n",
      "onc health it certification program; and\n",
      "    (c) where use of the updated version of a standard does not disrupt \n",
      "an end user's ability to access the data described in paragraph (b) of \n",
      "this section through the api described in paragraph (a) of this \n",
      "section.\n",
      "    (d) documentation requirements for apis. for each api implemented \n",
      "in accordance with paragraph (a) of this section, an ma organization \n",
      "must make publicly accessible, by posting directly on its website or \n",
      "via publicly accessible hyperlink(s), complete accompanying \n",
      "documentation that contains, at a minimum:\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return variables and their types/\n",
      "structures, exceptions and exception handling methods and their \n",
      "returns;\n",
      "    (2) the software components and configurations an application must \n",
      "use in order to successfully interact with the api and process its \n",
      "response(s); and\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with any authorization server(s) \n",
      "deployed in conjunction with the api.\n",
      "    (e) denial or discontinuation of access to the api. an ma \n",
      "organization may deny or discontinue any third party application's \n",
      "connection to the api required under paragraph (a) of this section if \n",
      "the ma organization:\n",
      "    (1) reasonably determines that allowing an application to connect \n",
      "or remain connected to the api would present an unacceptable level of \n",
      "risk to the security of protected health information on the ma \n",
      "organization's systems; and\n",
      "\n",
      "[[page 7675]]\n",
      "\n",
      "    (2) makes this determination using objective, verifiable criteria \n",
      "that are applied fairly and consistently across all applications and \n",
      "developers through which enrollees seek to access their electronic \n",
      "health information, as defined at 45 cfr 171.102, including but not \n",
      "limited to criteria that may rely on automated monitoring and risk \n",
      "mitigation tools.\n",
      "    (f) coordination among payers. (1) ma organizations must maintain a \n",
      "process for the electronic exchange of, at a minimum, the data classes \n",
      "and elements included in the regulations regarding the content standard \n",
      "adopted at 45 cfr 170.213. such information received by an ma \n",
      "organization must be incorporated into the ma organization's records \n",
      "about the enrollee. at the request of an enrollee, the ma organization \n",
      "must:\n",
      "    (i) receive such data from any other health care plan that has \n",
      "provided coverage to the enrollee within the preceding 5 years;\n",
      "    (ii) at any time an enrollee is currently enrolled in the ma plan \n",
      "and up to 5 years after disenrollment, send such data to any other \n",
      "health care plan that currently covers the enrollee; and\n",
      "    (iii) at any time the enrollee is currently enrolled in the ma plan \n",
      "and up to 5 years after disenrollment, send such data to a recipient \n",
      "designated by the enrollee.\n",
      "    (2) ma organizations must participate in a trusted exchange network \n",
      "which:\n",
      "    (i) is capable of exchanging protected health information, defined \n",
      "at 45 cfr 160.103, in compliance with all applicable state and federal \n",
      "laws across jurisdictions;\n",
      "    (ii) is capable of connecting to inpatient electronic health \n",
      "records and ambulatory electronic health records; and\n",
      "    (iii) supports secure messaging or electronic querying by and \n",
      "between providers, payers and patients.\n",
      "    (g) enrollee resources regarding privacy and security. an ma \n",
      "organization must provide on its website and through other appropriate \n",
      "mechanisms through which it ordinarily communicates with current and \n",
      "former enrollees seeking to access their health information held by the \n",
      "ma organization, educational resources in non-technical, simple and \n",
      "easy-to-understand language explaining at a minimum:\n",
      "    (1) general information on steps the individual may consider taking \n",
      "to help protect the privacy and security of their health information, \n",
      "including factors to consider in selecting an application, and \n",
      "understanding the security and privacy practices of any application to \n",
      "which they will entrust their health information; and\n",
      "    (2) an overview of which types of organizations or individuals are \n",
      "and are not likely to be hipaa covered entities, the oversight \n",
      "responsibilities of ocr and ftc, and how to submit a complaint to:\n",
      "    (i) the hhs office for civil rights; and\n",
      "    (ii) the federal trade commission (ftc).\n",
      "    (h) applicability. this section is applicable beginning on and \n",
      "after january 1, 2020.\n",
      "0\n",
      "7. section 422.504 is amended by adding paragraph (a)(18) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  422.504  contract provisions.\n",
      "\n",
      "* * * * *\n",
      "    (a) * * *\n",
      "    (18) to comply with the requirements for access to health data and \n",
      "plan information under sec.  422.119.\n",
      "* * * * *\n",
      "\n",
      "part 423--voluntary medicare prescription drug benefit\n",
      "\n",
      "0\n",
      "8. the authority citation for part 423 is revised to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c. 1302, 1306, 1395w-101 through 1395w-152, \n",
      "and 1395hh.\n",
      "\n",
      "0\n",
      "9. section 423.910 is amended--\n",
      "0\n",
      "a. in paragraph (b)(1) introductory text by removing the phrase \n",
      "``monthly reporting requirement for the monthly enrollment reporting'' \n",
      "and adding in its place the phrase ``state enrollment reporting \n",
      "requirement described in paragraph (d) of this section'';\n",
      "0\n",
      "b. in paragraph (d) by revising the paragraph heading and by \n",
      "redesignating the text of paragraph (d) introductory text as paragraph \n",
      "(d)(1).\n",
      "0\n",
      "c. in newly redesignated paragraph (d)(1), by removing the phrase \n",
      "``effective june 2005, and each subsequent month,'', and following the \n",
      "phrase ``in a manner specified by cms'' by adding the following phrase \n",
      "``and frequency specified in paragraph (d)(2) of this section,''; and\n",
      "0\n",
      "d. by adding paragraph (d)(2).\n",
      "    the addition reads as follows:\n",
      "\n",
      "\n",
      "sec.  423.910  requirements.\n",
      "\n",
      "* * * * *\n",
      "    (d) state enrollment reporting. * * *\n",
      "    (2)(i) for the period prior to april 1, 2022, states must submit \n",
      "the file at least monthly and may submit updates to that file on a more \n",
      "frequent basis.\n",
      "    (ii) for the period beginning april 1, 2022, states must submit the \n",
      "file at least monthly and must submit updates to that file on a daily \n",
      "basis.\n",
      "* * * * *\n",
      "\n",
      "part 431--state organization and general administration\n",
      "\n",
      "0\n",
      "10. the authority citation for part 431 is revised to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c. 1302.\n",
      "\n",
      "0\n",
      "11. section 431.60 is added to subpart b to read as follows:\n",
      "\n",
      "\n",
      "sec.  431.60  beneficiary access to and exchange of data.\n",
      "\n",
      "    (a) application programming interface to support medicaid \n",
      "beneficiaries. a state must implement and maintain an open application \n",
      "programming interface (api) that permits third-party applications to \n",
      "retrieve, with the approval and at the direction of a beneficiary, data \n",
      "specified in paragraph (b) of this section through the use of common \n",
      "technologies and without special effort from the beneficiary.\n",
      "    (b) accessible content. a state must make the following information \n",
      "accessible to its beneficiaries through the api described in paragraph \n",
      "(a) of this section:\n",
      "    (1) standardized data concerning adjudicated claims, including \n",
      "claims data for payment decisions that may be appealed, were appealed, \n",
      "or are in the process of appeal, and provider remittances and \n",
      "beneficiary cost-sharing pertaining to such claims, no later than one \n",
      "(1) business day after a claim is processed;\n",
      "    (2) standardized encounter data through the api within one (1) \n",
      "business day of receiving the data from providers, other than mcos, \n",
      "pihps, and pahps, compensated on the basis of capitation payments;\n",
      "    (3) provider directory information specified in section 1902(a)(83) \n",
      "of the act, no later than 30 calendar days after the state receives \n",
      "provider directory information or updates to provider directory \n",
      "information;\n",
      "    (4) clinical data, including laboratory results, if the state \n",
      "manages any such data, no later than one (1) business day after the \n",
      "data is received by the state; and\n",
      "    (5) information about covered outpatient drugs and updates to such \n",
      "information, including, where applicable, preferred drug list \n",
      "information, no later than one (1) business day after the effective \n",
      "date of any such information or updates to such information.\n",
      "    (c) technical requirements. a state:\n",
      "    (1) must implement, maintain, and use api technology conformant \n",
      "with 45 cfr 170.215;\n",
      "    (2) must conduct routine testing and monitoring to ensure the api \n",
      "functions properly, including assessments to\n",
      "\n",
      "[[page 7676]]\n",
      "\n",
      "verify that the api is fully and successfully implementing privacy and \n",
      "security features such as, but not limited to, those minimally required \n",
      "to comply with hipaa privacy and security requirements in 45 cfr part \n",
      "164, 42 cfr parts 2 and 3, and other applicable law protecting the \n",
      "privacy and security of individually identifiable data;\n",
      "    (3) must comply with the following regulations regarding content \n",
      "and vocabulary standards for data available through the api, where \n",
      "applicable to the data type or data element, unless alternate standards \n",
      "are required by other applicable law:\n",
      "    (i) content and vocabulary standards at 45 cfr 170.213 where such \n",
      "standards are the only available standards for the data type or \n",
      "element;\n",
      "    (ii) content and vocabulary standards at 45 cfr part 162 and 42 cfr \n",
      "423.160 where required by law, or where such standards are the only \n",
      "available standards for the data type or element; or\n",
      "    (iii) the content and vocabulary standards in either paragraphs \n",
      "(c)(3)(i) or (ii) of this section, as determined appropriate for the \n",
      "data type or element, where a specific data type or element may be \n",
      "encoded or formatted using content and vocabulary standards in either \n",
      "paragraph (c)(3)(i) or (ii) of this section.\n",
      "    (4) may use an updated version of any standard or all standards \n",
      "required under paragraph (c)(1) or (3) of this section, where:\n",
      "    (i) use of the updated version of the standard is required by other \n",
      "applicable law, or\n",
      "    (ii) use of the updated version of the standard is not prohibited \n",
      "under other applicable law, provided that:\n",
      "    (a) for content and vocabulary standards other than those at 45 cfr \n",
      "170.213, the secretary has not prohibited use of the updated version of \n",
      "a standard for purposes of this section or 45 cfr part 170;\n",
      "    (b) for standards at 45 cfr 170.213 and 45 cfr 170.215, the \n",
      "national coordinator has approved the updated version for use in the \n",
      "onc health it certification program; and\n",
      "    (c) where use of the updated version of a standard does not disrupt \n",
      "an end user's ability to access the data described in paragraph (b) of \n",
      "this section through the api described in paragraph (a) of this \n",
      "section.\n",
      "    (d) documentation requirements for apis. for each api implemented \n",
      "in accordance with paragraph (a) of this section, a state must make \n",
      "publicly accessible, by posting directly on its website or via publicly \n",
      "accessible hyperlink(s), complete accompanying documentation that \n",
      "contains, at a minimum:\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return variables and their types/\n",
      "structures, exceptions and exception handling methods and their \n",
      "returns;\n",
      "    (2) the software components and configurations an application must \n",
      "use in order to successfully interact with the api and process its \n",
      "response(s); and\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with any authorization server(s) \n",
      "deployed in conjunction with the api.\n",
      "    (e) denial or discontinuation of access to the api. a state may \n",
      "deny or discontinue any third-party application's connection to the api \n",
      "required under paragraph (a) of this section if the state:\n",
      "    (1) reasonably determines that allowing an application to connect \n",
      "or remain connected to the api would present an unacceptable level of \n",
      "risk to the security of protected health information on the state's \n",
      "systems; and\n",
      "    (2) makes this determination using objective, verifiable criteria \n",
      "that are applied fairly and consistently across all applications and \n",
      "developers through which beneficiaries seek to access their electronic \n",
      "health information as defined at 45 cfr 171.102, including but not \n",
      "limited to criteria that may rely on automated monitoring and risk \n",
      "mitigation tools.\n",
      "    (f) beneficiary resources regarding privacy and security. the state \n",
      "must provide on its website and through other appropriate mechanisms \n",
      "through which it ordinarily communicates with current and former \n",
      "beneficiaries seeking to access their health information held by the \n",
      "state medicaid agency, educational resources in non-technical, simple \n",
      "and easy-to-understand language explaining at a minimum:\n",
      "    (1) general information on steps the individual may consider taking \n",
      "to help protect the privacy and security of their health information, \n",
      "including factors to consider in selecting an application, and \n",
      "understanding the security and privacy practices of any application to \n",
      "which they will entrust their health information; and\n",
      "    (2) an overview of which types of organizations or individuals are \n",
      "and are not likely to be hipaa covered entities, the oversight \n",
      "responsibilities of ocr and ftc, and how to submit a complaint to:\n",
      "    (i) the hhs office for civil rights; and\n",
      "    (ii) the federal trade commission (ftc).\n",
      "    (g) applicability. this section is applicable beginning on or after \n",
      "july 1, 2020.\n",
      "\n",
      "part 438--managed care\n",
      "\n",
      "0\n",
      "12. the authority citation for part 438 is revised to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c. 1302.\n",
      "\n",
      "0\n",
      "13. section 438.62 is amended by adding paragraph (b)(1)(vi) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  438.62  continued services to enrollees.\n",
      "\n",
      "* * * * *\n",
      "    (b) * * *\n",
      "    (1) * * *\n",
      "    (vi) a process for the electronic exchange of, at a minimum, the \n",
      "data classes and elements included in the regulations regarding the \n",
      "content standard at 45 cfr 170.213. information received by the mco, \n",
      "pihp, or pahp must be incorporated into the mco's, pihp's, or pahp's \n",
      "records about the enrollee. at the request of an enrollee, the mco, \n",
      "pihp, or pahp must:\n",
      "    (a) accept such data from any other health care plan that has \n",
      "provided coverage to the enrollee within the preceding 5 years;\n",
      "    (b) at any time the enrollee is currently enrolled in the mco, \n",
      "pihp, or pahp and up to 5 years after disenrollment, send such data to \n",
      "any other health care plan that currently covers the enrollee; and\n",
      "    (c) at any time the enrollee is currently enrolled in the mco, \n",
      "pihp, or pahp and up to 5 years after disenrollment, send such data to \n",
      "any other recipient designated by the enrollee.\n",
      "* * * * *\n",
      "0\n",
      "14. section 438.242 is amended by adding paragraphs (b)(5) and (6) to \n",
      "read as follows:\n",
      "\n",
      "\n",
      "sec.  438.242  health information systems.\n",
      "\n",
      "* * * * *\n",
      "    (b) * * *\n",
      "    (5) participate in a trusted exchange network which:\n",
      "    (i) is capable of exchanging protected health information as \n",
      "defined in 45 cfr 160.103, in compliance with all applicable state and \n",
      "federal laws from all relevant jurisdictions;\n",
      "    (ii) is capable of connecting to inpatient electronic health \n",
      "records and ambulatory electronic health records, and;\n",
      "    (iii) supports secure messaging or electronic querying by and \n",
      "between providers, payers and patients.\n",
      "    (6) implement an application programming interface (api) as \n",
      "specified in sec.  431.60 of this chapter as if such requirements \n",
      "applied directly to the mco, pihp, or pahp and\n",
      "\n",
      "[[page 7677]]\n",
      "\n",
      "    (i) include all standardized encounter data, including encounter \n",
      "data from any network providers the mco, pihp, or pahp is compensating \n",
      "on the basis of capitation payments and adjudicated claims and \n",
      "encounter data from any subcontractors; and\n",
      "    (ii) provider directory information required in sec.  431.60(b)(3) \n",
      "of this chapter, which must include all information required in sec.  \n",
      "438.10(h)(1).\n",
      "* * * * *\n",
      "\n",
      "part 457--allotments and grants to states\n",
      "\n",
      "0\n",
      "15. the authority citation for part 457 is revised to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c. 1302.\n",
      "\n",
      "0\n",
      "16. section 457.700 is amended by--\n",
      "0\n",
      "a. redesignating paragraphs (a)(1) and (2) as paragraphs (a)(2) and \n",
      "(3), respectively;\n",
      "0\n",
      "b. adding paragraph (a)(1);\n",
      "0\n",
      "c. revising paragraph (c).\n",
      "    the addition and revision reads as follows:\n",
      "\n",
      "\n",
      "sec.  457.700  basis, scope, and applicability.\n",
      "\n",
      "    (a) * * *\n",
      "    (1) section 2101(a) of the act, which sets forth that the purpose \n",
      "of title xxi is to provide funds to states to provide child health \n",
      "assistance to uninsured, low-income children in an effective and \n",
      "efficient manner that is coordinated with other sources of health \n",
      "benefits coverage;\n",
      "* * * * *\n",
      "    (c) applicability. the requirements of this subpart apply to \n",
      "separate child health programs and medicaid expansion programs, except \n",
      "that sec.  457.730 does not apply to medicaid expansion programs. \n",
      "separate child health programs that provide benefits exclusively \n",
      "through managed care organizations may meet the requirements of sec.  \n",
      "457.730 by requiring the managed care organizations to meet the \n",
      "requirements of sec.  457.1233(d)(2).\n",
      "0\n",
      "17. section 457.730 is added to read as follows:\n",
      "\n",
      "\n",
      "sec.  457.730  beneficiary access to and exchange of data.\n",
      "\n",
      "    (a) application programming interface to support chip \n",
      "beneficiaries. a state must implement and maintain an open application \n",
      "programming interface (api) that permits third-party applications to \n",
      "retrieve, with the approval and at the direction of the individual \n",
      "beneficiary, data specified in paragraph (b) of this section through \n",
      "the use of common technologies and without special effort from the \n",
      "beneficiary.\n",
      "    (b) accessible content. a state must make the following information \n",
      "accessible to its beneficiaries through the api described in paragraph \n",
      "(a) of this section:\n",
      "    (1) standardized data concerning adjudicated claims, including \n",
      "claims data for payment decisions that may be appealed, were appealed, \n",
      "or are in the process of appeal, and provider remittances and \n",
      "beneficiary cost-sharing pertaining to such claims, no later than one \n",
      "(1) business day after a claim is processed;\n",
      "    (2) standardized encounter data through the api within one (1) \n",
      "business day of receiving the data from providers, other than mcos, \n",
      "pihps, or pahps, compensated on the basis of capitation payments;\n",
      "    (3) provider directory information, including updated provider \n",
      "information no later than 30 calendar days after the state receives \n",
      "updated provider information;\n",
      "    (4) clinical data, including laboratory results, if a state manages \n",
      "any such data, no later than one (1) business day after the data is \n",
      "received by the state; and\n",
      "    (5) information, about covered outpatient drugs and updates to such \n",
      "information, including, where applicable, preferred drug list \n",
      "information, no later than one (1) business day after the effective \n",
      "date of the information or updates to such information.\n",
      "    (c) technical requirements. a state:\n",
      "    (1) must implement, maintain, and use api technology conformant \n",
      "with 45 cfr 170.215;\n",
      "    (2) must conduct routine testing and monitoring to ensure the api \n",
      "functions properly, including assessments to verify that the api \n",
      "technology is fully and successfully implementing privacy and security \n",
      "features such as, but not limited to, those minimally required to \n",
      "comply with hipaa privacy and security requirements in 45 cfr part 164, \n",
      "42 cfr parts 2 and 3, and other applicable law protecting the privacy \n",
      "and security of individually identifiable data;\n",
      "    (3) must comply with the following regulations regarding content \n",
      "and vocabulary standards for data available through the api, where \n",
      "applicable to the data type or data element, unless alternate standards \n",
      "are required by other applicable law:\n",
      "    (i) content and vocabulary standards at 45 cfr 170.213 where such \n",
      "standards are the only available standards for the data type or \n",
      "element;\n",
      "    (ii) content and vocabulary standards at 45 cfr part 162 and 42 cfr \n",
      "423.160 where required by law, or where such standards are the only \n",
      "available standards for the data type or element; or\n",
      "    (iii) the content and vocabulary standards in either paragraphs \n",
      "(c)(3)(i) or (ii) of this section, as determined appropriate for the \n",
      "data type or element, where a specific data type or element may be \n",
      "encoded or formatted using content and vocabulary standards in either \n",
      "paragraphs (c)(3)(i) or (ii) of this section.\n",
      "    (4) may use an updated version of any standard or all standards \n",
      "required under paragraphs (c)(1) or (3) of this section, where:\n",
      "    (i) use of the updated version of the standard is required by other \n",
      "applicable law, or\n",
      "    (ii) use of the updated version of the standard is not prohibited \n",
      "under other applicable law, provided that:\n",
      "    (a) for content and vocabulary standards other than those at 45 cfr \n",
      "170.213, the secretary has not prohibited use of the updated version of \n",
      "a standard for purposes of this section or 45 cfr part 170;\n",
      "    (b) for standards at 45 cfr 170.213 and 45 cfr 170.215, the \n",
      "national coordinator has approved the updated version for use in the \n",
      "onc health it certification program; and\n",
      "    (c) where use of the updated version of a standard does not disrupt \n",
      "an end user's ability to access the data described in paragraph (b) of \n",
      "this section through the api described in paragraph (a) of this \n",
      "section.\n",
      "    (d) documentation requirements for apis. for each api implemented \n",
      "in accordance with paragraph (a) of this section, a state must make \n",
      "publicly accessible, by posting directly on its website or via publicly \n",
      "accessible hyperlink(s), complete accompanying documentation that \n",
      "contains, at a minimum:\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return variables and their types/\n",
      "structures, exceptions and exception handling methods and their \n",
      "returns;\n",
      "    (2) the software components and configurations that an application \n",
      "must use in order to successfully interact with the api and process its \n",
      "response(s); and\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with any authorization server(s) \n",
      "deployed in conjunction with the api.\n",
      "    (e) denial or discontinuation of access to the api. a state may \n",
      "deny or discontinue any third-party application's connection to the api \n",
      "required under paragraph (a) of this section if the state:\n",
      "\n",
      "[[page 7678]]\n",
      "\n",
      "    (1) reasonably determines that allowing an application to connect \n",
      "or remain connected to the api would present an unacceptable level of \n",
      "risk to the security of protected health information on the state's \n",
      "systems; and\n",
      "    (2) makes this determination using objective, verifiable criteria \n",
      "that are applied fairly and consistently across all applications and \n",
      "developers through which beneficiaries seek to access their electronic \n",
      "health information as defined at 45 cfr 171.102, including but not \n",
      "limited to criteria that may rely on automated monitoring and risk \n",
      "mitigation tools.\n",
      "    (f) beneficiary resources regarding privacy and security. a state \n",
      "must provide on its website and through other appropriate mechanisms \n",
      "through which it ordinarily communicates with current and former \n",
      "beneficiaries seeking to access their health information held by the \n",
      "state chip agency, educational resources in non-technical, simple and \n",
      "easy-to-understand language explaining at a minimum:\n",
      "    (1) general information on steps the individual may consider taking \n",
      "to help protect the privacy and security of their health information, \n",
      "including factors to consider in selecting an application, and \n",
      "understanding the security and privacy practices of any application to \n",
      "which they will entrust their health information; and\n",
      "    (2) an overview of which types of organizations or individuals are \n",
      "and are not likely to be hipaa covered entities, the oversight \n",
      "responsibilities of ocr and ftc, and how to submit a complaint to:\n",
      "    (i) the hhs office for civil rights; and\n",
      "    (ii) the federal trade commission (ftc).\n",
      "    (g) applicability. this section is applicable beginning on or after \n",
      "july 1, 2020.\n",
      "0\n",
      "18. section 457.1233 is amended by revising paragraph (d) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  457.1233  structure and operations standards.\n",
      "\n",
      "* * * * *\n",
      "    (d) health information systems. (1) the state must ensure, through \n",
      "its contracts, that each mco, pihp, and pahp complies with the health \n",
      "information systems requirements as provided in sec.  438.242(a), \n",
      "(b)(1) through (5), (c), (d), and (e) of this chapter.\n",
      "    (2) each mco, pihp, and pahp must implement an application \n",
      "programming interface (api) as specified in sec.  457.730 as if such \n",
      "requirements applied directly to the mco, pihp, or pahp, and\n",
      "    (i) include all standardized encounter data, including encounter \n",
      "data from any network providers the mco, pihp, or pahp is compensating \n",
      "on the basis of capitation payments and adjudicated claims and \n",
      "encounter data from any subcontractors; and\n",
      "    (ii) provider directory information required in sec.  \n",
      "457.730(b)(3), which must include all information required in sec.  \n",
      "438.10(h)(1) of this chapter.\n",
      "* * * * *\n",
      "\n",
      "part 482--conditions of participation: hospitals\n",
      "\n",
      "0\n",
      "19. the authority citation for part 482 is revised to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c. 1302, 1395hh, and 1395rr, unless otherwise \n",
      "noted.\n",
      "\n",
      "0\n",
      "20. sections 482.24 is amended by adding paragraph (d) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  482.24  conditions of participation: medical record services.\n",
      "\n",
      "* * * * *\n",
      "    (d) standard: electronic notifications. if the hospital utilizes an \n",
      "electronic medical records system with the capacity to generate \n",
      "information for patient event notifications in accordance with \n",
      "paragraph (d)(2) of this section, then the hospital must demonstrate \n",
      "that--\n",
      "    (1) the system's notification capacity is fully operational and \n",
      "that it operates in accordance with all state and federal statutes and \n",
      "regulations regarding the exchange of patient health information;\n",
      "    (2) the system complies with the regulations regarding the content \n",
      "exchange standard at 45 cfr 170.205(a)(4)(i);\n",
      "    (3) the system sends notifications that must include the minimum \n",
      "patient health information (which must be patient name, treating \n",
      "practitioner name, sending institution name, and, if not prohibited by \n",
      "other applicable law, patient diagnosis);\n",
      "    (4) at the time of the patient's admission to the hospital, the \n",
      "system sends notifications directly or through an intermediary that \n",
      "facilitates exchange of health information, to licensed and qualified \n",
      "practitioners, other patient care team members, and post-acute care \n",
      "services providers and suppliers:\n",
      "    (i) that receive the notification for treatment, care coordination, \n",
      "or quality improvement purposes;\n",
      "    (ii) that have an established care relationship with the patient \n",
      "relevant to his or her care; and\n",
      "    (iii) for whom the hospital has a reasonable certainty of receipt \n",
      "of notifications; and\n",
      "    (4) either immediately prior to or at the time of the patient's \n",
      "discharge or transfer from the hospital, the system sends notifications \n",
      "directly or through an intermediary that facilitates exchange of health \n",
      "information, to licensed and qualified practitioners, other patient \n",
      "care team members, and post-acute care services providers and \n",
      "suppliers:\n",
      "    (i) that receive the notification for treatment, care coordination, \n",
      "or quality improvement purposes;\n",
      "    (ii) that have an established care relationship with the patient \n",
      "relevant to his or her care; and\n",
      "    (iii) for whom the hospital has a reasonable certainty of receipt \n",
      "of notifications.\n",
      "0\n",
      "21. section 482.61 is amended by adding paragraph (f) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  482.61  condition of participation: special medical record \n",
      "requirements for psychiatric hospitals.\n",
      "\n",
      "* * * * *\n",
      "    (f) standard: electronic notifications. if the hospital utilizes an \n",
      "electronic medical records system with the capacity to generate \n",
      "information for patient event notifications in accordance with \n",
      "paragraph (f)(2) of this section, then the hospital must demonstrate \n",
      "that--\n",
      "    (1) the system's notification capacity is fully operational and \n",
      "that it operates in accordance with all state and federal statutes and \n",
      "regulations regarding the exchange of patient health information;\n",
      "    (2) the system complies with the regulations regarding the content \n",
      "exchange standard at 45 cfr 170.205(a)(4)(i);\n",
      "    (3) the system sends notifications that must include the minimum \n",
      "patient health information (which must be patient name, treating \n",
      "practitioner name, sending institution name, and, if not prohibited by \n",
      "other applicable law, patient diagnosis);\n",
      "    (4) at the time of the patient's admission to the hospital, the \n",
      "system sends notifications directly, or through an intermediary that \n",
      "facilitates exchange of health information, to licensed and qualified \n",
      "practitioners, other patient care team members, and post-acute care \n",
      "services providers and suppliers:\n",
      "    (i) that receive the notification for treatment, care coordination, \n",
      "or quality improvement purposes;\n",
      "    (ii) that have an established care relationship with the patient \n",
      "relevant to his or her care; and\n",
      "    (iii) for whom the hospital has a reasonable certainty of receipt \n",
      "of notifications; and\n",
      "    (5) either immediately prior to or at the time of the patient's \n",
      "discharge or transfer from the hospital, the system sends notifications \n",
      "directly or through an intermediary that facilitates exchange\n",
      "\n",
      "[[page 7679]]\n",
      "\n",
      "of health information, to licensed and qualified practitioners, other \n",
      "patient care team members, and post-acute care services providers and \n",
      "suppliers:\n",
      "    (i) that receive the notification for treatment, care coordination, \n",
      "or quality improvement purposes;\n",
      "    (ii) that have an established care relationship with the patient \n",
      "relevant to his or her care; and\n",
      "    (iii) for whom the hospital has a reasonable certainty of receipt \n",
      "of notifications.\n",
      "\n",
      "part 485--conditions of participation: specialized providers\n",
      "\n",
      "0\n",
      "22. the authority citation for part 485 is revised to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c. 1302 and 1395hh.\n",
      "\n",
      "0\n",
      "23. section 485.638 is amended by adding paragraph (d) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  485.638  conditions of participation: clinical records.\n",
      "\n",
      "* * * * *\n",
      "    (d) standard: electronic notifications. if the cah utilizes an \n",
      "electronic medical records system with the capacity to generate \n",
      "information for patient event notifications in accordance with \n",
      "paragraph (d)(2) of this section, then the cah must demonstrate that--\n",
      "    (1) the system's notification capacity is fully operational and \n",
      "that it operates in accordance with all state and federal statutes and \n",
      "regulations regarding the exchange of patient health information;\n",
      "    (2) the system complies with the regulations regarding the content \n",
      "exchange standard at 45 cfr 170.205(a)(4)(i);\n",
      "    (3) the system sends notifications that must include the minimum \n",
      "patient health information (which must be patient name, treating \n",
      "practitioner name, sending institution name, and, if not prohibited by \n",
      "other applicable law, patient diagnosis);\n",
      "    (4) at the time of the patient's admission to the cah, the system \n",
      "sends notifications directly or through an intermediary that \n",
      "facilitates exchange of health information, to licensed and qualified \n",
      "practitioners, other patient care team members, and post-acute care \n",
      "services providers and suppliers:\n",
      "    (i) that receive the notification for treatment, care coordination, \n",
      "or quality improvement purposes;\n",
      "    (ii) that have an established care relationship with the patient \n",
      "relevant to his or her care; and\n",
      "    (iii) for whom the cah has a reasonable certainty of receipt of \n",
      "notifications; and\n",
      "    (5) either immediately prior to or at the time of the patient's \n",
      "discharge or transfer from the cah, the system sends notifications \n",
      "directly or through an intermediary that facilitates exchange of health \n",
      "information, to licensed and qualified practitioners, other patient \n",
      "care team members, and post-acute care services providers and \n",
      "suppliers:\n",
      "    (i) that receive the notification for treatment, care coordination, \n",
      "or quality improvement purposes;\n",
      "    (ii) that have an established care relationship with the patient \n",
      "relevant to his or her care; and\n",
      "    (iii) for whom the cah has a reasonable certainty of receipt of \n",
      "notifications.\n",
      "\n",
      "title 45--public welfare\n",
      "\n",
      "subtitle a--department of health and human services\n",
      "\n",
      "part 156--health insurance issuer standards under the affordable \n",
      "care act, including standards related to exchanges\n",
      "\n",
      "0\n",
      "24. the authority citation for part 156 is revised to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c. 18021-18024, 18031-18032, 18041-18042, \n",
      "18044, 18054, 18061, 18063, 18071, 18082, 26 u.s.c. 36b, and 31 \n",
      "u.s.c. 9701.\n",
      "\n",
      "0\n",
      "25. section 156.221 is added to read as follows:\n",
      "\n",
      "\n",
      "sec.  156.221  access to and exchange of health data and plan \n",
      "information.\n",
      "\n",
      "    (a) application programming interface to support enrollees. subject \n",
      "to paragraph (h) of this section, qhp issuers in a federally-\n",
      "facilitated exchange, not including stand-alone dental plans (sadp) \n",
      "issuers, must implement and maintain an open application programming \n",
      "interface (api) that permits third-party applications to retrieve, with \n",
      "the approval and at the direction of an individual enrollee, data \n",
      "specified in paragraph (b) of this section through the use of common \n",
      "technologies and without special effort from the enrollee.\n",
      "    (b) accessible content. (1) a qhp issuer in a federally-facilitated \n",
      "exchange must make the following information accessible to its \n",
      "enrollees through the api described in paragraph (a) of this section:\n",
      "    (i) standardized data concerning adjudicated claims, including \n",
      "claims data for payment decisions that may be appealed, were appealed, \n",
      "or are in the process of appeal, and provider remittances and enrollee \n",
      "cost-sharing pertaining to such claims, no later than one (1) business \n",
      "day after a claim is processed;\n",
      "    (ii) standardized encounter data, no later than one (1) business \n",
      "day after data concerning the encounter is received by the qhp issuer; \n",
      "and\n",
      "    (iii) clinical data, including laboratory results, if the qhp \n",
      "issuer maintains such data, no later than one (1) business day after \n",
      "data is received by the issuer.\n",
      "    (c) technical requirements. a qhp issuer in a federally-facilitated \n",
      "exchange:\n",
      "    (1) must implement, maintain, and use api technology conformant 45 \n",
      "cfr 170.215;\n",
      "    (2) must conduct routine testing and monitoring to ensure the api \n",
      "functions properly, including assessments to verify the api is fully \n",
      "and successfully implementing privacy and security features such as, \n",
      "but not limited to, those minimally required to comply with hipaa \n",
      "privacy and security requirements in 45 cfr part 164, 42 cfr parts 2 \n",
      "and 3, and other applicable law protecting privacy and security of \n",
      "individually identifiable data;\n",
      "    (3) must comply with the following regulations regarding the \n",
      "content and vocabulary standards for data available through the api \n",
      "where applicable to the data type or data element, unless alternate \n",
      "standards are required by other applicable law:\n",
      "    (i) content and vocabulary standards at 45 cfr 170.213 where such \n",
      "are the only available standards for the data type or element;\n",
      "    (ii) content and vocabulary standards at 45 cfr part 162 and 42 cfr \n",
      "423.160 where required by law, or where such standards are the only \n",
      "available standards for the data type or element; or\n",
      "    (iii) the content and vocabulary standards in either paragraph \n",
      "(c)(3)(i) or (ii) of this section as determined appropriate for the \n",
      "data type or element, where a specific data type or element may be \n",
      "encoded or formatted using content and vocabulary standards in either \n",
      "paragraph (c)(3)(i) or (ii) of this section.\n",
      "    (4) may use an updated version of any standard or all standards \n",
      "required under paragraphs (c)(1) or (3) of this section, where:\n",
      "    (i) use of the updated version of the standard is required by other \n",
      "applicable law, or\n",
      "    (ii) use of the updated version of the standard is not prohibited \n",
      "under other applicable law, provided that:\n",
      "    (a) for content and vocabulary standards other than those at 45 cfr \n",
      "170.213, the secretary has not prohibited use of the updated version of \n",
      "a standard for purposes of this section or 45 cfr part 170;\n",
      "    (b) for standards at 45 cfr 170.213 and 45 cfr 170.215, the \n",
      "national\n",
      "\n",
      "[[page 7680]]\n",
      "\n",
      "coordinator has approved the updated version for use in the onc health \n",
      "it certification program; and\n",
      "    (iii) where use of the updated version of a standard does not \n",
      "disrupt an end user's ability to access the data described in paragraph \n",
      "(b) of this section through the api described in paragraph (a) of this \n",
      "section.\n",
      "    (d) documentation requirements for apis. for each api implemented \n",
      "in accordance with paragraph (a) of this section, a qhp issuer must \n",
      "make publicly accessible, by posting directly on its website and/or via \n",
      "publicly accessible hyperlink(s), complete accompanying documentation \n",
      "that contains, at a minimum:\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return variables and their types/\n",
      "structures, exceptions and exception handling methods and their \n",
      "returns;\n",
      "    (2) the software components and configurations an application must \n",
      "use in order to successfully interact with the api and process its \n",
      "response(s); and\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with any authorization server(s) \n",
      "deployed in conjunction with the api.\n",
      "    (e) denial or discontinuation of access to the api. a qhp issuer in \n",
      "a federally-facilitated exchange may deny or discontinue any third \n",
      "party application's connection to the api required under paragraph (a) \n",
      "of this section if the issuer:\n",
      "    (1) reasonably determines that allowing an application to connect \n",
      "or remain connected to the api would present an unacceptable level of \n",
      "risk to the security of personally identifiable information, including \n",
      "protected health information, on the qhp issuer's systems; and\n",
      "    (2) makes this determination using objective, verifiable criteria \n",
      "that are applied fairly and consistently across all applications and \n",
      "developers through which enrollees seek to access their electronic \n",
      "health information as defined at 45 cfr 171.102, including but not \n",
      "limited to criteria that may rely on automated monitoring and risk \n",
      "mitigation tools.\n",
      "    (f) exchange of data between plans. (1) subject to paragraph (d) of \n",
      "this section, qhp issuers in a federally-facilitated exchange, not \n",
      "including sadp issuers, must maintain a process for the electronic \n",
      "exchange of, at a minimum, the data classes and elements included in \n",
      "the regulations regarding the content standard at 45 cfr 170.213 of \n",
      "this subchapter. information received by a qhp issuer must be \n",
      "incorporated into the qhp issuer's records about the enrollee. at the \n",
      "request. a qhp issuer must:\n",
      "    (i) accept such data from any other health care plan that has \n",
      "provided coverage to the enrollee within the preceding 5 years;\n",
      "    (ii) at any time the enrollee is currently enrolled in the plan and \n",
      "up to 5 years after disenrollment, send such data to any other health \n",
      "care plan that currently covers the enrollee; and\n",
      "    (iii) at any time the enrollee is currently enrolled in the plan \n",
      "and up to 5 years after disenrollment, send such data to a recipient \n",
      "designated by the enrollee.\n",
      "    (2) qhp issuers must participate in a trusted exchange network \n",
      "which:\n",
      "    (i) is capable of exchanging protected health information, defined \n",
      "at 45 cfr 160.103 of this subchapter, in compliance with all applicable \n",
      "state and federal laws of relevant jurisdictions;\n",
      "    (ii) is capable of connecting to inpatient electronic health \n",
      "records and ambulatory electronic health records; and\n",
      "    (iii) supports secure messaging or electronic querying by and \n",
      "between providers, payers and patients.\n",
      "    (g) enrollee resources regarding privacy and security. a qhp issuer \n",
      "in a federally-facilitated exchange must provide on its website and \n",
      "through other appropriate mechanisms through which it ordinarily \n",
      "communicates with current and former enrollees seeking to access their \n",
      "health information held by the qhp issuer, educational resources in \n",
      "non-technical, simple and easy-to-understand language explaining at a \n",
      "minimum:\n",
      "    (1) general information on steps the individual may consider taking \n",
      "to help protect the privacy and security of their health information, \n",
      "including factors to consider in selecting an application, and \n",
      "understanding the security and privacy practices of any application to \n",
      "which they will entrust their health information; and\n",
      "    (2) an overview of which types of organizations or individuals are \n",
      "and are not likely to be hipaa covered entities, the oversight \n",
      "responsibilities of ocr and ftc, and how to submit a complaint to:\n",
      "    (i) the hhs office for civil rights; and\n",
      "    (ii) the federal trade commission (ftc).\n",
      "    (h) exception. (1) if a plan applying for qhp certification to be \n",
      "offered through a federally-facilitated exchange believes it cannot \n",
      "satisfy the requirements in paragraphs (a), (b), or (c) of this \n",
      "section, the issuer must include as part of its qhp application a \n",
      "narrative justification describing the reasons why the plan cannot \n",
      "reasonably satisfy the requirements for the applicable plan year, the \n",
      "impact of non-compliance upon enrollees, the current or proposed means \n",
      "of providing health information to enrollees, and solutions and a \n",
      "timeline to achieve compliance with the requirements of this section.\n",
      "    (2) the federally-facilitated exchange may grant an exception to \n",
      "the requirements in paragraphs (a), (b), or (c) if the exchange \n",
      "determines that making such health plan available through such exchange \n",
      "is in the interests of qualified individuals and qualified employers in \n",
      "the state or states in which such exchange operates.\n",
      "    (i) applicability. this section is applicable for plan years \n",
      "beginning on or after january 1, 2020.\n",
      "    (ii) [reserved]\n",
      "\n",
      "    dated: december 14, 2018.\n",
      "seema verma,\n",
      "administrator, centers for medicare & medicaid services.\n",
      "    dated: january 10, 2019.\n",
      "alex m. azar ii,\n",
      "secretary, department of health and human services.\n",
      "[fr doc. 2019-02200 filed 2-22-19; 4:15 pm]\n",
      " billing code 4120-01-p\n",
      "\n",
      "\n",
      "</pre></body>\n",
      "</html>\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in CMS-2019-0039:  25%|██▌       | 1/4 [00:00<00:00,  3.57it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Added /Users/ha/Downloads/mirrulations/specific/CMS-2019-0039/raw-data/documents/CMS-2019-0039-0001_content.htm to vector store.\n",
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 85 issue 85 (friday, may 1, 2020)</title>\n",
      "</head>\n",
      "<body><pre>[federal register volume 85, number 85 (friday, may 1, 2020)]\n",
      "[rules and regulations]\n",
      "[pages 25510-25640]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2020-05050]\n",
      "\n",
      "\n",
      "\n",
      "[[page 25509]]\n",
      "\n",
      "vol. 85\n",
      "\n",
      "friday,\n",
      "\n",
      "no. 85\n",
      "\n",
      "may 1, 2020\n",
      "\n",
      "part ii\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "department of health and human services\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "centers for medicare & medicaid services\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "42 cfr parts 406, 407, 422, et al.\n",
      "\n",
      "45 cfr part 156\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "medicare and medicaid programs; patient protection and affordable care \n",
      "act; interoperability and patient access for medicare advantage \n",
      "organization and medicaid managed care plans, state medicaid agencies, \n",
      "chip agencies and chip managed care entities, issuers of qualified \n",
      "health plans on the federally-facilitated exchanges, and health care \n",
      "providers; final rule\n",
      "\n",
      "\u0000\u0000federal register / vol. 85, no. 85 / friday, may 1, 2020 / rules and \n",
      "regulations\u0000\u0000\n",
      "\n",
      "[[page 25510]]\n",
      "\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of health and human services\n",
      "\n",
      "centers for medicare & medicaid services\n",
      "\n",
      "42 cfr parts 406, 407, 422, 423, 431, 438, 457, 482, and 485\n",
      "\n",
      "office of the secretary\n",
      "\n",
      "45 cfr part 156\n",
      "\n",
      "[cms-9115-f]\n",
      "rin 0938-at79\n",
      "\n",
      "\n",
      "medicare and medicaid programs; patient protection and affordable \n",
      "care act; interoperability and patient access for medicare advantage \n",
      "organization and medicaid managed care plans, state medicaid agencies, \n",
      "chip agencies and chip managed care entities, issuers of qualified \n",
      "health plans on the federally-facilitated exchanges, and health care \n",
      "providers\n",
      "\n",
      "agency: centers for medicare & medicaid services (cms), hhs.\n",
      "\n",
      "action: final rule.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: this final rule is intended to move the health care ecosystem \n",
      "in the direction of interoperability, and to signal our commitment to \n",
      "the vision set out in the 21st century cures act and executive order \n",
      "13813 to improve the quality and accessibility of information that \n",
      "americans need to make informed health care decisions, including data \n",
      "about health care prices and outcomes, while minimizing reporting \n",
      "burdens on affected health care providers and payers.\n",
      "\n",
      "dates: these regulations are effective on june 30, 2020.\n",
      "\n",
      "for further information contact: \n",
      "    alexandra mugge, (410) 786-4457, for issues related to \n",
      "interoperability, cms health it strategy, and technical standards.\n",
      "    denise st. clair, (410) 786-4599, for issues related api policies \n",
      "and related standards.\n",
      "    natalie albright, (410) 786-1671, for issues related to medicare \n",
      "advantage.\n",
      "    laura snyder, (410) 786-3198, for issues related to medicaid.\n",
      "    rebecca zimmermann, (301) 492-4396, for issues related to qualified \n",
      "health plans.\n",
      "    meg barry, (410) 786-1536, for issues related to chip.\n",
      "    thomas novak, (202) 322-7235, for issues related to trust exchange \n",
      "networks and payer to payer coordination.\n",
      "    sharon donovan, (410) 786-9187, for issues related to federal-state \n",
      "data exchange.\n",
      "    daniel riner, (410) 786-0237, for issues related to physician \n",
      "compare.\n",
      "    ashley hain, (410) 786-7603, for issues related to hospital public \n",
      "reporting.\n",
      "    melissa singer, (410) 786-0365, for issues related to provider \n",
      "directories.\n",
      "    capt scott cooper, usphs, (410) 786-9465, for issues related to \n",
      "hospital and critical access hospital conditions of participation.\n",
      "    russell hendel, (410) 786-0329, for issues related to the \n",
      "collection of information or the regulation impact analysis sections.\n",
      "\n",
      "supplementary information: \n",
      "\n",
      "table of contents\n",
      "\n",
      "i. background and summary of provisions\n",
      "    a. purpose\n",
      "    b. overview\n",
      "    c. executive order and myhealthedata\n",
      "    d. past efforts\n",
      "    e. challenges and barriers to interoperability\n",
      "    f. summary of major provisions\n",
      "ii. technical standards related to interoperability provisions, and \n",
      "analysis of and responses to public comments\n",
      "    a. technical approach and standards\n",
      "    b. content and vocabulary standards\n",
      "    c. application programming interface (api) standard\n",
      "    d. updates to standards\n",
      "iii. provisions of patient access through apis, and analysis of and \n",
      "responses to public comments\n",
      "    a. background on medicare blue button\n",
      "    b. expanding the availability of health information\n",
      "    c. standards-based api proposal for ma, medicaid, chip, and qhp \n",
      "issuers on the ffes\n",
      "iv. api access to published provider directory data provisions, and \n",
      "analysis of and responses to public comments\n",
      "    a. interoperability background and use cases\n",
      "    b. broad api access to provider directory data\n",
      "v. the health information exchange and care coordination across \n",
      "payers: establishing a coordination of care transaction to \n",
      "communicate between plans provisions, and analysis of and responses \n",
      "to public comments\n",
      "vi. care coordination through trusted exchange networks: trust \n",
      "exchange network requirements for ma plans, medicaid managed care \n",
      "plans, chip managed care entities, and qhps on the ffes provisions, \n",
      "and analysis of and responses to public comments\n",
      "vii. improving the medicare-medicaid dually eligible experience by \n",
      "increasing the frequency of federal-state data exchanges provisions, \n",
      "and analysis of and responses to public comments\n",
      "    a. increasing the frequency of federal-state data exchanges for \n",
      "dually eligible individuals\n",
      "    b. request for stakeholder input\n",
      "viii. information blocking background and public reporting \n",
      "provisions, and analysis of and responses to public comments\n",
      "    a. information blocking background\n",
      "    b. public reporting and prevention of information blocking on \n",
      "physician compare\n",
      "    c. public reporting and prevention of information blocking for \n",
      "eligible hospitals and critical access hospitals (cahs)\n",
      "ix. provider digital contact information provisions, and analysis of \n",
      "and responses to public comments\n",
      "    a. background\n",
      "    b. public reporting of missing digital contact information\n",
      "x. conditions of participation for hospitals and critical access \n",
      "hospitals (cahs) provisions, and analysis of and responses to public \n",
      "comments\n",
      "    a. background\n",
      "    b. provisions for hospitals (42 cfr 482.24(d))\n",
      "    c. provisions for psychiatric hospitals (42 cfr 482.61(f))\n",
      "    d. provisions for cahs (42 cfr 485.638(d))\n",
      "xi. provisions of the final regulations\n",
      "xii. collection of information requirements\n",
      "    a. background\n",
      "    b. wage estimates\n",
      "    c. information collection requirements (icrs)\n",
      "xiii. regulatory impact analysis\n",
      "    a. statement of need\n",
      "    b. overall impact\n",
      "    c. anticipated effects\n",
      "    d. alternatives considered\n",
      "    e. accounting statement and table\n",
      "    f. regulatory reform analysis under e.o. 13771\n",
      "    g. conclusion\n",
      "regulation text\n",
      "\n",
      "i. background and summary of provisions\n",
      "\n",
      "    in the march 4, 2019 federal register, we published the ``medicare \n",
      "and medicaid programs; patient protection and affordable care act; \n",
      "interoperability and patient access for medicare advantage organization \n",
      "and medicaid managed care plans, state medicaid agencies, chip agencies \n",
      "and chip managed care entities, issuers of qualified health plans on \n",
      "the federally-facilitated exchanges and health care providers'' \n",
      "proposed rule (84 fr 7610) (hereinafter referred to as the ``cms \n",
      "interoperability and patient access proposed rule''). the proposed rule \n",
      "outlined our proposed policies that were intended to move the health \n",
      "care ecosystem in the direction of interoperability, and to signal our \n",
      "commitment to the vision set out in the 21st century cures act and \n",
      "executive order 13813 to improve quality and accessibility of \n",
      "information that americans need to make informed\n",
      "\n",
      "[[page 25511]]\n",
      "\n",
      "health care decisions, including data about health care prices and \n",
      "outcomes, while minimizing reporting burdens on affected health care \n",
      "providers and payers. we solicited public comments on the cms \n",
      "interoperability and patient access proposed rule. in this final rule, \n",
      "we address those public comments and outline our final policies in the \n",
      "respective sections of this rule.\n",
      "\n",
      "a. purpose\n",
      "\n",
      "    this final rule is the first phase of policies centrally focused on \n",
      "advancing interoperability and patient access to health information \n",
      "using the authority available to the centers for medicare & medicaid \n",
      "services (cms). we believe this is an important step in advancing \n",
      "interoperability, putting patients at the center of their health care, \n",
      "and ensuring they have access to their health information. we are \n",
      "committed to working with stakeholders to solve the issue of \n",
      "interoperability and getting patients access to information about their \n",
      "health care, and we are taking an active approach to move participants \n",
      "in the health care market toward interoperability and the secure and \n",
      "timely exchange of health information by adopting policies for the \n",
      "medicare and medicaid programs, the children's health insurance program \n",
      "(chip), and qualified health plan (qhp) issuers on the individual \n",
      "market federally-facilitated exchanges (ffes). for purposes of this \n",
      "rule, references to qhp issuers on the ffes excludes issuers offering \n",
      "only stand-alone dental plans (sadps), unless otherwise noted for a \n",
      "specific proposed or finalized policy. likewise, we are also excluding \n",
      "qhp issuers only offering qhps in the federally-facilitated small \n",
      "business health options program exchanges (ff-shops) from the \n",
      "provisions of this rule and so, for purposes of this rule references to \n",
      "qhp issuers on the ffes excludes issuers offering qhps only on the ff-\n",
      "shops. we note that, in this final rule, ffes include ffes in states \n",
      "that perform plan management functions. state-based exchanges on the \n",
      "federal platform (sbe-fps) are not ffes, even though consumers in these \n",
      "states enroll in coverage through <a href=\"http://healthcare.gov\">healthcare.gov</a>, and qhp issuers in \n",
      "sbe-fps are not subject to the requirements in this rule.\n",
      "\n",
      "b. overview\n",
      "\n",
      "    we are dedicated to enhancing and protecting the health and well-\n",
      "being of all americans. one critical issue in the u.s. health care \n",
      "system is that people cannot easily access their health information in \n",
      "interoperable forms. patients and the health care providers caring for \n",
      "them are often presented with an incomplete picture of their health and \n",
      "care as pieces of their information are stored in various, unconnected \n",
      "systems and do not accompany the patient to every care setting. \n",
      "although more than 95 percent of hospitals \\1\\ and 75 percent of \n",
      "office-based clinicians \\2\\ are utilizing certified health it, \n",
      "challenges remain in creating a comprehensive, longitudinal view of a \n",
      "patient's health history.<sup>3 4 5</sup> this siloed nature of health \n",
      "care data prevents physicians, pharmaceutical companies, manufacturers, \n",
      "and payers from accessing and interpreting important data sets, \n",
      "instead, encouraging each group to make decisions based upon a part of \n",
      "the information rather than the whole. without an enforced standard of \n",
      "interoperability, data exchanges are often complicated and time-\n",
      "consuming.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\1\\ office of the national coordinator. (2019). hospitals' use \n",
      "of electronic health records data, 2015-2017. retrieved from <a href=\"https://www.healthit.gov/sites/default/files/page/2019-04/ahaehrusedatabrief.pdf\">https://www.healthit.gov/sites/default/files/page/2019-04/ahaehrusedatabrief.pdf</a>.\n",
      "    \\2\\ office of the national coordinator. (2019, december 18). \n",
      "health it playbook, section 1: electronic health records. retrieved \n",
      "from <a href=\"https://www.healthit.gov/playbook/electronic-health-records/\">https://www.healthit.gov/playbook/electronic-health-records/</a>.\n",
      "    \\3\\ powell, k. r. & alexander, g. l. (2019). mitigating barriers \n",
      "to interoperability in health care. online journal of nursing \n",
      "informatics, 23(2). retrieved from <a href=\"https://www.himss.org/library/mitigating-barriers-interoperability-health-care\">https://www.himss.org/library/mitigating-barriers-interoperability-health-care</a>.\n",
      "    \\4\\ hochman, m., garber, j., & robinson, e. j. (2019, august \n",
      "14). health information exchange after 10 years: time for a more \n",
      "assertive, national approach. retrieved from <a href=\"https://www.healthaffairs.org/do/10.1377/hblog20190807.475758/full/\">https://www.healthaffairs.org/do/10.1377/hblog20190807.475758/full/</a>.\n",
      "    \\5\\ payne, t. h., lovis, c., gutteridge, c., pagliari, c., \n",
      "natarajan, s., yong, c., & zhao, l. (2019). status of health \n",
      "information exchange: a comparison of six countries. journal of \n",
      "global health, 9(2). doi: 10.7189/jogh.09.020427.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we believe patients should have the ability to move from payer to \n",
      "payer, provider to provider, and have both their clinical and \n",
      "administrative information travel with them throughout their journey. \n",
      "when a patient receives care from a new provider, a record of their \n",
      "health information should be readily available to that care provider, \n",
      "regardless of where or by whom care was previously provided. when a \n",
      "patient is discharged from a hospital to a post-acute care (pac) \n",
      "setting there should be no question as to how, when, or where their \n",
      "data will be exchanged. likewise, when an enrollee changes payers or \n",
      "ages into medicare, the enrollee should be able to have their claims \n",
      "history and encounter data follow so that information is not lost. as \n",
      "discussed in more detail in section iii. of this final rule, claims and \n",
      "encounter data can offer a more holistic understanding of a patient's \n",
      "health, providing insights into everything from the frequency and types \n",
      "of care provided and for what reason, medication history and adherence, \n",
      "and the evolution and adherence to a care plan. this information can \n",
      "empower patients to make better decisions and inform providers to \n",
      "support better health outcomes.\n",
      "    for providers in clinical and community settings, health \n",
      "information technology (health it) should be a resource, enabling \n",
      "providers to deliver high quality care, creating efficiencies and \n",
      "allowing them to access all payer and provider data for their patients. \n",
      "therefore, health it should not detract from the clinician-patient \n",
      "relationship, from the patient's experience of care, or from the \n",
      "quality of work life for physicians, nurses, other health care \n",
      "professionals, and social service providers. through standards-based \n",
      "interoperability and information exchange, health it has the potential \n",
      "to facilitate efficient, safe, high-quality care for individuals and \n",
      "populations.\n",
      "    all payers should have the ability to exchange data seamlessly with \n",
      "other payers for timely benefits coordination or transitions, and with \n",
      "health care and social service providers to facilitate more coordinated \n",
      "and efficient care. payers are in a unique position to provide \n",
      "enrollees with a comprehensive picture of their claims and encounter \n",
      "data, allowing patients to piece together their own information that \n",
      "might otherwise be lost in disparate systems. this information can \n",
      "contribute to better informed decision making, helping to inform the \n",
      "patient's choice of coverage options and care providers to more \n",
      "effectively manage their own health, care, and costs.\n",
      "    we are committed to working with stakeholders to solve the issue of \n",
      "interoperability and patient access in the u.s. health care system \n",
      "while reducing administrative burdens on providers and are taking an \n",
      "active approach using all available policy levers and authorities to \n",
      "move participants in the health care market toward interoperability and \n",
      "the secure and timely exchange of health care information.\n",
      "\n",
      "c. executive order and myhealthedata\n",
      "\n",
      "    on october 12, 2017, president trump issued executive order 13813 \n",
      "to promote healthcare choice and competition across the united states. \n",
      "section 1(c)(iii) of executive order 13813 states that the \n",
      "administration will improve access to, and the quality of, information \n",
      "that americans need to make informed health care decisions, including \n",
      "information about health care\n",
      "\n",
      "[[page 25512]]\n",
      "\n",
      "prices and outcomes, while minimizing reporting burdens on impacted \n",
      "providers, and payers, meaning providers and payers subject to this \n",
      "rule.\n",
      "    in support of executive order 13813, the administration launched \n",
      "the myhealthedata initiative. this government-wide initiative aims to \n",
      "empower patients by ensuring that they have access to their own health \n",
      "information and the ability to decide how their data will be used, \n",
      "while keeping that information safe and secure. myhealthedata aims to \n",
      "break down the barriers that prevent patients from gaining electronic \n",
      "access to their health information from the device or application of \n",
      "their choice, empowering patients and taking a critical step toward \n",
      "interoperability and patient data exchange.\n",
      "    in march 2018, the white house office of american innovation and \n",
      "the cms administrator announced the launch of myhealthedata, and cms's \n",
      "direct, hands-on role in improving patient access and advancing \n",
      "interoperability. as part of the myhealthedata initiative, we are \n",
      "taking a patient-centered approach to health information access and \n",
      "moving to a system in which patients have immediate access to their \n",
      "computable health information such that they can be assured that their \n",
      "health information will follow them as they move throughout the health \n",
      "care system from provider to provider, payer to payer. to accomplish \n",
      "this, we have launched several initiatives related to data sharing and \n",
      "interoperability to empower patients and encourage payer and provider \n",
      "competition. we continue to advance the policies and goals of the \n",
      "myhealthedata initiative through various provisions included in this \n",
      "final rule.\n",
      "    as finalized in this rule, our policies are wide-reaching and will \n",
      "have an impact on all facets of the health care system. several key \n",
      "touch points of the policies in this rule include:\n",
      "    <bullet> patients: enabling patients to access their health \n",
      "information electronically without special effort by requiring the \n",
      "payers subject to this final rule to make data available through an \n",
      "application programming interface (api) to which third-party software \n",
      "applications connect to make data available to patients for their \n",
      "personal use. this encourages patients to take charge of and better \n",
      "manage their health care, and thus these initiatives are imperative to \n",
      "improving a patient's long-term health outcomes.\n",
      "    <bullet> clinicians and hospitals: ensuring that health care \n",
      "providers have ready access to health information about their patients, \n",
      "regardless of where the patient may have previously received care. we \n",
      "are also implementing policies to prevent health care providers from \n",
      "inappropriately restricting the flow of information to other health \n",
      "care providers and payers. finally, we are working to ensure that \n",
      "better interoperability reduces the burden on health care providers.\n",
      "    <bullet> payers: implementing requirements to ensure that payers \n",
      "(that is, entities and organizations that pay for health care), such as \n",
      "payers in medicare advantage, medicaid, and chip, make enrollee \n",
      "electronic health information held by the payer available through an \n",
      "api such that, with use of software expected to be developed by payers \n",
      "and third parties, the information becomes easily accessible to the \n",
      "enrollee and data flow seamlessly with the enrollee as such enrollees \n",
      "change health care and social service providers and payers. \n",
      "additionally, our policies ensure that payers make it easy for current \n",
      "and prospective enrollees to identify which providers are within a \n",
      "given plan's network in a way that is simple and easy for enrollees to \n",
      "access and understand, and thus find the providers that are right for \n",
      "them.\n",
      "    as a result of our efforts to standardize data and technical \n",
      "approaches to advance interoperability, we believe health care \n",
      "providers and their patients, as well as other key participants within \n",
      "the health care ecosystem such as payers, will have appropriate access \n",
      "to the information necessary to coordinate individual care; analyze \n",
      "population health trends, outcomes, and costs; and manage benefits and \n",
      "the health of populations, while tracking progress through quality \n",
      "improvement initiatives. we are working with other federal partners \n",
      "including the office of the national coordinator for health information \n",
      "technology (onc) on this effort with the clear objectives of improving \n",
      "patient access and care, alleviating provider burden, and reducing \n",
      "overall health care costs, all while taking steps to protect the \n",
      "privacy and security of patients' personal health information. as \n",
      "evidence of this partnership, onc is releasing the onc 21st century \n",
      "cures act final rule (published elsewhere in this issue of the federal \n",
      "register) in tandem with this final rule. it is this coordinated \n",
      "federal effort, in conjunction with strong support and innovation from \n",
      "our stakeholders, that will help us move ever closer to true \n",
      "interoperability.\n",
      "\n",
      "d. past efforts\n",
      "\n",
      "    the department of health and human services (hhs) has been working \n",
      "to advance the interoperability of electronic health information for \n",
      "over 15 years. for a detailed explanation of past efforts, see the cms \n",
      "interoperability and patient access proposed rule (84 fr 7612 through \n",
      "7614).\n",
      "\n",
      "e. challenges and barriers to interoperability\n",
      "\n",
      "    through significant stakeholder feedback, we understand that there \n",
      "are many barriers to interoperability, which have obstructed progress \n",
      "over the years. we have conducted stakeholder meetings and roundtables; \n",
      "solicited comments via rfis; and received additional feedback through \n",
      "letters and rulemaking. all of this input together contributed to the \n",
      "policies in our interoperability and patient access proposed rule, and \n",
      "when combined with the comments we received on the proposed rule, the \n",
      "content of this final rule. some of the main barriers shared with us, \n",
      "specifically patient identification, lack of standardization, \n",
      "information blocking, the lack of adoption and use of certified health \n",
      "it among post-acute care (pac) providers, privacy concerns, and \n",
      "uncertainty about the requirements of the health insurance portability \n",
      "and\n",
      "    accountability act of 1996 (hipaa) privacy, security, and breach \n",
      "notification rules, were discussed in the proposed rule (84 fr 7614 \n",
      "through 7617). while we have made efforts to address some of these \n",
      "barriers in this final rule and through prior rules and actions, we \n",
      "believe there is still considerable work to be done to overcome some of \n",
      "these challenges toward achieving interoperability, and we will \n",
      "continue this work as we move forward with our interoperability \n",
      "efforts.\n",
      "\n",
      "f. summary of major provisions\n",
      "\n",
      "    this final rule empowers patients in ma organizations, medicaid and \n",
      "chip ffs programs, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers on the ffes, by finalizing several \n",
      "initiatives that will break down those barriers currently keeping \n",
      "patients from easily accessing their electronic health care \n",
      "information. additionally, the rule creates and implements new \n",
      "mechanisms to enable patients to access their own health care \n",
      "information through third-party software applications, thereby \n",
      "providing them with the ability to decide how, when, and with whom to \n",
      "share their information.\n",
      "\n",
      "[[page 25513]]\n",
      "\n",
      "    we are finalizing with modifications our proposal to require ma \n",
      "organizations, medicaid and chip ffs programs, medicaid managed care \n",
      "plans, chip managed care entities, and qhp issuers on the ffes to \n",
      "implement and maintain a standards-based patient access api. this \n",
      "patient access api must meet the technical standards finalized by hhs \n",
      "in the onc 21st century cures act final rule (published elsewhere in \n",
      "this issue of the federal register) at 45 cfr 170.215 (currently \n",
      "including health level 7[supreg] (hl7) fast healthcare interoperability \n",
      "resources[supreg] (fhir) release 4.0.1) and the content and vocabulary \n",
      "standards finalized by hhs in the onc 21st century cures act final rule \n",
      "(published elsewhere in this issue of the federal register) at 45 cfr \n",
      "170.213, as well as content and vocabulary standards at 45 cfr part 162 \n",
      "and the content and vocabulary standards at 42 cfr 423.160. we are \n",
      "finalizing that through the patient access api, payers must permit \n",
      "third-party applications to retrieve, with the approval and at the \n",
      "direction of a current enrollee, data specified at 42 cfr 422.119, \n",
      "431.60, 457.730, and 45 cfr 156.221. specifically, we are requiring \n",
      "that the patient access api must, at a minimum, make available \n",
      "adjudicated claims (including provider remittances and enrollee cost-\n",
      "sharing); encounters with capitated providers; and clinical data, \n",
      "including laboratory results (when maintained by the impacted payer). \n",
      "data must be made available no later than one (1) business day after a \n",
      "claim is adjudicated or encounter data are received. we are requiring \n",
      "that beginning january 1, 2021, impacted payers make available through \n",
      "the patient access api the specified data they maintain with a date of \n",
      "service on or after january 1, 2016. this is consistent with the \n",
      "requirements for the payer-to-payer data exchange detailed in section \n",
      "v. of this final rule. together these policies facilitate the creation \n",
      "and maintenance of a patient's cumulative health record with their \n",
      "current payer.\n",
      "    we are finalizing regulations to require that ma organizations, \n",
      "medicaid and chip ffs programs, medicaid managed care plans, and chip \n",
      "managed care entities make standardized information about their \n",
      "provider networks available through a provider directory api that is \n",
      "conformant with the technical standards finalized by hhs in the onc \n",
      "21st century cures act final rule (published elsewhere in this issue of \n",
      "the federal register) at 45 cfr 170.215, excluding the security \n",
      "protocols related to user authentication and authorization and any \n",
      "other protocols that restrict availability of this information to \n",
      "particular persons or organizations. authentication and authorization \n",
      "protocols are not necessary when making publicly available data \n",
      "accessible via an api. we are finalizing that the provider directory \n",
      "api must be accessible via a public-facing digital endpoint on the \n",
      "payer's website to ensure public discovery and access. at a minimum, \n",
      "these payers must make available via the provider directory api \n",
      "provider names, addresses, phone numbers, and specialties. for ma \n",
      "organizations that offer ma-pd plans, they must also make available, at \n",
      "a minimum, pharmacy directory data, including the pharmacy name, \n",
      "address, phone number, number of pharmacies in the network, and mix \n",
      "(specifically the type of pharmacy, such as ``retail pharmacy''). all \n",
      "directory information must be made available to current and prospective \n",
      "enrollees and the public through the provider directory api within 30 \n",
      "calendar days of a payer receiving provider directory information or an \n",
      "update to the provider directory information. the provider directory \n",
      "api is being finalized at 42 cfr 422.120 for ma organizations, at 42 \n",
      "cfr 431.70 for medicaid state agencies, at 42 cfr 438.242(b)(6) for \n",
      "medicaid managed care plans, at 42 cfr 457.760 for chip state agencies, \n",
      "and at 42 cfr 457.1233(d)(3) for chip managed care entities. here we \n",
      "are finalizing that access to the published provider directory api must \n",
      "be fully implemented by january 1, 2021. we do strongly encourage \n",
      "payers to make their provider directory api public as soon as possible \n",
      "to make and show progress toward meeting all the api requirements being \n",
      "finalized in this rule.\n",
      "    we are finalizing our proposal, with certain modifications as \n",
      "detailed in section v. of this final rule, to require ma organizations, \n",
      "medicaid managed care plans, chip managed care entities, and qhp \n",
      "issuers on the ffes to coordinate care between payers by exchanging, at \n",
      "a minimum, the data elements specified in the current content and \n",
      "vocabulary standard finalized by hhs in the onc 21st century cures act \n",
      "final rule (published elsewhere in this issue of the federal register) \n",
      "at 45 cfr 170.213 (currently the ``united states core data for \n",
      "interoperability'' (uscdi) version 1 \\6\\). this payer-to-payer data \n",
      "exchange requires these payers, as finalized at 42 cfr 422.119(f) for \n",
      "ma organizations, at 42 cfr 438.62(b)(1)(vi) for medicaid managed care \n",
      "plans (and by extension under sec.  457.1216 chip managed care \n",
      "entities), and at 45 cfr 156.221(f) for qhp issuers on the ffes, to \n",
      "send, at a current or former enrollee's request, specific information \n",
      "they maintain with a date of service on or after january 1, 2016 to any \n",
      "other payer identified by the current enrollee or former enrollee. this \n",
      "is consistent with the patient access api detailed in section iii. of \n",
      "this final rule. we are also finalizing a provision that a payer is \n",
      "only obligated to share data received from another payer under this \n",
      "regulation in the electronic form and format it was received. this is \n",
      "intended to reduce burden on payers. we are finalizing that this payer-\n",
      "to-payer data exchange must be fully implemented by january 1, 2022.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\6\\ office of the national coordinator. (n.d.). u.s. core data \n",
      "for interoperability (uscdi). retrieved from <a href=\"https://www.healthit.gov/isa/us-core-data-interoperability-uscdi\">https://www.healthit.gov/isa/us-core-data-interoperability-uscdi</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in response to comments discussed more fully below, we are not \n",
      "finalizing our proposal to require ma organizations, medicaid managed \n",
      "care plans, chip managed care entities, and qhp issuers on the ffes to \n",
      "participate in a trusted exchange network given the concerns commenters \n",
      "raised regarding the need for a mature trusted exchange framework and \n",
      "common agreement (tefca) to be in place first, and appreciating that \n",
      "work on tefca is ongoing at this time.\n",
      "    we are finalizing the requirements that all states participate in \n",
      "daily exchange of buy-in data, which includes both sending data to cms \n",
      "and receiving responses from cms daily, and that all states submit the \n",
      "mma file data to cms daily by april 1, 2022 in accordance with 42 cfr \n",
      "406.26, 407.40, and 423.910, respectively, as proposed. these \n",
      "requirements will improve the experience of dually eligible individuals \n",
      "by improving the ability of providers and payers to coordinate \n",
      "eligibility, enrollment, benefits, and/or care for this population.\n",
      "    we are finalizing our proposal to include an indicator on physician \n",
      "compare for the eligible clinicians and groups that submit a ``no'' \n",
      "response to any of the three prevention of information blocking \n",
      "statements for mips. in the event that these statements are left blank, \n",
      "the attestations will be considered incomplete, and we will not include \n",
      "an indicator on physician compare. the indicator will be posted on \n",
      "physician compare, either on the profile pages or in the downloadable \n",
      "database, starting with the 2019 performance period data available for \n",
      "public reporting starting in late 2020.\n",
      "\n",
      "[[page 25514]]\n",
      "\n",
      "    we are finalizing our proposal to include information on a publicly \n",
      "available cms website indicating that an eligible hospital or critical \n",
      "access hospital (cah) attesting under the medicare ffs promoting \n",
      "interoperability program had submitted a ``no'' response to any of the \n",
      "three attestation statements related to the prevention of information \n",
      "blocking. in the event that an eligible hospital or cah leaves a \n",
      "``blank'' response, the attestations will be considered incomplete, and \n",
      "no information will be posted related to these attestation statements. \n",
      "we will post this information starting with the attestations for the \n",
      "ehr reporting period in 2019 and expect this information will be posted \n",
      "in late 2020.\n",
      "    additionally, as detailed in section ix. of this final rule, we are \n",
      "finalizing our proposal to publicly report the names and npis of those \n",
      "providers who do not have digital contact information included in the \n",
      "national plan and provider enumeration system (nppes) system beginning \n",
      "in the second half of 2020 as proposed. additionally, we will continue \n",
      "to ensure providers are aware of the benefits of including digital \n",
      "contact information in nppes, and when and where their names and npis \n",
      "will be posted if they do not include this information. we do strongly \n",
      "encourage providers to include fhir endpoint information in nppes if \n",
      "and when they have the information, as well.\n",
      "    to further advance electronic exchange of information that supports \n",
      "effective transitions of care we are finalizing the requirement for a \n",
      "hospital, psychiatric hospital, and cah, which utilizes an electronic \n",
      "medical records system or other electronic administrative system that \n",
      "is conformant with the content exchange standard at 45 cfr \n",
      "170.205(d)(2) to demonstrate that: (1) its system's notification \n",
      "capacity is fully operational and that it operates in accordance with \n",
      "all state and federal statutes and regulations regarding the exchange \n",
      "of patient health information; (2) its system sends notifications that \n",
      "must include the minimum patient health information specified in \n",
      "section x. of this final rule; and (3) its system sends notifications \n",
      "directly, or through an intermediary that facilitates exchange of \n",
      "health information, and at the time of a patient's registration in the \n",
      "emergency department or admission to inpatient services, and also prior \n",
      "to, or at the time of, a patient's discharge and/or transfer from the \n",
      "emergency department or inpatient services, to all applicable post-\n",
      "acute care services providers and suppliers, primary care practitioners \n",
      "and groups, and other practitioners and groups identified by the \n",
      "patient as primarily responsible for his or her care, and who or which \n",
      "need to receive notification of the patient's status for treatment, \n",
      "care coordination, or quality improvement purposes. we are establishing \n",
      "that this policy will be applicable 12 months after publication of this \n",
      "rule for hospitals, including psychiatric hospitals, and cahs to allow \n",
      "for adequate and additional time for these institutions, especially \n",
      "small and/or rural hospitals as well as cahs, to come into compliance \n",
      "with the new requirements.\n",
      "    finally, we note that we included two rfis in the proposed rule: \n",
      "one related to interoperability and health it adoption in pac settings \n",
      "and one related to the role of patient matching in interoperability and \n",
      "improved patient care. we thank commenters for the insights shared on \n",
      "these two topics. we are reviewing these comments and will take them \n",
      "into consideration for potential future rulemaking.\n",
      "    throughout this final rule, we refer to terms such as ``patient,'' \n",
      "``consumer,'' ``beneficiary,'' ``enrollee,'' and ``individual.'' we \n",
      "note that every reader of this final rule is a patient and has or will \n",
      "receive medical care at some point in their life. in this final rule, \n",
      "we use the term ``patient'' as an inclusive term, but because we have \n",
      "historically referred to patients using the other terms noted above in \n",
      "our regulations, we use specific terms as applicable in sections of \n",
      "this final rule to refer to individuals covered under the health care \n",
      "programs that cms administers and regulates. we also note that when we \n",
      "discuss patients, we acknowledge a patient's personal representative. \n",
      "per the hipaa privacy regulations at 45 cfr 164.502(g), a personal \n",
      "representative is someone authorized under state or other applicable \n",
      "law to act on behalf of the individual in making health care related \n",
      "decisions (such as a parent, guardian, or person with a medical power \n",
      "of attorney).\\7\\ policies in this final rule that require a patient's \n",
      "action could be addressed by a patient's personal representative.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\7\\ see ocr guidance regarding personal representatives at \n",
      "<a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2069/under-hipaa-when-can-a-family-member/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2069/under-hipaa-when-can-a-family-member/index.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we also use terms such as ``payer,'' ``plan,'' and ``issuer'' in \n",
      "this final rule. certain portions of this final rule are applicable to \n",
      "the medicare fee-for-service (ffs) program, the medicaid ffs program, \n",
      "the chip ffs program, medicare advantage (ma) organizations, medicaid \n",
      "managed care plans (managed care organizations (mcos), prepaid \n",
      "inpatient health plans (pihps), and prepaid ambulatory health plans \n",
      "(pahps)), chip managed care entities (mcos, pihps, and pahps), and qhp \n",
      "issuers on the ffes. we use the term ``payer'' in the preamble of this \n",
      "final rule as an inclusive term for all these programs (and plan types \n",
      "in the case of plans), but we also use specific terms as applicable in \n",
      "sections of this final rule. finally, we use the term ``provider,'' \n",
      "too, as an inclusive term comprising individuals, organizations, and \n",
      "institutions that provide health services, such as clinicians, \n",
      "hospitals, skilled nursing facilities, home health agencies, hospice \n",
      "settings, laboratories, suppliers of durable medical equipment, \n",
      "community based organizations, etc., as appropriate in the context \n",
      "used.\n",
      "\n",
      "ii. technical standards related to interoperability provisions, and \n",
      "analysis of and responses to public comments\n",
      "\n",
      "a. technical approach and standards\n",
      "\n",
      "1. use of health level 7[supreg] (hl7) fast healthcare interoperability \n",
      "resources[supreg] (fhir) for apis\n",
      "    section 106(b)(1)(b)(ii) of the medicare access and chip \n",
      "reauthorization act of 2015 (macra) defines health it \n",
      "``interoperability'' as the ability of two or more health information \n",
      "systems or components to exchange clinical and other information and to \n",
      "use the information that has been exchanged using common standards to \n",
      "provide access to longitudinal information for health care providers in \n",
      "order to facilitate coordinated care and improved patient outcomes. \n",
      "interoperability is also defined in section 3000 of the public health \n",
      "service act (phsa) (42 u.s.c. 300jj), as amended by section 4003 of the \n",
      "21st century cures act. under that definition, ``interoperability,'' \n",
      "with respect to health it, means such health it that enables the secure \n",
      "exchange of electronic health information with, and use of electronic \n",
      "health information from, other health it without special effort on the \n",
      "part of the user; allows for complete access, exchange, and use of all \n",
      "electronically accessible health information for authorized use under \n",
      "applicable state or federal law; and does not constitute information \n",
      "blocking as defined in section 3022(a) of the phsa, which was added by \n",
      "section 4004 of the cures act. we believe the phsa definition is \n",
      "consistent with the macra definition of ``interoperability''. \n",
      "consistent with the cms interoperability and patient access\n",
      "\n",
      "[[page 25515]]\n",
      "\n",
      "proposed rule (84 fr 7619), we will use the phsa definition of \n",
      "``interoperability'' for the purposes of this final rule.\n",
      "    we believe the phsa definition of ``interoperability'' is useful as \n",
      "a foundational reference for our approach to advancing the \n",
      "interoperability and exchange of electronic health information for \n",
      "individuals throughout the united states, and across the entire \n",
      "spectrum of provider types and care settings with which health \n",
      "insurance issuers and administrators need to efficiently exchange \n",
      "multiple types of relevant data. we noted the phsa definition of \n",
      "``interoperability'' is not limited to a specific program or \n",
      "initiative, but rather can be applied to all activities under the title \n",
      "of the phsa that establishes onc's responsibilities to support and \n",
      "shape the health information ecosystem, including the exchange \n",
      "infrastructure for the u.s. health care system as a whole. the phsa \n",
      "definition is also consistent with hhs's vision and strategy for \n",
      "achieving a health information ecosystem within which all individuals, \n",
      "their personal representatives, their health care providers, and their \n",
      "payers are able to send, receive, find, and use electronic health \n",
      "information in a manner that is appropriate, secure, timely, and \n",
      "reliable to support the health and wellness of individuals through \n",
      "informed, shared decision-making,\\8\\ as well as to support consumer \n",
      "choice of payers and providers.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\8\\ see, for example, office of the national coordinator. \n",
      "(2015). connecting health and care for the nation: a shared \n",
      "nationwide interoperability roadmap, final version 1.0. retrieved \n",
      "from <a href=\"https://www.healthit.gov/sites/default/files/hie-interoperability/nationwide-interoperability-roadmap-final-version-1.0.pdf\">https://www.healthit.gov/sites/default/files/hie-interoperability/nationwide-interoperability-roadmap-final-version-1.0.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we summarize the public comment we received on use of the phsa \n",
      "definition of ``interoperability'' and provide our response.\n",
      "    comment: one commenter specifically supported the use of the phsa \n",
      "definition of ``interoperability''.\n",
      "    response: we appreciate the commenter's support.\n",
      "    a core policy principle we aim to support across all policies in \n",
      "this rule is that every american should be able, without special effort \n",
      "or advanced technical skills, to see, obtain, and use all \n",
      "electronically available information that is relevant to their health, \n",
      "care, and choices--of plans, providers, and specific treatment options. \n",
      "in the proposed rule, we explained this included two types of \n",
      "information: personal health information that health care providers and \n",
      "health plans, or payers, must make available to an individual, such as \n",
      "their current and past medical conditions and care received; and \n",
      "information that is of general interest and should be widely available, \n",
      "such as plan provider networks, the plan's formulary, and coverage \n",
      "policies (84 fr 7619).\n",
      "    we also discussed that while many consumers today can often access \n",
      "their own electronic health information through patient or enrollee \n",
      "portals and proprietary applications made available by various \n",
      "providers and health plans, they must typically go through separate \n",
      "processes to obtain access to each system, and often need to manually \n",
      "aggregate information that is delivered in various, often non-\n",
      "standardized, formats. the complex tasks of accessing and piecing \n",
      "together this information can be burdensome and frustrating to \n",
      "consumers.\n",
      "    an api can be thought of as a set of commands, functions, \n",
      "protocols, or tools published by one software developer (``a'') that \n",
      "enable other software developers to create programs (applications or \n",
      "``apps'') that can interact with a's software without needing to know \n",
      "the internal workings of a's software, all while maintaining consumer \n",
      "privacy data standards.\\9\\ this is how api technology enables the \n",
      "seamless user experiences associated with applications familiar from \n",
      "other aspects of many consumers' daily lives, such as travel and \n",
      "personal finance. standardized, transparent, and pro-competitive api \n",
      "technology can enable similar benefits to consumers of health care \n",
      "services.\\10\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\9\\ see <a href=\"https://www.hl7.org/fhir/security.html\">https://www.hl7.org/fhir/security.html</a> for information \n",
      "on how fhir servers and resources integrate privacy and security \n",
      "protocols into the data exchange via an api.\n",
      "    \\10\\ onc has made available a succinct, non-technical overview \n",
      "of apis in context of consumers' access to their own medical \n",
      "information across multiple providers' ehr systems, which is \n",
      "available at the <a href=\"http://healthit.gov\">healthit.gov</a> website at <a href=\"https://www.healthit.gov/api-education-module/story_html5.html\">https://www.healthit.gov/api-education-module/story_html5.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while acknowledging the limits of our authority to require use of \n",
      "apis to address our goals for interoperability and data access, we \n",
      "proposed to use our programmatic authority to require that a variety of \n",
      "data be made accessible by requiring that ma organizations, medicaid \n",
      "state agencies, medicaid managed care plans, chip agencies, chip \n",
      "managed care entities, and qhp issuers on the ffes, adopt and implement \n",
      "``openly published,'' or secure, standards-based apis. in the cms \n",
      "interoperability and patient access proposed rule, we used the short \n",
      "form terminology, ``open api''. we appreciate that this term can be \n",
      "misunderstood to mean ``open'' as in ``not secure''. in actuality, an \n",
      "``open api'' is a secure, standards-based api that has certain \n",
      "technical information openly published to facilitate uniform use and \n",
      "data sharing in a secure, standardized way. to avoid this \n",
      "misinterpretation, we will use the term ``standards-based api'' in this \n",
      "final rule where we used ``open api'' in the proposed rule. this is \n",
      "also in better alignment with the terminology used in the onc 21st \n",
      "century cures act proposed rule (84 fr 7453) and final rule (published \n",
      "elsewhere in this issue of the federal register). we noted that having \n",
      "certain data available through standards-based apis would allow \n",
      "impacted enrollees to use the application of their choice to access and \n",
      "use their own electronic health information and other related \n",
      "information to manage their health. see section iii.c.2.a. of the cms \n",
      "interoperability and patient access proposed rule for further \n",
      "discussion (84 fr 7629).\n",
      "    much like our efforts under medicare blue button 2.0, also part of \n",
      "the myhealthedata initiative, which made parts a, b, and d claims and \n",
      "encounter data available via an api to medicare beneficiaries, the \n",
      "policies in this rule extend these benefits to even more patients. as \n",
      "of january 2020, over 53,000 medicare beneficiaries have taken \n",
      "advantage of blue button. currently, there are 55 production \n",
      "applications and over 2,500 developers working in the blue button \n",
      "sandbox. for more information on blue button 2.0 see section iii. of \n",
      "this final rule. as we noted in the cms interoperability and patient \n",
      "access proposed rule, we believe that our patient access api, in \n",
      "particular, will result in claims and encounter information becoming \n",
      "easily accessible for the vast majority of patients enrolled with \n",
      "payers regulated by cms. as finalized, these policies will apply to all \n",
      "ma organizations, all medicaid and chip ffs programs, all types of \n",
      "medicaid managed care plans (mcos, pihps, and pahps), as well as chip \n",
      "managed care entities, and qhp issuers on the ffes. we hope that states \n",
      "operating exchanges might consider adopting similar requirements for \n",
      "qhps on the state-based exchanges (sbes), and that other payers in the \n",
      "private sector might consider voluntarily offering data accessibility \n",
      "of the type included in the policies being finalized here so that even \n",
      "more patients across the american health care system can easily have \n",
      "and use such information to advance their choice and participation in \n",
      "their health care. in this way, we hope that the example being set by \n",
      "cms will raise consumers' expectations and\n",
      "\n",
      "[[page 25516]]\n",
      "\n",
      "encourage other payers in the market to take similar steps to advance \n",
      "patient access and empowerment outside the scope of the requirements \n",
      "being finalized in this rule.\n",
      "    we explained in the cms interoperability and patient access \n",
      "proposed rule (84 fr 7620) that those seeking further information \n",
      "regarding what a standards-based api is are encouraged to review the \n",
      "discussion of the standardized api criterion and associated policy \n",
      "principles and technical standards included in onc's 21st century cures \n",
      "act proposed rule (84 fr 7424) and final rule (published elsewhere in \n",
      "this issue of the federal register). these rules provide more detailed \n",
      "information on api functionality and interoperability standards \n",
      "relevant to electronic health information. we noted that while that \n",
      "discussion was specific to health it, including electronic health \n",
      "records (ehr) systems, certified under onc's health it certification \n",
      "program rather than the information systems generally used by payers \n",
      "and plan issuers for claims, encounters, or other administrative or \n",
      "plan operational data, it included information applicable to \n",
      "interoperability standards, as well as considerations relevant to \n",
      "establishing reasonable and non-discriminatory terms of service for \n",
      "applications seeking to connect to the standards-based api discussed in \n",
      "this rule. while we reiterate that we did not propose to require payers \n",
      "to use health it modules certified under onc's program to make \n",
      "administrative data such as claims history or provider directory \n",
      "information available to enrollees, we believe that the discussion of \n",
      "apis and related standards in the onc 21st century cures act rules will \n",
      "be of use to those seeking to better understand the role of apis in \n",
      "health care information exchange.\n",
      "    we also discussed in our proposed rule how other industries have \n",
      "advanced the sort of standards-based api-driven interoperability and \n",
      "innovation that we seek in the health system (84 fr 7620). we have \n",
      "sought to collaborate and align with onc's proposed and final policies \n",
      "specifically related to apis under the cures act as we developed and \n",
      "finalized these policies. in general, as we noted in our proposed rule, \n",
      "we believe the following three attributes of standards-based apis are \n",
      "particularly important to achieving the goal of offering individuals \n",
      "convenient access, through applications they choose, to available and \n",
      "relevant electronic health and health-related information:\n",
      "    <bullet> the api technologies themselves, not just the data \n",
      "accessible through them, are standardized;\n",
      "    <bullet> the apis are technically transparent; and\n",
      "    <bullet> the apis are implemented in a pro-competitive manner.\n",
      "    in that section of the cms interoperability and patient access \n",
      "proposed rule, we discussed these concepts generally and how they were \n",
      "applicable in the health care context for all payers, and explained how \n",
      "these were relevant to our specific proposals, which are discussed in \n",
      "detail in section iii. of this final rule. to revisit this full \n",
      "discussion, see the proposed rule (84 fr 7620 through 7621). we did not \n",
      "receive comments on this general discussion. any comments on specific \n",
      "proposals that refer to these three attributes are discussed in this \n",
      "final rule in the context of the specific proposals.\n",
      "2. privacy and security concerns in the context of apis\n",
      "    as we noted in the cms interoperability and patient access proposed \n",
      "rule, hhs has received a wide range of stakeholder feedback on privacy \n",
      "and security issues in response to prior proposals \\11\\ about policies \n",
      "related to apis that would allow consumers to use an app of their \n",
      "choosing to access protected health information (phi) held by or on \n",
      "behalf of a hipaa covered entity. such feedback included concerns about \n",
      "potential security risks to phi created by an api connecting to third-\n",
      "party applications and the implications of an individual's data being \n",
      "shared with these third-party apps at the direction of the individual.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\11\\ for instance, see discussion of stakeholder comments in the \n",
      "2015 edition final rule at 80 fr 62676.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    as we discussed in our interoperability and patient access proposed \n",
      "rule (84 fr 7621), deploying api technology would offer consumers the \n",
      "opportunity to access their electronic health information held by \n",
      "covered entities (including, but not limited to ma organizations, the \n",
      "medicare part a and b programs, the medicaid program, chip, qhp issuers \n",
      "on the ffes, and other health insurance issuers in the private \n",
      "markets), and would not lessen any such covered entity's duties under \n",
      "hipaa and other laws to protect the privacy and security of information \n",
      "it creates, receives, maintains, or transmits, including but not \n",
      "limited to phi. a covered entity implementing an api to enable \n",
      "individuals to access their health information must take reasonable \n",
      "steps to ensure an individual's information is only disclosed as \n",
      "permitted or required by applicable law. the entity must take greater \n",
      "care in configuring and maintaining the security functionalities of the \n",
      "api and the covered entities' electronic information systems to which \n",
      "it connects than would be needed if it was implementing an api simply \n",
      "to allow easier access to widely available public information. in \n",
      "accordance with the hipaa privacy and security rules, the covered \n",
      "entity is required to implement reasonable safeguards to protect phi \n",
      "while in transit. if an individual requests their phi in an ehr be sent \n",
      "to the third party by unencrypted email or in another unsecure manner, \n",
      "which the individual has a right to request, reasonable safeguards \n",
      "could include, for example, carefully checking the individual's email \n",
      "address for accuracy and warning the individual of risks associated \n",
      "with the unsecure transmission. we note that the standards-based apis \n",
      "discussed in this final rule are secure methods of data exchange.\n",
      "    hipaa covered entities and their business associates continue to be \n",
      "responsible for compliance with the hipaa rules, the federal trade \n",
      "commission act (ftc act), and all other laws applicable to their \n",
      "business activities including but not limited to their handling of \n",
      "enrollees' phi and other data. as we stated in the cms interoperability \n",
      "and patient access proposed rule (84 fr 7610), nothing proposed in that \n",
      "rule was intended to alter or should be construed as altering existing \n",
      "responsibilities to protect phi under the hipaa rules or any other laws \n",
      "that are currently applicable.\n",
      "    however, we acknowledged that a number of industry stakeholders may \n",
      "mistakenly believe that they are responsible for determining whether an \n",
      "application to which an individual directs their phi employs \n",
      "appropriate safeguards regarding the information it receives. in the \n",
      "proposed rule we discussed office for civil rights (ocr) guidance that \n",
      "noted that covered entities are not responsible under the hipaa rules \n",
      "for the security of phi once it has been received by a third-party \n",
      "application chosen by an individual (84 fr 7621 through 7622).\n",
      "    further, we noted in the cms interoperability and patient access \n",
      "proposed rule that the hipaa privacy rule \\12\\ established the \n",
      "individual's right of access, including a right to inspect\n",
      "\n",
      "[[page 25517]]\n",
      "\n",
      "and/or receive a copy of phi held in designated record sets by covered \n",
      "entities and their business associates as detailed at 45 cfr 164.524. \n",
      "we specifically noted in the proposed rule that ocr had indicated in \n",
      "regulations and guidance, that an individual could exercise their right \n",
      "of access by requesting that their information be sent to a third \n",
      "party.\\13\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\12\\ more information on the privacy rule, including related \n",
      "rulemaking actions and additional interpretive guidance, is \n",
      "available at <a href=\"https://www.hhs.gov/hipaa/for-professionals/privacy/index.html\">https://www.hhs.gov/hipaa/for-professionals/privacy/index.html</a>.\n",
      "    \\13\\ see 45 cfr 164.524(c)(2) and (3), and 164.308(a)(1), ocr \n",
      "hipaa guidance/faq-2036: <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2036/can-an-individual-through-the-hipaa-right/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2036/can-an-individual-through-the-hipaa-right/index.html</a>, and ocr hipaa guidance/faq-2037: <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/2037/are-there-any-limits-or-exceptions-to-the-individuals-right/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/2037/are-there-any-limits-or-exceptions-to-the-individuals-right/index.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    as we also noted in the proposed rule (84 fr 7622), we are aware of \n",
      "stakeholder concerns about which protections apply to non-covered \n",
      "entities, such as direct-to-consumer applications. as we explained in \n",
      "the proposed rule, when a non-covered entity discloses an individual's \n",
      "confidential information in a manner or for a purpose not consistent \n",
      "with the privacy notice and terms of use to which the individual \n",
      "agreed, the ftc has authority under section 5 of the ftc act (15 u.s.c. \n",
      "sec. 45(a)) to investigate and take action against unfair or deceptive \n",
      "trade practices. the ftc has applied this authority to a wide variety \n",
      "of entities.\\14\\ the ftc also enforces the ftc health breach \n",
      "notification rule, which applies to certain types of entities, \n",
      "including vendors of personal health records and third-party service \n",
      "providers, that fall outside of the scope of hipaa, and therefore, are \n",
      "not subject to the hipaa breach notification rule.\\15\\ this ftc health \n",
      "breach notification rule explains the process and steps third parties \n",
      "must follow when they discover a breach of identifiable personal health \n",
      "record information they maintain. any violation of this rule is \n",
      "enforced by the ftc as an unfair or deceptive act or practice under the \n",
      "ftc act.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\14\\ see also cases where this authority was used, such as 2012 \n",
      "ftc action against facebook (see <a href=\"https://www.ftc.gov/enforcement/cases-proceedings/092-3184/facebook-inc\">https://www.ftc.gov/enforcement/cases-proceedings/092-3184/facebook-inc</a>) and 2012 ftc action against \n",
      "myspace (see <a href=\"https://www.ftc.gov/enforcement/cases-proceedings/102-3058/myspace-llc-matter\">https://www.ftc.gov/enforcement/cases-proceedings/102-3058/myspace-llc-matter</a>).\n",
      "    \\15\\ see 16 cfr part 318; see also <a href=\"https://www.healthit.gov/sites/default/files/non-covered_entities_report_june_17_2016.pdf\">https://www.healthit.gov/sites/default/files/non-covered_entities_report_june_17_2016.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we recognized that this is a complex landscape for patients, who we \n",
      "anticipate will want to exercise due diligence on their own behalf in \n",
      "reviewing the terms of service and other information about the \n",
      "applications they consider selecting. therefore, we proposed specific \n",
      "requirements on payers to ensure enrollees have the opportunity to \n",
      "become more informed about how to protect their phi, important things \n",
      "to consider in selecting an application, and where they can submit a \n",
      "complaint if they believe a hipaa covered entity or business associate \n",
      "may not be in compliance with their duties under the hipaa rules, or if \n",
      "they believe they have been subjected to unfair or deceptive acts or \n",
      "practices related to a direct-to-consumer application's privacy \n",
      "practices or terms of use. a full discussion of the enrollee and \n",
      "beneficiary resources regarding privacy and security provision can be \n",
      "found in section iii.c.2.h. of this final rule.\n",
      "    in some circumstances, we noted that the information that we \n",
      "proposed to require be made available through an api per a patient's \n",
      "request, under the various program-specific authorities authorizing \n",
      "this rulemaking, were also consistent with the enrollee's right of \n",
      "access for their data held by a covered entity or their business \n",
      "associate under the hipaa privacy rule. but we also noted that some \n",
      "data to which an individual is entitled to access under hipaa may not \n",
      "be required to be transferred through the api. for instance, when the \n",
      "covered entity does not hold certain information electronically. in \n",
      "those instances, we noted that the inability to access data via an api \n",
      "would in no way limit or alter responsibilities and requirements under \n",
      "other law (including though not limited to the hipaa privacy, security, \n",
      "and breach notification rules) that apply to the organizations that \n",
      "would be subject to this regulation. even as these requirements are \n",
      "finalized, the organization may still be called upon to respond to \n",
      "individuals' request for information not available through the api, or \n",
      "for all of their information through means other than the api. we \n",
      "encouraged hipaa covered entities and business associates to review the \n",
      "ocr website for resources on the individual access standard at <a href=\"https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\">https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html</a> \n",
      "to ensure they understand their responsibilities.\n",
      "    we again encourage hipaa covered entities and business associates \n",
      "to review their responsibilities under hipaa in light of the recent \n",
      "decision in ciox health, llc v. azar, et al., no. 18-cv-0040 (d.d.c. \n",
      "january 23, 2020).\\16\\ the court order vacates a portion of the hipaa \n",
      "privacy rule related to the individual right of access ``insofar as it \n",
      "expands the hitech act's third-party directive beyond requests for a \n",
      "copy of an electronic health record with respect to [protected health \n",
      "information] of an individual . . . in an electronic format.'' \\17\\ \n",
      "generally, the court order vacates a portion of the hipaa privacy rule \n",
      "that provides an individual the right to direct a covered entity to \n",
      "send protected health information that is not in an ehr to a third \n",
      "party identified by the individual.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\16\\ see, <a href=\"https://ecf.dcd.uscourts.gov/cgi-bin/show_public_doc?2018cv0040-51\">https://ecf.dcd.uscourts.gov/cgi-bin/show_public_doc?2018cv0040-51</a>.\n",
      "    \\17\\ see, <a href=\"https://hds.sharecare.com/wp-content/uploads/2020/01/ciox-health-v.-hhs-court-order-3-24-2020.pdf\">https://hds.sharecare.com/wp-content/uploads/2020/01/ciox-health-v.-hhs-court-order-3-24-2020.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    this decision does not affect cms' programmatic authorities, as \n",
      "discussed in detail in section iii. of the cms interoperability and \n",
      "patient access proposed rule (83 fr 7629 through 7630) and section iii. \n",
      "of this final rule, to propose and finalize the patient access api for \n",
      "the programs specified. additionally, the court's decision did not \n",
      "alter individuals' right under hipaa to request and obtain a copy of \n",
      "their records. because the goal of the patient access api in our \n",
      "programs is to give patients access to their own information for their \n",
      "own personal use through a third-party app, we believe these policies \n",
      "as adopted in this rule remain consistent with the spirit of access \n",
      "rights under hipaa.\n",
      "    as discussed in detail below, many commenters discussed the issues \n",
      "of privacy and security in regard to information made available to \n",
      "third-party applications. here, we summarize the public comments we \n",
      "received on general issues and concerns around privacy and security of \n",
      "a standards-based api, and provide our responses.\n",
      "    comment: a few commenters supported ocr's efforts to more clearly \n",
      "account for use cases, or specific situations, in which apps are used \n",
      "to exchange patients' electronic health information. some commenters \n",
      "noted support for ocr's faq that specifies that covered entities are \n",
      "not responsible or liable for the privacy and security of phi once it \n",
      "is transmitted at the individual's direction to and received by a \n",
      "third-party application. one commenter expressed concern that cms and \n",
      "onc proposed requirements would make the safeguards of hipaa moot if \n",
      "hipaa is not extended to third-party applications that are able under \n",
      "this rule to display patient data. without extending hipaa, the \n",
      "commenter fears payers and providers will be liable if the third-party \n",
      "misuses patient data.\n",
      "    response: we appreciate the commenters' support. we reiterate that \n",
      "hipaa covered entities and business associates are responsible for \n",
      "meeting their hipaa privacy and security obligations to protect patient \n",
      "data they\n",
      "\n",
      "[[page 25518]]\n",
      "\n",
      "maintain, and absent patient requests to the contrary, are obligated to \n",
      "take reasonable measures to protect these data in transit. once these \n",
      "data are transmitted and no longer under the control of the covered \n",
      "entity or business associate, those entities no longer have any \n",
      "obligations under hipaa for the privacy and security of the phi, \n",
      "because these data are no longer subject to hipaa. we stress, as \n",
      "discussed in the cms interoperability and patient access proposed rule, \n",
      "nothing in this rule alters covered entities' or business associates' \n",
      "responsibilities to protect phi under the hipaa privacy and security \n",
      "rules.\n",
      "    the only instance per the policies proposed in this rule that would \n",
      "allow a payer to deny access to an app, as discussed in the proposed \n",
      "rule and underlying the rationale for finalizing 42 cfr 422.119(e), \n",
      "431.60(e), 438.242(b)(6) (redesignated as sec.  438.242(b)(5) see \n",
      "section vi. in this rule), 457.730(e), 457.1233(d)(2), and 45 cfr \n",
      "156.221(e), would be if the covered entity or its business associate's \n",
      "own systems would be endangered if it were to engage with a specific \n",
      "third-party application through an api, for instance if allowing such \n",
      "access would result in an unacceptable security risk. therefore, as we \n",
      "also noted, covered entities and business associates are free to offer \n",
      "advice to patients on the potential risks involved with requesting data \n",
      "transfers to an application or entity not covered by hipaa, but such \n",
      "efforts generally must stop at education and awareness or advice \n",
      "regarding concerns related to a specific app. for instance, if a payer \n",
      "notes that an app a patient requests receive their data does not lay \n",
      "out in its privacy policy specifically how the patient's personal data \n",
      "will be used, the payer could choose to inform the patient they may not \n",
      "want to share their data with that app without a clear understanding of \n",
      "how the app may use the data, including details about the app's \n",
      "secondary data use policy. if the patient still wants their data to be \n",
      "shared, or does not respond to the payer's warning, the payer would \n",
      "need to share these data via the api absent an unacceptable security \n",
      "risk to the payer's own system. for more information on this ability to \n",
      "inform patients, see section iii.c.2.g. of this final rule. the \n",
      "requirements finalized in this rule do not impact or change obligations \n",
      "under the hipaa privacy and security rules in any way.\n",
      "    comment: a few commenters noted discrepancies in the terminology \n",
      "used in the ocr faq mentioned in the cms interoperability and patient \n",
      "access proposed rule compared to terminology used throughout the cms \n",
      "interoperability and patient access proposed rule and the onc 21st \n",
      "century cures act proposed rule, and suggested that any terminology \n",
      "inconsistencies be addressed and harmonized. these commenters noted \n",
      "that the ocr faq pertains to ``electronic protected health \n",
      "information'' (ephi), and uses the term ``electronic health record \n",
      "(ehr) system developer'', which differs from terms used in the cms \n",
      "interoperability and patient access and the onc 21st century cures act \n",
      "proposed rules.\n",
      "    response: we appreciate comments regarding variance in the \n",
      "terminology used in ocr guidance and the cms interoperability and \n",
      "patient access proposed rule. regarding the relationship between ephi \n",
      "and electronic health information (ehi), we refer readers to the \n",
      "discussion in the onc 21st century cures act final rule (published \n",
      "elsewhere in this issue of the federal register). ocr guidance uses the \n",
      "term ``electronic health record system developer'' \\18\\ to refer to a \n",
      "health it developer that develops and maintains electronic health \n",
      "record systems containing phi for a covered entity, and therefore is a \n",
      "business associate of those covered entities. the guidance also uses \n",
      "``app developer'' to describe the creator of the app that is designated \n",
      "to receive an individual's phi. onc uses related terms that have a \n",
      "specific meaning within the context of onc programs. for instance, onc \n",
      "uses the term ``health it developer'' for the purposes of the onc \n",
      "health it certification program to refer to a vendor, self-developer, \n",
      "or other entity that presents health it for certification or has health \n",
      "it certified under the program. in addition, the onc 21st century cures \n",
      "act proposed rule proposed to define the term ``health it developer of \n",
      "certified health it'' for the purposes of implementing provisions of \n",
      "the cures act (84 fr 7510). we do not use these onc program-specific \n",
      "terms in this cms rule. we simply refer to any developer of a third-\n",
      "party app, of which an electronic record systems developer may be one.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\18\\ see office of the national coordinator. (n.d.). health \n",
      "information technology. retrieved from <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/health-information-technology/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/health-information-technology/index.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    comment: one commenter requested clarification on a covered \n",
      "entity's liability under hipaa if a patient transfers their health \n",
      "information from a covered entity's mobile access portal or application \n",
      "to a third-party application not covered under hipaa.\n",
      "    response: as noted above, hipaa covered entities and business \n",
      "associates are responsible for meeting their hipaa privacy and security \n",
      "obligations to protect patient data they maintain, and absent patient \n",
      "requests to the contrary, are obligated to take reasonable measures to \n",
      "protect these data in transit. once these data are received by a third-\n",
      "party and no longer under the control of the covered entity or its \n",
      "business associate, the covered entity and business associate are not \n",
      "liable for the privacy and security of the phi or any electronic health \n",
      "information sent. while hipaa covered entities and their business \n",
      "associates may notify patients of their potential concerns regarding \n",
      "exchanging data with a specific third-party not covered by hipaa, they \n",
      "are not required to do so, and they may not substitute their own \n",
      "judgment for that of the patient requesting the data be transferred.\n",
      "    comment: several commenters recommended that cms include a safe \n",
      "harbor provision in the regulatory text of this final rule to indicate \n",
      "that plans and providers are not responsible for the downstream privacy \n",
      "and security of phi.\n",
      "    response: regarding commenters' interest in a ``safe harbor'' \n",
      "provision for covered entities when data is transmitted to a third-\n",
      "party app, we do not have the authority, nor do we believe it is \n",
      "necessary, to incorporate these principles in a safe harbor provision \n",
      "under the hipaa privacy and security rules. covered entities and \n",
      "business associates are not responsible for the data after the data \n",
      "have been received by the intended recipient. this has been taken into \n",
      "account in developing the requirements for the patient access api.\n",
      "    comment: several commenters expressed concerns that app developers \n",
      "are not subject to many of the current laws protecting the privacy and \n",
      "security of electronic health information. several commenters requested \n",
      "that hhs specify what requirements non-hipaa covered app developers \n",
      "will be subject to.\n",
      "    response: we appreciate the commenters' concerns. as discussed in \n",
      "the cms interoperability and patient access proposed rule (84 fr 7622), \n",
      "hipaa protections do not extend to third-party apps (that is, software \n",
      "applications from entities that are not covered entities or business \n",
      "associates). however, the ftc has the authority to investigate and take \n",
      "action against unfair or deceptive trade practices under the ftc act \n",
      "and the ftc health breach notification rule when a third-party app does \n",
      "not adhere to the stated privacy policy. we have shared these comments \n",
      "with the ftc. state laws may provide additional protections as well.\n",
      "\n",
      "[[page 25519]]\n",
      "\n",
      "although cms cannot regulate the third-party apps directly, and thus \n",
      "cannot establish specific requirements for them, we are sharing best \n",
      "practices and lessons learned from our experience with blue button 2.0, \n",
      "as applicable, with app developers to further support strong privacy \n",
      "and security practices: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>. also, as previously noted, payers will \n",
      "be required to share educational resources with patients regarding how \n",
      "to choose a third-party application while protecting their health \n",
      "information. further, as discussed in section iii. of this final rule, \n",
      "we are providing payers with a framework they can use to request that \n",
      "third-party apps attest to covering certain criteria in their privacy \n",
      "policy, such as information about secondary data use, which payers can \n",
      "use to educate patients about their options.\n",
      "    in addition, there are technical requirements for apis defined in \n",
      "the onc 21st century cures act proposed rule, and finalized by hhs in \n",
      "onc's final rule (published elsewhere in this issue of the federal \n",
      "register) at 45 cfr 170.215, that enable and support persistent user \n",
      "authentication and app authorization processes. it is important to \n",
      "clarify that any app accessing the patient access api would be doing so \n",
      "only with the approval and at the direction of the specific patient. \n",
      "while these technical standards at 45 cfr 170.215 establish the \n",
      "requirements for the api itself, when implemented, these technical \n",
      "standards in turn set requirements on the app developer for the app's \n",
      "identity proofing and authentication processes that must be met in \n",
      "order to connect to the api and access the specific patient's data \n",
      "through the api, as further discussed in section iii. of this final \n",
      "rule. these technical requirements do not, however, address concerns \n",
      "around data security and use once data are with the third-party. this \n",
      "level of privacy and security would be addressed in the app's terms and \n",
      "conditions or privacy notice.\n",
      "    comment: many commenters expressed concern regarding the secondary \n",
      "use of health information by business partners of third-party \n",
      "applications. a few commenters noted that consumers may not always be \n",
      "aware of the business partners of third-party apps, especially as this \n",
      "information is typically part of a lengthy privacy notice or dense or \n",
      "difficult to understand terms and conditions.\n",
      "    response: we appreciate the commenters' concerns. as noted, we do \n",
      "not have the authority to directly regulate third-party apps. as a \n",
      "result, we cannot dictate how an app uses or shares data. we have \n",
      "chosen to require payers to educate patients about how to choose a \n",
      "third-party app that best mitigates potentially risks related to \n",
      "secondary data uses. one way we will address these concerns is to offer \n",
      "payers and app developers best practices from our own experiences using \n",
      "a patient-centered privacy policy, particularly related to blue button \n",
      "2.0. as we discuss in section iii.c.2.h. of this final rule, we \n",
      "recognize that the payers that will be subject to the api provisions of \n",
      "this final rule are in the best position to ensure that patients have \n",
      "the information that they need to critically assess the privacy and \n",
      "security of their designated third-party options, and may be best \n",
      "situated to identify for patients the potential implications of sharing \n",
      "data and to advise a patient if there is a breach of their data. this \n",
      "is why we proposed and are finalizing a requirement at 42 cfr \n",
      "422.119(g), 431.60(f), 457.730(f), 438.242(b)(5) (proposed as sec.  \n",
      "438.242(b)(6) see section vi. in this rule), and 457.1233(d)(2), and 45 \n",
      "cfr 156.221(g), detailing the beneficiary and enrollee resources \n",
      "regarding consumer-friendly, patient facing privacy and security \n",
      "information that must be made available on the websites of the payers \n",
      "subject to this final rule. as discussed in greater detail in section \n",
      "iii.c.2.h. of this final rule, cms will be providing payers with \n",
      "suggested content they can consult and tailor as they work to produce \n",
      "the required patient resource document. we are also sharing best \n",
      "practices and links to model language of an easy-to-understand, non-\n",
      "technical, consumer-friendly privacy policy, again building off of our \n",
      "lessons learned with blue button 2.0, to support payers and developers \n",
      "in this effort: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>. also, as noted above, we discuss in section \n",
      "iii. of this final rule, a framework payers can use to request that \n",
      "third-party apps attest to covering certain criteria in their privacy \n",
      "policy, such as information about secondary data use. it will be \n",
      "important to encourage patients' understanding of app privacy policies, \n",
      "including secondary use policies. the policies we are finalizing in \n",
      "this rule help us support payers and developers as they work to make \n",
      "sure patients are informed consumers through education and awareness, \n",
      "and that patients understand their rights.\n",
      "    comment: several commenters expressed concerns over the complexity \n",
      "of overlapping federal and state privacy laws, which they noted would \n",
      "be perpetuated by uncertainty in privacy and security requirements when \n",
      "apps become more widely used in the health care space. these commenters \n",
      "requested work be done to harmonize state and federal privacy laws. \n",
      "another commenter recommended that congress enact comprehensive \n",
      "consumer privacy protections.\n",
      "    response: we appreciate these commenters' concerns and \n",
      "recommendations. however, these comments are beyond the scope of this \n",
      "regulation.\n",
      "    comment: several commenters recommended that cms work closely with \n",
      "other hhs agencies and the ftc to establish a transparent regulatory \n",
      "framework for safeguarding the privacy and security of patient \n",
      "electronic health information shared with apps. a few commenters \n",
      "recommended cms establish workgroups to share experiences and technical \n",
      "assistance for implementing privacy and security approaches.\n",
      "    response: we appreciate the commenters' suggestions. as noted \n",
      "above, we have shared commenter's concerns with the ftc and relevant \n",
      "hhs operating divisions, such as ocr.\n",
      "3. specific technical approach and standards\n",
      "    achieving interoperability throughout the health system is \n",
      "essential to achieving an effective, value-conscious health system \n",
      "within which consumers are able to choose from an array of health plans \n",
      "and providers. an interoperable system should ensure that consumers can \n",
      "both easily access their electronic health information held by plans \n",
      "and routinely expect that their claims, encounter, and other relevant \n",
      "health history information will follow them smoothly from plan to plan \n",
      "and provider to provider without burdensome requirements for them or \n",
      "their providers to reassemble or re-document the information. ready \n",
      "availability of health information can be especially helpful when an \n",
      "individual cannot access their usual source of care, for instance if \n",
      "care is needed outside their regular provider's business hours, while \n",
      "traveling, or in the wake of a natural disaster.\n",
      "    the proposals described in section iii.c.2. of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7628 through \n",
      "7639) would impose new requirements on ma organizations, medicaid and \n",
      "chip ffs programs, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers on the ffes (excluding issuers offering only \n",
      "sadps or issuers in the ff-shop,\n",
      "\n",
      "[[page 25520]]\n",
      "\n",
      "unless otherwise noted) to implement standardized, transparent apis. \n",
      "using the api, these entities would be required to provide current \n",
      "enrollees with specified claims and encounter data and certain clinical \n",
      "information if such information is maintained. we proposed that these \n",
      "entities would also be required to make available through the api \n",
      "information already required to be widely available, including provider \n",
      "directory and plan coverage information, such as formulary information. \n",
      "in developing the proposal delineating the information that would be \n",
      "required to be made available through an api, consistent with the \n",
      "proposed technical requirements, we were guided by an intent to have \n",
      "available through the api all of the individual's electronic health \n",
      "information held by the payer in electronic format that is compatible \n",
      "with the api or that can, through automated means, be formatted to be \n",
      "accurately rendered through the api. we were also guided by an intent \n",
      "to make available through standardized, secure api technology all of \n",
      "the provider directory and formulary information maintained by the \n",
      "impacted payers that can be made compatible with the api.\n",
      "    both the api technology itself and the data it makes available must \n",
      "be standardized to support true interoperability. therefore, as \n",
      "discussed in detail in the proposed rule, we proposed to require \n",
      "compliance with both (1) onc's 21st century cures act rule proposed \n",
      "regulations regarding content and vocabulary standards for representing \n",
      "electronic health information as finalized and (2) technical standards \n",
      "for an api by which the electronic health information would be required \n",
      "to be made available as finalized. for the proposals described in \n",
      "section iii.c.2.b. of the cms interoperability and patient access \n",
      "proposed rule (which addressed transmissions for purposes other than \n",
      "those covered by hipaa transaction standards, with which all the payers \n",
      "subject to this final rule will continue to be required to comply under \n",
      "45 cfr part 162), we proposed requiring compliance with the \n",
      "interoperability standards proposed for hhs adoption in the onc 21st \n",
      "century cures act proposed rule (84 fr 7424) as finalized.\n",
      "    in proposing to require that regulated entities comply with onc-\n",
      "proposed regulations for non-hipaa covered transactions (84 fr 7424) \n",
      "and therefore, requiring the use of specified standards, we noted that \n",
      "we intended to preclude regulated entities from implementing api \n",
      "technology using alternative technical standards to those onc proposed \n",
      "for hhs adoption at 45 cfr 170.215, which details the api technical \n",
      "standards, including the use of fhir. other technical standards that \n",
      "would be precluded include, but are not limited to, those not widely \n",
      "used to exchange electronic health information in the u.s. health \n",
      "system. we further noted that we intended to preclude entities from \n",
      "using earlier versions of the technical standards adopted at 45 cfr \n",
      "170.215 by requiring compliance with only specified provisions of 45 \n",
      "cfr part 170, and deliberately excluding others. we also discussed how \n",
      "by proposing to require use of the proposed content and vocabulary \n",
      "standards as finalized by requiring compliance with 42 cfr 423.160 and \n",
      "45 cfr part 162, and proposed at 45 cfr 170.213, we intended to \n",
      "prohibit use of alternative standards that could potentially be used \n",
      "for these same data classes and elements, as well as earlier versions \n",
      "of the adopted standards named in 42 cfr 423.160, 45 cfr part 162, and \n",
      "proposed at 45 cfr 170.213.\n",
      "    while we generally intended to preclude regulated entities from \n",
      "using content and vocabulary standards other than those described in 42 \n",
      "cfr 423.160, 45 cfr part 162, or proposed 45 cfr 170.213 (and technical \n",
      "standards at 45 cfr 170.215), we recognized there may be circumstances \n",
      "that render the use of other content and vocabulary alternatives \n",
      "necessary. as discussed below, we proposed to allow the use of \n",
      "alternative content and vocabulary standards in two circumstances. \n",
      "first, where other content or vocabulary standards are expressly \n",
      "mandated by applicable law, we proposed to permit use of those other \n",
      "mandated standards. second, where no appropriate content or vocabulary \n",
      "standard exists within 45 cfr part 162, 42 cfr 423.160, or proposed 45 \n",
      "cfr 170.213 and 170.215, we proposed we would permit use of any \n",
      "suitable gap-filling options, as may be applicable to the specific \n",
      "situation.\n",
      "    we used two separate rulemakings because the 21st century cures act \n",
      "proposed rule (84 fr 7424), which included api interoperability \n",
      "standards proposed for hhs adoption, would have broader reach than the \n",
      "scope of the cms interoperability and patient access proposed rule (84 \n",
      "fr 7610). at the same time, we wished to assure stakeholders that the \n",
      "api standards required of ma organizations, state medicaid agencies, \n",
      "state chip agencies, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers on the ffes under the proposal would be \n",
      "consistent with the api standards proposed by onc for hhs adoption \n",
      "because we would require that the regulated entities follow specified, \n",
      "applicable provisions of the onc-proposed requirements as finalized.\n",
      "    requiring that cms-regulated entities comply with the regulations \n",
      "regarding standards finalized by hhs in onc's 21st century cures act \n",
      "rule will support greater interoperability across the health care \n",
      "system, as health it products and applications that would be developed \n",
      "for different settings and use cases would be developed according to a \n",
      "consistent base of standards that supports more seamless exchange of \n",
      "information. in the cms interoperability and patient access proposed \n",
      "rule, we welcomed public comment on our proposal to require compliance \n",
      "with the standards proposed for adoption by hhs through onc's 21st \n",
      "century cures act proposed rule, as well as on the best method to \n",
      "provide support in identifying and implementing the applicable content \n",
      "and vocabulary standards for a given data element.\n",
      "    finally, while noting that we believed that the proposal to require \n",
      "compliance with the standards proposed by onc for hhs adoption was the \n",
      "best approach, we sought public comment on any alternative by which cms \n",
      "would separately adopt the standards proposed for adoption in the onc \n",
      "21st century cures act proposed rule and identified throughout the cms \n",
      "interoperability and patient access proposed rule, as well as future \n",
      "interoperability, content, and vocabulary standards. we stated that we \n",
      "anticipated any alternative would include incorporating by reference \n",
      "the fhir r2, r3, and/or r4 based on comments and oauth 2.0 technical \n",
      "standards and the uscdi version 1 content and vocabulary standard \n",
      "(described in sections ii.a.3.b. and ii.a.3.a. of the cms \n",
      "interoperability and patient access proposed rule, respectively) in cms \n",
      "regulation to replace the proposed references to onc regulations at 45 \n",
      "cfr 170.215, 170.213, and 170.205, respectively. however, we \n",
      "specifically sought comment on whether this alternative would present \n",
      "an unacceptable risk of creating multiple regulations requiring \n",
      "standards or versions of standards across hhs' programs, and an \n",
      "assessment of the benefits or burdens of separately adopting new \n",
      "standards and incorporating updated versions of standards in cfr text \n",
      "on a program by program basis. furthermore, we sought comment on: how \n",
      "such an option might impact health it development timelines; how \n",
      "potentially creating multiple regulations regarding standards over time \n",
      "across hhs might impact system implementation; and other\n",
      "\n",
      "[[page 25521]]\n",
      "\n",
      "factors related to the technical aspect of implementing these \n",
      "requirements.\n",
      "    we summarize the public comments we received regarding separately \n",
      "adopting standards in this cms rule and provide our responses.\n",
      "    comment: many commenters supported cms' proposed alignment with the \n",
      "standards proposed in onc's 21st century cures act proposed rule to be \n",
      "adopted by hhs to promote interoperability, noting it was the most \n",
      "effective and efficient approach. commenters explained that this \n",
      "alignment was critical to ensure interoperability across the health \n",
      "care industry, and overwhelmingly preferred ``one source of truth'' for \n",
      "all standards referenced in the cms interoperability and patient access \n",
      "proposed rule. these commenters explained having highly technical \n",
      "standards, including content and vocabulary standards, in different cms \n",
      "and onc regulations would create the potential for error and \n",
      "misalignment of standards or versions of standards across hhs programs. \n",
      "commenters supported alignment across agencies, and indicated concern \n",
      "that if the standards were adopted in different regulations, it would \n",
      "complicate the process of updating the standards when necessary, and \n",
      "increase the cost and burden of data capture, data management, and data \n",
      "exchange. commenters did note opportunities for even greater alignment \n",
      "across the cms and onc rulemakings at the data element level, \n",
      "indicating that the onc rule should include all data elements required \n",
      "in the cms rule, specifically calling out data elements in an \n",
      "explanation of benefits (eob) not specifically included in the uscdi \n",
      "(proposed for codification at 45 cfr 170.213).\n",
      "    response: we appreciate the commenters' support for alignment of \n",
      "the regulations adopted in this final rule with the standards as \n",
      "finalized by hhs in the onc 21st century cures act final rule \n",
      "(published elsewhere in this issue of the federal register). we agree \n",
      "that the best way to ensure continued alignment is to have the \n",
      "regulations we are adopting here--governing ma organizations, state \n",
      "medicaid ffs programs, medicaid managed care plans, chip ffs programs, \n",
      "chip managed care entities, and qhp issuers on the ffes--cross \n",
      "reference the specific regulations codifying the standards adopted by \n",
      "hhs in the onc 21st century cures act final rule. our intent is to \n",
      "ensure alignment and consistent standards across the regulated \n",
      "programs. we agree that this will help support interoperability across \n",
      "the health care industry and help set clear and consistent goals for \n",
      "all payers, providers, vendors, and developers. cms and onc will \n",
      "continue to coordinate closely on standards, including content and \n",
      "vocabulary standards and impacted data elements and use cases, and we \n",
      "will continue to work closely with all stakeholders to ensure that this \n",
      "process is consensus-based. regarding the recommendation to add data \n",
      "elements from the eob not yet included in the uscdi, we have shared \n",
      "these recommendations with onc, and we refer readers to the discussion \n",
      "in onc's 21st century cures act final rule on the uscdi and the \n",
      "standards version advancement process (published elsewhere in this \n",
      "issue of the federal register).\n",
      "\n",
      "b. content and vocabulary standards\n",
      "\n",
      "    the content and vocabulary standards hhs ultimately adopts \n",
      "applicable to the data provided through the standards-based api will, \n",
      "by necessity, vary by use case and within a use case. for instance, \n",
      "content and vocabulary standards supporting consumer access vary \n",
      "according to what specific data elements ma organizations, medicaid and \n",
      "chip ffs programs, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers on the ffes have available electronically. \n",
      "where another law does not require use of a specific standard, we \n",
      "proposed to require use of, in effect, a catalogue of content and \n",
      "vocabulary standards from which the regulated entities may choose in \n",
      "order to satisfy the proposed requirements in 42 cfr 422.119, 431.60, \n",
      "457.730, 438.252, and 457.1233, and 45 cfr 156.221. a further \n",
      "discussion of these proposals can be found in section ii.b. of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7623 through \n",
      "7624). these proposals are detailed in section iii.c.2.b. of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7626 through \n",
      "7639), and comments received on these proposals are summarized with our \n",
      "responses in section iii.c.2.b. of this final rule. specifically, we \n",
      "note that we proposed to adopt the content and vocabulary standards as \n",
      "finalized by hhs in onc's 21st century cures act final rule (published \n",
      "elsewhere in this issue of the federal register) at 45 cfr 170.213. \n",
      "this standard is currently the uscdi version 1.\n",
      "\n",
      "c. application programming interface (api) standard\n",
      "\n",
      "    in section iii.c.2.b. of the cms interoperability and patient \n",
      "access proposed rule, we proposed to require compliance with the api \n",
      "technical standard proposed by onc for hhs adoption at 45 cfr 170.215 \n",
      "as finalized (84 fr 7589). by requiring compliance with 45 cfr 170.215, \n",
      "we proposed to require use of the foundational health level 7[supreg] \n",
      "(hl7) \\19\\ fast healthcare interoperability resources[supreg] (fhir) \n",
      "standard,\\20\\ several implementation specifications specific to fhir, \n",
      "and complementary security and app registration protocols, specifically \n",
      "the substitutable medical applications, reusable technologies (smart) \n",
      "application launch implementation guide (ig) 1.0.0 (including mandatory \n",
      "support for ``refresh tokens,'' ``standalone launch,'' and ``ehr \n",
      "launch'' requirements), which is a profile of the oauth 2.0 \n",
      "specification, as well as the openid connect core 1.0 standard, \n",
      "incorporating errata set 1. a further discussion of these proposals can \n",
      "be found in section ii.c. (84 fr 7624 through 7625) and the proposals \n",
      "are detailed in section iii. of the cms interoperability and patient \n",
      "access proposed rule (84 fr 7626 through 7639). comments received on \n",
      "these proposals are summarized with our responses in section iii. of \n",
      "this final rule.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\19\\ health level seven international[supreg] (hl7) is a not-\n",
      "for-profit, ansi-accredited standards development organization (sdo) \n",
      "focused on developing consensus standards for the exchange, \n",
      "integration, sharing, and retrieval of electronic health information \n",
      "that supports clinical practice and the management, delivery and \n",
      "evaluation of health services. learn more at ``about hl7'' web page, \n",
      "last accessed 06/27/2018.\n",
      "    \\20\\ fhir overview. (n.d.). retrieved from <a href=\"https://www.hl7.org/fhir/overview.html\">https://www.hl7.org/fhir/overview.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we proposed to adopt the technical standards as finalized by hhs in \n",
      "the onc 21st century cures act final rule (published elsewhere in this \n",
      "issue of the federal register) at 45 cfr 170.215. hhs is finalizing \n",
      "adoption of hl7 fhir release 4.0.1 as the foundational standard for \n",
      "apis at 45 cfr 170.215(a)(1). instead of the argonaut ig and server to \n",
      "support exchange of the uscdi proposed at 45 cfr 170.215(a)(3) and \n",
      "(a)(4) (84 fr 7424), hhs is finalizing the hl7 fhir us core ig stu \n",
      "3.1.0 at 45 cfr 170.215(a)(2). the hl7 smart application launch \n",
      "framework ig release 1.0.0 was proposed at 45 cfr 170.215(a)(5) (84 fr \n",
      "7424). hhs is finalizing the hl7 smart application launch framework ig \n",
      "release 1.0.0 (which is a profile of the oauth 2.0 specification), \n",
      "including mandatory support for the ``smart on fhir core \n",
      "capabilities,'' at 45 cfr 170.215(a)(3). hhs is finalizing as proposed \n",
      "adoption of openid connect core 1.0, incorporating errata set 1 at 45 \n",
      "cfr 170.215(b), as well as adoption of version 1.0.0: stu 1 of the fhir \n",
      "bulk data access specification at 45 cfr\n",
      "\n",
      "[[page 25522]]\n",
      "\n",
      "170.215(a)(4). hhs is not finalizing the adoption of fhir release 2 or \n",
      "fhir release 3, api resource collection in health (arch) version 1, or \n",
      "the hl7 consent2share fhir consent profile design that were proposed at \n",
      "45 cfr 170.215(a)(1), (c)(1), (a)(2), or (c)(2), respectively (84 fr \n",
      "7424). for a full discussion, see the onc 21st century cures act final \n",
      "rule (published elsewhere in this issue of the federal register). the \n",
      "content and vocabulary standards and technical standards finalized by \n",
      "hhs in the onc 21st century cures act final rule provide the foundation \n",
      "needed to support implementation of the policies as proposed and now \n",
      "finalized in this rule.\n",
      "\n",
      "d. updates to standards\n",
      "\n",
      "    in addition to efforts to align standards across hhs, we recognized \n",
      "in the proposed rule that while we must codify in regulation a specific \n",
      "version of each standard, the need for continually evolving standards \n",
      "development has historically outpaced our ability to amend regulatory \n",
      "text. to address how standards development can outpace our rulemaking \n",
      "schedule, we proposed in section iii.c.2.b. of the cms interoperability \n",
      "and patient access proposed rule (84 fr 7630 through 7631) that \n",
      "regulated entities may use updated versions of required standards if \n",
      "use of the updated version is required by other applicable law. in \n",
      "addition, under certain circumstances, we proposed to allow use of an \n",
      "updated version of a standard if the standard is not prohibited under \n",
      "other applicable law.\n",
      "    for content and vocabulary standards at 45 cfr part 162 or 42 cfr \n",
      "423.160, we proposed to allow the use of an updated version of the \n",
      "content or vocabulary standard adopted under rulemaking, unless the use \n",
      "of the updated version of the standard: is prohibited for entities \n",
      "regulated by that part or the program under that section; is prohibited \n",
      "by the secretary for purposes of these policies or for use in onc's \n",
      "health it certification program; or is precluded by other applicable \n",
      "law. we remind readers that other applicable law includes statutes and \n",
      "regulations that govern the specific entity. for the content and \n",
      "vocabulary standards proposed by onc for hhs adoption at 45 cfr 170.213 \n",
      "(84 fr 7589) (currently, uscdi version 1),\\21\\ as well as for api \n",
      "technical standards proposed by onc for hhs adoption at 45 cfr 170.215 \n",
      "(84 fr 7589) (including hl7 fhir and other standards and implementation \n",
      "guides (igs) as discussed above),\\22\\ we proposed to allow the use of \n",
      "an updated version of a standard adopted by hhs, provided such updated \n",
      "version has been approved by the national coordinator through the \n",
      "standards version advancement process described in the onc 21st century \n",
      "cures act proposed rule (84 fr 7424), as finalized. a further \n",
      "discussion of these proposals can be found in section ii.d. of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7625 through \n",
      "7626). these proposals are also detailed in section iii. of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7626 through \n",
      "7639), and comments received on these proposals are summarized with our \n",
      "responses in section iii. of this final rule.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\21\\ for more information on the uscdi, see <a href=\"https://www.healthit.gov/uscdi\">https://www.healthit.gov/uscdi</a>.\n",
      "    \\22\\ for more information on fhir, see <a href=\"https://www.hl7.org/fhir/overview.html\">https://www.hl7.org/fhir/overview.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "iii. provisions of patient access through apis, and analysis of and \n",
      "responses to public comments\n",
      "\n",
      "a. background on medicare blue button\n",
      "\n",
      "    as discussed in the cms interoperability and patient access \n",
      "proposed rule (84 fr 7626), we are committed to advancing \n",
      "interoperability, putting patients at the center of their health care, \n",
      "and ensuring they have simple and easy access, without special effort, \n",
      "to their health information. with the establishment of the initial \n",
      "medicare blue button[supreg] service in 2010, medicare beneficiaries \n",
      "became able to download their part a, part b, and part d health care \n",
      "claims and encounter data through <a href=\"http://mymedicare.gov\">mymedicare.gov</a> in either pdf or text \n",
      "format. while the original blue button effort was a first step toward \n",
      "liberating patient health information, we recognized that significant \n",
      "opportunities remain to modernize access to that health information and \n",
      "the ability to share health information across the health ecosystem. we \n",
      "believe that moving to a system in which patients have access to and \n",
      "use of their health information will empower them to make better \n",
      "informed decisions about their health care. additionally, \n",
      "interoperability, and the ability for health information systems and \n",
      "software applications to communicate, exchange, and interpret health \n",
      "information in a usable and readable format, is vital to improving \n",
      "health care. allowing access to health information only through pdf and \n",
      "text formats limit the utility of and the ability to effectively share \n",
      "the health information.\n",
      "    medicare blue button 2.0 is a new, modernized version of the \n",
      "original blue button service. it enables beneficiaries to access their \n",
      "medicare parts a, b, and d claims and encounter data and share that \n",
      "electronic health information through an application programming \n",
      "interface (api) with applications, services, and research programs they \n",
      "select. as discussed in section ii.a. of the cms interoperability and \n",
      "patient access proposed rule (see 84 fr 7618 through 7623), api \n",
      "technology allows software from different developers to connect with \n",
      "one another and exchange electronic health information in electronic \n",
      "formats that can be more easily compiled and leveraged by patients and \n",
      "their caregivers. beneficiaries may also select third-party \n",
      "applications to compile and leverage their electronic health \n",
      "information to help them manage their health and engage in a more fully \n",
      "informed way in their health care.\n",
      "    today, blue button 2.0 contains 4 years of medicare part a, b, and \n",
      "d data for 53 million medicare beneficiaries. these data are available \n",
      "to patients to help them make more informed decisions. beneficiaries \n",
      "dictate how their data can be used and by whom, with identity and \n",
      "authorization controlled through <a href=\"http://mymedicare.gov\">mymedicare.gov</a>. medicare beneficiaries \n",
      "can authorize sharing their information with an application using their \n",
      "<a href=\"http://mymedicare.gov\">mymedicare.gov</a> account information. beneficiaries authorize each \n",
      "application, service, or research program they wish to share their data \n",
      "with individually. a beneficiary can go back to <a href=\"http://mymedicare.gov\">mymedicare.gov</a> at any \n",
      "time and change the way an application uses their information. using \n",
      "blue button 2.0, beneficiaries can access their health information; \n",
      "share it with doctors, caregivers, or anyone they choose; and get help \n",
      "managing and improving their health through a wide range of apps and \n",
      "other computer-based services. blue button 2.0 is an optional service--\n",
      "beneficiaries choose the apps and services they want to use.\n",
      "    today, medicare beneficiaries using blue button 2.0 can connect \n",
      "with apps that keep track of tests and services they need and receive \n",
      "reminders, track their medical claims, make appointments and send \n",
      "messages to their doctors, get personalized information about their \n",
      "symptoms and medical conditions, find health and drug plans, keep track \n",
      "of their medical notes and questions, and connect to research \n",
      "projects.\\23\\ these are\n",
      "\n",
      "[[page 25523]]\n",
      "\n",
      "just some of the ways blue button 2.0 is using a standards-based, fhir-\n",
      "enabled api to lead the charge and unleash the power of health data.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\23\\ to review a list of apps currently available to blue button \n",
      "2.0 users, visit <a href=\"https://www.medicare.gov/manage-your-health/medicares-blue-button-blue-button-20/blue-button-apps\">https://www.medicare.gov/manage-your-health/medicares-blue-button-blue-button-20/blue-button-apps</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "b. expanding the availability of health information\n",
      "\n",
      "1. patient benefits of information access\n",
      "    as discussed in the cms interoperability and patient access \n",
      "proposed rule, we believe there are numerous benefits associated with \n",
      "individuals having simple and easy access to their health care data \n",
      "under a standard that is widely used. whereas ehr data are frequently \n",
      "locked in closed, disparate health systems, care and treatment \n",
      "information in the form of claims and encounter data is comprehensively \n",
      "combined in a patient's claims and billing history. claims and \n",
      "encounter data, used in conjunction with ehr data, can offer a broader \n",
      "and more holistic understanding of an individual's interactions with \n",
      "the health care system than ehr data alone. as one example, \n",
      "inconsistent benefit utilization patterns in an individual's claims \n",
      "data, such as a failure to fill a prescription or receive recommended \n",
      "therapies, can indicate that the individual has had difficulty \n",
      "financing a treatment regimen and may require less expensive \n",
      "prescription drugs or therapies, additional explanation about the \n",
      "severity of their condition, or other types of assistance. identifying \n",
      "and finding opportunities to address the individual's non-adherence to \n",
      "a care plan are critical to keeping people with chronic conditions \n",
      "healthy and engaged so they can avoid hospitalizations. while a health \n",
      "plan can use claims and encounter data to help it identify which \n",
      "enrollees could benefit from an assessment of why they are not filling \n",
      "their prescriptions or who might be at risk for particular problems, \n",
      "putting this information into the hands of the individual's chosen care \n",
      "provider--such as the doctor or nurse practitioner prescribing the \n",
      "medications or the pharmacist who fills the prescriptions--helps them \n",
      "to engage the patient in shared decision making that can help address \n",
      "some of the reasons the individual might not be willing or able to take \n",
      "medications as prescribed. by authorizing their providers to access the \n",
      "same information through a standards-based api, individuals can further \n",
      "facilitate communication with their care teams. enabling the provider \n",
      "to integrate claims and encounter information with ehr data gives the \n",
      "provider the ability to use the combined information, with relevant \n",
      "clinical decision support tools, as part of normal care delivery in a \n",
      "less burdensome way, leading to improved care. this may be particularly \n",
      "important during times of system surge, an event that generates a large \n",
      "and sudden demand for health services, for example, when access to such \n",
      "information may help to inform patient triage, transfer, and care \n",
      "decisions.\n",
      "    further, we noted that we believe patients who have immediate \n",
      "electronic access to their health information are empowered to make \n",
      "more informed decisions when discussing their health needs with \n",
      "providers, or when considering changing to a different health plan. we \n",
      "discussed that currently not all beneficiaries enrolled in ma plans \n",
      "have immediate electronic access to their claims and encounter data and \n",
      "those who do have it, cannot easily share it with providers or others. \n",
      "the same is true of medicaid beneficiaries and chip enrollees, whether \n",
      "enrolled in ffs or managed care programs, and enrollees in qhps on the \n",
      "ffes. as industries outside of health care continue to integrate \n",
      "multiple sources of data to understand and predict their consumers' \n",
      "needs, we believe it is important to position ma organizations, \n",
      "medicaid and chip ffs programs and managed care entities, and qhp \n",
      "issuers on the ffes to do the same to encourage competition, \n",
      "innovation, and value.\n",
      "    we noted that cms has programmatic authority over ma organizations, \n",
      "medicaid programs (both ffs and managed care), chip (both ffs and \n",
      "managed care), and qhp issuers on the ffes. we proposed to leverage cms \n",
      "authority to make claims and encounter data available through apis as a \n",
      "means to further access for patients in these programs along with other \n",
      "plan data (such as provider directory data) as detailed in sections \n",
      "iii.c. and iv. of the cms interoperability and patient access proposed \n",
      "rule. for a complete discussion of these proposals, see the proposed \n",
      "rule (84 fr 7626 through 7640).\n",
      "2. alignment with the hipaa right of access\n",
      "    as discussed in section ii. of this final rule, the recent decision \n",
      "in ciox health, llc v. azar, et al. vacates a portion of the hipaa \n",
      "privacy rule that provides an individual the right to direct a covered \n",
      "entity to send protected health information that is not in an ehr to a \n",
      "third party identified by the individual. it does not alter a patient's \n",
      "right to request access to their records. in addition, the decision \n",
      "does not affect cms' programmatic authorities, as discussed in detail \n",
      "in section iii. of the cms interoperability and patient access proposed \n",
      "rule (83 fr 7629 through 7630) and later in this section of this final \n",
      "rule. prior to this decision, in the cms interoperability and patient \n",
      "access proposed rule, we discussed that the hipaa privacy rule, at 45 \n",
      "cfr 164.524, provides that an individual has a right of access to \n",
      "inspect and obtain a copy of their phi \\24\\ that is maintained by or on \n",
      "behalf of a covered entity (a health plan or covered health care \n",
      "provider \\25\\) in a designated record set.\\26\\ it was noted that, at \n",
      "that time, a covered entity was required to provide the access in any \n",
      "readily producible form and format requested by the individual, and \n",
      "that the right of access also includes individual's right to direct a \n",
      "covered entity to transmit phi directly to a third party the individual \n",
      "designates to receive it.\\27\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\24\\ see 45 cfr 160.103, definition of protected health \n",
      "information.\n",
      "    \\25\\ the third type of hipaa covered entity, a health care \n",
      "clearinghouse, is not subject to the same requirements as other \n",
      "covered entities with respect to the right of access. see 45 cfr \n",
      "164.500(b).\n",
      "    \\26\\ see 45 cfr 164.501, definition of designated record set.\n",
      "    \\27\\ for more information, see <a href=\"https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html\">https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/access/index.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we explained that software applications using the patient access \n",
      "api proposed at 42 cfr 422.119, 431.60, 438.242(b)(6) (finalized as \n",
      "438.242(b)(5) in this rule; see section vi.), 457.730, and \n",
      "457.1233(d)(2), and 45 cfr 156.221, and further discussed below, would \n",
      "provide an additional mechanism through which the individuals who so \n",
      "choose could exercise the hipaa right of access to their phi, by giving \n",
      "them a simple and easy electronic way to request, receive, and share \n",
      "data they want and need, including with a designated third party. \n",
      "however, as discussed in section ii. of the cms interoperability and \n",
      "patient access proposed rule (84 fr 7621 through 7622), due to \n",
      "limitations in the current availability of interoperability standards \n",
      "for some types of health information, or data, we noted the api \n",
      "requirement may not be sufficient to support access to all of the phi \n",
      "subject to the hipaa right of access because a patient's phi may not \n",
      "all be transferable through the api. for instance, we proposed to \n",
      "require payers to make claims and encounter data as well as a specified \n",
      "set of clinical data (that is, clinical data maintained by the \n",
      "applicable payer in the form of the uscdi version 1 data set) available \n",
      "through the patient access api.\n",
      "\n",
      "[[page 25524]]\n",
      "\n",
      "however, a patient may request access to an x-ray image as well. \n",
      "currently, the x-ray image itself is not captured under the uscdi \n",
      "version 1 data set, and though the necessary fhir resources to share \n",
      "this information via an api like the patient access api are available, \n",
      "use is not required under this rulemaking and so a payer may not be \n",
      "able to share such information via the api. therefore, under our \n",
      "proposal, a hipaa covered entity would have to share this type of \n",
      "information in a form and format other than the patient access api in \n",
      "order to comply with our program proposals and in keeping with the \n",
      "hipaa privacy rule right of access.\n",
      "\n",
      "c. standards-based api proposal for ma, medicaid, chip, and qhp issuers \n",
      "on the ffes\n",
      "\n",
      "1. introduction\n",
      "    we proposed to add new provisions at 42 cfr 422.119, 431.60, \n",
      "438.242(b)(6) (finalized as sec.  438.242(b)(5) in this rule; see \n",
      "section vi.), 457.730, 457.1233(d), and 45 cfr 156.221, that would, \n",
      "respectively, require each ma organization, medicaid ffs program, \n",
      "medicaid managed care plan, chip ffs program, chip managed care entity, \n",
      "and qhp issuer on an ffe to implement, test, and monitor a standards-\n",
      "based api that is accessible to third-party applications and \n",
      "developers. we noted that states with chips were not required to \n",
      "operate ffs systems and that some states' chips were exclusively \n",
      "operated by managed care entities. we did not intend to require chips \n",
      "that do not operate a ffs program to establish an api; rather, we noted \n",
      "that these states may rely on each of their contracted plans, referred \n",
      "to throughout the cms interoperability and patient access proposed rule \n",
      "and this final rule as chip managed care entities, to set up such a \n",
      "system.\n",
      "    as discussed, the api would allow enrollees and beneficiaries of ma \n",
      "organizations, medicaid and chip ffs programs, medicaid managed care \n",
      "plans, chip managed care entities, and qhp issuers on the ffes to \n",
      "exercise their hipaa right of access to certain health information \n",
      "specific to their plan electronically, through the use of common \n",
      "technologies and without special effort. we explained how ``common \n",
      "technologies,'' for purposes of the proposal, means those that are \n",
      "widely used and readily available, such as computers, smartphones, or \n",
      "tablets.\n",
      "    the proposals are detailed in section iii.c. of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7626 through \n",
      "7639), and comments received on these proposals and our responses are \n",
      "noted below in this final rule.\n",
      "2. the standards-based api proposal\n",
      "    in the proposed rule, we addressed the following components of the \n",
      "standards-based api. specifically, we discussed:\n",
      "    <bullet> authority to require implementation of a standards-based \n",
      "api by ma organizations, medicaid and chip state agencies, medicaid \n",
      "managed care plans, chip managed care entities, and qhp issuers on the \n",
      "ffes;\n",
      "    <bullet> the api technical standard and content and vocabulary \n",
      "standards;\n",
      "    <bullet> data required to be available through the standards-based \n",
      "api and timeframes for data availability;\n",
      "    <bullet> documentation requirements for apis;\n",
      "    <bullet> routine testing and monitoring of standards-based apis;\n",
      "    <bullet> compliance with existing privacy and security \n",
      "requirements;\n",
      "    <bullet> denial or discontinuation of access to the api;\n",
      "    <bullet> enrollee and beneficiary resources regarding privacy and \n",
      "security;\n",
      "    <bullet> exceptions or provisions specific to certain programs or \n",
      "sub-programs; and\n",
      "    <bullet> applicability and timing.\n",
      "\n",
      "we also included an rfi on information sharing between payers and \n",
      "providers through apis.\n",
      "\n",
      "    specifically, we proposed nearly identical language for the \n",
      "regulations requiring standards-based apis at 42 cfr 422.119; 431.60, \n",
      "and 457.730, and 45 cfr 156.221 for ma organizations, medicaid state \n",
      "agencies, state chip agencies, and qhp issuers on the ffes; medicaid \n",
      "managed care plans would be required, at 42 cfr 438.242(b)(6) \n",
      "(finalized as 438.242(b)(5) in this rule; see section vi.), to comply \n",
      "with the requirement at 42 cfr 431.60, and chip managed care entities \n",
      "would be required by 42 cfr 457.1233(d)(2) to comply with the \n",
      "requirement at 42 cfr 457.730. as discussed in detail in the cms \n",
      "interoperability and patient access proposed rule, we proposed similar \n",
      "if not identical requirements for these various entities to establish \n",
      "and maintain a standards-based api, make specified data available \n",
      "through that api, disclose api documentation, provide access to the \n",
      "api, and make resources available to enrollees. we noted that we \n",
      "believed that such nearly identical text is appropriate as the reasons \n",
      "and need for the proposal and the associated requirements are the same \n",
      "across these programs. we intended to interpret and apply the \n",
      "regulations proposed in section iii.c. of the cms interoperability and \n",
      "patient access proposed rule similarly and starting with similar text \n",
      "is an important step to communicate that to the applicable entities \n",
      "that would be required to comply (except as noted below with regard to \n",
      "specific proposals).\n",
      "    in paragraph (a) of each applicable proposed regulation, we \n",
      "proposed that the regulated entity (that is, the ma organization, the \n",
      "state medicaid or chip agency, the medicaid managed care plan, the chip \n",
      "managed care entity, or the qhp issuer on an ffe, as applicable) would \n",
      "be required to implement and maintain a standards-based api that \n",
      "permits third-party applications to retrieve, with the approval and at \n",
      "the direction of the individual patient, data specified in paragraph \n",
      "(b) of each regulation through the use of common technologies and \n",
      "without special effort from the beneficiary. by ``common technologies \n",
      "and without special effort'' by the enrollee, we explained that the \n",
      "regulation means use of common consumer technologies, like smart \n",
      "phones, home computers, laptops, or tablets, to request, receive, use, \n",
      "and approve transfer of the data that would be available through the \n",
      "standards-based api technology. by ``without special effort,'' we \n",
      "proposed to codify our expectation that third-party software, as well \n",
      "as proprietary applications and web portals operated by the payer could \n",
      "be used to connect to the api and provide access to the data to the \n",
      "enrollee. in the cms interoperability and patient access proposed rule \n",
      "(84 fr 7628 through 7638), we addressed the data that must be made \n",
      "available through the api in paragraph (b); the regulation regarding \n",
      "the technical standards for the api and the data it contains in \n",
      "paragraph (c); the documentation requirements for the api in paragraph \n",
      "(d); explicit authority for the payer regulated under each regulation \n",
      "to deny or discontinue access to the api in paragraph (e); and, \n",
      "requirements for posting information about resources on security and \n",
      "privacy for beneficiaries in paragraphs (f) or (g). additional \n",
      "requirements specific to certain programs, discussed in sections iv. \n",
      "and v. of the cms interoperability and patient access proposed rule, \n",
      "were also included in some of the regulations that address the api. we \n",
      "address those additional requirements in sections iv. and v. of this \n",
      "final rule.\n",
      "a. authority to require implementation of a standards-based api\n",
      "    as noted in the cms interoperability and patient access proposed \n",
      "rule (84 fr 7629 through 7630), the proposal would apply to ma \n",
      "organizations, medicaid\n",
      "\n",
      "[[page 25525]]\n",
      "\n",
      "state agencies and managed care plans, state chip agencies and managed \n",
      "care entities, and qhp issuers on the ffes. we noted that the proposal \n",
      "for medicaid managed care plans, at 42 cfr 438.242(b)(6) (finalized as \n",
      "438.242(b)(5) in this rule; see section vi.), would require mcos, \n",
      "pihps, and pahps to comply with the regulation that we proposed for \n",
      "medicaid state agencies at 42 cfr 431.60 as if that regulation applied \n",
      "to the medicaid managed care plan. similarly, we intended for chip \n",
      "managed care entities to comply with the requirements we proposed at 42 \n",
      "cfr 457.730 via the regulations proposed at 42 cfr 457.1233(d)(2). we \n",
      "proposed to structure the regulations this way to avoid ambiguity and \n",
      "to ensure that the api proposal would result in consistent access to \n",
      "information for medicaid beneficiaries and chip enrollees, regardless \n",
      "of whether they are in a ffs delivery system administered by the state \n",
      "or in a managed care delivery system. we noted that chip currently \n",
      "adopts the medicaid requirements at 42 cfr 438.242 in whole. we \n",
      "proposed revisions to 42 cfr 457.1233(d)(1) to indicate chip's \n",
      "continued adoption of 42 cfr 438.242(a), (b)(1) through (5), (c), (d), \n",
      "and (e), while we proposed specific text for chip managed care entities \n",
      "to comply with the regulations proposed at 42 cfr 457.1233(d)(2) in \n",
      "lieu of the proposed medicaid revision, which we noted would add 42 cfr \n",
      "438.242(b)(6) (finalized as sec.  438.242(b)(5) in this rule; see \n",
      "section vi.). in our discussion of the specifics of the proposal and \n",
      "how we proposed to codify it at 42 cfr 422.119, 431.60, 457.730, and 45 \n",
      "cfr 156.221, we referred in the cms interoperability and patient access \n",
      "proposed rule and refer in this final rule only generally to 42 cfr \n",
      "438.242(b)(5) (proposed as 438.242(b)(6); see section vi.) and \n",
      "457.1233(d)(2) for this reason.\n",
      "(1) medicare advantage\n",
      "    sections 1856(b) and 1857(e) of the social security act (the act) \n",
      "provide cms with the authority to add standards and requirements for ma \n",
      "organizations that the secretary finds necessary and appropriate and \n",
      "not inconsistent with part c of the medicare statute. in addition, \n",
      "section 1852(c) of the act requires disclosure by ma organizations of \n",
      "specific information about the plan, covered benefits, and the network \n",
      "of providers; section 1852(h) of the act requires ma organizations to \n",
      "provide their enrollees with timely access to medical records and \n",
      "health information insofar as ma organizations maintain such \n",
      "information. the information required to be made available under these \n",
      "authorities through the apis in this final rule is within the scope of \n",
      "information that ma organizations must make available under section \n",
      "1852(c) and (h) of the act and the implementing regulations at 42 cfr \n",
      "422.111 and 422.118. as technology evolves to allow for faster, more \n",
      "efficient methods of information transfer, so do expectations as to \n",
      "what is generally considered ``timely.'' thus, we noted in the cms \n",
      "interoperability and patient access proposed rule our belief that to \n",
      "align the standards with 21st century demands, we must take steps for \n",
      "ma enrollees to have immediate, electronic access to their health \n",
      "information and plan information. we further noted that the proposed \n",
      "requirements were intended to achieve this goal by providing patients \n",
      "access to their health information through third-party apps retrieve \n",
      "data via the required apis.\n",
      "    the cms interoperability and patient access proposed rule \n",
      "provisions for ma organizations relied on our authority in sections \n",
      "1856(b) and 1857(e) of the act (which provide cms with the authority to \n",
      "add standards and requirements for ma organizations), and explained how \n",
      "the information to be provided is consistent with the scope of \n",
      "disclosure under section 1852(c) and (h) of the act, to propose that ma \n",
      "organizations make specific types of information, at minimum, \n",
      "accessible through a standards-based api and require timeframes for \n",
      "update cycles. requirements for the patient access api further \n",
      "implement and adopt standards for how ma organizations must ensure \n",
      "enrollee access to medical records or other health information as \n",
      "required by section 1852(h) of the act. similarly, the provider \n",
      "directory api is a means to implement the disclosure requirements in \n",
      "section 1852(c) regarding plan providers. throughout section iii.c. of \n",
      "the cms interoperability and patient access proposed rule, we explained \n",
      "how and why the standards-based api proposal was necessary and \n",
      "appropriate for ma organizations and the ma program. we discussed how \n",
      "these requirements would give patients simple and easy access to their \n",
      "health information through common technologies, such as smartphones, \n",
      "tablets, or laptop computers, without special effort on the part of the \n",
      "user by facilitating the ability of patients to get their health \n",
      "information from their ma organization through a user-friendly third-\n",
      "party app. the goals and purposes of achieving interoperability for the \n",
      "health care system as a whole are equally applicable to ma \n",
      "organizations and their enrollees. thus, the discussion in section ii. \n",
      "of the cms interoperability and patient access proposed rule served to \n",
      "provide further explanation as to how a standards-based api proposal is \n",
      "necessary and appropriate in the ma program. in addition, we noted that \n",
      "having easy access to their claims, encounter, and other health \n",
      "information would also facilitate beneficiaries' ability to detect and \n",
      "report fraud, waste, and abuse--a critical component of an effective \n",
      "programs.\n",
      "    to the extent necessary, we also relied on section 1860d-12(b)(3) \n",
      "of the act to add provisions specific to the part d benefit offered by \n",
      "certain ma organizations; that provision incorporates the authority to \n",
      "add program requirements to the contracts from section 1857(e)(1) of \n",
      "the act. for ma organizations that offer ma prescription drug plans, we \n",
      "proposed requirements in 42 cfr 422.119(b)(2) regarding electronic \n",
      "health information for part d coverage. we explained that this proposal \n",
      "was supported by the disclosure requirements imposed under section \n",
      "1860d-4(a) of the act, requiring part d claims information, pharmacy \n",
      "directory information, and formulary information to be disclosed to \n",
      "enrollees. also, we note here that 42 cfr 423.136(d) requires part d \n",
      "plans to ensure timely access by enrollees to the records and \n",
      "information that pertain to them. the apis in this rule further \n",
      "implement and build on these authorities for ensuring that part d \n",
      "enrollees have access to information.\n",
      "(2) medicaid and chip\n",
      "    we proposed new provisions at 42 cfr 431.60(a), 457.730, \n",
      "438.242(b)(6) (finalized as 42 cfr 438.242(b)(5) in this rule; see \n",
      "section vi.), and 457.1233(d)(2) that would require states \n",
      "administering medicaid ffs or chip ffs, medicaid managed care plans, \n",
      "and chip managed care entities to implement a standards-based api that \n",
      "permits third-party applications with the approval and at the direction \n",
      "of the beneficiary or enrollee to retrieve certain standardized data. \n",
      "the proposed requirement would provide medicaid beneficiaries' and chip \n",
      "enrollees simple and easy access to their information through common \n",
      "technologies, such as smartphones, tablets, or laptop computers, and \n",
      "without special effort on the part of the user.\n",
      "    for medicaid, we proposed these new requirements under our \n",
      "authority under section 1902(a)(4) of the act, which requires that a \n",
      "state medicaid plan provide such methods of administration as are found \n",
      "by the secretary to be necessary for the proper and efficient\n",
      "\n",
      "[[page 25526]]\n",
      "\n",
      "operation of the plan, and section 1902(a)(19) of the act, which \n",
      "requires that care and services be provided in a manner consistent with \n",
      "simplicity of administration and the best interests of the recipients. \n",
      "for chip, we proposed these requirements under the authority in section \n",
      "2101(a) of the act, which sets forth that the purpose of title xxi is \n",
      "to provide funds to states to provide child health assistance to \n",
      "uninsured, low-income children in an effective and efficient manner \n",
      "that is coordinated with other sources of health benefits coverage. \n",
      "together we noted that these proposals would provide us with authority \n",
      "(in conjunction with our delegation of authority from the secretary) to \n",
      "adopt requirements for medicaid and chip that are necessary to ensure \n",
      "the provision of quality care in an efficient and cost-effective way, \n",
      "consistent with simplicity of administration and the best interest of \n",
      "the beneficiary.\n",
      "    we noted that we believed that requiring state medicaid and chip \n",
      "agencies and managed care plans/entities to take steps to make medicaid \n",
      "beneficiaries' and chip enrollees' claims, encounters, and other health \n",
      "information available through interoperable technology would ultimately \n",
      "lead to these enrollees accessing that information in a convenient, \n",
      "timely, and portable way, which is essential for these programs to be \n",
      "effectively and efficiently administered in the best interests of \n",
      "beneficiaries. further, we noted that there are independent statutory \n",
      "provisions that require the disclosure and delivery of information to \n",
      "medicaid beneficiaries and chip enrollees; the proposal would result in \n",
      "additional implementation of those requirements in a way that is \n",
      "appropriate and necessary in the 21st century. we also noted that we \n",
      "believed making this information available in apis and ultimately apps \n",
      "may result in better health outcomes and patient satisfaction and \n",
      "improve the cost effectiveness of the entire health care system, \n",
      "including medicaid and chip. having easy access to their claims, \n",
      "encounter, and other health information may also facilitate \n",
      "beneficiaries' ability to detect and report fraud, waste, and abuse--a \n",
      "critical component of an effective programs.\n",
      "    we discussed that as technology has advanced, we have encouraged \n",
      "states, health plans, and providers to adopt various forms of \n",
      "technology to improve the accurate and timely exchange of standardized \n",
      "health care information. we noted that the proposal would move medicaid \n",
      "and chip programs in the direction of enabling better information \n",
      "access by medicaid beneficiaries and chip enrollees, which would make \n",
      "them active partners in their health care by providing a way for them \n",
      "to easily monitor and share their data. by requiring that certain \n",
      "information be available in and through standardized formats and \n",
      "technologies, we noted that the proposal moved these programs toward \n",
      "interoperability, which is key for data sharing and access, and \n",
      "ultimately, improved health outcomes. we also noted that states would \n",
      "be expected to implement the chip provisions using chip administrative \n",
      "funding, which is limited under sections 2105(a)(1)(d)(v) and \n",
      "2105(c)(2)(a) of the act to 10 percent of a state's total annual chip \n",
      "expenditures.\n",
      "(3) qualified health plan issuers on the federally-facilitated \n",
      "exchanges\n",
      "    we proposed a new qhp minimum certification standard at 45 cfr \n",
      "156.221(a) that would require qhp issuers on the ffes to implement a \n",
      "standards-based api that would permit third-party applications, with \n",
      "the approval and at the direction of the individual enrollee, to \n",
      "retrieve standardized data as specified in the proposal. we also \n",
      "proposed to require that the data be made available to qhp enrollees \n",
      "through common technologies, such as smartphones or tablets, and \n",
      "without special effort from enrollees.\n",
      "    we proposed the new requirements under our authority in section \n",
      "1311(e)(1)(b) of the patient protection and affordable care act, as \n",
      "amended by the health care and education reconciliation act of 2010 \n",
      "(pub. l. 111-148, enacted march 23, 2010, and pub. l. 111-152, enacted \n",
      "march 30, 2010, respectively) (collectively referred to as the \n",
      "affordable care act), which afforded the exchanges the discretion to \n",
      "certify qhps that are in the best interests of qualified individuals \n",
      "and qualified employers. specifically, section 1311(e) of the \n",
      "affordable care act authorized exchanges to certify qhps that meet the \n",
      "qhp certification standards established by the secretary, and if the \n",
      "exchange determined that making available such health plan through such \n",
      "exchange is in the interests of qualified individuals and qualified \n",
      "employers in the state in which such exchange operates.\n",
      "    in the cms interoperability and patient access proposed rule, we \n",
      "noted specifically in our discussion on qhp issuers on the ffes, but \n",
      "applicable to all payers impacted by this rule, that we believe there \n",
      "are numerous benefits associated with individuals having access to \n",
      "their health plan data that is built upon widely used standards. the \n",
      "ability to easily obtain, use, and share claims, encounter, and other \n",
      "health data enables patients to more effectively and easily use the \n",
      "health care system. for example, by being able to easily access a \n",
      "comprehensive list of their adjudicated claims, patients can ensure \n",
      "their providers know what services they have already received, can \n",
      "avoid receiving duplicate services, and can help their providers verify \n",
      "when prescriptions were filled. we noted that we believe these types of \n",
      "activities would result in better health outcomes and patient \n",
      "satisfaction and improve the cost effectiveness of the entire health \n",
      "care system. having simple and easy access, without special effort, to \n",
      "their health information, including cost and payment information, also \n",
      "facilitates patients' ability to detect and report fraud, waste, and \n",
      "abuse--a critical component of an effective program. we noted that \n",
      "existing and emerging technologies provide a path to make information \n",
      "and resources for health and health care management universal, \n",
      "integrated, equitable, accessible to all, and personally relevant. \n",
      "specifically, for qhp issuers on the ffes, we stated that we believe \n",
      "generally certifying only health plans that make enrollees' health \n",
      "information available to them in a convenient, timely, and portable way \n",
      "is in the interests of qualified individuals and qualified employers in \n",
      "the state or states in which an ffe operates. we also noted we \n",
      "encouraged sbes to consider whether a similar requirement should be \n",
      "applicable to qhp issuers participating in their exchange.\n",
      "    we did not receive comments on the authorities discussed in this \n",
      "section to implement the patient access api. we are finalizing these \n",
      "provisions, with the modifications discussed in section iii.c. of this \n",
      "rule, under this authority. additionally, we are making two \n",
      "modifications to the regulation text to more clearly identify issuers \n",
      "subject to the regulation. first, we are modifying the scope of the \n",
      "applicability of the regulation to issuers on the individual market \n",
      "ffes, effectively excluding issuers offered through the ff-shop, and we \n",
      "are explicitly excluding qhp issuers on the ffes that only offer sadps.\n",
      "b. api technical standard and content and vocabulary standards\n",
      "    we proposed to require compliance with 45 cfr 170.215 as finalized \n",
      "at 42 cfr 422.119(a) and (c), sec.  431.60(a) and (c), 457.730(a) and \n",
      "(c), 438.242(b)(6) (finalized as 438.242(b)(5) in this rule; see \n",
      "section vi.) and 457.1233(d)(2), and 45 cfr 156.221(a) and (c), so that \n",
      "ma organizations, medicaid and chip ffs\n",
      "\n",
      "[[page 25527]]\n",
      "\n",
      "programs, medicaid managed care plans, chip managed care entities, and \n",
      "qhp issuers on the ffes implement standards-based api technology \n",
      "conformant with the api technical standards finalized by hhs in the onc \n",
      "21st century cures act final rule (published elsewhere in this issue of \n",
      "the federal register), as discussed in section ii.a.3. of the cms \n",
      "interoperability and patient access proposed rule and section ii. of \n",
      "this final rule. we further proposed to require that the data available \n",
      "through the api be in compliance with the regulations regarding the \n",
      "following content and vocabulary standards, where applicable to the \n",
      "data type or data element, unless an alternate standard is required by \n",
      "other applicable law: standards adopted at 45 cfr part 162 and 42 cfr \n",
      "423.160; and standards finalized by hhs in the onc 21st century cures \n",
      "act final rule at 45 cfr 170.213 (uscdi version 1). see section ii.a.3. \n",
      "of the cms interoperability and patient access proposed rule for \n",
      "further information about how entities subject to this rule would be \n",
      "required to utilize these standards. we proposed that both the api \n",
      "technical standard and the content and vocabulary standards would be \n",
      "required across the ma program, medicaid program, and chip, and by qhp \n",
      "issuers on the ffes.\n",
      "    with the proposed requirements to implement and maintain an api at \n",
      "42 cfr 422.119(a), 431.60(a), and 457.730(a), we proposed corresponding \n",
      "requirements at 42 cfr 422.119(c) for ma plans, 431.60(c) for medicaid \n",
      "ffs programs, and 457.730(c) for chip ffs programs implementing the \n",
      "proposed api technology. at proposed 42 cfr 422.119(c), 431.60(c), and \n",
      "457.730(c), ma plans and the state medicaid or chip agency (for states \n",
      "that operate chip ffs systems) would be required to implement, \n",
      "maintain, and use api technology conformant with the standards \n",
      "finalized by hhs in the onc 21st century cures act final rule \n",
      "(published elsewhere in this issue of the federal register) at 45 cfr \n",
      "170.215; for data available through the api, to use content and \n",
      "vocabulary standards adopted at 45 cfr part 162 and 42 cfr 423.160, and \n",
      "finalized at 45 cfr 170.213, unless alternate standards are required by \n",
      "other applicable law; and to ensure that technology functions in \n",
      "compliance with applicable law protecting the privacy and security of \n",
      "the data, including but not limited to 45 cfr parts 162, 42 cfr part 2, \n",
      "and the hipaa privacy and security rules.\n",
      "    we similarly proposed at 45 cfr 156.221(c) that qhp issuers on the \n",
      "ffes must implement, maintain, and use api technology conformant with \n",
      "the api technical standards finalized by hhs in the onc 21st century \n",
      "cures act final rule (published elsewhere in this issue of the federal \n",
      "register) at 45 cfr 170.215; for data available through the api, use \n",
      "content and vocabulary standards adopted at 45 cfr part 162 and 42 cfr \n",
      "423.160, and finalized at 45 cfr 170.213, unless alternate standards \n",
      "are required by other applicable law; and ensure that technology \n",
      "functions in compliance with applicable law protecting the privacy and \n",
      "security of the data, including but not limited to 45 cfr part 162, 42 \n",
      "cfr part 2, and the hipaa privacy and security rules.\n",
      "    we noted that we believed these proposals would serve to create a \n",
      "health care information ecosystem that allows and encourages the health \n",
      "care market to tailor products and services to better serve and compete \n",
      "for patients, thereby increasing quality, decreasing costs, and \n",
      "empowering patients with information that helps them live better, \n",
      "healthier lives. additionally, under our proposal, clinicians would be \n",
      "able to review, with the approval and at the direction of the patient, \n",
      "information on the patient's current prescriptions and services \n",
      "received by the patient; the patient could also allow clinicians to \n",
      "access such information by sharing data received through the api with \n",
      "the clinician's ehr system--by forwarding the information once the \n",
      "patient receives it or by letting the clinician see the information on \n",
      "the patient's smartphone using an app that received the data through \n",
      "the api. developers and providers could also explore approaches where \n",
      "patients can authorize release of the data through the api directly to \n",
      "the clinician's ehr system.\n",
      "    we also encouraged payers to consider using the proposed api \n",
      "infrastructure as a means to exchange health information for other \n",
      "health care purposes, such as to health care providers for treatment \n",
      "purposes. sharing interoperable information directly with the patient's \n",
      "health care provider in advance of a patient visit would save time \n",
      "during appointments and ultimately improve the quality of care \n",
      "delivered to patients. most clinicians and patients have access to the \n",
      "internet, providing many access points for viewing health information \n",
      "over secure connections. we noted that we believed these proposed \n",
      "requirements would significantly improve patients' experiences by \n",
      "providing a mechanism through which they can access their data in a \n",
      "standardized, computable, and digital format in alignment with other \n",
      "public and private health care entities. we stated that we designed the \n",
      "proposals to empower patients to have simple and easy access to their \n",
      "data in a usable digital format, and therefore, empower them to decide \n",
      "how their health information is going to be used. however, we reminded \n",
      "payers, and proposed to codify that the regulation regarding the api \n",
      "would not lower or change their obligations as hipaa covered entities \n",
      "to comply with regulations regarding standard transactions at 45 cfr \n",
      "part 162.\n",
      "    finally, we also proposed to add a new ma contract requirement at \n",
      "42 cfr 422.504(a)(18) specifying that ma organizations must comply with \n",
      "the requirement for access to health data and plan information under 42 \n",
      "cfr 422.119.\n",
      "    we summarize the public comments we received on the patient access \n",
      "api proposal, generally, and the technical standards we proposed for \n",
      "the api and its content, and provide our responses.\n",
      "    comment: many commenters indicated support for the overall proposal \n",
      "to require the specified payers to provide patients access to their \n",
      "health care information through a standards-based api. these commenters \n",
      "supported the goals to provide patients near real-time, electronic \n",
      "access to their claims, treatment, and quality information. many \n",
      "commenters were also supportive of provider access to patient data \n",
      "through apis, if the patient consented to (or authorized) access, in \n",
      "order to support coordinated care. one commenter was specifically in \n",
      "favor of the patient access proposal noting it supports patient access \n",
      "to their historical claims information. finally, one commenter \n",
      "requested that cms explain whether ``api technology'' has the same \n",
      "definition as in the onc proposed rule.\n",
      "    response: we appreciate the commenters' support for the patient \n",
      "access api proposal and are finalizing this policy with modifications, \n",
      "as discussed in detail below. we also note that both the cms and onc \n",
      "rules use the term ``api'' consistently as we work together to align \n",
      "technology and standards and forward interoperability across the entire \n",
      "health care system. we do note, however, that the patient access api \n",
      "did not propose to include quality information.\n",
      "    comment: one commenter requested cms specify the historical look-\n",
      "back period for api exchange. in addition, one commenter requested that \n",
      "cms not require data older than from 2019 be made available through \n",
      "apis due to the implementation costs of standardizing older \n",
      "information.\n",
      "\n",
      "[[page 25528]]\n",
      "\n",
      "    response: we appreciate the commenters' suggestions. the proposed \n",
      "rule did not specify a historical look-back period for the patient \n",
      "access api or limit the timeframe of the data that must be available \n",
      "through the api. to ensure consistent implementation and minimize the \n",
      "burden on payers, we are finalizing additional text in the applicable \n",
      "regulations to specify that ma organizations at 42 cfr 422.119(h), \n",
      "state medicaid ffs programs at 42 cfr 431.60(g), medicaid managed care \n",
      "plans at 42 cfr 438.62(b)(1)(vii), chip ffs programs at 42 cfr \n",
      "457.730(g), chip managed care entities at 42 cfr 457.1233(d), and qhp \n",
      "issuers on the ffes at 45 cfr 156.221(i), beginning january 1, 2021 (or \n",
      "plan years beginning on or after january 1, 2021 for qhps on the ffes), \n",
      "must make available through the patient access api data that they \n",
      "maintain with a date of service on or after january 1, 2016. this means \n",
      "that no information with a date of service earlier than january 1, 2016 \n",
      "will need to be made available through the patient access api. by \n",
      "``date of service,'' we mean the date the patient received the item or \n",
      "service, regardless of when it was paid for or ordered. this is \n",
      "consistent with how we are finalizing the payer-to-payer data exchange \n",
      "requirement for ma organizations at 42 cfr 422.119(f), medicaid managed \n",
      "care plans at sec.  438.62(b)(1)(vi) (made applicable to chip managed \n",
      "care entities through incorporation in sec.  457.1216), and qhp issuers \n",
      "on the ffes at 45 cfr 156.221(f). aligning the years of data available \n",
      "through the patient access api with the payer-to-payer data exchange \n",
      "will minimize cost and burden specific to this regulatory requirement \n",
      "and will provide patients with the same timeframe of information as \n",
      "payers, furthering transparency. together these policies facilitate the \n",
      "creation and maintenance of a patient's cumulative health record with \n",
      "their current payer.\n",
      "    we do not believe limiting the patient access api to data only from \n",
      "january 1, 2019 forward is sufficient to help patients most benefit \n",
      "from this data availability. however, we do appreciate that making \n",
      "older data available for electronic data exchange via the patient \n",
      "access api is part of the cost of the api. as a result, limiting this \n",
      "to data with a date of service of january 1, 2016 forward minimizes \n",
      "cost and burden while maximizing patient benefit.\n",
      "    comment: a few commenters expressed concerns and indicated that \n",
      "they did not believe the patient access api proposal would move the \n",
      "health care industry toward the stated goal of helping patients make \n",
      "more informed care decisions. several commenters were concerned that \n",
      "certain patient groups, such as those with low technology access and/or \n",
      "health literacy, would not make use of electronic applications for \n",
      "making health care decisions. a few commenters recommended cms not \n",
      "limit patient access to health information through apps alone, \n",
      "especially for populations with low technology access and/or literacy.\n",
      "    response: we appreciate the commenters' concerns. however, more and \n",
      "more americans are using portable technology like smart phones and \n",
      "tablets to conduct a myriad of daily activities. approximately 81 \n",
      "percent of u.s. adults reported owning a smartphone and 52 percent \n",
      "reported owning a tablet computer in 2019.\\28\\ an american community \n",
      "survey report from the u.s. census bureau reported that in 2016, 82 \n",
      "percent of households reported an internet subscription and 83 percent \n",
      "reported a cellular data plan.\\29\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\28\\ pew research center. (2019, june 12). retrieved from \n",
      "<a href=\"https://www.pewinternet.org/fact-sheet/mobile\">https://www.pewinternet.org/fact-sheet/mobile</a>.\n",
      "    \\29\\ ryan, c. (2018). computer and internet use in the united \n",
      "states: 2016 (american community survey reports, acs-39). retrieved \n",
      "from <a href=\"https://www.census.gov/content/dam/census/library/publications/2018/acs/acs-39.pdf\">https://www.census.gov/content/dam/census/library/publications/2018/acs/acs-39.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    people have a right to be able to manage their health information \n",
      "in this way should they choose. we appreciate that not everyone is \n",
      "comfortable with, has access to, or uses electronic applications in \n",
      "making health care decisions. such patients will maintain the same \n",
      "access that they have to their personal health information today. this \n",
      "regulation does not change any existing patient information rights. \n",
      "this regulation simply adds new options to ensure patients have the \n",
      "information they need, when, and how they need it.\n",
      "    comment: several commenters indicated concerns over what they \n",
      "believe would be a costly implementation. a few commenters questioned \n",
      "who would be required to bear the costs of implementation and \n",
      "maintenance of the apis, with one commenter requesting cms explicitly \n",
      "permit payers to charge patients and other third-party partners for the \n",
      "costs of api implementation and maintenance. in contrast, a few \n",
      "commenters recommended that payers should not be allowed to charge \n",
      "patients to access their information through apis. a few commenters \n",
      "requested cms provide federal grant funding to support payers in \n",
      "implementing the proposed apis.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. as discussed in section xiii. of this final rule, we \n",
      "are providing updated cost estimates for implementing and maintaining \n",
      "the patient access api, moving from a single point estimate to a \n",
      "range--including a low, primary, and high estimate--to better take into \n",
      "account the many factors that impact the cost of implementation. we \n",
      "have revised our original estimate of $788,414 per payer, to a primary \n",
      "estimate of $1,576,829 per payer, increasing our original estimate by a \n",
      "factor of 2 to account for additional information that was provided by \n",
      "commenters, which we still believe is relatively minimal in relation to \n",
      "the overall budget of these impacted payers. we have included a low \n",
      "estimate of $718,414.40 per organization, and a high estimate of \n",
      "$2,365,243 per organization. we refer readers to sections xii. and \n",
      "xiii. of this final rule for a detailed discussion of our revised cost \n",
      "estimates.\n",
      "    we acknowledge that payers may pass these costs to patients via \n",
      "increased premiums. in this way, patients could absorb the cost of the \n",
      "api. however, we note the costs of ``premiums'' for ma, medicaid, and \n",
      "chip enrollees are primarily borne by the government, as are some \n",
      "premium costs for enrollees of qhp issuers on the ffes who receive \n",
      "premium tax credits. we believe that the benefits created by the \n",
      "patient access api outweigh the costs to patients if payers choose to \n",
      "increase premiums as a result.\n",
      "    at this time, we are not able to offer support for the \n",
      "implementation of this policy through federal grant funding. regarding \n",
      "costs for medicaid managed care plans--since the patient access api \n",
      "requirements must be contractual obligations under the medicaid managed \n",
      "care contract--the state must include these costs in the development of \n",
      "a plan's capitation rates. these capitation rates would be matched at \n",
      "the state's medical assistance match rate. state medicaid agency \n",
      "implementation costs would be shared by the state and federal \n",
      "government, based on the relevant level of federal financial \n",
      "participation, which is 50 percent for general administrative costs and \n",
      "90 percent for system development costs.\n",
      "    comment: a few commenters described concerns with the maturity of \n",
      "apis for data exchange, as well as the fact that implementation of \n",
      "fhir-based apis is so new in health care, and expressed that they \n",
      "believed there were challenges with meeting the proposed requirement \n",
      "given the newness of the needed standards, particularly regarding \n",
      "standardizing the required data elements and vocabularies. several\n",
      "\n",
      "[[page 25529]]\n",
      "\n",
      "commenters were concerned that apis would not be implemented in a \n",
      "standardized fashion, which could lead to interoperability challenges, \n",
      "and noted the need for testing for certain use cases, such as \n",
      "exchanging data from plan to patients and from plan-to-plan, as well as \n",
      "the exchange of provider directory and/or pharmacy/formulary \n",
      "information. several commenters suggested cms and/or hhs publish \n",
      "implementation guides to support consistent and standardized \n",
      "implementation of fhir-based apis and their associated data standards.\n",
      "    response: we appreciate the commenters' concerns. as stated in \n",
      "section ii. of this final rule, the content and vocabulary standards \n",
      "and technical standards hhs is finalizing in the onc 21st century cures \n",
      "act final rule (published elsewhere in this issue of the federal \n",
      "register) provide the foundation needed to support implementation of \n",
      "the policies as proposed and now finalized in this rule. that said, we \n",
      "have been working with hl7 and other industry partners to ensure the \n",
      "implementation guides requested are freely available to payers to use \n",
      "if they choose to use them. use of these implementation guides is not \n",
      "mandatory; however, if a payer does choose to use the publicly \n",
      "available guidance, it will limit payer burden and support consistent, \n",
      "interoperable api development and implementation. therefore, use of \n",
      "this publicly available guidance can help address the consistency \n",
      "concerns raised. part of the development process of any implementation \n",
      "guide is consensus review, balloting, and testing. we are providing a \n",
      "link to specific implementations guides and reference implementations \n",
      "for all interested payers for both the patient access api and the \n",
      "provider directory api (discussed in section iv. of this final rule) \n",
      "that provide valuable guidance to further support sharing the needed \n",
      "data using the required standards: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>. the implementation guides \n",
      "provide information payers can use to meet the requirements of the \n",
      "policies being finalized in this rule without having to develop an \n",
      "approach independently, saving time and resources. in addition, the \n",
      "reference implementations allow payers to see the apis in action and \n",
      "support testing and development.\n",
      "    comment: a few commenters indicated concerns with an impending \n",
      "proliferation of multiple health plan apis. instead, commenters \n",
      "recommended a centralized, standardized approach where cms would \n",
      "require the use of blue button 2.0 as the platform for providing \n",
      "patient access to their health data from all impacted programs \n",
      "(medicare advantage, medicaid, chip, and qhps on the ffes). commenters \n",
      "suggested this would also reduce the burden on app developers to \n",
      "develop to one api rather than multiple apis for various regulated \n",
      "entities.\n",
      "    one commenter requested cms implement a pilot program for the api \n",
      "proposals, citing cms' blue button pilot. one commenter suggested cms \n",
      "convene a group of 10-12 subject matter experts from payers along with \n",
      "other relevant stakeholders, such as developers, to meet with cms, onc, \n",
      "and the ftc to facilitate a smooth path to the api compliance deadline \n",
      "and ensure a successful implementation.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. however, we do not wish to require use of the blue \n",
      "button 2.0 platform as a centralized solution. we believe that industry \n",
      "will best have the ability to take interoperability to the next level \n",
      "by leading the development of apis that meet the requirements in the \n",
      "regulations at 42 cfr 422.119, 431.60, 438.242, 457.730, and 457.1233, \n",
      "as well as 45 cfr 156.221, and which they maintain and control. blue \n",
      "button is essentially the hub for the medicare data that cms, as a \n",
      "payer, is making available to our beneficiaries. we do not wish to \n",
      "require the centralization of other payer data under this rule. we are \n",
      "requiring other payers to also unleash their data and provide the same \n",
      "benefits to their enrollees in a standardized way. as noted above, we \n",
      "are providing a link to specific implementation guides and reference \n",
      "implementations to further support implementation of the patient access \n",
      "api, as well as the provider directory api (discussed in section iv. of \n",
      "this final rule), for all payers to use: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>. use of these \n",
      "freely available materials is not required, but if used will reduce \n",
      "development burden for both payers and app developers and facilitate \n",
      "industry-wide interoperability.\n",
      "    although we appreciate the recommendation to consider a pilot, we \n",
      "believe it is important to move ahead with apis at this time to help \n",
      "the health care sector as a whole--including patients, providers and \n",
      "payers--start to benefit from this technology as so many other sectors \n",
      "have. also, as previously noted in this final rule, we will share \n",
      "lessons learned and best practices from our experience with blue button \n",
      "as relevant and appropriate to aid the successful implementation of the \n",
      "api requirements included in this final rule.\n",
      "    regarding the request to convene subject matter experts, we \n",
      "reiterate our commitment to continuing our collaboration with our \n",
      "federal partners and a diversity of industry stakeholders to ensure a \n",
      "successful and smooth implementation of the requirements included in \n",
      "this final rule. as this collaboration is ongoing, we do not believe it \n",
      "is necessary to convene a new, dedicated group.\n",
      "    comment: one commenter recommended that cms consider standards to \n",
      "allow payers and providers to upload patient data directly to a patient \n",
      "portal that is owned and managed by the patient. one commenter \n",
      "suggested that health information exchanges (hies) and health \n",
      "information networks (hins) can be a central source for patients to \n",
      "obtain aggregated data in a single location.\n",
      "    response: we thank commenters for these recommendations. we \n",
      "appreciate that hies and hins can provide patients with valuable \n",
      "information, and we look forward to innovative solutions from this \n",
      "community. one option would be to leverage apis and support patient \n",
      "access via this technology. we did not propose to use a portal \n",
      "approach. one of the advantages of an api approach is that any system \n",
      "can make data available and that data can be used by any other system \n",
      "that is following the same approach to mapping and transporting data \n",
      "without a need to otherwise link the systems or ensure any system-level \n",
      "compatibility. having apis that can be accessed by third-party apps \n",
      "permits the patient to choose how they want to access their data, and \n",
      "it promotes innovation in industry to find ways to best help patients \n",
      "interact with their data in a way that is most meaningful and helpful \n",
      "to them. this same flexibility and interoperability is not easily \n",
      "realized through a portal solution, and thus we will not consider this \n",
      "recommendation at this time.\n",
      "    comment: a few commenters requested cms confirm the proposed \n",
      "preclusion policy for versions of standards and standards themselves at \n",
      "42 cfr 422.119(c)(4) for ma organizations, 42 cfr 431.60(c)(4) for \n",
      "medicaid ffs programs, 42 cfr 438.242(b)(5) for medicaid managed care \n",
      "plans, 42 cfr 457.730(c)(4) for chip ffs programs, 42 cfr \n",
      "457.1233(d)(1) for chip managed care entities, and 45 cfr 156.221(c)(4) \n",
      "for qhp issuers on the ffes. these commenters recommended cms indicate \n",
      "that the preclusion policy would prohibit plans from using standards \n",
      "not named by cms for the\n",
      "\n",
      "[[page 25530]]\n",
      "\n",
      "specified api functions, but would not prohibit them from using those \n",
      "standards for other use cases not regulated by cms.\n",
      "    response: we confirm that the requirements in this regulation will \n",
      "not preclude a payer from using a standard not finalized in this rule \n",
      "for use cases that are not specifically discussed in this final rule as \n",
      "required for use with the patient access api requirement or the \n",
      "provider directory api requirement (discussed in section iv. of this \n",
      "final rule). the content and vocabulary standards being adopted are \n",
      "specifically applicable to the data identified and required to be made \n",
      "available through the patient access api and provider directory api; \n",
      "this means that if there is a content standard identified in the \n",
      "regulation text for the information specified in the regulation text as \n",
      "required to be made available through the api, the payer subject to the \n",
      "regulation must make available through the api at least these data \n",
      "elements using the named content standard. this final rule indicates \n",
      "the minimum data that must be made available via these apis. this does \n",
      "not prevent a payer from including more information via either api \n",
      "using other available standards. we do strongly support the continued \n",
      "use and adoption of fhir standards for additional use cases to promote \n",
      "interoperability and efficient and effective transfer of electronic \n",
      "health information, generally.\n",
      "    comment: a few commenters expressed concerns that contracts between \n",
      "health care providers and payers need to be standardized in order to \n",
      "support the requirements of the cms interoperability and patient access \n",
      "proposed rule. a few additional commenters specifically noted that \n",
      "timing requirements for making information available through apis \n",
      "should be specified in these contracts. one commenter requested cms \n",
      "prohibit payers from using the patient access api requirements to place \n",
      "additional contractual demands on health care providers.\n",
      "    response: we appreciate the commenters' concerns that there will be \n",
      "downstream impacts from the patient access api requirements on the \n",
      "relationship between payers and their contracted health care providers. \n",
      "it will be up to each payer's discretion to address whether this \n",
      "information needs to be included in contracts with providers. we do not \n",
      "believe it is necessary or appropriate for cms to adopt regulations to \n",
      "standardize all contracts between payers and health care providers to \n",
      "accomplish this and are not convinced it would be wise to try to do so \n",
      "as each payer is unique, as are their relationships with their \n",
      "contracted providers. we are finalizing the implementation timeline \n",
      "with modifications from the proposal, as further discussed below, to \n",
      "provide payers and providers more time to address all implementation \n",
      "issues. we do not anticipate this will create significant additional \n",
      "provider burden.\n",
      "    comment: several commenters supported the cms proposal to adopt \n",
      "fhir as the technical standard for payer apis. several commenters \n",
      "recommended adopting fhir release 4 (r4), also referred to as ``version \n",
      "4,'' noting it is more robust than release 2 (r2), particularly \n",
      "regarding laboratory information. a few other commenters supported the \n",
      "use of fhir r2 with the eventual transition to r4. one commenter \n",
      "indicated their recommendation on the version of fhir to adopt (r2 vs \n",
      "r4) would depend on the timeline cms provides payers for compliance. a \n",
      "few commenters also suggested cms align with the version of fhir that \n",
      "onc adopts in its final rule.\n",
      "    response: we thank commenters for their recommendations, which we \n",
      "have shared with onc. we are adopting the standards as finalized by hhs \n",
      "in onc's 21st century cures act final rule (published elsewhere in this \n",
      "issue of the federal register). as a result, the regulations we are \n",
      "finalizing will require the use of the standards identified at 45 cfr \n",
      "170.215, which specifically include the use of hl7 fhir release 4.0.1. \n",
      "as previously stated, we believe that requiring regulated entities to \n",
      "comply with the specified standards regulations finalized by hhs in \n",
      "onc's 21st century cures act final rule (published elsewhere in this \n",
      "issue of the federal register) will support greater alignment and \n",
      "interoperability across the health care system, as health it products \n",
      "and applications that will be developed for different settings and use \n",
      "cases will be developed according to a consistent base of standards \n",
      "that support a more seamless exchange of information. extending the \n",
      "implementation date, as further discussed below, should provide the \n",
      "necessary time to build to and use fhir release 4.0.1.\n",
      "    comment: although many commenters were generally in support of the \n",
      "proposal to use fhir, several commenters did raise specific \n",
      "implementation concerns. several commenters expressed concerns about \n",
      "the costs and burden for payers and providers to update to the \n",
      "necessary fhir standard for content exchange, especially for historical \n",
      "data that may not currently be coded to support fhir. many of these \n",
      "commenters cautioned cms from proceeding too quickly with fhir adoption \n",
      "and implementation. one commenter noted that semantic interoperability \n",
      "is needed for true interoperability but that significant mapping and \n",
      "implementation efforts would be needed to achieve this goal. one \n",
      "commenter requested cms provide federal funding to support adoption and \n",
      "implementation of fhir-based apis.\n",
      "    response: we appreciate the commenters' concerns. regarding the \n",
      "readiness of the fhir standards and the need for semantic \n",
      "interoperability, we agree that semantic interoperability is important. \n",
      "as noted in this section, though not required for use, we are providing \n",
      "a link to specific implementation guides and reference implementations \n",
      "that include information about the fhir resources to use to code and \n",
      "map the required data elements as to facilitate interoperable data \n",
      "exchange via the patient access api, as well as the provider directory \n",
      "api (discussed in section iv. of this final rule). this addresses the \n",
      "concern raised regarding semantic interoperability.\n",
      "    regarding burden, as indicated in section xiii. of this final rule, \n",
      "we do not anticipate that upgrading to hl7 fhir release 4.0.1 and \n",
      "preparing historical data for electronic transfer via an api using \n",
      "these standards will be more than a relatively minimal expense. we are \n",
      "also limiting the amount of historic information that will need to be \n",
      "included in the patient access api to information with a date of \n",
      "service on or after january 1, 2016. this should also help address \n",
      "concerns around expense and burden. in addition, we note the discussion \n",
      "below regarding the implementation date for this policy appreciating \n",
      "the commenters' concerns about moving too quickly. regarding federal \n",
      "funding and costs, we note that for several of the types of payers that \n",
      "must comply with the patient access api requirements, there is \n",
      "significant federal participation in the costs.\n",
      "    for medicaid ffs, the provision of enhanced federal match rate is \n",
      "addressed in section 1903(a)(3)(a) of the act and provides a 90 percent \n",
      "match rate for the sums expended during such quarter as are \n",
      "attributable to the design, development, or installation of such \n",
      "mechanized claims processing and information retrieval systems as the \n",
      "secretary determines are likely to provide more efficient, economical, \n",
      "and effective administration of the plan.\n",
      "    for medicaid managed care plans, since the patient access api \n",
      "requirements must be contractual obligations under the medicaid\n",
      "\n",
      "[[page 25531]]\n",
      "\n",
      "managed care contract, the costs must be included in the development of \n",
      "a plan's capitation rates. approved capitation rates would be matched \n",
      "at the state's medical assistance match rate.\n",
      "    as is discussed in section xiii. of this final rule, ma \n",
      "organizations may include in their bids the costs of implementing \n",
      "provisions of this rule that pertain to ma. the bid, as compared to the \n",
      "benchmark, is a significant component of what the government pays ma \n",
      "organizations for the provision of part a and part b benefits: (1) for \n",
      "bids at or below the benchmark, the government pays the bid as the \n",
      "capitation amount, and (2) for bids that are above the benchmark, the \n",
      "government pays the benchmark and the remainder of the bid amount is \n",
      "the premium charged to enrollees of the plan.\n",
      "    for chip, the federal government pays an enhanced federal medical \n",
      "assistance percentage (efmap) to states for all costs associated with \n",
      "chip, including systems costs. for federal fy 2020, the efmaps will \n",
      "range from approximately 65 to 81.5 percent. we note that states will \n",
      "be expected to implement the chip provisions using chip administrative \n",
      "funding, which is limited under section 2105(a)(1)(d)(v) and \n",
      "2105(c)(2)(a) of the act to 10 percent of a state's total annual chip \n",
      "expenditures.\n",
      "    for qhp issuers on the ffes, we would expect that issuers would \n",
      "raise premiums in the short term in order to cover the costs associated \n",
      "with developing and implementing these new standards. to the extent \n",
      "that premiums are raised for all qhp issuers on the ffes, federal \n",
      "contributions for the subsidized population in the form of advanced \n",
      "premium tax credits will increase proportionally in those initial \n",
      "years. non-subsidized consumers will be expected to pay for the \n",
      "increase in premiums themselves and any increases may impact the \n",
      "ability of some consumers to afford coverage. some consumers may \n",
      "instead select other options or opt out of coverage if they find qhps \n",
      "unaffordable.\n",
      "    comment: a few commenters indicated they did not support cms' \n",
      "proposal to use one standard adopted by hhs (fhir, which onc had \n",
      "proposed for adoption at 45 cfr 170.215) as the foundational standard \n",
      "for standards-based apis. a few commenters suggested cms permit the use \n",
      "of other standards for exchanging the proposed patient data during a \n",
      "transition period or until the fhir standards are more mature. one \n",
      "commenter recommended the use of hipaa administrative simplification \n",
      "transaction standards such as those maintained by x12. one commenter \n",
      "noted that these hipaa transaction standards were more accessible to \n",
      "payers to represent clinical and case management data. this commenter \n",
      "suggested cms should precisely identify the specific claims data layout \n",
      "of the hipaa administrative simplification transaction standards that \n",
      "payers would be required to generate and receive because the hipaa \n",
      "administrative simplification transaction standards layout varies by \n",
      "payer type. however, one commenter noted that patients may not find \n",
      "information available through hipaa standards useful.\n",
      "    a few commenters suggested cms should assist affected payers with \n",
      "meeting the technical implementation requirements by explaining the \n",
      "intent of the required use of the hipaa administrative simplification \n",
      "transaction content and vocabulary standards with the hl7 fhir \n",
      "standards. commenters recommended that cms review and reconcile \n",
      "differences between existing standards that are required for medicaid \n",
      "programs, in particular. for example, commenters suggested identifying \n",
      "situations in which cms has required the use of x12 electronic data \n",
      "interchange standards and reconciling these requirements with the \n",
      "adoption of the hl7 fhir standards.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. the policies included in this final rule are not \n",
      "intended to alter hipaa requirements in any way, and these electronic \n",
      "data exchanges are not defined transactions under hipaa regulations, \n",
      "therefore there is no need to reconcile use of x12 and the hl7 fhir \n",
      "standards required in this rule. we appreciate that the hipaa standards \n",
      "are more known to many payers at this time; however, we believe the use \n",
      "of fhir standards is important for advancing the policies finalized in \n",
      "this rule, which require the transmission of information beyond what is \n",
      "available using x12 standards alone. at the same time, as discussed in \n",
      "the proposed rule, we are requiring entities subject to this rule to \n",
      "use hipaa content and vocabulary standards at 45 cfr part 162 where \n",
      "required by other applicable law, or where such standards are the only \n",
      "available standards for the data type or element (84 fr 7623). the use \n",
      "of the fhir standard supports making this information available through \n",
      "an api. this is not in conflict with the use of other standards to \n",
      "represent the data being transmitted through the api. instead, the fhir \n",
      "standard can be thought of as defining an envelope, while the contents \n",
      "of the envelope can be represented by different content and vocabulary \n",
      "standards used in conjunction with fhir to make data interoperable and \n",
      "accessible. for additional information on fhir standards, we direct \n",
      "commenters to the onc's 21st century cures act final rule (published \n",
      "elsewhere in this issue of the federal register). to support \n",
      "implementation of the policies included in this final rule, we are \n",
      "providing a link to specific implementation guides and reference \n",
      "implementations that provide valuable guidance to further support \n",
      "sharing the needed data using the required standards: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>.\n",
      "    as discussed in section ii.a.3. of the cms interoperability and \n",
      "patient access proposed rule (84 fr 7622 through 7623), we recognized \n",
      "that while we must codify in regulation a specific version of each \n",
      "standard, the need for continually evolving standards development has \n",
      "historically outpaced our ability to amend regulations. to address how \n",
      "standards development can outpace our rulemaking schedule, we offered \n",
      "several proposals. we proposed that regulated entities may use an \n",
      "updated version of a standard where required by other applicable law. \n",
      "we also proposed that regulated entities may use an updated version of \n",
      "the standard where not prohibited by other applicable law, under \n",
      "certain circumstances.\n",
      "    we summarize the public comments we received on our approach to \n",
      "allowing voluntary adoption of updated standards and provide our \n",
      "responses.\n",
      "    comment: a few commenters expressed support for the proposal to \n",
      "allow plans to upgrade to newer versions of standards supporting data \n",
      "classes in the uscdi as standards evolve. a few commenters specifically \n",
      "supported the proposal to align with onc's proposed standards version \n",
      "advancement process and allow payers to adopt newer versions of fhir \n",
      "once approved for use by hhs. a few commenters were concerned with \n",
      "backwards compatibility if implementers--payers and developers--are \n",
      "permitted to move to new versions of standards, while a few commenters \n",
      "supported the proposed requirement to maintain compatibility with \n",
      "adopted standards while upgrading to newer standards. one commenter \n",
      "expressed concerns with difficulty tracking compliance with standards \n",
      "as they move through different versions, generally, and requested cms \n",
      "establish\n",
      "\n",
      "[[page 25532]]\n",
      "\n",
      "a versioning system or identifier for consistency and transparency.\n",
      "    a few commenters specifically discussed the ncpdp script standard; \n",
      "however, these comments are out of scope for this rulemaking because \n",
      "this rulemaking does not apply to eprescribing transactions.\n",
      "    response: we appreciate the commenters' input. we are adopting the \n",
      "ability to use updated standards. as proposed, implementers will need \n",
      "to ensure that use of the updated (or newer) standard (instead of the \n",
      "standard specified in the applicable regulation) does not disrupt an \n",
      "end user's ability to access the data available through the api, which \n",
      "should address concerns raised around backward compatibility. \n",
      "specifically, we are finalizing at 42 cfr 422.119(c)(4) for ma \n",
      "organizations, 42 cfr 431.60(c)(4) for medicaid ffs programs, 42 cfr \n",
      "438.242(b)(5) for medicaid managed care plans, 42 cfr 457.730(c)(4) for \n",
      "chip ffs programs, 42 cfr 457.1233(d)(1) for chip managed care \n",
      "entities, and 45 cfr 156.221(c)(4) for qhp issuers on the ffes \n",
      "permission to use an updated version of standards adopted at 45 cfr \n",
      "170.215, 45 cfr 170.213, 45 cfr part 162, or 42 cfr 423.160, subject to \n",
      "the conditions proposed. as long as use of the updated version of a \n",
      "standard is not otherwise prohibited, permitted in accordance with the \n",
      "conditions described, and, does not disrupt an end user's ability to \n",
      "access the data per the requirements of the api, it may be used.\n",
      "    regarding the recommendation for cms to establish a versioning \n",
      "system or identifier, we appreciate this recommendation and will review \n",
      "the suggestion for future consideration.\n",
      "c. data required to be available through the standards-based api & \n",
      "timeframes for data availability\n",
      "    we proposed the content that must be accessible for each enrollee \n",
      "of an entity subject to the standards-based api proposal as set out at \n",
      "proposed paragraph (b) of 42 cfr 422.119, 431.60, and 457.730, and 45 \n",
      "cfr 156.221; as noted previously, the regulations for medicaid managed \n",
      "care plans and chip managed care entities cross-reference and \n",
      "incorporate the regulations we proposed for medicaid and chip ffs \n",
      "programs. we noted that the types of content proposed would represent \n",
      "the minimum threshold for compliance; at their discretion, ma \n",
      "organizations, state medicaid and chip ffs programs, medicaid managed \n",
      "care plans, chip managed care entities, and qhp issuers on the ffes \n",
      "would have the option to use the api required by the proposed rule to \n",
      "make additional types of health information or plan information \n",
      "available, exceeding these minimum requirements.\n",
      "    we requested comment on the data proposed to be made available as \n",
      "detailed in the subsections below. we proposed that ma organizations, \n",
      "medicaid and chip ffs programs, medicaid managed care plans, chip \n",
      "managed care entities, and qhp issuers on the ffes permit third-party \n",
      "applications to retrieve, with the approval and at the direction of an \n",
      "enrollee, certain specific data: adjudicated claims data, including \n",
      "provider remittances and beneficiary or enrollee cost-sharing data; \n",
      "encounter data from capitated providers; and clinical data, including \n",
      "laboratory results (but only if maintained by the payer).\n",
      "(1) patient claims and encounter data\n",
      "    we proposed that the adjudicated claims data required to be \n",
      "provided include approved and denied claims. under the proposal, \n",
      "adjudicated claims data includes that for which the plan has made an \n",
      "initial payment decision even when the period during which an enrollee \n",
      "can file an appeal is still in effect, or when the enrollee has filed \n",
      "an appeal and is awaiting a decision on that appeal. such appeal \n",
      "decisions might be called reconsiderations, reconsidered decisions, \n",
      "organization determinations, or use other terms, but the term is not \n",
      "relevant. we specifically requested comments from plans regarding the \n",
      "feasibility of including such claims data, including any possible \n",
      "timing issues.\n",
      "    the proposal included timeframe requirements for making these \n",
      "various categories of data available through the standards-based api. \n",
      "for ma organizations, proposed 42 cfr 422.119(b)(1)(i), (ii), and \n",
      "(b)(2)(i) would require standards-based api access to all claims \n",
      "activity pertaining to standardized adjudicated claims (including cost, \n",
      "specifically provider remittances and enrollee cost-sharing) and \n",
      "standardized encounter data for benefits covered by the plan (that is, \n",
      "medicare part a and part b items and services, part d prescription \n",
      "drugs if covered by the ma plan, and any supplemental benefits) no \n",
      "later than one (1) business day after a claim is processed or the \n",
      "encounter data are received by the ma organization. we used the terms \n",
      "``adjudicated'' and ``processed'' interchangeably in this context.\n",
      "    for medicaid state agencies and managed care plans, we proposed \n",
      "that standardized claims data and encounter data would be required \n",
      "(specifically at 42 cfr 431.60(b)(1) and (2)) through the api no later \n",
      "than one (1) business day after the claim is processed or the data are \n",
      "received. for state medicaid agencies in connection with the ffs \n",
      "program, we explained that the api would have to include all claims \n",
      "data concerning adjudicated claims and encounter data from providers \n",
      "(other than mcos, pihps or pahps) that are paid using capitated \n",
      "payments. the requirement for medicaid managed care plans to provide \n",
      "encounter data is specified, in conjunction with the incorporation of \n",
      "the medicaid ffs requirement into the medicaid managed care \n",
      "regulations, at 42 cfr 438.242(b)(6)(i) (finalized as sec.  \n",
      "438.242(b)(5)(i) in this rule; see section vi.). similarly, we proposed \n",
      "that encounter data that medicaid managed care plans must make \n",
      "available through the api would include any data from subcontractors \n",
      "and providers compensated by the managed care plan on the basis of \n",
      "capitation payments, such as behavioral health organizations, dental \n",
      "management organizations, and pharmacy benefit managers. the api for \n",
      "medicaid managed care plans would have to include all claims and, \n",
      "therefore, encounter data that would be included regardless if it is \n",
      "adjudicated or generated by the managed care plan itself, a \n",
      "subcontractor, or a provider compensated on the basis of capitation \n",
      "payments. all data would need to be obtained in a timely manner to \n",
      "comply with these proposed requirements that these types of data be \n",
      "available through the api no later than one (1) business data after a \n",
      "claim is processed or the encounter data are received.\n",
      "    for chip agencies and managed care entities, access to standardized \n",
      "claims data and encounter data would be required (specifically at 42 \n",
      "cfr 457.730(b)(1) and (2)) through the api no later than one (1) \n",
      "business day after the claim is processed or the encounter data are \n",
      "received. the proposal for chip state agencies (regarding ffs programs) \n",
      "and chip managed care entities is identical to the proposal for \n",
      "medicaid state agencies (regarding ffs programs) and medicaid managed \n",
      "care plans. for qhp issuers on the ffes, the proposed regulation at 45 \n",
      "cfr 156.221(b) would require claims and encounter data to be available \n",
      "through the patient access api no later than one (1) business day after \n",
      "adjudication or receipt, respectively.\n",
      "    specifically regarding qhp issuers on the ffes, at 45 cfr \n",
      "156.221(b)(1)(i) and (ii), we proposed to require that qhp issuers \n",
      "participating on the ffes make available through the api standardized \n",
      "data concerning adjudicated claims (including cost) and standardized\n",
      "\n",
      "[[page 25533]]\n",
      "\n",
      "encounter data. under proposed paragraph (b)(1)(i), we proposed that \n",
      "qhp issuers on the ffes would be required to make available \n",
      "standardized data concerning adjudicated claim, provider remittance, \n",
      "and enrollee cost-sharing data through the api within one (1) business \n",
      "day after the claim is processed. under proposed paragraph (b)(1)(ii), \n",
      "we proposed that qhp issuers on the ffes would be required to provide \n",
      "standardized encounter data through the api no later than one (1) \n",
      "business day after the data are received by the issuer.\n",
      "    as discussed in the cms interoperability and patient access \n",
      "proposed rule (84 fr 7632 through 7633), the proposed timeframe--making \n",
      "the data available to the third-party app with the approval and at the \n",
      "direction of the patient through the api no later than one (1) business \n",
      "day after processing a claim or receiving encounter data--would ensure \n",
      "that data provided to the third-party app, and ultimately the patient, \n",
      "through the api would be the most current data available. providing the \n",
      "most current data may be critical if the data are provided by an \n",
      "enrollee to his or her health care provider to use in making clinical \n",
      "decisions. as proposed, the claims and encounter data to be disclosed \n",
      "would include information such as enrollee identifiers, dates of \n",
      "service, payment information (provider remittance if applicable and \n",
      "available), and enrollee cost-sharing. our proposal did not exclude any \n",
      "elements from the claims and encounter--or the clinical data--required \n",
      "to be made available through the patient access api. the ability for \n",
      "enrollees--created and facilitated by the api required under the \n",
      "proposal--to access this information electronically would make it \n",
      "easier for them to take it with them as they move from payer to payer \n",
      "or among providers across the care continuum.\n",
      "    regarding the provision of encounter data through the api no later \n",
      "than one (1) business day after receiving the data, we noted that the \n",
      "proposal would mean that a payer must rely on capitated providers \n",
      "submitting their encounter data in a timely manner to ensure that \n",
      "patients receive a timely and complete set of data. to the extent \n",
      "providers do not submit in a timely manner, there would be a delay in \n",
      "patients having access to their data. we recommended that ma \n",
      "organizations, medicaid managed care plans, chip managed care entities, \n",
      "and qhp issuers on the ffes that would need this information in order \n",
      "to meet the proposed api requirements in a timely manner should \n",
      "consider whether their contracts with network providers should include \n",
      "timing requirements for the submission of encounter data and claims so \n",
      "that the payer can comply with the api requirements more timely. for \n",
      "medicaid and chip ffs programs, we encouraged states to consider other \n",
      "means to ensure that necessary encounter data from providers is also \n",
      "provided on a timely basis.\n",
      "    we summarize the public comments we received on making claims and \n",
      "encounter data available via the patient access api and provide our \n",
      "responses.\n",
      "    comment: a few commenters expressed concern that there are no named \n",
      "or mature industry fhir-based standards available for representing and \n",
      "exchanging claims information. one commenter requested cms only require \n",
      "a specific subset of claims information that would be most useful to \n",
      "patients, suggesting patient name, diagnoses codes, procedure codes, \n",
      "drug codes, service date(s), provider of service, and out-of-pocket \n",
      "costs.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. we have been working with industry partners to ensure \n",
      "the necessary fhir standard and implementation guides as specified at \n",
      "45 cfr 170.215 are now available to ensure that payers can fully \n",
      "implement sharing claims data via a fhir-based api, as we are \n",
      "finalizing our proposal to have payers impacted by this rule make \n",
      "claims and encounter data available via the standards-based patient \n",
      "access api no later than one (1) business day after claims processing \n",
      "or encounter data receipt. to further support payers as they work to \n",
      "build the patient access api and map claims and encounter data for \n",
      "exchange via a fhir-based api, in partnership with industry, we have \n",
      "worked to ensure relevant implementation guides and reference \n",
      "implementations are available. a link to specific implementation guides \n",
      "and reference implementations for claims and encounter data have been \n",
      "produced and tested and can be found at <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>. though not \n",
      "mandatory, using these publicly available resources will reduce payer \n",
      "burden as they work to prepare their data for exchange via a fhir-based \n",
      "api.\n",
      "    we also appreciate the recommendation to only include a subset of \n",
      "claims information. however, we believe it is important for patients to \n",
      "have all of their claims information in order to facilitate informed \n",
      "decision making. patients have a right to their claims data. while that \n",
      "information currently can be obtained through various means, we decline \n",
      "to require that only a subset of the available claims information be \n",
      "available through the patient access api.\n",
      "    comment: one commenter noted that health plans cannot verify the \n",
      "accuracy of all information contained in a claim. this commenter \n",
      "requested cms should state that these policies do not mandate that \n",
      "payers audit and correct all information furnished by health care \n",
      "providers beyond what is currently necessary for existing rules, \n",
      "regulations, and internal business purposes.\n",
      "    response: we appreciate the commenter's concern. we agree that our \n",
      "regulations, as proposed and as finalized, for this patient access api \n",
      "do not require that payers do any additional audit or review of the \n",
      "claims they receive beyond current practices. to the extent that payers \n",
      "wish to, they may include a disclaimer or other notice to enrollees as \n",
      "part of the api to indicate this. such a disclaimer would be \n",
      "permissible under these regulations.\n",
      "    comment: a few commenters recommended that further standardization \n",
      "work be done to improve the accuracy of the claims data field that \n",
      "identifies the attributed health care provider administering services. \n",
      "if this data element is accurate, commenters note it will help ensure \n",
      "patients are reaching out to the right clinician. commenters believe \n",
      "this could reduce confusion when patients seek clarification or request \n",
      "amendments to their health information.\n",
      "    response: we appreciate the commenters' recommendation and will \n",
      "evaluate potential future options to address this concern through our \n",
      "work with hl7 and other industry partners. we do note, however, this \n",
      "seems to be a data accuracy issue and not a standardization issue. that \n",
      "said, we do strongly encourage all payers and providers to work \n",
      "together to ensure the accuracy of these and all data.\n",
      "    comment: a few commenters were concerned that claims data were not \n",
      "accurate representations of clinical findings and therefore not \n",
      "valuable in assisting patients in making health care decisions. these \n",
      "commenters expressed fears that patients may misinterpret claims \n",
      "information for health care decision-making when claims data serve a \n",
      "payment use case.\n",
      "    response: we appreciate the commenters' concerns. we do note, \n",
      "however, that there is valuable information on the claim relevant to a \n",
      "patient's care and care history that can inform health care decision-\n",
      "making. for instance, this information provides patients with the names \n",
      "of the providers they have visited, when they visited\n",
      "\n",
      "[[page 25534]]\n",
      "\n",
      "certain providers for certain medical needs, when tests or procedures \n",
      "were conducted, and more information about these tests and procedures. \n",
      "this information alone is very useful to patients as they plan and \n",
      "discuss future care with their providers. also, in the absence of \n",
      "clinical data (which is required to be provided through the patient \n",
      "access api under this rule only if the payer maintains such data), \n",
      "claims and encounter data provide a basis of information for patients \n",
      "to work with and get value from.\n",
      "    comment: one commenter sought clarification on the scope of \n",
      "medicaid-covered services to which the requirement to make claims and \n",
      "encounter data available through an api applies. this commenter \n",
      "recommended that cms specify that this requirement to make claims and \n",
      "encounter data available does not apply to long-term care waiver \n",
      "services, such as in-home care, meal preparation or delivery, and \n",
      "transportation. the commenter stated that providing claims and \n",
      "encounter data for these services through the api would be cumbersome \n",
      "for a variety of reasons including the fact that long-term care waiver \n",
      "services tend to have frequent (daily or weekly) utilization by each \n",
      "participant, which would result in an unwieldly number of claims or \n",
      "encounters being provided through the api for each individual.\n",
      "    response: we confirm that under 42 cfr 431.60(b)(1) and (2), 42 cfr \n",
      "457.730(b)(1) and (2), 42 cfr 438.242(b)(5) (proposed as sec.  \n",
      "438.242(b)(6); see section vi.), and 42 cfr 457.1233(d), states and \n",
      "managed care plans must make adjudicated claims and encounter data \n",
      "available through the api for all medicaid- or chip-covered services, \n",
      "including long-term services and supports (ltss). this requirement \n",
      "extends to in-home care, transportation services, and all other \n",
      "medicaid- or chip-covered services for which a claim or encounter is \n",
      "generated and adjudicated. we do not believe the number of claims \n",
      "generated by ltss will make the data unwieldy or unusable by the \n",
      "beneficiary. we believe that the benefits of providing claims and \n",
      "encounter data to beneficiaries so they can make better health care \n",
      "decisions and know which providers have been paid for providing \n",
      "services to them is no less important simply because it is a frequently \n",
      "provided service. some beneficiaries may find having such data on \n",
      "frequently rendered services more important since billing with such \n",
      "frequency may make it more prone to errors, fraud, waste, and abuse.\n",
      "    comment: several commenters were concerned with the appropriateness \n",
      "of sharing certain claims information, particularly specific costs such \n",
      "as negotiated rates that commenters believed could reveal trade secrets \n",
      "or be considered proprietary information. these commenters requested \n",
      "cms ensure that confidential, proprietary cost information is excluded \n",
      "from the proposed requirements. one commenter believed that disclosure \n",
      "of information such as negotiated rates would lead to higher health \n",
      "prices in the industry and other anticompetitive behavior. \n",
      "specifically, this commenter gave the example where dominant payers in \n",
      "a geographic or other market use this price information to deter \n",
      "competitors from entering into value-based payment arrangements. one \n",
      "commenter also requested that third-party apps be prohibited from \n",
      "aggregating or using any cost information for purposes other than \n",
      "transfer of the data to the patient.\n",
      "    response: we note that we take our obligations seriously to protect \n",
      "from disclosure information that is protected under current law. we \n",
      "also affirm our commitment to safeguarding data protected by law from \n",
      "inappropriate use and disclosure. we understand the concerns raised \n",
      "around sharing cost data. we appreciate the commenters' concerns, \n",
      "however we reiterate that we are committed to giving patients access to \n",
      "their health information, and we believe the benefits of making this \n",
      "information available to patients through third-party apps outweigh \n",
      "these concerns. it is critical for patients to better understand health \n",
      "care costs and be able to plan and budget as well as possible. having \n",
      "cost information, which is already accessible to patients, available to \n",
      "them in a more easy-to-understand presentation would allow patients to \n",
      "get the maximum benefit from this information. if a patient uses an app \n",
      "to view their health information that does not clearly indicate it will \n",
      "not use this cost data for any other purpose, there is a chance the app \n",
      "could aggregate or otherwise analyze the data, assuming the single app \n",
      "has access to enough patient data in a given market or patients who use \n",
      "a particular payer or plan, to make such an analysis possible. \n",
      "appreciating patients already have access to this information and \n",
      "understanding the possibility for secondary uses of such data, we are \n",
      "finalizing the policy as proposed to require plans to share adjudicated \n",
      "claims, including provider remittances and enrollee cost-sharing \n",
      "information, via the fhir-based patient access api so patients can \n",
      "continue to access this information in ways that will be most useful to \n",
      "them. we reiterate, however, that we do not have the authority to \n",
      "directly regulate third-party apps.\n",
      "    comment: a few commenters also indicated that even if patients had \n",
      "access to price information, they would not have the ability to \n",
      "negotiate or impact health care costs. one commenter noted that \n",
      "patients would find prospective cost information more valuable than \n",
      "retrospective payment information.\n",
      "    response: we appreciate the commenters' input. with access to price \n",
      "information, patients who would have cost sharing that is tied to such \n",
      "prices can be more informed consumers of their health care. even \n",
      "patients who have no direct financial responsibility tied to these \n",
      "prices can benefit from knowing the information in the event their \n",
      "insurance coverage changes in the future or so they can appreciate the \n",
      "relationship between the services they receive and their cost to the \n",
      "health care system. it is important for patients to understand as much \n",
      "as they can about their care. for instance, understanding the costs of \n",
      "past services can help them plan for future services. as a result, this \n",
      "information has great value to patients even if it does not directly \n",
      "impact their ability to specifically influence what they pay for their \n",
      "care, or tell them exactly how much their next service will cost out of \n",
      "pocket.\n",
      "    comment: many comments were received regarding price transparency, \n",
      "generally, and were beyond the scope of the discussion in this rule. \n",
      "overall, these were out of scope for this final rule as they referenced \n",
      "other rulemaking activities within hhs.\n",
      "    response: we appreciate the commenters' strong interest in greater \n",
      "price transparency in health care. we strongly support the \n",
      "administration's and department's efforts to continue to move toward \n",
      "greater transparency to help health care consumers make the most \n",
      "informed decisions. we point to the recent release of the cy 2020 \n",
      "hospital outpatient prospective payment system policy changes and \n",
      "payment rates and ambulatory surgical center payment system policy \n",
      "changes and payment rates. price transparency requirements for \n",
      "hospitals to make standard charges public final rule (84 fr 65524). \n",
      "this final rule establishes requirements for all hospitals operating in \n",
      "the united states to make their standard charges available to the \n",
      "public under section 2718(e) of the phsa, as well as an enforcement \n",
      "scheme under section 2718(b)(3) to enforce those requirements. \n",
      "specifically, sections 2718(b)(3) and 2718(e) of the phsa require that \n",
      "for each year each hospital operating within the united states\n",
      "\n",
      "[[page 25535]]\n",
      "\n",
      "establish (and update) and make public a list of the hospital's \n",
      "standard charges for items and services provided by the hospital, \n",
      "including for diagnosis-related groups established under section \n",
      "1886(d)(4) of the act. this final rule requires hospitals (as defined \n",
      "at 45 cfr 180.20) to establish, update, and make public a list of their \n",
      "gross charges, payer-specific negotiated charges (including the de-\n",
      "identified minimum and maximum negotiated charges), and discounted cash \n",
      "prices for all items and services online in a single digital file that \n",
      "is in a machine-readable format, as well as their payer-specific \n",
      "negotiated charges (including the de-identified minimum and maximum \n",
      "negotiated charges) and discounted cash prices (or gross charges, if a \n",
      "discounted cash price is not offered by the hospital) for a more \n",
      "limited set of shoppable services online in a consumer-friendly format.\n",
      "    we also direct commenters to the tri-agency transparency in \n",
      "coverage proposed rule (84 fr 65464) for additional proposals to \n",
      "further price transparency.\n",
      "    comment: some commenters generally opposed the proposal to make \n",
      "claims and encounter data available through a standards-based api no \n",
      "later than one (1) business day after receiving it. some commenters \n",
      "suggested the proposed data availability timeframe is challenging due \n",
      "to the timeline for sharing adjudicated claims, in particular, noting \n",
      "the different timeframes for payment discharge, benefit determination, \n",
      "and settlement of the patient account. one commenter noted the reliance \n",
      "on third-party contractors to adjudicate claims and the time required \n",
      "to migrate data from one system to another and that validation could \n",
      "take longer than one (1) business day. several commenters expressed \n",
      "concern about the timeframe based on revised determinations or revised \n",
      "decisions triggered by data that arrives after the initial \n",
      "determination. one commenter specifically questioned the value of \n",
      "third-party application use of claims data when an enrollee has filed \n",
      "an appeal and is awaiting a reconsideration decision. one commenter \n",
      "recommended cms only permit finalized claims where a determination has \n",
      "been made be available to be shared via the patient access api.\n",
      "    some commenters specifically referenced the reliance of ma plans on \n",
      "pharmacy benefit management organizations for the administration of \n",
      "part d benefits as a factor in the ability to make these claims data \n",
      "available within one (1) business day after receiving them. other \n",
      "commenters referenced the explanation of benefit requirements that \n",
      "provide a timeframe for information adjustment, which means that the \n",
      "final information may not be available in one (1) business day.\n",
      "    several commenters suggested an alternative timeframe of 3 or 5 \n",
      "days for vendor-adjudicated claims, citing time and costs. some \n",
      "commenters recommended a grace period for plans when there is a delay \n",
      "due to delayed provider encounter data submission. in addition, some \n",
      "requested an exception for specific conditions attributable to certain \n",
      "claims and encounter data. other commenters recommended that cms work \n",
      "with stakeholders to determine an appropriate timeframe for making \n",
      "claims and encounter data available via the patient access api.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations, including comments regarding claims that may be under \n",
      "appeal. we are finalizing this policy as proposed that payers make \n",
      "available through the patient access api, no later than one (1) \n",
      "business day after the information is received: (1) adjudicated claims, \n",
      "including claims data for payment decisions that may be appealed, were \n",
      "appealed, or are in the process of appeal, and (2) encounter data. we \n",
      "reiterate that this is one (1) business day after the claim is \n",
      "adjudicated or encounter data are received. this allows for potential \n",
      "delays in adjudication or delays in providers submitting their \n",
      "encounter data. it does not require payers and providers to change \n",
      "their contractual relationships or current processes for receipt, \n",
      "though we strongly encourage payers and providers to work together to \n",
      "make patient data available in as timely a manner as possible.\n",
      "    we believe it is valuable to patients to be able to have their data \n",
      "in as timely a manner as possible. having access to this information \n",
      "within one (1) business day could empower patients to have the \n",
      "information they need when they need it to inform care coordination and \n",
      "improve patient outcomes. if a patient needs to get follow-up care, \n",
      "having the information relevant to their previous visit is important \n",
      "and valuable. api technology allows this exchange to happen more \n",
      "quickly and efficiently, and we believe it is important to leverage \n",
      "this technological opportunity to ensure patients have the most current \n",
      "information about their care.\n",
      "    it is also important for patients to get this information timely \n",
      "even if there is the possibility of a change in determination due to \n",
      "appeal or other factors. we conducted research to evaluate the maturity \n",
      "of claims to inform researchers using the chronic conditions data \n",
      "warehouse (ccw) data.\\30\\ this research indicates that nearly half of \n",
      "all medicare ffs or carrier claims are submitted once and unchanged, \n",
      "and nearly 85 percent of inpatient claims are never adjusted. for \n",
      "carrier claims, 99 percent are fully mature at 10 months; and of non-\n",
      "inpatient claims that were adjusted, 0.13 percent or less had the \n",
      "diagnosis code changed. what this research shows is that many claims \n",
      "remain unchanged, and those that do take more that 3 or 5 days after \n",
      "adjudication to begin to mature. this wait would not provide patients \n",
      "more accurate or complete data; it would only delay their ability to \n",
      "benefit from access to their information. patients have a right to see \n",
      "the full lifecycle of their claims and encounter information, and we \n",
      "believe they should be able to have access to their information as soon \n",
      "as it is available. even if the payment amounts may change due to \n",
      "appeal, for instance, the services received and the providers who \n",
      "rendered them are less likely to change. this is very useful \n",
      "information and could impact care decisions and facilitate better care \n",
      "coordination if available as soon as possible. we do appreciate that \n",
      "there are many factors that could influence when some data are \n",
      "available. again, we encourage payers to work with health care \n",
      "providers and third-party contractors to ensure timely data processing.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\30\\ chronic conditions data warehouse. (2017, october). ccw \n",
      "white paper: medicare claims maturity (version 2.0). retrieved from \n",
      "<a href=\"https://protect2.fireeye.com/url?k=7bd1837b-2785aa50-7bd1b244-0cc47a6d17cc-590a0fb580f6d595&u=http://www2.ccwdata.org/documents/10280/19002256/medicare-claims-maturity.pdf\">https://protect2.fireeye.com/url?k=7bd1837b-2785aa50-7bd1b244-0cc47a6d17cc-590a0fb580f6d595&u=http://www2.ccwdata.org/documents/10280/19002256/medicare-claims-maturity.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    comment: several commenters expressed concern that the proposed \n",
      "timeframe for payers to share claims and encounter data with patients \n",
      "could require providers to accelerate their submissions to payers \n",
      "triggering additional requirements in existing contracts for the \n",
      "submission of claims and encounter data. some commenters cautioned \n",
      "there could be potential downstream consequences such as narrowing a \n",
      "payer's provider network. one commenter recommended removal of proposed \n",
      "rule preamble language suggesting that ma plans, medicaid managed care \n",
      "plans, chip managed care entities, and qhp issuers on the ffes could \n",
      "consider adding time requirements for submission of claims and \n",
      "encounter data in their contracts with providers. one commenter \n",
      "recommended cms provide sample contract language or dedicate resources\n",
      "\n",
      "[[page 25536]]\n",
      "\n",
      "to educating providers about the intent of these possible contract \n",
      "revisions.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. as discussed in the cms interoperability and patient \n",
      "access proposed rule, we do appreciate that some payers may consider \n",
      "adding timeframes to contracts with providers to help ensure patients \n",
      "get timely access to their claims and encounter data. again, we \n",
      "strongly encourage providers to make this information available in as \n",
      "timely a fashion as possible to best assist patients in having access \n",
      "to their health information. adding language to contracts is one way \n",
      "for payers and providers to work together to ensure patients get this \n",
      "valuable information in as timely a manner as possible. we believe \n",
      "providers can benefit as well if this information is available sooner; \n",
      "it could be shared with them for the purposes of care coordination in a \n",
      "more timely manner, too. it may take some time for providers to improve \n",
      "internal efficiencies to meet potential new timeline requirements, but \n",
      "we believe the long-term benefit outweighs potential short term \n",
      "implementation burden. we do note, however, that the policy being \n",
      "finalized in this rule is specific to payers making adjudicated claims \n",
      "and encounter information available to patients via the patient access \n",
      "api within one (1) business day after the payer receives the \n",
      "information. any additional timeframes are between the payers and their \n",
      "providers.\n",
      "(2) provider directory data\n",
      "    we proposed at 42 cfr 422.119(b)(1)(iii), 431.60(b)(3), \n",
      "438.242(b)(6)(ii), 457.730(b)(3), and 457.1233(d)(2)(ii) that the \n",
      "required patient access api make available provider directory data, \n",
      "including updates to such data. the proposal at 45 cfr 156.221 would \n",
      "not require qhp issuers to permit third-party retrieval of provider \n",
      "directory (and preferred drug list information) because such \n",
      "information is already required to be provided by qhp issuers on the \n",
      "ffes.\n",
      "    for ma organizations, at proposed 42 cfr 422.119(b)(1)(iii), we \n",
      "proposed to specify that ma organizations make specific provider \n",
      "directory information for their network of contracted providers \n",
      "accessible through their patient access apis: the names of providers; \n",
      "addresses; phone numbers; and specialty. this information is the same \n",
      "information ma organizations are already required to disclose to their \n",
      "enrollees under 42 cfr 422.111(b)(3) and make available online under 42 \n",
      "cfr 422.111(h)(2)(ii). as proposed, ma organizations would be required \n",
      "to ensure the availability of this information through the patient \n",
      "access api for all ma plans. we noted that including this information \n",
      "in a standards-based api allows non-ma third-party applications to \n",
      "consume, aggregate, and display this data in different contexts, \n",
      "allowing patients to understand and compare plan information in a way \n",
      "that can best serve their individual needs. as proposed, ma plans would \n",
      "be required to update provider directory information available through \n",
      "the api no later than 30 business days after changes to the provider \n",
      "directory are made.\n",
      "    under proposed 42 cfr 431.60(b)(3) and 457.730(b)(3), state \n",
      "medicaid and chip agencies respectively would be required to make \n",
      "provider directory information available through the patient access \n",
      "api, including updated provider information no later than 30 calendar \n",
      "days after the state receives this provider directory information or \n",
      "updates to provider directory information. the proposed regulation for \n",
      "medicaid managed care plans at 42 cfr 438.242(b)(6) (finalized as sec.  \n",
      "438.242(b)(6) in this final rule; see section iv. of this final rule) \n",
      "and for chip managed care entities at 42 cfr 457.1233(d)(2) would \n",
      "require mcos, pihps, and pahps to comply with the same timeframe, with \n",
      "the addition of specific provider directory information as noted in 42 \n",
      "cfr 438.242(b)(6)(ii) and 457.1233(d)(2)(ii). for medicaid managed care \n",
      "plans and chip managed care entities, we proposed the provider \n",
      "directory information available through the api must include all \n",
      "information that is specified in 42 cfr 438.10(h)(1) about provider \n",
      "directories for disclosure to managed care enrollees. we proposed that \n",
      "the patient access api be updated with new provider directory \n",
      "information within 30 calendar days from when the updated information \n",
      "is received by the state (or the managed care plan under 42 cfr \n",
      "438.242(b)(6) (finalized as sec.  438.242(b)(6) in this final rule; see \n",
      "section iv. of this final rule) and sec.  457.1233(d)(2)) to be \n",
      "consistent with existing medicaid managed care rules at 42 cfr \n",
      "438.10(h)(3). we proposed that the api implemented by the state \n",
      "medicaid agency would include the data elements specified for \n",
      "disclosure by medicaid state agencies in section 1902(a)(83) of the \n",
      "act; we proposed at 42 cfr 438.242(b)(6)(ii) that the patient access \n",
      "api implemented by medicaid managed care plans would have the data \n",
      "elements specified for disclosure at 42 cfr 438.10(h)(1). for chip \n",
      "agencies that operate ffs systems and chip managed care entities at 42 \n",
      "cfr 457.730(b)(3) and 457.1233(d)(2)(ii), respectively, we also \n",
      "proposed that provider directory data be available through the api no \n",
      "later than 30 calendar days after receipt of updated information.\n",
      "    we did not propose a similar requirement for qhp issuers on the \n",
      "ffes. as discussed in the cms interoperability and patient access \n",
      "proposed rule (84 fr 7633), these issuers are already required, under \n",
      "45 cfr 156.230(c) and implementing guidance, to make provider directory \n",
      "information accessible in a machine-readable format. because this \n",
      "information is already highly accessible in this format, we noted that \n",
      "we did not believe the benefits of making it also available through a \n",
      "standards-based api outweigh the burden for qhp issuers on the ffes. \n",
      "however, we sought comment as to whether this same requirement should \n",
      "apply to qhp issuers, or if such a requirement would be overly \n",
      "burdensome for them.\n",
      "    to avoid unnecessary duplication of effort and potential confusion, \n",
      "we are not finalizing the proposal to include provider directory \n",
      "information in the patient access api. instead, we are finalizing the \n",
      "inclusion of this information (consistent in scope as proposed for the \n",
      "patient access api) in the public facing provider directory api \n",
      "discussed in section iv. of this final rule, which requires ma \n",
      "organizations, medicaid ffs programs, medicaid managed care plans, chip \n",
      "ffs programs, and chip managed care entities to provide public access \n",
      "to complete and accurate provider directory information at 42 cfr \n",
      "422.120, 431.70, 438.242(b)(6), 457.760, and 457.1233(d)(3). \n",
      "appreciating that the comments we received on provider directory \n",
      "information and apis addressed issues relevant to both including these \n",
      "data in the patient access api discussed in this section of the final \n",
      "rule, but more so making this information more widely available through \n",
      "the provider directory api as discussed in section iv. of this final \n",
      "rule, all comments and our responses related to provider directory \n",
      "information via apis can be found in section iv. of this final rule.\n",
      "(3) clinical data including laboratory results\n",
      "    regarding the provision of clinical data, including laboratory \n",
      "results, we proposed at 42 cfr 422.119(b)(1)(iv) that ma organizations \n",
      "make clinical data, such as laboratory test results, available through \n",
      "the api if the ma organization maintains such data. we also proposed in \n",
      "paragraph (c)(3)(i) that\n",
      "\n",
      "[[page 25537]]\n",
      "\n",
      "the uscdi standard, proposed by onc for hhs adoption at 45 cfr 170.213, \n",
      "be used as the content and vocabulary standard for the clinical data \n",
      "made available through the api. we intended the proposal to mean that \n",
      "the data required under paragraph (b)(1)(iv) be the same as the data \n",
      "that is specified in that content and vocabulary standard defined at 45 \n",
      "cfr 170.213. in effect, we proposed that at a minimum any clinical data \n",
      "included in the uscdi standard, proposed by onc for hhs adoption at 45 \n",
      "cfr 170.213, be available through the patient access api if such data \n",
      "are maintained by the ma organization. we recognized that some ma \n",
      "organizations receive this information regularly, or as a part of their \n",
      "contracted arrangements for health services, but that not all ma \n",
      "organizations do. therefore, we proposed that this requirement would \n",
      "apply to ma organizations, regardless of the type of ma plan offered by \n",
      "the ma organization, but only under circumstances when the ma \n",
      "organization receives and maintains this clinical data as a part of its \n",
      "normal operations. the proposed requirement aligned with existing \n",
      "regulations at 42 cfr 422.118, which required ma organizations to \n",
      "disclose to individual enrollees any medical records or other health or \n",
      "enrollment information the ma organizations maintain with respect to \n",
      "their enrollees. we proposed that this data be available through the \n",
      "api no later than one (1) business day from its receipt by the ma \n",
      "organization.\n",
      "    similarly, the proposed regulations for medicaid and chip ffs \n",
      "programs and managed care plans (proposed 42 cfr 431.60(b)(4) and sec.  \n",
      "457.730(b)(4)), required provision through the patient access api of \n",
      "standardized clinical data, including laboratory results, if available, \n",
      "no later than one (1) business day after the data are received (by the \n",
      "state or the managed care plan or entity). we noted that this would \n",
      "ensure that data provided through the api would be the most current \n",
      "data available, which may be critical if the data are being shared by \n",
      "an enrollee with a health care provider who is basing clinical \n",
      "decisions on these data. as noted, like proposed 42 cfr 422.119(c), the \n",
      "medicaid and chip regulations proposed compliance with the regulations \n",
      "regarding the uscdi standard, proposed by onc for hhs adoption at 45 \n",
      "cfr 170.213, as the content and vocabulary standard for the clinical \n",
      "data available through the patient access api; therefore, we proposed \n",
      "that at a minimum any clinical data included in that uscdi standard be \n",
      "made available through the patient access api within one (1) business \n",
      "day of receipt. for state agencies managing medicaid or chip ffs \n",
      "programs, we proposed that such data be made available through the api \n",
      "under the proposal if the state maintains clinical data. the proposed \n",
      "regulation for medicaid managed care plans at 42 cfr 438.242(b)(6) \n",
      "(finalized as sec.  438.242(b)(5) in this rule; see section vi.) and \n",
      "chip managed care entities at 42 cfr 457.1233(d)(2) would require mcos, \n",
      "pihps, and pahps to comply with the same standard in terms of the scope \n",
      "of information and the timing of its availability through the patient \n",
      "access api; the limitation that the clinical data be maintained by the \n",
      "entity for it to be required to be sent via the patient access api \n",
      "would carry through to managed care plans and entities under the \n",
      "proposal.\n",
      "    proposed 45 cfr 156.221(b)(1)(iii) would require qhp issuers on the \n",
      "ffes to also make these clinical data, including laboratory results, \n",
      "available via the patient access api, with the approval and at the \n",
      "direction of the enrollee, if the qhp maintains such data.\n",
      "    we recognized not all of the entities subject to this requirement \n",
      "have uniform access to this type of data and sought comment on what \n",
      "barriers exist that would discourage them from obtaining, maintaining, \n",
      "and making these data available through the patient access api.\n",
      "    we summarize the public comments we received on the inclusions of \n",
      "clinical data, specifically the data included in the uscdi standard, \n",
      "via the patient access api and provide our responses below.\n",
      "    comment: several commenters expressed concerns that payers are \n",
      "typically not the original source of clinical information, including \n",
      "data elements that are part of the uscdi, and would not be the best \n",
      "source of the most accurate clinical data for patients. these \n",
      "commenters noted concerns with data accuracy provided by payers who are \n",
      "typically secondary sources of this clinical information and explained \n",
      "that payers do not verify this information. one commenter believed the \n",
      "originator should be providing the data, or that payers should be \n",
      "allowed to indicate the provenance of the data and where to direct \n",
      "questions regarding data accuracy. there was concern that the \n",
      "administrative burden on providers could increase due to patient \n",
      "inquiries and requests to correct or clarify their data.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. we understand that payers are not the source of this \n",
      "clinical information; however, payers do maintain clinical data that \n",
      "can be of great value to patients. we note that provenance is one data \n",
      "class within the uscdi. as such, this information would be available to \n",
      "patients. we also note, that as discussed above, we intend to provide \n",
      "suggested content for educational information that payers will be able \n",
      "to tailor and use to communicate with their patients about the patient \n",
      "access api. payers can choose to indicate the part of a data exchange \n",
      "that was received from an outside source so the receiving party \n",
      "understands where to direct questions. this will also help patients \n",
      "understand how to address incorrect information as it can be made clear \n",
      "where questions should be directed. payers are under no obligation \n",
      "under this patient access api requirement to validate or correct \n",
      "clinical data received from another source; and, providers are under no \n",
      "obligation to submit updated data to payers should patients suggest \n",
      "there is an error in their data. we do encourage payers and providers \n",
      "to continually work to ensure the accuracy of the patient data they \n",
      "maintain and share to the extent possible. the patient access api must \n",
      "include all of the specified clinical information for the enrollee \n",
      "maintained by the payer with a date of service on or after january 1, \n",
      "2016.\n",
      "    comment: a few commenters were concerned that payers could use \n",
      "clinical data to discriminate against providers, such as through \n",
      "discriminatory reimbursement models, for instance offering lower \n",
      "reimbursement rates for certain types of care that a physician deems \n",
      "necessary or in the best interest of the patient based on the data \n",
      "viewed about the doctor and the care they provide.\n",
      "    response: we appreciate the commenters' concerns; however, we note \n",
      "the fact that some payers are already automatically accessing a \n",
      "physician's ehr for other purposes, either as an elective offering or \n",
      "through contractual requirements. as a result, additional data than is \n",
      "required to meet the requirements of this final rule are already being \n",
      "shared between providers and payers. we reiterate that payers are not \n",
      "entitled to receive information from a health care provider if such \n",
      "information is protected by applicable federal, state, or local law \n",
      "from disclosure to the payer. this final rule does not change any such \n",
      "existing legal obligations.\n",
      "    comment: a few commenters expressed concerns over provider \n",
      "liability for the quality or accuracy of\n",
      "\n",
      "[[page 25538]]\n",
      "\n",
      "clinical data and for being given certain sensitive patient diagnosis \n",
      "and problems information, particularly if the provider is a downstream \n",
      "recipient of such data.\n",
      "    response: we appreciate the commenters' concerns, but reiterate \n",
      "that the policies finalized in this regulation do not change any payer \n",
      "or provider's obligations to abide by existing federal and state \n",
      "regulations and law, including 42 cfr part 2, which governs certain \n",
      "substance use disorder records, which are some of the most sensitive \n",
      "health information. we note, however, that the patient can direct the \n",
      "entity to transfer this sensitive data upon their designation of a \n",
      "recipient, or may provide consent or authorization for the transfer, as \n",
      "applicable. as a provider, and likely as a covered entity under hipaa, \n",
      "providers are experienced in handling sensitive data. access through an \n",
      "api will provide a new route to receiving sensitive data, not add to \n",
      "the burden of protecting such information, given the continued need to \n",
      "maintain compliance with all applicable rules and regulations. these \n",
      "policies just allow this information to be transmitted via an api with \n",
      "the approval and at the direction of the patient.\n",
      "    comment: some commenters expressed concern that patients may not \n",
      "understand, or may be confused by, the health information that will be \n",
      "available, and questioned if this information will all be relevant to \n",
      "patients. a few commenters recommended that educational materials and \n",
      "resources be developed to ensure that the data are useful and do not \n",
      "cause alarm.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. we appreciate that every patient may not understand \n",
      "every piece of information in their medical record. we intend to \n",
      "provide suggested content for educational materials or other patient \n",
      "resources that payers can tailor and use to ensure that patients have \n",
      "information about how to accurately and productively navigate their \n",
      "health care information, as further discussed below in this section. it \n",
      "is important for patients to have access to their records, review them, \n",
      "and have an opportunity to raise questions and seek clarification about \n",
      "the information maintained in them.\n",
      "    comment: one commenter requested cms explain the requirement that \n",
      "ma organizations make clinical data available through the patient \n",
      "access api if the entity ``manages such data,'' particularly what is \n",
      "meant by ``manages such data.'' this commenter noted that providers \n",
      "manage clinical data and requested clarification of whether the \n",
      "requirement applies to ma organizations. another commenter expressed \n",
      "similar concerns and inquired whether ``managed by the payer'' would \n",
      "include only lab results or all clinical data. commenters questioned if \n",
      "``manage'' meant ``electronically stored in a database under the \n",
      "payer's control''?\n",
      "    response: we appreciate the commenters' request for additional \n",
      "information. as noted in the cms interoperability and patient access \n",
      "proposed rule, payers, including ma organizations, need to make these \n",
      "data available through the api when the payer receives and maintains \n",
      "these data as a part of its normal operations (84 fr 7633). we used the \n",
      "verb ``manages'' to communicate that this proposed requirement would \n",
      "apply when the payer has access to the data, control over the data, and \n",
      "the authority to make the data available through the api. in order to \n",
      "more closely align with how the relevant hipaa privacy rule requirement \n",
      "refers to such activity, we are finalizing the regulation text at 42 \n",
      "cfr 422.119(b)(1)(iii), 431.60(b)(3), and 457.730(b)(3), as well as 45 \n",
      "cfr 156.221(b)(1)(iii) with the verb ``maintains'' in place of the verb \n",
      "``manages''. as such, we define ``maintain'' to mean the payer has \n",
      "access to the data, control over the data, and authority to make the \n",
      "data available through the api.\n",
      "    comment: one commenter questioned if medicaid agencies will be \n",
      "required to provide clinical data regardless of the type of transaction \n",
      "by which the agency received the data.\n",
      "    response: we confirm that medicaid and chip agencies, and their \n",
      "respective managed care plans, will be required under 42 cfr \n",
      "431.60(b)(3), 457.730(b)(3), 438.242(b)(5), and 457.1233(d) to provide \n",
      "clinical data through the api if the state or managed care plan \n",
      "maintains such clinical data. clinical data subject to this requirement \n",
      "includes laboratory results and other clinical data, and must be made \n",
      "available through the patient access api regardless of the type of \n",
      "transaction by which the state or managed care plan received the data \n",
      "originally. however, if the data were received under the payer-to-payer \n",
      "data exchange requirement finalized in section v. of this final rule at \n",
      "42 cfr 422.119(f), 438.62(b)(1)(vi), and 457.1216, and 45 cfr \n",
      "156.221(f), then the payer would only need to share the clinical data \n",
      "received via the payer-to-payer data exchange via the patient access \n",
      "api if the data were received from another payer via a standards-based \n",
      "api. as required at 42 cfr 422.119(f)(1)(iii), 438.62(b)(1)(vi)(c), and \n",
      "457.1216 and 45 cfr 156.221(f)(1)(iii), data received via the payer-to-\n",
      "payer data exchange only need to be made available to share in the \n",
      "electronic form and format they were received from another payer. if a \n",
      "payer receives data specifically for the payer-to-payer data exchange \n",
      "via an api, they can then make these data available via the patient \n",
      "access api without additional burden--the payer will not be required \n",
      "per this final rule to take data from another payer received as a \n",
      "direct result of the payer-to-payer data exchange policy and prepare it \n",
      "to be shared via the patient access fhir-based api; the payer will only \n",
      "be required to incorporate that data into the enrollee's record so that \n",
      "it can be shared with a new payer, if requested by the patient, in the \n",
      "electronic form and format received. appreciating concerns raised \n",
      "around the burden of preparing data for exchange via an api, we have \n",
      "provided this guidance to minimize this burden. we note that medicaid \n",
      "and chip state agencies are not subject to the payer-to-payer data \n",
      "exchange requirement in this rulemaking, as we did not propose this \n",
      "policy for these entities.\n",
      "    comment: a few commenters recommended that patients have access to \n",
      "detailed and accurate lab test and results information through the \n",
      "patient access api. a few commenters were not supportive of cms' \n",
      "proposal that laboratory information be made available only where \n",
      "available. one commenter recommended that these same api requirements \n",
      "apply to laboratories providing service to medicare and medicaid \n",
      "patients as any provider receiving reimbursement for medical services. \n",
      "one commenter expressed concern that lab information is not \n",
      "standardized and may be difficult to exchange.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. these regulations requiring the patient access api and \n",
      "detailing the data available through the patient access api, as \n",
      "proposed and as finalized, do not apply to laboratories or to any \n",
      "providers--these requirements are specific to payers as detailed above, \n",
      "but we will review the recommendations made for potential future \n",
      "consideration.\n",
      "    regarding concerns about standardized data exchange of laboratory \n",
      "information, the regulations finalized in this rule provide the content \n",
      "and vocabulary standards at 45 cfr 170.213 needed to address sharing \n",
      "laboratory data through the api. implementation guidance, now\n",
      "\n",
      "[[page 25539]]\n",
      "\n",
      "available at <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>, though not mandatory, can be used to further \n",
      "support sharing these data utilizing the content and vocabulary \n",
      "standards adopted in this rule. these implementation guides and \n",
      "reference implementations provide additional support to help payers \n",
      "implement this policy in a standardized way that facilitates \n",
      "interoperability.\n",
      "    comment: some commenters were concerned about the proposed timeline \n",
      "and challenges specifically because of the nature of laboratory data, \n",
      "specifically laboratory results. final results can replace preliminary \n",
      "results, and laboratory data coming from third parties can take time to \n",
      "receive. additionally, there may be conflicting disclosure requirements \n",
      "that permit up to 30 days to pass before laboratory data are available \n",
      "to a payer.\n",
      "    response: we appreciate the commenters' concerns. we do understand \n",
      "that there are many factors that could influence when some data are \n",
      "available. however, we reiterate that this patient access api policy \n",
      "requires the information to be shared no later than one (1) business \n",
      "day after it is received by the regulated payer. if it takes additional \n",
      "time for laboratory information to be provided to a payer, that does \n",
      "not impact the payer's obligation to make the data available via the \n",
      "patient access api no later than one (1) business day after the receipt \n",
      "of the information by the payer. therefore, we strongly encourage all \n",
      "payers and providers to work to make data available in as timely a \n",
      "fashion as possible to ensure an optimally informed health care \n",
      "ecosystem.\n",
      "    comment: many commenters supported the proposal to require \n",
      "providing the information in the uscdi via the patient access api. \n",
      "commenters supported alignment with onc on this and encouraged \n",
      "additional alignment across government data sets. commenters also \n",
      "supported the data classes and associated standards in the proposed onc \n",
      "uscdi. one commenter specifically noted support for the pediatric vital \n",
      "signs proposed as part of the uscdi. a few commenters recommended the \n",
      "addition of data classes that are already proposed as part of the \n",
      "uscdi, such as clinical notes, provenance, and unique device \n",
      "identifiers. a few commenters strongly supported the inclusion of notes \n",
      "in the uscdi, citing several studies of the benefits of patients having \n",
      "this information including, but not limited to, patient literacy, \n",
      "empowerment, health care coordination, medication adherence, and \n",
      "safety. one commenter recommended only final notes be considered \n",
      "applicable to the uscdi and that the imaging note be removed from the \n",
      "types of required notes. this commenter also indicated that notes that \n",
      "contain sensitive information were likely subject to a variety of state \n",
      "privacy laws. a few commenters noted further standardization work was \n",
      "needed for provenance data fields.\n",
      "    response: we appreciate the commenters' support and \n",
      "recommendations; we have shared these comments about the uscdi with onc \n",
      "for future consideration. we agree that aligning with onc and \n",
      "finalizing exchange of the uscdi as defined at 45 cfr 170.213 in onc's \n",
      "21st century cures act final rule (published elsewhere in this issue of \n",
      "the federal register) has many benefits and will help us reach our \n",
      "interoperability goals. we refer readers to onc's final rule for the \n",
      "specifics of exactly how the uscdi standard is being finalized by hhs. \n",
      "as finalized here, the clinical data required to be made available \n",
      "through the patient access api at 42 cfr 422.119(b)(1)(iii), \n",
      "431.60(b)(3), and 457.730(b)(3), and 45 cfr 156.221(b)(1)(iii) at a \n",
      "minimum are the uscdi version 1 as defined at 45 cfr 170.213 and \n",
      "specified in this rule at 42 cfr 422.119(c)(3)(i), 431.60(c)(3)(i), and \n",
      "457.730(c)(3)(i), and 45 cfr 156.221(c)(3)(i). we do note the policies \n",
      "finalized in this regulation do not alter obligations under existing \n",
      "federal and state laws. we reiterate that we are working closely with \n",
      "hl7 and other partners leading the effort to develop standards to \n",
      "ensure helpful guidance is available for payers to consult as they work \n",
      "to implement the policies being finalized in this rule. again, we note \n",
      "that, though not mandatory, we are providing a link to specific \n",
      "implementation guides and reference implementations that provide \n",
      "valuable guidance to support payers as they work to implement the \n",
      "patient access api: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>.\n",
      "    comment: one commenter requested that all the data elements in the \n",
      "uscdi be specifically enumerated in the regulation text of this final \n",
      "rule for clarity. a few commenters recommended cms and onc limit the \n",
      "definition of electronic health information to solely the data classes \n",
      "included in the uscdi. another commenter did not believe this \n",
      "definition should be limited to identifiable information. one commenter \n",
      "suggested that the definition of electronic health information should \n",
      "include real price information.\n",
      "    response: we appreciate the commenters' recommendations. we are \n",
      "finalizing our regulation text that requires use of the standard \n",
      "specified at 45 cfr 170.213 in onc's separate rulemaking to ensure \n",
      "alignment and consistency across the two regulations. that specific \n",
      "standard is currently the uscdi version 1 and therefore the uscdi will \n",
      "be the initial standard applicable under this final rule. additional \n",
      "information about the data classes and data elements included in uscdi \n",
      "can be found at <a href=\"http://www.healthit.gov/uscdi\">http://www.healthit.gov/uscdi</a>. we continue to use \n",
      "``electronic health information'' as defined by onc at 45 cfr 171.102. \n",
      "with regard to specifically listing the data elements in the uscdi, we \n",
      "believe cross referencing onc's regulation better supports our goal of \n",
      "aligning with onc's policy regarding this information.\n",
      "    comment: one commenter did not support the proposed requirement to \n",
      "provide patients with the uscdi data because the commenter believed it \n",
      "was not feasible for payers. the commenter indicated that payers do not \n",
      "typically collect clinical data. one commenter recommended that cms use \n",
      "fhir bundles, or a collection of relevant fhir resources, rather than \n",
      "the uscdi. one commenter was concerned with how free text fields would \n",
      "be addressed in the uscdi. one commenter expressed concern that cms \n",
      "would require the use of non-hipaa standards in the uscdi for providing \n",
      "data to patients.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. we acknowledge that payers do not maintain all \n",
      "clinical data for all patients and our regulation text at 42 cfr \n",
      "422.119(b)(1)(iii), 431.60(b)(3), and 457.730(b)(3), and 45 cfr \n",
      "156.221(b)(1)(iii), as finalized, specifically limits the obligation to \n",
      "make clinical data available through the patient access api to those \n",
      "payers that maintain any such data. if a payer subject to these \n",
      "regulations (including the medicaid and chip managed care plans that \n",
      "are subject to regulations that incorporate these requirements) \n",
      "maintain the data elements specified in this final rule, these data \n",
      "elements must be shared as noted in this final rule using the standards \n",
      "indicated. if payers do maintain valuable clinical data about patients, \n",
      "patients have a right to these data. this is a first step in providing \n",
      "patients with information from their medical record in an efficient \n",
      "electronic format.\n",
      "    we appreciate the recommendation to look at alternatives to the \n",
      "uscdi, but we believe it is critical for interoperability to align with \n",
      "onc and see great value\n",
      "\n",
      "[[page 25540]]\n",
      "\n",
      "in the continued coordination between cms, onc, and partners such as \n",
      "hl7 to ensure helpful guidance is available for payers to consult as \n",
      "they work to successfully implement these final rule policies. to this \n",
      "end, we again note that we have provided a link to specific \n",
      "implementation guides and reference implementations that, though not \n",
      "mandatory, can be used to support consistent implementation. we refer \n",
      "readers to additional information on the uscdi at <a href=\"http://www.healthit.gov/uscdi\">http://www.healthit.gov/uscdi</a> and available guidance at <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a> to best \n",
      "understand how to implement all data classes and elements included in \n",
      "the uscdi including text fields. regarding the use of non-hipaa versus \n",
      "hipaa standards, we do not believe there is a conflict, and we refer \n",
      "readers to the discussion of administrative simplification transaction \n",
      "standards in section iii.c.2.b. of this final rule for more \n",
      "information.\n",
      "    comment: one commenter suggested that standards development \n",
      "organizations such as hl7 would be better positioned to support data \n",
      "standardization rather than the proposed uscdi approach. a few \n",
      "commenters noted there are different use cases for various data types \n",
      "and that coordination is required to expand the data in the uscdi. one \n",
      "commenter recommended cms allow voluntary extensions to data sets \n",
      "outside of the uscdi to support the growth of new standards and data \n",
      "types from a payer perspective.\n",
      "    response: we appreciate the commenters' recommendations. in \n",
      "addition, we appreciate the valuable role of standards development \n",
      "organizations, like hl7, and reiterate our commitment to working with \n",
      "such partners as industry develops the necessary standards and \n",
      "associated guidance to implement the policies being finalized in this \n",
      "rule. we will continue to refer to the uscdi as finalized by hhs in \n",
      "onc's 21st century cures act final rule (published elsewhere in this \n",
      "issue of the federal register) at 45 cfr 170.213 to ensure alignment \n",
      "and consistency across the two regulations. we further refer readers to \n",
      "additional information about the uscdi and the expansion process as \n",
      "defined by onc at <a href=\"http://www.healthit.gov/uscdi\">http://www.healthit.gov/uscdi</a>. we note that this \n",
      "expansion process is a consensus process that allows for public input \n",
      "and comment and strongly recommend stakeholders continue to engage in \n",
      "this valuable process. this coordination and consensus is a cornerstone \n",
      "of our interoperability efforts. we also note that the data elements \n",
      "required in this final rule represent the minimum data that must be \n",
      "shared under our finalized policy through a payer's patient access api. \n",
      "we strongly encourage payers to share more data as the more data that \n",
      "patients have access to, the more they will benefit from this access. \n",
      "we agree that continuing to push these limits will spur innovation and \n",
      "growth.\n",
      "    comment: a few commenters requested additional information \n",
      "regarding the definitions of terminology used when discussing the uscdi \n",
      "in the cms interoperability and patient access proposed rule. one \n",
      "commenter requested more information on the meaning of ``state \n",
      "agencies,'' in reference to ``any clinical data included in the uscdi \n",
      "standard . . . be available through the api,'' and if this meant that \n",
      "if the state agency managed an immunization registry it would be \n",
      "required to make the data available through an api. another commenter \n",
      "requested cms to provide more information about the use of ``forward'' \n",
      "(in the preamble) versus ``send'' (in the regulatory text) regarding \n",
      "the uscdi, including whether the information needs to be available to \n",
      "the receiving payer and whether use of a trusted exchange network is \n",
      "required.\n",
      "    response: we appreciate the commenters' requests for additional \n",
      "information. we note that the term ``state agencies'' in this instance \n",
      "in the proposed rule (84 fr 7634) refers to those state agencies that \n",
      "manage medicaid and chip programs. if a medicaid or chip state agency \n",
      "has immunization data in connection with its medicaid program or chip \n",
      "as defined in the uscdi, these data would be required to be available \n",
      "via the patient access api per our proposal as finalized. we note that \n",
      "in section v. of this final rule, we require the exchange of the uscdi \n",
      "between payers subject to this regulation; this payer-to-payer data \n",
      "exchange does not require the use of an api. as finalized, our policies \n",
      "do not require the use of a trusted exchange network. regarding the use \n",
      "of terms ``forward'' and ``send,'' we note this means that the data \n",
      "must be exchanged with the patient as specified here in section iii. of \n",
      "this final rule or between payers as discussed in section v. of this \n",
      "final rule.\n",
      "(4) drug benefit data, including pharmacy directory, and formulary data\n",
      "    we proposed that drug benefit data, including pharmacy directory \n",
      "information and formulary or preferred drug list data, also be \n",
      "available through the patient access api at proposed 42 cfr \n",
      "422.119(b)(2)(ii) and (iii), 431.60(b)(5), and 457.730(b)(5). (our \n",
      "proposal for providing prescription drug claims through this api is \n",
      "discussed in section iii.c.2.c.(1) of the cms interoperability and \n",
      "patient access proposed rule (84 fr 7632).) as previously discussed, \n",
      "medicaid managed care plans would be required by 42 cfr 438.242(b)(6) \n",
      "(finalized as sec.  438.242(b)(5) in this rule; see section vi.) to \n",
      "comply with the requirement at 42 cfr 431.60(b)(5), and chip managed \n",
      "care entities would be required by 42 cfr 457.1233(d)(2) to comply with \n",
      "the requirement at 42 cfr 457.730(b)(5).\n",
      "    we proposed at 42 cfr 422.119(b)(2)(ii) and (iii) that ma \n",
      "organizations offering ma-pd plans must make available through the api \n",
      "the following pharmacy benefit data: (1) pharmacy directory data, \n",
      "including the number, mix (specifically the type of pharmacy, such as \n",
      "``retail pharmacy''), and addresses of pharmacies in the plan network; \n",
      "and (2) formulary data including covered part d drugs and any tiered \n",
      "formulary structure or utilization management procedure which pertains \n",
      "to those drugs. the pharmacy directory information is the same \n",
      "information that ma-pd plans--like all part d plans--must provide on \n",
      "their websites under 42 cfr 423.128(b)(5) and (d)(2). while \n",
      "prescription drug claims would have to be made available through the \n",
      "patient access api no later than one (1) business day after the ma-pd \n",
      "plan's receipt of that information, we did not propose a specific \n",
      "timeframe for pharmacy directory or formulary information to be \n",
      "available (or updated) through the api. we noted that we intended that \n",
      "the requirements in 42 cfr part 423 requiring when and how information \n",
      "related to pharmacy directories be updated would apply to the provision \n",
      "of this information through the api; we solicited comment whether we \n",
      "should address this in the regulation text or otherwise impose a \n",
      "timeframe for this information to be made available through the api.\n",
      "    at 42 cfr 431.60(b)(5), for medicaid ffs programs, and at 42 cfr \n",
      "457.730(b)(5) for chip ffs programs, we proposed that states would be \n",
      "required to include and update information about covered outpatient \n",
      "drugs and updates to such information, including, where applicable, \n",
      "preferred drug list information, no later than one (1) business day \n",
      "after the effective date of any such information or updates to such \n",
      "information.\n",
      "    we did not propose a similar requirement for qhp issuers on the \n",
      "ffes because, like the provider\n",
      "\n",
      "[[page 25541]]\n",
      "\n",
      "directory information, qhp issuers are required to make drug formulary \n",
      "data accessible in a machine-readable format.\n",
      "    as discussed above for the provider directory information, to avoid \n",
      "unnecessary duplication of effort and potential confusion, we are also \n",
      "not finalizing the proposal to include pharmacy directory information \n",
      "in the patient access api. instead, we are only finalizing the \n",
      "inclusion of this information as proposed and explained above be \n",
      "included in the public facing provider directory api discussed in \n",
      "section iv. of this final rule, which requires ma organizations that \n",
      "offer ma-pd plans to provide public access to pharmacy directory \n",
      "information at 42 cfr 422.120(b). relevant comments are also discussed \n",
      "in section iv. of this final rule.\n",
      "    we summarize the public comments received on our proposal that \n",
      "information about drug coverage and pharmacy benefit coverage be \n",
      "available through the patient access api and provide our responses.\n",
      "    comment: one commenter recommended cms require that ma plans make \n",
      "information about patients' step therapy available for sharing \n",
      "electronically. this commenter opposes step therapy and recommended \n",
      "that it not be used in ma or part d.\n",
      "    response: the use of step therapy is beyond the scope of this rule. \n",
      "however, because step therapy is a utilization management procedure, it \n",
      "is included among the types of information ma-pds must make available \n",
      "about part d drugs through the api. in regard to information about \n",
      "utilization management that pertains to basic benefits, which was not \n",
      "addressed in this rule, we appreciate the commenter's recommendations \n",
      "and will evaluate them for potential future consideration.\n",
      "    comment: one commenter strongly recommended the inclusion and \n",
      "standardization of prescription drug monitoring program data (pdmp) for \n",
      "exchange through apis, although this commenter referred more to \n",
      "exchange between providers for downstream clinical decision support and \n",
      "analytics rather than for patient access. a few commenters were not in \n",
      "favor of sharing pdmp data through apis. a few commenters were not \n",
      "supportive of pdmp data being available to other providers and payers.\n",
      "    response: we appreciate the commenters' recommendations and \n",
      "concerns. however, we note that this information is not required to be \n",
      "available through the patient access api as it is not within the scope \n",
      "of 422.119(b)(2).\n",
      "    comment: several commenters expressed concern that the proposals in \n",
      "42 cfr 431.60(b)(5), 457.730(b)(5), 438.242(b)(6) (finalized as 42 cfr \n",
      "431.60(b)(4), 457.730(b)(4), and 438.242(b)(5) in this rule), and 45 \n",
      "cfr 457.1233(d) to provide information on covered outpatient drugs and \n",
      "preferred drug lists through an api within one (1) business day after \n",
      "the effective date of the information or updates to the information may \n",
      "be a challenge for state medicaid and chip agencies and medicaid and \n",
      "chip managed care entities. one commenter recommended to first require \n",
      "state medicaid pharmacy programs to focus on developing interoperable \n",
      "standards for api development and only require managed care entities to \n",
      "adopt the standards once the api has been tested and scaled at the \n",
      "state level.\n",
      "    response: we appreciate the commenters' concerns. we understand \n",
      "that our proposed timeframe of one (1) business day may be \n",
      "operationally challenging for states and managed care plans but \n",
      "continue to believe that this timeframe is critical in order for \n",
      "beneficiaries and prescribers to have this information as soon as the \n",
      "information is applicable to coverage or in near real time since this \n",
      "information could improve care and health outcomes. we believe that \n",
      "timely data are particularly important during urgent or emergency \n",
      "situations. we note that having access to this information as soon as, \n",
      "or even before, it is effective is necessary for patients and their \n",
      "providers to make important decisions about which medications should be \n",
      "included in a patient's care plan. this is particularly important for \n",
      "patients who may not be able to cover a medication out of pocket if it \n",
      "is not covered by their plan. therefore, we are finalizing the \n",
      "timeframe. we decline to only apply these requirements to state \n",
      "medicaid programs (and decline to postpone application of the timeframe \n",
      "to managed care plans until a future time as recommended by the \n",
      "commenter) because this approach would not be consistent with our goal \n",
      "of ensuring that the patients covered by the payers impacted by this \n",
      "requirement have access to the specified data. we also note that we are \n",
      "providing a link to specific implementation guidance and reference \n",
      "implementations for all payers to further support sharing the needed \n",
      "data using the required standards: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>. we are finalizing these \n",
      "requirements for the api to include formulary information for ma \n",
      "organizations offering ma-pd plans, state medicaid and chip ffs \n",
      "programs, medicaid managed care plans, and chip managed care entities.\n",
      "    in addition to comments about the specific types of information we \n",
      "proposed be made available through the patient access api, we also \n",
      "received comments on additional types of information stakeholders would \n",
      "like to see included. we summarize the public comments we received on \n",
      "this topic and provide our responses.\n",
      "    comment: commenters made a number of suggestions for additional \n",
      "data to be made available to patients via the patient access api. some \n",
      "of the data requested is already included in the proposal and being \n",
      "finalized for inclusion as proposed. in addition to these requests, a \n",
      "few commenters recommended cms also require the inclusion of \n",
      "information regarding prior authorization decisions, drug pricing, and \n",
      "a direct phone number for patients to call providers and their staff \n",
      "about prior authorization issues. a few commenters specifically \n",
      "requested prior authorization decision information, including active \n",
      "prior authorizations, be made accessible to patients; a few other \n",
      "commenters suggested this prior authorization information be available \n",
      "to providers.\n",
      "    commenters recommended future versions of the uscdi include \n",
      "additional data so that these data would be available via the patient \n",
      "access api. a few commenters recommended the uscdi include social \n",
      "determinants of health data. one commenter recommended cms and onc \n",
      "include additional immunization data elements from the cdc endorsed \n",
      "data elements for immunization and the american immunization registry \n",
      "association's functional guide. one commenter recommended care team \n",
      "data class as well as data class provenance ``author health \n",
      "profession'' be added. one commenter recommended including coverage and \n",
      "explanation of benefit data to the uscdi per the carin alliance's \n",
      "implementation guide. another commenter recommended cms include data \n",
      "elements related to administrative transactions. one commenter \n",
      "recommended the uscdi include digital imaging and communications in \n",
      "medicine (dicom) images in addition to the already included imaging \n",
      "notes. a few commenters requested cms specifically require the use of \n",
      "systematized nomenclature of dentistry (snodent) for dentistry \n",
      "findings, disorders, and diagnoses, versus making snodent optional as \n",
      "part of the proposed uscdi.\n",
      "\n",
      "[[page 25542]]\n",
      "\n",
      "    a few commenters recommended that additional care settings or \n",
      "provider types are considered for additional uscdi data classes in the \n",
      "future. these included anesthesiology, registered dietitian \n",
      "nutritionists, and post-acute care settings (including hospice). one \n",
      "commenter recommended that the uscdi include additional fhir-based \n",
      "pharmacy benefit standard-based formulary and drug benefit data. \n",
      "another commenter requested that admission, discharge, and transfer \n",
      "(adt) data classes and data elements be included in the uscdi. one \n",
      "commenter recommended cms work with the industry to standardize \n",
      "unstructured encounter data. one commenter was concerned that the uscdi \n",
      "includes data traditionally collected in ehrs and that data/standards \n",
      "for non-health care transactions are not included (for example, home \n",
      "modifications). one commenter expressed concerns that the uscdi does \n",
      "not include the entire designated record set, such as images and \n",
      "genomic test reports and recommends this be included.\n",
      "    response: we appreciate the commenters' recommendations and will \n",
      "work with onc to evaluate these recommendations for possible future \n",
      "consideration, as appropriate and feasible.\n",
      "    we also received comments detailing concerns with the volume of \n",
      "data being proposed to be made available through the patient access \n",
      "api. we summarize the public comments we received on this topic and \n",
      "provide our responses.\n",
      "    comment: a few commenters were concerned with the potential volume \n",
      "of data that will be made available to patients through the patient \n",
      "access api. a few commenters requested cms provide more information \n",
      "regarding the minimum information required to be shared under our \n",
      "policies. one commenter suggested that an advisory panel determine the \n",
      "volume and types of information that patients should receive.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. regarding the data to be made available to patients, \n",
      "as noted in section iii.c.2.b. of this final rule, to ensure consistent \n",
      "implementation and minimize the burden on payers, we are finalizing in \n",
      "the applicable regulations additional text to specify that ma \n",
      "organizations at 42 cfr 422.119(h), state medicaid ffs programs at 42 \n",
      "cfr 431.60(g), medicaid managed care plans at 42 cfr 438.62(b)(1)(vii), \n",
      "chip ffs programs at 42 cfr 457.730(g), chip managed care entities at \n",
      "42 cfr 457.1233(d), and qhp issuers on the ffes at 45 cfr 156.221(i), \n",
      "beginning january 1, 2021 (or beginning with plan years beginning on or \n",
      "after january 1, 2021 for qhps on the ffes), must make available \n",
      "through the patient access api data they maintain with a date of \n",
      "service on or after january 1, 2016. we are also finalizing the same \n",
      "years of data be available through the patient access api and for the \n",
      "payer-to-payer data exchange requirement discussed in section v. of \n",
      "this final rule. these policies support the ultimate goal to provide \n",
      "patients access to their cumulative health information.\n",
      "    we are finalizing as proposed the minimum content required to be \n",
      "accessible through the patient access api in the regulation text at 42 \n",
      "cfr 422.119(b), 431.60(b), 438.242(b)(5), and 457.730(b), and 45 cfr \n",
      "156.221(b). this specifically includes adjudicated claims (including \n",
      "cost); encounters with capitated providers; provider remittances; \n",
      "enrollee cost-sharing; and clinical data (including laboratory results) \n",
      "(where maintained by the applicable payer), as well as formularies or \n",
      "preferred drug lists for all impacted payers except qhp issuers on the \n",
      "ffes. as discussed above, these data must be shared using the content \n",
      "and vocabulary standards at 45 cfr 170.213, finalized by hhs in onc's \n",
      "21st century cures act final rule (published elsewhere in this issue of \n",
      "the federal register), and in 45 cfr part 162 and 42 cfr 423.160. we \n",
      "believe that patients have a right to their health care information so \n",
      "they can use and share this information to best inform their health \n",
      "care decisions. we appreciate the recommendation to create an advisory \n",
      "panel, and will evaluate it for potential future consideration.\n",
      "d. documentation requirements for apis\n",
      "    we proposed that the specific business and technical documentation \n",
      "necessary to interact with the proposed apis be made freely and \n",
      "publicly accessible. as discussed in section ii.a.1 of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7620), we \n",
      "believed transparency about api technology is needed to ensure that any \n",
      "interested third-party application developer can easily obtain the \n",
      "information needed to develop applications technically compatible with \n",
      "the organization's api. transparency is also needed so that third-\n",
      "parties can understand how to successfully interact with an \n",
      "organization's api. this includes how to satisfy any requirements the \n",
      "organization may establish for verifying a developer's identity and \n",
      "their applications' authenticity, consistent with the payer's security \n",
      "risk analysis and related organizational policies and procedures. in \n",
      "this way payers can ensure they maintain an appropriate level of \n",
      "privacy and security protection for data on their systems.\n",
      "    specifically, at 42 cfr 422.119(d), 431.60(d), 457.730(d), and 45 \n",
      "cfr 156.221(d), we proposed virtually identical text to require the \n",
      "regulated entities to make complete accompanying documentation \n",
      "regarding the api publicly accessible by posting this documentation \n",
      "directly on the applicable entity's website or via a publicly \n",
      "accessible hyperlink. as previously discussed, medicaid managed care \n",
      "plans would be required by 42 cfr 438.242(b)(6) (finalized as sec.  \n",
      "438.242(b)(5) in this rule; see section vi.) to comply with the \n",
      "requirement at 42 cfr 431.60(d), and chip managed care entities would \n",
      "be required by 42 cfr 457.1233(d)(2) to comply with the requirement at \n",
      "42 cfr 457.730(d). in requiring that this documentation be made \n",
      "``publicly accessible,'' we noted that we expected that any person \n",
      "using commonly available technology to browse the internet could access \n",
      "the information without any preconditions or additional steps beyond \n",
      "downloading and using a third-party application to access data through \n",
      "the api. we also noted that this was not intended to preclude use of \n",
      "links the user would click to review the full text of lengthy documents \n",
      "or access sources of additional information, such as if the \n",
      "technology's supplier prefers to host technical documentation at a \n",
      "centralized location. rather, we meant ``additional steps'' to include \n",
      "actions such as: collecting a fee for access to the documentation; \n",
      "requiring the reader to receive a copy of the material via email; or \n",
      "requiring the user to read promotional material or agree to receive \n",
      "future communications from the organization making the documentation \n",
      "available.\n",
      "    we summarize the public comments received on our proposal regarding \n",
      "api documentation and provide our responses.\n",
      "    comment: some commenters opposed the api documentation proposal \n",
      "indicating payers and providers will be required to provide data \n",
      "without a charge, but the freely and publicly accessible documentation \n",
      "would enable applications to collect data and possibly sell the data \n",
      "back to payers and providers if needed for secondary uses such as \n",
      "provider directories.\n",
      "    some commenters supported fees for documentation noting the funds \n",
      "required to create and maintain data for sharing between payers and \n",
      "enrollees.\n",
      "\n",
      "[[page 25543]]\n",
      "\n",
      "commenters believed third parties should be charged a fee to maintain \n",
      "the api. one commenter expressed concern that the business model of the \n",
      "third-party applications hinges on their ability to sell the data they \n",
      "collect for secondary uses while payers and providers would be required \n",
      "to provide information to vendors absent a fee. this commenter argued \n",
      "that charging third-party vendors a fee for documentation could be one \n",
      "way for vendors to absorb some of the cost of maintaining the api in \n",
      "exchange for the data they could potentially use to make a profit.\n",
      "    response: we also appreciate the concerns raised around the \n",
      "secondary uses of data shared with third-parties. we note that under \n",
      "section 5 of the ftc act (15 u.s.c. sec. 45(a)), it is considered a \n",
      "deceptive act to use a person's sensitive information without \n",
      "disclosing in product documentation how this information will be \n",
      "shared.\\31\\ in addition, we do not believe that charging a fee to \n",
      "access api documentation is appropriate to offset secondary data use \n",
      "concerns. we refer readers to the additional discussion below regarding \n",
      "informing patients about potential secondary uses of data.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\31\\ see also cases where this authority was used, such as 2012 \n",
      "ftc action against facebook (see <a href=\"https://www.ftc.gov/enforcement/cases-proceedings/092-3184/facebook-inc\">https://www.ftc.gov/enforcement/cases-proceedings/092-3184/facebook-inc</a>), the 2012 ftc action \n",
      "against myspace (see <a href=\"https://www.ftc.gov/enforcement/cases-proceedings/102-3058/myspace-llc-matter\">https://www.ftc.gov/enforcement/cases-proceedings/102-3058/myspace-llc-matter</a>), and the 2017 ftc action \n",
      "against vizio (see <a href=\"https://www.ftc.gov/enforcement/cases-proceedings/162-3024/vizio-inc-vizio-inscape-services-llc\">https://www.ftc.gov/enforcement/cases-proceedings/162-3024/vizio-inc-vizio-inscape-services-llc</a>).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the data that must be shared via the api under this policy are data \n",
      "that the payers have and must currently share with patients under \n",
      "existing law. the public directory data is already public information. \n",
      "we do not believe it is appropriate to charge a fee for documentation \n",
      "required to access such available data. taking the example of provider \n",
      "directory data raised by commenters, currently there are vendors that \n",
      "collect the publicly available directory data, clean these data, \n",
      "supplement these data, and offer this enhanced data product back to \n",
      "payers and providers. it is not the data the vendors are charging for \n",
      "as much as it is the service of cleaning and enhancing these data. \n",
      "vendors may generate revenue from their third-party apps, but a major \n",
      "component of this is the service they are providing--building the app, \n",
      "making the data the patient directs to them most usable and valuable--\n",
      "that generates the revenue. payers must already make these data \n",
      "available to patients. these data alone may also drive revenue, but it \n",
      "is the patient's prerogative to provide their data to a third-party in \n",
      "order to get a service in exchange. being sure patients are as informed \n",
      "as possible about secondary uses of data and how this may impact them \n",
      "is important. as a result, we discuss this issue more below.\n",
      "    comment: some commenters indicated support for permitting access to \n",
      "documentation without access fees, citing concern that the fees would \n",
      "be extended to consumers as well as logistical concerns for how they \n",
      "would be paid. a few commenters specifically recommended alignment with \n",
      "the onc 21st century cures act proposed rule api documentation \n",
      "requirement by using the language included in the discussion of the \n",
      "proposed requirement at 45 cfr 170.315(g)(10) stating that the \n",
      "documentation should be ``accessible to the public via a hyperlink \n",
      "without additional access requirements, including, without limitation, \n",
      "any form of registration, account creation, `click-through' agreements, \n",
      "or requirement to provide contact details or other information prior to \n",
      "accessing the documentation'' (84 fr 7484).\n",
      "    response: we do appreciate the requests to explicitly state what we \n",
      "mean by ``public access'' and ensure it is clear this does not permit \n",
      "any additional restrictions or fees. as a result, to further align with \n",
      "the discussion in the onc 21st century cures act proposed rule (84 fr \n",
      "7477), and the cms interoperability and patient access proposed rule \n",
      "(84 fr 7620), we are finalizing regulation text stating that ``publicly \n",
      "accessible'' means we expect that any person using commonly available \n",
      "technology to browse the internet could access the information without \n",
      "any preconditions or additional steps, such as a fee for access to the \n",
      "documentation; a requirement to receive a copy of the material via \n",
      "email; a requirement to register or create an account to receive the \n",
      "documentation; or a requirement to read promotional material or agree \n",
      "to receive future communications from the organization making the \n",
      "documentation available. we are finalizing this requirement at 42 cfr \n",
      "422.119(d), 431.60(d), 438.242(b)(5) (through cross-reference to \n",
      "medicaid ffs), 457.730(d), 457.1233(d)(2) (through cross-reference to \n",
      "chip ffs), and 45 cfr 156.221(d).\n",
      "    comment: one commenter did not support this documentation proposal \n",
      "for security reasons as the commenter believed that if the \n",
      "documentation was public, any third-party or organization could \n",
      "potentially call, or connect to, a payer's api. this commenter \n",
      "preferred an alternate approach where cms stipulates in order to call \n",
      "an api, there would need to be appropriate security tokens in place \n",
      "between the two parties engaged in the data exchange.\n",
      "    response: we appreciate the commenters' concerns. we note, however, \n",
      "that making the documentation available publicly does not impact the \n",
      "security of the standards-based api itself. this level of transparency \n",
      "is common in other industries and across standards, and has been shown \n",
      "to lead to innovation and competition. hl7 is built on free and open \n",
      "documentation to ensure that all developers can equally access \n",
      "information. reviewing the documentation available for fhir is one way \n",
      "of appreciating the value of this information and how having it freely \n",
      "accessible can allow innovators to engage with health care data in the \n",
      "most meaningful ways.\\32\\ having access to the documentation is not the \n",
      "same as access to the actual api for the purposes of data exchange.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\32\\ hl7 international. (n.d.). fhir overview. retrieved from \n",
      "<a href=\"https://www.hl7.org/fhir/overview.html\">https://www.hl7.org/fhir/overview.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    appreciating the comments received and the need to have \n",
      "documentation available to ensure successful implementation and use of \n",
      "the patient access api, we are finalizing our proposal to make publicly \n",
      "accessible documentation that includes, at a minimum: (1) api syntax, \n",
      "function names, required and optional parameters supported and their \n",
      "data types, return variables and their types/structures, exceptions and \n",
      "exception handling methods and their returns; (2) the software \n",
      "components and configurations an application must use in order to \n",
      "successfully interact with the api and process its response(s); and (3) \n",
      "all applicable technical requirements and attributes necessary for an \n",
      "application to be registered with any authorization server(s) deployed \n",
      "in conjunction with the api. as noted, we have made one modification by \n",
      "adding the definition of ``publicly accessible'' to the relevant \n",
      "regulation text.\n",
      "e. routine testing and monitoring of standards-based apis\n",
      "    at 42 cfr 422.119(c)(2), 431.60(c)(2), 457.730(c)(2), and 45 cfr \n",
      "156.221(c)(2) for ma organizations, state medicaid and chip ffs \n",
      "programs, and qhp issuers on the ffes, respectively, we proposed that \n",
      "the api must be routinely tested and monitored to ensure it is \n",
      "functioning properly, including assessments to verify that the api is \n",
      "fully and successfully implementing privacy and security features such \n",
      "as but not limited to those required to\n",
      "\n",
      "[[page 25544]]\n",
      "\n",
      "comply with the hipaa privacy and security rules, 42 cfr parts 2 and 3, \n",
      "and other applicable law protecting privacy and security of \n",
      "individually identifiable health information. as proposed, medicaid \n",
      "managed care plans would be required by 42 cfr 438.242(b)(6) \n",
      "(redesignated as 438.242(b)(5) in this final rule; see section vi. of \n",
      "this final rule) to comply with the requirement at 42 cfr 431.60(c), \n",
      "and chip managed care entities would be required by 42 cfr \n",
      "457.1233(d)(2) to comply with the requirement at 42 cfr 457.730(c).\n",
      "    additionally, we noted that while federal laws that regulate ma \n",
      "organizations and ma plans supersede any state law except where noted \n",
      "under section 1856(b)(3) of the act, some state, local, or tribal laws \n",
      "that pertain to privacy and security of individually identifiable \n",
      "information generally, and that are not specific to health insurance, \n",
      "may also apply to ma organizations and ma plans in the context of the \n",
      "proposal. for the other entities regulated under the proposals in these \n",
      "various programs, we noted that we also intended the phrase ``other \n",
      "applicable law'' to include federal, state, tribal or local laws that \n",
      "apply to the entity.\n",
      "    we proposed this requirement to establish and maintain processes to \n",
      "routinely test and monitor the standards-based apis to ensure they are \n",
      "functioning properly, especially with respect to their privacy and \n",
      "security features. we explained in the preamble of the proposed rule \n",
      "that under the proposal, ma organizations, medicaid and chip ffs \n",
      "programs, medicaid managed care plans, chip managed care entities, and \n",
      "qhp issuers on the ffes would have to implement, properly maintain, \n",
      "update (as appropriate), and routinely test authentication features \n",
      "that will be used to verify the identity of individual enrollees who \n",
      "seek to access their claims and encounter data and other phi through \n",
      "the api. similarly, as discussed, compliance with the proposed \n",
      "requirements would mean that these entities must implement, maintain, \n",
      "update (as appropriate), and routinely test authorization features to \n",
      "ensure an individual enrollee or their personal representative can only \n",
      "access claims and encounter data or other phi that belongs to that \n",
      "enrollee. as is the case under existing hipaa privacy rule \n",
      "requirements, where an individual is also a properly designated \n",
      "personal representative of another enrollee, the hipaa covered entity \n",
      "must provide the personal representative appropriate access to the \n",
      "information about the enrollee that has designated them as their \n",
      "personal representative, just as they would if the personal \n",
      "representative were the enrollee.\n",
      "    we summarize the public comments we received on routine testing and \n",
      "monitoring and provide our responses.\n",
      "    comment: several commenters supported the proposal to require that \n",
      "payers routinely test and monitor the standards-based api needed to \n",
      "meet the requirements of this proposal. one commenter recommended that \n",
      "this be self-regulated rather than mandated, however. a few commenters \n",
      "expressed concern with the requirement to test and monitor the api. a \n",
      "few additional commenters expressed concern that there is no consensus \n",
      "on a common testing environment. one commenter believed that testing \n",
      "and monitoring will be costly.\n",
      "    several commenters urged cms to provide additional information and \n",
      "guidance on any requirements for testing and monitoring apis, including \n",
      "the expected frequency of testing. a few commenters requested \n",
      "additional information on whether payers will be required to \n",
      "demonstrate compliance by submitting or reporting on testing plans. one \n",
      "commenter requested clarification on the process if an issue is found \n",
      "during testing or monitoring. one commenter requested that cms specify \n",
      "what ``routine'' means.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. we did not specify exactly at what intervals or \n",
      "frequency testing should be done, and thus did not quantify \n",
      "``routine,'' as we believe it is important that payers put a process in \n",
      "place that works best for them to conduct testing and monitoring at \n",
      "regular intervals to ensure the required api remains in compliance and \n",
      "is working as expected. we will provide best practice information, \n",
      "including information on available api testing tools to support payers \n",
      "with this required activity. in our review of the proposed regulation \n",
      "text, we realized that the regulation text at 42 cfr 422.119(c)(2), \n",
      "431.60(c)(2), 457.730(c)(2), and 45 cfr 156.221(c)(2) did not specify \n",
      "the requirement to also update (as appropriate) the api to ensure it \n",
      "functions properly and includes assessments to verify an individual \n",
      "enrollee or their personal representative can only access claims and \n",
      "encounter data or other phi that belongs to that enrollee. we are \n",
      "finalizing additional text to this effect. we are also removing the \n",
      "word ``minimally'' from this regulation text in order to ensure it is \n",
      "clear that privacy and security features must be reasonable and \n",
      "appropriate, consistent with the requirements of the hipaa security \n",
      "rule. we note that this testing requirement is accounted for in \n",
      "sections xii. and xiii. of this final rule as one of the expected steps \n",
      "of implementing and maintaining an api. this is part of the cost \n",
      "factored into implementation of the api and is a necessary part of \n",
      "using an api. it is also part of current software development best \n",
      "practices. payers implementing apis can incorporate testing tools into \n",
      "a comprehensive testing plan and continuous integration (ci) system, \n",
      "which can automatically validate adherence to the implementation guide \n",
      "when changes are made to further mitigate this cost.\n",
      "f. compliance with existing privacy and security requirements\n",
      "    in the hands of a hipaa covered entity or its business associate, \n",
      "individually identifiable health information, including information in \n",
      "patient claims and encounter data, is phi and protected by the hipaa \n",
      "rules. ensuring the privacy and security of the claims, encounter, and \n",
      "other health information when it is transmitted through the api is \n",
      "important. therefore, in the cms interoperability and patient access \n",
      "proposed rule (84 fr 7635), we reminded ma organizations, state \n",
      "medicaid and chip ffs programs, medicaid managed care plans, chip \n",
      "managed care entities, and qhp issuers on the ffes that mechanisms and \n",
      "practices to release phi, including but not limited to authorization \n",
      "and authentication protocols and practices, must provide protection \n",
      "sufficient to comply with the hipaa rules and other privacy and \n",
      "security law (whether federal, state, tribal, or local) that may apply \n",
      "based on the specific circumstances. as proposed, the entities subject \n",
      "to these requirements would need to continuously ensure that all \n",
      "authorization and authentication mechanisms provide sufficient \n",
      "protections to enrollee phi and that they function as intended. we \n",
      "specifically requested public comment on whether existing privacy and \n",
      "security standards, including but not limited to those in 45 cfr part \n",
      "164, are sufficient with respect to these proposals, or whether \n",
      "additional privacy and security standards should be required by cms as \n",
      "part of the proposal.\n",
      "    we note that comments and our responses related to privacy and \n",
      "security issues, generally, can be found in section ii.a.2. of this \n",
      "final rule. here, we summarize the public comments we received on \n",
      "privacy and security as it relates to consent, authentication, and \n",
      "identity verification and provide our responses.\n",
      "\n",
      "[[page 25545]]\n",
      "\n",
      "    comment: a few commenters expressed concerns with using the \n",
      "proposed fhir standards for obtaining patient consent, with some noting \n",
      "the lack of mature consent mechanisms supported through fhir. a few \n",
      "commenters expressed concerns that there are no mature or widely \n",
      "accepted standards for documenting patient consent electronically, \n",
      "generally. one commenter suggested that the patient be able to see \n",
      "their consent preferences and the types of data that have been \n",
      "authorized for sharing from a central location.\n",
      "    one commenter recommended that cms or ocr develop a standardized \n",
      "data sharing patient consent form that payers, providers, and health it \n",
      "vendors can use to ensure appropriate consent. a few commenters \n",
      "recommended that cms require payers and/or apps to use onc's model \n",
      "privacy notice. one commenter recommended that cms and ftc should \n",
      "develop plain language consumer notifications that could be used by app \n",
      "developers. one commenter recommended that cms require payers to \n",
      "include in their enrollment process an efficient ``check off'' \n",
      "authorization for an enrollee to release their information to their \n",
      "providers. a few commenters noted that it should be the responsibility \n",
      "of the app to verify the patient's ability to provide consent.\n",
      "    response: we appreciate the commenters concerns and \n",
      "recommendations, and we have shared these with onc for consideration. \n",
      "regarding fhir standards for consent, we refer readers to discussion in \n",
      "the onc 21st century cures act final rule (published elsewhere in this \n",
      "issue of the federal register), which considers the status of current \n",
      "development efforts around consent resources. we will continue to work \n",
      "with onc and industry partners to monitor the development of fhir \n",
      "resources to support consent management. we believe that the security \n",
      "protocols at 45 cfr 170.215 are sufficient to authenticate users and \n",
      "authorize individuals to access their data maintained by payers in \n",
      "accordance with the requirements described in this rule and, therefore, \n",
      "provide the necessary consent mechanisms for payers to implement the \n",
      "policies in this rule.\n",
      "    we appreciate the additional recommendations made regarding \n",
      "developing consent materials for all payers to use, as well as \n",
      "recommendations around the use of the onc model privacy notice. more \n",
      "information on available consent options can be found at <a href=\"https://gforge.hl7.org/gf/project/cbcc/frs/\">https://gforge.hl7.org/gf/project/cbcc/frs/</a>, and onc's model privacy notice is \n",
      "available at <a href=\"https://www.healthit.gov/topic/privacy-security-and-hipaa/model-privacy-notice-mpn\">https://www.healthit.gov/topic/privacy-security-and-hipaa/model-privacy-notice-mpn</a>, which interested payers or app vendors can \n",
      "use. we will evaluate recommendations made that would add requirements \n",
      "on payers that we had not proposed, including any centralized solution, \n",
      "for possible future rulemaking.\n",
      "    comment: several commenters supported efforts to verify if an \n",
      "entity is authorized to access the data they are seeking. one commenter \n",
      "supported the proposed use of the oauth standard. one commenter \n",
      "believes that the use of oauth 2.0 for client application authorization \n",
      "and openid connect for client application authentication should include \n",
      "authenticity, integrity, and non-repudiation standards. another \n",
      "commenter suggested cms permit flexibility in the implementation of \n",
      "security standards. a few commenters expressed concerns with using the \n",
      "proposed fhir standards for identity proofing alone and supported \n",
      "additional measures, such as biometrics, be employed as well. a few \n",
      "commenters expressed concern about open-ended token access once \n",
      "initially authenticated and instead recommended cms implement a 90-day \n",
      "timeframe for the authentication token to remain open. one commenter \n",
      "suggested that encryption of authentication credentials is not \n",
      "sufficient.\n",
      "    one commenter believed that the only true means by which an \n",
      "individual can assert their identity is through a government-issued id, \n",
      "and if this cannot be produced, the commenter noted several limitations \n",
      "that should be put in place to prohibit data sharing until further \n",
      "authentication can be done. another commenter suggested cms look into \n",
      "biometrics as a means for improving identity proofing. a few commenters \n",
      "recommended the use of multi-factor authentication to verify the \n",
      "identification of an individual.\n",
      "    a few commenters recommended requiring payers give their members an \n",
      "online way to self-enroll for the necessary credentials to access their \n",
      "health information via an api. one commenter stated that this will \n",
      "reduce the time it takes for an organization to verify a request. one \n",
      "commenter recommended that this should apply to any of a payer's \n",
      "patients who have been a member in the past 5 years. one commenter \n",
      "expressed concern that without clear guidelines for how patients can \n",
      "access their data, patients may face barriers such as trying to get \n",
      "authentication credentials, and trying to get an app authorized.\n",
      "    a few commenters recommended cms develop a common method to \n",
      "validate the identity and authority of the requesting party. one \n",
      "commenter recommended cms issue guidance on authenticating the \n",
      "requestor that offers a simple, secure method to obtain authentication \n",
      "across all entities. a few commenters supported efforts to develop \n",
      "methods to verify a caregiver for a patient and allow that caregiver to \n",
      "access all health information systems.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. we are finalizing as proposed to require compliance \n",
      "with 45 cfr 170.215 as finalized by hhs in the onc 21st century cures \n",
      "act final rule (published elsewhere in this issue of the federal \n",
      "register). this requires use of hl7 fhir release 4.0.1, and \n",
      "complementary security and app registration protocols, specifically the \n",
      "smart application launch implementation guide (smart ig) 1.0.0 \n",
      "(including mandatory support for the ``smart on fhir core \n",
      "capabilities''), which is a profile of the oauth 2.0 specification, and \n",
      "the openid connect core 1.0 standard, incorporating errata set 1). \n",
      "additional information and implementation guidance can be found at \n",
      "<a href=\"http://hl7.org/fhir/smart-app-launch/\">http://hl7.org/fhir/smart-app-launch/</a>. the goal of using these \n",
      "resources is to make authorization electronic, efficient, and secure so \n",
      "that patients can access their health information as effortlessly as \n",
      "possible.\n",
      "    we agree that multifactor authentication represents a best practice \n",
      "for privacy and security in health care settings, and we note that an \n",
      "important benefit of the oauth 2.0 standard hhs is finalizing is that \n",
      "it provides robust support for multifactor authentication. by requiring \n",
      "that payers subject to our patient access api requirement use an api \n",
      "that is conformant with 45 cfr 170.215, where hhs has finalized the \n",
      "smart ig, we are supporting the use of multifactor authentication. we \n",
      "also note that as part of onc's 21st century cures act final rule \n",
      "(published elsewhere in this issue of the federal register), hhs is \n",
      "finalizing a new provision in the onc certification program that would \n",
      "require health it developers to attest as to whether they support \n",
      "multifactor authentication, further encouraging adoption of such \n",
      "security practices. we also strongly encourage payers subject to the \n",
      "requirements in this final rule to employ robust privacy and security \n",
      "protocols, and use multifactor authentication, where appropriate. \n",
      "multifactor authentication is industry accepted, routinely used across \n",
      "many sectors,\n",
      "\n",
      "[[page 25546]]\n",
      "\n",
      "known to patients, and a low burden option that could significantly \n",
      "increase security.\n",
      "    though we appreciate commenters' requests to leave flexibility \n",
      "here, we do believe adopting the standards as finalized by hhs in onc's \n",
      "21st century cures act final rule regarding the use of the smart ig \n",
      "(using the oauth 2.0 standard) and openid connect core 1.0 is an \n",
      "important starting point. in addition, we note that the technical \n",
      "standards at 45 cfr 170.215 address the comments regarding tokens, as \n",
      "hhs is finalizing use of tokens at 45 cfr 170.215 as part of the smart \n",
      "ig. we note that onc is requiring that a token be valid for at least 3 \n",
      "months for certified health it; we encourage payers subject to this \n",
      "final rule to align with this best practice. we appreciate \n",
      "recommendations for a centralized solution to patient authentication \n",
      "and identity proofing, and caregiver access, and will take these under \n",
      "consideration as appropriate.\n",
      "    comment: many commenters expressed that patients should have \n",
      "ultimate authority and the ability to consent to what type of \n",
      "information can be shared as well as who can access their health \n",
      "information. one commenter recommended cms require that patients have \n",
      "the ability to filter or request only the specific data that they want \n",
      "to be shared. one commenter requested that payers be able to access the \n",
      "specific types of data a patient authorized the app to access. one \n",
      "commenter added patients should also have an accounting of disclosures \n",
      "or access to their data.\n",
      "    a few commenters expressed concerns over the sharing of patient \n",
      "electronic health information with health care providers that the \n",
      "patient has not consented to share with. a few commenters expressed \n",
      "specific concerns with sharing electronic health information beyond the \n",
      "immediate health care provider, such as with providers with which a \n",
      "patient may be seeking a second opinion or additional care. one \n",
      "commenter was concerned with the sharing of family health history data \n",
      "particularly for family members who have not consented.\n",
      "    a few commenters recommended that providers be able to pre-filter \n",
      "or select which data can be made available to the patient, citing \n",
      "concerns with the sensitivity of some provider notes or patient \n",
      "confusion in interpreting certain information. a few commenters also \n",
      "suggested that providers be able to select which information can be \n",
      "made available to the payer.\n",
      "    response: we appreciate the commenters' concerns and suggestions. \n",
      "collectively, hhs has been working to evaluate various technical \n",
      "specifications for data segmentation to enhance privacy protections and \n",
      "comply with applicable law (such as laws regarding privacy for minors \n",
      "or 42 cfr part 2). both hhs and the industry as a whole are currently \n",
      "evaluating future use cases related to segmenting data at the patient \n",
      "request. at this time, however, the policies as they are being \n",
      "finalized under this rule require that the payers, with the approval \n",
      "and at the direction of the patient, provide all of the data as \n",
      "specified in the applicable regulation text. beyond this, payers, \n",
      "providers, and patients cannot direct specific segments of data be made \n",
      "available via this patient access api. the necessary technical \n",
      "specifications to allow a patient to request some data elements be \n",
      "shared but not others are not widely adopted.\\33\\ if the patient \n",
      "requests their data via the patient access api from a payer, the payer \n",
      "must make available all of the data allowed per current law, such as 42 \n",
      "cfr part 2 and relevant state laws, including the data as specified in \n",
      "this final rule. we reiterate, however, that the data that are \n",
      "available to be shared are only to be shared at the patient's request. \n",
      "if there are data elements the patient does not want to be shared, they \n",
      "can choose not to make the request. in addition, we note that this \n",
      "policy allows data to be exchanged from the payer to a third-party app \n",
      "of the patient's choice for their personal use. this rule does not \n",
      "require any data exchange directly between or with providers.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\33\\ for information on adoption levels for technical \n",
      "specifications related to data segmentation, see the \n",
      "interoperability standards advisory at <a href=\"https://www.healthit.gov/isa/data-segmentation-sensitive-information\">https://www.healthit.gov/isa/data-segmentation-sensitive-information</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    specifically regarding the comment on sharing family history, we \n",
      "note that the health information required to be shared under this \n",
      "policy includes claims and encounter data as well as the data included \n",
      "in the uscdi version 1. at this time, ``family history'' is not a \n",
      "specific data class within the uscdi. as a result, we do not believe \n",
      "this should be an issue under this current policy. we will, however, \n",
      "take this into consideration as we consider future policy options.\n",
      "    we appreciate the recommendation for patients to have a full record \n",
      "of disclosures or access to their health information via the api. at \n",
      "present, the hipaa privacy rule requires accountings of certain \n",
      "disclosures. consistent with the spirit of this accounting of \n",
      "disclosures, we encourage payers to consider setting up functionality \n",
      "to allow patients to view a record of when and with whom their data \n",
      "have been shared via the api.\n",
      "    comment: many commenters expressed concerns over the complexity \n",
      "with parsing or segmenting electronic health information that is \n",
      "considered sensitive and/or is subject to 42 cfr part 2 rules. \n",
      "commenters requested cms take into account these situations with these \n",
      "api proposals and cited use cases such as women's health, sexual \n",
      "health, young adult health, mental health, and substance abuse \n",
      "treatment. a few commenters noted concerns that some health care \n",
      "providers may discriminate or treat a patient differently if they were \n",
      "able to access certain patient's health information. a few commenters \n",
      "recommended that hhs align part 2 and hipaa regulations. one commenter \n",
      "recommended the use of the consent2share (c2s) fhir consent profile \n",
      "developed by samhsa. another commenter suggested cms defer adoption of \n",
      "the data segmentation for privacy standards until an api fhir standard \n",
      "version is finalized and the consent2share guide is revised to conform \n",
      "to that version.\n",
      "    response: we appreciate the commenters concerns and \n",
      "recommendations. we are currently evaluating future options around \n",
      "parsing or segmenting data, generally, using the api. as noted above, \n",
      "hhs is collectively working to explore standards and technical supports \n",
      "for data segmentation for privacy and consent management and point \n",
      "commenters to the onc 21st century cures act final rule for additional \n",
      "discussion on this. we also note that using the appropriate fhir \n",
      "profiles, such as those being finalized by hhs in the onc 21st century \n",
      "cures act final rule (published elsewhere in this issue of the federal \n",
      "register) for api technical standards, including the smart ig (using \n",
      "the oauth 2.0 standard) and openid connect as finalized at 45 cfr \n",
      "170.215, can be leveraged to support this. again, we note that \n",
      "additional information and implementation guidance can be found at \n",
      "<a href=\"http://hl7.org/fhir/smart-app-launch/\">http://hl7.org/fhir/smart-app-launch/</a>. however, we reiterate that \n",
      "payers' privacy and security obligations under the hipaa rules and 42 \n",
      "cfr part 2 are not impacted by this final rule.\n",
      "    comment: a few commenters expressed particular concern for \n",
      "appropriate authorization of parent/guardian proxies for minor \n",
      "patients. one commenter recommended cms align the cms interoperability \n",
      "and patient access proposed rule with the children's online privacy \n",
      "protection act (coppa), which was created to\n",
      "\n",
      "[[page 25547]]\n",
      "\n",
      "protect the privacy of children under 13 and has been in effect since \n",
      "2000.\n",
      "    response: we appreciate the commenters concerns and \n",
      "recommendations, which we are reviewing for future possible \n",
      "consideration in regulation. we note that this current regulation does \n",
      "not change any existing privacy relationships between minors and \n",
      "parents. if, for instance, a teenage minor has asserted their \n",
      "protections to not have their guardians see their explanation of \n",
      "benefits, the payer would be obligated to maintain these protections \n",
      "when sharing data via the api. for non-minor dependents, again the \n",
      "existing policies hold true.\n",
      "    regarding privacy in an enrollment group, at this time, a \n",
      "policyholder can see the claims for all members of their enrollment \n",
      "group unless there is an agreed upon privacy provision available and in \n",
      "place. the hipaa privacy rule states at 45 cfr 164.522 that individuals \n",
      "have a right to request restrictions on how a covered entity will use \n",
      "and disclose protected health information about them for treatment, \n",
      "payment, and health care operations. however, a covered entity is not \n",
      "generally required to agree to an individual's request for a \n",
      "restriction unless certain limited exceptions are met \\34\\, but is \n",
      "bound by any restrictions to which it does agree. after the affordable \n",
      "care act extended the age that group health plans and issuers of health \n",
      "insurance coverage in the group or individual market that offer \n",
      "dependent coverage of children must continue to make such coverage \n",
      "available to adult children until age 26, some states, including \n",
      "california, colorado, washington, oregon, and maryland, have enacted \n",
      "stricter protections regarding privacy rights, and although all of \n",
      "these states operate their own sbes and issuers on these exchanges are \n",
      "not implicated in this rule, to the extent issuers are operating in \n",
      "both these and ffe states and have applied their privacy policies \n",
      "across markets, consumers in ffe states may also benefit from these \n",
      "stricter protections. this final rule does not alter obligations under \n",
      "any existing federal, state, local, or tribal law. again, we note that \n",
      "this data sharing is currently ongoing; the api just provides an \n",
      "additional way to facilitate this exchange.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\34\\ see 45 cfr 154.522(a)(1)(vi) for a discussion of the \n",
      "limited exceptions.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "g. issues related to denial or discontinuation of access to the api\n",
      "    we believe patients have a right to their health information. \n",
      "however, a covered entity is not expected to tolerate unacceptable \n",
      "levels of risk to the phi held by the covered entity in its systems, as \n",
      "determined by its own risk analysis. accordingly, it may be appropriate \n",
      "for an organization to deny or terminate specific applications' \n",
      "connection to its api under certain circumstances in which the \n",
      "application poses an unacceptable risk to the phi on its systems.\n",
      "    at 42 cfr 422.119(e), sec.  431.60(e), 438.242(b)(6) (redesignated \n",
      "as sec.  438.242(b)(5) in this rule; see section vi.), 457.730(e), \n",
      "457.1233(d)(2) and 45 cfr 156.221(e) for ma organizations, state \n",
      "medicaid and chip ffs programs, medicaid managed care plans, chip \n",
      "managed care entities, and qhp issuers on the ffes, respectively, we \n",
      "proposed to specify the circumstances under which these regulated \n",
      "entities, which are all hipaa covered entities subject to hipaa privacy \n",
      "and security requirements, may decline to establish or may terminate a \n",
      "third-party application's connection to the covered entity's api while \n",
      "remaining in compliance with the proposed requirement to offer patients \n",
      "access through standards-based apis. we noted in the cms \n",
      "interoperability and patient access proposed rule that we intended for \n",
      "the proposal to be consistent with the hipaa rules, and we noted that \n",
      "these circumstances apply to specific applications, rather than the \n",
      "third party itself (84 fr 7635 through 7636).\n",
      "    specifically, we proposed that a payer subject to our api proposal \n",
      "could deny access to the api if the payer reasonably determined that \n",
      "allowing that application to connect or remain connected to the api \n",
      "would present an unacceptable level of risk to the security of phi on \n",
      "the payer's systems. we further proposed that this determination would \n",
      "be made consistent with the payer's hipaa security rule obligations and \n",
      "based on objective, verifiable criteria that would be applied fairly \n",
      "and consistently across all applications through which enrollees seek \n",
      "to access their electronic health information as defined at 45 cfr \n",
      "171.102, including but not limited to criteria that may rely on \n",
      "automated monitoring and risk mitigation tools.\n",
      "    where we proposed to require access through standards-based apis to \n",
      "otherwise publicly available information, such as provider directories, \n",
      "the entities subject to the proposal may also deny or terminate an \n",
      "application's connection to the api when it makes a similar \n",
      "determination about risk to its systems. however, depending on how the \n",
      "organization's systems are designed and configured, we recognize that \n",
      "the criteria and tolerable risk levels appropriate to assessing an \n",
      "application for connection to an api for access to publicly available \n",
      "information may differ from those required for api access to non-\n",
      "published personally identifiable information (pii).\n",
      "    we also anticipated that, where an application's connection has \n",
      "been terminated under these circumstances, it might be feasible in some \n",
      "instances for the organization to allow the application to reconnect to \n",
      "the api if and when the flaw or compromise of the application has been \n",
      "addressed sufficiently that the organization can no longer fairly say \n",
      "the application's api connection continues to pose an unacceptable \n",
      "risk.\n",
      "    we summarize the public comments we received on denial or \n",
      "discontinuation of service and provide our responses.\n",
      "    comment: several commenters supported the proposal to allow payers \n",
      "to deny or discontinue access to apps that pose security risks. one \n",
      "commenter specifically supported that the proposal does not allow \n",
      "payers to deny requests based on concerns about the worthiness of the \n",
      "third-party as a recipient of phi, because patients have the right to \n",
      "share their health information with the app they choose.\n",
      "    several commenters encouraged cms to develop and/or further define \n",
      "guidelines for identifying ``unacceptable risk'' and establish a \n",
      "clearer standard for acceptable circumstances when api access can be \n",
      "restricted or denied. a few commenters expressed concerns that the \n",
      "proposed requirements may be interpreted differently among payers, \n",
      "apps, users, and providers. one commenter expressed concern because \n",
      "payers are liable for breaches that occur during data exchange and the \n",
      "commenter does not believe the proposal provides clear authority to \n",
      "deny access based on such security concerns. a few commenters requested \n",
      "that cms provide more information regarding whether payers may delay \n",
      "and/or deny certain apps that are suspected, or proven to be bad \n",
      "actors. one commenter requested that cms make the distinction between \n",
      "the risk posed by providing phi and providing other widely available \n",
      "payer data. a few commenters requested cms define a time period for how \n",
      "long the ban on access may remain in place. one commenter sought \n",
      "additional\n",
      "\n",
      "[[page 25548]]\n",
      "\n",
      "information on whether payers will be able to deny third-party access \n",
      "across the board for all patient queries and plans. a few commenters \n",
      "suggested that cms should develop a clear process for app developers to \n",
      "follow in the event that a covered entity denies access to an api. a \n",
      "few commenters recommended that cms include in the final rule a \n",
      "reference to onc's information blocking definition and clarify that \n",
      "unacceptable levels of risk could be an exception to information \n",
      "blocking.\n",
      "    response: we appreciate the commenters' concerns. as discussed in \n",
      "the cms interoperability and patient access proposed rule, the criteria \n",
      "and process for assessing unacceptable risk to a payer's system are \n",
      "part of the payer's responsibilities under the hipaa security rule (84 \n",
      "fr 7635). the hipaa security rule requires a covered entity to perform \n",
      "risk analysis as part of its security management processes.\\35\\ hhs \n",
      "makes a number of tools available to assess risk.\\36\\ additional tools \n",
      "are available through the national institute of standards and \n",
      "technology (nist).\\37\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\35\\ 45 cfr 164.308(a)1)(ii)(a).\n",
      "    \\36\\ for more information, see <a href=\"https://www.hhs.gov/hipaa/for-professionals/security/index.html\">https://www.hhs.gov/hipaa/for-professionals/security/index.html</a>.\n",
      "    \\37\\ brooks, s., garcia, m., lefkovitz, ligthman, s., & nadeau, \n",
      "e. (2017, january). nistir 8062\n",
      "    an introduction to privacy engineering and risk management in \n",
      "federal systems. retrieved from <a href=\"https://nvlpubs.nist.gov/nistpubs/ir/2017/nist.ir.8062.pdf\">https://nvlpubs.nist.gov/nistpubs/ir/2017/nist.ir.8062.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we note that this policy regarding denial or discontinuation of \n",
      "service refers to a payer's determination that allowing access to their \n",
      "api by a third party would result in risk to their system. as also \n",
      "noted previously, covered entities, in accordance with hipaa privacy \n",
      "and security obligations, should take reasonable measures to protect \n",
      "data in transit, unless an individual expressly asks that the \n",
      "information be conveyed in an unsecure form or format (assuming the \n",
      "individual was warned of and accepted the risks associated with the \n",
      "unsecure transmission). as explained in this section above, it is the \n",
      "responsibility of payers to assess the risk to their system and act \n",
      "accordingly regardless of whether the data being accessed via the api \n",
      "is phi or not. if the concern is the security of the payer's system, \n",
      "the type of data being transferred is not at issue. absent an \n",
      "individual's instruction to disregard in-transit security, if while \n",
      "assessing the security of the app's connection to the api, the covered \n",
      "entity determines the data could be compromised in transit, the payer \n",
      "could discontinue or deny access in order to project the ephi on its \n",
      "system. again, this assessment must be based on objective, verifiable \n",
      "criteria in accordance with obligations under the hipaa security rule. \n",
      "having considered comments, we are finalizing that payers may deny or \n",
      "discontinue any third-party application's connection to their api if \n",
      "the payer reasonably determines, consistent with its security analysis \n",
      "under 45 cfr part 164 subpart c, that allowing an application to \n",
      "connect or remain connected to the api would present an unacceptable \n",
      "level of risk to the security of protected health information on the \n",
      "payer's systems or in transit in instances in which the individual did \n",
      "not tell the payer to disregard in-transit risk. for example, where an \n",
      "individual requests that their unencrypted ephi be transmitted to an \n",
      "app, the payer would not be responsible for unauthorized access to the \n",
      "individual's ephi while in transmission to the app. when access has \n",
      "been denied or discontinued due to security concerns, we encourage \n",
      "payers and third parties to work together to address the concerns if \n",
      "and as possible to best serve patients. we are not able to set a \n",
      "specific time period or process for this as it is beyond our authority, \n",
      "however, we do note that the hipaa privacy rule requires access to be \n",
      "provided to the individual in a timely manner. regarding information \n",
      "blocking, we refer readers to the onc 21st century cures act final rule \n",
      "(published elsewhere in this issue of the federal register).\n",
      "    comment: one commenter requested that cms indicate whether third-\n",
      "party applications will be subject to hipaa or ftc regulations. one \n",
      "commenter requested information about whether patients will be able to \n",
      "terminate third-party access to their health data.\n",
      "    response: we appreciate the commenters' request for more \n",
      "information. we refer commenters to ocr and ftc for additional \n",
      "information about jurisdiction over third-party apps. we do note, as \n",
      "discussed earlier, that under section 5 of the ftc act (15 u.s.c. sec. \n",
      "45(a)), the ftc does regulate such third-party apps. regarding a \n",
      "patient's ability to terminate third-party access, this would be \n",
      "something determined in the terms and conditions of each app.\n",
      "    comment: a few commenters recommended that covered payers should \n",
      "have the flexibility to establish additional terms and conditions when \n",
      "denying third-party applications access to their systems. one commenter \n",
      "stated that payers should be able to develop their own validation \n",
      "process for enrollees and have the right to not release the data where \n",
      "the full scope cannot be validated. one commenter stated the payers \n",
      "should be able to refuse to connect to non-vetted apps. another \n",
      "commenter stated that payers should be able to restrict access if the \n",
      "information exchanged is not permitted under the hipaa privacy rule or \n",
      "if the exchange or use would compromise the confidentiality, integrity, \n",
      "and availability of the information. one commenter recommended that cms \n",
      "allow covered entities to remove an app from their system if the app \n",
      "does not follow the approved privacy policy. one commenter recommended \n",
      "that providers should be allowed to require a business associate \n",
      "agreement (baa) with third-party app developers that connect to the api \n",
      "required under this final rule. one commenter suggested allowing \n",
      "restrictions on data mining. however, one commenter expressed concern \n",
      "that payers may place unnecessary barriers and burdens on third-party \n",
      "app developers. the commenter encouraged cms to ensure that payers \n",
      "cannot place additional constraints on apps, such as requiring a baa, \n",
      "additional security audits, or requiring that apps make commitments \n",
      "about how it will or will not use the information patients store on it.\n",
      "    response: we appreciate the commenters' recommendations. \n",
      "specifically, regarding the ability to deny access to a third-party \n",
      "app, we are finalizing this policy as proposed with one modification to \n",
      "add additional clarity around what it means to reasonably determine \n",
      "risk. as such, and as noted above, we are finalizing that payers may \n",
      "deny or discontinue any third-party application's connection to their \n",
      "api if the payer reasonably determines, consistent with its security \n",
      "analysis under 45 cfr part 164 subpart c, that allowing an application \n",
      "to connect or remain connected to the api would present an unacceptable \n",
      "level of risk to the security of protected health information on the \n",
      "payer's systems and the payer makes this determination using objective, \n",
      "verifiable criteria that are applied fairly and consistently across all \n",
      "applications and developers. as patients have a right to their data and \n",
      "this proposal provides the payers the ability to appropriately protect \n",
      "their systems and the data they hold on it, we do not believe any \n",
      "additional restrictions are needed at this time. we also note it would \n",
      "not be appropriate to require a patient-designated third party to enter \n",
      "into a baa with a payer as the api-facilitated exchange is taking place \n",
      "per the request of the patient and not by,\n",
      "\n",
      "[[page 25549]]\n",
      "\n",
      "on behalf of, or in service to the payer.\\38\\ in addition, we reiterate \n",
      "that it is beyond our authority to regulate third parties directly. we \n",
      "do note that under section 5 of the ftc act (15 u.s.c. sec. 45(a)), it \n",
      "is considered a deceptive act to use a person's sensitive information \n",
      "without disclosing in product documentation how this information will \n",
      "be shared. we do, however, believe patient privacy and security are \n",
      "vitally important. as a result, we lay out an option for payers to ask \n",
      "a third-party app to attest to certain privacy provisions, to help make \n",
      "patients aware of the privacy risks associated with their choices, as \n",
      "detailed in the next section.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\38\\ see 45 cfr 164.103 definitions, regarding functions of \n",
      "business associate.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    comment: several commenters had suggestions on how to further this \n",
      "proposal. a few commenters recommended that cms could require apps to \n",
      "attest to certain privacy and security provisions, and if they did not, \n",
      "payers could deny access to the api. one commenter recommended that \n",
      "payers be required to vet third-party applications centrally, rather \n",
      "than requiring vetting for every payer and plan. a few commenters \n",
      "expressed concern that it will be significantly burdensome for payers \n",
      "and providers to vet every app that patients may choose to use in \n",
      "support of more central vetting. one commenter suggested that app \n",
      "developers should be able to proactively request to be vetted by a \n",
      "payer, even if the app developer has not received a request from a \n",
      "member.\n",
      "    many commenters recommended cms and/or hhs establish a \n",
      "certification, independent verification, or vetting process for third-\n",
      "party applications and vendors that would vet or test apps for certain \n",
      "functions, including privacy and security assurances. as an \n",
      "alternative, one commenter recommended cms require apps generate an \n",
      "accounting of disclosures or join a trusted exchange network.\n",
      "    a few commenters requested cms share its best practices with app \n",
      "authorization and access under the blue button 2.0 initiative. a few \n",
      "commenters recommended cms, or the payers pre-approve and/or maintain a \n",
      "list of approved apps in order for them to access data. several \n",
      "commenters supported cms' proposal to allow patients to select any app \n",
      "of their choice. one commenter recommended that providers and payers be \n",
      "required to authenticate the apps their patients choose to use to gain \n",
      "access.\n",
      "    one commenter recommended that third-party application should be \n",
      "clear in their terms and conditions when a consumer downloads an app, \n",
      "and if they are not, a payer should not be required to interface with \n",
      "the app. one commenter recommended that the proposal for payers to deny \n",
      "or terminate specific applications from connecting to its api if the \n",
      "risk posed to its systems is unacceptable should be extended to \n",
      "hospitals, health systems, and other health care providers. one \n",
      "commenter suggested that payers should be required to consider the \n",
      "security risks related to provider ehr systems when determining whether \n",
      "to deny or terminate a third-party application. one commenter \n",
      "recommended that cms develop three options for denial of an \n",
      "application: denial at each api endpoint, centralized application \n",
      "denial, or no denial. one commenter suggested that cms could consider \n",
      "allowing providers to voluntarily seek assurances or certifications \n",
      "that third-parties are abiding by the api's terms.\n",
      "    response: we appreciate the commenters' recommendations, and we \n",
      "appreciate the concerns raised around privacy and security and the \n",
      "discussion regarding additional steps we can take to protect patient \n",
      "health information. we note that hospitals, health systems, and other \n",
      "health care providers are considered covered entities under hipaa, and \n",
      "the hipaa privacy and security rules apply.\n",
      "    we do appreciate that app vetting, in particular, is an issue of \n",
      "great interest to payers and providers. we note that we strongly value \n",
      "the role that industry can play in this capacity, and we support \n",
      "efforts within industry to facilitate efficient and effective, publicly \n",
      "accessible information on vetted apps and vendors. we believe industry \n",
      "is in the best position to collectively find the best ways to identify \n",
      "those apps with strong privacy and security practices. we also \n",
      "appreciate the commenters' request for best practices learned through \n",
      "our experience with blue button 2.0. you can find this information at \n",
      "<a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>.\n",
      "    we are not going to pursue the recommendation to develop a cms or \n",
      "hhs app certification program. under our current authorities, we do not \n",
      "believe we have the ability to require a third-party app to take part \n",
      "in such a certification program.\n",
      "    we do appreciate that, above all else, stakeholders commented on \n",
      "privacy and security and the need to do more to protect patient health \n",
      "information. throughout this rule we have noted the limitations to our \n",
      "authority to directly regulate third-party applications. we have also \n",
      "explained that we are finalizing that payers can deny api access to a \n",
      "third-party app that a patient wishes to use only if the payer assesses \n",
      "that such access would pose a risk to the phi on their system. we \n",
      "appreciate, however, that more needs to be done.\n",
      "    in the onc 21st century cures act final rule (published elsewhere \n",
      "in this federal register), onc notes that it is not information \n",
      "blocking to inform a patient about the advantages and disadvantages and \n",
      "any associated risks with sharing their health information with a third \n",
      "party. in this rule, we are finalizing that impacted payers must share \n",
      "educational resources with patients to help them be informed stewards \n",
      "of their health information and understand the possible risk of sharing \n",
      "their data with third-party apps. as discussed above, commenters \n",
      "believe it is a risk when patients do not understand what happens after \n",
      "their data leaves the protection of hipaa and are transmitted to a \n",
      "third-party app. commenters were specifically concerned about secondary \n",
      "uses of data. a clear, plain language privacy policy is the primary way \n",
      "a patient can be informed about how their information will be protected \n",
      "and how it will be used once shared with a third-party app.\n",
      "    taking into consideration comments indicating strong public support \n",
      "for additional privacy and security measures, we are further building \n",
      "off of the privacy and security policies we are finalizing in this rule \n",
      "by asserting that ma organizations, medicaid ffs programs, medicaid \n",
      "managed care plans, chip ffs programs, chip managed care entities, and \n",
      "qhp issuers on the ffes are encouraged, but are not required, to \n",
      "request third-party apps attest to having certain privacy and security \n",
      "provisions included in their privacy policy prior to providing the app \n",
      "access to the payer's api. if a payer chooses, they can ask that the \n",
      "apps requesting access to their api with the approval and at the \n",
      "direction of the patient to attest that important provisions that can \n",
      "help keep a patient's data private and secure are in place. explaining \n",
      "certain practices around privacy and security in a patient-friendly, \n",
      "easy-to-read privacy policy helps inform patients about an app's \n",
      "practices for handling their data. it helps patients understand if and \n",
      "how the app will protect their health information and how they can be \n",
      "an active participant in the protection of their information. also, as \n",
      "explained earlier in this final rule, if an app has a written privacy \n",
      "policy and does not follow the policies as written, the ftc has \n",
      "authority to intervene. as a result,\n",
      "\n",
      "[[page 25550]]\n",
      "\n",
      "we assert that impacted payers can, but are not required to, ask a \n",
      "third-party app to attest that:\n",
      "    <bullet> the app has a publicly available privacy policy, written \n",
      "in plain language,\\39\\ that has been affirmatively shared with the \n",
      "patient prior to the patient authorizing app access to their health \n",
      "information. to ``affirmatively share'' means that the patient had to \n",
      "take an action to indicate they saw the privacy policy, such as click \n",
      "or check a box or boxes.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\39\\ plain language action and information network. (2011, may). \n",
      "federal plain language guidelines. retrieved from <a href=\"https://www.plainlanguage.gov/media/federalplguidelines.pdf\">https://www.plainlanguage.gov/media/federalplguidelines.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> the app's privacy policy includes, at a minimum, the \n",
      "following important information:\n",
      "    ++ how a patient's health information may be accessed, exchanged, \n",
      "or used by any person or other entity, including whether the patient's \n",
      "health information may be shared or sold at any time (including in the \n",
      "future);\n",
      "    ++ a requirement for express consent from a patient before the \n",
      "patient's health information is accessed, exchanged, or used, including \n",
      "receiving express consent before a patient's health information is \n",
      "shared or sold (other than disclosures required by law or disclosures \n",
      "necessary in connection with the sale of the application or a similar \n",
      "transaction);\n",
      "    ++ if an app will access any other information from a patient's \n",
      "device; or\n",
      "    ++ how a patient can discontinue app access to their data and what \n",
      "the app's policy and process is for disposing of a patient's data once \n",
      "the patient has withdrawn consent.\n",
      "    payers can look to industry best practices, including the carin \n",
      "alliance's code of conduct \\40\\ and the onc model privacy notice\\41\\ \n",
      "for other provisions to include in their attestation request that best \n",
      "meet the needs of their patient population. if a payer chooses to \n",
      "request third-party apps provide this attestation, the payer must not \n",
      "discriminate in its implementation, including for the purposes of \n",
      "competitive advantage. specifically, if a payer requests this \n",
      "attestation of one app, it must request it of all apps that seek to \n",
      "obtain data. if the third-party app does not attest that their privacy \n",
      "policy meets the provisions indicated by the payer, the payer may \n",
      "inform patients that the app did not attest and advise them to \n",
      "reconsider using this third-party app. the notification to the patient \n",
      "should make it clear that the app has not attested to having the basic \n",
      "privacy and security protections and indicate what those are, and that \n",
      "the patient should exercise caution before opting to disclose their \n",
      "information to the app. if the patient still requests the payer make \n",
      "their data available to the third-party app, the payer must provide api \n",
      "access to the app unless doing so would endanger the security of phi on \n",
      "the payer's systems. this process should not overly delay the patient's \n",
      "access. if the app does not attest positively or at all, the payer must \n",
      "work to quickly inform the patient and provide a short window for the \n",
      "patient to cancel their request the data be shared. if the patient does \n",
      "not actively respond, the payer must move forward as the patient has \n",
      "already directed their data be shared and this initial request must be \n",
      "honored.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\40\\ see <a href=\"https://www.carinalliance.com/our-work/trust-framework-and-code-of-conduct/\">https://www.carinalliance.com/our-work/trust-framework-and-code-of-conduct/</a>.\n",
      "    \\41\\ see <a href=\"https://www.healthit.gov/topic/privacy-security-and-hipaa/model-privacy-notice-mpn\">https://www.healthit.gov/topic/privacy-security-and-hipaa/model-privacy-notice-mpn</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we believe it is important for patients to have a clear \n",
      "understanding of how their health information may be used by a third-\n",
      "party, as well as how to stop sharing their health information with a \n",
      "third-party, if they so choose. we believe the use of this attestation, \n",
      "in combination with patient education, will help patients be as \n",
      "informed as possible while providing payers with a lower burden vetting \n",
      "option. we believe this will better help protect patient privacy and \n",
      "security and mitigate many of the concerns raised. together, this \n",
      "framework and the requirement for payers to provide patients with \n",
      "educational resources will help continue to move us toward a safer data \n",
      "exchange environment. this is a critical focus for cms, and we look \n",
      "forward to continuing to work with stakeholders to keep patient privacy \n",
      "and data security a top priority.\n",
      "h. enrollee and beneficiary resources regarding privacy and security\n",
      "    as discussed in section ii.a. of the cms interoperability and \n",
      "patient access proposed rule (84 fr 7618 through 7623), we are \n",
      "committed to maximizing enrollees' access to and control over their \n",
      "health information. we noted that we believed this calls for providing \n",
      "enrollees that would access data under the proposal with essential \n",
      "information about the privacy and security of their information, and \n",
      "what to do if they believe they have been misled or deceived about an \n",
      "application's terms of use or privacy policy.\n",
      "    at 42 cfr 422.119(g), 431.60(f), and 457.730(f), and 45 cfr \n",
      "156.221(g), we proposed to require ma organizations, state medicaid and \n",
      "chip ffs programs, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers on the ffes, to make available to their \n",
      "current and former enrollees certain information about: factors to \n",
      "consider in selecting a health information management application, \n",
      "practical strategies to help them safeguard the privacy and security of \n",
      "their data, and how to submit complaints to ocr or ftc. the proposed \n",
      "obligations would apply to medicaid managed care plans and chip managed \n",
      "care entities through cross-references proposed in 42 cfr 438.242(b)(6) \n",
      "(finalized as sec.  438.242(b)(5) in this final rule; see section vi. \n",
      "of this final rule) and sec.  457.1233(d)(2).\n",
      "    the general information about the steps individuals can take to \n",
      "help protect the privacy and security of their health information \n",
      "should not be limited to, but should specifically include and emphasize \n",
      "the importance of understanding the privacy and security practices of \n",
      "any application to which they entrust their data. information about \n",
      "submitting complaints should include both specific contact information \n",
      "for the ocr and ftc complaints processes and a brief overview, in \n",
      "simple and easy-to-understand language, of: what organizations are \n",
      "hipaa covered entities, ocr's responsibility to oversee compliance with \n",
      "hipaa, and ftc's complementary responsibility to take action against \n",
      "unfair or deceptive practices, including by non-covered entities that \n",
      "may offer direct-to-consumer health information management \n",
      "applications.\n",
      "    we proposed that this information must be made available on the \n",
      "website of the payers subject to the proposed requirement, and through \n",
      "other appropriate mechanisms through which the payer ordinarily \n",
      "communicates with enrollees that are seeking to access their health \n",
      "information held by the payer. this could include customer portals, \n",
      "online customer service help desks, and other locations, such as any \n",
      "portals through which enrollees and former enrollees might request \n",
      "disclosure of their data to a third-party application through the \n",
      "payer's api. we also proposed that the payer must make this information \n",
      "available in non-technical, simple, and easy to understand language.\n",
      "    we explained in the proposed rule how we anticipate that payers \n",
      "could meet the requirement to provide information to current and former \n",
      "enrollees in whole or in part using materials designed for consumer \n",
      "audiences that are available on the hhs website. however, we noted that \n",
      "whether the organization chooses to draft its own resource materials to \n",
      "provide the required information or to\n",
      "\n",
      "[[page 25551]]\n",
      "\n",
      "rely on governmental or other sources for such materials, the \n",
      "organization will be responsible for ensuring that the content of the \n",
      "materials is adequate to inform the patient regarding the privacy and \n",
      "security risks, and that it remains current as relevant law and policy \n",
      "may evolve over time. we sought comment on the proposal, and we invited \n",
      "additional comments on what specific information resources in addition \n",
      "to those already available on the websites noted above would be most \n",
      "useful to entities in meeting this requirement. we anticipated using \n",
      "this feedback to help inform hhs planning and prioritization of \n",
      "informational resource development work in addition to making a \n",
      "decision on the final rule regarding the proposal.\n",
      "    we summarize the public comments we received on enrollee resources \n",
      "and provide our responses.\n",
      "    comment: several commenters supported the enrollee resources \n",
      "proposal that would require payers to make information available to \n",
      "consumers about selecting an app, safeguarding data, and submitting \n",
      "complaints. several commenters supported the recommendation that the \n",
      "resources be available in consumer-friendly language and be presented \n",
      "in a way that is easy for consumers to understand. one commenter \n",
      "requested more information about whether payers may make the \n",
      "educational information available through electronic disclosures, such \n",
      "as emailing the information to enrollees, in addition to making the \n",
      "information available online.\n",
      "    response: we appreciate the commenters' support. we do note that \n",
      "payers may share the information through other appropriate mechanisms \n",
      "usually used to communicate with patients, such as secure email, as \n",
      "well as include the information on a payer website.\n",
      "    comment: a few commenters recommended that cms provide patient \n",
      "education resources to help patients understand the information \n",
      "available to them through the payers' apis. these commenters expressed \n",
      "concerns that patients may not fully understand the context of the \n",
      "data, such as detailed claims information that may not be intuitive to \n",
      "understand. several commenters expressed concern with consumers' lack \n",
      "of knowledge about the privacy and security of their health information \n",
      "as it relates to third-party applications. several commenters expressed \n",
      "concern that consumers may not understand that their health information \n",
      "is not protected by hipaa once the information is sent to a non-covered \n",
      "third-party app or how an app may use their health information.\n",
      "    many commenters recommended that cms develop and/or support \n",
      "education for consumers. several commenters stated that cms should have \n",
      "the responsibility to develop educational materials, rather than the \n",
      "payers or providers. many commenters recommended that cms collaborate \n",
      "with other regulatory agencies, including ocr and the ftc, to provide \n",
      "consumer education and notification materials. several commenters \n",
      "recommended that cms and other hhs agencies develop a campaign to \n",
      "educate patients about the privacy and security of health information, \n",
      "including the risks and challenges when connecting to third-party apps \n",
      "as well as differences between hipaa and non-hipaa covered entities and \n",
      "how the differences may affect how their data are used, stored, and \n",
      "shared.\n",
      "    specifically, a few commenters recommended that cms and ftc should \n",
      "require that third-party app developers inform consumers that hipaa \n",
      "privacy rules will not apply when they agree to share their data with \n",
      "apps and describe how they will use the consumer's data. one commenter \n",
      "recommended that educational materials include information on the \n",
      "differences between hipaa and ftc protections. one commenter \n",
      "recommended that cms, ocr, or ftc publish the resources on their \n",
      "website and maintain a complaint portal. a few commenters stated that \n",
      "it is the responsibility of all stakeholders to inform consumers of \n",
      "their rights and use of phi. one commenter recommended that the \n",
      "responsibility of providing educational materials to the consumer \n",
      "should fall on an organization where the patient may have a longer-\n",
      "term, non-transactional relationship, such as an hie.\n",
      "    several commenters expressed concern that educational resources \n",
      "will not be enough to promote privacy and security. several commenters \n",
      "recommended that cms and onc should require third-party apps to provide \n",
      "notifications on how they may use, share, or sell their health \n",
      "information. one commenter expressed concern that there will not be \n",
      "enough oversight over third-party apps. the commenter recommended that \n",
      "cms use hipaa as a framework for developing a privacy structure for \n",
      "third-party apps.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. we agree it is important to help ensure patients fully \n",
      "understand their health information, their rights, and the implications \n",
      "of sharing their information. it is also important patients know what \n",
      "to do if there is a breach of their health information. we appreciate \n",
      "that it would eliminate some burden from payers and providers if we \n",
      "assist with the production of the educational materials needed for the \n",
      "purposes of the requirements in this final rule. as a result, cms is \n",
      "providing suggested content for educational materials that payers can \n",
      "use to tailor to their patient population and share with patients. we \n",
      "are finalizing the requirement with modification that payers must \n",
      "publish on their websites the necessary educational information, but we \n",
      "will help supply the content needed to meet this requirement. the \n",
      "suggested content we are providing for the educational materials will \n",
      "be shared through our normal communication channels including via \n",
      "listservs and is available via our website: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>. the \n",
      "modification we are making is to refine the language in the regulation \n",
      "text to expressly state that payers must include a discussion about a \n",
      "third-party app's secondary uses of data when providing factors to \n",
      "consider in selecting an application at 42 cfr 422.119(g)(1), \n",
      "431.60(f)(1), and 457.730(f)(1), and 45 cfr 156.221(g)(1). in addition, \n",
      "at 42 cfr 422.119(g), 431.60(f), and 457.730(f), and 45 cfr 156.221(g), \n",
      "we are modifying the regulation text to state the payer must make these \n",
      "materials available in an easily accessible location on its public \n",
      "website.\n",
      "    we note, however, that our authority is limited to helping payers \n",
      "educate patients about their privacy and security rights and where they \n",
      "can go for additional information. we have shared commenter feedback \n",
      "with our federal partners and will continue to work with all \n",
      "stakeholders to ensure patients, providers, and payers have the \n",
      "information they need to address privacy and security issues relevant \n",
      "to the regulations finalized in this rule. we will also continue \n",
      "coordinating with onc and all of our federal partners through the \n",
      "federal health it coordinating council and other federal partnering \n",
      "opportunities to ensure we are tracking the impact of this final rule \n",
      "together, as appropriate. privacy and security, however, is a much \n",
      "larger issue, and we remind commenters that cms does not have authority \n",
      "to regulate third-party apps or their developers or develop privacy \n",
      "frameworks that exceed the scope of our authority or this final rule.\n",
      "    comment: several commenters provided additional recommendations \n",
      "related to patient resources. one commenter recommended requiring\n",
      "\n",
      "[[page 25552]]\n",
      "\n",
      "payers to include information on how the consumer can contact the payer \n",
      "directly to report a privacy or security breach. one commenter \n",
      "recommended that cms develop an easy-to-understand questionnaire for \n",
      "third-party applications to fill out that included information about \n",
      "how the app plans to use the data. this questionnaire could be \n",
      "available to patients. one commenter recommended that educational \n",
      "information about tools be available to family members and clinicians \n",
      "and not just the patient. one commenter suggested including educational \n",
      "content for specific conditions or patient populations, such as for \n",
      "pediatric care.\n",
      "    several commenters recommended that cms include a requirement that \n",
      "the educational materials developed for consumers should also include \n",
      "materials for consumers who may be limited english proficient or have \n",
      "low health literacy. a few commenters recommended that educational \n",
      "materials should be developed with special considerations for \n",
      "vulnerable populations. one commenter recommended that consistent \n",
      "information be available across multiple settings to accommodate \n",
      "varying levels of technology literacy.\n",
      "    response: we appreciate the commenters' recommendations. as \n",
      "indicated above, we will be providing suggested content for educational \n",
      "materials to assist payers in meeting their educational obligations \n",
      "under this final rule as detailed at 42 cfr 422.119(g), 431.60(f), and \n",
      "457.730(f), and 45 cfr 156.221(g). we note that this would also be \n",
      "available to caregivers and family members as we are requiring this \n",
      "material to be posted on the payer's website. payers can tailor these \n",
      "materials to best meet the needs of their patient populations, \n",
      "including literacy levels, languages spoken, conditions, etc. regarding \n",
      "recommendations to have patients contact the payer directly in the \n",
      "event of a breach, that is the patient's prerogative; a payer is \n",
      "required by the hipaa privacy rule to have procedures for individuals \n",
      "to submit complaints, and to provide directions for doing so in its \n",
      "notice of privacy practices. individuals may also submit complaints to \n",
      "the ocr and ftc, in the appropriate situations, to address these \n",
      "concerns. finally, we reiterate that we do not have the authority to \n",
      "regulate apps, so we cannot ask apps to fill out a questionnaire or \n",
      "facilitate sharing that information with patients. we do note that we \n",
      "are making available a document containing best practices for app \n",
      "developers to follow, with a special emphasis on ways to protect the \n",
      "privacy and security of patient data: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>.\n",
      "i. exceptions or provisions specific to certain programs or sub-\n",
      "programs\n",
      "    we proposed certain exceptions or specific additional provisions as \n",
      "part of the cms interoperability and patient access proposed rule (84 \n",
      "fr 7637) for certain qhp issuers on the ffes. we also proposed \n",
      "specifics about how ma organizations subject to the regulations \n",
      "finalized here would have to include certain information about the part \n",
      "d benefit if the ma organization also offered part d benefits; those \n",
      "aspects of the proposals are addressed in section iii.c.2.c(1) of this \n",
      "final rule.\n",
      "    related to qhp issuers, we specifically proposed two exceptions. \n",
      "first, we proposed that the requirements proposed in 45 cfr 156.221(a) \n",
      "not apply to issuers offering only sadps on the ffes. in contrast to \n",
      "qhp issuers of medical plans, issuers offering only sadps offer \n",
      "enrollees access to a unique and specialized form of medical care. we \n",
      "believed the proposed standards and health it investment would be \n",
      "overly burdensome for sadp issuers as related to their current \n",
      "enrollment and premium intake and could result in sadp issuers no \n",
      "longer participating in ffes, which would not be in the best interest \n",
      "of enrollees. additionally, we believed much of the benefit to \n",
      "enrollees from requiring issuers of qhps to make patient data more \n",
      "easily available through a standard format depends upon deployment of \n",
      "standards-based api technology that conforms to standards proposed by \n",
      "onc for hhs adoption at 45 cfr 170.215 (84 fr 7589) and a corresponding \n",
      "energetic response by the developer community in developing innovative, \n",
      "useful, usable, and affordable consumer-facing applications through \n",
      "which plan enrollees can conveniently access, use, and share their \n",
      "information as they choose. based on the proposals to require \n",
      "implementation of standards-based api technology in the medicare, \n",
      "medicaid and chip programs, as well as by qhp issuers on the ffes, we \n",
      "would anticipate significantly expanding the implementation of \n",
      "standards-based apis by medical plans. however, we noted that we did \n",
      "not anticipate similar widespread usage with respect to sadps. \n",
      "therefore, we believed that the utility of access to issuers' data is \n",
      "less applicable to dental coverage, and did not believe it would be in \n",
      "the interest of qualified individuals and qualified employers in the \n",
      "states in which an ffe operates to not certify sadps because they do \n",
      "not provide patient access to their data through a standards-based api. \n",
      "we sought comment on whether we should apply this policy to sadp \n",
      "issuers in the future.\n",
      "    we also proposed to provide an exceptions process through which the \n",
      "ffes may certify health plans that do not provide patient access \n",
      "through a standards-based api, but otherwise meet the requirements for \n",
      "qhp certification. we proposed in 45 cfr 156.221(h)(1) that if a plan \n",
      "applying for qhp certification that is to be offered through an ffe \n",
      "does not provide patient access to their data through a standards-based \n",
      "api, the issuer must include as part of its qhp application a narrative \n",
      "justification outlining the reasons why the plan cannot reasonably \n",
      "satisfy the requirements in proposed 45 cfr 156.221(a), (b), or (c), \n",
      "the impact of non-compliance upon enrollees, the current or proposed \n",
      "means of providing health information to enrollees, and proposed \n",
      "solutions and timeline to achieve api compliance. in 45 cfr \n",
      "156.221(h)(2), we proposed that the ffe may grant an exception to the \n",
      "requirement to provide enrollees access to data through standards-based \n",
      "api technology, if the ffe determines that making available such health \n",
      "plan is in the interest of qualified individuals and qualified \n",
      "employers in a particular ffe state. we anticipated that this exception \n",
      "would be provided in limited situations. for example, we would consider \n",
      "providing an exception for small issuers, issuers who are only in the \n",
      "individual or small group market, financially vulnerable issuers, or \n",
      "new entrants to the ffes who demonstrate that deploying standards-based \n",
      "api technology consistent with the required interoperability standards \n",
      "would pose a significant barrier to the issuer's ability to provide \n",
      "coverage to consumers, and not certifying the issuer's qhp or qhps \n",
      "would result in consumers having few or no plan options in certain \n",
      "areas. we sought comment on other circumstances in which the ffe should \n",
      "consider providing an exception.\n",
      "    we summarize the public comments we received on qhp exemptions and \n",
      "provide our responses.\n",
      "    comment: several commenters supported cms' proposal to exempt sadps \n",
      "from the requirements to provide a patient api. these commenters agreed \n",
      "with the justification offered that dental information may not be as \n",
      "useful to patients, as well as the resource burden concern for sadps. a \n",
      "few commenters did not support the proposal to exempt sadps from the \n",
      "patient api proposed requirements, suggesting it may help dentists and \n",
      "their patients make more\n",
      "\n",
      "[[page 25553]]\n",
      "\n",
      "informed decisions and that dental information may help other health \n",
      "care providers for patient treatment.\n",
      "    response: we appreciate the commenters support, as well as the \n",
      "concerns raised. we believe the financial impact on sadp issuers may \n",
      "result in fewer sadps available in the ffes. we may consider the \n",
      "application of this policy to sadp issuers in future rulemaking. we are \n",
      "finalizing this policy as proposed and exempting sadps from the patient \n",
      "access api at this time.\n",
      "    comment: a few commenters expressed support for the proposal to \n",
      "allow cms to review a qhp issuer's justification for an exception to \n",
      "the patient access api proposal. one commenter recommended cms require \n",
      "qhps that are granted an exception to notify potential enrollees that \n",
      "they will not be compliant with the requirement to provide enrollees \n",
      "access to data through standards-based api technology. a few commenters \n",
      "did not support or expressed concern with cms' proposal to grant qhps \n",
      "an exception process, fearing an impact to patient care and uneven \n",
      "patient access to health data. one commenter did not want plans and \n",
      "entities to function solely as data consumers or aggregators. one \n",
      "commenter suggested that exceptions should be rare, limited, and for a \n",
      "defined duration.\n",
      "    a few commenters recommended cms establish or work with plans to \n",
      "make clear the evaluation criteria for reviewing exception requests to \n",
      "ensure parity. one commenter recommended cms define a standard for \n",
      "expected alternative api implementation timeline. this commenter also \n",
      "recommended cms establish a timeline for evaluating exception requests. \n",
      "one commenter requested cms specify how justifications will be \n",
      "submitted as well as guidance in its annual letter to issuers in the \n",
      "ffes to assist providers in understanding the requirements of the \n",
      "exception application process.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. regarding concerns that this exception would impact \n",
      "care and access to health data, we believe it is more important to \n",
      "ensure patients have access to qhps, and if an exception can provide \n",
      "consumers continued coverage, the exception is the preferable approach. \n",
      "we are evaluating the additional recommendations provided for future \n",
      "consideration. further, in order to better clarify the applicability of \n",
      "the api-related requirements, we are revising 45 cfr 156.221(h) to \n",
      "expand the exceptions process to encompass all requirements in \n",
      "paragraphs (a) through (g), rather than (a) through (c) in the proposed \n",
      "rule. this will ensure that qhp issuers on the ffes that are not able \n",
      "to meet any of the standards will be subject to the exceptions process. \n",
      "again, we believe that ensuring patients have access to qhps is \n",
      "paramount. we also note that additional guidance will be provided to \n",
      "qhp issuers in the future in order to specify how issuers will \n",
      "demonstrate compliance with these standards.\n",
      "    comment: several commenters recommended that cms expand the \n",
      "proposal to provide exemptions to the patient access api proposal to \n",
      "other types of plans for similar reasons including implementation \n",
      "burden and potential unintended consequences, such as driving plans out \n",
      "of the market. the types of payers that the commenters recommended be \n",
      "provided exemptions include ma, medicaid (including mcos, medicare-\n",
      "medicaid plans, fully integrated dual-eligible special needs plan, \n",
      "long-term services and supports), chip, public health agencies, smaller \n",
      "qhps and small plans, and new and current qhp issuers. a few commenters \n",
      "recommended cms include ``local plans'' in the definition of ``small \n",
      "issuer.'' one commenter recommended that tribes also be exempt from \n",
      "this policy.\n",
      "    response: we appreciate the commenters' recommendations, and we \n",
      "appreciate the concerns that certain payers may have unique \n",
      "circumstances making new requirements potentially more challenging. we \n",
      "note that these policies only apply to medicare advantage \n",
      "organizations, medicaid and chip ffs programs, medicaid managed care \n",
      "plans, chip managed care entities, and qhp issuers on the ffes. we are \n",
      "only finalizing one exemption, the exception noted below, not \n",
      "identified in the proposed rule, however. we do not believe the burden \n",
      "or potential unintended consequences outweigh the immense benefit to \n",
      "patients and the potential for improved health outcomes these policies \n",
      "can facilitate.\n",
      "    as noted earlier in this final rule, we are modifying the scope of \n",
      "the applicability of the regulations to qhp issuers on an individual \n",
      "market ffe. in considering the application to issuers offering plans \n",
      "through the ff-shops, we believe that, like the exception for issuers \n",
      "of sadps discussed above, the financial burden to implement these \n",
      "policies may result in fewer issuers offering plans through the ff-\n",
      "shops and could result in small employers and consumers having fewer or \n",
      "no ff-shop plan options. further, we believe that most ff-shop issuers \n",
      "likely would qualify for exclusion via the exceptions process we are \n",
      "finalizing. we have modified 45 cfr 156.221(h)(2) to remove the \n",
      "reference to ``qualified employers'' and paragraph (i) to include \n",
      "applicability to individual market ffes.\n",
      "j. applicability and timing\n",
      "    at 42 cfr 422.119(h) and 45 cfr 156.221(i), we proposed specific \n",
      "provisions regarding applicability and timing for ma organizations and \n",
      "qhp issuers on the ffes that would be subject to the proposal. we did \n",
      "not propose specific regulation text for 42 cfr 431.60 or 438.242 \n",
      "because we intended to make the regulation text effective on the \n",
      "applicable date, as discussed below. we noted that we expected that \n",
      "state medicaid and chip agencies would be aware of upcoming new \n",
      "regulations and planning for compliance with them when they are \n",
      "applicable, even if the new regulation is not yet codified in the cfr; \n",
      "we similarly expected that such agencies will ensure that their managed \n",
      "care plans/entities will be prepared for compliance. unlike medicaid \n",
      "state agencies and managed care plans and state chip agencies and \n",
      "managed care entities, ma organizations and qhp issuers on the ffes \n",
      "generally are subject to rules regarding bid and application \n",
      "submissions to cms in advance of the coverage period; for example, ma \n",
      "organizations must submit bids to cms by the first monday in june of \n",
      "the year before coverage starts in order to be awarded an ma contract. \n",
      "in an abundance of caution and to ensure that these requirements for ma \n",
      "organizations and qhp issuers on the ffes are enforceable and reflected \n",
      "in the bids and applications these entities submit to us in advance of \n",
      "when the actual requirements must be met, we proposed to codify the \n",
      "actual compliance and applicability dates of these requirements. we \n",
      "solicited comment on this approach.\n",
      "    for ma organizations, under 42 cfr 422.119(h), we proposed that the \n",
      "requirements would be applicable beginning january 1, 2020. under the \n",
      "proposal, the requirements at 42 cfr 422.119 would be applicable for \n",
      "all ma organizations with contracts to offer any ma plan on that date \n",
      "and thereafter. we requested feedback about the proposed timing from \n",
      "the industry. in particular, we solicited information and requested \n",
      "comment from ma organizations about their current capability to \n",
      "implement an api consistent with the proposal and the costs associated \n",
      "with compliance by january 1, 2020, versus compliance by a future date.\n",
      "    for medicaid ffs at 42 cfr 431.60, chip agencies that operate ffs \n",
      "systems at 42 cfr 457.730, medicaid managed\n",
      "\n",
      "[[page 25554]]\n",
      "\n",
      "care plans at 42 cfr 438.242(b)(6) (finalized as sec.  438.242(b)(5) in \n",
      "this rule; see section vi.), and chip managed care entities at 42 cfr \n",
      "457.1233(d)(2), we proposed that the api requirements would be \n",
      "applicable beginning july 1, 2020, regardless of when the managed care \n",
      "contract started. we noted that given the expected date of publication \n",
      "of the final rule, we believed july 1, 2020, would provide state \n",
      "medicaid agencies and chip agencies that operate ffs systems, medicaid \n",
      "managed care plans, and chip managed care entities sufficient time to \n",
      "implement. we solicited comment on the proposal and whether additional \n",
      "flexibility would be necessary to take into account the contract terms \n",
      "that states use for their medicaid managed care plans.\n",
      "    for chip, we noted that we are aware that some states do not \n",
      "provide any benefits on a ffs basis, and we did not intend for those \n",
      "states to implement an api outside their managed care plans. therefore, \n",
      "we proposed in 42 cfr 457.700(c) that separate chip agencies that \n",
      "provide benefits exclusively through managed care entities may meet the \n",
      "requirements of 42 cfr 457.730 by requiring the managed care entities \n",
      "to meet the requirements of 42 cfr 457.1233(d)(2) beginning july 1, \n",
      "2020.\n",
      "    for qhp issuers on the ffes, we proposed in 45 cfr 156.221(i) that \n",
      "these requirements would be applicable for plan years beginning on or \n",
      "after january 1, 2020. we sought comment on the timing of these \n",
      "requirements, and on how long issuers, particularly smaller issuers, \n",
      "anticipate it would take to come into compliance with these \n",
      "requirements.\n",
      "    we explained in the cms interoperability and patient access \n",
      "proposed rule our belief that these proposals would help to create a \n",
      "health care information ecosystem that allows and encourages the health \n",
      "care market to tailor products and services to compete for patients, \n",
      "thereby increasing quality, decreasing costs, and helping them live \n",
      "better, healthier lives. additionally, under these proposals, \n",
      "physicians would be able to access information on their patient's \n",
      "current prescriptions and services by reviewing the information with \n",
      "the patient on the patient's personal device or by the patient sharing \n",
      "data with the provider's ehr system, which would save time during \n",
      "appointments and ultimately improve the quality of care delivered to \n",
      "beneficiaries. most health care professionals and consumers have \n",
      "widespread access to the internet, providing many access points for \n",
      "viewing health care data over secure connections. these proposed \n",
      "requirements would significantly improve beneficiaries' experiences by \n",
      "providing a secure mechanism through which they can access their data \n",
      "in a standardized, computable format.\n",
      "    we noted that these proposals were designed to empower patients by \n",
      "making sure that they have access to health information about \n",
      "themselves in a usable digital format and can make decisions about how, \n",
      "with whom, and for what uses they will share it. by making claims data \n",
      "readily available and portable to the enrollee, these initiatives \n",
      "supported efforts to move our health care system away from a ffs \n",
      "payment system that pays for volume and toward a payment system that \n",
      "pays for value and quality by reducing duplication of services, adding \n",
      "efficiency to patient visits to providers; and, facilitating \n",
      "identification of fraud, waste, and abuse. data interoperability is \n",
      "critical to the success of new payment models and approaches that \n",
      "incentivize high quality, efficient care. all of the health care \n",
      "providers for a patient need to coordinate their care for a value-based \n",
      "system to work, and that requires information to be securely shareable \n",
      "in standardized, computable formats. moreover, we noted that patients \n",
      "needed to understand and be actively involved in their care under a \n",
      "value-based framework. we committed to supporting requirements that \n",
      "focus on these goals, and we noted we believe that the specific \n",
      "proposals supported these efforts.\n",
      "    we summarize the public comments we received on applicability and \n",
      "timing of the patient access api and provide our responses.\n",
      "    comment: a few commenters supported the proposed timeline for \n",
      "implementing apis. one commenter believes that payers have sufficient \n",
      "time to prepare apis and recommended that cms maintain the proposed \n",
      "timeline. one commenter suggested that to address payer concerns cms \n",
      "could reward plans, such as through higher hedis scores, who are able \n",
      "to meet the january 1, 2020 date.\n",
      "    many commenters expressed concern with the proposed implementation \n",
      "timelines. many commenters believed that payers and developers will \n",
      "need more time to implement the requirements and encouraged cms to \n",
      "delay the implementation date. a few commenters were concerned that \n",
      "without sufficient time and resources to implement security protocols, \n",
      "payers will be unable to meet the proposed requirements. many \n",
      "commenters believed that additional time will allow health it vendors \n",
      "and payers to develop, test, and implement the necessary systems. \n",
      "several commenters expressed concern with the costs needed to implement \n",
      "the proposals under the proposed timelines.\n",
      "    several commenters recommended an implementation deadline no \n",
      "earlier than 2021, while several other commenters recommended a \n",
      "proposed implementation date of january 1, 2022. one commenter each \n",
      "suggested january 1, 2023 and january 1, 2024, while another \n",
      "recommended 12 months after the publication of the rule. many \n",
      "commenters recommended a timeline of at least 18 to 24 months after \n",
      "publication of the final rule. several commenters recommended aligning \n",
      "the cms timelines with the onc timelines, therefore recommending cms \n",
      "implement policies in this final rule 2 years after the publication of \n",
      "this final rule. a few commenters recommended a 36-month timeline for \n",
      "all proposed policy implementation dates included in this rulemaking.\n",
      "    a few commenters did not support proposing a timeline yet. the \n",
      "commenters noted that the standards and the infrastructure should be \n",
      "more mature before implementation dates are set. one commenter \n",
      "suggested that cms and onc convene a planning group to establish a more \n",
      "appropriate timeline.\n",
      "    several commenters encouraged cms take a phased approach, which \n",
      "some explained as creating a ``glide path'' from ``proof of concept'' \n",
      "to more advanced use cases and a more expansive set of data. commenters \n",
      "had a few different recommendations for which data elements could be \n",
      "included in which phase of the implementation in such a scenario. a few \n",
      "commenters suggested an approach where smaller plans meet fewer \n",
      "requirements initially and phase-in to full adoption. one commenter \n",
      "requested that cms exempt small issuers from the requirements of the \n",
      "rule.\n",
      "    a few commenters recommended delaying any disincentives and/or \n",
      "penalties until 2 years after implementation. one commenter expressed \n",
      "concern that the different implementation dates for different payers \n",
      "may create confusion, particularly for dual eligible beneficiaries.\n",
      "    response: we appreciate the commenters' concerns and \n",
      "recommendations. we understand that payers need time to be able to \n",
      "develop, test, and implement the apis being finalized in this rule. we \n",
      "appreciate that it will take time to map and prepare historic data for \n",
      "sharing via the standards-based fhir api. we want to be sure that \n",
      "payers have the time and guidance needed to fully and accurately\n",
      "\n",
      "[[page 25555]]\n",
      "\n",
      "implement the policies being finalized in this rulemaking. we do not \n",
      "agree, however, that it is necessary to convene a planning group to \n",
      "develop a timeline for implementation. the public has had the \n",
      "opportunity to provide feedback on this issue as part of this \n",
      "rulemaking. as a result, we are finalizing the implementation date of \n",
      "the patient access api as january 1, 2021 for all payers impacted by \n",
      "this rulemaking, except for qhp issuers on the ffes, for which the rule \n",
      "will be applicable beginning with plan years beginning on or after \n",
      "january 1, 2021. we strongly encourage payers to implement these \n",
      "policies as soon as they are capable, but the patient access api will \n",
      "not be required until january 1, 2021. for medicaid managed care, we \n",
      "remind states that should they determine that obligations in this rule \n",
      "warrant a retroactive adjustment to capitation rates, those adjustments \n",
      "must be certified by an actuary in a revised rate certification and \n",
      "submitted to cms as a contract amendment, pursuant to 42 cfr 438.7(c).\n",
      "    we do appreciate the commenters' suggestion to evaluate a phased \n",
      "implementation approach. as a result, you will see in section iv. of \n",
      "this final rule how we are using the provider directory api proposal as \n",
      "a way for payers to show they are making progress toward api \n",
      "development and access.\n",
      "k. request for information on information sharing between payers and \n",
      "providers through apis\n",
      "    we proposed the implementation of standards-based apis for making \n",
      "accessible data that a third party could use to create applications for \n",
      "patients to access data in order to coordinate and better participate \n",
      "in their medical treatment. while in some instances, direct provider to \n",
      "health plan transmission of health information may be more appropriate \n",
      "than sharing data through a standards-based api, in other instances a \n",
      "patient may wish to send a provider a copy of their health information \n",
      "via another health care provider's api. in such cases, patients could \n",
      "direct the payer to transmit the health information to an application \n",
      "(for example, an application offered by a health care provider to \n",
      "obtain patient claims and encounter data, as well as lab test results \n",
      "(if applicable)) on a one-off and as-needed basis. to the extent a \n",
      "hipaa covered entity offers patients access to their records via a \n",
      "standards-based application, another hipaa covered entity may be able \n",
      "to obtain an individual's health information from the app for \n",
      "treatment, payment, or certain health care operations purposes, without \n",
      "need of an individual's authorization, consistent with the hipaa rules \n",
      "(see 45 cfr 164.506). under other laws, providers may need to obtain \n",
      "specific individual consent to obtain health information related to \n",
      "care provided by a behavioral health provider, treatment received at a \n",
      "substance use disorder treatment facility, certain 42 cfr part 2-\n",
      "covered diagnoses or other claims-related information, or labs that \n",
      "suggest a part 2 diagnosis. we explained in the cms interoperability \n",
      "and patient access proposed rule how we did not intend to expand any \n",
      "scope of authority to access patient data nor to contravene existing \n",
      "requirements related to disclosure of phi under the hipaa rules and \n",
      "other legal standards, but instead specified a new and additional \n",
      "mechanism by which to share health information as directed by the \n",
      "individual, through the use of api technology in compliance with all \n",
      "existing federal, state, local, and tribal privacy and security laws.\n",
      "    we explained how, in the future, we anticipate payers and providers \n",
      "may seek to coordinate care and share information in such a way as to \n",
      "request data on providers' or a payer's patient/insured overlapping \n",
      "population(s) in one transaction. we sought comment for possible \n",
      "consideration in future rulemaking on the feasibility of providers \n",
      "being able to request a download on a shared patient population using a \n",
      "standards-based api. we thank commenters for their insights and are \n",
      "reviewing the comments received for inclusion in potential future \n",
      "rulemaking.\n",
      "    in addition to the comments we received about the specific sections \n",
      "of this patient access api proposal, we also received a number of \n",
      "comments that were specific to the types of payers impacted by the \n",
      "proposal, generally. we summarize these public comments by payer type \n",
      "and provide our responses.\n",
      "    we received these public comments related to medicare advantage.\n",
      "    comment: one commenter suggested cms require that ma organizations \n",
      "make patient data maintained in connection with the organizations' \n",
      "various individual and small group market plans available for access \n",
      "and exchange through the patient access api.\n",
      "    response: we appreciate the commenter's suggestion. however, in \n",
      "light of the limits on cms's authority over ma organizations, \n",
      "commercial insurance, and group health plans, we are not adopting \n",
      "requirements to apply as broadly as the commenter suggested. we note \n",
      "that qhp issuers on the individual market ffes are required under this \n",
      "final rule to implement the patient access api, and we encourage other \n",
      "individual markets, as well as small group market plans and group \n",
      "health plans to do so, as well.\n",
      "    comment: one commenter recommended cms specify the expectations of \n",
      "ma organizations regarding supplemental benefits in relation to the \n",
      "patient access api. one commenter recommended cms evaluate whether the \n",
      "standards proposed for this api are appropriate for the dental care \n",
      "space.\n",
      "    response: we appreciate the commenter's request for additional \n",
      "information. we note that ma claims data, encounter data, and clinical \n",
      "data related to supplemental benefits, including dental services, are \n",
      "subject to the api requirement, even if issuers only offering sadps on \n",
      "ffes are not subject to the requirement.\n",
      "    comment: one commenter requested additional information on whether \n",
      "medicare advantage d-snps would be required to provide patients an api.\n",
      "    response: we appreciate the commenter's request for additional \n",
      "information. we note d-snps are ma plans offered by ma organizations \n",
      "and therefore subject to the api requirement adopted at 42 cfr 422.119.\n",
      "    comment: one commenter requested additional information of whether \n",
      "data shared via an api would be subject to member communication rules, \n",
      "such as medicare communications and marketing guidelines.\n",
      "    response: we appreciate the commenter's request for additional \n",
      "information. whether or not data shared via the patient access api \n",
      "being finalized at 42 cfr 422.119(b) falls under the purview of cms's \n",
      "communication and marketing rules would be dependent on factors such as \n",
      "the relationship of the developer and the ma plan(s), the content \n",
      "accompanying the api data, and the intended outcome of the application \n",
      "using the api data. ma plans must continue to follow the provisions of \n",
      "42 cfr part 422 (such as but not limited to 42 cfr 422.118(d), 422.2260 \n",
      "through 422.2268), including in circumstances when their communications \n",
      "and marketing materials include data that is retrieved through an api. \n",
      "for example, if a field marketing organization (fmo) uses api data to \n",
      "create a software application that compares the provider networks for \n",
      "the plans the fmo is contracted to sell, the application would fall \n",
      "under the ma marketing and communications regulations and cms's \n",
      "oversight. conversely, if a developer uses api data to create an \n",
      "independent application that provides an alternative\n",
      "\n",
      "[[page 25556]]\n",
      "\n",
      "means of scheduling provider appointments, the application would fall \n",
      "outside of cms's purview.\n",
      "    we received these public comments related to medicaid and chip.\n",
      "    comment: several commenters requested additional information on \n",
      "which medicaid programs would be required to implement and maintain a \n",
      "standards-based api. one commenter wanted additional information as to \n",
      "whether all state's medicaid management information systems (mmis) \n",
      "would be required to develop apis. this commenter stated that while it \n",
      "seemed clear that the rule does not require health plans to use health \n",
      "it modules to make administrative data available, the role of a payer's \n",
      "claims adjudication system (including mmis) is unclear.\n",
      "    response: we appreciate the commenters' request for information. in \n",
      "proposed 42 cfr 431.60 and 457.730, we specified that states would have \n",
      "to implement and maintain an api for ffs medicaid programs and chip; we \n",
      "also proposed in 42 cfr 438.242(b)(6) (finalized as 42 cfr \n",
      "438.242(b)(5) in this rule; see section vi.) and 457.1233(d) that \n",
      "states would have to require each mco, pihp, and pahp to comply with 42 \n",
      "cfr 431.60 (under medicaid managed care contracts) and 457.730 (under \n",
      "chip managed care contracts) as if such requirements applied directly \n",
      "to them. we are finalizing these policies as proposed. sections 431.60 \n",
      "and 457.730 do not require a specific system to be used for the \n",
      "implementation and maintenance of the api, thus we defer to each state \n",
      "and medicaid managed care plan to determine which of their systems \n",
      "would be the most appropriate.\n",
      "    comment: one commenter requested that cms clarify if an arrangement \n",
      "in which a state provided beneficiaries access to their ffs data by \n",
      "delegating the api function to a managed care plan would be sufficient \n",
      "to satisfy the rule, or if each entity in the chain is required to \n",
      "implement their own systems, portals, and/or api interfaces. this \n",
      "commenter questioned if cms envisioned the creation of a national \n",
      "network to exchange medicare/medicaid records that would satisfy these \n",
      "requirements in a centralized fashion.\n",
      "    response: we appreciate the commenter's request for information. we \n",
      "are, however, somewhat unclear what the commenter meant by ``delegating \n",
      "the api function to a managed care plan.'' we believe the commenter may \n",
      "be questioning if a state could utilize a managed care plan to \n",
      "implement the api required for the state's ffs beneficiaries in lieu of \n",
      "the state implementing the api required in 42 cfr 431.60. if so, the \n",
      "proposed rule did not anticipate nor prohibit that type of an \n",
      "arrangement. as such, this final rule could permit such an arrangement, \n",
      "but we remind a state contemplating using such an arrangement that it \n",
      "must meet the all of the requirements in this final rule, including the \n",
      "timelines and scope specified for data accessibility in sec.  \n",
      "431.60(b). there is no plan for a national network to exchange \n",
      "medicare/medicaid records in lieu of the apis being finalized in this \n",
      "rule at this time.\n",
      "    comment: one commenter suggested that cms establish a stakeholder \n",
      "workgroup to identify best practices in data-sharing with medicaid \n",
      "beneficiaries.\n",
      "    response: we appreciate this suggestion and encourage states and \n",
      "medicaid managed care plans to work with their stakeholders to identify \n",
      "best practices for data-sharing with medicaid beneficiaries in their \n",
      "states.\n",
      "    comment: a commenter expressed concern that reimbursing states for \n",
      "modification of their it systems at an enhanced match rate while \n",
      "reimbursing managed care plans for their system modifications at the \n",
      "state's standard match rate creates an uneven playing field for \n",
      "medicaid managed care plans and a disparity of funding. this commenter \n",
      "noted that in states that make extensive use of managed care, the bulk \n",
      "of system modifications needed to carry out and maintain the proposed \n",
      "interoperability capabilities for medicaid enrollees will be borne by \n",
      "medicaid managed care plans and requested that cms revise its proposal \n",
      "to reflect that all costs attributable to design, development, \n",
      "installation, enhancement, or ongoing operation of both state and \n",
      "medicaid managed care plan systems will receive the appropriate \n",
      "enhanced federal match. finally, this commenter requested that cms take \n",
      "a more rigorous approach and update its methodology for review of state \n",
      "mco capitation rates to ensure that proposed rates include reasonable \n",
      "allowances for costs of it systems work performed by the state's \n",
      "medicaid managed care plans in furtherance of the proposals in this \n",
      "regulation.\n",
      "    response: we appreciate the commenter's concern. however, we do not \n",
      "agree that the difference in the federal match rate creates an uneven \n",
      "playing field. capitation rates must be actuarially sound independent \n",
      "of the federal matching rate that applies to the payment of those \n",
      "rates. the provision of enhanced federal match rate is addressed in \n",
      "section 1903(a)(3)(a) of the act and provides a 90 percent match rate \n",
      "for ``. . . the sums expended during such quarter as are attributable \n",
      "to the design, development, or installation of such mechanized claims \n",
      "processing and information retrieval systems as the secretary \n",
      "determines are likely to provide more efficient, economical, and \n",
      "effective administration of the plan . . .'' it does not specifically \n",
      "provide an enhanced match rate for the portion of a capitation rate \n",
      "that may be included for information technology expenditures, and we do \n",
      "not have the authority to extend the enhanced match rate beyond the \n",
      "conditions specified in statute. we already have a very rigorous \n",
      "capitation rate review process and will review any changes noted by the \n",
      "states in those rates, including any specifically noted for it system \n",
      "enhancements specific to the requirements finalized in this rule.\n",
      "    comment: one commenter requested that the new requirement to \n",
      "implement and maintain an api must be uniform across the system and \n",
      "non-negotiable to medicaid managed care plans, state government, and \n",
      "providers. one commenter noted that cms should address situations where \n",
      "states may choose to adopt additional or conflicting data sharing \n",
      "requirements in medicaid or chip managed care contracts. this commenter \n",
      "further stated that it is critical that covered health plans be subject \n",
      "to uniform standards for data accessed through an api and that cms \n",
      "should work with state medicaid and chip programs to ensure that any \n",
      "state mandated requirements for data accessed through an api are \n",
      "harmonized with the new federal standards. this commenter suggested \n",
      "that submission of the encounters in a timely manner by all involved \n",
      "with the new rule must be a non-negotiable condition for the receipt of \n",
      "medicare or medicaid reimbursement. in addition, the commenter noted \n",
      "that enforcement cannot be left to plans based on variable contract \n",
      "terms but must be provided by federal agencies.\n",
      "    response: we agree with the commenter that implementation of \n",
      "standards-based apis should be consistent across states and medicaid \n",
      "and chip managed care plans and have codified the requirements for apis \n",
      "in 42 cfr 431.60(b), 457.730(b), 438.242(b)(6) (finalized as \n",
      "438.242(b)(5) in this rule; see section vi.), and 457.1233(d) to ensure \n",
      "an appropriate level of uniformity and consistency while still \n",
      "providing states with an adequate level of flexibility to go beyond the \n",
      "minimum standards included in this final rule when they believe doing \n",
      "so benefits their beneficiaries. while we do not have a specific \n",
      "provisions that\n",
      "\n",
      "[[page 25557]]\n",
      "\n",
      "conditions payment on the timely receipt of encounters, states and \n",
      "managed care plans may find that a useful provision to include in their \n",
      "contracts. states must have a monitoring system in effect for their \n",
      "medicaid managed care programs under sec.  438.66(b)(6), which also \n",
      "specifies ``information systems, including encounter data reporting'' \n",
      "as a required element. similarly, we have certain program oversight \n",
      "responsibilities, such as the review of certain medicaid and chip \n",
      "managed care contracts and all capitation rates, and will incorporate \n",
      "oversight of requirements in this final rule to the extent appropriate.\n",
      "    comment: one commenter noted that cms encourages the medicaid and \n",
      "chip ffs programs to use the api as a means to exchange phi with \n",
      "providers for treatment purposes, suggesting the data would be shared \n",
      "in advance of a patient's visit. but cms also states that this proposal \n",
      "can empower the patient to decide how their health information is going \n",
      "to be used. this commenter requested additional information of the role \n",
      "cms intends for the patient and the provider to have in the use of \n",
      "apis.\n",
      "    response: while we believe that a beneficiary's use of an api to \n",
      "obtain their health care data will play an important role in their \n",
      "health care, as proposed and finalized, this rule does not set \n",
      "standards for health care provider use of apps to obtain information \n",
      "from payers. as proposed and finalized in 42 cfr 431.60(a) and \n",
      "457.730(a), the api permits third-party applications to retrieve a \n",
      "patient's data at the patient's request. a beneficiary may make the \n",
      "decision to obtain their health care data through such an app and share \n",
      "it with a provider in advance of a visit or otherwise.\n",
      "    comment: one commenter requested clarity on whether the proposed \n",
      "rule requires all states' mmis [medicaid management information system] \n",
      "to make information available to patients within one (1) business day \n",
      "of receipt or adjudication of administrative data (adjudicated claims, \n",
      "encounters, provider remittance, etc.). this commenter expressed \n",
      "concern that these data could appear to conflict with data obtained by \n",
      "a patient directly from a managed care plan, causing confusion and \n",
      "increasing administrative overhead.\n",
      "    response: we appreciate the commenter's request for additional \n",
      "information. medicaid beneficiaries should not be receiving the \n",
      "information from both the state and managed care plan for the same \n",
      "service. if the beneficiary is receiving a service under the state's \n",
      "medicaid ffs program, the requirements in sec.  431.60 apply; that is, \n",
      "the state is responsible for providing the specified data elements in \n",
      "sec.  431.60(b) through the api. if the beneficiary is enrolled in a \n",
      "managed care plan (receiving the service under the managed care plan's \n",
      "contract), the requirements in sec.  438.242(b)(5) (proposed as sec.  \n",
      "438.242(b)(6); see section vi.) apply; that is, the managed care plan \n",
      "is responsible for providing the specified data elements in sec.  \n",
      "431.60(b) through the api. the beneficiary should not receive data that \n",
      "is in conflict with other data that is made available through the api. \n",
      "the same is true for chip. if the beneficiary is in chip ffs, the \n",
      "requirements in sec.  457.730 apply; that is, the state is responsible \n",
      "for providing the specified data elements in sec.  457.730(b) through \n",
      "an api. if the beneficiary is enrolled in a managed care plan, the \n",
      "requirements in sec.  457.1233(d) apply; that is, the managed care plan \n",
      "is responsible for providing the specified data elements in sec.  \n",
      "457.730(b) through the api.\n",
      "    comment: one commenter expressed concerns regarding the ongoing \n",
      "burden for state medicaid and chip agencies to monitor the api, privacy \n",
      "and security features, and potential security risks posed by the \n",
      "numerous applications that may connect to the api. this commenter \n",
      "recommended that states be required to monitor the compliance of each \n",
      "of their managed care plans regarding the api requirements.\n",
      "    response: we understand the commenter's concerns about burden \n",
      "related to the api, as well as the need for states to monitor the api \n",
      "for privacy and security. these requirements are specified at 42 cfr \n",
      "431.60(c)(1) and (2) and 457.730(c)(1) and (2). while we understand \n",
      "that there is some burden for states and managed care plans related to \n",
      "the development and implementation of the api, we continue to believe \n",
      "that the benefits and potential for improved health outcomes outweigh \n",
      "the burden associated with these requirements. we also confirm for \n",
      "commenters that states are required to monitor compliance for their \n",
      "contracted managed care plans in regard to the api requirements under \n",
      "42 cfr 438.242(b)(5) (proposed as 42 cfr 438.242(b)(6); see section \n",
      "vi.) and 457.1233(d). since these requirements apply to managed care \n",
      "plans, states are required to include the requirements under their \n",
      "managed care contracts and must ensure that plans comply with the \n",
      "standards specified in 42 cfr 431.60 and 457.730 as if those \n",
      "requirements applied directly to the managed care plan.\n",
      "    comment: several commenters stated that the patient access api \n",
      "proposal places a significant burden on medicaid and chip beneficiaries \n",
      "to monitor the privacy and security of their own health information \n",
      "while it is being accessed by non-hipaa covered entities. one commenter \n",
      "recommended that cms consider how educational efforts could be uniquely \n",
      "tailored to specific populations, such as medicaid beneficiaries, \n",
      "particularly given the need for special considerations when attempting \n",
      "to engage with vulnerable populations. this commenter recommended that \n",
      "cms amend or revise the current language in its proposed rule to \n",
      "explicitly require that api vendors be responsible for the education of \n",
      "consumers. another commenter noted that many medicaid and chip \n",
      "beneficiaries are children and that app developers, states, and managed \n",
      "care plans will also need to develop resources for minor access and \n",
      "control over health information and educate members accordingly.\n",
      "    response: we appreciate the commenters' concerns, and we \n",
      "acknowledge that some medicaid beneficiaries may find negotiating the \n",
      "privacy and security app landscape burdensome. any patient, including \n",
      "one who is not comfortable with technology, may choose not to use this \n",
      "method of data exchange. however, we would like all beneficiaries to be \n",
      "able to benefit from these apps. one way we are looking to mitigate \n",
      "this burden is through education. we believe that it is important for \n",
      "beneficiaries to have the educational resources to be able to best \n",
      "evaluate their third-party options. states and managed care plans must \n",
      "comply with the requirements 42 cfr 431.60(f) and 457.730(f) that \n",
      "require states and managed care plans to develop and provide on a \n",
      "public website beneficiary resources regarding privacy and security, \n",
      "including information on how beneficiaries can protect the privacy and \n",
      "security of their health information in non-technical, simple and easy-\n",
      "to-understand language. we note in section iii.c.2.h. of this final \n",
      "rule, that cms will provide suggested content for educational material \n",
      "payers can use to meet this requirement. states, medicaid managed care \n",
      "plans, and chip managed care entities have vast experience with \n",
      "techniques for creating effective communications for their \n",
      "beneficiaries and we encourage states and managed care plans to tailor \n",
      "these resources for their medicaid and chip populations. we also agree \n",
      "that states and managed care plans will need to develop or refine \n",
      "resources to address patient access for minor populations and for \n",
      "populations based on health literacy levels. we do\n",
      "\n",
      "[[page 25558]]\n",
      "\n",
      "note that we do not have the authority to regulate vendors. while we \n",
      "agree that api vendors should have a role in educating consumers, \n",
      "states and managed care plans are the entities responsible for \n",
      "developing and implementing the api; therefore, we believe it is more \n",
      "appropriate for states and managed care plans to develop and provide \n",
      "the educational resources for beneficiaries.\n",
      "    comment: a few commenters requested that cms modify the rule to \n",
      "exempt medicaid managed care plans. commenters noted that medicaid \n",
      "managed care plans are already operating with razor thin margins and \n",
      "the proposed rule will substantially increase the costs for medicaid \n",
      "managed care plans. further, commenters noted that due to the \n",
      "substantial increase in costs, plans may not be able to meet the mlr \n",
      "requirements in 42 cfr 438.8. another commenter suggested that cms \n",
      "explicitly exclude from the requirements of the rule long[hyphen]term \n",
      "services and supports (ltss) plans. some commenters also recommended \n",
      "that cms exclude dental plans from the requirements in the proposed \n",
      "rule.\n",
      "    response: we appreciate the commenters' concerns, however we are \n",
      "not exempting medicaid or chip managed care plans, including ltss or \n",
      "dental plans, from the requirements in this rule, as such an approach \n",
      "would not be consistent with our goal of ensuring that all \n",
      "beneficiaries across the health care market, including medicaid ffs and \n",
      "managed care, have access to and can exchange specified health care \n",
      "data. we are finalizing the patient access api requirements for state \n",
      "medicaid and chip agencies and managed care plans, including ltss and \n",
      "dental plans. states and managed care plans must make adjudicated \n",
      "claims and encounter data available through the api for all medicaid-\n",
      "covered services, including ltss and dental. this requirement extends \n",
      "to all medicaid-covered services for which a claim, or encounter claim, \n",
      "is generated and adjudicated. regarding costs for managed care plans--\n",
      "since the patient access api requirements must be contractual \n",
      "obligations under the managed care contract--the state must include \n",
      "these costs in the development of a plan's capitation rates.\n",
      "    final action: after consideration of the comments received, and for \n",
      "the reasons outlined in our response to these comments and in the cms \n",
      "interoperability and patient access proposed rule, we are finalizing \n",
      "with modifications our proposal to require ma organizations, medicaid \n",
      "and chip ffs programs, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers on the ffes to implement and maintain a \n",
      "standards-based patient access api that meets the technical standards \n",
      "as finalized by hhs in the onc 21st century cures act final rule \n",
      "(published elsewhere in this issue of the federal register) at 45 cfr \n",
      "170.215, content and vocabulary standards adopted at 45 cfr part 162 \n",
      "and 42 cfr 423.160, and finalized by hhs at 45 cfr 170.213 (uscdi \n",
      "version 1), unless alternate standards are required by other applicable \n",
      "law; includes the data elements specified in this final rule, and \n",
      "permits third-party applications to retrieve, with the approval and at \n",
      "the direction of the enrollee, data specified at 42 cfr 422.119, \n",
      "431.60, 457.730, and 45 cfr 156.221. specifically, we are finalizing \n",
      "that the patient access api must, at a minimum, make available \n",
      "adjudicated claims; encounters with capitated providers; provider \n",
      "remittances; enrollee cost-sharing; and clinical data, including \n",
      "laboratory results (where maintained by the impacted payer). data must \n",
      "be made available no later than one (1) business day after a claim is \n",
      "adjudicated or encounter data are received by the impacted payer. we \n",
      "are not finalizing a requirement for the patient access api to make \n",
      "provider directory and pharmacy directory information available. \n",
      "instead, to limit burden, we are only requiring provider and, in the \n",
      "case of ma-pd plans, pharmacy directory information be included in the \n",
      "provider directory api discussed in section iv. of this final rule.\n",
      "    we are finalizing the proposed documentation requirements noting \n",
      "business and technical documentation necessary to interact with the api \n",
      "must be made freely and publicly accessible. we note that the apis need \n",
      "to comply with all existing federal and state privacy and security \n",
      "laws. we are finalizing, consistent with the hipaa rules that a payer \n",
      "may deny access to the patient access api if the payer reasonably \n",
      "determines that allowing a specific third-party application to connect \n",
      "or remain connected to the api would present an unacceptable level of \n",
      "risk to the security of phi on the payer's systems based on objective \n",
      "and verifiable criteria. we are also finalizing that payers need to \n",
      "make available to enrollees resources explaining factors to consider in \n",
      "selecting an app for their health information, practical strategies to \n",
      "safeguard their privacy and security, and how to submit complaints to \n",
      "ocr or ftc. we do note that we are providing payers with suggested \n",
      "content they can use and tailor to meet this requirement, available \n",
      "here: <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>. we also note that impacted payers are allowed \n",
      "to request that third-party apps attest to having certain information \n",
      "included in their privacy policy, and inform patients about this \n",
      "attestation, to help ensure patients are aware of the privacy risks \n",
      "associated with their choices.\n",
      "    we are finalizing this policy with the following technical \n",
      "corrections and additional information. at 42 cfr 422.119(a) and \n",
      "(b)(1); 42 cfr 431.60(a) and (b); 42 cfr 457.730(a) and (b); and, 45 \n",
      "cfr 156.221(a) and (b) we specify these policies apply to current \n",
      "patients and their personal representatives. at 42 cfr \n",
      "422.119(b)(1)(i), (1)(ii), and (2)(i); 42 cfr 431.60(b)(1) and (2); 42 \n",
      "cfr 457.730(b)(1) and (2); and, 45 cfr 156.221(b)(1)(i) and (ii) we are \n",
      "removing the word ``standardized'' to avoid confusion as the standards \n",
      "are specified elsewhere. we are finalizing the regulation text at 42 \n",
      "cfr 422.119(b)(1)(iii), 431.60(b)(3), and 457.730(b)(3), with the verb \n",
      "``maintains'' in place of the verb ``manages'' in order to more closely \n",
      "align with the relevant hipaa privacy rule requirement. we are \n",
      "finalizing a technical correction at 42 cfr 431.60(b)(2) and 42 cfr \n",
      "457.730(b)(2) to replace ``within one (1) business day'' with ``no \n",
      "later than 1 business day after'' to be consistent across payers. we \n",
      "have added text to specifically indicate that the technical \n",
      "requirements at 42 cfr 422.119(c), 431.60(c), and 457.730(c), and 45 \n",
      "cfr 156.221(c) apply to the api under paragraph (a) of the respective \n",
      "sections. we are finalizing at 42 cfr 422.119(c)(2), 431.60(c)(2), \n",
      "457.730(c)(2), and 45 cfr 156.221(c)(2), to include additional text to \n",
      "explicitly require, as described in the cms interoperability and \n",
      "patient access proposed rule (84 fr 7635) the requirement to also \n",
      "update (as appropriate) the api to ensure it functions properly and \n",
      "includes assessments to verify an individual enrollee or their personal \n",
      "representative can only access claims and encounter data or other phi \n",
      "that belongs to that enrollee. in addition, we are removing the word \n",
      "``minimally'' from this regulation text in order to ensure it is clear \n",
      "that privacy and security features must be reasonable and appropriate, \n",
      "consistent with the requirements of hipaa privacy and security rules, \n",
      "42 cfr parts 2 and 3, and other applicable law protecting privacy and \n",
      "security of individually identifiable health information. we are making \n",
      "a technical\n",
      "\n",
      "[[page 25559]]\n",
      "\n",
      "change for readability only at 42 cfr 422.119(c)(3) and (4)(ii)(c), \n",
      "431.60(c)(3) and (4)(ii)(c), 438.242(b)(5), 457.730(c)(3) and \n",
      "(4)(ii)(c), 457.1233(d)(1), and 45 cfr 156.221(c)(3) and (4)(ii)(c). in \n",
      "addition, we have refined the language at 42 cfr 422.119(g), 431.60(f), \n",
      "and 457.730(f), and 45 cfr 156.221(g) to state the payer must make \n",
      "education materials available ``in an easily accessible location on its \n",
      "public website,'' and at 42 cfr 422.119(g)(1), 431.60(f)(1), and \n",
      "457.730(f)(1), and 45 cfr 156.221(g)(1) to include a reference to \n",
      "``secondary uses of data.''\n",
      "    at 42 cfr 422.119(d), 431.60(d), 457.730(d), and 45 cfr 156.221(d), \n",
      "we are finalizing additional text to specify that ``publicly \n",
      "accessible'' means that any person using commonly available technology \n",
      "to browse the internet could access the information without any \n",
      "preconditions or additional steps, such as a fee for access to the \n",
      "documentation; a requirement to receive a copy of the material via \n",
      "email; a requirement to register or create an account to receive the \n",
      "documentation; or a requirement to read promotional material or agree \n",
      "to receive future communications from the organization making the \n",
      "documentation available.\n",
      "    in the cms interoperability and patient access proposed rule, the \n",
      "criteria and process for assessing unacceptable risk to a payers system \n",
      "was explained as part of the payer's responsibilities under the hipaa \n",
      "security rule (84 fr 7635). at 42 cfr 422.119(e)(1), 431.60(e)(1), \n",
      "438.242(b)(5), 457.730(e)(1), and 457.1233(d), as well as 45 cfr \n",
      "156.221(e)(1) we are finalizing additional text to note that payers \n",
      "should determine risk consistent with its security risk analysis under \n",
      "45 cfr part 164 subpart c to indicate the specific section of the hipaa \n",
      "security rule implicated here. we are modifying 45 cfr 156.221(h)(2) to \n",
      "remove the reference to ``qualified employers'' and 45 cfr 156.221(i) \n",
      "to include applicability to ``individual market'' ffes to exclude \n",
      "issuers offering plans through the ff-shops. finally, we are finalizing \n",
      "for ma organizations at 42 cfr 422.119(h), medicaid ffs programs at 42 \n",
      "cfr 431.60(g), medicaid managed care plans at 42 cfr 438.62(b)(1)(vii), \n",
      "chip ffs programs at 42 cfr 457.730(g), chip managed care entities at \n",
      "42 cfr 457.1233(d), that beginning january 1, 2021, and for qhp issuers \n",
      "on the ffes at 45 cfr 156.221(i) beginning with plan years beginning on \n",
      "or after january 1, 2021, these payers must make available through the \n",
      "patient access api data they maintain with a date of service on or \n",
      "after january 1, 2016, consistent with the payer-to-payer data exchange \n",
      "requirement discussed in section v. of this final rule.\n",
      "\n",
      "iv. api access to published provider directory data provisions, and \n",
      "analysis of and responses to public comments\n",
      "\n",
      "a. interoperability background and use cases\n",
      "\n",
      "    in section iii. of the cms interoperability and patient access \n",
      "proposed rule (84 fr 7626 through 7639), we focused on patient access \n",
      "to their own data through a standardized, transparent api--the patient \n",
      "access api. as part of this proposal, we discussed and sought comment \n",
      "on requiring payers at 42 cfr 422.119(b)(1)(iii) and (b)(2)(ii) for ma \n",
      "organizations, 42 cfr 431.60(b)(3) for medicaid ffs programs, 42 cfr \n",
      "438.242(b)(6)(ii) for medicaid managed care plans, 42 cfr 457.730(b)(3) \n",
      "for chip ffs programs, and 42 cfr 457.1233(d)(2)(ii) for chip managed \n",
      "care entities to provide their provider directory information through \n",
      "that same patient access api. in addition, the proposed rule sought \n",
      "comment on making the provider directory information available through \n",
      "a public-facing standards-based api. as we discussed in the cms \n",
      "interoperability and patient access proposed rule (84 fr 7639), making \n",
      "provider directory information available through a public-facing api \n",
      "raised different issues than api access proposals related to patient \n",
      "data. based on our consideration of public comments summarized and \n",
      "responded to below, and in an effort to avoid duplicative effort and \n",
      "additional burden resulting from having the provider directory \n",
      "information included in both the patient access api and the provider \n",
      "directory api, we are finalizing the requirement for a public-facing \n",
      "provider directory api at 42 cfr 422.120 for ma organizations, 42 cfr \n",
      "431.70 for medicaid ffs programs, 42 cfr 438.242(b)(6) for medicaid \n",
      "managed care plans, 42 cfr 457.760 for chip ffs programs, and 42 cfr \n",
      "457.1233(d)(3) for chip managed care entities, but we will not finalize \n",
      "our proposal to also provide access to this provider directory \n",
      "information through the patient access api at 422.119, 42 cfr 431.60, \n",
      "42 cfr 438.242(b)(6), 42 cfr 457.730, and 42 cfr 457.1233(d)(2), \n",
      "respectively.\n",
      "    provider directories make key information about health care \n",
      "professionals and organizations available to help consumers identify a \n",
      "provider when they enroll in an insurance plan or as new health needs \n",
      "arise. for example, such information might include hours of operation, \n",
      "languages spoken, specialty/services, and availability for new \n",
      "patients. provider directories also function as a resource used by the \n",
      "provider community to discover contact information of other providers \n",
      "to facilitate referrals, transitions of care, and care coordination for \n",
      "enrollees.\n",
      "    as discussed in the cms interoperability and patient access \n",
      "proposed rule, the current applicable regulations for ma plans (42 cfr \n",
      "422.111) and medicaid and chip managed care plans (42 cfr \n",
      "438.10(e)(2)(vi) and (h) and 457.1207, respectively) already require \n",
      "that provider directories be made available to enrollees and potential \n",
      "enrollees in hard copy and on the plan's website. section 1902(a)(83) \n",
      "of the act requires state medicaid agencies to publish a directory of \n",
      "certain physicians on the public website of the state agency. a \n",
      "regulation for qhp issuers (45 cfr 156.230(b)) requires public access \n",
      "to the qhp's provider directory in addition to distribution and access \n",
      "for enrollees. in addition to mandating that this information be \n",
      "accessible, the current regulations also address the content of such \n",
      "directories and the format and manner in which ma plans, medicaid \n",
      "managed care plans, chip managed care entities, and qhp issuers on the \n",
      "ffes must make the information available.\n",
      "    making this required provider directory information available to \n",
      "enrollees and prospective enrollees through an api could support \n",
      "development of third-party software applications, or apps, (whether \n",
      "standalone or integrated with providers' ehr technology) that would \n",
      "pull in current information about available providers to meet \n",
      "enrollees' current needs. broad availability of provider directory data \n",
      "through interoperable api technology would also allow for innovation in \n",
      "applications or other services that help enrollees and prospective \n",
      "enrollees to more easily compare provider networks while they are \n",
      "considering their options for changing health plans. finally, we noted \n",
      "in our proposal that a consistent, fhir-based api-driven approach to \n",
      "making provider directory data accessible could reduce provider burden \n",
      "by enabling payers to more widely share basic information about the \n",
      "providers in their networks, such as provider type, specialty, contact \n",
      "information, and whether or not they are accepting new patients.\n",
      "\n",
      "[[page 25560]]\n",
      "\n",
      "b. broad api access to provider directory data\n",
      "\n",
      "    in sections iii.c. and iv. of the cms interoperability and patient \n",
      "access proposed rule (84 fr 7633, 7639 through 7642), we proposed to \n",
      "require at 42 cfr 422.119(b)(1)(iii) for ma organizations, 42 cfr \n",
      "431.60(b)(3) for medicaid ffs programs, 42 cfr 438.242(b)(6)(ii) for \n",
      "medicaid managed care plans, 42 cfr 457.730(b)(3) for chip ffs \n",
      "programs, and 42 cfr 457.1233(d)(2)(ii) for chip managed care entities \n",
      "that payers subject to the proposed rule make standardized information \n",
      "about their provider networks available through api technology, so that \n",
      "the public, including third-party app developers and patients, could \n",
      "access and use that information, including republishing the information \n",
      "or information derived from that information in a user-friendly way. as \n",
      "discussed in the preamble of the cms interoperability and patient \n",
      "access proposed rule, we sought comment on making provider directory \n",
      "information more generally available (84 fr 7639 through 7642). we \n",
      "discussed requiring that the api technology conform to the api \n",
      "standards proposed by onc for hhs adoption at 45 cfr 170.215 (84 fr \n",
      "7589). currently, because qhp issuers on the ffes are already required \n",
      "to make provider directory information available in a specified, \n",
      "machine-readable format,\\42\\ we did not propose that qhp issuers would \n",
      "have to make provider directory information available through an api. \n",
      "however, we requested information regarding whether this same \n",
      "requirement should apply to qhp issuers, or if such a requirement would \n",
      "be overly burdensome for them. we thank commenters for their insights \n",
      "on this request for information and are reviewing the comments received \n",
      "for inclusion in potential future rulemaking.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\42\\ available at <a href=\"http://cmsgov.github.io/qhp-provider-formulary-apis/developer/index.html\">http://cmsgov.github.io/qhp-provider-formulary-apis/developer/index.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we noted in the preamble of the proposed rule that, since this \n",
      "provider directory information is already available and accessible to \n",
      "enrollees without cost to them under existing law, this information \n",
      "should be as accessible through the api as it is required to be when \n",
      "posted on the organization's websites. therefore, we proposed that the \n",
      "technical standards proposed (now finalized) by hhs in the onc 21st \n",
      "century cures act final rule (published elsewhere in this issue of the \n",
      "federal register) at 45 cfr 170.215 (specifically at paragraphs (a)(3) \n",
      "and (b)) that are specific to authenticating users and confirming \n",
      "individuals' authorization or request to disclose their personal \n",
      "information to a specific application through an api, namely the smart \n",
      "ig (using the oauth 2.0 standard) and openid connect core 1.0, should \n",
      "not apply to our proposed public access to provider directory \n",
      "information through apis (84 fr 7639). we noted that while we were \n",
      "aware the organization will nevertheless need to take appropriate steps \n",
      "to mitigate the potential security risks of allowing any application to \n",
      "connect to the api through which it offers provider directory access, \n",
      "we emphasized that these steps should be appropriate to the level of \n",
      "risk associated with the specific use case of accessing otherwise \n",
      "public information through api technology. we also noted that those \n",
      "wishing to access these data should not be unduly burdened by security \n",
      "protocols that are not necessary to provide the appropriate degree of \n",
      "protection for the organization's systems and data.\n",
      "    as referenced in sections ii. and iii. of the cms interoperability \n",
      "and patient access proposed rule (84 fr 7618 through 7639), we intended \n",
      "to develop additional guidance, incorporating feedback from industry \n",
      "that provides implementation best practices relevant to fhir-conformant \n",
      "standards-based apis to help organizations subject to the requirements \n",
      "proposed in this rulemaking. to that end, we solicited comment on what \n",
      "specific resources would be most helpful to organizations implementing \n",
      "apis under requirements proposed in the proposed rule.\n",
      "    we summarize all public comments we received on making provider \n",
      "directory information available through an api--in terms of requiring a \n",
      "dedicated, publicly accessible provider directory api and more \n",
      "generally sharing provider directory information via an api, including \n",
      "as proposed under the patient access api discussed in section iii. of \n",
      "this final rule and provide our responses.\n",
      "    comment: many commenters supported a requirement for ma \n",
      "organizations, state medicaid and chip ffs programs, medicaid managed \n",
      "care plans, and chip managed care entities to make standardized \n",
      "information about their provider networks available through api \n",
      "technology to current enrollees, prospective enrollees, and possibly \n",
      "the general public. commenters stated that they believe accurate \n",
      "provider directory data will improve transparency and accessibility of \n",
      "information regarding a provider's network status, which will help with \n",
      "efforts to address surprise billing and other coverage issues related \n",
      "to whether providers are in or out-of-network.\n",
      "    response: we thank commenters for their support. appreciating that \n",
      "provider information is already publicly available, and unlike the \n",
      "other information included in the patient access api discussed in \n",
      "section iii. of this final rule, is of a less sensitive nature, to \n",
      "avoid potential confusion and reduce burden resulting from having the \n",
      "provider directory information included in both the patient access api \n",
      "and the provider directory api, we are only requiring that one api--the \n",
      "provider directory api--provide access to provider directory \n",
      "information. as a result, we are finalizing additional regulation text \n",
      "to require the provider directory api at 42 cfr 422.120 for ma \n",
      "organizations; at 42 cfr 431.70 for medicaid state agencies; at 42 cfr \n",
      "438.242(b)(6) for managed care plans; at 42 cfr 457.760 for chip state \n",
      "agencies; and at 42 cfr 457.1233(d)(3) for chip managed care entities. \n",
      "this provider directory api must include the same information about the \n",
      "provider directory as originally proposed for the patient access api. \n",
      "specifically, the provider directory api must include provider \n",
      "directory data on a payer's network of contracted providers, including \n",
      "names, addresses, phone numbers, and specialties, updated no later than \n",
      "30 calendar days after a payer receives provider directory information \n",
      "or updates to provider directory information. we are finalizing the \n",
      "applicable regulation text with the phrase ``complete and accurate'' to \n",
      "emphasize our intent that the directory data meet this standard. for ma \n",
      "organizations that offer ma-pd plans, the provider directory api must \n",
      "also make available pharmacy directory data, we are specifying that the \n",
      "plans must make available, at a minimum, pharmacy name, address, phone \n",
      "number, number of pharmacies in the network, and mix (specifically the \n",
      "type of pharmacy, such as ``retail pharmacy''). as with the provider \n",
      "directory information, we are finalizing that pharmacy directory \n",
      "information must be updated no later than 30 calendar days after the ma \n",
      "organization that offers the ma-pd plan receives pharmacy directory \n",
      "information or updates to pharmacy directory information.\n",
      "    comment: some commenters disagreed with the proposal. they stated \n",
      "that payers are already required to make this information available and \n",
      "this proposal could result in unnecessary duplication of effort and \n",
      "additional costs. one commenter suggested cms provide an exemption for \n",
      "payers that are\n",
      "\n",
      "[[page 25561]]\n",
      "\n",
      "already providing this information in a manner that aligns with the \n",
      "requirements in the proposed rule.\n",
      "    response: we appreciate the commenters' concern about potentially \n",
      "duplicative effort. while we understand that different payers are \n",
      "already required to make this information available in a machine \n",
      "readable format or on a public website according to the different rules \n",
      "associated with each program, we believe that making this information \n",
      "available through a standardized api will bring additional benefits to \n",
      "enrollees and prospective enrollees by making it easier for developers \n",
      "to incorporate this information into consumer-facing applications. we \n",
      "note that we did not propose to extend the requirement regarding \n",
      "provider directory information to qhp issuers on the ffes, as these \n",
      "issuers are already required to make provider directory information \n",
      "available according to a specific standard for the electronic transfer \n",
      "of this information, as discussed in the cms interoperability and \n",
      "patient access proposed rule (84 fr 7633).\n",
      "    comment: many commenters raised concerns about the accuracy of \n",
      "provider directory information that would be available through the api, \n",
      "and how these inaccuracies can have a negative impact on consumers. one \n",
      "commenter stated that there is a high prevalence of inaccurate provider \n",
      "directories issued by ma organizations, in particular, and for other \n",
      "public and private payers, generally, and that this can bring into \n",
      "question the adequacy and validity of a network. another noted that \n",
      "inaccurate provider directories have also resulted in patients \n",
      "receiving surprise bills as a result of seeing an out-of-network \n",
      "physician. commenters expressed concern that making provider directory \n",
      "information more accessible through an api could exacerbate the impact \n",
      "of inaccuracies resulting in conflicting and confusing information for \n",
      "consumers, for instance, where an enrollee participates in two plans \n",
      "and receives different information about the same provider from each.\n",
      "    commenters discussed a variety of steps that cms should take in \n",
      "concert with the proposal to ensure that provider directory information \n",
      "made available through the api is tested to ensure it is current, \n",
      "correct, and accurate. one commenter suggested cms require payers to \n",
      "provide api vendors with accurate provider directory information.\n",
      "    response: we appreciate commenters' concerns and thank the \n",
      "commenters for their suggestions. we have taken a number of steps to \n",
      "improve the accuracy of provider directory information for plans \n",
      "subject to direct regulation by cms, such as implementing a process to \n",
      "audit directory information with ma organizations to identify \n",
      "deficiencies in an effort to increase data accuracy (for more \n",
      "information see <a href=\"https://www.cms.gov/medicare/health-plans/managedcaremarketing/downloads/provider_directory_review_industry_report_round_3_11-28-2018.pdf\">https://www.cms.gov/medicare/health-plans/managedcaremarketing/downloads/provider_directory_review_industry_report_round_3_11-28-2018.pdf</a>). we \n",
      "will take the suggestions provided into consideration as we continue \n",
      "this effort. we encourage all enrollees to check with a new provider \n",
      "about network participation to avoid surprises and continue to explore \n",
      "ways to work with the payers that we directly regulate (like ma \n",
      "organizations) to improve the accuracy of directories.\n",
      "    we are finalizing regulation text on the provider directory api at \n",
      "42 cfr 422.120(b), 431.70(b), 438.242(b)(6), 457.760(b), and \n",
      "457.1233(d)(3) to require that accurate and complete provider directory \n",
      "information be made available through the api. we believe that this \n",
      "language will clarify our expectation that payers take steps to ensure \n",
      "provider directory information made available through the api \n",
      "accurately reflects the current providers within the payer's network.\n",
      "    commenter: several commenters responded to our proposal that \n",
      "impacted payers update provider directory information made available \n",
      "through the api to current and prospective enrollees within 30 days of \n",
      "receiving an update to their directory information. the commenters \n",
      "suggested that cms should decrease the amount of time allowed for \n",
      "updates; for instance, one commenter suggested that cms should require \n",
      "that provider directory information is updated within 48 hours of a \n",
      "change, while another recommended directory updates occur in real time, \n",
      "or on a regular basis as frequently as possible.\n",
      "    some commenters who supported the requirement that provider \n",
      "directories be publicly available through api technology specifically \n",
      "expressed concerns with how frequently directories must be updated in \n",
      "the case of medicaid and chip programs. one commenter recommended that \n",
      "the clock for the 30-day requirement begins from the date the state \n",
      "provides the information to the medicaid or chip managed care plan. \n",
      "another commenter recommended that entities should be required to \n",
      "update provider directories in real-time.\n",
      "    response: we appreciate commenters' suggestions, and agree that \n",
      "more frequent updates of the provider directory information made \n",
      "available through the api could help to increase the accuracy of this \n",
      "information. our proposed 30-day time frame was not intended to \n",
      "preclude payers from updating the information available via the api on \n",
      "a shorter timeframe, or from making updates in real time. however, we \n",
      "understand that payers may have different operational processes for \n",
      "making updates to their provider directories and are seeking to set a \n",
      "minimum floor for how frequently information available through the api \n",
      "must be updated. this is consistent with timeframes for other updates \n",
      "some of these payers are required to make. for instance, medicaid \n",
      "managed care plans must update paper provider directories monthly and \n",
      "electronic provider directories no later than 30 days after the plan \n",
      "receives the updated information under sec.  438.10(h)(3).\n",
      "    the provider directory api regulations finalized here require that \n",
      "state medicaid and chip agencies, and managed care plans, make \n",
      "available through the api provider directory information no later than \n",
      "30 calendar days after the state or managed care plan receives the \n",
      "provider directory information or updates to the provider directory \n",
      "information. we confirm that the state or managed care plan must make \n",
      "the provider directory information available through the api within 30 \n",
      "calendar days of receiving the information. this timeframe for managed \n",
      "care plans is consistent with the requirement in sec.  438.10(h)(3) for \n",
      "medicaid managed care plans, which applies to chip managed care \n",
      "entities under sec.  457.1207.\n",
      "    we decline to require updates to provider directories in real-time \n",
      "as we do not believe that such a timeframe is operationally feasible \n",
      "for ma organizations, states or medicaid and chip managed care plans at \n",
      "this time. we are finalizing our proposal that ma organizations, state \n",
      "medicaid and chip ffs programs, medicaid managed care plans, and chip \n",
      "managed care entities update provider directory information made \n",
      "available through this api within 30 days of receiving a change as \n",
      "proposed.\n",
      "    comment: several commenters believe that, in order to increase the \n",
      "accuracy of provider directory data, cms should take steps to hold \n",
      "providers responsible for the accuracy of their provider directory \n",
      "information. one commenter suggested cms require health care providers \n",
      "to update their information with a centralized entity, for instance a \n",
      "trusted health information exchange, rather than looking to impacted \n",
      "payers to include these mandates in their contracts with\n",
      "\n",
      "[[page 25562]]\n",
      "\n",
      "providers. another suggested that cms should require providers to \n",
      "submit rosters to cms each month indicating which health plans they \n",
      "contract with, enabling cms to validate information provided through \n",
      "the proposed api. another commenter suggested cms ensure that cms-\n",
      "regulated payers are provided with updated provider information in a \n",
      "timely manner by making such reporting requirements a condition of \n",
      "participation in medicare.\n",
      "    response: we appreciate commenters' suggestions, and agree that \n",
      "providers have an important role to play in ensuring that provider \n",
      "directory information about them, provided to, and used by the payers \n",
      "with which they contract or participate, is up-to-date. while we did \n",
      "not include any proposals in this rulemaking specifically focused on \n",
      "provider responsibility for updating the information to be made \n",
      "available through the proposed api, we will continue to work with \n",
      "federal and industry partners to identify opportunities to improve the \n",
      "accuracy of provider directory information across the health care \n",
      "system.\n",
      "    comment: several commenters noted that a centralized repository \n",
      "that can serve as a ``source of truth'' for provider directory \n",
      "information is needed to ensure accuracy, and urged cms to support work \n",
      "across stakeholders for such an approach. one commenter noted that \n",
      "health information exchanges (hies) could help payers to update their \n",
      "information through access to the directories that hies use for \n",
      "clinical data exchange.\n",
      "    response: we thank commenters for their input. our policy is \n",
      "focused around payers making provider directory information available \n",
      "through apis to provide greater access to specific information on the \n",
      "providers in their networks. however, we believe entities focused on \n",
      "aggregating provider directory information can serve an important role, \n",
      "and we encourage payers to work with partners that maintain this \n",
      "information to improve accuracy.\n",
      "    comment: several commenters suggested additional information for \n",
      "inclusion as part of the provider directory information made available \n",
      "through the api for current and prospective enrollees (in addition to \n",
      "provider names, addresses, phone numbers, and specialties), such as \n",
      "npis for individual and group providers, practice group name, health \n",
      "system name, as well as the specific plan(s) and tiers a provider \n",
      "participates in. one commenter also suggested including minimum \n",
      "provider demographics to be included in the clinical and administrative \n",
      "transactions to ensure accurate provider matching; whether the provider \n",
      "is accepting new patients; information about which providers are in-\n",
      "network for a plan by geography and/or specialty regardless of whether \n",
      "the individual is a member of a particular plan or is researching plan \n",
      "options; and which clinicians are in-network for care coordination and \n",
      "plan switching purposes.\n",
      "    response: we appreciate commenters' suggestions and agree that this \n",
      "additional information may be helpful to consumers. however, at this \n",
      "time we are seeking to minimize the burden for the regulated payers \n",
      "that must comply with this proposal, and have sought to identify a \n",
      "minimum set of provider directory information that aligns with existing \n",
      "requirements applicable to ma organizations (including ma organizations \n",
      "that offer ma-pd plans), state medicaid and chip ffs programs, medicaid \n",
      "managed care plans, and chip managed care entities regarding such \n",
      "directories. we do encourage payers to explore how they can make \n",
      "additional provider directory data available through the api to most \n",
      "benefit current and prospective enrollees. also, we note that the \n",
      "requirements in this final rule set out the minimum requirements; \n",
      "payers are strongly encouraged to go beyond that minimum, if and as \n",
      "possible, to make useful information available for their enrollees and \n",
      "beneficiaries.\n",
      "    comment: one commenter who supported our proposal also urged cms to \n",
      "take additional steps to make provider directories more accessible to \n",
      "enrollees, for instance by integrating a provider directory in future \n",
      "iterations of plan finder for ma plans, and ensuring the directory data \n",
      "is accurate and up to date.\n",
      "    response: we thank the commenter for the suggestions. we will take \n",
      "these suggestions into consideration.\n",
      "    comment: several commenters addressed issues with technical \n",
      "standards for provider directory information, with several stating that \n",
      "appropriate standards for making this information available through an \n",
      "api are still emerging. for instance, one commenter noted that current \n",
      "provider directory standards were written for fhir release 3 and that \n",
      "the standard has not been adopted by the field. the commenter stated \n",
      "that before cms requires payers to make provider directory information \n",
      "available via a standards-based api, more work is needed to build the \n",
      "provider directory specification in fhir release 4.\n",
      "    several commenters suggested that cms should delay implementing \n",
      "this proposal, proposed to be applicable starting january 1, 2020, \n",
      "until stakeholders have been able to establish consensus-based \n",
      "standards for the creation and display of directory information. one \n",
      "commenter encouraged cms to develop a voluntary, multi-stakeholder \n",
      "partnership to establish data content fhir-based standards related to \n",
      "provider directories and then wait to establish the timeframe for \n",
      "provider directory data updates until the development of these fhir-\n",
      "based standards are completed.\n",
      "    response: we appreciate commenters' concerns, and agree that \n",
      "updated fhir-based provider directory implementation guidance is \n",
      "important for implementation of this policy. we confirm here that hl7 \n",
      "fhir release 4.0.1--the api standard adopted at 45 cfr 170.215 and \n",
      "which must be used under our provider directory api requirement--\n",
      "provides a base standard for moving information through an api. the \n",
      "basic information (name, phone number, address, and specialty) required \n",
      "for this provider directory api can all be represented through fhir \n",
      "release 4.0.1. additional implementation guidance will provide \n",
      "additional information for how to use the fhir release 4.0.1 base \n",
      "standard to make provider directory information available and ensure \n",
      "greater uniformity in implementation and reduce implementation burden \n",
      "for payers. as noted in section iii. of this final rule, we have been \n",
      "working with hl7 and partners to ensure the necessary consensus-based \n",
      "standards and associated guidance are available so that impacted payers \n",
      "can consistently implement all of the requirements included in this \n",
      "final rule. we are providing a link to a specific fhir release 4.0.1 \n",
      "implementation guide and reference implementation for all interested \n",
      "payers for the provider directory api that provide valuable guidance to \n",
      "further support sharing the needed data using the required standards: \n",
      "<a href=\"https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index\">https://www.cms.gov/regulations-and-guidance/guidance/interoperability/index</a>. though not mandatory, using this guidance will lower payer \n",
      "burden and support consistent implementation of the fhir release 4.0.1 \n",
      "apis.\n",
      "    appreciating the time needed for payers to build, implement, and \n",
      "test these apis, we are providing additional time for implementation, \n",
      "and are finalizing january 1, 2021 as the implementation date for the \n",
      "provider directory api for all payers subject to this requirement. \n",
      "appreciating the value of making this information publicly accessible, \n",
      "we do encourage payers to\n",
      "\n",
      "[[page 25563]]\n",
      "\n",
      "implement this provider directory api as soon as they are able. we are \n",
      "requiring at 42 cfr 422.120 for ma organizations, at 42 cfr 431.70 for \n",
      "medicaid state agencies, at 42 cfr 438.242(b)(6) for medicaid managed \n",
      "care plans, at 42 cfr 457.760 for chip state agencies, and at 42 cfr \n",
      "457.1233(d)(3) for chip managed care entities that these payers make \n",
      "the provider directory api accessible via a public-facing digital \n",
      "endpoint on their website. we will check a random sample of payer \n",
      "websites for links to these publicly accessible apis, starting in \n",
      "january 2021 to evaluate compliance.\n",
      "    comment: one commenter suggested that, as cms already requires \n",
      "provider directory information to be made available online by payers \n",
      "subject to this rule, for interoperability transactions cms should \n",
      "require use of a standard described as ``the hipaa 274 transaction.'' \n",
      "the commenter stated that the metadata defined within this transaction \n",
      "can drive a consistent payload for an api to support provider directory \n",
      "information sharing.\n",
      "    response: we appreciate the commenter's suggestion, but at this \n",
      "time we are finalizing requirements for provider directory information \n",
      "to be available through an api using the standards at 45 cfr 170.215, \n",
      "including, fhir release 4.0.1 standards finalized by hhs in the onc \n",
      "21st century cures act final rule (published elsewhere in this issue of \n",
      "the federal register) to consistently align all various api formats \n",
      "throughout the rule with a single modern standard capable of meeting \n",
      "all requirements. cms understands that some information within the x12 \n",
      "274 transaction (healthcare provider information transaction set for \n",
      "use within the context of an electronic data interchange (edi) \n",
      "environment) may provide the basic provider information to support an \n",
      "api. hhs, however, has not adopted the x12 274 transaction standard \n",
      "under hipaa or for any other use. moreover, the required availability \n",
      "of a plan's entire provider directory via an api is not a hipaa \n",
      "transaction that has been defined or associated with a specific \n",
      "transaction under hipaa. we believe that using fhir release 4.0.1 for \n",
      "the purpose of this provider directory api will provide greater long \n",
      "term flexibility for payers subject to this rule, allowing them the \n",
      "ability to meet minimum requirements, and extend beyond these \n",
      "requirements based on the industry's diverse and evolving needs \n",
      "surrounding provider directories, while reducing impact on those who \n",
      "may not be ready to receive additional information beyond the minimum \n",
      "set of data required by this final rule.\n",
      "    comment: one commenter requested that cms ensure public health \n",
      "agencies are also able to access provider directory information made \n",
      "available through the api, while another commenter requested that \n",
      "approved agents and brokers be granted access to this information.\n",
      "    response: under this final rule, the provider directory api must be \n",
      "publicly accessible, so that any third party can access an impacted \n",
      "payer's provider directory information. our regulation text reflects \n",
      "this by requiring that the provider directory api be accessible via a \n",
      "public-facing digital endpoint on the applicable payer's website. the \n",
      "value of making this information available via an api is that third-\n",
      "party developers will be able to access it to make it available in \n",
      "valuable and useful ways for all interested stakeholders. we therefore \n",
      "anticipate that public health agencies, agents, and brokers, and any \n",
      "other member of the public would be able to access these data via \n",
      "third-party apps.\n",
      "    comment: several commenters suggested cms require payers to include \n",
      "other types of non-physician professionals within their provider \n",
      "directories, such as nurse practitioners, certified registered nurse \n",
      "anesthetists, physical therapists, and post-acute care providers. \n",
      "commenters stated that including additional qualified licensed non-\n",
      "physician providers could help increase patient access to care.\n",
      "    response: we appreciate commenters' suggestions. we did not propose \n",
      "to change the parameters of the information required to be included in \n",
      "provider directories for the payers subject to the provider directory \n",
      "api requirement here. existing requirements for paper and on-line \n",
      "provider directories, such as those in 42 cfr 422.111 and 438.10(h), \n",
      "are not changed or limited by this final rule. instead, our api \n",
      "proposals and this final rule focus on making certain payers (that is, \n",
      "ma organizations, state medicaid and chip ffs programs, medicaid \n",
      "managed care plans, and chip managed care entities) share provider \n",
      "directory information through an api. how ``provider'' is defined in \n",
      "this context is outside the scope of this regulation.\n",
      "    comment: one commenter recommended that cms amend the api \n",
      "requirement to also include fhir endpoint information for providers as \n",
      "part of provider directory information, to ensure access to regional/\n",
      "national directories in addition to the current partial ones.\n",
      "    response: we agree with commenters that fhir endpoint information \n",
      "is important to improve interoperability across providers. we discuss \n",
      "fhir endpoints in section ix. of this final rule. for this provider \n",
      "directory api, we have focused on a minimum set of information of \n",
      "primary interest to patients and typically found in provider \n",
      "directories. however, we encourage payers to consider including other \n",
      "data elements that may add value to the provider directory api. we may \n",
      "consider expanding this minimum set of information in potential future \n",
      "rulemaking.\n",
      "    comment: one commenter suggested that cms impose penalties on plans \n",
      "that do not comply with the provider directory requirement.\n",
      "    response: we thank the commenter for this suggestion. we did not \n",
      "propose to establish additional penalties for noncompliance with the \n",
      "requirement to make provider directory information available through an \n",
      "api; however, we note that the requirement to make provider directory \n",
      "information available through an api will be a requirement for ma \n",
      "organizations, medicaid managed care plans and chip managed care \n",
      "entities to fulfill under their contracts in their respective programs. \n",
      "therefore, existing enforcement authority for ensuring compliance with \n",
      "those contracts will apply. further, the api requirements, including \n",
      "the provider directory components of the required api(s) will be \n",
      "required for state medicaid and chip agencies operating ffs medicaid \n",
      "programs and chips.\n",
      "    final action: after consideration of the comments received, and for \n",
      "the reasons outlined in our response to these comments and in the cms \n",
      "interoperability and patient access proposed rule, we are finalizing \n",
      "regulations to require that ma organizations, medicaid and chip ffs \n",
      "programs, medicaid managed care plans, and chip managed care entities \n",
      "make standardized information about their provider networks available \n",
      "via a fhir-based api conformant with the standards finalized by hhs in \n",
      "the onc 21st century cures act final rule (published elsewhere in this \n",
      "issue of the federal register) at 45 cfr 170.215 (including fhir \n",
      "release 4.0.1), excluding the security protocols related to user \n",
      "authentication and authorization and any other protocols that restrict \n",
      "the availability of this information to anyone wishing to access it. at \n",
      "a minimum, these payers must make available via the provider directory \n",
      "api provider names, addresses, phone numbers, and specialties. for ma \n",
      "organizations that offer ma-pd plans, we are specifying that they must \n",
      "make available, at a minimum, pharmacy\n",
      "\n",
      "[[page 25564]]\n",
      "\n",
      "directory data, including the pharmacy name, address, phone number, \n",
      "number of pharmacies in the network, and mix (specifically the type of \n",
      "pharmacy, such as ``retail pharmacy''), updating the regulation text \n",
      "from the proposed rule, which simply stated ``number, mix, and \n",
      "addresses of network pharmacies''. all directory information must be \n",
      "available through the api within 30 calendar days of a payer receiving \n",
      "the directory information or an update to the directory information. we \n",
      "note we have also revised the proposed regulation text for making \n",
      "directory information available through an api to specify consistently \n",
      "that the directory information must be complete and accurate and that \n",
      "updates must be made in ``calendar'' days.\n",
      "    the provider directory api is being finalized at 42 cfr 422.120 for \n",
      "ma organizations, at 42 cfr 431.70 for medicaid state agencies, at 42 \n",
      "cfr 438.242(b)(6) for medicaid managed care plans, at 42 cfr 457.760 \n",
      "for chip state agencies, and at 42 cfr 457.1233(d)(3) for chip managed \n",
      "care entities. we are finalizing that access to the published provider \n",
      "directory api must be fully implemented by january 1, 2021 for all \n",
      "payers subject to this new requirement. we encourage payers to \n",
      "implement this provider directory api as soon as they are able to make \n",
      "and show progress toward the api requirements in this final rule and to \n",
      "signal their commitment to making the information that will empower \n",
      "their patients easily accessible and usable. under this final rule, ma \n",
      "organizations, medicaid and chip ffs programs, medicaid managed care \n",
      "plans, and chip managed care entities must make the provider directory \n",
      "api accessible via a public-facing digital endpoint on their website to \n",
      "ensure public discovery and access.\n",
      "\n",
      "v. the health information exchange and care coordination across payers: \n",
      "establishing a coordination of care transaction to communicate between \n",
      "plans provisions, and analysis of and responses to public comments\n",
      "\n",
      "    we proposed a new requirement for ma organizations, medicaid \n",
      "managed care plans, chip managed care entities, and qhp issuers on the \n",
      "ffes to require these payers to maintain a process to coordinate care \n",
      "between payers by exchanging, at a minimum, the uscdi at the enrollee's \n",
      "request as specified in the proposed regulation text. instead of \n",
      "specifically proposing use of the uscdi, we proposed use of a content \n",
      "standard adopted by onc at 45 cfr 170.213, which was proposed in a \n",
      "companion proposed rule, the onc 21st century cures act proposed rule \n",
      "as the uscdi (version 1) (84 fr 7441 through 7444). understanding that \n",
      "enrollees' information is already exchanged between plans for use in \n",
      "carrying out various plan functions,\\43\\ payers have experience \n",
      "exchanging, receiving, and incorporating data from other plans into an \n",
      "enrollee's record. we proposed requiring the uscdi data set be \n",
      "exchanged at the enrollee's direction, and when received by a payer, \n",
      "incorporated into the recipient payer's data system. as proposed, upon \n",
      "request from an enrollee, the uscdi data set would have to be sent to \n",
      "another payer that covers the enrollee or a payer identified by the \n",
      "enrollee at any time during coverage or up to 5 years after coverage \n",
      "ends, and the payer would have to receive the uscdi data set from any \n",
      "payer that covered the enrollee within the preceding 5 years. these \n",
      "proposals were intended to support patient directed coordination of \n",
      "care; that is, each of the payers subject to the requirement would be \n",
      "required to, upon an enrollee's request: (1) receive the data set from \n",
      "another payer that had covered the enrollee within the previous 5 \n",
      "years; (2) send the data set at any time during an enrollee's \n",
      "enrollment and up to 5 years later, to another payer that currently \n",
      "covers the enrollee; and (3) send the data set at any time during \n",
      "enrollment or up to 5 years after enrollment has ended to a recipient \n",
      "identified by the enrollee.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\43\\ see office for civil rights. (2016, august 16). 3014-hipaa \n",
      "and health plans--uses and disclosures for care coordination and \n",
      "continuity of care. retrieved from <a href=\"https://www.hhs.gov/hipaa/for-professionals/faq/3014/uses-and-disclosures-for-care-coordination-and-continuity-of-care/index.html\">https://www.hhs.gov/hipaa/for-professionals/faq/3014/uses-and-disclosures-for-care-coordination-and-continuity-of-care/index.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we identified in the proposed rule that this proposal is based on \n",
      "our authority under sections 1856(b) and 1857(e) of the act to adopt \n",
      "standards and contract terms for ma plans; section 1902(a)(4) of the \n",
      "act to adopt methods of administration for state medicaid plans, \n",
      "including requirements for medicaid managed care plans (mcos, pihps, \n",
      "and pahps); section 2101(a) of the act for chip managed care entities \n",
      "(mcos, pihps, and pahps); and section 1311(e)(1)(b) of the affordable \n",
      "care act for qhp issuers on the ffes. we explained in the cms \n",
      "interoperability and patient access proposed rule our belief that the \n",
      "proposal will help to reduce provider burden and improve patient access \n",
      "to their health information through coordination of care between payers \n",
      "(84 fr 7640 through 7642). we also noted that the chip regulations \n",
      "incorporate and apply, through an existing cross-reference at 42 cfr \n",
      "457.1216, the medicaid managed care plan requirements codified at 42 \n",
      "cfr 438.62(b)(1)(vi). therefore, the proposal for medicaid managed care \n",
      "plans described also applied to chip managed care entities even though \n",
      "we did not propose new regulation text in part 457. we proposed that \n",
      "this new requirement would be applicable starting january 1, 2020 for \n",
      "ma organizations, medicaid managed care plans, chip managed care \n",
      "entities, and beginning with plan years beginning on or after january \n",
      "1, 2020 for qhp issuers on the ffes. among other topics related to the \n",
      "proposal, we solicited comments on the proposed date these policies \n",
      "would be applicable.\n",
      "    we proposed to codify this new requirement at 42 cfr 422.119(f) for \n",
      "ma organizations; at 42 cfr 438.62(b)(1)(vi) for medicaid managed care \n",
      "plans (and by extension under existing rules at 42 cfr 457.1216, to \n",
      "chip managed care entities); and at 45 cfr 156.221(f) for qhp issuers \n",
      "on the ffes. the proposed new requirement was virtually identical for \n",
      "ma organizations, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers on the ffes, with modifications in the \n",
      "proposal necessary for specific payer types to account for the program \n",
      "needs of each. the proposed regulation text references the content \n",
      "standard adopted at 45 cfr 170.213, which onc proposed as the uscdi \n",
      "(version 1) data set (84 fr 7441 through 7444). we noted we believed \n",
      "that exchanging this data set would help both enrollees and health care \n",
      "providers coordinate care and reduce administrative burden to ensure \n",
      "that payers provide coordinated high-quality care in an efficient and \n",
      "cost-effective way that protects program integrity. for a full \n",
      "discussion of the benefits we anticipate from this data exchange \n",
      "requirement, see the discussion in the cms interoperability and patient \n",
      "access proposed rule (84 fr 7640).\n",
      "    in addition to the benefits for care coordination at the payer \n",
      "level and reduced provider burden, we noted that once the requested \n",
      "information, as specified by the uscdi standard, was made available to \n",
      "the patient's current plan, the enrollee would have access to multiple \n",
      "years of their health information through the proposed patient access \n",
      "api, discussed in section iii.c. of the cms interoperability and \n",
      "patient access proposed rule and in this final rule. this is the case \n",
      "because the proposal required the receiving payer to incorporate the \n",
      "received data into its records about the patient, therefore making \n",
      "these data the payer maintains, and data available to share with the\n",
      "\n",
      "[[page 25565]]\n",
      "\n",
      "patient via the patient access api. the uscdi data set includes \n",
      "clinical data points essential for care coordination. access to these \n",
      "data would provide the patient with a more comprehensive history of \n",
      "their medical care, helping them to make better informed health care \n",
      "decisions. we sought comment on how plans might combine records and \n",
      "address error reconciliation or other factors in establishing a more \n",
      "longitudinal record for each patient.\n",
      "    we proposed to allow multiple methods for electronic exchange of \n",
      "the information, including use of the apis proposed in section iii. of \n",
      "the cms interoperability and patient access proposed rule (84 fr 7627 \n",
      "through 7639), to allow for patient-mediated exchange of payer \n",
      "information or direct payer-to-payer communication, subject to hipaa \n",
      "requirements, 42 cfr part 2, and other applicable federal and state \n",
      "laws. we noted that we considered requiring the use of the fhir-based \n",
      "api discussed in section iii. of the proposed rule for this information \n",
      "exchange; however, we understood that some geographic areas might have \n",
      "a regional health information exchange (hie) that could coordinate such \n",
      "data transfers for any hie-participating ma plans, medicaid managed \n",
      "care plans, chip managed care entities, and qhp issuers on the ffes \n",
      "that are subject to the proposal. we sought comment on whether it would \n",
      "be beneficial to interoperability and patient care coordination for us \n",
      "to require the use of the fhir-based api otherwise proposed, and \n",
      "whether this should be the only mechanism allowed for this exchange, or \n",
      "whether multiple methods for electronic exchange of the information \n",
      "should be allowed under the proposed policy and whether cms might be \n",
      "able to leverage its program authority to facilitate the data exchanges \n",
      "contemplated by the proposal. we expected enrollees to have constant \n",
      "access to requesting an exchange of data as the proposal would require \n",
      "exchange of the uscdi data set whenever an enrollee makes such a \n",
      "request, which may occur at times other than enrollment or \n",
      "disenrollment. we acknowledged that in some cases payers subject to the \n",
      "proposed requirement may be exchanging patient health information with \n",
      "other payers that are not similarly required to exchange uscdi data \n",
      "sets for enrollees, for example, if a consumer changes their health \n",
      "coverage from a qhp on an ffe to employer-sponsored coverage, and we \n",
      "requested comment on how to support patients and providers in those \n",
      "situations.\n",
      "    we also proposed that a patient should be able to request his or \n",
      "her information from their prior payer up to 5 years after dis-\n",
      "enrollment, which is considerably less than existing data retention \n",
      "policies for some of the payers.\\44\\ further, we proposed that the \n",
      "health information received as part of the uscdi (version 1) data set \n",
      "under our proposal would have to be incorporated into the it and data \n",
      "systems of each payer that receives the uscdi data set under the \n",
      "proposed requirement, such that the enrollee's data would be cumulative \n",
      "and move with the enrollee as he or she changes enrollment. for \n",
      "example, if a patient is enrolled in plan 1 in 2020 and plan 2 in 2021, \n",
      "then requests the data from plan 1 to be sent to plan 2, plan 2 would \n",
      "have at least 2 years (2020 and 2021) of health information for that \n",
      "patient. if the patient moves to plan 3 in 2022, plan 3 should receive \n",
      "both 2020 and 2021 data from plan 2 at the patient's request. while the \n",
      "proposal would require compliance (and thus exchange of these data \n",
      "sets) only by ma plans, medicaid managed care plans, chip managed care \n",
      "entities, and qhp issuers on the ffes, we noted that we hoped that \n",
      "compliance by these payers could be the first step toward adoption and \n",
      "implementation of these standards on a voluntary basis by other payers \n",
      "throughout the health care system.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\44\\ under 42 cfr 422.504(d) and 438.3(u), ma organizations and \n",
      "medicaid managed care plans, and chip plans must retain records for \n",
      "at least 10 years. under 45 cfr 156.705; 45 cfr 155.1210(b)(2), (3) \n",
      "and (5), qhp issuers on the ffes must also retain records for 10 \n",
      "years.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    research indicates that the completeness of a patient record and \n",
      "the availability of up-to-date and relevant health information at the \n",
      "point of care can have a significant impact on patient outcomes.\\45\\ we \n",
      "noted that we believe the proposal for ma organizations, medicaid \n",
      "managed care plans, chip managed care entities, and qhp issuers on the \n",
      "ffes to exchange the uscdi data set in particular scenarios would \n",
      "support improvement in care coordination by allowing for sharing of key \n",
      "patient health information when an enrollee requests it.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\45\\ office of the national coordinator. (2019, june 4). \n",
      "improved diagnostics & patient outcomes. retrieved from <a href=\"https://www.healthit.gov/topic/health-it-and-health-information-exchange-basics/improved-diagnostics-patient-outcomes\">https://www.healthit.gov/topic/health-it-and-health-information-exchange-basics/improved-diagnostics-patient-outcomes</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we proposed that the payers subject to this new requirement would \n",
      "be required to exchange, at a minimum, the data classes and elements \n",
      "included in the content standard proposed to be adopted at 45 cfr \n",
      "170.213 in the onc 21st century cures act proposed rule, specifically, \n",
      "the uscdi (version 1) data set. on behalf of hhs, onc proposed to adopt \n",
      "the uscdi as a standard (84 fr 7441 through 7444), to be codified at 45 \n",
      "cfr 170.213, and the proposed regulation text cross-references this \n",
      "regulation. these data exchanges would provide the enrollee's new payer \n",
      "with a core set of data that could be used to support better care \n",
      "coordination and improved outcomes for the enrollee. we considered \n",
      "requiring plans to exchange all the data that we proposed be available \n",
      "through an api (see section iii. of the cms interoperability and \n",
      "patient access proposed rule (84 fr 7627 through 7639)) but we \n",
      "understood that ingesting data and reconciling errors has challenges \n",
      "and proposed this more limited data set to address those concerns. we \n",
      "sought comment on whether the uscdi data set would be comprehensive \n",
      "enough to facilitate the type of care coordination and patient access \n",
      "described in the proposal, or whether additional data fields and data \n",
      "elements that would be available under the api proposal in section iii. \n",
      "of the cms interoperability and patient access proposed rule (84 fr \n",
      "7627 through 7639) should also be required. for a full discussion of \n",
      "the benefits of the uscdi for this data exchange, see the cms \n",
      "interoperability and patient access proposed rule (84 fr 7641).\n",
      "    we stated that we believed that the proposed requirement would also \n",
      "support dually eligible individuals who are concurrently enrolled in ma \n",
      "plans and medicaid managed care plans. under the proposal, both of the \n",
      "dually eligible individual's payers would be subject to the requirement \n",
      "to exchange that individual's data in the form of the uscdi, which \n",
      "should improve the ability of both payers to coordinate care based on \n",
      "that data, as discussed in the cms interoperability and patient access \n",
      "proposed rule (84 fr 7642). we sought comment on how payers should \n",
      "coordinate care and exchange information for dually eligible \n",
      "individuals. we also sought comment on the associated burden on plans \n",
      "to exchange the uscdi data set under the proposal. in addition, we \n",
      "noted that we were interested in comments about potential legal \n",
      "barriers to exchanging the uscdi data set as would be required under \n",
      "the proposal; for example, whether there were federal, state, local, \n",
      "and tribal laws governing privacy for specific use cases (such as in \n",
      "the care of minors or for certain behavioral health treatments) that \n",
      "would raise additional considerations that we should address in this \n",
      "regulation or in guidance.\n",
      "    we stated that activities related to the proposed requirement could \n",
      "qualify as a quality improvement activity (qia)\n",
      "\n",
      "[[page 25566]]\n",
      "\n",
      "meeting the criteria described in section 2718(a)(2) of the phsa for \n",
      "purposes of the medical loss ratio (mlr) requirements for qhp issuers \n",
      "on an ffe,\\46\\ and similar standards for treatment of qia standards \n",
      "applicable to medicaid managed care plans (mcos, pihps, and pahps) \n",
      "under 42 cfr 438.8, chip managed care entities under 42 cfr \n",
      "457.1203(f), and ma plans under 42 cfr 422.2400 through 422.2490. an \n",
      "entity's mlr is generally calculated as the proportion of revenue spent \n",
      "on clinical services and qia. there are several specific criteria an \n",
      "expense must meet, such as being designed to improve health quality and \n",
      "health outcomes through activities such as care coordination, in order \n",
      "to qualify as qia.\\47\\ we requested comments related to this assumption \n",
      "and its implications.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\46\\ while this rulemaking is specific to qhp issuers \n",
      "participating on the ffes, we note that to the extent other \n",
      "commercial market issuers incur similar costs for coverage sold in \n",
      "the individual or group markets, those expenses may similarly \n",
      "qualify as qia.\n",
      "    \\47\\ see, for example, 45 cfr 158.150 and 45 cfr 158.151.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we summarize the public comments we received on the payer-to-payer \n",
      "data exchange, as well as on whether these new activities may qualify \n",
      "as qia for mlr purposes, and provide our responses.\n",
      "    comment: many commenters were very supportive of this proposal and \n",
      "indicated their belief that these new data exchange requirements could \n",
      "improve care coordination by reducing burden on both beneficiaries and \n",
      "providers by limiting the need for duplicative letters of medical \n",
      "necessity, preventing inappropriate step therapy, and reducing \n",
      "unnecessary utilization reviews and prior authorizations.\n",
      "    response: we appreciate the commenters' support for this payer-to-\n",
      "payer data exchange proposal. we are finalizing this proposal with some \n",
      "modifications as detailed below. under this final rule, payers subject \n",
      "to this requirement must maintain a process for the electronic exchange \n",
      "of, at a minimum, the data classes and elements included in the content \n",
      "standard finalized by hhs in the onc 21st century cures act final rule \n",
      "(published elsewhere in this issue of the federal register) at 45 cfr \n",
      "170.213, which is currently version 1 of the uscdi. we are also \n",
      "finalizing that payers must use this process to exchange the uscdi-\n",
      "defined data set with the approval and at the direction of a current or \n",
      "former enrollee, or the enrollee's personal representative, to align \n",
      "with the language used for the api requirements. furthermore, we are \n",
      "finalizing the proposal that upon receipt, the receiving payer must \n",
      "incorporate the data set into the payer's own records about the \n",
      "enrollee with a clarification that this obligation applies to records \n",
      "about current enrollees. we clarify here that incorporating the data \n",
      "into the payer's records under this specific regulation would not \n",
      "require that the payer treat or rely on these data as its own, but that \n",
      "the payer must include these data in the record it maintains for each \n",
      "enrollee. while the obligation to incorporate data received from other \n",
      "payers into the receiving payer's records applies only for data about \n",
      "current enrollees, once incorporated, these data must be maintained \n",
      "even after a current enrollee leaves the payer's coverage. we do not \n",
      "want to be overly prescriptive about how these data are used by each \n",
      "payer at this time. initially, we are only requiring that these data \n",
      "are incorporated into the existing record to facilitate the creation \n",
      "and maintenance of a patient's cumulative health record with their \n",
      "current payer. in subsequent rulemaking, however, we may be more \n",
      "specific, depending on proposed use cases, and propose more \n",
      "prescriptive use of specific data.\n",
      "    comment: some commenters expressed concern about each payer's \n",
      "increased access to clinical information impacting coverage decision-\n",
      "making. commenters noted that while historically physicians have \n",
      "controlled the patient's clinical data in determining what to submit to \n",
      "obtain reimbursement for care provided, payers would now have access to \n",
      "information outside of the scope of the specific service being billed \n",
      "by a provider. commenters noted that a payer may access the exchanged \n",
      "health data from a prior payer and determine that a patient has already \n",
      "received treatment for a condition and deny, delay, and/or require \n",
      "prior authorization for allegedly duplicative treatment. additionally, \n",
      "a few commenters expressed concern that payers may use prior \n",
      "information to restrict coverage for medically necessary care that a \n",
      "patient may have received previously. a few commenters recommended that \n",
      "cms require that payers must attest that the exchanged data cannot be \n",
      "used to deny or delay treatment, increase rates, or implement step \n",
      "therapy.\n",
      "    response: we appreciate the commenters' concerns. we note that this \n",
      "regulation does not make any changes to when payers can deny coverage. \n",
      "the data received via this data exchange must be used per all \n",
      "applicable law, regulation, and in accordance with payer contracts as \n",
      "it relates to coverage decisions and, specifically, coverage denial. \n",
      "nothing in this regulation changes any existing obligations or policies \n",
      "related to coverage or services. further, as proposed and finalized, \n",
      "the regulations regarding the exchange of data among payers is \n",
      "triggered by an enrollee's request that the information be sent or \n",
      "received and incorporated. the individual enrollee retains control in \n",
      "this situation and can refrain from requesting information be sent to a \n",
      "new or current payer. we do note, however, that there are currently \n",
      "scenarios where payers can exchange data without an enrollee's request, \n",
      "such as for payment and health care operations.\n",
      "    comment: several commenters were concerned about the responsibility \n",
      "of ma plans, medicaid managed care plans, chip managed care entities, \n",
      "and qhp issuers on the ffes to forward information from other payers or \n",
      "information from outside their organization where they did not control \n",
      "data integrity. also, commenters were concerned there might be \n",
      "information that is contradictory and were unsure of each payer's \n",
      "responsibilities in that case.\n",
      "    response: we appreciate the commenters' concerns. we do believe \n",
      "that patients have a right to their data. in addition, they have a \n",
      "right to request that their health data follow them throughout their \n",
      "health care journey. it is only when patients are able to facilitate \n",
      "the sharing of their data, and even see it themselves, such as via the \n",
      "patient access api, that they will be able to understand where there \n",
      "may be opportunities to work with their previous and current providers \n",
      "and payers to ensure they have an accurate health record. today, to the \n",
      "extent permitted by law, payers may exchange patient data without the \n",
      "patient's consent for various purposes including payment and health \n",
      "care operations. the policy we are finalizing here will allow the \n",
      "patient to facilitate that exchange of their health information. in \n",
      "using this process, patients can ensure their payers and providers have \n",
      "the most accurate and up-to-date information about them.\n",
      "    payers can choose to indicate which data being exchanged were \n",
      "received from a previous payer so the receiving payer, or even a \n",
      "patient, understands where to direct questions and is aware of the \n",
      "scope of control over data integrity. this will also help receiving \n",
      "payers and patients understand how to reconcile contradictory \n",
      "information as it can be made clear where questions should be directed. \n",
      "payers are under no obligation under this regulation to update, \n",
      "validate, or correct data received from another payer.\n",
      "\n",
      "[[page 25567]]\n",
      "\n",
      "    comment: several commenters agreed with the proposed suggestion \n",
      "that activities related to this proposal may qualify as qia meeting the \n",
      "criteria described in section 2718(a)(2) of the phsa for purposes of \n",
      "the mlr requirements for qhp issuers on the ffes, and similar standards \n",
      "for treatment of quality improvement standards applicable to medicaid \n",
      "managed care plans (mcos, pihps, and pahps) under 42 cfr 438.8, chip \n",
      "managed care entities under 42 cfr 457.1203(f), and ma plans under 42 \n",
      "cfr 422.2400 through 422.2490.\n",
      "    response: we confirm that we continue to believe that expenses for \n",
      "the care coordination data exchanges required by this final rule may \n",
      "qualify as qia for purposes of calculating the mlr for payers that \n",
      "engage in such exchanges. as noted above, while this rulemaking is \n",
      "specific to qhp issuers participating on the ffes, to the extent other \n",
      "commercial market issuers incur similar costs for coverage sold in the \n",
      "individual or group markets, those expenses may similarly qualify as \n",
      "qia. we appreciate the commenters' support and will consider \n",
      "recognizing the expenses related to this data exchange as qia in future \n",
      "rulemaking or guidance, as may be necessary.\n",
      "    comment: many commenters were concerned about the time frame to \n",
      "implement this provision and were concerned making this policy \n",
      "applicable in 2020 would not provide enough time to operationalize this \n",
      "policy.\n",
      "    response: we appreciate the commenters' concerns and understand \n",
      "that it will take time to fully and properly implement this policy. we \n",
      "are finalizing this payer-to-payer data exchange requirement with an \n",
      "applicability date of january 1, 2022 with respect to the exchange of \n",
      "the uscdi data set.\n",
      "    although we did not propose to require payers to use an api to \n",
      "exchange the uscdi under this payer-to-payer data exchange proposal, we \n",
      "appreciate and support that some payers would like to leverage the \n",
      "patient access api (discussed in section iii. of this final rule) to \n",
      "meet the requirements of this payer-to-payer data exchange. the patient \n",
      "access api requirement makes uscdi data available to the patient or a \n",
      "third party at the patient's direction. because the patient access api \n",
      "is facilitating the exchange of the uscdi, some of the work to develop \n",
      "an api to exchange these data and the work to map the relevant uscdi \n",
      "data will be completed by january 1, 2021, when the patient access api \n",
      "must be made available as finalized in section iii. of this rule. in \n",
      "addition, if a payer receives data via an api, the payer could then \n",
      "incorporate it into a patient's record and in turn share it with the \n",
      "patient via the patient access api with little additional work needed.\n",
      "    we appreciate the value of using an api for this data exchange, and \n",
      "we understand the efficiencies that it can add to both this payer-to-\n",
      "payer data exchange as well as the patient access api policy. we also \n",
      "appreciate that incorporating data from other payers received via an \n",
      "api will be a new experience for payers, however. for instance, payers \n",
      "will need to develop a process to incorporate data from other payers \n",
      "into their systems, including potentially processes for tagging these \n",
      "data as originating with another payer so they can efficiently share \n",
      "that information with patients and future payers. these are additional \n",
      "processing steps that take time to implement.\n",
      "    in evaluating the comments on the proposals in this rule, and \n",
      "appreciating the value of sharing and exchanging data via apis, we see \n",
      "the benefit of having all data exchanged via apis. therefore, we may \n",
      "consider for future rulemaking an api-based payer-to-payer data \n",
      "exchange. at this time, we believe that an applicability date of \n",
      "january 1, 2022 for compliance with this requirement is appropriate. \n",
      "this provides time for payers to get experience with the patient access \n",
      "api, and provides payers with additional time to fully and successfully \n",
      "implement this payer-to-payer data exchange requirement.\n",
      "    to support a more seamless data exchange and to further clarify \n",
      "this payer-to-payer data exchange requirement, we are finalizing some \n",
      "modifications of the proposed regulation text at 42 cfr \n",
      "422.119(f)(1)(ii) and (iii) for ma organizations; at 42 cfr \n",
      "438.62(b)(1)(vi)(b) and (c) for medicaid managed care plans (and by \n",
      "cross-reference from 42 cfr 457.1216, to chip managed care entities); \n",
      "and at 45 cfr 156.221(f)(1)(ii) and (iii) for qhp issuers on the ffes \n",
      "to clearly indicate payers are obligated under this proposal to, with \n",
      "the approval and at the direction of a current or former enrollee, \n",
      "exchange data with any other payer identified by the enrollee. the \n",
      "proposed regulation text used both the term ``recipient'' and ``any \n",
      "other health care plan'' to identify where these data would be sent at \n",
      "an enrollee's request; the term ``recipient'' could have been \n",
      "interpreted more broadly than we intended. in the final regulation \n",
      "text, we are using ``payer'' instead and consolidating the proposed \n",
      "provisions that would require the payer that is subject to these rules \n",
      "to send data at the enrollee's request at any time during enrollment or \n",
      "up to 5 years after enrollment ends. as discussed in section iii. of \n",
      "this final rule, we are also specifying in the final regulations that a \n",
      "payer is only required to send data received under this payer-to-payer \n",
      "data exchange requirement in the electronic form and format it was \n",
      "received. in this way, a payer would not be asked to receive paper \n",
      "records from another payer under this policy and then in turn share \n",
      "those paper records with another payer in the future at the patient's \n",
      "direction. if the payer received a patient's information via an api, \n",
      "the payer must share it via an api if the payer they are sending to has \n",
      "the capacity to receive it. if a patient requests that a former payer \n",
      "send their information to their new payer and then requests that their \n",
      "new payer make their data accessible via that new payer's patient \n",
      "access api, the new payer would only be required to include the \n",
      "information received from the former payer at the patient's direction \n",
      "if this newly acquired information was received via a fhir-based api. \n",
      "otherwise, the new payer is only required to share data via the patient \n",
      "access api that the payer already maintains and has prepared to be \n",
      "shared via a fhir-based api.\n",
      "    we are also finalizing new regulation text, at 42 cfr 422.119(h) \n",
      "for ma organizations; at 42 cfr 438.62(b)(1)(vii) for medicaid managed \n",
      "care plans (and by cross-reference from 42 cfr 457.1216, to chip \n",
      "managed care entities); and at 45 cfr 156.221(i) for qhp issuers on the \n",
      "ffes, that these regulated payers will need to comply with the payer-\n",
      "to-payer data exchange requirements beginning january 1, 2022 (or \n",
      "beginning with plan years beginning on or after january 1, 2022 for qhp \n",
      "issuers on the ffes). in addition, this requirement, as finalized, \n",
      "provides that payers are required to exchange data they maintain with a \n",
      "date of service on or after january 1, 2016. in this way, payers only \n",
      "have to prepare a defined initial historical set of data for sharing \n",
      "via this payer-to-payer data exchange policy, as also required under \n",
      "the patient access api policy discussed in section iii. of this final \n",
      "rule. we believe that delaying implementation to january 1, 2022 and \n",
      "specifying that only data with a date of service on or after january 1, \n",
      "2016 must be exchanged under the new requirement addresses concerns \n",
      "about the timing and level of burden involved in meeting this \n",
      "requirement. this also clarifies that if certain information is not \n",
      "maintained by the\n",
      "\n",
      "[[page 25568]]\n",
      "\n",
      "payer, the payer is not obligated to seek out and obtain the data.\n",
      "    we also sought comment on how this policy might impact dually \n",
      "eligible individuals. we summarize the public comments we received on \n",
      "this payer-to-payer data exchange specifically regarding our request \n",
      "for comment for how this policy might impact dually eligible \n",
      "individuals who are concurrently enrolled in ma plans and medicaid \n",
      "managed care plans and provide our responses.\n",
      "    comment: a few commenters supported the proposal because it could \n",
      "improve care coordination for dually eligible beneficiaries. one \n",
      "commenter noted that because of this proposal, ma plans and medicaid \n",
      "mco plans would have the same data and health history for an \n",
      "individual. one commenter believed that this could help states that do \n",
      "not have an easily accessible source of data for knowing when their \n",
      "medicaid beneficiaries are enrolled for medicare. this commenter \n",
      "recommended including enrollment source and enrollment and \n",
      "disenrollment dates in the data exchanged between payers.\n",
      "    response: we appreciate the commenters' support and the suggestion \n",
      "noted. we will further evaluate this suggestion for future \n",
      "consideration.\n",
      "    comment: one commenter requested additional information regarding \n",
      "how plans should account for gaps in plan coverage over the course of 5 \n",
      "years. the commenter believed this will be particularly important for \n",
      "dual eligible and medicaid beneficiaries who may move in and out of a \n",
      "health plan program as their status may change due to changing \n",
      "circumstances.\n",
      "    response: we appreciate the commenter's request for information. we \n",
      "note that one payer would only be obligated to send another payer \n",
      "information that the payer maintains (which could include data received \n",
      "from other payers under this final rule that must be incorporated into \n",
      "the current payer's records). if in the 5 years prior to january 1, \n",
      "2022, a patient was in a medicaid managed care plan for 1 year in 2019 \n",
      "and then there was a break in service with the patient returning for 1 \n",
      "year in 2021, this medicaid managed care plan would be required to \n",
      "share data from 2019 and 2021 if requested by the patient. it would not \n",
      "be the managed care plan's responsibility to address the gaps in the \n",
      "data that the plan maintains. assuming that the patient was enrolled in \n",
      "an ma plan or another medicaid managed care plan in 2020, the patient \n",
      "could request that the plan they had in 2020 independently send their \n",
      "data to the payer they have indicated. in this way, the indicated payer \n",
      "is now the holder of the comprehensive information, as under this \n",
      "requirement a payer must incorporate the data received from other \n",
      "payers under this policy into their data system. if the patient leaves \n",
      "to go to a new payer in 2023, the one payer that now maintains their \n",
      "data from 2019 to 2022 would be the one payer that could forward the \n",
      "data to the new payer, in the electronic form and format it was \n",
      "received. we acknowledge that this may be complex for dually eligible \n",
      "beneficiaries.\n",
      "    comment: a few commenters noted advantages, burdens, and \n",
      "complexities associated with plans serving dually eligible \n",
      "beneficiaries continuously aggregating real-time member data from \n",
      "multiple plans. one commenter noted that each payer should only be \n",
      "responsible for their own data set and the coordination of data across \n",
      "multiple plans and providers would be more ideally done through a \n",
      "trusted exchange framework and common agreement (tefca). this commenter \n",
      "noted that additional technical capabilities will be required due to \n",
      "the possibility of overlapping coverage when combining and \n",
      "incorporating records.\n",
      "    response: we appreciate these thoughtful comments. we note that \n",
      "this payer-to-payer data exchange is only required when initiated by an \n",
      "enrollee's request, and only applies to the payers who are subject to \n",
      "our final regulations at 42 cfr 422.119(f)(1) and (h) for ma \n",
      "organizations; 42 cfr 438.62(b)(1)(vi) and (vii) for medicaid managed \n",
      "care plans (and by cross-reference from 42 cfr 457.1216, to chip \n",
      "managed care entities); and at 45 cfr 156.221(f) and (i) for qhp \n",
      "issuers on the ffes. the enrollee may request this payer-to-payer \n",
      "exchange just once, or more frequently. we did not propose, and are not \n",
      "finalizing, any requirement for continuous data exchange, however.\n",
      "    final action: after consideration of the comments received, and for \n",
      "the reasons outlined in our response to these comments and in the cms \n",
      "interoperability and patient access proposed rule, we are finalizing \n",
      "with modifications our proposal at 42 cfr 422.119(f)(1) and \n",
      "438.62(b)(1)(vi), and at 45 cfr 156.221(f)(1) to require ma \n",
      "organizations, medicaid managed care plans, chip managed care entities, \n",
      "and qhp issuers on the ffes to maintain a process for the electronic \n",
      "exchange of, at a minimum, the data classes and elements included in \n",
      "the content standard adopted at 45 cfr 170.213 (currently version 1 of \n",
      "the uscdi), as outlined in section iii. of this final rule. \n",
      "specifically, we are finalizing as proposed that the payers subject to \n",
      "these regulations incorporate the data they receive into the enrollee's \n",
      "record. in the final regulation text, we are using the language ``with \n",
      "the approval and at the direction'' of the enrollee versus ``at the \n",
      "request'' of the enrollee to align with the language used for the api \n",
      "requirements.\n",
      "    we are finalizing modifications to the proposed regulation text to \n",
      "streamline the text and best specify the scope of the policy as \n",
      "intended, as well as to align the text for all payer types as \n",
      "appropriate. specifically, at 42 cfr 422.119(f)(1)(i), \n",
      "438.62(b)(1)(vi)(a) (and by cross-reference from 42 cfr 457.1216), and \n",
      "at 45 cfr 156.221(f)(1)(i), the regulation text states that relevant \n",
      "payers ``receive'' versus ``accept'' data for current enrollees. at 42 \n",
      "cfr 422.119(f)(1)(ii), 438.62(b)(1)(vi)(b) (and by cross-reference from \n",
      "42 cfr 457.1216), and at 45 cfr 156.221(f)(1)(ii), the final \n",
      "regulations provide that a payer must send the defined information set \n",
      "to any other payer. in addition, at 42 cfr 422.119(f)(1)(iii), \n",
      "438.62(b)(1)(vi)(c) (and by cross-reference from 42 cfr 457.1216), and \n",
      "at 45 cfr 156.221(f)(1)(iii), we specify that a payer is only obligated \n",
      "to send data received from another payer under this policy in the \n",
      "electronic form and format it was received. this is intended to reduce \n",
      "burden on payers. we note the final regulations do use the term \n",
      "``payer'' in place of ``health care plan'' to clarify that the scope of \n",
      "the obligations are for all payers impacted by this regulation. also at \n",
      "45 cfr 156.221(f)(1), we updated the title of the paragraph to align \n",
      "with the parallel regulations for other payers types, and we corrected \n",
      "an incomplete sentence. finally, we specify that this policy also \n",
      "applies to an enrollee's personal representative.\n",
      "    we are also finalizing regulation text to address when these \n",
      "regulated payers must comply with these new requirements at 42 cfr \n",
      "422.119(h) for ma organizations; at 42 cfr 438.62(b)(1)(vii) for \n",
      "medicaid managed care plans (and at 42 cfr 457.1216, to chip managed \n",
      "care entities); and at 45 cfr 156.221(i) for qhp issuers on the ffes. \n",
      "starting january 1, 2022, and for qhp issuers on the ffes starting with \n",
      "plan years beginning on or after january 1, 2022, the finalized \n",
      "regulation requires these payers to exchange data with a date of \n",
      "service on or after january 1, 2016 that meets the requirements of this \n",
      "section and which the payer maintains. in this way, payers only have to \n",
      "prepare an initial historical set of data for sharing via this payer-\n",
      "to-payer data exchange policy that is consistent with the data set to \n",
      "be available through the\n",
      "\n",
      "[[page 25569]]\n",
      "\n",
      "patient access api, as finalized in section iii. of this final rule.\n",
      "\n",
      "vi. care coordination through trusted exchange networks: trust exchange \n",
      "network requirements for ma plans, medicaid managed care plans, chip \n",
      "managed care entities, and qhp issuers on the ffes provisions, and \n",
      "analysis of and responses to public comments\n",
      "\n",
      "    we proposed to require ma plans, medicaid managed care plans, chip \n",
      "managed care entities, and qhp issuers on the ffes to participate in \n",
      "trust networks in order to improve interoperability in these programs. \n",
      "we noted that we would codify this requirement in, respectively, 42 cfr \n",
      "422.119(f)(2), sec.  438.242(b)(5), and sec.  457.1233(d) (which cross-\n",
      "references the requirements in 42 cfr 438.242(b)(5)) and 45 cfr \n",
      "156.221(f). in general, payers and patients' ability to communicate \n",
      "between themselves and with health care providers could considerably \n",
      "improve patient access to data, reduce provider burden, and reduce \n",
      "redundant and unnecessary procedures. trusted exchange networks allow \n",
      "for broader interoperability beyond one health system or point to point \n",
      "connections among payers, providers, and patients. such networks \n",
      "establish rules of the road for interoperability, and with maturing \n",
      "technology, such networks are scaling interoperability and gathering \n",
      "momentum with participants, including several federal agencies, ehr \n",
      "vendors, retail pharmacy chains, large provider associations, and \n",
      "others.\n",
      "    the importance of a trusted exchange framework to such \n",
      "interoperability is reflected in section 4003(b) of the cures act, \n",
      "which was discussed in more detail in section i.d. of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7612 through \n",
      "7614). in section vi. of the cms interoperability and patient access \n",
      "proposed rule (84 fr 7642), we discussed and explained our proposal to \n",
      "require certain payers to participate in trusted exchange networks. a \n",
      "trusted exchange framework allows for the secure exchange of electronic \n",
      "health information with, and use of electronic health information from, \n",
      "other health it. widespread payer participation in such a framework \n",
      "might allow for more complete access and exchange of all electronically \n",
      "accessible health information for authorized use under applicable state \n",
      "or federal law, which we believe would lead to better use of such data. \n",
      "we noted that while we cannot require widespread payer participation in \n",
      "trust networks, we proposed to use our program authority in the ma \n",
      "program, medicaid managed care program, chip managed care program, and \n",
      "qhp certification program for the ffes to increase participation in \n",
      "trust networks and to bring the potential benefits of participating in \n",
      "such programs, including improved interoperable communication and care \n",
      "coordination, which result in opportunities for improved patient \n",
      "outcomes and burden reduction.\n",
      "    we proposed to require, beginning january 1, 2020, that ma plans, \n",
      "medicaid managed care plans, chip managed care entities, and qhp \n",
      "issuers on the ffes participate in a trusted exchange network. the \n",
      "proposal was based on our authority under: sections 1856(b) and 1857(e) \n",
      "of the act to adopt standards and contract terms for ma plans; section \n",
      "1902(a)(4) of the act to adopt methods of administration for the \n",
      "administration state medicaid plans, including requirements for \n",
      "medicaid managed care plans (mcos, pihps, and pahps); section 2101(a) \n",
      "for chip managed care entities (mcos, pihps, and pahps); and section \n",
      "3001(c)(9)(f)(iii) of the phsa and section 1311(e)(1)(b) of the \n",
      "affordable care act for qhp issuers on an ffe. under the proposal, and \n",
      "consistent with section 4003(b) of the cures act, participation would \n",
      "be required in a trusted exchange framework that met the following \n",
      "criteria:\n",
      "    (1) the trusted exchange network must be able to exchange phi, \n",
      "defined at 45 cfr 160.103, in compliance with all applicable state and \n",
      "federal laws across jurisdictions.\n",
      "    (2) the trusted exchange network must be capable of connecting both \n",
      "inpatient ehrs and ambulatory ehrs.\n",
      "    (3) the trusted exchange network must support secure messaging or \n",
      "electronic querying by and between patients, providers, and payers.\n",
      "    we proposed to codify these requirements for these payers at 42 cfr \n",
      "422.119(f)(2) for ma organizations, sec.  438.242(b)(5) for medicaid \n",
      "managed care plans, sec.  457.1233(d)(2) for chip managed care \n",
      "entities, and 45 cfr 156.221(f) for qhps on the ffes.\n",
      "    on april 19, 2019, onc released the draft trusted exchange \n",
      "framework and common agreement (tefca draft 2) for public comment.\\48\\ \n",
      "previous commenters on draft 1 of the tefca, particularly payers \n",
      "providing comments, requested that existing trust networks that are \n",
      "operating successfully be leveraged in further advancing \n",
      "interoperability; thus, we considered a possible future approach to \n",
      "payer-to-payer and payer-to-provider interoperability that leverages \n",
      "existing trust networks to support care coordination and improve \n",
      "patient access to their data. we requested comments on this approach \n",
      "and how it might be aligned in the future with section 4003(b) of the \n",
      "cures act. we also requested comments on the applicability date we \n",
      "proposed for the trusted exchange network participation requirement and \n",
      "what benefits and challenges the payers subject to our proposal might \n",
      "face meeting this requirement for additional consideration in future \n",
      "rulemaking.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\48\\ see <a href=\"https://www.healthit.gov/sites/default/files/page/2019-04/finaltefcaqtf41719508version.pdf\">https://www.healthit.gov/sites/default/files/page/2019-04/finaltefcaqtf41719508version.pdf</a>. for additional information \n",
      "about tefca, see <a href=\"https://www.healthit.gov/topic/interoperability/trusted-exchange-framework-and-common-agreement\">https://www.healthit.gov/topic/interoperability/trusted-exchange-framework-and-common-agreement</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we summarize the public comments we received on this topic and \n",
      "provide our responses.\n",
      "    comment: although many stakeholders supported the concept of this \n",
      "proposal, there were strong exceptions. many commenters, particularly \n",
      "payers, indicated that it was premature for cms to finalize a proposal \n",
      "related to trusted exchange network participation before the first \n",
      "version of the common agreement under onc's tefca was finalized. \n",
      "commenters noted that, even though they supported using a trusted \n",
      "exchange network, it would not be advisable until after tefca as \n",
      "outlined in section 4003 of the 21st century cures act was available to \n",
      "facilitate this proposal.\n",
      "    response: we appreciate that although commenters supported the \n",
      "general concept of trusted exchange network participation and how it \n",
      "could advance interoperability and data exchange, the true value of \n",
      "this concept might be best realized via tefca in the future. we agree \n",
      "that trusted exchange networks can play a positive role, but given the \n",
      "concerns commenters raised regarding the need for a mature tefca, and \n",
      "appreciating the ongoing work on tefca being done at this time, we are \n",
      "not finalizing this policy at this time.\n",
      "    comment: some commenters noted that more detail would be needed to \n",
      "understand how this proposal would be operationalized. these commenters \n",
      "also indicated more information would be needed to understand how this \n",
      "policy would relate to existing health information exchanges (hies) and \n",
      "health information networks (hins) and whether these entities would \n",
      "qualify as trusted exchange networks. a few commenters indicated this \n",
      "policy may be redundant appreciating the existing role of hies and \n",
      "hins.\n",
      "    response: we appreciate the commenters' concerns and requests for\n",
      "\n",
      "[[page 25570]]\n",
      "\n",
      "additional information. we will keep these in mind as we consider \n",
      "possible future proposals around participation in trusted exchange \n",
      "networks.\n",
      "    comment: many commenters expressed concerns with the proposed \n",
      "implementation timeline. they did not believe this policy could be \n",
      "implemented by january 1, 2020. commenters indicated it would take more \n",
      "time to meet the necessary requirements and fully understand the \n",
      "implications of the policy, particularly for hies and hins. many \n",
      "commenters suggested a delay ranging from 12 to 24 months. other \n",
      "commenters suggested cms align the timeline of this proposal with tefca \n",
      "implementation milestones. in addition to a delay, some commenters \n",
      "suggested an exemption process.\n",
      "    response: we appreciate the commenters concerns, and based on these \n",
      "concerns and those summarized from other commenters, we are not \n",
      "finalizing this proposal at this time. to reflect this in this final \n",
      "rule, the regulation text proposed for all impacted payers is not being \n",
      "finalized. in addition, as 42 cfr 438.242(b)(5) is not being finalized, \n",
      "the regulation text proposed at 42 cfr 438.242(b)(6) is being \n",
      "redesignated as 42 cfr 438.242(b)(5).\n",
      "    final action: after consideration of the comments received, and for \n",
      "the reasons outlined in our response to these comments, we are not \n",
      "finalizing this proposal to require ma organizations, medicaid managed \n",
      "care plans, chip managed care entities, and qhp issuers on the ffes to \n",
      "participate in a trusted exchange network.\n",
      "\n",
      "vii. improving the medicare-medicaid dually eligible experience by \n",
      "increasing the frequency of federal-state data exchanges provisions, \n",
      "and analysis of and responses to public comments\n",
      "\n",
      "a. increasing the frequency of federal-state data exchanges for dually \n",
      "eligible individuals\n",
      "\n",
      "1. background\n",
      "    the medicare and medicaid programs were originally created as \n",
      "distinct programs with different purposes. the programs have different \n",
      "rules for eligibility, covered benefits, and payment. the programs have \n",
      "operated as separate and distinct systems despite a growing number of \n",
      "people who depend on both programs (known as dually eligible \n",
      "individuals) for their health care. there is an increasing need to \n",
      "align these programs--and the data and systems that support them--to \n",
      "improve care delivery and the beneficiary experience for dually \n",
      "eligible individuals, while reducing administrative burden for \n",
      "providers, health plans, and states. the interoperability of state and \n",
      "cms eligibility and medicaid management information system (mmis) \n",
      "systems is a critical part of modernizing the programs and improving \n",
      "beneficiary and provider experiences. improving the accuracy of data on \n",
      "dual eligibility by increasing the frequency of federal-state data \n",
      "exchanges is a strong first step in improving how these systems work \n",
      "together.\n",
      "2. data exchanges to support state buy-in for medicare parts a and b\n",
      "    states and cms routinely exchange data on who is enrolled in \n",
      "medicare and medicaid, and which parties are liable for paying that \n",
      "beneficiary's parts a and b premiums. these data exchanges support \n",
      "state, cms, and social security administration (ssa) premium \n",
      "accounting, collections, and enrollment functions. section 1843 of the \n",
      "act permits states to enter into an agreement with the secretary to \n",
      "facilitate state ``buy-in,'' that is, payment of medicare premiums, in \n",
      "this case part b premiums, on behalf of certain individuals. for those \n",
      "beneficiaries covered under the agreement, the state pays the \n",
      "beneficiary's monthly part b premium. section 1818(g) of the act \n",
      "establishes the option for states to amend their buy-in agreement to \n",
      "include enrollment and payment of the part a premium for certain \n",
      "specified individuals. all states and the district of columbia have a \n",
      "part b buy-in agreement; 36 states and the district of columbia have a \n",
      "part a buy-in agreement.\n",
      "    to effectuate the state payment of medicare part a or part b \n",
      "premiums, a state submits data on a buy-in file to cms via an \n",
      "electronic file transfer (eft) exchange setup. the state's input file \n",
      "includes a record for each medicare beneficiary for whom the state is \n",
      "adding or deleting coverage, or changing buy-in status. in response, \n",
      "cms returns an updated transaction record that provides data \n",
      "identifying, for each transaction on the state file, whether cms \n",
      "accepted, modified, or rejected it, as well a part a or part b billing \n",
      "record showing the state's premium responsibility. in addition, the cms \n",
      "file may ``push'' new updates obtained from ssa to the state, for \n",
      "example, changes to the medicare beneficiary identifier number or a \n",
      "change of address.\n",
      "    we have issued regulations for certain details of the state buy-in \n",
      "processes. for medicare part a, 42 cfr 407.40 describes the option for \n",
      "states to amend the buy-in agreement to cover part a premiums for \n",
      "qualified medicare beneficiaries (qmbs). for medicare part b, 42 cfr \n",
      "406.26 codifies the process for modifying the buy-in agreement to \n",
      "identify the eligibility groups covered. cms subregulatory guidance, \n",
      "specifically chapter 3 of the state buy-in manual,\\49\\ specifies that \n",
      "states should exchange buy-in data with cms at least monthly, but \n",
      "describes the option for states to exchange buy-in data with cms daily \n",
      "or weekly. likewise, states can choose to receive the cms response data \n",
      "file daily or monthly. we note that 35 states and the district of \n",
      "columbia are now submitting buy-in data to cms daily; 31 states and the \n",
      "district of columbia are now receiving buy-in response files from cms \n",
      "daily.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\49\\ centers for medicare and medicaid services. (2003). state \n",
      "buy-in manual: chapter 3--data exchange. retrieved from <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/buyin_c03.pdf\">https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/buyin_c03.pdf</a>. (last accessed june 24, 2019).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while many states submit and receive buy-in files daily, some \n",
      "continue to only do so on a monthly basis. we have become increasingly \n",
      "concerned about the limitations of monthly buy-in data exchanges with \n",
      "states. the relatively long lag in updating buy-in data means that the \n",
      "state is not able to terminate or activate buy-in coverage sooner, so \n",
      "the state or beneficiary may be paying premiums for longer than \n",
      "appropriate. in most cases, funds must be recouped and redistributed--a \n",
      "burdensome administrative process involving debits and payments between \n",
      "the beneficiary, state, cms, and ssa. additionally, transaction errors \n",
      "do occur in the current data exchange processes. in a monthly exchange, \n",
      "it can take multiple months to correct and resubmit an improperly \n",
      "processed transaction, exacerbating the delays in appropriately \n",
      "assigning premium liability, leading to larger mispayment, recoupment, \n",
      "and redistribution of premiums. exchanging the buy-in data with greater \n",
      "frequency supports more timely access to coverage.\n",
      "    all states' systems already have the capacity to exchange buy-in \n",
      "data. we acknowledge that states that do not already exchange data \n",
      "daily will need an initial, one-time systems change to do so. however, \n",
      "moving to a daily data exchange would result in a net reduction of \n",
      "burden for states, and further, reduce administrative complexity for \n",
      "beneficiaries and providers. more frequent submission of updates to \n",
      "individuals' buy-in status positively impacts all involved. for a full \n",
      "discussion of the benefits, see the cms interoperability and patient \n",
      "access\n",
      "\n",
      "[[page 25571]]\n",
      "\n",
      "proposed rule (84 fr 7643 through 7644).\n",
      "    while there exist opportunities to modernize the platform for buy-\n",
      "in data exchange, we believe that an important first step is to promote \n",
      "the exchange of the most current available data. section 1843(f) of the \n",
      "act specifies that part b buy-in agreements shall contain such \n",
      "provisions as will facilitate the financial transactions of the state \n",
      "and the carrier with respect to deductions, coinsurance, and otherwise, \n",
      "and as will lead to economy and efficiency of operation. further, \n",
      "section 1818(g)(2)(a) of the act on part a buy-in identifies this \n",
      "section 1843(f) requirement as applicable to part a buy-in. while the \n",
      "regulations governing buy-in agreements (see 42 cfr 406.26 and 407.40) \n",
      "are silent on the frequency of buy-in data exchanges, current guidance \n",
      "articulates that the required buy-in data may be submitted daily, \n",
      "weekly, or monthly. therefore, we proposed to establish frequency \n",
      "requirements in the regulations at 42 cfr 406.26(a)(1) and 407.40(c) to \n",
      "require all states to participate in daily exchange of buy-in data with \n",
      "cms, with ``daily'' meaning every business day, but that if no new \n",
      "transactions are available to transmit, data would not need to be \n",
      "submitted on a given business day. we noted that we believe these \n",
      "requirements will improve the economy and efficiency of operation of \n",
      "the buy-in process. we proposed that states would be required to begin \n",
      "participating in daily exchange of buy-in data with cms by april 1, \n",
      "2022. we noted that we believe this applicability date would allow \n",
      "states to phase in any necessary operational changes or bundle them \n",
      "with any new systems implementation. in the cms interoperability and \n",
      "patient access proposed rule, we estimated that 19 states would need to \n",
      "make a system change to send buy-in data to cms daily and 22 states \n",
      "would need to make a system change to receive buy-in data from cms \n",
      "daily (84 fr 7668). based on more recent data, we estimate that 26 and \n",
      "19 states would require such system changes, respectively. we updated \n",
      "our estimates to determine the one-time cost to be $85,000 per state, \n",
      "per change, so a state that needs to make systems updates to both send \n",
      "buy-in data daily, and receive buy-in data daily would have a one-time \n",
      "cost of just over $170,000. we sought comment on the proposals.\n",
      "    we summarize the public comments we received on data exchanges to \n",
      "support state buy-in for medicare parts a and b and provide our \n",
      "responses.\n",
      "    comment: almost all those who commented on these provisions \n",
      "supported the proposal to require that all states participate in daily \n",
      "exchange of buy-in data with cms by april 1, 2022. commenters stated \n",
      "that the changes would improve the timeliness and accuracy of \n",
      "eligibility and enrollment data, and enhance capability for \n",
      "coordination of benefits.\n",
      "    response: we appreciate the strong support for the proposed change \n",
      "to the regulation.\n",
      "    comment: one commenter supported the change, but also encouraged \n",
      "cms to modify its own processes and systems to effectively leverage \n",
      "daily data exchanges to support enhanced care for dually eligible \n",
      "individuals. another commenter requested clarification if the daily \n",
      "state submission of the buy-in file encompasses a reciprocal daily \n",
      "response from cms to the states.\n",
      "    response: we agree that cms and states both play important roles in \n",
      "implementing systems changes to support the state buy-in process. \n",
      "currently, states can choose to exchange buy-in data with cms daily, \n",
      "weekly, or monthly; and separately, they can choose to receive the cms \n",
      "response data file daily, weekly, or monthly. we proposed that all \n",
      "states both send data to cms and receive responses from cms on a daily \n",
      "basis. we will continue to look for opportunities to optimize cms \n",
      "systems and processes to support better care for dually eligible \n",
      "individuals.\n",
      "    comment: one commenter supported requiring frequent exchanges of \n",
      "this data as a way to eliminate current inefficiencies and improve \n",
      "benefit coordination for the dually eligible population so long as this \n",
      "requirement does not impose additional reporting requirements on \n",
      "clinicians.\n",
      "    response: we appreciate the support for our proposal. we confirm \n",
      "that the regulation as proposed does not create additional reporting \n",
      "requirements on clinicians. as noted in the preamble to the cms \n",
      "interoperability and patient access proposed rule, we estimate that the \n",
      "change to a daily submission would result in a net reduction of burden \n",
      "for states, and further, reduce administrative complexity for \n",
      "beneficiaries and providers.\n",
      "    comment: one commenter noted that the proposed applicability date \n",
      "of april 1, 2022 will be sufficient for this change, but for overall \n",
      "unity in the rule's proposed changes, encouraged cms to consider \n",
      "aligning the applicability date of this proposal with an overall \n",
      "extended implementation time frame of at least 2 years--and ideally 5 \n",
      "years--for the remainder of the rule's provisions.\n",
      "    response: we appreciate the value in aligned implementation \n",
      "timelines. however, given that other provisions in this rule for health \n",
      "plans and states are distinct from this requirement, and will be \n",
      "required beginning in 2020, we continue to believe that the april 1, \n",
      "2022 implementation timeline proposed for daily exchange of buy-in data \n",
      "is appropriate.\n",
      "    comment: commenters recommended that cms establish a process for \n",
      "states to provide medicare dual eligible special needs plans (d-snps) \n",
      "with, at a minimum, data on beneficiaries' medicaid coverage. \n",
      "commenters requested cms align the eligibility and enrollment \n",
      "information that health plans receive with the information being shared \n",
      "between states and the federal government so there is a single ``source \n",
      "of truth'' on these data. commenters noted this consistency is critical \n",
      "to improving care coordination for dually eligible individuals.\n",
      "    response: d-snps have an important role in supporting their \n",
      "enrollees' access to medicaid benefits. we understand that in many \n",
      "states d-snps have limited access to timely data on medicaid \n",
      "enrollment. we note that we do provide data to d-snps and other ma \n",
      "plans on the medicaid status of their members. while we appreciate the \n",
      "value of d-snps getting additional medicaid coverage data such as \n",
      "medicaid plan enrollment, we decline to modify the regulations to \n",
      "require states to do so as it is beyond the scope of this proposal. \n",
      "however, we continue to explore opportunities to provide plans with \n",
      "data that would assist them in better coordinating benefits and \n",
      "coverage for their dually eligible enrollees.\n",
      "    comment: one commenter noted that the cms interoperability and \n",
      "patient access proposed rule does not require states to input the \n",
      "latest eligibility data in a specific timeframe on their claims \n",
      "platforms. the commenter noted that not having this clarity means that \n",
      "there could be a potential for inconsistent data. the commenter \n",
      "recommended that cms require state medicaid programs to update their \n",
      "claims platforms daily to assist with accurate data exchanges.\n",
      "    response: we appreciate the point the commenter is making. our \n",
      "proposal did not explicitly address how states incorporate eligibility \n",
      "data with claims and other systems. we will consider this \n",
      "recommendation for the future as we gain additional experience with \n",
      "daily data exchange.\n",
      "    comment: two commenters stated that daily exchange of buy-in data \n",
      "would require significant systems changes and costs. one of these \n",
      "commenters recommended that cms revise the proposal to update the \n",
      "frequency of exchange from monthly to\n",
      "\n",
      "[[page 25572]]\n",
      "\n",
      "weekly, rather than daily. the commenter noted that it would seldom \n",
      "have new information to send on a daily basis, but that determining on \n",
      "a daily basis whether there was any new information to send would be a \n",
      "large effort. finally, the commenter requested if cms finalized the \n",
      "regulation to require daily updates, that provisions be made for states \n",
      "whose systems cycles are other than within a calendar day, for example, \n",
      "6 p.m. to 6 a.m.\n",
      "    response: we appreciate the costs that the state may bear to make \n",
      "the systems changes necessary to implement these provisions. we will \n",
      "provide technical assistance and opportunities for shared learning \n",
      "through webinars and training to support states' transition.\n",
      "    we also note that federal matching funds at the standard rate of 50 \n",
      "percent for administration will reduce the states' costs. states may \n",
      "also be eligible for enhanced 90 percent federal matching funds for the \n",
      "costs of developing and implementing any necessary system changes \n",
      "required by regulation, and enhanced 75 percent federal matching funds \n",
      "for their system's maintenance and operation costs. these enhanced \n",
      "federal matching funds would be available for their eligibility and \n",
      "enrollment (e&e) systems (and, if necessary, their medicaid management \n",
      "information system (mmis)). states would request enhanced funding \n",
      "through the advance planning document (apd) process.\n",
      "    even though there are costs to the states in implementing daily \n",
      "exchange of buy-in data, other commenters uniformly supported the value \n",
      "of daily exchanges in improving the experience of dually eligible \n",
      "individuals, and in reducing burden on states, providers, and plans to \n",
      "reconcile payment. as a result, we decline to make the suggested \n",
      "change.\n",
      "    with respect to the point that there would often not be updates on \n",
      "a daily basis, we reiterate that no file would be required on business \n",
      "days where there were no updates. we expect that states would be able \n",
      "to automate their systems so that they check daily for changes to buy-\n",
      "in status that would need to be submitted to cms on the buy-in file, \n",
      "but also automate a process by which the system only generates a buy-in \n",
      "file upon identifying such a change. we appreciate the additional \n",
      "coding required to implement this logic but expect that once \n",
      "implemented, no additional interventions would be needed. we will work \n",
      "with states that have implemented these changes to identify and share \n",
      "best practices in identifying data changes to trigger daily \n",
      "submissions.\n",
      "    finally, in response to the concern about whether states that have \n",
      "an overnight processing cycle would be permitted to continue doing so, \n",
      "we affirm that the proposed regulation would permit this.\n",
      "    after consideration of the public comments and for the reasons \n",
      "articulated in the cms interoperability and patient access proposed \n",
      "rule and our responses to comments, we are finalizing changes to 42 cfr \n",
      "406.26 and 407.40 as proposed.\n",
      "3. exchange of state mma data files\n",
      "    states submit data on files at least monthly to cms to identify all \n",
      "dually eligible individuals, including full-benefit and partial-benefit \n",
      "dually eligible individuals (that is, those who get medicaid help with \n",
      "medicare premiums, and often for cost-sharing). the file is called the \n",
      "``mma file,'' but is occasionally referred to as the ``state phasedown \n",
      "file.'' the mma file was originally developed to meet the need to \n",
      "timely identify dually eligible individuals for the then-new medicare \n",
      "part d prescription drug benefit. the medicare modernization act (mma) \n",
      "established that, beginning january 1, 2006, medicare would be \n",
      "primarily responsible for prescription drug coverage for full-benefit \n",
      "dually eligible individuals; established auto-enrollment of full-\n",
      "benefit dually eligible individuals into medicare prescription drug \n",
      "plans (with regulations further establishing facilitated enrollment \n",
      "into prescription drug plans for partial-benefit dually eligible \n",
      "individuals), provided that dually eligible individuals are treated as \n",
      "eligible for the medicare part d low income subsidy (lis), sometimes \n",
      "called extra help; defined phased down state contributions to partly \n",
      "finance part d costs for dually eligible individuals; and required \n",
      "risk-adjusting capitation payments for lis (which include dually \n",
      "eligible) enrollees of part d plans. to support these new requirements, \n",
      "we issued 42 cfr 423.910, establishing monthly reporting by states, in \n",
      "which states would submit, at least monthly, a data file identifying \n",
      "dually eligible individuals in their state. over time, we used these \n",
      "files' data on dual eligibility status to support part c capitation \n",
      "risk-adjustment, and most recently, to feed dual eligibility status to \n",
      "part a and b eligibility and claims processing systems so providers, \n",
      "suppliers, and individuals have accurate information on beneficiary \n",
      "cost-sharing obligations.\n",
      "    currently, regulations require states to submit at least one mma \n",
      "file each month. however, states have the option to submit multiple mma \n",
      "files throughout the month (up to one per day). most states submit mma \n",
      "data files at least weekly. in the cms interoperability and patient \n",
      "access proposed rule, we estimated that 37 states and dc would need to \n",
      "make a system change to send mma data to cms daily (84 fr 7668). based \n",
      "on more recent data, we estimate that 36 states and dc would require \n",
      "such system changes. as cms now leverages mma data on dual eligibility \n",
      "status into systems supporting all four parts of the medicare program, \n",
      "it is becoming even more essential that dual eligibility status is \n",
      "accurate and up-to-date. dual eligibility status can change at any time \n",
      "in a month. waiting up to a month for status updates can negatively \n",
      "impact access to the correct level of benefit at the correct level of \n",
      "payment. based on our experience with states that exchange data daily, \n",
      "more frequent mma file submissions benefit states, individuals, and \n",
      "providers, in a number of ways. for a full discussion of the benefits, \n",
      "see the cms interoperability and patient access proposed rule (84 fr \n",
      "7644).\n",
      "    as noted, current regulation requires that each state submit an mma \n",
      "file at least monthly. we have implemented ``work-arounds'' for lags in \n",
      "dual eligibility status for part d, including the ``best available \n",
      "evidence'' policy (see 42 cfr 423.800(d)), as well as the limited \n",
      "income newly eligible transition demonstration, which provides short \n",
      "term drug coverage for dually eligible individuals with no part d plan \n",
      "enrollment in a given month (see medicare prescription drug benefit \n",
      "manual, chapter 3, section 40.1.4).\\50\\ while these work-arounds \n",
      "provide needed protections, more frequent data exchanges would mitigate \n",
      "the need for them.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\50\\ centers for medicare and medicaid services. (2017). \n",
      "medicare prescription drug benefit manual: chapter 3--eligibility, \n",
      "enrollment and disenrollment. retrieved from <a href=\"https://www.cms.gov/medicare/eligibility-and-enrollment/medicarepresdrugeligenrol/downloads/cy_2018_pdp_enrollment_and_disenrollment_guidance_6-15-17.pdf\">https://www.cms.gov/medicare/eligibility-and-enrollment/medicarepresdrugeligenrol/downloads/cy_2018_pdp_enrollment_and_disenrollment_guidance_6-15-17.pdf</a>. (last accessed june 24, 2019).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    ensuring information on dual eligibility status is accurate and up-\n",
      "to-date by increasing the frequency of federal-state data exchange is \n",
      "an important step in the path to interoperability. as a result, we \n",
      "proposed to update the frequency requirements in 42 cfr 423.910(d) to \n",
      "require that, starting april 1, 2022, all states submit the required \n",
      "mma file data to cms daily, and to make conforming edits to 42 cfr \n",
      "423.910(b)(1). daily would mean every\n",
      "\n",
      "[[page 25573]]\n",
      "\n",
      "business day, but that if no new transactions are available to \n",
      "transmit, states would not need to submit data on a given business day. \n",
      "we proposed requiring that states begin submitting these data daily to \n",
      "cms by april 1, 2022 because we believed this applicability date would \n",
      "allow states to phase in any necessary operational changes or bundle \n",
      "them with any new systems implementation. we estimated an updated one-\n",
      "time cost for a state to be $85,000 for this mma data systems change. \n",
      "for a detailed discussion of the costs associated with these \n",
      "requirements, we refer readers to section xvi. of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7660 through \n",
      "7673), as well as section xvi of this final rule. we sought comment on \n",
      "these proposals.\n",
      "    we summarize the public comments we received on exchange of state \n",
      "mma data files and provide our responses.\n",
      "    comment: almost all those who commented on this provision supported \n",
      "the proposal to require all states to participate in daily submission \n",
      "of mma file data with cms by april 1, 2022. commenters noted that the \n",
      "changes would improve the timeliness and accuracy of eligibility and \n",
      "enrollment data, enhance coordination of benefits, and support greater \n",
      "integration of care.\n",
      "    response: we appreciate the strong support for the proposed change \n",
      "to the regulation.\n",
      "    comment: one commenter supported the proposed change, but requested \n",
      "cms consider standardizing which file types and data sets will be \n",
      "acceptable to support standardized daily submissions, for the overall \n",
      "purpose of improving the state and cms data exchanges.\n",
      "    response: we understand the suggestion that we standardize which \n",
      "upstream data sets (for example, cms finder files, state eligibility \n",
      "data) states should use to support daily mma file submissions. to that \n",
      "end, we will provide technical assistance to states that need to make \n",
      "changes to submit the file daily. as part of that effort, we will work \n",
      "with states that already submit mma files daily to understand and share \n",
      "information on best practices on the upstream data sets necessary to \n",
      "implement daily mma file submissions.\n",
      "    comment: one commenter noted that the proposed applicability date \n",
      "of april 1, 2022 will be sufficient for this change, but for overall \n",
      "unity in the rule's proposed changes, encouraged cms to consider \n",
      "aligning the effective date of this proposal with an overall extended \n",
      "implementation time frame of at least 2 years--and ideally 5 years--for \n",
      "the remainder of the rule's provisions.\n",
      "    response: we appreciate the value in aligned implementation \n",
      "timelines. however, given that other provisions in this rule for health \n",
      "plans and states are distinct from this requirement, and will be \n",
      "required beginning in 2020, we continue to believe that the april 1, \n",
      "2022 implementation timeline proposed for daily mma file submissions is \n",
      "appropriate.\n",
      "    comment: a few commenters noted the value of the data in the mma \n",
      "file to medicaid managed care organizations (mco), medicare dual \n",
      "eligible special needs plans (d-snps), health information exchanges, \n",
      "and providers for the purposes of coordinating enrollment, benefits, \n",
      "and/or care for dually eligible individuals. these commenters requested \n",
      "access to the daily mma file. one commenter noted that some states are \n",
      "sharing medicare plan enrolment data from these files with their \n",
      "medicaid mcos while also providing batch inquiry data sharing \n",
      "mechanisms to d-snps on medicaid plan enrollment. this commenter \n",
      "recommended that cms encourage or require all states to follow this \n",
      "process at a minimum.\n",
      "    commenters also encouraged cms to leverage the mma file to support \n",
      "parties complying with the d-snp integration standards recently issued \n",
      "in 42 cfr 422.2.\n",
      "    response: we appreciate these suggestions to promote access to data \n",
      "for plans and providers serving dually eligible individuals, and we \n",
      "will explore these ideas further for potential future consideration. \n",
      "however, we decline to modify the regulation as suggested, as the \n",
      "recommended changes are beyond the scope of the proposal, which is \n",
      "limited to the frequency of the file exchange.\n",
      "    comment: a few commenters made additional suggestions for \n",
      "streamlining data exchanges. in addition to making the mma files \n",
      "accessible to plans and providers, some commenters recommended adding \n",
      "medicaid plan enrollment information to mma files to create a single \n",
      "source of medicare-medicaid enrollment data for dually eligible \n",
      "individuals. another commenter suggested a potential pathway to \n",
      "streamlining data exchanges would be for cms to allow state transformed \n",
      "medicaid statistical information system (t-msis) files to serve as the \n",
      "beneficiary data source for third-party applications.\n",
      "    response: we appreciate the value of streamlining data exchanges, \n",
      "including access to a consistent data source on eligibility and \n",
      "enrollment. we also acknowledge the overlap of certain data exchanged \n",
      "in the mma and t-msis file, though we note we would need to carefully \n",
      "explore the implications and impacts of merging operational data \n",
      "exchanges such as the mma file--which result in changes to an \n",
      "individual's medicare benefit--with informational exchanges such as t-\n",
      "msis. we will consider exploring these opportunities further for \n",
      "potential future consideration. however, we decline to modify the \n",
      "regulation as suggested, as the recommended changes are beyond the \n",
      "scope of the proposal, which is limited to the frequency of the file \n",
      "exchange.\n",
      "    comment: several commenters noted significant system changes and \n",
      "cost to update the frequency of exchanging mma files to daily. one \n",
      "commenter stated that they believe hhs has underestimated the cost to \n",
      "upgrade the mma system to support daily exchange. the commenter \n",
      "encouraged cms to provide an updated estimate for the costs to upgrade \n",
      "the system that include additional operational costs. this commenter \n",
      "and others encouraged cms to consider providing additional funding to \n",
      "state medicaid programs that will need to upgrade their data systems. \n",
      "one commenter questioned if cms would consider increasing the fmap \n",
      "states receive for interoperability activities that support dual \n",
      "eligible plans integrations and in particular, for programmatic or \n",
      "systems changes to come into compliance with d-snp integration. the \n",
      "commenter noted that this increase could exceed existing enhanced \n",
      "matches, for example allowing the 90 percent match to apply for ongoing \n",
      "systems operations that facilitate care coordination.\n",
      "    response: we appreciate the input on the level of effort needed to \n",
      "submit the mma file daily. as noted elsewhere, we will provide \n",
      "technical assistance and opportunities for shared learning through \n",
      "webinars and training to support states' transition. we also note that \n",
      "federal matching funds of 50 percent for administration will reduce the \n",
      "states' costs. states may also be eligible for enhanced 90 percent \n",
      "federal matching funds for the costs of developing and implementing any \n",
      "necessary system changes required by regulation, and enhanced 75 \n",
      "percent federal matching funds for their system's maintenance and \n",
      "operation costs. these enhanced federal matching funds would be \n",
      "available for their eligibility and enrollment systems (and, if \n",
      "necessary, their medicaid management information system (mmis)). states \n",
      "would request enhanced funding through the advance planning document \n",
      "(apd) process.\n",
      "\n",
      "[[page 25574]]\n",
      "\n",
      "    as commenters did not provide specific information on the costs in \n",
      "excess of our assessment, we find that we have no basis to make a \n",
      "reasonable adjustment. as such, we are maintaining our estimate of the \n",
      "number of hours required, as detailed in sections xii. and xiii. of \n",
      "this final rule.\n",
      "    comment: one commenter opposed increasing states submission of the \n",
      "mma file from monthly to daily, recommending instead that the frequency \n",
      "be increased to weekly. the commenter stated that determining on a \n",
      "daily basis whether there was any new information to send would be a \n",
      "significant effort, as multiple upstream systems may have to be \n",
      "changed, and further, that there would seldom be new data to send on a \n",
      "daily basis. the commenter requested that if cms finalized the \n",
      "regulation to require daily exchanges that states be permitted to \n",
      "continue to existing processing cycles that cross business, for \n",
      "example, run overnight between 6:00 p.m. to 6:00 a.m.\n",
      "    response: we acknowledge the commenter's concerns about resources, \n",
      "but note that other commenters--even those who echoed concerns about \n",
      "resources--uniformly supported the value of daily exchanges in \n",
      "improving the experience of dually eligible individuals and the ability \n",
      "of providers and plans to coordinate eligibility, enrollment, benefits, \n",
      "and/or care for this population. as we note above, we are committed to \n",
      "providing technical assistance and federal matching funds to support \n",
      "needed systems changes at the state. as a result, we decline to make \n",
      "the recommended change.\n",
      "    with respect to the point that there would not be updates on a \n",
      "daily basis, we reiterate that no file would be required on business \n",
      "days when there were no updates. we expect that states would be able to \n",
      "automate their systems so that they check daily for changes to data \n",
      "that would need to be submitted to cms on the mma file, but also \n",
      "automate a process by which the system only generates an mma file upon \n",
      "identifying such a change. we appreciate the additional coding required \n",
      "to implement this logic but that that once implemented, no additional \n",
      "interventions would be needed. we will work with states that have \n",
      "implemented these changes to identify and share best practices in \n",
      "identifying data changes to trigger daily submissions.\n",
      "    finally, in response to the concern about states that have an \n",
      "overnight processing cycle to continue so to meet the definition of \n",
      "``daily,'' the proposed regulation would permit this.\n",
      "    after consideration of the public comments and for the reasons \n",
      "articulated in the cms interoperability and patient access proposed \n",
      "rule and our responses to comments, we are finalizing 42 cfr 423.910 as \n",
      "proposed.\n",
      "\n",
      "b. request for stakeholder input\n",
      "\n",
      "    in addition to the proposals discussed above, we sought public \n",
      "comment for consideration in potential future rulemaking on how we can \n",
      "achieve greater interoperability of federal-state data for dually \n",
      "eligible individuals, including in the areas of program integrity and \n",
      "care coordination, coordination of benefits and crossover claims, \n",
      "beneficiary eligibility and enrollment, and their underlying data \n",
      "infrastructure. for more information on our request for comment, see \n",
      "the cms interoperability and patient access proposed rule (84 fr 7645). \n",
      "we thank commenters for their input. we will consider the information \n",
      "received for potential future rulemaking.\n",
      "    final action: we will require all states to participate in daily \n",
      "exchange of buy-in data, which includes both sending data to cms and \n",
      "receiving responses from cms daily, and require all states submit the \n",
      "required mma file data to cms daily by april 1, 2022. these policies \n",
      "are being finalized in 42 cfr 406.26, 407.40, and 423.910, \n",
      "respectively, as proposed. these requirements will improve the \n",
      "experience of dually eligible individuals and the ability of providers \n",
      "and payers to coordinate eligibility, enrollment, benefits, and/or care \n",
      "for this population. federal matching funds of 50 percent for \n",
      "administration are available to support states' costs. states may also \n",
      "be eligible for enhanced 90 percent federal matching funds for the \n",
      "costs of developing and implementing any necessary system changes \n",
      "required by this regulation, and enhanced 75 percent federal matching \n",
      "funds for their system's maintenance and operation costs. cms will \n",
      "provide technical assistance to the states that need to make changes to \n",
      "submit their files daily, including best practices on the upstream data \n",
      "sets necessary to implement daily mma file submissions.\n",
      "\n",
      "viii. information blocking background and public reporting provisions, \n",
      "and analysis of and responses to public comments\n",
      "\n",
      "a. information blocking background\n",
      "\n",
      "1. legislative background and policy considerations\n",
      "    the nature and extent of information blocking has come into focus \n",
      "in recent years. in 2015, at the request of the congress, onc submitted \n",
      "a report on health information blocking \\51\\ (hereinafter referred to \n",
      "as the ``information blocking congressional report''), in which onc \n",
      "commented on the then current state of technology, health it, and \n",
      "health care markets. notably, onc observed that prevailing market \n",
      "conditions create incentives for some individuals and entities to \n",
      "exercise their control over electronic health information in ways that \n",
      "limit its availability and use. since that time, onc and other \n",
      "divisions of hhs have continued to receive feedback from patients, \n",
      "clinicians, health care executives, payers, app developers and other \n",
      "technology companies, registries and health information exchanges, \n",
      "professional and trade associations, and many other stakeholders \n",
      "regarding practices which may constitute information blocking. despite \n",
      "significant public and private sector efforts to improve \n",
      "interoperability and data liquidity, engagement with stakeholders \n",
      "confirms that adverse incentives remain and continue to undermine \n",
      "progress toward a more connected health system.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\51\\ office of the national coordinator. (2015, april 9). report \n",
      "to congress on health information blocking. retrieved from <a href=\"https://www.healthit.gov/sites/default/files/reports/info_blocking_040915.pdf\">https://www.healthit.gov/sites/default/files/reports/info_blocking_040915.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    based on these economic realities and first-hand experience working \n",
      "with the health it industry and stakeholders, onc concluded in the \n",
      "information blocking congressional report that information blocking is \n",
      "a serious problem and recommended that the congress prohibit \n",
      "information blocking and provide penalties and enforcement mechanisms \n",
      "to deter these harmful practices.\n",
      "    macra became law in the same month that the information blocking \n",
      "congressional report was published. section 106(b)(2)(a) of macra \n",
      "amended section 1848(o)(2)(a)(ii) of the act to require that an \n",
      "eligible professional must demonstrate that he or she has not knowingly \n",
      "and willfully taken action (such as to disable functionality) to limit \n",
      "or restrict the compatibility or interoperability of certified ehr \n",
      "technology, as part of being a meaningful ehr user. section \n",
      "106(b)(2)(b) of macra made corresponding amendments to section \n",
      "1886(n)(3)(a)(ii) of the act for eligible hospitals and, by extension, \n",
      "under section 1814(l)(3) of the act for cahs. sections 106(b)(2)(a) and \n",
      "(b) of macra provide that the manner of this demonstration is to be \n",
      "through a process specified by the secretary, such as the use of an \n",
      "attestation. to implement these provisions, as discussed further\n",
      "\n",
      "[[page 25575]]\n",
      "\n",
      "below, we established and codified attestation requirements to support \n",
      "the prevention of information blocking, which consist of three \n",
      "statements containing specific representations about a health care \n",
      "provider's implementation and use of cehrt. to review our discussion of \n",
      "these requirements, we refer readers to the cy 2017 quality payment \n",
      "program final rule (81 fr 77028 through 77035).\n",
      "    recent empirical and economic research further underscores the \n",
      "complexity of the information blocking problem and its harmful effects. \n",
      "for a full discussion of the research, see the cms interoperability and \n",
      "patient access proposed rule (84 fr 7645 through 7646).\n",
      "    in december 2016, section 4004 of the cures act added section 3022 \n",
      "of the phsa (the ``phsa information blocking provision''), which \n",
      "defines conduct by health care providers, health it developers, and \n",
      "health information exchanges and networks that constitutes information \n",
      "blocking. the phsa information blocking provision was enacted in \n",
      "response to ongoing concerns that some individuals and entities are \n",
      "engaging in practices that unreasonably limit the availability and use \n",
      "of electronic health information for authorized and permitted purposes \n",
      "(see the definition of electronic health information proposed by onc \n",
      "for hhs adoption at 45 cfr 171.102 (84 fr 7588)). these practices \n",
      "undermine public and private sector investments in the nation's health \n",
      "it infrastructure and frustrate efforts to use modern technologies to \n",
      "improve health care quality and efficiency, accelerate research and \n",
      "innovation, and provide greater value and choice to health care \n",
      "consumers.\n",
      "    the information blocking provision defines and creates possible \n",
      "penalties and disincentives for information blocking in broad terms, \n",
      "working to deter the entire spectrum of practices likely to interfere \n",
      "with, prevent, or materially discourage access, exchange, or use of \n",
      "electronic health information. the phsa information blocking provision \n",
      "applies to health care providers, health it developers, exchanges, and \n",
      "networks. the information blocking provision also provides that the \n",
      "``secretary, through rulemaking, shall identify reasonable and \n",
      "necessary activities that do not constitute information blocking for \n",
      "purposes of the definition at section 3022(a)(1) of the phsa.'' onc's \n",
      "21st century cures act proposed rule proposed ``exceptions'' to the \n",
      "information blocking provision. these exceptions are reasonable and \n",
      "necessary activities that would not constitute information blocking. in \n",
      "addition to the attestation discussed in this section, all health care \n",
      "providers would also be subject to the separate information blocking \n",
      "regulations proposed by onc for hhs adoption at 45 cfr part 171 (84 fr \n",
      "7601 through 7605).\n",
      "\n",
      "b. public reporting and prevention of information blocking on physician \n",
      "compare\n",
      "\n",
      "    physician compare (<a href=\"http://www.medicare.gov/physiciancompare\">http://www.medicare.gov/physiciancompare</a>) draws \n",
      "its operating authority from section 10331(a)(1) of the affordable care \n",
      "act. consistent with section 10331(a)(2) of the affordable care act, \n",
      "physician compare initiated a phased approach to publicly reporting \n",
      "performance scores that provide comparable information on quality and \n",
      "patient experience measures. a complete history of public reporting on \n",
      "physician compare is detailed in the cy 2016 physician fee schedule \n",
      "(pfs) final rule with comment period (80 fr 71117 through 71122). more \n",
      "information about physician compare, including the history of public \n",
      "reporting and regular updates about what information is currently \n",
      "available, can also be accessed on the physician compare initiative \n",
      "website at <a href=\"https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/physician-compare-initiative/\">https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/physician-compare-initiative/</a>.\n",
      "    as discussed in the cy 2018 quality payment program final rule (82 \n",
      "fr 53820), physician compare has continued to pursue a phased approach \n",
      "to public reporting under macra in accordance with section 1848(q)(9) \n",
      "of the act. for a discussion of public reporting on physician compare, \n",
      "see the cms interoperability and patient access proposed rule (84 fr \n",
      "7646 through 7647).\n",
      "    building upon the continuation of our phased approach to public \n",
      "reporting and understanding the importance of preventing information \n",
      "blocking, promoting interoperability, and the sharing of information, \n",
      "we proposed to make certain data about the attestation statements on \n",
      "the prevention of information blocking referenced in the cms \n",
      "interoperability and patient access proposed rule (84 fr 7645) \n",
      "available for public reporting on physician compare, drawing upon our \n",
      "authority under section 10331(a)(2) of affordable care act, which \n",
      "required us to make publicly available on physician compare information \n",
      "on physician performance that provides comparable information for the \n",
      "public on quality and patient experience measures. section 10331(a)(2) \n",
      "of the affordable care act provided that to the extent scientifically \n",
      "sound measures that are developed consistent with the requirements of \n",
      "section 10331 of the affordable care act are available, such \n",
      "information shall include, to the extent practicable, an assessment of \n",
      "the coordination of care and other information as determined \n",
      "appropriate by the secretary. we noted our belief that section \n",
      "10331(a)(2) of the affordable care act provided the statutory authority \n",
      "to publicly report certain data about the prevention of information \n",
      "blocking attestation statements as an assessment of care coordination \n",
      "and as other information determined appropriate by the secretary. \n",
      "furthermore, the prevention of information blocking attestation \n",
      "statements are required for a clinician to earn a promoting \n",
      "interoperability performance category score, which is then incorporated \n",
      "into the final score for mips, and we are required to publicly report \n",
      "both of these scores under section 1848(q)(9)(a) of the act. publicly \n",
      "posting this information as an indicator is consistent with our \n",
      "finalized policy to publicly report, either on the profile pages or in \n",
      "the downloadable database, other aspects of the promoting \n",
      "interoperability performance category, such as objectives, activities, \n",
      "or measures specified in the cy 2018 quality payment program final rule \n",
      "(82 fr 53826 through 53827). we note that we finalized at 42 cfr \n",
      "414.1395(b), that, with the exception of data that must be mandatorily \n",
      "reported on physician compare, for each program year, we rely on the \n",
      "established public reporting standards to guide the information \n",
      "available for inclusion on physician compare. the public reporting \n",
      "standards require data included on physician compare to be \n",
      "statistically valid, reliable, and accurate; be comparable across \n",
      "submission mechanisms; and, meet the reliability threshold. to be \n",
      "included on the public facing profile pages, the data must also \n",
      "resonate with website users, as determined by cms.\n",
      "    there are three prevention of information blocking attestation \n",
      "statements under 42 cfr 414.1375(b)(3)(ii)(a) through (c) to which \n",
      "eligible clinicians reporting on the promoting interoperability \n",
      "performance category of mips must attest. to report successfully on the \n",
      "promoting interoperability performance category, in addition to \n",
      "satisfying other requirements, an eligible clinician must submit an \n",
      "attestation response of ``yes'' for each of these statements. for more \n",
      "information about these statements, we refer readers to the preamble \n",
      "discussion\n",
      "\n",
      "[[page 25576]]\n",
      "\n",
      "in the cy 2017 quality payment program final rule (81 fr 77028 through \n",
      "81 fr 77035).\n",
      "    the promoting interoperability performance category weight \n",
      "comprises 25 percent of a mips eligible clinician's final score for \n",
      "each mips payment year, as specified at 42 cfr 414.1375(a). as \n",
      "specified at 42 cfr 414.1405(b)(2), mips eligible clinicians with a \n",
      "final score below the performance threshold receive a negative mips \n",
      "payment adjustment factor on a linear sliding scale. certain mips \n",
      "eligible clinicians who submit data for the promoting interoperability \n",
      "performance category may be eligible for reweighting, as specified \n",
      "under 42 cfr 414.1380(c)(2). as specified at 42 cfr 414.1405(a), \n",
      "(b)(1), and (b)(2), mips eligible clinicians may receive a positive, \n",
      "neutral, or negative mips payment adjustment factor. as specified at 42 \n",
      "cfr 414.1405(c), the applicable percent for mips payment year 2021 is 7 \n",
      "percent. for mips payment year 2022, and each subsequent mips payment \n",
      "year, it is 9 percent. for more information about the mips, we refer \n",
      "readers to the preamble discussion in the cy 2020 quality payment \n",
      "program final rule (84 fr 62946 through 63083).\n",
      "    we noted our belief that it would benefit the public to know if \n",
      "eligible clinicians have attested negatively to the statements under 42 \n",
      "cfr 414.1375(b)(3)(ii) as this may assist the patient in selecting a \n",
      "clinician or group who collaborates with other clinicians, groups, or \n",
      "other types of health care providers by sharing information \n",
      "electronically, and does not withhold information that may result in \n",
      "better care. therefore, we proposed to include an indicator on \n",
      "physician compare for the eligible clinicians and groups that submit a \n",
      "``no'' response to any of the three statements under 42 cfr \n",
      "414.1375(b)(3)(ii)(a) through (c). in the event that these statements \n",
      "are left blank, that is, a ``yes'' or a ``no'' response is not \n",
      "submitted, the attestations would be considered incomplete, and we \n",
      "would not include an indicator on physician compare. we also proposed \n",
      "to post this indicator on physician compare, either on the profile \n",
      "pages or the downloadable database, as feasible and appropriate, \n",
      "starting with the 2019 performance period data available for public \n",
      "reporting starting in late 2020. we refer readers to the 2019 promoting \n",
      "interoperability information blocking factsheet at <a href=\"https://qpp-cm-prod-content.s3.amazonaws.com/uploads/282/2019%20pi%20information%20blocking%20fact%20sheet.pdf\">https://qpp-cm-prod-content.s3.amazonaws.com/uploads/282/2019%20pi%20information%20blocking%20fact%20sheet.pdf</a> for more \n",
      "information about the attestation statements.\n",
      "    under 42 cfr 414.1395(b), these data must meet our established \n",
      "public reporting standards, including that to be included on the public \n",
      "facing profile pages, the data must resonate with website users, as \n",
      "determined by cms. in previous testing with patients and caregivers, we \n",
      "learned that effective use of cehrt is important to them when making \n",
      "informed health care decisions. for more information about previous \n",
      "testing with patients and caregivers, we refer readers to the physician \n",
      "compare technical expert panel (tep) summary report at <a href=\"https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/physician-compare-initiative/downloads/physician-compare-tep-summary-2018.pdf\">https://www.cms.gov/medicare/quality-initiatives-patient-assessment-instruments/physician-compare-initiative/downloads/physician-compare-tep-summary-2018.pdf</a>. to determine how to best display and meaningfully \n",
      "communicate the indicator on the physician compare website, the exact \n",
      "wording and, if applicable, profile page indicator would be determined \n",
      "after user testing and shared with stakeholders through the physician \n",
      "compare initiative page, listservs, webinars, and other available \n",
      "communication channels. we noted that the proposal was contingent upon \n",
      "the availability of and technical feasibility to use the data for \n",
      "public reporting.\n",
      "    we summarize the public comments we received on this topic and \n",
      "provide our responses.\n",
      "    comment: most commenters supported our proposal to publicly report \n",
      "an indicator on the physician compare website for the eligible \n",
      "clinicians and groups that submit a ``no'' response to any of the three \n",
      "prevention of information blocking attestation statements, noting that \n",
      "the indicator would discourage clinicians and groups from information \n",
      "blocking and help medicare patients and caregivers make informed health \n",
      "care decisions.\n",
      "    response: we thank commenters for their support and agree that \n",
      "publicly reporting an indicator on physician compare will discourage \n",
      "clinicians and groups from information blocking and help medicare \n",
      "patients and caregivers make informed decisions.\n",
      "    comment: some commenters expressed concern for various reasons \n",
      "about publicly reporting an indicator on the physician compare website \n",
      "for the eligible clinicians and groups that submit a ``no'' response to \n",
      "any of the three prevention of information blocking attestation \n",
      "statements. several of these commenters thought the indicator would be \n",
      "redundant, since there is already an incentive for clinicians to attest \n",
      "to the prevention of information blocking statements in order to earn a \n",
      "mips promoting interoperability performance category score. some \n",
      "commenters were concerned that an indicator may not accurately reflect \n",
      "whether a clinician or group is knowingly or willfully information \n",
      "blocking, since they may be confused about the attestation statements' \n",
      "meanings. a few commenters suggested delaying physician compare's \n",
      "indicator implementation in order to give clinicians and groups, \n",
      "particularly small and rural practices, time to become more familiar \n",
      "with the attestations. other commenters expressed concern as to whether \n",
      "medicare patients and caregivers would find the indicator useful; one \n",
      "of these commenters suggested conducting a pilot study to make such a \n",
      "determination. finally, several commenters suggested an appeal process \n",
      "or an opportunity for clinicians and groups to review their information \n",
      "prior to public reporting.\n",
      "    response: we appreciate the commenters' concerns. we believe \n",
      "publicly reporting an indicator on physician compare for the eligible \n",
      "clinicians and groups that submit a ``no'' response to any of the three \n",
      "prevention of information blocking attestation statements is not \n",
      "redundant, as medicare patients and caregivers do not currently have \n",
      "access to this type of information, which could aid them in making \n",
      "informed health care decisions.\n",
      "    regarding concerns about clinicians, including small and rural \n",
      "practices, needing time to become familiar with the attestations, we \n",
      "believe there has been sufficient time for clinicians to become \n",
      "familiar with them, since these attestation statements have been a mips \n",
      "promoting interoperability performance category requirement since the \n",
      "2017 performance period. we also believe that webinars and educational \n",
      "materials that cms has made available have provided clinicians and \n",
      "groups an opportunity to become familiar with the information blocking \n",
      "attestation statements. we will also continue to support small and \n",
      "rural practices by offering free and customized resources available \n",
      "within local communities, including direct, one-on-one support from the \n",
      "small, underserved, and rural support initiative along with our other \n",
      "no-cost technical assistance (83 fr 59720). regarding whether an \n",
      "information blocking indicator would be meaningful to patients and \n",
      "caregivers, we note that under 42 cfr 414.1395(b), these data must meet \n",
      "our established public reporting standards, including that to be posted \n",
      "on public facing profile pages, the data must resonate with website \n",
      "users, as determined by cms. such user testing to date has shown that\n",
      "\n",
      "[[page 25577]]\n",
      "\n",
      "effective cehrt usage is important to patients when making health care \n",
      "decisions. in addition, as specified at 42 cfr 414.1375(b)(3)(ii), mips \n",
      "eligible clinicians must attest to the prevention of information \n",
      "blocking statements. for more information about these statements, we \n",
      "refer readers to the preamble discussion in the cy 2017 quality payment \n",
      "program final rule (81 fr 77028 through 81 fr 77035). in addition, we \n",
      "note that section 4004 of the cures act added section 3022 of the phsa, \n",
      "which directs hhs to identify reasonable and necessary activities \n",
      "conducted by health care providers, health it developers, and health \n",
      "information exchanges and networks that would not constitute \n",
      "information blocking as defined in section 3022. for more information, \n",
      "see the information blocking discussion in onc's 21st century cures act \n",
      "final rule (published elsewhere in this issue of the federal register).\n",
      "    while we appreciate the commenter's suggestion to conduct a pilot \n",
      "study, we believe that further user testing will allow us to gain the \n",
      "additional understanding necessary.\n",
      "    regarding the comments requesting an opportunity to review or an \n",
      "appeal process, we note that, under 42 cfr 414.1395(d), for each \n",
      "program year, cms provides a 30-day preview period for any clinician or \n",
      "group with quality payment program data before the data are publicly \n",
      "reported on physician compare. although at this time we do not preview \n",
      "indicator information, clinicians and groups will be able to preview \n",
      "their promoting interoperability performance category information, \n",
      "including their attestation responses to the three statements during \n",
      "the mips targeted review process. all performance data publicly \n",
      "reported on physician compare will reflect the scores eligible \n",
      "clinicians and groups receive in their mips performance feedback, which \n",
      "will be available for review and potential correction during the \n",
      "targeted review process (83 fr 59912).\n",
      "    comment: many commenters recommended additional actions to prevent \n",
      "information blocking, beyond publicly reporting an indicator on \n",
      "physician compare. some commenters recommended implementing additional \n",
      "penalties for clinicians and groups that attest ``no'' to the \n",
      "prevention of information blocking attestations, such as corrective \n",
      "action. other commenters suggested cms offer more positive incentives. \n",
      "several commenters suggested having additional indicators, such a \n",
      "positive one for those who attest ``yes.'' another commenter \n",
      "recommended treating a blank response to the three attestation \n",
      "statements as a ``no'' response. a few commenters recommended that the \n",
      "proposed indicator not be used for clinicians and groups that \n",
      "participate in trusted exchange networks.\n",
      "    response: we appreciate commenters' suggestions and will consider \n",
      "them for potential future rulemaking, to the extent permitted by our \n",
      "authority. to the extent of our authority, we will consider treatment \n",
      "of attestation statements that are left blank, use of a positive \n",
      "indicator on the physician compare profile pages or downloadable \n",
      "database, and the use of the proposed indicator for clinicians and \n",
      "groups that participate in trusted exchange networks for potential \n",
      "future rulemaking.\n",
      "    regarding commenters' suggestions for additional penalties, we note \n",
      "that section 4004 of the cures act identifies potential penalties and \n",
      "disincentives for information blocking. health care providers \n",
      "determined by the inspector general to have committed information \n",
      "blocking shall be referred to the appropriate agency to be subject to \n",
      "appropriate disincentives using authorities under applicable federal \n",
      "law, as the secretary sets forth through notice and comment rulemaking. \n",
      "in the onc 21st century cures act proposed rule, a request for \n",
      "information regarding disincentives for health care providers was \n",
      "included (84 fr 7553).\n",
      "    comment: some commenters requested additional information on the \n",
      "proposed information blocking indicator. a few of these commenters \n",
      "requested additional information on the attestation requirements for \n",
      "clinicians and groups participating in other programs, such as medicare \n",
      "advantage. several commenters requested additional guidance on \n",
      "exceptions to the attestations. another commenter requested more \n",
      "information on the implications for clinicians and groups who leave the \n",
      "attestation statements blank and do not attest ``yes'' or ``no.'' \n",
      "several commenters questioned how clinicians' responses to the three \n",
      "attestation statements would be verified for accuracy.\n",
      "    response: the three attestation statements are required under the \n",
      "mips, which is a medicare ffs program. we note that 42 cfr 414.1310(b) \n",
      "and (c) provide that qualifying apm participants (qps) and partial qps \n",
      "who do not report on applicable measures and activities that are \n",
      "required to be reported under mips for any given performance period in \n",
      "a year are excluded from this definition at 42 cfr 414.1305 of a mips \n",
      "eligible clinician per the statutory exclusions defined in section \n",
      "1848(q)(1)(c)(ii) and (v) of the act. therefore, the prevention of \n",
      "information blocking indicator would be applicable only to mips \n",
      "eligible clinicians and groups under medicare ffs and not to other \n",
      "programs, such as ma. under mips, the attestation statements are \n",
      "required for all eligible clinicians under the promoting \n",
      "interoperability performance category of mips, as specified at 42 cfr \n",
      "414.1375(b)(3)(ii) (81 fr 77035). if the attestation statements are \n",
      "left blank, that is, a ``yes'' or ``no'' response is not submitted, the \n",
      "attestations would be considered incomplete and the clinician or group \n",
      "would not receive a promoting interoperability performance category \n",
      "score. in this situation, we would not have an affirmative or negative \n",
      "response to the three attestation statements from the clinician or \n",
      "group, and we would not have enough information to determine whether \n",
      "the clinician or group is knowingly and willfully information blocking. \n",
      "regarding exceptions to the attestation requirements, under 42 cfr \n",
      "414.1380(c)(2) the promoting interoperability performance category may \n",
      "be reweighted to zero percent of the final score for a mips eligible \n",
      "clinician in certain circumstances, and clinicians who receive \n",
      "reweighting would not have to submit data for the promoting \n",
      "interoperability performance category, including their responses to the \n",
      "attestation statements. regarding verification of clinicians' \n",
      "attestation statements, we note that we finalized in prior rulemaking \n",
      "that we will perform ongoing monitoring of mips eligible clinicians and \n",
      "groups on an ongoing basis for data validation, auditing, program \n",
      "integrity issues, and instances of non-compliance with mips \n",
      "requirements. if a mips eligible clinician or group is found to have \n",
      "submitted inaccurate data for mips, we finalized that we would reopen \n",
      "and revise the determination in accordance with the rules set forth at \n",
      "42 cfr 405.980 through 405.986 (81 fr 77362).\n",
      "    final action: after consideration of the comments received, and for \n",
      "the reasons outlined in our responses to these comments, we are \n",
      "finalizing this policy as proposed. specifically, we are finalizing to \n",
      "include an indicator on physician compare for the eligible clinicians \n",
      "and groups that submit a ``no'' response to any of the three prevention \n",
      "of information blocking attestation statements for mips under 42 cfr \n",
      "414.1375(b)(3)(ii)(a) through (c), as proposed. in the event that these \n",
      "statements are left blank, that is, a ``yes''\n",
      "\n",
      "[[page 25578]]\n",
      "\n",
      "or a ``no'' response is not submitted, the attestations will be \n",
      "considered incomplete, and we will not include an indicator on \n",
      "physician compare. we will post this indicator on physician compare, \n",
      "either on the profile pages or in the downloadable database, as \n",
      "feasible and appropriate, starting with the 2019 performance period \n",
      "data available for public reporting starting in late 2020.\n",
      "\n",
      "c. public reporting and prevention of information blocking for eligible \n",
      "hospitals and critical access hospitals (cahs)\n",
      "\n",
      "    section 1886(n)(4)(b) of the act requires the secretary to post in \n",
      "an easily understandable format a list of the names and other relevant \n",
      "data, as determined appropriate by the secretary, of eligible hospitals \n",
      "and cahs who are meaningful ehr users under the medicare ffs program, \n",
      "on a cms website. in addition, that section requires the secretary to \n",
      "ensure that an eligible hospital or cah has the opportunity to review \n",
      "the other relevant data that are to be made public with respect to the \n",
      "eligible hospital or cah prior to such data being made public. we noted \n",
      "in the cms interoperability and patient access proposed rule (84 fr \n",
      "7647) that we believed certain information related to the prevention of \n",
      "information blocking attestation statements under 42 cfr \n",
      "495.40(b)(2)(i)(i)(1) through (3) would constitute other relevant data \n",
      "under section 1886(n)(4)(b) of the act. specifically, we referred to \n",
      "the three prevention of information blocking attestation statements \n",
      "under 42 cfr 495.40(b)(2)(i)(i)(1) through (3) to which eligible \n",
      "hospitals and cahs must attest for purposes of the promoting \n",
      "interoperability program. as part of successfully demonstrating that an \n",
      "eligible hospital or cah is a meaningful ehr user for purposes of the \n",
      "promoting interoperability program, the eligible hospital or cah must \n",
      "submit an attestation response of ``yes'' for each of these statements. \n",
      "for more information about these statements, we referred readers to the \n",
      "preamble discussion in the cy 2017 quality payment program final rule \n",
      "(81 fr 77028 through 77035).\n",
      "    we noted in the cms interoperability and patient access proposed \n",
      "rule (84 fr 7647) that we believed it would be relevant to the public \n",
      "to know if eligible hospitals and cahs have attested negatively to the \n",
      "statements under 42 cfr 495.40(b)(2)(i)(i)(1) through (3) as it could \n",
      "indicate that they are knowingly and unreasonably interfering with the \n",
      "exchange or use of electronic health information in ways that limit its \n",
      "availability and use to improve health care. as we stated in the cy \n",
      "2017 quality payment program final rule, we believed that addressing \n",
      "issues related to information blocking would require additional and \n",
      "more comprehensive measures (81 fr 77029). in addition, publicly \n",
      "posting this information would reinforce our commitment to focus on \n",
      "increased interoperability and the appropriate exchange of health \n",
      "information. we proposed to post information on a cms website available \n",
      "to the public indicating that an eligible hospital or cah attesting \n",
      "under the medicare ffs promoting interoperability program submitted a \n",
      "``no'' response to any of the three statements under 42 cfr \n",
      "495.40(b)(2)(i)(i)(1) through (3). in the event that these statements \n",
      "are left blank, that is, a ``yes'' or a ``no'' response is not \n",
      "submitted, we proposed the attestations would be considered incomplete, \n",
      "and we would not post any information related to these attestation \n",
      "statements for that hospital or cah. we proposed to post this \n",
      "information starting with the attestations for the ehr reporting period \n",
      "in 2019, and we expected the information would be posted in late 2020. \n",
      "in accordance with section 1886(n)(4)(b) of the act, we proposed to \n",
      "establish a process for each eligible hospital and cah to review the \n",
      "information related to their specific prevention of information \n",
      "blocking attestation statements before it is publicly posted on a cms \n",
      "website. specifically, for each program year, we proposed a 30-day \n",
      "preview period for an eligible hospital or cah to review this \n",
      "information before it is publicly posted. during the 30-day preview \n",
      "period, we proposed that all of the information that we would publicly \n",
      "post would be available for the eligible hospital or cah to review, and \n",
      "we would consider making changes to the information on a case-by-case \n",
      "basis (for example, in the event the eligible hospital or cah \n",
      "identifies an error, and we subsequently determine that the information \n",
      "is not accurate). additional information on the review process would be \n",
      "provided outside of the rulemaking process through the usual \n",
      "communication channels for the program.\n",
      "    we summarize the public comments we received on this topic and \n",
      "provide our responses.\n",
      "    comment: many commenters indicated their strong support for this \n",
      "proposal and suggested that we finalize the proposal, as commenters \n",
      "believe it is necessary in building an interoperable health system. one \n",
      "commenter believes that maintaining accountability and enforcing \n",
      "penalties is critical to maintaining individual health and safety. \n",
      "another commenter agreed, stating that information blocking is \n",
      "detrimental to the health, safety, and welfare of patients. many \n",
      "commenters indicated that information blocking should not be tolerated \n",
      "for competitive or financial reasons, further indicating that consumers \n",
      "and stakeholders should be made aware of those who participate in \n",
      "information blocking practices, as this transparency can prevent \n",
      "potential medical errors and improve the overall quality of care.\n",
      "    response: we thank commenters for their support for the proposal. \n",
      "we agree with the commenters and believe that the proposed policy would \n",
      "be both appropriate and effective in reinforcing our commitment to \n",
      "focus on increasing interoperability and the appropriate exchange of \n",
      "health information. knowingly or willfully preventing, avoiding, or \n",
      "withholding information limits interoperability and prevents the \n",
      "sharing of important health information.\n",
      "    comment: many commenters indicated support for the promotion of \n",
      "health information exchange and the prevention of information blocking, \n",
      "generally, but expressed several concerns about the implementation of \n",
      "this proposal. a couple of commenters were concerned that there is not \n",
      "enough time to develop the policies and procedures needed to streamline \n",
      "the proposed process, and in response, suggested building in a period \n",
      "of non-enforcement (a practice period without posting any information \n",
      "publicly). several commenters expressed concern that there will not be \n",
      "an opportunity to dispute information prior to publication, and \n",
      "requested including a guarantee of the proposed 30-day preview period \n",
      "prior to the publication of certain information on a cms website. \n",
      "finally, commenters had concerns about how policies related to \n",
      "information blocking and changes to the 2015 edition of certified \n",
      "health it proposed in onc's 21st century cures act proposed rule may \n",
      "impact the prevention of information blocking attestations under the \n",
      "promoting interoperability program.\n",
      "    response: we appreciate the commenters' concerns and suggestions. \n",
      "we are finalizing the proposal to post this information starting with \n",
      "the attestations for the ehr reporting period in 2019, and we are \n",
      "targeting for this information to be posted in late 2020. although we \n",
      "will not have a period of non-enforcement (postponing posting of \n",
      "information publicly), we are building in a 30-day preview period \n",
      "during which any discrepancies or concerns may be addressed on a case-\n",
      "by-case\n",
      "\n",
      "[[page 25579]]\n",
      "\n",
      "basis prior to posting. additional information on the preview period \n",
      "will be provided outside of the rulemaking process through the usual \n",
      "communication channels for the program. with regard to onc's 21st \n",
      "century cures act rule, the prevention of information blocking \n",
      "attestation statements under the promoting interoperability program are \n",
      "not affected by onc's final rule policies and remain unchanged.\n",
      "    comment: a number of commenters supported the prevention of \n",
      "information blocking, but had concerns about the additional burden this \n",
      "proposal may add. one commenter requested reassurance that this process \n",
      "will not increase burden, while a few other commenters shared concerns \n",
      "that this process will increase burden.\n",
      "    response: we appreciate the commenters' concerns. as eligible \n",
      "hospitals and cahs are already required to respond to these three \n",
      "attestation statements under the promoting interoperability program, we \n",
      "do not believe this proposal would require additional reporting effort, \n",
      "or thereby increase burden. we do not believe the 30-day preview period \n",
      "would increase burden as it will be an opportunity for eligible \n",
      "hospitals and cahs to ensure the accuracy of the information that will \n",
      "be posted publicly, should they choose to take advantage of this \n",
      "opportunity.\n",
      "    comment: many commenters stated that there should be an audit or \n",
      "spot check process to validate the responses provided to the three \n",
      "attestation statements. commenters indicated concern that those who \n",
      "knowingly participate in information blocking practices will answer \n",
      "`yes' to the three attestation statements simply to complete the \n",
      "question/answer sequencing in the reporting system. further, commenters \n",
      "expressed concern regarding how easy it could be for their peers to \n",
      "respond dishonestly, and requested more stringent auditing practices \n",
      "from cms. a number of commenters requested additional information on \n",
      "how a ``blank'' response would be treated for purposes of this \n",
      "proposal; one commenter believed that a ``blank'' should be considered \n",
      "a ``no'', and another commenter believed that a ``blank'' should simply \n",
      "be considered as a ``blank.''\n",
      "    response: we appreciate the commenters' concerns. we do not have a \n",
      "specific auditing practice in place for these specific attestation \n",
      "statements. instead, all eligible hospitals and cahs are required to \n",
      "submit responses to the attestation statements under the promoting \n",
      "interoperability program and must respond accurately, as any eligible \n",
      "hospital or cah participating in the promoting interoperability program \n",
      "may be subject to an audit. in the event that an eligible hospital or \n",
      "cah leaves a ``blank'' response to an attestation statement, where a \n",
      "``yes'' or a ``no'' response is not submitted, the response would be \n",
      "considered incomplete, and no information would be posted related to \n",
      "these attestation statements at this time.\n",
      "    comment: many commenters supported the effort to prevent \n",
      "information blocking, though several believed that posting certain \n",
      "information on a cms website of those who attest `no' to the prevention \n",
      "of information blocking statements may not strongly impact the issue. \n",
      "of the reasons given, one commenter remained agnostic on whether such a \n",
      "policy would have tangible success in deterring information blocking, \n",
      "several commenters stated that the information posted on a cms website \n",
      "will have little meaning to consumers, and others believed that this \n",
      "process would not promote interoperability nor would it improve patient \n",
      "access to information.\n",
      "    response: we appreciate all of the commenters' concerns. as \n",
      "discussed in the cy 2017 quality payment program final rule (81 fr \n",
      "77029), the act of information blocking is a systemic problem that \n",
      "congress has expressed concerns about. growing evidence has established \n",
      "that there is a strong incentive for health care providers to \n",
      "unreasonably interfere with the exchange of health information. we \n",
      "believe that publicly posting certain information on a cms website is \n",
      "one valuable tool in our continued effort to deter these information \n",
      "blocking practices.\n",
      "    as patients gain access to more data, they become more empowered \n",
      "and more informed decision makers. knowing if a physician may be \n",
      "information blocking could influence their decision to see that \n",
      "physician. in addition, knowing patients can see this information may \n",
      "deter physicians from engaging in this behavior. for these reasons, we \n",
      "do believe that this effort will have an impact and be meaningful to \n",
      "consumers. we do also believe that this policy will promote \n",
      "interoperability and improve patient access to information. with \n",
      "patients becoming more empowered, this drives health care providers to \n",
      "move toward information sharing rather than information blocking, which \n",
      "directly leads to improved patient access to information.\n",
      "    comment: a couple commenters suggested moving away from posting \n",
      "public information, and instead focusing on creating positive incentive \n",
      "programs, enhancing guidance, providing more education, and fostering \n",
      "change through encouraging the prevention of information blocking. some \n",
      "commenters agreed with the approach, but believed cms could develop \n",
      "more concrete measures that would have a stronger justification for \n",
      "posting information on a cms website versus using the three attestation \n",
      "statements.\n",
      "    response: thank you for these comments and suggestions. to the \n",
      "extent that the commenters are requesting that we create positive \n",
      "incentive programs that include incentive payments to eligible \n",
      "hospitals and cahs, we note that we can only do so to the extent \n",
      "authorized by law. we will take into consideration the suggestions for \n",
      "enhancing prevention of information blocking guidance, providing more \n",
      "education, and fostering change through encouragement in potential \n",
      "future rulemaking.\n",
      "    comment: a few commenters were in favor of posting certain \n",
      "information on eligible hospitals and/or cahs that provide a ``no'' \n",
      "response to the prevention of information blocking attestation \n",
      "statements, but have requested additional ways to discourage this \n",
      "practice. commenters requested that those who are knowingly and \n",
      "willfully blocking the transfer of information also be fined, per \n",
      "instance or per patient, as a way of disincentivizing this practice. a \n",
      "couple commenters suggested strengthening this provision by \n",
      "establishing an easy way for stakeholders to report potential \n",
      "information blocking activities.\n",
      "    response: we appreciate the commenters' suggestions regarding \n",
      "additional ways to discourage information blocking. we refer commenters \n",
      "to section 3022(b)(2)(b) of the phsa, which provides that any health \n",
      "care provider determined by the office of the inspector general (oig) \n",
      "to have committed information blocking shall be referred to the \n",
      "appropriate agency to be subject to appropriate disincentives using \n",
      "authorities under applicable federal law, as the secretary sets forth \n",
      "through notice and comment rulemaking. health care providers would also \n",
      "be subject to the separate information blocking regulations proposed by \n",
      "onc for hhs adoption at 45 cfr part 171 (84 fr 7601 through 7605). \n",
      "further, we note that onc's 21st century cures act proposed rule \n",
      "included a request for information regarding disincentives for health \n",
      "care providers (84 fr 7553).\n",
      "    comment: many commenters, while in agreement with publicly posting \n",
      "certain information related to\n",
      "\n",
      "[[page 25580]]\n",
      "\n",
      "information blocking, had concerns that eligible hospitals and cahs are \n",
      "being held accountable for the practices of health it vendors. many \n",
      "commenters were concerned that vendors are restricting the transfer of \n",
      "data by data embargoing, actively blocking, and refusing or prohibiting \n",
      "the transfer of data. further, there were concerns that vendors are \n",
      "requiring complex programs, the purchase of many costly programs, and \n",
      "requiring excessive fees to conduct data transfer. last, several \n",
      "commenters requested that vendors be penalized equally, and in the same \n",
      "manner, as eligible hospitals and cahs.\n",
      "    response: we appreciate the commenters' support for the proposal, \n",
      "and we also appreciate their concerns. we emphasize that the \n",
      "information blocking provision (section 4004 of the cures act) applies \n",
      "to health it developers of certified health it. section 3022(a)(1) of \n",
      "the phsa, in defining information blocking, refers to four classes of \n",
      "individuals and entities that may engage in information blocking and \n",
      "which include: health care providers, health it developers of certified \n",
      "health it, networks, and exchanges. in the onc 21st century cures act \n",
      "proposed rule, onc proposed to adopt definitions of these terms to \n",
      "provide clarity regarding the types of individuals and entities to whom \n",
      "the information blocking provision applies (84 fr 7601 through 7602).\n",
      "    regarding penalties, section 4004 of the cures act identifies \n",
      "potential penalties and disincentives for information blocking. health \n",
      "it developers, health information networks, and health information \n",
      "exchanges that the inspector general, following an investigation, \n",
      "determines to have committed information blocking shall be subject to a \n",
      "civil monetary penalty determined by the secretary for all such \n",
      "violations identified through such investigation, which may not exceed \n",
      "$1,000,000 per violation. such determination shall take into account \n",
      "factors such as the nature and extent of the information blocking and \n",
      "harm resulting from such information blocking, including, where \n",
      "applicable, the number of patients affected, the number of providers \n",
      "affected, and the number of days the information blocking persisted. \n",
      "health care providers determined by the inspector general to have \n",
      "committed information blocking shall be referred to the appropriate \n",
      "agency to be subject to appropriate disincentives using authorities \n",
      "under applicable federal law, as the secretary sets forth through \n",
      "notice and comment rulemaking.\n",
      "    comment: one commenter suggested a collaboration between cms, onc, \n",
      "and oig in order to address information blocking together, to combat \n",
      "information blocking consistently and from all angles.\n",
      "    response: we appreciate the commenter's suggestion, and note that \n",
      "cms, onc, and oig are consistently working together on issues such as \n",
      "information blocking so that our policies are complementary and work \n",
      "together to address the issue.\n",
      "    final action: after consideration of the comments received, and for \n",
      "the reasons outlined in our response to these comments and in the cms \n",
      "interoperability and patient access proposed rule, we are finalizing \n",
      "this policy as proposed. we will include information on a cms website \n",
      "available to the public indicating that an eligible hospital or cah \n",
      "attesting under the medicare ffs promoting interoperability program \n",
      "submitted a ``no'' response to any of the three prevention of \n",
      "information blocking attestation statements under 42 cfr \n",
      "495.40(b)(2)(i)(i)(1) through (3). we will post this information \n",
      "starting with the attestations for the ehr reporting period in 2019, \n",
      "and expect the information will be posted in late 2020. in the event \n",
      "that an eligible hospital or cah leaves a ``blank'' response to an \n",
      "attestation statement, where a ``yes'' or a ``no'' response is not \n",
      "submitted, the attestations will be considered incomplete, and no \n",
      "information will be posted related to these attestation statements. we \n",
      "will establish a process for each eligible hospital and cah to review \n",
      "the information related to their specific prevention of information \n",
      "blocking attestation statements before it is publicly posted on the cms \n",
      "website. for each program year, we will have a 30-day preview period \n",
      "for an eligible hospital or cah to review this information before it is \n",
      "publicly posted. during the 30-day preview period, all of the \n",
      "information that we will publicly post will be available for the \n",
      "eligible hospital or cah to review, and we will consider making changes \n",
      "to the information on a case-by-case basis.\n",
      "\n",
      "ix. provider digital contact information provisions, and analysis of \n",
      "and responses to public comments\n",
      "\n",
      "a. background\n",
      "\n",
      "    congress required the secretary to create a provider digital \n",
      "contact information index in section 4003 of the cures act. this index \n",
      "must include all individual health care providers and health care \n",
      "facilities, or practices, in order to facilitate a comprehensive and \n",
      "open exchange of patient health information. congress gave the \n",
      "secretary the authority to use an existing index or to facilitate the \n",
      "creation of a new index. in comments received on the fy 2019 ipps \n",
      "proposed rule rfi, there was strong support for a single, public \n",
      "directory of provider digital contact information. commenters noted \n",
      "that digital communication could improve interoperability by \n",
      "facilitating efficient exchange of patient records, eliminating the \n",
      "burden of working with scanned paper documents, and ultimately \n",
      "enhancing care coordination.\n",
      "    to ensure the index is accessible to all clinicians and facilities, \n",
      "we updated the national plan and provider enumeration system (nppes) \n",
      "\\52\\ to be able to capture digital contact information for both \n",
      "individuals and facilities. it is important to note that the \n",
      "aforementioned updates to the nppes entailed the addition of two \n",
      "additional data fields. however, due to an administrative oversight, \n",
      "the data elements which allow for the digital capture of contact \n",
      "information are not omb approved. cms acknowledges this violation of \n",
      "the paperwork reduction act of 1995 (pra) and is currently working to \n",
      "remediate the issue by creating a new pra package and thereby come into \n",
      "compliance with the pra. prior to its submission for omb approval, the \n",
      "new information collection request will be made available for public \n",
      "review and comment as required by the pra.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\52\\ the nppes website at <a href=\"https://nppes.cms.hhs.gov/\">https://nppes.cms.hhs.gov/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    nppes currently supplies national provider identifier (npi) numbers \n",
      "to health care providers (both individuals and facilities), maintains \n",
      "their npi record, and publishes the records online. the secretary \n",
      "adopted the npi as the hipaa administrative simplification standard \n",
      "identifier for health care providers (69 fr 3434). hipaa covered \n",
      "entities, including health care providers, health plans, and health \n",
      "care clearinghouses, must use the npi in hipaa transactions. all health \n",
      "care providers that transmit health information in electronic form in \n",
      "connection with a hipaa transaction must obtain an npi.\n",
      "    health care providers are required to communicate to the nppes any \n",
      "information that has changed within 30 days of the change (45 cfr \n",
      "162.410(a)(4)). we review nppes to ensure a provider has a valid npi as \n",
      "part of the medicare enrollment process, as well as the revalidation \n",
      "process, which occurs every 3 to 5 years depending on the provider or \n",
      "supplier type.\n",
      "\n",
      "[[page 25581]]\n",
      "\n",
      "    information in nppes is publicly accessible via both an online \n",
      "search option and a downloadable database option. as a result, adding \n",
      "digital contact information to this existing index is an efficient and \n",
      "effective way to meet the congressional requirement to establish a \n",
      "digital contact information index and to promote the sharing of \n",
      "information.\n",
      "    as of june 2018, nppes has been updated to include the capability \n",
      "to capture one or more pieces of digital contact information that can \n",
      "be used to facilitate secure sharing of health information. for \n",
      "instance, providers can submit a direct address, which functions \n",
      "similar to a regular email address, but includes additional security \n",
      "measures to ensure that messages are only accessible to the intended \n",
      "recipient in order to keep the information confidential and secure. \n",
      "``direct'' is a technical standard for exchanging health information. \n",
      "direct addresses are available from a variety of sources, including ehr \n",
      "vendors, state health information exchange entities, regional and local \n",
      "health information exchange entities, as well as private service \n",
      "providers offering direct exchange capabilities called health \n",
      "information service providers (hisps) (<a href=\"https://www.healthit.gov/sites/default/files/directbasicsforprovidersqa_05092014.pdf\">https://www.healthit.gov/sites/default/files/directbasicsforprovidersqa_05092014.pdf</a>). nppes can also \n",
      "capture information about a wide range of other types of endpoints that \n",
      "providers can use to facilitate secure exchange of health information, \n",
      "for instance a fhir server url or query endpoint associated with a \n",
      "health information exchange. we strongly encourage the inclusion of \n",
      "this fhir endpoint information in nppes in support of the patient \n",
      "access api policy discussed in section iii. of this final rule and the \n",
      "provider directory api policy discussed in section iv. of this final \n",
      "rule. using nppes as one way to make these endpoints publicly known \n",
      "will significantly support interoperability throughout the health care \n",
      "system.\n",
      "    in addition, nppes can now maintain information about the type of \n",
      "contact information providers and organizations are associated with, \n",
      "along with the preferred uses for each address. each provider in nppes \n",
      "can maintain their own unique information or associate themselves with \n",
      "information shared among a group of providers. finally, in march 2019, \n",
      "nppes added a public api which can be used to obtain the digital \n",
      "contact information stored in the database. although nppes is now \n",
      "better equipped to maintain provider digital contact information, many \n",
      "providers have not submitted this information. in the 2015 final rule, \n",
      "``medicare and medicaid programs; electronic health record incentive \n",
      "program-stage 3 and modifications to meaningful use in 2015 through \n",
      "2017'' (80 fr 62901), we finalized a policy to collect information in \n",
      "nppes about the electronic addresses of participants in the ehr \n",
      "incentive program (specifically, a direct address and/or other \n",
      "``electronic service information'' as available). however, this policy \n",
      "was not fully implemented at the time, in part due to the limitations \n",
      "of the nppes system which have since been addressed. as a result, many \n",
      "providers have not yet added their digital contact information to nppes \n",
      "and digital contact information is frequently out of date.\n",
      "    in light of these updates to the nppes system, all individual \n",
      "health care providers and facilities can take immediate action to \n",
      "update their nppes record online to add digital contact information. \n",
      "this simple step will significantly improve interoperability by making \n",
      "valuable contact information easily accessible. for those providers who \n",
      "continue to rely on the use of cumbersome, fax-based modes of sharing \n",
      "information, we hope that greater availability of digital contact \n",
      "information will help to reduce barriers to electronic communication \n",
      "with a wider set of providers with whom they share patients. \n",
      "ubiquitous, public availability of digital contact information for all \n",
      "providers is a crucial step towards eliminating the use of fax machines \n",
      "for the exchange of health information. we urged all providers to take \n",
      "advantage of this resource to implement congress' requirement that the \n",
      "secretary establish a digital contact information index.\n",
      "\n",
      "b. public reporting of missing digital contact information\n",
      "\n",
      "    entities seeking to engage in electronic health information \n",
      "exchange need accurate information about the electronic addresses (for \n",
      "example, direct address, fhir server url, query endpoint, or other \n",
      "digital contact information) of potential exchange partners. a common \n",
      "directory of the electronic addresses of health care providers and \n",
      "organizations could enhance interoperability and information exchange \n",
      "by providing a resource where users can obtain information about how to \n",
      "securely transmit electronic health information to a provider.\n",
      "    we proposed to increase the number of providers with valid and \n",
      "current digital contact information available through nppes by publicly \n",
      "reporting the names and npis of those providers who do not yet have \n",
      "their digital contact information included in the nppes system. we \n",
      "proposed to begin this public reporting in the second half of 2020, to \n",
      "allow individuals and facilities time to review their records in nppes \n",
      "and update the system with appropriate digital contact information. we \n",
      "also requested comment from stakeholders on the most appropriate way to \n",
      "pursue this public reporting initiative, including where these names \n",
      "should be posted, with what frequency, and any other information \n",
      "stakeholders believed would be helpful.\n",
      "    we noted that we believed this information would be extremely \n",
      "valuable to facilitate interoperability, and we appreciated congress' \n",
      "leadership in requiring the establishment of this directory. we \n",
      "requested stakeholder comment on additional possible enforcement \n",
      "authorities to ensure that individuals and facilities make their \n",
      "digital contact information publicly available through nppes. for \n",
      "example, we questioned if medicare reporting programs, such as mips, \n",
      "should require eligible clinicians to update their nppes data with \n",
      "their digital contact information? should cms require this information \n",
      "to be included as part of the medicare enrollment and revalidation \n",
      "process? how can cms work with states to promote adding information to \n",
      "the directory through state medicaid programs and chip? should cms \n",
      "require providers to submit digital contact information as part of \n",
      "program integrity processes related to prior authorization and \n",
      "submission of medical record documentation? we noted that we would \n",
      "review comments for possible consideration in future rulemaking on \n",
      "these questions.\n",
      "    we summarize the public comments we received on this topic and \n",
      "provide our responses.\n",
      "    comment: many stakeholders shared our goal of improving the \n",
      "accuracy and completeness of data in the nppes.\n",
      "    response: we thank commenters for their support and are finalizing \n",
      "this policy as proposed.\n",
      "    comment: many commenters, while supporting the ultimate goal of the \n",
      "proposal, noted doubts about whether the proposal would be effective at \n",
      "increasing the accuracy and completeness of digital contact information \n",
      "in nppes. commenters believed that a public reporting mechanism would \n",
      "not serve as a meaningful deterrent to providers leaving their \n",
      "information blank. one commenter stated that they believed, even with \n",
      "the implementation of this proposal, high rates of inaccuracies would \n",
      "persist in nppes, and\n",
      "\n",
      "[[page 25582]]\n",
      "\n",
      "stakeholders would continue to rely on internal sources of information. \n",
      "several commenters stated that, given the likelihood that this proposal \n",
      "would not result in meaningful improvements, this proposal would \n",
      "represent unnecessary administrative burden for providers.\n",
      "    response: we thank commenters for their feedback on the potential \n",
      "effectiveness of this proposal. while we believe that this proposal is \n",
      "an important initial step toward increasing the accuracy of information \n",
      "in nppes, we appreciate that this proposal may not be sufficient to \n",
      "fully realize the goal of nppes serving as a comprehensive index of \n",
      "provider digital contact information. to this end, we requested comment \n",
      "on other programs that cms could leverage to improve the completeness \n",
      "and accuracy of information in nppes. the responses to this comment \n",
      "solicitation are discussed in more detail below.\n",
      "    comment: many commenters recommended that, instead of pursuing a \n",
      "policy based on ``public shaming,'' it would be more effective for cms \n",
      "to consider incentive-based policies for updating their digital contact \n",
      "information in nppes.\n",
      "    response: we thank commenters for their recommendations. while we \n",
      "believe the proposed policy is an important step toward increasing the \n",
      "completeness and accuracy of information in nppes, we believe that \n",
      "other policy initiatives using incentives may be effective as well, \n",
      "such as leveraging opportunities under the mips program, and we will \n",
      "consider these approaches for potential inclusion in future rulemaking.\n",
      "    comment: in the proposed rule, cms requested comment on additional \n",
      "possible enforcement authorities to ensure that individuals and \n",
      "facilities make their digital contact information publicly available \n",
      "through nppes. many commenters supported the use of other authorities \n",
      "to increase the accuracy and completeness of digital contact \n",
      "information in nppes, stating that they believe these authorities were \n",
      "more likely to be effective than the proposed policy for publicly \n",
      "reporting the names and npis of those providers that have not included \n",
      "digital contact information in nppes.\n",
      "    for instance, many commenters believed that including this \n",
      "requirement in the mips program would be a more effective strategy for \n",
      "achieving the goals of the policy. commenters believed this would be \n",
      "more effective due to the incentives available through the mips \n",
      "program. commenters also believed that use of the mips program would be \n",
      "more effective since the promoting interoperability category of mips \n",
      "already includes requirements to electronically exchange health \n",
      "information, and the goal of increasing availability of digital contact \n",
      "information would align with those features of the program. commenters \n",
      "also believed that tying this policy to the mips program would help to \n",
      "ensure annual updates of digital contact information as part of \n",
      "required mips data submissions.\n",
      "    several commenters also supported the use of the medicare \n",
      "enrollment or revalidation process and the use of program integrity \n",
      "processes as ways to promote updating of digital contact information in \n",
      "nppes.\n",
      "    response: we thank commenters for their input on additional \n",
      "enforcement mechanisms. we will take these comments under consideration \n",
      "as we consider potential future rulemaking or operational changes to \n",
      "these programs that are consistent with each program's statutory \n",
      "authority.\n",
      "    comment: many commenters suggested that cms provide additional \n",
      "education and guidance about the benefits of adding their digital \n",
      "contact information to nppes. these commenters recommended that cms \n",
      "engage in public education as a necessary step before proceeding with \n",
      "public reporting in order to build awareness among providers of the \n",
      "importance of updating this information. for instance, one commenter \n",
      "noted that many hospital-based physicians are not aware of their \n",
      "digital contact information, currently relying on their institution's \n",
      "informatics division to manage this data. others suggested that \n",
      "providers are not aware of the new functionality in nppes allowing for \n",
      "submission of digital contact information and that education will be \n",
      "needed to familiarize providers with this feature. commenters \n",
      "recommended that public education initiatives be targeted at those \n",
      "providers least likely to be familiar with the new functionality, and \n",
      "that cms should work with specialty societies and other provider \n",
      "representatives to ensure education reaches a wide variety of \n",
      "providers. some commenters also stated that a public education \n",
      "initiative alone would be a more appropriate alternative to public \n",
      "reporting of providers' names and npis.\n",
      "    response: we appreciate commenters' recommendations around the need \n",
      "for public education. since updating the functionality in nppes \n",
      "starting in 2018, we have taken steps to familiarize the provider \n",
      "community with these updates and plan to continue and expand this \n",
      "outreach. we agree that education efforts will be important to ensure \n",
      "that providers are aware of their responsibilities and that they may be \n",
      "at risk of having their names and npis publicly reported if they do not \n",
      "update their digital contact information in nppes in a timely manner. \n",
      "while recognizing the importance of public education, we also believe \n",
      "that more aggressive steps are needed to accelerate the accuracy of \n",
      "completeness of information within nppes, therefore we are finalizing \n",
      "the policy to publicly report the names and npis of providers that do \n",
      "not include digital contact information in nppes.\n",
      "    comment: cms proposed to begin public reporting in the second half \n",
      "of 2020. a number of commenters suggested that cms delay this timeframe \n",
      "to allow providers more time to be made aware of the policy, review \n",
      "their nppes record, and add missing information. one commenter believed \n",
      "that this timeline was not consistent with the time that would be \n",
      "required for cms to reach small providers with information about the \n",
      "new policy, and recommended a delay of at least an additional 12 months \n",
      "before public reporting begins.\n",
      "    response: we appreciate commenters' concerns and suggestions \n",
      "regarding the appropriate timeframe for public reporting under this \n",
      "proposal. however, we believe that the proposed timeline allows \n",
      "sufficient time for outreach and education to make providers aware of \n",
      "the requirement. we are therefore finalizing this timeframe as \n",
      "proposed.\n",
      "    comment: many commenters expressed concerns about the accuracy of \n",
      "information in nppes, stating that inaccurate information imposes a \n",
      "burden on both providers and consumers who may try to collect and use \n",
      "this information only to find out that it is incorrect. these \n",
      "commenters noted inaccurate contact information also poses a problem \n",
      "for providers who are concerned with sending protected health \n",
      "information to the wrong recipient. one commenter stated that these \n",
      "challenges raise questions about whether a public file is appropriate \n",
      "to serve as the basis for increasing interoperability across provider \n",
      "systems.\n",
      "    commenters suggested steps cms could take to improve the accuracy \n",
      "of information in nppes. one commenter suggested that cms establish a \n",
      "requirement that providers update their information within a set time \n",
      "period. another commenter suggested that nppes post the date that \n",
      "information associated with a given npi was last updated so that \n",
      "individuals reviewing the database could assess its accuracy. several \n",
      "commenters urged cms to\n",
      "\n",
      "[[page 25583]]\n",
      "\n",
      "conduct direct outreach to providers to confirm their information, or \n",
      "to validate provider information with other sources, such as state \n",
      "licensing boards, in order to increase accuracy.\n",
      "    response: we appreciate commenters' concerns about the accuracy of \n",
      "provider contact information within nppes. the ``last updated'' date is \n",
      "posted on the ``npi view'' page for records in the public nppes npi \n",
      "registry. it should also be noted that providers are required to update \n",
      "information included in nppes within 30 days of a change (45 cfr \n",
      "162.410(a)(4)). however, we understand from commenters that in practice \n",
      "these updates often do not occur, contributing to historical challenges \n",
      "with the accuracy of nppes data.\n",
      "    we appreciate commenters' suggestions for ways to improve the \n",
      "accuracy of data within nppes, and we will take these suggestions into \n",
      "consideration.\n",
      "    comment: several commenters noted that providers who have not \n",
      "participated in the promoting interoperability program (formerly the \n",
      "ehr incentive programs) are more likely to not have digital contact \n",
      "information available than those that have participated and received \n",
      "incentives for adoption of health information. commenters stated that \n",
      "these providers would be at a disadvantage under the proposed policy, \n",
      "and that identifying these providers as noncompliant through a public \n",
      "reporting mechanism would be unfair. commenters stated that this group \n",
      "likely includes smaller practices, rural clinicians, hospital-based \n",
      "clinicians, and clinicians employed at a variety of settings which were \n",
      "not eligible for ehr incentives, such as rehabilitation centers.\n",
      "    response: we appreciate commenters' concerns regarding those \n",
      "clinicians that are less likely to have existing digital contact \n",
      "information. while we understand that it may take more time for these \n",
      "clinicians to obtain and submit digital contact information to nppes, \n",
      "we believe that the timeframe for implementing this proposal will \n",
      "provide sufficient notice to clinicians. we also believe that obtaining \n",
      "digital contact information, such as a direct address, is now widely \n",
      "available to clinicians, including those who do not have certified ehr \n",
      "systems. accordingly, we believe that these providers will be able to \n",
      "obtain digital contact information and add it to their nppes record \n",
      "with relatively minimal burden.\n",
      "    comment: many commenters suggested that cms establish a process for \n",
      "offering providers a chance to review their information and correct any \n",
      "issues prior to the implementation of public reporting. commenters \n",
      "stated that cms should issue communication to providers informing them \n",
      "of the status of their digital contact information, and that \n",
      "communications should include mechanisms which allow the provider to \n",
      "make corrections. one commenter recommended that cms institute a 60-day \n",
      "review period prior to public reporting similar to the review period \n",
      "established for data included on the physician compare website.\n",
      "    response: we appreciate commenters' suggestions regarding \n",
      "opportunities for clinicians to review their information prior to the \n",
      "implementation of this public reporting policy. we have already \n",
      "implemented multiple methods for providers to review their information \n",
      "allowing them to correct any issues with their nppes record. providers \n",
      "can review their information using the nppes npi registry (<a href=\"https://npiregistry.cms.hhs.gov/\">https://npiregistry.cms.hhs.gov/</a>), the nppes npi registry api (<a href=\"https://npiregistry.cms.hhs.gov/registry/help-api\">https://npiregistry.cms.hhs.gov/registry/help-api</a>), or the nppes data \n",
      "dissemination file (<a href=\"https://www.cms.gov/regulations-and-guidance/administrative-simplification/nationalprovidentstand/datadissemination\">https://www.cms.gov/regulations-and-guidance/administrative-simplification/nationalprovidentstand/datadissemination</a>). each source currently contains all the information \n",
      "that will allow providers to determine the correctness of their \n",
      "information. as discussed above, we will also engage in continued \n",
      "public education efforts to ensure providers are aware of the benefits \n",
      "of including digital contact information in nppes, as well as the \n",
      "associated public reporting policy.\n",
      "    comment: several commenters requested additional information about \n",
      "what kind of digital contact information would satisfy this \n",
      "requirement. one commenter recommended that providers should be able to \n",
      "specify other digital endpoints besides a direct address. another \n",
      "commenter requested clarity on whether the digital fax numbers would \n",
      "qualify as digital contact information.\n",
      "    response: as discussed in the proposed rule, nppes is able to \n",
      "capture a variety of different digital endpoints. a digital fax number \n",
      "is not considered a digital endpoint for the purposes of this proposal. \n",
      "for more information on the digital contact information which can be \n",
      "added to nppes, see <a href=\"https://nppes.cms.hhs.gov/webhelp/nppeshelp/health%20information%20exchange.html\">https://nppes.cms.hhs.gov/webhelp/nppeshelp/health%20information%20exchange.html</a>.\n",
      "    comment: several commenters recommended that cms partner with other \n",
      "centralized authorities that collect provider information. commenters \n",
      "stated that relying on providers alone to update their information will \n",
      "not provide the levels of accuracy necessary for other providers to \n",
      "utilize nppes for routine exchange of electronic health information. \n",
      "commenters noted that today, directory services that employ appropriate \n",
      "identify proofing processes and other means for ensuring records are \n",
      "up-to-date are much more likely to possess accurate information than \n",
      "nppes, and cms should seek to improve the quality of nppes by working \n",
      "with these partners. commenters believed that by working with these \n",
      "entities, cms could greatly reduce provider burden associated with \n",
      "entering information into and updating information in nppes.\n",
      "    response: we appreciate commenters' input regarding other \n",
      "strategies to improve the accuracy of the digital contact information \n",
      "within nppes.\n",
      "    comment: several commenters requested additional guidance on how \n",
      "the public reporting mechanism would operate. one commenter sought \n",
      "information on where the names would be publicly reported. another \n",
      "commenter questioned how cms would address public reporting of \n",
      "providers that have an npi but do not have active practice locations \n",
      "where they are providing services under medicare or engaging in \n",
      "communication with patients.\n",
      "    response: we thank commenters for these questions. following the \n",
      "publication of the final rule, we will release additional information \n",
      "around the public reporting mechanism including where we intend to \n",
      "publish the names and npis of providers that do not have digital \n",
      "contact information in nppes, as well as information about whether \n",
      "certain providers would be exempt from public reporting.\n",
      "    comment: one commenter questioned how providers would be expected \n",
      "to know their digital contact information as this information may not \n",
      "be visible to providers in many ehr systems.\n",
      "    response: we encourage providers, especially clinicians, to work \n",
      "with health it administrators in their organization or directly with \n",
      "their health it vendor if they are unclear on where their digital \n",
      "contact information can be found. we also note that nppes now provides \n",
      "for bulk uploading of information to multiple npi records, and \n",
      "encourage clinicians to work with health it administrators in their \n",
      "organization to develop streamlined processes for updating this \n",
      "information in a way that imposes minimal burden on clinicians.\n",
      "    comment: several commenters noted the provider enrollment, chain, \n",
      "and ownership system (pecos) system\n",
      "\n",
      "[[page 25584]]\n",
      "\n",
      "would be the most appropriate location for storing digital contact \n",
      "information.\n",
      "    response: while we understand the interest in using pecos as the \n",
      "location for storing digital contact information, we are not \n",
      "considering this as an option at this time. pecos collects information \n",
      "specific to provider and supplier enrollment in the medicare program \n",
      "and the system is limited to the fields on the cms 855 enrollment \n",
      "forms. any other data outside of this is optional. there are also many \n",
      "operational and systematic issues that prevent pecos from being \n",
      "utilized to implement the digital contact information requirement.\n",
      "    comment: several commenters raised questions about what entities \n",
      "would have access to the information in nppes. one commenter stated \n",
      "that any entity should be able to gain access to nppes in order to \n",
      "advance interoperability. another noted that making digital endpoints \n",
      "publicly accessible via an api that may be accessible to third parties \n",
      "could pose a risk to the security of protected health information \n",
      "available through those apis, and recommended that cms make this \n",
      "information available to other entities only if the third-party entity \n",
      "requests access from the api owner.\n",
      "    response: nppes already furnishes a public downloadable data \n",
      "dissemination file as well as a public api that provides the public \n",
      "information available in the npi registry. both files are publicly \n",
      "accessible. please note that this proposal is not related to the \n",
      "patient access api discussed in section iii. of this final rule that \n",
      "can include patient protected health information.\n",
      "    comment: a number of commenters requested additional information on \n",
      "issues related to nppes functionality, and sought guidance on how to \n",
      "enter digital contact information. for instance, numerous commenters \n",
      "believed that the nppes does not allow for a provider to enter \n",
      "information for multiple practice and billing locations. several \n",
      "commenters sought information about whether a provider could enter \n",
      "multiple digital endpoints, for instance if they employ different \n",
      "endpoints for different types of communication. one commenter requested \n",
      "information on whether a provider could enter digital contact \n",
      "information for his or her employer, rather than individual \n",
      "information.\n",
      "    response: for more information on how information is captured in \n",
      "nppes, we encourage commenters to review information available on the \n",
      "nppes website at <a href=\"https://nppes.cms.hhs.gov/webhelp/nppeshelp/health%20information%20exchange.html\">https://nppes.cms.hhs.gov/webhelp/nppeshelp/health%20information%20exchange.html</a>.\n",
      "    comment: several commenters suggested that cms develop a digital \n",
      "contact information interoperability standard for facilitating \n",
      "efficient exchange of patient records.\n",
      "    response: we appreciate commenters' suggestions, and note that we \n",
      "continue to collaborate with onc, other federal partners, and industry \n",
      "stakeholders, to develop more robust provider directory standards that \n",
      "can support exchange of this information. we also direct commenters to \n",
      "the discussion of the provider directory api in section iv. of this \n",
      "final rule.\n",
      "    final action: after consideration of the comments received, and for \n",
      "the reasons outlined in our response to these comments and in the cms \n",
      "interoperability and patient access proposed rule, we are finalizing to \n",
      "publicly report the names and npis of those providers who do not have \n",
      "digital contact information included in the nppes system beginning in \n",
      "the second half of 2020 as proposed. additionally, we will engage in \n",
      "continued public education efforts to ensure providers are aware of the \n",
      "benefits of including digital contact information in nppes, including \n",
      "fhir api endpoints, and when and where this information will be posted.\n",
      "\n",
      "x. conditions of participation for hospitals and critical access \n",
      "hospitals (cahs) provisions, and analysis of and responses to public \n",
      "comments\n",
      "\n",
      "a. background\n",
      "\n",
      "    as noted in the cms interoperability and patient access proposed \n",
      "rule (84 fr 7649 through 7653), we appreciate the pathways congress has \n",
      "created for action on interoperability and have been working diligently \n",
      "with onc to implement them. in order to ensure broad stakeholder input \n",
      "to inform the proposals, we published a request for information (rfi) \n",
      "on interoperability in several proposed rules, including the fy 2019 \n",
      "ipps proposed rule (83 fr 20550). specifically, we published the rfi \n",
      "entitled, ``promoting interoperability and electronic healthcare \n",
      "information exchange through possible revisions to the cms patient \n",
      "health and safety requirements for hospitals and other medicare- and \n",
      "medicaid-participating providers and suppliers.'' we requested \n",
      "stakeholders' input on how we could use the cms health and safety \n",
      "standards that are required for providers and suppliers participating \n",
      "in the medicare and medicaid programs (that is, the conditions of \n",
      "participation (cops), conditions for coverage (cfcs), and requirements \n",
      "for long term care facilities) to further advance electronic exchange \n",
      "of information that supports safe, effective transitions of care \n",
      "between hospitals and community providers. specifically, we requested \n",
      "comment on revisions to the current cms cops for hospitals such as: \n",
      "requiring that hospitals transferring medically necessary information \n",
      "to another facility upon a patient transfer or discharge do so \n",
      "electronically; requiring that hospitals electronically send required \n",
      "discharge information to a community provider via electronic means if \n",
      "possible and if a community provider can be identified; and requiring \n",
      "that hospitals make certain information available to patients or a \n",
      "specified third-party application (for example, required discharge \n",
      "instructions) via electronic means if requested.\n",
      "    the rfi discussed several steps we have taken in recent years to \n",
      "update and modernize the cops and other health and safety standards to \n",
      "reflect current best practices for clinical care, especially in the \n",
      "area of care coordination and discharge planning. for a complete \n",
      "discussion of this work, see the proposed rule (84 fr 7649 through \n",
      "7650).\n",
      "    in the september 30, 2019 federal register, we published a final \n",
      "rule, ``medicare and medicaid programs; revisions to requirements for \n",
      "discharge planning'' (84 fr 51836) (``discharge planning final rule''), \n",
      "that revises the discharge planning requirements that hospitals \n",
      "(including psychiatric hospitals, long-term care hospitals, and \n",
      "inpatient rehabilitation facilities), critical access hospitals (cahs), \n",
      "and home health agencies, must meet to participate in medicare and \n",
      "medicaid programs. the rule supports cms' interoperability efforts by \n",
      "promoting the exchange of patient information between health care \n",
      "settings, and by ensuring that a patient's necessary medical \n",
      "information is transferred with the patient after discharge from a \n",
      "hospital, cah, or post-acute care services provider. by requiring that \n",
      "all of the patient's necessary medical information, including his or \n",
      "her post-discharge goals of care and treatment preferences, must be \n",
      "documented in the patient's medical record and transferred along with \n",
      "the patient at the time of discharge to an appropriate receiving health \n",
      "care facility, such as a pac service provider or agency, and to other \n",
      "outpatient service providers and practitioners responsible for the \n",
      "patient's follow-up or ancillary care, the rule aims to better prepare \n",
      "patients and their caregivers to be active partners and advocates for \n",
      "their health care and community support needs upon\n",
      "\n",
      "[[page 25585]]\n",
      "\n",
      "discharge from the hospital or post-acute care setting.\n",
      "    while we finalized a broad requirement for sending necessary \n",
      "medical information in accordance with all applicable laws, rather than \n",
      "listing specific data elements (such as those explicitly aligned with \n",
      "the data referenced as part of the common clinical data set (ccds) that \n",
      "was finalized in the 2015 final rule, ``medicare and medicaid programs; \n",
      "electronic health record incentive program--stage 3 and modifications \n",
      "to meaningful use in 2015 through 2017'' (80 fr 62762), we also ensured \n",
      "that the revisions to the cops did not conflict with the ccds, or \n",
      "future standards proposed for adoption for electronic exchange of \n",
      "health information, specifically the uscdi. the discharge planning cops \n",
      "do not bar providers from sending all additional appropriate medical \n",
      "information regarding the patient's current course of illness and \n",
      "treatment, post-discharge goals of care, and treatment preferences in \n",
      "accordance with applicable laws. however, we note here that the \n",
      "discharge planning final rule does not require hospitals, cahs, and \n",
      "hhas to transfer the necessary patient medical information exclusively \n",
      "by electronic means nor does it require that providers notify the \n",
      "appropriate providers, suppliers, and practitioners receiving the \n",
      "necessary medical information of the patient's discharge as we are now \n",
      "requiring in this final rule.\n",
      "    additionally, the discharge planning final rule further supports \n",
      "interoperability and a patient's access to his or her own medical \n",
      "records by updating the hospital patient rights cop to now state that \n",
      "the patient has the right to access his or her medical records in the \n",
      "form and format requested (including in an electronic form or format \n",
      "when such medical records are maintained electronically). therefore, \n",
      "the hospital cops now include an explicit requirement that, as a \n",
      "condition of participation, hospitals must provide patients with access \n",
      "to their medical records in an electronic format upon the patient's \n",
      "request if the hospital has the capacity to do so.\n",
      "    in response to the rfi in the fy 2019 ipps proposed rule, many \n",
      "stakeholders supported our goals of increasing interoperability, and \n",
      "acknowledged the important role that hospital settings play in \n",
      "supporting care coordination. stakeholders agreed that use of \n",
      "electronic technology was an important factor in ensuring safe \n",
      "transitions. multiple stakeholders emphasized that electronic data \n",
      "exchange between hospitals and physician offices, as well as with \n",
      "hospices, hhas, snfs, and other post-acute care services providers, was \n",
      "especially important during care transitions when maintaining access to \n",
      "patient health information, including medication information, and is \n",
      "extremely relevant to the patient's next phase of care. additionally, \n",
      "stakeholders noted that giving patients and their caregivers access to \n",
      "important health information (such as discharge information along with \n",
      "accurately reconciled lists of discharge medications) created a more \n",
      "patient-centered health care system, and reduced the risk of errors and \n",
      "hospital readmissions. but many stakeholders also expressed concerns \n",
      "about implementing policy changes within the cops that might increase \n",
      "the compliance burden on hospitals. however, several stakeholders also \n",
      "strongly recommended that cms add details to the cops, and require that \n",
      "hospitals share not only medically necessary information with physician \n",
      "offices, hhas, and snfs (such as pending tests and discharge \n",
      "summaries), but also notifications of when patients were admitted to \n",
      "the hospital as well as discharged or transferred from the hospital and \n",
      "admitted to the care of applicable pac services providers and \n",
      "suppliers.\n",
      "    given responses to the rfi, as well as previous rulemaking \n",
      "activities, we sought to further expand cms requirements for \n",
      "interoperability within the hospital and cah cops as part of the cms \n",
      "interoperability and patient access proposed rule by focusing on \n",
      "electronic patient event notifications. in addition, we noted that we \n",
      "were committed to taking further steps to ensure that facilities that \n",
      "are electronically capturing information are electronically exchanging \n",
      "that information with providers who have the capacity to accept it.\n",
      "    infrastructure supporting the exchange of electronic health \n",
      "information across settings has matured substantially in recent years. \n",
      "research studies have increasingly found that health information \n",
      "exchange interventions can affect positive outcomes in health care \n",
      "quality and public health, in addition to more longstanding findings \n",
      "around reductions in utilization and costs. a recent review of how \n",
      "health information exchange interventions can improve cost and quality \n",
      "outcomes identified a growing body of high-quality studies showing that \n",
      "these interventions are associated with beneficial results.\\53\\ the \n",
      "authors identified a number of studies demonstrating positive effects \n",
      "on outcomes associated with better care coordination, such as \n",
      "reductions in 30-day readmissions,<sup>54 55 56</sup> and improved \n",
      "medication reconciliation.\\57\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\53\\ menachemi, n., rahurkar, s., harle, c.a., & vest, j.r. \n",
      "(2018). the benefits of health information exchange: an updated \n",
      "systematic review. journal of the american medical informatics \n",
      "association, 25(9), 1259-1265. doi: 10.1093/jamia/ocy035.\n",
      "    \\54\\ yeaman, b., ko, k., del castillo, r. (2015). care \n",
      "transitions in long-term care and acute care: health information \n",
      "exchange and readmission rates. the online journal of issues in \n",
      "nursing, 20(3). doi: 10.3912/ojin.vol20no03man05.\n",
      "    \\55\\ vest, j.r., kern, l.m., silver, m.d., & kaushal, r. (2015). \n",
      "the potential for community-based health information exchange \n",
      "systems to reduce hospital readmissions. journal of the american \n",
      "medical informatics association, 22(2), 435-442. doi: 10.1136/\n",
      "amiajnl-2014-002760.\n",
      "    \\56\\ unruh, m.a., jung, h.-y., kaushal, r., & vest, j.r. (2017). \n",
      "hospitalization event notifications and reductions in readmissions \n",
      "of medicare fee-for-service beneficiaries in the bronx, new york. \n",
      "journal of the american medical informatics association, 24(e1), \n",
      "e150-e156. doi: 10.1093/jamia/ocw139.\n",
      "    \\57\\ boockvar, k.s., ho, w., pruskowski, j., dipalo, k.e., wong, \n",
      "j.j., patel, j., . . . hung, w. (2017). effect of health information \n",
      "exchange on recognition of medication discrepancies is interrupted \n",
      "when data charges are introduced: results of a cluster-randomized \n",
      "controlled trial. journal of the american medical informatics \n",
      "association, 24(6), 1095-1101. doi: 10.1093/jamia/ocx044.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    electronic patient event notifications from hospitals, or clinical \n",
      "event notifications, are one type of health information exchange \n",
      "intervention that has been increasingly recognized as an effective and \n",
      "scalable tool for improving care coordination across settings, \n",
      "especially for patients at discharge. this approach has been associated \n",
      "with a reduction in readmissions following implementation of such \n",
      "notifications.\\58\\ we noted that the evidence cited in this section to \n",
      "support the use of innovative health information exchange interventions \n",
      "and approaches, such as the patient event notifications that we \n",
      "proposed to require, can be applied to various types of hospitals, \n",
      "including psychiatric hospitals, as well as to cahs, as discussed \n",
      "below.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\58\\ unruh, m.a., jung, h.-y., kaushal, r., & vest, j.r. (2017). \n",
      "hospitalization event notifications and reductions in readmissions \n",
      "of medicare fee-for-service beneficiaries in the bronx, new york. \n",
      "journal of the american medical informatics association, 24(e1), \n",
      "e150-e156. doi: 10.1093/jamia/ocw139.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    patient event notifications are automated, electronic \n",
      "communications from the discharging provider to another facility, or to \n",
      "another applicable community provider as identified by the patient \n",
      "(such as a patient's primary care practitioner or practice group, post-\n",
      "acute care services providers and suppliers, and other practitioners \n",
      "and providers that need the notification for post-acute care \n",
      "coordination, treatment, and/or quality improvement purposes),\n",
      "\n",
      "[[page 25586]]\n",
      "\n",
      "which alerts the receiving provider that the patient has received care \n",
      "at a different setting. depending on the implementation, information \n",
      "included with these notifications can range from conveying the \n",
      "patient's name, other basic demographic information, and the sending \n",
      "institution to a richer set of clinical data on the patient. even with \n",
      "a minimum set of information included, these notifications can help \n",
      "ensure that a receiving provider, facility, or practitioner is aware \n",
      "that the patient has received care elsewhere. the notification triggers \n",
      "a receiving provider, facility, or practitioner to reach out to the \n",
      "patient and deliver appropriate follow-up care in a timely manner. by \n",
      "notifying the individuals and entities that need notification of the \n",
      "patient's status for treatment, care coordination, or quality \n",
      "improvement purposes, the notification can help to improve post-\n",
      "discharge transitions and reduce the likelihood that a patient would \n",
      "face complications from inadequate follow-up care.\n",
      "    in addition to their effectiveness in supporting care coordination, \n",
      "virtually all ehr systems generate the basic messages commonly used to \n",
      "support electronic patient event notifications. these notifications are \n",
      "based on admission, discharge, and transfer (adt) messages, a standard \n",
      "message used within an ehr as the vehicle for communicating information \n",
      "about key changes in a patient's status as they are tracked by the \n",
      "system (more information about the current standard supporting these \n",
      "messages is available at <a href=\"http://www.hl7.org/implement/standards/product_brief.cfm?product_id=144\">http://www.hl7.org/implement/standards/product_brief.cfm?product_id=144</a>). as noted in the interoperability \n",
      "standards advisory (isa) published by onc, this messaging standard has \n",
      "been widely adopted across the health care system (see <a href=\"https://www.healthit.gov/isa/sending-a-notification-a-patients-admission-discharge-andor-transfer-status-other-providers\">https://www.healthit.gov/isa/sending-a-notification-a-patients-admission-discharge-andor-transfer-status-other-providers</a>).\n",
      "    adt messages provide each patient's personal or demographic \n",
      "information (such as the patient's name, insurance, next of kin, and \n",
      "attending physician), when that information has been updated, and also \n",
      "indicate when an adt status has changed. to create an electronic \n",
      "patient event notification, a system can use the change in adt status \n",
      "to trigger a message to a receiving provider or to a health information \n",
      "exchange system that can then route the message to the appropriate \n",
      "provider. in addition to the basic demographic information contained in \n",
      "the adt message, some patient event notification implementations attach \n",
      "more detailed information to the message regarding the patient's \n",
      "clinical status and care received from the sending provider.\n",
      "\n",
      "b. provisions for hospitals (42 cfr 482.24(d))\n",
      "\n",
      "    we proposed to revise the cops for medicare- and medicaid-\n",
      "participating hospitals at 42 cfr 482.24 by adding a new standard at \n",
      "paragraph (d), ``electronic notifications,'' that would require \n",
      "hospitals to send electronic patient event notifications of a patient's \n",
      "admission, discharge, and/or transfer to another health care facility \n",
      "or to another community provider or practitioner. we proposed to \n",
      "require hospitals to convey, at a minimum, the patient's basic personal \n",
      "or demographic information, as well as the name of the sending \n",
      "institution (that is, the hospital), and, if not prohibited by other \n",
      "applicable law, the patient's diagnosis. in proposing that patient \n",
      "event notifications sent by a hospital's medical records system include \n",
      "diagnosis, where not prohibited by other applicable law, we requested \n",
      "comment on the technical feasibility of this proposal, noting that we \n",
      "recognize some existing adt messages might not include diagnosis, as \n",
      "well as the challenges in appropriately segmenting this information in \n",
      "instances where the diagnosis may not be permitted for disclosure under \n",
      "other applicable laws.\n",
      "    we also encouraged hospitals, as their systems and those of the \n",
      "receiving providers allowed, to work with patients and their \n",
      "practitioners to offer more robust patient information and clinical \n",
      "data upon request in accordance with applicable law.\n",
      "    for a hospital that currently possesses an ehr system with the \n",
      "capacity to generate the basic patient personal or demographic \n",
      "information for electronic patient event notifications, we proposed \n",
      "that compliance with the proposed standard within the medical records \n",
      "services cop (42 cfr 482.24) would be determined by the hospital \n",
      "demonstrating to the surveyor or accrediting organization that its \n",
      "system: (1) is fully operational and that it operates in accordance \n",
      "with all state and federal statutes and regulations regarding the \n",
      "exchange of patient health information; (2) utilizes the content \n",
      "exchange standard incorporated by reference at 45 cfr 170.205(a)(4)(i); \n",
      "(3) sends notifications that would have to include the minimum patient \n",
      "health information (which, as noted above, would be the patient's name, \n",
      "treating practitioner name, sending institution name, and, if not \n",
      "prohibited by other applicable law, patient diagnosis); and (4) sends \n",
      "notifications directly, or through an intermediary that facilitates \n",
      "exchange of health information, and at the time of the patient's \n",
      "admission to the hospital and either immediately prior to or at the \n",
      "time of the patient's discharge and/or transfer from the hospital.\n",
      "    we proposed to limit this requirement to only those hospitals which \n",
      "currently possess ehr systems with the technical capacity to generate \n",
      "information for electronic patient event notifications as discussed \n",
      "below, recognizing that not all medicare- and medicaid-participating \n",
      "hospitals have been eligible for past programs promoting adoption of \n",
      "ehr systems. we noted our goal in proposing the requirement was to \n",
      "ensure that hospital ehr systems have a basic capacity to generate \n",
      "messages that can be utilized for notifications by a wide range of \n",
      "receiving providers, enabled by common standards. we believed that a \n",
      "system that utilizes the adt messaging standard, which is widely used \n",
      "as the basis for implementing these notifications and other similar use \n",
      "cases, would meet this goal by supporting the availability of \n",
      "information that can be used to generate information for patient event \n",
      "notifications. specifically, we proposed that the system utilize the \n",
      "adt messaging standard incorporated by reference at 45 cfr \n",
      "170.205(a)(4)(i).\\59\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\59\\ health level seven messaging standard version 2.5.1 (hl7 \n",
      "2.5.1), an application protocol for electronic data exchange in \n",
      "healthcare environments, february 21, 2007.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we noted that, while there are no criteria under the onc health it \n",
      "certification program which certifies health it to create and send \n",
      "electronic patient event notifications, the adt standard is referenced \n",
      "by other certification criteria under the program. specifically, this \n",
      "standard supports certification criteria related to transferring \n",
      "information to immunization registries, as well as transmission of \n",
      "laboratory results to public health agencies as described at 45 cfr \n",
      "170.315(f) under the 2015 edition certification criteria, and at 45 cfr \n",
      "170.314(f) under the 2014 edition. thus, we expect systems that include \n",
      "health it modules certified to meet criteria which reference this \n",
      "standard will possess the basic capacity to generate information for \n",
      "notification messages. we further noted that adopting certified health \n",
      "it that meets these criteria has been required for any hospital seeking \n",
      "to qualify for the promoting interoperability programs (formerly the \n",
      "ehr incentive programs).\n",
      "    we recognized that there is currently significant variation in how \n",
      "hospitals have utilized the adt messages to\n",
      "\n",
      "[[page 25587]]\n",
      "\n",
      "support implementation of patient event notifications. we also \n",
      "recognized that many hospitals, which have already implemented \n",
      "notifications, may be delivering additional information beyond the \n",
      "basic information included in the adt message (both automatically when \n",
      "a patient's status changes and then upon request from receiving \n",
      "providers) to receiving practitioners, patient care team members, and \n",
      "post-acute care services providers and suppliers with whom they have \n",
      "established patient care relationships and agreements for patient \n",
      "health information exchange as allowed by law. we believe consensus \n",
      "standards for adt-based notifications may become more widely adopted in \n",
      "the future (we refer readers to onc's isa \\60\\ for more information \n",
      "about standards under consideration). however, at this time, we stated \n",
      "that we did not wish to restrict hospitals from pursuing more advanced \n",
      "content as part of patient notifications, nor to create redundant \n",
      "requirements where hospitals already have a suitable notification \n",
      "system in place. accordingly, while we specified that hospitals subject \n",
      "to the proposal possess a system utilizing this standard, we proposed \n",
      "that hospitals could utilize other standards or features to support \n",
      "their notification systems. we requested comment on the proposal, \n",
      "including whether this requirement would achieve the goal of setting a \n",
      "baseline for hospitals' capacity to generate information for electronic \n",
      "notifications, while still allowing for innovative approaches that \n",
      "would potentially increase the effectiveness of these notifications \n",
      "toward improving patient outcomes and safety during transitions in \n",
      "care.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\60\\ office of the national coordinator. (n.d.). admission, \n",
      "discharge, and transfer. retrieved from <a href=\"https://www.healthit.gov/isa/admission-discharge-and-transfer\">https://www.healthit.gov/isa/admission-discharge-and-transfer</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we further proposed that the hospital would need to demonstrate \n",
      "that the system's notification capacity was fully operational, that it \n",
      "operated in accordance with all state and federal statutes and \n",
      "regulations regarding the exchange of patient health information. we \n",
      "intended for these notifications to be required, at minimum, for \n",
      "inpatients admitted to, and discharged and/or transferred from the \n",
      "hospital. however, we also noted that patient event notifications are \n",
      "an effective tool for coordinating care across a wider set of patients \n",
      "that may be cared for by a hospital. for instance, a patient event \n",
      "notification could ensure that a primary care physician was aware that \n",
      "his or her patient had received care at the emergency room, and \n",
      "initiate outreach to the patient to ensure that appropriate follow-up \n",
      "for the emergency visit was pursued. while we encouraged hospitals to \n",
      "extend the coverage of their notification systems to serve additional \n",
      "patients, outside of those admitted and seen as inpatients, we also \n",
      "sought comment on whether we should identify a broader set of patients \n",
      "to whom this requirement would apply, and if so, how we should \n",
      "implement such a requirement in a way that minimizes administrative \n",
      "burden on hospitals.\n",
      "    additionally, we proposed that the hospital would have to \n",
      "demonstrate that its system sends notifications that include the \n",
      "minimum patient health information (specifically, patient name, \n",
      "treating practitioner name, sending institution name, and, if not \n",
      "prohibited by other applicable law, patient diagnosis). we proposed \n",
      "that the hospital would also need to demonstrate that the system sends \n",
      "notifications directly, or through an intermediary that facilitates \n",
      "exchange of health information, at the time of the patient's hospital \n",
      "admission, discharge, or transfer, to licensed and qualified \n",
      "practitioners, other patient care team members, and pac services \n",
      "providers and suppliers that: (1) receive the notification for \n",
      "treatment, care coordination, or quality improvement purposes; (2) have \n",
      "an established care relationship with the patient relevant to his or \n",
      "her care; and (3) the hospital has reasonable certainty that such \n",
      "notifications are received. we noted that we believed the proposal \n",
      "would allow for a diverse set of strategies that hospitals might use \n",
      "when implementing patient event notifications.\n",
      "    through these provisions, we sought to allow for different ways \n",
      "that a hospital might identify those practitioners, other patient care \n",
      "team members, and pac services providers and suppliers that are most \n",
      "relevant to both the pre-admission and post-discharge care of a \n",
      "patient. we proposed that hospitals send notifications to those \n",
      "practitioners or providers that had an established care relationship \n",
      "with the patient relevant to his or her care. we recognized that \n",
      "hospitals and their partners may identify appropriate recipients \n",
      "through various methods. for instance, hospitals might identify \n",
      "appropriate practitioners by requesting this information from patients \n",
      "or caregivers upon arrival, or by obtaining information about care team \n",
      "members from the patient's record. we expected hospitals might develop \n",
      "or optimize processes to capture information about established care \n",
      "relationships directly, or work with an intermediary that maintains \n",
      "information about care relationships. in other cases, we noted that \n",
      "hospitals may, directly or through an intermediary, identify \n",
      "appropriate notification recipients through the analysis of care \n",
      "patterns or other attribution methods that seek to determine the \n",
      "provider most likely to be able to effectively coordinate care post-\n",
      "discharge for a specific patient. the hospital or intermediary might \n",
      "also develop processes to allow a provider to specifically request \n",
      "notifications for a given patient for whom they are responsible for \n",
      "care coordination as confirmed through conversations with the patient.\n",
      "    additionally, we expected hospitals, psychiatric hospitals, and \n",
      "cahs to comply with the hipaa rules set out at 45 cfr parts 160 and 164 \n",
      "if these proposed cop requirements for patient event notifications were \n",
      "finalized. as required at 42 cfr 482.11 for hospitals and psychiatric \n",
      "hospitals and at 42 cfr 485.608 for cahs, these providers must comply \n",
      "with all pertinent currently existing federal laws, including the hipaa \n",
      "privacy and security rules. the privacy rule permits patient event \n",
      "notifications as disclosures for treatment purposes (the proposed \n",
      "required notifications, when finalized, also may be treated as \n",
      "disclosures required by law (see 45 cfr 164.502(a)).\n",
      "    we also recognized that factors outside of the hospital's control \n",
      "might determine whether or not a notification was successfully received \n",
      "and utilized by a practitioner. accordingly, we proposed that a \n",
      "hospital would only need to send notifications to those practitioners \n",
      "for whom the hospital has reasonable certainty of receipt. while we \n",
      "stated that we expected hospitals would, to the best of their ability, \n",
      "seek to ensure that notification recipients were able to receive \n",
      "notifications (for instance, by obtaining a recipient's direct address \n",
      "\\61\\), we understood that technical issues beyond the hospital's \n",
      "control could prevent successful receipt and use of a notification.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\61\\ for more information about obtaining a direct addresses, \n",
      "see <a href=\"https://www.healthit.gov/sites/default/files/directbasicsforprovidersqa_05092014.pdf\">https://www.healthit.gov/sites/default/files/directbasicsforprovidersqa_05092014.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    finally, we noted that hospitals have an existing responsibility \n",
      "under the cops at 42 cfr 482.43(d) to ``transfer or refer patients, \n",
      "along with necessary medical information, to appropriate facilities, \n",
      "agencies, or outpatient services, as needed, for follow-up or ancillary \n",
      "care.'' we emphasized that the proposal regarding patient event \n",
      "notifications would be separate from the\n",
      "\n",
      "[[page 25588]]\n",
      "\n",
      "requirement regarding necessary medical information at 42 cfr \n",
      "482.43(d). however, we recognized that processes to implement the \n",
      "proposal, if finalized, could intersect with the hospital's discharge \n",
      "planning process. we noted that nothing in the proposal would affect \n",
      "the hospital's responsibilities under 42 cfr 482.43(d). however, we \n",
      "noted if the proposal was finalized, hospitals might wish to consider \n",
      "ways to fulfill these requirements in ways that reduce redundancy while \n",
      "still remaining compliant with existing requirements. for instance, \n",
      "where appropriate and allowed by law, hospitals might seek to include \n",
      "required necessary medical information within the same message as a \n",
      "patient event notification.\n",
      "\n",
      "c. provisions for psychiatric hospitals (42 cfr 482.61(f))\n",
      "\n",
      "    medicare- and medicaid-participating psychiatric hospitals must \n",
      "comply with all of the hospital cops at 42 cfr 482.1 through 482.23 and \n",
      "at 42 cfr 482.25 through 482.57. they also must adhere to special \n",
      "provisions regarding medical records at 42 cfr 482.61 and staffing \n",
      "requirements at 42 cfr 482.62. since the medical records requirements \n",
      "are different for psychiatric hospitals, and since these hospitals do \n",
      "not have to comply with the regulations at 42 cfr 482.24, we proposed a \n",
      "new electronic notification standard at 42 cfr 482.61(f) within the \n",
      "special provisions for psychiatric hospitals in this section.\n",
      "    similar to the proposal for hospitals at 42 cfr 482.24(d), we \n",
      "proposed a new standard at 42 cfr 482.61(f), ``electronic \n",
      "notifications,'' that would require psychiatric hospitals to send \n",
      "electronic patient event notifications of a patient's admission, \n",
      "discharge, and/or transfer to another health care facility or to \n",
      "another community provider.\n",
      "    as we proposed for hospitals, we proposed to limit this requirement \n",
      "to only those psychiatric hospitals which currently possess ehr systems \n",
      "with the technical capacity to generate information for electronic \n",
      "patient event notifications, defined as systems that utilize the \n",
      "content exchange standard incorporated by reference at 45 cfr \n",
      "170.205(a)(4)(i). we proposed that that for a psychiatric hospital that \n",
      "currently possessed an ehr system with the capacity to generate the \n",
      "basic patient personal or demographic information for electronic \n",
      "patient event (adt) notifications, compliance with the proposed \n",
      "standard within the special medical records requirements for \n",
      "psychiatric hospitals cop (42 cfr 482.61) would be determined by the \n",
      "hospital demonstrating that its system: (1) is fully operational and \n",
      "that it operated in accordance with all state and federal statutes and \n",
      "regulations regarding the exchange of patient health information; (2) \n",
      "utilizes the content exchange standard incorporated by reference at 45 \n",
      "cfr 170.205(a)(4)(i); (3) sends notifications that would have to \n",
      "include the minimum patient health information (specifically, patient \n",
      "name, treating practitioner name, sending institution name, and, if not \n",
      "prohibited by other applicable law, patient diagnosis); and (4) sends \n",
      "notifications directly, or through an intermediary that facilitates \n",
      "exchange of health information, and at the time of the patient's \n",
      "admission to the hospital and either immediately prior to or at the \n",
      "time of the patient's discharge and/or transfer from the hospital. we \n",
      "requested comment on the policy as part of this hospital proposal in \n",
      "section x.b. of the cms interoperability and patient access proposed \n",
      "rule (84 fr 7650 through 7652).\n",
      "    we also proposed that the hospital would need to demonstrate that \n",
      "the system sends notifications directly, or through an intermediary \n",
      "that facilitates exchange of health information, and either immediately \n",
      "prior to or at the time of the patient's hospital admission, discharge, \n",
      "or transfer, to licensed and qualified practitioners, other patient \n",
      "care team members, and pac services providers and suppliers that: (1) \n",
      "receive the notification for treatment, care coordination, or quality \n",
      "improvement purposes; (2) have an established care relationship with \n",
      "the patient relevant to his or her care; and (3) the hospital is \n",
      "reasonably certain will receive such notifications.\n",
      "    we referred readers to the extended discussion of the proposals in \n",
      "sections x.a. and b. of the cms interoperability and patient access \n",
      "proposed rule (84 fr 7649 through 7652). we sought comment on these \n",
      "proposals.\n",
      "\n",
      "d. provisions for cahs (42 cfr 485.638(d))\n",
      "\n",
      "    we believe implementation of patient event notifications are also \n",
      "important for cahs to support improved care coordination from these \n",
      "facilities to other providers in their communities. therefore, similar \n",
      "to the proposals for the hospital and psychiatric hospital medical \n",
      "records requirements as discussed in the preceding sections, we \n",
      "proposed to revise 42 cfr 485.638, by adding a new standard to the cah \n",
      "clinical records cop at paragraph (d), ``electronic notifications.'' as \n",
      "discussed, the proposed standard would require cahs to send electronic \n",
      "patient event notifications of a patient's admission, discharge, and/or \n",
      "transfer to another health care facility or to another community \n",
      "provider.\n",
      "    we proposed to limit this requirement to only those cahs which \n",
      "currently possess ehr systems with the technical capacity to generate \n",
      "information for electronic patient event notifications, defined as \n",
      "systems that utilize the content exchange standard incorporated by \n",
      "reference at 45 cfr 170.205(a)(4)(i). we proposed that for a cah that \n",
      "currently possessed an ehr system with the capacity to generate the \n",
      "basic patient personal or demographic information for electronic \n",
      "patient event (adt) notifications, compliance with the proposed \n",
      "standard within the clinical records services cop (42 cfr 485.638) \n",
      "would be determined by the cah demonstrating that its system: (1) is \n",
      "fully operational and that it operates in accordance with all state and \n",
      "federal statutes and regulations regarding the exchange of patient \n",
      "health information; (2) utilizes the content exchange standard \n",
      "incorporated by reference at 45 cfr 170.205(a)(4)(i); (3) sends \n",
      "notifications that would have to include the minimum patient health \n",
      "information (specifically, patient name, treating practitioner name, \n",
      "sending institution name, and, if not prohibited by other applicable \n",
      "law, patient diagnosis); and (4) sends notifications directly, or \n",
      "through an intermediary that facilitates exchange of health \n",
      "information, and at the time of the patient's admission to the cah and \n",
      "either immediately prior to or at the time of the patient's discharge \n",
      "and/or transfer from the cah. we requested comment on the policy as \n",
      "part of the hospital proposal in section x.b. of the cms \n",
      "interoperability and patient access proposed rule (84 fr 7650 through \n",
      "7652).\n",
      "    additionally, we proposed that the cah would need to demonstrate \n",
      "that the system sends notifications directly, or through an \n",
      "intermediary that facilitated exchange of health information, and at or \n",
      "immediately prior to the time of the patient's cah admission, \n",
      "discharge, or transfer, to licensed and qualified practitioners, other \n",
      "patient care team members, and pac services providers and suppliers \n",
      "that: (1) receive the notification for treatment, care coordination, or \n",
      "quality improvement purposes; (2) have an established care relationship \n",
      "with the patient relevant to his or her care; and (3) the cah is \n",
      "reasonably certain will receive such notifications.\n",
      "\n",
      "[[page 25589]]\n",
      "\n",
      "e. comments and responses on the provisions of the proposed rule; final \n",
      "actions and provisions of the final rule for hospitals (42 cfr \n",
      "482.24(d)), psychiatric hospitals (42 cfr 482.61(f)); and cahs (42 cfr \n",
      "485.638(d))\n",
      "\n",
      "    we requested comments on the proposals including stakeholder \n",
      "feedback about how the proposals should be operationalized. \n",
      "additionally, we sought comment on how cms should implement these \n",
      "proposals as part of survey and certification guidance in a manner that \n",
      "minimizes compliance burden on hospitals, psychiatric hospitals, and \n",
      "cahs while ensuring adherence with the standards. we also sought \n",
      "stakeholder input about a reasonable timeframe for implementation of \n",
      "these proposals for hospitals, psychiatric hospitals, and cahs, \n",
      "respectively.\n",
      "    we received more than 600 public comments on this section that were \n",
      "specific to the patient event notification requirements proposed for \n",
      "inclusion in the cops, but which generally did not distinguish among \n",
      "the requirements individually proposed for hospitals, psychiatric \n",
      "hospitals, and cahs at 42 cfr 482.24(d), 482.61(f), and 485.638(d), \n",
      "respectively. we summarize the public comments we received on our \n",
      "proposals related to the conditions of participation and provide our \n",
      "responses in this section. this summary of the public comments and our \n",
      "responses apply equally to all three provider types included under this \n",
      "proposed requirement and the specific provisions proposed for each \n",
      "unless otherwise noted. we provide the final actions and the provisions \n",
      "of the final rule at the end of this section.\n",
      "    comment: many commenters supported the proposals to require \n",
      "hospitals (including psychiatric hospitals) and cahs to send electronic \n",
      "patient event notifications of a patient's admission, discharge, and/or \n",
      "transfer to another health care facility or to another community \n",
      "provider. commenters stated that they believed implementing patient \n",
      "event notifications would be a highly effective tool to improve care \n",
      "transitions for patients moving between a hospital and other settings, \n",
      "including returning home. commenters believed that increasing the \n",
      "sharing of patient event notifications at admission and discharge can \n",
      "lead to improved outcomes, higher quality, and lower cost care. \n",
      "commenters also pointed to many instances in which these notifications \n",
      "are being utilized today, stating that they believe that patient event \n",
      "notifications had effectively contributed to improved care \n",
      "coordination. for instance, one commenter pointed to the statewide \n",
      "requirement for hospitals in maryland to transmit notifications, noting \n",
      "that this has been an important policy supporting care coordination in \n",
      "the state. several commenters noted that the availability of \n",
      "notification information is especially important for the success of \n",
      "value-based payment models, such as aco initiatives, where participants \n",
      "may be financially at risk for costs associated with poor care \n",
      "transitions.\n",
      "    response: we appreciate commenters' support for the proposal and \n",
      "are finalizing our proposal with modifications as discussed below.\n",
      "    comment: while many commenters agreed that patient event \n",
      "notifications are an important way to improve care coordination, some \n",
      "disagreed that the cops were the appropriate vehicle for advancing \n",
      "their use. many commenters stated that by placing the patient event \n",
      "notification requirements in the cops, cms is putting hospitals' \n",
      "participation in medicare at risk, which they stated would be an \n",
      "excessive penalty for failure to implement patient event notifications \n",
      "in accordance with the proposed requirements.\n",
      "    commenters also stated that the survey and certification process \n",
      "was not well-suited to determining compliance with the proposed cop \n",
      "``electronic notifications'' standard. these commenters questioned how \n",
      "surveyors would assess compliance with the requirements, including one \n",
      "commenter who questioned how a hospital would demonstrate that its \n",
      "system sent notifications that improve the coordination of care, and \n",
      "not just show that its system is merely functioning as required. they \n",
      "further stated that a survey team would need clear guidance on how to \n",
      "assess providers for compliance to ensure that hospitals are \n",
      "transmitting patient information to, and receiving it from, other \n",
      "providers.\n",
      "    additionally, one commenter stated that hospital accreditation \n",
      "programs are not the appropriate entities to assess compliance, due to \n",
      "the technical nature of the requirements.\n",
      "    commenters also expressed concern that tying these requirements to \n",
      "the cops could lead to hospitals sending more information than is \n",
      "necessary to ensure compliance, further increasing excessive \n",
      "information received by providers.\n",
      "    response: we appreciate the commenters' concerns regarding use of \n",
      "the cops to advance the use of patient notifications; however, we \n",
      "disagree that the cops are an inappropriate vehicle for this purpose. \n",
      "we believe that the capability to send patient event notifications \n",
      "should be a fundamental feature of hospital medical record systems to \n",
      "support effective care transitions and promote patient safety during \n",
      "transitions. this belief is consistent with the statutory authority for \n",
      "establishing and appropriately updating the cops as that authority is \n",
      "contained in section 1861(e) of the act, which defines institutions \n",
      "that meet the definition of a hospital for medicare purposes. \n",
      "specifically, section 1861(e)(2) of the act requires that a hospital \n",
      "``maintains clinical records on all patients,'' and section 1861(e)(9) \n",
      "of the act requires that a hospital ``meets such other requirements as \n",
      "the secretary finds necessary in the interest of the health and safety \n",
      "of individuals who are furnished services in the institution.'' as \n",
      "discussed in the proposed rule (84 fr 7650), we believe patient event \n",
      "notifications can help to improve care coordination for patients \n",
      "discharged from the hospital and reduce the incidence of events such as \n",
      "hospital readmissions that could have been avoided through more timely \n",
      "follow-up care.\n",
      "    further, including a cop requirement for patient event \n",
      "notifications at the time of a patient's discharge or transfer as we \n",
      "have proposed and are finalizing in this rule is also consistent with \n",
      "section 1861(ee)(2) of the act, which states that the secretary shall \n",
      "develop guidelines and standards for the discharge planning process in \n",
      "order to ensure a timely and smooth transition to the most appropriate \n",
      "type of and setting for post-hospital or rehabilitative care. we \n",
      "believe patient event notifications are an effective tool for ensuring \n",
      "that the settings responsible for follow-up care are made aware that \n",
      "their patients have been discharged in an expeditious manner. we \n",
      "believe that these notifications can be utilized to more effectively \n",
      "trigger care coordination activities that promote timely transitions. \n",
      "we have chosen to include these requirements in the cops for medical \n",
      "records services, and not those for discharge planning, because we \n",
      "believe that the medical records cops provide a more global approach to \n",
      "the notifications than do the discharge planning cops, especially since \n",
      "we are requiring notifications for inpatient admissions as well as ed \n",
      "and outpatient observation admissions or registrations in addition to \n",
      "patient discharges and transfers. therefore, given this statutory \n",
      "authority, we maintain that the cops are an appropriate vehicle for \n",
      "advancing the use of patient event notifications.\n",
      "    we also disagree that the cops are an inappropriate vehicle for \n",
      "this policy due to what the commenters' characterize as\n",
      "\n",
      "[[page 25590]]\n",
      "\n",
      "the disproportionate penalties associated with noncompliance with this \n",
      "cop. we note that while the cops are a significant regulatory \n",
      "mechanism, noncompliance with one subordinate standard under one cop \n",
      "must be considered relative to a hospital's compliance or noncompliance \n",
      "with the many other cops and standards as well as the severity of the \n",
      "noncompliance and the risk it poses to patient health and safety. under \n",
      "the heading, ``determining the severity of deficiencies,'' the state \n",
      "operations manual (som), appendix a--survey protocol, regulations and \n",
      "interpretive guidelines for hospitals cites the regulations at 42 cfr \n",
      "488.26 (``the decision as to whether there is compliance with a \n",
      "particular requirement, condition of participation, or condition for \n",
      "coverage, depends upon the manner and degree to which the provider or \n",
      "supplier satisfies the various standards within each condition.'') as \n",
      "the basis for determining the various levels of noncompliance with the \n",
      "cops during a survey (<a href=\"https://www.cms.gov/regulations-andguidance/guidance/manuals/downloads/som107ap_a_hospitals.pdf\">https://www.cms.gov/regulations-andguidance/guidance/manuals/downloads/som107ap_a_hospitals.pdf</a>; p.19).\n",
      "    from page 19 of the som, appendix a:\n",
      "    ``when noncompliance with a condition of participation is noted, \n",
      "the determination of whether a lack of compliance is at the standard or \n",
      "condition level depends upon the nature (how severe, how dangerous, how \n",
      "critical, etc.) and extent (how prevalent, how many, how pervasive, how \n",
      "often, etc.) of the lack of compliance. the cited level of the \n",
      "noncompliance is determined by the interrelationship between the nature \n",
      "and extent of the noncompliance.\n",
      "    ``a deficiency at the condition level may be due to noncompliance \n",
      "with requirements in a single standard or several standards within the \n",
      "condition, or with requirements of noncompliance with a single part \n",
      "(tag) representing a severe or critical health or safety breach. even a \n",
      "seemingly small breach in critical actions or at critical times can \n",
      "kill or severely injure a patient, and represents a critical or severe \n",
      "health or safety threat.\n",
      "    ``a deficiency is at the standard level when there is noncompliance \n",
      "with any single requirement or several requirements within a particular \n",
      "standard that are not of such character as to substantially limit a \n",
      "facility's capacity to furnish adequate care, or which would not \n",
      "jeopardize or adversely affect the health or safety of patients if the \n",
      "deficient practice recurred.''\n",
      "    regarding the comments questioning how surveyors, either state \n",
      "surveyors or those from one of the hospital accreditation programs, \n",
      "would determine compliance with the notification requirements, we will \n",
      "issue, as we do with all new or revised cop requirements, new \n",
      "interpretive guidelines, which include survey procedures, for the state \n",
      "operations manual, following finalization of this rule and prior to the \n",
      "rule's effective date. we will advise and train state surveyors on the \n",
      "new requirements as is the normal procedure when new and/or revised \n",
      "cops and standards are finalized. for example, the current medical \n",
      "record services cop requirements, contained at 42 cfr 482.24, and in \n",
      "which we are finalizing these new patient event notification \n",
      "requirements, primarily contain provisions for administrative systems \n",
      "or processes where the hospital is responsible for demonstrating that \n",
      "the various components of its medical records system or process are in \n",
      "place and operational in order to comply with the overall requirements \n",
      "of the cop. surveyors would then approach these new requirements in a \n",
      "similar fashion and apply similar survey procedures and methods that do \n",
      "not require surveyors to have deep technical knowledge of various \n",
      "systems in order to determine compliance. as with the survey of the \n",
      "hospital's total medical records system, surveyors would utilize basic \n",
      "and effective survey procedures and methods such as:\n",
      "    <bullet> review of the organizational structure and policy \n",
      "statements and an interview with the person responsible for the medical \n",
      "records service to first ascertain that the hospital has a system that \n",
      "meets the initial requirements for patient event notifications in order \n",
      "to determine whether or not the hospital is exempt from the specific \n",
      "patient event notification requirements that follow.\n",
      "    <bullet> review of a sample of active and closed medical records \n",
      "for completeness and accuracy, including any patient event \n",
      "notifications, in accordance with federal and state laws and \n",
      "regulations and hospital policy.\n",
      "    <bullet> interview of medical records and other hospital staff, \n",
      "including physicians and other practitioners, to determine \n",
      "understanding of the patient events notification function of the \n",
      "system.\n",
      "    <bullet> conducting observations and interviews with medical \n",
      "records staff and leadership to determine if requirements for patient \n",
      "event notifications are being met.\n",
      "    cms-approved accreditation organizations (aos) with hospital \n",
      "programs are required, at a minimum, to enforce standards that meet or \n",
      "exceed hospital cop requirements, so each ao will be responsible for \n",
      "training its survey and accreditation staff on the patient event \n",
      "notification requirements finalized in this rule ahead of the \n",
      "applicable date established by cms.\n",
      "    finally, the patient event notification requirements that we are \n",
      "finalizing require a hospital to send only a minimal amount of patient \n",
      "information in order to be in compliance with the provisions. these \n",
      "requirements are consistent with our belief that existing patient event \n",
      "notification systems have demonstrated that a minimal set of \n",
      "information can achieve the desired effect of improving care \n",
      "coordination while imposing minimal burden on providers. however, \n",
      "hospitals are not prohibited from sending more detailed information \n",
      "under these requirements and we would expect each hospital is fully \n",
      "aware of its own capacity to send additional patient information, other \n",
      "applicable laws governing this, and the capacities of the intended \n",
      "recipients to receive additional patient information, and would base \n",
      "its decisions to send additional information on these factors as well \n",
      "as on what is best for the patient. based on our experience with \n",
      "hospitals, we disagree with the commenter that a hospital would \n",
      "unnecessarily send ``excessive'' amounts of patient information in an \n",
      "attempt to ensure a determination that the hospital was in compliance. \n",
      "to prevent such confusion, we have clearly delineated the patient \n",
      "information requirements in this final rule.\n",
      "    comment: many commenters stated that the cops were not appropriate \n",
      "for advancing goals related to interoperability and the use of health \n",
      "it. commenters stated that cms currently regulates provider use of \n",
      "technology through a variety of other avenues, such as the promoting \n",
      "interoperability programs, and that adding the proposed requirements \n",
      "under the cops would add an unnecessary additional mechanism for \n",
      "addressing these issues. commenters believed this could lead to \n",
      "additional provider burden and confusion, as stakeholders would be \n",
      "required to navigate duplicative requirements around the electronic \n",
      "exchange of information. several commenters stated that, by shifting \n",
      "focus to compliance with the proposed requirements, and requiring \n",
      "hospitals to engage in duplicative reporting on information exchange, \n",
      "this proposal could divert funding and attention from necessary \n",
      "investments in interoperable health information exchange. commenters \n",
      "stated that they believed using the cops\n",
      "\n",
      "[[page 25591]]\n",
      "\n",
      "in this fashion was inconsistent with congressional intent for how hhs \n",
      "should regulate the use of health it.\n",
      "    commenters also noted that hhs is currently seeking to establish a \n",
      "range of new policies designed to advance the interoperable exchange of \n",
      "health information. commenters believed these policies could have a \n",
      "significant impact on the sharing of health information, including the \n",
      "sharing of patient event notifications, and that cms should refrain \n",
      "from rulemaking through the cops until these polices have been \n",
      "finalized. one commenter also noted that, at the time the comment \n",
      "period on the cms interoperability and patient access proposed rule \n",
      "closed, cms' discharge planning rule (80 fr 68125) had not yet been \n",
      "finalized, and that it would be premature to add this requirement in \n",
      "advance of finalizing related revisions to the discharge planning \n",
      "section of the cops.\n",
      "    commenters further stated that hhs has a variety of other \n",
      "mechanisms for advancing electronic information exchange and improving \n",
      "the infrastructure for exchange that would be more effective than \n",
      "adding requirements to the cops. several commenters expressed concern \n",
      "that using the cops would set static requirements that are ill-suited \n",
      "to an evolving technology environment and the innovation needed to \n",
      "increase adoption of notifications across providers.\n",
      "    response: we appreciate commenters' input. as noted above, we \n",
      "disagree with commenters who stated that the cops are not an \n",
      "appropriate mechanism for policy related to interoperability or the use \n",
      "of health it. existing cops address requirements related to medical \n",
      "records systems as well as the transfer of health information, and we \n",
      "believe there is no reason that these regulations should not address \n",
      "technology issues where the use of technology may be relevant to \n",
      "patient health and safety, provided that such references to technology \n",
      "in the cops do not lead to ``static requirements'' as noted by the \n",
      "commenter, and which we believe we have avoided doing in both the \n",
      "proposed and final rules. furthermore, while a 2017 review of the \n",
      "current available scientific evidence on the impact of different health \n",
      "information technologies on improving patient safety outcomes, warned \n",
      "that health care organizations ``need to be selective in which \n",
      "technology to invest in, as literature shows that some technologies \n",
      "have limited evidence in improving patient safety outcomes,'' the \n",
      "review also stated that there ``should be no doubt that health \n",
      "information technology is an important tool for improving healthcare \n",
      "quality and safety.'' \\62\\ according to the authors of the review, \n",
      "evidence from a number of studies shows that health it offers numerous \n",
      "opportunities for improving and transforming health care that includes \n",
      "the potential to reduce human errors, improve clinical outcomes, \n",
      "facilitate care coordination, improve practice efficiencies, and track \n",
      "data over time. based on this evidence as well as the evidence directly \n",
      "related to patient event notifications that we cited previously, we \n",
      "believe that the requirements for patient event notifications that we \n",
      "have proposed and that we are finalizing in this rule will have a \n",
      "positive impact on many of these same areas, especially regarding the \n",
      "facilitation of care coordination for patients, leading to improved \n",
      "outcomes and enhanced patient health and safety.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\62\\ alotaibi, y., & federico, f. (2017). the impact of health \n",
      "information technology on patient safety. saudi medical journal, \n",
      "38(12), 1173-1180. doi: 10.15537/smj.2017.12.20631.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while we appreciate the importance of aligning policies across \n",
      "different programs to minimize provider burden, we believe that the \n",
      "proposed requirements are not addressed elsewhere and are appropriate \n",
      "for inclusion in the cops. additionally, we disagree with commenters \n",
      "who stated that the proposed requirements will require hospitals to \n",
      "engage in duplicative reporting on information exchange since the \n",
      "proposed requirements do not require hospitals and cahs to do any type \n",
      "of reporting to cms in order to comply with the requirements. we also \n",
      "understand that other proposed or recently finalized policies may be \n",
      "relevant to the proposed requirements in this rule; however, we believe \n",
      "these policies will complement one another and serve to enable the \n",
      "proposed requirements around patient event notifications. as we noted \n",
      "above regarding the final rule published on september 30, 2019, \n",
      "discharge planning final rule (84 fr 51836), the revised discharge \n",
      "planning cops do not require hospitals, cahs, and hhas to transfer \n",
      "necessary patient medical information exclusively by electronic means, \n",
      "nor do they require that providers notify the appropriate providers, \n",
      "suppliers, and practitioners receiving the necessary medical \n",
      "information of the patient's discharge (or admission) as we are now are \n",
      "requiring in this final rule. we believe that the two rules, as written \n",
      "and finalized, do not conflict, but instead complement and support each \n",
      "other in cms' goal of improving patient care transitions. therefore, we \n",
      "disagree with the comments stating that the patient event notification \n",
      "requirements are premature or duplicative in relation to the final \n",
      "discharge planning requirements for hospitals, cahs, and hhas.\n",
      "    regarding concerns that it will be challenging to update the cops \n",
      "to reflect changing technology requirements, our proposal sought to \n",
      "focus primarily on functional requirements that will allow hospitals \n",
      "the flexibility to pursue innovation and adapt their systems over time, \n",
      "similar to other functional requirements under the medical records \n",
      "services cop. where we do reference a specific standard, in order to \n",
      "determine whether or not a hospital's system would be subject to the \n",
      "proposed ``electronic notifications'' standard, we reference a content \n",
      "exchange standard at 45 cfr 170.205(d)(2) common to many ehrs that we \n",
      "believe is unlikely to undergo changes that would require frequent \n",
      "updates.\n",
      "    comment: commenters stated that including these requirements under \n",
      "the cops would significantly increase the compliance burden for \n",
      "providers. commenters believed that the proposed policy was contrary to \n",
      "other recent hhs burden reduction initiatives for providers. commenters \n",
      "also believed that this proposal would add additional layers of \n",
      "regulation to what is a common practice for many hospitals today, \n",
      "further increasing provider burden.\n",
      "    several commenters stated that cms had underestimated the burden \n",
      "associated with this proposal. they disagreed that implementing patient \n",
      "event notifications would be largely limited to a one-time cost, and \n",
      "stated that there would be substantial work required prior to \n",
      "implementing the proposal and continuous work around receiving \n",
      "notifications from other providers. commenters suggested that cms \n",
      "pursue other initiatives to alleviate costs, such as standardizing the \n",
      "data set for patient event notifications. stakeholders also urged cms \n",
      "to ensure that providers have cost-effective choices for required \n",
      "technology solutions, and to not create an environment that encourages \n",
      "over-pricing of solutions.\n",
      "    response: we appreciate commenters' concerns about additional \n",
      "provider burden. while we understand that this new requirement may \n",
      "impose some additional implementation burden on hospitals, commenters \n",
      "also expressed that there are many ways for hospitals to minimize this \n",
      "burden through the use of existing technologies and services, such as \n",
      "health information exchanges and other service providers which capture \n",
      "notification information from a hospital's ehr and route it to\n",
      "\n",
      "[[page 25592]]\n",
      "\n",
      "appropriate recipients. we believe that there is sufficient flexibility \n",
      "in the current proposal to ensure hospitals have a broad range of \n",
      "options for implementation and will be able to comply in a way that \n",
      "aligns with their existing capabilities.\n",
      "    we believe that care coordination can have a significant positive \n",
      "impact on the quality of life, consumer experience, and health outcomes \n",
      "for patients. however, we acknowledge that though such activities can \n",
      "have positive impact, they will likely generate some costs. we believe \n",
      "it is difficult to quantify the impact of these changes because ehr \n",
      "implementation across care settings varies in maturity rates, leading \n",
      "to potential variance in cost and impact across such settings. \n",
      "nonetheless, we have attempted to estimate the burden for those \n",
      "hospitals and cahs that currently utilize electronic medical records \n",
      "systems or other electronic administrative systems that are conformant \n",
      "with the content exchange standard at 45 cfr 170.205(d)(2), and which \n",
      "generate information to support the basic messages commonly used for \n",
      "electronic patient event notifications, but which are not currently \n",
      "transmitting notifications. the cost of implementing these changes will \n",
      "include a one-time cost related to initial implementation of the \n",
      "notification system. additionally, we have also estimated recurring \n",
      "maintenance costs for either those hospitals or cahs that use hospital \n",
      "or cah it services staff to perform this recurring maintenance, or for \n",
      "those hospitals and cahs that contract with third party outside \n",
      "services providers to perform this maintenance. we also stress that the \n",
      "requirements that we are finalizing here do not mandate that a hospital \n",
      "or cah must purchase and implement a new ehr system. rather, as \n",
      "finalized here, the provisions require a hospital or a cah to \n",
      "demonstrate compliance with all of the provisions contained at 42 cfr \n",
      "482.24(d), 482.61(f), and 485.638(d) only if it utilizes an electronic \n",
      "medical records system or other electronic administrative system that \n",
      "is conformant with the content exchange standard at 45 cfr \n",
      "170.205(d)(2). we note here then that a hospital or a cah that does not \n",
      "meet the basic requirements denoted in the standard language at \n",
      "paragraphs 42 cfr 482.24(d), 482.61(f), and 485.638(d) is exempt from \n",
      "demonstrating compliance with the requirements that follow and will not \n",
      "be surveyed for those specific provisions once a surveyor determines \n",
      "that the system used by the hospital or cah is not conformant with the \n",
      "content exchange standard discussed here.\n",
      "    comment: many commenters supported the proposal to limit the \n",
      "application of the proposed requirements to hospitals that possess a \n",
      "system capable of generating information for patient event \n",
      "notifications, while several disagreed with cms and thought that cms \n",
      "should not limit these requirements to only certain hospitals. numerous \n",
      "commenters also sought additional information on how cms will determine \n",
      "whether a hospital's system is subject to the proposed cop standard. \n",
      "commenters stated that the proposed rule did not indicate how surveyors \n",
      "would determine which electronic records systems possess required \n",
      "attributes, and that surveyors would not have the technical expertise \n",
      "required to make this determination.\n",
      "    response: in the cms interoperability and patient access proposed \n",
      "rule, we proposed to limit this requirement to only those hospitals \n",
      "which currently possess ehr systems with the technical capacity to \n",
      "generate information for electronic patient event notifications. we \n",
      "defined a system with this capacity as one that utilizes the adt \n",
      "messaging standard, health level seven (hl7[supreg]) messaging standard \n",
      "version 2.5.1 (hl7 2.5.1)) incorporated by reference at 45 cfr \n",
      "170.205(a)(4)(i). we noted that this standard is referenced by \n",
      "certification criteria related to transferring information to \n",
      "immunization registries, as well as transmission of laboratory results \n",
      "to public health agencies as described at 45 cfr 170.315(f), and that \n",
      "adoption of certified health it that meets these criteria has been \n",
      "required for any hospital seeking to qualify for the promoting \n",
      "interoperability program. we believe hospitals and surveyors will be \n",
      "able to determine whether an ehr system possesses the capacity to \n",
      "generate information for electronic patient event notifications, \n",
      "defined for the purposes of the cop as a system conformant with the \n",
      "specified adt messaging standard (hl7 2.5.1), based on existing \n",
      "requirements for other programs, such as the promoting interoperability \n",
      "program. in general, we believe that information about whether a system \n",
      "complies with this provision will be easy to obtain from a hospital's \n",
      "health it developer.\n",
      "    as discussed below, we are finalizing a citation to the adt \n",
      "messaging standard (hl7 2.5.1) at 45 cfr 170.205(d)(2).\n",
      "    comment: a commenter noted that in some instances a hospital's \n",
      "patient event notification system is connected to the hospital's \n",
      "registration system rather than its ehr system, which is used for \n",
      "clinical purposes only.\n",
      "    response: we appreciate the comment and the opportunity to note \n",
      "here that the ``electronic medical records system'' described in the \n",
      "cops is not limited to the ehr system used for the management of \n",
      "clinical data. hospitals would also be permitted to send patient event \n",
      "notifications using their registration system. based on this comment, \n",
      "we are revising the language at 42 cfr 482.24(d), 482.61(f), and \n",
      "485.638(d) in this final rule to now state that if the hospital (or \n",
      "psychiatric hospital or cah), ``. . . utilizes an electronic medical \n",
      "records system or other electronic administrative system,'' then the \n",
      "hospital (or psychiatric hospital or cah) would need to demonstrate \n",
      "that its system complies with the provisions that follow in this \n",
      "section.\n",
      "    comment: in the proposed rule we sought comment on whether we \n",
      "should identify a broader set of patients to whom this requirement \n",
      "would apply, beyond those admitted and treated as inpatients. for \n",
      "instance, we noted that a patient event notification could ensure a \n",
      "primary care physician is aware that their patient has received care at \n",
      "the emergency room, and initiate outreach to the patient to ensure that \n",
      "appropriate follow-up for the emergency visit is pursued (84 fr 7651).\n",
      "    many stakeholders responded to this request for comment by stating \n",
      "that they supported extending this policy to also include patients seen \n",
      "in a hospital's emergency department (ed). commenters stated that \n",
      "requiring systems to be able to send these notifications would be an \n",
      "important way to support better care coordination and prevent \n",
      "unnecessary repeat visits to the emergency department. commenters also \n",
      "suggested that this requirement should include patients seen in the \n",
      "hospital for ``observational'' stays, but who are not admitted as \n",
      "inpatients.\n",
      "    response: we agree with the commenters that ed patients should be \n",
      "included in the patient event notification system, and have revised the \n",
      "regulatory text at 42 cfr 482.24(3)(i) and (4)(i), 482.61(3)(i) and \n",
      "(4)(i), and 485.638(3)(i) and (4)(i) to include these patients. many \n",
      "patients registered in the ed are eventually discharged home after \n",
      "being treated, while others are either held for observation in a \n",
      "hospital bed as outpatients or admitted as inpatients to the hospital. \n",
      "the revisions we are finalizing here would require a hospital's system \n",
      "to send patient event notifications for patients who are registered in \n",
      "the ed, if applicable, and then also for patients admitted as\n",
      "\n",
      "[[page 25593]]\n",
      "\n",
      "inpatients, regardless if the patient was admitted from the ed, from an \n",
      "observation stay, or as a direct admission from home, from their \n",
      "practitioner's office, or as a transfer from some other facility. we \n",
      "agree with the commenters and believe that if we were not to include ed \n",
      "patients in the notification requirements in this final rule, we would \n",
      "miss an important opportunity for positively impacting the care \n",
      "transitions and the continuing care of a significant number of patients \n",
      "seen in the nation's hospital emergency departments. including ed \n",
      "patients in the patient event notification requirements is consistent \n",
      "with the purpose of the cops as a regulatory means of promoting and \n",
      "protecting the overall health and safety of all hospital patients, \n",
      "regardless of their physical location in the hospital.\n",
      "    to illustrate when a patient event notification is, and is not, \n",
      "required, we would like to point out the following scenarios. a \n",
      "hospital's system would be expected to send one notification when a \n",
      "patient is first registered in a hospital's ed or as an observational \n",
      "stay (that is, in both of these cases, the patient would be considered \n",
      "an outpatient and not an inpatient at this point in time), and a second \n",
      "notification if the same patient was then later admitted to a hospital \n",
      "inpatient services unit (for example, medical unit, labor and delivery \n",
      "unit, telemetry unit, neurology unit, surgical unit, intensive care \n",
      "unit (icu), etc.), or if the same patient was admitted for inpatient \n",
      "services, but was being boarded in the ed while waiting for an \n",
      "inpatient unit bed. in contrast, a second patient event notification \n",
      "would not be required if an already admitted inpatient was transferred \n",
      "from one inpatient services unit of the hospital to another (for \n",
      "example, if the patient was admitted to the hospital's icu, but was \n",
      "then later transferred to the hospital's ``step-down'' or \n",
      "``intermediate care'' unit or to a medical unit, in which case, the \n",
      "patient continued to remain an inpatient of the hospital), or if an \n",
      "already admitted patient was being boarded in the ed and then was \n",
      "transferred to an inpatient unit when a bed became available. however, \n",
      "while the requirements do not prohibit a hospital from electing to send \n",
      "a patient event notification when a patient is transferred to one \n",
      "inpatient services unit of the hospital to another, the requirements \n",
      "finalized in this rule are based on a change in the patient's status \n",
      "from outpatient to inpatient, and not necessarily on the physical \n",
      "location of the patient.\n",
      "    finally, in all cases, a patient's discharge or transfer from the \n",
      "hospital, either from the ed or an observational stay or an inpatient \n",
      "services unit, would still require the hospital to send another and \n",
      "separate patient event notification to the applicable entities as \n",
      "required under this rule.\n",
      "    comment: we proposed that hospitals should send notifications to \n",
      "those practitioners or providers that have an established care \n",
      "relationship with the patient relevant to his or her care (84 fr 7652). \n",
      "many commenters sought additional information about the term \n",
      "``established care relationship'' and how hospitals should discern who \n",
      "has an established care relationship with a patient. commenters noted \n",
      "that the list of providers who have an ``established care \n",
      "relationship'' with a patient could be very extensive and requested \n",
      "more information on the extent of the specialization of care team \n",
      "members covered by the requirement. one commenter suggested cms \n",
      "indicate that the term ``established care relationship'' only applies \n",
      "to one that is current and directly related to the patient's diagnosis \n",
      "for which the notification is sent. another commenter suggested that \n",
      "cms define ``established care relationship'' as the principle physician \n",
      "identified by the patient and any institution that the patient \n",
      "identifies. several commenters suggested that cms replace the term \n",
      "``established care relationship'' with ``active relationship,'' and \n",
      "noted that this would also ensure payers received the notifications, as \n",
      "their relationship with a patient may not be included under the \n",
      "definition of a ``care'' relationship. one commenter suggested that cms \n",
      "note that hospitals have the latitude to choose the recipient of the \n",
      "notification. commenters also sought direction on how hospitals should \n",
      "approach a situation in which a patient does not have a primary care \n",
      "provider, or in which a provider who has an established care \n",
      "relationship with the patient cannot be easily identified. several \n",
      "commenters noted that effective notification systems are often \n",
      "organized around a subscription model, in which receiving providers are \n",
      "responsible for identifying those patients for whom they would like to \n",
      "receive notifications.\n",
      "    response: we appreciate commenters' input. we agree that the term \n",
      "``established care relationship'' could be subject to an overly broad \n",
      "interpretation that is not consistent with our goal to set a minimum \n",
      "floor for these requirements under the cops. accordingly, we are \n",
      "finalizing a more limited set of recipients to whom a hospital's system \n",
      "must send patient event notifications for the purposes of meeting this \n",
      "cop. we are finalizing at 42 cfr 482.24(d)(5), 482.61(f)(5), and \n",
      "485.638(d)(5) requirements that the hospital's system send \n",
      "notifications to the following recipients as applicable: the patient's \n",
      "established primary care practitioner; the patient's established \n",
      "primary care practice group or entity; or other practitioners or \n",
      "practice groups or entities, identified by the patient as the \n",
      "practitioner, or practice group or entity, primarily responsible for \n",
      "his or her care. we believe that the use of the modifier \n",
      "``established,'' as finalized here in the context of a patient's \n",
      "established primary care practitioner or his or her established primary \n",
      "care practice group or entity, more clearly signifies a care \n",
      "relationship that the patient recognizes as primary or one that is \n",
      "evidenced by documentation of the relationship in the patient's medical \n",
      "record. as an example, if the patient's established primary care \n",
      "practitioner refers the patient to the hospital, this primary care \n",
      "practitioner should receive the event notification. we believe this \n",
      "language improves upon the proposed term ``established care \n",
      "relationship,'' which commenters correctly noted is too vague in \n",
      "meaning, too broad in scope, and too open to various interpretations, \n",
      "all of which could prove burdensome for hospitals to demonstrate \n",
      "compliance with the requirements here. we note that this final policy \n",
      "does not prevent a hospital from sending patient event notifications to \n",
      "other practitioners, in accordance with all applicable laws, who may be \n",
      "relevant to a patient's post-discharge care and would benefit from \n",
      "receiving patient event notifications, nor would it prevent a hospital \n",
      "from seeking to identify these other practitioners. however, we believe \n",
      "this more limited set of recipients is more appropriate to our goal of \n",
      "setting baseline requirements and will provide hospitals with \n",
      "sufficient specificity to comply with the requirements.\n",
      "    in cases where a hospital is not able to identify a primary care \n",
      "practitioner for a patient, the patient has not identified a provider \n",
      "to whom they would like information about their care to be sent, or \n",
      "there is no applicable pac provider or supplier identified, we would \n",
      "not expect a hospital to send a patient event notification for that \n",
      "patient. we note that under the cop, a hospital would be required to \n",
      "demonstrate that its system sends notifications to appropriate \n",
      "recipients. we expect that hospitals would demonstrate this capability \n",
      "in variety of ways, for instance, by demonstrating that the hospital \n",
      "has processes and policies in place to identify patients' primary care \n",
      "practitioners and\n",
      "\n",
      "[[page 25594]]\n",
      "\n",
      "incorporate this information into the patient event notification \n",
      "system, or through recording information received from patients about \n",
      "their providers.\n",
      "    comment: commenters stated that obtaining information about \n",
      "providers who have an ``established care relationship'' with a given \n",
      "patient and maintaining lists of these providers and contact \n",
      "information for delivery of patient event notifications would impose \n",
      "significant burden on hospitals. one commenter noted that patients may \n",
      "not reliably provide information about their providers, and recommended \n",
      "that in those cases the recipient of the patient event notification \n",
      "should identify their relationship with a patient in advance.\n",
      "    several commenters noted that, to the extent hospitals already have \n",
      "operational processes and infrastructure in place to determine \n",
      "destinations for notifications, these processes should be left in \n",
      "place. several commenters noted that, in order to successfully route \n",
      "messages to the appropriate provider, hospitals would need to be able \n",
      "to overcome challenges associated with patient matching: the ability \n",
      "for a hospital to accurately match records about a patient with the \n",
      "records held by a receiving provider. commenters stated that challenges \n",
      "with patient matching could inhibit patient event notifications from \n",
      "being received by the correct provider and will lead to frequent \n",
      "pushback from providers about receiving notifications regarding \n",
      "patients they are not affiliated with. commenters also noted the \n",
      "importance of community-wide directories that map the address of a \n",
      "provider to their electronic endpoint destination, which would allow a \n",
      "hospital to query a directory and find the destination of the patient's \n",
      "choice.\n",
      "    response: as noted, we are finalizing a more limited minimum set of \n",
      "recipients for patient event notifications than originally proposed. \n",
      "this set of recipients is focused on a patient's established primary \n",
      "care practitioner (or established primary care practice group or \n",
      "entity) or any other practitioner (or practice group or entity) \n",
      "identified by the patient as primarily responsible for his or her care. \n",
      "however, we are retaining inclusion in this final rule of pac providers \n",
      "and suppliers as required recipients of notifications as originally \n",
      "proposed. in order to clarify the pac services providers and suppliers \n",
      "that are required recipients, we are modifying this proposal to refer \n",
      "to ``all applicable pac services providers and suppliers.'' for \n",
      "purposes of this policy, applicable pac services providers and \n",
      "suppliers would be those pac services providers and suppliers with whom \n",
      "the patient has an established care relationship prior to admission or \n",
      "to whom the patient is being transferred or referred. similar to our \n",
      "modification to reference the patient's established primary care \n",
      "practitioner, these pac services providers and suppliers would be those \n",
      "with an established care relationship immediately preceding the \n",
      "hospital registration or admission (such as a pac services provider or \n",
      "supplier from which the patient was transferred to the hospital) or \n",
      "those with which a relationship is being established for purposes of \n",
      "treatment and/or care coordination post-discharge from the hospital. \n",
      "the potential recipients of patient event notifications will be limited \n",
      "to only those that need to receive notification of the patient's status \n",
      "for treatment, care coordination, or quality improvement purposes. we \n",
      "believe that this final policy will reduce potential operational burden \n",
      "associated with a broader ``established care relationship'' definition. \n",
      "we believe that increasing numbers of hospitals now commonly seek to \n",
      "identify patients' primary care practitioners and their contact \n",
      "information, including any digital contact information, or partner with \n",
      "intermediaries that identify primary care practitioners, and that many \n",
      "hospitals will be able to continue to use their existing processes to \n",
      "satisfy the cop. if a hospital has processes in place for identifying \n",
      "patients' primary care practitioners and other applicable providers, \n",
      "but is not able to identify an appropriate recipient for a patient \n",
      "event notification for a specific patient, the hospital would not be \n",
      "expected to send a notification for that patient.\n",
      "    research using cms data on readmission rates in medicare-\n",
      "participating hospitals from 2007 to 2015 shows that the readmission \n",
      "rates for targeted conditions (that is, a set of specific diagnoses \n",
      "measured by medicare) declined from 21.5 percent to 17.8 percent, and \n",
      "rates for non-targeted conditions declined from 15.3 percent to 13.1 \n",
      "percent.\\63\\ while this decline in readmissions rates is attributable \n",
      "to multiple factors, we believe that one of the significant factors \n",
      "driving down avoidable patient readmissions is identification by the \n",
      "hospital of the patient's established primary care practitioner (or \n",
      "practice group) and his or her contact information prior to discharge \n",
      "and/or transfer. increased and early identification of the patient's \n",
      "primary care practitioner is more likely to lead to more accurate and \n",
      "timely transfer of patient health information from hospital-based \n",
      "practitioners to community-based primary care practitioners. \n",
      "additionally, early identification of a patient's primary care \n",
      "practitioner along with the patient event notification to the \n",
      "practitioner that his or her patient is about to be discharged from the \n",
      "hospital is most likely to have a net positive effect on scheduled \n",
      "post-discharge follow-up rates for patients most at risk for avoidable \n",
      "readmissions.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\63\\ alper, e., o'malley, t.a., & greenwald, j. (n.d.). hospital \n",
      "discharge and readmission. retrieved from <a href=\"https://www.uptodate.com/contents/hospital-discharge-and-readmission\">https://www.uptodate.com/contents/hospital-discharge-and-readmission</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we appreciate commenters concerns about patient matching \n",
      "challenges. this is a larger issue beyond the scope of this cop \n",
      "proposal and this current rule, but we will consider this issue for \n",
      "future revisions and updates to the cops. with the continued increase \n",
      "in the use of electronic data in health care organizations and among \n",
      "providers of health care services, there has been a continued need for \n",
      "patient matching, or patient identity management (pim) processes, in \n",
      "health care organizations, including hospitals. pim has been defined as \n",
      "the ability to uniquely ascertain the identity of a patient, assign \n",
      "that patient's record an identifier that is unique within the \n",
      "organization, system, or exchange network, and match that patient's \n",
      "record within and between systems using a number of demographic data \n",
      "elements, such as the patient's first name, last name, address, and \n",
      "date of birth. effective pim supports patient identity integrity, which \n",
      "the national association of healthcare access management defines as \n",
      "accurately identifying and matching the right patient with his or her \n",
      "complete medical record, every time, in every provider setting.\\64\\ \n",
      "accurate patient identity management is critical to successfully \n",
      "delivering the right care to the correct patients.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\64\\ national association of healthcare access management. \n",
      "(2016, march 17). naham public policy statement on patient identity \n",
      "integrity. retrieved from <a href=\"https://nahamnews.blogspot.com/2016/03/naham-public-policy-statement-on.html\">https://nahamnews.blogspot.com/2016/03/naham-public-policy-statement-on.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    capturing incorrect or incomplete data can result in critical \n",
      "patient care issues and risk privacy breaches. health care \n",
      "organizations are more likely to have their ehr system filled with \n",
      "duplicate patient records and inaccurate information about their \n",
      "patients when they are not managing an effective pim process. having an \n",
      "ineffective pim process will most definitely negatively impact a \n",
      "hospital's patient event notification system, which is one of the many \n",
      "reasons why a rigorous pim process is essential to patient care as \n",
      "health it moves forward. additionally, pim has become crucial in order \n",
      "to (1)\n",
      "\n",
      "[[page 25595]]\n",
      "\n",
      "enable health record document consumers to obtain trusted views of \n",
      "their patient subjects; (2) facilitate data exchange projects; (3) \n",
      "abide by the current regulations concerning patient information-related \n",
      "transparency, privacy, disclosure, handling, and documentation; and (4) \n",
      "make the most efficient use of limited health care resources by \n",
      "reducing redundant data collection.\\65\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\65\\ gliklich, r., dreyer, n., & leavy, m. (eds.). (2014). \n",
      "registries for evaluating patient outcomes: a user's guide (3rd \n",
      "ed.). rockville, md: ahrq publication. retrieved from <a href=\"https://www.ncbi.nlm.nih.gov/books/nbk208616/\">https://www.ncbi.nlm.nih.gov/books/nbk208616/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    nationally recognized practices and standards for ensuring patient \n",
      "identity integrity have been identified by organizations such as the \n",
      "national association of healthcare access management, american health \n",
      "information management association, the agency for healthcare research \n",
      "and quality, and onc. these standards include standardizing demographic \n",
      "data fields and internally evaluating the accuracy of patient matching \n",
      "within health care organizations.\n",
      "    we believe this presents an opportunity for the health it industry \n",
      "to lead the way in developing innovative solutions to patient matching, \n",
      "or pim, that can benefit all facets of the health care industry. \n",
      "however, appreciating the importance of accurate patient matching, cms \n",
      "will continue to evaluate ways to support improved patient matching \n",
      "solutions.\n",
      "    comment: several commenters suggested additional provider types \n",
      "that should receive patient event notifications. for instance, \n",
      "commenters suggested health plans should be included on the list of \n",
      "recipients for patient event notifications, noting that this \n",
      "information would be valuable to plans responsible for coordinating \n",
      "services for beneficiaries and reducing readmissions. one commenter \n",
      "also recommended sending notifications to public health departments. \n",
      "several commenters also requested that specific health care \n",
      "professionals be identified as recipients. commenters also suggested \n",
      "that other caregivers such as relatives be included on the list of \n",
      "recipients.\n",
      "    response: we appreciate commenters' suggestions about adding \n",
      "additional recipients for patient event notifications. while there may \n",
      "be other entities that could benefit from receiving patient event \n",
      "notifications, we believe it is more appropriate for the purposes of \n",
      "the cop requirements to focus on a minimal set of recipients for \n",
      "notifications. this approach would not preclude hospitals from sending \n",
      "notifications to other entities, including health plans, provided \n",
      "hospitals comply with applicable laws and regulations regarding sharing \n",
      "of patient data.\n",
      "    comment: many commenters suggested that cms should consider \n",
      "approaches that aim to incentivize providers to implement patient event \n",
      "notifications, rather than requiring hospitals to do so through the \n",
      "cops. commenters stated that adding this requirement would result in \n",
      "unnecessary and burdensome duplication of requirements that hospitals \n",
      "are already subject to as part of existing programs focused on \n",
      "advancing health information exchange. specifically, many commenters \n",
      "recommended that cms seek to advance these goals through the promoting \n",
      "interoperability program. commenters suggested cms consider adding a \n",
      "measure to the program based on patient event notifications, noting \n",
      "that such a measure could mirror the ``active engagement'' concept \n",
      "currently used for public health measures under the program or be \n",
      "assessed through an attestation similar to current attestations related \n",
      "to information blocking. several commenters also noted our discussion \n",
      "of potentially establishing a set of ``health it activities'' under the \n",
      "promoting interoperability program (84 fr 7618) that would not be \n",
      "linked to performance measures, noting that such a concept would be \n",
      "well-suited to advancing patient event notifications. one commenter \n",
      "noted that the promoting interoperability program, with its annual \n",
      "performance assessment, is more appropriate to supporting progress on \n",
      "technology goals than the cops, and that a measure reported annually \n",
      "could better assess the degree to which providers are improving their \n",
      "usage of patient event notifications.\n",
      "    commenters also recommended other alternative strategies that cms \n",
      "could engage in to incentivize use of patient event notifications, such \n",
      "as models established under innovation center authority. commenters \n",
      "believed that highlighting the use of patient event notifications in \n",
      "connection with alternative payment models could help to strengthen the \n",
      "business case for this intervention. another commenter recommended that \n",
      "the use of patient event notifications could be incentivized through an \n",
      "offset or bonus in a hospital-focused quality program, or through \n",
      "offering regulatory flexibility (for instance around telehealth) to \n",
      "hospitals that choose to implement a system for notifications.\n",
      "    response: we appreciate commenters' suggestions to encourage the \n",
      "use of patient event notifications through the promoting \n",
      "interoperability program. in order for an action to serve as the basis \n",
      "for a measure under the promoting interoperability program, the action \n",
      "must require the use of certified health it. as discussed in the cms \n",
      "interoperability and patient access proposed rule, at this time there \n",
      "is no certification criterion included in onc's certification program \n",
      "for the creation and transmission of patient event notifications (84 fr \n",
      "7651). as discussed elsewhere in this final rule, onc does not believe \n",
      "there is a widely adopted consensus standard for patient event \n",
      "notifications at this time. onc will continue to monitor adoption of \n",
      "standards for this use case and consider whether it would be \n",
      "appropriate to develop a certification criterion for this \n",
      "functionality. accordingly, we believe it would not be feasible to add \n",
      "a measure related to patient event notifications to the promoting \n",
      "interoperability program at this time.\n",
      "    we appreciate commenters input about other programs that could \n",
      "advance the use of patient event notifications, such as models \n",
      "established under innovation center authority, and will take these \n",
      "under consideration.\n",
      "    comment: several commenters addressed the use of the adt standard \n",
      "for patient event notifications. one commenter noted that the adt \n",
      "messaging standard is very broad and that implementations are subject \n",
      "to significant variability and customization. commenters highlighted \n",
      "the fact that there is significant variation in the implementation of \n",
      "the adt standard, limiting interoperability across interfaces using \n",
      "this standard, and suggested that cms clarify specific content and \n",
      "triggering events for adt data exchange. another commenter noted that \n",
      "the lack of an implementation guide for the use of adt messages for \n",
      "notifications is challenging, as this guidance is essential for \n",
      "understanding what information must be sent and how. commenters who \n",
      "believed that the reference to the adt standard would require the \n",
      "establishment of new interfaces for exchanging adt messages stated that \n",
      "recipient providers would not be able to receive adt messages if they \n",
      "do not have an inbound adt interface in place. many commenters believed \n",
      "that specifying the hl7 2.5.1 adt message standard would be overly \n",
      "restrictive and recommended that cms not specify a specific standard \n",
      "for these transactions at this time. commenters urged cms to focus on \n",
      "creating functional requirements rather than identifying specific \n",
      "mechanisms or standards for\n",
      "\n",
      "[[page 25596]]\n",
      "\n",
      "the data. other commenters stated that any standard should be required \n",
      "as a floor, rather than a ceiling. one stakeholder recommended that cms \n",
      "compile stakeholder feedback to better understand which standard would \n",
      "be preferred by the industry.\n",
      "    several commenters supported adoption of the adt message standard \n",
      "(hl7 2.5.1), stating that it is the most frequently used standard for \n",
      "the transmission of patient event notifications. one commenter urged \n",
      "cms to avoid policies that allow a hospital to deviate from a required \n",
      "standard, and to align with standards proposed by onc to ensure \n",
      "consistency across different types of data exchange.\n",
      "    one commenter suggested that cms explore moving to later versions \n",
      "of the hl7 2.5.1 standard, which provide additional message types, \n",
      "segments, and codes while others noted that additional work will be \n",
      "needed by standards setting bodies such as hl7 to develop a more robust \n",
      "standard in the future.\n",
      "    other commenters supported the flexibility discussed in the cms \n",
      "interoperability and patient access proposed rule with respect to using \n",
      "other standards and features to support sending patient event \n",
      "notifications. one commenter supported the flexibility provided in the \n",
      "proposed rule, but believed that this flexibility may introduce \n",
      "challenges for those providers receiving and incorporating information \n",
      "provided by a hospital.\n",
      "    several commenters urged cms to not require the use of certified \n",
      "ehr technology (cehrt) to send adt messages, noting that hospitals \n",
      "currently use a variety of solutions to send patient event \n",
      "notifications. one commenter noted that the hl7 protocol cannot be sent \n",
      "using direct messaging or other exchanges used for continuity of care \n",
      "documents. one commenter noted that adt information is not available in \n",
      "real time, and that an open api for both the hospital and receiving \n",
      "provider would be needed to enable real-time notifications. commenters \n",
      "recommended that cms instead focus on the use of standards-based feeds \n",
      "from the hospital's technology of choice.\n",
      "    response: we appreciate commenters' feedback. we recognized in the \n",
      "cms interoperability and patient access proposed rule that there is \n",
      "currently significant variation in how hospitals have utilized adt \n",
      "messages to support implementation of patient event notifications (84 \n",
      "fr 7651). in recognition of this current state, we proposed to require \n",
      "that a hospital would be subject to this cop if its system complied \n",
      "with the adt messaging standard, but we did not propose to require that \n",
      "hospitals use a specific standard to format or deliver patient event \n",
      "notifications. we believe this flexibility is necessary due to \n",
      "significant variation in how hl7 2.5.1 messages have been used to \n",
      "support notifications, and allows providers to use other standards for \n",
      "structuring and delivering this information that they may be currently \n",
      "using to implement patient event notifications, or may prefer to use \n",
      "for other reasons.\n",
      "    as noted, our intent is to allow flexibility; therefore, we have \n",
      "refrained from specifying a standard for delivery of patient event \n",
      "notifications that could be overly limiting for hospitals. we are \n",
      "finalizing revised regulation text at 42 cfr 482.24(d), 482.61(f), and \n",
      "485.638(d) that specifies that a hospital system's conformance with the \n",
      "adt standard will be used solely to determine whether a hospital is \n",
      "subject to the cop. requirements regarding the content and format of \n",
      "the patient event notifications, which a hospital's system must send to \n",
      "satisfy the cop, are limited to the minimal information elements \n",
      "described elsewhere in this final rule. we are not specifying a \n",
      "standard for the content, format, or delivery of these notifications.\n",
      "    we also note that we did not specify that hospitals must use a \n",
      "specific technology to send patient event notifications; for instance, \n",
      "we did not specify that a hospital must use the capabilities of \n",
      "certified health it to send notifications, nor that hospitals must send \n",
      "notifications via an interface adhering to the hl7 messaging standard. \n",
      "we hope that this response addresses commenters' concerns, and \n",
      "clarifies that the reference to the hl7 messaging standard in these \n",
      "requirements does not preclude use of other standards for transporting \n",
      "patient event notifications. in addition, we note that our \n",
      "understanding is that many successful patient event notification \n",
      "implementations have used the content of hl7 messages in conjunction \n",
      "with other forms of transport, such as direct messages.\n",
      "    while we agree with commenters that common usage of a single, \n",
      "strictly defined standard would increase interoperability for these \n",
      "transactions, we do not believe that this is possible at this time. at \n",
      "the same time, we strongly encourage hospitals, and any intermediaries \n",
      "a hospital may partner with, to adopt standards-based approaches to the \n",
      "structure and transmission of patient event notifications, including \n",
      "the many standards-based solutions described by commenters. we \n",
      "acknowledge that, at this time, the use of different standards may \n",
      "result in decreased ability for certain providers to receive \n",
      "notifications from sending hospitals, depending on the attributes of \n",
      "their respective systems. we will consider whether there are additional \n",
      "ways we can encourage hospitals to move towards increased \n",
      "interoperability for these transactions in the future.\n",
      "    we also wish to address and clarify a discrepancy in the way we \n",
      "referenced the adt messaging standard in the proposed rule. \n",
      "specifically, in the preamble of the proposed rule we cited 45 cfr \n",
      "170.299(f)(2), where the hl7 2.5.1 messaging standard is listed for \n",
      "incorporation by reference. however, in the regulation text of the \n",
      "proposed rule, we erroneously cited to 45 cfr 170.205(a)(4)(i), which \n",
      "contains the c-cda standard instead of hl7 2.5.1. the c-cda standard is \n",
      "referenced in certification criteria related to summary of care records \n",
      "(84 fr 7678). as discussed above, we are finalizing our policy that a \n",
      "hospital will be subject to the requirements in this section if it uses \n",
      "a system conformant with the hl7 2.5.1 content exchange standard, which \n",
      "indicates a system has the basic capacity to generate information for \n",
      "patient event notifications. in this final rule, we are revising the \n",
      "regulation text and finalizing a citation to the hl7 2.5.1 content \n",
      "exchange standard where it is currently referenced at 45 cfr \n",
      "170.205(d)(2). we believe that this citation is the most appropriate \n",
      "way to reference the hl7 2.5.1 standard.\n",
      "    comment: several commenters requested that cms indicate whether it \n",
      "would be acceptable to transmit information using other standards than \n",
      "the adt message, specifically delivering messages using the c-cda \n",
      "standard, which providers must use to satisfy the requirements of the \n",
      "transitions of care measures under the promoting interoperability \n",
      "programs. several commenters stated that they would prefer to format \n",
      "messages using this standard, which they already use for the promoting \n",
      "interoperability program, and that a requirement to deliver messages \n",
      "according to the hl7 adt messaging standard would result in duplicative \n",
      "work. others questioned whether transmitting notifications via a \n",
      "fhir[supreg]-based api would be permissible.\n",
      "    response: in the proposed rule, we stated that a hospital's medical \n",
      "records system is a compliant system if it utilizes the adt messaging \n",
      "standard. however, we did not propose a specific format or standard for \n",
      "the patient event notification that a hospital would be required to \n",
      "send under the proposed cop. thus, hospitals would be allowed to \n",
      "transmit patient event notifications\n",
      "\n",
      "[[page 25597]]\n",
      "\n",
      "using other standards, such as the c-cda or via a fhir-based api.\n",
      "    comment: many commenters supported the inclusion of diagnosis in \n",
      "patient event notifications where permitted by law, stating that this \n",
      "information is helpful for supporting care coordination between a \n",
      "hospital and other providers. one commenter noted that this information \n",
      "can be included by leveraging certain segments of the hl7 adt feed, and \n",
      "that this segment can also be filtered for sensitive diagnoses that are \n",
      "prohibited for transmission under certain state or federal laws.\n",
      "    a number of commenters expressed concerns about requiring the \n",
      "inclusion of diagnosis, noting that hospitals may not have this \n",
      "information at the time of admission, when only the presenting symptom \n",
      "may be available, or immediately at discharge. other commenters noted \n",
      "that while this is important information for improving care \n",
      "coordination, diagnosis is not included in the most basic versions of \n",
      "the hl7 adt messaging standard. other commenters noted that clinical \n",
      "data is more appropriate for transfer through other standards for \n",
      "sharing clinical data, such as the c-cda standard, which is specified \n",
      "to support the exchange of clinical summaries using certified health \n",
      "it. these commenters noted that rather than requiring the inclusion of \n",
      "diagnosis in the patient event notification, it would make more sense \n",
      "to allow hospitals to transfer this information by attaching a clinical \n",
      "summary to the notification, or by providing this information upon \n",
      "request from a receiving provider.\n",
      "    response: we agree with commenters that diagnosis is an important \n",
      "data element to share during care transitions. however, our intention \n",
      "for this proposal has been to set a minimal floor for patient event \n",
      "notifications, allowing for significant flexibility, in recognition of \n",
      "the wide variety of ways that providers are currently implementing \n",
      "patient event notifications. we are concerned that the proposed \n",
      "requirement to include diagnosis could introduce unnecessary burden for \n",
      "hospitals that will be seeking to satisfy this requirement utilizing \n",
      "the most basic information available in an adt message to support \n",
      "patient event notifications. as a result, we are not finalizing a \n",
      "requirement that diagnosis must be included in patient event \n",
      "notifications at 42 cfr 482.24(d)(2), 482.61(f)(2), and 485.638(d)(2). \n",
      "we wish to reiterate that this final policy in no way precludes \n",
      "hospitals from including additional information, such as diagnosis, in \n",
      "a patient event notification. we also note that hospitals are required \n",
      "to send other necessary medical information to receiving providers \n",
      "under the hospital cop on discharge planning at 42 cfr 482.43. in \n",
      "addition, certain clinical information such as diagnosis is included in \n",
      "the summary of care record which hospitals must be capable of \n",
      "transferring electronically in order to meet the health information \n",
      "exchange measures under the promoting interoperability program.\n",
      "    comment: several commenters suggested cms require hospitals to \n",
      "include additional informational elements in patient event \n",
      "notifications, such as: discharge disposition; chief complaint; \n",
      "medication profile; insurance policy coverage information; additional \n",
      "information about the hospital, such as address and tax id; contact \n",
      "information for a variety of resources such as social services agencies \n",
      "and legal assistance providers; and other information that can be used \n",
      "for patient matching. commenters believe that additional information \n",
      "would have a positive impact on care coordination. other commenters \n",
      "supported the proposal to require only a limited data set. one \n",
      "commenter recommended that cms impose additional parameters on the \n",
      "information included as part of patient event notifications, including \n",
      "a requirement that data must be recent and relevant to patient care.\n",
      "    response: we appreciate commenters' suggestions, and agree that \n",
      "this additional information can have a positive impact on care \n",
      "coordination, patient matching, and other requirements. however, we do \n",
      "not believe that this information should be required within the cops \n",
      "for patient event notifications. we have heard from many stakeholders \n",
      "that even patient event notifications with extremely limited \n",
      "information can have a positive effect on care coordination when they \n",
      "are delivered in a timely manner. in addition, we understand that \n",
      "hospitals are currently delivering patient event notifications with \n",
      "widely varying sets of information. finally, we note that hospitals are \n",
      "required to send other necessary medical information to receiving \n",
      "providers under the hospital cop on discharge planning at 42 cfr \n",
      "482.43. while we decline to require additional data at this time, to \n",
      "ensure that hospitals are able to satisfy the requirement with minimal \n",
      "effort, we encourage hospitals to consider other information that can \n",
      "be added to patient event notifications to support care coordination.\n",
      "    comment: many commenters suggested that cms work with onc to add a \n",
      "certification criterion or a condition of certification related to the \n",
      "transmission of patient event notifications under onc's certification \n",
      "program. many commenters stated that hospitals should not be required \n",
      "to comply with the proposed requirements until they have had an \n",
      "opportunity to adopt certified technology supporting these \n",
      "requirements. commenters believed this would assure hospitals that \n",
      "their systems are compliant with the proposed requirements. moreover, \n",
      "commenters expressed concern that without complementary regulation \n",
      "directed toward health it developers, the burden for ensuring these \n",
      "technical capabilities would rest on hospital providers alone. some \n",
      "commenters suggested that onc should also include data elements related \n",
      "to patient event notifications in the uscdi, or seek to standardize \n",
      "notification data elements in another way, to ensure that notifications \n",
      "can be received by other ehr systems. commenters also pointed to a \n",
      "variety of emerging initiatives which focus on barriers to information \n",
      "exchange, such as tefca, policies to address information blocking, and \n",
      "updates to api technology under the onc certification program. \n",
      "commenters urged cms to leverage these initiatives to advance the use \n",
      "of patient event notifications, for instance, by incorporating patient \n",
      "event notification functionality through the networks established as \n",
      "part of tefca.\n",
      "    response: we appreciate commenters' input. as we noted in the cms \n",
      "interoperability and patient access proposed rule, there is currently \n",
      "no certification criterion specific to creating and sending electronic \n",
      "patient event notifications included in onc's certification program (84 \n",
      "fr 7651). while onc monitors the development of consensus standards for \n",
      "patient event notifications as part of its isa (<a href=\"https://www.healthit.gov/isa/admission-discharge-and-transfer\">https://www.healthit.gov/isa/admission-discharge-and-transfer</a>), onc has not yet \n",
      "proposed to develop a certification criterion based on any of these \n",
      "standards. instead of focusing on the use of a specific certification \n",
      "criterion, we have sought to allow hospitals flexibility in how they \n",
      "satisfy the proposed cop. we believe this is consistent with current \n",
      "practices around patient event notifications that have been implemented \n",
      "in a wide variety of ways across hospitals. we appreciate that many \n",
      "other policy initiatives may intersect with how hospitals implement \n",
      "patient event notification requirements. while we believe that \n",
      "providers will be\n",
      "\n",
      "[[page 25598]]\n",
      "\n",
      "able to implement patient event notifications based on existing systems \n",
      "and infrastructure, we believe that many of the initiatives commenters \n",
      "mentioned will help to enable and enhance notification capabilities as \n",
      "they are introduced.\n",
      "    comment: a number of commenters stated that the proposal would \n",
      "disproportionately burden rural and critical access hospitals. \n",
      "commenters noted that providers in these settings may not have an ehr \n",
      "system, or may be unable to upgrade to the newest edition of certified \n",
      "technology. for small and rural providers that do have an ehr system, \n",
      "commenters expressed concern about the implementation costs providers \n",
      "would need to incur as they work with their ehr vendors to deploy new \n",
      "functionality. commenters noted that, while working with an \n",
      "intermediary could substantially reduce the burden associated with this \n",
      "proposal, many small and rural hospitals are operating in geographic \n",
      "areas that are not yet served by entities such as health information \n",
      "exchanges that could serve as intermediaries, requiring these hospitals \n",
      "to dedicate significant resources to developing a compliant solution. \n",
      "this lack of access to appropriate infrastructure would put small and \n",
      "rural hospitals at disproportionate risk of noncompliance with the cop \n",
      "standard, despite the significant effects penalties for noncompliance \n",
      "may have on underserved communities. several commenters raised concerns \n",
      "about these providers' ability to shoulder compliance costs with the \n",
      "proposed requirements, and suggested cms provide funding opportunities \n",
      "to these hospitals to mitigate the potential burden associated with the \n",
      "proposal.\n",
      "    response: we appreciate commenters' concerns about the impact of \n",
      "this proposal on small, rural, and critical access hospitals (cahs). we \n",
      "note that those hospitals without an ehr system with the technical \n",
      "capacity to generate information for electronic patient event \n",
      "notifications, defined as a system conformant with the adt messaging \n",
      "standard (hl7 2.5.1), will not be subject to this final rule. \n",
      "furthermore, we believe that changes finalized in this rule will ease \n",
      "some of the potential compliance burden associated with the rule, and \n",
      "make it easier for these hospitals to comply successfully with the cop \n",
      "standard. for example, our final policy extends the applicable date for \n",
      "the requirements as well as defining a more limited set of a recipients \n",
      "to whom hospitals must send notifications for the purposes of \n",
      "compliance with the cop.\n",
      "    comment: many commenters noted that patient event notifications are \n",
      "most effective when they take into account receiving providers' \n",
      "preferences. commenters noted that recipients need flexibility to \n",
      "determine the information that they want to be notified about, the \n",
      "frequency of notification delivery, and how they would like \n",
      "notifications delivered; otherwise providers may experience ``signal \n",
      "fatigue'' due to receiving an excessive number of messages that do not \n",
      "contain information the provider finds useful. commenters expressed \n",
      "concern that, under the proposed requirements, hospitals would not have \n",
      "flexibility to take into account receiving providers' preferences for \n",
      "receiving patient event notifications. they further believed that the \n",
      "proposed requirements would result in hospitals sending information to \n",
      "all providers regardless of their interest in receiving notifications, \n",
      "while implementation experience has shown that notifications are more \n",
      "successful when receiving providers can request the information they \n",
      "would like to receive.\n",
      "    response: we appreciate commenters' concerns about the importance \n",
      "of incorporating provider recipients' preferences when implementing \n",
      "patient notification systems. we understand from stakeholders that a \n",
      "key feature of successful patient event notification implementations is \n",
      "flexibility with respect to the manner in which notifications are \n",
      "delivered, to allow for better alignment with individual providers' \n",
      "workflows. without such flexibility, providers are more likely not to \n",
      "find notification systems useful, reducing their effectiveness to \n",
      "improve care coordination.\n",
      "    we note that under the proposed requirement, hospital systems must \n",
      "send patient notifications in accordance with the proposed \n",
      "requirements. however, this would not preclude hospitals, working \n",
      "either directly with providers or through an intermediary, from \n",
      "tailoring the delivery of patient notifications in a manner consistent \n",
      "with individual provider preferences. for instance, while a hospital's \n",
      "system must be able to send notifications at both admission and \n",
      "discharge, as well as at the time of registration in the emergency \n",
      "department, if a specific provider prefers only to receive \n",
      "notifications upon discharge, nothing would prevent the hospital from \n",
      "limiting the notifications sent to that provider accordingly.\n",
      "    we note that our revised regulation text states that hospitals must \n",
      "send notifications to those recipients that ``need to receive \n",
      "notification of the patient's status for treatment, care coordination, \n",
      "or quality improvement purposes.'' we believe that this standard will \n",
      "allow hospitals the discretion to determine which recipients need to \n",
      "receive notifications, for instance, by declining to send certain \n",
      "notifications where a practitioner has stated that such notifications \n",
      "are not necessary or effective for supporting care coordination. in \n",
      "cases where the hospital has partnered with an intermediary to deliver \n",
      "notifications, the intermediary may exercise this discretion on behalf \n",
      "of a hospital.\n",
      "    comment: many commenters supported the proposal to allow use of an \n",
      "intermediary to deliver patient event notifications. commenters stated \n",
      "that use of an intermediary could reduce operational burden on \n",
      "hospitals by maintaining recipient information, supporting more \n",
      "effective patient matching, and delivering notifications in accordance \n",
      "with receiving providers' preferences. commenters pointed to numerous \n",
      "examples of how intermediaries, such as health information exchanges, \n",
      "are successfully facilitating the delivery of more complete and \n",
      "accurate patient event notifications from today.\n",
      "    response: we thank commenters for their support and agree that the \n",
      "use of intermediaries to deliver patient notifications can reduce \n",
      "burden on hospitals and support effective notification systems.\n",
      "    comment: several commenters sought additional information on our \n",
      "proposals with respect to the use of an intermediary, and whether \n",
      "exclusive use of an intermediary, provided other requirements are met, \n",
      "would satisfy the cop. commenters stated that they believe hospitals \n",
      "should be able to exclusively make use of an intermediary. other \n",
      "commenters suggested that cms should ``deem'' a hospital compliant with \n",
      "the cop if they demonstrate that they are using an intermediary to \n",
      "deliver notifications, as long as the intermediary has not been found \n",
      "to violate information blocking rules.\n",
      "    response: in the cms interoperability and patient access proposed \n",
      "rule, we stated that, if finalized, hospitals would be required to send \n",
      "notifications ``directly or through an intermediary that facilitates \n",
      "exchange of health information.'' we believe this would allow exclusive \n",
      "use of either method, or a combination of these methods, provided other \n",
      "requirements of the cop are met. for instance, if a hospital makes \n",
      "exclusive use of an intermediary to satisfy the cop, the hospital would \n",
      "still be subject to the requirement that\n",
      "\n",
      "[[page 25599]]\n",
      "\n",
      "notifications must be sent to the set of recipients we are finalizing \n",
      "in this rule, specifically all applicable post-acute care services \n",
      "providers and suppliers as well as a patients' primary care \n",
      "practitioners or practice groups and entities primarily responsible for \n",
      "a patient's care, as well as practitioners identified by the patient. \n",
      "given this requirement, exclusive use of an intermediary with a limited \n",
      "ability to deliver notifications to the specified set of recipients, \n",
      "for instance an intermediary which restricts its delivery to only those \n",
      "providers within a specific integrated health care system, would not \n",
      "satisfy the cop. alternatively, if a hospital demonstrates that an \n",
      "intermediary connects to a wide range of recipients and does not impose \n",
      "restrictions on which recipients are able to receive notifications \n",
      "through the intermediary, exclusive use of such an intermediary would \n",
      "satisfy the cop.\n",
      "    comment: commenters sought additional information on whether it \n",
      "would be permissible for a hospital to delegate responsibility for \n",
      "making a determination about the existence of a patient's care \n",
      "relationships to an intermediary that facilitates delivery of a patient \n",
      "notification.\n",
      "    response: in the cms interoperability and patient access proposed \n",
      "rule we discussed a variety of methods through which hospitals can \n",
      "identify recipients for patient notifications, including through \n",
      "partnering with intermediaries such as health information exchanges (84 \n",
      "fr 7652). we reiterate that we believe this is one way that hospitals \n",
      "are currently identifying recipients for notifications, and that using \n",
      "an intermediary to do so may reduce operational burden for hospitals. \n",
      "thus, hospitals would be permitted to delegate this authority.\n",
      "    comment: several commenters requested additional information on \n",
      "whether acos would be entitled to receive patient event notifications. \n",
      "commenters stated that acos represent groups of providers and suppliers \n",
      "and work directly on their behalf. therefore, it was unclear whether \n",
      "they would be considered intermediaries or providers and suppliers for \n",
      "the purposes of the proposed cop. commenters stated that patient event \n",
      "notifications are used by many acos today, and that acos both receive \n",
      "notifications directly from hospitals and through other intermediaries \n",
      "such as health information exchanges.\n",
      "    response: we note that the proposed cop does not create an \n",
      "entitlement for any specific provider or intermediary to receive \n",
      "patient event notifications. rather, it requires hospitals to \n",
      "demonstrate that their medical records system sends patient event \n",
      "notifications in a manner compliant with the proposed requirements. we \n",
      "believe there is nothing in the proposed requirements that would \n",
      "prevent acos that have business associate relationships with the \n",
      "intended primary care practitioner or practice group or entity from \n",
      "receiving patient event notifications on behalf of that practitioner, \n",
      "group, or entity so long as their business associate agreement allows \n",
      "them to fulfill that role.\n",
      "    comment: several commenters suggested that cms should develop a \n",
      "mechanism for allowing community providers to report that they have not \n",
      "received notifications from a given hospital, or that the notifications \n",
      "received are incomplete or unreasonably delayed. commenters believe \n",
      "that such a mechanism would ensure patient event notification systems \n",
      "are functional and help to establish delivery parameters across a \n",
      "community.\n",
      "    response: we appreciate commenters' input, but are unclear here as \n",
      "to whether the commenters are requesting that we develop a regulatory \n",
      "mechanism within the cop provisions to allow for a community provider \n",
      "to report to a hospital any issues it may be experiencing with the \n",
      "hospital's notification system or if the request is for cms to develop \n",
      "some other type of mechanism to accomplish this, such as an incentive-\n",
      "based payment mechanism as a means of encouraging a hospital to include \n",
      "this reporting function as part of its notification system. if it is \n",
      "the latter type of request, then such a mechanism would be outside the \n",
      "scope of the cops and this section of the rule. however, if it is the \n",
      "former type of request, we will consider these ideas as we evaluate \n",
      "future updates and revisions to the cops with regard to patient event \n",
      "notifications.\n",
      "    comment: we proposed that a hospital would only need to send \n",
      "notifications to those practitioners for whom the hospital has \n",
      "reasonable certainty of receipt (84 fr 7652). we further explained that \n",
      "we expected hospitals would, to the best of their ability, seek to \n",
      "ensure that notification recipients were able to receive notifications, \n",
      "but that we recognized that factors outside of the hospital's control \n",
      "may determine whether or not a notification was successfully received \n",
      "and utilized by a practitioner.\n",
      "    many commenters stated that a standard of ``reasonable certainty'' \n",
      "would hold hospitals responsible for factors outside of their control \n",
      "that prevent delivery of notifications, and that hospitals should only \n",
      "be held accountable for transmission of information, not receipt. \n",
      "commenters stated that it would be very difficult for hospitals to \n",
      "obtain reasonable certainty given the limitations of the infrastructure \n",
      "that is currently available for sharing health information. several \n",
      "commenters believed that the phrase ``reasonable certainty'' would \n",
      "impose a new affirmative duty to validate receipt of notifications, \n",
      "which would result in significant additional administrative burden for \n",
      "hospitals. several commenters suggested that cms replace the term \n",
      "``reasonable certainty'' with alternatives such as ``reasonable \n",
      "effort'' or ``reasonable confidence.'' they believed these alternative \n",
      "standards would better reflect actions within the hospital's control.\n",
      "    response: we appreciate commenters' feedback. in proposing that \n",
      "hospitals send notifications to those practitioners for whom the \n",
      "hospital has reasonable certainty of receipt, we sought to adapt a \n",
      "similar standard currently identified in guidance for the promoting \n",
      "interoperability program (see <a href=\"https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/medicareeh_2019_obj2-.pdf\">https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/medicareeh_2019_obj2-.pdf</a>) regarding the expectations of participants \n",
      "in that program when they transfer a summary of care record to another \n",
      "provider. however, we concur with commenters that a standard of \n",
      "``reasonable certainty,'' while appropriate for the promoting \n",
      "interoperability program, in which participants are required to use \n",
      "certified technology for the transmission and receipt of summary of \n",
      "care documents, may not be appropriate in the context of this proposal, \n",
      "which permits flexibility in both the technology used to send and \n",
      "receive patient event notifications and the format of the notification \n",
      "itself. we agree that a standard that better reflects actions within \n",
      "the hospital's control would be much more appropriate in this \n",
      "circumstance. accordingly, we are revising our final policy (at 42 cfr \n",
      "482.24(d)(5), 482.61(f)(5), and 485.638(d)(5)) to now require that a \n",
      "hospital (or a cah) must demonstrate that it ``has made a reasonable \n",
      "effort to ensure that'' the system sends the notifications to any of \n",
      "the following that need to receive notification of the patient's status \n",
      "for treatment, care coordination, or quality improvement purposes to \n",
      "all applicable post-acute care services providers and suppliers and: \n",
      "(1) the patient's established primary care practitioner; (2) the \n",
      "patient's established primary care practice group or entity; or (3) \n",
      "other\n",
      "\n",
      "[[page 25600]]\n",
      "\n",
      "practitioner, or other practice group or entity, identified by the \n",
      "patient as the practitioner, or practice group or entity, primarily \n",
      "responsible for his or her care.\n",
      "    we believe that this modified standard will provide hospitals and \n",
      "cahs with appropriate flexibility and can account for the constraints \n",
      "of providers' existing systems. we also believe that this modified \n",
      "standard takes into account the fact that some recipients may not be \n",
      "able to receive patient event notifications, or may not be able to \n",
      "receive notifications in a manner consistent with a hospital system's \n",
      "capabilities, and the fact that hospitals and cahs may not be able to \n",
      "identify provider recipients for some patients. we expect that \n",
      "surveyors will evaluate whether a hospital is making a reasonable \n",
      "effort to send patient event notifications while working within the \n",
      "constraints of its existing technology infrastructure.\n",
      "    comment: several commenters offered their assessments of readiness \n",
      "across hospitals to implement patient event notifications. one \n",
      "commenter pointed to hospitals' high levels of engagement in some form \n",
      "of health information exchange as an indication that hospitals are \n",
      "well-positioned to distribute patient event notifications, and stated \n",
      "that establishing adt-based notification feeds did not impose \n",
      "significant burdens on hospitals. another commenter agreed that the \n",
      "technical capabilities to implement notifications exists today, and \n",
      "stated that the primary challenge for hospitals would be in updating \n",
      "business and operational practices to comply.\n",
      "    other commenters stated that functionality to use adt message \n",
      "information for patient event notifications is not part of certified \n",
      "electronic health record technology and that not all ehrs are capable \n",
      "of generating notifications. they stated that ehrs are not able to \n",
      "automatically send and receive notifications and cautioned cms against \n",
      "oversimplifying the development burden associated with implementation. \n",
      "one commenter suggested that cms should provide supplemental funding to \n",
      "support hospitals' costs, workflow changes, and technical expertise \n",
      "associated with implementation.\n",
      "    response: we thank commenters for their insights. we share the \n",
      "assessment of commenters who stated that most hospitals will be able to \n",
      "implement patient event notifications with minimal burden due to the \n",
      "widespread adoption of technology systems that can be utilized to \n",
      "support generating and sending these notifications. patient event \n",
      "notifications have been widely recognized as an important way to \n",
      "support patient safety, by enabling providers and suppliers responsible \n",
      "for the post-discharge care of a patient to quickly initiate care \n",
      "coordination protocols that can mitigate the risk of deterioration of a \n",
      "patient's condition following a hospital stay. we understand some \n",
      "commenters' concerns that the ability to send patient event \n",
      "notifications has not been included as a capability certified under the \n",
      "onc certification program, and that there is no widely adopted, uniform \n",
      "approach to sending patient event notifications at this time. however, \n",
      "as noted by many commenters, we believe there are a wide variety of \n",
      "available, low-cost solutions that providers can adopt to fulfill the \n",
      "minimal requirements described in this final rule. accordingly, we have \n",
      "provided significant flexibility for providers to meet these \n",
      "requirements by not including additional technical specifications about \n",
      "how patient event notifications must be formatted and shared. we \n",
      "believe that this approach allows flexibility for hospitals to \n",
      "establish patient event notifications that meet the requirements in \n",
      "ways that minimize implementation burden; however, we recognize that \n",
      "the lack of a uniform approach may lead to instances where a provider \n",
      "is unable to receive notifications sent by a hospital in a seamless, \n",
      "interoperable fashion.\n",
      "    comment: commenters stated that national infrastructure for health \n",
      "information exchange was not yet mature enough to support the \n",
      "widespread implementation of patient event notifications and that \n",
      "successful implementation of notifications requires the ability to \n",
      "acquire data feeds and a rules engine to support alerting routing and \n",
      "delivery, as well as a patient index function to create and verify \n",
      "patient panels. while many commenters believed that this infrastructure \n",
      "might be available in the future, for instance, through establishment \n",
      "of the tefca, they stated that it is not ubiquitous today. without this \n",
      "infrastructure, commenters noted that providers would be required to \n",
      "support a large number of point-to-point interfaces with other \n",
      "providers that lack scalability, and will be highly costly, \n",
      "inefficient, and burdensome to develop and maintain. one commenter \n",
      "recommended that cms establish that, for compliance purposes, a \n",
      "hospital would only be required to demonstrate a notification has been \n",
      "sent for a single patient. this would allow surveyors to confirm that \n",
      "the system is functional while allowing for variation across hospitals \n",
      "depending on their capabilities to send notifications under different \n",
      "circumstances. one commenter suggested that cms should focus on \n",
      "incentivizing providers to participate in existing scalable networks \n",
      "that support health information exchange, including patient event \n",
      "notifications.\n",
      "    response: we agree with commenters that the national health \n",
      "information exchange infrastructure to support patient event \n",
      "notifications is not yet ubiquitous. however, we believe that the \n",
      "health information infrastructure that exists today will be sufficient \n",
      "to provide substantial support for the requirements we are finalizing \n",
      "in this rule. as other commenters noted, organizations such as health \n",
      "information exchanges are supporting the sharing of patient event \n",
      "notifications in many areas today. while we understand there is \n",
      "variation in availability of this infrastructure, we believe there are \n",
      "options increasingly available for hospitals to implement basic patient \n",
      "event notifications that will allow hospitals to demonstrate they have \n",
      "made a ``reasonable effort'' to ensure their system sends the required \n",
      "notifications, as per the policy finalized in this final rule.\n",
      "    we appreciate the suggestion that the cop should specify a hospital \n",
      "could achieve compliance through demonstrating that a notification has \n",
      "been sent for a single patient, and that this would ease compliance \n",
      "concerns expressed by stakeholders. however, we believe that these \n",
      "concerns are addressed through the more limited standard in our final \n",
      "policy that requires a hospital (or cah) to make a ``reasonable \n",
      "effort'' to ensure that its system sends these notifications. in \n",
      "addition, and as previously noted, survey and certification \n",
      "interpretive guidelines utilize a variety of approaches to evaluate \n",
      "whether a hospital has satisfied the cop, and in this final rule we \n",
      "decline to employ overly prescriptive regulatory language that might \n",
      "significantly limit options for surveyors as they assess compliance.\n",
      "    comment: many commenters identified challenges related to the \n",
      "proposal that a hospital demonstrate that its system sends \n",
      "notifications to licensed and qualified practitioners, other patient \n",
      "care team members, and post-acute care services providers and suppliers \n",
      "meeting certain conditions (84 fr 7651). commenters stated that the \n",
      "proposal seemed to require a hospital to be able to send a notification \n",
      "to any other health care provider and assumed that the receiving \n",
      "provider would have the technological capabilities to receive this \n",
      "information. commenters stated that this is not realistic given the \n",
      "current\n",
      "\n",
      "[[page 25601]]\n",
      "\n",
      "state of technology adoption among receiving providers, and that \n",
      "recipients would need to develop capabilities to receive, incorporate, \n",
      "and use these notifications for the proposal to be effective.\n",
      "    commenters stated that, today, notifications would only be likely \n",
      "to reach recipients only a percentage of the time citing many factors \n",
      "related to the limitations of ehr technology that prevent providers and \n",
      "clinicians from incorporating electronic information into their ehrs. \n",
      "for instance, commenters noted that ehrs must be able to confidentially \n",
      "match transferred data to a patient, incorporate the notification into \n",
      "the ehr, and ensure that it is reviewed and stored in a clinically \n",
      "appropriate way to ensure it is effectively used. commenters stated \n",
      "that cms should consider complementary requirements and/or supports for \n",
      "ambulatory and other facilities to ensure they are able to receive \n",
      "patient event notifications provided by hospitals. commenters requested \n",
      "additional information on the expectations for receiving providers to \n",
      "successfully receive and incorporate patient event notifications, and \n",
      "noted they may face significant burden associated with technical \n",
      "development if expected to be able to receive these notifications.\n",
      "    moreover, commenters expressed concerns about the capacity of \n",
      "specific providers, including small and rural physician practices and \n",
      "post-acute care providers and suppliers, to receive patient event \n",
      "notifications. commenters specifically noted that post-acute care \n",
      "providers were not provided financial incentives under the hitech, and \n",
      "therefore many post-acute care providers are not using ehrs or are \n",
      "using ehrs that are not able to exchange information with hospital \n",
      "ehrs. several commenters recommended that cms not hold hospitals \n",
      "accountable for delivering patient event notifications to post-acute \n",
      "care suppliers, given the difficulties these suppliers would have in \n",
      "receiving these notifications. others stated that the inability of \n",
      "these providers to receive notifications would limit the effectiveness \n",
      "of the proposed requirements.\n",
      "    response: we appreciate commenters input on this issue. in the cms \n",
      "interoperability and patient access proposed rule, we stated that a \n",
      "hospital subject to the proposed requirements must demonstrate that its \n",
      "system sends notifications to certain recipients. we do not expect that \n",
      "a hospital would ``demonstrate'' that its system meets these \n",
      "requirements through meeting a comprehensive measure of performance. \n",
      "likewise, we would not expect a hospital's system to be capable of \n",
      "electronically communicating with every possible provider, facility, or \n",
      "practitioner system, or of satisfying every possible preference for \n",
      "delivery of patient event notifications that a provider, facility, or \n",
      "practitioner might attempt to impose on the hospital. as noted above, \n",
      "we are modifying our proposal to require that a hospital makes a \n",
      "``reasonable effort'' to ensure that its system sends patient event \n",
      "notifications to the specified recipients.\n",
      "    under the survey and certification process we would expect a \n",
      "hospital to demonstrate its system's compliance with the cop in a \n",
      "variety of ways, subject to the system's capabilities. for instance, if \n",
      "a given system sends notifications via direct messaging, we might \n",
      "expect surveyors to review whether the hospital has a process in place \n",
      "for capturing direct addresses of patients' primary care practitioners \n",
      "to enable the system to send patient event notifications to these \n",
      "recipients.\n",
      "    finally, with regard to comments about pac services providers and \n",
      "suppliers that were not eligible for incentives for ehr adoption under \n",
      "the ehr incentive programs established by the hitech act, we again note \n",
      "that the requirements in this final rule are limited to only those \n",
      "hospitals and cahs that possess and utilize ehr or other administrative \n",
      "systems with the technical capacity to generate information for \n",
      "electronic patient event notifications. moreover, a hospital or cah \n",
      "with such a system must only demonstrate that it has made a \n",
      "``reasonable effort'' to ensure that its system sends notifications to \n",
      "any of the specified recipients, including all applicable post-acute \n",
      "care services providers and suppliers (that is, to those pac services \n",
      "providers and suppliers to whom the patient is being transferred or \n",
      "referred).\n",
      "    comment: in the cms interoperability and patient access proposed \n",
      "rule, we did not explicitly address the effective implementation date \n",
      "for the proposed revisions to the cops. however, we note that revisions \n",
      "to the cops are generally applicable 60 days from the publication of a \n",
      "final rule.\n",
      "    many commenters recommended cms allow additional time for \n",
      "implementation beyond the usual applicable date of these revisions. \n",
      "commenters stated that additional time was required to allow providers \n",
      "to complete technical upgrades and train staff on new workflows. one \n",
      "commenter suggested that cms finalize different timeframes based on \n",
      "whether hospitals are in an area with existing infrastructure for \n",
      "transmitting patient event notifications. another commenter suggested \n",
      "that cms develop working groups to determine appropriate timelines for \n",
      "implementation.\n",
      "    response: we agree with commenters that additional time would be \n",
      "appropriate for hospitals and cahs to implement the proposed \n",
      "requirements. therefore, we are finalizing that the requirements will \n",
      "be applicable 12 months after the publication date of this final rule.\n",
      "    comment: multiple commenters addressed privacy implications of the \n",
      "proposed requirements. commenters sought clarity on whether patient \n",
      "consent would be required to send a patient event notification, or \n",
      "whether hospitals would be able to honor a patient's request to opt-out \n",
      "of sharing information with providers in the form of a patient event \n",
      "notification. commenters urged cms to issue further guidance about \n",
      "privacy and security challenges associated with sending patient event \n",
      "notifications, for instance, how hospitals should address cases where \n",
      "they cannot confirm the identity of a provider, and/or where \n",
      "transmission could risk improper disclosure of protected health \n",
      "information. several commenters suggested that concerns about \n",
      "noncompliance could lead some hospitals to be overly hasty in sending \n",
      "patient event notifications without considering the privacy impact of \n",
      "the transmission, potentially leading to inappropriate disclosures of \n",
      "information.\n",
      "    response: we appreciate commenters' concerns about preserving \n",
      "patient privacy. nothing in this proposed rule should be construed to \n",
      "supersede hospitals' compliance with hipaa or other state or federal \n",
      "laws and regulations related to the privacy of patient information. we \n",
      "note that hospitals would not be required to obtain patient consent for \n",
      "sending a patient event notification for treatment, care coordination, \n",
      "or quality improvement purposes as described in this final policy. \n",
      "however, we also recognize that it is important for hospitals to be \n",
      "able to honor patient preferences to not share their information. while \n",
      "the cop would require hospitals to demonstrate that their systems can \n",
      "send patient event notifications, we do not intend to prevent a \n",
      "hospital from recording a patient's request to not share their \n",
      "information with another provider, and, where consistent with other \n",
      "law, restrict the delivery of notifications as requested by the patient \n",
      "and consistent with the individual right to request restriction of uses \n",
      "and disclosures established in the\n",
      "\n",
      "[[page 25602]]\n",
      "\n",
      "hipaa privacy rule. similarly, if a hospital is working with an \n",
      "intermediary to deliver patient event notifications, the intermediary \n",
      "may record information about a patient's preferences for how their \n",
      "information is shared, and, where consistent with other law, restrict \n",
      "the delivery of notifications accordingly. based on commenters' \n",
      "concerns regarding a patient's ability to request that his or her \n",
      "medical information (in the form of a patient event notification) is \n",
      "not shared with other settings, we are revising and finalizing a \n",
      "requirement in this rule that a hospital (or cah) must demonstrate that \n",
      "its notification system sends notifications, ``to the extent \n",
      "permissible under applicable federal and state law and regulations and \n",
      "not inconsistent with the patient's expressed privacy preferences.''\n",
      "    regarding improper disclosure of health information where a \n",
      "hospital cannot confirm the identity of a receiving provider, we note \n",
      "that under this policy a hospital would not be under any obligation to \n",
      "send a patient event notification in this case. under our final policy, \n",
      "hospitals would be required to make a ``reasonable effort'' to ensure \n",
      "their systems send notifications to the specified recipients. we \n",
      "believe this standard will account for instances in which a hospital \n",
      "(or its intermediary) cannot identify an appropriate recipient for a \n",
      "patient event notification despite establishing processes for \n",
      "identifying recipients, and thus is unable to send a notification for a \n",
      "given patient.\n",
      "    comment: many commenters raised concerns about how hospitals would \n",
      "be able to implement the proposed patient event notifications while \n",
      "complying with state and federal laws and regulations around the \n",
      "transmission of sensitive data. commenters noted these issues are \n",
      "particularly relevant for psychiatric hospitals included in the \n",
      "proposal. commenters noted that some states have more stringent privacy \n",
      "and consent requirements that apply to individuals treated in mental \n",
      "health facilities which may impact the sending of patient event \n",
      "notifications. one commenter noted that hospitals with behavioral \n",
      "health units do not disclose patient event information as part of their \n",
      "primary system data feed due to requirements that disclosure of this \n",
      "information must be accompanied by written consent. commenters also \n",
      "noted that appropriately segregating this data is expensive and time \n",
      "consuming.\n",
      "    response: nothing in this requirement should be construed as \n",
      "conflicting with hospitals' ability to comply with laws and regulations \n",
      "restricting the sharing of sensitive information. while hospitals \n",
      "subject to the cop would need to demonstrate their system sends \n",
      "notifications to appropriate recipients, hospitals would not be \n",
      "expected to share patient information through a notification unless \n",
      "they have obtained any consents necessary to comply with existing laws \n",
      "and regulations.\n",
      "    comment: many commenters supported the proposal to require a \n",
      "hospital's system demonstrate that it sends patient event notifications \n",
      "at the time of admission, and at, or just prior to, the time of \n",
      "discharge. commenters emphasized that it is important for notification \n",
      "information to be timely in order for it to be effective in improving \n",
      "care coordination. one commenter stated that some providers find that \n",
      "notifications triggered by an adt message are triggered too early, \n",
      "prior to the availability of a discharge summary, and sought additional \n",
      "information about whether hospitals may use other triggers for a \n",
      "patient event notification.\n",
      "    response: we appreciate commenters' support for the proposal. we \n",
      "believe patient event notifications are most useful when tied to \n",
      "admission (or registration, as is the term generally used for patients \n",
      "seen in the ed) and discharge events, as receiving near-real time \n",
      "information about a patient's hospitalization can ensure receiving \n",
      "providers, facilities, and practitioners are able to act quickly to \n",
      "ensure successful care coordination. while we agree that sending \n",
      "available clinical information along with a patient event notification \n",
      "can be helpful, we believe that delaying notifications until all of the \n",
      "information about a patient's hospitalization is available would likely \n",
      "decrease the value of the notification.\n",
      "    comment: several commenters suggested that the requirements should \n",
      "be limited to external providers and not include providers that may \n",
      "share the same ehr as the hospital as part of an integrated delivery \n",
      "system. commenters noted that organizations may have other ways to \n",
      "notify these providers about a discharge, and that hospitals should be \n",
      "exempt from sending notifications to these providers.\n",
      "    response: under the proposed requirements, we are not specifying a \n",
      "format or transport method for patient event notifications. \n",
      "accordingly, hospitals could use a mix of approaches to deliver patient \n",
      "event notifications, for instance, by partnering with an intermediary \n",
      "to deliver notifications to external providers, while using features \n",
      "internal to a shared ehr system to transmit information to providers \n",
      "that are part of the same organization.\n",
      "    comment: several commenters sought clarity on how the patient event \n",
      "notifications would relate to information blocking policy, and urged \n",
      "cms to ensure that any new cop requirements are aligned with other \n",
      "policies around information blocking. several commenters suggested \n",
      "that, as an alternative to the proposed requirements, cms should \n",
      "establish a standard under the cops that states hospitals will not \n",
      "engage in information blocking, to be aligned with policies established \n",
      "by onc in the 21st century cures act final rule.\n",
      "    response: we note that there are currently three prevention of \n",
      "information blocking attestation statements under 42 cfr \n",
      "495.40(b)(2)(i)(i)(1) through (3) to which eligible hospitals and cahs \n",
      "must attest for purposes of the promoting interoperability program. as \n",
      "part of successfully demonstrating that an eligible hospital or cah is \n",
      "a meaningful ehr user for purposes of the promoting interoperability \n",
      "program, the eligible hospital or cah must submit an attestation \n",
      "response of ``yes'' for each of these statements. these attestations \n",
      "are discussed further in section viii. of this final rule. we also \n",
      "refer commenters to section 3022(b)(2)(b) of the public health service \n",
      "act (phsa), which provides that any health care provider determined by \n",
      "the oig to have committed information blocking shall be referred to the \n",
      "appropriate agency to be subject to appropriate disincentives using \n",
      "authorities under applicable federal law, as set forth by the secretary \n",
      "through notice and comment rulemaking. further, we refer commenters to \n",
      "the onc 21st century cures act proposed rule for additional discussion \n",
      "on disincentives (84 fr 7553).\n",
      "    final action: after consideration of the comments received, and for \n",
      "the reasons outlined in our response to these comments and in the cms \n",
      "interoperability and patient access proposed rule, we are finalizing \n",
      "these proposals with some modifications and reorganization of the \n",
      "provisions. these policies are being finalized at 42 cfr 482.24(d), \n",
      "482.61(f), and 485.638(d) for conditions of participation for \n",
      "hospitals, psychiatric hospitals, and specialized providers (cahs).\n",
      "    based on public comments, and to further advance electronic \n",
      "exchange of information that supports effective transitions of care for \n",
      "patients between hospitals and cahs and their community pac services \n",
      "providers and suppliers as well as their primary care practitioners, \n",
      "the following requirements at 42 cfr 482.24(d),\n",
      "\n",
      "[[page 25603]]\n",
      "\n",
      "482.61(f), and 485.638(d) are being finalized here with modifications \n",
      "and reorganization from the proposed requirements (84 fr 7678):\n",
      "    <bullet> we are revising 42 cfr 482.24(d) by deleting the reference \n",
      "to ``paragraph (d)(2) of this section'';\n",
      "    <bullet> we are revising 42 cfr 482.61(f) by deleting the reference \n",
      "to ``paragraph (d)(2) of this section'';\n",
      "    <bullet> we are revising 42 cfr 485.638(d) by deleting the \n",
      "reference to ``paragraph (d)(2) of this section'';\n",
      "    <bullet> we are revising 42 cfr 482.24(d) by adding new language to \n",
      "the regulatory text so that it now includes ``or other electronic \n",
      "administrative system, which is conformant with the content exchange \n",
      "standard at 45 cfr 170.205(d)(2),'';\n",
      "    <bullet> we are revising 42 cfr 482.61(f) by adding new language to \n",
      "the regulatory text so that it now includes ``or other electronic \n",
      "administrative system, which is conformant with the content exchange \n",
      "standard at 45 cfr 170.205(d)(2),'';\n",
      "    <bullet> we are revising 42 cfr 485.638(d) by adding new language \n",
      "to the regulatory text so that it now includes ``or other electronic \n",
      "administrative system, which is conformant with the content exchange \n",
      "standard at 45 cfr 170.205(d)(2),'';\n",
      "    <bullet> we are deleting all of the regulatory text proposed at 42 \n",
      "cfr 482.24(d)(2), 482.61(f)(2), and 485.638(d)(2), including the \n",
      "inaccurate references to ``45 cfr 170.205(a)(4)(i);''\n",
      "    <bullet> we are redesignating 42 cfr 482.24(d)(3), 482.61(f)(3), \n",
      "and 485.638(d)(3) as 42 cfr 482.24(d)(2), 482.61(f)(2), and \n",
      "485.638(d)(2), respectively, and also revising the regulatory text to \n",
      "now state that the system sends notifications that must include at \n",
      "least patient name, treating practitioner name, and sending institution \n",
      "name;\n",
      "    <bullet> we are redesignating 42 cfr 482.24(d)(4), 482.61(f)(4), \n",
      "and 485.638(d)(4) as 42 cfr 482.24(d)(3), 482.61(f)(3), and \n",
      "485.638(d)(3), respectively, and also revising the regulatory text to \n",
      "now state that, ``to the extent permissible under applicable federal \n",
      "and state law and regulations, and not inconsistent with the patient's \n",
      "expressed privacy preferences, the system sends notifications directly, \n",
      "or through an intermediary that facilitates exchange of health \n",
      "information, at the time of: the patient's registration in the \n",
      "hospital's [or cah's] emergency department (if applicable); or the \n",
      "patient's admission to the hospital's [or cah's] inpatient services (if \n",
      "applicable).''\n",
      "    <bullet> we are redesignating 42 cfr 482.24(d)(5), 482.61(f)(5), \n",
      "and 485.638(d)(5) as 42 cfr 482.24(d)(4), 482.61(f)(4), and \n",
      "485.638(d)(4), respectively, and also revising the regulatory text to \n",
      "state that, ``to the extent permissible under applicable federal and \n",
      "state law and regulations, and not inconsistent with the patient's \n",
      "expressed privacy preferences, the system sends notifications directly, \n",
      "or through an intermediary that facilitates exchange of health \n",
      "information, at the time of: the patient's discharge or transfer from \n",
      "the hospital's [or cah's] emergency department (if applicable): or the \n",
      "patient's discharge or transfer from the hospital's [or cah's] \n",
      "inpatient services (if applicable).''\n",
      "    <bullet> we are deleting the regulatory text proposed at 42 cfr \n",
      "482.24(d)(5), 482.61(f)(5), and 485.638(d)(5) and adding new regulatory \n",
      "text to state that, ``the hospital [or cah] has made a reasonable \n",
      "effort to ensure that the system sends the notifications to all \n",
      "applicable post-acute care services providers and suppliers, as well as \n",
      "to any of the following practitioners and entities, which need to \n",
      "receive notification of the patient's status for treatment, care \n",
      "coordination, or quality improvement purposes: the patient's \n",
      "established primary care practitioner; the patient's established \n",
      "primary care practice group or entity; or other practitioner, or other \n",
      "practice group or entity, identified by the patient as the \n",
      "practitioner, or practice group or entity, primarily responsible for \n",
      "his or her care.''\n",
      "    finally, recognizing that hospitals, including psychiatric \n",
      "hospitals and cahs, are on the front lines of the covid-19 public \n",
      "health emergency, and in response to the number of comments received \n",
      "regarding concerns with the applicability date for this rule, we are \n",
      "establishing an applicability date of 12 months after finalization of \n",
      "this rule for hospitals, including psychiatric hospitals, and cahs to \n",
      "allow for adequate and additional time for these institutions, \n",
      "especially small and/or rural hospitals as well as cahs, to come into \n",
      "compliance with the new requirements.\n",
      "\n",
      "xi. provisions of the final regulations\n",
      "\n",
      "    generally, this final rule incorporates the provisions of the cms \n",
      "interoperability and patient access proposed rule as proposed. the \n",
      "following provisions of this final rule differ from the proposed rule.\n",
      "    we are finalizing four proposals with modifications.\n",
      "    1. we are requiring ma organizations, medicaid managed care plans, \n",
      "chip managed care entities, and qhp issuers on the ffes to maintain a \n",
      "process for the electronic exchange of, at a minimum, the data classes \n",
      "and elements included in the content and vocabulary standard finalized \n",
      "by hhs in the onc 21st century cures act final rule (published \n",
      "elsewhere in this issue of the federal register) at 45 cfr 170.213 \n",
      "(currently version 1 of the uscdi), via a payer-to-payer data exchanged \n",
      "as outlined in this section v. of this final rule. specifically, we are \n",
      "finalizing as proposed that impacted payers incorporate the data they \n",
      "receive into the enrollee's record. we are finalizing that with the \n",
      "approval and at the direction of a current or former enrollee, a payer \n",
      "must send the defined information set to any other payer. in addition, \n",
      "we specify that a payer is only obligated to send data received from \n",
      "another payer under this policy in the electronic form and format it \n",
      "was received.\n",
      "    starting january 1, 2022, and for qhp issuers on the ffes starting \n",
      "with plan years beginning on or after january 1, 2022, the finalized \n",
      "regulation requires these payers to make data available with a date of \n",
      "service on or after january 1, 2016 that meets the requirements of this \n",
      "section and which the payer maintains. in this way, payers only have to \n",
      "prepare an initial historical set of data for sharing via this payer-\n",
      "to-payer data exchange policy that is consistent with the data set to \n",
      "be available through the patient access api, as finalized in section \n",
      "iii. of this final rule.\n",
      "    2. regarding the patient access api, we are finalizing requirements \n",
      "for ma organizations, medicaid and chip ffs programs, medicaid managed \n",
      "care plans, chip managed care entities, and qhp issuers on the ffes to \n",
      "implement and maintain a standards-based patient access api that meets \n",
      "the technical standards as finalized by hhs in the onc 21st century \n",
      "cures act final rule (published elsewhere in this issue of the federal \n",
      "register) at 45 cfr 170.215, that include the data elements specified \n",
      "in this final rule, and that permit third-party applications to \n",
      "retrieve, with the approval and at the direction of a current enrollee, \n",
      "data specified at 42 cfr 422.119, 431.60, 457.730, and 45 cfr 156.221. \n",
      "specifically, we are finalizing that the patient access api must, at a \n",
      "minimum, make available adjudicated claims; encounters with capitated \n",
      "providers; provider remittances; enrollee cost-sharing; and clinical \n",
      "data, including laboratory results (where maintained by the impacted \n",
      "payer). we are not finalizing a requirement to include provider \n",
      "directory information as part of the\n",
      "\n",
      "[[page 25604]]\n",
      "\n",
      "patient access api. instead, to limit burden, we are only requiring \n",
      "provider and, in the case of ma-pd plans, pharmacy directory \n",
      "information, be included in the provider directory api discussed in \n",
      "section iv. of this final rule. data via the patient access api must be \n",
      "made available no later than one (1) business day after a claim is \n",
      "adjudicated or encounter data are received by the impacted payer. we \n",
      "are finalizing that ma organizations, medicaid state agencies, medicaid \n",
      "managed care plans, chip state agencies, and chip managed care entities \n",
      "must make available the date they maintain with a date of service on or \n",
      "after january 1, 2016 beginning january 1, 2021, and for qhp issuers on \n",
      "the ffes beginning with plan years beginning on or after january 1, \n",
      "2021.\n",
      "    3. we are finalizing a provider directory api for ma organizations, \n",
      "medicaid state agencies, medicaid managed care plans, chip state \n",
      "agencies, and chip managed care entities making standardized \n",
      "information about their provider networks available via a fhir-based \n",
      "api conformant with the technical standards finalized by hhs in the onc \n",
      "21st century cures act final rule (published elsewhere in this issue of \n",
      "the federal register) at 45 cfr 170.215 (which include hl7 fhir release \n",
      "4.0.1), excluding the security protocols related to user authentication \n",
      "and authorization, or any other protocols that restrict the \n",
      "availability of this information to anyone wishing to access it. at a \n",
      "minimum, these payers must make available via the provider directory \n",
      "api provider names, addresses, phone numbers, and specialties. for ma \n",
      "organizations that offer ma-pd plans, they must also make available, at \n",
      "a minimum, pharmacy directory data, including the pharmacy name, \n",
      "address, phone number, number of pharmacies in the network, and mix \n",
      "(specifically the type of pharmacy, such as ``retail pharmacy''). this \n",
      "provider directory api must be fully implemented by january 1, 2021 for \n",
      "all payers subject to this new requirement. under this final rule, ma \n",
      "organizations, medicaid and chip ffs programs, medicaid managed care \n",
      "plans, and chip managed care entities must make the provider directory \n",
      "api accessible via a public-facing digital endpoint on their website to \n",
      "ensure public discovery and access.\n",
      "    modifications being finalized for the timelines for these policies \n",
      "will provide impacted payers ample time to build and test the required \n",
      "standards-based apis to meet the new api requirements. in addition, \n",
      "providing more time for payer-to-payer data exchange between impacted \n",
      "payers will ensure successful implementation, and better enable plans \n",
      "to use a standards-based api to meet this requirement if they so \n",
      "choose. we are not finalizing the care coordination through trusted \n",
      "exchange networks proposal. although some commenters did show support \n",
      "for the proposal, others raised strong concerns. given the concerns \n",
      "commenters raised specifically regarding the need for a mature tefca to \n",
      "be in place first, and appreciating the ongoing work on the tefca being \n",
      "done at this time, we are not finalizing this trusted exchange proposal \n",
      "in this rule.\n",
      "    4. we are finalizing the revisions to the conditions of \n",
      "participation for hospitals and critical access hospitals proposal with \n",
      "modifications that are based on public comments. additionally, and \n",
      "based on strong support from commenters, we are including patient event \n",
      "notification requirements for any patient who accesses services in a \n",
      "hospital (or cah) emergency department. in response to the number of \n",
      "comments received regarding concerns with the applicable date for this \n",
      "policy, we are finalizing an applicability date of 12 months after \n",
      "publication of this rule for hospitals, including psychiatric \n",
      "hospitals, and cahs to allow for adequate time for these institutions, \n",
      "especially small and/or rural hospitals as well as cahs, to come into \n",
      "compliance with the new requirements.\n",
      "    all other policies are being substantially finalized as proposed.\n",
      "\n",
      "xii. collection of information requirements\n",
      "\n",
      "    under the paperwork reduction act of 1995, we are required to \n",
      "provide 30-day notice in the federal register and solicit public \n",
      "comment before a collection of information requirement is submitted to \n",
      "the office of management and budget (omb) for review and approval. in \n",
      "order to fairly evaluate whether an information collection should be \n",
      "approved by omb, section 3506(c)(2)(a) of the paperwork reduction act \n",
      "of 1995 requires that we solicit comment on the following issues:\n",
      "    <bullet> the need for the information collection and its usefulness \n",
      "in carrying out the proper functions of our agency.\n",
      "    <bullet> the accuracy of our estimate of the information collection \n",
      "burden.\n",
      "    <bullet> the quality, utility, and clarity of the information to be \n",
      "collected.\n",
      "    <bullet> recommendations to minimize the information collection \n",
      "burden on the affected public, including automated collection \n",
      "techniques.\n",
      "    we solicited public comment on each of these issues for the \n",
      "following sections of this document that contain information collection \n",
      "requirements (icrs):\n",
      "\n",
      "a. background\n",
      "\n",
      "    payers should have the ability to exchange data instantly with \n",
      "other payers for care and payment coordination or transitions, and with \n",
      "providers to facilitate more efficient care. payers are in a unique \n",
      "position to provide patients a complete picture of their claims and \n",
      "encounter data, allowing patients to piece together their own \n",
      "information that might otherwise be lost in disparate systems. to \n",
      "advance our commitment to interoperability, we are finalizing our \n",
      "proposals for the patient access api, the provider directory api, and \n",
      "the payer-to-payer data exchange as discussed above.\n",
      "    we noted that these proposals were designed to empower patients by \n",
      "making sure that they have access to health information about \n",
      "themselves in a usable digital format and can make decisions about how, \n",
      "with whom, and for what uses they will share it. by making claims data \n",
      "readily available and portable to the enrollee, these initiatives \n",
      "supported efforts to reduce burden and cost and improve patient care by \n",
      "reducing duplication of services, adding efficiency to patient visits \n",
      "to providers; and, facilitating identification of fraud, waste, and \n",
      "abuse.\n",
      "\n",
      "b. wage estimates\n",
      "\n",
      "    to derive average costs, we used data from the u.s. bureau of labor \n",
      "statistics' (bls) may 2018 national occupational employment and wage \n",
      "estimates (<a href=\"https://www.bls.gov/oes/current/oes_nat.htm\">https://www.bls.gov/oes/current/oes_nat.htm</a>). table 1 \n",
      "presents the mean hourly wage, the cost of fringe benefits (calculated \n",
      "at 100 percent of salary), and the adjusted hourly wage. in the cms \n",
      "interoperability and patient access proposed rule, table 1 was based on \n",
      "the latest 2017 wage data (84 fr 7658). in this final rule, we have \n",
      "updated table 1 to reflect 2018 wage data, which is now the latest \n",
      "available data.\n",
      "\n",
      "[[page 25605]]\n",
      "\n",
      "\n",
      "\n",
      "                                    table 1--occupation titles and wage rates\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                                      fringe         adjusted\n",
      "                occupation title                    occupation     mean  hourly    benefit  ($/    hourly  wage\n",
      "                                                       code        wage  ($/hr)         hr)           ($/hr)\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "administrators and network architects...........         15-1140          $45.09          $45.09          $90.18\n",
      "security engineer...............................         17-2199           47.80           47.80           95.60\n",
      "computer and information analysts...............         15-1120           45.67           45.67           91.34\n",
      "general operations manager......................         11-1021           59.56           59.56          119.12\n",
      "operations research analysts....................         15-2031           42.48           42.48           84.96\n",
      "software developers, applications...............         15-1132           51.96           51.96          103.92\n",
      "computer and information systems managers.......         11-3021           73.49           73.49          146.98\n",
      "designers.......................................         27-1020           24.05           24.05           48.10\n",
      "technical writer................................         27-3042           36.30           36.30           72.60\n",
      "computer systems analysts.......................         15-1121           45.01           45.01           90.02\n",
      "network and computer systems administrators.....         15-1142           41.86           41.86           83.72\n",
      "medical records and health information                   29-2071           21.16           21.16           42.32\n",
      " technician.....................................\n",
      "medical and health service managers.............         11-9111           54.68           54.68          109.36\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    as indicated, we are adjusting the employee hourly wage estimates \n",
      "by a factor of 100 percent. this is necessarily a rough adjustment, \n",
      "both because fringe benefits and overhead costs vary significantly from \n",
      "employer to employer, and because methods of estimating these costs \n",
      "vary widely from study to study. nonetheless, there is no practical \n",
      "alternative and we believe that doubling the hourly wage to estimate \n",
      "total cost is a reasonable accurate estimation method.\n",
      "\n",
      "c. information collection requirements (icrs)\n",
      "\n",
      "1. icrs regarding mma file requirements (42 cfr 423.910)\n",
      "    states transmit system generated data files, at least monthly, to \n",
      "cms to identify all dually eligible individuals, including full-benefit \n",
      "and partial-benefit dually eligible beneficiaries (that is, those who \n",
      "get medicaid help with medicare premiums, and often for cost-sharing). \n",
      "the file is called the mma file, but is occasionally referred to as the \n",
      "``state phasedown file.'' section 423.910(d) requires states to \n",
      "transmit at least one mma file each month. however, states have the \n",
      "option to transmit multiple mma files throughout the month (up to one \n",
      "per day). most states transmit at least weekly. this information \n",
      "collection activity is currently approved under omb control number \n",
      "0938-0958.\n",
      "    ensuring information on dual eligibility status is accurate and up-\n",
      "to-date by increasing the frequency of federal-state data exchange is \n",
      "an important step toward interoperability. as a result, we proposed to \n",
      "update the frequency requirements in 42 cfr 423.910(d) to require that \n",
      "starting april 1, 2022, all states transmit the required mma file data \n",
      "to cms daily, and to make conforming edits to 42 cfr 423.910(b)(1). \n",
      "daily would mean every business day, but if no new transactions are \n",
      "available to transmit, data would not need to be transmitted on a given \n",
      "business day. we estimate it would take a computer systems analyst \n",
      "about 6 months (approximately 960 hours) to complete the systems \n",
      "updates necessary to process and transmit the mma data daily. after \n",
      "completion of system updates, these system generated reports would be \n",
      "set to run and transmitted to cms on an automated production schedule.\n",
      "    as a result of updated information, we are revising the number of \n",
      "states currently transmitting mma daily data from 13 states, as stated \n",
      "in the cms interoperability and patient access proposed rule, to 15 \n",
      "states. consequently, we estimate a one-time aggregate burden for 36 \n",
      "entities (51 total entities (50 states and the district of columbia) \n",
      "minus the 15 states currently transmitting mma daily data) to comply \n",
      "with the requirement of transmission of daily mma data at an aggregate \n",
      "burden of $3,111,091 (36 entities * 960 hours * $90.02 per hour for a \n",
      "computer system analyst to perform the updates). we have only estimated \n",
      "the cost of system updates since the system transfers are done \n",
      "automatically and this has no additional cost. we will be revising the \n",
      "information collection request currently approved under 0938-0958 to \n",
      "include the requirements discussed in this section.\n",
      "2. icrs regarding api proposals (42 cfr 422.119, 422.120, 431.60, \n",
      "431.70, 438.242, 457.730, 457.760, 457.1233, and 45 cfr 156.221)\n",
      "    to promote our commitment to interoperability, we are finalizing \n",
      "new requirements for a patient access api for ma organizations at 42 \n",
      "cfr 422.119, medicaid ffs at 42 cfr 431.60, chip ffs at 42 cfr 457.730, \n",
      "medicaid managed care at 42 cfr 438.242(b)(5), chip managed care at 42 \n",
      "cfr 457.1233(d), and qhp issuers on the ffes at 45 cfr 156.221. \n",
      "additionally, we are finalizing a publicly available provider directory \n",
      "api for ma organizations at 42 cfr 422.120, at 42 cfr 431.70 for \n",
      "medicaid ffs, at 42 cfr 438.242(b)(6) for medicaid managed care, at 42 \n",
      "cfr 457.760 for chip ffs, and at 42 cfr 457.1233(d)(3) for chip managed \n",
      "care. we proposed to require these entities to establish standards-\n",
      "based apis that permit third-party applications to retrieve \n",
      "standardized data for adjudicated claims, encounters with capitated \n",
      "providers, provider remittances, beneficiary cost-sharing, reports of \n",
      "lab test results, provider directories (and pharmacy directories for \n",
      "ma-pds), and preferred drug lists, where applicable. we finalized the \n",
      "requirement for a patient access api and a provider directory api; this \n",
      "final rule requires generally the same information as proposed to be \n",
      "available through apis but we are finalizing the requirement for two \n",
      "apis. additionally, we proposed and are finalizing at 42 cfr \n",
      "422.119(f)(1) and 438.62(b)(1)(vi), and at 45 cfr 156.221(f)(1) to \n",
      "require ma organizations, medicaid managed care plans, chip managed \n",
      "care entities, and qhp issuers on the ffes to maintain a process for \n",
      "the electronic exchange of, at a minimum, the data classes and elements \n",
      "included in the content standard adopted at 45 cfr 170.213 (currently \n",
      "version 1 of the uscdi). to implement the new requirements for apis and \n",
      "payer to payer data exchange, we estimate that plans and states will \n",
      "conduct three major work phases: initial design, development and \n",
      "testing, and long-term support and maintenance. in the proposed rule, \n",
      "we provided detailed\n",
      "\n",
      "[[page 25606]]\n",
      "\n",
      "estimations of the required labor categories and number of hours \n",
      "required to implement the api provisions (84 fr 7659). we originally \n",
      "estimated a one-time burden of $789,356.00 per organization or state \n",
      "per implementation, with an ongoing maintenance cost $158,359.00 per \n",
      "organization or state (84 fr 7659). we noted that, in the initial \n",
      "design phase, we believed tasks would include: determining available \n",
      "resources (personnel, hardware, cloud space, etc.); assessing whether \n",
      "to use in-house resources to facilitate an api connection or contract \n",
      "the work to a third party; convening a team to scope, build, test, and \n",
      "maintain the api; performing a data availability scan to determine any \n",
      "gaps between internal data models and the data required for the \n",
      "necessary fhir resources; and, mitigating any gaps discovered in the \n",
      "available data.\n",
      "    during the development and testing phase, we noted that plans and \n",
      "states would need to conduct the following: map existing data to hl7 \n",
      "\\66\\ fhir standards, which would constitute the bulk of the work \n",
      "required for implementation; allocate hardware for the necessary \n",
      "environments (development, testing, production); build a new fhir \n",
      "server or leverage existing fhir servers; determine the frequency and \n",
      "method by which internal data are populated on the fhir server; build \n",
      "connections between the databases and fhir server; perform capability \n",
      "and security testing; and vet third-party applications, which includes \n",
      "potentially asking third-party applications to attest to certain \n",
      "privacy provisions.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\66\\ health level seven international (hl7[supreg]) is a not-\n",
      "for-profit, ansi-accredited standards development organization (sdo) \n",
      "focused on developing consensus standards for the exchange, \n",
      "integration, sharing, and retrieval of electronic health information \n",
      "that supports clinical practice and the management, delivery and \n",
      "evaluation of health services. learn more at ``about hl7'' web page, \n",
      "last accessed june 27, 2018.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    after the completion of the api development, plans and states would \n",
      "need to conduct the following throughout each year: allocate resources \n",
      "to maintain the fhir server, which includes the cost of maintaining the \n",
      "necessary patient data, and perform capability and security testing.\n",
      "    in the proposed rule, we proposed a new requirement for ma plans, \n",
      "medicaid managed care plans, chip managed care entities, and qhp \n",
      "issuers on the ffes to maintain a process to coordinate care between \n",
      "plans by exchanging, at a minimum, the uscdi at the enrollee's request \n",
      "(84 fr 7640). originally, we noted that we would allow multiple methods \n",
      "for electronic exchange of the information, including use of the apis. \n",
      "although we considered requiring the use of the fhir-based api, we \n",
      "understood that some geographic areas might have a regional health \n",
      "information exchange that could coordinate such transactions. we also \n",
      "noted other ways to exchange this data, such as: direct plan-to-plan \n",
      "exchange; leveraging connections to hies, or beneficiary-facing third-\n",
      "party applications. since the requirements for the payer-to-payer data \n",
      "exchange and the api provisions share a content and vocabulary standard \n",
      "and because plans will be investing in the development of the apis in \n",
      "this final rule, we believe that plans would overwhelmingly use these \n",
      "apis to meet the payer to payer data exchange requirements. as we had \n",
      "no reliable way to determine which plans would utilize any of the \n",
      "available methods to meet the payer-to-payer data exchange requirement \n",
      "or how to determine the cost of each of these methods, given that each \n",
      "plan could be at a different technology maturity level, we accounted \n",
      "for costs for all impacted payers assuming the use of a newly developed \n",
      "api to implement the payer-to-payer data exchange requirements, as this \n",
      "would account for a higher effort options, and included this in our \n",
      "original estimates for the api provisions.\n",
      "    we summarize the public comments we received on concerns raised \n",
      "regarding our proposed cost of implementing and maintaining the apis \n",
      "and provide our responses.\n",
      "    comment: some commenters expressed concern that cms underestimated \n",
      "the complexity of implementing the api requirements and did not agree \n",
      "with the agency's estimation that the api implementation is a one-time \n",
      "cost. these commenters noted that additional costs include: the costs \n",
      "to contract with third-party applications, the costs of ongoing \n",
      "education, and the cost of answering questions from members about data \n",
      "and errors. commenters argued that the proposed api requirements \n",
      "significantly add to overhead costs and will increase costs for \n",
      "providers and payers, rather than facilitate information exchange and \n",
      "better care for patients. one commenter estimated a range of between $1 \n",
      "million and $1.5 million to implement the api requirements, with an \n",
      "additional $200,000 to maintain the api. another commenter argued that \n",
      "the costs of implementation could be as high as four times the \n",
      "estimates cms provided.\n",
      "    response: we thank commenters for their input and understand their \n",
      "concerns associated with the cost required to implement the \n",
      "requirements of this final rule. we understand that our estimates \n",
      "regarding the implementation of the api provisions may vary depending \n",
      "on a number of factors, including, but not limited to a payer's current \n",
      "knowledge of and experience with implementing fhir-based apis, and \n",
      "whether an impacted payer will develop this technology in-house or seek \n",
      "a third party contractor to support this effort.\n",
      "    to further develop our cost estimates, we reviewed the cost \n",
      "estimates associated with updating blue button from blue button 1.0 to \n",
      "2.0 to include a standards-based api, similar to the requirements of \n",
      "this final rule. this update was estimated at $2 million. however, we \n",
      "believe that the estimates associated with updating the existing blue \n",
      "button 1.0 to a standards-based api for blue button 2.0 do not \n",
      "accurately represent the costs for payers impacted by this final rule. \n",
      "blue button 1.0 was developed across several federal agencies, \n",
      "including the departments of defense, health and human services, and \n",
      "veterans affairs, with a capability to allow beneficiaries online \n",
      "access to their own personal health records, such as the ability to \n",
      "download pdf documents. unlike the standards-based apis required under \n",
      "this final rule, blue button 1.0 was not originally developed with a \n",
      "prescribed set of standards that allow for third-party apps to connect \n",
      "and retrieve data via an api. the estimates for blue button account for \n",
      "upgrading an existing technology platform that was not originally \n",
      "developed to allow third-party app access via an api, which we believe \n",
      "adds additional cost that may not impact all payers under this final \n",
      "rule. additionally, we note that costs related to federal procurement \n",
      "and the need to engage multiple contractors to implement the updates to \n",
      "blue button, while at the same time maintaining access to the original \n",
      "system, caused the cost of implementing standards-based apis for blue \n",
      "button 2.0 to be higher than those costs for payers impacted by this \n",
      "final rule. therefore, we believe that the estimates for upgrading blue \n",
      "button from 1.0 to 2.0 are not truly representative of the cost to \n",
      "implement the standards-based api required by this final rule, but \n",
      "nonetheless are valuable in further informing our cost estimates.\n",
      "    as noted above, we did receive one comment that suggested a cost \n",
      "range between $1 million and $1.5 million to implement the api \n",
      "requirements of this final rule, with another commenter indicating a \n",
      "four-fold increase in costs relative to the estimates included in the \n",
      "proposed rule. while disagreeing with\n",
      "\n",
      "[[page 25607]]\n",
      "\n",
      "our bottom line, these commenters did not provide where in our detailed \n",
      "analysis we underestimated costs. for example, it is unclear if the \n",
      "commenters were including voluntary provider costs, or other costs when \n",
      "calculating the dollar amounts for compliance. therefore, without \n",
      "specific examples of additional costs that need to be accounted for in \n",
      "this impact analysis, we believe that our estimates are reasonable. to \n",
      "address commenters' concerns regarding ongoing costs, we remind readers \n",
      "that we specifically are accounting for a cost of $157,656 per \n",
      "organization, for costs throughout the year to include: allocating \n",
      "resources to maintain the fhir server, which includes the cost of \n",
      "maintaining the necessary patient data, and perform capability and \n",
      "security testing.\n",
      "    however, in an effort to take into account the additional \n",
      "information that commenters presented regarding our costs estimates, \n",
      "and understanding there are many factors that may influence the cost of \n",
      "implementing these policies, as noted above, we are adjusting our cost \n",
      "estimates to reflect a range instead of a point estimate. we believe \n",
      "that our cost projections for an initial one-time cost to implement the \n",
      "api requirements of this final rule of $718,414 per organization, \n",
      "reflecting 6 months of work by a team of ten professionals, can now \n",
      "serve as a minimum estimate; in other words, we do not believe it is \n",
      "technically feasible to implement the requirements of this final rule \n",
      "in less than 6 months. for a primary estimate, we have increased our \n",
      "cost estimates by a factor of 2 to account for cost variation. we note \n",
      "that using this factor of 2, the cost per organization is consistent \n",
      "with the commenter stating a $1 million to $1.5 million per \n",
      "organization cost. for a high estimate we have increased our cost \n",
      "estimates by a factor of 3. although, one commenter noted a factor of 4 \n",
      "should be included, all other information available to us, including \n",
      "the commenter who noted a range between $1 million and $1.5 million, \n",
      "and our estimates for upgrading blue button, a factor of 4 does not \n",
      "appear to be reflective of the costs for implementation and represents \n",
      "more of an outlier for cost estimating purposes. as shown in section \n",
      "xiii. of this final rule, we have revised down our estimate of affected \n",
      "individual market enrollees from 76 million (all commercial market \n",
      "enrollees) to 17.5 million (those individual market enrollees directly \n",
      "affected by this final rule). this reduction by a factor of 4 (76 \n",
      "million former estimate/17.5 million revised estimate) raises the cost \n",
      "per individual market enrollee per year by a factor of 4 consistent \n",
      "with the commenter's suggested factor of 4. this factor of 4, however, \n",
      "only affects cost per enrollee per year; it does not affect total costs \n",
      "as calculated in table 2.\n",
      "    additionally, we note that as part of our original estimated costs \n",
      "associated with the annual burden of the requirements of this final \n",
      "rule, we accounted for additional capability testing and long-term \n",
      "support of the apis, increased data storage needs, such as additional \n",
      "servers, or cloud storage to store any additional patient health \n",
      "information, and allocation of resources to maintain the fhir server, \n",
      "and perform capability and security testing. therefore, our estimates \n",
      "related to the annual burden account for the ongoing cost, and we are \n",
      "not providing additional estimates for maintenance as this is already \n",
      "factored in.\n",
      "    the burden estimate related to the new requirements for \n",
      "implementing and maintaining the apis reflects the time and effort \n",
      "needed to collect the information described above and disclose this \n",
      "information. we now estimate:\n",
      "    <bullet> an initial set one-time costs associated with the \n",
      "implementing the api requirements.\n",
      "    <bullet> an ongoing maintenance cost after the system is set up, \n",
      "and the costs associated with additional data storage, system testing, \n",
      "and maintenance.\n",
      "    consistent with our discussion above, we now regard this as a low \n",
      "or minimum estimate, the argument being that a complex system cannot be \n",
      "designed in less than 6 months. our high estimate now reflects 18 \n",
      "months of work (4,320 hours) for administrators and network architects. \n",
      "this is obtained by using a factor of 3 (4,320 hours (high estimate) = \n",
      "3*1440 hours, the original estimate). for a primary estimate, we \n",
      "estimate 12 months of work or 2,880 hours (1,440 hours * 2) for \n",
      "administrators and network architects. the use of a factor of 2 is \n",
      "consistent with a $2 million cost per entity and consistent with the \n",
      "commenter who estimated an implementation cost of $1 million to $1.5 \n",
      "million. we note that, in terms of actual implementation, this \n",
      "assumption is focused on the 2,880 hours of work that could be \n",
      "conducted in less than 12 months through necessary personnel or third-\n",
      "party contractor allocation, if needed. as a result, the ``12-month'' \n",
      "assumption is also consistent with the implementation of the new api \n",
      "requirements, which must be implemented by january 1, 2021.\n",
      "    as can be seen from the bottom rows of table 2:\n",
      "    <bullet> for a low estimate, first year implementation will require \n",
      "a total of 8,400 hours per organization at a cost of $718,414.40 per \n",
      "organization (this number is obtained by adding the products of hourly \n",
      "wages and hours required in each row, for example 1440*$90.18 + \n",
      "960*$95.60, etc.).\n",
      "    <bullet> for a high estimate, first year implementation will \n",
      "require a total of 25,200 hours per organization at a cost of \n",
      "$2,365,243 per organization (this number is obtained by adding the \n",
      "products of hourly wages and hours required in each row).\n",
      "    <bullet> for a primary estimate, first year implementation will \n",
      "require a total of 16,800 hours of work per organization at a cost of \n",
      "$1,576,829 per organization.\n",
      "    <bullet> therefore, the aggregate burden of the first year \n",
      "implementation across 345 parent organizations \\67\\ is 2,898,000 hours \n",
      "(8400 * 345) at a cost of $272 million ($718,414 * 345) for the low \n",
      "estimate. similar calculations show that the primary estimate is \n",
      "5,796,000 hours at an aggregate cost of $544,005,936 million, and the \n",
      "high estimate is 8,694,000 hours at a cost of $816,008,904.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\67\\ we provide a detailed rationale for how we determined the \n",
      "number of parent organizations in section xiii.c.1. of this final \n",
      "rule. in that analysis we determined that 288 issuers and 56 states, \n",
      "territories, and u.s. commonwealths, which operate ffs programs, \n",
      "will be subject to the api provisions for medicare, medicaid, and \n",
      "the commercial market. to this we added the one state that operates \n",
      "its chip and medicaid separately. thus, we have a total of 345 \n",
      "parent entities (288+56+1).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> similarly, ongoing maintenance after the first year will \n",
      "require a total of 1,710 hours per organization at a cost of \n",
      "$157,656.60 per organization.\n",
      "    <bullet> therefore, the aggregate burden of ongoing implementation \n",
      "across 345 parent organizations is $54.4 million ($157,656.60 * 345).\n",
      "    we explicitly note that a low and high estimate were only provided \n",
      "for the first year, but not for subsequent years.\n",
      "\n",
      "[[page 25608]]\n",
      "\n",
      "\n",
      "\n",
      "                                             table 2--first year and maintenance cost of the api provisions\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                         mean                  adjusted                     first year\n",
      "                                          occupation    hourly      fringe      hourly      first year         hours        first year      maintenance\n",
      "            occupation title                  code     wage  ($/    benefit    wage  ($/    hours  (low      (primary      hours  (high        hours\n",
      "                                                          hr)       ($/hr)        hr)        estimate)       estimate)       estimate)\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "administrators and network architects...     15-1140      $45.09      $45.09      $90.18            1440            2880            4320             180\n",
      "security engineer.......................     17-2199       47.80       47.80       95.60             960            1920            2880             240\n",
      "computer and information analysts.......     15-1120       45.67       45.67       91.34             480             960            1440              60\n",
      "general operations manager..............     11-1021       59.56       59.56      119.12             720            1440            2160              90\n",
      "operations research analysts............     15-2031       42.48       42.48       84.96             960            1920            2880             120\n",
      "software developers, applications.......     15-1132       51.96       51.96      103.92             960            1920            2880             240\n",
      "computer and information systems             11-3021       73.49       73.49      146.98             720            1440            2160              90\n",
      " managers...............................\n",
      "designers...............................     27-1020       24.05       24.05       48.10             960            1920            2880             120\n",
      "technical writer........................     27-3042       36.30       36.30       72.60             240             480             720              30\n",
      "computer systems analysts...............     15-1121       45.01       45.01       90.02             960            1920            2880             120\n",
      "network and computer systems                 15-1142       41.86       41.86       83.72  ..............               0               0             420\n",
      " administrators.........................\n",
      "    total hours per system..............  ..........  ..........  ..........  ..........           8,400          16,800          25,200           1,710\n",
      "    total cost per system (dollars)       ..........  ..........  ..........  ..........         788,414       1,576,829       2,365,243         157,657\n",
      "     (millions).........................\n",
      "    total hours for 345 organizations     ..........  ..........  ..........  ..........       2,898,000       5,796,000       8,694,000         589,950\n",
      "     (hours)............................\n",
      "    total cost for 345 organizations      ..........  ..........  ..........  ..........     272,002,968     544,005,936     816,008,904      54,391,527\n",
      "     (millions $).......................\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "3. icrs regarding conditions of participation for hospitals and \n",
      "critical access hospitals (42 cfr 482.24(d), 482.61(f), 485.638(d))\n",
      "    we are expanding our requirements for interoperability within the \n",
      "hospital and cah cops by focusing on electronic patient event \n",
      "notifications. we are implementing new requirements in section x. of \n",
      "this final rule for hospitals at 42 cfr 482.24(d), for psychiatric \n",
      "hospitals at 42 cfr 482.61(f), and for cahs at 42 cfr 485.638(d). \n",
      "specifically, for hospitals, psychiatric hospitals, and cahs, we are \n",
      "finalizing similar requirements to revise the cops for medicare- and \n",
      "medicaid-participating hospitals, psychiatric hospitals, and cahs by \n",
      "adding a new standard, ``electronic notifications,'' that will require \n",
      "hospitals, psychiatric hospitals, and cahs to make electronic patient \n",
      "event notifications available to applicable post-acute care services \n",
      "providers and suppliers, and to community practitioners such as the \n",
      "patient's established primary care practitioner, established primary \n",
      "care practice group or entity, or other practitioner or practice group \n",
      "or entity identified by the patient as primarily responsible for his or \n",
      "her care. we are limiting this requirement to only those hospitals, \n",
      "psychiatric hospitals, and cahs that utilize electronic medical records \n",
      "systems, or other electronic administrative systems, which are \n",
      "conformant with the content exchange standard at 45 cfr 170.205(d)(2), \n",
      "recognizing that not all medicare- and medicaid-participating hospitals \n",
      "have been eligible for past programs promoting adoption of ehr systems. \n",
      "if the hospital's (or cah's) system conforms to the content exchange \n",
      "standard at 45 cfr 170.205(d)(2), the hospital (or cah) must then \n",
      "demonstrate that its system's notification capacity is fully \n",
      "operational and that the hospital (or cah) uses it in accordance with \n",
      "all state and federal statutes and regulations applicable to the \n",
      "hospital's (or cah's) exchange of patient health information, and that \n",
      "its system (to the extent permissible under applicable federal and \n",
      "state law and regulations, and not inconsistent with the patient's \n",
      "expressed privacy preferences) sends the notifications either directly, \n",
      "or through an intermediary that facilitates exchange of health \n",
      "information. it must also demonstrate that the notifications include at \n",
      "least patient name, treating practitioner name, and sending institution \n",
      "name.\n",
      "    upon the patient's registration in the emergency department or \n",
      "admission to inpatient services, and also either immediately prior to, \n",
      "or at the time of, the patient's discharge or transfer (from the \n",
      "emergency department or inpatient services), the hospital (or cah) must \n",
      "also demonstrate that it has made a reasonable effort to ensure that \n",
      "its system sends the notifications to all applicable post-acute care \n",
      "services providers and suppliers, as well as to any of the following \n",
      "practitioners and entities, which need to receive notification of the \n",
      "patient's status for treatment, care coordination, or quality \n",
      "improvement purposes: (1) the patient's established primary care \n",
      "practitioner; (2) the patient's established primary care practice group \n",
      "or entity; or (3) other practitioner, or other practice group or \n",
      "entity, identified by the patient as the\n",
      "\n",
      "[[page 25609]]\n",
      "\n",
      "practitioner, or practice group or entity, primarily responsible for \n",
      "his or her care.\n",
      "    these requirements will help support coordination of a patient's \n",
      "care between settings or with services received through different care \n",
      "settings. electronic patient event notifications from these care \n",
      "settings, or clinical event notifications, are one type of health \n",
      "information exchange intervention that has been increasingly recognized \n",
      "as an effective and scalable tool for improving care coordination \n",
      "across settings. these notifications are typically automated, \n",
      "electronic communications from the admitting or discharging provider to \n",
      "applicable post-acute care services providers and suppliers, and also \n",
      "to community practitioners identified by the patient, that alert the \n",
      "receiving providers or community practitioners that a patient is \n",
      "receiving, or has received, care at a different setting.\n",
      "    these notifications are frequently based on ``admission, discharge, \n",
      "and transfer (adt)'' messages, a standard message used within an ehr as \n",
      "the vehicle for communicating information about key changes in a \n",
      "patient's status as they are tracked by the system (more information \n",
      "about the current standard supporting these messages is available at \n",
      "<a href=\"http://www.hl7.org/implement/standards/product_brief.cfm?product_id=144\">http://www.hl7.org/implement/standards/product_brief.cfm?product_id=144</a>). as noted in the isa published by \n",
      "onc, this messaging standard has been widely adopted across the health \n",
      "care system (see <a href=\"https://www.healthit.gov/isa/sending-a-notification-a-patients-admission-discharge-andor-transfer-status-other-providers\">https://www.healthit.gov/isa/sending-a-notification-a-patients-admission-discharge-andor-transfer-status-other-providers</a>).\n",
      "    we continue to believe that care coordination can have a \n",
      "significant positive impact on the quality of life, consumer \n",
      "experience, and health outcomes for patients. as we have noted in the \n",
      "preamble to this rule, virtually all ehr systems (as well as older \n",
      "legacy electronic administrative systems, such as electronic patient \n",
      "registrations systems, and which we are including in this final rule) \n",
      "generate information to support the basic messages commonly used for \n",
      "electronic patient event notifications. while we acknowledge that some \n",
      "level of implementation cost would be realized for those providers not \n",
      "already transmitting notifications, we also note there is substantial \n",
      "agreement that implementation of these basic messaging and notification \n",
      "functions within such existing systems constitutes a relatively low \n",
      "cost burden for providers, particularly when such costs are considered \n",
      "alongside the innovative and beneficial patient care transition \n",
      "solutions and models for best practices they provide.\n",
      "    although we do not have current data on how many facilities are \n",
      "already transmitting electronic patient event notifications, 59 percent \n",
      "of hospitals were found to be routinely electronically notifying a \n",
      "patient's primary care provider upon his or her entry to the hospital's \n",
      "emergency department in 2015, which is an over 50 percent increase \n",
      "since 2012.\\68\\ by using this historical data to plot a power trend \n",
      "line (r-squared: 0.9928), we estimate that approximately 71 percent of \n",
      "hospitals may have been routinely transmitting patient event \n",
      "notifications by 2018; therefore, we assume that 29 percent of \n",
      "hospitals, or approximately 1,392, will incur costs associated with \n",
      "updating or configuring their respective ehr systems for electronic \n",
      "patient event notifications. while we do not have parallel data for \n",
      "cahs, we assume that a similar percentage, or approximately 394 cahs, \n",
      "will incur this burden. we note that this upwards trend of patient \n",
      "event notification adoption may continue to some unknown extent absent \n",
      "this final rule; however, we are limiting our projection of hospitals \n",
      "that are most affected by these requirements to 2018 due to the amount \n",
      "of uncertainty involved in quantifying this burden.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\68\\ office of the national coordinator. (n.d.). hospital \n",
      "routine electronic notification: percent of u.s. hospitals that \n",
      "routinely electronically notify patient's primary care provider upon \n",
      "emergency room entry, 2015. retrieved from <a href=\"https://dashboard.healthit.gov/quickstats/pages/fig-hospital-routine-electronic-notification.php\">https://dashboard.healthit.gov/quickstats/pages/fig-hospital-routine-electronic-notification.php</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we assume that this process will primarily require the services of \n",
      "two medical records and health information technicians at approximately \n",
      "$42.32/hour for 16 hours each, and 3 hours of time from a medical and \n",
      "health services manager at approximately $109.36/hour, including the \n",
      "costs of overhead and fringe benefits. thus, the total burden per \n",
      "facility is anticipated to be 35 hours, or approximately $1,682.32 ((16 \n",
      "hours * $42.32/hour * 2 health information technicians) + (3 hours * \n",
      "$109.36/hour * 1 manager)). we assume that the ongoing burden \n",
      "associated with maintenance of these systems would be approximately one \n",
      "quarter of these amounts for the 2 medical records and health \n",
      "information technicians, or 4 hours each, for a total of 8 hours and \n",
      "$338.56 per facility (4 hours * $42.32/hour * 2 health information \n",
      "technicians).\n",
      "    in this lower-bound scenario, we estimate that the total first-year \n",
      "burden for hospitals and psychiatric hospitals is approximately 48,720 \n",
      "hours (35 hours * 1,392 hospitals) or $2,341,789 ($1,682.32 * 1,392 \n",
      "hospitals). in subsequent years, we estimate the burden is \n",
      "approximately 11,136 hours (8 hours * 1,392 hospitals) or $471,276 \n",
      "($338.56 * 1,392 hospitals).\n",
      "    for cahs we estimate that the total first-year burden is \n",
      "approximately 13,790 hours (35 hours * 394 cahs) or $662,834 ($1,682.32 \n",
      "* 394 cahs). in subsequent years, we estimate the burden for cahs is \n",
      "approximately 3,152 hours (8 hours * 394 cahs) or $133,393 ($338.56 * \n",
      "394 cahs).\n",
      "    due to the amount of uncertainty involved in these estimates, we \n",
      "are also presenting estimates for a scenario in which the number of \n",
      "hospitals that routinely electronically notify primary care providers \n",
      "both inside and outside of the hospital's system is assumed to have \n",
      "remained static at the 2015 rate of 29 percent. this upper-bound \n",
      "scenario would indicate that in 2018 approximately 3,407 hospitals and \n",
      "964 cahs did not routinely utilize patient event notification, and \n",
      "therefore several thousand additional providers would incur the \n",
      "previously estimated burden per facility.\n",
      "    for the purposes of the pra, we are assuming the midpoint of this \n",
      "range of effects. in this scenario 2,400 hospitals and psychiatric \n",
      "hospitals, and 679 cahs would incur the estimated burden. the burden \n",
      "estimates associated with the revised cops are detailed in table 3. \n",
      "this information collection will be submitted to omb under omb control \n",
      "number 0938-new.\n",
      "\n",
      "[[page 25610]]\n",
      "\n",
      "\n",
      "\n",
      "                                       table 3--summary of hour and dollar burden by number of affected providers\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                                       hospitals and psychiatric                     cahs\n",
      "---------------------------------------------------------------------------------              hospitals             -----------------------------------\n",
      "                                                                                 ------------------------------------\n",
      "                                                                                       year 1       subsequent years       year 1       subsequent years\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "lower bound...................................  affected providers..............                 1,392\n",
      "                                                                        394\n",
      "                                               ---------------------------------------------------------------------------------------------------------\n",
      "                                                total burden (hours)............            48,720            11,136            13,790             3,152\n",
      "                                                total cost......................     $2,341,789.44       $471,275.52       $662,834.08       $133,392.64\n",
      "                                               ---------------------------------------------------------------------------------------------------------\n",
      "primary estimate..............................  affected providers..............                 2,400\n",
      "                                                                        679\n",
      "                                               ---------------------------------------------------------------------------------------------------------\n",
      "                                                total burden (hours)............            84,000            19,200            23,765             5,432\n",
      "                                                total cost......................     $4,037,568.00       $812,544.00     $1,142,295.28       $229,882.24\n",
      "                                               ---------------------------------------------------------------------------------------------------------\n",
      "upper bound...................................  affected providers..............                 3,407\n",
      "                                                                        964\n",
      "                                               ---------------------------------------------------------------------------------------------------------\n",
      "                                                total burden (hours)............           119,245            27,256            33,740             7,712\n",
      "                                                total cost......................     $5,731,664.24     $1,153,473.92     $1,621,756.48       $326,371.84\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "4. summary of information collection burdens\n",
      "\n",
      "                                               table 4--summary of primary information collection burdens\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                                                                      hourly\n",
      "                                                                                          burden per     total      labor cost  total labor  total labor\n",
      "       regulation  section(s)             omb control no.       number of    number of     response      annual         of        cost 1st       cost\n",
      "                                                               respondents   responses     (hours)       burden     reporting     year ($)    subsequent\n",
      "                                                                                                        (hours)        ($)                    years ($)\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "sec.   423.910......................  0938-0958 *............           36           36          960       34,560       $90.02    3,111,091    3,111,091\n",
      "sec.   422.119, sec.   431.60, sec.   0938-new...............          345          345       16,800    5,796,000       varies  544,005,936            0\n",
      "  457.730, sec.   438.242, sec.\n",
      " 457.1233 and sec.   156.221.\n",
      "sec.   422.119, sec.   431.60, sec.   0938-new...............          345          345        1,710      589,950       varies  ...........   54,391,527\n",
      "  457.730, sec.   438.242, sec.\n",
      " 457.1233, and sec.   156.221.\n",
      "sec.   482.24(d) and sec.             0938-new...............        2,400        2,400           35       84,000       varies    4,037,568  ...........\n",
      " 482.61(f).\n",
      "sec.   482.24(d) and sec.             0938-new...............        2,400        2,400            8       19,200       varies  ...........      812,544\n",
      " 482.61(f).\n",
      "sec.   485.638(d)...................  0938-new...............          679          679           35       23,765       varies    1,142,295  ...........\n",
      "sec.   485.638(d)...................  0938-new...............          679          679            8        5,432       varies  ...........   229,882.24\n",
      "                                     -------------------------------------------------------------------------------------------------------------------\n",
      "    total...........................  .......................  ...........        6,884       varies    6,552,907       varies  552,296,890   58,545,044\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "* this currently approved icr will be revised to include the burden discussed in this rule.\n",
      "\n",
      "xiii. regulatory impact analysis\n",
      "\n",
      "a. statement of need\n",
      "\n",
      "    as described in detail in section iii. of this rule, the changes to \n",
      "42 cfr parts 422, 431, 438, 457, and 45 cfr part 156 are part of the \n",
      "agency's broader efforts to empower patients by ensuring that they have \n",
      "full access to their own health care data, through common technologies \n",
      "and without special effort, while keeping that information safe and \n",
      "secure. interoperability and the capability for health information \n",
      "systems and software applications to communicate, exchange, and \n",
      "interpret data in a usable and readable format, such as pdf or text, is \n",
      "vital, but allowing access to health care data through pdf and text \n",
      "format also limits the utility and sharing of data. moving to a system \n",
      "in which patients have access to their health care data will help \n",
      "empower them to make informed decisions about their health care, as \n",
      "well as share their data with providers who can assist these patients \n",
      "with their health care. the policies are designed to move medicare, ma, \n",
      "medicaid, chip, and qhp issuers on the ffes further to that ultimate \n",
      "goal of empowering their enrollees. as technology has advanced, we have \n",
      "encouraged states, payers, and providers to adopt various forms of \n",
      "technology to improve the accurate and timely exchange of standardized \n",
      "health care information. the policies in this final rule enable \n",
      "patients to be active partners in the exchange of electronic health \n",
      "care data by easily monitoring or sharing their data.\n",
      "    states and cms routinely exchange data on who is enrolled in \n",
      "medicare, and which parties are liable for paying that beneficiary's \n",
      "parts a and b\n",
      "\n",
      "[[page 25611]]\n",
      "\n",
      "premiums. these ``buy-in'' data exchanges support state, cms, and ssa \n",
      "premium accounting, collections, and enrollment functions. we have \n",
      "become increasingly concerned about the limitations of monthly buy-in \n",
      "data exchanges with states. the relatively long lag in updating buy-in \n",
      "data means that the state is not able to terminate or activate buy-in \n",
      "coverage sooner, so the state or beneficiary may be paying premiums for \n",
      "longer than appropriate. we note that once the data catch up, states \n",
      "and cms reconcile the premiums by recouping and re-billing, so premiums \n",
      "collected are ultimately accurate, but only with an administratively \n",
      "burdensome process involving debits and payments between the \n",
      "beneficiary, state, cms, ssa, and potentially providers. daily buy-in \n",
      "data exchange will reduce this administrative burden.\n",
      "    states submit data on files at least monthly to cms to identify all \n",
      "dually eligible individuals, including full-benefit and partial-benefit \n",
      "dually eligible beneficiaries (that is, those who get medicaid help \n",
      "with medicare premiums, and often for cost-sharing). the mma file was \n",
      "originally developed to meet the need to timely identify dually \n",
      "eligible beneficiaries for the then-new medicare part d prescription \n",
      "drug benefit. over time, we use these files' data on dual eligibility \n",
      "status to support part c capitation risk-adjustment, and most recently, \n",
      "feeding dual eligibility status to part a and b eligibility and claims \n",
      "processing systems so providers, suppliers, and beneficiaries have \n",
      "accurate information on beneficiary cost-sharing obligations. as cms \n",
      "now utilizes mma data on dual eligibility status in systems supporting \n",
      "all four parts of the medicare program, it is becoming even more \n",
      "essential that dual eligibility status is accurate and up-to-date. dual \n",
      "eligibility status can change at any time in a month. waiting up to a \n",
      "month for status updates can negatively impact access to the correct \n",
      "level of benefit at the correct level of payment. as described in \n",
      "detail in section vii. of this rule, the changes to 42 cfr parts 406, \n",
      "407, and 423 establish frequency requirements that necessitate all \n",
      "states to participate in daily exchange of buy-in data, and updates \n",
      "frequency requirements to require all states to participate in daily \n",
      "exchange of mma file data, with cms by april 1, 2022.\n",
      "\n",
      "b. overall impact\n",
      "\n",
      "    we have examined the impacts of this final rule as required by \n",
      "executive order 12866 on regulatory planning and review (september 30, \n",
      "1993), executive order 13563 on improving regulation and regulatory \n",
      "review (january 18, 2011), the regulatory flexibility act (rfa) \n",
      "(september 19, 1980, pub. l. 96-354), section 1102(b) of the social \n",
      "security act, section 202 of the unfunded mandates reform act of 1995 \n",
      "(march 22, 1995; pub. l. 104-4), executive order 13132 on federalism \n",
      "(august 4, 1999), the congressional review act (5 u.s.c. 804(2)), and \n",
      "executive order 13771 on reducing regulation and controlling regulatory \n",
      "costs (january 30, 2017).\n",
      "    executive orders 12866 and 13563 direct agencies to assess all \n",
      "costs and benefits of available regulatory alternatives and, if \n",
      "regulation is necessary, to select regulatory approaches that maximize \n",
      "net benefits (including potential economic, environmental, public \n",
      "health and safety effects, distributive impacts, and equity). section \n",
      "3(f) of executive order 12866 defines a ``significant regulatory \n",
      "action'' as an action that is likely to result in a rule: (1) having an \n",
      "annual effect on the economy of $100 million or more in any 1 year, or \n",
      "adversely and materially affecting a sector of the economy, \n",
      "productivity, competition, jobs, the environment, public health or \n",
      "safety, or state, local or tribal governments or communities (also \n",
      "referred to as ``economically significant''); (2) creating a serious \n",
      "inconsistency or otherwise interfering with an action taken or planned \n",
      "by another agency; (3) materially altering the budgetary impacts of \n",
      "entitlement grants, user fees, or loan programs or the rights and \n",
      "obligations of recipients thereof; or (4) raising novel legal or policy \n",
      "issues arising out of legal mandates, the president's priorities, or \n",
      "the principles set forth in the executive order.\n",
      "    a regulatory impact analysis (ria) must be prepared for major rules \n",
      "with economically significant effects ($100 million or more in any 1 \n",
      "year). we estimate that this rulemaking is ``economically significant'' \n",
      "as measured by the $100 million threshold, and hence also a major rule \n",
      "under the congressional review act. accordingly, we have prepared an \n",
      "ria that to the best of our ability presents the costs and benefits of \n",
      "the rulemaking. table 5 summarizes the estimated costs presented in \n",
      "section xii. of this final rule.\n",
      "    in the proposed rule, we provided detailed estimations of the \n",
      "required labor categories and number of hours required to implement \n",
      "standards-based apis (84 fr 7659). we originally estimated a one-time \n",
      "burden of $789,356 per organization or state, per implementation, with \n",
      "an ongoing maintenance cost $158,359.80 per organization or state (84 \n",
      "fr 7659). as we detailed in section xii., to account for additional \n",
      "information commenters presented regarding our costs estimates, we are \n",
      "adjusting our original cost estimates to reflect a range, instead of a \n",
      "point estimate. our original estimate for the initial one-time cost to \n",
      "implement the api requirements of this final rule of $788,414 per \n",
      "organization will now serve as a minimum estimate. we have increased \n",
      "our primary cost estimate by a factor of 2 to an initial one-time cost \n",
      "of $1,576,829 per organization or state. additionally, we are \n",
      "increasing our original cost estimate by a factor of 3 for an initial \n",
      "one-time cost of $2,365,243 per organization or state to serve as a \n",
      "high estimate (detailed cost estimates are located in table 5).\n",
      "    table 5 reflects updated wages for 2018, the latest available from \n",
      "the bureau of labor statistics (bls) website; the cms interoperability \n",
      "and patient access proposed rule used 2017 wage estimates. \n",
      "nevertheless, the change in total impact was small. we note that \n",
      "estimates below do not account for enrollment growth or higher costs \n",
      "associated with medical care. this is because the cost of requirements \n",
      "to implement patient access through apis and for states to comply with \n",
      "data exchange requirements are not impacted by enrollment growth or \n",
      "higher costs associated with medical care. per omb guidelines, the \n",
      "projected estimates are expressed in constant-year dollars (in this \n",
      "case, using 2018 prices and wages).\n",
      "    table 5 forms the basis for allocating costs by year and program to \n",
      "the federal government, state medicaid agencies, and parent \n",
      "organizations.\n",
      "\n",
      "[[page 25612]]\n",
      "\n",
      "\n",
      "\n",
      "                                             table 5--estimated costs (millions) of final rule by provision\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "             provision                  dual        patient\n",
      "-----------------------------------   eligible     access api\n",
      "                                        care          (low\n",
      "                                    coordination   estimate)\n",
      "                                   ---------------------------\n",
      "                                                      sec.                                                                                    percent of\n",
      "                                                    422.119,                                                                     months in     25 month\n",
      "                                                      sec.       patient      patient     total cost   total cost   total cost    year for    window for\n",
      "                                        sec.        431.60,     access api   access api      (low       (primary      (high      compliance   compliance\n",
      "          regulatory text           406.26, sec.      sec.       (primary      (high      estimate)    estimate)    estimate)     for dual    with dual\n",
      "                                        407.40,     438.242,    estimate)    estimate)                                            eligible     eligible\n",
      "                                        sec.          sec.                                                                       provisions   provisions\n",
      "                                       423.910      457.730,\n",
      "                                                      sec.\n",
      "                                                    457.123,\n",
      "                                                      sec.\n",
      "                                                    156.221\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "2020..............................           2.8        272.0        544.0        816.0        274.8        546.8        818.8           10           40\n",
      "2021..............................           3.4         54.4         54.4         54.4         57.8         57.8         57.8           12           48\n",
      "2022..............................           0.8         54.4         54.4         54.4         55.2         55.2         55.2            3           12\n",
      "2023..............................           0.0         54.4         54.4         54.4         54.4         54.4         54.4  ...........  ...........\n",
      "2024..............................             0         54.4         54.4         54.4         54.4         54.4         54.4  ...........  ...........\n",
      "2025..............................           0.0         54.4         54.4         54.4         54.4         54.4         54.4  ...........  ...........\n",
      "2026..............................           0.0         54.4         54.4         54.4         54.4         54.4         54.4  ...........  ...........\n",
      "2027..............................           0.0         54.4         54.4         54.4         54.4         54.4         54.4  ...........  ...........\n",
      "2028..............................           0.0         54.4         54.4         54.4         54.4         54.4         54.4  ...........  ...........\n",
      "2029..............................           0.0         54.4         54.4         54.4         54.4         54.4         54.4  ...........  ...........\n",
      "                                   ---------------------------------------------------------------------------------------------------------------------\n",
      "    total.........................           7.0        761.5       1033.5       1305.5        768.5       1040.5       1312.5         25.0          100\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "note: totals may not equal sum of parts due to rounding.\n",
      "\n",
      "    allocation of cost impact by payer: as stated in section xii. of \n",
      "this final rule, cost estimates have been aggregated at the parent \n",
      "organization level because we believe that an organization that offers \n",
      "qhps on the ffes, medicare, medicaid, and chip products would create \n",
      "one system that would be used by all ``plans'' to whom it offers access \n",
      "to data via apis. we note that due to the implementation of apis across \n",
      "multiple business lines, there is no straightforward method to \n",
      "immediately estimate parent organization expenditures on how much of \n",
      "the cost is born by each payer. although this section provides such \n",
      "estimates it is important to understand how they are arrived at. a \n",
      "summary by table in this section is provided in table 6. as shown in \n",
      "table 6:\n",
      "    <bullet> we first ascertain total costs of implementing this final \n",
      "rule by provision in (table 5);\n",
      "    <bullet> as indicated earlier, we have no straightforward way of \n",
      "ascertaining total costs by payer since we do not have internal data \n",
      "for each parent organization on how it allocates costs by program;\n",
      "    <bullet> therefore, to approximate costs we developed approximated \n",
      "proportions of total cost of each parent organization by payer \n",
      "(medicare, medicaid, chip, and individual market, including individual \n",
      "market plans sold on and off the exchanges, as we expect that, among \n",
      "parent organizations of issuers that offer qhps on the ffes, costs will \n",
      "be passed on through all plans the issuers offer in the individual \n",
      "market. since this rule does not apply to qhp issuers offering qhps \n",
      "only on federally-facilitated small business health options program \n",
      "exchanges (ff-shops) they were not included in our analysis.\n",
      "    <bullet> our use of available data includes many approximations due \n",
      "to data limitations discussed in detail below (table 7);\n",
      "    <bullet> table 7 then allows us to obtain proportions of total \n",
      "costs for this final rule by payer (table 8);\n",
      "    <bullet> since we know the way federal payments for both medicare \n",
      "and medicaid are calculated, we can then obtain total costs by payer \n",
      "incurred by the federal government (table 9);\n",
      "    <bullet> we next subtracted federal payments by payer (table 9) \n",
      "from total costs by payer (table 8) to obtain the non-federal costs of \n",
      "this final rule by payer (table 10);\n",
      "    <bullet> table 11 presents the same data as table 10; table 10 \n",
      "presents total non-federal costs per payer, while table 11 presents \n",
      "average non-federal costs per enrollee per payer;\n",
      "    <bullet> table 12 presents the same data as table 9; while table 9 \n",
      "presents total costs to the federal government by payer, table 12 \n",
      "presents average federal costs per enrollee by payer; and\n",
      "    <bullet> table 13 lists potential means for payers to deal with new \n",
      "costs.\n",
      "\n",
      " table 6--outline of the flow of logic by table for this impact analysis\n",
      "------------------------------------------------------------------------\n",
      "            table               content of table      comments on table\n",
      "------------------------------------------------------------------------\n",
      "5...........................  total costs by        costs are fully\n",
      "                               provision (api,       developed in the\n",
      "                               dual).                collection of\n",
      "                                                     information section\n",
      "                                                     of this final rule\n",
      "                                                     (section xii. of\n",
      "                                                     this final rule).\n",
      "7...........................  proportion of         there is no\n",
      "                               premiums by program   straightforward way\n",
      "                               (2016-2018) used,     to directly assess\n",
      "                               in later tables, as   parent organization\n",
      "                               a proxy for           cost by payer.\n",
      "                               proportion of cost    therefore, for each\n",
      "                               by program.           payer we develop\n",
      "                                                     approximate\n",
      "                                                     percentages of cost\n",
      "                                                     per payer.\n",
      "8...........................  api costs total cost  we obtain the total\n",
      "                               by year and program   api costs for this\n",
      "                               (medicare,            final rule per\n",
      "                               medicaid,             program by\n",
      "                               individual market     multiplying the api\n",
      "                               plans, and chip).     costs (for all\n",
      "                               this total cost is    programs) of this\n",
      "                               divided by cost to    final rule (table\n",
      "                               the federal           5) by the\n",
      "                               government (table     proportion of\n",
      "                               9) and non-federal    premiums presented\n",
      "                               costs to plans and    in table 7.\n",
      "                               enrollees (table\n",
      "                               10).\n",
      "\n",
      "[[page 25613]]\n",
      "\n",
      " \n",
      "9...........................  total costs incurred  based on how federal\n",
      "                               by the federal        payments are\n",
      "                               government by         calculated in\n",
      "                               program and year.     medicare and\n",
      "                                                     medicaid, we have\n",
      "                                                     projected federal\n",
      "                                                     proportions of the\n",
      "                                                     total cost and\n",
      "                                                     these are applied\n",
      "                                                     to table 8 to\n",
      "                                                     obtain table 9.\n",
      "10..........................  non-federal total     table 9 = table 8-\n",
      "                               costs for api by      table 10--non-\n",
      "                               program by year.      federal costs are\n",
      "                                                     obtained by\n",
      "                                                     subtracting federal\n",
      "                                                     costs (table 9)\n",
      "                                                     from total costs\n",
      "                                                     (table 8).\n",
      "11..........................  average non-federal   tables 11 and 10\n",
      "                               cost per enrollee     present the same\n",
      "                               per year by program   data in different\n",
      "                               for plans.            forms. table 10\n",
      "                                                     presents total non-\n",
      "                                                     federal cost by\n",
      "                                                     program for states\n",
      "                                                     and plans, while\n",
      "                                                     table 11 presents\n",
      "                                                     average non-federal\n",
      "                                                     costs per enrollee\n",
      "                                                     per year for states\n",
      "                                                     and plans.\n",
      "12..........................  average federal cost  tables 12 and 9\n",
      "                               per enrollee per      present the same\n",
      "                               year by program for   data in different\n",
      "                               the federal           forms. table 9\n",
      "                               government.           presents total cost\n",
      "                                                     to the federal\n",
      "                                                     government (due to\n",
      "                                                     matching programs),\n",
      "                                                     while table 12\n",
      "                                                     presents average\n",
      "                                                     cost per enrollee\n",
      "                                                     to the federal\n",
      "                                                     government.\n",
      "13..........................  how payers would      this table lists\n",
      "                               defray the            potential means for\n",
      "                               remaining costs.      a plan to deal with\n",
      "                                                     extra costs. we\n",
      "                                                     have no way of\n",
      "                                                     predicting what\n",
      "                                                     will actually\n",
      "                                                     happen.\n",
      "------------------------------------------------------------------------\n",
      "\n",
      "    preliminary estimates: this section provides several detailed \n",
      "estimates of cost by payer (table 7); we also account for federal \n",
      "matching for medicaid and payments by the trust fund for medicare \n",
      "advantage organizations (table 9); we indicate remaining burden on \n",
      "plans (tables 10, 11) and how they might account for it (table 12). \n",
      "however, these estimates are approximate as explained in detail below.\n",
      "    data sources for cost by payer: to obtain allocation of cost by \n",
      "payer we used the cms public use files for mlr data, for 2016.\\69\\ the \n",
      "mlr data sets are for private insurance plans but the issuers of that \n",
      "private insurance in many cases also have contracts to provide ma, \n",
      "medicaid, and chip managed care plans and report revenue, expense, and \n",
      "enrollment data for these plans on the private insurance mlr reporting \n",
      "form.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\69\\ center for consumer information and insurance oversight. \n",
      "(n.d.). medical loss ratio data and system resources. retrieved from \n",
      "<a href=\"https://www.cms.gov/cciio/resources/data-resources/mlr.html\">https://www.cms.gov/cciio/resources/data-resources/mlr.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    thus, these mlr data sets omit organizations that only have \n",
      "medicare or medicaid. the data from the cms mlr files also omit: (1) \n",
      "the chip program; and (2) state medicaid agencies. we now discuss these \n",
      "omissions to assess the accuracy of using these mlr files.\n",
      "    chip: eighty-five percent of the 194 chip managed care plans also \n",
      "offer medicaid and hence are covered by the parent entity. we believe \n",
      "it reasonable that the remaining chip plans also have commercial \n",
      "offerings since it would be inefficient to operate a chip-only plan, as \n",
      "the total national chip enrollment is currently only about 7 million. \n",
      "similarly, except for one state, chip programs are run through the \n",
      "state medicaid agency; again, there would be one interoperability cost \n",
      "for the one state agency since the resulting software and systems would \n",
      "be used both for medicaid and chip. thus, while we are leaving out chip \n",
      "programs in this analysis since they are not in the cms mlr files, we \n",
      "do not believe this materially alters the overall picture.\n",
      "    medicare advantage: we compared the cms mlr files with the cms \n",
      "trustee report.\\70\\ according to the trustee report (table iv.c2), \n",
      "total ma revenue for 2016 was $189.1 billion. thus, the reported amount \n",
      "in the cms mlr files of $157 billion for ma represents 83 percent (157/\n",
      "189.1) of all ma activity reflected in the trustee report. therefore, \n",
      "we believe the proportions obtained from these mlr files are accurate.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\70\\ see table iv.c2 in, boards of trustees (federal hospital \n",
      "insurance and federal supplementary medical insurance trust funds). \n",
      "(2018, june 5). the 2018 annual report of the boards of trustees of \n",
      "the federal hospital insurance and federal supplementary medical \n",
      "insurance trust funds. retrieved from <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2018.pdf\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2018.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    medicaid: for the year for which these mlr files provide data \n",
      "(2016), about 70 percent of medicaid enrollees were enrolled in \n",
      "medicaid managed care.\\71\\ thus, although the mlr files omit state \n",
      "agencies, we believe that the 70 percent of medicaid enrollees enrolled \n",
      "in medicaid managed care provides a good approximation.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\71\\ centers for medicare and medicaid services. (2018, november \n",
      "8). cms proposes changes to streamline and strengthen medicaid and \n",
      "chip managed care regulations. retrieved from <a href=\"https://www.cms.gov/newsroom/press-releases/cms-proposes-changes-streamline-and-strengthen-medicaid-and-chip-managed-care-regulations\">https://www.cms.gov/newsroom/press-releases/cms-proposes-changes-streamline-and-strengthen-medicaid-and-chip-managed-care-regulations</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    individual and small group market plans: the mlr files contain data \n",
      "on all commercial parent organizations whether these organizations have \n",
      "other lines of business, such as medicare advantage or medicaid, or \n",
      "not. in discussing commercial plans, we account for: (a) large group \n",
      "market plans; (b) small group market plans, including shop plans; (c) \n",
      "individual market exchange plans; and (d) individual market off-\n",
      "exchange plans.\n",
      "    <bullet> we have carved out the large employer plans since the \n",
      "provisions of this final rule do not apply to them, and we do not \n",
      "believe that parent organizations would pass on costs for individual \n",
      "and small group market plans to large group employer-sponsored plans.\n",
      "    <bullet> we have noted that the provisions of this final rule do \n",
      "not apply to qhp issuers offering qhps only on ff-shops, so we are not \n",
      "including small group market plans in this analysis.\n",
      "    <bullet> we believe it is reasonable, that even though the \n",
      "provisions of this final rule do not apply to off-exchange individual \n",
      "market plans, issuers subject to this rule offering qhps on the ffes \n",
      "will spread the cost to all plans issuers offer in the individual \n",
      "market. they will also likely offer the benefits of the apis to all \n",
      "covered lives, as they can be marketed as a value add service, and it \n",
      "is logistically more challenging to offer a service to only a limited \n",
      "number of enrollees.\n",
      "    <bullet> we estimate that off-exchange plans offered by issuers who \n",
      "offer no qhps on\n",
      "\n",
      "[[page 25614]]\n",
      "\n",
      "ffes are about 7 percent of total individual market enrollment. \n",
      "therefore, to the extent that we are including off-exchange plans, the \n",
      "calculations below will be an approximation, but given this low \n",
      "proportion of off-exchange-only issuers, we do not believe including \n",
      "them in this approximation will have a major impact.\n",
      "    best estimates of impact per program and payer: we present two \n",
      "methods to obtain an estimate of cost by program and payer, both for \n",
      "purposes of assessing impact on: (1) small entities; (2) the federal \n",
      "government; (3) payers (states and plans); and (4) enrollees. we could \n",
      "assume costs proportional to current enrollment, or alternatively, we \n",
      "could assume costs proportional to total premium. for purposes of \n",
      "analyzing impact on small entities and impacts of the provision on the \n",
      "federal government, payers, plans, and enrollees we are using the \n",
      "method of assuming costs proportional to total premium (the method of \n",
      "assuming costs proportional to current enrollment will be used below to \n",
      "assess impact on transfers to enrollees).\n",
      "    the cms interoperability and patient access proposed rule used 2016 \n",
      "cms mlr files (84 fr 7662). since its publication, 2017 and 2018 data \n",
      "have become available. however, we are only using these data to obtain \n",
      "proportions and, as table 7 shows, the proportions for premiums have \n",
      "not changed significantly (only one quarter to one third percent for \n",
      "medicare and medicaid). therefore, we retain and continue to use the \n",
      "2016 proportions for purposes of this analysis with a note that they \n",
      "generally have remained constant. these proportions of premiums are \n",
      "being used as a proxy to approximate total cost.\n",
      "    in the proposed rule we used the full $370 billion in commercial \n",
      "premium in determining our proportions (84 fr 7662). as discussed \n",
      "above, we are revising the estimates because upon further \n",
      "consideration, we have concluded that issuers in the commercial group \n",
      "markets are unlikely to spread the costs through increasing premium \n",
      "rates on those types of plans because issuers are not required to \n",
      "implement and maintain the api requirements of this final rule in the \n",
      "group markets and there are no indications that employer groups in \n",
      "these markets would be willing to pay for this provision through \n",
      "increased premium rates. consequently, the $370 billion commercial \n",
      "premium is being reduced to $77 billion and the 76 million enrollees \n",
      "are being reduced to 17.5 million.\n",
      "    as discussed above, the $370 billion (and 76 million enrollees) \n",
      "represented both individual and small group and large group market \n",
      "plans; the $77 billion and 17.5 million enrollees represent all \n",
      "individual market plans whether they are sold on and/or off-exchange. \n",
      "we note that this reduction from our original estimate is due to the \n",
      "fact that most plans are large employer plans, and the individual \n",
      "market is only 20 to 23 percent of the full health insurance market. \n",
      "this refinement better aligns with the proportion of the market \n",
      "impacted by this final rule.\n",
      "    among issuers with products in both the individual market and ma or \n",
      "the individual market and medicaid, the 2016 cms mlr files show $77 \n",
      "billion reported in premium for individual market plans, $157 billion \n",
      "reported for ma, and $113 billion reported for medicaid. consequently, \n",
      "the proportion of interoperability cost for each of the programs is \n",
      "22.19 percent (77/(77+157+113)), 45.24 percent (157/(77+157+113)), and \n",
      "32.56 percent (113/(77+157+113)) for individual market plans, ma, and \n",
      "medicaid respectively. table 7 shows similar proportions for 2017 and \n",
      "2018.\n",
      "\n",
      "        table 7--proportion of premiums (in billions) for medicare, medicaid, and individual market plans\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                     medicare       individual\n",
      "                      year                           medicaid        advantage     market plans       totals\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "2016 premium (billions).........................             113             157              77             347\n",
      "2017 premium (billions).........................           119.5           170.3              86             376\n",
      "2018 premium (billions).........................             127             184              91             402\n",
      "2016 percentage (used in this ria in all                  32.56%          45.24%          22.19%         100.00%\n",
      " estimates) of total costs by program...........\n",
      "2017 percentage.................................          31.78%          45.29%          22.93%         100.00%\n",
      "2018 percentage.................................          31.62%          45.81%          22.56%         100.00%\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    as indicated earlier, since cost allocation at the parent \n",
      "organization level and the allocations of each parent organization may \n",
      "differ by program (medicare, medicaid, chip, and individual market \n",
      "plans) and is an internal business decision, we cannot directly assess \n",
      "per-payer costs. however, using the mlr tables, we can assess the \n",
      "proportions of cost by program. we can then multiply these proportions \n",
      "(as presented in table 7) by the total costs of this final rule as \n",
      "presented in table 5 to obtain table 8, which breaks out the total \n",
      "column in table 5, the total cost by year of implementing and \n",
      "maintaining the api, to offer api costs by year and program.\n",
      "\n",
      "                              table 8--api costs (in millions) by year and program\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                full\n",
      "                                           implementation\n",
      "                                           and maintenance     individual                           medicare\n",
      "                  year                    costs (millions)    market plans      medicaid and        advantage\n",
      "                                           (from table 5)       (22.19%)        chip (32.56%)       (45.24%)\n",
      "                                               for api\n",
      "                                              provision\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "2020 (low estimate).....................             272.0              60.4              88.6             123.1\n",
      "2020 (primary estimate).................             544.0             120.7             177.2             246.1\n",
      "2020 (high estimate)....................             816.0             181.1             265.7             369.2\n",
      "2021....................................              54.4              12.1              17.7              24.6\n",
      "2022....................................              54.4              12.1              17.7              24.6\n",
      "\n",
      "[[page 25615]]\n",
      "\n",
      " \n",
      "2023....................................              54.4              12.1              17.7              24.6\n",
      "2024....................................              54.4              12.1              17.7              24.6\n",
      "2025....................................              54.4              12.1              17.7              24.6\n",
      "2026....................................              54.4              12.1              17.7              24.6\n",
      "2027....................................              54.4              12.1              17.7              24.6\n",
      "2028....................................              54.4              12.1              17.7              24.6\n",
      "2029....................................              54.4              12.1              17.7              24.6\n",
      "                                         -----------------------------------------------------------------------\n",
      "    total (low estimate)................             761.5             169.0             248.0             344.6\n",
      "    total (primary estimate)............            1033.5             229.3             336.6             467.6\n",
      "    total (high estimate)...............            1305.5             289.7             425.1             590.7\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "methods of bearing cost by payer\n",
      "\n",
      "    qhps on the ffes: individual market plans have the option to deal \n",
      "with increased costs by either temporarily absorbing them (for purposes \n",
      "of market competitiveness), increasing premiums to enrollees, or \n",
      "reducing non-essential health benefits. to the extent that issuers \n",
      "increase premiums for individual market plans on the ffes, there would \n",
      "be federal premium tax credit (ptc) impacts. the purpose of the ptc is \n",
      "to assist enrollees in paying premium costs. since ptcs are only \n",
      "available if an individual purchases an individual market plan on an \n",
      "exchange, the ptc estimates apply only to exchange plans. in the ptc \n",
      "estimate, we have accounted for the fact that some issuers have both \n",
      "exchange and non-exchange plans, and some issuers have only non-\n",
      "exchange plans. we reflected these assumptions with global adjustments, \n",
      "so we believe the estimates are reasonable in aggregate.\n",
      "    medicare advantage: ma organizations may increase bids to reflect \n",
      "the costs of this final rule. some of these expected increased bid \n",
      "costs may increase medicare trust fund payments. for those (most) ma \n",
      "organizations whose bid amount is below the benchmark, the trust fund \n",
      "provides total expenditures to the ma organizations consisting of: (1) \n",
      "full payment of the bid amount; and (2) the rebate, a portion of the \n",
      "difference between the benchmark and the bid amount. since ma \n",
      "organizations are increasing their bid amounts to reflect the costs of \n",
      "this final rule, it follows that the rebate, equaling the difference \n",
      "between the benchmark and bid, is decreased, resulting in less rebates \n",
      "paid to the ma organizations. based on our past experience and \n",
      "projections for the future, the rebate is estimated as 34 percent of \n",
      "the difference between benchmark and bid. thus, although the trust fund \n",
      "pays the bid in full, nevertheless, 66 percent of the increased bid \n",
      "costs arising from this final rule, are reduced from the rebates. the \n",
      "ma organizations in its submitted bid, can address this reduction of \n",
      "rebates by either: (1) temporarily, for marketing purposes, absorbing \n",
      "the loss by reducing its profit margin; (2) reducing the supplemental \n",
      "benefits it provides the enrollee paid for by the rebate; or (3) \n",
      "raising enrollee premiums in order to provide supplemental benefits for \n",
      "which premiums are not paid by the rebate. the decision of what \n",
      "approach to use is an internal business decision in part motivated by \n",
      "unforeseen forces of marketing; we therefore have no way of predicting \n",
      "what will happen.\n",
      "    medicaid: state medicaid agencies may be allowed to allocate the \n",
      "costs of state information retrieval systems between the costs \n",
      "attributable to design, development, installation, or enhancement of \n",
      "the system--at a 90 percent federal match--and for ongoing operations \n",
      "of the system--at a 75 percent federal match.\n",
      "    for medicaid managed care entities, we assume an mco, pihp, and \n",
      "pahp cost for implementing the standards-based api provisions would be \n",
      "built into the capitation rates and paid for by the state medicaid \n",
      "agency, with the state medicaid agency being reimbursed at the state's \n",
      "medical assistance match rate. for purposes of these estimates we use \n",
      "the weighted fmap, 58.44, which is based on our past experience with \n",
      "this program.\n",
      "    medicaid managed care costs constitute 52 percent of the medicaid \n",
      "program costs.\\72\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\72\\ allen, k. (2019, april 18). medicaid managed care spending \n",
      "in 2018. retrieved from <a href=\"https://www.healthmanagement.com/blog/medicaid-managed-care-spending-in-2018/\">https://www.healthmanagement.com/blog/medicaid-managed-care-spending-in-2018/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    consequently, for the first year (implementation year), the federal \n",
      "matching is (0.48*0.90+0.52*0.5844) of the total program costs, \n",
      "reflecting the 90 percent first year implementation matching for state \n",
      "agencies which comprise 48 percent of the program cost plus 58.44 \n",
      "percent matching for the medicaid managed care plans which comprise 52 \n",
      "percent of the program costs. similarly, for years after the first the \n",
      "federal costs are (0.48*0.75+0.52*0.5844) of total program costs.\n",
      "    chip: most states operate medicaid and chip from the same state \n",
      "agency. one state is a notable exception in that it has a separate \n",
      "medicaid and chip agency. the federal government pays an enhanced \n",
      "federal medical assistance percentage (efmap) to states for all costs \n",
      "associated with chip, including systems costs (this is unlike medicaid \n",
      "where there are different fmaps for different types of costs). for \n",
      "federal fy 2019, the efmaps will range from 88 to 100 percent. for \n",
      "federal fy 2020, the efmaps will range from approximately 76.5 to 93 \n",
      "percent. after federal fy 2020, the efmaps will range from \n",
      "approximately 65 to 81.5 percent. since the chip program federal rebate \n",
      "ranges include the 90 percent and 75 percent federal matching \n",
      "proportions of the medicaid program, we are applying the 90 percent and \n",
      "75 percent from medicaid to the chip programs. since the chip program \n",
      "is small relative to the medicaid program, we believe this approach \n",
      "reasonable.\n",
      "    table 9 uses these proportions to estimate the impact of the api on \n",
      "the federal government. for example, the $65.2 million cost to the \n",
      "federal government for medicaid/chip for 2020\n",
      "\n",
      "[[page 25616]]\n",
      "\n",
      "(low estimate), the implementation year of the api, is obtained by \n",
      "multiplying the total $88.6 million (low estimate) cost listed in table \n",
      "8 by (0.48*0.90+0.52*0.5844) the ratio indicated in the previous \n",
      "paragraphs.\n",
      "    these assumptions on all first-year federal expenses are reflected \n",
      "in table 9 which includes ptc payments as well as federal matching in \n",
      "medicaid and medicare. for ptc and medicare we have assumed federal \n",
      "payment in 2021. we note that we are not discussing at this point how \n",
      "parent organizations will bear these costs. this will be discussed \n",
      "below. however, the basis for the discussion is the calculation of non-\n",
      "federal cost born by enrollees and plans which is obtained by \n",
      "subtracting federal costs from total costs.\n",
      "\n",
      "                         table 9--costs incurred by federal government program and year\n",
      "                                                  [in millions]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                  for individual   for medicaid    for medicare\n",
      "                              year                                 market plans        chip          advantage\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "2020 (low estimate).............................................             0.0            65.2             0.0\n",
      "2020 (primary estimate).........................................             0.0           130.4             0.0\n",
      "2020 (high estimate)............................................             0.0           195.5             0.0\n",
      "2021 (low estimate).............................................             6.1            11.8            50.2\n",
      "2021 (primary estimate).........................................             6.1            11.8            92.1\n",
      "2022 (high estimate)............................................             6.1            11.8           133.9\n",
      "2022............................................................             6.2            11.8             8.4\n",
      "2023............................................................             6.2            11.8             8.4\n",
      "2024............................................................             6.3            11.8             8.4\n",
      "2025............................................................             6.3            11.8             8.4\n",
      "2026............................................................             6.3            11.8             8.4\n",
      "2027............................................................             6.3            11.8             8.4\n",
      "2028............................................................             6.3            11.8             8.4\n",
      "2029............................................................             6.4            11.8             8.4\n",
      "                                                                 -----------------------------------------------\n",
      "    total (low estimate)........................................            56.4           171.0           117.1\n",
      "                                                                 -----------------------------------------------\n",
      "    total (primary estimate)....................................            56.4           236.2           159.0\n",
      "                                                                 -----------------------------------------------\n",
      "    total (high estimate).......................................            56.4           301.4           200.8\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "note: the following percentages were applied to table 8 to obtain table 9: 0 percent for individual market\n",
      "  plans, 34 percent for medicare advantage plans and 0.48*0.90+0.52*0.5844 (1st year) and 0.48*0.75+0.52*0.5844\n",
      "  (later years) for medicaid. furthermore, as discussed above, federal payments to medicare advantage for\n",
      "  implementation occurs fully in 2021.\n",
      "\n",
      "    by taking the difference between the respective cells in tables 8 \n",
      "(total costs by program) and 9 (total matching by the federal \n",
      "government), we obtain the remaining costs for the api for medicare \n",
      "advantage plans and for state medicaid agencies. to this amount (which \n",
      "only deals with the api provisions) must be added the coordination cost \n",
      "for the dual eligible (column 3 of table 5) multiplied by the \n",
      "proportion of costs presented in table 7. this remaining cost born by \n",
      "medicare advantage plans and state medicaid agencies is presented in \n",
      "table 10. since the federal government does not match qhp costs, the \n",
      "total cost for qhps on the ffes is born in its entirety by the plans. \n",
      "this also is listed in table 10; however, in subtracting table 9 from \n",
      "table 8, we exclude ptc costs. these are federal costs, but unlike \n",
      "medicare advantage and medicaid, the qhps on the ffes must account for \n",
      "the full cost of implementation. these ptc costs are not used to defray \n",
      "api costs.\n",
      "    for example, table 10 lists for 2020 (low estimate), medicaid/chip \n",
      "a remaining cost to states of $24.3 million ($88.6 million total (low \n",
      "estimate) cost for 2020 (table 8)-$65.2 million matched by the federal \n",
      "government (table 9) + ($2.8 million total cost for coordination of \n",
      "dual eligibles (table 5) * 32.56 percent (proportion of total costs \n",
      "incurred by medicaid/chip (table 7)). (there are minor differences due \n",
      "to rounding.)\n",
      "\n",
      "                              table 10--remaining costs by program for api by year\n",
      "                                                  [in millions]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                  for individual   for medicaid/   for medicare\n",
      "                              year                                  market plans       chip          advantage\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "2020 (low estimate).............................................            61.0            24.3           124.3\n",
      "2020 (primary estimate).........................................           121.3            47.7           247.4\n",
      "2020 (high estimate)............................................           181.7            71.1           370.1\n",
      "2021 (low estimate).............................................            12.8             7.0           -24.1\n",
      "2021(primary estimate)..........................................            12.8             7.0           -65.9\n",
      "2021 (high estimate)............................................            12.8             7.0          -107.8\n",
      "2022............................................................            12.3             6.2            16.6\n",
      "2023............................................................            12.1             6.0            16.2\n",
      "2024............................................................            12.1             6.0            16.2\n",
      "2025............................................................            12.1             6.0            16.2\n",
      "2026............................................................            12.1             6.0            16.2\n",
      "2027............................................................            12.1             6.0            16.2\n",
      "2028............................................................            12.1             6.0            16.2\n",
      "\n",
      "[[page 25617]]\n",
      "\n",
      " \n",
      "2029............................................................            12.1             6.0            16.2\n",
      "                                                                 -----------------------------------------------\n",
      "    total (low estimate)........................................           170.5            79.3           230.6\n",
      "                                                                 -----------------------------------------------\n",
      "    total (primary estimate)....................................           230.9           102.6           311.8\n",
      "                                                                 -----------------------------------------------\n",
      "    total (high estimate).......................................           291.3           126.0           392.7\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    we next discuss in tables 11 through 13 how payers and the federal \n",
      "government will deal with these extra costs. we also discuss whether \n",
      "the costs are excessive for existing plans as well as how new plans \n",
      "might deal with these costs.\n",
      "    the further discussion of bearing these costs is illustrated by \n",
      "reformulating the costs in terms of costs per enrollee (per year), \n",
      "which is obtained by dividing the total cost to the payer for all \n",
      "programs in which it participates (medicare, medicaid, chip, and \n",
      "individual market plans) by its total enrollment. as an example, if a \n",
      "payer hypothetically spent $1 billion in a year for 100,000 enrollees \n",
      "then the cost per enrollee per year is $10,000 ($1 billion/100,000).\n",
      "    as can be seen from this example, the cost per enrollee metric \n",
      "facilitates comparison of costs. since program expenditures for both \n",
      "medicaid and ma are typically hundreds of millions (or billions) of \n",
      "dollars, concepts like burden and negligibility may not have intuitive \n",
      "meaning, as opposed to the costs per enrollee, which are more \n",
      "manageable and understandable.\n",
      "    to provide background, the 2018 medicare trust fund report \\73\\ \n",
      "states that costs per enrollee are projected to be roughly $12,000--\n",
      "$14,000 for contract years 2020--2023 (table iv.c3). the costs per \n",
      "enrollee for the medicaid program are similarly several thousand \n",
      "dollars. the estimates in the 2019 medicare trust fund report are \n",
      "identical.\\74\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\73\\ boards of trustees (federal hospital insurance and federal \n",
      "supplementary medical insurance trust funds). (2018, june 5). the \n",
      "2018 annual report of the boards of trustees of the federal hospital \n",
      "insurance and federal supplementary medical insurance trust funds. \n",
      "retrieved from <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2018.pdf\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2018.pdf</a>.\n",
      "    \\74\\ see page 154 in, boards of trustees (federal hospital \n",
      "insurance and federal supplementary medical insurance trust funds). \n",
      "(2019, april 22). the 2019 annual report of the boards of trustees \n",
      "of the federal hospital insurance and federal supplementary medical \n",
      "insurance trust funds. retrieved from <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2019.pdf\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/reportstrustfunds/downloads/tr2019.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    for purposes of indicating the cost per enrollee, we estimate 110.5 \n",
      "million enrollees will be affected by these provisions since currently \n",
      "there are 17.5, 66,\\75\\ 20,\\76\\ and 7 \\77\\ million enrollees covered by \n",
      "payers in the individual market, medicaid, ma, and separate chip \n",
      "programs, respectively. table 11 presents costs per enrollee by program \n",
      "for payers after reducing total costs by federal matching, while table \n",
      "12 presents costs per enrollee by program for the federal government.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\75\\ centers for medicare and medicaid services. (n.d.). october \n",
      "2019 medicaid & chip enrollment data highlights. retrieved from \n",
      "<a href=\"https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html\">https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html</a>.\n",
      "    \\76\\ centers for medicare and medicaid services. (n.d.). monthly \n",
      "contract summary report--august 2018. retrieved from <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/monthly-contract-and-enrollment-summary-report-items/contract-summary-2018-08.html?dlpage=1&dlentries=10&dlsort=1&dlsortdir=descending\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/monthly-contract-and-enrollment-summary-report-items/contract-summary-2018-08.html?dlpage=1&dlentries=10&dlsort=1&dlsortdir=descending</a>.\n",
      "    \\77\\ centers for medicare and medicaid services. (n.d.). october \n",
      "2019 medicaid & chip enrollment data highlights. retrieved from \n",
      "<a href=\"https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html\">https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    for example, the 2020 (low estimate) cost per enrollee for \n",
      "commercial individual market plans is $3.48 (table 11), which is \n",
      "obtained by dividing the total, 2020, low-estimate, non-federal, \n",
      "individual market plan cost of $61 million (table 10) by 17.5 million \n",
      "enrollees. (this is based on the low estimate of cost for api; the high \n",
      "estimate of cost would be $10.38 = $181.7 million/17.5 million).\n",
      "    the 2022 cost per enrollee for state medicaid agencies after \n",
      "federal matching is 9 cents per enrollee (table 11), which is obtained \n",
      "by dividing the total non-federal cost per program after federal \n",
      "matching, $6.2 million (table 10) by 73 million enrollees (66 million \n",
      "in medicaid + 7 million in chip). each of these three calculations \n",
      "restates total spending per program per stakeholder (government, state \n",
      "medicaid agencies, or medicare advantage plans) in terms of cost per \n",
      "enrollee.\n",
      "\n",
      "             table 11--average cost per enrollee per year (dollars and cents) by program for payers\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                    individual                       medicare\n",
      "             current enrollment by payer (millions)                market plans      medicaid        advantage\n",
      "                                                                      (17.5)        plans (73)      plans (20)\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "2020 (low estimate).............................................            3.48            0.33            6.22\n",
      "2020 (primary estimate).........................................            6.93            0.65           12.37\n",
      "2020 (high estimate)............................................           10.38            0.97           18.51\n",
      "2021 (low estimate).............................................            0.73            0.10           -1.20\n",
      "2021(primary estimate)..........................................            0.73            0.10           -3.30\n",
      "2021 (high estimate)............................................            0.73            0.10           -5.39\n",
      "2022............................................................            0.70            0.09            0.83\n",
      "2023............................................................            0.69            0.08            0.81\n",
      "2024............................................................            0.69            0.08            0.81\n",
      "2025............................................................            0.69            0.08            0.81\n",
      "\n",
      "[[page 25618]]\n",
      "\n",
      " \n",
      "2026............................................................            0.69            0.08            0.81\n",
      "2027............................................................            0.69            0.08            0.81\n",
      "2028............................................................            0.69            0.08            0.81\n",
      "    2029........................................................            0.69            0.08            0.81\n",
      "                                                                 -----------------------------------------------\n",
      "    total (low estimate)........................................             9.7             1.1            11.5\n",
      "                                                                 -----------------------------------------------\n",
      "    total (primary estimate)....................................            13.2             1.4            15.6\n",
      "                                                                 -----------------------------------------------\n",
      "    total (high estimate).......................................            16.6             1.7            19.6\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "       table 12--average cost per enrollee per year (dollars and cents) by program for federal government\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                    individual                       medicare\n",
      "             current enrollment by payer (millions)                market plans      medicaid        advantage\n",
      "                                                                      (17.5)        plans (73)      plans (20)\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "2020 (low estimate).............................................            0.00            0.89            0.00\n",
      "2020 (primary estimate).........................................            0.00            1.79            0.00\n",
      "2020 (high estimate)............................................            0.00            2.68            0.00\n",
      "2021 (low estimate).............................................            0.35            0.16            2.51\n",
      "2021(primary estimate)..........................................            0.35            0.16            4.60\n",
      "2021 (high estimate)............................................            0.35            0.16            6.69\n",
      "2022............................................................            0.35            0.16            0.42\n",
      "2023............................................................            0.35            0.16            0.42\n",
      "2024............................................................            0.36            0.16            0.42\n",
      "2025............................................................            0.36            0.16            0.42\n",
      "2026............................................................            0.36            0.16            0.42\n",
      "2027............................................................            0.36            0.16            0.42\n",
      "2028............................................................            0.36            0.16            0.42\n",
      "2029............................................................            0.37            0.16            0.42\n",
      "                                                                 -----------------------------------------------\n",
      "    total (low estimate)........................................             3.2             2.3             5.9\n",
      "                                                                 -----------------------------------------------\n",
      "    total (primary estimate)....................................             3.2             3.2             7.9\n",
      "                                                                 -----------------------------------------------\n",
      "    total (high estimate).......................................             3.2             4.1            10.0\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    in table 13, we explain possible ways payers may deal with these \n",
      "extra costs. we emphasize that table 13 lists potential legal \n",
      "possibilities. what actually happens will depend on market dynamics and \n",
      "internal business decisions, and we have no straightforward way of \n",
      "predicting what these actual behaviors and responses will be.\n",
      "    individual market plans: as noted above, individual market plans \n",
      "have the option of absorbing costs or passing costs to enrollees either \n",
      "in the form of higher premiums or reduced benefits that are non-\n",
      "essential health benefits (ehbs). the average estimated cost per \n",
      "enrollee in 2021 through 2028 is under a dollar, which we assume \n",
      "issuers would pass on to enrollees. however, for purposes of market \n",
      "competitiveness, it is possible that some of the 2020 average estimated \n",
      "cost of $3.48 per enrollee (low estimate) or $10.38 per enrollee per \n",
      "year (high estimate) would be absorbed by each qhp issuer on an ffe.\n",
      "    medicaid: state medicaid agencies and chip are adding a cost under \n",
      "10 cents per enrollee for 2021 through 2029. total costs per enrollee \n",
      "for the medicaid program are several thousand dollars. we note, the \n",
      "federal government is incurring costs capped at $2.68 per enrollee per \n",
      "year in 2020 and at 16 cents per enrollee per year in 2021 through \n",
      "2029.\n",
      "    medicare advantage: in their bids (submitted the june prior to the \n",
      "beginning of the coverage year), medicare advantage plans would address \n",
      "the reduced rebates (arising from increased bid costs due to the \n",
      "increased costs of this final rule being included in the bid) by \n",
      "either: (1) temporarily absorbing costs by reducing profit margins; (2) \n",
      "reducing the supplemental benefits paid for by the rebates; or (3) \n",
      "raising enrollee cost sharing or premiums (however, we believe many \n",
      "plans for competitive reasons would chose to remain zero premium and \n",
      "either absorb losses for one year or reduce rebate-funded supplemental \n",
      "benefits in the amount per enrollee shown in table 9). table 13 \n",
      "summarizes these methods of bearing the remaining costs.\n",
      "\n",
      "[[page 25619]]\n",
      "\n",
      "\n",
      "\n",
      "            table 13--how payers would defray remaining costs\n",
      "------------------------------------------------------------------------\n",
      " \n",
      "------------------------------------------------------------------------\n",
      "individual market plans...........  individual market plans generally\n",
      "                                     have the option of absorbing costs\n",
      "                                     (for example, for reasons of market\n",
      "                                     competitiveness), increasing\n",
      "                                     premiums to enrollees, or modifying\n",
      "                                     cost-sharing or non-ehb covered\n",
      "                                     benefits. cost would be spread over\n",
      "                                     all parent organization enrollees\n",
      "                                     in a specified state and the\n",
      "                                     individual market in ffe states.\n",
      "                                     small commercial individual market\n",
      "                                     issuers seeking certification of\n",
      "                                     plans as qhps on the ffes may\n",
      "                                     request an exception to the api\n",
      "                                     provisions.\n",
      "medicaid/chip.....................  state medicaid agencies would bear\n",
      "                                     the cost (under 10 cents per\n",
      "                                     enrollee). medicaid plans are fully\n",
      "                                     capitated but may have to defer\n",
      "                                     first year costs.\n",
      "medicare advantage (ma)...........  ma plans in their june-submitted\n",
      "                                     bids would address the reduced\n",
      "                                     rebates (arising from increased bid\n",
      "                                     costs due to the increased costs of\n",
      "                                     this final rule being included in\n",
      "                                     the bid) by either: (1) temporarily\n",
      "                                     absorbing costs by reducing profit\n",
      "                                     margins; (2) reducing additional\n",
      "                                     benefits paid for by the rebates;\n",
      "                                     or (3) raising enrollee cost\n",
      "                                     sharing (however, many plans for\n",
      "                                     competitive reasons would chose to\n",
      "                                     remain zero premium and either\n",
      "                                     absorb losses for one year or\n",
      "                                     reduce additional, rebate-funded\n",
      "                                     benefits in the amount per enrollee\n",
      "                                     shown in table 9). tax deferment\n",
      "                                     and amortization as applicable\n",
      "                                     ameliorates cost. capital costs are\n",
      "                                     spread over entire parent\n",
      "                                     organization enrollees. new plans\n",
      "                                     are allowed to enter with initial\n",
      "                                     negative margins with the\n",
      "                                     expectation that they will\n",
      "                                     stabilize over the first few years.\n",
      "------------------------------------------------------------------------\n",
      "\n",
      "    ptc impact: first, we note that there will be no impact on the \n",
      "expected 2020 ptc payment because 2020 premium rates were finalized \n",
      "last year, so even if issuers incur expenses that they did not \n",
      "anticipate when setting rates, they will not be able to reflect those \n",
      "expenses in the premium rates, and therefore, the expected ptc payments \n",
      "for 2020 will not change.\n",
      "    table 10 shows that for 2021 through 2029 the estimated impact to \n",
      "qhps on the ffes is a $12 million expense. this estimated $12 million \n",
      "expense burden represents an increase to annual ffe premium of \n",
      "approximately 0.03 percent.\n",
      "    within the ffe states, the estimated expense burden will impact \n",
      "premium rates in the individual market, and is spread across both \n",
      "exchange and non-exchange qhps. ptcs are only paid for qhps offered \n",
      "through exchanges, and are calculated as a function of the second \n",
      "lowest cost silver plan. because of the wide variability of exchange \n",
      "plans we make the simplifying assumption that the industry would \n",
      "increase the second-lowest-cost silver plan premium rate in the same \n",
      "amount as the overall premium rate increase as a result of the ria \n",
      "expense estimate. we can then apply the overall rate increase to the \n",
      "projected ptc payments in the ffe states to estimate the impact to ptc \n",
      "payments.\n",
      "    therefore, we estimate that impact to ptcs in the ffe states will \n",
      "be approximately $6 million per year starting in 2021, which is about \n",
      "0.02 percent of the total 2021 expected ptc payment in ffe states. \n",
      "again, the calculated ptc impacts in 2021 through 2029 are included \n",
      "with all federal impacts in table 9.\n",
      "    we next summarize the public comments we received on our estimated \n",
      "impacts and provide our responses.\n",
      "    comment: some commenters requested that the government share more \n",
      "in the associated costs of the open, standards-based api implementation \n",
      "for both ma and medicaid plans. these commenters noted that additional \n",
      "financial sharing by the federal government would help remedy offsets \n",
      "potentially being absorbed by the health plan that may result in \n",
      "decreased benefits and/or increase premiums.\n",
      "    medicare advantage: some commenters requested that the costs be \n",
      "included in ma bids. other commenters recommended that if cms is going \n",
      "to make specific technological requirements around implementation of \n",
      "the cms interoperability and patient access proposed rule then health \n",
      "plans should be allowed to include a percentage of these costs in their \n",
      "ma bids. one commenter recommended that cms could consider adding a \n",
      "fixed dollar amount to ma bids if health plans complied with the \n",
      "requirements of the proposed rule, or cms could add it into the bid \n",
      "tool.\n",
      "    medicaid: similar comments were made for medicaid plans. one \n",
      "commenter recommended that cms provide states with a 100 percent \n",
      "federal matching to facilitate implementation and that state medicaid \n",
      "agencies be required to include plan implementation costs into \n",
      "capitation rates. another commenter requested that cms require state \n",
      "medicaid agencies to include a fixed amount of dollars or a percentage \n",
      "of implementation costs into plan administrative costs to remedy the \n",
      "cost impact of implementation.\n",
      "    response: we appreciate the commenters' concerns and suggestions. \n",
      "as noted previously in this ria, we have assumed traditional federal \n",
      "sharing of costs for both the ma and medicaid programs. the results \n",
      "have been presented in tables 9 through 12 with table 13 indicating how \n",
      "payers and the federal government would defray costs. in tables 11 and \n",
      "12 the average estimated costs per enrollee (under $15) is compared \n",
      "with overall costs per enrollee (several thousand dollars). \n",
      "additionally, we have been careful in our analysis to distinguish \n",
      "between federal matching to state medicaid entities in the first year, \n",
      "federal matching to state medicaid entities in later years, and federal \n",
      "matching of state payment of capitation rates to state medicaid \n",
      "agencies. we take note that the commenter's concerns for specific \n",
      "federal matching for the provisions of this final rule would require \n",
      "legislative action. consequently, when writing the cms interoperability \n",
      "and patient access proposed rule, we did not believe it was necessary \n",
      "to propose additional federal spending beyond the already existing \n",
      "federal reimbursement to ma, medicaid plans, and state agencies.\n",
      "    comment: a few commenters expressed concern that the cms \n",
      "interoperability and patient access proposed rule was not clear with \n",
      "regard to whether or not state medicaid agencies would be allowed to \n",
      "allocate the costs of this implementation--at a 90 percent federal \n",
      "match--and for ongoing operations of the system--at a 75 percent \n",
      "federal match. commenters requested that cms provide clarity around the \n",
      "use of such language and exactness of ``pay fors'' since this is vital \n",
      "for state medicaid agencies' cost estimates in implementing the \n",
      "requirements of this rule.\n",
      "    response: we agree with the commenters. we therefore have revised \n",
      "the calculations to table 10 to reflect the following more precise \n",
      "accounting of costs: (1) 90 percent of state medicaid costs are paid or \n",
      "matched by the federal government in the first year of implementing new \n",
      "systems; (2) 75 percent of medicaid costs are matched for maintenance \n",
      "costs; and (3) on average, state medicaid agencies are\n",
      "\n",
      "[[page 25620]]\n",
      "\n",
      "matched 58.44 percent. we believe this heightened level of detail \n",
      "should satisfy commenter concerns. the revised numbers are reflected in \n",
      "tables 10 and table 11.\n",
      "    comment: one commenter noted that the developers of apis may want \n",
      "additional fees to implement or provide access to their apis. the \n",
      "commenter noted that these fees severely limit innovation in the \n",
      "marketplace for health it solutions for storing and utilizing patient \n",
      "data, both on the patient and provider side of the equation.\n",
      "    response: the data that must be shared via the api under this \n",
      "policy are data that the payers have and must currently make available \n",
      "to patients. we also anticipate that many payers will develop the apis \n",
      "in-house. if this commenter is more referencing the vendors creating \n",
      "apps, versus apis for payers, we also do not believe it is appropriate \n",
      "to charge a fee, as discussed in section iii. of this final rule. if \n",
      "fees are charged for certain apps, it is not the data that are \n",
      "generating the fee, it is the product or services; indeed, there is a \n",
      "logical connection between the potential benefits of this rule \n",
      "(facilitated by new or enhanced services) and non-quantified potential \n",
      "costs (possibly including those associated with the development or \n",
      "improvement of such services). currently there are vendors that collect \n",
      "the publicly available directory data, clean these data, supplement \n",
      "these data, and offer this enhanced data product back to payers and \n",
      "providers. it is not the data the vendors are charging for as much as \n",
      "it is the service of cleaning and enhancing these data. vendors may \n",
      "generate revenue from their third-party apps, but a major component of \n",
      "this is the service they are providing--building the app, making the \n",
      "data the patient directs to them most usable and valuable--that \n",
      "generates the revenue. payers must already make these data available to \n",
      "patients. these data alone may also drive revenue, but it is the \n",
      "patient's prerogative to provide their data to a third party in order \n",
      "to get a service in exchange\n",
      "    comment: a few commenters noted that ria does not contain any costs \n",
      "for provider ehr connectivity. one commenter noted that ehr developers' \n",
      "contracts with providers and health systems do not include the cost of \n",
      "system updates that will be required to comply with this proposal. \n",
      "another commenter was concerned that ehr developers will charge \n",
      "providers significant fees to perform the updates required to comply \n",
      "with cms' proposals, and providers will likely need to make additional \n",
      "investments to learn how to use standards-based apis and other new \n",
      "technologies. another commenter believes that for the clinical data to \n",
      "be available in any api, the cehrt used by providers needs to be \n",
      "connected to a trusted exchange network. for many clinicians, the \n",
      "commenter noted the costs for connecting their cehrt to a trusted \n",
      "network continues to remain a barrier.\n",
      "    response: to address commenters' concerns with api connectivity to \n",
      "an ehr, we note that there is no requirement for a payer to link the \n",
      "patient access api to an ehr in this final rule, and there are \n",
      "associated challenges, as discussed elsewhere in this ria, with \n",
      "attributing impacts to various interacting regulatory and other \n",
      "policies. indeed, we do note that if a provider does elect to connect \n",
      "an ehr to the apis finalized in this rule, they would be required to \n",
      "meet all the requirements of onc's health it certification program.\\78\\ \n",
      "as part of that program, the 2015 cehrt includes, for example, \n",
      "``application access'' certification criteria that requires health it \n",
      "to demonstrate it can provide application access to the common clinical \n",
      "data set (ccds) via an api.\\79\\ furthermore, nearly a third of ehr \n",
      "vendors are also using the fhir standard to meet 2015 cehrt \n",
      "requirements.\\80\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\78\\ office of the national coordinator. (2019, march 27). about \n",
      "the onc health it certification program. retrieved from <a href=\"https://www.healthit.gov/topic/certification-ehrs/about-onc-health-it-certification-program\">https://www.healthit.gov/topic/certification-ehrs/about-onc-health-it-certification-program</a>.\n",
      "    \\79\\ centers for medicare and medicaid services. (n.d.). 2019 \n",
      "promoting interoperability programs: 2015 edition certified ehr \n",
      "technology fact sheet. retrieved from <a href=\"https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/cehrt2015ed_factsheet-.pdf\">https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/cehrt2015ed_factsheet-.pdf</a>.\n",
      "    \\80\\ posnack, s. & baker, w. (2018, october 1). heat wave: the \n",
      "u.s. is poised to catch fhir in 2019. retrieved from <a href=\"https://www.healthit.gov/buzz-blog/interoperability/heat-wave-the-u-s-is-poised-to-catch-fhir-in-2019\">https://www.healthit.gov/buzz-blog/interoperability/heat-wave-the-u-s-is-poised-to-catch-fhir-in-2019</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "c. anticipated effects\n",
      "\n",
      "    the rfa, as amended, requires agencies to analyze options for \n",
      "regulatory relief of small businesses, if a rule has a significant \n",
      "impact on a substantial number of small entities. for purposes of the \n",
      "rfa, small entities include small businesses, nonprofit organizations, \n",
      "and small governmental jurisdictions.\n",
      "    the api requirements in this final rule affect: 1) qhp issuers on \n",
      "the ffes, 2) ma organizations, including those that are also part d \n",
      "sponsors of ma-pd plans, as well as 3) medicaid mcos with a minimum \n",
      "threshold for small business size of $41.5 million (<a href=\"https://www.sba.gov/federal-contracting/contracting-guide/size-standards\">https://www.sba.gov/federal-contracting/contracting-guide/size-standards</a>).\n",
      "    assessment of impact is complicated by the fact that costs have \n",
      "been aggregated at the parent organization level. a typical parent \n",
      "organization might have products with qhp issuers on the ffes, ma, or \n",
      "medicaid/chip programs. we have no way of directly assessing the size \n",
      "of parent organizations. therefore, as a proxy, we analyze each payer \n",
      "separately.\n",
      "    medicare advantage: we first assess the impact on ma plans. to \n",
      "clarify the flow of payments between these entities and the federal \n",
      "government, we note that ma organizations submit proposed plan designs \n",
      "and estimates of the amount of revenue necessary to cover the cost of \n",
      "those plan designs (called bids) by the first monday in june of the \n",
      "year preceding the coverage year. regulations governing this process \n",
      "are in 42 cfr part 422, subpart f. these bids must be broken down in \n",
      "the following:\n",
      "    (1) the revenue requirements for providing medicare part a and part \n",
      "b benefits with actuarially equivalent cost sharing (this is the \n",
      "``basic benefit bid'');\n",
      "    (2) the revenue requirements for providing supplemental benefits;\n",
      "    (3) the revenue requirements for non-benefit expenses such as sales \n",
      "& marketing, direct and indirect administration, net cost of \n",
      "reinsurance, and insurance fees; and\n",
      "    (4) for ma-pd plans, a part d bid consistent with part d \n",
      "regulations in 42 cfr part 423.\n",
      "    these bids project payments to hospitals, providers and staff for \n",
      "covered benefits, as well as the cost of plan administration and \n",
      "profits. because the api requirements finalized in this rule will apply \n",
      "to every ma plan and each ma plan must furnish at least the medicare \n",
      "part a and part b benefits, the cost of the api will be built into the \n",
      "administrative component of the basic benefit bid. these bids in turn \n",
      "determine one component of the payments of the medicare trust fund to \n",
      "the ma organizations who reimburse providers and subcontractors for \n",
      "their services. a second component of the trust fund payment to ma \n",
      "organizations are the rebates, which are a portion of the difference \n",
      "between the basic benefit bid compared to an administratively-set \n",
      "benchmark for the ma plan's service area (currently, based on our past \n",
      "and projected experience, rebates vary by plan and are approximately 66 \n",
      "percent). benchmarks are based on a formula using an estimate of the \n",
      "medicare ffs per capita cost for the geographic area, which are \n",
      "adjusted to reflect the per capita cost of each county in the u.s. and \n",
      "its territories and adjusted for the enrollees' health status\n",
      "\n",
      "[[page 25621]]\n",
      "\n",
      "which is also known as the risk score. payments from the medicare trust \n",
      "funds for monthly capitation rates (for basic benefits) are capped at \n",
      "the benchmark; for basic benefit bids under the benchmark, a portion, \n",
      "currently approximately 66 percent, of the difference between the bid \n",
      "and benchmark is made available to the ma organization to either: (1) \n",
      "pay for additional supplemental benefits; (2) include reductions in \n",
      "cost sharing in the plan design; or (3) provide buy-downs of part b or \n",
      "part d premiums. basic benefit bids that are at or above the benchmark \n",
      "receive payment from the trust funds of the benchmark amount, with any \n",
      "excess charged to the enrollee as a premium.\n",
      "    ma organizations are made aware of the benchmark through the annual \n",
      "cms publication, ``announcement of calendar year [x] medicare advantage \n",
      "capitation rates and medicare advantage and part d payment policies,'' \n",
      "which, consistent with section 1853 of the act, is released prior to ma \n",
      "organizations submission of bids. this publication of the benchmark \n",
      "when coupled with plan awareness that they will receive rebates if \n",
      "their plan bids fall below the benchmark facilitates that bids of most \n",
      "ma organizations are below the benchmark and consequently most ma \n",
      "organizations receive from the trust fund a total expenditure equaling \n",
      "payment for the bid plus the rebate.\n",
      "    because of these api provisions, we assume that ma organizations \n",
      "will be raising the june-submitted bid amount to reflect additional \n",
      "administrative costs. while the trust fund pays these bid amounts in \n",
      "full, the rebate goes down as the bid increases: that is, since the bid \n",
      "amount goes up, the rebate, equaling the difference between the \n",
      "benchmark and bid, decreases and results in less rebate payment to the \n",
      "ma organization. the ma organization has several options of dealing \n",
      "with these increased bid costs and reduced rebates: the ma organization \n",
      "might decide to: (1) temporarily absorb the loss by reducing its profit \n",
      "margin (so as to reduce the bid amount and thereby increase the \n",
      "rebates); (2) reduce additional benefits paid to the enrollee from the \n",
      "rebates; or (3) raise enrollee premiums so as to compensate for the \n",
      "reduction of enrollee premium that would have happened if the bid had \n",
      "not been increased (note: for marketing purposes, many plans operate at \n",
      "zero premium, and we do not consider this third option a likely \n",
      "possibility). in this ria, we have referred to options (2) and (3) \n",
      "(reduction of additional benefits and raising of enrollee premiums) as \n",
      "``passing the costs to the enrollee'' so that the ``effect'' of reduced \n",
      "rebates is fewer supplemental benefits or higher enrollee premiums than \n",
      "would have happened had the cost of the complying with the api \n",
      "provisions of this final rule not been imposed.\n",
      "    there are various types of medicare health plans, including ma \n",
      "hmos, pos plans, and ppos; demonstration plans; cost plans; \n",
      "prescription drug plans (pdp); and programs of all-inclusive care for \n",
      "the elderly (pace) organization plans. this final rule affects ma hmos, \n",
      "ma pos plans, and ma ppos including those that are ma-pds, but does not \n",
      "affect cost plans, stand-alone prescription drug plans, nor pace \n",
      "organizations.\n",
      "    there are a variety of ways to assess whether ma organizations meet \n",
      "the $41.5 million threshold for small businesses. the assessment can be \n",
      "done by examining net worth, net income, cash flow from operations and \n",
      "projected claims as indicated in their bids. using projected monetary \n",
      "requirements and projected enrollment for 2018 from submitted bids, \n",
      "approximately 30 percent of the ma organizations fell below the $41.5 \n",
      "million threshold for small businesses. additionally, an analysis of \n",
      "2016 data, the most recent year for which we have actual data on ma \n",
      "organization net worth, shows that approximately 30 percent of all ma \n",
      "organizations fall below the minimum threshold for small businesses.\n",
      "    medicaid: we next assess the impact on medicaid managed care plans. \n",
      "since medicaid managed care plans receive 100 percent capitation from \n",
      "the state, we generally expect that the costs associated with the api \n",
      "provisions of this final rule, will be included in their capitation \n",
      "rates and may be reasonable, appropriate, and attainable costs whether \n",
      "they are a small business or not.\n",
      "    qhp issuers on the ffes: based on the 2016 cms mlr data, \n",
      "approximately 85 out of 494, or 17 percent of companies (that either \n",
      "had only individual market business, or had individual market plus \n",
      "medicare and/or medicaid business) had total premium revenue of less \n",
      "than $41,500,000. in other words, for ma, medicaid, and qhp issuers on \n",
      "the ffes, a significant number of small plans are affected. the rfa \n",
      "requires us to assess whether the rule has a significant impact on the \n",
      "plans, which we do next.\n",
      "    if a rule has a substantial impact on a substantial number of small \n",
      "entities, the rule must discuss steps taken, including alternatives, to \n",
      "minimize burden on small entities. while a significant number (more \n",
      "than 5 percent) of not-for-profit organizations and small businesses \n",
      "are affected by this final rule, the impact is not significant. to \n",
      "assess impact, we use the data in table 5, which shows that the total \n",
      "raw (not discounted) net effect of this final rule over 10 years is \n",
      "$714 million.\n",
      "    medicare advantage: we first assess impact on ma plans. comparing \n",
      "the $714 million number to the total monetary amounts projected to be \n",
      "needed just for 2018, the most recent year on which we have finalized \n",
      "plan submitted bid data (and which is expected to be less than the need \n",
      "in future years including 2019), we find that that the impact of this \n",
      "final rule is significantly below the 3 percent-5 percent threshold for \n",
      "significant impact for ma plans.\n",
      "    medicaid: we next assess impact on medicaid managed care plans. the \n",
      "total projected capitation payment and premiums for 2019 is projected \n",
      "to be $337.6 billion.\\81\\ hence, the total cost of this final rule over \n",
      "10 years, $714 million, is significantly below the 3 percent-5 percent \n",
      "threshold for significant impact to medicaid managed care plans.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\81\\ see ``capitation payments & premiums'' in table 17 of \n",
      "appendix d in, office of the actuary (centers for medicare and \n",
      "medicaid services). (2016). 2016 actuarial report on the financial \n",
      "outlook for medicaid. retrieved from <a href=\"https://www.medicaid.gov/medicaid/finance/downloads/medicaid-actuarial-report-2016.pdf\">https://www.medicaid.gov/medicaid/finance/downloads/medicaid-actuarial-report-2016.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    qhp issuers on the ffes: as discussed prior to table 6 based on \n",
      "data in the public cms mlr files, commercial health insurance issuers \n",
      "had premium revenue of $77 billion for individual market plan coverage \n",
      "in 2016. therefore, the aggregate raw cost of this final rule over 10 \n",
      "years, $762 million (low estimate) and $1.3 billion (high estimate), is \n",
      "significantly below the 3 percent to 5 percent threshold for \n",
      "significant impact to commercial plans. we believe, that although a \n",
      "significant number of small plans under each program are affected by \n",
      "this rule, on average this impact is not significant. additionally, we \n",
      "note that for those small entities that do find the cost of the \n",
      "provisions of this final rule burdensome, an exception process has been \n",
      "described in section iii.c. of this final rule. specifically, we note \n",
      "that we may provide an exceptions process through which the ffes may \n",
      "certify health plans that do not provide patient access through a \n",
      "standards-based api, but otherwise meet the requirements for qhp \n",
      "certification. this process could apply for small issuers, issuers who \n",
      "are only in the individual or small group market, financially \n",
      "vulnerable issuers, or new entrants to the ffes who demonstrate that \n",
      "deploying standards-\n",
      "\n",
      "[[page 25622]]\n",
      "\n",
      "based api technology consistent with the required interoperability \n",
      "standards would pose a significant barrier to the issuer's ability to \n",
      "provide coverage to consumers, and not certifying the issuer's qhp or \n",
      "qhps would result in consumers having few or no plan options in certain \n",
      "areas.\n",
      "    consequently, the secretary has determined that this final rule \n",
      "will not have a significant economic impact on a substantial number of \n",
      "small entities and the requirements of the rfa have been met. please \n",
      "see our detailed analysis of apportionment of costs per payer in tables \n",
      "6 through 13 and section xiii.h. of this final rule for further \n",
      "details.\n",
      "    in addition, section 1102(b) of the act requires cms to prepare an \n",
      "ria if a rule may have a significant impact on the operations of a \n",
      "substantial number of small rural hospitals. this analysis must conform \n",
      "to the provisions of section 604 of the rfa. for purposes of section \n",
      "1102(b) of the act, we define a small rural hospital as a hospital that \n",
      "is located outside a metropolitan statistical area and has fewer than \n",
      "100 beds. we are not preparing an analysis for section 1102(b) of the \n",
      "act because we have determined, and the secretary certifies, that this \n",
      "final rule would not have a significant impact on the operations of a \n",
      "substantial number of small rural hospitals.\n",
      "    section 202 of the unfunded mandates reform act of 1995 (umra) \n",
      "(pub. l. 104-04, enacted march 22, 1995) also requires that agencies \n",
      "assess anticipated costs and benefits before issuing any rule whose \n",
      "mandates, except those that are conditions of federal program \n",
      "participation, require spending in any 1 year of $100 million in 1995 \n",
      "dollars, updated annually for inflation. in 2020, that is approximately \n",
      "$156 million. this rule does not impose any such unfunded mandates.\n",
      "    executive order 13132 establishes certain requirements that an \n",
      "agency must meet when it promulgates a proposed rule (and subsequent \n",
      "final rule) that imposes substantial direct requirement costs on state \n",
      "and local governments, preempts state law, or otherwise has federalism \n",
      "implications. this final rule will not have a substantial direct effect \n",
      "on state or local governments, preempt state law, or otherwise have a \n",
      "federalism implication. therefore, the requirements of executive order \n",
      "13132 are not applicable.\n",
      "    if regulations impose administrative costs, such as the time needed \n",
      "to read and interpret this final rule, we should estimate the cost \n",
      "associated with regulatory review. there are currently 288 \n",
      "organizations and 56 states and territories. we assume each \n",
      "organization will have one designated staff member who will read the \n",
      "entire rule.\n",
      "    using the wage information from the bls for medical and health \n",
      "service managers (code 11-9111), we estimate that the cost of reviewing \n",
      "this rule is $139.14 per hour, including overhead and fringe benefits \n",
      "(<a href=\"https://www.bls.gov/oes/current/naics5_524114.htm\">https://www.bls.gov/oes/current/naics5_524114.htm</a>). assuming an \n",
      "average reading speed, we estimate that it would take approximately 6 \n",
      "hours for each person to review this final rule. for each payer that \n",
      "reviews the rule, the estimated cost is $834.84 (6 hours x $139.14). \n",
      "therefore, we estimate that the total cost of reviewing this regulation \n",
      "is $288,020 ($834.84 x 345 reviewers).\n",
      "1. requirements for patient access through apis\n",
      "    to promote our commitment to interoperability, we are implementing \n",
      "new requirements in section iii. of this final rule for ma \n",
      "organizations at 42 cfr 422.119, medicaid ffs at 42 cfr 431.60, \n",
      "medicaid managed care at 42 cfr 438.242, chip ffs at 42 cfr 457.730, \n",
      "chip managed care at 42 cfr 457.1233, and qhp issuers on the ffes, \n",
      "excluding qhp issuers offering only sadps or only ff-shop plans, at 45 \n",
      "cfr 156.221 to implement standards-based apis for making certain data \n",
      "available to current enrollees. the patient access api will permit \n",
      "third-party applications to retrieve data concerning adjudicated \n",
      "claims, encounters with capitated providers, provider remittances, \n",
      "patient cost-sharing, a subset of clinical data including lab test \n",
      "results, if maintained by the payer, and, preferred drug lists, and for \n",
      "ma-pd plans only, formulary data that includes covered part d drugs, \n",
      "and any tiered formulary structure or utilization management procedure, \n",
      "which pertains to those drugs for ma-pd plans.\n",
      "    at 42 cfr 422.120 for ma organizations, at 42 cfr 431.70 for state \n",
      "medicaid agencies, at 42 cfr 438.242(b)(6) for medicaid managed care \n",
      "plans, at 42 cfr 457.760 for chip state agencies, and at 42 cfr \n",
      "457.1233(d)(3) for chip managed care entities, we are finalizing the \n",
      "provider directory api. we believe that these policies are designed to \n",
      "empower patients by requiring that impacted payers take steps--by \n",
      "implementing the two required apis--to enable enrollees to have access \n",
      "to their data in a usable digital format and have (potentially) easier \n",
      "means to share that data. by making these data readily available and \n",
      "portable to the patient, these initiatives may help patients have the \n",
      "ability to move from payer to payer, provider to provider, and have \n",
      "both their clinical and administrative information travel with them \n",
      "throughout their health care journey. payers are in a unique position \n",
      "to provide enrollees with a comprehensive picture of their claims and \n",
      "encounter data, allowing patients to piece together their own \n",
      "information that might otherwise be lost in disparate systems. this \n",
      "information can contribute to better informed decision making, helping \n",
      "to inform the patient's choice of coverage options and care providers \n",
      "to more effectively manage their own health, care, and costs. by \n",
      "encouraging them to take charge of and better manage their health and \n",
      "having access to their health information, patients will have the \n",
      "ability to share this information with their other providers, which may \n",
      "reduce duplication of services, add efficiency to provider visits, and \n",
      "facilitate identification of fraud, waste, and abuse.\n",
      "    to estimate the number of impacted payers, we reviewed parent \n",
      "organizations of health plans across ma organizations, medicaid mcos, \n",
      "and qhp issuers on the ffes to remove organizations that would not be \n",
      "subject to the policy, such as issuers that offer only sadps; \n",
      "transportation plans, and brokers such as non-emergency medical \n",
      "transportation (nemts) brokers; pace; visiting nurse and home health \n",
      "care organizations; senior organizations such as area agencies on \n",
      "aging; and other organizations such as community action programs. after \n",
      "removing these organizations, we then reviewed the remaining names of \n",
      "parent organizations and health plans in the national association of \n",
      "insurance commissioners (naic) consumer information support (cis) \n",
      "system to determine the legal name of the entity and whether the entity \n",
      "was registered with the naic. we also used the 2018 naic listing of \n",
      "companies to determine whether various health plans had associated \n",
      "parent organizations using the naic's group coding and numbering \n",
      "system. if the health plan or parent organization did not appear in the \n",
      "naic cis or in the 2018 naic listing of companies, we then reviewed the \n",
      "name of the entity in the securities and exchange online edgar system \n",
      "to locate the entity's form 10-k filing, which includes an exhibit \n",
      "(exhibit 21) that requires the entity to list its subsidiaries. if the \n",
      "health plan or organization did not appear in these online systems or \n",
      "listings, an online internet search using google search\n",
      "\n",
      "[[page 25623]]\n",
      "\n",
      "engine was conducted. after review, we have determined that 288 issuers \n",
      "and 56 states, territories, and u.s. commonwealths, which operate ffs \n",
      "programs, will be subject to the api provisions for medicare, medicaid, \n",
      "and qhp issuers on the ffes. to this we add the one state that operates \n",
      "its chip and medicaid separately. thus, we have a total of 345 parent \n",
      "organizations (288+56+1). we note that although 42 states have some \n",
      "lower-income children in an expansion of medicaid, and some higher-\n",
      "income children or pregnant women in a separate chip, all but one of \n",
      "these programs are operated out of the same agency. although the chip \n",
      "programs may be distinct, we believe they will use the same \n",
      "infrastructure built for medicaid. thus, the addition of 1 parent \n",
      "organization for chip is reasonable and plausible.\n",
      "    as noted in section xii.c.3. of this final rule, to implement the \n",
      "patient access api together with the payer-to-payer data exchange \n",
      "policies to facilitate a payer maintaining a cumulative health record \n",
      "for their current enrollees, we estimated that organizations and states \n",
      "would conduct three major work phases: initial design; development and \n",
      "testing; and long-term support of the apis, including increased data \n",
      "storage, such as additional servers, or cloud storage to store patient \n",
      "health information and maintain it, and allocation of resources to \n",
      "maintain the fhir server, and perform capability and security testing. \n",
      "(for a detailed description of these phases, see section xii.c.3. of \n",
      "this final rule.)\n",
      "    as part of our research into the regulatory impact, we reviewed a \n",
      "sample of health plan organizations offering ma plans to determine \n",
      "whether any currently offer patient portal functionality with the ma \n",
      "plan. if yes, we reviewed whether they offered the opportunity to \n",
      "connect to medicare's blue button 2.0. health plan organizations \n",
      "offering ma plans were identified from june 2018 data and statistics \n",
      "compiled at <a href=\"https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/index.html\">https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/mcradvpartdenroldata/index.html</a>. we \n",
      "initially reviewed the functionality offered by three organizations, \n",
      "which together enroll over half of ma members through review of \n",
      "publicly-available information such as press releases and website \n",
      "informational materials. we found from this review that these \n",
      "organizations not only offered patient portals primarily focused on \n",
      "claims and user-entered data on their website, but that all three also \n",
      "offered enrollees the opportunity to connect to blue button. we then \n",
      "identified a selection of other health plan organizations at random and \n",
      "conducted the same evaluation. results indicate that the majority of \n",
      "the health plan organizations we reviewed offer patients a way to \n",
      "access claims data and other information via their websites and \n",
      "sometimes via applications.\n",
      "    we also cross-referenced health plan organizations offering ma \n",
      "plans with health plan organizations that offer plans in the federal \n",
      "employees health benefits (fehb) program because a percentage of those \n",
      "organizations offer plans with patient portal access and blue button \n",
      "functionality. the fehb program, administered by the office of \n",
      "personnel management (opm), reported in 2014 that 90 percent of its \n",
      "participating plans offered enrollees access to a personal health \n",
      "record on the organization's website. in addition, opm reported that \n",
      "over half of the fehb participating plans expected to offer blue button \n",
      "functionality by january 1, 2016. we sought to learn whether there was \n",
      "any overlap between these two lists of organizations to gauge whether \n",
      "additional organizations may already have the capability to offer \n",
      "either patient portals or blue button, albeit in a different business \n",
      "arm, as having internal capability may assuage some of the cost of \n",
      "building out a new api to support patient access to claims data. while \n",
      "we found significant overlap between unitedhealthcare and the blue \n",
      "cross blue shield affiliates, we also were able to identify other \n",
      "organizations that offer both ma plans and plans included in the fehb. \n",
      "while not definitive, this data allows us to draw the conclusion that a \n",
      "number of health plan organizations have the technology in place to \n",
      "offer patient portals to ma enrollees and, further, also have the \n",
      "ability to offer ma enrollees blue button functionality.\n",
      "    as detailed in section xii. of this final rule and summarized in \n",
      "table 5, given the current state of interoperability, we estimate the \n",
      "burden related to the new requirements for apis to have an initial set \n",
      "one-time costs of $788,414 per implementation or an aggregate cost of \n",
      "$272 million ($788,414 x 345 parent organizations) minimum estimate; an \n",
      "initial one-time cost of $1,576,829 per organization or state or an \n",
      "aggregate cost of $544 million ($1,576,829 x 345 parent organizations) \n",
      "primary estimate; and, an initial one-time cost of $2,365,243 per \n",
      "organization or organization or an aggregate $816 million ($2,365,243 x \n",
      "345 parent organizations) high estimate. for a detailed discussion of \n",
      "the one-time costs associated with implementing the api requirements we \n",
      "refer readers to section xii.c.3. of this final rule. once the api is \n",
      "established, we believe that there will be an annual cost for \n",
      "performing necessary capability and security testing, performing \n",
      "necessary upgrades, vetting of third-party applications, and \n",
      "maintaining patient health information. we estimate the burden related \n",
      "to the requirements for apis to have an annual cost of $157,657 per \n",
      "implementation or an aggregate cost of $54 million (345 parent \n",
      "organizations x $157,657). for a detailed discussion of the annual \n",
      "costs associated with implementing the api requirements, we refer \n",
      "readers to section xii.c.3. of this final rule.\n",
      "    we are committed to fulfilling our role in promoting \n",
      "interoperability, putting patients first and ensuring they have access \n",
      "to their health care data. we recognize that there are significant \n",
      "opportunities to modernize access to patient data and its ability to \n",
      "share across the health ecosystem. we realize the importance of \n",
      "interoperability and the capability for health information systems and \n",
      "software applications to communicate, exchange, and interpret data in a \n",
      "usable and readable format. although allowing access to health care \n",
      "data through pdf and text format is vital, it limits the utility of the \n",
      "data, and its ability to be easily accessed and shared. additionally, \n",
      "we realize that moving to a system in which patients have access to \n",
      "their health care data will ultimately empower them to make informed \n",
      "decisions about their health care. our policies here do not go as far \n",
      "as our goals for how patients will be ultimately empowered, but take \n",
      "steps in that direction.\n",
      "    we note that the federal government has spent over $35 billion \n",
      "under the ehr incentive programs \\82\\ to incentivize the adoption of \n",
      "ehr systems; however, despite the fact that 78 percent of physicians \n",
      "and 96 percent of hospitals now use an ehr system,\\83\\ progress on \n",
      "system-wide data sharing has been limited. previous attempts to advance \n",
      "interoperability have made incremental progress but have failed to \n",
      "align the necessary stakeholders to drive momentum in a single \n",
      "direction. in 2018, the administration launched the\n",
      "\n",
      "[[page 25624]]\n",
      "\n",
      "myhealthedata initiative.\\84\\ this government-wide initiative aims to \n",
      "empower patients by ensuring that they have access to their own health \n",
      "care data and the ability to decide how their data will be used, while \n",
      "keeping that information safe and secure. myhealthedata aims to break \n",
      "down the barriers that prevent patients from gaining electronic access \n",
      "to their health care data and allow them to access that data from the \n",
      "device or application of their choice that will connect to a plan's \n",
      "api, empowering patients and taking a critical step toward \n",
      "interoperability and patient data exchange.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\82\\ centers for medicare and medicaid services. (2018, may). \n",
      "ehr incentive program, payment summary report. retrieved from \n",
      "<a href=\"https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/may2018_summaryreport.pdf\">https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/may2018_summaryreport.pdf</a>.\n",
      "    \\83\\ office of the national coordinator. (2015). health it \n",
      "dashboard--office-based physician health it adoption: state rates of \n",
      "physician ehr adoption, health information exchange & \n",
      "interoperability, and patient engagement. retrieved from <a href=\"https://dashboard.healthit.gov/apps/physician-health-it-adoption.php\">https://dashboard.healthit.gov/apps/physician-health-it-adoption.php</a>.\n",
      "    \\84\\ centers for medicare and medicaid services. (2018, may 6). \n",
      "trump administration announces myhealthedata initiative to put \n",
      "patients at the center of the us healthcare system. retrieved from \n",
      "<a href=\"https://www.cms.gov/newsroom/mediareleasedatabase/press-releases/2018-press-releases-items/2018-03-06.html\">https://www.cms.gov/newsroom/mediareleasedatabase/press-releases/2018-press-releases-items/2018-03-06.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    payers should have the ability to exchange data instantly with \n",
      "other payers for care coordination or transitions, and with providers \n",
      "to facilitate more efficient care. payers are in a unique position to \n",
      "provide enrollees a complete picture of their claims and encounter \n",
      "data, allowing patients to piece together their own information that \n",
      "might otherwise be lost in disparate systems. we are committed to \n",
      "solving the issue of interoperability and achieving complete patient \n",
      "access in the u.s. health care system and are taking an active approach \n",
      "using all available policy levers and authorities available to move all \n",
      "participants in the health care market toward interoperability and the \n",
      "secure exchange of health care data. the modern internet app economy \n",
      "thrives on a standards-based api software environment. part of the \n",
      "health care api evolution is incorporating many of the current \n",
      "protocols from leading standards development organizations with the \n",
      "newer fhir web developer-friendly way of representing clinical data.\n",
      "2. increasing the frequency of federal-state data exchanges for dually \n",
      "eligible individuals\n",
      "    we routinely exchange data with states on who is enrolled in \n",
      "medicare, and which parties are liable for paying that beneficiary's \n",
      "part a and b premiums. these buy-in data exchanges support state, cms, \n",
      "and ssa premium accounting, collections, and enrollment functions. cms \n",
      "subregulatory guidance, specifically chapter 3 of the state buy-in \n",
      "manual, specifies that states should exchange buy-in data with cms at \n",
      "least monthly, but provides the option for states to exchange buy-in \n",
      "data with cms daily or weekly. likewise, states can choose to receive \n",
      "the cms response data on a file daily or monthly.\n",
      "    we are establishing the frequency requirements in the regulation \n",
      "itself to require all states to participate in daily exchange of buy-in \n",
      "data to cms, with ``daily'' meaning every business day, but that if no \n",
      "new transactions are available to transmit, data would not need to be \n",
      "submitted on a given business day. states will be required to begin \n",
      "participating in daily exchange of buy-in data with cms by april 1, \n",
      "2022.\n",
      "    to estimate impact, we first note that there are a total of 51 \n",
      "entities, consisting of the 50 states and the district of columbia that \n",
      "can be affected by buy-in. currently, 25 entities (24 states and the \n",
      "district of columbia) now submit buy-in data files to cms daily and 32 \n",
      "entities (31 states and the district of columbia) receive buy-in data \n",
      "files from cms daily. consequently, we expect a one-time burden for 26 \n",
      "states (51 total entities minus 25 entities currently submitting daily \n",
      "buy-in data) to comply with the daily buy-in data submissions, and a \n",
      "similar one-time burden for 19 states (51 total entities minus 32 \n",
      "entities currently receiving buy-in data) to comply with the receipt of \n",
      "daily buy-in data.\n",
      "    these numbers changed from those in the cms interoperability and \n",
      "patient access proposed rule to reflect the most current data available \n",
      "to cms as of july 1, 2019. between july 1 and publication of the final \n",
      "rule it is likely that the numbers may change more. however, as can be \n",
      "seen from table 5, this aspect of the rule has minor impact (only a few \n",
      "million dollars) compared with the overall impact of the rule (several \n",
      "hundred million). consequently, we are using these july 1 numbers in \n",
      "the final rule.\n",
      "    we estimate that each required change, whether to submit buy-in \n",
      "data or receive buy-in data, would take 6 months of work (approximately \n",
      "960 hours) by a programmer working at an hourly rate of $90.02 per \n",
      "hour. since there are 45 required changes (19 states that need to \n",
      "comply with receiving data plus 26 states that need to comply with \n",
      "submitting data) we estimate an aggregate burden of $3,888,864 (45 \n",
      "changes * 960 hours of programming work * $90.02/hour).\n",
      "    the cost per state per change is approximately $85,000 (960 * \n",
      "$90.02 = $86,419 exactly) and the costs for both changes (to both send \n",
      "and receive buy-in data daily would be approximately $170,000 (2 * \n",
      "$85,000).\n",
      "    we did not estimate any savings related to exchanging buy-in data \n",
      "with greater frequency, as data lags only delay when states are billed \n",
      "for premium costs; delays do not impact the applicability date and \n",
      "total costs. while we did not estimate premium savings (since premium \n",
      "collection is ultimately correct), we anticipate that states may \n",
      "experience longer term reduction in administrative burden of making \n",
      "those corrections.\n",
      "    as noted in section xii.c. of this final rule, we are updating the \n",
      "frequency requirements in 42 cfr 423.910(d) to require that starting \n",
      "april 1, 2022, all states submit the required mma file data to cms \n",
      "daily, and to make conforming edits to 42 cfr 423.910(b)(1). daily \n",
      "would mean every business day, but that if no new transactions are \n",
      "available to transmit, data would not need to be submitted on a given \n",
      "business day. as noted in section xii.c. of this final rule, the \n",
      "estimated burden across impacted states is $3,111,091.\n",
      "    thus, the total burden to comply with increased frequency of \n",
      "submission of mma files and increased frequency of submission and \n",
      "receipt of daily buy-in data files is $7 million ($3,888,864 total cost \n",
      "for the buy-in provision plus $3,111,091 total cost for the mma file \n",
      "requirements).\n",
      "    we estimate a 25-month implementation period for these system \n",
      "updates, from march 2020 to and including march 2022. in the cms \n",
      "interoperability and patient access proposed rule, we assumed a 3-year \n",
      "implementation period reflecting a may 1st start date and an april 1, \n",
      "2022 applicability date. the revised 25-month implementation period \n",
      "reflects an expected publication of this final rule in march 2020, with \n",
      "implementation beginning march 2020, and with the applicability date of \n",
      "april 1, 2022 unchanged. although the implementation period is shorter \n",
      "(25 months versus 36 months) the purpose of the 25-month window is to \n",
      "give organizations flexibility in finding a 6-month period to perform \n",
      "updates as indicated in section xii. of this final rule. although the \n",
      "flexibility window for this 6-month period is shortened (plans have \n",
      "less choice of which 6 months to work in), data are lacking with which \n",
      "to refine the cost estimates to reflect the shortened compliance \n",
      "period.\n",
      "    states will have the ability to choose, in consultation with cms, \n",
      "when in the 25-month implementation period they want to make this \n",
      "change, with numerous factors impacting in which year they would do so. \n",
      "for the purposes of this impact analysis, we estimated a uniform \n",
      "distribution beginning in march 2020 and ending in april 2022 as \n",
      "calculated in table 5.\n",
      "\n",
      "[[page 25625]]\n",
      "\n",
      "    therefore, since, as noted above, the total cost impact over 25 \n",
      "months is $7 million, when apportioned uniformly over the 25 months, \n",
      "the resulting impacts $2.8, $3.4, and $0.8 million for 2020, 2021, and \n",
      "2022 respectively corresponding to 10 months, 12 months, and 3 months \n",
      "in 2020, 2021 and 2022 respectively. these calculations are \n",
      "transparently presented in table 5.\n",
      "3. revisions to the conditions of participation for hospitals and \n",
      "critical access hospitals (cahs)\n",
      "    we are expanding cms' requirements for interoperability within the \n",
      "hospital and cah cops by focusing on electronic patient event \n",
      "notifications. we are implementing new requirements in section x. of \n",
      "this final rule for hospitals at 42 cfr 482.24(d), for psychiatric \n",
      "hospitals at 42 cfr 482.61(f), and for cahs at 42 cfr 485.638(d). \n",
      "specifically, for hospitals, psychiatric hospitals, and cahs, we are \n",
      "finalizing similar requirements to revise the cops for medicare- and \n",
      "medicaid-participating hospitals, psychiatric hospitals, and cahs by \n",
      "adding a new standard, ``electronic notifications,'' that will require \n",
      "hospitals, psychiatric hospitals, and cahs to make electronic patient \n",
      "event notifications available to applicable post-acute care services \n",
      "providers and suppliers, and to community practitioners, such as the \n",
      "patient's established primary care practitioner, established primary \n",
      "care practice group or entity, or other practitioner or practice group \n",
      "or entity identified by the patient as primarily responsible for his or \n",
      "her care. we are limiting this requirement to only those hospitals, \n",
      "psychiatric hospitals, and cahs that utilize electronic medical records \n",
      "systems, or other electronic administrative systems, which are \n",
      "conformant with the content exchange standard at 45 cfr 170.205(d)(2), \n",
      "recognizing that not all medicare- and medicaid-participating hospitals \n",
      "have been eligible for past programs promoting adoption of ehr systems. \n",
      "if the hospital's (or cah's) system conforms to the content exchange \n",
      "standard at 45 cfr 170.205(d)(2), the hospital (or cah) must then \n",
      "demonstrate that its system's notification capacity is fully \n",
      "operational and that it operates in accordance with all state and \n",
      "federal statutes and regulations regarding the exchange of patient \n",
      "health information, and that its system, to the extent permissible \n",
      "under applicable federal and state law and regulations, and not \n",
      "inconsistent with the patient's expressed privacy preferences, sends \n",
      "the notifications either directly, or through an intermediary that \n",
      "facilitates exchange of health information. it must also demonstrate \n",
      "that the notifications include at least patient name, treating \n",
      "practitioner name, and sending institution name.\n",
      "    upon the patient's registration in the emergency department or \n",
      "admission to inpatient services, and also either immediately prior to, \n",
      "or at the time of, the patient's discharge or transfer (from the \n",
      "emergency department or inpatient services), the hospital (or cah) must \n",
      "also demonstrate that it has made a reasonable effort to ensure that \n",
      "its system sends the notifications to all applicable post-acute care \n",
      "services providers and suppliers, as well as to any of the following \n",
      "practitioners and entities, which need to receive notification of the \n",
      "patient's status for treatment, care coordination, or quality \n",
      "improvement purposes: (1) the patient's established primary care \n",
      "practitioner; (2) the patient's established primary care practice group \n",
      "or entity; or (3) other practitioner, or other practice group or \n",
      "entity, identified by the patient as the practitioner, or practice \n",
      "group or entity, primarily responsible for his or her care.\n",
      "    as we noted, infrastructure supporting the exchange of electronic \n",
      "health information across settings has matured substantially in recent \n",
      "years. research studies have increasingly found that health information \n",
      "exchange interventions can effectuate positive outcomes in health care \n",
      "quality and public health outcomes, in addition to more longstanding \n",
      "findings around reductions in utilization and costs. electronic patient \n",
      "event notifications from hospitals, or clinical event notifications, \n",
      "are one type of health information exchange intervention that has been \n",
      "increasingly recognized as an effective and scalable tool for improving \n",
      "care coordination across settings, especially for patients at \n",
      "discharge. this approach has been identified with a reduction in \n",
      "readmissions following implementation.\\85\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\85\\ unruh, m. a., jung, h., kaushal, r., & vest, j. r. (2017). \n",
      "hospitalization event notifications and reductions in readmissions \n",
      "of medicare fee-for-service beneficiaries in the bronx, new york. \n",
      "journal of the american medical informatics association, 24(e1), \n",
      "e150-e156. doi: 10.1093/jamia/ocw139.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in addition, the cms innovation center has been partnering with \n",
      "states through the state innovation models initiative to advance multi-\n",
      "payer health care payment and delivery system reform models. through \n",
      "this initiative 34 states have been awarded over $900 million to \n",
      "implement their respective state health care innovation plans, many of \n",
      "which included enhancements in hit and hie. while these models are \n",
      "ongoing, evaluation reports thus far are reporting that many states are \n",
      "experiencing favorable outcomes on ed visit rates and other quality \n",
      "measures.\\86\\ although patient event notifications are only a small \n",
      "piece of these models, we want to continue the momentum towards \n",
      "nationwide adoption.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\86\\ centers for medicare and medicaid services. (2019, december \n",
      "6). state innovation models initiative: general information. \n",
      "retrieved from <a href=\"https://innovation.cms.gov/initiatives/state-innovations/\">https://innovation.cms.gov/initiatives/state-innovations/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    these notifications are automated, electronic communications from \n",
      "the provider to applicable post-acute care services providers and \n",
      "suppliers, and also to community practitioners identified by the \n",
      "patient. these automated communications alert the receiving provider or \n",
      "practitioner that the patient has received care at a different setting. \n",
      "information included with these notifications can range from simply \n",
      "conveying the patient's name, basic demographic information, and the \n",
      "sending institution, to a richer set of clinical data depending upon \n",
      "the level of technical implementation. even with a minimum set of \n",
      "information included, these notifications can help ensure that a \n",
      "receiving provider or community practitioner is aware that the patient \n",
      "has received care elsewhere. the notification triggers a receiving \n",
      "provider or practitioner to reach out to the patient to deliver \n",
      "appropriate follow-up care in a timely manner. by providing timely \n",
      "notifications, the alert may improve post-discharge transitions and \n",
      "reduce the likelihood of complications resulting from inadequate \n",
      "follow-up care.\n",
      "    we believe that care coordination can have a significant positive \n",
      "impact on the quality of life, consumer experience, and health outcomes \n",
      "for patients. as we have noted in the preamble to this rule, virtually \n",
      "all ehr systems (as well as older legacy electronic administrative \n",
      "systems, such as electronic patient registrations systems, and which we \n",
      "are including in this final rule) generate the basic messages commonly \n",
      "used to support electronic patient event notifications. in addition, \n",
      "while we acknowledge that some level of implementation cost would be \n",
      "realized for those providers not already sending notifications, we also \n",
      "note there is also substantial agreement that implementation of these \n",
      "basic messaging and notification functions within such existing systems \n",
      "constitutes a relatively low cost burden for providers, particularly \n",
      "when such costs are considered alongside the innovative and beneficial \n",
      "patient care transition\n",
      "\n",
      "[[page 25626]]\n",
      "\n",
      "solutions and models for best practices they provide.\n",
      "    as detailed in section xi., we estimate that the total cost imposed \n",
      "on hospitals, psychiatric hospitals, and cahs by these provisions to be \n",
      "approximately $5,179,863 in the first year and $1,042,426 in subsequent \n",
      "years.\n",
      "4. effects of other policy changes\n",
      "    in addition to those policy changes discussed previously that we \n",
      "are able to model, we are finalizing various other changes in this \n",
      "final rule. generally, we have limited or no specific data available \n",
      "with which to estimate the impacts of the policy changes. our estimates \n",
      "of the likely impacts associated with these other changes are discussed \n",
      "in this section.\n",
      "a. care coordination across payers\n",
      "    the majority of the 64 million people on medicare are covered by \n",
      "ffs, however, about 34 percent are covered in ma plans. since 2003, the \n",
      "number of beneficiaries enrolled in ma plans has increased fivefold \n",
      "from 4.6 million in 2010 to 22 million in 2019.\\87\\ given the growth in \n",
      "ma enrollment and the ability for ma beneficiaries to change plans, we \n",
      "believe it is important to supporting efficient care coordination by \n",
      "requiring the sharing of key patient health information when an \n",
      "enrollee requests it. therefore, we are requiring ma organizations, \n",
      "medicaid managed care plans, chip managed care entities, and qhp \n",
      "issuers on the ffes to maintain a process for the electronic exchange \n",
      "of, at a minimum, the data classes and elements included in the content \n",
      "standard finalized by hhs in the onc 21st century cures act final rule \n",
      "(published elsewhere in this issue of the federal register) at 45 cfr \n",
      "170.213 (currently version 1 of the uscdi), via a payer-to-payer data \n",
      "exchanged as outlined in this section v. of this final rule. \n",
      "furthermore, we are finalizing as proposed a regulatory requirement at \n",
      "42 cfr 422.119(f)(1) and 438.62(b)(1)(vi), and at 45 cfr 156.221(f)(1) \n",
      "to require ma organizations, medicaid managed care plans, chip managed \n",
      "care entities, and qhp issuers on the ffes to incorporate the data they \n",
      "receive into the payer's record about the enrollee. we are also \n",
      "finalizing that with the approval and at the direction of an enrollee, \n",
      "a payer must send the defined information set to any other payer. we \n",
      "specify that a payer is only obligated to send data received from \n",
      "another payer under this policy in the electronic form and format it \n",
      "was received. however, we have noted that such transactions will need \n",
      "to be made in compliance with any other applicable laws.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\87\\ medicare payment advisory commission. (2019, july 19). a \n",
      "data book: health care spending and the medicare program--june 2019. \n",
      "retrieved from <a href=\"http://www.medpac.gov/docs/default-source/data-book/jun19_databook_entirereport_sec.pdf?sfvrsn=0\">http://www.medpac.gov/docs/default-source/data-book/jun19_databook_entirereport_sec.pdf?sfvrsn=0</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we believe that sending and receiving these data will help both \n",
      "plan enrollees and health care providers in coordinating care and \n",
      "reducing administrative burden. we believe that this entails utilizing \n",
      "all tools available to us to ensure that plans provide coordinated \n",
      "high-quality care in an efficient and cost-effective way that protects \n",
      "program integrity. leveraging interoperability to facilitate care \n",
      "coordination among plans can, with thoughtful execution, significantly \n",
      "reduce unnecessary care, as well as ensure that health care providers \n",
      "are able to spend their time providing care rather than performing \n",
      "unnecessary administrative tasks. for instance, effective information \n",
      "exchange between plans could improve care coordination by reducing the \n",
      "need for health care providers to write unneeded letters of medical \n",
      "necessity; by reducing instances of inappropriate step therapy; and by \n",
      "reducing repeated utilization reviews, risk screenings, and \n",
      "assessments.\n",
      "    we believe that this policy will impose minimal additional costs on \n",
      "plans. we note that we are not specifying a transport standard and \n",
      "anticipate that plans may opt to use apis, such as the patient access \n",
      "api that this final rule also requires. we also anticipate that plans \n",
      "may choose to utilize a regional health information exchange. we \n",
      "believe it is difficult to quantify the impact of this change because \n",
      "plans will likely implement different transport methods, and we cannot \n",
      "predict the selected method plans will choose.\n",
      "b. care coordination through trusted exchange networks\n",
      "    in section vi. of the cms interoperability and patient access \n",
      "proposed rule, we proposed requiring ma organization, medicaid managed \n",
      "care plans, chip managed care entities, and qhp issuers on the ffes to \n",
      "participate in trust networks in order to improve interoperability. we \n",
      "also listed the requirements for participation in a trusted exchange \n",
      "network.\n",
      "    as a result of comments and re-examination of our desired policies, \n",
      "we have decided not to finalize this provision. however, as pointed out \n",
      "in the proposed rule, had this provision been finalized, it would \n",
      "impose minimal additional costs on plans. consequently, not finalizing \n",
      "this policy does not impact this ria.\n",
      "5. non-mandatory effects and regulatory interaction\n",
      "    we note in this ria when we had difficulty quantifying costs due to \n",
      "lack of applicable research or data. more specifically, the \n",
      "establishment of a health care information ecosystem could only be \n",
      "achieved with new actions that are conducted widely throughout the \n",
      "health care field--including by entities, especially non-hospital \n",
      "providers, for whom costs have not been estimated in either this ria or \n",
      "the ria for the accompanying onc 21st century cures act final rule \n",
      "(published elsewhere in this issue of the federal register). although \n",
      "data limitations have prevented the quantification of these costs, the \n",
      "benefits of the two rules--some of which have been quantified in the \n",
      "onc ria--and the rules' potential transfer impacts--including \n",
      "reductions in fraudulent payments, as discussed by parente et al. \n",
      "(2008) \\88\\--are largely contingent upon such costs being incurred. \n",
      "additionally, there are ongoing regulatory and policy activities \n",
      "outside of this final rule that might influence the rule's impact in an \n",
      "unquantifiable manner. when possible, we acknowledge these complexities \n",
      "as well.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\88\\ parente, stephen t., karen mandelbaum, susan p. hanson, \n",
      "bonnie s. cassidy and donald w. simborg. ``crime and punishment: can \n",
      "the nhin reduce the cost of healthcare fraud?'' journal of \n",
      "healthcare information management 22(3): 42-51. june 2008.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "d. alternatives considered\n",
      "\n",
      "    in march 2018, the white house office of american innovation and \n",
      "the cms administrator announced the launch of myhealthedata, and cms's \n",
      "direct, hands-on role in improving patient access and advancing \n",
      "interoperability. as part of the myhealthedata initiative, we are \n",
      "taking a patient-centered approach to health information access and \n",
      "moving to a system in which patients have immediate access to their \n",
      "electronic health information and can be assured that their health \n",
      "information will follow them as they move throughout the health care \n",
      "system from provider to provider, payer to payer. this final rule \n",
      "contains a range of policies. it provides descriptions of the statutory \n",
      "provisions that are addressed, identifies the policies, and presents \n",
      "rationales for our decisions and, where relevant, alternatives that \n",
      "were considered. we carefully considered alternatives to the policies \n",
      "we are adopting in this final rule but concluded that none of the\n",
      "\n",
      "[[page 25627]]\n",
      "\n",
      "alternatives would adequately and immediately begin to address the \n",
      "critical issues of the lack of patient access and interoperability, or \n",
      "the difficulty exchanging health care data within the health care \n",
      "system.\n",
      "    as we noted in the cms interoperability and patient access proposed \n",
      "rule, we believe the following three attributes of standards-based apis \n",
      "are particularly important to achieving the goal of offering \n",
      "individuals convenient access, through applications they choose, to \n",
      "available and relevant electronic health and health-related \n",
      "information: the api technologies themselves, not just the data \n",
      "accessible through them, are standardized; the apis are technically \n",
      "transparent; and the apis are implemented in a pro-competitive manner \n",
      "(84 fr 7620). the api requirements proposed and finalized in this rule \n",
      "were developed to ensure these goals are met.\n",
      "    some of the reasons that we selected the fhir standard were due to \n",
      "the flexibility it provides and the wide industry adoption that it \n",
      "offers. the open and extensible nature of fhir allows for health care \n",
      "integration to be transparent and accessible. fhir is open source, and \n",
      "as such, it has garnered a community that includes developers and \n",
      "vendors. for example, large consumer brands are becoming a driving \n",
      "force behind the adoption of fhir. apple is implementing fhir in apple \n",
      "health as part of ios 11.3, and serves as a member of the argonaut \n",
      "project and carin alliance--two hl7 fhir accelerators; \\89\\ google \n",
      "supports fhir by partnering with hl7, as well as through its membership \n",
      "in the carin alliance; and microsoft published an azure api for fhir to \n",
      "create and deploy fhir service health data solutions.\\90\\ furthermore, \n",
      "according to an onc report, nearly 51 percent of health it developers \n",
      "appear to be using a version of fhir combined with oauth 2.0 to respond \n",
      "to requests for patient data. additionally, of the hospitals and merit-\n",
      "based incentive payment system (mips) eligible clinicians that use \n",
      "certified products, almost 87 percent of hospitals and 69 percent of \n",
      "mips eligible clinicians are served by health it developers with \n",
      "product(s) certified to any fhir version.\\91\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\89\\ the hl7 fhir accelerator program is designed to assist \n",
      "communities and collaborative groups across the global health care \n",
      "spectrum in the creation and adoption of high quality fhir \n",
      "implementation guides or other standard artifacts to move toward the \n",
      "realization of global health data interoperability. for further \n",
      "details, see <a href=\"https://www.hl7.org/about/fhir-accelerator/\">https://www.hl7.org/about/fhir-accelerator/</a>.\n",
      "    \\90\\ shrestha, r., mohan, s., & grieve, g. (2018, february 14). \n",
      "state of the healthcare api economy (an innovation forum session: \n",
      "session 217). retrieved from <a href=\"https://365.himss.org/sites/himss365/files/365/handouts/552739129/handout-219_final.pdf\">https://365.himss.org/sites/himss365/files/365/handouts/552739129/handout-219_final.pdf</a>. see also <a href=\"https://azure.microsoft.com/en-us/services/azure-api-for-fhir/\">https://azure.microsoft.com/en-us/services/azure-api-for-fhir/</a> and <a href=\"https://www.apple.com/healthcare/health-records/\">https://www.apple.com/healthcare/health-records/</a>.\n",
      "    \\91\\ posnack, s. & baker, w. (2018, october 1). heat wave: the \n",
      "u.s. is poised to catch fhir in 2019. retrieved from <a href=\"https://www.healthit.gov/buzz-blog/interoperability/heat-wave-the-u-s-is-poised-to-catch-fhir-in-2019\">https://www.healthit.gov/buzz-blog/interoperability/heat-wave-the-u-s-is-poised-to-catch-fhir-in-2019</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    for additional ways to allow consumers access to their health data, \n",
      "we note that we did receive comments that cms could consider allowing \n",
      "payers and providers to upload patient data directly to a patient \n",
      "portal that is owned and managed by the patient. one option would allow \n",
      "for hies and hins to serve as a central source for patients to obtain \n",
      "aggregated data in a single location. while hies and hins can provide \n",
      "patients with valuable information via a portal, research has indicated \n",
      "that portals have not gained widespread use by patients. according to \n",
      "onc, as of 2017, 52 percent of individuals have been offered online \n",
      "access to their medical records by a health provider or payer. of the \n",
      "52 percent that were offered access, only half of those viewed their \n",
      "record.\\92\\ additionally, we believe that there would be additional \n",
      "burden associated with using portals because providers and patients \n",
      "would need to access multiple portals and websites to access patient \n",
      "data, instead of a single app. unlike portals that would require \n",
      "developers to link systems or ensure system-level compatibility, fhir-\n",
      "based apis have the ability to make data available without the need to \n",
      "link multiple systems or portals and would provide a patient a single-\n",
      "point of access to their data. having apis that can be accessed by \n",
      "third-party apps permits the patient to choose how they want to access \n",
      "their data, and it promotes innovation in industry to find ways to best \n",
      "help patients interact with their data in a way that is most meaningful \n",
      "and helpful to them. additionally, we believe it would be very \n",
      "difficult to evaluate the cost impacts of making individual portals \n",
      "available via an hie or hin because business models and process are \n",
      "varied, and there is a lack of standardization in the way the \n",
      "information is stored and transmitted across hies and hins.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\92\\ patel, v. & johnson, c. (2018, april). individuals' use of \n",
      "online medical records and technology for health needs (onc data \n",
      "brief no. 40). retrieved from <a href=\"https://www.healthit.gov/sites/default/files/page/2018-03/hints-2017-consumer-data-brief-3.21.18.pdf\">https://www.healthit.gov/sites/default/files/page/2018-03/hints-2017-consumer-data-brief-3.21.18.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    other alternatives that we considered were how broadly or narrowly \n",
      "to apply the policies and requirements. for example, we could have \n",
      "required health plans to provide more data elements via a standards-\n",
      "based api then just data for adjudicated claims, encounters with \n",
      "capitated providers, provider remittances, beneficiary cost-sharing, \n",
      "clinical data including laboratory results, provider directories (and \n",
      "pharmacy directories for ma-pds), and preferred drug lists, where \n",
      "applicable. in the cms interoperability proposed rule, we originally \n",
      "required ma organizations, state medicaid ffs programs, medicaid \n",
      "managed care plans, chip ffs programs, and chip managed care entities \n",
      "to make available provider directory data through the patient access \n",
      "api (84 fr 7633) and publicly available to current and prospective \n",
      "enrollees (84 fr 7639). after consideration of public comments, we have \n",
      "removed the requirements that these impacted payers make provider \n",
      "directory information available through the patient access api. ma \n",
      "organizations, state medicaid ffs programs, medicaid managed care \n",
      "plans, chip ffs programs, and chip managed care entities will only need \n",
      "to make provider directory information available via a publicly \n",
      "accessible provider directory api. we note the provider directory api \n",
      "does not need to conform to the security protocols finalized by hhs at \n",
      "45 cfr 170.215(a)(3) and (b) that are specific to authenticating users \n",
      "and confirming individuals' authorization or request to disclose their \n",
      "personal information to a specific application through an api, namely \n",
      "the smart ig (using the oauth 2.0 standard) and openid connect core \n",
      "1.0. by only requiring the provider directory api make these otherwise \n",
      "publicly accessible data available, we are seeking to avoid duplicative \n",
      "effort and additional burden.\n",
      "    additionally, several commenters suggested additional information \n",
      "be added to the requirement for provider directory information to be \n",
      "available through an api, such as npis for individual and group \n",
      "providers, practice group name, health system name, as well as the \n",
      "specific plan(s) and tiers a provider participates in ``provider \n",
      "demographics;'' whether the provider is accepting new patients; and \n",
      "information about which providers are in-network for a plan by \n",
      "geography and/or specialty. while we agreed with commenters that this \n",
      "information would be helpful to patients, we did not modify the \n",
      "proposed requirements for the information that is required to be made \n",
      "available by the provider directory api because we believe additional \n",
      "data would be a cost driver. by not adding additional required\n",
      "\n",
      "[[page 25628]]\n",
      "\n",
      "information we are seeking to minimize the burden for the regulated \n",
      "payers that must comply with this policy. instead we are identifying a \n",
      "minimum set of provider directory information that aligns with existing \n",
      "requirements applicable to ma organizations (including ma organizations \n",
      "that offer ma-pd plans), state medicaid and chip ffs programs, medicaid \n",
      "managed care plans, and chip managed care entities that beneficiaries \n",
      "can currently access.\n",
      "    we also looked at policy alternatives related to specific aspects \n",
      "of the api requirements. for instance, we considered whether to modify \n",
      "the requirement to make claims and encounter data, as well as clinical \n",
      "data, available through the patient access api no later than one (1) \n",
      "business day after a payer receives it. we reviewed several suggested \n",
      "alternatives such as increasing the timeframe to three (3) or five (5) \n",
      "business days to account for vendor-adjudicated claims. while we \n",
      "considered these alternatives, we ultimately decided not to adjust the \n",
      "proposed requirements because having access to this information within \n",
      "one (1) business day could empower patients to have the information \n",
      "they need, when they need it to inform care coordination. patients have \n",
      "a right to see the full lifecycle of their claims and encounter \n",
      "information as soon as it is available, even if the payment amounts may \n",
      "change due to appeal. additionally, as we noted in section xii. of this \n",
      "final rule, the burden related to api requirements is in the initial \n",
      "implementation of the system to make this information available in one \n",
      "(1) business day once received. this requirement is being implemented \n",
      "in the design and build phase and the system update cost for electronic \n",
      "availability would be the same regardless of the number of days the \n",
      "system is set up to accommodate. there is also no data on whether \n",
      "providing three (3) or five (5) days, versus one (1) day, will provide \n",
      "patients with more complete or accurate data.\n",
      "    as an alternative, we considered requiring all qhp issuers on all \n",
      "exchanges to meet the new api requirements as part of qhp \n",
      "certification. consistent with some other qhp certification \n",
      "requirements, we opted not to require sbes to include this as part of \n",
      "their certification requirements, but we strongly urge them to do so to \n",
      "ensure equitable treatment of issuers nationally and to allow consumers \n",
      "to access their health information through a third-party application no \n",
      "matter where they are insured across the country. states are the most \n",
      "knowledgeable about their consumers and insurance markets and are \n",
      "responsible for issuer compliance activities. while we believe that \n",
      "these api requirements have the potential to provide great benefit to \n",
      "consumers, complying with them will be mainly operational and sbe \n",
      "states would be required to assess qhp issuer compliance. therefore, we \n",
      "believe that sbe states should be given the flexibility to determine \n",
      "whether or not these requirements are required of their qhp issuers.\n",
      "    an additional alternative that we considered was based off one \n",
      "commenter's suggestion to incentivize plans who meet the required \n",
      "implementation dates through higher healthcare effectiveness data and \n",
      "information set (hedis) scores. although the commenter was not clear \n",
      "regarding a specific recommendation as to how to implement changes to \n",
      "the hedis score, we evaluated options such as adding a new measure \n",
      "specific to data exchange using hl7 fhir-based apis between payers and \n",
      "third-parties on the behalf of patients, or adding bonus points to the \n",
      "total score or some appropriate measure set for implementing the fhir-\n",
      "based apis required. however, after further evaluation, we believe that \n",
      "this is not a viable alternative at this time. cms cannot give a higher \n",
      "hedis score for using a digital specification because it would not be \n",
      "an accurate measure of plan performance. to consider adding a bonus to \n",
      "the highest rating if the plan meets certain standards would \n",
      "necessitate requiring a new adjustment to the star rating methodology. \n",
      "this would be a significant change to how the current star ratings are \n",
      "calculated and would have to be proposed through notice and comment \n",
      "rulemaking. given the implementation date for the api provisions for ma \n",
      "organizations, medicaid ffs programs, medicaid managed care plans, chip \n",
      "ffs programs, and chip managed care entities is january 1, 2021, and \n",
      "for qhp issuers on the ffes beginning with plan years beginning on or \n",
      "after january 1, 2021, implementing changes to the star ratings would \n",
      "not be achievable within the available timeframe to incentivize \n",
      "implementation as the commenter suggested.\n",
      "    as we recognize that advancing interoperability is no small or \n",
      "simple matter, we continue to explore alternatives and potential future \n",
      "policies. in the cms interoperability and patient access proposed rule, \n",
      "we requested comment for consideration in future rulemaking or \n",
      "subregulatory guidance on a number of alternatives related to whether \n",
      "additional policies or requirements, beyond those proposed, should be \n",
      "imposed to promote interoperability. for example, the cms innovation \n",
      "center sought comment on general principles around promoting \n",
      "interoperability as part of the design and testing of innovative \n",
      "payment and service delivery models. additionally, we sought comment on \n",
      "how we may leverage our program authority to provide support to those \n",
      "working on improving patient matching. for example, we requested \n",
      "comment on whether cms should require impacted payers use a particular \n",
      "patient matching software solution with a proven success rate of a \n",
      "certain percentage validated by hhs or a third party. we also noted \n",
      "that we will continue to consider feedback received from rfis issued in \n",
      "various rules over the course of the past 2 years and incorporate those \n",
      "suggestions into our strategy. we thank commenters for their input on \n",
      "these rfis. we will consider the comments received for potential future \n",
      "rulemaking.\n",
      "\n",
      "e. accounting statement and table\n",
      "\n",
      "    in accordance with omb circular a- 4, table 14 depicts an \n",
      "accounting statement summarizing the assessment of the benefits, costs, \n",
      "and transfers associated with this regulatory action.\n",
      "\n",
      "[[page 25629]]\n",
      "\n",
      "\n",
      "\n",
      "                                         table 14--accounting statement\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                                       units\n",
      "                                                      primary    -----------------------------------------------\n",
      "                    category                         estimate                      discount rate      period\n",
      "                                                                   year dollars      (percent)        covered\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                    benefits\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "qualitative.....................................     <bullet> api requirements will alleviative the burden for\n",
      "                                                   patients to go through separate processes to obtain access to\n",
      "                                                    each system, and the need to manually aggregate information\n",
      "                                                   that is delivered in various, often non-standardized, formats\n",
      "                                                    (not necessarily additional to the benefits assessed in the\n",
      "                                                     ria for the accompanying onc 21st century cures act final\n",
      "                                                      rule, (published elsewhere in this issue of the federal\n",
      "                                                                            register)).\n",
      "                                                    <bullet> api requirement allows for the administration of a\n",
      "                                                      more efficient and effective medicaid program by taking\n",
      "                                                   advantage of commonly used methods of information sharing and\n",
      "                                                                       data standardization.\n",
      "                                                   <bullet> api requirements would help to create a health care\n",
      "                                                    information ecosystem that allows and encourages the health\n",
      "                                                    care market to tailor products and services to compete for\n",
      "                                                      patients, thereby increasing quality, decreasing costs,\n",
      "                                                    providing potential benefits (not necessarily additional to\n",
      "                                                     the benefits assessed in the ria for the accompanying onc\n",
      "                                                    final rule), and helping them live better, healthier lives.\n",
      "                                                   <bullet> privacy and security policies are being implemented\n",
      "                                                    that permit payers to request third-party apps to attest to\n",
      "                                                    privacy and security provisions prior to providing the app\n",
      "                                                                    access to the payer's api.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                      costs\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "annualized monetized $ millions/year (low                   85.2            2019               7       2020-2029\n",
      " estimate)......................................            80.8            2019               3       2020-2029\n",
      "annualized monetized $ millions/year (primary              122.0            2019               7       2020-2029\n",
      " estimate)......................................           112.4            2019               3       2020-2029\n",
      "annualized monetized $ millions/year (high                 158.8            2019               7       2020-2029\n",
      " estimate)......................................           144.0            2019               3       2020-2029\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "non-quantified costs: non-hospital provider costs associated with development of a broad health care information\n",
      " ecosystem (regulatory benefits and fraud reduction are largely contingent upon these non-mandatory costs being\n",
      " incurred).\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                  transfers from the federal government to enrollees of commercial plans (ptc)\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "annualized monetized $ millions.................             5.4            2019               7       2020-2029\n",
      "annualized monetized $ millions.................             5.5            2018               3       2020-2029\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "non-quantified transfers: reduced fraudulent payments to providers from the federal government and other payers.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    the preceding discussion was an actual cost impact (not a transfer) \n",
      "since goods and computer services are being paid for. plans have the \n",
      "option of transferring their expenses to enrollees. in practice, \n",
      "because of market competitive forces a plan may decide to operate at a \n",
      "(partial) loss and not transfer the entire cost. it is important to \n",
      "estimate the maximum the transfer could be. some costs are transferred \n",
      "to the states (for medicaid and chip) and ultimately to the federal \n",
      "government (for medicare, medicaid, and chip, and potentially for qhp \n",
      "issuers on the ffes in the form of higher ptcs)), mitigating the amount \n",
      "transferred to enrollees. one approach to estimate impact on enrollees \n",
      "was made in section xii.b. of this ria. however, this analysis did not \n",
      "take into account transfers.\n",
      "    we now re-estimate the potential full transfer. as noted in tables \n",
      "5 through 10, we have in 2021 through 2029 under a dollar increase in \n",
      "premiums as the worst-case scenario, and we used actual costs per year. \n",
      "in this alternate analysis, we use actual amounts for each of 2021 \n",
      "through 2029 with the initial 1-year cost amortized over 9 years. in \n",
      "other words, we assume an aggregate annual cost of $84.6 million ($272 \n",
      "million/9 + $54.4 million), this is based on the low estimate 1st year \n",
      "cost of $272 million. if we use the high estimate cost $816 million we \n",
      "obtain $145 million average ($816 million/9 + $54.4 million).\n",
      "    we note that this premium increase could be counterbalanced by \n",
      "projected savings arising from the provisions in this final rule. more \n",
      "specifically, we expect the availability of portable electronic \n",
      "transfer of medical data proposed by this rule will help patients have \n",
      "the ability to move from payer to payer, provider to provider, and have \n",
      "both their clinical and administrative information travel with them \n",
      "throughout their health care journey. allowing patients to piece \n",
      "together their own information that might otherwise be lost in \n",
      "disparate systems could help make better informed patients and may lead \n",
      "to increase prevention of future medical illnesses due to improvements \n",
      "in care coordination due to better data accessibility. the savings from \n",
      "avoiding one illness or one cheaper procedure would offset the under \n",
      "one-dollar impact. however, we have no way, at this point, of \n",
      "estimating this aspect of the future savings of the rule.\n",
      "\n",
      "[[page 25630]]\n",
      "\n",
      "    we present two estimates. first, we estimate using the enrollment \n",
      "figures used in table 9 of this ria. table 9 shows that we have 110.5 \n",
      "million enrollees (17.5+73+20) in programs that will be spending about \n",
      "$84.6 million per year. ignoring federal subsidies, and assuming that \n",
      "all costs will be passed on to enrollees (which is contrary to our \n",
      "experience), the 110.5 million enrollees would each incur an extra 77 \n",
      "cents per enrollee ($84.6 million/110.5 million) a year to achieve the \n",
      "$84.6 million goal. this is the low estimate cost. the corresponding \n",
      "high estimate cost would be $1.31 per enrollee per year ($145 million/\n",
      "110.5 million). we next estimate using premium versus enrollment as was \n",
      "done in section xii.b. of this ria.\n",
      "    prior to discussing potential transfers to enrollees, we discuss \n",
      "how this final rule may affect patients not covered by plans subject to \n",
      "this rule. it is both possible and likely that an organization offering \n",
      "a plan subject to this rule may also offer plans not subject to this \n",
      "rule, and comply with the requirements of this rule for all of its \n",
      "plans, including those not subject to this rule. consequently, it is \n",
      "possible that to cover the cost of complying with this rule for plans \n",
      "that are subject to this rule and plans that are not subject to this \n",
      "rule, organizations may raise premiums for their plans that are subject \n",
      "to this rule and their plans that are not subject to this rule. it is \n",
      "possible (and we contend likely) that this final rule will affect \n",
      "enrollees in individual market plans other than qhps on the ffes, even \n",
      "though there is no requirement for such coverage to comply with this \n",
      "rule. therefore, we calculate the cost impact per enrollee should \n",
      "organizations offering plans not subject to this rule choose to comply \n",
      "with this rule with regard to those plans. the rest of the discussion \n",
      "below explores this possibility.\n",
      "    qhp issuers on the ffes: rebates are required under section \n",
      "2718(b)(1)(a) of the phsa and the implementing regulations at 45 cfr \n",
      "part 158 when an issuer does not meet the applicable threshold. the \n",
      "commercial market mlr is generally calculated as the percent of each \n",
      "dollar of after-tax premium revenue spent by the issuer on \n",
      "reimbursement for clinical services, and activities that improve the \n",
      "quality of health care. if the issuer's mlr for a state market is below \n",
      "the applicable threshold, then the issuer must return the difference to \n",
      "policyholders. it follows, that if costs of complying with this rule \n",
      "raise plan costs, and if additionally, the issuers pass on the full \n",
      "cost in the form of premium and/or are able to treat these costs as \n",
      "qias, then premiums and rebates will change. the following two highly \n",
      "simplified examples are illustrative.\n",
      "    suppose the mlr threshold is 80 percent (in practice it can vary by \n",
      "state market), but the issuer's mlr is below the threshold at 70 \n",
      "percent. then, the issuer would have to return the 10 percent as a \n",
      "rebate. if the costs of complying with this rule for an issuer are on \n",
      "average 6 percent of premium and the issuer treats these expenses as \n",
      "qia, the issuer will now have to rebate only 4 percent instead of 10 \n",
      "percent (that is, the issuer's mlr would be 76 percent rather than 70 \n",
      "percent). similarly, if both the applicable threshold and issuer mlr \n",
      "are 80 percent, then the issuer would not owe a rebate.\n",
      "    there are two effects of recognizing these costs as qia: (1) for \n",
      "issuers subject to this rule who are below the applicable mlr \n",
      "threshold, the rebate from issuers to policyholders would go down by \n",
      "some amount between $0 and the cost of complying with this rule; and \n",
      "(2) for issuers subject to this rule who are at or above the mlr \n",
      "standards, the premium transfers from enrollees to issuers will go up \n",
      "by some amount between $0 and the cost of complying with this rule. we \n",
      "note that both mlr and rebates are calculated by combining all of an \n",
      "issuer's business (on- and off-exchange) within a state and market.\n",
      "    to estimate these amounts, we used the public use 2016 mlr files on \n",
      "the cms website that were used for tables 6 through 9 of this ria. the \n",
      "total reported 2016 premium revenue on the commercial side for \n",
      "individual market plans was approximately $77 billion (see table 7). of \n",
      "the $77 billion, the total reported 2016 premium revenue of issuers \n",
      "that were below the commercial mlr standard (80 or 85 percent, \n",
      "depending on the market) was approximately $4 billion.\n",
      "    as mentioned earlier, to proceed further we use the estimates of \n",
      "the costs of complying with this rule, which are $84.6 million per \n",
      "year. this cost is for all parent organizations with each parent \n",
      "organization possibly dealing with up to four lines of business subject \n",
      "to mlr requirements and the requirements of this rule: ma (including \n",
      "part d sponsors); medicaid; chip; and qhp issuers on the ffes. thus, of \n",
      "the $84.6 million level annual cost of complying with this rule, we \n",
      "estimate $18.8 million (22.19 percent commercial proportion * $84.6 \n",
      "million level annual cost complying with this rule) to be the cost for \n",
      "individual market plans.\n",
      "    in estimating the transfers to policyholders in individual market \n",
      "plans, we must distinguish between the $4 billion of premium revenues \n",
      "of issuers whose mlr was below the applicable threshold and the $73 \n",
      "billion of premium revenues ($77 billion total revenue for individual \n",
      "market plans- $4 billion) of individual market issuers whose mlr was at \n",
      "or above the applicable threshold. we can now calculate the estimated \n",
      "aggregate transfer in the commercial health insurance market from \n",
      "individual market policyholders to issuers whether through premium or \n",
      "rebates as follows:\n",
      "    <bullet> percentage cost of complying with this rule = 0.0244 \n",
      "percent of revenue premium ($18.8 million cost/$77 billion total \n",
      "revenue).\n",
      "    <bullet> reduced mlr rebates = $1 million (0.0244 percent x $4 \n",
      "billion premium from issuers below the applicable mlr threshold).\n",
      "    <bullet> increased premiums = up to $17.8 million (0.0244 percent x \n",
      "($77 billion total revenue-$4 billion premium from issuers below the \n",
      "applicable mlr threshold)).\n",
      "    <bullet> total transfer from enrollees = up to $418.8 million \n",
      "($17.8 million increased premium + $1 million reduced rebate).\n",
      "    <bullet> transfer per enrollee = $1.07 ($418.8 million/17.5 million \n",
      "commercial health insurance enrollees).\n",
      "    we note that the $1.07 (under a dollar per enrollee) is consistent \n",
      "with the results obtained in tables 6 through 10 (with exact raw \n",
      "amounts by year without amortization of a large first year expense). \n",
      "these calculations are summarized in table 15. the $1.07 is the low \n",
      "estimate of first year costs. the high estimate $1.85 per enrollee per \n",
      "year is obtained by replacing the low estimate cost of $272 million \n",
      "with $816 million.\n",
      "\n",
      "                          table 15--transfers to enrollee resulting from the final rule\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "         label                      item                amount             source                comments\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(a)....................  first year cost of                  272.0  estimated in this     in millions.\n",
      "                          interoperability (low                      proposed rule.\n",
      "                          estimate).\n",
      "\n",
      "[[page 25631]]\n",
      "\n",
      " \n",
      "(b)....................  first year cost amortized            30.2  (a) / 9.............  in millions.\n",
      "                          over 9 years.\n",
      "(c)....................  continuation year cost of            54.4  estimated in this     in millions.\n",
      "                          interoperability.                          proposed rule.\n",
      "(d)....................  level interoperability               84.6  (b) + (c)...........  in millions.\n",
      "                          cost per year.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                     commercial percent of premium revenues\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(e)....................  total premium revenues in             347  table 7.............  in billions.\n",
      "                          individual market,\n",
      "                          medicaid and medicare.\n",
      "(f)....................  individual market plans                77  22.19%..............  table 7.\n",
      "                          premium revenues (dollar\n",
      "                          amount and percent).\n",
      "(g)....................  medicare advantage                    157  45.24%..............  table 7.\n",
      "                          premium revenues (dollar\n",
      "                          amount and percent).\n",
      "(h)....................  medicaid premium revenues             113  32.56%..............  table 7.\n",
      "                          (dollar amount and\n",
      "                          percent).\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "   annual interoperability cost as a percent of commercial individual market health insurance premium revenues\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(i)....................  annual level                         84.6  (d).................  in millions.\n",
      "                          interoperability cost.\n",
      "(j)....................  percent of total                   22.19%  (f).................\n",
      "                          individual market plans\n",
      "                          revenues.\n",
      "(k)....................  interoperability cost for            18.8  (i) x (j)...........  in millions.\n",
      "                          individual market plans.\n",
      "(l)....................  commercial premium                 77,000  (e).................  2016 data in millions.\n",
      "                          revenues for individual\n",
      "                          market plans.\n",
      "(m)....................  interoperability cost as          0.0244%  (k) / (l)...........\n",
      "                          a percent of total\n",
      "                          commercial revenue for\n",
      "                          individual market plans.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "      individual market plans revenue broken out by whether above or below mlr threshold (requiring rebate)\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(n)....................  total individual market            77,000  (e).................  in millions.\n",
      "                          plan revenue.\n",
      "(o)....................  revenues of individual              4,037  2016 cms mlr data in  in millions.\n",
      "                          market health plans                        millions.\n",
      "                          whose mlr is below\n",
      "                          regulatory threshold.\n",
      "(p)....................  revenues of individual             72,963  (n)-(o).............  in millions.\n",
      "                          market plans whose mlr\n",
      "                          is below regulatory\n",
      "                          threshold.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                 transfer to enrollee per enrollee from decreased rebates and increased premium\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "(q)....................  reduction in rebates from             1.0  (n) x (o)...........  in millions.\n",
      "                          interoperability in\n",
      "                          those plans paying\n",
      "                          rebates.\n",
      "(r)....................  premium increase from                17.8  (n) x (p)...........\n",
      "                          interoperability in\n",
      "                          those plans not paying\n",
      "                          rebates.\n",
      "(s)....................  total increase to                    18.8  (q) + (r)...........  in millions.\n",
      "                          commercial individual\n",
      "                          market plans enrollees\n",
      "                          from interoperability.\n",
      "(t)....................  number commercial                    17.5  from 2016 mlr files,  in millions.\n",
      "                          enrollees in individual                    in millions.\n",
      "                          market plans.\n",
      "(u)....................  dollar increase in                  $1.07  (s) / (t)...........\n",
      "                          premium per enrollee\n",
      "                          (low estimate).\n",
      "(v)....................  dollar increase in                  $1.46  obtained by\n",
      "                          premium per enrollee                       replacing 272\n",
      "                          (medium estimate).                         million in row (a)\n",
      "                                                                     with $544 million.\n",
      "(w)....................  dollar increase in                  $1.84  obtained by\n",
      "                          premium per enrollee                       replacing 272\n",
      "                          (high estimate).                           million in row (a)\n",
      "                                                                     with $816 million.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "f. regulatory reform analysis under e.o. 13771\n",
      "\n",
      "    executive order 13771, titled reducing regulation and controlling \n",
      "regulatory costs, was issued on january 30, 2017 and requires that the \n",
      "costs associated with significant new regulations ``shall, to the \n",
      "extent permitted by law, be offset by the elimination of existing costs \n",
      "associated with at least two prior regulations.'' this final rule is \n",
      "considered an e.o. 13771 regulatory action. we estimate that this rule \n",
      "generates $77.8 million in annualized costs, discounted at 7 percent \n",
      "relative to year 2016, over an infinite time horizon estimate. details \n",
      "on the estimated costs of this final rule can be found in the preceding \n",
      "analysis.\n",
      "\n",
      "g. conclusion\n",
      "\n",
      "    the analysis above, together with the preceding preamble, provides \n",
      "an ria.\n",
      "    in accordance with the provisions of executive order 12866, this \n",
      "regulation was reviewed by the office of management and budget.\n",
      "\n",
      "list of subjects\n",
      "\n",
      "42 cfr part 406\n",
      "\n",
      "    health facilities, diseases, medicare.\n",
      "\n",
      "42 cfr part 407\n",
      "\n",
      "    medicare.\n",
      "\n",
      "42 cfr part 422\n",
      "\n",
      "    administrative practice and procedure, health facilities, health \n",
      "maintenance organizations (hmo), medicare, penalties, privacy, \n",
      "reporting and recordkeeping requirements.\n",
      "\n",
      "42 cfr part 423\n",
      "\n",
      "    administrative practice and procedure, emergency medical services, \n",
      "health facilities, health maintenance organizations (hmo), medicare, \n",
      "penalties, privacy, reporting and recordkeeping requirements.\n",
      "\n",
      "[[page 25632]]\n",
      "\n",
      "42 cfr part 431\n",
      "\n",
      "    grant programs--health, health facilities, medicaid, privacy, \n",
      "reporting and recordkeeping requirements.\n",
      "\n",
      "42 cfr part 438\n",
      "\n",
      "    grant programs--health, medicaid, reporting and recordkeeping \n",
      "requirements.\n",
      "\n",
      "42 cfr part 457\n",
      "\n",
      "    administrative practice and procedure, grant programs--health, \n",
      "health insurance, reporting and recordkeeping requirements.\n",
      "\n",
      "42 cfr part 482\n",
      "\n",
      "    grant programs--health, hospitals, medicaid, medicare, reporting \n",
      "and recordkeeping requirements.\n",
      "\n",
      "42 cfr part 485\n",
      "\n",
      "    grant programs--health, health facilities, medicaid, privacy, \n",
      "reporting and recordkeeping requirements.\n",
      "\n",
      "45 cfr part 156\n",
      "\n",
      "    administrative practice and procedure, advertising, advisory \n",
      "committees, brokers, conflict of interests, consumer protection, grant \n",
      "programs--health, grants administration, health care, health insurance, \n",
      "health maintenance organization (hmo), health records, hospitals, \n",
      "indians, individuals with disabilities, loan programs--health, \n",
      "medicaid, organization and functions (government agencies), public \n",
      "assistance programs, reporting and recordkeeping requirements, state \n",
      "and local governments, sunshine act, technical assistance, women, \n",
      "youth.\n",
      "\n",
      "    for the reasons set forth in the preamble, the centers for medicare \n",
      "& medicaid services (cms) amends 42 cfr chapter iv and the office of \n",
      "the secretary (hhs) amends 45 cfr subtitle a, subchapter b, as set \n",
      "forth below:\n",
      "\n",
      "title 42--public health\n",
      "\n",
      "chapter iv--centers for medicare & medicaid services, department of \n",
      "health and human services\n",
      "\n",
      "part 406--hospital insurance eligibliity and entitlement\n",
      "\n",
      "0\n",
      "1. the authority citation for part 406 is revised to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c 1302 and 1395hh.\n",
      "\n",
      "\n",
      "0\n",
      "2. section 406.26 is amended by adding paragraph (a)(1)(i) and adding \n",
      "and reserving paragraph (a)(1)(ii) to read as follows:\n",
      "\n",
      "\n",
      "sec.  406.26  enrollment under state buy-in.\n",
      "\n",
      "    (a) * * *\n",
      "    (1) * * *\n",
      "    (i) any state that has a buy-in agreement in effect must \n",
      "participate in daily exchanges of enrollment data with cms.\n",
      "    (ii) [reserved]\n",
      "* * * * *\n",
      "\n",
      "part 407--supplementary medical insurance (smi) enrollment and \n",
      "entitlement\n",
      "\n",
      "0\n",
      "3. the authority citation for part 407 is revised to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c 1302 and 1395hh.\n",
      "\n",
      "\n",
      "0\n",
      "4. section 407.40 is amended by adding paragraph (c)(4) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  407.40  enrollment under a state buy-in agreement.\n",
      "\n",
      "* * * * *\n",
      "    (c) * * *\n",
      "    (4) any state that has a buy-in agreement in effect must \n",
      "participate in daily exchanges of enrollment data with cms.\n",
      "\n",
      "part 422--medicare advantage program\n",
      "\n",
      "0\n",
      "5. the authority citation for part 422 continues to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c 1302 and 1395hh.\n",
      "\n",
      "\n",
      "0\n",
      "6. section 422.119 is added to read as follows:\n",
      "\n",
      "\n",
      "sec.  422.119  access to and exchange of health data and plan \n",
      "information.\n",
      "\n",
      "    (a) application programming interface to support ma enrollees. a \n",
      "medicare advantage (ma) organization must implement and maintain a \n",
      "standards-based application programming interface (api) that permits \n",
      "third-party applications to retrieve, with the approval and at the \n",
      "direction of a current individual ma enrollee or the enrollee's \n",
      "personal representative, data specified in paragraph (b) of this \n",
      "section through the use of common technologies and without special \n",
      "effort from the enrollee.\n",
      "    (b) accessible content. (1) an ma organization must make the \n",
      "following information accessible to its current enrollees or the \n",
      "enrollee's personal representative through the api described in \n",
      "paragraph (a) of this section:\n",
      "    (i) data concerning adjudicated claims, including claims data for \n",
      "payment decisions that may be appealed, were appealed, or are in the \n",
      "process of appeal, and provider remittances and enrollee cost-sharing \n",
      "pertaining to such claims, no later than one (1) business day after a \n",
      "claim is processed;\n",
      "    (ii) encounter data from capitated providers, no later than one (1) \n",
      "business day after data concerning the encounter is received by the ma \n",
      "organization; and\n",
      "    (iii) clinical data, including laboratory results, if the ma \n",
      "organization maintains any such data, no later than one (1) business \n",
      "day after the data is received by the ma organization.\n",
      "    (2) in addition to the information specified in paragraph (b)(1) of \n",
      "this section, an ma organization that offers an ma-pd plan must make \n",
      "the following information accessible to its enrollees through the api \n",
      "described in paragraph (a) of this section:\n",
      "    (i) data concerning adjudicated claims for covered part d drugs, \n",
      "including remittances and enrollee cost-sharing, no later than one (1) \n",
      "business day after a claim is adjudicated; and,\n",
      "    (ii) formulary data that includes covered part d drugs, and any \n",
      "tiered formulary structure or utilization management procedure which \n",
      "pertains to those drugs.\n",
      "    (c) technical requirements. an ma organization implementing an api \n",
      "under paragraph (a) of this section:\n",
      "    (1) must implement, maintain, and use api technology conformant \n",
      "with 45 cfr 170.215;\n",
      "    (2) must conduct routine testing and monitoring, and update as \n",
      "appropriate, to ensure the api functions properly, including \n",
      "assessments to verify that the api is fully and successfully \n",
      "implementing privacy and security features such as, but not limited to, \n",
      "those required to comply with hipaa privacy and security requirements \n",
      "in 45 cfr parts 160 and 164, 42 cfr parts 2 and 3, and other applicable \n",
      "law protecting the privacy and security of individually identifiable \n",
      "data;\n",
      "    (3) must comply with the content and vocabulary standard \n",
      "requirements in paragraphs (c)(3)(i) and (ii) of this section, as \n",
      "applicable to the data type or data element, unless alternate standards \n",
      "are required by other applicable law:\n",
      "    (i) content and vocabulary standards at 45 cfr 170.213 where such \n",
      "standards are applicable to the data type or element, as appropriate; \n",
      "and\n",
      "    (ii) content and vocabulary standards at 45 cfr part 162 and sec.  \n",
      "423.160 of this chapter where required by law or where such standards \n",
      "are applicable to the data type or element, as appropriate.\n",
      "    (4) may use an updated version of any standard or all standards \n",
      "required under paragraph (c)(1) or (3) of this section, where:\n",
      "    (i) use of the updated version of the standard is required by other \n",
      "applicable law; or\n",
      "\n",
      "[[page 25633]]\n",
      "\n",
      "    (ii) use of the updated version of the standard is not prohibited \n",
      "under other applicable law, provided that:\n",
      "    (a) for content and vocabulary standards other than those at 45 cfr \n",
      "170.213, the secretary has not prohibited use of the updated version of \n",
      "a standard for purposes of this section or 45 cfr part 170;\n",
      "    (b) for standards at 45 cfr 170.213 and 45 cfr 170.215, the \n",
      "national coordinator has approved the updated version for use in the \n",
      "onc health it certification program; and\n",
      "    (c) use of the updated version of a standard does not disrupt an \n",
      "end user's ability to access the data described in paragraph (b) of \n",
      "this section through the api described in paragraph (a) of this \n",
      "section.\n",
      "    (d) documentation requirements for apis. for each api implemented \n",
      "in accordance with paragraph (a) of this section, an ma organization \n",
      "must make publicly accessible, by posting directly on its website or \n",
      "via publicly accessible hyperlink(s), complete accompanying \n",
      "documentation that contains, at a minimum the information listed in \n",
      "this paragraph. for the purposes of this section, ``publicly \n",
      "accessible'' means that any person using commonly available technology \n",
      "to browse the internet could access the information without any \n",
      "preconditions or additional steps, such as a fee for access to the \n",
      "documentation; a requirement to receive a copy of the material via \n",
      "email; a requirement to register or create an account to receive the \n",
      "documentation; or a requirement to read promotional material or agree \n",
      "to receive future communications from the organization making the \n",
      "documentation available;\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return variables and their types/\n",
      "structures, exceptions and exception handling methods and their \n",
      "returns;\n",
      "    (2) the software components and configurations an application must \n",
      "use in order to successfully interact with the api and process its \n",
      "response(s); and\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with any authorization server(s) \n",
      "deployed in conjunction with the api.\n",
      "    (e) denial or discontinuation of access to the api. an ma \n",
      "organization may deny or discontinue any third party application's \n",
      "connection to the api required under paragraph (a) of this section if \n",
      "the ma organization:\n",
      "    (1) reasonably determines, consistent with its security risk \n",
      "analysis under 45 cfr part 164 subpart c, that allowing an application \n",
      "to connect or remain connected to the api would present an unacceptable \n",
      "level of risk to the security of protected health information on the ma \n",
      "organization's systems; and\n",
      "    (2) makes this determination using objective, verifiable criteria \n",
      "that are applied fairly and consistently across all applications and \n",
      "developers through which enrollees seek to access their electronic \n",
      "health information, as defined at 45 cfr 171.102, including but not \n",
      "limited to criteria that may rely on automated monitoring and risk \n",
      "mitigation tools.\n",
      "    (f) coordination among payers. (1) an ma organization must maintain \n",
      "a process for the electronic exchange of, at a minimum, the data \n",
      "classes and elements included in the content standard adopted at 45 cfr \n",
      "170.213. such information received by an ma organization must be \n",
      "incorporated into the ma organization's records about the current \n",
      "enrollee. with the approval and at the direction of a current or former \n",
      "enrollee or the enrollee's personal representative, the ma organization \n",
      "must:\n",
      "    (i) receive all such data for a current enrollee from any other \n",
      "payer that has provided coverage to the enrollee within the preceding 5 \n",
      "years;\n",
      "    (ii) at any time an enrollee is currently enrolled in the ma plan \n",
      "and up to 5 years after disenrollment, send all such data to any other \n",
      "payer that currently covers the enrollee or a payer the enrollee or the \n",
      "enrollee's personal representative specifically requests receive the \n",
      "data; and\n",
      "    (iii) send data received from another payer under this paragraph \n",
      "(f) in the electronic form and format it was received.\n",
      "    (2) [reserved]\n",
      "    (g) enrollee resources regarding privacy and security. an ma \n",
      "organization must provide in an easily accessible location on its \n",
      "public website and through other appropriate mechanisms through which \n",
      "it ordinarily communicates with current and former enrollees seeking to \n",
      "access their health information held by the ma organization, \n",
      "educational resources in non-technical, simple and easy-to-understand \n",
      "language explaining at a minimum:\n",
      "    (1) general information on steps the individual may consider taking \n",
      "to help protect the privacy and security of their health information \n",
      "including factors to consider in selecting an application including \n",
      "secondary uses of data, and the importance of understanding the \n",
      "security and privacy practices of any application to which they will \n",
      "entrust their health information; and\n",
      "    (2) an overview of which types of organizations or individuals are \n",
      "and are not likely to be hipaa covered entities, the oversight \n",
      "responsibilities of the office for civil rights (ocr) and the federal \n",
      "trade commission (ftc), and how to submit a complaint to:\n",
      "    (i) the hhs office for civil rights (ocr); and\n",
      "    (ii) the federal trade commission (ftc).\n",
      "    (h) applicability. (1) an ma organization must comply with the \n",
      "requirements in paragraphs (a) through (e) and (g) of this section \n",
      "beginning january 1, 2021, and with the requirements in paragraph (f) \n",
      "beginning january 1, 2022 with regard to data:\n",
      "    (i) with a date of service on or after january 1, 2016; and\n",
      "    (ii) that are maintained by the ma organization.\n",
      "    (2) [reserved]\n",
      "\n",
      "0\n",
      "7. section 422.120 is added to read as follows:\n",
      "\n",
      "\n",
      "sec.  422.120  access to published provider directory information.\n",
      "\n",
      "    (a) an ma organization must implement and maintain a publicly \n",
      "accessible, standards-based application programming interface (api) \n",
      "that is conformant with the technical requirements at sec.  422.119(c), \n",
      "excluding the security protocols related to user authentication and \n",
      "authorization and any other protocols that restrict the availability of \n",
      "this information to particular persons or organizations, the \n",
      "documentation requirements at sec.  422.119(d), and is accessible via a \n",
      "public-facing digital endpoint on the ma organization's website.\n",
      "    (b) the api must provide a complete and accurate directory of--\n",
      "    (1) the ma plan's network of contracted providers, including names, \n",
      "addresses, phone numbers, and specialties, updated no later than 30 \n",
      "calendar days after the ma organizations receives provider directory \n",
      "information or updates to provider directory information; and\n",
      "    (2) for an ma organization that offers an ma-pd plan, the ma-pd's \n",
      "pharmacy directory, including the pharmacy name, address, phone number, \n",
      "number of pharmacies in the network, and mix (specifically the type of \n",
      "pharmacy, such as ``retail pharmacy'') updated no later than 30 \n",
      "calendar days after the ma organization receives pharmacy directory \n",
      "information or updates to pharmacy directory information.\n",
      "    (c) this section is applicable beginning january 1, 2021.\n",
      "\n",
      "[[page 25634]]\n",
      "\n",
      "\n",
      "0\n",
      "8. section 422.504 is amended by adding paragraph (a)(18) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  422.504  contract provisions.\n",
      "\n",
      "* * * * *\n",
      "    (a) * * *\n",
      "    (18) to comply with the requirements for access to health data and \n",
      "plan information under sec. sec.  422.119 and 422.120 of this chapter.\n",
      "* * * * *\n",
      "\n",
      "part 423--voluntary medicare perscription drug benefit\n",
      "\n",
      "0\n",
      "9. the authority citation for part 423 is revised to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c. 1302, 1306, 1395w-101 through 1395w-152, \n",
      "and 1395hh.\n",
      "\n",
      "\n",
      "0\n",
      "10. section 423.910 is amended--\n",
      "0\n",
      "a. in paragraph (b)(1) introductory text by removing the phrase \n",
      "``monthly reporting requirement for the monthly enrollment reporting'' \n",
      "and adding in its place the phrase ``state enrollment reporting \n",
      "requirement described in paragraph (d) of this section'';\n",
      "0\n",
      "b. in paragraph (d) by revising the paragraph heading and by \n",
      "redesignating the text of paragraph (d) introductory text as paragraph \n",
      "(d)(1).\n",
      "0\n",
      "c. in newly redesignated paragraph (d)(1), by removing the phrase \n",
      "``effective june 2005, and each subsequent month, states must submit an \n",
      "electronic file, in a manner specified by cms'' and by adding the \n",
      "following phrase ``states must submit an electronic file as specified \n",
      "in paragraph (d)(2) of this section,''; and\n",
      "0\n",
      "d. by adding paragraph (d)(2).\n",
      "    the revision and addition read as follows:\n",
      "\n",
      "\n",
      "sec.  423.910  requirements.\n",
      "\n",
      "* * * * *\n",
      "    (d) * * *\n",
      "    (2)(i) for the period prior to april 1, 2022, states must submit \n",
      "the file at least monthly and may submit updates to that file on a more \n",
      "frequent basis.\n",
      "    (ii) for the period beginning april 1, 2022, states must submit the \n",
      "file at least monthly and must submit updates to that file on a daily \n",
      "basis.\n",
      "* * * * *\n",
      "\n",
      "part 431--state organization and general administration\n",
      "\n",
      "0\n",
      "11. the authority citation for part 431 is revised to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c. 1302.\n",
      "\n",
      "\n",
      "0\n",
      "12. section 431.60 is added to subpart b to read as follows:\n",
      "\n",
      "\n",
      "sec.  431.60  beneficiary access to and exchange of data.\n",
      "\n",
      "    (a) application programming interface to support medicaid \n",
      "beneficiaries. a state must implement and maintain a standards-based \n",
      "application programming interface (api) that permits third-party \n",
      "applications to retrieve, with the approval and at the direction of a \n",
      "current beneficiary or the beneficiary's personal representative, data \n",
      "specified in paragraph (b) of this section through the use of common \n",
      "technologies and without special effort from the beneficiary.\n",
      "    (b) accessible content. a state must make the following information \n",
      "accessible to its current beneficiaries or the beneficiary's personal \n",
      "representative through the api described in paragraph (a) of this \n",
      "section:\n",
      "    (1) data concerning adjudicated claims, including claims data for \n",
      "payment decisions that may be appealed, were appealed, or are in the \n",
      "process of appeal, and provider remittances and beneficiary cost-\n",
      "sharing pertaining to such claims, no later than one (1) business day \n",
      "after a claim is processed;\n",
      "    (2) encounter data no later than one (1) business day after \n",
      "receiving the data from providers, other than mcos, pihps, and pahps, \n",
      "compensated on the basis of capitation payments;\n",
      "    (3) clinical data, including laboratory results, if the state \n",
      "maintains any such data, no later than one (1) business day after the \n",
      "data is received by the state; and\n",
      "    (4) information about covered outpatient drugs and updates to such \n",
      "information, including, where applicable, preferred drug list \n",
      "information, no later than one (1) business day after the effective \n",
      "date of any such information or updates to such information.\n",
      "    (c) technical requirements. a state implementing an api under \n",
      "paragraph (a) of this section:\n",
      "    (1) must implement, maintain, and use api technology conformant \n",
      "with 45 cfr 170.215;\n",
      "    (2) must conduct routine testing and monitoring, and update as \n",
      "appropriate, to ensure the api functions properly, including \n",
      "assessments to verify that the api is fully and successfully \n",
      "implementing privacy and security features such as, but not limited to, \n",
      "those required to comply with hipaa privacy and security requirements \n",
      "in 45 cfr parts 160 and 164, 42 cfr parts 2 and 3, and other applicable \n",
      "law protecting the privacy and security of individually identifiable \n",
      "data;\n",
      "    (3) must comply with the content and vocabulary standards \n",
      "requirements in paragraphs (c)(3)(i) and (ii) of this section, as \n",
      "applicable to the data type or data element, unless alternate standards \n",
      "are required by other applicable law:\n",
      "    (i) content and vocabulary standards at 45 cfr 170.213 where such \n",
      "standards are applicable to the data type or element, as appropriate; \n",
      "and\n",
      "    (ii) content and vocabulary standards at 45 cfr part 162 and sec.  \n",
      "423.160 of this chapter where required by law, or where such standards \n",
      "are applicable to the data type or element, as appropriate.\n",
      "    (4) may use an updated version of any standard or all standards \n",
      "required under paragraph (c)(1) or (3) of this section, where:\n",
      "    (i) use of the updated version of the standard is required by other \n",
      "applicable law, or\n",
      "    (ii) use of the updated version of the standard is not prohibited \n",
      "under other applicable law, provided that:\n",
      "    (a) for content and vocabulary standards other than those at 45 cfr \n",
      "170.213, the secretary has not prohibited use of the updated version of \n",
      "a standard for purposes of this section or 45 cfr part 170;\n",
      "    (b) for standards at 45 cfr 170.213 and 45 cfr 170.215, the \n",
      "national coordinator has approved the updated version for use in the \n",
      "onc health it certification program; and\n",
      "    (c) use of the updated version of a standard does not disrupt an \n",
      "end user's ability to access the data described in paragraph (b) of \n",
      "this section through the api described in paragraph (a) of this \n",
      "section.\n",
      "    (d) documentation requirements for apis. for each api implemented \n",
      "in accordance with paragraph (a) of this section, a state must make \n",
      "publicly accessible, by posting directly on its website or via publicly \n",
      "accessible hyperlink(s), complete accompanying documentation that \n",
      "contains, at a minimum the information listed in this paragraph. for \n",
      "the purposes of this section, ``publicly accessible'' means that any \n",
      "person using commonly available technology to browse the internet could \n",
      "access the information without any preconditions or additional steps, \n",
      "such as a fee for access to the documentation; a requirement to receive \n",
      "a copy of the material via email; a requirement to register or create \n",
      "an account to receive the documentation; or a requirement to read \n",
      "promotional material or agree to receive future communications from the \n",
      "organization making the documentation available;\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return\n",
      "\n",
      "[[page 25635]]\n",
      "\n",
      "variables and their types/structures, exceptions and exception handling \n",
      "methods and their returns;\n",
      "    (2) the software components and configurations an application must \n",
      "use in order to successfully interact with the api and process its \n",
      "response(s); and\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with any authorization server(s) \n",
      "deployed in conjunction with the api.\n",
      "    (e) denial or discontinuation of access to the api. a state may \n",
      "deny or discontinue any third-party application's connection to the api \n",
      "required under paragraph (a) of this section if the state:\n",
      "    (1) reasonably determines, consistent with its security risk \n",
      "analysis under 45 cfr part 164 subpart c, that allowing an application \n",
      "to connect or remain connected to the api would present an unacceptable \n",
      "level of risk to the security of protected health information on the \n",
      "state's systems; and\n",
      "    (2) makes this determination using objective, verifiable criteria \n",
      "that are applied fairly and consistently across all applications and \n",
      "developers through which beneficiaries seek to access their electronic \n",
      "health information as defined at 45 cfr 171.102, including but not \n",
      "limited to criteria that may rely on automated monitoring and risk \n",
      "mitigation tools.\n",
      "    (f) beneficiary resources regarding privacy and security. the state \n",
      "must provide in an easily accessible location on its public website and \n",
      "through other appropriate mechanisms through which it ordinarily \n",
      "communicates with current and former beneficiaries seeking to access \n",
      "their health information held by the state medicaid agency, educational \n",
      "resources in non-technical, simple and easy-to-understand language \n",
      "explaining at a minimum:\n",
      "    (1) general information on steps the individual may consider taking \n",
      "to help protect the privacy and security of their health information, \n",
      "including factors to consider in selecting an application including \n",
      "secondary uses of data, and the importance of understanding the \n",
      "security and privacy practices of any application to which they will \n",
      "entrust their health information; and\n",
      "    (2) an overview of which types of organizations or individuals are \n",
      "and are not likely to be hipaa covered entities, the oversight \n",
      "responsibilities of the office for civil rights (ocr) and the federal \n",
      "trade commission (ftc), and how to submit a complaint to:\n",
      "    (i) the hhs office for civil rights (ocr); and\n",
      "    (ii) the federal trade commission (ftc).\n",
      "    (g) data availability. (1) the state must comply with the \n",
      "requirements in paragraph (a) through (f) of this section beginning \n",
      "january 1, 2021 with regard to data:\n",
      "    (i) with a date of service on or after january 1, 2016; and\n",
      "    (ii) that are maintained by the state.\n",
      "    (2) [reserved]\n",
      "\n",
      "0\n",
      "13. section 431.70 is added to subpart b to read as follows:\n",
      "\n",
      "\n",
      "sec.  431.70  access to published provider directory information.\n",
      "\n",
      "    (a) the state must implement and maintain a publicly accessible, \n",
      "standards-based application programming interface (api) that is \n",
      "conformant with the technical requirements at sec.  431.60(c), \n",
      "excluding the security protocols related to user authentication and \n",
      "authorization and any other protocols that restrict the availability of \n",
      "this information to particular persons or organizations, the \n",
      "documentation requirements at sec.  431.60(d), and is accessible via a \n",
      "public-facing digital endpoint on the state's website.\n",
      "    (b) the api must provide a complete and accurate directory of--\n",
      "    (1) the state's provider directory information specified in section \n",
      "1902(a)(83) of the act, updated no later than 30 calendar days after \n",
      "the state receives provider directory information or updates to \n",
      "provider directory information.\n",
      "    (2) [reserved]\n",
      "    (c) this section is applicable beginning january 1, 2021.\n",
      "\n",
      "part 438--managed care\n",
      "\n",
      "0\n",
      "14. the authority citation for part 438 is revised to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c. 1302.\n",
      "\n",
      "\n",
      "0\n",
      "15. section 438.62 is amended by adding paragraphs (b)(1)(vi) and (vii) \n",
      "to read as follows:\n",
      "\n",
      "\n",
      "sec.  438.62  continued services to enrollees.\n",
      "\n",
      "* * * * *\n",
      "    (b) * * *\n",
      "    (1) * * *\n",
      "    (vi) a process for the electronic exchange of, at a minimum, the \n",
      "data classes and elements included in the content standard adopted at \n",
      "45 cfr 170.213. such information received by the mco, pihp, or pahp \n",
      "must be incorporated into the mco's, pihp's, or pahp's records about \n",
      "the current enrollee. with the approval and at the direction of a \n",
      "current or former enrollee or the enrollee's personal representative, \n",
      "the mco, pihp, or pahp must:\n",
      "    (a) receive all such data for a current enrollee from any other \n",
      "payer that has provided coverage to the enrollee within the preceding 5 \n",
      "years;\n",
      "    (b) at any time the enrollee is currently enrolled in the mco, \n",
      "pihp, or pahp and up to 5 years after disenrollment, send all such data \n",
      "to any other payer that currently covers the enrollee or a payer the \n",
      "enrollee or the enrollee's personal representative specifically \n",
      "requests receive the data; and\n",
      "    (c) send data received from another payer under this paragraph in \n",
      "the electronic form and format it was received.\n",
      "    (vii) applicability.\n",
      "    (a) the mco, pihp, or pahp must comply with the requirements in \n",
      "paragraph (b)(1)(vi) of this section beginning january 1, 2022 with \n",
      "regard to data:\n",
      "    (1) with a date of service on or after january 1, 2016; and\n",
      "    (2) that are maintained by the mco, pihp, or pahp.\n",
      "    (b) [reserved]\n",
      "* * * * *\n",
      "\n",
      "0\n",
      "16. section 438.242 is amended by adding paragraphs (b)(5) and (6) to \n",
      "read as follows:\n",
      "\n",
      "\n",
      "sec.  438.242  health information systems.\n",
      "\n",
      "* * * * *\n",
      "    (b) * * *\n",
      "    (5) implement an application programming interface (api) as \n",
      "specified in sec.  431.60 of this chapter as if such requirements \n",
      "applied directly to the mco, pihp, or pahp and include--\n",
      "    (i) all encounter data, including encounter data from any network \n",
      "providers the mco, pihp, or pahp is compensating on the basis of \n",
      "capitation payments and adjudicated claims and encounter data from any \n",
      "subcontractors.\n",
      "    (ii) [reserved]\n",
      "    (6) implement, by january 1, 2021, and maintain a publicly \n",
      "accessible standards-based api described in sec.  431.70, which must \n",
      "include all information specified in sec.  438.10(h)(1) and (2) of this \n",
      "chapter.\n",
      "* * * * *\n",
      "\n",
      "part 457--allotments and grants to states\n",
      "\n",
      "0\n",
      "17. the authority citation for part 457 is revised to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c. 1302.\n",
      "\n",
      "\n",
      "0\n",
      "18. section 457.700 is amended by--\n",
      "0\n",
      "a. redesignating paragraphs (a)(1) and (2) as paragraphs (a)(2) and \n",
      "(3), respectively;\n",
      "0\n",
      "b. adding paragraph (a)(1); and\n",
      "0\n",
      "c. revising paragraph (c).\n",
      "    the addition and revision reads as follows:\n",
      "\n",
      "[[page 25636]]\n",
      "\n",
      "sec.  457.700   basis, scope, and applicability.\n",
      "\n",
      "    (a) * * *\n",
      "    (1) section 2101(a) of the act, which sets forth that the purpose \n",
      "of title xxi is to provide funds to states to provide child health \n",
      "assistance to uninsured, low-income children in an effective and \n",
      "efficient manner that is coordinated with other sources of health \n",
      "benefits coverage;\n",
      "* * * * *\n",
      "    (c) applicability. the requirements of this subpart apply to \n",
      "separate child health programs and medicaid expansion programs, except \n",
      "that sec.  457.730 does not apply to medicaid expansion programs. \n",
      "separate child health programs that provide benefits exclusively \n",
      "through managed care organizations may meet the requirements of sec.  \n",
      "457.730 by requiring the managed care organizations to meet the \n",
      "requirements of sec.  457.1233(d)(2).\n",
      "\n",
      "0\n",
      "19. section 457.730 is added to read as follows:\n",
      "\n",
      "\n",
      "sec.  457.730  beneficiary access to and exchange of data.\n",
      "\n",
      "    (a) application programming interface to support chip \n",
      "beneficiaries. a state must implement and maintain a standards-based \n",
      "application programming interface (api) that permits third-party \n",
      "applications to retrieve, with the approval and at the direction of the \n",
      "current individual beneficiary or the beneficiary's personal \n",
      "representative, data specified in paragraph (b) of this section through \n",
      "the use of common technologies and without special effort from the \n",
      "beneficiary.\n",
      "    (b) accessible content. a state must make the following information \n",
      "accessible to its current beneficiaries or the beneficiary's personal \n",
      "representative through the api described in paragraph (a) of this \n",
      "section:\n",
      "    (1) data concerning adjudicated claims, including claims data for \n",
      "payment decisions that may be appealed, were appealed, or are in the \n",
      "process of appeal, and provider remittances and beneficiary cost-\n",
      "sharing pertaining to such claims, no later than one (1) business day \n",
      "after a claim is processed;\n",
      "    (2) encounter data no later than 1 business day after receiving the \n",
      "data from providers, other than mcos, pihps, or pahps, compensated on \n",
      "the basis of capitation payments;\n",
      "    (3) clinical data, including laboratory results, if a state \n",
      "maintains any such data, no later than one (1) business day after the \n",
      "data is received by the state; and\n",
      "    (4) information, about covered outpatient drugs and updates to such \n",
      "information, including, where applicable, preferred drug list \n",
      "information, no later than one (1) business day after the effective \n",
      "date of the information or updates to such information.\n",
      "    (c) technical requirements. a state implementing an api under \n",
      "paragraph (a) of this section:\n",
      "    (1) must implement, maintain, and use api technology conformant \n",
      "with 45 cfr 170.215;\n",
      "    (2) must conduct routine testing and monitoring, and update as \n",
      "appropriate, to ensure the api functions properly, including \n",
      "assessments to verify that the api technology is fully and successfully \n",
      "implementing privacy and security features such as, but not limited to, \n",
      "those required to comply with hipaa privacy and security requirements \n",
      "in 45 cfr parts 160 and 164, 42 cfr parts 2 and 3, and other applicable \n",
      "law protecting the privacy and security of individually identifiable \n",
      "data;\n",
      "    (3) must comply with the content and vocabulary standard \n",
      "requirements in paragraphs (c)(3)(i) and (ii) of this section, as \n",
      "applicable to the data type or data element, unless alternate standards \n",
      "are required by other applicable law:\n",
      "    (i) content and vocabulary standards at 45 cfr 170.213 where such \n",
      "standards are applicable to the data type or element, as appropriate; \n",
      "and\n",
      "    (ii) content and vocabulary standards at 45 cfr part 162 and sec.  \n",
      "423.160 of this chapter where required by law, or where such standards \n",
      "are applicable to the data type or element, as appropriate.\n",
      "    (4) may use an updated version of any standard or all standards \n",
      "required under paragraphs (c)(1) or (3) of this section, where:\n",
      "    (i) use of the updated version of the standard is required by other \n",
      "applicable law, or\n",
      "    (ii) use of the updated version of the standard is not prohibited \n",
      "under other applicable law, provided that:\n",
      "    (a) for content and vocabulary standards other than those at 45 cfr \n",
      "170.213, the secretary has not prohibited use of the updated version of \n",
      "a standard for purposes of this section or 45 cfr part 170;\n",
      "    (b) for standards at 45 cfr 170.213 and 170.215, the national \n",
      "coordinator has approved the updated version for use in the onc health \n",
      "it certification program; and\n",
      "    (c) use of the updated version of a standard does not disrupt an \n",
      "end user's ability to access the data described in paragraph (b) of \n",
      "this section through the api described in paragraph (a) of this \n",
      "section.\n",
      "    (d) documentation requirements for apis. for each api implemented \n",
      "in accordance with paragraph (a) of this section, a state must make \n",
      "publicly accessible, by posting directly on its website or via publicly \n",
      "accessible hyperlink(s), complete accompanying documentation that \n",
      "contains, at a minimum the information listed in this paragraph. for \n",
      "the purposes of this section, ``publicly accessible'' means that any \n",
      "person using commonly available technology to browse the internet could \n",
      "access the information without any preconditions or additional steps, \n",
      "such as a fee for access to the documentation; a requirement to receive \n",
      "a copy of the material via email; a requirement to register or create \n",
      "an account to receive the documentation; or a requirement to read \n",
      "promotional material or agree to receive future communications from the \n",
      "organization making the documentation available;\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return variables and their types/\n",
      "structures, exceptions and exception handling methods and their \n",
      "returns;\n",
      "    (2) the software components and configurations that an application \n",
      "must use in order to successfully interact with the api and process its \n",
      "response(s); and\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with any authorization server(s) \n",
      "deployed in conjunction with the api.\n",
      "    (e) denial or discontinuation of access to the api. a state may \n",
      "deny or discontinue any third-party application's connection to the api \n",
      "required under paragraph (a) of this section if the state:\n",
      "    (1) reasonably determines, consistent with its security risk \n",
      "analysis under 45 cfr part 164 subpart c, that allowing an application \n",
      "to connect or remain connected to the api would present an unacceptable \n",
      "level of risk to the security of protected health information on the \n",
      "state's systems; and\n",
      "    (2) makes this determination using objective, verifiable criteria \n",
      "that are applied fairly and consistently across all applications and \n",
      "developers through which beneficiaries seek to access their electronic \n",
      "health information as defined at 45 cfr 171.102, including but not \n",
      "limited to criteria that may rely on automated monitoring and risk \n",
      "mitigation tools.\n",
      "    (f) beneficiary resources regarding privacy and security. a state \n",
      "must provide in an easily accessible location on its public website and \n",
      "through other appropriate mechanisms through which it ordinarily \n",
      "communicates with current and former beneficiaries seeking to\n",
      "\n",
      "[[page 25637]]\n",
      "\n",
      "access their health information held by the state chip agency, \n",
      "educational resources in non-technical, simple and easy-to-understand \n",
      "language explaining at a minimum:\n",
      "    (1) general information on steps the individual may consider taking \n",
      "to help protect the privacy and security of their health information, \n",
      "including factors to consider in selecting an application including \n",
      "secondary uses of data, and the importance of understanding the \n",
      "security and privacy practices of any application to which they will \n",
      "entrust their health information; and\n",
      "    (2) an overview of which types of organizations or individuals are \n",
      "and are not likely to be hipaa covered entities, the oversight \n",
      "responsibilities of ocr and ftc, and how to submit a complaint to:\n",
      "    (i) the hhs office for civil rights (ocr); and\n",
      "    (ii) the federal trade commission (ftc).\n",
      "    (g) data availability. (1) the state must comply with the \n",
      "requirements in paragraphs (a) through (f) of this section beginning \n",
      "january 1, 2021 with regard to data:\n",
      "    (i) with a date of service on or after january 1, 2016; and\n",
      "    (ii) that are maintained by the state.\n",
      "    (2) [reserved]\n",
      "\n",
      "0\n",
      "20. section 457.760 is added to subpart g to read as follows:\n",
      "\n",
      "\n",
      "sec.  457.760  access to published provider directory information.\n",
      "\n",
      "    (a) the state must implement and maintain a publicly accessible, \n",
      "standards-based application programming interface (api) that is \n",
      "conformant with the technical requirements at sec.  457.730(c), \n",
      "excluding the security protocols related to user authentication and \n",
      "authorization and any other protocols that restrict the availability of \n",
      "this information to particular persons or organizations, the \n",
      "documentation requirements at sec.  457.730(d), and is accessible via a \n",
      "public-facing digital endpoint on the state's website.\n",
      "    (b) the api must provide a complete and accurate directory of--\n",
      "    (1) the state's provider directory information including provider \n",
      "names, addresses, phone numbers, and specialties, updated no later than \n",
      "30 calendar days after the state receives provider directory \n",
      "information or updates to provider directory information.\n",
      "    (2) [reserved]\n",
      "    (c) this section is applicable beginning january 1, 2021.\n",
      "\n",
      "0\n",
      "21. section 457.1233 is amended by revising paragraph (d) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  457.1233  structure and operations standards.\n",
      "\n",
      "* * * * *\n",
      "    (d) health information systems. (1) the state must ensure, through \n",
      "its contracts, that each mco, pihp, and pahp complies with the health \n",
      "information systems requirements as provided in sec.  438.242(a), \n",
      "(b)(1) through (4), (c), (d), and (e) of this chapter.\n",
      "    (2) each mco, pihp, and pahp must implement an application \n",
      "programming interface (api) as specified in sec.  457.730 as if such \n",
      "requirements applied directly to the mco, pihp, or pahp, and include--\n",
      "    (i) all encounter data, including encounter data from any network \n",
      "providers the mco, pihp, or pahp is compensating on the basis of \n",
      "capitation payments and adjudicated claims and encounter data from any \n",
      "subcontractors.\n",
      "    (ii) [reserved]\n",
      "    (3) implement, by january 1, 2021, and maintain a publicly \n",
      "accessible standards-based api described in sec.  457.760, which must \n",
      "include all information specified in sec.  438.10(h)(1) and (2) of this \n",
      "chapter.\n",
      "* * * * *\n",
      "\n",
      "part 482--conditions of participation: hospitals\n",
      "\n",
      "0\n",
      "22. the authority citation for part 482 is revised to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c. 1302, 1395hh, and 1395rr, unless otherwise \n",
      "noted.\n",
      "\n",
      "\n",
      "0\n",
      "23. section 482.24 is amended by adding paragraph (d) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  482.24  conditions of participation: medical record services.\n",
      "\n",
      "* * * * *\n",
      "    (d) standard: electronic notifications. if the hospital utilizes an \n",
      "electronic medical records system or other electronic administrative \n",
      "system, which is conformant with the content exchange standard at 45 \n",
      "cfr 170.205(d)(2), then the hospital must demonstrate that--\n",
      "    (1) the system's notification capacity is fully operational and the \n",
      "hospital uses it in accordance with all state and federal statutes and \n",
      "regulations applicable to the hospital's exchange of patient health \n",
      "information.\n",
      "    (2) the system sends notifications that must include at least \n",
      "patient name, treating practitioner name, and sending institution name.\n",
      "    (3) to the extent permissible under applicable federal and state \n",
      "law and regulations, and not inconsistent with the patient's expressed \n",
      "privacy preferences, the system sends notifications directly, or \n",
      "through an intermediary that facilitates exchange of health \n",
      "information, at the time of:\n",
      "    (i) the patient's registration in the hospital's emergency \n",
      "department (if applicable).\n",
      "    (ii) the patient's admission to the hospital's inpatient services \n",
      "(if applicable).\n",
      "    (4) to the extent permissible under applicable federal and state \n",
      "law and regulations and not inconsistent with the patient's expressed \n",
      "privacy preferences, the system sends notifications directly, or \n",
      "through an intermediary that facilitates exchange of health \n",
      "information, either immediately prior to, or at the time of:\n",
      "    (i) the patient's discharge or transfer from the hospital's \n",
      "emergency department (if applicable).\n",
      "    (ii) the patient's discharge or transfer from the hospital's \n",
      "inpatient services (if applicable).\n",
      "    (5) the hospital has made a reasonable effort to ensure that the \n",
      "system sends the notifications to all applicable post-acute care \n",
      "services providers and suppliers, as well as to any of the following \n",
      "practitioners and entities, which need to receive notification of the \n",
      "patient's status for treatment, care coordination, or quality \n",
      "improvement purposes:\n",
      "    (i) the patient's established primary care practitioner;\n",
      "    (ii) the patient's established primary care practice group or \n",
      "entity; or\n",
      "    (iii) other practitioner, or other practice group or entity, \n",
      "identified by the patient as the practitioner, or practice group or \n",
      "entity, primarily responsible for his or her care.\n",
      "\n",
      "0\n",
      "24. section 482.61 is amended by adding paragraph (f) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  482.61  condition of participation: special medical record \n",
      "requirements for psychiatric hospitals.\n",
      "\n",
      "* * * * *\n",
      "    (f) standard: electronic notifications. if the hospital utilizes an \n",
      "electronic medical records system or other electronic administrative \n",
      "system, which is conformant with the content exchange standard at 45 \n",
      "cfr 170.205(d)(2), then the hospital must demonstrate that--\n",
      "    (1) the system's notification capacity is fully operational and the \n",
      "hospital uses it in accordance with all state and federal statutes and \n",
      "regulations applicable to the hospital's exchange of patient health \n",
      "information.\n",
      "    (2) the system sends notifications that must include at least \n",
      "patient name, treating practitioner name, and sending institution name.\n",
      "\n",
      "[[page 25638]]\n",
      "\n",
      "    (3) to the extent permissible under applicable federal and state \n",
      "law and regulations, and not inconsistent with the patient's expressed \n",
      "privacy preferences, the system sends notifications directly, or \n",
      "through an intermediary that facilitates exchange of health \n",
      "information, at the time of:\n",
      "    (i) the patient's registration in the hospital's emergency \n",
      "department (if applicable).\n",
      "    (ii) the patient's admission to the hospital's inpatient services \n",
      "(if applicable).\n",
      "    (4) to the extent permissible under applicable federal and state \n",
      "law and regulations, and not inconsistent with the patient's expressed \n",
      "privacy preferences, the system sends notifications directly, or \n",
      "through an intermediary that facilitates exchange of health \n",
      "information, either immediately prior to, or at the time of:\n",
      "    (i) the patient's discharge or transfer from the hospital's \n",
      "emergency department (if applicable).\n",
      "    (ii) the patient's discharge or transfer from the hospital's \n",
      "inpatient services (if applicable).\n",
      "    (5) the hospital has made a reasonable effort to ensure that the \n",
      "system sends the notifications to all applicable post-acute care \n",
      "services providers and suppliers, as well as to any of the following \n",
      "practitioners and entities, which need to receive notification of the \n",
      "patient's status for treatment, care coordination, or quality \n",
      "improvement purposes:\n",
      "    (i) the patient's established primary care practitioner;\n",
      "    (ii) the patient's established primary care practice group or \n",
      "entity; or\n",
      "    (iii) other practitioner, or other practice group or entity, \n",
      "identified by the patient as the practitioner, or practice group or \n",
      "entity, primarily responsible for his or her care.\n",
      "\n",
      "part 485--conditions of participation: specialized providers\n",
      "\n",
      "0\n",
      "25. the authority citation for part 485 is revised to read as follows:\n",
      "\n",
      "    authority:  42 u.s.c. 1302 and 1395hh.\n",
      "\n",
      "\n",
      "0\n",
      "26. section 485.638 is amended by adding paragraph (d) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  485.638  conditions of participation: clinical records.\n",
      "\n",
      "* * * * *\n",
      "    (d) standard: electronic notifications. if the cah utilizes an \n",
      "electronic medical records system or other electronic administrative \n",
      "system, which is conformant with the content exchange standard at 45 \n",
      "cfr 170.205(d)(2), then the cah must demonstrate that--\n",
      "    (1) the system's notification capacity is fully operational and the \n",
      "cah uses it in accordance with all state and federal statutes and \n",
      "regulations applicable to the cah's exchange of patient health \n",
      "information.\n",
      "    (2) the system sends notifications that must include at least \n",
      "patient name, treating practitioner name, and sending institution name.\n",
      "    (3) to the extent permissible under applicable federal and state \n",
      "law and regulations, and not inconsistent with the patient's expressed \n",
      "privacy preferences, the system sends notifications directly, or \n",
      "through an intermediary that facilitates exchange of health \n",
      "information, at the time of:\n",
      "    (i) the patient's registration in the cah's emergency department \n",
      "(if applicable).\n",
      "    (ii) the patient's admission to the cah's inpatient services (if \n",
      "applicable).\n",
      "    (4) to the extent permissible under applicable federal and state \n",
      "law and regulations, and not inconsistent with the patient's expressed \n",
      "privacy preferences, the system sends notifications directly, or \n",
      "through an intermediary that facilitates exchange of health \n",
      "information, either immediately prior to, or at the time of:\n",
      "    (i) the patient's discharge or transfer from the cah's emergency \n",
      "department (if applicable).\n",
      "    (ii) the patient's discharge or transfer from the cah's inpatient \n",
      "services (if applicable).\n",
      "    (5) the cah has made a reasonable effort to ensure that the system \n",
      "sends the notifications to all applicable post-acute care services \n",
      "providers and suppliers, as well as to any of the following \n",
      "practitioners and entities, which need to receive notification of the \n",
      "patient's status for treatment, care coordination, or quality \n",
      "improvement purposes:\n",
      "    (i) the patient's established primary care practitioner;\n",
      "    (ii) the patient's established primary care practice group or \n",
      "entity; or\n",
      "    (iii) other practitioner, or other practice group or entity, \n",
      "identified by the patient as the practitioner, or practice group or \n",
      "entity, primarily responsible for his or her care.\n",
      "\n",
      "title 45--public welfare\n",
      "\n",
      "subtitle a--department of health and human services\n",
      "\n",
      "part 156--health insurance issuer standards under the affordable \n",
      "care act, including standards related to exchanges\n",
      "\n",
      "0\n",
      "27. the authority citation for part 156 continues to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c. 18021-18024, 18031-18032, 18041-18042, \n",
      "18044, 18054, 18061, 18063, 18071, 18082, 26 u.s.c. 36b, and 31 \n",
      "u.s.c. 9701.\n",
      "\n",
      "\n",
      "0\n",
      "28. section 156.221 is added to read as follows:\n",
      "\n",
      "\n",
      "sec.  156.221  access to and exchange of health data and plan \n",
      "information.\n",
      "\n",
      "    (a) application programming interface to support enrollees. subject \n",
      "to paragraph (h) of this section, a qhp issuer on a federally-\n",
      "facilitated exchange must implement and maintain a standards-based \n",
      "application programming interface (api) that permits third-party \n",
      "applications to retrieve, with the approval and at the direction of a \n",
      "current individual enrollee or the enrollee's personal representative, \n",
      "data specified in paragraph (b) of this section through the use of \n",
      "common technologies and without special effort from the enrollee.\n",
      "    (b) accessible content. (1) a qhp issuer on a federally-facilitate \n",
      "exchange must make the following information accessible to its current \n",
      "enrollees or the enrollee's personal representative through the api \n",
      "described in paragraph (a) of this section:\n",
      "    (i) data concerning adjudicated claims, including claims data for \n",
      "payment decisions that may be appealed, were appealed, or are in the \n",
      "process of appeal, and provider remittances and enrollee cost-sharing \n",
      "pertaining to such claims, no later than one (1) business day after a \n",
      "claim is processed;\n",
      "    (ii) encounter data from capitated providers, no later than one (1) \n",
      "business day after data concerning the encounter is received by the qhp \n",
      "issuer; and\n",
      "    (iii) clinical data, including laboratory results, if the qhp \n",
      "issuer maintains any such data, no later than one (1) business day \n",
      "after data is received by the issuer.\n",
      "    (2) [reserved]\n",
      "    (c) technical requirements. a qhp issuer on a federally-facilitated \n",
      "exchange implementing an api under paragraph (a) of this section:\n",
      "    (1) must implement, maintain, and use api technology conformant \n",
      "with 45 cfr 170.215;\n",
      "\n",
      "[[page 25639]]\n",
      "\n",
      "    (2) must conduct routine testing and monitoring, and update as \n",
      "appropriate, to ensure the api functions properly, including \n",
      "assessments to verify the api is fully and successfully implementing \n",
      "privacy and security features such as, but not limited to, those \n",
      "required to comply with hipaa privacy and security requirements in \n",
      "parts 160 and 164, 42 cfr parts 2 and 3, and other applicable law \n",
      "protecting privacy and security of individually identifiable data;\n",
      "    (3) must comply with the content and vocabulary standard \n",
      "requirements in paragraphs (c)(3)(i) and (ii) of this section, as \n",
      "applicable, to the data type or data element, unless alternate \n",
      "standards are required by other applicable law:\n",
      "    (i) content and vocabulary standards at 45 cfr 170.213 where such \n",
      "are applicable to the data type or element, as appropriate; and\n",
      "    (ii) content and vocabulary standards at part 162 of this \n",
      "subchapter and 42 cfr 423.160 where required by law, or where such \n",
      "standards are applicable to the data type or element, as appropriate.\n",
      "    (4) may use an updated version of any standard or all standards \n",
      "required under paragraphs (c)(1) or (3) of this section, where:\n",
      "    (i) use of the updated version of the standard is required by other \n",
      "applicable law, or\n",
      "    (ii) use of the updated version of the standard is not prohibited \n",
      "under other applicable law, provided that:\n",
      "    (a) for content and vocabulary standards other than those at 45 cfr \n",
      "170.213, the secretary has not prohibited use of the updated version of \n",
      "a standard for purposes of this section or part 170 of this subchapter;\n",
      "    (b) for standards at 45 cfr 170.213 and 45 cfr 170.215, the \n",
      "national coordinator has approved the updated version for use in the \n",
      "onc health it certification program; and\n",
      "    (c) use of the updated version of a standard does not disrupt an \n",
      "end user's ability to access the data described in paragraph (b) of \n",
      "this section through the api described in paragraph (a) of this \n",
      "section.\n",
      "    (d) documentation requirements for apis. for each api implemented \n",
      "in accordance with paragraph (a) of this section, a qhp issuer on a \n",
      "federally-facilitated exchange must make publicly accessible, by \n",
      "posting directly on its website and/or via publicly accessible \n",
      "hyperlink(s), complete accompanying documentation that contains, at a \n",
      "minimum the information listed in this paragraph. for the purposes of \n",
      "this section, ``publicly accessible'' means that any person using \n",
      "commonly available technology to browse the internet could access the \n",
      "information without any preconditions or additional steps, such as a \n",
      "fee for access to the documentation; a requirement to receive a copy of \n",
      "the material via email; a requirement to register or create an account \n",
      "to receive the documentation; or a requirement to read promotional \n",
      "material or agree to receive future communications from the \n",
      "organization making the documentation available;\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return variables and their types/\n",
      "structures, exceptions and exception handling methods and their \n",
      "returns;\n",
      "    (2) the software components and configurations an application must \n",
      "use in order to successfully interact with the api and process its \n",
      "response(s); and\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with any authorization server(s) \n",
      "deployed in conjunction with the api.\n",
      "    (e) denial or discontinuation of access to the api. a qhp issuer on \n",
      "a federally-facilitated exchange may deny or discontinue any third \n",
      "party application's connection to the api required under paragraph (a) \n",
      "of this section if the qhp issuer:\n",
      "    (1) reasonably determines, consistent with its security risk \n",
      "analysis under 45 cfr part 164 subpart c, that allowing an application \n",
      "to connect or remain connected to the api would present an unacceptable \n",
      "level of risk to the security of personally identifiable information, \n",
      "including protected health information, on the qhp issuer's systems; \n",
      "and\n",
      "    (2) makes this determination using objective, verifiable criteria \n",
      "that are applied fairly and consistently across all applications and \n",
      "developers through which enrollees seek to access their electronic \n",
      "health information as defined at sec.  171.102 of this subchapter, \n",
      "including but not limited to criteria that may rely on automated \n",
      "monitoring and risk mitigation tools.\n",
      "    (f) coordination among payers. (1) a qhp issuer on a federally-\n",
      "facilitated exchange must maintain a process for the electronic \n",
      "exchange of, at a minimum, the data classes and elements included in \n",
      "the content standard adopted at 45 cfr 170.213. such information \n",
      "received by a qhp issuer on a federally-facilitated exchange must be \n",
      "incorporated into the qhp issuer's records about the current enrollee. \n",
      "with the approval and at the direction of a current or former enrollee \n",
      "or the enrollee's personal representative, a qhp issuer on a federally-\n",
      "facilitated exchange must:\n",
      "    (i) receive all such data for a current enrollee from any other \n",
      "payer that has provided coverage to the enrollee within the preceding 5 \n",
      "years;\n",
      "    (ii) at any time the enrollee is currently enrolled in the plan and \n",
      "up to 5 years after disenrollment, send all such data to any other \n",
      "payer that currently covers the enrollee or a payer the enrollee or the \n",
      "enrollee's personal representative specifically requests receive the \n",
      "data; and\n",
      "    (iii) send data received from another payer under this paragraph \n",
      "(f) in the electronic form and format it was received.\n",
      "    (2) [reserved]\n",
      "    (g) enrollee resources regarding privacy and security. a qhp issuer \n",
      "on a federally-facilitated exchange must provide in an easily \n",
      "accessible location on its public website and through other appropriate \n",
      "mechanisms through which it ordinarily communicates with current and \n",
      "former enrollees seeking to access their health information held by the \n",
      "qhp issuer, educational resources in non-technical, simple and easy-to-\n",
      "understand language explaining at a minimum:\n",
      "    (1) general information on steps the individual may consider taking \n",
      "to help protect the privacy and security of their health information, \n",
      "including factors to consider in selecting an application including \n",
      "secondary uses of data, and the importance of understanding the \n",
      "security and privacy practices of any application to which they will \n",
      "entrust their health information; and\n",
      "    (2) an overview of which types of organizations or individuals are \n",
      "and are not likely to be hipaa covered entities, the oversight \n",
      "responsibilities of the office for civil rights (ocr) and the federal \n",
      "trade commission (ftc), and how to submit a complaint to:\n",
      "    (i) the hhs office for civil rights (ocr); and\n",
      "    (ii) the federal trade commission (ftc).\n",
      "    (h) exception. (1) if a plan applying for qhp certification to be \n",
      "offered through a federally-facilitated exchange believes it cannot \n",
      "satisfy the requirements in paragraphs (a) through (g) of this section, \n",
      "the issuer must include as part of its qhp application a narrative \n",
      "justification describing the reasons why the plan cannot reasonably \n",
      "satisfy the requirements for the applicable plan year, the impact of \n",
      "non-compliance upon enrollees, the current or proposed means of \n",
      "providing health information to enrollees, and solutions and a timeline \n",
      "to achieve compliance with the requirements of this section.\n",
      "\n",
      "[[page 25640]]\n",
      "\n",
      "    (2) the federally-facilitated exchange may grant an exception to \n",
      "the requirements in paragraphs (a) through (g) of this section if the \n",
      "exchange determines that making such health plan available through such \n",
      "exchange is in the interests of qualified individuals in the state or \n",
      "states in which such exchange operates.\n",
      "    (i) applicability. a qhp issuer on an individual market federally-\n",
      "facilitated exchange, not including qhp issuers offering only stand-\n",
      "alone dental plans, must comply with the requirements in paragraphs (a) \n",
      "through (e) and (g) of this section beginning with plan years beginning \n",
      "on or after january 1, 2021, and with the requirements in paragraph (f) \n",
      "of this section beginning with plan years beginning on or after january \n",
      "1, 2022 with regard to data:\n",
      "    (1) with a date of service on or after january 1, 2016; and\n",
      "    (2) that are maintained by the qhp issuer for enrollees in qhps.\n",
      "\n",
      "    dated: january 21, 2020.\n",
      "seema verma,\n",
      "administrator, centers for medicare & medicaid services.\n",
      "    dated: march 5, 2020.\n",
      "alex m. azar ii,\n",
      "secretary, department of health and human services.\n",
      "[fr doc. 2020-05050 filed 4-21-20; 4:15 pm]\n",
      " billing code p\n",
      "\n",
      "\n",
      "</pre></body>\n",
      "</html>\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in CMS-2019-0039: 100%|██████████| 4/4 [00:00<00:00,  5.01it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Added /Users/ha/Downloads/mirrulations/specific/CMS-2019-0039/raw-data/documents/CMS-2019-0039-1625_content.htm to vector store.\n",
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 86 issue 235 (friday, december 10, 2021)</title>\n",
      "</head>\n",
      "<body><pre>[federal register volume 86, number 235 (friday, december 10, 2021)]\n",
      "[rules and regulations]\n",
      "[pages 70412-70413]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2021-26764]\n",
      "\n",
      "\n",
      "=======================================================================\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of health and human services\n",
      "\n",
      "centers for medicare & medicaid services\n",
      "\n",
      "42 cfr parts 422, 431, 435, 438, 440, and 457\n",
      "\n",
      "[cms-9115-n2]\n",
      "\n",
      "\n",
      "medicare and medicaid programs; patient protection and affordable \n",
      "care act; interoperability and patient access for medicare advantage \n",
      "organizations and medicaid managed care plans, state medicaid agencies, \n",
      "chip agencies and chip managed care entities, issuers of qualified \n",
      "health plans on the federally-facilitated exchanges, and health care \n",
      "providers\n",
      "\n",
      "agency: centers for medicare & medicaid services (cms), department of \n",
      "health and human services (hhs).\n",
      "\n",
      "action: notification of enforcement discretion.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: this notification is to inform the public that cms is \n",
      "exercising its discretion in how it enforces the payer-to-payer data \n",
      "exchange provisions. as a matter of enforcement discretion, cms does \n",
      "not expect to take action to enforce compliance with these specific \n",
      "provisions until we are able to address certain implementation \n",
      "challenges.\n",
      "\n",
      "dates: the notification of enforcement discretion is effective on \n",
      "december 10, 2021.\n",
      "\n",
      "for further information contact: alexandra mugge, (410) 786-4457; or \n",
      "lorraine doo, (443) 615-1309.\n",
      "\n",
      "supplementary information: on may 1, 2020, we published the cms \n",
      "interoperability and patient access final rule (85 fr 25510) to \n",
      "establish policies that advance interoperability and patient access to \n",
      "health information. the rule required medicare advantage (ma) \n",
      "organizations, medicaid managed care plans, children's health insurance \n",
      "program (chip) managed care entities, and qualified health plan (qhp) \n",
      "issuers on the federally-facilitated exchanges (ffes) (collectively \n",
      "referred to as ``impacted payers''), to facilitate enhanced data \n",
      "sharing by exchanging data with other payers at the patient's request, \n",
      "starting january 1, 2022, for:\n",
      "    <bullet> ma organizations (42 cfr 422.119(f)); or\n",
      "    <bullet> medicaid managed care plans (42 cfr 438.62(b)(1)(vi)); and \n",
      "chip managed care entities (42 cfr 457.1216).\n",
      "    for plan or policy years beginning on or after january 1, 2022, for \n",
      "qhp issuers on the ffes (45 cfr 156.221(f)), as applicable. we also \n",
      "required these impacted payers to incorporate and maintain the data \n",
      "they receive through this payer-to-payer data exchange into the \n",
      "enrollee's record, with the goal of increasing transparency for \n",
      "patients, promoting better coordinated care, reducing administrative \n",
      "burden, and enabling patients to establish a collective patient health \n",
      "care record as they move throughout the health care system (see \n",
      "applicable regulations at (sec.  422.119(f) for ma organizations; sec.  \n",
      "438.62(b)(1)(vi) for medicaid managed care plans (and by extension \n",
      "under existing rules at sec.  457.1216, to chip managed care entities); \n",
      "and sec.  156.221(f)(i) through (iii) for qhp issuers on the ffes). \n",
      "these policies are collectively referred to as the payer-to-payer data \n",
      "exchange requirement.\n",
      "    to provide payers with flexibility to support timely adoption and \n",
      "rapid implementation, cms did not require an application programming \n",
      "interface (api) or any a specific mechanism for the payer-to-payer data \n",
      "exchange. rather, we required impacted payers to receive data in \n",
      "whatever format it was sent and to send data in the form and format it \n",
      "was received, which ultimately complicated implementation by requiring \n",
      "payers to accept data in different formats.\n",
      "    since the rule was finalized in may 2020, multiple impacted payers \n",
      "have indicated to cms that the absence of a required standard or \n",
      "specification for the payer-to-payer data exchange requirement is \n",
      "creating challenges for implementation and may lead to differences in \n",
      "implementation across industry, poor data quality, operational \n",
      "challenges, and increased administrative burden. for example, payers \n",
      "expressed concerns about receiving volumes of portable document format \n",
      "(pdf) documents and files from other payers using a variety of \n",
      "technical approaches--from file transfer protocols (ftp), to email, to \n",
      "fast healthcare interoperability resources (fhir). payers explained \n",
      "that differences in implementation approaches may create gaps in \n",
      "patient health information that conflict directly with the intended \n",
      "goal of an interoperable payer-to-payer data exchange.\n",
      "    after listening to stakeholder concerns about implementing the \n",
      "payer-to-payer data exchange requirement and considering the potential \n",
      "for negative outcomes that impede, rather than support, interoperable \n",
      "payer-to-payer data exchange, cms published three frequently asked \n",
      "questions (faqs) on the cms and hhs good guidance websites \\1\\ to \n",
      "announce that it would be exercising enforcement discretion for the \n",
      "payer-to-payer data exchange requirement. in one of the faqs, cms \n",
      "encouraged payers that have already developed fhir-based application \n",
      "api\n",
      "\n",
      "[[page 70413]]\n",
      "\n",
      "solutions to support the payer-to-payer data exchange to continue to \n",
      "move forward with implementation. the faq noted that for those impacted \n",
      "payers that are not capable of making the data available in a fhir-\n",
      "based format, we believed that this policy of exercising enforcement \n",
      "discretion would alleviate industry tension regarding implementation; \n",
      "avoid the risk of discordant, non-standard data flowing between payers; \n",
      "provide time for data standards to mature further; and allow payers \n",
      "additional time to implement the more sophisticated payer-to-payer data \n",
      "exchange solutions. we are now announcing that we expect to extend this \n",
      "exercise of enforcement discretion of the payer-to-payer data exchange \n",
      "requirement until we are able to address the identified implementation \n",
      "challenges through future rulemaking. we anticipate providing an update \n",
      "on any evaluation of this enforcement discretion notification and \n",
      "related actions during calendar year 2022. we continue to encourage \n",
      "impacted payers that have already developed fhir-based api solutions to \n",
      "support payer-to-payer data exchange to continue to move forward with \n",
      "implementation and make this functionality available on january 1, \n",
      "2022, or for plan or policy years beginning on or after january 1, \n",
      "2022, in accordance with the cms interoperability and patient access \n",
      "final rule policies. however, for those impacted payers that are not \n",
      "capable of making the data available in a fhir-based api format, we \n",
      "believe this exercise of enforcement discretion will alleviate issues \n",
      "regarding implementation; avoid the risk of discordant, non-standard \n",
      "data flowing between payers; provide time for data standards to further \n",
      "mature through constant development, testing, and reference \n",
      "implementations; and allow payers additional time to implement more \n",
      "sophisticated payer-to-payer data exchange solutions.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\1\\ link to cms website with faqs for interoperability rule, and \n",
      "enforcement discretion: <a href=\"https://www.cms.gov/about-cms/health-informatics-and-interoperability-group/faqs#122\">https://www.cms.gov/about-cms/health-informatics-and-interoperability-group/faqs#122</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while the policy in this notification may result in temporary delay \n",
      "of some enrollees' ability to bring their data with them from one payer \n",
      "to the next, we believe this decision could ultimately lead to more \n",
      "standardization and cohesion of data about enrollees as cms provides \n",
      "additional implementation guidance through future rulemaking.\n",
      "    finally, our decision to exercise enforcement discretion for the \n",
      "payer-to-payer policy until future rulemaking is finalized does not \n",
      "affect any other existing regulatory requirements and implementation \n",
      "timelines finalized in the cms interoperability and patient access rule \n",
      "finalized on may 1, 2020.\n",
      "    chiquita brooks-lasure, administrator of the centers for medicare & \n",
      "medicaid services, approved this document on october 15, 2021.\n",
      "\n",
      "    dated: december 7, 2021.\n",
      "xavier becerra,\n",
      "secretary, department of health and human services.\n",
      "[fr doc. 2021-26764 filed 12-8-21; 11:15 am]\n",
      "billing code 4120-01-p\n",
      "\n",
      "\n",
      "</pre></body>\n",
      "</html>\n",
      "Added /Users/ha/Downloads/mirrulations/specific/CMS-2019-0039/raw-data/documents/CMS-2019-0039-1626_content.htm to vector store.\n",
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 84 issue 78 (tuesday, april 23, 2019)</title>\n",
      "</head>\n",
      "<body><pre>[federal register volume 84, number 78 (tuesday, april 23, 2019)]\n",
      "[proposed rules]\n",
      "[page 16834]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2019-08181]\n",
      "\n",
      "\n",
      "\n",
      "[[page 16834]]\n",
      "\n",
      "=======================================================================\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of health and human services\n",
      "\n",
      "centers for medicare & medicaid services\n",
      "\n",
      "42 cfr parts 406, 407, 422, 423, 431, 438, 457, 482, and 485\n",
      "\n",
      "[cms-9115-n]\n",
      "rin 0938-at79\n",
      "\n",
      "\n",
      "medicare and medicaid programs; patient protection and affordable \n",
      "care act; interoperability and patient access for medicare advantage \n",
      "organization and medicaid managed care plans, state medicaid agencies, \n",
      "chip agencies and chip managed care entities, issuers of qualified \n",
      "health plans in the federally-facilitated exchanges and health care \n",
      "providers; supplement and extension of comment period\n",
      "\n",
      "agency: centers for medicare & medicaid services (cms), hhs.\n",
      "\n",
      "action: proposed rule; supplement and extension of comment period.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: this document extends the comment period for the proposed rule \n",
      "entitled ``medicare and medicaid programs; patient protection and \n",
      "affordable care act; interoperability and patient access for medicare \n",
      "advantage organization and medicaid managed care plans, state medicaid \n",
      "agencies, chip agencies and chip managed care entities, issuers of \n",
      "qualified health plans in the federally-facilitated exchanges and \n",
      "health care providers'' that appeared in the march 4, 2019 federal \n",
      "register. the comment period for the proposed rule, which would end on \n",
      "may 3, 2019, is extended 30 days to june 3, 2019. we additionally note \n",
      "that based on public comments received on this proposed rule, we will \n",
      "adjust the effective dates of our policies to allow for adequate \n",
      "implementation timelines, as appropriate.\n",
      "\n",
      "dates: the comment period for the proposed rule (84 fr 7610) is \n",
      "extended to 5 p.m., eastern daylight time, on june 3, 2019.\n",
      "\n",
      "addresses: you may submit comments as outlined in the march 4, 2019 \n",
      "proposed rule (84 fr 7610). please choose only one method listed.\n",
      "\n",
      "for further information contact: alexandra mugge, (410) 786-4457, for \n",
      "issues related to interoperability, cms health it strategy, technical \n",
      "standards and patient matching.\n",
      "    natalie albright, (410) 786-1671, for issues related to medicare \n",
      "advantage.\n",
      "    john giles, (410) 786-1255, for issues related to medicaid.\n",
      "    emily pedneau, (301) 492-4448, for issues related to qualified \n",
      "health plans.\n",
      "    meg barry, (410) 786-1536, for issues related to chip.\n",
      "    thomas novak, (202) 322-7235, for issues related to trust exchange \n",
      "networks and payer to payer coordination.\n",
      "    sharon donovan, (410) 786-9187, for issues related to federal-state \n",
      "data exchange.\n",
      "    daniel riner, (410) 786-0237, for issues related to physician \n",
      "compare.\n",
      "    ashley hain, (410) 786-7603, for issues related to hospital public \n",
      "reporting.\n",
      "    melissa singer, (410) 786-0365, for issues related to provider \n",
      "directories.\n",
      "    capt scott cooper, usphs, (410) 786-9465, for issues related to \n",
      "hospital and critical access hospital conditions of participation.\n",
      "    lisa bari, (410) 786-0087, for issues related to advancing \n",
      "interoperability in innovative models.\n",
      "    russell hendel, (410) 786-0329, for issues related to the \n",
      "collection of information or the regulation impact analysis sections.\n",
      "\n",
      "supplementary information: in the ``medicare and medicaid programs; \n",
      "patient protection and affordable care act; interoperability and \n",
      "patient access for medicare advantage organization and medicaid managed \n",
      "care plans, state medicaid agencies, chip agencies and chip managed \n",
      "care entities, issuers of qualified health plans in the federally-\n",
      "facilitated exchanges and health care providers'' proposed rule that \n",
      "appeared in the march 4, 2019 federal register (84 fr 7610), we \n",
      "solicited public comments on proposed policies that aim to move the \n",
      "health care ecosystem in the direction of interoperability, and to \n",
      "signal our commitment to the vision set out in the 21st century cures \n",
      "act and executive order 13813 to improve access to, and the quality of, \n",
      "information that americans need to make informed health care decisions, \n",
      "including data about health care prices and outcomes, while minimizing \n",
      "reporting burdens on affected plans, health care providers, or payers.\n",
      "    since the issuance of the proposed rule, we have received inquiries \n",
      "from a variety of stakeholders, including healthcare provider \n",
      "organizations and industry representatives requesting an extension to \n",
      "the comment period. in order to maximize the opportunity for the public \n",
      "to provide meaningful input to cms, we believe that it is important to \n",
      "allow additional time for the public to prepare comments on the \n",
      "proposed rule. in addition, we believe that granting an extension to \n",
      "the public comment period in this instance would further our overall \n",
      "objective to obtain public input on the proposed provisions to move the \n",
      "health care ecosystem in the direction of interoperability. therefore, \n",
      "we are extending the comment period for the proposed rule for an \n",
      "additional 30 days.\n",
      "    while we believe it is in the best interest of the public and our \n",
      "proposed policies to extend the comment period for this proposed rule, \n",
      "we also acknowledge that stakeholders require appropriate \n",
      "implementation timelines that could be impacted by this extension. \n",
      "therefore, we note that based on public comments received on this \n",
      "proposed rule, we will adjust the effective dates of our policies to \n",
      "allow for adequate implementation timelines as appropriate.\n",
      "\n",
      "    dated: april 18, 2019.\n",
      "seema verma,\n",
      "administrator, centers for medicare & medicaid services.\n",
      "[fr doc. 2019-08181 filed 4-19-19; 8:45 am]\n",
      "billing code 4120-01-p\n",
      "\n",
      "\n",
      "</pre></body>\n",
      "</html>\n",
      "Added /Users/ha/Downloads/mirrulations/specific/CMS-2019-0039/raw-data/documents/CMS-2019-0039-0397_content.htm to vector store.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in .DS_Store: 0it [00:00, ?it/s]\n",
      "Processing files in DEA-2016-0015: 100%|██████████| 2/2 [00:00<00:00, 32.51it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 81 issue 169 (wednesday, august 31, 2016)</title>\n",
      "</head>\n",
      "<body><pre>\n",
      "[federal register volume 81, number 169 (wednesday, august 31, 2016)]\n",
      "[proposed rules]\n",
      "[pages 59929-59934]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2016-20803]\n",
      "\n",
      "\n",
      "=======================================================================\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of justice\n",
      "\n",
      "drug enforcement administration\n",
      "\n",
      "21 cfr part 1308\n",
      "\n",
      "[docket no. dea-442]\n",
      "\n",
      "\n",
      "schedules of controlled substances: temporary placement of \n",
      "mitragynine and 7-hydroxymitragynine into schedule i\n",
      "\n",
      "agency: drug enforcement administration, department of justice.\n",
      "\n",
      "action: notice of intent.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: the administrator of the drug enforcement administration is \n",
      "issuing this notice of intent to temporarily schedule the opioids \n",
      "mitragynine and 7-hydroxymitragynine, which are the main active \n",
      "constituents of the plant kratom, into schedule i pursuant to the \n",
      "temporary scheduling provisions of the controlled substances act. this \n",
      "action is based on a finding by the administrator that the placement of \n",
      "these opioids into schedule i of the controlled substances act is \n",
      "necessary to avoid an imminent hazard to the public safety. any final \n",
      "order will impose the administrative, civil, and criminal sanctions and \n",
      "regulatory controls applicable to schedule i controlled substances \n",
      "under the controlled substances act on the manufacture, distribution, \n",
      "possession, importation, and exportation of, and research and conduct \n",
      "of instructional activities of these opioids.\n",
      "\n",
      "dates: august 31, 2016.\n",
      "\n",
      "for further information contact: michael j. lewis, office of diversion \n",
      "control, drug enforcement administration; mailing address: 8701 \n",
      "morrissette drive, springfield, virginia 22152; telephone: (202) 598-\n",
      "6812.\n",
      "\n",
      "supplementary information: any final order will be published in the \n",
      "federal register and may not be effective prior to september 30, 2016.\n",
      "\n",
      "legal authority\n",
      "\n",
      "    the drug enforcement administration (dea) implements and enforces \n",
      "titles ii and iii of the comprehensive drug abuse prevention and \n",
      "control act of 1970, as amended. 21 u.s.c. 801-971. titles ii and iii \n",
      "are referred to as the ``controlled substances act'' and the \n",
      "``controlled substances import and export act,'' respectively, and are \n",
      "collectively referred to as the ``controlled substances act'' or the \n",
      "``csa'' for the purpose of this action. the dea publishes the \n",
      "implementing regulations for these statutes in title 21 of the code of \n",
      "federal regulations (cfr), chapter ii. the csa and its implementing \n",
      "regulations are designed to prevent, detect, and eliminate the \n",
      "diversion of controlled substances and listed chemicals into the \n",
      "illicit market while providing for the legitimate medical, scientific, \n",
      "research, and industrial needs of the united states. controlled \n",
      "substances have the potential for abuse and dependence and are \n",
      "controlled to protect the public health and safety.\n",
      "    under the csa, each controlled substance is classified into one of \n",
      "five schedules based upon its potential for abuse, its currently \n",
      "accepted medical use in treatment in the united states, and the degree \n",
      "of dependence the drug or other substance may cause. 21 u.s.c. 812. the \n",
      "initial schedules of controlled substances established by congress are \n",
      "found at 21 u.s.c. 812(c), and the current list of all scheduled \n",
      "substances is published at 21 cfr part 1308.\n",
      "    section 201 of the csa, 21 u.s.c. 811, provides the attorney \n",
      "general with the authority to temporarily place a substance into \n",
      "schedule i of the csa for two years without regard to the requirements \n",
      "of 21 u.s.c. 811(b) if she finds that such action is necessary to avoid \n",
      "an imminent hazard to the public safety. 21 u.s.c. 811(h)(1). in \n",
      "addition, if proceedings to control a substance are initiated under 21 \n",
      "u.s.c. 811(a)(1), the attorney general may extend the temporary \n",
      "scheduling for up to one year. 21 u.s.c. 811(h)(2).\n",
      "    where the necessary findings are made, a substance may be \n",
      "temporarily scheduled if it is not listed in any other schedule under \n",
      "section 202 of the csa, 21 u.s.c. 812, or if there is no exemption or \n",
      "approval in effect for the substance under section 505 of the federal \n",
      "food, drug, and cosmetic act (fdca), 21 u.s.c. 355. 21 u.s.c. \n",
      "811(h)(1). the attorney general has delegated scheduling authority \n",
      "under 21 u.s.c. 811 to the administrator of the dea. 28 cfr 0.100.\n",
      "\n",
      "background\n",
      "\n",
      "    section 201(h)(4) of the csa, 21 u.s.c. 811(h)(4), requires the \n",
      "administrator to notify the secretary of the department of health and \n",
      "human services (hhs) of his intention to temporarily place a substance \n",
      "into schedule i of the csa.\\1\\ the administrator transmitted notice of \n",
      "his intent to place mitragynine and 7-hydroxymitragynine in schedule i \n",
      "on a temporary basis to the assistant secretary by letter dated may 6, \n",
      "2016. the assistant secretary responded to this notice by letter dated \n",
      "may 18, 2016, and advised that based on review by the food and drug \n",
      "administration (fda), there are currently no investigational new drug \n",
      "applications or approved new drug applications for mitragynine and 7-\n",
      "hydroxymitragynine. the assistant secretary also stated that the hhs \n",
      "has no objection to the temporary placement of mitragynine and 7-\n",
      "hydroxymitragynine into schedule i of the csa. neither mitragynine nor \n",
      "7-hydroxymitragynine is currently listed in any schedule under the csa, \n",
      "and no approved new drug applications or investigational new drug \n",
      "applications for mitragynine or 7-hydroxymitragynine exist, 21 u.s.c. \n",
      "355. the dea has found that the control of mitragynine and 7-\n",
      "hydroxymitragynine in schedule i on a temporary basis is necessary to \n",
      "avoid an imminent hazard to public safety.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\1\\ as discussed in a memorandum of understanding entered into \n",
      "by the food and drug administration (fda) and the national institute \n",
      "on drug abuse (nida), the fda acts as the lead agency within the \n",
      "department of health and human services (hhs) in carrying out the \n",
      "secretary's scheduling responsibilities under the csa, with the \n",
      "concurrence of nida. 50 fr 9518, mar. 8, 1985. the secretary of the \n",
      "hhs has delegated to the assistant secretary for health of the hhs \n",
      "the authority to make domestic drug scheduling recommendations. 58 \n",
      "fr 35460, july 1, 1993.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    to find that placing a substance temporarily into schedule i of the \n",
      "csa is necessary to avoid an imminent hazard to the public safety, the \n",
      "administrator is required to consider three of the eight factors set \n",
      "forth in section 201(c) of the csa, 21 u.s.c.\n",
      "\n",
      "[[page 59930]]\n",
      "\n",
      "811(c): the substance's history and current pattern of abuse; the \n",
      "scope, duration and significance of abuse; and what, if any, risk there \n",
      "is to the public health. 21 u.s.c. 811(h)(3). consideration of these \n",
      "factors includes actual abuse, diversion from legitimate channels, and \n",
      "clandestine importation, manufacture, or distribution. 21 u.s.c. \n",
      "811(h)(3).\n",
      "    a substance meeting the statutory requirements for temporary \n",
      "scheduling may only be placed in schedule i. 21 u.s.c. 811(h)(1). \n",
      "substances in schedule i are those that have a high potential for \n",
      "abuse, no currently accepted medical use in treatment in the united \n",
      "states, and a lack of accepted safety for use under medical \n",
      "supervision. 21 u.s.c. 812(b)(1).\n",
      "\n",
      "mitragynine and 7-hydroxymitragynine, the main active constituents of \n",
      "the plant kratom\n",
      "\n",
      "    mitragynine and 7-hydroxymitragynine are the main active \n",
      "constituents of the plant mitragyna speciosa korth (commonly known as \n",
      "kratom), an indigenous plant of southeast asia. kratom is the only \n",
      "known species of mitragyna to contain mitragynine and 7-\n",
      "hydroxymitragynine. kratom is abused for its ability to produce opioid-\n",
      "like effects. kratom is available in several different forms to include \n",
      "dried/crushed leaves, powder, capsules, tablets, liquids, and gum/\n",
      "resin. consequently, kratom, which contains the main active \n",
      "constituents mitragynine and 7-hydroxymitragynine, is an increasingly \n",
      "popular drug of abuse and readily available on the recreational drug \n",
      "market in the united states. attempted importations of kratom are \n",
      "routinely misdeclared and falsely labeled. this is similar to other \n",
      "attempts to import controlled substances or substances intended to \n",
      "mimic controlled substances. the amount of kratom material seized by \n",
      "law enforcement for the first half of 2016 greatly exceeds any previous \n",
      "year totals and easily accounts for millions of dosage units intended \n",
      "for the recreational market.\\2\\ available data and information for \n",
      "mitragynine and 7-hydroxymitragynine, the main active constituents of \n",
      "the plant kratom, and the plant kratom, are summarized below. available \n",
      "information indicates that these opioid substances, constituents of the \n",
      "plant kratom, have a high potential for abuse, no currently accepted \n",
      "medical use in treatment in the united states, and a lack of accepted \n",
      "safety for use under medical supervision. the dea's three-factor \n",
      "analysis is available in its entirety under of the public docket of \n",
      "this action as a supporting document at <a href=\"http://www.regulations.gov\">www.regulations.gov</a> under \n",
      "docket number dea-442.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\2\\ 2015-cder-dea memorandum of understanding for sharing \n",
      "information (provided under 21 cfr 20.85) dated august 4, 2016.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "factor 4. history and current pattern of abuse\n",
      "\n",
      "    kratom, which contains the main active alkaloids mitragynine and 7-\n",
      "hydroxymitragynine, has a long history of use in southeast asia as an \n",
      "opium substitute. kratom is also known in southeast asia as thang, \n",
      "thom, krathom, kakuam, ketum, and biak. in recent years, the presence \n",
      "of the psychoactive plant kratom has increased dramatically on the \n",
      "recreational market in the united states due to its opioid-like \n",
      "effects. numerous vendors selling kratom have appeared in the past few \n",
      "years, markedly increasing its availability.\n",
      "    kratom preparations, which contain the main active alkaloids \n",
      "mitragynine and 7-hydroxymitragynine, are easily obtained from smoke \n",
      "shops and over the internet. the internet is the most utilized source \n",
      "for the purchase of kratom products, making kratom just ``a click'' \n",
      "away for users. in the united states, law enforcement has seized \n",
      "kratom/mitragynine products in the following forms: powder/plant, \n",
      "powder, plant or vegetable material, capsules, tablets, liquids, gum/\n",
      "resin, and drug patch.\n",
      "    since abusers obtain kratom, which contains the main active \n",
      "alkaloids mitragynine and 7-hydroxymitragyine, through unknown sources, \n",
      "the identity, purity, and quantity of these substances are uncertain \n",
      "and inconsistent, thus posing significant adverse health risks to \n",
      "users. several studies have analyzed the concentrations of mitragynine \n",
      "\\3\\ and/or 7-hydroxymitragynine \\4\\ in different kratom products. the \n",
      "studies showed that there were inconsistencies in the levels of the \n",
      "opioid mitragynine present in similar kratom products, and some \n",
      "products contained other psychoactive substances (see 3-factor \n",
      "analysis). based on the variability of the mitragynine concentration in \n",
      "each product, users may experience differing effects when consuming \n",
      "similar amounts of different products.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\3\\ mitragynine is the most abundant alkaloid in kratom and \n",
      "constitutes about 66 percent of the total alkaloid content of the \n",
      "plant. the alkaloid content of mitragynine was 45 percent of all \n",
      "alkaloids detected during analyses performed. such large relative \n",
      "differences in proportions of plant alkaloids (66%:45%) are common \n",
      "among plant species and will lead to variations in potency and the \n",
      "risk of overdose.\n",
      "    \\4\\ 7-hydroxymitragynine is a more potent agonist than \n",
      "mitragynine although it only comprises about 1.6 percent of the \n",
      "total alkaloid content of the plant. the alkaloid content of 7-\n",
      "hydroxymitragynine was 4 percent of all alkaloids detected in \n",
      "analyses performed. such large relative differences in proportions \n",
      "of plant alkaloids (4.0%:1.6%) are common among plant species and \n",
      "will lead to variations in potency and the risk of overdose.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    evidence suggests that kratom, which contains the main active \n",
      "alkaloids mitragynine and 7-hydroxymitragynine, is abused individually, \n",
      "and with other psychoactive substances. in a 2016 publication, the \n",
      "centers for disease control (cdc) characterized kratom exposures \n",
      "reported to poison centers and uploaded to the national poison data \n",
      "system (npds) \\5\\ from january 2010 through december 2015. during the \n",
      "stated timeframe, u.s. poison centers received 660 calls related to \n",
      "kratom exposure. of the calls reported, 487 (73.8%) reported \n",
      "intentional exposure to kratom, and 595 (90.2%) reported ingestion of \n",
      "the drug. in addition to reports of isolated exposures to kratom (428 \n",
      "(64.8%)), reports of kratom being used with other substances (ethanol, \n",
      "benzodiazepines, narcotics, acetaminophen, and other botanicals) were \n",
      "also recorded. additionally, forensic laboratory analyses of drug \n",
      "evidence have identified kratom/mitragynine, along with synthetic \n",
      "cannabinoids and synthetic opioids during the analyses of products \n",
      "seized on the illicit market. the consumption of kratom individually, \n",
      "or in conjunction with alcohol or other drugs, is of serious concern as \n",
      "it can lead to severe adverse effects and death.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\5\\ the national poison data system (npds) is a national \n",
      "database of information logged by the country's regional poison \n",
      "centers serving all 50 united states, puerto rico and the district \n",
      "of columbia. the npds is maintained by the american association of \n",
      "poison control centers. npds case records are the result of call \n",
      "reports made by users (i.e., self-reports), friends and family \n",
      "members, and health care providers.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    kratom does not have an approved medical use in the united states \n",
      "and has not been studied as a treatment agent in the united states. \n",
      "kratom has a history of being used as an opium substitute in southeast \n",
      "asia. kratom has also been used to self-treat chronic pain and \n",
      "withdrawal symptoms from opioid use. especially concerning, reports \n",
      "note users have turned to kratom as a replacement for other opioids, \n",
      "such as heroin.\n",
      "    in the united states, kratom is misused to self-treat chronic pain \n",
      "and opioid withdrawal symptoms, with users reporting its effects to be \n",
      "comparable to prescription opioids. users have also reported dose-\n",
      "dependent psychoactive effects to include euphoria, simultaneous \n",
      "stimulation and relaxation, analgesia, vivid dreams, and sedation (at \n",
      "higher\n",
      "\n",
      "[[page 59931]]\n",
      "\n",
      "doses). as noted in the actions by the united states food and drug \n",
      "administration,\\6\\ kratom products have been encountered with false \n",
      "claims, an extremely concerning issue for public health and safety. \n",
      "these products are marketed as safe for self-medication, but have not \n",
      "been approved by the food and drug administration (fda) for any medical \n",
      "uses.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\6\\ 2015-cder-dea memorandum of understanding for sharing \n",
      "information (provided under 21 cfr 20.85) dated august 4, 2016.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    information from the published literature, poison control centers \n",
      "data, and medical examiner data, suggests that kratom, which contains \n",
      "the main active alkaloids mitragynine and 7-hydroxymitragynine, is \n",
      "abused by a diverse population to include recreational opioid users, \n",
      "young adults, and adults. the most commonly described route of \n",
      "administration of kratom, which contains the main active alkaloids \n",
      "mitragynine and 7-hydroxymitragynine, is oral. the leaves are typically \n",
      "brewed and ingested as a tea; however, smoking, chewing the raw leaves \n",
      "(done traditionally), and ingestion of kratom capsules or resin \n",
      "extracts have also been reported.\n",
      "\n",
      "factor 5. scope, duration and significance of abuse\n",
      "\n",
      "    the abuse of kratom, containing the main active alkaloids \n",
      "mitragynine and 7-hydroxymitragynine, is increasing in the united \n",
      "states and remains extremely concerning for law enforcement and public \n",
      "health. as the abuse of the plant increases, as demonstrated by the \n",
      "increasing availability per border encounters,\\7\\ it has been noted \n",
      "that physicians should be aware of the kratom's adverse health effects, \n",
      "toxicity, dependence, and withdrawal .is.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\7\\ 2015-cder-dea memorandum of understanding for sharing \n",
      "information (provided under 21 cfr 20.85) dated august 4, 2016.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    reports from law enforcement indicate that kratom is being imported \n",
      "for widespread distribution to the public within the united states.\\8\\ \n",
      "between february 2014 and july 2016, over 55,000 kilograms (kg) of \n",
      "kratom material were encountered by law enforcement at various ports of \n",
      "entry within the united states.\\9\\ additionally, over 57,000 kg of \n",
      "kratom material offered for import at numerous ports of entry, between \n",
      "2014 and 2016, are awaiting an fda admissibility decision.\\10\\ the \n",
      "amount of kratom currently seized or awaiting an admissibility decision \n",
      "by law enforcement, between 2014 and 2016, is enough to produce over 12 \n",
      "million doses of kratom.\\11\\ such alarming quantities create an \n",
      "imminent public health and safety threat.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\8\\ 2015-cder-dea memorandum of understanding for sharing \n",
      "information (provided under 21 cfr 20.85) dated august 4, 2016. \n",
      "represents customs and border patrol (cbp) seizures from february \n",
      "2014 through july 2016.\n",
      "    \\9\\ 2015-cder-dea memorandum of understanding for sharing \n",
      "information (provided under 21 cfr 20.85) dated august 4, 2016. \n",
      "represents customs and border patrol (cbp) seizures from february \n",
      "2014 through july 2016.\n",
      "    \\10\\ 2015-cder-dea memorandum of understanding for sharing \n",
      "information (provided under 21 cfr 20.85) dated august 4, 2016.\n",
      "    \\11\\ 2015-cder-dea memorandum of understanding for sharing \n",
      "information (provided under 21 cfr 20.85) dated august 4, 2016. \n",
      "assuming a high dose of 9 g of kratom.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    according to press announcements released in 2014 and 2016, the fda \n",
      "requested the seizure, by us marshals, of more than 25,000 pounds of \n",
      "raw kratom material, nearly 90,000 bottles of dietary supplements \n",
      "labeled as containing kratom, and over 100 cases of products labeled as \n",
      "kratom, respectively.\\12\\ the fda stated that kratom products ``pose a \n",
      "risk to the public health and have the potential for abuse'' and the \n",
      "seizure of certain kratom products was necessary ``to safeguard the \n",
      "public from a dangerous product''.\\13\\ the fda has also warned the \n",
      "public not to use any products labeled as containing kratom due to \n",
      "serious concerns about toxicity and potential health impacts.\\14\\ to \n",
      "further protect the public health and safety from the large influx of \n",
      "kratom materials, the fda issued and updated two import alerts related \n",
      "to numerous kratom and kratom-containing products.\\15\\ these import \n",
      "alerts allow for detention without physical examination of dietary \n",
      "supplements and bulk ingredients that are or contain kratom, and \n",
      "detention without physical examination of unapproved new drugs promoted \n",
      "in the united states, which includes kratom products that make false \n",
      "health claims. since 2014, 121 firms have been added to these import \n",
      "alerts for importing kratom products.\\16\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\12\\ relevant press release can be found online at: <a href=\"http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm416318.htm\">www.fda.gov/newsevents/newsroom/pressannouncements/ucm416318.htm</a>; <a href=\"http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm480344.htm\">http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm480344.htm</a>; \n",
      "and <a href=\"http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm515085.htm\">http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm515085.htm</a>.\n",
      "    \\13\\ relevant press release can be found online at: <a href=\"http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm416318.htm\">www.fda.gov/newsevents/newsroom/pressannouncements/ucm416318.htm</a>.\n",
      "    \\14\\ relevant press release can be found online at: <a href=\"http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm515085.htm\">http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm515085.htm</a>.\n",
      "    \\15\\ relevant import alerts (#'s 54-15 and 66-41) can be found \n",
      "online at: <a href=\"http://www.accessdata.fda.gov/cms_ia/importalert_1137.html.and\">www.accessdata.fda.gov/cms_ia/importalert_1137.html.and</a> \n",
      "<a href=\"http://www.accessdata.fda.gov/cms_ia/importalert_190.html\">www.accessdata.fda.gov/cms_ia/importalert_190.html</a>.\n",
      "    \\16\\ 2015-cder-dea memorandum of understanding for sharing \n",
      "information (provided under 21 cfr 20.85) dated august 4, 2016.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    drug reports pertaining to the trafficking, distribution, and abuse \n",
      "of kratom/mitragynine \\17\\ were analyzed by federal, state, and local \n",
      "forensic laboratories.\\18\\ according to data from the system to \n",
      "retrieve information from drug evidence (stride) and starlims (a web-\n",
      "based, commercial laboratory information management system), from \n",
      "january 2006 through march 2016, there were 293 records for kratom and/\n",
      "or mitragynine. from january 2010 through may 2016, the national \n",
      "forensic laboratory information system (nflis) registered 720 reports \n",
      "containing mitragynine (see 3-factor analysis). nflis and stride/\n",
      "starlims records/reports were reported across 43 states, thus showing \n",
      "the widespread abuse and trafficking of kratom/mitragynine.\\19\\ the \n",
      "presence of these substances during drug evidence analyses demonstrates \n",
      "the presence of these substances on the recreational drug market.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\17\\ mitrgynine is used to confirmatively identify plant \n",
      "material as kratom.\n",
      "    \\18\\ while law enforcement data is not direct evidence of abuse, \n",
      "it can lead to an inference that a drug has been diverted and \n",
      "abused.\n",
      "    \\19\\ stride, starlims, and nflis data reflect data reported by \n",
      "the forensic laboratory systems. encounters reported in these \n",
      "systems, and the overall number of seizures, may be low because \n",
      "kratom/mitragynine is not federally controlled under the csa. \n",
      "typically, after control, these numbers will increase.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    growing concern over the use of kratom is reflected in the \n",
      "increased requests for analyses of mitragynine and 7-hydroxymitragynine \n",
      "in human toxicology panels (blood/urine samples) \\20\\ to private \n",
      "analytical laboratories.\\21\\ these analyses have been requested by \n",
      "addiction treatment facilities/pain management doctors, drug courts, \n",
      "medical examiner/coroner offices, drug testing facilities, state \n",
      "laboratory systems, state police department, and private entities.\\22\\ \n",
      "the number of positive results from these analyses increased as \n",
      "follows: 31 positive results from august 2012 to july 2013 for \n",
      "mitragynine and/or 7-hydroxymitragynine; \\23\\ 274 positive results for \n",
      "mitragynine between july 2013 and may 2014; \\24\\ 555 positive\n",
      "\n",
      "[[page 59932]]\n",
      "\n",
      "results for mitragynine between december 2014 and march 2016.\\25\\ the \n",
      "increasing trend in the number of positive results from these analyses \n",
      "demonstrates the growing abuse and popularity of these substances and \n",
      "the concern related to the abuse of this plant material and its \n",
      "psychoactive constituents.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\20\\ the quantitative values for mitragynine and 7-\n",
      "hydroxymitragynine were not available for all positive results \n",
      "shown.\n",
      "    \\21\\ substances are tested as part of a toxicology panel that \n",
      "includes illicit or commonly abused substances routinely analyzed.\n",
      "    \\22\\ email correspondences with analytical laboratories in \n",
      "willow grove, pa, clearwater, fl, and santa rosa, ca.\n",
      "    \\23\\ located in willow grove, pa, analyzed blood/urine samples \n",
      "from canada and thirteen u.s. states. correspondences on file with \n",
      "dea.\n",
      "    \\24\\ located in clearwater, fl, analyzed urine samples from \n",
      "multiple states across the u.s. correspondences on file with dea.\n",
      "    \\25\\ located in santa rosa, ca, analyzed urine samples from \n",
      "multiple states across the united states. correspondences on file \n",
      "with dea.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    evidence from poison control centers in the united states also \n",
      "shows that there is an increase in the number of individuals abusing \n",
      "kratom, which contains the main active alkaloids mitragynine and 7-\n",
      "hydroxymitragynine. as such, there has been a steady increase in the \n",
      "reporting of kratom exposures by poison control centers. the american \n",
      "association of poison control centers identified two exposures to \n",
      "kratom between 2000 and 2005. additionally, the texas poison center \n",
      "network (tpcn), which is comprised of six poison centers that service \n",
      "the state of texas, reported 14 exposures to kratom between january \n",
      "2009 and september 2013. between january 2010 and december 2015 u.s. \n",
      "poison centers received 660 calls related to kratom exposure. during \n",
      "this time, there was a tenfold increase in the number of calls \n",
      "received, from 26 in 2010 to 263 in 2015.\n",
      "    furthermore, the abuse and addictive properties of kratom, which \n",
      "contains the main active alkaloids mitragynine, and 7-\n",
      "hydroxymitragynine, have prompted at least 15 countries,\\26\\ and 6 \n",
      "states and the district of columbia to ban kratom, mitragynine and/or \n",
      "7-hydroxymitragynine and two states within the united states,\\27\\ to \n",
      "place regulatory controls on these substances. six other states within \n",
      "the united states have proposed to ban or place regulatory controls on \n",
      "these substances.\\28\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\26\\ z. aziz, kratom the epidemiology, use and abuse, addiction \n",
      "potential, and legal status, in kratom and other mitragynines the \n",
      "chemistry and pharmacology of opioids from a non-opium source 309-\n",
      "319 (raffa, r.b., ed 2014); european monitoring center for drugs and \n",
      "drug addiction, drug profiles: kratom, www.emcdda.europa.eu/\n",
      "publications/drug-profiles/kratom (accessed 08/28/2013); misuse of \n",
      "drugs act 1977 order 2011 (s.i. no. 551/2011) (ir.); misuse of drugs \n",
      "(amendment regulations 2011 (s.i. no. 552/2011) (ir.).\n",
      "    \\27\\ alabama--ala. code sec.  20-2-23; arkansas--ark. admin. \n",
      "code 007.07.2; illinois--il st ch 720 sec.  642/5; indiana--ic 35-\n",
      "31.5-2-321; louisiana--la r.s. 40:989.3; tennessee--t.c.a. sec.  39-\n",
      "17-452; vermont--vt. admin. code 12-5-23:4.0; wisconsin--w.s.a. \n",
      "961.14 and district of columbia--22-b dc adc sec.  1201.\n",
      "    \\28\\ new hampshire--2015 nh s.b. 540 and 2015 nh s.b. 540; new \n",
      "jersey--2016 nj a.b. 3281; new york--2015 ny a.b. 9121, 2015 ny a.b. \n",
      "9068, 2015 ny a.b. 8670, and 2015 ny s.b. 6345; north carolina--2015 \n",
      "nc h.b. 747 (ns) and 2015 nc s.b. 830 (ns); florida--2016 fl s.b. \n",
      "1182 and 2016 fl h.b. 73; and kentucky--2016 ky s.b. 136.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    internationally, the increased presence and abuse of kratom, \n",
      "containing the main active alkaloids mitragynine and 7-\n",
      "hydroxymitragynine, have garnered the attention of the international \n",
      "narcotics control board (incb).\\29\\ in a 2010 report, the incb noted \n",
      "the increased interest in the recreational use of kratom. the incb \n",
      "recommended that governments experiencing problems with persons \n",
      "trafficking or using kratom \\30\\ recreationally should consider \n",
      "controlling kratom and kratom preparations at the national level, where \n",
      "necessary.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\29\\ the incb is an independent monitoring body that is \n",
      "responsible for evaluating the implementation of the united nations \n",
      "international drug controls conventions.\n",
      "    \\30\\ kratom was listed as a plant material containing \n",
      "psychoactive substances in the incb report for which recommendations \n",
      "were made for specified plant materials.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "factor 6. what, if any, risk there is to the public health\n",
      "\n",
      "    the use of kratom and associated products, which contains the main \n",
      "active alkaloids mitragynine and 7-hydroxymitragine, pose an imminent \n",
      "hazard to public safety. these substances produce opioid-like effects, \n",
      "making their abuse a serious public health concern. information from \n",
      "published literature, public health officials, and poison control \n",
      "center data demonstrate that the use of kratom, which contains the main \n",
      "active alkaloids mitragynine and 7-hydroxymitragynine, has caused \n",
      "numerous adverse effects on users.\n",
      "    in a 2016 publication, the cdc characterized kratom exposures \n",
      "reported to poison centers and uploaded to the npds from january 2010 \n",
      "through december 2015.\\31\\ these exposures resulted in medical outcomes \n",
      "that varied in severity, ranging from minor (having minimal signs or \n",
      "symptoms that resolved rapidly with no residual disability), moderate \n",
      "(having non-life threatening and no residual disability, but requiring \n",
      "some form of treatment), major (having life-threatening signs or \n",
      "symptoms with some residual disability), and death. additionally, \n",
      "several adverse effects related to kratom exposure were reported, which \n",
      "include agitation or irritability, tachycardia, nausea, drowsiness, and \n",
      "hypertension. the severity of the reported outcomes, health effects, \n",
      "and increased use of kratom suggests an emerging public health threat.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\31\\ calls from healthcare providers comprised a large portion \n",
      "of calls received, representing 75.2% of calls reported.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    information from the scientific literature also demonstrates the \n",
      "health risks associated with kratom use. reports of hepatotoxicity, \n",
      "psychosis, seizure, weight loss, insomnia, tachycardia, vomiting, poor \n",
      "concentration, hallucinations, and death associated with kratom use \n",
      "have been documented. additionally, published case reports describe \n",
      "events where individuals sought medical care for the purported use of \n",
      "kratom. some examples of the reported adverse events involving kratom \n",
      "exposure are described in the 3-factor analysis.\n",
      "    numerous deaths associated with kratom, which contains the main \n",
      "active constituents mitragynine and 7-hydroxymitragynine, have been \n",
      "reported indicating that this substance is a serious public health \n",
      "threat. in 2016, dea has received correspondences from public/state \n",
      "officials which indicate that there were a significant number of \n",
      "overdoses and traffic fatalities directly, or indirectly, involving \n",
      "kratom.\\32\\ deaths related to kratom exposure have been reported in the \n",
      "scientific literature beginning in 2009-2010, with a cluster of nine \n",
      "deaths in sweden from use of the kratom product ``krypton''. since \n",
      "then, five more deaths related to kratom exposure were reported in the \n",
      "scientific literature, and sixteen other deaths related to kratom \n",
      "exposure, have been confirmed by autopsy/medical examiner reports \n",
      "(mitragynine and/or 7-hydroxymitragynine were identified in biological \n",
      "samples).\\33\\ of these deaths, 15 occurred between 2014 and 2016. this \n",
      "information demonstrates the severe risks associated with kratom misuse \n",
      "and the increasing occurrence of fatal outcomes related to kratom \n",
      "exposure. details of some of these events are summarized in the 3-\n",
      "factor analysis.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\32\\ correspondences on file with dea (dated april 19, 2016).\n",
      "    \\33\\ autopsy/medical examiner (me) reports on file with dea.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    since abusers obtain kratom, which contains the main active \n",
      "alkaloids mitragynine and 7-hydroxymitragyine, through unknown sources, \n",
      "the identity, purity, and quantity of these substances are uncertain \n",
      "and inconsistent, thus posing significant adverse health risks to \n",
      "users. according to the fda, in a letter dated may 18, 2016, there are \n",
      "no approved new drug applications, or investigational new drug \n",
      "applications for mitragynine or 7-hydroxymitragynine. as such, kratom \n",
      "products have no accepted medical use\n",
      "\n",
      "[[page 59933]]\n",
      "\n",
      "within the united states. despite fda warnings, kratom products \n",
      "continue to be easily available and abused by diverse populations. \n",
      "distributors of kratom are knowingly putting the public at risk. \n",
      "unknown factors including detailed product analysis and dosage \n",
      "variations between various packages present a significant danger to an \n",
      "abusing individual. with no accepted medical use, the abuse of kratom, \n",
      "which contains mitragynine and 7-hydroxymitragynine, poses an imminent \n",
      "hazard to the public safety.\n",
      "\n",
      "finding of necessity of schedule i placement to avoid imminent hazard \n",
      "to public safety\n",
      "\n",
      "    in accordance with 21 u.s.c. 811(h)(3), based on the available data \n",
      "and information, summarized above, the continued uncontrolled \n",
      "manufacture, distribution, reverse distribution, importation, \n",
      "exportation, conduct of research and chemical analysis, possession, and \n",
      "abuse of mitragynine and 7-hydroxymitragynine pose an imminent hazard \n",
      "to the public safety. the dea is not aware of any currently accepted \n",
      "medical uses for these substances in the united states. a substance \n",
      "meeting the statutory requirements for temporary scheduling, 21 u.s.c. \n",
      "811(h)(1), may only be placed in schedule i. substances in schedule i \n",
      "are those that have a high potential for abuse, no currently accepted \n",
      "medical use in treatment in the united states, and a lack of accepted \n",
      "safety for use under medical supervision. available data and \n",
      "information for mitragynine and 7-hydroxymitragynine indicate that \n",
      "these substances have a high potential for abuse, no currently accepted \n",
      "medical use in treatment in the united states, and a lack of accepted \n",
      "safety for use under medical supervision. as required by section \n",
      "201(h)(4) of the csa, 21 u.s.c. 811(h)(4), the administrator, through a \n",
      "letter dated may 6, 2016, notified the assistant secretary of the \n",
      "department of health and human services of the dea's intention to \n",
      "temporarily place these substances in schedule i.\n",
      "\n",
      "conclusion\n",
      "\n",
      "    this notice of intent initiates an expedited temporary scheduling \n",
      "action and provides the 30-day notice pursuant to section 201(h) of the \n",
      "csa, 21 u.s.c. 811(h). in accordance with the provisions of section \n",
      "201(h) of the csa, 21 u.s.c. 811(h), the administrator considered \n",
      "available data and information, herein set forth the grounds for his \n",
      "determination that it is necessary to temporarily schedule mitragynine \n",
      "and 7-hydroxymitragynine in schedule i of the csa, and finds that \n",
      "placement of these opioid substances into schedule i of the csa is \n",
      "necessary in order to avoid an imminent hazard to the public safety.\n",
      "    because the administrator hereby finds that it is necessary to \n",
      "temporarily place these opioids into schedule i to avoid an imminent \n",
      "hazard to the public safety, any subsequent final order temporarily \n",
      "scheduling these substances will be effective on the date of \n",
      "publication in the federal register, and will be in effect for a period \n",
      "of two years, with a possible extension of one additional year, pending \n",
      "completion of the regular scheduling process. 21 u.s.c. 811(h) (1) and \n",
      "(2). it is the intention of the administrator to issue such a final \n",
      "order as soon as possible after the expiration of 30 days from the date \n",
      "of publication of this notice. mitragynine and 7-hydroxymitragynine \n",
      "will then be subject to the regulatory controls and administrative, \n",
      "civil, and criminal sanctions applicable to the manufacture, \n",
      "distribution, reverse distribution, importation, exportation, research, \n",
      "conduct of instructional activities and chemical analysis, and \n",
      "possession of a schedule i controlled substance.\n",
      "    the csa sets forth specific criteria for scheduling a drug or other \n",
      "substance. regular scheduling actions in accordance with 21 u.s.c. \n",
      "811(a) are subject to formal rulemaking procedures done ``on the record \n",
      "after opportunity for a hearing'' conducted pursuant to the provisions \n",
      "of 5 u.s.c. 556 and 557. 21 u.s.c. 811. the regular scheduling process \n",
      "of formal rulemaking affords interested parties with appropriate \n",
      "process and the government with any additional relevant information \n",
      "needed to make a determination. final decisions that conclude the \n",
      "regular scheduling process of formal rulemaking are subject to judicial \n",
      "review. 21 u.s.c. 877. temporary scheduling orders are not subject to \n",
      "judicial review. 21 u.s.c. 811(h)(6).\n",
      "\n",
      "regulatory matters\n",
      "\n",
      "    section 201(h) of the csa, 21 u.s.c. 811(h), provides for an \n",
      "expedited temporary scheduling action where such action is necessary to \n",
      "avoid an imminent hazard to the public safety. as provided in this \n",
      "subsection, the attorney general may, by order, schedule a substance in \n",
      "schedule i on a temporary basis. such an order may not be issued before \n",
      "the expiration of 30 days from (1) the publication of a notice in the \n",
      "federal register of the intention to issue such order and the grounds \n",
      "upon which such order is to be issued, and (2) the date that notice of \n",
      "the proposed temporary scheduling order is transmitted to the assistant \n",
      "secretary of hhs. 21 u.s.c. 811(h)(1).\n",
      "    inasmuch as section 201(h) of the csa directs that temporary \n",
      "scheduling actions be issued by order and sets forth the procedures by \n",
      "which such orders are to be issued, the dea believes that the notice \n",
      "and comment requirements of section 553 of the administrative procedure \n",
      "act (apa), 5 u.s.c. 553, do not apply to this notice of intent. in the \n",
      "alternative, even assuming that this notice of intent might be subject \n",
      "to section 553 of the apa, the administrator finds that there is good \n",
      "cause to forgo the notice and comment requirements of section 553, as \n",
      "any further delays in the process for issuance of temporary scheduling \n",
      "orders would be impracticable and contrary to the public interest in \n",
      "view of the manifest urgency to avoid an imminent hazard to the public \n",
      "safety.\n",
      "    although the dea believes this notice of intent to issue a \n",
      "temporary scheduling order is not subject to the notice and comment \n",
      "requirements of section 553 of the apa, the dea notes that in \n",
      "accordance with 21 u.s.c. 811(h)(4), the administrator will take into \n",
      "consideration any comments submitted by the assistant secretary with \n",
      "regard to the proposed temporary scheduling order.\n",
      "    further, the dea believes that this temporary scheduling action is \n",
      "not a ``rule'' as defined by 5 u.s.c. 601(2), and, accordingly, is not \n",
      "subject to the requirements of the regulatory flexibility act (rfa). \n",
      "the requirements for the preparation of an initial regulatory \n",
      "flexibility analysis in 5 u.s.c. 603(a) are not applicable where, as \n",
      "here, the dea is not required by section 553 of the apa or any other \n",
      "law to publish a general notice of proposed rulemaking.\n",
      "    additionally, this action is not a significant regulatory action as \n",
      "defined by executive order 12866 (regulatory planning and review), \n",
      "section 3(f), and, accordingly, this action has not been reviewed by \n",
      "the office of management and budget (omb).\n",
      "    this action will not have substantial direct effects on the states, \n",
      "on the relationship between the national government and the states, or \n",
      "on the distribution of power and responsibilities among the various \n",
      "levels of government. therefore, in accordance with executive order \n",
      "13132 (federalism) it is determined that this action does not have \n",
      "sufficient federalism implications to warrant the preparation of a \n",
      "federalism assessment.\n",
      "\n",
      "[[page 59934]]\n",
      "\n",
      "list of subjects in 21 cfr part 1308\n",
      "\n",
      "    administrative practice and procedure, drug traffic control, \n",
      "reporting and recordkeeping requirements.\n",
      "\n",
      "    for the reasons set out above, the dea proposes to amend 21 cfr \n",
      "part 1308 as follows:\n",
      "\n",
      "part 1308--schedules of controlled substances\n",
      "\n",
      "0\n",
      "1. the authority citation for part 1308 continues to read as follows:\n",
      "\n",
      "    authority:  21 u.s.c. 811, 812, 871(b), unless otherwise noted.\n",
      "\n",
      "0\n",
      "2. in sec.  1308.11, add paragraphs (h)(28) and (29) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  1308.11  schedule i\n",
      "\n",
      "* * * * *\n",
      "    (h) * * *\n",
      "    (28) mitragynine (to include synthetic equivalents as well as \n",
      "mitragynine naturally contained in the plant of the genus and species \n",
      "name: mitragyna speciosa korth, also known as kratom) its isomers, \n",
      "esters, ethers, salts and salts of isomers, esters and ethers . . . \n",
      "(9823)\n",
      "    (29) 7-hydroxymitragynine (to include synthetic equivalents as well \n",
      "as 7-hydroxymitragynine naturally contained in the plant of the genus \n",
      "and species name: mitragyna speciosa korth, also known as kratom) its \n",
      "isomers, esters, ethers, salts and salts of isomers, esters and ethers \n",
      ". . . (9838)\n",
      "\n",
      "    dated: august 25, 2016.\n",
      "chuck rosenberg,\n",
      "acting administrator.\n",
      "[fr doc. 2016-20803 filed 8-30-16; 8:45 am]\n",
      " billing code 4410-09-p\n",
      "\n",
      "\n",
      "</pre></body>\n",
      "</html>\n",
      "Added /Users/ha/Downloads/mirrulations/specific/DEA-2016-0015/raw-data/documents/DEA-2016-0015-0003_content.htm to vector store.\n",
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 81 issue 198 (thursday, october 13, 2016)</title>\n",
      "</head>\n",
      "<body><pre>\n",
      "[federal register volume 81, number 198 (thursday, october 13, 2016)]\n",
      "[proposed rules]\n",
      "[pages 70652-70654]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2016-24659]\n",
      "\n",
      "\n",
      "=======================================================================\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of justice\n",
      "\n",
      "drug enforcement administration\n",
      "\n",
      "21 cfr part 1308\n",
      "\n",
      "[docket no. dea-442w]\n",
      "\n",
      "\n",
      "withdrawal of notice of intent to temporarily place mitragynine \n",
      "and 7-hydroxymitragynine into schedule i\n",
      "\n",
      "agency: drug enforcement administration, department of justice.\n",
      "\n",
      "action: withdrawal of notice of intent; solicitation of comments.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: on august 31, 2016, the drug enforcement administration (dea) \n",
      "published in the federal register a notice of intent to temporarily \n",
      "place mitragynine and 7-hydroxymitragynine, which are the main \n",
      "psychoactive constituents of the plant mitragyna speciosa, also \n",
      "referred to as kratom, into schedule i pursuant to the temporary \n",
      "scheduling provisions of the controlled substances act. since \n",
      "publishing that notice, dea has received numerous comments from members \n",
      "of the public challenging the scheduling action and requesting that the \n",
      "agency consider those comments and accompanying information before \n",
      "taking further action. in addition, dea will receive from the food and \n",
      "drug administration (fda) a scientific and medical evaluation and \n",
      "scheduling recommendation for these substances, which dea previously \n",
      "requested.\n",
      "    dea is therefore taking the following actions: dea is withdrawing \n",
      "the august 31, 2016 notice of intent; and soliciting comments from the \n",
      "public regarding the scheduling of mitragynine and 7-hydroxymitragynine \n",
      "under the controlled substances act.\n",
      "\n",
      "dates: the notice of intent that was published on august 31, 2016 (81 \n",
      "fr 59929) is withdrawn as of october 13, 2016. the comment period will \n",
      "be open until december 1, 2016. all comments for the public record must \n",
      "be submitted electronically or in writing in accordance with the \n",
      "procedures outlined below. electronic comments must be submitted, and \n",
      "written comments must be postmarked, on or before december 1, 2016. \n",
      "commenters should be aware that the electronic federal docket \n",
      "management system will not accept comments after 11:59 p.m. eastern \n",
      "time on the last day of the comment period. please note that if you \n",
      "previously submitted a comment via email or regular mail following the \n",
      "august 31, 2016 notice, that comment is being considered by dea--it is \n",
      "not necessary to resubmit the same comment unless you wish to provide \n",
      "additional information, or you wish to have your comment posted for \n",
      "public view in accordance with the instructions provided below.\n",
      "\n",
      "addresses: to ensure proper handling of comments, please reference \n",
      "``docket no. dea-442w'' on all correspondence, including any \n",
      "attachments.\n",
      "    <bullet> electronic comments: the drug enforcement administration \n",
      "encourages that all comments be submitted electronically through the \n",
      "federal erulemaking portal, which provides the ability to type short \n",
      "comments directly into the comment field on the web page or attach a \n",
      "file for lengthier comments. please go to <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a> \n",
      "and follow the online instructions at that site for submitting \n",
      "comments. upon completion of your submission, you will receive a \n",
      "comment tracking number for your comment. please be aware that \n",
      "submitted comments are not instantaneously available for public view on \n",
      "<a href=\"http://regulations.gov\">regulations.gov</a>. if you have\n",
      "\n",
      "[[page 70653]]\n",
      "\n",
      "received a comment tracking number, your comment has been successfully \n",
      "submitted and there is no need to resubmit the same comment.\n",
      "    <bullet> paper comments: paper comments that duplicate the \n",
      "electronic submission are not necessary and are discouraged. should you \n",
      "wish to mail a paper comment in lieu of an electronic comment, it \n",
      "should be sent via regular or express mail to: drug enforcement \n",
      "administration, attn: dea federal register representative/odw, 8701 \n",
      "morrissette drive, springfield, virginia 22152.\n",
      "\n",
      "for further information contact: michael j. lewis, diversion control \n",
      "division, drug enforcement administration; mailing address: 8701 \n",
      "morrissette drive, springfield, virginia 22152; telephone: (202) 598-\n",
      "6812.\n",
      "\n",
      "supplementary information:\n",
      "\n",
      "posting of public comments\n",
      "\n",
      "    please note that all comments received in response to this notice \n",
      "are considered part of the public record. if you previously submitted a \n",
      "comment via email or regular mail following the august 31, 2016 notice, \n",
      "that comment is being considered by dea--it is not necessary to \n",
      "resubmit the same comment unless you wish to provide additional \n",
      "information, or you wish to have your comment posted for public view in \n",
      "accordance with the instructions provided below.\n",
      "    all comments received in response to this notice of opportunity to \n",
      "comment will, unless reasonable cause is given, be made available by \n",
      "dea for public inspection online at <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a>. such \n",
      "information includes personal identifying information (such as your \n",
      "name, address, etc.) voluntarily submitted by the commenter. the \n",
      "freedom of information act (foia) applies to all comments received. if \n",
      "you want to submit personal identifying information (such as your name, \n",
      "address, etc.) as part of your comment, but do not want it to be made \n",
      "publicly available, you must include the phrase ``personal identifying \n",
      "information'' in the first paragraph of your comment. you must also \n",
      "place all of the personal identifying information you do not want made \n",
      "publicly available in the first paragraph of your comment and identify \n",
      "what information you want redacted.\n",
      "    if you want to submit confidential business information as part of \n",
      "your comment, but do not want it to be made publicly available, you \n",
      "must include the phrase ``confidential business information'' in the \n",
      "first paragraph of your comment. you must also prominently identify the \n",
      "confidential business information to be redacted within the comment.\n",
      "    comments containing personal identifying information and \n",
      "confidential business information identified as directed above will \n",
      "generally be made publicly available in redacted form. if a comment has \n",
      "so much personal identifying information or confidential business \n",
      "information that it cannot be effectively redacted, all or part of that \n",
      "comment may not be made publicly available. comments posted to <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a> may include any personal identifying information \n",
      "(such as name, address, and phone number) or confidential business \n",
      "information included in the text of your electronic submission that is \n",
      "not identified as directed above as personal or confidential.\n",
      "\n",
      "background\n",
      "\n",
      "withdrawal of notice of intent\n",
      "\n",
      "    the controlled substances act (csa) contains a temporary scheduling \n",
      "provision, 21 u.s.c. 811(h), pursuant to which the dea administrator \n",
      "\\1\\ may temporarily place a substance in schedule i where he finds that \n",
      "doing so is necessary to avoid an imminent hazard to the public safety. \n",
      "this provision of the csa requires dea to publish a notice in the \n",
      "federal register of its intent to issue a temporary scheduling order at \n",
      "least 30 days before issuing any such order. dea published such a \n",
      "notice of intent on august 31, 2016, with respect to mitragynine and 7-\n",
      "hydroxymitragynine, which are the main psychoactive constituents of the \n",
      "plant commonly known as kratom. 81 fr 59929.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\1\\ the attorney general has delegated her functions under the \n",
      "csa to the dea administrator.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in response to the notice of intent, dea received numerous comments \n",
      "from the public on mitragynine and 7-hydroxymitragynine, including \n",
      "comments offering their opinions regarding the pharmacological effects \n",
      "of these substances. to allow consideration of these comments, as well \n",
      "as others received on or before december 1, 2016, dea has decided to \n",
      "withdraw the august 31, 2016 notice of intent published at 81 fr 59929. \n",
      "dea has also requested that the fda expedite its scientific and medical \n",
      "evaluation and scheduling recommendation for these substances, which \n",
      "dea previously requested in accordance with 21 u.s.c. 811(b).\\2\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\2\\ section 811(b) provides that the scientific and medical \n",
      "evaluation and scheduling recommendation shall be conducted by the \n",
      "secretary of health and human services (hhs). this function has been \n",
      "delegated to the assistant secretary for health. 58 fr 35460 (1993). \n",
      "within hhs, the fda has primary responsibility for conducting the \n",
      "evaluation and making the recommendation.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    accordingly, the august 31, 2016, notice of intent to temporarily \n",
      "place mitragynine and 7-hydroxymitragynine in schedule i is withdrawn. \n",
      "mitragynine and 7-hydroxymitragynine therefore remain--as has been the \n",
      "case--noncontrolled substances under federal law.\\3\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\3\\ under some state and local laws, kratom and/or its \n",
      "constituents mitragynine and 7-hydroxymitragynine are currently \n",
      "listed as controlled substances or otherwise subject to control. \n",
      "nothing in this publication alters the validity of such laws, or any \n",
      "pending state efforts to implement those laws or enact new laws \n",
      "controlling these substances.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "consideration of public comments and fda's analysis\n",
      "\n",
      "    with respect to mitragynine and 7-hydroxymitragynine, dea will \n",
      "consider all public comments received under the above procedures, as \n",
      "well as fda's scientific and medical evaluation and scheduling \n",
      "recommendation for these substances. once dea has received and \n",
      "considered all of this information, dea will decide whether to proceed \n",
      "with permanent scheduling of mitragynine and 7-hydroxymitragynine, or \n",
      "both permanent and temporary scheduling of these substances.\n",
      "    permanent scheduling process: as the csa provides, if dea \n",
      "determines that the medical and scientific facts contained in the fda \n",
      "scheduling evaluation, along with all other relevant data and \n",
      "information, constitute substantial evidence of potential for abuse to \n",
      "support permanent scheduling of mitragynine and 7-hydroxymitragynine, \n",
      "dea will publish in the federal register a notice of proposed \n",
      "rulemaking, which will give interested members of the public an \n",
      "additional opportunity to submit comments and request a hearing.\\4\\ as \n",
      "provided in 21 u.s.c. 811(a), permanent scheduling rules shall be made \n",
      "on the record after opportunity for a hearing pursuant to the \n",
      "rulemaking procedures prescribed by 5 u.s.c. 553, 556, and 557.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\4\\ in permanent scheduling actions, when dea reviews the fda \n",
      "evaluation and scheduling recommendation, the fda determinations as \n",
      "to scientific and medical matters are binding on dea. 21 u.s.c. \n",
      "811(b).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    temporary scheduling process: the pendency of permanent scheduling \n",
      "proceedings for a substance does not preclude a simultaneous or \n",
      "subsequent order to temporarily control that substance. if dea finds in \n",
      "light of fda's scientific and medical evaluation and after \n",
      "consideration of all public\n",
      "\n",
      "[[page 70654]]\n",
      "\n",
      "comments and other relevant information that, based on the criteria of \n",
      "section 811(h), temporary placement of mitragynine and 7-\n",
      "hydroxymitragynine in schedule i is necessary to avoid an imminent \n",
      "hazard to the public safety, dea will follow the statutory procedures \n",
      "for issuing such a temporary scheduling order. as indicated above, \n",
      "before issuing such a temporary scheduling order, dea would be required \n",
      "---------------------------------------------------------------------------\n",
      "to publish in the federal register a new notice of intent.\n",
      "\n",
      "    dated: october 6, 2016.\n",
      "chuck rosenberg,\n",
      "acting administrator.\n",
      "[fr doc. 2016-24659 filed 10-12-16; 8:45 am]\n",
      "billing code 4410-09-p\n",
      "\n",
      "\n",
      "</pre></body>\n",
      "</html>\n",
      "Added /Users/ha/Downloads/mirrulations/specific/DEA-2016-0015/raw-data/documents/DEA-2016-0015-0006_content.htm to vector store.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in DEA-2024-0059:   0%|          | 0/2 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 89 issue 99 (tuesday, may 21, 2024)</title>\n",
      "</head>\n",
      "<body><pre>\n",
      "[federal register volume 89, number 99 (tuesday, may 21, 2024)]\n",
      "[proposed rules]\n",
      "[pages 44597-44622]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2024-11137]\n",
      "\n",
      "\n",
      "=======================================================================\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of justice\n",
      "\n",
      "drug enforcement administration\n",
      "\n",
      "21 cfr part 1308\n",
      "\n",
      "[docket no. dea-1362; a.g. order no. 5931-2024]\n",
      "\n",
      "\n",
      "schedules of controlled substances: rescheduling of marijuana\n",
      "\n",
      "agency: drug enforcement administration, department of justice.\n",
      "\n",
      "action: notice of proposed rulemaking.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: the department of justice (``doj'') proposes to transfer \n",
      "marijuana from schedule i of the controlled substances act (``csa'') to \n",
      "schedule iii of the csa, consistent with the view of the department of \n",
      "health and human services (``hhs'') that marijuana has a currently \n",
      "accepted medical use as well as hhs's views about marijuana's abuse \n",
      "potential and level of physical or psychological dependence. the csa \n",
      "requires that such actions be made through formal rulemaking on the \n",
      "record after opportunity for a hearing. if the transfer to schedule iii \n",
      "is finalized, the regulatory controls applicable to schedule iii \n",
      "controlled substances would apply, as appropriate, along with existing \n",
      "marijuana-specific requirements and any additional controls that might \n",
      "be implemented, including those that might be implemented to meet u.s. \n",
      "treaty obligations. if marijuana is transferred into schedule iii, the \n",
      "manufacture, distribution, dispensing, and possession of marijuana \n",
      "would remain subject to the applicable criminal prohibitions of the \n",
      "csa. any drugs containing a substance within the csa's definition of \n",
      "``marijuana'' would also remain subject to the applicable prohibitions \n",
      "in the federal food, drug, and cosmetic act (``fdca''). doj is \n",
      "soliciting comments on this proposal.\n",
      "\n",
      "dates: comments must be submitted electronically or postmarked on or \n",
      "before july 22, 2024. interested persons may file a request for a \n",
      "hearing or waiver of an opportunity for a hearing or to participate in \n",
      "a hearing pursuant to 21 cfr 1308.44 and in accordance with 21 cfr \n",
      "1316.47 or 1316.49, as applicable, which must be received or postmarked \n",
      "on or before june 20, 2024.\n",
      "\n",
      "addresses: to ensure proper handling of comments, please reference \n",
      "``docket no. dea-1362'' on all correspondence, including any \n",
      "attachments.\n",
      "    <bullet> electronic comments: doj encourages that all comments be \n",
      "submitted through the federal erulemaking portal, which provides the \n",
      "ability to type short comments directly\n",
      "\n",
      "[[page 44598]]\n",
      "\n",
      "into the comment field on the web page or to attach a file for \n",
      "lengthier comments. please go to <a href=\"https://www.regulations.gov\">https://www.regulations.gov</a> and follow \n",
      "the online instructions at that site for submitting comments. upon \n",
      "completion of your submission, you will receive a comment tracking \n",
      "number for your comment. please be aware that submitted comments are \n",
      "not instantaneously available for public view on <a href=\"https://www.regulations.gov\">https://www.regulations.gov</a>. if you have received a comment tracking number, \n",
      "your comment has been successfully submitted and there is no need to \n",
      "resubmit the same comment. commenters should be aware that the \n",
      "electronic federal docket management system will not accept comments \n",
      "after 11:59 p.m. eastern time on the last day of the comment period.\n",
      "    <bullet> paper comments: paper comments that duplicate electronic \n",
      "submissions are not necessary and are discouraged. should you wish to \n",
      "mail a paper comment in lieu of submitting a comment electronically, it \n",
      "should be sent via regular or express mail to: drug enforcement \n",
      "administration, attn: dea federal register representative/dpw, 8701 \n",
      "morrissette drive, springfield, virginia 22152.\n",
      "    <bullet> hearing requests: all requests for a hearing and waivers, \n",
      "together with a written statement of position on the matters of fact \n",
      "and law asserted in the hearing, must be filed with dea. such requests \n",
      "must be sent to: drug enforcement administration, attn: administrator, \n",
      "8701 morrissette drive, springfield, virginia 22152. for informational \n",
      "purposes, a courtesy copy of requests for hearing and waivers should \n",
      "also be sent to: (1) drug enforcement administration, attn: hearing \n",
      "clerk/oalj, 8701 morrissette drive, springfield, virginia 22152; and \n",
      "(2) drug enforcement administration, attn: dea federal register \n",
      "representative/dpw, 8701 morrissette drive, springfield, virginia \n",
      "22152.\n",
      "\n",
      "for further information contact: drug & chemical evaluation section, \n",
      "diversion control division, drug enforcement administration; telephone: \n",
      "(571) 362-3249; email: <a href=\"/cdn-cgi/l/email-protection#7a140a08173a1e1f1b541d150c\"><span class=\"__cf_email__\" data-cfemail=\"e08e90928da0848581ce878f96\">[email&#160;protected]</span></a>.\n",
      "\n",
      "supplementary information: to be considered as part of this rulemaking, \n",
      "comments and requests for a hearing must be submitted in response to \n",
      "this proposed rule within the timeframe specified above, regardless of \n",
      "whether the comment, hearing request, or other information was \n",
      "previously submitted to the drug enforcement administration (``dea'') \n",
      "in connection with any prior matter relating to the scheduling of \n",
      "marijuana.\n",
      "\n",
      "i. posting of public comments\n",
      "\n",
      "    please note that all comments received in response to this docket \n",
      "are considered part of the public record. doj will make comments \n",
      "available for public inspection online at <a href=\"https://www.regulations.gov\">https://www.regulations.gov</a>. \n",
      "such information includes personal or business identifiers (such as \n",
      "name, address, state or federal identifiers, etc.) voluntarily \n",
      "submitted by the commenter. generally, all information voluntarily \n",
      "submitted by the commenter, unless clearly marked as ``confidential \n",
      "information'' in the method described below, will be publicly posted. \n",
      "comments may be submitted anonymously. the freedom of information act, \n",
      "5 u.s.c. 552, applies to all comments received.\n",
      "    commenters submitting comments that include personal identifying \n",
      "information (``pii'') or confidential or proprietary business \n",
      "information that the commenter does not want made publicly available \n",
      "should submit two copies of the comment. one copy must be marked \n",
      "``contains confidential information'' and should clearly identify all \n",
      "pii or business information the commenter does not want to be made \n",
      "publicly available, including any supplemental materials. doj will \n",
      "review this copy, including the claimed pii and confidential business \n",
      "information, in its consideration of comments. the second copy should \n",
      "be marked ``to be publicly posted'' and must have all claimed \n",
      "confidential pii and business information already redacted. doj will \n",
      "post only the version of the comment with redactions on <a href=\"https://www.regulations.gov\">https://www.regulations.gov</a> for public inspection.\n",
      "    an electronic copy of this document and supplemental information to \n",
      "this proposed rule are available at <a href=\"https://www.regulations.gov\">https://www.regulations.gov</a> for \n",
      "easy reference. doj specifically solicits written comments regarding \n",
      "the economic analysis of the impact of these proposed changes. doj \n",
      "requests that commenters provide detailed descriptions in their \n",
      "comments of any expected economic impacts, especially to small \n",
      "entities. commenters should provide empirical data to illustrate the \n",
      "nature and scope of such impact.\n",
      "\n",
      "ii. request for hearing, notice of appearance at, or waiver of \n",
      "participation in hearing\n",
      "\n",
      "    pursuant to 21 u.s.c. 811(a), this scheduling action is a formal \n",
      "rulemaking ``on the record after opportunity for a hearing.'' such \n",
      "proceedings are conducted pursuant to the administrative procedure act \n",
      "(``apa''), 5 u.s.c. 551-559. see 21 cfr 1308.41 through 1308.45; id \n",
      "part 1316, subpart d. interested persons, as defined in 21 cfr \n",
      "1300.01(b), may file requests for a hearing in conformity with the \n",
      "requirements of 21 cfr 1308.44(a) and 1316.47(a), and such requests \n",
      "must:\n",
      "    (1) state with particularity the interest of the person in the \n",
      "proceeding;\n",
      "    (2) state with particularity the objections or issues concerning \n",
      "which the person desires to be heard; and\n",
      "    (3) state briefly the position of the person regarding the \n",
      "objections or issues.\n",
      "    all requests for a hearing and waivers of an opportunity for a \n",
      "hearing or participation, together with a written statement of position \n",
      "on the matters of fact and law involved in such hearing, must be sent \n",
      "to dea using the address information provided above.\n",
      "    the decision whether an in-person hearing will be needed to address \n",
      "such matters of fact and law in the rulemaking will be made by the \n",
      "administrator of dea. upon the administrator's determination to grant \n",
      "an in-person hearing, dea will publish a notice of hearing on the \n",
      "proposed rulemaking in the federal register. see 21 cfr 1308.44(b), \n",
      "1316.53.\n",
      "    if the administrator determines to grant an in-person hearing to \n",
      "address such matters of fact and law in this rulemaking, the \n",
      "administrator will then designate an administrative law judge (``alj'') \n",
      "to preside over the hearing. the alj's functions shall commence upon \n",
      "designation, as provided in 21 cfr 1316.52. the alj will have all \n",
      "powers necessary to conduct a fair hearing, to take all necessary \n",
      "action to avoid delay, and to maintain order. id. the alj's authorities \n",
      "include the power to hold conferences to simplify or determine the \n",
      "issues in the hearing or to consider other matters that may aid in the \n",
      "expeditious disposition of the hearing; require parties to state their \n",
      "position in writing; sign and issue subpoenas to compel the production \n",
      "of documents and materials to the extent necessary to conduct the \n",
      "hearing; examine witnesses and direct witnesses to testify; receive, \n",
      "rule on, exclude, or limit evidence; rule on procedural items; and take \n",
      "any action permitted by the presiding officer under dea's hearing \n",
      "procedures and the apa. id.\n",
      "    comments on or objections to the proposed rule submitted under 21 \n",
      "cfr 1308.43(g) will be offered as evidence at the hearing, but the \n",
      "presiding officer shall admit only evidence that is competent, \n",
      "relevant, material, and not unduly repetitive. 21 cfr 1316.59(a).\n",
      "\n",
      "[[page 44599]]\n",
      "\n",
      "    any interested person may file a waiver of opportunity for a \n",
      "hearing or to participate in a hearing in conformity with the \n",
      "requirements of 21 cfr 1308.44(c), together with a written statement of \n",
      "position on the matters of fact and law involved in any hearing. 21 cfr \n",
      "1316.49. such statement, if admissible, will be included in the record \n",
      "and considered as described in 21 cfr 1308.44(c).\n",
      "    in accordance with 21 u.s.c. 811 and 812, the purpose of a hearing \n",
      "would be to ``receiv[e] factual evidence and expert opinion regarding'' \n",
      "whether marijuana should be transferred to schedule iii of the list of \n",
      "controlled substances. 21 cfr 1308.42. concurrent with this rulemaking, \n",
      "dea will consider the marijuana-specific controls that would be \n",
      "necessary to comply with relevant treaty obligations in the event that, \n",
      "after the hearing, a final order reschedules marijuana, and, to the \n",
      "extent such controls are needed if marijuana is rescheduled, will seek \n",
      "to finalize any such regulations as soon as possible.\n",
      "    all requests for hearing and waivers of an opportunity for a \n",
      "hearing or participation must be sent to dea using the address \n",
      "information above, on or before the date specified above.\n",
      "\n",
      "iii. legal authority\n",
      "\n",
      "    under the csa, 21 u.s.c. 801 et seq., the attorney general shall, \n",
      "before initiating proceedings to control, decontrol, or transfer \n",
      "between schedules a drug or other substance, request from the secretary \n",
      "of hhs a scientific and medical evaluation, and the secretary's \n",
      "recommendations, as to whether such drug or other substance should be \n",
      "so controlled or removed as a controlled substance. 21 u.s.c. 811(b). \n",
      "the recommendations of the secretary shall include recommendations with \n",
      "respect to the appropriate schedule, if any, under which such drug or \n",
      "other substance should be listed. id.\n",
      "    hhs recommended in august 2023 that marijuana be rescheduled to \n",
      "schedule iii. see letter for anne milgram, administrator, dea, from \n",
      "rachel l. levine, m.d., assistant secretary for health, hhs (aug. 29, \n",
      "2023) (``august 2023 letter''). the attorney general then sought the \n",
      "legal advice of the office of legal counsel (``olc'') at doj on \n",
      "questions relevant to this rulemaking proceeding. among other \n",
      "conclusions, olc concluded that ``hhs's scientific and medical \n",
      "determinations must be binding until issuance of a notice of proposed \n",
      "rulemaking [(`nprm')].'' questions related to the potential \n",
      "rescheduling of marijuana, 45 op. o.l.c. __, at *25 (apr. 11, 2024) \n",
      "(``olc op.'').\\1\\ after the issuance of a notice of rulemaking \n",
      "proceedings, hhs's scientific and medical determinations are accorded \n",
      "``significant deference'' through the rest of the rulemaking \n",
      "process.\\2\\ olc op. at *26.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\1\\ olc's opinion is available in its entirety under \n",
      "``supporting and related material'' of the public docket for this \n",
      "proposed rule at <a href=\"https://www.regulations.gov\">https://www.regulations.gov</a> under docket number \n",
      "dea-1362.\n",
      "    \\2\\ the csa's reliance on formal rulemaking for scheduling \n",
      "decisions indicates that hhs's determinations do not bind doj for \n",
      "the entirety of the rulemaking process, because outside participants \n",
      "may submit additional scientific and medical evidence during the \n",
      "rulemaking that doj would need to consider. olc op. at *25. however, \n",
      "doj ``may not simply cast aside hhs's scientific and medical \n",
      "recommendations once it initiates rulemaking proceedings by issuing \n",
      "an nprm,'' since ``[t]he categorical use of the word `binding' in \n",
      "section 811(b) suggests that congress intended hhs's scientific and \n",
      "medical views to at least be a very significant input in the \n",
      "scheduling process,'' and the legislative history of the csa \n",
      "bolsters that conclusion. id. at 25-26 (citing h.r. rep. no. 91-\n",
      "1444, at 22-23 (1970)).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    under the csa, when recommending or determining that a drug should \n",
      "be controlled (and if so, under which schedule), the secretary and the \n",
      "attorney general must consider eight factors set forth in 21 u.s.c. \n",
      "811(c). the eight factors are:\n",
      "    1. the drug's actual or relative potential for abuse;\n",
      "    2. scientific evidence of its pharmacological effect, if known;\n",
      "    3. the state of current scientific knowledge regarding the drug or \n",
      "other substance;\n",
      "    4. its history and current pattern of abuse;\n",
      "    5. the scope, duration, and significance of abuse;\n",
      "    6. what, if any, risk there is to the public health;\n",
      "    7. its psychic or physiological dependence liability; and\n",
      "    8. whether the substance is an immediate precursor of a substance \n",
      "already controlled.\n",
      "21 u.s.c. 811(c); see also id. 811(b) (specifying how hhs should \n",
      "consider each of the eight factors).\n",
      "    the united states is a party to the 1961 united nations single \n",
      "convention on narcotic drugs, march 30, 1961, 18 u.s.t. 1407, 520 \n",
      "u.n.t.s. 151 (``single convention''), as amended by the 1972 protocol, \n",
      "march 25, 1972, 26 u.s.t. 1439, 976 u.n.t.s. 3. under 21 u.s.c. \n",
      "811(d)(1), if control of a substance is required ``by united states \n",
      "obligations under international treaties, conventions, or protocols in \n",
      "effect on october 27, 1970,'' the attorney general must issue an order \n",
      "controlling such drug ``under the schedule he deems most appropriate to \n",
      "carry out such obligations, without regard to the findings'' required \n",
      "by 21 u.s.c. 811(a) or 812(b), ``and without regard to the procedures'' \n",
      "prescribed by 21 u.s.c. 811(a) and (b). marijuana is a drug covered by \n",
      "the single convention. see single convention art. 1(1)(b); olc op. at \n",
      "*26 & n.7.\n",
      "    olc and the united states court of appeals for the d.c. circuit \n",
      "have explained that section 811(d)(1) does not supersede the scheduling \n",
      "procedures set forth in sections 811(a) through (b) and 812(b), \n",
      "including the requirement to consider the eight factors set forth in \n",
      "section 811(c). instead, section 811(d)(1) allows the attorney general \n",
      "to ``identify which schedules would satisfy the united states' \n",
      "international obligations with respect to a particular drug, and then--\n",
      "if more than one schedule would do so--select which schedule to use \n",
      "through the section 811(a) through (b) and 812(b) procedures.'' olc op. \n",
      "at *29 n.8; accord nat'l org. for reform of marijuana laws (norml ii) \n",
      "v. dea, 559 f.2d 735, 747 (d.c. cir. 1977). hhs performed the eight-\n",
      "factor analysis. see memorandum for dea, from hhs, re: basis for the \n",
      "recommendation to reschedule marijuana to schedule iii of the \n",
      "controlled substances act (``hhs basis for rec.''). as noted above, \n",
      "hhs's scientific and medical determinations are binding on doj until an \n",
      "nprm is published, and, in addition, doj must accord ``significant \n",
      "deference'' to hhs's scientific and medical determinations throughout \n",
      "the rulemaking process. olc op. at *25-26.\n",
      "    once the determination is made that a particular drug or substance \n",
      "must be controlled under the csa, the attorney general must determine \n",
      "the level of control over the drug or substance under the csa. see 21 \n",
      "u.s.c. 811(a), (b). the csa divides controlled substances into five \n",
      "levels of control, or ``schedules,'' based on (1) a drug's potential \n",
      "for abuse, (2) whether the drug has a currently accepted medical use in \n",
      "treatment in the united states (``camu''), and (3) whether there is a \n",
      "lack of accepted safety for use of the drug under medical supervision \n",
      "or the level of psychological or physical dependence that could result \n",
      "from abuse of the drug. see id. 812(b). schedule i drugs have a high \n",
      "potential for abuse, no camu, and a lack of accepted safety for use \n",
      "under medical supervision. id. 812(b)(1). schedule ii drugs also have a \n",
      "high potential for abuse but have a camu (or a camu with ``severe \n",
      "restrictions''), and abuse of the drug may lead to severe psychological \n",
      "or physical dependence. id. 812(b)(2). schedule iii drugs, meanwhile, \n",
      "have a lower potential for\n",
      "\n",
      "[[page 44600]]\n",
      "\n",
      "abuse when compared to drugs in schedules i and ii, have a camu, and \n",
      "their abuse may lead to moderate or low physical dependence or high \n",
      "psychological dependence.\\3\\ 21 u.s.c. 812(b)(3). the initial schedules \n",
      "of controlled substances established by congress are found at 21 u.s.c. \n",
      "812(c), and the current list of all scheduled substances is published \n",
      "at 21 cfr part 1308.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\3\\ schedule iv includes drugs that have a low potential for \n",
      "abuse relative to those in schedule iii, that have a camu, and for \n",
      "which abuse may lead to limited physical or psychological dependence \n",
      "relative to those in schedule iii. 21 u.s.c. 812(b)(4). schedule v \n",
      "includes drugs that have a low potential for abuse relative to those \n",
      "in schedule iv, that have a camu, and for which abuse may lead to \n",
      "limited physical or psychological dependence relative to those in \n",
      "schedule iv. id. 812(b)(5).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    pursuant to 21 u.s.c. 811(a)(1), the attorney general may, by rule, \n",
      "add to such a schedule or transfer between such schedules any drug or \n",
      "other substance if he (a) finds that such drug or other substance has a \n",
      "potential for abuse, and (b) makes with respect to such drug or other \n",
      "substance the findings prescribed by 21 u.s.c. 812(b) for the schedule \n",
      "in which such drug is to be placed. the csa provides that proceedings \n",
      "for the issuance, amendment, or repeal of the scheduling of any drug or \n",
      "other substance may be initiated by the attorney general on his own \n",
      "motion, at the request of the secretary, or on the petition of any \n",
      "interested party. id.\n",
      "\n",
      "iv. background\n",
      "\n",
      "    when congress enacted the csa in 1970, it placed marijuana in \n",
      "schedule i. comprehensive drug abuse prevention and control act of \n",
      "1970, public law 91-513, tit. ii, sec. 202(c), 84 stat. 1236, 1249 \n",
      "(1970); 21 u.s.c. 812(c).\\4\\ the attorney general is authorized to \n",
      "amend this initial placement. 21 u.s.c. 812(c); see also id. 811, \n",
      "812(b). other schedule i substances include heroin, lysergic acid \n",
      "diethylamide (commonly known as lsd), and 3,4-\n",
      "methylenedioxymethamphetamine (ecstasy). see 21 cfr 1308.11. drugs \n",
      "controlled under schedule ii include cocaine, methamphetamine, \n",
      "methadone, oxycodone, and fentanyl. id. sec.  1308.12. drugs controlled \n",
      "under schedule iii include products containing less than 90 milligrams \n",
      "of codeine per dosage unit, ketamine, and anabolic steroids. id. sec.  \n",
      "1308.13. petitioners have requested that marijuana be rescheduled \n",
      "several times over the years. see, e.g., schedule of controlled \n",
      "substances: petition to remove marihuana from control or in the \n",
      "alternative to control marihuana in schedule v of the controlled \n",
      "substances act, 37 fr 18097 (sept. 7, 1972); notice of denial of \n",
      "petition, 66 fr 20038 (apr. 18, 2001); denial of petition to initiate \n",
      "proceedings to reschedule marijuana, 76 fr 40552 (july 8, 2011).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\4\\ the csa refers to the drug as ``marijuana'' and \n",
      "``marihuana'' interchangeably. see, e.g., 21 u.s.c. 802(16)(a), \n",
      "812(c). as used in this nprm, ``marijuana'' means the term defined \n",
      "at 21 u.s.c. 802(16).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    dea and hhs last examined the issue of whether to reschedule \n",
      "marijuana eight years ago, in 2016, when dea denied two petitions to \n",
      "reschedule marijuana.\\5\\ at the time, hhs concurred that marijuana \n",
      "should remain a schedule i drug because it met the three criteria for \n",
      "placement in schedule i. 81 fr 53706-07. in accordance with the \n",
      "requirements for placement in schedule i, hhs found that: (1) marijuana \n",
      "had a high potential for abuse; (2) it did not have a camu; and (3) \n",
      "there was a lack of accepted safety for use of marijuana under medical \n",
      "supervision. id. as discussed in detail below, in 2023, hhs conducted a \n",
      "scientific and medical evaluation of marijuana based on a comprehensive \n",
      "review of available data at that time and recommended that marijuana be \n",
      "transferred to schedule iii.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\5\\ denial of petition to initiate proceedings to reschedule \n",
      "marijuana, 81 fr 53688 (aug. 12, 2016); denial of petition to \n",
      "initiate proceedings to reschedule marijuana, 81 fr 53767 (aug. 12, \n",
      "2016).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    since 1996, 38 states, the district of columbia, and 4 federal \n",
      "territories have legalized the use of medical marijuana. hhs basis for \n",
      "rec. at 30; olc op at *9. these laws typically allow the cultivation, \n",
      "sale, and use of marijuana by patients (or their caregivers) whose \n",
      "health care practitioners have recommended that they use marijuana to \n",
      "treat certain health conditions. see, e.g., ohio rev. code secs. \n",
      "3796.01(a)(6)(a)-(v), 3796.01(a); n.y. cannabis law secs. 3(18), 30, \n",
      "31; n.m. stat. secs. 26-2b-3(f)(1)-(23), 26-2b-3(n), 26-2b-4(a). \n",
      "further, beginning in fiscal year 2015, congress has adopted an \n",
      "appropriations rider every year that prohibits doj from using funds to \n",
      "prevent certain states, territories, and the district of columbia from \n",
      "implementing their own laws with respect to medical marijuana. e.g., \n",
      "consolidated appropriations act, 2024, public law 118-42, sec. 531, 138 \n",
      "stat. 25; consolidated appropriations act, 2023, public law 117-328, \n",
      "sec. 531, 136 stat. 4459, 4561 (2022); see also cong. research serv., \n",
      "r44782, the evolution of marijuana as a controlled substance and the \n",
      "federal-state policy gap 26 & n.159 (updated apr. 7, 2022) (collecting \n",
      "additional appropriations riders).\n",
      "    marijuana is generally defined by statute to mean ``the plant \n",
      "cannabis sativa l., whether growing or not; the seeds thereof; the \n",
      "resin extracted from any part of such plant; and every compound, \n",
      "manufacture, salt, derivative, mixture, or preparation of such plant, \n",
      "its seeds or resin.'' 21 u.s.c. 802(16)(a). in 2018, congress amended \n",
      "the csa to remove ``(i) hemp, as defined in section [1639o of title 7 \n",
      "of the u.s. code]'' from the definition of marijuana.\\6\\ agricultural \n",
      "improvement act of 2018, public law 115-334, sec. 12619, 132 stat. \n",
      "4490, 5018. section 1639o(1) of title 7 in turn defines hemp as ``the \n",
      "plant cannabis sativa l. and any part of that plant, including the \n",
      "seeds thereof and all derivatives, extracts, cannabinoids, isomers, \n",
      "acids, salts, and salts of isomers, whether growing or not, with a \n",
      "delta-9-tetrahydrocannabinol concentration of not more than 0.3 percent \n",
      "on a dry weight basis.'' delta-9-tetrahydrocannabinol (``[delta]9-\n",
      "thc'') is the major psychoactive intoxicating cannabinoid in marijuana. \n",
      "see hhs basis for rec. at 10. this exclusion of hemp from the \n",
      "definition of marijuana had the effect of removing many products \n",
      "containing predominantly cannabidiol (``cbd'') derived from hemp and \n",
      "containing no more than 0.3 percent [delta]9-thc on a dry weight basis \n",
      "from control as marijuana.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\6\\ marijuana under the csa also does not include ``the mature \n",
      "stalks of [the cannabis] plant, fiber produced from such stalks, oil \n",
      "or cake made from the seeds of such plant, any other compound, \n",
      "manufacture, salt, derivative, mixture, or preparation of such \n",
      "mature stalks (except the resin extracted therefrom), fiber, oil, or \n",
      "cake, or the sterilized seed of [the cannabis] plant which is \n",
      "incapable of germination.'' 21 u.s.c. 802(16)(b)(ii).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    on october 6, 2022, president biden requested that the attorney \n",
      "general and the secretary of hhs ``initiate the administrative process \n",
      "to review expeditiously how marijuana is scheduled under federal law.'' \n",
      "\\7\\ hhs thereafter undertook a scientific and medical evaluation of \n",
      "marijuana as defined under the csa in accordance with the president's \n",
      "request.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\7\\ the white house, statement from president biden on marijuana \n",
      "reform (oct. 6, 2022), <a href=\"https://www.whitehouse.gov/briefing-room/statements-releases/2022/10/06/statement-from-president-biden-on-marijuana-reform/\">https://www.whitehouse.gov/briefing-room/statements-releases/2022/10/06/statement-from-president-biden-on-marijuana-reform/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in a letter dated august 29, 2023, admiral rachel l. levine, m.d., \n",
      "hhs's assistant secretary for health, recommended to the administrator \n",
      "of dea that marijuana be controlled in schedule iii of the csa. august \n",
      "2023 letter. hhs found that marijuana has a potential for abuse less \n",
      "than the drugs or other substances in schedules i and ii; that \n",
      "marijuana has a camu; and that the abuse of marijuana may lead to \n",
      "moderate or low physical dependence or high psychological dependence. \n",
      "hhs\n",
      "\n",
      "[[page 44601]]\n",
      "\n",
      "basis for rec. at 62-65. these findings correspond to the criteria for \n",
      "placement of a substance in schedule iii. see 21 u.s.c. 812(b)(3). dea \n",
      "has not yet made a determination as to its views of the appropriate \n",
      "schedule for marijuana.\n",
      "\n",
      "v. proposal to reschedule marijuana\n",
      "\n",
      "    the csa vests the attorney general with the authority to schedule, \n",
      "reschedule, or decontrol drugs. 21 u.s.c. 811(a). the attorney general \n",
      "has delegated that authority to the dea administrator, see 28 cfr \n",
      "0.100, but also retains the authority to schedule drugs under the csa \n",
      "in the first instance, see 28 u.s.c. 509, 510. the hhs assistant \n",
      "secretary for health has provided a recommendation for transferring \n",
      "marijuana to schedule iii. in light of that recommendation, the \n",
      "attorney general is exercising the attorney general's authority under \n",
      "21 u.s.c. 811(a) to initiate a rulemaking that proposes the placement \n",
      "of marijuana in schedule iii.\n",
      "    dea believes that additional information arising from this \n",
      "rulemaking will further inform the findings regarding the appropriate \n",
      "schedule for marijuana. dea has maintained an active review of the \n",
      "scientific literature addressing marijuana with a focus on how it \n",
      "relates to the scientific and medical evaluation and informs any \n",
      "updates to the eight-factor analysis. in addition to hhs's scientific \n",
      "and medical determinations, which are binding until the issuance of \n",
      "this nprm and which must be accorded significant deference throughout \n",
      "the rulemaking, dea believes that factual evidence (including \n",
      "scientific data) and expert opinions, including additional data \n",
      "regarding different forms, formulations, and delivery methods for \n",
      "marijuana, as well as evidence regarding the effects of marijuana at \n",
      "various dosages or concentrations, may be relevant.\n",
      "    the hhs basis for recommendation, dea's analyses explaining its \n",
      "decisions to deny the petitions to reschedule marijuana in 2016, and \n",
      "the 2024 olc opinion (cited throughout) are available in their entirety \n",
      "under ``supporting and related material'' of the public docket for this \n",
      "proposed rule at <a href=\"https://www.regulations.gov\">https://www.regulations.gov</a> under docket number dea-\n",
      "1362.\n",
      "\n",
      "vi. eight-factor analysis\n",
      "\n",
      "    doj has reviewed the scientific and medical evaluation and \n",
      "scheduling recommendation provided by hhs and has conducted a separate \n",
      "review of the eight factors identified in 21 u.s.c. 811(c). at this \n",
      "point in the proceedings, doj must treat hhs's scientific and medical \n",
      "determinations as binding. see olc op. at *4, *25. hhs's scientific and \n",
      "medical determinations are included below, as well as certain \n",
      "information from dea.\n",
      "\n",
      "1. marijuana's actual or relative potential for abuse\n",
      "\n",
      "    the first factor that doj and hhs must consider under 21 u.s.c. \n",
      "811(c) is the actual or relative potential for abuse of marijuana. the \n",
      "term ``abuse'' is not defined in the csa. however, consistent with the \n",
      "legislative history of the csa, dea and hhs have typically weighed the \n",
      "following factors in determining whether a particular drug or substance \n",
      "has a potential for abuse: \\8\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\8\\ see, e.g., 81 fr 53740; see also hhs basis for rec. at 6 \n",
      "(citing comprehensive drug abuse prevention and control act of 1970, \n",
      "h.r. rep. no. 91-1444 (1970), reprinted in 1970 u.s.c.c.a.n. 4566, \n",
      "4603).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    a. whether there is evidence that individuals are taking the drug \n",
      "or drugs containing such a substance in amounts sufficient to create a \n",
      "hazard to their health or to the safety of other individuals or to the \n",
      "community.\n",
      "    as part of its analysis, hhs concluded that evidence shows that, \n",
      "although some individuals are taking marijuana in amounts sufficient to \n",
      "create a hazard to their health and to the safety of other individuals \n",
      "and the community, the vast majority of individuals who use marijuana \n",
      "are doing so in a manner that does not lead to dangerous outcomes to \n",
      "themselves or others. hhs basis for rec. at 6-7. the data supportive of \n",
      "this conclusion are discussed in detail in hhs's analysis of factors 4, \n",
      "5, and 6. see hhs basis for rec. at 28-57.\n",
      "    in particular, hhs emphasized that an evaluation of various \n",
      "epidemiological databases of adverse outcomes from 2015 to 2021 \n",
      "involving marijuana or comparator drugs that are used nonmedically \n",
      "showed that the utilization-adjusted rate of adverse outcomes involving \n",
      "marijuana was consistently lower than the utilization-adjusted rates of \n",
      "adverse outcomes involving heroin, cocaine, and, for certain outcomes, \n",
      "other comparators, including alcohol. also, alcohol or heroin typically \n",
      "ranked first or in immediately subsequent positions among the \n",
      "comparators in terms of incidence of adverse outcomes, with marijuana \n",
      "in a lower place in that ranking. this pattern also was observed for \n",
      "serious medical outcomes, including death, observed in poison center \n",
      "data, where marijuana was in the lowest ranking group. this suggests \n",
      "consistency across databases, across drugs, and over time. hhs thus \n",
      "concluded that although abuse of marijuana produces clear evidence of \n",
      "harmful consequences, these appear to be relatively less common and \n",
      "less severe than the consequences of some other comparator substances. \n",
      "hhs basis for rec. at 7-8.\n",
      "    importantly, these comparisons of the prevalence of adverse \n",
      "outcomes were from descriptive analyses only, following the established \n",
      "practice in previous eight-factor analyses. thus, differences in \n",
      "outcome frequency and severity, and the ranked order across \n",
      "comparators, may be attributable in part to underlying differences in \n",
      "the populations being compared (e.g., age or pre-existing medical \n",
      "conditions), among other things. despite these limitations, qualitative \n",
      "synthesis of descriptive analyses is the established practice in \n",
      "previous eight-factor analyses, and hhs determined that it is the most \n",
      "appropriate approach here. hhs basis for rec. at 7-8.\n",
      "    hhs also concluded that the public-health risks posed by marijuana \n",
      "are lower compared to those posed by other drugs of abuse (e.g., \n",
      "heroin, oxycodone, cocaine), based on hhs's evaluation of various \n",
      "epidemiological databases for emergency department (``ed'') visits, \n",
      "hospitalizations, unintentional exposures, and most importantly, \n",
      "overdose deaths. the rank order of the comparators in terms of greatest \n",
      "adverse consequences typically ranked heroin, benzodiazepines, and \n",
      "cocaine first or in immediately subsequent positions, with marijuana in \n",
      "a lower place in the ranking, especially when hhs adjusted for \n",
      "utilization. for overdose deaths, marijuana is always in the lowest \n",
      "ranking among comparator drugs. these evaluations demonstrate that \n",
      "there is consistency across databases, across substances, and over \n",
      "time. hhs thus concluded that although abuse of marijuana produces \n",
      "clear evidence of a risk to public health, that risk is relatively \n",
      "lower than that posed by most other comparator drugs. hhs basis for \n",
      "rec. at 7-8.\n",
      "    dea notes that data provided by hhs in its recommendation included \n",
      "a 2023 national survey that tracks drug use trends among 8th-, 10th-, \n",
      "and 12th-grade students, and showed that by 12th grade, 20.2 percent of \n",
      "students reported using marijuana in the past month.\\9\\ dea also notes \n",
      "that the same study showed that the prevalence of ingesting marijuana \n",
      "by vaping is evidenced by\n",
      "\n",
      "[[page 44602]]\n",
      "\n",
      "students reporting vaping in the 30 days prior at the following rates: \n",
      "4.2 percent for 8th graders, 10.3 percent for 10th graders, and 14.8 \n",
      "percent for 12th graders.\\10\\ in 2022, the substance abuse and mental \n",
      "health services administration's (``samhsa'') drug abuse warning \n",
      "network (``dawn'') reported that 11.9 percent of drug-related ed visits \n",
      "nationwide involved cannabis.\\11\\ the rate of cannabis-related ed \n",
      "visits was highest in these demographic groups: 18 to 25 years old, \n",
      "male, black or african american, and not hispanic or latino.\\12\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\9\\ see hhs basis for rec. at 35 (discussing richard a. miech et \n",
      "al., univ. of mich. inst. for soc. rsch., monitoring the future: \n",
      "national survey results on drug use, 1975-2022: secondary school \n",
      "students 71 (2023), <a href=\"https://monitoringthefuture.org/wp-content/uploads/2022/12/mtf2022.pdf\">https://monitoringthefuture.org/wp-content/uploads/2022/12/mtf2022.pdf</a>).\n",
      "    \\10\\ miech et al., supra note 9, at 75.\n",
      "    \\11\\ drug abuse warning network, substance abuse & mental health \n",
      "servs. admin., findings from drug-related emergency department \n",
      "visits, 2022, at 1 (2023), <a href=\"https://store.samhsa.gov/sites/default/files/pep23-07-03-001.pdf\">https://store.samhsa.gov/sites/default/files/pep23-07-03-001.pdf</a>.\n",
      "    \\12\\ id.at 27.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in addition to the data considered by the hhs basis for \n",
      "recommendation, the data considered by hhs and dea in their 2015 eight-\n",
      "factor analysis, and the additional data discussed above, dea \n",
      "anticipates that additional data on seizures of marijuana by law \n",
      "enforcement, cannabis-related ed visits, as well as updated \n",
      "epidemiological survey data since 2022, may be appropriate for \n",
      "consideration.\n",
      "    b. whether there is significant diversion of the drug or drugs \n",
      "containing such a substance from legitimate drug channels.\n",
      "    hhs found that there is a lack of evidence of significant diversion \n",
      "of marijuana from legitimate drug channels. hhs basis for rec. at 8. it \n",
      "noted that marijuana is used by researchers for clinical research under \n",
      "investigational new drug (``ind'') applications, and that there are \n",
      "multiple dea registrants that are approved to produce marijuana and \n",
      "derived formulations for use in dea-authorized nonclinical and clinical \n",
      "research. hhs observed that these authorizations represent the only \n",
      "federally sanctioned drug channels in the united states, and there is a \n",
      "lack of data indicating diversion occurring from these entities or \n",
      "activities. however, there are significant additional sources of \n",
      "marijuana in the united states, including from illicit cultivation and \n",
      "production, illicit importation from other countries, and from state \n",
      "programs that permit dispensing of marijuana for medical use and, in \n",
      "some states, recreational adult use. hhs basis for rec. at 8.\n",
      "    given this unique landscape, dea believes that the lack of data \n",
      "indicating diversion of marijuana from federally sanctioned drug \n",
      "channels to the illicit market is not indicative of a lack of potential \n",
      "for abuse of the drug. dea anticipates that additional data on \n",
      "diversion from state programs and dea-registered manufacturers may aid \n",
      "in a determination of whether diversion is taking place.\n",
      "    c. whether individuals are taking the drug or drugs containing such \n",
      "a substance on their own initiative rather than on the basis of medical \n",
      "advice from a practitioner licensed by law to administer such drugs in \n",
      "the course of their professional practice.\n",
      "    as hhs notes, the food and drug administration (``fda'') has not \n",
      "approved a new drug application (``nda'') for a drug product containing \n",
      "botanical marijuana for any therapeutic indication. thus, the only way \n",
      "an individual can use marijuana on the basis of medical advice through \n",
      "legitimate channels under federal law is by participating in research \n",
      "under an ind. however, 38 states and the district of columbia have \n",
      "enacted laws allowing individuals to use marijuana under certain \n",
      "circumstances for medical purposes. outside of the federal- and state-\n",
      "sanctioned medical use of marijuana, individuals are using marijuana on \n",
      "their own initiative for medical, as well as nonmedical, purposes. \n",
      "epidemiological data related to nonmedical use of marijuana is detailed \n",
      "in hhs's analysis of factor 4. hhs basis for rec. at 8.\n",
      "    dea notes that data is not available to determine the number of \n",
      "individuals using marijuana under state law. according to 2022 national \n",
      "survey on drug use and health (``nsduh'') data on people who are 12 and \n",
      "older in the united states, 61.9 million people reported using \n",
      "marijuana in the past year, and marijuana was the illicit drug used \n",
      "with the greatest frequency.\\13\\ specifically, 42.3 million people \n",
      "reported use in the past month, including 14.7 million people who vaped \n",
      "marijuana in that same period, representing 5.2 percent of the study's \n",
      "target population.\\14\\ furthermore, as reported by nsduh in 2022, 3.7 \n",
      "million people initiated marijuana use in the past year, with more than \n",
      "half (53 percent or 2.0 million people) initiating marijuana use before \n",
      "the age of 21.\\15\\ dea also notes that hhs concluded that, outside of \n",
      "the federal- and state-sanctioned medical use of marijuana, individuals \n",
      "are using marijuana on their own initiative for medical as well as \n",
      "nonmedical purposes. hhs basis for rec. at 8. in 2016, dea reached a \n",
      "similar conclusion.\\16\\ in addition to the data considered in the hhs \n",
      "basis for recommendation, and by hhs and dea in their earlier eight-\n",
      "factor analyses, dea anticipates that updated epidemiological survey \n",
      "data since 2022 may be appropriate for consideration.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\13\\ substance abuse & mental health servs. admin., key \n",
      "substance use and mental health indicators in the united states: \n",
      "results from the 2022 national survey on drug use and health 14 \n",
      "(nov. 2023), <a href=\"https://www.samhsa.gov/data/sites/default/files/reports/rpt42731/2022-nsduh-nnr.pdf\">https://www.samhsa.gov/data/sites/default/files/reports/rpt42731/2022-nsduh-nnr.pdf</a>.\n",
      "    \\14\\ id. at 13.\n",
      "    \\15\\ id. at 27.\n",
      "    \\16\\ 81 fr 53691 (``based on the large number of individuals \n",
      "reporting current use of marijuana and the lack of an fda-approved \n",
      "drug product in the united states, one can assume that it is likely \n",
      "that the majority of individuals using marijuana do so on their own \n",
      "initiative rather than on the basis of medical advice from a \n",
      "licensed practitioner.'').\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    d. whether the drug or drugs containing such a substance are new \n",
      "drugs so related in their action to a drug or drugs already listed as \n",
      "having a potential for abuse to make it likely that it will have the \n",
      "same potentiality for abuse as such drugs, thus making it reasonable to \n",
      "assume that there may be significant diversions from legitimate \n",
      "channels, significant use contrary to or without medical advice, or \n",
      "that they have a substantial capability of creating hazards to the \n",
      "health of the user or to the safety of the community.\n",
      "    marijuana has been a schedule i substance since the csa was enacted \n",
      "in 1970. see public law 91-513, tit. ii, sec. 202(c), 84 stat. 1236, \n",
      "1249 (1970); 21 u.s.c. 812(c); see also 21 cfr 1308.11(d)(23). the \n",
      "primary compound in marijuana that is responsible for its abuse \n",
      "potential is [delta]9-thc (also known as dronabinol, when specifically \n",
      "referring to the (-)-trans-[delta]9-thc stereoisomer), which has \n",
      "agonist activity at cannabinoid cb<inf>1</inf> receptors. hhs found \n",
      "that there are extensive nonclinical and clinical studies establishing \n",
      "that marijuana, due to the cb<inf>1</inf> agonist activity of its main \n",
      "cannabinoid constituent [delta]9-thc, produces rewarding effects that \n",
      "would be consistent with observed long-term patterns of nonmedical use \n",
      "and abuse, both before and in the years since enactment of the csa. hhs \n",
      "basis for rec. at 9. for further discussion of these effects, see hhs \n",
      "basis for rec. at 9-18 (factor 2), 28-37 (factor 4).\n",
      "    additionally, fda has approved two drug products containing \n",
      "dronabinol: marinol (in 1985; schedule iii) and syndros (in 2016; \n",
      "schedule ii). hhs basis for rec. at 9. marinol was approved by fda in \n",
      "1985 for the treatment of nausea and vomiting associated with cancer \n",
      "chemotherapy in patients who did not respond to conventional anti-\n",
      "emetic treatments. fda approved marinol in 1992 for the treatment of \n",
      "anorexia associated with weight loss in patients with acquired\n",
      "\n",
      "[[page 44603]]\n",
      "\n",
      "immunodeficiency syndrome (``aids''). after the first fda approval, \n",
      "marinol was transferred from schedule i to schedule ii and was later \n",
      "rescheduled to schedule iii. syndros, a drug product also containing \n",
      "dronabinol but formulated in an oral solution, was approved by fda in \n",
      "2016 for the treatment of anorexia associated with weight loss in \n",
      "patients with aids, as well as nausea and vomiting associated with \n",
      "cancer chemotherapy in patients who failed to respond adequately to \n",
      "conventional anti-emetic treatments. in 2017, dea rescheduled ``fda-\n",
      "approved products containing dronabinol in an oral solution'' from \n",
      "schedule i into schedule ii. hhs basis for rec. at 4.\n",
      "    when marinol and syndros were being developed, they underwent a \n",
      "systematic evaluation of their abuse potential based on animal and \n",
      "human behavioral studies, which showed that dronabinol has abuse \n",
      "potential. the abuse-related studies confirmed the abuse potential of \n",
      "[delta]9-thc. hhs has concluded that these findings suggest that \n",
      "marijuana will continue to be used nonmedically, diverted from \n",
      "legitimate channels, and trafficked in illicit channels as a potential \n",
      "source for continued nonmedical use in the united states. hhs basis for \n",
      "rec. at 9; see also hhs basis for rec. at 37-45 (factor 5).\n",
      "hhs conclusion with respect to factor 1\n",
      "    hhs determined that epidemiological data indicate that marijuana \n",
      "has the potential for creating hazards to the health of the user and to \n",
      "the safety of the community. however, as a relative finding on abuse \n",
      "liability, when comparing marijuana to heroin, oxycodone, hydrocodone, \n",
      "fentanyl, cocaine, ketamine, benzodiazepines, zolpidem, tramadol, and \n",
      "alcohol in various epidemiological databases that allow for some or all \n",
      "of these comparisons, marijuana is not typically among the substances \n",
      "producing the most frequent incidence of adverse outcomes or severity \n",
      "of substance use disorder. hhs basis for rec. at 9; see also hhs basis \n",
      "for rec. at 28-57 (factors 4, 5, and 6). but as noted above, there are \n",
      "limitations in comparing descriptive data on adverse outcomes across \n",
      "drugs, although descriptive analyses of epidemiologic data are an \n",
      "established practice in previous eight-factor analyses. hhs basis for \n",
      "rec. at 9.\n",
      "    in 2016, dea found that ``[m]arijuana has a high potential for \n",
      "abuse. preclinical and clinical data show that it has reinforcing \n",
      "effects characteristic of drugs of abuse. . . . data on marijuana \n",
      "seizures show widespread availability and trafficking.'' 81 fr 53739. \n",
      "dea believes that additional data in this area may be appropriate for \n",
      "consideration in assessing marijuana's actual or relative potential for \n",
      "abuse.\n",
      "\n",
      "2. scientific evidence of marijuana's pharmacological effects, if known\n",
      "\n",
      "    the second factor that doj and hhs must consider under 21 u.s.c. \n",
      "811(c) is the scientific evidence of marijuana's pharmacological \n",
      "effects, if known. in making its recommendation, hhs considered the \n",
      "scientific evidence of the pharmacological effects of marijuana based \n",
      "on the effects of [delta]9-thc. hhs conducted a scientific evaluation \n",
      "of the neurochemistry, receptor pharmacology, animal abuse-related \n",
      "behavioral effects, and human behavioral and physiological effects of \n",
      "marijuana. hhs basis for rec. at 9.\n",
      "a. neurochemistry and receptor pharmacology of marijuana\n",
      "    cannabis is the genus of a plant that contains numerous natural \n",
      "constituents, including cannabinoids. see hhs basis for rec. at 18-21 \n",
      "(discussing factor 3). because cultivated chemovars may vary in their \n",
      "composition and concentration of various chemical constituents, \n",
      "including with respect to whether they contain significant amounts of \n",
      "[delta]9-thc or other cannabinoids, marijuana products from different \n",
      "strains will have differing biological and pharmacological profiles. \n",
      "hhs basis for rec. at 10.\n",
      "    marijuana contains at least 560 identified natural constituents, \n",
      "including 125 compounds classified as cannabinoids. most major \n",
      "cannabinoid compounds occurring naturally in cannabis have been \n",
      "identified chemically, but new and minor compounds are continuously \n",
      "being characterized. hhs basis for rec. at 10.\n",
      "    the two most abundant cannabinoids present in marijuana are \n",
      "[delta]9-thc and cbd. [delta]9-thc is the major psychoactive \n",
      "intoxicating cannabinoid in marijuana and is the component of marijuana \n",
      "that is primarily responsible for its abuse potential. in contrast, cbd \n",
      "has negligible abuse potential, as assessed by fda during the nda \n",
      "review for epidiolex, an fda-approved drug product containing plant \n",
      "derived, highly purified cbd. hhs basis for rec. at 10.\n",
      "    there are two cannabinoid receptors: cb<inf>1</inf> and \n",
      "cb<inf>2</inf>. cb<inf>1</inf> and cb<inf>2</inf> receptors belong to \n",
      "the family of g-protein-coupled receptors and present a typical seven \n",
      "transmembrane-spanning domain structure. cannabinoid receptors \n",
      "primarily link to an inhibitory g protein (g<inf>i/o</inf>), such that \n",
      "adenylate cyclase activity is inhibited when a cannabinoid ligand binds \n",
      "to the receptor. this, in turn, prevents the conversion of adenosine \n",
      "triphosphate to the second messenger, cyclic amp (``camp''), which \n",
      "decreases camp levels. as hhs's analysis described, g proteins also \n",
      "contain beta/gamma g protein units that are also liberated following \n",
      "ligand binding, which then bind to and alter ion channel function, \n",
      "including inhibition of voltage-gated ion channels and activation of \n",
      "potassium channels. ligand binding can also activate some subforms of \n",
      "phospholipase c as well as beta-arrestin protein. all of these second \n",
      "messenger routes amplify the neural signal following cannabinoid \n",
      "binding at the cb<inf>1</inf> and cb<inf>2</inf> receptors. hhs basis \n",
      "for rec. at 10.\n",
      "    cb<inf>1</inf> receptors are found primarily in the central nervous \n",
      "system (``cns''), but are also present in peripheral tissues, such as \n",
      "the liver, heart, and lungs. in the brain, cb<inf>1</inf> receptors are \n",
      "expressed with highest density in the cortical regions, hippocampus, \n",
      "basal ganglia, and cerebellum and with lowest density in brainstem and \n",
      "hypothalamic areas. the localization of these receptors may explain \n",
      "cannabinoid effects on movement coordination, memory, and cognition. \n",
      "additionally, cb<inf>1</inf> receptors are found in glial cells as well \n",
      "as in the immune system. however, the concentration of cb<inf>1</inf> \n",
      "receptors is considerably lower in peripheral tissues than in the cns. \n",
      "cb<inf>2</inf> receptors are found primarily in the immune system, \n",
      "including in numerous leukocyte cell types, as well as in activated cns \n",
      "microglia. additionally, there is some evidence that cb<inf>2</inf> \n",
      "receptors are localized in the brain, primarily in the cerebellum and \n",
      "hippocampus. the distribution of cb<inf>2</inf> receptors throughout \n",
      "the body is less extensive than the distribution of cb<inf>1</inf> \n",
      "receptors. hhs basis for rec. at 10-11.\n",
      "    there are two endogenous cannabinoid receptor agonists: anandamide \n",
      "and arachidonyl glycerol (``2-ag''). at cb<inf>1</inf> receptors, \n",
      "anandamide is a partial agonist with low intrinsic efficacy while 2-ag \n",
      "is a full agonist with high intrinsic efficacy. these endogenous \n",
      "cannabinoid ligands are present in central as well as peripheral \n",
      "tissues. a combination of uptake and hydrolysis terminates the action \n",
      "of anandamide and 2-ag. the endogenous cannabinoid system is a locally \n",
      "active signaling system activated on demand in response to changes to \n",
      "the local conditions to help restore homeostasis. the endogenous \n",
      "cannabinoid system, including the endogenous cannabinoids and the \n",
      "cannabinoid receptors, demonstrates substantial plasticity in response \n",
      "to several physiological and pathological\n",
      "\n",
      "[[page 44604]]\n",
      "\n",
      "stimuli. this plasticity is particularly evident in the cns. hhs basis \n",
      "for rec. at 11.\n",
      "    [delta]9-thc and cbd have varying affinity and effects at the \n",
      "cannabinoid receptors. hhs determined that [delta]9-thc is a partial \n",
      "agonist at both cb<inf>1</inf> (ki = 18-218 nm) and cb<inf>2</inf> \n",
      "receptors (ki = 36-309 nm). however, cb<inf>1</inf> receptors are the \n",
      "main pharmacological site of action for [delta]9-thc, making \n",
      "cb<inf>1</inf> receptors the site that is responsible for the abuse \n",
      "potential of marijuana. the other cns site where [delta]9-thc may have \n",
      "activity is the 5ht<inf>3</inf> receptor, where it functions as an \n",
      "antagonist. in contrast, cbd has low affinity for both cb<inf>1</inf> \n",
      "and cb<inf>2</inf> receptors and may act as a negative allosteric \n",
      "modulator or weak antagonist at these sites. cbd has additional cns \n",
      "effects as a serotonin 5ht<inf>1a</inf> agonist and a serotonin \n",
      "5ht<inf>2a</inf> weak partial agonist, as well as a serotonin \n",
      "5ht<inf>3a</inf> antagonist. hhs basis for rec. at 11.\n",
      "    in the past 30 years, the potency of marijuana with regard to \n",
      "[delta]9-thc has increased dramatically. hhs described one study \n",
      "finding that the concentration of [delta]9-thc in marijuana samples in \n",
      "the united states increased from 3 percent in 1991 to 17.1 percent in \n",
      "2017. these increases are likely due to an increase in the number of \n",
      "high potency samples (i.e., sinsemilla) in the overall samples tested. \n",
      "based on an evaluation of marijuana seized by dea, the majority of \n",
      "samples contained high concentrations of [delta]9-thc and low \n",
      "concentrations of cbd. hhs basis for rec. at 11-12.\n",
      "b. animal abuse-related behavioral effects\n",
      "self-administration\n",
      "    self-administration is a method that assesses the ability of a drug \n",
      "to produce rewarding effects. the presence of rewarding effects \n",
      "increases the likelihood that individuals will try to obtain additional \n",
      "quantities of a drug. animal self-administration of a drug is often \n",
      "useful in suggesting whether humans will experience a particular \n",
      "substance as having rewarding effects, which is indicative of abuse \n",
      "potential. for example, the tendency of rhesus monkeys to self-\n",
      "administer a drug is correlated with humans' propensity to abuse it. \n",
      "hhs basis for rec. at 12.\n",
      "    since self-administration is a methodology in which the test drug \n",
      "is typically administered intravenously to rats, it is not possible to \n",
      "evaluate botanical marijuana through self- administration. however, \n",
      "given that [delta]9-thc is the primary substance that confers abuse \n",
      "potential to marijuana, its ability to induce self-administration can \n",
      "serve as an indicator of the abuse potential of marijuana. hhs basis \n",
      "for rec. at 12.\n",
      "    hhs concluded, after weighing the relevant scientific evidence, \n",
      "that [delta]9-thc produces rewarding effects that lead an animal to \n",
      "repeatedly seek out the substance. hhs basis for rec. at 12. \n",
      "specifically, some studies have demonstrated successful animal self-\n",
      "administration of [delta]9-thc following intravenous administration, \n",
      "administration of inhaled vapor, oral administration, and \n",
      "intracerebroventricular administration. other recent animal studies \n",
      "have not been able to produce [delta]9-thc self-administration \n",
      "following intravenous administration and oral administration, but hhs \n",
      "concluded that these results were due to the specific methodology of \n",
      "those respective studies, rather than valid evidence of the rewarding \n",
      "effects of [delta]9-thc, and thus do not negate hhs's reliance on \n",
      "studies in which [delta]9-thc was actively self-administered by \n",
      "animals. hhs basis for rec. at 12-13.\n",
      "    furthermore, a comprehensive deconstruction of which animal \n",
      "methodology is optimal for producing preclinical self-administration of \n",
      "[delta]9-thc is not necessary for an evaluation of the abuse potential \n",
      "of marijuana in humans because it is already clear that humans utilize \n",
      "marijuana for its rewarding properties. hhs basis for rec. at 13. \n",
      "animal self-administration is used primarily to predict whether a novel \n",
      "substance is likely to be used by humans for its rewarding properties \n",
      "as an indication of its abuse potential. however, epidemiological data \n",
      "already amply demonstrates that humans self-administer substances that \n",
      "contain [delta]9-thc, including botanical marijuana, for their ability \n",
      "to produce positive subjective responses, including euphoria. hhs basis \n",
      "for rec. at 13; see also sections vi.4-6 of this preamble (discussing \n",
      "factors 4-6).\n",
      "conditioned place preference\n",
      "    a conditioned place preference (``cpp'') study is another method \n",
      "for determining whether drugs have rewarding properties; a cpp study \n",
      "relies on an animal's decision to spend time in a location associated \n",
      "with receiving a drug. the studies in which [delta]9-thc successfully \n",
      "produced cpp occurred under very specific experimental conditions, \n",
      "similar to the [delta]9-thc self-administration studies in animals. \n",
      "experimental manipulations in cpp studies with [delta]9-thc have \n",
      "included varying the animal species, sex, dose, or route of \n",
      "administration; introducing flavors to obscure unpleasant taste; and \n",
      "varying the drug history of the animals tested. however, as with animal \n",
      "self-administration, the purpose of cpp studies is typically to \n",
      "determine if a new drug produces rewarding sensations, which would \n",
      "suggest that a drug has abuse potential in humans. since it is clear \n",
      "that humans self-administer substances that contain [delta]9-thc, \n",
      "including botanical marijuana, hhs determined that it was not necessary \n",
      "to determine which cpp methods are optimal for demonstrating that \n",
      "[delta]9-thc has rewarding properties in animals. hhs basis for rec. at \n",
      "13.\n",
      "drug discrimination studies\n",
      "    drug discrimination is a method in which animals indicate whether a \n",
      "test drug produces sensations similar to those produced by a training \n",
      "drug with a known pharmacological mechanism of action. drug \n",
      "discrimination is considered to be an abuse-related study only when the \n",
      "training drug is a known drug of abuse that is scheduled under the csa \n",
      "and the test drug may have abusable effects similar to the training \n",
      "drug based on having a similar mechanism of action to the training \n",
      "drug. because animal drug discrimination studies often use [delta]9-thc \n",
      "as the standard for establishing if new drugs have classic marijuana-\n",
      "like pharmacological activity, hhs did not examine whether this method \n",
      "should be applied when evaluating the abuse potential of [delta]9-thc. \n",
      "hhs basis for rec. at 14.\n",
      "c. human behavioral and physiological effects\n",
      "subjective effects of [delta]9-thc\n",
      "    the psychological, behavioral, and subjective responses to \n",
      "marijuana in humans have been known and characterized since antiquity. \n",
      "in the modern period, data on the psychological, behavioral, and \n",
      "subjective responses to marijuana are available from the drug labels of \n",
      "fda-approved drug products, from prospective human abuse potential \n",
      "(``hap'') studies, from accounts published in the scientific and \n",
      "medical literature, and from an evaluation published in 2017 by the \n",
      "national academies of science, engineering, and medicine (``nasem''). \n",
      "hhs basis for rec. at 14.\n",
      "fda-approved drug products containing [delta]9-thc\n",
      "    clinical scientific studies investigated the effects of [delta]9-\n",
      "thc on humans during the development of the fda-approved drug product \n",
      "marinol, which contains 2.5, 5, and 10 mg dronabinol ((-)-trans-\n",
      "[delta]9-thc of synthetic origin in sesame seed oil). during controlled \n",
      "clinical\n",
      "\n",
      "[[page 44605]]\n",
      "\n",
      "trials (as reported in section 6.1 of the drug labels for marinol and \n",
      "syndros (which relied on the safety data from marinol during drug \n",
      "development)), various adverse events (``aes'') were observed, \n",
      "including amnesia, anxiety/nervousness, ataxia, confusion, \n",
      "depersonalization, hallucination, asthenia, palpitations, tachycardia, \n",
      "vasodilation/facial flush, euphoria, paranoid reaction, somnolence, \n",
      "abnormal thinking, dizziness, abdominal pain, nausea, and vomiting. hhs \n",
      "basis for rec. at 14-15.\n",
      "hap studies\n",
      "    hap studies evaluate whether a test drug produces positive \n",
      "subjective responses compared to a placebo and a known drug of abuse \n",
      "that is scheduled under the csa and serves as the positive control. if \n",
      "the test drug produces rewarding effects that are statistically \n",
      "significantly greater than the placebo, and beyond the acceptable \n",
      "placebo range of response, it is an indication that the drug may have \n",
      "abuse potential. the relative abuse potential is suggested by the \n",
      "responses from the positive control on these measures in comparison to \n",
      "the test drug. hhs basis for rec. at 15.\n",
      "    after analyzing a number of hap studies of marijuana and [delta]9-\n",
      "thc, which varied in the in dose of [delta]9-thc, the route of \n",
      "administration, or whether the [delta]9-thc was provided in the form of \n",
      "marijuana or isolated compound, hhs identified a number of \n",
      "commonalities. first, following administration of the study drug (i.e., \n",
      "marijuana or [delta]9-thc), there were increases in positive subjective \n",
      "responses. second, the studies demonstrated increases on the addiction \n",
      "research center inventory scales for the morphine benzedrine group \n",
      "(euphoria), marijuana, and amphetamine. hhs concluded that these data \n",
      "consistently demonstrated that [delta]9-thc, in the form of marijuana \n",
      "or as an isolated compound, produces rewarding effects that are \n",
      "indicative of abuse potential when it is administered under controlled \n",
      "experimental conditions. third, and in contrast to the prior findings, \n",
      "the data also demonstrated that the administration of marijuana or \n",
      "[delta]9-thc may result in negative subjective responses reflecting \n",
      "negative drug effects and sedation; these are often delayed in onset \n",
      "from when the positive subjective effects begin. hhs noted that the \n",
      "positive and negative subjective responses following administration of \n",
      "marijuana or [delta]9-thc were often dose-dependent. it also noted that \n",
      "there were typically few differences between responses to marijuana and \n",
      "[delta]9-thc, or between responses based on route of administration of \n",
      "the study drug. hhs basis for rec. at 15.\n",
      "common responses to marijuana in humans published in scientific and \n",
      "medical literature\n",
      "    hhs concluded that the responses to dronabinol reported during \n",
      "development of marinol and the responses to marijuana and [delta]9-thc \n",
      "reported in hap studies paralleled the common responses to marijuana \n",
      "that have been described by other medical scientists. these responses \n",
      "include positive subjective responses (such as euphoria or happiness), \n",
      "sedative responses (such as drowsiness or changes in sleep), anxiety \n",
      "and negative responses (such as panic attacks, agitation, and \n",
      "paranoia), perceptual changes (such as hallucinations and changes in \n",
      "perception), psychiatric, social, and cognitive changes (such as drug \n",
      "abuse, delusions, memory and concentration impairment, and impaired \n",
      "judgment), and physiological responses (such as nausea, tachycardia, \n",
      "facial flushing, dry mouth, tremor, dizziness, ataxia, and \n",
      "hyperemesis). the literature reviewed by hhs also concluded that the \n",
      "positive changes that occur following use of marijuana are pleasurable \n",
      "to many humans and are associated with drug-seeking and drug-taking; \n",
      "and that these effects are typically dose-dependent, with higher doses \n",
      "and routes of administration that produce faster onset producing more \n",
      "intense responses and the likelihood of more negative subjective \n",
      "effects. hhs basis for rec. at 16-17.\n",
      "national academies of science, engineering, and medicine (nasem)\n",
      "    hhs also reviewed a book-length evaluation of marijuana by nasem \n",
      "entitled the health effects of cannabis and cannabinoids: the current \n",
      "state of evidence and recommendations for research.\\17\\ according to \n",
      "hhs, in this evaluation, nasem provided a brief summary of the clinical \n",
      "features of marijuana intoxication and found that (1) during acute \n",
      "cannabis intoxication, the user's sociability and sensitivity to \n",
      "certain stimuli (e.g., colors, music) may be enhanced, the perception \n",
      "of time is altered, and the appetite for sweet and fatty foods is \n",
      "heightened; (2) some users report feeling relaxed or experiencing a \n",
      "pleasurable rush or buzz after smoking cannabis; (3) these subjective \n",
      "effects were often associated with decreased short-term memory, dry \n",
      "mouth, and impaired perception and motor skills; and (4) when very high \n",
      "blood levels of [delta]9-thc were attained, persons might experience \n",
      "panic attacks, paranoid thoughts, and hallucinations. hhs basis for \n",
      "rec. at 17-18.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\17\\ national academies of science, engineering, & medicine, the \n",
      "health effects of cannabis & cannabinoids: the current state of \n",
      "evidence & recommendations for research (2017), <a href=\"https://nap.nationalacademies.org/read/24625/chapter/1\">https://nap.nationalacademies.org/read/24625/chapter/1</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "hhs conclusion with respect to factor 2\n",
      "    based on its analysis of the studies discussed above, hhs concluded \n",
      "that [delta]9-thc, the substance largely responsible for the abuse \n",
      "potential of marijuana, is a partial agonist at the cannabinoid \n",
      "cb<inf>1</inf> receptor. when [delta]9-thc is administered to animals, \n",
      "it produces rewarding responses, as evidenced by its ability to induce \n",
      "self-administration and cpp. this is consistent with the data from \n",
      "human studies and from clinical observations, where administration of \n",
      "[delta]9-thc or use of marijuana produces euphoria and other \n",
      "pleasurable responses, as well as sedation and anxiety responses. \n",
      "psychiatric, social, and cognitive responses, which are often \n",
      "experienced as negative, are also reported, as are physiological \n",
      "responses such as dry mouth, ataxia, and increased hunger. as described \n",
      "in hhs's analysis of factor 4, see hhs basis for rec. at 32-37, the \n",
      "rewarding responses observed in humans are consistent with the \n",
      "prevalence of nonmedical use of marijuana, which includes abuse of the \n",
      "substance. abuse of marijuana by individuals can lead to other negative \n",
      "consequences, including addiction and the need to seek medical \n",
      "attention through calls to poison centers or visits to an ed, as \n",
      "described in factor 5, see hhs basis for rec. at 38-39, 42. hhs basis \n",
      "for rec. at 18.\n",
      "    dea believes that additional data on marijuana's pharmacological \n",
      "effects may be appropriate for consideration in assessing this factor.\n",
      "\n",
      "3. the state of current scientific knowledge regarding marijuana\n",
      "\n",
      "    the third factor that doj and hhs must consider under 21 u.s.c. \n",
      "811(c) is the state of current scientific knowledge regarding \n",
      "marijuana. in considering this factor and making its recommendation, \n",
      "hhs examined the chemistry of marijuana and the human pharmacokinetics \n",
      "of marijuana. hhs basis for rec. at 18-24.\n",
      "chemistry\n",
      "    cannabis is a genus of annual flowering plant with digitate leaves \n",
      "in the family cannabaceae martinov that likely originated in central or \n",
      "southeast asia over 10,000 years ago and was first cultivated in china \n",
      "for fiber and seed production. cultivation eventually\n",
      "\n",
      "[[page 44606]]\n",
      "\n",
      "spread across asia, africa, and europe and then to the americas. a \n",
      "longstanding and significant historical debate by botanists and \n",
      "taxonomists continues today regarding the number of species in the \n",
      "cannabis genus, but it is generally treated as a single, highly \n",
      "polymorphic species known as cannabis sativa l., with the other two \n",
      "previously reported species listed as cannabis indica lam. and cannabis \n",
      "ruderalis janisch. plants previously believed to be part of the latter \n",
      "two species are generally recognized as varieties (or subspecies) of \n",
      "cannabis sativa l., which are commonly referred to as sativa var. \n",
      "indica and sativa var. ruderalis. cannabis sativa and sativa var. \n",
      "indica plants are widely cultivated for their size, branching, and \n",
      "cannabinoid content, while sativa var. ruderalis is rarely cultivated \n",
      "alone because it is shorter, is often unbranched, and has very low \n",
      "cannabinoid content. worldwide cannabis varieties are separated into \n",
      "hundreds of different cultivars and strains. plants selected for \n",
      "cultivation are known as cultivated varieties or cultivars, whereas \n",
      "plants reproduced asexually from a cultivar through clonal propagation \n",
      "are known as strains. these practices have resulted in significantly \n",
      "different chemical profiles for cannabis cultivars, and the \n",
      "classification term to account for these chemical profile differences \n",
      "has evolved. the term ``chemovar'' accounts for the plant's chemical \n",
      "profile and is a more meaningful classification for clinical \n",
      "researchers studying the plant's potential drug effects. marijuana \n",
      "products developed from diverse chemovars will have different safety, \n",
      "biological, pharmacological, and toxicological profiles. hhs basis for \n",
      "rec. at 18-19.\n",
      "    cannabis is a dioecious plant, meaning female and male flowers \n",
      "occur on separate plants, and rarely occurs as a monoecious plant \n",
      "(i.e., single plant containing male and female flowers). the glandular \n",
      "trichomes found on the female plant's unfertilized flower heads and \n",
      "bracts contain the highest concentrations of cannabinoids. for this \n",
      "reason, unfertilized female chemovars are favored to harvest large \n",
      "inflorescences (i.e., complete flower head) for their rich cannabinoid \n",
      "and terpene content. hhs basis for rec. at 19.\n",
      "    the cannabis sativa l. plant naturally contains many different \n",
      "compounds, and more than 550 have been identified, such as \n",
      "cannabinoids, terpenoids, flavonoids, stilbenoids, steroids, \n",
      "polysaccharides, benzoquinone, phenanthrenes, spiroindans, lignans, \n",
      "fatty acids, sugars, hydrocarbons, amino acids, and proteins. \n",
      "cannabinoids are mainly found in living cannabis sativa l. plants in \n",
      "their non-psychoactive carboxylated forms (i.e., acid form), which \n",
      "require drying, heating, combustion, or aging to decarboxylate to their \n",
      "neutral forms, and are primarily composed of c<inf>21</inf> \n",
      "terpenophenolic compounds. the most abundant neutral form cannabinoids \n",
      "are [delta]9-thc and cbd, but nearly 200 have been identified in the \n",
      "plant and are divided into subclasses: cannabigerols, cannabichromenes, \n",
      "cbds, [delta]9-thcs, (-)-[delta]8-trans-tetrahydrocannabinols \n",
      "(``[delta]8-thcs''), cannabicyclols, cannabielsoins, cannabinols, \n",
      "cannabinodiols, cannabitriols, and the miscellaneous cannabinoids. hhs \n",
      "basis for rec. at 19.\n",
      "    like any other botanical substance, marijuana plants are \n",
      "heterogeneous in nature and contain a complex chemical profile. \n",
      "moreover, variable organic plant material, as well as manufactured \n",
      "preparations, result in a variety of product forms that dictate \n",
      "different routes of administration, associated risks, and differences \n",
      "in quality of the product used, which may also influence risk for \n",
      "users. among other things, these differences can result from \n",
      "differences in harvest location, growing conditions, the season in \n",
      "which the marijuana is harvested, and the manner in which the marijuana \n",
      "is processed, handled, transported, and tested. the potential for high \n",
      "variability of marijuana and marijuana-derived products, both in \n",
      "product composition and impurity profile, is a major consideration for \n",
      "the potential variability of drug effects and safety. hhs basis for \n",
      "rec. at 19-20.\n",
      "    processing of marijuana and its use in further manufacturing can \n",
      "lead to a range of forms that individuals may use or consume, including \n",
      "crude mixtures and highly purified substances of botanical origin, many \n",
      "of which may be cannabinoid compounds. among known cannabinoids in the \n",
      "cannabis plant, both [delta]9-thc and [delta]8-thc produce marijuana's \n",
      "psychoactive effects. because [delta]9-thc is significantly more \n",
      "abundant than [delta]8-thc, marijuana's intoxicating effects are \n",
      "largely attributed to the former. only small quantities of [delta]8-thc \n",
      "acid and [delta]8-thc have been identified in plants. hhs basis for \n",
      "rec. at 20.\n",
      "    as noted above, the 2018 amendments to the csa removed hemp from \n",
      "the definition of marijuana. however, the term ``cannabis'' is still \n",
      "often broadly used to refer to a wide variety of products manufactured \n",
      "from the cannabis sativa l. plant, regardless of their control status. \n",
      "as a result of the 2018 amendments to the csa, a large hemp marketplace \n",
      "exists, containing a wide variety of products. in addition, the public \n",
      "has access to cannabis products within the csa definition of marijuana \n",
      "through state-authorized adult-use (i.e., nonmedical use) and medical-\n",
      "use programs, as well as via the illicit marketplace. see hhs basis for \n",
      "rec. at 28-37 (factor 4). because of these diverse sources of \n",
      "marijuana, there is a lack of unified controls on cultivation and \n",
      "manufacturing, which raises concerns related to the safety, quality, \n",
      "and consistency of botanical substances (e.g., botanical raw materials, \n",
      "extracts, and intermediates) and final product formulations that are \n",
      "currently accessed for medical and nonmedical use. products sourced \n",
      "from state-authorized adult-use and medical-use programs are subject to \n",
      "a patchwork of inconsistent product standards and safety requirements. \n",
      "although some state programs have a set of standards (for example, on \n",
      "manufacturing, testing, labeling, and packaging), each program's \n",
      "controls are different, leading to a wide variation of products across \n",
      "state-authorized programs. and the illicit marketplace is not subject \n",
      "to any standards or oversight. as a result, the range of products \n",
      "within the csa's definition of marijuana encompasses a large degree of \n",
      "variation in forms for consumption, composition of biologically \n",
      "relevant constituents, potency, and contaminants. hhs basis for rec. at \n",
      "21.\n",
      "    in short, marijuana has hundreds of chemovars containing variable \n",
      "concentrations of [delta]9-thc, cannabinoids, and other compounds. as a \n",
      "result, in evaluating whether to recommend that marijuana be \n",
      "rescheduled, hhs focused to the greatest extent possible on wide-\n",
      "ranging substances derived from cannabis plants that are vehicles for \n",
      "the self-administration of [delta]9-thc as the key biologically active \n",
      "substance on which the csa's current definition of marijuana is based. \n",
      "hhs basis for rec. at 21.\n",
      "human pharmacokinetics of [delta]9-thc\n",
      "    hhs reported that the pharmacokinetics of [delta]9-thc in humans--\n",
      "i.e., the study of how the body interacts with [delta]9-thc--have been \n",
      "evaluated following inhaled administration of marijuana and oral \n",
      "administration of marijuana. these are the most frequently used routes \n",
      "of administration for marijuana or isolated [delta]9-thc. hhs basis for \n",
      "rec. at 21.\n",
      "    marijuana is commonly administered by humans via inhalation through \n",
      "smoking and, more recently, through vaping (e.g., heating and \n",
      "inhalation of\n",
      "\n",
      "[[page 44607]]\n",
      "\n",
      "botanical matter or other volatile substances containing [delta]9-thc). \n",
      "generally, inhalation of a drug is the route that produces the fastest \n",
      "rate of drug absorption. once marijuana is inhaled, [delta]9-thc is \n",
      "absorbed through the lungs in the form of an aerosol within seconds. \n",
      "peak plasma levels of [delta]9-thc following inhalation occur very \n",
      "quickly, within 6 to 10 minutes. psychoactive effects begin immediately \n",
      "following absorption, although peak subjective effects do not coincide \n",
      "with peak plasma [delta]9-thc levels and are often delayed. following \n",
      "administration of marijuana through inhalation, the bioavailability of \n",
      "[delta]9-thc is 10 percent to 35 percent. that bioavailability is \n",
      "relatively low and varies widely due to several factors. an \n",
      "individual's experience and technique with smoking marijuana also \n",
      "determines the dose absorbed. hhs basis for rec. at 22.\n",
      "    when marijuana or [delta]9-thc is administered orally (such as by \n",
      "eating marijuana-infused foods), the effects start within 30 to 90 \n",
      "minutes, reach their peak at 1.5 to 3 hours, and remain measurable for \n",
      "4 to 12 hours. oral bioavailability of [delta]9-thc, following \n",
      "ingestion of an edible containing marijuana or isolated [delta]9-thc, \n",
      "ranges from 5 to 20 percent. the low and variable bioavailability of \n",
      "[delta]9-thc from oral ingestion is a consequence of its first-pass \n",
      "hepatic elimination from blood and erratic absorption from stomach and \n",
      "bowel. ingestion of brownies containing marijuana also results in lower \n",
      "[delta]9-thc plasma levels relative to inhalation of marijuana. hhs \n",
      "basis for rec. at 22-23.\n",
      "    although there are differences in absorption of [delta]9-thc \n",
      "depending on route of administration, the distribution, metabolism, and \n",
      "excretion of [delta]9-thc is similar regardless of how the drug is \n",
      "administered. plasma concentrations of [delta]9-thc decrease quickly \n",
      "after absorption through rapid distribution into tissues and through \n",
      "liver metabolism. because [delta]9-thc has high lipophilicity, the \n",
      "apparent volume of distribution of [delta]9-thc is high (10 l/kg) as it \n",
      "is distributed initially into organs such as lung, heart, brain, and \n",
      "liver that are highly perfused. over time with regular exposure to \n",
      "marijuana, [delta]9-thc will concentrate and be retained in fat. hhs \n",
      "basis for rec. at 23.\n",
      "    metabolism of [delta]9-thc occurs primarily via cytochrome p450 \n",
      "isozymes (cyp2c9, cyp2c19, and cyp3a4) via microsomal hydroxylation to \n",
      "both active and inactive metabolites. the primary active metabolite of \n",
      "[delta]9-thc is 11-hydroxy-[delta]9-thc. [delta]9-thc clears from the \n",
      "blood relatively rapidly, largely because it is redistributed to other \n",
      "tissues in the body. metabolism of [delta]9-thc in most tissues is \n",
      "relatively slow or absent. the majority of the absorbed [delta]9-thc \n",
      "dose is eliminated in feces, and about 33 percent in urine. hhs basis \n",
      "for rec. at 23.\n",
      "hhs conclusion with respect to factor 3\n",
      "    in conclusion, hhs found that the pharmacokinetic profile of \n",
      "marijuana varies greatly depending on route of administration. \n",
      "inhalation of marijuana produces a rapid increase in plasma levels of \n",
      "[delta]9-thc and an immediate onset of psychological effects. in \n",
      "comparison, oral administration of marijuana produces a much slower \n",
      "increase in plasma levels of [delta]9-thc and onset of psychological \n",
      "effects. once [delta]9-thc has been absorbed, however, the metabolism \n",
      "and excretion of [delta]9-thc follows a standard path. hhs basis for \n",
      "rec. at 24.\n",
      "    dea likewise notes that there is considerable variability in the \n",
      "cannabinoid concentrations and chemical constituency among marijuana \n",
      "samples and that the interpretation of clinical data related to \n",
      "marijuana is complicated. a primary issue is the lack of consistent \n",
      "concentrations of [delta]9-thc and other substances in marijuana, which \n",
      "complicates the interpretation of the effects of different marijuana \n",
      "constituents. additionally, the non-cannabinoid components in marijuana \n",
      "may potentially modify the overall pharmacological and toxicological \n",
      "properties of various marijuana strains and products. dea anticipates \n",
      "that additional data on other marijuana constituents, routes of \n",
      "administration of marijuana, and the impact on [delta]9-thc potency may \n",
      "be appropriate for consideration.\n",
      "\n",
      "4. marijuana's history and current pattern of abuse\n",
      "\n",
      "    the fourth factor that doj and hhs must consider under 21 u.s.c. \n",
      "811(c) is marijuana's history and current pattern of abuse, which can \n",
      "include its abuse relative to relevant comparator substances that are \n",
      "abused. see hhs basis for rec. at 28-37. hhs concluded that it is \n",
      "appropriate to consider the federal- and state-level history of \n",
      "marijuana control, marijuana sources for nonmedical and medical use, \n",
      "marijuana use in the united states since passage of the csa, and \n",
      "current patterns of use and abuse of marijuana. hhs basis for rec. at \n",
      "28.\n",
      "federal history of marijuana control\n",
      "    according to hhs, marijuana was described in the united states \n",
      "pharmacopoeia \\18\\ as early as 1850. around the time that congress \n",
      "passed the pure food and drug act of 1906, public law 59-384, 34 stat. \n",
      "768, drugs such as marijuana, alcohol, heroin, morphine, and cocaine \n",
      "began to be characterized by the federal government as addictive and \n",
      "dangerous. these drugs were frequently included in patent medicines, \n",
      "often without the consumer's knowledge. the 1906 law required accurate \n",
      "drug labeling with respect to ingredients and dosage. but it did not \n",
      "prohibit the sale or possession of drugs characterized as addictive and \n",
      "dangerous drugs, including marijuana. as nonmedical use of marijuana \n",
      "and opioids became more popular in the united states, congress provided \n",
      "funding in 1929 for two ``narcotic farms'' in lexington, kentucky, and \n",
      "fort worth, texas, which were medical treatment centers run by the \n",
      "public health service for federal prisoners who were ``habitual users \n",
      "of narcotics,'' including marijuana-derived products. hhs basis for \n",
      "rec. at 28-29.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\18\\ the united states pharmacopoeia was formed as an \n",
      "``independent, scientific, non-profit organization dedicated to \n",
      "public health'' that published ``a national, uniform set of \n",
      "guidelines for the best understood medicinal substances and \n",
      "preparations of the day.'' building trust for over 200 years: a \n",
      "timeline of usp, u.s. pharmacopoeia, <a href=\"https://www.usp.org/200-anniversary/usp-timeline\">https://www.usp.org/200-anniversary/usp-timeline</a> (last visited may 11, 2024).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in the first half of the twentieth century, marijuana use was \n",
      "curbed by several federal laws. in 1931, the importation of marijuana \n",
      "into the united states began to be restricted under regulations under \n",
      "the pure food and drug act, except for medicinal purposes. the \n",
      "marihuana tax act of 1937, public law 75-238, 50 stat. 551, imposed \n",
      "taxes that effectively prohibited marijuana use for medical, \n",
      "nonmedical, scientific, or industrial purposes. five years later, in \n",
      "1942, marijuana was removed from the united states pharmacopoeia. \n",
      "through the imposition of mandatory minimums, the boggs act of 1951, \n",
      "public law 82-255, 65 stat. 767, lengthened the average sentence for \n",
      "first time marijuana offenders to 2 to 5 years, similar to that for \n",
      "opioid offenses, regardless of whether the individual was a nonmedical \n",
      "user or a trafficker. the narcotic control act of 1956, public law 84-\n",
      "728, 70 stat. 567, increased the minimum sentence for a first offender \n",
      "for marijuana to 2 to 10 years. hhs basis for rec. at 29.\n",
      "    despite the legal consequences, nonmedical marijuana use increased \n",
      "dramatically in the 1960s, especially among youth. congress passed the \n",
      "csa in 1970. the csa effectively repealed\n",
      "\n",
      "[[page 44608]]\n",
      "\n",
      "all previous federal drug laws, including the marihuana tax act, and \n",
      "provided a unified framework for control of drugs with abuse potential. \n",
      "when the csa was enacted, marijuana was placed into schedule i, which \n",
      "prohibited use of marijuana for medicinal or nonmedical purposes other \n",
      "than legitimate scientific research and analysis. this placement was \n",
      "consistent with the criteria established by the csa under 21 u.s.c. \n",
      "812. hhs basis for rec. at 29-30.\n",
      "marijuana control at the state level\n",
      "    according to hhs, changes in state-level marijuana laws in the \n",
      "united states in the modern era began in 1996 with the approval of \n",
      "proposition 215, the compassionate use act, by voters in california. \n",
      "this law legalized the use, possession, and cultivation of marijuana \n",
      "for treatment of patients with cancer, anorexia, aids, chronic pain, \n",
      "spasticity, glaucoma, arthritis, migraine, or any other illness for \n",
      "which marijuana provides relief, when recommended by a physician. under \n",
      "the law, marijuana could also be cultivated by patient caregivers. hhs \n",
      "basis for rec. at 30.\n",
      "    as of august 2023, when hhs submitted its basis for recommendation \n",
      "to dea, state-level laws allowing medicinal use of marijuana had been \n",
      "passed in a total of 38 states, plus the district of columbia: alabama, \n",
      "alaska, arizona, arkansas, california, colorado, connecticut, delaware, \n",
      "district of columbia, florida, hawaii, illinois, kentucky, louisiana, \n",
      "maine, maryland, massachusetts, michigan, minnesota, mississippi, \n",
      "missouri, montana, nevada, new hampshire, new jersey, new mexico, new \n",
      "york, north dakota, ohio, oklahoma, oregon, pennsylvania, rhode island, \n",
      "south dakota, utah, vermont, virginia, washington, and west virginia. \n",
      "medical use of marijuana was legalized through the action of 20 state \n",
      "legislatures and by 18 ballot measures.\\19\\ hhs basis for rec. at 30.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\19\\ data on the number of patients who participate in state-\n",
      "sanctioned medical cannabis use is available here: medical cannabis \n",
      "patient numbers, marijuana pol'y project, <a href=\"https://www.mpp.org/issues/medical-marijuana/state-by-state-medical-marijuana-laws/medical-marijuana-patient-numbers\">https://www.mpp.org/issues/medical-marijuana/state-by-state-medical-marijuana-laws/medical-marijuana-patient-numbers</a> (last visited may 13, 2024).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in 2012, colorado and washington became the first states to \n",
      "legalize the nonmedical use of marijuana. as of august 2023, state-\n",
      "level legalization of the nonmedical use of marijuana has occurred in a \n",
      "total of 23 states and the district of columbia: alaska, arizona, \n",
      "california, colorado, connecticut, delaware, district of columbia, \n",
      "illinois, maine, maryland, massachusetts, michigan, minnesota, \n",
      "missouri, montana, nevada, new jersey, new mexico, new york, oregon, \n",
      "rhode island, vermont, virginia, and washington. nonmedical use of \n",
      "marijuana was legalized by ballot initiatives in 13 states and by state \n",
      "legislatures in 9 states. hhs basis for rec. at 30.\n",
      "marijuana use in the united states since passage of the csa\n",
      "    marijuana use has varied since the csa was passed in 1970. gallup \n",
      "poll data from 1969 to 2013 show a steady increase over time in \n",
      "affirmative responses to whether the respondent had personally tried \n",
      "marijuana, with only 4 percent of people saying they had tried \n",
      "marijuana in 1969 compared to 38 percent in 2013. as hhs observed, the \n",
      "2017 nasem report stated that the prevalence of marijuana use peaked in \n",
      "the late 1970s, declined through the 1980s, and then increased again in \n",
      "the mid-1990s. from 2007 to 2017, there were steady year-over-year \n",
      "increases in the share of the general population that used marijuana in \n",
      "the past month, although there is no clear explanation for the post-\n",
      "2007 increase in use rates. hhs basis for rec. at 31-32.\n",
      "current patterns of use and abuse of marijuana\n",
      "    in considering current patterns of use and abuse of marijuana and \n",
      "marijuana-derived products, hhs analyzed epidemiological databases from \n",
      "2015 to the most recent years of available data (which vary among data \n",
      "sources). a wide variety of epidemiological databases provide necessary \n",
      "data for hhs's analyses. these include the nsduh; behavioral risk \n",
      "factor surveillance system (``brfss''); research abuse, diversion and \n",
      "addiction-related surveillance (``radars''); nonmedical use of \n",
      "prescription drugs (``nmurx''); monitoring the future (``mtf''); youth \n",
      "risk behavioral surveillance system (``yrbss''); and international \n",
      "cannabis policy study (``icps''). hhs basis for rec. at 32.\n",
      "national survey on drug use and health\n",
      "    based on nsduh data, hhs concluded that from 2015 to 2019 the past-\n",
      "year use of marijuana for any reason (nonmedical and medical) among \n",
      "people ages 12 years and older increased from 14 percent to 18 percent. \n",
      "by contrast, past-year (nonmedical and medical) use of comparator drugs \n",
      "that have fda-approved therapeutic indications declined or remained \n",
      "relatively stable over the same timeframe, including hydrocodone (22 \n",
      "percent to 16 percent), benzodiazepines (12 percent to 11 percent, 2017 \n",
      "to 2019 only), oxycodone (11 percent to 9 percent), tramadol (7 percent \n",
      "to 6 percent), zolpidem (4 percent to 3 percent), and ketamine (less \n",
      "than 1 percent). although there were trend breaks for the years 2020 \n",
      "and 2021,\\20\\ marijuana past-year use continued to increase during \n",
      "these two years. hhs basis for rec. at 32-33.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\20\\ hhs noted that nsduh data collection was disrupted in 2020 \n",
      "and 2021 due to the covid-19 pandemic, leading to trend breaks in \n",
      "these years. hhs basis for rec. at 32.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    based on nsduh data, hhs concluded that from 2015 to 2019, the \n",
      "prevalence of past-year nonmedical use of marijuana (i.e., use without \n",
      "a health care provider (``hcp'') recommendation) among people ages 12 \n",
      "years and older also increased. hhs's finding was based on an increase \n",
      "in the prevalence of overall nonmedical use of marijuana from 12 \n",
      "percent to 15 percent and on an increase in nonmedical use of marijuana \n",
      "only, without nonmedical use of other drugs that are abused, from 8 \n",
      "percent to 11 percent during this period. there was a slight decrease \n",
      "in both categories in 2020, but the prevalence of both kinds of uses \n",
      "increased again in 2021 (to 16 percent and 11 percent, respectively) to \n",
      "levels that were higher than those reported in 2019. in contrast, the \n",
      "prevalence of past-year nonmedical use of comparator drugs was less \n",
      "than 3 percent for heroin, cocaine, oxycodone, hydrocodone, tramadol, \n",
      "benzodiazepines, and zolpidem, which is much less than that for \n",
      "marijuana, either alone or with other drugs. over the 2015 to 2021 \n",
      "reporting period, the overall use of these comparator drugs declined \n",
      "slightly or remained fairly stable. notably, the majority of \n",
      "individuals who reported nonmedical use of marijuana did not report \n",
      "nonmedical use of the comparator drugs. and over the same reporting \n",
      "period of 2015 to 2021, the prevalence of past-year use of alcohol \n",
      "ranged from 62 percent to 65 percent for individuals ages 12 years and \n",
      "older, far exceeding the prevalence for marijuana or other comparator \n",
      "drugs. these data demonstrate that alcohol has the highest prevalence \n",
      "of past-year-only use, followed by nonmedical use of marijuana. the \n",
      "prevalence of the other comparators is far below that of alcohol and \n",
      "marijuana. hhs basis for rec. at 33.\n",
      "    hhs also concluded that the nsduh data show that most individuals \n",
      "who used marijuana in the past year did not do so based on a \n",
      "recommendation from an hcp, but marijuana use was more frequent among \n",
      "users with an hcp\n",
      "\n",
      "[[page 44609]]\n",
      "\n",
      "recommendation. the yearly percentage of individuals who used marijuana \n",
      "but did not have an hcp recommendation ranged between 84 and 89 percent \n",
      "between 2015 and 2021; by comparison, exclusive medical use of \n",
      "marijuana that was recommended by an hcp ranged between 7 and 10 \n",
      "percent of marijuana users in the same period. according to hhs, \n",
      "approximately 50 percent of those individuals without an hcp \n",
      "recommendation used marijuana for 60 or fewer days in the year, while \n",
      "29 percent used marijuana for more than 241 days in the year. in \n",
      "contrast, for those individuals whose use of marijuana was sometimes or \n",
      "always recommended by an hcp, 51 percent and 55 percent (respectively) \n",
      "used marijuana at least 241 days in the year. hhs basis for rec. at 33-\n",
      "34.\n",
      "    the nsduh data from 2021 showed that among individuals who used any \n",
      "marijuana in the past year, 69 percent used marijuana in the prior \n",
      "month. for comparator drugs, the percentage of individuals with past-\n",
      "year use who used each substance nonmedically in the past month was 76 \n",
      "percent for alcohol, 49 percent for heroin, 38 percent for cocaine, and \n",
      "28 percent for ketamine. hhs basis for rec. at 34.\n",
      "behavioral risk factor surveillance system\n",
      "    brfss is a national, state-based, cross-sectional telephone survey \n",
      "conducted by the centers for disease control and prevention (``cdc''). \n",
      "the participants in the 2021 brfss module for marijuana included \n",
      "approximately 68 million individuals 18 years and older, residing in 24 \n",
      "states and territories: alaska, connecticut, delaware, hawaii, idaho, \n",
      "illinois, indiana, kentucky, maine, maryland, minnesota, montana, \n",
      "nebraska, nevada, new hampshire, new york, north dakota, ohio, \n",
      "oklahoma, rhode island, utah, vermont, wyoming, and guam. hhs basis for \n",
      "rec. at 34.\n",
      "    for the 2021 survey year, the estimated prevalence of past-month \n",
      "marijuana use for any reason in the brfss survey was 12 percent, with \n",
      "88 percent reporting no marijuana use. among those with past-month \n",
      "marijuana use, the mean frequency of use was 17 days per month, with \n",
      "half of respondents reporting that they used marijuana 20 to 30 days \n",
      "per month. this pattern was consistent across all age and sex \n",
      "categories. hhs basis for rec. at 34.\n",
      "    when the reason for use was evaluated, the percentage of \n",
      "individuals who reported use for both medical and nonmedical reasons \n",
      "was 39 percent, compared to 36 percent for those who reported use for \n",
      "nonmedical reasons only, and 25 percent for those who reported use for \n",
      "medical reasons only. those individuals who reported past-month use of \n",
      "marijuana for medical reasons were more likely to be adults 55 years \n",
      "and older, while individuals who reported past-month marijuana use for \n",
      "nonmedical reasons only were more likely to be younger adults aged 18 \n",
      "to 24 years. hhs basis for rec. at 34.\n",
      "    individuals who reported using marijuana in the past 30 days for \n",
      "both nonmedical and medical reasons were more likely (62 percent) to \n",
      "report marijuana use near daily (20 to 30 days per month) than \n",
      "individuals who reported marijuana use for nonmedical reasons only (34 \n",
      "percent). similarly, individuals who used marijuana for medical reasons \n",
      "only were also more likely (57 percent) to report near daily use than \n",
      "those who used it for nonmedical reasons only. hhs basis for rec. at \n",
      "34.\n",
      "researched abuse, diversion and addiction-related surveillance system \n",
      "survey of nonmedical use of prescription drugs\n",
      "    the radars system conducts the nmurx program, a serial, cross-\n",
      "sectional, online survey of the general adult population (18 years and \n",
      "older) to elicit information on the nonmedical use of drugs \n",
      "(prescription, nonprescription, unapproved, and illicit). the nmurx \n",
      "program estimates represent measures of past-year drug use in an \n",
      "enriched sample of united states adults with higher-than-average \n",
      "nonmedical use of prescription pain relievers and illicit drugs. nmurx \n",
      "program data demonstrated that past-year use of marijuana was reported \n",
      "by 21 percent of individuals, while past-year use of comparator \n",
      "substances was substantially lower: benzodiazepines (4 percent), \n",
      "hydrocodone, oxycodone, tramadol (2 percent), cocaine or crack (less \n",
      "than 2 percent), and illicit fentanyl, heroin, and ketamine (less than \n",
      "1 percent). this pattern of much greater marijuana use compared to \n",
      "other drugs is consistent with the patterns reported in nsduh and \n",
      "brfss. hhs basis for rec. at 35.\n",
      "monitoring the future\n",
      "    mtf collects information on the use of selected prescription and \n",
      "illicit drugs and alcohol by conducting an annual, nationally \n",
      "representative, cross-sectional survey of 8th, 10th, and 12th graders \n",
      "in public and private schools.\\21\\ mtf data showed that during the \n",
      "years 2012 to 2022, the illicit drug most frequently used by 12th-grade \n",
      "students who reported past-year drug use was marijuana/hashish \n",
      "(approximately 35 percent per year from 2012 to 2020, with a reduction \n",
      "to 30 percent per year in 2021 and 2022). in contrast, in 2022, alcohol \n",
      "was used by 52 percent of 12th-grade students within the last 12 \n",
      "months, similar to percentages in 2019 and 2020 (52 percent and 55 \n",
      "percent, respectively), but higher than the 2021 level of 47 percent. \n",
      "all other comparator drugs (hydrocodone, heroin, tramadol, cocaine, \n",
      "ketamine, and zolpidem) were each used in the past year by fewer than 5 \n",
      "percent of 12th graders from 2012 to 2022. hhs basis for rec. at 35.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\21\\ as a result of the covid-19 pandemic, there is a potential \n",
      "trend break in the 2020 mtf data. hhs basis for rec. at 35.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    mtf data for past-month use showed a similar pattern. during the \n",
      "years 2012 to 2022, the illicit drug most frequently used by 12th-grade \n",
      "students who reported past-month drug use was marijuana/hashish \n",
      "(approximately 20 to 22 percent per year) compared to past-month use of \n",
      "cocaine (approximately 1 percent per year) or heroin (less than 0.5 \n",
      "percent per year). however, past-month alcohol use by 12th-grade \n",
      "students (28 percent) exceeded that of marijuana in 2022. for those who \n",
      "used marijuana in the past month, 6 to 7 percent used it daily. by \n",
      "comparison, for those who used cocaine and heroin in the last month, \n",
      "less than one percent used it daily. mtf does not provide past-month \n",
      "use data for hydrocodone, heroin, tramadol, ketamine, or zolpidem. hhs \n",
      "basis for rec. at 35.\n",
      "youth risk behavior surveillance system\n",
      "    yrbss was established by the cdc and conducts school-based surveys \n",
      "every 2 years, in partnership with state, local, territorial, and \n",
      "tribal governments, with a focus on youth health behavior in the united \n",
      "states. the yrbss high school component, the youth risk behavior \n",
      "survey, includes a nationally representative survey of 9th- through \n",
      "12th-grade students. yrbss data showed that from 2009 to 2019, \n",
      "approximately 20 percent of students in 9th through 12th grade reported \n",
      "using marijuana at least once in the past month during each year \n",
      "evaluated. when students 17 years and older were asked how old they \n",
      "were when they first used marijuana, 43 percent reported they initiated \n",
      "use between the ages of 15 to 16 years, 25 percent initiated use \n",
      "between the ages of 13 to 14 years, and 13 percent initiated use at 12 \n",
      "years of age and younger. yrbss data also showed, however, that past-\n",
      "month alcohol use by high school students (29 percent) in 2019 was \n",
      "greater than that of marijuana use, while past month\n",
      "\n",
      "[[page 44610]]\n",
      "\n",
      "prescription opioid misuse (including codeine, hydrocodone, or \n",
      "oxycodone) (7 percent) in 2019 was much lower than that of both alcohol \n",
      "and marijuana use. hhs basis for rec. at 36.\n",
      "international cannabis policy study\n",
      "    icps conducted serial, cross-sectional surveys from 2019 to 2021 of \n",
      "individuals ages 16 to 65 years living in the united states to \n",
      "understand the public health impact of marijuana legalization. hhs's \n",
      "evaluation of that survey data focused on respondents who reported at \n",
      "least some past-year marijuana nonmedical use (by indicating that they \n",
      "were not a medical marijuana user, defined as someone who uses \n",
      "marijuana only to treat a medical condition). hhs basis for rec. at 36.\n",
      "    according to hhs, icps data showed that the prevalence of past-year \n",
      "nonmedical use of marijuana ranged from 18 percent to 22 percent of \n",
      "individuals surveyed from 2019 to 2021, while the prevalence of past-\n",
      "month nonmedical use was lower, ranging from 12 percent to 14 percent \n",
      "of individuals surveyed. individuals aged 26 to 34 years had the \n",
      "highest relative prevalence of nonmedical marijuana use, with 26 \n",
      "percent reporting past-year use and 18 percent reporting past-month \n",
      "use. when those individuals who reported past-year marijuana use in \n",
      "2021 were asked why they used the drug, 33 percent reported use for \n",
      "medical reasons, while 61 percent were classified as using marijuana \n",
      "for nonmedical reasons only. (the other 6 percent did not respond.) hhs \n",
      "basis for rec. at 36.\n",
      "    when frequency of nonmedical use of marijuana was evaluated in icps \n",
      "for those individuals who used marijuana nonmedically at least once a \n",
      "year, individuals aged 16 to 17 years had the highest percentage of use \n",
      "less than once a month (approximately 40 percent, compared to \n",
      "approximately 25 to 31 percent for other age cohorts); while \n",
      "individuals aged 26 to 34 years had the highest percentage of daily use \n",
      "(approximately 43 percent, compared to approximately 34 to 37 percent \n",
      "for individuals in other adult cohorts and approximately 24 percent \n",
      "among individuals 16 and 17 years). among individuals who used \n",
      "marijuana for nonmedical reasons in the past year, 49 percent reported \n",
      "never using alcohol and marijuana at the same time, while 35 percent \n",
      "sometimes used the two substances together, 9 percent often used them \n",
      "together, and 5 percent used alcohol every time they used marijuana. \n",
      "hhs basis for rec. at 36-37.\n",
      "hhs conclusion with respect to factor 4\n",
      "    in light of the evidence cited above, hhs determined that certain \n",
      "conclusions could be drawn about marijuana's current pattern of abuse. \n",
      "hhs concluded that the use of marijuana for medical and nonmedical \n",
      "purposes is extensive in the united states. hhs also concluded that the \n",
      "prevalence of marijuana use is less than that of alcohol and \n",
      "significantly more than that of other drugs of abuse that are scheduled \n",
      "under the csa. specifically, hhs noted that nsduh data from 2015 to \n",
      "2019 showed that the prevalence of past-year use of alcohol was five to \n",
      "six times greater than that of nonmedical use of marijuana. in \n",
      "contrast, the prevalence of past-year nonmedical use of heroin, \n",
      "cocaine, oxycodone, hydrocodone, tramadol, benzodiazepines, and \n",
      "zolpidem was four to five times less than that of marijuana nonmedical \n",
      "use. similar past-year comparative drug use data were reported in \n",
      "radars-nmurx, mtf, and icps. hhs basis for rec. at 37. in 2016, dea \n",
      "found that marijuana continues to be the most widely used illicit drug. \n",
      "it noted that in 2014, there were 22.2 million current users; that \n",
      "there were also 2.6 million new users, most of whom were less than 18 \n",
      "years of age; and that marijuana was the most frequently identified \n",
      "drug identified in federal, state, and local forensic laboratories. 81 \n",
      "fr 53739. in addition to the data provided in the hhs basis for \n",
      "recommendation and the data considered by hhs and dea in their 2015 \n",
      "eight-factor analyses, dea anticipates that additional information \n",
      "arising from this rulemaking will further inform the findings that must \n",
      "be made to reschedule marijuana, including with respect to this factor. \n",
      "dea also notes that, according to the world health organization, \n",
      "cannabis is globally the most commonly used psychoactive substance \n",
      "under international control.\\22\\ accounting for half of all drug \n",
      "seizures worldwide, the global annual prevalence of cannabis \n",
      "consumption is 2.5 percent or about 147 million people.\\23\\ in 2016, an \n",
      "estimated 28.6 million individuals age 12 or older were current (in the \n",
      "past month) illicit drug users.\\24\\ by 2020, approximately 59.3 million \n",
      "individuals age 12 or older reported using an illicit drug within the \n",
      "past year; 83.6 percent (49.6 million) of those past-year illicit drug \n",
      "users reported using marijuana.\\25\\ in 2022, the domestic cannabis \n",
      "eradication and suppression program was responsible for the eradication \n",
      "of 4,435,859 illegally cultivated outdoor cannabis plants and 1,245,980 \n",
      "illegally cultivated indoor plants for a total of 5,681,839 illegally \n",
      "cultivated marijuana plants.\\26\\ dea believes that additional data on \n",
      "marijuana's pattern of abuse may be appropriate for consideration in \n",
      "assessing this factor.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\22\\ world health org., the health and social effects of \n",
      "nonmedical cannabis use, at v (2016), <a href=\"https://iris.who.int/bitstream/handle/10665/251056/9789241510240-eng.pdf\">https://iris.who.int/bitstream/handle/10665/251056/9789241510240-eng.pdf</a>.\n",
      "    \\23\\ alcohol, drugs & addictive behaviours unit, cannabis, world \n",
      "health org., <a href=\"https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis\">https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis</a> (last visited may 13, 2024).\n",
      "    \\24\\ substance abuse & mental health servs. admin., key \n",
      "substance use and mental health indicators in the united states: \n",
      "results from the 2016 national survey on drug use and health 1 \n",
      "(2017), <a href=\"https://www.samhsa.gov/data/sites/default/files/nsduh-ffr1-2016/nsduh-ffr1-2016.pdf\">https://www.samhsa.gov/data/sites/default/files/nsduh-ffr1-2016/nsduh-ffr1-2016.pdf</a>.\n",
      "    \\25\\ substance abuse & mental health servs. admin, key substance \n",
      "use and mental health indicators in the united states: results from \n",
      "the 2020 national survey on drug use and health 2 (2021), <a href=\"https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/nsduhffrpdfwhtmlfiles2020/2020nsduhffr1pdfw102121.pdf\">https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/nsduhffrpdfwhtmlfiles2020/2020nsduhffr1pdfw102121.pdf</a>.\n",
      "    \\26\\ domestic cannabis suppression/eradication program, dea, \n",
      "<a href=\"https://www.dea.gov/operations/eradication-program\">https://www.dea.gov/operations/eradication-program</a> (last visited may \n",
      "13, 2024).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "5. the scope, duration, and significance of abuse\n",
      "\n",
      "    the fifth factor that doj and hhs must consider under 21 u.s.c. \n",
      "811(c) is the scope, duration, and significance of marijuana abuse. in \n",
      "conducting its analysis, hhs analyzed the consequences over time of \n",
      "marijuana abuse compared to the abuse of other substances based on data \n",
      "from the united states poison centers national poison data system \n",
      "(``npds''), nsduh, the treatment episode data set (``teds''), the \n",
      "national addictions vigilance intervention and prevention program \n",
      "(``navippro''), the national emergency department sample (``neds''), \n",
      "the national inpatient sample (``nis''), and the national forensic \n",
      "laboratory information system (``nflis''). hhs basis for rec. at 37-45.\n",
      "epidemiological data on consequences of marijuana abuse\n",
      "national poison data system\n",
      "    data from npds provide information on the scope of contacts with a \n",
      "poison center (``pc'') following marijuana abuse relative to abuse of \n",
      "selected comparators. hhs basis for rec. at 38.\n",
      "    the number of pc abuse cases for a substance (either alone or in \n",
      "combination with another substance) for the period of 2015 to 2021 \n",
      "showed that the highest number of pc abuse cases was for alcohol, \n",
      "followed by heroin and\n",
      "\n",
      "[[page 44611]]\n",
      "\n",
      "then benzodiazepines. the fourth highest number of pc abuse cases was \n",
      "for marijuana, with all other comparators showing fewer pc abuse cases. \n",
      "when the pc abuse cases for 2015 to 2021 were analyzed for cases \n",
      "involving a single substance only, the rank order of pc abuse cases by \n",
      "number was the same as the order from all pc abuse cases for substances \n",
      "used alone or in combination with another substance, meaning that \n",
      "marijuana accounted for the fourth highest number of pc abuse cases for \n",
      "a single substance. hhs basis for rec. at 38.\n",
      "    hhs's analysis of the data from 2015 to 2021 showed cases resulting \n",
      "from abuse (as opposed to those resulting from other causes, such as \n",
      "accidental ingestion) made up the largest proportion of pc cases for \n",
      "illicit fentanyl (72 percent), heroin (65 percent), cocaine (41 \n",
      "percent) and ketamine (40 percent). the fifth highest percentage was \n",
      "for cases involving marijuana (36 percent), followed by alcohol (15 \n",
      "percent), oxycodone (13 percent), benzodiazepines (8 percent), \n",
      "hydrocodone (5 percent), tramadol (4 percent), and zolpidem (3 \n",
      "percent). a similar analysis for single-substance-only abuse for the \n",
      "same period showed that the three substances most likely to lead to a \n",
      "pc call following abuse were heroin (65 percent), oxycodone (47 \n",
      "percent), and tramadol (47 percent). the fourth highest percentage was \n",
      "for marijuana and ketamine (46 percent), followed by alcohol (43 \n",
      "percent), zolpidem (40 percent), hydrocodone (37 percent), illicit \n",
      "fentanyl (34 percent), benzodiazepines (32 percent), and cocaine (28 \n",
      "percent). hhs basis for rec. at 38.\n",
      "    annual utilization-adjusted abuse case rates were calculated by \n",
      "dividing the number of pc abuse case counts by the prevalence of past-\n",
      "year use based on nsduh estimates from people aged 12 years and older, \n",
      "for the period 2015 to 2019, for both (1) any past-year use of the \n",
      "substance and (2) past-year nonmedical use of the substance. these \n",
      "utilization-adjusted rates convey the likelihood that use of a drug \n",
      "will result in pc abuse cases when considering how many people use the \n",
      "drug for either (1) any reason or (2) nonmedical reasons. the \n",
      "utilization-adjusted abuse rates for any past-year use of a substance \n",
      "showed the highest rate for heroin (increasing from 4,038 to 7,201 \n",
      "cases per one million people). the next highest rates were for \n",
      "ketamine, cocaine, and benzodiazepines; all these rates were \n",
      "considerably lower than the rate for heroin. the rates for marijuana \n",
      "(relatively stable at 75 to 70 cases per one million people) and \n",
      "oxycodone were similar, as were the rates for alcohol, zolpidem, \n",
      "tramadol, and hydrocodone; all these rates were considerably lower than \n",
      "the rates for ketamine, cocaine, and benzodiazepines. a similar pattern \n",
      "of utilization-adjusted abuse rates was seen among cases involving a \n",
      "single substance only during the same time period. hhs basis for rec. \n",
      "at 39.\n",
      "    an analysis of medical outcomes related to exposure based on \n",
      "severity, timing, and assessment of clinical effects for all single-\n",
      "substance pc abuse cases involving marijuana or comparator drugs showed \n",
      "that serious medical outcomes (moderate effect, major effect, or death) \n",
      "were greatest for illicit fentanyl (81 percent) and heroin (79 \n",
      "percent), followed by oxycodone (70 percent), ketamine (64 percent), \n",
      "tramadol (62 percent), cocaine (59 percent), hydrocodone (44 percent), \n",
      "marijuana (41 percent), benzodiazepines (32 percent), alcohol (31 \n",
      "percent), and zolpidem (27 percent). hhs noted that death rates are \n",
      "underreported in npds, but hhs observed that the highest death rate was \n",
      "for fentanyl (25 percent); cocaine, heroin, and alcohol had \n",
      "comparatively very low death rates (3 percent, 2 percent, and 2 \n",
      "percent, respectively), with all other comparators reporting death \n",
      "rates of less than 1 percent. hhs basis for rec. at 39-40.\n",
      "national survey on drug use and health\n",
      "    data from nsduh provide nationally representative information on \n",
      "the prevalence of substance use disorder (``sud'') in 2021 among \n",
      "individuals aged 12 years or older who reported nonmedical use of \n",
      "marijuana in past year in comparison to heroin, cocaine, or alcohol use \n",
      "in the past year. a diagnosis of sud is made when an individual \n",
      "endorses at least 2 of the 11 criteria for sud according to the \n",
      "diagnostic and statistical manual of mental disorders, fifth edition \n",
      "(``dsm-v''). individuals are classified with a mild sud if they meet \n",
      "two to three of the criteria, a moderate sud if they meet four to five \n",
      "of the criteria, and a severe sud if they meet six or more of the \n",
      "criteria. hhs basis for rec. at 40.\n",
      "    nsduh data showed that, among individuals with past-year heroin use \n",
      "in 2021, there was an 81 percent prevalence of meeting the criteria for \n",
      "a heroin sud. in comparison, there was a 30 percent prevalence of \n",
      "meeting the criteria for marijuana sud among individuals who used \n",
      "marijuana for nonmedical reasons only (17 percent mild, 8 percent \n",
      "moderate, and 5 percent severe). for individuals who used marijuana for \n",
      "nonmedical purposes and did not use other drugs illicitly, there was a \n",
      "slightly lower prevalence (24 percent) of meeting the criteria for sud \n",
      "(15 percent mild, 6 percent moderate, and 3 percent severe). for \n",
      "cocaine, 30 percent of individuals who used cocaine in the past year \n",
      "met criteria for cocaine sud (13 percent mild, 5 percent moderate, and \n",
      "12 percent severe). for individuals who used alcohol in the past year, \n",
      "the prevalence of alcohol sud was 17 percent (10 percent mild, 4 \n",
      "percent moderate, and 3 percent severe). hhs basis for rec. at 40.\n",
      "    although the 2021 nsduh data showed that the likelihood of meeting \n",
      "the criteria for a sud was highest for heroin, followed by marijuana, \n",
      "cocaine, and alcohol, the absolute number of individuals who met the \n",
      "criteria had a different order. alcohol had the highest number of such \n",
      "individuals (approximately 29,544,000), followed by marijuana \n",
      "(approximately 13,078,000 people with marijuana nonmedical-only use, \n",
      "and approximately 7,454,000 with nonmedical-only use and no nonmedical \n",
      "use of other drugs), cocaine (approximately 1,408,000), and heroin \n",
      "(approximately 894,000). hhs basis for rec. at 40.\n",
      "treatment episode data set\n",
      "    teds is a database run by samhsa within hhs that presents \n",
      "information on the demographic and substance use characteristics of \n",
      "annual admissions for treatment for alcohol and drug abuse in state-\n",
      "approved facilities that are required by the states to provide teds \n",
      "client-level data. because teds is based only on reports from these \n",
      "facilities, teds data do not represent the total national demand for \n",
      "substance abuse treatment or the prevalence of substance abuse in the \n",
      "general population. hhs basis for rec. at 40-41.\n",
      "    out of 1.4 million admissions documented in the 2020 teds dataset, \n",
      "the most frequently reported primary drug of admission was alcohol (31 \n",
      "percent, or 442,014 admissions), followed by heroin (21 percent, or \n",
      "292,126 admissions), marijuana (10 percent, or 139,481 admissions), and \n",
      "cocaine (5 percent, or 71,725 admissions). other comparator drugs were \n",
      "each reported as the primary drug in less than 2 percent of admissions. \n",
      "over the reporting period of 2015 to 2020, the proportion of admissions \n",
      "each year ranged from 30 to 33 percent for alcohol; from 21 to 26 \n",
      "percent for heroin; from 10 to 14 percent for marijuana; and from 5 to \n",
      "6 percent for cocaine. the proportion of admissions with marijuana as \n",
      "the primary drug declined each year from 14 percent in 2015 to a low of \n",
      "10 percent in 2020,\n",
      "\n",
      "[[page 44612]]\n",
      "\n",
      "while the proportion of admissions with cocaine as the primary drug \n",
      "increased slightly during this time from 5 percent in 2015 to 6 percent \n",
      "in 2019. during this reporting period, other comparator drugs were each \n",
      "reported as the primary drug in less than 2 percent of admissions each \n",
      "year. hhs basis for rec. at 41.\n",
      "    in 2020, marijuana and cocaine were most likely to be reported as \n",
      "the secondary drug at admission (25 percent and 24 percent, \n",
      "respectively), followed by alcohol (15 percent), heroin (8 percent), \n",
      "and benzodiazepines (6 percent), with all other comparators reported as \n",
      "less than 2 percent. for tertiary drugs at admission, marijuana (29 \n",
      "percent) was reported most frequently, followed by cocaine (18 \n",
      "percent), alcohol (16 percent), and heroin (5 percent), with all other \n",
      "comparators reported as less than 2 percent. hhs basis for rec. at 41.\n",
      "national addictions vigilance intervention and prevention program\n",
      "    navippro is a surveillance system for substance use and nonmedical \n",
      "use of prescription medication in a convenience sample of adults \n",
      "seeking treatment or being assessed for sud treatment at participating \n",
      "facilities across the united states. navippro addiction severity index-\n",
      "multimedia version (``asi-mv'') is a clinical assessment tool that \n",
      "collects data on recent drug use behaviors for evaluation and treatment \n",
      "planning at intake. from 2020 through 2021, there were a total of \n",
      "76,249 navippro asi-mv assessments in individuals entering or being \n",
      "assessed for sud treatment at a center participating in the navippro \n",
      "network. the drug most frequently endorsed for past-month use was \n",
      "marijuana (20,458 individuals, or 27 percent), followed by alcohol (5 \n",
      "or more alcoholic drinks per day, 16,388 individuals, or 22 percent), \n",
      "heroin (9,078 individuals, or 16 percent), fentanyl (6,186 individuals, \n",
      "or 8 percent), hydrocodone (3,448 individuals, or 5 percent), oxycodone \n",
      "(3,186 individuals, or 4 percent), cocaine or crack (5,417 individuals, \n",
      "or 7 percent), tramadol (543 individuals, or 1 percent), and ketamine \n",
      "(169 individuals, or less than 1 percent). hhs basis for rec. at 41.\n",
      "nationwide emergency department sample\n",
      "    neds is the largest all-payer ed database in the united states, as \n",
      "developed for hhs's agency for healthcare research and quality \n",
      "(``ahrq''). neds is a sample of records from ed visits from the state \n",
      "emergency department databases, which capture discharge information on \n",
      "all ed visits that do not result in hospital admission, and the state \n",
      "inpatient databases, which contain information on patients first seen \n",
      "in the ed and then admitted. the 2020 ed sample covered 995 hospital \n",
      "eds and 41 states; the unweighted 2020 sample contained data from over \n",
      "28 million ed visits, which resulted in a weighted estimate of 123 \n",
      "million ed visits. hhs compared ed visits that noted an alcohol, \n",
      "marijuana, or cocaine-related disorder; this comparison included ed \n",
      "visits not directly due to a specific substance-related disorder, but \n",
      "in which the patient was recorded as having had an alcohol, marijuana, \n",
      "or cocaine-related disorder in the administrative claim associated with \n",
      "the visit. hhs basis for rec. at 42.\n",
      "    based on neds data, from 2016 to 2020, the highest estimated number \n",
      "of annual ed visits was for an alcohol-related disorder, with between 4 \n",
      "million and 4.1 million visits each year, 3.2 million of which involved \n",
      "alcohol as a single substance. over the same timeframe, estimated \n",
      "annual ed visits involving a marijuana-related disorder ranged from \n",
      "approximately 1.3 million to over 1.7 million, with the estimated \n",
      "annual ed visits for single-substance marijuana disorder ranging from \n",
      "757,731 to 1.08 million. for cocaine, the estimated annual ed visits \n",
      "involving a related disorder were between 559,165 and 774,737, with \n",
      "annual visits for single-substance cocaine-related disorder ranging \n",
      "from 204,257 to 266,614. hhs basis for rec. at 42.\n",
      "    hhs calculated a utilization-adjusted rate of estimated ed visits, \n",
      "and the highest rate was for cocaine-related disorder, which ranged \n",
      "from 11,765 to 14,014 visits per 100,000 individuals, of which 4,011 to \n",
      "4,952 were single-substance visits. marijuana had the second-highest \n",
      "utilization-adjusted rate of estimated ed visits, ranging from 3,472 to \n",
      "3,940 per 100,000 individuals 2,017 to 2,413 of which were single-\n",
      "substance visits. the utilization-adjusted rate of visits involving an \n",
      "alcohol disorder, the lowest of the three substances, ranged from 2,225 \n",
      "to 2,327 per 100,000 individuals, of which 1,775 to 1,843 were single-\n",
      "substance ed visits. hhs basis for rec. at 42-43.\n",
      "national inpatient sample\n",
      "    nis is the largest publicly available all-payer inpatient \n",
      "administrative health care database in the united states, and it is \n",
      "sponsored by ahrq. it is a sample of discharges from participating \n",
      "community hospitals from 46 to 48 states and the district of columbia \n",
      "each year, with approximately 7 million unweighted inpatient stays \n",
      "annually, accounting for weighted annual estimates of 35 million \n",
      "hospitalizations. hhs used nis data to compare alcohol, marijuana, and \n",
      "cocaine. hhs basis for rec. at 43.\n",
      "    from 2016 to 2020, alcohol-related disorder had the highest \n",
      "estimated annual number of hospitalizations, at approximately 1.8 \n",
      "million each year, of which approximately 1.2 to 1.25 million involved \n",
      "single-substance alcohol-related disorder. marijuana-related disorder \n",
      "had the second-highest estimated annual number of hospitalizations, \n",
      "increasing from 795,140 in 2016 to 914,810 in 2020, of which 373,160 to \n",
      "452,985 were for single-substance marijuana-related disorder. cocaine \n",
      "had the lowest estimated annual number of hospitalizations, ranging \n",
      "from 387,385 to 453,955, of which 94,695 to 112,725 were for single-\n",
      "substance cocaine-related disorder. hhs basis for rec. at 43.\n",
      "    hhs then calculated a utilization-adjusted rate of estimated \n",
      "hospitalizations, and the highest rate was for cocaine-related \n",
      "disorder, which ranged from 7,185 to 8,211 hospitalizations per 100,000 \n",
      "individuals with any past-year use, of which 1,796 to 2,039 were \n",
      "single-substance hospitalizations. marijuana-related disorder had the \n",
      "second-highest rate of estimated hospitalizations, ranging from 1,850 \n",
      "to 2,117 per 100,000 individuals, of which 906 to 1,026 were single-\n",
      "substance hospitalizations. alcohol had the lowest rate, ranging from \n",
      "987 to 1,039 per 100,000 individuals, of which 675 to 715 were single-\n",
      "substance hospitalizations. hhs basis for rec. at 43.\n",
      "national forensic laboratory information system\n",
      "    nflis is a program of the diversion control division of dea. the \n",
      "nflis-drug system is a component of the nflis that contains data that \n",
      "serve as a surveillance resource to monitor drug encounters by law \n",
      "enforcement across the united states, including data on drugs seized by \n",
      "law enforcement and submitted to federal, state, and local forensic \n",
      "laboratories for analysis. in nflis, a law enforcement investigation \n",
      "(``case'') may result in one or more ``reports'' or ``exhibits'' of \n",
      "drug evidence, and each report or exhibit may contain one drug or \n",
      "multiple drugs. however, nflis-drug data has limitations because not \n",
      "all drugs encountered by law enforcement are sent for analysis and not \n",
      "all drugs sent to reporting forensic laboratories are tested. to \n",
      "account for nonreporting\n",
      "\n",
      "[[page 44613]]\n",
      "\n",
      "laboratories, among other things, dea publishes nflis-drug national \n",
      "report estimates annually and semiannually. analyzing national \n",
      "estimates data allows for a comparison of the number of reports by year \n",
      "and reporting trends. in calculating national and regional estimates, \n",
      "dea uses all nflis-drug reporting laboratories. hhs basis for rec. at \n",
      "43-44.\n",
      "    in 2021, there were 1,326,205 drug reports from state and local \n",
      "forensic laboratories in the united states, an increase of 3 percent \n",
      "from 2020. nationally, 61 percent of all drug reports in nflis were \n",
      "identified as involving methamphetamine (406,200 reports or 31 \n",
      "percent), cannabis/thc (167,669 reports or 13 percent), cocaine \n",
      "(165,162 reports or 12 percent), or heroin (72,315 reports or 5 \n",
      "percent). hhs basis for rec. at 44-45.\n",
      "    in 2021, there were 1,027,219 drug-specific cases submitted to and \n",
      "analyzed by state and local laboratories, a 2 percent increase from \n",
      "2020. although the total nflis-drug number of drug reports increased in \n",
      "2021 from 2020, the total number of cases and drugs reported continues \n",
      "to be noticeably lower than the numbers reported for the years before \n",
      "the covid-19 pandemic. nationally, in 2021, 45 percent of all drug \n",
      "cases contained one or more reports of methamphetamine, followed by \n",
      "cocaine (18 percent), cannabis/thc (17 percent), and heroin (8 \n",
      "percent). nationally, the number of cannabis/thc reports as well as the \n",
      "number of cases in which cannabis/thc was identified decreased from \n",
      "2015 through 2021, including a decrease from 188,735 to 167,669 from \n",
      "2020 to 2021. hhs noted that this could mean there was a decrease in \n",
      "the number of cannabis/thc encounters, but it could also mean that \n",
      "there was a decrease in the number of exhibits submitted by law \n",
      "enforcement for analysis or a decrease in the number of exhibits \n",
      "processed (analyzed) by forensic laboratories. hhs basis for rec. at \n",
      "45.\n",
      "hhs conclusion with respect to factor 5\n",
      "    in hhs's view, the most notable conclusion from its evaluation of \n",
      "epidemiological databases related to the medical outcomes from drug \n",
      "abuse is that, for all evaluated measures from 2015 to 2020, the rank \n",
      "order of comparators in terms of greatest adverse consequences \n",
      "typically placed alcohol (unscheduled), heroin (schedule i), and \n",
      "cocaine (schedule ii) in the first or immediately subsequent position, \n",
      "with marijuana in a lower position. this pattern also held for pc data \n",
      "for serious medical outcomes, including death, where marijuana was in \n",
      "the lowest ranking group. hhs determined that this demonstrated that \n",
      "there is consistency across databases, across substances, and over \n",
      "time, and that although abuse of marijuana produces clear evidence of \n",
      "harmful consequences, including sud, the consequences are relatively \n",
      "less common and less harmful than some other comparator drugs. \n",
      "additionally, hhs concluded, the number of law enforcement encounters \n",
      "with marijuana decreased from 2020 to 2021, at a time when law \n",
      "enforcement encounters were increasing for other scheduled drugs of \n",
      "abuse. however, as it noted with respect to factor 1.a, hhs emphasized \n",
      "that there are limitations in comparing descriptive data on adverse \n",
      "outcomes across drugs, although descriptive analyses of epidemiologic \n",
      "data are an established practice in previous eight-factor analyses. hhs \n",
      "basis for rec. at 45.\n",
      "    in 2016, dea found that abuse of marijuana is widespread and \n",
      "significant. 81 fr 53739. in addition, dea found in 2016 that a \n",
      "significant proportion of all admissions for substance abuse treatment \n",
      "are for marijuana/hashish as the primary drug of abuse. id. dea notes \n",
      "that national data demonstrate that marijuana is one of the most widely \n",
      "used federally illicit substances in the united states, consistent with \n",
      "findings from the hhs basis for recommendation. according to the nsduh, \n",
      "in 2022, among people aged 12 or older in the united states, an \n",
      "estimated 61.9 million people (22 percent) had used marijuana in the \n",
      "past year, and 42.3 million (15.0 percent) had used it in the past \n",
      "month. dea notes that, according to one national institutes of health-\n",
      "supported study, the prevalence of daily marijuana use reached its \n",
      "highest level reported in 2021, at 11 percent of americans aged 12 or \n",
      "older, a 3 percent increase from 2017 and a 5 percent increase from \n",
      "2012.\\27\\ it also notes that the average percentage of [delta]9-thc in \n",
      "seized marijuana has increased over time.\\28\\ also, teds data showed \n",
      "that, in 2020, marijuana was the primary drug of admission in \n",
      "approximately 10 percent of all admissions to substance abuse treatment \n",
      "among patients aged 12 and older. hhs basis for rec. at 41, 46. dea \n",
      "also notes that teds data for 2021 reported that marijuana/hashish was \n",
      "the primary substance of abuse in 10.2 percent of all admissions to \n",
      "substance abuse treatment among patients aged 12 and older.\\29\\ the \n",
      "2021 teds data further reported that new york, california, georgia, \n",
      "north carolina, new jersey, texas, minnesota, south carolina, florida, \n",
      "and connecticut accounted for 55.9 percent of admissions to substance \n",
      "use treatments services where marijuana/hashish was listed as the \n",
      "primary substance.\\30\\ dea also believes that additional information \n",
      "regarding the scope, duration, and significance of marijuana abuse may \n",
      "be appropriate for consideration in assessing this factor.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\27\\ marijuana and hallucinogen use among young adults reached \n",
      "all time-high in 2021, nat'l inst. on drug abuse (aug. 22, 2022), \n",
      "<a href=\"https://nida.nih.gov/news-events/news-releases/2022/08/marijuana-and-hallucinogen-use-among-young-adults-reached-all-time-high-in-2021\">https://nida.nih.gov/news-events/news-releases/2022/08/marijuana-and-hallucinogen-use-among-young-adults-reached-all-time-high-in-2021</a>.\n",
      "    \\28\\ cannabis potency data, nat'l inst. on drug abuse (nov. 23, \n",
      "2022), <a href=\"https://nida.nih.gov/research/research-data-measures-resources/cannabis-potency-data\">https://nida.nih.gov/research/research-data-measures-resources/cannabis-potency-data</a>.\n",
      "    \\29\\ substance abuse & mental health servs. admin., treatment \n",
      "episode data set (teds) 2021: admissions to and discharges from \n",
      "substance use treatment services reported by single state agencies \n",
      "10 (2023), <a href=\"https://www.samhsa.gov/data/sites/default/files/reports/rpt42794/2021-teds-annual-report.pdf\">https://www.samhsa.gov/data/sites/default/files/reports/rpt42794/2021-teds-annual-report.pdf</a> (figure 3.a.9).\n",
      "    \\30\\ id. at 29 (figure 6.b.4).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "6. what, if any, risk there is to the public health\n",
      "\n",
      "    the sixth factor that doj and hhs must consider under 21 u.s.c. \n",
      "811(c) is the risk posed to the public health by marijuana. in \n",
      "analyzing this factor, hhs examined nsduh data related to the \n",
      "demographics of u.s. individuals meeting criteria for marijuana use \n",
      "disorder, teds data related to the demographics of admission to \n",
      "treatment centers for marijuana use disorder, neds and nis data on \n",
      "admissions to eds and hospitals related to marijuana poisoning, toxic \n",
      "core registry data on intentional and unintentional exposure, and npds \n",
      "data describing the risks to youth of unintentional exposure to \n",
      "marijuana. hhs also assessed the risks to the public health through \n",
      "nsduh data on driving under the influence of marijuana in adults and \n",
      "high school students. finally, hhs reported data regarding the risk of \n",
      "serious aes and death associated with nonmedical use/use of uncertain \n",
      "intent of marijuana as reported to the fda adverse event reporting \n",
      "system, center for food safety and applied nutrition adverse event \n",
      "reporting system, national vital statistics system-mortality (``nvss-\n",
      "m''), dawn, fda's sentinel distributed database system, and centers for \n",
      "medicare and medicaid services, and as reflected in the drug-involved \n",
      "mortality data linking nvss-m to death certificates. hhs basis for rec. \n",
      "at 46.\n",
      "hhs conclusion with respect to factor 6\n",
      "    hhs's detailed analysis of the risks posed by marijuana to the \n",
      "public health\n",
      "\n",
      "[[page 44614]]\n",
      "\n",
      "can be found at pages 46-57 of the hhs basis for recommendation. in \n",
      "summary, hhs found that the risks to the public health posed by \n",
      "marijuana are low compared to other drugs of abuse (e.g., heroin \n",
      "(schedule i), cocaine (schedule ii)), based on its evaluation of \n",
      "various epidemiological databases for ed visits, hospitalizations, \n",
      "unintentional exposures, and, most importantly, for overdose deaths. \n",
      "the rank order of comparator drugs in terms of greatest adverse \n",
      "consequences typically places heroin, benzodiazepines, or cocaine in \n",
      "the first or immediately subsequent positions, with marijuana in a \n",
      "lower place in the ranking, especially when comparing among individuals \n",
      "who reported using the respective drugs at least once in the prior \n",
      "year. for overdose deaths, marijuana is always ranked the lowest among \n",
      "comparator drugs. hhs interpreted these evaluations to demonstrate that \n",
      "there is consistent evidence across databases, across substances, and \n",
      "over time that, although the abuse of marijuana poses a risk to public \n",
      "health, the risk is relatively lower than that posed by most other \n",
      "comparator drugs. however, as hhs noted in its discussion of factor 1, \n",
      "see hhs basis for rec. at 7-8, there are limitations in comparing \n",
      "descriptive data on adverse outcomes across drugs. hhs basis for rec. \n",
      "at 57.\n",
      "    in 2016, dea found that, ``[t]ogether with the health risks \n",
      "outlined in terms of pharmacological effects above, public health risks \n",
      "from acute use of marijuana include impaired psychomotor performance, \n",
      "impaired driving, and impaired performance on tests of learning and \n",
      "associative processes. chronic use of marijuana poses a number of other \n",
      "risks to the public health including physical as well as psychological \n",
      "dependence.'' 81 fr 53739-40. in addition to the data provided in the \n",
      "hhs basis for recommendation and the data considered by hhs and dea in \n",
      "their prior eight-factor analyses, dea anticipates that additional data \n",
      "on public safety risks, risks from acute and chronic marijuana use via \n",
      "oral and inhaled administration routes, and the impact of [delta]9-thc \n",
      "potency may be appropriate for consideration.\n",
      "    as discussed in the hhs basis for recommendation, dea notes that \n",
      "studies have examined the risk associated with marijuana use and \n",
      "driving. hhs basis for rec. at 50. the rocky mountain high intensity \n",
      "drug trafficking area reported in a publication that traffic deaths in \n",
      "colorado in which drivers tested positive for marijuana more than \n",
      "doubled from 55 in 2013 to 131 in 2020, although other evidence in the \n",
      "same report suggests that driving under the influence citations \n",
      "involving marijuana have grown at a rate similar to the rate for \n",
      "citations involving other drugs.\\31\\ dea also identified some evidence \n",
      "suggesting that, among drivers who test positive for at least one drug \n",
      "in a traffic stop, a growing share test positive for cannabis.\\32\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\31\\ see 8 rocky mountain high intensity drug trafficking area, \n",
      "the legalization of marijuana in colorado: the impact 8, 13 (2021), \n",
      "<a href=\"https://www.rmhidta.org/_files/ugd/4a67c3_b391ac360f974a8bbf868d2e3e25df3d.pdf\">https://www.rmhidta.org/_files/ugd/4a67c3_b391ac360f974a8bbf868d2e3e25df3d.pdf</a>. note that the \n",
      "publication did not address the timing of marijuana use associated \n",
      "with fatal traffic accidents.\n",
      "    \\32\\ see fernando a. wilson et al., fatal crashes from drivers \n",
      "testing positive for drugs, 1993-2010, 129 public health reports \n",
      "342, 347-348 (2014).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "7. marijuana's psychic or physiological dependence liability\n",
      "\n",
      "    the seventh factor that doj and hhs are required to consider under \n",
      "21 u.s.c. 811(c) is the psychic or physiologic dependence liability of \n",
      "marijuana.\n",
      "a. psychic dependence\n",
      "    the term ``psychic or psychological dependence'' has been used to \n",
      "refer to a state similar to addiction. for diagnosis purposes, the dsm-\n",
      "v has combined the diagnoses ``abuse'' and ``drug dependence'' (i.e., \n",
      "addiction), which the dsm's fourth edition specified separately, into a \n",
      "single ``substance use disorder,'' which may occur in a broad range of \n",
      "severity, from mild to severe. hhs basis for rec. at 57.\n",
      "    the abuse potential of a drug can be assessed, in part, by \n",
      "evaluating the rewarding effects produced by that drug in humans and \n",
      "animals. as hhs described in its analysis of factor 2, see hhs basis \n",
      "for rec. at 12-13, rodent behavioral studies show that [delta]9-thc \n",
      "produces both self-administration and cpp. hhs determined that these \n",
      "results demonstrate that [delta]9-thc has rewarding properties that are \n",
      "indicative of abuse potential. further, as hhs described in its \n",
      "analysis of factor 4, see hhs basis for rec. at 32-37, there is ample \n",
      "epidemiological evidence that marijuana is self-administered by humans, \n",
      "which may result from its ability to produce rewarding psychological \n",
      "effects, such as euphoria, see hhs basis for rec. at 15. hhs basis for \n",
      "rec. at 58.\n",
      "    in some individuals, extensive use of marijuana can lead to sud. \n",
      "hhs noted that, in general, suds listed in the dsm-v are defined by an \n",
      "inability to cease drug use despite harmful consequences; cannabis use \n",
      "disorder (``cud'') shares this and other diagnostic criteria common to \n",
      "suds for other drugs of abuse. estimates of cud in individuals who \n",
      "regularly use marijuana vary and range from about 10 to 20 percent. \n",
      "these estimates are similar to data from the united states national \n",
      "comorbidity study, which showed that 9 percent of lifetime cannabis \n",
      "users met the criteria for dependence outlined in the dsm's revised \n",
      "third edition at some time in their life, compared to 32 percent of \n",
      "tobacco users, 23 percent of opiate users, and 15 percent of alcohol \n",
      "users. the national epidemiologic survey on alcohol and related \n",
      "conditions also reported a nine percent lifetime cumulative probability \n",
      "of transitioning from marijuana use to dependence, with a higher risk \n",
      "of dependence in individuals with a history of psychiatric or other \n",
      "substance dependence comorbidity. in the united states, data from the \n",
      "2020 nsduh show that approximately 14 million individuals aged 12 or \n",
      "older who use marijuana or other cannabinoid preparations met criteria \n",
      "for cud, representing 5.1 percent of all individuals aged 12 or older \n",
      "meeting the nsduh survey inclusion criteria. hhs basis for rec. at 58.\n",
      "    individuals who develop a sud, including cud, may seek treatment. \n",
      "from 2015 to 2020, teds documented approximately 10.8 million treatment \n",
      "episode admissions reported by individuals treated at publicly funded \n",
      "substance use treatment programs. out of 1.4 million treatment \n",
      "admissions documented by teds in 2020, marijuana was reported as the \n",
      "primary substance of abuse in approximately 10 percent of admissions, \n",
      "making it the third most frequently reported primary substance of \n",
      "abuse, after alcohol (31.2 percent) and heroin (20.6 percent). a \n",
      "similar pattern was seen from 2015 to 2019. hhs basis for rec. at 58.\n",
      "    hhs concluded that the animal behavioral data show that [delta]9-\n",
      "thc produces rewarding properties that underlie the abuse potential of \n",
      "marijuana. epidemiological data demonstrate that some individuals who \n",
      "use marijuana for its rewarding properties go on to develop cud, which \n",
      "shows that marijuana can produce psychological dependence. among those \n",
      "individuals who seek admission for treatment for sud associated with a \n",
      "drug of abuse, marijuana was the third most frequently reported primary \n",
      "substance of abuse. thus, marijuana can produce psychic dependence in \n",
      "some individuals who use the drug. hhs basis for rec. at 58-59.\n",
      "b. physical dependence\n",
      "    physical dependence is a state of adaptation manifested by a drug-\n",
      "class\n",
      "\n",
      "[[page 44615]]\n",
      "\n",
      "specific withdrawal syndrome produced by abrupt cessation, rapid dose \n",
      "reduction, decreasing blood level of the drug, or administration of an \n",
      "antagonist. although physical dependence is often associated with \n",
      "addiction, it can be produced by repeated administration of drugs both \n",
      "with and without abuse potential. hhs basis for rec. at 59.\n",
      "    as hhs discussed in its analysis of factor 2, see hhs basis for \n",
      "rec. at 11, [delta]9-thc is a partial agonist at cb<inf>1</inf> \n",
      "receptors. when marijuana (or isolated [delta]9-thc) is administered \n",
      "chronically, there is a down-regulation of cb<inf>1</inf> receptors, \n",
      "which leads to behavioral tolerance. the underlying mechanism for \n",
      "marijuana withdrawal appears to be the uncoupling or desensitization of \n",
      "cb<inf>1</inf> receptors that precedes receptor down-regulation. abrupt \n",
      "discontinuation of marijuana after prolonged administration produces \n",
      "withdrawal symptoms in rats and in humans that are typically opposite \n",
      "to those that occur with activation of the cb<inf>1</inf> receptor. \n",
      "precipitated withdrawal can also be induced with administration of \n",
      "cb<inf>1</inf> antagonists following chronic administration, while \n",
      "administration of cb<inf>1</inf> agonists can attenuate some withdrawal \n",
      "symptoms associated with marijuana discontinuation. these data confirm \n",
      "the importance of the cb<inf>1</inf> receptor in marijuana physical \n",
      "dependence. hhs basis for rec. at 59.\n",
      "    hhs noted that research has not yet documented the occurrence of \n",
      "withdrawal symptoms in individuals who use marijuana only occasionally. \n",
      "however, in individuals who use marijuana heavily and chronically, drug \n",
      "discontinuation can lead to a withdrawal syndrome. most marijuana \n",
      "withdrawal symptoms begin within 24 to 48 hours of drug \n",
      "discontinuation, peak within two to six days, and reduce over one to \n",
      "two weeks as [delta]9-thc levels decline. hhs basis for rec. at 59.\n",
      "    the most commonly reported withdrawal symptoms from clinical \n",
      "investigations are sleep difficulties, decreased appetite and weight \n",
      "loss, craving, irritability, anger, anxiety or nervousness, and \n",
      "restlessness. less commonly reported withdrawal symptoms include \n",
      "depressed mood, sweating, shakiness, physical discomfort, and chills. \n",
      "hhs described the symptoms of ``cannabis withdrawal'' listed in the \n",
      "dsm-v as being similar to those reported in the experimental studies, \n",
      "including nervousness or anxiety, irritability or aggression, insomnia \n",
      "or unpleasant dreams, depressed mood, decreased appetite or weight \n",
      "loss, restlessness, abdominal pain, shakiness or tremors, sweating, \n",
      "fever, chills, and headache. hhs basis for rec. at 59-60.\n",
      "    hhs reported that up to 40 to 50 percent of individuals who use \n",
      "marijuana on a regular basis may experience physical dependence. a \n",
      "meta-analysis of 23,518 individuals who frequently used marijuana \n",
      "showed that 47 percent of subjects reported symptoms of marijuana \n",
      "withdrawal. the prevalence of physical dependence was 54 percent in \n",
      "outpatient samples, 17 percent in community samples, and 87 percent \n",
      "among inpatients in drug abuse treatment centers. this is consistent \n",
      "with data showing that 90 percent of individuals who were diagnosed \n",
      "with cud also reported physical dependence. further, individuals \n",
      "diagnosed with cud experience more severe and longer lasting withdrawal \n",
      "symptoms when discontinuing marijuana than individuals who do not have \n",
      "a diagnosis of cud. this may be because individuals with cud have \n",
      "greater exposure to marijuana. hhs basis for rec. at 60.\n",
      "    symptoms associated with marijuana withdrawal appear to be \n",
      "relatively mild compared to those associated with alcohol withdrawal, \n",
      "which can include agitation, paranoia, seizures, and even death. \n",
      "multiple studies comparing the withdrawal symptoms associated with \n",
      "tobacco (not scheduled in the csa) and marijuana demonstrate that the \n",
      "magnitude and time course of the two withdrawal syndromes are similar. \n",
      "animal studies have shown that after short-term administration of \n",
      "equianalgesic doses of heroin and [delta]9-thc to monkeys, withdrawal \n",
      "signs were observed after heroin administration but not after [delta]9-\n",
      "thc administration, further demonstrating that withdrawal from \n",
      "marijuana is associated with less severe symptoms than withdrawal from \n",
      "other drug classes. hhs basis for rec. at 60.\n",
      "hhs conclusion with respect to factor 7\n",
      "    in conclusion, hhs found experimental and clinical evidence that \n",
      "chronic, but not acute, use of marijuana can produce both psychic and \n",
      "physical dependence in humans. epidemiological data, discussed in \n",
      "greater detail in the sections describing factors 4 and 5 in sections \n",
      "vi.4 and vi.5 of this preamble, provide additional evidence of psychic \n",
      "dependence. the symptoms associated with both kinds of dependence are \n",
      "relatively mild for most individuals, although their severity may be \n",
      "greater with increased exposure to marijuana. hhs basis for rec. at 61.\n",
      "    in 2016, dea found that ``[l]ong-term, heavy use of marijuana can \n",
      "lead to physical dependence and withdrawal following discontinuation, \n",
      "as well as psychic or psychological dependence.'' 81 fr 53740. dea \n",
      "notes that some physicians have argued that cud is underdiagnosed and \n",
      "undertreated in the medical setting,\\33\\ and that other medical \n",
      "professionals have noted that cud needs to be better understood and \n",
      "characterized to better inform users and treatment professionals.\\34\\ \n",
      "dea anticipates that additional psychic or physiological dependence \n",
      "liability may be appropriate for consideration.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\33\\ see, e.g., theresa a. matson et al., association between \n",
      "cannabis use disorder symptom severity and probability of \n",
      "clinically-documented diagnosis and treatment in a primary care \n",
      "sample, 251 drug & alcohol dependence, no. 110946, 2023.\n",
      "    \\34\\ see, e.g., gwen t. lapham et al., prevalence of cannabis \n",
      "use disorder and reasons for use among adults in a u.s. state where \n",
      "recreational cannabis use is legal, 6 jama open no. e2328934, 2023, \n",
      "at 7.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "8. whether marijuana is an immediate precursor of a substance already \n",
      "controlled under the csa\n",
      "\n",
      "    the eighth factor that doj and hhs are required to consider under \n",
      "21 u.s.c. 811(c) is whether marijuana is an immediate precursor of a \n",
      "substance already controlled under the csa. hhs concluded that \n",
      "marijuana is not an immediate precursor of another controlled \n",
      "substance. hhs basis for rec. at 61. this finding is consistent with \n",
      "dea's finding in 2016. 81 fr 53740. dea welcomes additional information \n",
      "on this factor.\n",
      "\n",
      "vii. determination of appropriate schedule for marijuana\n",
      "\n",
      "    after conducting the eight-factor analysis in 2023, hhs has \n",
      "recommended three findings regarding the appropriate schedule in which \n",
      "to place marijuana. the three findings relate to: (1) a substance's \n",
      "abuse potential; (2) whether the substance has a camu; and (3) the \n",
      "safety or dependence potential of the substance. 21 u.s.c. 812(b); hhs \n",
      "basis for rec. at 62-65.\n",
      "1. potential for abuse\n",
      "    in 2016, hhs found that many factors indicated marijuana's high \n",
      "abuse potential, ``including the large number of individuals regularly \n",
      "using marijuana, marijuana's widespread use, and the vast amount of \n",
      "marijuana available for illicit use.'' 81 fr 53688 at 53706. as a \n",
      "result of its most recent evaluation, which incorporates post-2016 data \n",
      "into its analysis, hhs has recommended a finding that marijuana has a \n",
      "potential for abuse less than the drugs or other substances in \n",
      "schedules i and ii.\n",
      "\n",
      "[[page 44616]]\n",
      "\n",
      "    marijuana contains [delta]9-thc (also known as dronabinol when \n",
      "specifically referring to (-)-trans-[delta]9-thc stereoisomer), the \n",
      "substance responsible for the abuse potential of marijuana. [delta]9-\n",
      "thc has agonist properties at cb<inf>1</inf> cannabinoid receptors and \n",
      "produces rewarding responses in animals, as evidenced by its ability to \n",
      "produce self-administration and cpp. when marijuana is administered to \n",
      "humans under experimental conditions, it produces a wide range of \n",
      "positive subjective responses in addition to certain negative \n",
      "subjective responses. common responses to marijuana when it is used by \n",
      "individuals for nonmedical purposes include euphoria and other positive \n",
      "subjective responses, as well as perceptual changes, sedative \n",
      "responses, anxiety responses, psychiatric, social, and cognitive \n",
      "changes, and physiological changes. hhs basis for rec. at 62.\n",
      "    hhs noted that epidemiological data from nsduh show that marijuana \n",
      "is the most frequently used federally illicit drug in the united states \n",
      "on a past-year and past-month basis among the illicit comparator drugs \n",
      "considered. although 50 percent of respondents in nsduh reported using \n",
      "marijuana nonmedically fewer than 5 days per month, another 30 percent \n",
      "reported using it nonmedically for 20 days or more per month. hhs basis \n",
      "for rec. at 62.\n",
      "    despite the high prevalence of nonmedical use of marijuana, hhs \n",
      "observed that an overall evaluation of epidemiological indicators \n",
      "suggests that it does not produce serious outcomes compared to drugs in \n",
      "schedules i or ii. hhs found this especially notable given the \n",
      "availability of marijuana and marijuana-derived products that contain \n",
      "extremely high levels of [delta]9-thc. due to such availability, the \n",
      "epidemiological data described in hhs's evaluation inherently include \n",
      "the outcomes from individuals who use marijuana and marijuana-derived \n",
      "products that have doses of [delta]9-thc that range from low to very \n",
      "high, and yet the data demonstrate that these products overall are \n",
      "producing fewer negative outcomes than drugs in schedules i or ii. hhs \n",
      "basis for rec. at 62.\n",
      "    hhs compared the rank ordering of selected drugs that are abused \n",
      "for various epidemiological measures and observed that marijuana was \n",
      "among the drugs at the very lowest ranking for a number of measures, \n",
      "including pc abuse cases, likelihood that any use would lead to a pc \n",
      "call, accidental or unintentional poisoning, utilization-adjusted rates \n",
      "of unintentional exposure, utilization-adjusted and population-adjusted \n",
      "rates for ed visits and hospitalizations, likelihood of being diagnosed \n",
      "with a serious sud, deaths reported to pcs, and overdose deaths when \n",
      "used with other drugs or as a single substance (as total numbers and \n",
      "when utilization-adjusted). in contrast, comparators such as heroin \n",
      "(schedule i), oxycodone (schedule ii), and cocaine (schedule ii) \n",
      "typically were in the highest rank ordering on these measures. hhs \n",
      "basis for rec. at 62.\n",
      "    for the various epidemiological measures evaluated above, hhs noted \n",
      "that marijuana was also compared to controlled substances in schedule \n",
      "iii (ketamine) and schedule iv (benzodiazepines, zolpidem, and \n",
      "tramadol), as well as to other schedule ii substances (fentanyl and \n",
      "hydrocodone). the analyses were conducted in this manner to provide a \n",
      "comprehensive assessment of the relative abuse potential of marijuana. \n",
      "however, the rank order of these substances regarding harms does not \n",
      "consistently align with the relative scheduling placement of these \n",
      "drugs in the csa due to the pharmacological differences between various \n",
      "classes of drugs. hhs basis for rec. at 63.\n",
      "    there are a number of confounding factors that likely influence the \n",
      "adverse outcomes measured in various epidemiological databases and \n",
      "account for the rank ordering of the drugs evaluated on these measures. \n",
      "for example, a different population abuses each substance, and each \n",
      "substance has a different prevalence of abuse and a different profile \n",
      "of severe adverse outcomes in a setting of nonmedical use and abuse. \n",
      "thus, it is challenging to reconcile the ranking of relative harms \n",
      "associated with the comparators used in this evaluation when the \n",
      "rankings differ across various epidemiological databases and when these \n",
      "rankings often do not align with the scheduling placement of these \n",
      "comparators under the csa. hhs basis for rec. at 63.\n",
      "    to address these challenges, hhs evaluated the totality of the \n",
      "available data and has concluded that it supports the placement of \n",
      "marijuana in schedule iii. overall, these data demonstrate that, \n",
      "although marijuana is associated with a high prevalence of abuse, the \n",
      "profile of and propensity for serious outcomes related to that abuse \n",
      "lead to a conclusion that marijuana is most appropriately controlled in \n",
      "schedule iii under the csa. hhs basis for rec. at 63.\n",
      "    the attorney general has considered hhs's recommendations and \n",
      "conclusions and accords hhs's scientific and medical determinations \n",
      "binding weight at this stage of the scheduling process. see olc op. at \n",
      "*22 n.6 (``hhs's recommendations with respect to `scientific and \n",
      "medical matters' are binding for all eight factors listed in section \n",
      "811(c).''). the attorney general concurs with hhs's recommendation, for \n",
      "purposes of initiation of these rulemaking proceedings, that marijuana \n",
      "has a potential for abuse less than the drugs or other substances in \n",
      "schedules i and ii.\n",
      "\n",
      "2. currently accepted medical use in treatment in the united states\n",
      "\n",
      "    in 2016, hhs recommended a finding that marijuana had no camu due \n",
      "in part to a lack of adequate safety studies or evidence that qualified \n",
      "experts accepted marijuana for use in treating a specific, recognized \n",
      "disorder. 81 fr 53688 at 53707. as a result of its most recent \n",
      "evaluation, which incorporates post-2016 data into its analysis, hhs \n",
      "recommends a finding that marijuana has a camu.\n",
      "    in making that recommendation, hhs analyzed whether there is (1) \n",
      "widespread current experience with medical use of the substance in the \n",
      "united states by licensed health care practitioners operating in \n",
      "accordance with implemented state-authorized programs, where the \n",
      "medical use is recognized by entities that regulate the practice of \n",
      "medicine; and (2) some credible scientific support for a least one of \n",
      "those medical uses. applying this test, hhs recommended a finding that \n",
      "marijuana has a currently accepted medical use in the united states, \n",
      "specifically for the treatment of anorexia related to a medical \n",
      "condition, nausea and vomiting (e.g., chemotherapy-induced), and pain. \n",
      "according to hhs, its evaluation also supported a finding that there is \n",
      "accepted safety for the use of marijuana under medical supervision for \n",
      "the treatment of anorexia related to a medical condition, nausea and \n",
      "vomiting (e.g., chemotherapy-induced), and pain. hhs basis for rec. at \n",
      "63-64.\n",
      "    in the past, dea has concluded that a substance has a camu under \n",
      "the csa only if one of two tests is satisfied. first, dea has \n",
      "determined that a substance has a camu if the substance has been \n",
      "approved by fda for marketing under the fdca, either through the nda \n",
      "process or by meeting the criteria to be recognized as a ``generally \n",
      "recognized as safe and effective'' (``grase'') drug. 57 fr 10499, 10503 \n",
      "(march 26, 1992). second, dea has determined a substance has a camu if \n",
      "the substance satisfies a five-part test established by dea in 1992 \n",
      "that was based on the ``core fdca standards for acceptance of drugs for \n",
      "medical use'':\n",
      "\n",
      "[[page 44617]]\n",
      "\n",
      "    1. there must be adequate safety studies;\n",
      "    2. the drug's chemistry must be known and reproducible;\n",
      "    3. there must be adequate and well-controlled studies proving \n",
      "efficacy;\n",
      "    4. the drug must be accepted by qualified experts; and\n",
      "    5. the scientific evidence must be widely available.\n",
      "\n",
      "57 fr 10499, 10503-06 (1992); see also all. for cannabis therapeutics \n",
      "v. dea, 15 f.3d 1131, 1135 (d.c. cir. 1994).\n",
      "\n",
      "    in its most recent evaluation, hhs informed dea of its view that \n",
      "dea's previous approach to determining whether a drug has a camu does \n",
      "not adequately account for certain indicia of medical use that, where \n",
      "present, are relevant to determining whether a substance has a camu for \n",
      "purposes of scheduling under the csa. specifically, hhs observed that \n",
      "dea's tests left no room for an evaluation of (1) whether there is \n",
      "widespread medical use of a drug under the supervision of licensed \n",
      "health care practitioners under state-authorized programs and, (2) if \n",
      "so, whether there is credible scientific evidence supporting such \n",
      "medical use. hhs therefore developed an alternative test composed of \n",
      "those two inquiries as a third, independently sufficient approach for \n",
      "determining whether a substance has a camu under the csa. hhs applied \n",
      "this two-part test to marijuana and recommended a finding that \n",
      "marijuana has a camu under the csa. hhs basis for rec. at 24-28.\n",
      "    upon receiving hhs's recommendation, the attorney general requested \n",
      "that olc advise on whether hhs's test, if satisfied, established a camu \n",
      "``even if the drug has not been approved by fda and even if the drug \n",
      "does not satisfy dea's five-part test.'' olc op. at *3. olc determined \n",
      "that dea's current approach to determining whether a drug has a camu is \n",
      "impermissibly narrow, because it ``ignor[es] widespread clinical \n",
      "experience with a drug that is sanctioned by state medical licensing \n",
      "regulators.'' id. at *13-14; see also id. at *12. olc further opined \n",
      "that satisfying hhs's two-part inquiry is sufficient to establish that \n",
      "a drug has a camu. id. at *4, *16-20. and olc concluded that, while \n",
      "hhs's camu recommendation is not binding on dea, the medical and \n",
      "scientific determinations that underlie its recommendation are binding \n",
      "until the initiation of formal rulemaking proceedings, and that dea \n",
      "must accord those determinations ``significant deference'' throughout \n",
      "the rulemaking process. id. at *4, *20-26.\n",
      "    under part 1 of the hhs camu test, the office of the assistant \n",
      "secretary for health (``oash'') considered whether there is widespread \n",
      "current experience with medical use of marijuana in the united states \n",
      "by licensed hcps operating in accordance with implemented state-\n",
      "authorized programs, where such medical use is recognized by entities \n",
      "that regulate the practice of medicine under these state jurisdictions. \n",
      "part 2 of the camu test evaluated whether there exists some credible \n",
      "scientific support for at least one of the medical conditions for which \n",
      "the part 1 test is satisfied. the evaluation in part 2, undertaken by \n",
      "fda, was not meant to be, nor is it, a determination of safety and \n",
      "efficacy under the federal food, drug, and cosmetic act's drug approval \n",
      "standard for new human or animal drugs. rather, hhs's two-part test is \n",
      "designed to evaluate whether a substance, in this case marijuana, has a \n",
      "camu for purposes of drug scheduling recommendations and placement in a \n",
      "drug schedule consistent with criteria set forth in 21 u.s.c. 812(b). \n",
      "hhs basis for rec. at 24.\n",
      "    in the evaluation and assessment under part 1 of the camu test, \n",
      "oash found that more than 30,000 hcps are authorized to recommend the \n",
      "use of marijuana for more than six million registered patients, \n",
      "constituting widespread clinical experience associated with various \n",
      "medical conditions recognized by a substantial number of jurisdictions \n",
      "across the united states. for several jurisdictions, these programs \n",
      "have been in place for several years, and include features that \n",
      "actively monitor medical use and product quality characteristics of \n",
      "marijuana dispensed. hhs basis for rec. at 24.\n",
      "    based on oash's findings in part 1 of the camu test, the assistant \n",
      "secretary for health concluded that an fda assessment under part 2 of \n",
      "the camu test was warranted to determine if credible scientific support \n",
      "exists for the use of marijuana to treat at least one of the medical \n",
      "conditions identified by oash under part 1. hhs basis for rec. at 24.\n",
      "    at this stage of initiating a rulemaking, the attorney general \n",
      "agrees with oash that there is widespread clinical experience with \n",
      "marijuana for at least one medical condition.\n",
      "    fda conducted part 2 of the camu test for seven indications, based \n",
      "in part on oash's findings under part 1 of the camu test \\35\\ and in \n",
      "part on fda's own analysis of the landscape in which marijuana is \n",
      "currently used medically, including information from state-authorized \n",
      "programs on how and to what extent marijuana is being utilized for \n",
      "medical purposes. the seven indications are: (1) anorexia; \\36\\ (2) \n",
      "anxiety; \\37\\ (3) epilepsy; (4) inflammatory bowel disease (``ibd''); \n",
      "(5) nausea and vomiting; (6) pain; and (7) post-traumatic stress \n",
      "disorder (``ptsd''). fda's evaluation under part 2 of the camu test was \n",
      "based on systematic reviews of studies investigating the safety and \n",
      "effectiveness of marijuana, relevant professional societies' position \n",
      "statements, data from state medical marijuana programs and united \n",
      "states national surveys, and the labeling of fda-approved products \n",
      "relevant to the analysis. hhs basis for rec. at 25.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\35\\ in part 1 of the camu test, oash identified at least 15 \n",
      "medical conditions for which there is widespread current experience \n",
      "with medical use of marijuana in the united states by licensed hcps \n",
      "operating in accordance with implemented state-authorized programs, \n",
      "where the medical use is recognized by entities that regulate the \n",
      "practice of medicine. these conditions include amyotrophic lateral \n",
      "sclerosis (commonly known as alsi), autism, cachexia, cancer, \n",
      "chronic pain, crohn's disease, epilepsy or condition causing \n",
      "seizures, glaucoma, hiv/aids, multiple sclerosis, parkinson's \n",
      "disease, persistent/severe muscle spasm, persistent/severe nausea, \n",
      "ptsd, and spasticity. fda conducted part 2 of the analysis for the \n",
      "medical conditions identified by oash that were likely to have the \n",
      "most robust evidence available for review; because the analysis \n",
      "concluded that the part 2 test has been met for at least one of the \n",
      "conditions identified in part 1, there was no need to analyze all of \n",
      "them. hhs basis for rec. at 25 n.9.\n",
      "    \\36\\ the anorexia indication reflects anorexia due to a medical \n",
      "condition (e.g., hiv/aids) and does not represent anorexia nervosa. \n",
      "hhs basis for rec. at 25 n.10.\n",
      "    \\37\\ while anxiety was not one of the specific medical \n",
      "conditions identified by oash, it is included herein because anxiety \n",
      "was identified by the fda during the part 2 review of state-level \n",
      "usage data. fda considered the medical use of marijuana for the \n",
      "treatment of anxiety of importance to evaluate given the reported \n",
      "prevalence of marijuana use for the treatment of anxiety regardless \n",
      "of the legal status of such use in a given jurisdiction. hhs basis \n",
      "for rec. at 25 n.11.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in evaluating whether there exists some credible scientific support \n",
      "under part 2 of the camu test for a particular use, factors in favor of \n",
      "a positive finding included whether: (1) favorable clinical studies of \n",
      "the medical use of marijuana, although not necessarily adequate and \n",
      "well-controlled clinical studies that would support approval of an nda, \n",
      "have been published in peer-reviewed journals or (2) qualified expert \n",
      "organizations (e.g., academic groups, professional societies, or \n",
      "government agencies) have opined in favor of the medical use or \n",
      "provided guidance to hcps on the medical use. factors that weigh \n",
      "against a finding that part 2 of the camu test is met included whether: \n",
      "(1) data or information indicate that medical use of the substance is \n",
      "associated with unacceptably high\n",
      "\n",
      "[[page 44618]]\n",
      "\n",
      "safety risks for the likely patient population, e.g., due to toxicity \n",
      "concerns; (2) clinical studies with negative efficacy findings for the \n",
      "medical use of marijuana have been published in peer reviewed journals; \n",
      "or (3) qualified expert organizations (e.g., academic or professional \n",
      "societies, government agencies) recommend against the medical use of \n",
      "marijuana based on the available data at the time of their position \n",
      "statement. hhs basis for rec. at 25.\n",
      "    fda's review of the available information identified mixed findings \n",
      "of effectiveness across indications, ranging from data showing \n",
      "inconclusive findings to considerable evidence in favor of \n",
      "effectiveness, depending on the source. the largest evidence base for \n",
      "effectiveness exists for marijuana use within the pain indication (in \n",
      "particular, neuropathic pain). numerous systematic reviews concluded \n",
      "that there exists some level of evidence supporting the use of \n",
      "marijuana for chronic pain. the 2017 nasem report concluded there was \n",
      "``substantial evidence'' \\38\\ supporting the use of cannabis products \n",
      "relevant to this review for pain, as have other reviews. the ahrq \n",
      "living systematic review has concluded that there is some support for \n",
      "the use of marijuana-related products in the treatment of chronic pain, \n",
      "but overall concluded these effects were small and the increased risk \n",
      "of dizziness, nausea, and sedation may limit the benefit. a systematic \n",
      "review of scientific and medical literature was conducted in 2023 by \n",
      "the university of florida (``uf'') under contract with fda. uf \n",
      "epidemiologists identified some data supporting effectiveness of \n",
      "marijuana, including some within their own meta-analysis; however, they \n",
      "ultimately concluded the results are inconclusive or mixed. fda also \n",
      "conducted a separate analysis of published scientific reviews, several \n",
      "of which drew conclusions similar to those of uf. hhs basis for rec. at \n",
      "25-26.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\38\\ the term ``substantial evidence'' refers to language used \n",
      "within the 2017 nasem report and is not meant to represent \n",
      "``substantial evidence'' as defined in 21 u.s.c. 355(d). hhs basis \n",
      "for rec. at 26 n.12.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    uf evaluated other therapeutic conditions mentioned above, i.e., \n",
      "anorexia, anxiety, epilepsy, ibd, nausea, and ptsd, employing a similar \n",
      "systematic review of scientific and medical literature. uf found that \n",
      "there is low- to moderate-quality evidence supporting the use of \n",
      "marijuana as medical treatment for outcomes in anorexia, nausea and \n",
      "vomiting, and ptsd. fda's review of systematic reviews showed mixed \n",
      "results for these indications. in particular, fda found that the \n",
      "potential for psychiatric adverse events associated with treating ptsd \n",
      "with marijuana may be more substantial than any limited benefit in \n",
      "observational studies. although uf did not conclude that there was \n",
      "evidence in support of the effectiveness of marijuana in ibd, both \n",
      "their review and other systematic reviews found some benefit with \n",
      "respect to subjective symptoms in this condition. with regard to \n",
      "epilepsy and anxiety, both uf's review and fda's review of other \n",
      "systematic reviews did not find support for marijuana providing benefit \n",
      "in the treatment of these conditions. where positive results on \n",
      "effectiveness outcome measures were found, the effects and the quality \n",
      "of evidence were generally in the low-to-moderate range. uf did not \n",
      "find high quality evidence supporting worsening of outcomes in any \n",
      "indication. hhs basis for rec. at 26.\n",
      "    fda concluded that none of the evidence from the systematic reviews \n",
      "included in the camu test part 2 analysis identified any safety \n",
      "concerns that would preclude the use of marijuana in the indications \n",
      "for which there exists some credible scientific support for its \n",
      "therapeutic benefit. fda assessed the clinical safety data identified \n",
      "in the literature from controlled trials as generally consistent \n",
      "between sources but limited in the rigor of safety reporting. fda also \n",
      "explained that the vast majority of the observational studies evaluated \n",
      "in the context of medical use were excluded from the final synthesis of \n",
      "evidence due to concerns regarding their quality (e.g., only one \n",
      "observational study for the anxiety indication and one for the ptsd \n",
      "indication were included). according to fda, data on safety from both \n",
      "clinical trials and observational studies were generally scarce, but \n",
      "the literature shows that marijuana has more aes when compared to a \n",
      "placebo or active control group, however, typically in the mild to \n",
      "moderate severity range. hhs basis for rec. at 26.\n",
      "    fda also reviewed results from state reporting data from 37 states \n",
      "with medical marijuana programs and surveys of patients using marijuana \n",
      "in maryland and minnesota, which had data available for review. surveys \n",
      "of patients using marijuana in these two states found most patients did \n",
      "not report any side effects and those that did report side effects \n",
      "mostly described them as mild. neither state's databases included \n",
      "patients who chose to stop using marijuana, which fda noted might \n",
      "result in an overestimation of positive experiences. hhs basis for rec. \n",
      "at 27.\n",
      "    as of august 2023, fda reported that the real-world data sources \n",
      "available to fda, in general, lack the necessary elements to identify \n",
      "the exposure (i.e., to marijuana), to distinguish the reason for use \n",
      "(medical vs. recreational) and, if applicable, the condition that \n",
      "prompted its medical use, and to permit sound inferential analyses. \n",
      "therefore, they were not included in hhs's review. hhs basis for rec. \n",
      "at 27.\n",
      "    according to fda, data from united states national surveys, in \n",
      "general, lacked details on patient characteristics and factors that \n",
      "prompted the use of marijuana for medical purposes, and data collection \n",
      "for these surveys was impacted by the covid-19 pandemic. fda observed \n",
      "that, despite these limitations, the data suggested that medical use of \n",
      "marijuana increases as age increases. only data from one survey \n",
      "provided information on the intended indication for use, suggesting \n",
      "that individuals often use marijuana to improve or manage conditions \n",
      "such as depression, anxiety, ptsd, pain, headaches or migraines, sleep \n",
      "disorders, nausea and vomiting, lack of appetite, and muscle spasms, \n",
      "but only approximately half of them reportedly had ever asked a health \n",
      "care professional for a recommendation to use medical marijuana. hhs \n",
      "basis for rec. at 27.\n",
      "    additionally, although the safety data obtained from use in a \n",
      "medical context are considered to be the most relevant for the camu \n",
      "analysis, fda evaluated the safety of marijuana in the nonmedical \n",
      "setting to inform the potential for more severe outcomes. specifically, \n",
      "fda evaluated safety outcomes related to marijuana use in the setting \n",
      "of nonmedical use, use of uncertain intent, and unintentional exposure \n",
      "through a variety of epidemiological data sources and in relation to \n",
      "several comparator substances controlled under the csa, including drugs \n",
      "in schedule i: heroin (an illicit opioid drug); schedule ii: \n",
      "hydrocodone and oxycodone (approved opioid prescription drug products), \n",
      "cocaine and fentanyl (largely illicitly produced drugs in the \n",
      "nonmedical use setting, although there are approved prescription \n",
      "drugs); schedule iii: ketamine (an approved prescription drug); and \n",
      "schedule iv: zolpidem, benzodiazepines, and tramadol (approved \n",
      "prescription drugs). according to fda, the comparative data demonstrate \n",
      "that, even in the context of nonmedical use, marijuana has a less \n",
      "concerning overall safety profile relative to the comparators for a \n",
      "number of important outcomes (e.g., single substance use overdose \n",
      "death,\n",
      "\n",
      "[[page 44619]]\n",
      "\n",
      "hospitalizations). however, fda observed that in young children, \n",
      "population-adjusted rates of ed visits and hospitalizations involving \n",
      "marijuana poisoning were higher than heroin, cocaine, and \n",
      "benzodiazepines for the periods studied. of note, some of the \n",
      "comparator substances are approved for use in conditions similar to the \n",
      "indications for which marijuana was evaluated in the camu analysis \n",
      "(e.g., opioids for pain, benzodiazepines for anxiety-related \n",
      "conditions). hhs basis for rec. at 27.\n",
      "    fda also considered position statements from professional \n",
      "organizations relevant to the indications discussed. the vast majority \n",
      "of professional organizations did not recommend the use of marijuana in \n",
      "their respective specialties; however, none specifically recommended \n",
      "against it, with the exception of the american psychiatric association, \n",
      "which stated that marijuana is known to worsen certain psychiatric \n",
      "conditions. hhs basis for rec. at 27-28.\n",
      "    on balance, fda found the available data indicated that there is \n",
      "some credible scientific support for the use of marijuana in the \n",
      "treatment of chronic pain, anorexia related to a medical condition, and \n",
      "nausea and vomiting, with varying degrees of support and consistency of \n",
      "findings. additionally, no safety concerns were identified in fda's \n",
      "review that would indicate that medical use of marijuana poses \n",
      "unacceptably high safety risks for the indications where there is some \n",
      "credible scientific evidence supporting its therapeutic use. hhs basis \n",
      "for rec. at 28.\n",
      "    based on the totality of the available data, fda concluded that \n",
      "there exists some credible scientific support for the medical use of \n",
      "marijuana in at least one of the indications for which there is \n",
      "widespread current experience in the united states, as identified by \n",
      "oash under part 1 of the camu test. the indications evaluated were \n",
      "anorexia related to a medical condition, anxiety, epilepsy, ibd, nausea \n",
      "and vomiting (e.g., chemotherapy-induced), pain, and ptsd. fda \n",
      "clarified that the analysis and conclusions on the available data are \n",
      "not meant to imply that safety and effectiveness have been established \n",
      "for marijuana that would support fda approval of a marijuana drug \n",
      "product for a particular indication. however, fda determined that the \n",
      "available data do provide some level of support for the way marijuana \n",
      "is being recommended by health care practitioners in clinical practice. \n",
      "thus, based on the widespread hcp experience and the extent of medical \n",
      "use evaluated by oash under the part 1 test, and fda's evaluation of \n",
      "available credible scientific support described herein for at least \n",
      "some therapeutic uses identified in the part 1 test, hhs recommended a \n",
      "finding that, for purposes of the drug scheduling criteria in 21 u.s.c. \n",
      "812(b), marijuana has a camu for: anorexia related to a medical \n",
      "condition; nausea and vomiting (e.g., chemotherapy-induced); and pain. \n",
      "hhs basis for rec. at 28.\n",
      "    the attorney general has considered hhs's recommendations and \n",
      "conclusions and accords hhs's scientific and medical determinations \n",
      "binding weight until the initiation of the formal rulemaking process. \n",
      "see olc op. at *24. applying hhs's two-part test, and in light of olc's \n",
      "legal opinion that the hhs's test is sufficient under the csa, the \n",
      "attorney general concurs with hhs's conclusion, for purposes of the \n",
      "initiation of these rulemaking proceedings, that there is a camu for \n",
      "marijuana.\n",
      "\n",
      "3. level of physical or psychological dependence\n",
      "\n",
      "    as a result of its most recent evaluation, which incorporates post-\n",
      "2016 data into its analysis, hhs has recommended a finding that abuse \n",
      "of marijuana may lead to moderate or low physical dependence or high \n",
      "psychological dependence. hhs basis for rec. at 65.\n",
      "    according to hhs, clinical studies have demonstrated that marijuana \n",
      "produces physical and psychological dependence. regarding physical \n",
      "dependence, as evidenced by its associated withdrawal symptomology upon \n",
      "abrupt discontinuation of use, the most commonly reported marijuana \n",
      "withdrawal symptoms in clinical investigations are sleep difficulties, \n",
      "decreased appetite and weight loss, craving, irritability, anger, \n",
      "anxiety or nervousness, and restlessness. marijuana withdrawal symptoms \n",
      "typically peak within two to six days and decline over one to two weeks \n",
      "as [delta]9-thc is eliminated. similarly, the drug labels for the fda-\n",
      "approved drug products marinol and syndros state that, following \n",
      "chronic administration of dronabinol, drug discontinuation leads to \n",
      "irritability, insomnia, and restlessness at 12 hours, and by 24 hours \n",
      "the withdrawal symptoms can include hot flashes, sweating, rhinorrhea, \n",
      "diarrhea, and anorexia. hhs basis for rec. at 64.\n",
      "    hhs observes that marijuana withdrawal syndrome has been reported \n",
      "in individuals with heavy, chronic marijuana use, but its occurrence in \n",
      "occasional users of marijuana has not been established. the marijuana \n",
      "withdrawal syndrome appears to be relatively mild compared to the \n",
      "withdrawal syndrome associated with alcohol, which can include more \n",
      "serious symptoms such as agitation, paranoia, seizures and even death. \n",
      "multiple studies comparing the withdrawal symptoms associated with \n",
      "marijuana and tobacco demonstrate that the magnitude and time course of \n",
      "the two withdrawal syndromes are similar. hhs basis for rec. at 64.\n",
      "    hhs also notes that the ability of marijuana to produce psychic \n",
      "dependence is shown through its ability to produce rewarding effects \n",
      "that underlie its nonmedical use and epidemiological outcomes related \n",
      "to abuse, as detailed in the first finding on abuse potential. hhs \n",
      "basis for rec. at 64-65.\n",
      "    based on the evidence, hhs determined that the abuse of marijuana \n",
      "may lead to moderate or low physical dependence, depending on frequency \n",
      "and degree of marijuana exposure. hhs further concluded that marijuana \n",
      "can produce psychic dependence in some individuals, but that the \n",
      "likelihood of serious outcomes is low, suggesting that high \n",
      "psychological dependence does not occur in most individuals who use \n",
      "marijuana. hhs basis for rec. at 65.\n",
      "    the attorney general has considered hhs's recommendations and \n",
      "conclusions and accords hhs's scientific and medical determinations \n",
      "binding weight at this stage of the scheduling process. see olc op. at \n",
      "*22 n.6. for purposes of the initiation of these rulemaking \n",
      "proceedings, the attorney general concurs with hhs's conclusion that \n",
      "the abuse of marijuana may lead to moderate or low physical dependence, \n",
      "depending on frequency and degree of marijuana exposure.\n",
      "determination to propose rescheduling marijuana to schedule iii\n",
      "    hhs has recommended a finding that marijuana has a camu. hhs basis \n",
      "for rec. at 63-64. after considering the foregoing facts and data and \n",
      "the recommendation of hhs, and after according binding weight to hhs's \n",
      "scientific and medical determinations, the attorney general concludes \n",
      "that there is, at present, substantial evidence that marijuana does not \n",
      "warrant control under schedule i of the csa. accordingly, the attorney \n",
      "general is issuing this notice of proposed rulemaking to initiate \n",
      "rulemaking proceedings to reschedule marijuana. 21 u.s.c. 811(b).\n",
      "    hhs has recommended that marijuana be transferred from schedule i \n",
      "to schedule iii rather than from schedule i to schedule ii based on its\n",
      "\n",
      "[[page 44620]]\n",
      "\n",
      "evaluation that the drug has a relatively lower level of abuse compared \n",
      "to drugs currently scheduled in schedules i and ii and its evaluation \n",
      "that marijuana may lead to moderate or low physical dependence and has \n",
      "a low likelihood of psychic dependence. consistent with hhs's analysis, \n",
      "the attorney general has determined at this initial stage that \n",
      "marijuana does not appear to meet the elements of a schedule ii drug, \n",
      "which include a high potential for abuse and a likelihood of severe \n",
      "physiological or physical dependence from such abuse. 21 u.s.c. \n",
      "812(b)(3). rather, marijuana's profile as a drug with a lower degree of \n",
      "abuse potential than schedule i (e.g., heroin) and schedule ii (e.g., \n",
      "fentanyl, cocaine) drugs and a moderate to low level of physical \n",
      "dependence militates in favor of rescheduling it in schedule iii. \n",
      "accordingly, in this notice of proposed rulemaking, the attorney \n",
      "general is proposing to reschedule marijuana in schedule iii and \n",
      "solicits comments on these preliminary findings.\n",
      "types of marijuana to be rescheduled\n",
      "    this rescheduling of marijuana would apply to marijuana as listed \n",
      "in 21 cfr 1308.11(d)(23). the rescheduling also would apply to \n",
      "marijuana extracts as defined in 21 cfr 1308.11(d)(58) because they \n",
      "meet the statutory definition of marijuana and, prior to 2017, were \n",
      "included in 21 cfr 1308.11(d)(23). see establishment of a new drug code \n",
      "for marihuana extract, 81 fr 90194 (dec. 14, 2016). in addition, this \n",
      "proposal would apply to [delta]9-thc derived from the marijuana plant \n",
      "(other than the mature stalks and seeds) that falls outside the \n",
      "definition of hemp, because it meets the statutory definition of \n",
      "marijuana.\n",
      "    this proposal would not apply to synthetically derived thc, which \n",
      "is outside the csa's definition of marijuana. those \n",
      "tetrahydrocannabinols that can be derived only through a process of \n",
      "artificial synthesis (e.g., delta-10-tetrahydrocannabinol) are \n",
      "excluded. hhs provided a recommendation only relating to ``marijuana'' \n",
      "as defined in the csa. that definition is limited to the plant (other \n",
      "than the mature stalks and seeds) and derivatives of the plant. \n",
      "therefore, synthetic thc will remain in schedule i. this rulemaking \n",
      "would not affect the status of hemp (as defined in 7 u.s.c. 1639o), \n",
      "because hemp is excluded from the definition of marijuana. this \n",
      "rulemaking is not proposing to reschedule any drug product containing \n",
      "marijuana or thc that previously has been rescheduled out of schedule i \n",
      "(e.g., marinol and syndros). nor does it impact the status of any \n",
      "previously scheduled synthetic cannabinoids.\n",
      "\n",
      "viii. international treaty obligations\n",
      "\n",
      "    in proposing an appropriate schedule for marijuana, the attorney \n",
      "general must also consider compliance with the treaty obligations of \n",
      "the united states. as the csa recognizes, the united states is a party \n",
      "to the single convention. 21 u.s.c. 801(7). parties to the single \n",
      "convention are obligated to maintain various control provisions related \n",
      "to the drugs that are covered by the treaty. see, e.g., single \n",
      "convention arts. 2, 4. congress enacted many of the csa's provisions \n",
      "for the specific purpose of ensuring u.s. compliance with the treaty. \n",
      "see olc op. at *27. among these is a scheduling provision, 21 u.s.c. \n",
      "811(d)(1). section 811(d)(1) provides that, where a drug is subject to \n",
      "control under the single convention, the attorney general must ``issue \n",
      "an order controlling such drug under the schedule he deems most \n",
      "appropriate to carry out such [treaty] obligations, without regard to \n",
      "the findings required by [21 u.s.c. 811(a) or 812(b)] and without \n",
      "regard to the procedures prescribed by [21 u.s.c. 811(a) and (b)].'' \n",
      "\\39\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\39\\ as noted above, olc and the d.c. circuit do not understand \n",
      "the ``without regard'' clause in section 811(d)(1) as prohibiting \n",
      "the attorney general from following the normal scheduling practices \n",
      "when international obligations are involved. instead, they have \n",
      "interpreted it as requiring the attorney general to identify which \n",
      "schedules would satisfy the international obligations of the united \n",
      "states with respect to a particular drug and, if more than one \n",
      "schedule would do so, to select among schedules using the procedures \n",
      "set forth in sections 811(a), 811(b), and 812(b). see olc op. at *29 \n",
      "n.8; norml ii, 559 f.2d at 747.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    marijuana is a drug covered in the single convention under the term \n",
      "``cannabis.'' \\40\\ olc initially advised in 1972 that controls under \n",
      "article 21 of the single convention would not be satisfied if marijuana \n",
      "were listed in schedule iii, iv, or v of the csa. memorandum for john \n",
      "e. ingersoll, director, bureau of narcotics and dangerous drugs, from \n",
      "mary c. lawton, deputy assistant attorney general, office of legal \n",
      "counsel, re: petition to decontrol marihuana; interpretation of section \n",
      "201 of the controlled substances act of 1970 at 12-13 (aug. 21, 1972). \n",
      "however, olc has reexamined the conclusion of its 1972 memorandum, \n",
      "taking into account statutory amendments since 1972 and a possibility \n",
      "it did not consider in 1972: placing marijuana into schedule iii while \n",
      "issuing regulations that would enable the united states to comply with \n",
      "its international obligations. olc op. at *4, 26-35. olc has concluded \n",
      "that both the single convention and the csa allow the attorney general \n",
      "to satisfy the treaty obligations of the united states with respect to \n",
      "marijuana by supplementing scheduling decisions with additional \n",
      "controls under the csa. id.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\40\\ under the single convention, ```[c]annabis plant' means any \n",
      "plant of the genus cannabis.'' single convention art. 1(1)(c). the \n",
      "single convention defines ``cannabis'' to mean ``the flowering or \n",
      "fruiting tops of the cannabis plant (excluding the seeds and leaves \n",
      "when not accompanied by the tops) from which the resin has not been \n",
      "extracted, by whatever name they may be designated.'' id. art. \n",
      "1(1)(b). this definition of ``cannabis'' under the single convention \n",
      "is slightly less inclusive in certain respects than the csa \n",
      "definition of ``marijuana,'' which includes all parts of the \n",
      "cannabis plant except for the mature stalks, sterilized seeds, oil \n",
      "from the seeds, and certain derivatives thereof. see 21 u.s.c. \n",
      "802(16). cannabis and cannabis resin are included in the list of \n",
      "drugs in schedule i of the single convention, and cannabis is \n",
      "subject to the same controls as schedule i drugs as well as \n",
      "additional controls. see single convention art. 2(6); id. art. 28.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    if marijuana were listed in schedule iii, most of the single \n",
      "convention's obligations would continue to be met by csa statutory \n",
      "authorities and associated regulations. see olc op. at *33-34. one \n",
      "potential gap concerns the quota on manufacturing cannabis required by \n",
      "article 21 of the convention, but that gap can be filled using the \n",
      "csa's regulatory authorities. see id. at *34; see also, e.g., 21 u.s.c. \n",
      "821 (authorizing the attorney general to impose restrictions \n",
      "``relate[ed] to the . . . control of the manufacture'' of a drug); id. \n",
      "871(b) (authorizing the attorney general to issue regulations \n",
      "``necessary and appropriate for the efficient execution of his \n",
      "functions under this subchapter''); id. 822(b) (allowing the attorney \n",
      "general to regulate ``the extent'' of manufacture of a drug through \n",
      "registration); id. 823(e) (requiring the attorney general to register \n",
      "an applicant to manufacture a schedule iii drug ``unless he determines \n",
      "that the issuance of such registration is inconsistent with the public \n",
      "interest'').\n",
      "    in addition, if marijuana is transferred into schedule iii, dea \n",
      "will continue to have authority to maintain its existing regulatory \n",
      "scheme, located at 21 cfr part 1318, governing the registration of \n",
      "manufacturers seeking to plant, grow, cultivate, or harvest marijuana, \n",
      "as required to comply with articles 23 and 28 of the single convention. \n",
      "authority for those regulations currently flows from 21 u.s.c. 823(a), \n",
      "which is applicable to drugs in schedules i and ii. olc has concluded, \n",
      "however, that 21 u.s.c. 823(e), which is applicable to drugs in \n",
      "schedules iii, iv, and v, provides an alternative source of authority \n",
      "for complying with articles 23 and 28 of the single convention. see\n",
      "\n",
      "[[page 44621]]\n",
      "\n",
      "olc op. at *34 n.9. the csa also recognizes that the united states is \n",
      "also a party to the convention on psychotropic substances, feb. 21, \n",
      "1971, 32 u.s.t. 543, 1019 u.n.t.s. 175 (``convention on psychotropic \n",
      "substances''). see also 21 u.s.c. 801a(2). as with the single \n",
      "convention, parties to the convention on psychotropic substances are \n",
      "obligated to take various control measures related to the drugs that \n",
      "are covered by the treaty. id. congress implemented the additional \n",
      "authority necessary to comply with the convention on psychotropic \n",
      "substances through various amendments to the csa. id. 801a(2)-(3).\n",
      "    [delta]9-thc is a substance covered by schedule ii of the \n",
      "convention on psychotropic substances. in this rule, doj proposes to \n",
      "reschedule [delta]9-thc that falls within the csa's definition of \n",
      "marijuana into csa schedule iii. as is the case for marijuana under the \n",
      "single convention, the controls available under csa schedule iii are \n",
      "sufficient to comply with the requirements of the convention on \n",
      "psychotropic substances with respect to [delta]9-thc, although \n",
      "additional regulatory action may be necessary to implement certain \n",
      "convention requirements, such as the export and import authorizations \n",
      "required by article 12. see, e.g., schedules of controlled substances: \n",
      "rescheduling of the food and drug administration approved product \n",
      "containing synthetic dronabinol [(-)-d \\9\\ -(trans)-\n",
      "tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin \n",
      "capsules from schedule ii to schedule iii, 64 fr 35928, 35928 (july 2, \n",
      "1999). compare, e.g., convention on psychotropic substances art. 12(1) \n",
      "(requiring export and import authorizations for substances in \n",
      "convention schedule ii), with 21 u.s.c. 952(b)(2) (authorizing import \n",
      "permits for csa schedule iii substances), and id. 953(e)(2) \n",
      "(authorizing export permits for csa schedule iii substances).\n",
      "    accordingly, concurrent with this rulemaking, dea will consider the \n",
      "marijuana-specific controls that would be necessary to meet u.s. \n",
      "obligations under the single convention and the convention on \n",
      "psychotropic substances in the event that marijuana is rescheduled to \n",
      "schedule iii, and, to the extent they are needed if marijuana is \n",
      "rescheduled, will seek to finalize any such regulations as soon as \n",
      "possible.\n",
      "\n",
      "ix. requirements for handling marijuana and other applicable controls\n",
      "\n",
      "    if marijuana is transferred to schedule iii, the regulatory \n",
      "controls applicable to schedule iii controlled substances would apply, \n",
      "as appropriate, along with existing marijuana-specific requirements and \n",
      "any additional controls that might be implemented, including those that \n",
      "might be implemented to meet u.s. treaty obligations. the manufacture, \n",
      "distribution, dispensing, and possession of marijuana would also remain \n",
      "subject to applicable criminal prohibitions under the csa. 21 u.s.c. \n",
      "841-844.\n",
      "    in addition, marijuana would remain subject to applicable \n",
      "provisions of the fdca. for example, under the fdca, a drug containing \n",
      "a substance within the csa's definition of ``marijuana'' would need fda \n",
      "approval to be lawfully ``introduce[d] or deliver[ed] for introduction \n",
      "into interstate commerce,'' unless an ind is in effect for that drug. \n",
      "see 21 u.s.c. 355(a), 355(i), 331(d). to date, although there have been \n",
      "inds for drugs containing a substance within the csa's definition of \n",
      "``marijuana,'' no such drugs have been approved by fda.\n",
      "    doj is seeking comment on the practical consequences of \n",
      "rescheduling marijuana into schedule iii under the relevant statutory \n",
      "frameworks.\n",
      "\n",
      "conclusion\n",
      "\n",
      "    based on the legal opinion of olc and consideration of the \n",
      "scientific and medical evaluation and accompanying recommendation of \n",
      "hhs, the attorney general is initiating a rulemaking that proposes the \n",
      "placement of marijuana in schedule iii of the csa. doj is soliciting \n",
      "comments on this proposal.\n",
      "\n",
      "x. regulatory analyses\n",
      "\n",
      "1. executive orders 12866 (regulatory planning and review), 13563 \n",
      "(improving regulation and regulatory review) and 14094 (modernizing \n",
      "regulatory review)\n",
      "\n",
      "    in accordance with 21 u.s.c. 811(a), this scheduling action is \n",
      "subject to formal rulemaking procedures done ``on the record after \n",
      "opportunity for a hearing,'' which are conducted pursuant to the \n",
      "provisions of 5 u.s.c. 556 and 557. the csa sets forth the criteria for \n",
      "removing a drug or other substance from the list of controlled \n",
      "substances. such actions are exempt from review by the office of \n",
      "management and budget pursuant to section 3(d)(1) of executive order \n",
      "12866 and the principles reaffirmed in executive order 13563 and 14094.\n",
      "    while this scheduling action is exempt from review under executive \n",
      "order 12866, doj recognizes this action may have unique economic \n",
      "impacts. as stated above, marijuana is subject to a number of state \n",
      "laws that have allowed a multibillion dollar industry to develop. doj \n",
      "acknowledges that there may be large impacts related to federal taxes \n",
      "and research and development investment for the pharmaceutical \n",
      "industry, among other things. doj is specifically soliciting comments \n",
      "on the economic impact of this proposed rule. doj will revise this \n",
      "section at the final rule stage if warranted after consideration of any \n",
      "comments received.\n",
      "\n",
      "2. executive order 12988 (civil justice reform)\n",
      "\n",
      "    this proposed regulation meets the applicable standards set forth \n",
      "in sections 3(a) and 3(b)(2) of executive order 12988 to eliminate \n",
      "drafting errors and ambiguity, minimize litigation, provide a clear \n",
      "legal standard for affected conduct, and promote simplification and \n",
      "burden reduction.\n",
      "\n",
      "3. executive order 13132 (federalism)\n",
      "\n",
      "    this rulemaking does not have federalism implications warranting \n",
      "the application of executive order 13132. the rule does not have \n",
      "substantial direct effects on the states, on the relationship between \n",
      "the federal government and the states, or the distribution of power and \n",
      "responsibilities among the various levels of government.\n",
      "\n",
      "4. executive order 13175 (consultation and coordination with indian \n",
      "tribal governments)\n",
      "\n",
      "    this proposed rule does not have tribal implications warranting the \n",
      "application of executive order 13175. this rule does not have \n",
      "substantial direct effects on one or more indian tribes, on the \n",
      "relationship between the federal government and indian tribes, or on \n",
      "the distribution of power and responsibilities between the federal \n",
      "government and indian tribes.\n",
      "\n",
      "5. regulatory flexibility act\n",
      "\n",
      "    doj has concluded that this action may have a significant economic \n",
      "impact on a substantial number of small entities under the regulatory \n",
      "flexibility act, 5 u.s.c. 601 et seq. for example, section 280e of the \n",
      "internal revenue code bars businesses from claiming tax deductions for \n",
      "otherwise allowable expenses where the business ``consists of \n",
      "trafficking in controlled substances (within the meaning of schedule i \n",
      "and ii of the controlled substances act).'' 26 u.s.c. 280e. if \n",
      "marijuana is ultimately transferred to schedule iii, section 280e would \n",
      "no longer serve as a statutory bar to claiming deductions for those \n",
      "expenses. in addition, small entities engaged in research on marijuana \n",
      "may\n",
      "\n",
      "[[page 44622]]\n",
      "\n",
      "be subject to different research protocols set by dea if the research \n",
      "is conducted on a schedule iii substance rather than a schedule i \n",
      "substance.\\41\\ however, doj is currently not in a position to estimate \n",
      "the number of small entities affected by these or other potential \n",
      "effects of this action. doj seeks comment and additional information to \n",
      "inform its analysis.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\41\\ see drug enforcement admin., researcher's manual 18-21 \n",
      "(2022), <a href=\"https://www.deadiversion.usdoj.gov/gdp/\">https://www.deadiversion.usdoj.gov/gdp/</a>(dea-dc-057)(e.o.-\n",
      "dea217)_researchers_manual_final_signed.pdf.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "6. unfunded mandates reform act of 1995\n",
      "\n",
      "    in accordance with the unfunded mandates reform act of 1995 \n",
      "(``umra''), 2 u.s.c. 1501 et seq., doj has determined that this action \n",
      "would not result in any federal mandate that may result ``in the \n",
      "expenditure by state, local, and tribal governments, in the aggregate, \n",
      "or by the private sector, of $100,000,000 or more (adjusted annually \n",
      "for inflation) in any 1 year.'' see 2 u.s.c. 1532(a). therefore, \n",
      "neither a small government agency plan nor any other action is required \n",
      "under umra.\n",
      "\n",
      "7. paperwork reduction act of 1995\n",
      "\n",
      "    this action does not impose any new or revised ``collection[s] of \n",
      "information'' as defined by the paperwork reduction act of 1995, 44 \n",
      "u.s.c. 3502(3).\n",
      "\n",
      "list of subjects in 21 cfr part 1308\n",
      "\n",
      "    administrative practice and procedure, drug traffic control, \n",
      "reporting and recordkeeping requirements.\n",
      "\n",
      "    for the reasons set out above, 21 cfr part 1308 is proposed to be \n",
      "amended as follows:\n",
      "\n",
      "part 1308--schedules of controlled substances\n",
      "\n",
      "0\n",
      "1. the authority citation for 21 cfr part 1308 continues to read as \n",
      "follows:\n",
      "\n",
      "    authority:  21 u.s.c. 811, 812, 871(b), 956(b), unless otherwise \n",
      "noted.\n",
      "\n",
      "0\n",
      "2. amend sec.  1308.11 by:\n",
      "0\n",
      "a. removing paragraphs (d)(23) and (58).\n",
      "0\n",
      "b. redesignating paragraphs (d)(24) through (57) and (59) through (104) \n",
      "as paragraphs (d)(23) through (102), respectively.\n",
      "0\n",
      "c. revising newly redesignated paragraph (d)(30).\n",
      "    the revision reads as follows:\n",
      "\n",
      "\n",
      "sec.  1308.11  schedule i.\n",
      "\n",
      "* * * * *\n",
      "    (d) * * *\n",
      "    (30) tetrahydrocannabinols--7370\n",
      "    (i) meaning tetrahydrocannabinols, except as in paragraphs \n",
      "(d)(30)(ii) and (iii) of this section, naturally contained in a plant \n",
      "of the genus cannabis (cannabis plant), as well as synthetic \n",
      "equivalents of the substances contained in the cannabis plant, or in \n",
      "the resinous extracts of such plant, or synthetic substances, \n",
      "derivatives, and their isomers with similar chemical structure and \n",
      "pharmacological activity to those substances contained in the plant.\n",
      "    (ii) tetrahydrocannabinols does not include any material, compound, \n",
      "mixture, or preparation that falls within the definition of hemp set \n",
      "forth in 7 u.s.c. 1639o.\n",
      "    (iii) tetrahydrocannabinols does not include any substance that \n",
      "falls within the definition of marijuana set forth in 21 u.s.c. \n",
      "802(16).\n",
      "* * * * *\n",
      "0\n",
      "3. amend sec.  1308.13 by adding paragraphs (h) through (j) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  1308.13  schedule iii.\n",
      "\n",
      "* * * * *\n",
      "    (h) marijuana. marijuana, as defined in 21 u.s.c. 802(16).\n",
      "    (i) marijuana extract. marijuana extract, meaning an extract \n",
      "containing one or more cannabinoids that has been derived from any \n",
      "plant of the genus cannabis, containing greater than 0.3 percent delta-\n",
      "9-tetrahydrocannabinol on a dry weight basis, other than the separated \n",
      "resin (whether crude or purified) obtained from the plant.\n",
      "    (j) naturally derived delta-9-tetrahydrocannabinols. (1) meaning \n",
      "those delta-9-tetrahydrocannabinols, except as in paragraphs (j)(2) and \n",
      "(3) of this section, that are naturally contained in a plant of the \n",
      "genus cannabis (cannabis plant).\n",
      "    (2) naturally derived delta-9-tetrahydrocannabinols do not include \n",
      "any material, compound, mixture, or preparation that falls within the \n",
      "definition of hemp set forth in 7 u.s.c. 1639o.\n",
      "    (3) naturally derived delta-9-tetrahydrocannabinols do not include \n",
      "any delta-9-tetrahydrocannabinols contained in substances excluded from \n",
      "the definition of marijuana as set forth in 21 u.s.c. 802(16)(b)(ii).\n",
      "\n",
      "    dated: may 16, 2024.\n",
      "merrick b. garland,\n",
      "attorney general.\n",
      "[fr doc. 2024-11137 filed 5-17-24; 11:15 am]\n",
      "billing code 4410-09-p\n",
      "\n",
      "\n",
      "</pre><script data-cfasync=\"false\" src=\"/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js\"></script></body>\n",
      "</html>\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in DEA-2024-0059:  50%|█████     | 1/2 [00:00<00:00,  8.77it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Added /Users/ha/Downloads/mirrulations/specific/DEA-2024-0059/raw-data/documents/DEA-2024-0059-0001_content.htm to vector store.\n",
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 89 issue 168 (thursday, august 29, 2024)</title>\n",
      "</head>\n",
      "<body><pre>\n",
      "[federal register volume 89, number 168 (thursday, august 29, 2024)]\n",
      "[proposed rules]\n",
      "[pages 70148-70149]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2024-19370]\n",
      "\n",
      "\n",
      "=======================================================================\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of justice\n",
      "\n",
      "drug enforcement administration\n",
      "\n",
      "21 cfr part 1301\n",
      "\n",
      "[docket no. dea-1362]\n",
      "rin 1117-ab77\n",
      "\n",
      "\n",
      "schedules of controlled substances: rescheduling of marijuana\n",
      "\n",
      "agency: drug enforcement administration, department of justice.\n",
      "\n",
      "action: notice of hearing on proposed rulemaking.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: this is notice that the drug enforcement administration will \n",
      "hold a hearing with respect to the proposed rescheduling of marijuana \n",
      "into schedule iii of the controlled substances act. the proposed \n",
      "rescheduling of marijuana was initially proposed in a notice of \n",
      "proposed rulemaking published in the federal register on may 21, 2024.\n",
      "\n",
      "dates: interested persons desiring to participate in this hearing must \n",
      "provide written notice of desired participation as set out below, on or \n",
      "before september 30, 2024.\n",
      "    the hearing will commence on december 2, 2024, at 9 a.m. et at 700\n",
      "\n",
      "[[page 70149]]\n",
      "\n",
      "army navy drive, arlington, va 22202. the hearing may be moved to a \n",
      "different place and may be continued from day to day or recessed to a \n",
      "later date without notice other than announcement thereof by the \n",
      "presiding officer at the hearing. 21 cfr 1316.53.\n",
      "\n",
      "addresses: to ensure proper handling of notification, please reference \n",
      "``docket no. dea-1362'' on all correspondence.\n",
      "    <bullet> electronic notification should be sent to <a href=\"/cdn-cgi/l/email-protection#ea849a9887aa8e8f8bc48d859c\"><span class=\"__cf_email__\" data-cfemail=\"610f11130c210504004f060e17\">[email&#160;protected]</span></a>.\n",
      "    <bullet> paper notification sent via regular or express mail should \n",
      "be sent to drug enforcement administration, attn: administrator, 8701 \n",
      "morrissette drive, springfield, virginia 22152.\n",
      "\n",
      "for further information contact: drug and chemical evaluation section, \n",
      "diversion control division, drug enforcement administration; telephone: \n",
      "(571) 362-3249. email: <a href=\"/cdn-cgi/l/email-protection#264856544b6642434708414950\"><span class=\"__cf_email__\" data-cfemail=\"3c524c4e517c58595d125b534a\">[email&#160;protected]</span></a>.\n",
      "\n",
      "supplementary information:\n",
      "\n",
      "background\n",
      "\n",
      "    on may 21, 2024, the department of justice published a notice of \n",
      "proposed rulemaking (nprm) to transfer marijuana from schedule i of the \n",
      "controlled substances act (csa) to schedule iii of the csa, consistent \n",
      "with the view of the department of health and human services (hhs) that \n",
      "marijuana has a currently accepted medical use, has a potential for \n",
      "abuse less than the drugs or other substances in schedules i and ii, \n",
      "and that its abuse may lead to moderate or low physical dependence or \n",
      "high psychological dependence.\\1\\ the csa requires that such actions be \n",
      "made through formal rulemaking on the record after opportunity for a \n",
      "hearing. 21 u.s.c. 811(a).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\1\\ schedules of controlled substances: rescheduling of \n",
      "marijuana, 89 fr 44597 (may 21, 2024).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the nprm stated that if the transfer to schedule iii is finalized, \n",
      "the regulatory controls applicable to schedule iii controlled \n",
      "substances would apply, as appropriate, along with existing marijuana-\n",
      "specific requirements and any additional controls that might be \n",
      "implemented, including those that might be implemented to meet u.s. \n",
      "treaty obligations. if marijuana is transferred into schedule iii, the \n",
      "manufacture, distribution, dispensing, and possession of marijuana \n",
      "would remain subject to the applicable criminal prohibitions of the \n",
      "csa. any drugs containing a substance within the csa's definition of \n",
      "``marijuana'' would also remain subject to the applicable prohibition \n",
      "in the federal food, drug, and cosmetic act (fdca).\n",
      "    the nprm invited interested parties to submit requests for hearing \n",
      "on or before june 20, 2024. dea received numerous requests for a \n",
      "hearing in response to the nprm.\n",
      "    upon review of the requests for a hearing, i am authorizing a \n",
      "hearing to be conducted in accordance with the administrative procedure \n",
      "act (5 u.s.c. 551-559), the csa (21 u.s.c. 811, et seq.) and the dea \n",
      "regulations.\n",
      "\n",
      "hearing notification\n",
      "\n",
      "    pursuant to 21 u.s.c. 811(a) and 21 cfr 1308.41, dea will convene a \n",
      "hearing on the nprm. the hearing will commence on december 2, 2024, at \n",
      "9 a.m. et at the dea hearing facility, 700 army navy drive, arlington, \n",
      "va 22202. the hearing will be conducted pursuant to the provisions of 5 \n",
      "u.s.c. 556 and 557, and 21 cfr 1308.41-1308.45, and 1316.41-1316.68. \n",
      "dea is committed to conducting a transparent proceeding. regarding the \n",
      "methods of public access, dea will provide updates on the dea website, \n",
      "<a href=\"https://www.dea.gov\">https://www.dea.gov</a>.\n",
      "    in accordance with 21 u.s.c. 811 and 812, the purpose of the \n",
      "hearing is to ``receiv[e] factual evidence and expert opinion \n",
      "regarding'' whether marijuana should be transferred to schedule iii of \n",
      "the list of controlled substances. 21 cfr 1308.42.\n",
      "    every interested person (defined in 21 cfr 1300.01(b) as ``any \n",
      "person adversely affected or aggrieved by any rule or proposed rule \n",
      "issuable'' under 21 u.s.c. 811), who wishes to participate in the \n",
      "hearing shall file a written notice of intention to participate for \n",
      "review by the agency. electronic filing may be made as a pdf attachment \n",
      "via email to the drug enforcement administration, attn: administrator \n",
      "at <a href=\"/cdn-cgi/l/email-protection#761806041b3612131758111900\"><span class=\"__cf_email__\" data-cfemail=\"bcd2ccced1fcd8d9dd92dbd3ca\">[email&#160;protected]</span></a>, on or before 11:59 p.m. eastern time on september 30, \n",
      "2024. if filing by mail, written notice must be filed with the drug \n",
      "enforcement administration, attn: administrator, 8701 morrissette \n",
      "drive, springfield, va 22152, and must be postmarked on or before \n",
      "september 30, 2024. paper requests that duplicate electronic \n",
      "submissions are not necessary and are discouraged.\n",
      "    each notice of intention to participate must conform to 21 cfr \n",
      "1308.44(b) and in the form prescribed in 21 cfr 1316.48. among those \n",
      "requirements, such requests must:\n",
      "    (1) state with particularity the interest of the person in the \n",
      "proceeding;\n",
      "    (2) state with particularity the objections or issues concerning \n",
      "which the person desires to be heard; and\n",
      "    (3) state briefly the position of the person regarding the \n",
      "objections or issues.\n",
      "    any person who has previously filed a request for hearing or to \n",
      "participate in a hearing need not file another request; the request for \n",
      "hearing is deemed to be a notice of appearance under 21 cfr 1308.44(b).\n",
      "    after the deadline to request to participate in the hearing, i will \n",
      "assess the notices submitted and make a determination of participants. \n",
      "following that assessment, i will designate a presiding officer to \n",
      "preside over the hearing. the presiding officer's functions shall \n",
      "commence upon designation, as provided in 21 cfr 1316.52. the presiding \n",
      "officer will have all powers necessary to conduct a fair hearing, to \n",
      "take all necessary action to avoid delay, and to maintain order. id. \n",
      "the presiding officer's authorities include the power to hold \n",
      "conferences to simplify or determine the issues in the hearing or to \n",
      "consider other matters that may aid in the expeditious disposition of \n",
      "the hearing; require parties to state their position in writing; sign \n",
      "and issue subpoenas to compel the production of documents and materials \n",
      "to the extent necessary to conduct the hearing; examine witnesses and \n",
      "direct witnesses to testify; receive, rule on, exclude, or limit \n",
      "evidence; rule on procedural items; and take any action permitted by \n",
      "the presiding officer under dea's hearing procedures and the apa. id.\n",
      "    comments on or objections to the proposed rule submitted under 21 \n",
      "cfr 1308.43(g) will be offered as evidence at the hearing, but the \n",
      "presiding officer shall admit only evidence that is competent, \n",
      "relevant, material, and not unduly repetitive. 21 cfr 1316.59(a).\n",
      "\n",
      "anne milgram,\n",
      "administrator.\n",
      "[fr doc. 2024-19370 filed 8-26-24; 4:45 pm]\n",
      "billing code 4410-09-p\n",
      "\n",
      "\n",
      "</pre><script data-cfasync=\"false\" src=\"/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js\"></script></body>\n",
      "</html>\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in DEA-2024-0059: 100%|██████████| 2/2 [00:00<00:00, 14.79it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Added /Users/ha/Downloads/mirrulations/specific/DEA-2024-0059/raw-data/documents/DEA-2024-0059-42928_content.htm to vector store.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in HHS-ONC-2019-0002:   0%|          | 0/2 [00:00<?, ?it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 84 issue 78 (tuesday, april 23, 2019)</title>\n",
      "</head>\n",
      "<body><pre>[federal register volume 84, number 78 (tuesday, april 23, 2019)]\n",
      "[proposed rules]\n",
      "[pages 16834-16835]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2019-08178]\n",
      "\n",
      "\n",
      "=======================================================================\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of health and human services\n",
      "\n",
      "office of the secretary\n",
      "\n",
      "45 cfr parts 170 and 171\n",
      "\n",
      "rin 0955-aa01\n",
      "\n",
      "\n",
      "21st century cures act: interoperability, information blocking, \n",
      "and the onc health it certification program\n",
      "\n",
      "agency: office of the national coordinator for health information \n",
      "technology (onc), department of health and human services (hhs).\n",
      "\n",
      "action: proposed rule; extension of comment period.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: on march 4, 2019, the department of health and human services \n",
      "(hhs) published a proposed rule that would implement certain provisions \n",
      "of the 21st century cures act, including conditions and maintenance of \n",
      "certification requirements for health information technology (health \n",
      "it) developers under the onc health it certification program (program), \n",
      "the voluntary certification of health it for use by pediatric health \n",
      "care providers, and reasonable and necessary activities that do not \n",
      "constitute information blocking. the comment period for the rule was \n",
      "scheduled to close on may 3, 2019. this document extends the comment \n",
      "period for the\n",
      "\n",
      "[[page 16835]]\n",
      "\n",
      "proposed rule by 30 days to june 3, 2019.\n",
      "\n",
      "dates: the comment period for the proposed rule published march 4, \n",
      "2019, at 84 fr 7424, is extended. comments must be received on or \n",
      "before june 3, 2019.\n",
      "\n",
      "addresses: you may submit comments, identified by rin 0955-aa01, by any \n",
      "of the following methods (please do not submit duplicate comments). \n",
      "because of staff and resource limitations, we cannot accept comments by \n",
      "facsimile (fax) transmission.\n",
      "    <bullet> federal erulemaking portal: follow the instructions for \n",
      "submitting comments. attachments should be in microsoft word, microsoft \n",
      "excel, or adobe pdf; however, we prefer microsoft word. <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a>.\n",
      "    <bullet> regular, express, or overnight mail: department of health \n",
      "and human services, office of the national coordinator for health \n",
      "information technology, attention: 21st century cures act: \n",
      "interoperability, information blocking, and the onc health it \n",
      "certification program proposed rule, mary e. switzer building, mail \n",
      "stop: 7033a, 330 c street sw, washington, dc 20201. please submit one \n",
      "original and two copies.\n",
      "    <bullet> hand delivery or courier: office of the national \n",
      "coordinator for health information technology, attention: 21st century \n",
      "cures act: interoperability, information blocking, and the onc health \n",
      "it certification program proposed rule, mary e. switzer building, mail \n",
      "stop: 7033a, 330 c street sw, washington, dc 20201. please submit one \n",
      "original and two copies. (because access to the interior of the mary e. \n",
      "switzer building is not readily available to persons without federal \n",
      "government identification, commenters are encouraged to leave their \n",
      "comments in the mail drop slots located in the main lobby of the \n",
      "building.)\n",
      "    enhancing the public comment experience: to facilitate public \n",
      "comment on this proposed rule, a copy will be made available in \n",
      "microsoft word format on onc's website (<a href=\"http://www.healthit.gov\">http://www.healthit.gov</a>). we \n",
      "believe this version will make it easier for commenters to access and \n",
      "copy portions of the proposed rule for use in their individual \n",
      "comments. additionally, a separate document (``public comment \n",
      "template'') is available on onc's website (<a href=\"http://www.healthit.gov\">http://www.healthit.gov</a>) for \n",
      "the public to use in providing comments on the proposed rule. this \n",
      "document is meant to provide the public with a simple and organized way \n",
      "to submit comments on proposals and respond to specific questions posed \n",
      "in the preamble of the proposed rule. while use of this document is \n",
      "entirely voluntary, we encourage commenters to consider using the \n",
      "document in lieu of unstructured comments, or to use it as an addendum \n",
      "to narrative cover pages. we believe that use of the document may \n",
      "facilitate our review and understanding of the comments received.\n",
      "    inspection of public comments: all comments received before the \n",
      "close of the comment period will be available for public inspection, \n",
      "including any personally identifiable or confidential business \n",
      "information that is included in a comment. please do not include \n",
      "anything in your comment submission that you do not wish to share with \n",
      "the general public. such information includes, but is not limited to: a \n",
      "person's social security number; date of birth; driver's license \n",
      "number; state identification number or foreign country equivalent; \n",
      "passport number; financial account number; credit or debit card number; \n",
      "any personal health information; or any business information that could \n",
      "be considered proprietary. we will post all comments that are received \n",
      "before the close of the comment period at <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a>.\n",
      "    docket: for access to the docket to read background documents or \n",
      "comments received, go to <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a> or the department \n",
      "of health and human services, office of the national coordinator for \n",
      "health information technology, mary e. switzer building, mail stop: \n",
      "7033a, 330 c street sw, washington, dc 20201 (call ahead to the contact \n",
      "listed below to arrange for inspection)..\n",
      "\n",
      "for further information contact: michael lipinski, office of policy, \n",
      "office of the national coordinator for health information technology, \n",
      "202-690-7151.\n",
      "\n",
      "supplementary information: in the ``21st century cures act: \n",
      "interoperability, information blocking, and the onc health it \n",
      "certification program'' proposed rule that appeared in the march 4, \n",
      "2019 federal register (84 fr 7424), we solicited public comments on \n",
      "proposals to implement certain provisions of the 21st century cures \n",
      "act, including conditions and maintenance of certification requirements \n",
      "for health information technology (health it) developers under the onc \n",
      "health it certification program (program), the voluntary certification \n",
      "of health it for use by pediatric health care providers, and reasonable \n",
      "and necessary activities that do not constitute information blocking. \n",
      "the comment period for the rule was scheduled to close on may 3, 2019. \n",
      "this document extends the comment period for the proposed rule by 30 \n",
      "days until june 3, 2019.\n",
      "    to date, we have received comments from organizations with broad \n",
      "stakeholder representation requesting that we extend the 60-day comment \n",
      "period for the proposed rule. for example, we have received comments \n",
      "requesting more time from clinicians, hospitals, health it developers \n",
      "and developer associations, professional societies, researchers, \n",
      "quality improvement organizations, health plans, and patient advocacy \n",
      "organizations. the commenters have stated that due to the depth and \n",
      "complexity of the policies proposed, it is critical for the public to \n",
      "have extended time in providing sufficient and thoughtful comments to \n",
      "advance shared goals and shape the interoperability landscape. based on \n",
      "these public comments and the stated goals of the proposed rule to \n",
      "improve interoperability and patient access to health information for \n",
      "the purposes of promoting competition and better care, we are extending \n",
      "the comment period for the proposed rule for an additional 30 days.\n",
      "\n",
      "    dated: april 18, 2019.\n",
      "alex m. azar ii,\n",
      "secretary, department of health and human services.\n",
      "[fr doc. 2019-08178 filed 4-19-19; 8:45 am]\n",
      "billing code 4150-45-p\n",
      "\n",
      "\n",
      "</pre></body>\n",
      "</html>\n",
      "Added /Users/ha/Downloads/mirrulations/specific/HHS-ONC-2019-0002/raw-data/documents/HHS-ONC-2019-0002-0257_content.htm to vector store.\n",
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 84 issue 42 (monday, march 4, 2019)</title>\n",
      "</head>\n",
      "<body><pre>\n",
      "[federal register volume 84, number 42 (monday, march 4, 2019)]\n",
      "[proposed rules]\n",
      "[pages 7424-7610]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2019-02224]\n",
      "\n",
      "\n",
      "\n",
      "[[page 7423]]\n",
      "\n",
      "vol. 84\n",
      "\n",
      "monday,\n",
      "\n",
      "no. 42\n",
      "\n",
      "march 4, 2019\n",
      "\n",
      "part ii\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "department of health and human services\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "centers for medicare & medicaid services\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "42 cfr parts 406, 407, 422, et al.\n",
      "\n",
      "45 cfr parts 156, 170, and 171\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "21st century cures act: interoperability, information blocking, and the \n",
      "onc health it certification program; medicare and medicaid programs; \n",
      "patient protection and affordable care act; interoperability and \n",
      "patient access for medicare advantage organization and medicaid managed \n",
      "care plans, state medicaid agencies, chip agencies and chip managed \n",
      "care entities, issuers of qualified health plans in the federally-\n",
      "facilitated exchanges and health care providers; proposed rules\n",
      "\n",
      "\u0000\u0000federal register / vol. 84 , no. 42 / monday, march 4, 2019 / \n",
      "proposed rules\u0000\u0000\n",
      "\n",
      "[[page 7424]]\n",
      "\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of health and human services\n",
      "\n",
      "office of the secretary\n",
      "\n",
      "45 cfr parts 170 and 171\n",
      "\n",
      "rin 0955-aa01\n",
      "\n",
      "\n",
      "21st century cures act: interoperability, information blocking, \n",
      "and the onc health it certification program\n",
      "\n",
      "agency: office of the national coordinator for health information \n",
      "technology (onc), department of health and human services (hhs).\n",
      "\n",
      "action: proposed rule.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: this proposed rule would implement certain provisions of the \n",
      "21st century cures act, including conditions and maintenance of \n",
      "certification requirements for health information technology (health \n",
      "it) developers under the onc health it certification program (program), \n",
      "the voluntary certification of health it for use by pediatric health \n",
      "care providers, and reasonable and necessary activities that do not \n",
      "constitute information blocking. the implementation of these provisions \n",
      "would advance interoperability and support the access, exchange, and \n",
      "use of electronic health information. the proposed rule would also \n",
      "modify the 2015 edition health it certification criteria and program in \n",
      "additional ways to advance interoperability, enhance health it \n",
      "certification, and reduce burden and costs.\n",
      "\n",
      "dates: to be assured consideration, written or electronic comments must \n",
      "be received at one of the addresses provided below, no later than 5 \n",
      "p.m. on may 3, 2019.\n",
      "\n",
      "addresses: you may submit comments, identified by rin 0955-aa01, by any \n",
      "of the following methods (please do not submit duplicate comments). \n",
      "because of staff and resource limitations, we cannot accept comments by \n",
      "facsimile (fax) transmission.\n",
      "    <bullet> federal erulemaking portal: follow the instructions for \n",
      "submitting comments. attachments should be in microsoft word, microsoft \n",
      "excel, or adobe pdf; however, we prefer microsoft word. <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a>.\n",
      "    <bullet> regular, express, or overnight mail: department of health \n",
      "and human services, office of the national coordinator for health \n",
      "information technology, attention: 21st century cures act: \n",
      "interoperability, information blocking, and the onc health it \n",
      "certification program proposed rule, mary e. switzer building, mail \n",
      "stop: 7033a, 330 c street sw, washington, dc 20201. please submit one \n",
      "original and two copies.\n",
      "    <bullet> hand delivery or courier: office of the national \n",
      "coordinator for health information technology, attention: 21st century \n",
      "cures act: interoperability, information blocking, and the onc health \n",
      "it certification program proposed rule, mary e. switzer building, mail \n",
      "stop: 7033a, 330 c street sw, washington, dc 20201. please submit one \n",
      "original and two copies. (because access to the interior of the mary e. \n",
      "switzer building is not readily available to persons without federal \n",
      "government identification, commenters are encouraged to leave their \n",
      "comments in the mail drop slots located in the main lobby of the \n",
      "building.)\n",
      "    enhancing the public comment experience: to facilitate public \n",
      "comment on this proposed rule, a copy will be made available in \n",
      "microsoft word format on onc's website (<a href=\"http://www.healthit.gov\">http://www.healthit.gov</a>). we \n",
      "believe this version will make it easier for commenters to access and \n",
      "copy portions of the proposed rule for use in their individual \n",
      "comments. additionally, a separate document (``public comment \n",
      "template'') will also be made available on onc's website (<a href=\"http://www.healthit.gov\">http://www.healthit.gov</a>) for the public to use in providing comments on the \n",
      "proposed rule. this document is meant to provide the public with a \n",
      "simple and organized way to submit comments on proposals and respond to \n",
      "specific questions posed in the preamble of the proposed rule. while \n",
      "use of this document is entirely voluntary, we encourage commenters to \n",
      "consider using the document in lieu of unstructured comments, or to use \n",
      "it as an addendum to narrative cover pages. we believe that use of the \n",
      "document may facilitate our review and understanding of the comments \n",
      "received. the public comment template will be available shortly after \n",
      "the proposed rule publishes in the federal register. this short delay \n",
      "will permit the appropriate citation in the public comment template to \n",
      "pages of the published version of the proposed rule.\n",
      "    inspection of public comments: all comments received before the \n",
      "close of the comment period will be available for public inspection, \n",
      "including any personally identifiable or confidential business \n",
      "information that is included in a comment. please do not include \n",
      "anything in your comment submission that you do not wish to share with \n",
      "the general public. such information includes, but is not limited to: a \n",
      "person's social security number; date of birth; driver's license \n",
      "number; state identification number or foreign country equivalent; \n",
      "passport number; financial account number; credit or debit card number; \n",
      "any personal health information; or any business information that could \n",
      "be considered proprietary. we will post all comments that are received \n",
      "before the close of the comment period at <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a>.\n",
      "    docket: for access to the docket to read background documents or \n",
      "comments received, go to <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a> or the department \n",
      "of health and human services, office of the national coordinator for \n",
      "health information technology, mary e. switzer building, mail stop: \n",
      "7033a, 330 c street sw, washington, dc 20201 (call ahead to the contact \n",
      "listed below to arrange for inspection).\n",
      "\n",
      "for further information contact: michael lipinski, office of policy, \n",
      "office of the national coordinator for health information technology, \n",
      "202-690-7151.\n",
      "\n",
      "supplementary information:\n",
      "\n",
      "table of contents\n",
      "\n",
      "i. executive summary\n",
      "    a. purpose of regulatory action\n",
      "    b. summary of major provisions and clarifications\n",
      "    1. deregulatory actions for previous rulemakings\n",
      "    2. updates to the 2015 edition certification criteria\n",
      "    a. adoption of the united states core data for interoperability \n",
      "as a standard\n",
      "    b. electronic prescribing\n",
      "    c. clinical quality measures--report\n",
      "    d. electronic health information export\n",
      "    e. application programming interfaces\n",
      "    f. privacy and security transparency attestations\n",
      "    g. data segmentation for privacy and consent management\n",
      "    3. modifications to the onc health it certification program\n",
      "    4. health it for the care continuum\n",
      "    5. conditions and maintenance of certification\n",
      "    6. information blocking\n",
      "    c. costs and benefits\n",
      "ii. background\n",
      "    a. statutory basis\n",
      "    1. standards, implementation specifications, and certification \n",
      "criteria\n",
      "    2. health it certification program(s)\n",
      "    b. regulatory history\n",
      "    1. standards, implementation specifications, and certification \n",
      "criteria rules\n",
      "    2. onc health it certification program rules\n",
      "iii. deregulatory actions for previous rulemakings\n",
      "    a. background\n",
      "    1. history of burden reduction and regulatory flexibility\n",
      "    2. executive orders 13771 and 13777\n",
      "\n",
      "[[page 7425]]\n",
      "\n",
      "    b. proposed deregulatory actions\n",
      "    1. removal of randomized surveillance requirements\n",
      "    2. removal of the 2014 edition from the code of federal \n",
      "regulations\n",
      "    3. removal of the onc-approved accreditor from the program\n",
      "    4. removal of certain 2015 edition certification criteria and \n",
      "standards\n",
      "    a. 2015 edition base ehr definition certification criteria\n",
      "    b. drug-formulary and preferred drug lists\n",
      "    c. patient-specific education resources\n",
      "    d. common clinical data set summary record--create; and common \n",
      "clinical data set summary record--receive\n",
      "    e. secure messaging\n",
      "    5. removal of certain onc health it certification program \n",
      "requirements\n",
      "    a. limitations disclosures\n",
      "    b. transparency and mandatory disclosures requirements\n",
      "    6. recognition of food and drug administration processes\n",
      "    a. fda software pre-certification pilot program\n",
      "    b. development of similar independent program processes--request \n",
      "for information\n",
      "iv. updates to the 2015 edition certification criteria\n",
      "    a. standards and implementation specifications\n",
      "    1. national technology transfer and advancement act\n",
      "    2. compliance with adopted standards and implementation \n",
      "specifications\n",
      "    3. ``reasonably available'' to interested parties\n",
      "    b. revised and new 2015 edition criteria\n",
      "    1. the united states core data for interoperability standard \n",
      "(uscdi)\n",
      "    a. uscdi 2015 edition certification criteria\n",
      "    b. uscdi standard--data classes included\n",
      "    c. uscdi standard--relationship to content exchange standards \n",
      "and implementation specifications\n",
      "    d. clinical notes c-cda implementation specification\n",
      "    2. electronic prescribing criterion\n",
      "    3. clinical quality measures--report criterion\n",
      "    4. electronic health information export criterion\n",
      "    a. patient access\n",
      "    b. transitions between health it systems\n",
      "    c. scope of ehi\n",
      "    d. export format\n",
      "    e. initial step to persistent access to all of a patient's ehi\n",
      "    f. timeframes\n",
      "    g. replaces the 2015 edition ``data export'' criterion in the \n",
      "2015 edition base ehr definition\n",
      "    5. standardized api for patient and population services \n",
      "criterion\n",
      "    6. privacy and security transparency attestations criteria\n",
      "    a. background\n",
      "    b. encrypt authentication credentials\n",
      "    c. multi-factor authentication\n",
      "    7. data segmentation for privacy and consent management criteria\n",
      "    a. implementation with the consolidated cda release 2.1\n",
      "    b. implementation with fhir standard\n",
      "    c. unchanged 2015 edition criteria--promoting interoperability \n",
      "programs reference alignment\n",
      "v. modifications to the onc health it certification program\n",
      "    a. corrections\n",
      "    1. auditable events and tamper resistance\n",
      "    2. amendments\n",
      "    3. view, download, and transmit to 3rd party\n",
      "    4. integrating revised and new certification criteria into the \n",
      "2015 edition privacy and security certification framework\n",
      "    b. principles of proper conduct for onc-acbs\n",
      "    1. records retention\n",
      "    2. conformance methods for certification criteria\n",
      "    3. onc-acbs to accept test results from any onc-atl in good \n",
      "standing\n",
      "    4. mandatory disclosures and certifications\n",
      "    c. principles of proper conduct for onc-atls--records retention\n",
      "vi. health it for the care continuum\n",
      "    a. health it for pediatric setting\n",
      "    1. background and stakeholder convening\n",
      "    2. recommendations for the voluntary certification of health it \n",
      "for use in pediatric care\n",
      "    a. 2015 edition certification criteria\n",
      "    b. new or revised certification criteria in this proposed rule\n",
      "    b. health it and opioid use disorder prevention and treatment--\n",
      "request for information\n",
      "    1. 2015 edition certification criteria\n",
      "    2. revised or new 2015 edition certification criteria in this \n",
      "proposed rule\n",
      "    3. emerging standards and innovations\n",
      "    4. additional comment areas\n",
      "vii. conditions and maintenance of certification\n",
      "    a. implementation\n",
      "    b. provisions\n",
      "    1. information blocking\n",
      "    2. assurances\n",
      "    a. full compliance and unrestricted implementation of \n",
      "certification criteria capabilities\n",
      "    b. certification to the ``electronic health information export'' \n",
      "criterion\n",
      "    c. records and information retention\n",
      "    d. trusted exchange framework and the common agreement--request \n",
      "for information\n",
      "    3. communications\n",
      "    a. background and purpose\n",
      "    b. condition of certification requirements\n",
      "    c. maintenance of certification requirements\n",
      "    4. application programming interfaces\n",
      "    a. statutory interpretation and api policy principles\n",
      "    b. key terms\n",
      "    c. proposed api standards, implementation specifications, and \n",
      "certification criterion\n",
      "    d. condition of certification requirements\n",
      "    e. maintenance of certification requirements\n",
      "    f. 2015 edition base ehr definition\n",
      "    5. real world testing\n",
      "    6. attestations\n",
      "    7. ehr reporting criteria submission\n",
      "    c. compliance\n",
      "    d. enforcement\n",
      "    1. onc direct review of the conditions and maintenance of \n",
      "certification requirements\n",
      "    2. review and enforcement only by onc\n",
      "    3. review processes\n",
      "    a. initiating review and health it developer notice\n",
      "    b. relationship with onc-acbs and onc-atls\n",
      "    c. records access\n",
      "    d. corrective action\n",
      "    e. certification ban and termination\n",
      "    f. appeal\n",
      "    g. suspension\n",
      "    h. proposed termination\n",
      "    4. public listing of certification ban and terminations\n",
      "    5. effect on existing program requirements and processes\n",
      "    6. concurrent enforcement by the office of inspector general\n",
      "    7. applicability of conditions and maintenance of certification \n",
      "requirements for self-developers\n",
      "viii. information blocking\n",
      "    a. statutory basis\n",
      "    b. legislative background and policy considerations\n",
      "    1. purpose of the information blocking provision\n",
      "    2. policy considerations and approach to the information \n",
      "blocking provisions\n",
      "    c. relevant statutory terms and provisions\n",
      "    1. ``required by law''\n",
      "    2. health care providers, health it developers, exchanges, and \n",
      "networks\n",
      "    a. health care providers\n",
      "    b. health it developers of certified health it\n",
      "    c. networks and exchanges\n",
      "    3. electronic health information\n",
      "    4. interests promoted by the information blocking provision\n",
      "    a. access, exchange, and use of ehi\n",
      "    b. interoperability elements\n",
      "    5. practices that may implicate the information blocking \n",
      "provision\n",
      "    a. prevention, material discouragement, and other interference\n",
      "    b. likelihood of interference\n",
      "    c. examples of practices likely to interfere with access, \n",
      "exchange, or use of ehi\n",
      "    6. applicability of exceptions\n",
      "    a. reasonable and necessary activities\n",
      "    b. treatment of different types of actors\n",
      "    c. establishing that activities and practices meet the \n",
      "conditions of an exception\n",
      "    d. proposed exceptions to the information blocking provision\n",
      "    1. preventing harm\n",
      "    2. promoting the privacy of ehi\n",
      "    3. promoting the security of ehi\n",
      "    4. recovering costs reasonably incurred\n",
      "    5. responding to requests that are infeasible\n",
      "    6. licensing of interoperability elements on reasonable and non-\n",
      "discriminatory terms\n",
      "    7. maintaining and improving health it performance\n",
      "    e. additional exceptions--request for information\n",
      "\n",
      "[[page 7426]]\n",
      "\n",
      "    1. exception for complying with common agreement for trusted \n",
      "exchange\n",
      "    2. new exceptions\n",
      "    f. complaint process\n",
      "    g. disincentives for health care providers--request for \n",
      "information\n",
      "ix. registries request for information\n",
      "x. patient matching request for information\n",
      "xi. incorporation by reference\n",
      "xii. response to comments\n",
      "xiii. collection of information requirements\n",
      "    a. onc-acbs\n",
      "    b. health it developers\n",
      "xiv. regulatory impact analysis\n",
      "    a. statement of need\n",
      "    b. alternatives considered\n",
      "    c. overall impact\n",
      "    1. executive orders 12866 and 13563--regulatory planning and \n",
      "review analysis\n",
      "    2. executive order 13771--reducing regulation and controlling \n",
      "regulatory costs\n",
      "    a. costs and benefits\n",
      "    b. accounting statement and table\n",
      "    3. regulatory flexibility act\n",
      "    4. executive order 13132--federalism\n",
      "    5. unfunded mandates reform act of 1995\n",
      "    6. executive order 13771 reducing regulation and controlling \n",
      "regulatory costs\n",
      "regulation text\n",
      "\n",
      "i. executive summary\n",
      "\n",
      "a. purpose of regulatory action\n",
      "\n",
      "    onc is responsible for the implementation of key provisions in \n",
      "title iv of the 21st century cures act (cures act) that are designed to \n",
      "advance interoperability; support the access, exchange, and use of \n",
      "electronic health information; and address occurrences of information \n",
      "blocking. this proposed rule would implement certain provisions of the \n",
      "cures act, including conditions and maintenance of certification \n",
      "requirements for health information technology (health it) developers, \n",
      "the voluntary certification of health it for use by pediatric health \n",
      "providers, and reasonable and necessary activities that do not \n",
      "constitute information blocking. in addition, the proposed rule would \n",
      "implement parts of section 4006(a) of the cures act to support patient \n",
      "access to their electronic health information (ehi), such as making a \n",
      "patient's ehi more electronically accessible through the adoption of \n",
      "standards and certification criteria and the implementation of \n",
      "information blocking policies that support patient electronic access to \n",
      "their health information at no cost. additionally, the proposed rule \n",
      "would modify the 2015 edition health it certification criteria and onc \n",
      "health it certification program (program) in other ways to advance \n",
      "interoperability, enhance health it certification, and reduce burden \n",
      "and costs.\n",
      "    in addition to fulfilling the cures act's requirements, the \n",
      "proposed rule would contribute to fulfilling executive order (e.o.) \n",
      "13813. the president issued e.o. 13813 on october 12, 2017, to promote \n",
      "health care choice and competition across the united states. section \n",
      "1(c) of the e.o., in relevant part, states that government rules \n",
      "affecting the united states health care system should re-inject \n",
      "competition into the health care markets by lowering barriers to entry \n",
      "and preventing abuses of market power. section 1(c) also states that \n",
      "government rules should improve access to and the quality of \n",
      "information that americans need to make informed health care decisions. \n",
      "for example, as mentioned above, the proposed rule focuses on \n",
      "establishing application programming interfaces (apis) for several \n",
      "interoperability purposes, including patient access to their health \n",
      "information without special effort. the api approach also supports \n",
      "health care providers having the sole authority and autonomy to \n",
      "unilaterally permit connections to their health it through certified \n",
      "api technology the health care providers have acquired. in addition, \n",
      "the proposed rule provides onc's interpretation of the information \n",
      "blocking definition as established in the cures act and the application \n",
      "of the information blocking provision by identifying reasonable and \n",
      "necessary activities that would not constitute information blocking. \n",
      "many of these activities focus on improving patient and health care \n",
      "provider access to electronic health information and promoting \n",
      "competition.\n",
      "\n",
      "b. summary of major provisions and clarifications\n",
      "\n",
      "1. deregulatory actions for previous rulemakings\n",
      "    since the inception of the program, we have aimed to implement and \n",
      "administer the program in the least burdensome manner that supports our \n",
      "policy goals. throughout the years, we have worked to improve the \n",
      "program with a focus on ways to reduce burden, offer flexibility to \n",
      "both developers and providers, and support innovation. this approach \n",
      "has been consistent with the principles of executive order 13563 on \n",
      "improving regulation and regulatory review (february 2, 2011), which \n",
      "instructs agencies to ``determine whether any [agency] regulations \n",
      "should be modified, streamlined, expanded, or repealed so as to make \n",
      "the agency's regulatory program more effective or less burdensome in \n",
      "achieving the regulatory objectives.'' to that end, we have \n",
      "historically, where feasible and appropriate, taken measures to reduce \n",
      "burden within the program and make the program more effective, \n",
      "flexible, and streamlined.\n",
      "    onc has reviewed and evaluated existing regulations to identify \n",
      "ways to administratively reduce burden and implement deregulatory \n",
      "actions through guidance. in this proposed rule, we also propose \n",
      "potential new deregulatory actions that will reduce burden for health \n",
      "it developers, providers, and other stakeholders. we propose six \n",
      "deregulatory actions in section iii.b: (1) removal of a threshold \n",
      "requirement related to randomized surveillance which allows onc-\n",
      "authorized certification bodies (onc-acbs) more flexibility to identify \n",
      "the right approach for surveillance actions, (2) removal of the 2014 \n",
      "edition from the code of federal regulations (cfr), (3) removal of the \n",
      "onc-approved accreditor (onc-aa) from the program, (4) removal of \n",
      "certain 2015 edition certification criteria, (5) removal of certain \n",
      "program requirements, and (6) recognition of relevant food and drug \n",
      "administration certification processes with a request for comment on \n",
      "the potential development of new processes for the program.\n",
      "2. updates to the 2015 edition certification criteria\n",
      "    this rule proposes to update the 2015 edition by not only proposing \n",
      "criteria for removal, but by proposing to revise and add new \n",
      "certification criteria that would establish the capabilities and \n",
      "related standards and implementation specifications for the \n",
      "certification of health it.\n",
      "a. adoption of the united states core data for interoperability (uscdi) \n",
      "as a standard\n",
      "    as part of onc's continued efforts to assure the availability of a \n",
      "minimum baseline of data classes that could be commonly available for \n",
      "interoperable exchange, we adopted the 2015 edition ``common clinical \n",
      "data set'' (ccds) definition and used the ccds shorthand in several \n",
      "certification criteria. however, the ccds definition also began to be \n",
      "colloquially used for many different purposes. as the ccds definition's \n",
      "relevance grew outside of its regulatory context, it became a symbolic \n",
      "and practical limit to the industry's collective interests to go beyond \n",
      "the ccds data for access, exchange, and use. in addition, as we move \n",
      "further towards value-based care, the need for the inclusion of \n",
      "additional data classes that go beyond clinical data is necessary. in \n",
      "order to advance interoperability, we propose to remove the ccds \n",
      "definition and its references\n",
      "\n",
      "[[page 7427]]\n",
      "\n",
      "from the 2015 edition and replace it with the ``united states core data \n",
      "for interoperability.'' we propose to adopt the uscdi as a standard, \n",
      "naming uscdi version 1 (uscdi v1) in sec.  170.213 and incorporating it \n",
      "by reference in sec.  170.299. the uscdi standard, if adopted, would \n",
      "establish a set of data classes and constituent data elements that \n",
      "would be required to be exchanged in support of interoperability \n",
      "nationwide. to achieve the goals set forth in the cures act, onc \n",
      "intends to establish and follow a predictable, transparent, and \n",
      "collaborative process to expand the uscdi, including providing \n",
      "stakeholders with the opportunity to comment on the uscdi's expansion. \n",
      "once the uscdi is adopted in regulation naming uscdi v1, health it \n",
      "developers would be allowed to take advantage of a flexibility under \n",
      "the maintenance of certification real world testing requirements, which \n",
      "we refer to as the ``standards version advancement process'' (described \n",
      "in section vii.b.5 of this proposed rule). the standards version \n",
      "advancement process would permit health it developers to voluntarily \n",
      "implement and use a new version of an adopted standard, such as the \n",
      "uscdi, so long as the newer version was approved by the national \n",
      "coordinator through the standards version advancement process for use \n",
      "in certification.\n",
      "b. electronic prescribing\n",
      "    we propose to update the electronic prescribing (e-rx) script \n",
      "standard in 45 cfr 170.205(b) to ncpdp script 2017071, which would \n",
      "result in a new e-rx standard eventually becoming the baseline for \n",
      "certification. we also propose to adopt a new certification criterion \n",
      "in sec.  170.315(b)(11) for e-rx to reflect these updated proposals. \n",
      "onc and cms have historically maintained complementary policies of \n",
      "maintaining aligned e-rx and medical history (mh) standards to ensure \n",
      "that the current standard for certification to the electronic \n",
      "prescribing criterion permits use of the current part d e-rx and mh \n",
      "standards. this proposal is made to ensure such alignment as cms \n",
      "recently finalized its part d standards to ncpdp script 2017071 for e-\n",
      "rx and mh, effective january 1, 2020 (83 fr 16440). in addition to \n",
      "continuing to reference the current transactions included in sec.  \n",
      "170.315(b)(3), in keeping with cms' final rule, we also propose to \n",
      "require all of the ncpdp script 2017071 standard transactions cms \n",
      "adopted at 42 cfr 423.160(b)(2)(iv).\n",
      "c. clinical quality measures--report\n",
      "    we propose to remove the hl7 quality reporting document \n",
      "architecture (qrda) standard requirements from the 2015 edition \n",
      "``cqms--report'' criterion in sec.  170.315(c)(3) and, in their place, \n",
      "require health it modules to support the cms qrda implementation guide \n",
      "(igs).\\1\\ this would reduce the burden for health it developers by only \n",
      "having to support one form of the qrda standard rather than two forms \n",
      "(i.e., the hl7 and cms forms).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\1\\ <a href=\"https://ecqi.healthit.gov/qrda-quality-reporting-document-architecture\">https://ecqi.healthit.gov/qrda-quality-reporting-document-architecture</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "d. electronic health information export\n",
      "    we propose a new 2015 edition certification criterion for \n",
      "``electronic health information (ehi) export'' in sec.  170.315(b)(10), \n",
      "which would replace the 2015 edition ``data export'' certification \n",
      "criterion (sec.  170.315(b)(6)) and become part of the 2015 edition \n",
      "base ehr definition. the proposed criterion supports situations in \n",
      "which we believe that all ehi produced and electronically managed by a \n",
      "developer's health it should be made readily available for export as a \n",
      "standard capability of certified health it. specifically, this \n",
      "criterion would: (1) enable the export of ehi for a single patient upon \n",
      "a valid request from that patient or a user on the patient's behalf, \n",
      "and (2) support the export of ehi when a health care provider chooses \n",
      "to transition or migrate information to another health it system. this \n",
      "criterion would also require that the export include the data format, \n",
      "made publicly available, to facilitate the receiving health it system's \n",
      "interpretation and use of the ehi to the extent reasonably practicable \n",
      "using the developer's existing technology.\n",
      "    this criterion provides developers with the ability to create \n",
      "innovative export capabilities according to their systems and data \n",
      "practices. we do not propose that the export must be executed according \n",
      "to any particular standard, but propose to require that the export must \n",
      "be accompanied by the data format, including its structure and syntax, \n",
      "to facilitate interpretation of the ehi therein. overall, this new \n",
      "criterion is intended to provide patients and health it users, \n",
      "including providers, a means to efficiently export the entire \n",
      "electronic health record for a single patient or all patients in a \n",
      "computable, electronic format.\n",
      "e. application programming interfaces (apis)\n",
      "    we propose to adopt a new api criterion in sec.  170.315(g)(10), \n",
      "which would replace the ``application access--data category request'' \n",
      "certification criterion (sec.  170.315(g)(8)) and become part of the \n",
      "2015 edition base ehr definition. this new ``standardized api for \n",
      "patient and population services'' certification criterion would require \n",
      "the use of health level 7 (hl7[supreg]) fast healthcare \n",
      "interoperability resources (fhir[supreg]) standards \\2\\ and several \n",
      "implementation specifications. the new criterion would focus on \n",
      "supporting two types of api-enabled services: (1) services for which a \n",
      "single patient's data is the focus and (2) services for which multiple \n",
      "patients' data are the focus.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\2\\ <a href=\"https://www.hl7.org/fhir/overview.html\">https://www.hl7.org/fhir/overview.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "f. privacy and security transparency attestations\n",
      "    we propose to adopt two new privacy and security transparency \n",
      "attestation certification criteria, which would identify whether \n",
      "certified health it supports encrypting authentication credentials and/\n",
      "or multi-factor authentication. in order to be issued a certification, \n",
      "we propose to require that a health it module developer attest to \n",
      "whether the health it module encrypts authentication credentials and \n",
      "whether the health it module supports multi-factor authentication. \n",
      "these criteria are not expected to place additional burden on health it \n",
      "developers since they do not require net new development or \n",
      "implementation to take place in order to be met. however, certification \n",
      "to these proposed criteria would provide increased transparency and \n",
      "potentially motivate health it developers to encrypt authentication \n",
      "credentials and support multi- factor authentication, which could help \n",
      "prevent exposure to unauthorized persons/entities.\n",
      "g. data segmentation for privacy and consent management\n",
      "    in the 2015 edition, we adopted two ``data segmentation for \n",
      "privacy'' (ds4p) certification criteria, one for creating a summary \n",
      "record according to the ds4p standard and one for receiving a summary \n",
      "record according to the ds4p standard. certification to the 2015 \n",
      "edition ds4p criteria focus on data segmentation only at the document \n",
      "level. as noted in the 2015 edition final rule (80 fr 62646)--and to \n",
      "our knowledge still an accurate assessment--certification to these \n",
      "criteria is currently not required to meet the certified ehr technology \n",
      "definition\n",
      "\n",
      "[[page 7428]]\n",
      "\n",
      "(cehrt) or required by any other hhs program. since the 2015 edition \n",
      "final rule, the health care industry has engaged in additional field \n",
      "testing and implementation of the ds4p standard. in addition, \n",
      "stakeholders shared with onc--through public forums, listening \n",
      "sessions, and correspondence--that focusing certification on \n",
      "segmentation to only the document level does not permit providers the \n",
      "flexibility to address more granular segmentation needs. therefore, we \n",
      "propose to remove the current 2015 edition ds4p criteria. we propose to \n",
      "replace these two criteria with three new 2015 edition ``ds4p'' \n",
      "certification criteria (two for c-cda and one for a fhir-based api) \n",
      "that would support a more granular approach to privacy tagging data \n",
      "consent management for health information exchange supported by either \n",
      "the c-cda- or fhir-based exchange standards.\n",
      "3. modifications to the onc health it certification program\n",
      "    we propose to make corrections to the 2015 edition privacy and \n",
      "security certification framework (80 fr 62705) and relevant regulatory \n",
      "provisions. these corrections have already been incorporated in the \n",
      "relevant certification companion guides (ccgs).\n",
      "    we propose new and revised principles of proper conduct (popc) for \n",
      "onc-authorized certification bodies (onc-acbs). we propose to clarify \n",
      "that the records retention provision includes the ``life of the \n",
      "edition'' as well as after the retirement of an edition related to the \n",
      "certification of complete ehrs and health it modules. we also propose \n",
      "to revise the popc in sec.  170.523(h) to clarify the basis for \n",
      "certification, including to permit a certification decision to be based \n",
      "on an evaluation conducted by the onc-acb for health it modules' \n",
      "compliance with certification criteria by use of conformity methods \n",
      "approved by the national coordinator for health information technology \n",
      "(national coordinator). we also propose to update sec.  170.523(h) to \n",
      "require onc-acbs to accept test results from any onc-atl that is in \n",
      "good standing under the program and is compliant with its iso 17025 \n",
      "accreditation requirements. we believe these proposed new and revised \n",
      "popcs would provide necessary clarifications for onc-acbs and would \n",
      "promote stability among the onc-acbs. we also propose to update sec.  \n",
      "170.523(k) to broaden the requirements beyond just the medicare and \n",
      "medicaid electronic health record (ehr) incentive programs (now renamed \n",
      "the promoting interoperability programs) and provide other necessary \n",
      "clarifications.\n",
      "    we propose to revise a popc for onc-atls. we propose to clarify \n",
      "that the records retention provision includes the ``life of the \n",
      "edition'' as well as after the retirement of an edition related to the \n",
      "certification of complete ehrs and health it modules.\n",
      "4. health it for the care continuum\n",
      "    section 4001(b) of the cures act includes two provisions related to \n",
      "supporting health it across the care continuum. the first instructs the \n",
      "national coordinator to encourage, keep or recognize through existing \n",
      "authorities, the voluntary certification of health it for use in \n",
      "medical specialties and sites of service where more technological \n",
      "advancement or integration is needed. the second outlines a provision \n",
      "related to the voluntary certification of health it for use by \n",
      "pediatric health providers to support the health care of children. \n",
      "these provisions align closely with onc's core purpose to promote \n",
      "interoperability to support care coordination, patient engagement, and \n",
      "health care quality improvement initiatives. advancing health it that \n",
      "promotes and supports patient care when and where it is needed \n",
      "continues to be a primary goal of the program. this means health it \n",
      "should support patient populations, specialized care, transitions of \n",
      "care, and practice settings across the care continuum.\n",
      "    onc has explored how we might work with the health it industry and \n",
      "with specialty organizations to collaboratively develop and promote \n",
      "health it that supports medical specialties and sites of service. over \n",
      "time, onc has taken steps to make the program modular, more open and \n",
      "accessible to different types of health it, and able to advance \n",
      "functionality that is generally applicable to a variety of care and \n",
      "practice settings. specific to the provisions in the cures act to \n",
      "support providers of health care for children, we considered a wide \n",
      "range of factors. these include: the evolution of health it across the \n",
      "care continuum, the costs and benefits associated with health it, the \n",
      "potential regulatory burden and compliance timelines, and the need to \n",
      "help advance health it that benefits multiple medical specialties and \n",
      "sites of service involved in the care of children. in consideration of \n",
      "these factors, and to advance implementation of sections 4001(b) of the \n",
      "cures act specific to pediatric care, we held a listening session where \n",
      "stakeholders could share their clinical knowledge and technical \n",
      "expertise in pediatric care and pediatric sites of service. through the \n",
      "information learned at this listening session and our analysis of the \n",
      "health it landscape for pediatric settings, we have identified existing \n",
      "2015 edition criteria, as well as new and revised 2015 edition criteria \n",
      "proposed in this rule, that we believe could benefit providers of \n",
      "pediatric care and pediatric settings. in this proposed rule, we seek \n",
      "comment on our analysis and the correlated certification criteria that \n",
      "we believe would support the health care of children.\n",
      "    we also recognize the significance of the opioid epidemic \n",
      "confronting our nation and the importance of helping to support the \n",
      "health it needs of health care providers committed to preventing \n",
      "inappropriate access to prescription opioids and to providing safe, \n",
      "appropriate treatment. we believe health it offers promising strategies \n",
      "to help assist medical specialties and sites of services impacted by \n",
      "the opioid epidemic. therefore, we request public comment on how our \n",
      "existing program requirements and the proposals in this rulemaking may \n",
      "support use cases related to opioid use disorder (oud) prevention and \n",
      "treatment and if there are additional areas that onc should consider \n",
      "for effective implementation of health it to help address oud \n",
      "prevention and treatment.\n",
      "5. conditions and maintenance of certification\n",
      "    we propose to establish certain conditions and maintenance of \n",
      "certification requirements for health it developers based on the \n",
      "conditions and maintenance of certification requirements outlined in \n",
      "section 4002 of the cures act. we propose an approach whereby the \n",
      "conditions and maintenance of certification express both initial \n",
      "requirements for health it developers and their certified health it \n",
      "module(s) as well as ongoing requirements that must be met by both \n",
      "health it developers and their certified health it module(s) under the \n",
      "program. in this regard, we propose to implement the cures act \n",
      "conditions of certification with further specificity as it applies to \n",
      "the program and propose to implement any accompanying maintenance of \n",
      "certification requirements as standalone requirements to ensure that \n",
      "not only are the conditions of certification met, but that they are \n",
      "continually being met through the maintenance of certification \n",
      "requirements. for ease of reference and to distinguish from other \n",
      "conditions, we propose to capitalize ``conditions of certification'' \n",
      "and ``maintenance of certification'' when referring to conditions and \n",
      "maintenance\n",
      "\n",
      "[[page 7429]]\n",
      "\n",
      "of certification requirements established under the cures act.\n",
      "information blocking\n",
      "    the cures act requires that a health it developer, as a condition \n",
      "and maintenance of certification under the program, not take any action \n",
      "that constitutes information blocking as defined in section 3022(a) of \n",
      "the public health service act (phsa). we propose to establish this \n",
      "information blocking condition of certification in sec.  170.401. the \n",
      "condition of certification would prohibit any health it developer under \n",
      "the program from taking any action that constitutes information \n",
      "blocking as defined by section 3022(a) of the phsa and proposed in \n",
      "sec.  171.103.\n",
      "assurances\n",
      "    section 3001(c)(5)(d)(ii) of the cures act requires that a health \n",
      "it developer, as a condition of certification under the program, \n",
      "provide assurances to the secretary that, unless for legitimate \n",
      "purposes specified by the secretary, the developer will not take any \n",
      "action that constitutes information blocking as defined in section \n",
      "3022(a) of the phsa, or any other action that may inhibit the \n",
      "appropriate exchange, access, and use of ehi. we propose to implement \n",
      "this provision through several conditions of certification and \n",
      "accompanying maintenance requirements, which are set forth in proposed \n",
      "sec.  170.402. we also propose to establish more specific conditions \n",
      "and maintenance of certification requirements to provide assurances \n",
      "that a health it developer does not take any other action that may \n",
      "inhibit the appropriate exchange, access, and use of ehi. these \n",
      "proposed requirements serve to provide further clarity under the \n",
      "program as to how health it developers can provide such broad \n",
      "assurances with more specific actions.\n",
      "communications\n",
      "    as a condition and maintenance of certification under the program, \n",
      "the cures act requires that health it developers do not prohibit or \n",
      "restrict communications about certain aspects of the performance of \n",
      "health it and the developers' related business practices. we propose \n",
      "that developers will be permitted to impose certain kinds of limited \n",
      "prohibitions and restrictions that we believe strike a reasonable \n",
      "balance between the need to promote open communication about health it \n",
      "and related developer business practices and the need to protect the \n",
      "legitimate interests of health it developers and other entities. \n",
      "however, certain narrowly-defined types of communications--such as \n",
      "communications required by law, made to a government agency, or made to \n",
      "a defined category of safety organization--would receive ``unqualified \n",
      "protection,'' meaning that developers would be absolutely prohibited \n",
      "from imposing any prohibitions or restrictions on such protected \n",
      "communications.\n",
      "    we propose that to maintain compliance with this condition of \n",
      "certification, a health it developer must not impose or enforce any \n",
      "contractual requirement or legal right that contravenes this condition \n",
      "of certification. furthermore, we propose that if a health it developer \n",
      "has contracts/agreements in existence that contravene this condition, \n",
      "the developer must notify all affected customers or other persons or \n",
      "entities that the prohibition or restriction will not be enforced by \n",
      "the health it developer. going forward, health it developers would be \n",
      "required to amend their contracts/agreements to remove or make void the \n",
      "provisions that contravene this condition of certification within a \n",
      "reasonable period of time, but not later than two years from the \n",
      "effective date of a subsequent final rule for this proposed rule.\n",
      "application programming interfaces (apis)\n",
      "    the cures act's api condition of certification includes several key \n",
      "phrases (including, for example, ``without special effort'') and \n",
      "requirements for health it developers that indicate the cures act's \n",
      "focus on the technical requirements as well as the actions and \n",
      "practices of health it developers in implementing the certified api. in \n",
      "section vii.b.4 of the preamble, we outline our proposals to implement \n",
      "the cures act's api condition of certification. these proposals include \n",
      "new standards, new implementation specifications, a new certification \n",
      "criterion, as well as detailed conditions and maintenance of \n",
      "certification requirements.\n",
      "real world testing\n",
      "    the cures act adds a new condition and maintenance of certification \n",
      "requirement that health it developers successfully test the real world \n",
      "use of the technology for interoperability in the type of setting in \n",
      "which such technology would be marketed. in this proposed rule, we \n",
      "outline what successful ``real world testing'' means for the purpose of \n",
      "this condition of certification, as well as proposed maintenance \n",
      "requirements--including standards updates for widespread and continued \n",
      "interoperability.\n",
      "    we propose to limit the applicability of this condition of \n",
      "certification to health it developers with health it modules certified \n",
      "to one or more 2015 edition certification criteria focused on \n",
      "interoperability and data exchange specified in section vii.b.5. we \n",
      "propose maintenance of certification requirements that would require \n",
      "health it developers to submit publicly available annual real world \n",
      "testing plans as well as annual real world testing results for \n",
      "certified health it products focused on interoperability. we also \n",
      "propose a maintenance of certification flexibility we have named the \n",
      "standards version advancement process, under which health it developers \n",
      "with health it certified to the criteria specified for interoperability \n",
      "and data exchange would have the option to update their health it to a \n",
      "more advanced version(s) of the standard(s) or implementation \n",
      "specification(s) included in the criteria once such versions are \n",
      "approved by the national coordinator through the standards version \n",
      "advancement process for use in health it certified under the program. \n",
      "similarly, we propose that health it developers presenting new health \n",
      "it for certification to one of the criteria specified in section \n",
      "vii.b.5 would have the option to certify to a national coordinator-\n",
      "approved more advanced version of the adopted standards or \n",
      "implementation specifications included in the criteria. we propose that \n",
      "health it developers voluntarily opting to avail themselves of the \n",
      "standards version advancement process must address their planned and \n",
      "actual timelines for implementation and rollout of standards updates in \n",
      "their annual real world testing plans and real world testing results \n",
      "submissions. we also propose that health it developers of products with \n",
      "existing certifications who plan to avail themselves of the standards \n",
      "version advancement process flexibility notify both their onc-acb and \n",
      "their affected customers of their intention and plans to update their \n",
      "certified health it and its anticipated impact on their existing \n",
      "certified health it and customers, specifically including but not \n",
      "limited to whether, and if so for how long, the health it developer \n",
      "intends to continue to support the certificate for the health it \n",
      "certified to the prior version of the standard.\n",
      "    we propose a new popc for onc-acbs that would require onc-acbs to \n",
      "review and confirm that applicable health it developers submit real \n",
      "world testing plans and real world results in accordance with our \n",
      "proposals. once\n",
      "\n",
      "[[page 7430]]\n",
      "\n",
      "completeness is confirmed, onc-acbs would upload the plans and results \n",
      "via hyperlinks to the certified health it product list (chpl). we \n",
      "propose to revise the popc in sec.  170.523(m) to require onc-acbs to \n",
      "collect, no less than quarterly, all updates successfully made to \n",
      "standards in certified health it pursuant to the developers having \n",
      "voluntarily opted to avail themselves of the standards version \n",
      "advancement process flexibility under the real world testing condition \n",
      "of certification. we propose in sec.  170.523(t), a new popc for onc-\n",
      "acbs requiring them to ensure that developers seeking to take advantage \n",
      "of the standards version advancement process flexibility in sec.  \n",
      "170.405(b)(5) comply with the applicable requirements.\n",
      "attestations\n",
      "    the cures act requires that a health it developer, as a condition \n",
      "and maintenance of certification under the program, provide to the \n",
      "secretary an attestation to all the conditions of certification \n",
      "specified in the cures act, except for the ``ehr reporting criteria \n",
      "submission'' condition of certification. we propose to implement the \n",
      "cures act ``attestations'' condition of certification in sec.  170.406. \n",
      "health it developers would attest twice a year to compliance with the \n",
      "conditions and maintenance of certification requirements (except for \n",
      "the ehr reporting criteria requirement, which would be metrics \n",
      "reporting requirements separately implemented through a future \n",
      "rulemaking). the 6-month attestation period we propose in sec.  \n",
      "170.406(b)(2) would properly balance the need to support appropriate \n",
      "enforcement with the attestation burden placed on health it developers. \n",
      "in this regard, the proposed rule includes provisions to make the \n",
      "process as simple and efficient for health it developers as possible \n",
      "(e.g., 14-day grace period, web-based form submissions, and attestation \n",
      "alert reminders).\n",
      "    we propose that attestations would be submitted to onc-acbs on \n",
      "behalf of onc and the secretary. we propose a new popc in sec.  \n",
      "170.523(q) that an onc-acb must review and submit the health it \n",
      "developers' attestations to onc. onc would then make the attestations \n",
      "publicly available through the chpl.\n",
      "ehr reporting criteria submission\n",
      "    the cures act specifies that health it developers be required, as a \n",
      "condition and maintenance of certification under the program, to submit \n",
      "reporting criteria on certified health it in accordance with the ehr \n",
      "reporting program established under section 3009a of the phsa, as added \n",
      "by the cures act. we have not yet established an ehr reporting program. \n",
      "once onc establishes such program, we will undertake rulemaking to \n",
      "propose and implement the associated condition and maintenance of \n",
      "certification requirement(s) for health it developers.\n",
      "enforcement\n",
      "    section 4002 of the cures act adds program requirements aimed at \n",
      "addressing health it developer actions and business practices through \n",
      "the conditions and maintenance of certification requirements, which \n",
      "expands the current focus of the program requirements beyond the \n",
      "certified health it itself. equally important, section 4002 also \n",
      "provides that the secretary of hhs may encourage compliance with the \n",
      "conditions and maintenance of certification requirements and take \n",
      "action to discourage noncompliance. we, therefore, propose a general \n",
      "enforcement approach to encourage consistent compliance with the \n",
      "requirements. the proposed rule outlines a corrective action process \n",
      "for onc to review potential or known instances where a condition or \n",
      "maintenance of certification requirement has not been or is not being \n",
      "met by a health it developer under the program. we propose, with minor \n",
      "modifications, to utilize the processes previously established for onc \n",
      "direct review of certified health it and codified in sec. sec.  170.580 \n",
      "and 170.581 for the enforcement of the conditions and maintenance of \n",
      "certification requirements. where noncompliance is identified, our \n",
      "first priority would be to work with the health it developer to remedy \n",
      "the matter through a corrective action process. however, we propose \n",
      "that, under certain circumstances, onc may ban a health it developer \n",
      "from the program or terminate the certification of one or more of its \n",
      "health it modules.\n",
      "6. information blocking\n",
      "    section 4004 of the cures act added section 3022 of the phsa (42 \n",
      "u.s.c. 300jj-52, ``the information blocking provision''), which defines \n",
      "conduct by health care providers, and health it developers of certified \n",
      "health it, exchanges, and networks that constitutes information \n",
      "blocking. section 3022(a)(1) of the phsa defines information blocking \n",
      "in broad terms, while section 3022(a)(3) authorizes and charges the \n",
      "secretary to identify reasonable and necessary activities that do not \n",
      "constitute information blocking (section 3022(a)(3) of the phsa).\n",
      "    we identify several reasonable and necessary activities as \n",
      "exceptions to the information blocking definition, each of which we \n",
      "propose would not constitute information blocking for purposes of \n",
      "section 3022(a)(1) of the phsa. the exceptions would extend to certain \n",
      "activities that interfere with the access, exchange, or use of ehi but \n",
      "that may be reasonable and necessary if certain conditions are met.\n",
      "    in developing the proposed exceptions, we were guided by three \n",
      "overarching policy considerations. first, the exceptions would be \n",
      "limited to certain activities that clearly advance the aims of the \n",
      "information blocking provision; promoting public confidence in health \n",
      "it infrastructure by supporting the privacy and security of ehi, and \n",
      "protecting patient safety; and promoting competition and innovation in \n",
      "health it and its use to provide health care services to consumers. \n",
      "second, each exception is intended to address a significant risk that \n",
      "regulated individuals and entities (i.e., health care providers, health \n",
      "it developers of certified health it, health information networks, and \n",
      "health information exchanges) will not engage in these reasonable and \n",
      "necessary activities because of potential uncertainty regarding whether \n",
      "they would be considered information blocking. third, and last, each \n",
      "exception is intended to be tailored, through appropriate conditions, \n",
      "so that it is limited to the reasonable and necessary activities that \n",
      "it is designed to exempt.\n",
      "    the seven proposed exceptions are set forth in section viii.d \n",
      "below. the first three exceptions, set forth in viii.d.1-d.3 address \n",
      "activities that are reasonable and necessary to promote public \n",
      "confidence in the use of health it and the exchange of ehi. these \n",
      "exceptions are intended to protect patient safety; promote the privacy \n",
      "of ehi; and promote the security of ehi. the next three exceptions, set \n",
      "forth in viii.d.4-d.6, address activities that are reasonable and \n",
      "necessary to promote competition and consumer welfare. these exceptions \n",
      "would allow for the recovery of costs reasonably incurred; excuse an \n",
      "actor from responding to requests that are infeasible; and permit the \n",
      "licensing of interoperability elements on reasonable and non- \n",
      "discriminatory terms. the last exception, set forth in viii.d.7, \n",
      "addresses activities that are reasonable and necessary to promote the \n",
      "performance of health it. this proposed exception recognizes that \n",
      "actors may make health it temporarily unavailable for maintenance or \n",
      "improvements that\n",
      "\n",
      "[[page 7431]]\n",
      "\n",
      "benefit the overall performance and usability of health it.\n",
      "    to qualify for any of these exceptions, we propose that an \n",
      "individual or entity would, for each relevant practice and at all \n",
      "relevant times, have to satisfy all of the applicable conditions of the \n",
      "exception. additionally, we propose (in section viii.c of this \n",
      "preamble) to define or interpret terms that are present in section 3022 \n",
      "of the phsa (such as the types of individuals and entities covered by \n",
      "the information blocking provision). we also propose certain new terms \n",
      "and definitions that are necessary to implement the information \n",
      "blocking provisions. we propose to codify the proposed exceptions and \n",
      "other information blocking proposals in a new part of title 45 of the \n",
      "code of federal regulations, part 171.\n",
      "\n",
      "c. costs and benefits\n",
      "\n",
      "    executive orders 12866 on regulatory planning and review (september \n",
      "30, 1993) and 13563 on improving regulation and regulatory review \n",
      "(february 2, 2011) direct agencies to assess all costs and benefits of \n",
      "available regulatory alternatives and, if regulation is necessary, to \n",
      "select regulatory approaches that maximize net benefits (including \n",
      "potential economic, environmental, public health and safety effects, \n",
      "distributive impacts, and equity). a regulatory impact analysis (ria) \n",
      "must be prepared for major rules with economically significant effects \n",
      "($100 million or more in any one year). omb has determined that this \n",
      "proposed rule is an economically significant rule as the potential \n",
      "costs associated with this proposed rule could be greater than $100 \n",
      "million per year. accordingly, we have prepared an ria that to the best \n",
      "of our ability presents the costs and benefits of this proposed rule.\n",
      "    we have estimated the potential monetary costs and benefits of this \n",
      "proposed rule for health it developers, health care providers, \n",
      "patients, onc-acbs, onc-atls, and the federal government (i.e., onc), \n",
      "and have broken those costs and benefits out into the following \n",
      "categories: (1) deregulatory actions (no associated costs); (2) updates \n",
      "to the updates to the 2015 edition health it certification criteria; \n",
      "(3) conditions and maintenance of certification for a health it \n",
      "developer; (4) oversight for the conditions and maintenance of \n",
      "certification; and (5) information blocking.\n",
      "    we note that we have rounded all estimates to the nearest dollar \n",
      "and all estimates are expressed in 2016 dollars as it is the most \n",
      "recent data available to address all cost and benefit estimates \n",
      "consistently. we also note that we did not have adequate data to \n",
      "quantify some of the costs and benefits within this ria. in those \n",
      "situations, we have described the qualitative costs and benefits of our \n",
      "proposals; however, such qualitative costs and benefits have not been \n",
      "accounted for in the monetary cost and benefit totals below.\n",
      "    we estimate that the total annual cost for this proposed rule for \n",
      "the first year after it is finalized (including one-time costs), based \n",
      "on the cost estimates outlined above and throughout this ria, would, on \n",
      "average, range from $365 million to $919 million with an average annual \n",
      "cost of $642 million. we estimate that the total perpetual cost for \n",
      "this proposed rule (starting in year two), based on the cost estimates \n",
      "outlined above, would, on average, range from $228 million to $452 \n",
      "million with an average annual cost of $340 million.\n",
      "    we estimate the total annual benefit for this proposed rule would \n",
      "range from $3.08 billion to $9.15 billion with an average annual \n",
      "benefit of $6.1 billion.\n",
      "    we estimate the total annual net benefit for this proposed rule for \n",
      "the first year after it is finalized (including one-time costs), based \n",
      "on the cost and benefit estimates outlined above, would range from $2.7 \n",
      "billion to $8.2 billion with an average net benefit of $5.5 billion. we \n",
      "estimate the total perpetual annual net benefit for this proposed rule \n",
      "(starting in year two), based on the cost-benefit estimates outlined \n",
      "above, would range from $2.9 billion to $8.7 billion with an average \n",
      "net benefit of $5.8 billion.\n",
      "\n",
      "ii. background\n",
      "\n",
      "a. statutory basis\n",
      "\n",
      "    the health information technology for economic and clinical health \n",
      "(hitech) act, title xiii of division a and title iv of division b of \n",
      "the american recovery and reinvestment act of 2009 (the recovery act) \n",
      "(pub. l. 111-5), was enacted on february 17, 2009. the hitech act \n",
      "amended the public health service act (phsa) and created ``title xxx--\n",
      "health information technology and quality'' (title xxx) to improve \n",
      "health care quality, safety, and efficiency through the promotion of \n",
      "health it and electronic health information (ehi) exchange.\n",
      "    the cures act was enacted on december 13, 2016, to accelerate the \n",
      "discovery, development, and delivery of 21st century cures, and for \n",
      "other purposes. the cures act, through title iv--delivery, amended the \n",
      "hitech act (title xiii of division a of pub. l. 111-5) by modifying or \n",
      "adding certain provisions to the phsa relating to health it.\n",
      "1. standards, implementation specifications, and certification criteria\n",
      "    the hitech act established two new federal advisory committees, the \n",
      "hit policy committee (hitpc) and the hit standards committee (hitsc). \n",
      "each was responsible for advising the national coordinator for health \n",
      "information technology (national coordinator) on different aspects of \n",
      "standards, implementation specifications, and certification criteria.\n",
      "    section 3002 of the cures act amended the phsa by replacing the \n",
      "hitpc and hitsc with one committee, the health information technology \n",
      "advisory committee (hit advisory committee or hitac). section 3002(a) \n",
      "establishes that the hitac shall advise and recommend to the national \n",
      "coordinator on different aspects of standards, implementation \n",
      "specifications, and certification criteria, relating to the \n",
      "implementation of a health it infrastructure, nationally and locally, \n",
      "that advances the electronic access, exchange, and use of health \n",
      "information. further described in section 3002(b)(1)(a) of the phsa, \n",
      "this includes providing to the national coordinator recommendations on \n",
      "a policy framework to advance interoperable health it infrastructure, \n",
      "updating recommendations to the policy framework, and making new \n",
      "recommendations, as appropriate. section 3002(b)(2)(a) identifies that \n",
      "in general, the hitac shall recommend to the national coordinator for \n",
      "purposes of adoption under section 3004, standards, implementation \n",
      "specifications, and certification criteria and an order of priority for \n",
      "the development, harmonization, and recognition of such standards, \n",
      "specifications, and certification criteria. like the process previously \n",
      "required of the former hitpc and hitsc, the hitac will develop a \n",
      "schedule for the assessment of policy recommendations for the secretary \n",
      "to publish in the federal register.\n",
      "    section 3004 of the phsa identifies a process for the adoption of \n",
      "health it standards, implementation specifications, and certification \n",
      "criteria and authorizes the secretary to adopt such standards, \n",
      "implementation specifications, and certification criteria. as specified \n",
      "in section 3004(a)(1), the secretary is required, in consultation with \n",
      "representatives of other relevant federal agencies, to jointly review \n",
      "standards, implementation specifications, and certification criteria \n",
      "endorsed by the national coordinator under section 3001(c) and \n",
      "subsequently\n",
      "\n",
      "[[page 7432]]\n",
      "\n",
      "determine whether to propose the adoption of any grouping of such \n",
      "standards, implementation specifications, or certification criteria. \n",
      "the secretary is required to publish all determinations in the federal \n",
      "register.\n",
      "    section 3004(b)(3) of the phsa titled, subsequent standards \n",
      "activity, provides that the secretary shall adopt additional standards, \n",
      "implementation specifications, and certification criteria as necessary \n",
      "and consistent with the schedule published by the hitac. we consider \n",
      "this provision in the broader context of the hitech act and cures act \n",
      "to grant the secretary the authority and discretion to adopt standards, \n",
      "implementation specifications, and certification criteria that have \n",
      "been recommended by the hitac and endorsed by the national coordinator, \n",
      "as well as other appropriate and necessary health it standards, \n",
      "implementation specifications, and certification criteria.\n",
      "2. health it certification program(s)\n",
      "    under the hitech act, section 3001(c)(5) of the phsa provides the \n",
      "national coordinator with the authority to establish a certification \n",
      "program or programs for the voluntary certification of health it. \n",
      "specifically, section 3001(c)(5)(a) specifies that the national \n",
      "coordinator, in consultation with the director of the national \n",
      "institute of standards and technology (nist), shall keep or recognize a \n",
      "program or programs for the voluntary certification of health it that \n",
      "is in compliance with applicable certification criteria adopted under \n",
      "this subtitle (i.e., certification criteria adopted by the secretary \n",
      "under section 3004 of the phsa). the certification program(s) must also \n",
      "include, as appropriate, testing of the technology in accordance with \n",
      "section 13201(b) of the hitech act. overall, section 13201(b) of the \n",
      "hitech act requires that with respect to the development of standards \n",
      "and implementation specifications, the director of nist shall support \n",
      "the establishment of a conformance testing infrastructure, including \n",
      "the development of technical test beds. the hitech act also indicates \n",
      "that the development of this conformance testing infrastructure may \n",
      "include a program to accredit independent, non-federal laboratories to \n",
      "perform testing.\n",
      "    section 3001(c)(5) of the phsa was amended by the cures act, which \n",
      "instructs the national coordinator to encourage, keep, or recognize, \n",
      "through existing authorities, the voluntary certification of health it \n",
      "under the program for use in medical specialties and sites of service \n",
      "for which no such technology is available or where more technological \n",
      "advancement or integration is needed. section 3001(c)(5)(c)(iii) \n",
      "identifies that the secretary, in consultation with relevant \n",
      "stakeholders, shall make recommendations for the voluntary \n",
      "certification of health it for use by pediatric health providers to \n",
      "support the care of children, as well as adopt certification criteria \n",
      "under section 3004 to support the voluntary certification of health it \n",
      "for use by pediatric health providers. the cures act further amended \n",
      "section 3001(c)(5) of the phsa by adding section 3001(c)(5)(d), which \n",
      "provides the secretary with the authority, through notice and comment \n",
      "rulemaking, to require conditions and maintenance of certification \n",
      "requirements for the program.\n",
      "\n",
      "b. regulatory history\n",
      "\n",
      "    the secretary issued an interim final rule with request for \n",
      "comments (75 fr 2014, jan. 13, 2010), which adopted an initial set of \n",
      "standards, implementation specifications, and certification criteria. \n",
      "on march 10, 2010, onc published a proposed rule (75 fr 11328) that \n",
      "proposed both a temporary and permanent certification program for the \n",
      "purposes of testing and certifying health it. a final rule establishing \n",
      "the temporary certification program was published on june 24, 2010 (75 \n",
      "fr 36158) and a final rule establishing the permanent certification \n",
      "program was published on january 7, 2011 (76 fr 1262). onc issued \n",
      "multiple rulemakings since these initial rulemaking to update \n",
      "standards, implementation specifications, and certification criteria \n",
      "and the certification program, a history of which can be found in the \n",
      "final rule titled, ``2015 edition health information (health it) \n",
      "certification criteria, 2015 edition base electronic health record \n",
      "(ehr) definition, and onc health it certification program \n",
      "modifications'' (oct. 16, 2015, 80 fr 62602) (``2015 edition final \n",
      "rule''). a correction notice was published for the 2015 edition final \n",
      "rule on december 11, 2015 (80 fr 76868) to correct preamble and \n",
      "regulatory text errors and clarify requirements of the common clinical \n",
      "data set (ccds), the 2015 edition privacy and security certification \n",
      "framework, and the mandatory disclosures for health it developers.\n",
      "    the 2015 edition final rule established a new edition of \n",
      "certification criteria (``2015 edition health it certification \n",
      "criteria'' or ``2015 edition'') and a new 2015 edition base ehr \n",
      "definition. the 2015 edition established the capabilities and specified \n",
      "the related standards and implementation specifications that cehrt \n",
      "would need to include to, at a minimum, support the achievement of \n",
      "``meaningful use'' by eligible clinicians, eligible hospitals, and \n",
      "critical access hospitals under the medicare and medicaid ehr incentive \n",
      "programs (ehr incentive programs) (now referred to as the promoting \n",
      "interoperability programs) \\3\\ when the 2015 edition is required for \n",
      "use under these and other programs referencing the cehrt definition. \n",
      "the 2015 edition final rule also made changes to the program. the final \n",
      "rule adopted a proposal to change the program's name to the ``onc \n",
      "health it certification program'' from the onc hit certification \n",
      "program, modified the program to make it more accessible to other types \n",
      "of health it beyond ehr technology and for health it that supports care \n",
      "and practice settings beyond the ambulatory and inpatient settings, and \n",
      "adopted new and revised principles of proper conduct (popc) for onc-\n",
      "acbs.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\3\\ <a href=\"https://www.federalregister.gov/d/2018-16766/p-4\">https://www.federalregister.gov/d/2018-16766/p-4</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    after issuing a proposed rule on march 2, 2016 (81 fr 11056), onc \n",
      "published a final rule titled, ``onc health it certification program: \n",
      "enhanced oversight and accountability'' (81 fr 72404) (``eoa final \n",
      "rule'') on october 19, 2016. the final rule finalized modifications and \n",
      "new requirements under the program, including provisions related to \n",
      "onc's role in the program. the final rule created a regulatory \n",
      "framework for onc's direct review of health it certified under the \n",
      "program, including, when necessary, requiring the correction of non-\n",
      "conformities found in health it certified under the program and \n",
      "suspending and terminating certifications issued to complete ehrs and \n",
      "health it modules. the final rule also sets forth processes for onc to \n",
      "authorize and oversee accredited testing laboratories under the \n",
      "program. in addition, it includes provisions for expanded public \n",
      "availability of certified health it surveillance results.\n",
      "\n",
      "iii. deregulatory actions for previous rulemakings\n",
      "\n",
      "a. background\n",
      "\n",
      "1. history of burden reduction and flexibility\n",
      "    since the inception of the onc health it certification program \n",
      "(program), we have aimed to implement and administer the program in the \n",
      "least burdensome manner that supports our policy goals. throughout the \n",
      "years, we\n",
      "\n",
      "[[page 7433]]\n",
      "\n",
      "have worked to improve the program with a focus on ways to reduce \n",
      "burden, offer flexibility to both developers and providers, and support \n",
      "innovation. this approach has been consistent with the principles of \n",
      "executive order 13563 on improving regulation and regulatory review \n",
      "(february 2, 2011), which instructs agencies to ``determine whether any \n",
      "[agency] regulations should be modified, streamlined, expanded, or \n",
      "repealed so as to make the agency's regulatory program more effective \n",
      "or less burdensome in achieving the regulatory objectives.'' to that \n",
      "end, we have historically, where feasible and appropriate, taken \n",
      "measures to reduce burden within the program and make the program more \n",
      "effective, flexible, and streamlined.\n",
      "    for example, in the 2014 edition final rule (77 fr 54164), we \n",
      "revised the certified electronic health record technology (cehrt) \n",
      "definition to provide flexibility and create regulatory efficiencies by \n",
      "narrowing required functionality to a core set of capabilities (i.e., \n",
      "the base ehr definition) plus the additional capabilities each eligible \n",
      "clinician, eligible hospital, and critical access hospital needed to \n",
      "successfully achieve the applicable objective and measures under the \n",
      "ehr incentive programs (now referred to as the promoting \n",
      "interoperability programs). onc has also supported more efficient \n",
      "testing and certification methods and reduced regulatory burden through \n",
      "the adoption of a gap certification policy. as explained in the 2014 \n",
      "edition final rule (77 fr 54254) and the 2015 edition final rule (80 fr \n",
      "62681), where applicable, gap certification allows for the use of a \n",
      "previously certified health it product's test results to certification \n",
      "criteria identified as unchanged. developers have been able to use gap \n",
      "certification for the more efficient certification of their health it \n",
      "when updating from the 2011 edition to the 2014 edition and from the \n",
      "2014 edition to the 2015 edition.\n",
      "    onc introduced further means to reduce regulatory burden, increase \n",
      "regulatory flexibility, and promote innovation in the 2014 edition \n",
      "release 2 final rule (79 fr 54430). the 2014 edition release 2 final \n",
      "rule established a set of optional 2014 edition certification criteria \n",
      "that provided flexibility and alternative certification pathways for \n",
      "health it developers and providers based on their specific \n",
      "circumstances. the 2014 edition release 2 final rule also simplified \n",
      "the program by discontinuing the use of the ``complete ehr'' \n",
      "certification concept beginning with the 2015 edition (79 fr 54443).\n",
      "    in the 2015 edition final rule, we did not ``carry forward'' \n",
      "certain 2014 edition certification criteria into the 2015 edition, such \n",
      "as the ``image results,'' ``patient list creation,'' and ``electronic \n",
      "medication administration record'' criteria. we determined that these \n",
      "criteria did not advance functionality or support interoperability (80 \n",
      "fr 62682-84). we also did not require all health it to be certified to \n",
      "the ``meaningful use measurement'' certification criteria for \n",
      "``automated numerator recording'' and ``automated measure calculation'' \n",
      "(80 fr 62605), which had been previously required for the 2014 edition. \n",
      "based on stakeholder feedback and program administration observations, \n",
      "we also permitted testing efficiencies for the 2015 edition ``automated \n",
      "numerator recording'' and ``automated measure calculation'' criteria by \n",
      "removing the live demonstration requirement of recording data and \n",
      "generating reports. health it developers may now self-test their health \n",
      "it modules(s) and submit the resulting reports to the onc- authorized \n",
      "testing laboratory (onc-atl) to verify compliance with the \n",
      "criterion.\\4\\ in order to further reduce burden for health it \n",
      "developers, we adopted a simpler, straight-forward approach to privacy \n",
      "and security certification requirements, which clarified which \n",
      "requirements are applicable to each criterion within the regulatory \n",
      "functional areas (80 fr 62605).\n",
      "2. executive orders 13771 and 13777\n",
      "    on january 30, 2017, the president issued executive order 13771 on \n",
      "reducing regulation and controlling regulatory costs, which requires \n",
      "agencies to identify deregulatory actions. this order was followed by \n",
      "executive order 13777, titled ``enforcing the regulatory reform \n",
      "agenda'' (february 24, 2017). executive order 13777 provides further \n",
      "direction on implementing regulatory reform by identifying a process by \n",
      "which agencies must review and evaluate existing regulations and make \n",
      "recommendations for repeal or simplification.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\4\\ <a href=\"https://www.healthit.gov/test-method/automated-numerator-recording\">https://www.healthit.gov/test-method/automated-numerator-recording</a> and <a href=\"https://www.healthit.gov/test-method/automated-measure-calculation\">https://www.healthit.gov/test-method/automated-measure-calculation</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in order to implement these regulatory reform initiatives and \n",
      "policies, over the past year onc reviewed and evaluated existing \n",
      "regulations. during our review, we sought to identify ways to further \n",
      "reduce administrative burden, to implement deregulatory actions through \n",
      "guidance, and to propose potential new deregulatory actions in this \n",
      "proposed rule that will reduce burden for health it developer, \n",
      "providers, and other stakeholders.\n",
      "    on august 21, 2017, onc issued relied upon software program \n",
      "guidance.\\5\\ health it developers are permitted to use ``relied upon \n",
      "software'' (76 fr 1276) to demonstrate compliance with certification \n",
      "criteria adopted at 45 cfr part 170, subpart c. historically, in cases \n",
      "where a health it module is paired with multiple ``relied upon \n",
      "software'' products for the same capability, health it developers were \n",
      "required to demonstrate compliance for the same certification criterion \n",
      "with each of those ``relied upon software'' products in order for the \n",
      "products to be listed on the certified health it product list (chpl). \n",
      "with the issued guidance, health it developers may now demonstrate \n",
      "compliance with only one ``relied upon software'' product for a \n",
      "criterion/capability. once the health it developer demonstrates \n",
      "compliance with a minimum of one ``relied upon software'' product, the \n",
      "developer can have multiple, additional ``relied upon software'' \n",
      "products for the same criterion/capability listed on the chpl (<a href=\"https://chpl.healthit.gov/\">https://chpl.healthit.gov/</a>). this approach reduces burden for health it \n",
      "developers, onc-atls, and onc-authorized certification bodies (onc-\n",
      "acbs).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\5\\ <a href=\"https://www.healthit.gov/sites/default/files/relieduponsoftwareguidance.pdf\">https://www.healthit.gov/sites/default/files/relieduponsoftwareguidance.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    on september 21, 2017, onc reduced the overall burden for testing \n",
      "health it to the 2015 edition.\\6\\ onc reviewed the 2015 edition test \n",
      "procedures, which identify minimum testing requirements onc-atls must \n",
      "evaluate during testing. onc changed 30 of the 2015 edition test \n",
      "procedures to attestation only (i.e., a ``yes'' self-declaration by the \n",
      "health it developer that their product has capabilities conformant with \n",
      "those specified in the associated certification criterion/criteria).\\7\\ \n",
      "this deregulatory action reduced burden and costs program-wide, while \n",
      "still maintaining the program's high level of integrity and assurances. \n",
      "health it developers now have reduced preparation and testing costs for \n",
      "testing to these criteria. specifically, the cost savings for health it \n",
      "developers have been estimated between $8.34 and $9.26 million. onc-\n",
      "atls also benefit by having more time and resources to focus on tool-\n",
      "based\n",
      "\n",
      "[[page 7434]]\n",
      "\n",
      "testing (for interoperability-oriented criteria) and being responsive \n",
      "to any retesting requirements that may arise from onc-acb surveillance \n",
      "activities. furthermore, providers and users of certified health it do \n",
      "not lose confidence in the program because this burden reduction effort \n",
      "in no way alters the expectations of conformance and responsibilities \n",
      "of program participants. health it developers are still required to \n",
      "meet certification criteria requirements and maintain their products' \n",
      "conformance to the full scope of the associated criteria, including \n",
      "when implemented in the field and in production use. similarly, onc and \n",
      "onc-acbs continue to conduct surveillance activities and respond to \n",
      "end-user complaints.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\6\\ <a href=\"https://www.healthit.gov/buzz-blog/healthit-certification/certification-program-updates-support-efficiency-reduce-burden/\">https://www.healthit.gov/buzz-blog/healthit-certification/certification-program-updates-support-efficiency-reduce-burden/</a>.\n",
      "    \\7\\ <a href=\"https://www.healthit.gov/sites/default/files/policy/selfdeclarationapproachprogramguidance17-04.pdf\">https://www.healthit.gov/sites/default/files/policy/selfdeclarationapproachprogramguidance17-04.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "b. proposed deregulatory actions\n",
      "\n",
      "    we propose six deregulatory actions below. we welcome comments on \n",
      "these potential deregulatory actions and any other potential \n",
      "deregulatory actions we should consider. we also refer readers to \n",
      "section xiv (regulatory impact analysis) of this proposed rule for a \n",
      "discussion of the estimated cost savings from these proposed \n",
      "deregulatory actions.\n",
      "1. removal of randomized surveillance requirements\n",
      "    onc-acbs are required to conduct surveillance of certified health \n",
      "it under the program to ensure that health it continues to conform and \n",
      "function as required by the full scope of the certification \n",
      "requirements. surveillance is categorized as either reactive \n",
      "surveillance (for example, complaint-based surveillance) or randomized \n",
      "surveillance, which, by regulation, requires onc-acbs to proactively \n",
      "surveil 2% of the certificates they issue annually. on september 21, \n",
      "2017, we exercised enforcement discretion with respect to the \n",
      "implementation of randomized surveillance by onc-acbs.\\8\\ consistent \n",
      "with this exercise of enforcement discretion, we now propose to \n",
      "eliminate certain regulatory randomized surveillance requirements.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\8\\ <a href=\"https://www.healthit.gov/sites/default/files/onc_enforcement_discretion_randomized_surveillance_8-30-17.pdf\">https://www.healthit.gov/sites/default/files/onc_enforcement_discretion_randomized_surveillance_8-30-17.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we propose to revise sec.  [thinsp]170.556(c) by changing the \n",
      "requirement that onc-acbs must conduct in-the-field, randomized \n",
      "surveillance to specify that onc-acbs may conduct in-the- field, \n",
      "randomized surveillance. we further propose to remove sec.  \n",
      "[thinsp]170.556(c)(2), which specifies that onc-acbs must conduct \n",
      "randomized surveillance for a minimum of 2% of certified health it \n",
      "products per year. we also propose to remove the requirements in sec.  \n",
      "170.556(c)(5) regarding the exclusion and exhaustion of selected \n",
      "locations for randomized surveillance. additionally, we propose to \n",
      "remove the requirements in sec.  [thinsp]170.556(c)(6) regarding the \n",
      "consecutive selection of certified health it for randomized \n",
      "surveillance. without these regulatory requirements, onc-acbs would \n",
      "still be required to perform reactive surveillance, and would be \n",
      "permitted to conduct randomized surveillance of their own accord, using \n",
      "the methodology identified by onc with respect to scope (sec.  \n",
      "[thinsp]170.556(c)(1)), selection method (sec.  [thinsp]170.556(c)(3)), \n",
      "and the number and types of locations for in-the-field surveillance \n",
      "(sec.  [thinsp]170.556(c)(4)).\n",
      "    stakeholders have expressed concern that the benefits of in-the-\n",
      "field, randomized surveillance may not outweigh the time commitment \n",
      "required by providers, particularly if no non-conformities are found. \n",
      "in general, providers have expressed that reactive surveillance (e.g., \n",
      "surveillance based on user complaints) is a more logical and economical \n",
      "approach to surveillance. the removal of randomized surveillance \n",
      "requirements would also give onc-acbs the flexibility and time to focus \n",
      "on other priorities, such as the certification of health it to the 2015 \n",
      "edition. therefore, as discussed above, we propose to eliminate certain \n",
      "regulatory randomized surveillance requirements.\n",
      "2. removal of the 2014 edition from the code of federal regulations\n",
      "    we propose to remove the 2014 edition from the code of federal \n",
      "regulations (cfr). the 2014 edition was the result of rulemaking \n",
      "completed in 2012 and includes standards and functionality that are now \n",
      "significantly outmoded. removal of the 2014 edition would make the 2015 \n",
      "edition the baseline for health it certification. the 2015 edition, \n",
      "including the additional certification criteria, standards, and \n",
      "requirements proposed in this proposed rule, better enables \n",
      "interoperability and the access, exchange, and use of electronic health \n",
      "information. adoption and implementation of the 2015 edition, including \n",
      "the proposals in this proposed rule, would also lead to the benefits \n",
      "outlined in the 2015 edition final rule (80 fr 62602-62603, 62605-\n",
      "62606, 62740) and in this proposed rule (see, for example, the \n",
      "executive summary and the ``assurances,'' ``api'', and ``real world \n",
      "testing'' conditions and maintenance of certification sections). \n",
      "equally important, adoption and implementation of the 2015 edition by \n",
      "providers would lead to the estimated costs savings in this proposed \n",
      "rule through improved interoperability supporting the access, exchange, \n",
      "and use of electronic health information.\n",
      "    removal of the 2014 edition would eliminate inconsistencies and \n",
      "costs caused by health it certification and implementation of two \n",
      "different editions with different functionalities and versions of \n",
      "standards. patient care could improve through the reduced risk of error \n",
      "that comes with the health care system's consistent implementation and \n",
      "use of health it certified to the 2015 edition. innovation could also \n",
      "improve with health it developers (including third-party software \n",
      "developers) developing to only one set of newer standards and \n",
      "implementation specifications, which would be more predictable and less \n",
      "costly.\n",
      "    removal of the 2014 edition would also reduce regulatory burden by \n",
      "no longer requiring the maintenance and support of the 2014 edition. \n",
      "maintaining compliance with only the 2015 edition would reduce the cost \n",
      "and burden for health it developers, onc-acbs, and onc-atls because \n",
      "they would no longer have to support two increasingly distinct sets of \n",
      "requirements as is the case now with certification to both the 2014 and \n",
      "2015 editions. more specifically, health it developers would not have \n",
      "to support two maintenance infrastructures and updating for their \n",
      "customers; nor would onc-atls and onc-acbs have to support testing, \n",
      "certification, and surveillance for two separate editions of certified \n",
      "health it.\n",
      "    as referenced by the hhs office of inspector general (oig) and \n",
      "centers for medicare & medicaid services (cms) in their rulemakings \n",
      "regarding donations of ehr items and services, we committed to retiring \n",
      "certification criteria editions that are no longer applicable.\\9\\ we \n",
      "first did this with the removal of the 2011 edition (79 fr 54447). \n",
      "accordingly, our proposal to remove the outdated 2014 edition for the \n",
      "reasons discussed above would also streamline program compliance \n",
      "requirements and ensure there is no regulatory confusion between onc's \n",
      "rules and other hhs rules.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\9\\ cms final rule ``medicare program; physicians' referrals to \n",
      "health care entities with which they have financial relationships: \n",
      "exception for certain electronic health records arrangements'' (78 \n",
      "fr 78751).oig final rule ``medicare and state health care programs: \n",
      "fraud and abuse; electronic health records safe harbor under the \n",
      "anti-kickback statute'' (78 fr 79202).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    to implement the removal of the 2014 edition from the cfr, we \n",
      "propose to remove the 2014 edition certification\n",
      "\n",
      "[[page 7435]]\n",
      "\n",
      "criteria (sec.  170.314) and related standards, terms, and requirements \n",
      "from the cfr. in regard to terms, we propose to retire the 2014 \n",
      "edition-related definitions found in sec.  170.102, including the \n",
      "``2014 edition base ehr,'' ``2014 edition ehr certification criteria,'' \n",
      "and ``complete ehr, 2014 edition.'' as explained in the 2015 edition \n",
      "final rule (80 fr 62719), the ability to maintain complete ehr \n",
      "certification is only permitted with health it certified to the 2014 \n",
      "edition certification criteria. because this concept was discontinued \n",
      "for the 2015 edition, we propose to remove sec.  170.545 and any \n",
      "references to complete ehr from the regulation text in conjunction with \n",
      "the removal of the 2014 edition. we also propose to remove references \n",
      "to the 2014 edition from the common clinical data set (ccds) \n",
      "definition. however, as discussed later in section iv.b.1 (``united \n",
      "states core data for interoperability'') of this proposed rule, we \n",
      "propose to remove the ccds definition from the cfr and effectively \n",
      "replace it with a new government-unique standard, the united states \n",
      "core data for interoperability (uscdi), proposing to adopt version 1 \n",
      "(v1) in sec.  170.213. the new standard would be applicable to certain \n",
      "2015 edition certification criteria that currently reference the ccds, \n",
      "subject to any of these criteria being removed through this \n",
      "rulemaking).\n",
      "    we propose to remove the standards and implementation \n",
      "specifications found in sec. sec.  170.200, 170.202, 170.204, 170.205, \n",
      "170.207, 170.210, and 170.299 that are only referenced in the 2014 \n",
      "edition certification criteria. adopted standards that are also \n",
      "referenced in the 2015 edition would remain. we propose to remove \n",
      "requirements in sec.  [thinsp]170.550(f) and any other requirements in \n",
      "subpart e, sec. sec.  [thinsp]170.500 through 170.599, which are \n",
      "specific to the 2014 edition and do not apply to the 2015 edition.\n",
      "    in order to avoid regulatory conflicts, we are taking into \n",
      "consideration the final rule released by cms on november 2, 2017, which \n",
      "makes payment and policy changes to the second year of the quality \n",
      "payment program (qpp). the cms's final rule, titled ``medicare program; \n",
      "cy 2018 updates to the quality payment program: extreme and \n",
      "uncontrollable circumstance policy for the transition year'' (82 fr \n",
      "53568), permits eligible clinicians to use health it certified to \n",
      "either the 2014 or 2015 edition certification criteria, or a \n",
      "combination of the two for the cy 2018 performance period. the qpp \n",
      "final rule also states that the 2015 edition will be the sole edition \n",
      "permitted to meet the cehrt definition starting with the cy 2019 \n",
      "program year.\n",
      "    therefore, we propose that the effective date of removal of the \n",
      "2014 edition certification criteria and related standards, terms, and \n",
      "requirements from the cfr would be the effective date of a subsequent \n",
      "final rule for this proposed rule, which we expect will be issued in \n",
      "the latter half of 2019. we note that we will continue to support \n",
      "medicare and medicaid program attestations by maintaining an archive on \n",
      "the chpl allowing the public to access historic information on a \n",
      "product certified to the 2014 edition.\n",
      "3. removal of the onc-approved accreditor from the program\n",
      "    we propose to remove the onc-approved accreditor (onc-aa) from the \n",
      "program. the onc-aa's role is to accredit certification bodies for the \n",
      "program and to oversee the onc-acbs. however, years of experience and \n",
      "changes with the program have led onc to conclude that, in many \n",
      "respects, the role of the onc-aa to oversee onc-acbs is now duplicative \n",
      "of onc's oversight. more specifically, onc's experience with \n",
      "administering the principles of proper conduct for onc-acbs as well as \n",
      "issuing necessary regulatory changes (e.g., onc-acb surveillance and \n",
      "reporting requirements in the 2015 edition final rule) has demonstrated \n",
      "that onc on its own has the capacity to provide the appropriate \n",
      "oversight of onc-acbs. therefore, we believe removal of the onc-aa \n",
      "would reduce the program's administrative complexity and burden.\n",
      "    to implement this proposed deregulatory action, we propose to \n",
      "remove the definition for ``onc-approved accreditor or onc-aa'' found \n",
      "in sec.  170.502. we also propose to remove processes related to onc-\n",
      "aas found in sec. sec.  [thinsp]170.501(c), 170.503, and 170.504 \n",
      "regarding requests for onc-aa status, onc-aa ongoing responsibilities, \n",
      "and reconsideration for requests for onc-aa status. regarding \n",
      "correspondence and communication with onc, we propose to remove \n",
      "specific references to the ``onc-aa'' and ``accreditation organizations \n",
      "requesting onc-aa status'' by revising sec.  170.505. we also propose \n",
      "to remove the final rule titled ``permanent certification program for \n",
      "health information technology; revisions to onc-approved accreditor \n",
      "processes'' (76 fr 72636) which established a process for addressing \n",
      "instances where the onc-aa engages in improper conduct or does not \n",
      "perform its responsibilities under the program. because this prior \n",
      "final rule relates solely to the role and removal of the onc-aa, we \n",
      "propose its removal and sec.  170.575, which codified the final rule in \n",
      "the cfr.\n",
      "    these proposed deregulatory actions would also provide an \n",
      "additional benefit for onc-acbs. onc-acbs would be able to obtain and \n",
      "maintain accreditation to iso/iec 17065, with an appropriate scope, \n",
      "from any accreditation body that is a signatory to the multilateral \n",
      "recognition arrangement (mla) with the international accreditation \n",
      "forum (iaf). accordingly, we propose to revise the application process \n",
      "for onc-acb status in sec.  170.520(a)(3) to require documentation that \n",
      "confirms that the applicant has been accredited to iso/iec 17065, with \n",
      "an appropriate scope, by any accreditation body that is a signatory to \n",
      "the multilateral recognition arrangement (mla) with the international \n",
      "accreditation forum (iaf), in place of the onc-aa accreditation \n",
      "documentation requirements. similarly, instead of requiring the onc-aa \n",
      "to evaluate the conformance of onc-acbs to iso/iec 17065, we propose to \n",
      "revise sec.  170.523(a) to simply require onc-acbs to maintain \n",
      "accreditation in good standing to iso/iec 17065 for the program. this \n",
      "means that onc-acbs would need to continue to comply with iso/iec 17065 \n",
      "and requirements specific to the onc health it certification program \n",
      "scheme.\n",
      "4. removal of certain 2015 edition certification criteria and standards\n",
      "    we have reviewed and analyzed the 2015 edition to determine whether \n",
      "there are certification criteria we could remove. we have identified \n",
      "both criteria and standards for removal as proposed below. we believe \n",
      "the removal of these criteria and standards will reduce burden and \n",
      "costs for health it developers and health care providers by eliminating \n",
      "the need to: design and meet specific certification functionalities; \n",
      "prepare, test, and certify health it in certain instances; adhere to \n",
      "associated reporting and disclosure requirements; maintain and update \n",
      "certifications for certified functionalities; and participate in \n",
      "surveillance of certified health it. to these points, if our proposals \n",
      "are finalized in a subsequent final rule, we would expect any already \n",
      "issued 2015 edition certificates to be updated to reflect the removal \n",
      "of applicable 2015 edition certification criteria. we welcome comment \n",
      "on the proposed removal of the identified criteria and standards below \n",
      "and any other 2015 edition criteria and standards we should consider \n",
      "for removal.\n",
      "\n",
      "[[page 7436]]\n",
      "\n",
      "a. 2015 edition base ehr definition criteria\n",
      "    we propose the removal of certain certification criteria from the \n",
      "2015 edition that are included in the 2015 edition base ehr definition. \n",
      "the removal of these criteria would support burden and cost reductions \n",
      "for health it developers and health care providers as noted above.\n",
      "i. problem list\n",
      "    we propose to remove the 2015 edition ``problem list'' \n",
      "certification criterion (sec.  170.315(a)(6)). the functionality in \n",
      "this criterion was first adopted as a 2011 edition certification \n",
      "criterion to support the associated meaningful use stage 1 objective \n",
      "and measure for recording problem list information. in this regard, \n",
      "snomed ct[supreg] was adopted specifically to support the measure. this \n",
      "2015 edition ``problem list'' criterion remains relatively functionally \n",
      "the same as the 2011 edition and has exactly the same functionally as \n",
      "the 2014 edition ``problem list'' criterion.\n",
      "    we propose to remove this criterion for multiple reasons. first, \n",
      "this criterion no longer supports the ``recording'' objective and \n",
      "measure of the cms promoting interoperability programs as such \n",
      "objective and measure no longer exist. second, the functionality is \n",
      "sufficiently widespread among health care providers since it has been \n",
      "part of certification and the certified ehr technology definition since \n",
      "the 2011 edition and has not substantively changed with the 2015 \n",
      "edition. third, we do not believe this functionality would be removed \n",
      "from health it systems because of our proposal to remove it from the \n",
      "2015 edition base ehr definition. this functionality is essential to \n",
      "clinical care and would be in ehr systems absent certification, \n",
      "particularly considering the limited certification requirements. \n",
      "fourth, this functionality does not directly support interoperability \n",
      "as the capabilities are focused on internally recording ehi. in this \n",
      "regard, representing problems with snomed ct[supreg] is part of the \n",
      "uscdi and, thus, better supports interoperability through its \n",
      "availability for access and exchange. accordingly, we propose to remove \n",
      "the ``problem list'' criterion from the 2015 edition, including the \n",
      "2015 edition base ehr definition. we note that once removed from the \n",
      "2015 edition, the criterion would also no longer be included in the \n",
      "2015 edition ``safety-enhanced design'' criterion.\n",
      "ii. medication list\n",
      "    we propose to remove the 2015 edition ``medication list'' \n",
      "certification criterion (sec.  170.315(a)(7)). the functionality in \n",
      "this criterion was first adopted as a 2011 edition certification \n",
      "criterion to support the associated meaningful use stage 1 objective \n",
      "and measure for recording medication list information. the criterion \n",
      "does not require use of a vocabulary standard to record medications. \n",
      "this 2015 edition ``medication list'' criterion remains functionally \n",
      "the same as the 2011 edition and 2014 edition ``medication list'' \n",
      "criteria.\n",
      "    we propose to remove this criterion for multiple reasons. first, \n",
      "this criterion no longer supports a ``recording'' objective and measure \n",
      "of the cms promoting interoperability programs as such objective and \n",
      "measure no longer exist. second, the functionality is sufficiently \n",
      "widespread among health care providers since it has been part of \n",
      "certification and the certified ehr technology definition since the \n",
      "2011 edition and has not substantively changed with the 2015 edition. \n",
      "third, we do not believe this functionality would be removed from ehr \n",
      "systems because of our proposal to remove it from the 2015 edition base \n",
      "ehr definition. this functionality is essential to clinical care and \n",
      "would be in ehr systems absent certification, particularly considering \n",
      "the limited certification requirements. fourth, this functionality does \n",
      "not directly support interoperability as the capabilities are focused \n",
      "on internally recording ehi. in this regard, this criterion does not \n",
      "even require representation of medications in standardized \n",
      "nomenclature. fifth, medications are included in the uscdi and must be \n",
      "represented in rxnorm as part of the uscdi. this approach better \n",
      "supports interoperability through medication information being \n",
      "availability for access and exchange in a structured format. \n",
      "accordingly, we propose to remove the ``medications list'' criterion \n",
      "from the 2015 edition, including the 2015 edition base ehr definition. \n",
      "we note that once removed from the 2015 edition, the criterion would \n",
      "also no longer be included in the 2015 edition ``safety-enhanced \n",
      "design'' criterion.\n",
      "iii. medication allergy list\n",
      "    we propose to remove the 2015 edition ``medication allergy list'' \n",
      "certification criterion (sec.  170.315(a)(8)). the functionality in \n",
      "this criterion was first adopted as a 2011 edition certification \n",
      "criterion to support the associated meaningful use stage 1 objective \n",
      "and measure for recording this information. the criterion does not \n",
      "require use of a vocabulary standard to record medication allergies. \n",
      "this 2015 edition ``medication allergy list'' criterion remains \n",
      "functionally the same as the 2011 edition and 2014 edition ``medication \n",
      "allergy list'' criteria.\n",
      "    we propose to remove this criterion for multiple reasons. first, \n",
      "this criterion no longer supports a ``recording'' objective and measure \n",
      "of the cms promoting interoperability programs as such objective and \n",
      "measure no longer exist. second, the functionality is sufficiently \n",
      "widespread among health care providers since it has been part of \n",
      "certification and the certified ehr technology definition since the \n",
      "2011 edition and has not substantively changed with the 2015 edition. \n",
      "third, we do not believe this functionality would be removed from ehr \n",
      "systems because of our proposal to remove it from the 2015 edition base \n",
      "ehr definition. this functionality is essential to clinical care and \n",
      "would be in ehr systems absent certification, particularly considering \n",
      "the limited certification requirements. fourth, this functionality does \n",
      "not directly support interoperability as the capabilities are focused \n",
      "on internally recording ehi. in this regard, this criterion does not \n",
      "even require representation of medication allergies in standardized \n",
      "nomenclature. fifth, medication allergies are included in the uscdi and \n",
      "must be represented in rxnorm as part of the uscdi. this approach \n",
      "better supports interoperability through medication allergy information \n",
      "being availability for access and exchange in a structured format. \n",
      "accordingly, we propose to remove the ``medication allergy list'' \n",
      "criterion from the 2015 edition, including the 2015 edition base ehr \n",
      "definition. we note that once removed from the 2015 edition, the \n",
      "criterion would also no longer be included in the 2015 edition \n",
      "``safety- enhanced design'' criterion.\n",
      "iv. smoking status\n",
      "    we propose to remove the 2015 edition ``smoking status'' criterion \n",
      "(sec.  170.315(a)(11)), which would include removing it from the 2015 \n",
      "edition base ehr definition. we previously adopted a 2015 edition \n",
      "``smoking status'' certification criterion that does not reference a \n",
      "standard. however, the ccds definition requires smoking status to be \n",
      "coded in accordance with snomed ct[supreg]. while we continue to \n",
      "believe that the capture of a patient's smoking status has significant \n",
      "value in assisting providers with addressing the number one cause of \n",
      "preventable death\n",
      "\n",
      "[[page 7437]]\n",
      "\n",
      "and disease in the united states, we no longer believe that a criterion \n",
      "that simply ensures this functionality exists in health it presented \n",
      "for certification is the right focus. as with other 2014 edition \n",
      "functionality, we believe this functionality is fairly ubiquitous now \n",
      "with the widespread adoption of health it certified to the 2014 \n",
      "edition. further, we continue to believe that, for the purposes of \n",
      "certification, having smoking status available for access and exchange \n",
      "via the uscdi is ultimately the key requirement for supporting \n",
      "interoperability.\n",
      "removal of specific uscdi smoking status code sets\n",
      "    as mentioned above, we believe having smoking status available for \n",
      "uscdi purposes is fundamentally important for supporting \n",
      "interoperability. we propose, however, to remove the requirement to \n",
      "code smoking status according to the adopted eight smoking status \n",
      "snomed ct[supreg] codes as referenced in the value set in sec.  \n",
      "170.207(h). these eight codes reflect an attempt to capture smoking \n",
      "status in a consistent manner. stakeholder feedback has, however, \n",
      "indicated that these eight codes do not appropriately and accurately \n",
      "capture all applicable patients' smoking statuses. accordingly, we \n",
      "propose to no longer require use of only the specific eight snomed \n",
      "ct[supreg] codes for representing smoking status (and remove the \n",
      "standard from sec.  170.207). rather, to continue to promote \n",
      "interoperability while also granting providers with flexibility to \n",
      "better support clinical care, we propose that health it would simply be \n",
      "required to be capable of representing smoking status in snomed \n",
      "ct[supreg] when such information is exchanged as part of the uscdi.\n",
      "b. drug-formulary and preferred drug lists\n",
      "    we propose to remove the 2015 edition ``drug formulary and \n",
      "preferred drug list checks'' criterion in sec.  170.315(a)(10). we \n",
      "adopted a 2015 edition ``drug-formulary and preferred drug list \n",
      "checks'' criterion that separates drug formulary and preferred drug \n",
      "list functionality, but does not require any standards or functionality \n",
      "beyond that included in the 2014 edition ``drug-formulary checks'' \n",
      "criterion. first, we believe this functionality is fairly ubiquitous \n",
      "now with the widespread adoption of health it certified to the 2014 \n",
      "edition, which included this general functionality. second, without \n",
      "standards, this criterion does not support or facilitate the critical \n",
      "goal of health it interoperability. therefore, removal of this \n",
      "criterion could reduce health it developer and health care provider \n",
      "burden.\n",
      "c. patient-specific education resources\n",
      "    we propose to remove the 2015 edition ``patient-specific education \n",
      "resources'' certification criterion (sec.  170.315(a)(13)). onc \n",
      "continues to support patient and provider interaction, and the \n",
      "identification and dissemination of patient-specific educational \n",
      "materials to promote positive health outcomes. however, we no longer \n",
      "believe that certification focused on a health it's ability to \n",
      "identifying the existence of patient-specific education materials \n",
      "encourages the advancement of this functionality or interoperability. \n",
      "first, this criterion would no longer be associated with an objective \n",
      "or measure under the promoting interoperability programs based on \n",
      "proposals and determinations in recent cms rulemakings (83 fr 35928; 83 \n",
      "fr 41664). second, based on the number of health it products that have \n",
      "been certified for this functionality as part of 2014 edition \n",
      "certification and already for 2015 edition certification, we believe \n",
      "that health it's ability to identify appropriate patient education \n",
      "materials is widespread now among health it developers and their \n",
      "customers (e.g., health care providers). third, we have recently seen \n",
      "innovative advancements in this field, including the use of automation \n",
      "and algorithms to provide appropriate educations materials to patients \n",
      "in a timely manner. these advancements help limit clinical workflow \n",
      "interruptions and demonstrate the use and promise of health it to \n",
      "create efficiencies and improve patient care. as such, removal of this \n",
      "criterion would prevent certification from creating an unnecessary \n",
      "burden for developers and providers and an impediment to innovation.\n",
      "d. ccds summary record--create; and ccds summary record--receive\n",
      "    we assessed the number of products certified to the 2015 edition \n",
      "``common clinical data set summary record--create'' (sec.  \n",
      "170.315(b)(4)) and ``common clinical data set summary record--receive'' \n",
      "(sec.  170.315(b)(5)) criteria that have not also been certified to the \n",
      "2015 edition ``transitions of care'' criterion (sec.  170.315(b)(1)). \n",
      "we did this because the 2015 edition ``ccds summary record'' criteria \n",
      "include the same functionality as the 2015 edition ``transitions of \n",
      "care'' criterion, except for direct-related transport functionality. \n",
      "based on our findings of only two unique products certified to these \n",
      "criteria at the time of the drafting of this proposed rule, there \n",
      "appears to be little market demand for certification to them. this \n",
      "outcome is likely attributable to the fact mentioned above regarding \n",
      "their relationship to the 2015 edition ``transition of care'' \n",
      "criterion, that they are not included in the 2015 edition base ehr \n",
      "definition, and that no hhs program specifically requires the use of \n",
      "health it certified to the criteria. therefore, we propose to remove \n",
      "these certification criteria from the 2015 edition.\n",
      "e. secure messaging\n",
      "    we propose to remove the 2015 edition ``secure messaging'' \n",
      "criterion (sec.  170.315(e)(2)). onc strongly supports patient and \n",
      "provider communication, as well as protecting the privacy and security \n",
      "of patient information. however, we no longer believe that separate \n",
      "certification focused on a health it's ability to send and receive \n",
      "secure messages between health care providers and patients is \n",
      "necessary. first, this criterion would no longer be associated with an \n",
      "objective or measure under the promoting interoperability programs \n",
      "based on proposals and determinations in recent cms rulemakings (83 fr \n",
      "41664; 83 fr 35929). second, there are multiple other 2015 edition \n",
      "certification criteria that support patient engagement, such as the \n",
      "2015 edition ``view, download, and transmit to 3rd party,'' ``api,'' \n",
      "and ``patient health information capture'' certification criteria. \n",
      "third, we have seen developers integrate this functionality as part of \n",
      "other patient engagement features, such as patient portals. with these \n",
      "considerations in mind and the lack of a negative impact on health it \n",
      "interoperability, we believe that the removal of this criterion will \n",
      "help reduce burden and costs, while also spurring further innovations \n",
      "in patient engagement.\n",
      "5. removal of certain onc health it certification program requirements\n",
      "    we propose to remove certain mandatory disclosure requirements and \n",
      "a related attestation requirement under the program. we believe removal \n",
      "of these requirements will reduce costs and burden for program \n",
      "stakeholders, particularly health it developers and onc-acbs. we \n",
      "welcome comment on the proposed removal of these requirements and any \n",
      "other certification or program requirements we should consider for \n",
      "removal.\n",
      "a. limitations disclosures\n",
      "    we propose to remove sec.  170.523(k)(1)(iii)(b), which requires \n",
      "onc-acbs to ensure that certified\n",
      "\n",
      "[[page 7438]]\n",
      "\n",
      "health it includes a detailed description of all known material \n",
      "information concerning limitations that a user may encounter in the \n",
      "course of implementing and using the certified health it, whether to \n",
      "meet ``meaningful use'' objectives and measures or to achieve any other \n",
      "use within the scope of the health it's certification. we also propose \n",
      "to remove sec.  170.523(k)(1)(iv)(b) and (c), which state that the \n",
      "types of information required to be disclosed include, but are not \n",
      "limited to: (b) limitations, whether by contract or otherwise, on the \n",
      "use of any capability to which technology is certified for any purpose \n",
      "within the scope of the technology's certification; or in connection \n",
      "with any data generated in the course of using any capability to which \n",
      "health it is certified; (c) limitations, including but not limited to \n",
      "technical or practical limitations of technology or its capabilities, \n",
      "that could prevent or impair the successful implementation, \n",
      "configuration, customization, maintenance, support, or use of any \n",
      "capabilities to which technology is certified; or that could prevent or \n",
      "limit the use, exchange, or portability of any data generated in the \n",
      "course of using any capability to which technology is certified.\n",
      "    these disclosure requirements regarding certified health it \n",
      "limitations are superseded by the cures act information blocking \n",
      "provision and conditions of certification, which we are implementing \n",
      "with this proposed rule. in particular, section 3001(c)(5)(d)(ii) of \n",
      "the cures act requires that a health it developer, as a condition of \n",
      "certification under the program, provide assurances to the secretary \n",
      "that, unless for legitimate purposes specified by the secretary, the \n",
      "developer will not take any action that constitutes information \n",
      "blocking as defined in section 3022(a) of the phsa, or any other action \n",
      "that may inhibit the appropriate exchange, access, and use of \n",
      "electronic health information. these assurances specifically focus on \n",
      "preventing information blocking and promoting appropriate exchange, \n",
      "access, and use of electronic health information. we further propose \n",
      "adding as a complementary condition of certification that developers \n",
      "would be prohibited from taking any action that could interfere with a \n",
      "user's ability to access or use certified capabilities for any purpose \n",
      "within the scope of the technology's certification. such actions may \n",
      "inhibit the appropriate access, exchange, or use of electronic health \n",
      "information and are therefore contrary to this proposed condition of \n",
      "certification and the statutory provision that it implements. based on \n",
      "these conditions of certification, we believe that disclosures of \n",
      "limitations by health it developers would be unlikely and unnecessary \n",
      "given their prohibition.\n",
      "b. transparency and mandatory disclosures requirements\n",
      "    we propose to remove the principle of proper conduct (popc) in \n",
      "sec.  170.523(k)(2), which requires a health it developer to submit an \n",
      "attestation that it will disclose all of the information in its \n",
      "mandatory disclosures per sec.  170.523(k)(1) to specified parties \n",
      "(e.g., potential customers or anyone inquiring about a product quote or \n",
      "description of services). we propose that this provision is no longer \n",
      "necessary and that its removal is appropriate to further reduce \n",
      "administrative burden for health it developers and onc-acbs. first, our \n",
      "experience with developer attestations to this requirement is that over \n",
      "90% of developers with certified health it have attested that they will \n",
      "provide ``transparency information.'' second, the information that \n",
      "developers would be asked to attest to, whether our proposal above to \n",
      "remove certain disclosure requirements is finalized or not, is now \n",
      "readily available on health it developers' websites as the mandatory \n",
      "disclosure requirements were implemented almost three years ago. \n",
      "therefore, we believe removal of this requirement is appropriate.\n",
      "6. recognition of food and drug administration processes\n",
      "    section 618 of the food and drug administration safety and \n",
      "innovation act (fdasia), public law 112-144, required that the food and \n",
      "drug administration (fda), in consultation with onc and the federal \n",
      "communications commission (fcc) (collectively referred to as ``the \n",
      "agencies'' \\10\\ for this proposal), develop a report that contains a \n",
      "proposed strategy and recommendations on an appropriate, risk-based \n",
      "regulatory framework pertaining to health it, including mobile medical \n",
      "applications, that promotes innovation, protects patient safety, and \n",
      "avoids regulatory duplication. the fdasia health it report of april \n",
      "2014 \\11\\ contains a proposed strategy and recommendations on an \n",
      "appropriate, risk-based regulatory framework pertaining to health it \n",
      "that promotes innovation, protects patient safety, and avoids \n",
      "regulatory duplication. public comments, received prior to the report \n",
      "and after,\\12\\ recommended that health it developers/manufacturers \n",
      "apply a single process that satisfies the requirements of all agencies \n",
      "and that existing safety and quality-related processes, systems, and \n",
      "standards should be leveraged for patient safety in health it. on july \n",
      "27, 2017, fda announced a voluntary software precertification (pre-\n",
      "cert) pilot program as part of a broader digital health innovation \n",
      "action plan.\\13\\ it was developed in order to create a tailored \n",
      "approach toward recognizing the unique characteristics of digital \n",
      "technology by looking first at the firm, rather than primarily at each \n",
      "product of the firm, as is currently done for traditional medical \n",
      "products. the fda plans to explore whether and how pre-certified \n",
      "companies that have demonstrated a culture of quality, patient safety, \n",
      "and organizational excellence could bring certain types of digital \n",
      "health products to market either without fda premarket review or with a \n",
      "more streamlined fda premarket review.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\10\\ onc is not an agency, but an office, within the department \n",
      "of health and human services.\n",
      "    \\11\\ <a href=\"https://www.fda.gov/downloads/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cdrh/cdrhreports/ucm391521.pdf\">https://www.fda.gov/downloads/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cdrh/cdrhreports/ucm391521.pdf</a>.\n",
      "    \\12\\ <a href=\"https://www.federalregister.gov/documents/2013/05/30/2013-12817/food-and-drug-administration-safety-and-innovation-act-fdasia-request-for-comments-on-the\">https://www.federalregister.gov/documents/2013/05/30/2013-12817/food-and-drug-administration-safety-and-innovation-act-fdasia-request-for-comments-on-the</a>; <a href=\"https://blogs.fda.gov/fdavoice/index.php/2014/04/fda-seeks-comment-on-proposed-health-it-strategy-that-aims-to-promote-innovation/\">https://blogs.fda.gov/fdavoice/index.php/2014/04/fda-seeks-comment-on-proposed-health-it-strategy-that-aims-to-promote-innovation/</a>; and <a href=\"https://www.regulations.gov/document?d=fda-2014-n-0339-0001\">https://www.regulations.gov/document?d=fda-2014-n-0339-0001</a>.\n",
      "    \\13\\ <a href=\"https://www.fda.gov/medicaldevices/digitalhealth/digitalhealthprecertprogram/default.htm\">https://www.fda.gov/medicaldevices/digitalhealth/digitalhealthprecertprogram/default.htm</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "a. fda software pre-certification pilot program\n",
      "    onc believes that health it developers that hold precertification \n",
      "under the fda digital health software precertification program (fda \n",
      "software precertification program) when they present health it for \n",
      "certification under the program could qualify for, and benefit from, \n",
      "further efficiencies under the program. title iv of the cures act \n",
      "provides onc with authority under the program to oversee health it \n",
      "developers through conditions and maintenance of certification \n",
      "requirements (see section vii conditions and maintenance of \n",
      "certification of this proposed rule). with this new authority and our \n",
      "authority over health it developers' health it certified under the \n",
      "program, we propose to establish processes that would provide health it \n",
      "developers that can document holding precertification under the fda \n",
      "software precertification program with exemptions to the onc health it \n",
      "certification program's requirements for testing and certification of \n",
      "its health it to the 2015\n",
      "\n",
      "[[page 7439]]\n",
      "\n",
      "edition ``quality management systems'' criterion (sec.  170.315(g)(4)) \n",
      "and the 2015 edition ``safety-enhanced design'' criterion (sec.  \n",
      "170.315(g)(3)), as these criteria are applicable to the health it \n",
      "developer's health it presented for certification. we also believe that \n",
      "such a ``recognition'' could, depending on the final framework of the \n",
      "fda software precertification program (e.g., the key performance \n",
      "indicators used to demonstrate performance and outcomes of excellence), \n",
      "be applicable to the functionally-based 2015 edition ``clinical'' \n",
      "certification criteria (sec.  170.315(a)). more specifically, this \n",
      "could address the ``computerized provider order entry (cpoe)'' (sec.  \n",
      "170.315(a)(1), (2), and (3)), ``drug-drug, drug-allergy interaction \n",
      "checks for cpoe'' (sec.  170.315(a)(4)), ``clinical decision support'' \n",
      "(sec.  170.315(a)(9)), and ``implantable device list'' (sec.  \n",
      "170.315(a)(14)) certification criteria. such ``recognition'' could also \n",
      "be appropriate to address any or all of the following functionally-\n",
      "based 2015 edition criteria in the event their proposed removal is not \n",
      "finalized: ``problem list'' (sec.  170.315(a)(6)), ``medication list'' \n",
      "(sec.  170.315(a)(7)), ``medication allergy list'' (sec.  \n",
      "170.315(a)(8)), ``drug-formulary and preferred drug list checks'' \n",
      "(sec.  170.315(a)(10)),'' and ``smoking status'' (sec.  \n",
      "170.315(a)(11)).\n",
      "    our proposed ``recognition'' would align with both executive orders \n",
      "13563 and 13771 regarding deregulatory, less burdensome, and more \n",
      "effective initiatives. it would also serve as a regulatory relief for \n",
      "those health it developers qualifying as small businesses under the \n",
      "regulatory flexibility act (see section xiv.c.3 regulatory flexibility \n",
      "act of this proposed rule). furthermore, it would closely align with \n",
      "fdasia's instruction to promote innovation, protect patient safety, and \n",
      "avoid regulatory duplication. however, despite these proffered \n",
      "benefits, there may be reasons not to adopt such a ``recognition'' \n",
      "approach. for example, stakeholders may not agree that the fda software \n",
      "precertification program (and/or subsequent finalized program) \n",
      "sufficiently aligns with our program. developers and providers may have \n",
      "varying and divergent views about the benefits and detriments of such \n",
      "an approach. further, while we believe that we could properly \n",
      "operationalize such an approach by ensuring certifications indicate \n",
      "which criteria have been ``deemed certified'' by onc (but still subject \n",
      "to onc-acb surveillance), stakeholders may have other operational \n",
      "concerns. accordingly, we welcome comments on these and other aspects \n",
      "of our proposed ``recognition'' approach, including the 2015 edition \n",
      "certification criteria that should be eligible for ``recognition.''\n",
      "b. development of similar independent program processes--request for \n",
      "information\n",
      "    recognition of the fda software pre-certification program for \n",
      "purposes of our program, as noted above, may eventually be determined \n",
      "to be infeasible or insufficient to meet our goals of reducing burden \n",
      "and promoting innovation. with this in mind, we request comment on \n",
      "whether onc should establish new regulatory processes tailored towards \n",
      "recognizing the unique characteristics of health it (e.g., ehr \n",
      "software) by looking first at the health it developer, rather than \n",
      "primarily at the health it presented for certification, as is currently \n",
      "done under the program. for example, onc could possibly establish \n",
      "conditions and maintenance of certification requirements, through \n",
      "rulemaking, that facilitate the deeming of all of a health it \n",
      "developer's health it as ``certified'' under the program for \n",
      "certification criteria identified by onc as solely ``functionally-\n",
      "based'' criteria (i.e., not essential to interoperability, such as the \n",
      "``cpoe'' criteria) or possibly broader in scope. this approach could \n",
      "rely on, but not be limited to, one or a combination of the following: \n",
      "(1) certain demonstrated health it developer processes or health it \n",
      "functionality; (2) prior successful certification of a health it \n",
      "developer's health it under the program; (3) results of real world \n",
      "testing for interoperability as required by the cures act and the \n",
      "proposed implementing regulatory condition of certification (see \n",
      "section vii.b.5 of this proposed rule); and/or (4) the results of the \n",
      "ehr reporting program once implemented (see section vii.b.7 of this \n",
      "proposed rule). no matter the specifics, we are most interested in \n",
      "whether stakeholders believe this is an approach we should pursue in \n",
      "conjunction with, or in lieu of, the proposed approach of recognizing \n",
      "the fda software pre-certification pilot program. we also welcome more \n",
      "specific comments on the health it developer criteria for such an \n",
      "approach and what the conditions and/or maintenance of certification \n",
      "requirements should be to support such an approach within the framework \n",
      "of the proposed conditions and maintenance of certification \n",
      "requirements discussed in section vii of this proposed rule.\n",
      "\n",
      "iv. updates to the 2015 edition certification criteria\n",
      "\n",
      "    this rule proposes to update the 2015 edition by revising and \n",
      "adding certification criteria that would establish the capabilities and \n",
      "related standards and implementation specifications for the \n",
      "certification of health it. the updates to the 2015 edition would \n",
      "enhance interoperability and improve the accessibility of patient \n",
      "records consistent with section 4006(a) of the cures act.\n",
      "\n",
      "a. standards and implementation specifications\n",
      "\n",
      "1. national technology transfer and advancement act\n",
      "    the national technology transfer and advancement act (nttaa) of \n",
      "1995 (15 u.s.c. 3701 et seq.) and the office of management and budget \n",
      "(omb) circular a-119 \\14\\ require the use of, wherever practical, \n",
      "technical standards that are developed or adopted by voluntary \n",
      "consensus standards bodies to carry out policy objectives or \n",
      "activities, with certain exceptions. the nttaa and omb circular a-119 \n",
      "provide exceptions to electing only standards developed or adopted by \n",
      "voluntary consensus standards bodies, namely when doing so would be \n",
      "inconsistent with applicable law or otherwise impractical. agencies \n",
      "have the discretion to decline the use of existing voluntary consensus \n",
      "standards if determined that such standards are inconsistent with \n",
      "applicable law or otherwise impractical, and instead use a government-\n",
      "unique standard or other standard. in addition to the consideration of \n",
      "voluntary consensus standards, the omb circular a-119 recognizes the \n",
      "contributions of standardization activities that take place outside of \n",
      "the voluntary consensus standards process. therefore, in instances \n",
      "where use of voluntary consensus standards would be inconsistent with \n",
      "applicable law or otherwise impracticable, other standards should be \n",
      "considered that meet the agency's regulatory, procurement or program \n",
      "needs, deliver favorable technical and economic outcomes, and are \n",
      "widely utilized in the marketplace. in this proposed rule, we use \n",
      "voluntary consensus standards except for:\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\14\\ <a href=\"https://www.whitehouse.gov/sites/whitehouse.gov/files/omb/circulars/a119/revised_circular_a-119_as_of_1_22.pdf\">https://www.whitehouse.gov/sites/whitehouse.gov/files/omb/circulars/a119/revised_circular_a-119_as_of_1_22.pdf</a>.\n",
      "\n",
      "    <bullet> the standard we propose to adopt in sec.  170.213. we \n",
      "propose to remove the common clinical data set (ccds) definition and \n",
      "effectively replace it with a government\n",
      "\n",
      "[[page 7440]]\n",
      "\n",
      "unique standard, the united states core data for interoperability \n",
      "(uscdi), version 1(v1);\n",
      "    <bullet> the standard we propose to adopt in sec.  \n",
      "170.215(a)(2). we propose the government unique api resource \n",
      "collection in health (arch) version 1 implementation specification;\n",
      "    <bullet> the standards we propose to adopt in sec.  \n",
      "170.215(a)(3) through (5) for application programming interfaces \n",
      "(apis). these market driven consortia standards have been developed \n",
      "through a streamlined process that does not meet the full definition \n",
      "of voluntary consensus standards development but still includes \n",
      "representation from those interested in the use cases supported by \n",
      "the standards (e.g., health it developers and health care \n",
      "providers). in the absence of available voluntary consensus \n",
      "standards that would meet our needs, these standards deliver \n",
      "favorable technical and economic outcomes, particularly improved \n",
      "interoperability. further, some of these standards may eventually \n",
      "proceed through a standards development organization for approval; \n",
      "and\n",
      "    <bullet> the standards we propose to adopt in sec.  \n",
      "170.205(h)(3) and (k)(3). we propose to replace the current hl7 qrda \n",
      "standards with government unique standards that more effectively \n",
      "support the associated certification criterion's use case, which is \n",
      "reporting ecqm data to cms.\n",
      "2. compliance with adopted standards and implementation specifications\n",
      "    in accordance with office of the federal register regulations \n",
      "related to ``incorporation by reference,'' 1 cfr part 51, which we \n",
      "follow when we adopt proposed standards and/or implementation \n",
      "specifications in any subsequent final rule, the entire standard or \n",
      "implementation specification document is deemed published in the \n",
      "federal register when incorporated by reference therein with the \n",
      "approval of the director of the federal register. once published, \n",
      "compliance with the standard and implementation specification includes \n",
      "the entire document unless we specify otherwise. for example, if we \n",
      "adopted the argonaut data query implementation guide (ig) proposed in \n",
      "this proposed rule (see section vii.b.4.b), health it certified to \n",
      "certification criteria referencing this ig would need to demonstrate \n",
      "compliance with all mandatory elements and requirements of the ig. if \n",
      "an element of the ig is optional or permissive in any way, it would \n",
      "remain that way for testing and certification unless we specified \n",
      "otherwise in regulation. in such cases, the regulatory text would \n",
      "preempt the permissiveness of the ig.\n",
      "3. ``reasonably available'' to interested parties\n",
      "    the office of the federal register has established requirements for \n",
      "materials (e.g., standards and implementation specifications) that \n",
      "agencies propose to incorporate by reference in the code of federal \n",
      "regulations (79 fr 66267; 1 cfr 51.5(a)). to comply with these \n",
      "requirements, in section xi (``incorporation by reference'') of this \n",
      "preamble, we provide summaries of, and uniform resource locators (urls) \n",
      "to, the standards and implementation specifications we propose to adopt \n",
      "and subsequently incorporate by reference in the code of federal \n",
      "regulations. to note, we also provide relevant information about these \n",
      "standards and implementation specifications throughout the relevant \n",
      "sections of the proposed rule.\n",
      "\n",
      "b. revised and new 2015 edition criteria\n",
      "\n",
      "    in order to capture and share patient data efficiently, health care \n",
      "providers need health it that store data in structured formats. \n",
      "structured data allows health care providers to easily retrieve and \n",
      "transfer patient information, and use health it in ways that can aid \n",
      "patient care. we propose to adopt revised and new 2015 edition \n",
      "certification criteria, including new standards, to support these \n",
      "objectives. some of these criteria and standards are included in the \n",
      "certified ehr technology (cehrt) definition used for participation in \n",
      "hhs programs, such as the promoting interoperability programs (formerly \n",
      "the ehr incentive programs), some are required to be met for \n",
      "participation in the onc health it certification program, and some, \n",
      "though beneficial, are unassociated with the cehrt definition and not \n",
      "required for participating in any hhs program, including the onc health \n",
      "it certification program.\n",
      "1. the united states core data for interoperability standard (uscdi)\n",
      "    the initial focus of the program was to support the medicare and \n",
      "medicaid ehr incentive programs (76 fr 1294) now referred to as the \n",
      "promoting interoperability programs (and referenced as such hereafter). \n",
      "as such, the 2014 edition certification criteria mirrored those \n",
      "functions specified by promoting interoperability programs' objectives \n",
      "and measures. in order to improve efficiency and streamline the common \n",
      "data within our program's certification criteria, we created a single \n",
      "definition for all the required data which could be referenced for all \n",
      "applicable certification criteria. we created the term ``common mu data \n",
      "set'' to encompass the common set of mu data types/elements (and \n",
      "associated vocabulary standards) for which certification would be \n",
      "required across several certification criteria (77 fr 54170).\n",
      "    the 2015 edition final rule modified the program to make it open \n",
      "and accessible to more types of health it, and health it that supports \n",
      "various care and practice settings beyond those included in the \n",
      "promoting interoperability programs (80 fr 62604). in comparison to the \n",
      "previous editions, the 2015 edition focused on identifying health it \n",
      "components necessary to establish an interoperable nationwide health \n",
      "information infrastructure, fostering innovation and open new market \n",
      "opportunities, and allowing for more health care provider and patient \n",
      "choices in electronic health information access and exchange. in order \n",
      "to align with this approach, we revised the concept of the ``common mu \n",
      "data set'' definition and changed the name to the ``common clinical \n",
      "data set'' (ccds) definition. the ccds definition was further revised \n",
      "in the 2015 edition rulemaking to account for new and updated \n",
      "vocabulary and content standards in order to improve and advance \n",
      "interoperability and health information exchange (80 fr 62604). it \n",
      "further expanded accessibility and availability of data exchanged by \n",
      "updating the definition of base electronic health record (ehr) (2015 \n",
      "edition base ehr definition) to include enhanced data export, \n",
      "transitions of care, and application programming interface (api) \n",
      "capabilities, all of which required that at a minimum the ccds be \n",
      "available (80 fr 62602-62604).\n",
      "    the regulatory approach to use and reference a ``definition'' to \n",
      "identify electronic health information, including with associated \n",
      "vocabulary codes, for access, exchange and use has had its drawbacks. \n",
      "while the ccds definition served its designed purpose, to cut down on \n",
      "repetitive text in each of the certification criteria in which it is \n",
      "referenced, it also began to be colloquially used for many different \n",
      "purposes. as the ccds definition's relevance grew outside of its \n",
      "regulatory context it became a symbolic and practical limit to the \n",
      "industry's collective interests to go beyond the ccds data for access, \n",
      "exchange, and use. as we move towards value-based care and the \n",
      "inclusion of data classes that go beyond clinical data, and as part of \n",
      "onc's continued efforts to evaluate the availability of a minimum \n",
      "baseline of data classes that must be commonly available for \n",
      "interoperable exchange, we acknowledge the need to change and improve \n",
      "our regulatory approach to the ccds. therefore, in order to advance \n",
      "interoperability by ensuring compliance with new data and vocabulary \n",
      "codes\n",
      "\n",
      "[[page 7441]]\n",
      "\n",
      "sets that support the data, we propose to remove the ``common clinical \n",
      "data set'' definition and its references from the 2015 edition and \n",
      "replace it with the ``united states core data for interoperability'' \n",
      "(uscdi) standard. the uscdi standard aims to achieve the goals set \n",
      "forth in the cures act by specifying a common set of data classes for \n",
      "interoperable exchange.\n",
      "    we propose to adopt the uscdi as a standard as such term is defined \n",
      "in sec.  170.102. in sec.  170.102, a ``standard'' is defined as a \n",
      "``technical, functional, or performance-based rule, condition, \n",
      "requirement, or specification that stipulates instructions, fields, \n",
      "codes, data, materials, characteristics, or actions.'' the uscdi \n",
      "standard would comprise data classes, which may be further delineated \n",
      "into groupings of specific data element(s). for example, ``patient \n",
      "demographics'' is a data class and within that data class there is \n",
      "``patient name,'' which is a data element. as noted in section \n",
      "iv.b.1.b, for the overall structure and organization of the uscdi, \n",
      "please consult <a href=\"http://www.healthit.gov/uscdi\">www.healthit.gov/uscdi</a>.\n",
      "    onc intends to establish and follow a predictable, transparent, and \n",
      "collaborative process to expand the uscdi, including providing \n",
      "stakeholders with the opportunity to comment on the uscdi's expansion. \n",
      "once the secretary adopts the first version of the uscdi through \n",
      "rulemaking, which we propose in this rulemaking, health it developers \n",
      "would be allowed to take advantage of the ``standards version \n",
      "advancement process'' flexibility. the standards version advancement \n",
      "process, proposed in section vii.b.5 (below), would permit health it \n",
      "developers to voluntarily implement and use a new version of an adopted \n",
      "standard (e.g., the uscdi), subject to certain conditions including a \n",
      "requirement that the new version is approved for use by the national \n",
      "coordinator.\n",
      "a. uscdi 2015 edition certification criteria\n",
      "    we propose to adopt the uscdi version 1 (uscdi v1) in sec.  \n",
      "170.213. \\15\\ the uscdi is a standardized set of health data classes \n",
      "and constituent data elements that would be required to support \n",
      "nationwide electronic health information exchange. once adopted in a \n",
      "final rule, health it developers would be required to update their \n",
      "certified health it to support the uscdi v1 for all certification \n",
      "criteria affected by this proposed change. we propose to revise the \n",
      "following ccds dependent 2015 edition certification criteria to \n",
      "incorporate the uscdi standard:\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\15\\ we note that uscdi v1is an updated version and \n",
      "distinguished from the draft united states core data for \n",
      "interoperability (uscdi) previously made available for public review \n",
      "and comment in the course of its development as a prospective \n",
      "standard.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> ``transitions of care'' (sec.  170.315(b)(1));\n",
      "    <bullet> ``view, download, and transmit to 3rd party'' (sec.  \n",
      "170.315(e)(1));\n",
      "    <bullet> ``consolidated cda creation performance'' (sec.  \n",
      "170.315(g)(6));\n",
      "    <bullet> ``transmission to public health agencies--electronic case \n",
      "reporting'' (sec.  170.315(f)(5)); and\n",
      "    <bullet> ``application access--all data request'' (sec.  \n",
      "170.315(g)(9)).\n",
      "    we note that we did not include the ``data export'' criterion \n",
      "(sec.  170.315(b)(6)) as we are proposing to remove it and adopt \n",
      "instead the ``ehi export'' criterion (sec.  170.315(b)(10)). for \n",
      "similar reasons, we did not include the ``application access--data \n",
      "category request'' criterion (sec.  170.315(g)(8)) because we are \n",
      "proposing to replace it with the api certification criterion (sec.  \n",
      "170.315(g)(10)), which derives its data requirements from the uscdi.\n",
      "    we propose, as a maintenance of certification requirement for the \n",
      "real world testing condition of certification, that health it \n",
      "developers with health it certified to the five above-identified \n",
      "certification criteria prior to the effective date of a subsequent \n",
      "final rule would have to update such certified health it to the \n",
      "proposed revisions. we further propose, as a maintenance of \n",
      "certification requirement for the real world testing condition of \n",
      "certification, that health it developers must provide the updated \n",
      "certified health it to all their customers with health it previously \n",
      "certified to the identified criteria no later than 24 months after the \n",
      "effective date of a final rule for this proposed rule. for the purposes \n",
      "of meeting this compliance timeline, we expect health it developers to \n",
      "update their certified health it without new mandatory testing and \n",
      "notify their onc-acb on the date at which they have reached compliance. \n",
      "developers would also need to factor these updates into their next real \n",
      "world testing plan as discussed in section vii.b.5 of this proposed \n",
      "rule. further, we refer health it developer to the next section, which \n",
      "describes how the uscdi differs from the current ccds.\n",
      "b. uscdi standard--data classes included\n",
      "    the uscdi version 1 (uscdi v1) and its constituent data elements \n",
      "account for the public comments we received on the draft uscdi and \n",
      "proposed expansion process\\16\\ published in january 2018 as well as \n",
      "initial feedback from the health it advisory committee. the standard as \n",
      "we propose to adopt it in sec.  170.213 also reflects and acknowledges \n",
      "the burden that rapidly expanding the uscdi v1 beyond the ccds could \n",
      "cause. as a result, the uscdi v1 is a modest expansion of the ccds, \n",
      "which we believe most health it developers already support, were \n",
      "already working toward, or should be capable of updating their health \n",
      "it to support in a timely manner. the following describes only the \n",
      "delta between the ccds and the uscdi v1. for the overall structure and \n",
      "organization of the uscdi standard, please consult <a href=\"http://www.healthit.gov/uscdi\">www.healthit.gov/uscdi</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\16\\ <a href=\"https://www.healthit.gov/sites/default/files/draft-uscdi.pdf\">https://www.healthit.gov/sites/default/files/draft-uscdi.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "i. updated versions of vocabulary standard code sets\n",
      "    we propose that the uscdi version 1 (uscdi v1) include the newest \n",
      "versions of the ``minimum standard'' code sets included in the ccds \n",
      "available at publication of a subsequent final rule. we request comment \n",
      "on this proposal and on whether this could result in any \n",
      "interoperability concerns. to note, criteria such as the 2015 edition \n",
      "``family health history'' criterion (sec.  170.315(a)(12)), the 2015 \n",
      "edition ``transmission to immunization registries'' criterion (sec.  \n",
      "170.315(f)(1)), and the 2015 edition ``transmission to public health \n",
      "agencies--syndromic surveillance'' criterion (sec.  170.315(f)(2)) \n",
      "reference ``minimum standard'' code sets; however, we are considering \n",
      "changing the certification baseline versions of the code set for these \n",
      "criteria from the versions adopted in the 2015 edition final rule to \n",
      "ensure complete interoperability alignment. we welcome comment on \n",
      "whether we should adopt such an approach.\n",
      "    we also note, for purposes of clarity, that consistent with sec.  \n",
      "170.555, unless the secretary prohibits the use of a newer version of \n",
      "an identified minimum standard code set for certification, health it \n",
      "could continue to be certified or upgraded to a newer version of an \n",
      "identified minimum standard code set than that included in uscdi v1 or \n",
      "the most recent uscdi version that the national coordinator has \n",
      "approved for use in the program via the standards version advancement \n",
      "process.\n",
      "ii. address and phone number\n",
      "    the uscdi v1 includes new data elements for ``address'' and ``phone \n",
      "number.'' the inclusion of ``address'' (to represent the postal \n",
      "location for the\n",
      "\n",
      "[[page 7442]]\n",
      "\n",
      "patient) and ``phone number'' (to represent the patient's telephone \n",
      "number) would improve the comprehensiveness of health information for \n",
      "patient care. the inclusion of these data elements is also consistent \n",
      "with the list of patient matching data elements already specified in \n",
      "the 2015 edition ``transitions of care'' certification criterion (sec.  \n",
      "170.315(b)(1)(iii)(g)), which supports the exchange of patient health \n",
      "information between providers of patient care.\n",
      "iii. pediatric vital signs\n",
      "    the uscdi v1 includes the pediatric vital sign data elements, which \n",
      "are specified as optional health information in the 2015 edition ccds \n",
      "definition. pediatric vital signs include: head occipital-frontal \n",
      "circumference for children less than 3 years of age, bmi percentile per \n",
      "age and sex for youth 2-20 years of age, weight for age per length and \n",
      "sex for children less than 3 years of age, and the reference range/\n",
      "scale or growth curve, as appropriate. as explained in section vi.a.2 \n",
      "of this proposed rule, the inclusion of pediatric vital sign data \n",
      "elements in the draft uscdi v1 would align with the provisions of the \n",
      "cures act related to health it to support the health care of children. \n",
      "stakeholders emphasized the value of pediatric vital sign data elements \n",
      "to better support the safety and quality of care delivered to children. \n",
      "we also note that, as discussed in the 2015 edition proposed rule, the \n",
      "centers for disease control and prevention (cdc) recommends the use of \n",
      "these pediatric vital signs for settings of care in which pediatric and \n",
      "adolescent patients are seen (80 fr 16818-16819) as part of best \n",
      "practices. the availability of a reference range/scale or growth curve \n",
      "would help with proper interpretation of the measurements for the bmi \n",
      "percentile per age and sex and weight for age per length and sex. \n",
      "further, the inclusion of this health information in the uscdi v1 is \n",
      "the appropriate next step after first specifying them as optional in \n",
      "the ccds definition as part of the 2015 edition rulemaking and as a \n",
      "means of supporting patient access to their ehi in a longitudinal \n",
      "format through certified health it (see section 3009(e)(2)(a)(i) of the \n",
      "phsa as amended by the cures act). we recognize, however, that certain \n",
      "health it developers and their customers may not find these \n",
      "capabilities and information useful. therefore, we request comment on \n",
      "the inclusion of pediatric vital signs in the uscdi v1, including the \n",
      "potential benefits and costs for all stakeholders stemming from its \n",
      "inclusion in the uscdi v1.\n",
      "iv. clinical notes\n",
      "    the uscdi v1 includes a new data class, titled ``clinical notes.'' \n",
      "``clinical notes'' is included in the uscdi v1 based on significant \n",
      "feedback from the industry since the 2015 edition final rule. we also \n",
      "received feedback during the trusted exchange framework and common \n",
      "agreement (tefca) stakeholder sessions and public comment period. it \n",
      "has been identified by stakeholders as highly desirable data for \n",
      "interoperable exchange. the free text portion of the clinical notes was \n",
      "most often relayed by clinicians as the data they sought, but were \n",
      "often missing during electronic health information exchange. clinical \n",
      "notes can be composed of text generated from structured (pick-list and/\n",
      "or check the box) fields as well as unstructured (free text) data. a \n",
      "clinical note may include the assessment, diagnosis, plan of care and \n",
      "evaluation of plan, patient teaching, and other relevant data points.\n",
      "    we recognize that a number of different clinical notes could be \n",
      "useful for stakeholders. it is our understanding that work is being \n",
      "done in the community to focus on a subset of clinical notes. we \n",
      "considered three options for identifying the different ``note types'' \n",
      "to adopt in uscdi v1. the first option we considered would allow for \n",
      "the community to offer any and all recommended notes. the second option \n",
      "we considered would set a minimum standard of eight note types. this \n",
      "option was derived from the eight note types identified by the argonaut \n",
      "project participants.\\17\\ the third option we identified would look to \n",
      "the eleven hl7 consolidated clinical data architecture (c-cda) document \n",
      "types identified in the c-cda release 2.1, which also included the note \n",
      "types being identified by the argonaut project participants. we \n",
      "ultimately decided to move forward with the second option because it \n",
      "unites public and private interests toward the same goal. the eight \n",
      "selected note types are a minimum bar and, in the future, the uscdi may \n",
      "be updated to include other clinical notes. specifically, we propose to \n",
      "include the following clinical note types for both inpatient and \n",
      "outpatient (primary care, emergency department, etc.) settings in uscdi \n",
      "v1 as a minimum standard: (1) discharge summary note; (2) history & \n",
      "physical; (3) progress note; (4) consultation note; (5) imaging \n",
      "narrative; (6) laboratory report narrative; (7) pathology report \n",
      "narrative; and (8) procedures note. we seek comment on whether to \n",
      "include additional note types as part of the uscdi v1.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\17\\ link to the clinical notes argonaut project identified (to \n",
      "clarify: seven bullets are listed, however, we split laboratory and \n",
      "pathology note types into their own note) <a href=\"http://wiki.hl7.org/index.php?title=201805_clinical_notes_track\">http://wiki.hl7.org/index.php?title=201805_clinical_notes_track</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "v. provenance\n",
      "    the uscdi v1 also includes a new data class, titled ``provenance.'' \n",
      "``provenance'' has been identified by stakeholders \\18\\ as valuable for \n",
      "interoperable exchange. the provenance of data was also referenced by \n",
      "stakeholders as a fundamental need to improve the trustworthiness and \n",
      "reliability of the data being exchanged. provenance describes the \n",
      "metadata, or extra information about data, that can help answer \n",
      "questions such as when and who created the data.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\18\\ <a href=\"https://www.healthit.gov/topic/interoperability/trusted-exchange-framework-and-common-agreement\">https://www.healthit.gov/topic/interoperability/trusted-exchange-framework-and-common-agreement</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the inclusion of ``provenance'' as a data class in the uscdi v1 \n",
      "would also complement the cures act requirement to support the exchange \n",
      "of data through the use of apis. this approach differs from the \n",
      "exchange of data via the c-cda. while c-cdas are often critiqued due to \n",
      "their relative ``length,'' the c-cda represents the output of a \n",
      "clinical encounter and includes relevant context. the same will not \n",
      "always be true in an api context. apis facilitate the granular exchange \n",
      "of data and, as noted in the 2015 edition final rule, offer the \n",
      "potential to aggregate data from multiple sources in a web or mobile \n",
      "application (80 fr 62675). the inclusion of provenance would help \n",
      "retain the relevant context so the recipient can better understand the \n",
      "origin of the data. as noted in section vii.b.4, we are also proposing \n",
      "to include provenance in our proposed ``api resource collection in \n",
      "health'' (arch) version 1 implementation specification in sec.  \n",
      "170.215(a)(2), which would list a set of base fast healthcare \n",
      "interoperability resources (fhir[supreg]) resources that health it \n",
      "modules certified to the proposed api criterion (sec.  170.315(g)(10)) \n",
      "would need to support.\n",
      "    we propose to further delineate the provenance data class into \n",
      "three data elements: ``the author,'' which represents the person(s) who \n",
      "is responsible for the information; ``the author's time stamp,'' which \n",
      "indicates the time the information was recorded; and ``the author's \n",
      "organization,'' which would be the organization the author is \n",
      "associated with at the time they interacted with the data. we have \n",
      "identified these three data elements as fundamental for data recipients \n",
      "to have\n",
      "\n",
      "[[page 7443]]\n",
      "\n",
      "available and both are commonly captured and currently available \n",
      "through standards. we request comment on the inclusion of these three \n",
      "data elements and whether any other provenance data elements, such as \n",
      "the identity of the individual or entity the data was obtained from or \n",
      "sent by (sometimes discussed in standards working groups as the \n",
      "provenance of the data's ``last hop''), would be essential to include \n",
      "as part of the uscdi v1 standard. we acknowledge that there is \n",
      "currently work to help define provenance in a standard robust manner, \n",
      "and we anticipate adopting the industry consensus once it becomes \n",
      "available.\n",
      "vi. unique device identifier(s) for a patient's implantable device(s)\n",
      "    we are aware of a recently published implementation guide (ig) \n",
      "within hl7 that provides further guidance on the unique device \n",
      "identifier (udi) requirements. the ig, health level 7 (hl7[supreg]) cda \n",
      "r2 implementation guide: c-cda supplemental templates for unique device \n",
      "identification (udi) for implantable medical devices, release 1-us \n",
      "realm,\\19\\ identifies changes needed to the c-cda to better facilitate \n",
      "the exchange of the individual udi components in the health care system \n",
      "when devices are implanted in a patient. the udi components include the \n",
      "device identifier (di) and the following individual production \n",
      "identifiers: the lot or batch number, serial number, manufacturing \n",
      "date, expiration date, and distinct identification code. however, as \n",
      "this new ig has been recently published, we request comment on whether \n",
      "we should add this udi ig as a requirement for health it to adopt in \n",
      "order to meet the requirements for udi uscdi data class. in addition, \n",
      "we do not have a reliable basis on which to estimate how much it would \n",
      "cost to meet the requirements outlined in the udi ig; and, therefore, \n",
      "we request comment on the cost and burden of complying with this \n",
      "proposed requirement.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\19\\ <a href=\"http://www.hl7.org/implement/standards/product_brief.cfm?product_id=486\">http://www.hl7.org/implement/standards/product_brief.cfm?product_id=486</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "vii. medication data request for comment\n",
      "    the uscdi v1 ``medication'' data class includes two constituent \n",
      "data elements within it: medications and medication allergies. with \n",
      "respect to the latter, medication allergies, we request comment on an \n",
      "alternative approach. this alternative would result in removing the \n",
      "medication allergies data element from the medication data class and \n",
      "creating a new data class titled, ``substance reactions,'' which would \n",
      "be meant to be inclusive of ``medication allergies.'' the new \n",
      "``substance reactions'' data class would include the following data \n",
      "elements: ``substance'' and ``reaction,'' and include snomed ct as an \n",
      "additional applicable standard for non-medication substances.\n",
      "c. uscdi standard--relationship to content exchange standards and \n",
      "implementation specifications\n",
      "    in order to align with our approach to be responsive to the \n",
      "evolution of standards and to facilitate updates to newer versions of \n",
      "standards, the uscdi v1 (sec.  170.213) is ``content exchange'' \n",
      "standard agnostic. it establishes ``data policy'' and does not directly \n",
      "associate with the content exchange standards and implementation \n",
      "specifications which, given a particular context, may be necessary to \n",
      "exchange the entire uscdi, a uscdi class, or elements within it. to our \n",
      "knowledge, all data classes in the uscdi v1 can be supported by \n",
      "commonly used ``content exchange'' standards, including hl7 c-cda \n",
      "release 2.1 and fhir[supreg].\n",
      "d. clinical notes c-cda implementation specification\n",
      "    in conjunction with our proposal to adopt the uscdi v1, we propose \n",
      "to adopt the hl7 cda[supreg] r2 ig: c-cda templates for clinical notes \n",
      "r1 companion guide, release 1 in sec.  170.205(a)(4)(i) (``c-cda \n",
      "companion guide''). the c-cda companion guide provides supplemental \n",
      "guidance and additional technical clarification for specifying data in \n",
      "the c-cda release 2.1.\\20\\ as noted above, the proposed uscdi v1 \n",
      "includes new data classes, such as ``clinical notes,'' which are \n",
      "further supported through the c-cda companion guide. for example, the \n",
      "c-cda companion guide provides specifications for clinical notes by \n",
      "indicating that clinical notes should be recorded in ``note activity'' \n",
      "and requires references to other discrete data, such as ``encounters.'' \n",
      "the c-cda companion guide also enhances implementation of the 2015 \n",
      "edition certification criteria that reference the c-cda release 2.1 \n",
      "(sec.  170.205(a)(4)). as noted by stakeholders, the c-cda release 2.1 \n",
      "includes some optionality and ambiguity with respect to data element \n",
      "components, such as the locations and value sets. we attempted to \n",
      "address some of this optionality by clarifying requirements using \n",
      "certification companion guides (ccgs) \\21\\ and by specifying in the \n",
      "ccds definition where certain data should be placed in the c-cda \n",
      "release 2.1 templates (e.g., ``goals'' in the goals section).\\22\\ the \n",
      "c-cda companion guide, which was released after the 2015 edition final \n",
      "rule, provides similar, but additional c-cda implementation structure. \n",
      "for example, race and ethnicity are required data elements in the uscdi \n",
      "(formerly the ccds) and must be included in c-cda exchanges if known, \n",
      "or they may be marked with a nullflavor of unk (unknown) if not known. \n",
      "the c-cda release 2.1 is unclear on the location and value set, but the \n",
      "c-cda companion guide clarifies the location and value set. the \n",
      "adoption of the c-cda companion guide would align with our goal to \n",
      "increase the consistent implementation of standards among health it \n",
      "developers and improve interoperability. we propose to adopt this c-cda \n",
      "companion guide to support best practice implementation of uscdi v1 \n",
      "data classes and 2015 edition certification criteria that reference c-\n",
      "cda release 2.1 (sec.  170.205(a)(4)). the criteria include:\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\20\\ <a href=\"http://www.hl7.org/implement/standards/product_brief.cfm?product_id=447\">http://www.hl7.org/implement/standards/product_brief.cfm?product_id=447</a>.\n",
      "    \\21\\ <a href=\"https://www.healthit.gov/topic/certification-ehrs/2015-edition-test-method\">https://www.healthit.gov/topic/certification-ehrs/2015-edition-test-method</a>.\n",
      "    \\22\\ <a href=\"https://www.healthit.gov/sites/default/files/topiclanding/2018-04/2015ed_ccg_ccds.pdf\">https://www.healthit.gov/sites/default/files/topiclanding/2018-04/2015ed_ccg_ccds.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> ``transitions of care'' (sec.  170.315(b)(1));\n",
      "    <bullet> ``clinical information reconciliation and incorporation'' \n",
      "(sec.  170.315(b)(2));\n",
      "    <bullet> ``care plan'' (sec.  170.315(b)(9));\n",
      "    <bullet> ``view, download, and transmit to 3rd party'' (sec.  \n",
      "170.315(e)(1));\n",
      "    <bullet> ``consolidated cda creation performance'' (sec.  \n",
      "170.315(g)(6)); and\n",
      "    <bullet> ``application access--all data request'' (sec.  \n",
      "170.315(g)(9)).\n",
      "    we propose, as a maintenance of certification requirement for the \n",
      "real world testing condition of certification, that health it \n",
      "developers with health it certified to the six above-identified \n",
      "certification criteria prior to the effective date of a subsequent \n",
      "final rule would have to update such certified health it to the \n",
      "proposed revisions. we further propose, as a maintenance of \n",
      "certification requirement for the real world testing condition of \n",
      "certification, that health it developers must provide the updated \n",
      "certified health it to all their customers with health it previously \n",
      "certified to the identified criteria no later than 24 months after the \n",
      "effective date of a final rule for this proposed rule. for the purposes \n",
      "of meeting this compliance timeline, we expect health it developers to \n",
      "update their certified health it without new mandatory testing and \n",
      "notify their\n",
      "\n",
      "[[page 7444]]\n",
      "\n",
      "onc-acb on the date at which they have reached compliance. developers \n",
      "would also need to factor these updates into their next real world \n",
      "testing plan as discussed in section vii.b.5 of this proposed rule.\n",
      "2. electronic prescribing standard and certification criterion\n",
      "    we propose to update the electronic prescribing (e-rx) script \n",
      "standard used for ``electronic prescribing'' in the 2015 edition to \n",
      "ncpdp script 2017071, which would result in a new e-rx standard \n",
      "becoming the baseline for certification. we propose to adopt this \n",
      "standard in sec.  170.205(b)(1). onc and cms have historically \n",
      "maintained complementary policies of aligning health it certification \n",
      "criteria and associated standard for e-prescribing with the cms \n",
      "medicare part d e-rx and mh standards (75 fr 44589; 77 fr 54198). to \n",
      "this end, cms has retired the current standard (ncpdp script version \n",
      "10.6) for e-rx and mh and adopted ncpdp script 2017071 as the standard \n",
      "for part d e-rx and mh effective january 1, 2020, conditional on onc \n",
      "updating the program to the ncpdp script 2017071 standard for its e-rx \n",
      "certification criterion (see also 42 cfr 423.160(b)(1)(v) and (2)(iv)). \n",
      "in addition, cms recently sought comment regarding whether the ncpdp \n",
      "script 2017071 standard could facilitate future reporting of the \n",
      "proposed query of prescription drug monitoring program (pdmp) measure \n",
      "in both the 2019 physician fee schedule proposed rule (83 fr 35923) and \n",
      "hospital inpatient prospective payment systems (ipps) fiscal year 2019 \n",
      "proposed rule (83 fr 20528).\n",
      "    as summarized in the ipps fiscal year 2019 final rule (83 fr \n",
      "41144), cms received comments supportive of using the ncpdp script \n",
      "2017071 medication history transactions for pdmp queries and responses, \n",
      "as well as comments asking cms to seek harmonizing of the 2015 edition \n",
      "e-prescribing certification criterion to the ncpdp script 2017071 \n",
      "standard specified in the part d program portions of the recent \n",
      "``medicare program; contract year 2019 policy and technical changes to \n",
      "the medicare advantage, medicare cost plan, medicare fee-for-service, \n",
      "the medicare prescription drug benefit programs, and the pace program'' \n",
      "final rule (83 fr 16440).\n",
      "    in addition to proposing to adopt the ncpdp script 2017071 standard \n",
      "for the transactions that are listed in the current ``electronic \n",
      "prescribing'' criterion (sec.  170.315(b)(3)), we propose to adopt and \n",
      "require conformance to all of the ncpdp script 2017071 standard \n",
      "transactions cms adopted at 42 cfr 423.160(b)(2)(iv) for ncpdp script \n",
      "2017071. therefore, we propose to adopt a new 2015 edition ``electronic \n",
      "prescribing'' criterion (sec.  170.315(b)(11)) that includes the \n",
      "following transactions:\n",
      "\n",
      "<bullet> create new prescriptions (newrx, newrxrequest, \n",
      "newrxresponsedenied)\n",
      "\n",
      "    a newrx transaction is a new prescription from a prescriber to a \n",
      "pharmacy so that it can be dispensed to a patient. a newrxrequest is a \n",
      "request from a pharmacy to a prescriber for a new prescription for a \n",
      "patient. a newrxresponsedenied is a denied response to a previously \n",
      "sent newrxrequest (if approved, a newrx would be sent). a \n",
      "newrxresponsedenied response may occur when the newrxrequest cannot be \n",
      "processed or if information is unavailable.\n",
      "\n",
      "<bullet> change prescriptions (rxchangerequest, rxchangeresponse)\n",
      "\n",
      "    an rxchangerequest transaction originates from a pharmacy to \n",
      "request: a change in the original prescription (new or fillable), \n",
      "validation of prescriber credentials, a prescriber to review the drug \n",
      "requested, or a prior authorization from the payer for the \n",
      "prescription. an rxchangeresponse transaction originates from a \n",
      "prescriber to respond: to a prescription change request from a \n",
      "pharmacy, to a request for a prior authorization from a pharmacy, or to \n",
      "a prescriber credential validation request from a pharmacy.\n",
      "\n",
      "<bullet> cancel prescriptions (cancelrx, cancelrxresponse)\n",
      "\n",
      "    a cancelrx transaction is a request from a prescriber to a pharmacy \n",
      "to not fill a previously sent prescription. a cancelrx must contain \n",
      "pertinent information for the pharmacy to be able to find the \n",
      "prescription in their system (patient, medication (name, strength, \n",
      "dosage, form), prescriber, prescription number if available). a \n",
      "cancelrxresponse is a response from a pharmacy to a prescriber to \n",
      "acknowledge a cancelrx, and is used to denote if the cancellation is \n",
      "approved or denied.\n",
      "\n",
      "<bullet> renew prescriptions (rxrenewalrequest, rxrenewalresponse)\n",
      "\n",
      "    an rxrenewalrequest transaction originates from a pharmacy to \n",
      "request additional refills beyond those originally prescribed. \n",
      "rxrenewalresponse originates from a prescriber to respond to the \n",
      "request.\n",
      "\n",
      "<bullet> receive fill status notifications (rxfill, \n",
      "rxfillindicatorchange)\n",
      "\n",
      "    an rxfill transaction is sent from a pharmacy to a prescriber or a \n",
      "long term or post-acute care (ltpac) facility indicating the fillstatus \n",
      "(dispensed, partially dispensed, not dispensed or returned to stock, \n",
      "transferred to another pharmacy) of the new, refill, or resupply \n",
      "prescriptions for a patient. rxfillindicator informs the pharmacy of \n",
      "the prescriber's intent for fill status notifications for a specific \n",
      "patient/medication. an rxfillindicatorchange is sent by a prescriber to \n",
      "a pharmacy to indicate that the prescriber is changing the types of \n",
      "rxfill transactions that were previously requested, where the \n",
      "prescriber may modify the fill status of transactions previously \n",
      "selected or cancel future rxfill transactions.\n",
      "\n",
      "<bullet> request and receive medication history (rxhistoryrequest, \n",
      "rxhistoryresponse)\n",
      "\n",
      "    an rxhistoryrequest transaction is a request from a prescriber for \n",
      "a list of medications that have been prescribed, dispensed, claimed, or \n",
      "indicated by a patient. this request could be sent to a state \n",
      "prescription drug monitoring program (pdmp). an rxhistoryresponse is a \n",
      "response to an rxhistoryrequest containing a patient's medication \n",
      "history. it includes the medications that were dispensed or obtained \n",
      "within a certain timeframe, and optionally includes the prescriber that \n",
      "prescribed it. rxhistoryrequest and rxhistoryresponse transactions may \n",
      "be sent directly or through an intermediary.\n",
      "\n",
      "<bullet> ask the mailbox if there are any transactions (getmessage)\n",
      "\n",
      "    this transaction is used by the prescriber or pharmacy asking the \n",
      "mailbox if there are any transactions. it is at the heart of the \n",
      "mechanism used by a pharmacy or prescriber system to receive \n",
      "transactions from each other or from a payer or the rems administrator \n",
      "via a switch, acting as a mailbox.\n",
      "\n",
      "<bullet> relay acceptance of a transaction back to the sender (status)\n",
      "\n",
      "    this transaction is used to relay acceptance of a transaction back \n",
      "to the sender. a status in response to any applicable transaction other \n",
      "than getmessage indicates acceptance and responsibility for a request. \n",
      "a status in response to getmessage indicates that no mail is waiting \n",
      "for pickup. a status cannot be mailboxed and may not contain an error.\n",
      "\n",
      "<bullet> respond that there was a problem with the transaction (error)\n",
      "\n",
      "    this transaction indicates an error has occurred, indicating the \n",
      "request was\n",
      "\n",
      "[[page 7445]]\n",
      "\n",
      "terminated. an error can be generated when there is a communication \n",
      "problem or when the transaction actually had an error. an error can be \n",
      "mailboxed, as it may be signifying to the originator that a transaction \n",
      "was unable to be delivered or encountered problems in the acceptance. \n",
      "the error must be a different response than a status, since the \n",
      "communication between the system and the mailbox must clearly denote \n",
      "the actions taking place. an error is a response being delivered on \n",
      "behalf of a previous transaction, and the status signifies no more \n",
      "mail.\n",
      "\n",
      "<bullet> respond that a transaction requesting a return receipt has \n",
      "been received (verify)\n",
      "\n",
      "    this transaction is a response to a pharmacy or prescriber \n",
      "indicating that a transaction requesting a return receipt has been \n",
      "received. verifications results when a ``return receipt requested'' \n",
      "flag is set in the original request. upon receiving a transaction with \n",
      "returnreceipt set, it is the responsibility of the receiver to either \n",
      "generate a verify in response to the request (recommended) or generate \n",
      "a status in response to this request, followed subsequently by a free \n",
      "standing verify. this transaction notifies the originator that the \n",
      "transaction was received at the software system. it is not a \n",
      "notification of action taking place, since time may elapse before the \n",
      "ultimate answer to the transaction may take place.\n",
      "\n",
      "<bullet> request to send an additional supply of medication (resupply)\n",
      "\n",
      "    this transaction is a request from a long term or post-acute care \n",
      "(ltpac) organization to a pharmacy to send an additional supply of \n",
      "medication for an existing order. an example use case is when a \n",
      "medication supply for a resident is running low (2-3 doses) and a new \n",
      "supply is needed from the pharmacy, the ltpac organization need a way \n",
      "to notify the pharmacy that an additional supply for the medication is \n",
      "needed.\n",
      "\n",
      "<bullet> communicate drug administration events (drugadministration)\n",
      "\n",
      "    this transaction communicates drug administration events from a \n",
      "prescriber/care facility to the pharmacy or other entity. it is a \n",
      "notification from a prescriber/care facility to a pharmacy or other \n",
      "entity that a drug administration event has occurred--for example, a \n",
      "medication was suspended or administration was resumed.\n",
      "\n",
      "<bullet> transfer one or more prescriptions (rxtransferrequest, \n",
      "rxtransferresponse, rxtransferconfirm)\n",
      "\n",
      "    the rxtransferrequest transaction is used when the pharmacy is \n",
      "asking for a transfer of one or more prescriptions for a specific \n",
      "patient to the requesting pharmacy. the rxtransferresponse transaction \n",
      "is the response to the rxtransferrequest which includes the \n",
      "prescription(s) being transferred or a rejection of the transfer \n",
      "request. it is sent from the transferring pharmacy to the requesting \n",
      "pharmacy. the rxtransferconfirm transaction is used by the pharmacy \n",
      "receiving (originally requesting) the transfer to confirm that the \n",
      "transfer prescription has been received and the transfer is complete.\n",
      "\n",
      "<bullet> recertify the continued administration of a medication order \n",
      "(recertification)\n",
      "\n",
      "    this transaction is a notification from a facility, on behalf of a \n",
      "prescriber, to a pharmacy recertifying the continued administration of \n",
      "a medication order. an example use is when an existing medication order \n",
      "has been recertified by the prescriber for continued use. long term or \n",
      "post-acute care use only.\n",
      "\n",
      "<bullet> complete risk evaluation and mitigation strategy (rems) \n",
      "transactions (remsinitiationrequest, remsinitiationresponse, \n",
      "remsrequest, and remsresponse)\n",
      "\n",
      "    with cms' recent adoption of these transactions in their recently \n",
      "issued final rule associated with e-prescribing for medicare part d (42 \n",
      "cfr 423.160(b)(2)(iv)(w)-(z)), we believe that it would be equally \n",
      "beneficial to include these four rems transactions as part of this \n",
      "proposed certification criterion: remsinitiationrequest, \n",
      "remsinitiationresponse, remsrequest, and remsresponse.\n",
      "    the food and drug administration amendments act (fdaaa) of 2007 \n",
      "(pub. l. 110-85) enables the food and drug administration (fda) to \n",
      "require a rems from a pharmaceutical manufacturer if the fda determines \n",
      "that a rems is necessary to ensure the benefits of a drug outweigh the \n",
      "risks associated with the drug. the currently approved rems programs \n",
      "vary in levels of complexity. typically a med guide and communication \n",
      "plan is required, but some also require elements to assure safe use \n",
      "(etasu). the large majority of existing rems programs are for drugs \n",
      "dispensed through specialty pharmacies, clinics, and hospitals, but as \n",
      "rems become more common they may ultimately have a greater impact on \n",
      "retail-based products.\n",
      "    the impact of rems is twofold. first, rems with etasu may require \n",
      "the pharmacist to verify prescriber, patient, and/or pharmacy \n",
      "enrollment in a registry and, in some cases, verify or check certain \n",
      "information, such as lab results. second, all rems, including those \n",
      "without etasu, must fulfill fda-approved reporting requirements. each \n",
      "rems program must also include a program assessment schedule that \n",
      "examines the program's effectiveness on intervals approved by the fda \n",
      "as part of the overall rems program. the results of these assessments \n",
      "are submitted to the fda as part of the ongoing evaluation of rems \n",
      "program effectiveness. accordingly, we propose to include the rems \n",
      "transactions as part of this proposed certification criterion. we would \n",
      "also note for commenters' benefit that the script 2017071 testing tool \n",
      "under development is being designed to support testing these rems \n",
      "transactions.\n",
      "    we believe that removing the 2015 edition certification criterion \n",
      "(codified in sec.  170.315(b)(3)) that references ncpdp script version \n",
      "10.6 and replacing it with an updated e-prescribing criterion (proposed \n",
      "to be codified in sec.  170.315(b)(11)) would harmonize with relevant \n",
      "cms program timelines, including part d e-prescribing requirements and \n",
      "the option for eligible clinicians, hospitals, and cahs to report on \n",
      "the query of prescription drug monitoring program (pdmp) quality \n",
      "measure for promoting interoperability programs. however, should our \n",
      "proposal to adopt the new e-prescribing criterion (sec.  \n",
      "170.315(b)(11)) be finalized prior to january 1, 2020, we also propose \n",
      "to permit continued certification to the current 2015 edition \n",
      "``electronic prescribing'' criterion (sec.  170.315(b)(3)) for the \n",
      "period of time in which it would continue to be used as a program \n",
      "standard in the cms medicare part d program or the cms promoting \n",
      "interoperability programs. once it is no longer used in those programs, \n",
      "we would no longer permit certification to that criterion and would \n",
      "remove it from the code of federal regulations. we will consider \n",
      "setting an effective date for such actions in a subsequent final rule \n",
      "based on stakeholder feedback and cms policies at the time. to this \n",
      "point, we note that the continued acceptability of a health it module \n",
      "certified to the criterion codified in sec.  170.315(b)(3) for purposes \n",
      "of meeting the cehrt definition and participating in the cms promoting \n",
      "interoperability programs would be a matter of cms policy.\n",
      "3. clinical quality measures--report criterion\n",
      "    in the 2015 edition final rule, onc adopted four clinical quality \n",
      "measure (cqm) certification criteria, sec.  170.315(c)(1) cqms--record \n",
      "and\n",
      "\n",
      "[[page 7446]]\n",
      "\n",
      "export, sec.  170.315(c)(2) cqms--import and calculate, sec.  \n",
      "170.315(c)(3) cqms--report, and sec.  170.315(c)(4) cqms--filter (80 fr \n",
      "62649-62655). these four criteria were adopted with the intent to \n",
      "support providers' quality improvement activities and in electronically \n",
      "generating cqm reports for reporting with certified health it to \n",
      "programs such as the ehr incentive programs, quality payment program, \n",
      "and comprehensive primary care plus initiative. all four cqm criteria \n",
      "require certified health it to be capable of generating cqm reports \n",
      "using the hl7 quality reporting document architecture (qrda) category i \n",
      "standard, which provides cqm reports for individual patients. \n",
      "specifically, we adopted hl7 cda[supreg] release 2 implementation guide \n",
      "for: quality reporting document architecture--category i (qrda i); \n",
      "release 1, draft standard for trial use (dstu) release 3 (us realm)), \n",
      "volume 1 (sec.  170.205(h)(2)). two of the cqm criteria, cqms--report \n",
      "(sec.  170.315(c)(3)) and cqms--filter (sec.  170.315(c)(4)), also \n",
      "require certified health it to be capable of generating cqm reports \n",
      "using the qrda category iii standard, which provides aggregate cqm \n",
      "reports for a set of patients. more specifically, we adopted qrda \n",
      "category iii, implementation guide for cda release 2 (sec.  \n",
      "170.205(k)(1)) and the errata to the hl7 implementation guide for \n",
      "cda[supreg] release 2: qrda category iii, dstu release 1 (us realm), \n",
      "september 2014 (sec.  170.205(k)(2)).\n",
      "    the ``cqms--report'' certification criterion (sec.  170.315(c)(3)) \n",
      "includes an optional certification provision for demonstrating that the \n",
      "health it can create qrda reports in the form and manner required for \n",
      "submission to cms programs, which is in accordance with cms' qrda \n",
      "implementation guide (igs).\\23\\ the cms qrda igs include specific \n",
      "requirements to support providers participating in cms programs in \n",
      "addition to the hl7 igs. at the time of the finalization of the 2015 \n",
      "edition final rule and in response to public comment, we noted that \n",
      "there was mixed feedback on whether this criterion should require \n",
      "adherence to the hl7 qrda category i and category iii standards or \n",
      "solely to the cms qrda igs. as such, we adopted an approach that \n",
      "allowed for flexibility and only required that certified health it \n",
      "support the hl7 qrda standards, which are program-agnostic and can \n",
      "support a number of use cases for exchanging cqm data. because the \n",
      "criterion has the optional provision for cms program- specific \n",
      "certification, developers can also support their end-users who intend \n",
      "to use their certified health it to report ecqms to cms in the ``form \n",
      "and manner'' cms requires (i.e., using the format specified in the cms \n",
      "qrda igs) (80 fr 62652).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\23\\ <a href=\"https://ecqi.healthit.gov/qrda-quality-reporting-document-architecture\">https://ecqi.healthit.gov/qrda-quality-reporting-document-architecture</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    since the 2015 edition final rule was published (october 16, 2015), \n",
      "we have gained additional certification experience and received \n",
      "feedback from the industry that health it certified to the ``cqms-\n",
      "report'' criterion (sec.  170.315(c)(3)) are only/primarily being used \n",
      "to submit ecqms to cms for participation in cms programs. therefore, as \n",
      "a means of reducing burden, we propose to remove the hl7 qrda standard \n",
      "requirements from the 2015 edition cqms--report criterion in sec.  \n",
      "170.315(c)(3), but require that health it certified to the criterion \n",
      "support the cms qrda igs. this would directly reduce burden on health \n",
      "it developers and indirectly providers as they would no longer have to, \n",
      "in practice, develop (health it developers) and support (both \n",
      "developers and providers) two forms of the qrda standard (i.e., the hl7 \n",
      "and cms forms). we note that the fast health interoperability resources \n",
      "(fhir) standard offers the potential for supporting quality improvement \n",
      "and reporting needs and promises to be a more efficient, modular, and \n",
      "interoperable standard to develop, implement, and utilize through apis. \n",
      "however, until the potential benefits of fhir apis can be realized for \n",
      "quality improvement and reporting, we believe that solely requiring the \n",
      "cms qrda igs for the ``cqms--report'' criterion balances the burden to \n",
      "developers and providers, while still meeting the goal of facilitating \n",
      "quality improvement and reporting to cms.\n",
      "    to support the proposal, we propose to incorporate by reference the \n",
      "latest annual cms qrda igs, specifically the 2019 cms qrda i \n",
      "implementation guide for hospital quality reporting \\24\\ and the 2019 \n",
      "cms qrda iii implementation guide for eligible professionals (eps) and \n",
      "eligible clinicians.\\25\\ a health it module would need to be certified \n",
      "to both standards to provide flexibility to providers. however, we \n",
      "solicit comment on whether we should consider an approach that permits \n",
      "certification to only one of the standards depending on the care \n",
      "setting for which the product is designed and implemented. we also \n",
      "solicit comment on the future possibility of fhir-enabled apis \n",
      "replacing or complementing qrda reports for quality reporting and \n",
      "improvement.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\24\\ <a href=\"https://ecqi.healthit.gov/system/files/qrda_hqr_2019_cms_ig_final_508.pdf\">https://ecqi.healthit.gov/system/files/qrda_hqr_2019_cms_ig_final_508.pdf</a>.\n",
      "    \\25\\ <a href=\"https://ecqi.healthit.gov/system/files/2019_cms_qrda_iii_eligible_clinicians_and_ep_ig-508.pdf\">https://ecqi.healthit.gov/system/files/2019_cms_qrda_iii_eligible_clinicians_and_ep_ig-508.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    if we finalize this proposal in a subsequent final rule, we propose \n",
      "to adopt the latest cms qrda igs at the time of final rule publication, \n",
      "as cms updates their qrda igs annually to support the latest ecqm \n",
      "specifications and only accepts ecqm reporting to the latest version.\n",
      "    we note that this approach would also facilitate a means for onc to \n",
      "permit developers to update its certified health it to newer versions \n",
      "of the cms qrda igs through the real world testing maintenance of \n",
      "certification provision for standards and implementation specification \n",
      "updates in support of ongoing interoperability (see section vii.b.5 of \n",
      "this proposed rule).\n",
      "4. electronic health information export\n",
      "    we propose to adopt a new 2015 edition certification criterion for \n",
      "ehi export in sec.  170.315(b)(10). this criterion is intended to \n",
      "provide patients and health it users with a means to efficiently export \n",
      "the entire electronic health record for a single patient or all \n",
      "patients in a computable, electronic format, and facilitate the \n",
      "receiving health it system's interpretation and use of the ehi, to the \n",
      "extent reasonably practicable using the developer's existing \n",
      "technology.\n",
      "    this outcome would promote access, exchange, and use of ehi and \n",
      "facilitate health care providers' ability to switch health it systems \n",
      "or to migrate ehi for use in other technologies. additionally, as \n",
      "discussed in section vii.b.2 of this preamble, certification to this \n",
      "criterion would provide some degree of assurance that a health it \n",
      "developer supports, and does not inhibit, the access, exchange, and use \n",
      "of ehi for the specific use cases that the criterion addresses.\n",
      "    this proposed criterion supports two specific use cases for which \n",
      "we believe that all ehi produced and electronically managed in a \n",
      "developer's technology should be made readily available for export as a \n",
      "standard capability of certified health it.\n",
      "    first, we propose that health it certified to this criterion would \n",
      "have to enable the export of ehi for a single patient upon a valid \n",
      "request from that patient or a user on the patient's behalf. this \n",
      "patient-focused export capability, which is discussed in more detail \n",
      "below, complements other provisions of this proposed rule that support \n",
      "patients' access to their ehi including information that may eventually \n",
      "be\n",
      "\n",
      "[[page 7447]]\n",
      "\n",
      "accessible via the apis described in section vii.b.4 of this preamble. \n",
      "ultimately, we expect all data to be transferred through apis or other \n",
      "advanced technologies. ehi export also supports longitudinal data \n",
      "record development, and aligns with section 4006(a) of the cures act, \n",
      "which requires [t]he secretary, in consultation with the national \n",
      "coordinator, [to] promote policies that ensure that a patient's ehi is \n",
      "accessible to that patient and the patient's designees, in a manner \n",
      "that facilitates communication with the patient's health care providers \n",
      "and other individuals, including researchers, consistent with such \n",
      "patient's consent.\n",
      "    second, this criterion would support the export of ehi when a \n",
      "health care provider chooses to transition or migrate information to \n",
      "another health it system. as discussed in section viii.c.5.c.iii of \n",
      "this preamble, health it developers are in a unique position to block \n",
      "the export and portability of data for use in competing systems or \n",
      "applications, or to charge rents for access to the basic technical \n",
      "information needed to facilitate the conversion or migration of data \n",
      "for these purposes. by providing at least a baseline capability for \n",
      "exporting ehi in a commercially reasonable format, we believe that this \n",
      "criterion would help to address some of these business practices and \n",
      "enable smoother transitions between health it systems.\n",
      "    this criterion is intended to further the two use cases outlined \n",
      "above while providing an incremental approach given the known and \n",
      "anticipated health it landscape when onc expects certified health it \n",
      "with this functionality will be widely available in the ecosystem. at \n",
      "the time of this rulemaking, we believe a focused certification \n",
      "criterion that is standards-agnostic will provide a useful first step \n",
      "to enabling patients to request and receive their ehi and for providers \n",
      "to more readily switch or migrate information between health it \n",
      "systems. understanding that open, standards-based apis are an emerging \n",
      "technology and that some health it developers today have implemented \n",
      "proprietary apis, this proposed criterion for ehi export provides an \n",
      "initial method for exporting patient health information in these \n",
      "circumstances. over time, onc may consider expanding the proposed \n",
      "criterion or replacing it to achieve the goals in sec.  170.402. it is \n",
      "also possible that in the future, this criterion will no longer be \n",
      "needed once standards-based apis are widely available in the health it \n",
      "ecosystem with the ability to facilitate exchange of a wider set of \n",
      "standardized data elements per the predictable, transparent, and \n",
      "collaborative process to expand the uscdi (see the discussion of the \n",
      "api condition of certification and the proposed api criterion in sec.  \n",
      "170.315(g)(10) in vii.b.4 for additional information).\n",
      "a. patient access\n",
      "    as noted above, the export functionality required by this \n",
      "certification criterion would support both a patient's access to their \n",
      "ehi and a provider's ability to switch to another health it system. in \n",
      "the patient access context, we propose that a user must be able to \n",
      "timely execute the single patient ehi export at any time the user \n",
      "chooses and without subsequent developer assistance to operate. the \n",
      "health it developer should enable the user to make data requests and \n",
      "receive the export efficiently, without unreasonable burden. for \n",
      "example, the health it developer should not: require the user to make a \n",
      "request multiple times for different types of ehi; provide unreasonable \n",
      "delays for the export; or prohibit reasonable user access to the system \n",
      "during the export process.\n",
      "    ``timely'' does not mean real-time; however, we stress that any \n",
      "delays in providing the export must be no longer than reasonably \n",
      "necessary to avoid interference with other clinical functions of the \n",
      "health it system. this is similar to the approach we have taken for \n",
      "export of clinical quality measure data. the export capability does not \n",
      "require that data be received instantaneously. rather, as we have \n",
      "stated before (80 fr 62650) a non-conformity would exist if \n",
      "surveillance revealed that processing or other delays were likely to \n",
      "substantially interfere with the ability of a provider or health system \n",
      "to view and verify their cqm results for quality improvement on a near \n",
      "real-time basis. similarly, a non-conformity would exist if delays were \n",
      "causing or contributing to users being presented with data files that \n",
      "no longer contained current, accurate, or valid data. to avoid these \n",
      "implementation issues and ensure that capabilities support all required \n",
      "outcomes, health it developers should seek to minimize processing times \n",
      "and other delays to the greatest extent possible.\\26\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\26\\ <a href=\"https://www.healthit.gov/test-method/clinical-quality-measures-cqms-record-and-export#ccg\">https://www.healthit.gov/test-method/clinical-quality-measures-cqms-record-and-export#ccg</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    as previously defined under the program, ``user'' is a health care \n",
      "professional or his or her office staff; or a software program or \n",
      "service that would interact directly with the certified health it (80 \n",
      "fr 62611, 77 fr 54168). we typically would expect the ``user'' in this \n",
      "case to be a provider or his or her office staff who will be performing \n",
      "the request on behalf of the patient given that a request of this \n",
      "nature would likely occur in the context of an individual exercising \n",
      "their right of access under the hipaa privacy rule (45 cfr 164.524). in \n",
      "this regard, the proposed 2015 edition ``ehi export'' criterion could \n",
      "facilitate and support the provision of a patient's record in an \n",
      "electronic format. in service to innovative and patient-centric \n",
      "approaches, a health it developer could develop a method that allows \n",
      "the patient using a technology application (e.g., portal or ``app'') to \n",
      "execute the request without needing a provider to do so on their \n",
      "behalf. we seek comment on whether this portion of the criterion should \n",
      "be made more prescriptive to only allow the patient and his or her \n",
      "authorized representative to be the requestor of their ehi, similar to \n",
      "how we have previously scoped such criteria as ``view, download, and \n",
      "transmit to 3rd party'' (sec.  170.315(e)(1)).\n",
      "    similar to the 2015 edition ``data export'' certification criterion \n",
      "(sec.  170.315(b)(6)), which we propose for removal below, we \n",
      "acknowledge potential privacy and security concerns may arise when ehi \n",
      "is exported and, therefore, propose that for provider-mediated \n",
      "requests, a developer may design the health it to limit the type of \n",
      "users that would be able to access and initiate ehi export functions. \n",
      "however, as we previously specified in the 2015 edition final rule, the \n",
      "ability to ``limit'' the single patient ehi export functionality is \n",
      "intended to be used by and at the discretion of the provider \n",
      "organization implementing the technology, not a way for health it \n",
      "developers to implicitly prevent the overarching user-driven aspect of \n",
      "this capability (80 fr 62646).\n",
      "b. transitions between health it systems\n",
      "    in addition to and separate from the patient access use case \n",
      "described above, health it certified to this criterion would facilitate \n",
      "the migration of ehi to another health it system. we propose that a \n",
      "health it developer of health it certified to this criterion must, at a \n",
      "customer's request, provide a complete export of all ehi that is \n",
      "produced or managed by means of the developer's certified health it. \n",
      "health it developers would have flexibility as to how this outcome is \n",
      "achieved, so long as a customer is able to receive the export in a \n",
      "timely and efficient manner, and in a format that is commercially \n",
      "reasonable. for example, in contrast with the patient export \n",
      "capability, which must be available to a user without subsequent\n",
      "\n",
      "[[page 7448]]\n",
      "\n",
      "developer assistance to operate, the ``database export'' capability of \n",
      "this criterion could require action or support on the part of the \n",
      "health it developer.\n",
      "    we note that while this criterion focuses on the technical outcomes \n",
      "supported by this capability, developers of health it certified to this \n",
      "criterion would be required to provide the assurances proposed in sec.  \n",
      "170.402, which include providing reasonable cooperation and assistance \n",
      "to other persons (including customers, users, and third-party \n",
      "developers) to enable the use of interoperable products and services. \n",
      "thus, while developers would have flexibility as to how they implement \n",
      "the export functionality for transitions between systems, they would \n",
      "ultimately be responsible for ensuring that the capability is deployed \n",
      "in a way that enables a customer and their third-party contractors to \n",
      "successfully migrate data. such cooperation and assistance could \n",
      "include, for example, assisting a customer's third-party developer to \n",
      "automate the export of ehi to other systems. we refer readers to \n",
      "section vii.b.2 of the proposed rule for further discussion of a health \n",
      "it developer's assurances as proposed in sec.  170.402.\n",
      "c. scope of ehi\n",
      "    for both use cases supported by this criterion, ehi export \n",
      "encompasses all the ehi that the health it system produces and \n",
      "electronically manages for a patient or group of patients. this applies \n",
      "to the health it's entire database, including but not limited to \n",
      "clinical, administrative, and claims/billing data. it would also \n",
      "include any data that may be stored in separate data warehouses that \n",
      "the system has access to, can produce, and electronically manages. for \n",
      "example, health it developers may store ehi in these warehouses to \n",
      "prevent performance impacts from data queries that may slow down the \n",
      "``main'' health it system's (e.g., ehr) clinical performance. we \n",
      "clarify that ``ehi'' also includes the oldest ehi available on that \n",
      "patient to the most recent, no matter the specific electronic format \n",
      "(e.g., pdfs are included). as mentioned above, our intention is that \n",
      "``produces and electronically manages'' refers to a health it product's \n",
      "entire database. however, we seek comment on the terminology used \n",
      "(``produces and electronically manages'') and whether that captures our \n",
      "intent or whether there are any alternatives to the language we should \n",
      "consider to further clarify our intent. alternative language we \n",
      "considered included ``produce and electronically retain'' data, which \n",
      "could encompass more data.\n",
      "    the use of the term ``electronic health information'' (ehi) is \n",
      "deliberate and in alignment with the cures act and the proposed \n",
      "definition of this term in sec.  170.102. its use supports consistency \n",
      "and the breadth of types of data envisioned by this criterion. clinical \n",
      "data would encompass imaging information--both images and narrative \n",
      "text about the image--as this is part of the patient's total record; \n",
      "however, we understand that ehrs may not be the standard storage \n",
      "location for images and solicit comment on the feasibility, \n",
      "practicality, and necessity of exporting images and/or imaging \n",
      "information. we request comment on what image elements, at a minimum, \n",
      "should be shared such as image quality, type, and narrative text. it is \n",
      "understandable that developers will not be able to export every \n",
      "existing data element, nor that all possible data elements are \n",
      "necessary for transfer. for finalization in a subsequent final rule, we \n",
      "solicit comment on whether we should require, to support transparency, \n",
      "health it developers to attest or publish as part of the export format \n",
      "documentation the types of ehi they cannot support for export.\n",
      "    we also propose the following metadata categories that would be \n",
      "excluded from this criterion, and have listed examples for clarity \n",
      "below. we seek comment on these exclusion categories, and request \n",
      "feedback on what metadata elements should remain included for export, \n",
      "or be added to the list of data that would be allowed to be excluded in \n",
      "a subsequent final rule:\n",
      "    <bullet> metadata present in internal databases used for physically \n",
      "storing the data. examples include: internal database table names, \n",
      "field names, schema, constraints, triggers, field size (number of \n",
      "bytes), field type (string, integer, double, long), and primary keys or \n",
      "object identifiers used internally for querying.\n",
      "    <bullet> metadata that may not be necessary to interpret ehi \n",
      "export, including information that is typically required for processing \n",
      "of transactions such as encryption keys, internal user roles, ancillary \n",
      "information such as information stored in different formats, local \n",
      "codes for internal use; audit logs, record reviews, or history of \n",
      "change.\n",
      "    <bullet> metadata that refers to data that is not present in the \n",
      "ehi export, such as links to files and other external attachments that \n",
      "are not part of the export, and information used in conjunction with \n",
      "data from other applications that is not part of the health it.\n",
      "    we also seek comment, for consideration in finalizing this \n",
      "criterion in a subsequent final rule, on types of ehi that may present \n",
      "challenges for meeting the intent of this proposed criterion.\n",
      "d. export format\n",
      "    the proposed certification criterion does not prescribe a content \n",
      "standard for the ehi export. however, it requires health it developers \n",
      "to provide the format, such as a data dictionary or export support \n",
      "file, for the exported information to assist the receiving system in \n",
      "processing the ehi without loss of information or its meaning to the \n",
      "extent reasonably practicable using the developer's existing \n",
      "technology. providing ehi export information is consistent with \n",
      "emerging industry practices and capabilities to offer requestors the \n",
      "ability to access, download, and move their information without \n",
      "unreasonable burden. companies such as facebook,\\27\\ google,\\28\\ and \n",
      "twitter \\29\\ offer publicly-available links which provide requestors \n",
      "necessary information on how to download their personal information \n",
      "including, in some cases, several download options for requestors \n",
      "alongside their export instructions. public access to comparable ehi \n",
      "export information would further support third-party companies in this \n",
      "space, as they would have additional information and general knowledge \n",
      "for use of available data. accordingly, we propose that the developer's \n",
      "export format should be made publicly available via a hyperlink as part \n",
      "of certification to the ``ehi export'' criterion, including keeping the \n",
      "hyperlink up-to-date with the current export format.\n",
      "    we believe that by making the export format publicly available at \n",
      "the time of certification (and keeping the information current) will \n",
      "stimulate a vibrant, competitive market in which third- party software \n",
      "developers can specialize in processing the data exported from \n",
      "certified health it products in support of patients and providers. \n",
      "moreover, we believe this proposal will transform today's current \n",
      "guess-work, one-off processes into something more predictable and \n",
      "transparent such that greater industry efficiencies can be realized. we \n",
      "note and clarify that the export format need not be the same format \n",
      "used internally by the health it system, and the health it developer \n",
      "would not need to make public their proprietary data model. the \n",
      "proposed certification criterion also\n",
      "\n",
      "[[page 7449]]\n",
      "\n",
      "does not prescribe how the exported ehi is made available to the user, \n",
      "as this may depend on the size and type of information. we would expect \n",
      "that the information be made available to the user or requestor in an \n",
      "acceptable manner without placing unreasonable burden on the user or \n",
      "requestor. please also generally see our discussion of information \n",
      "blocking in section viii and particularly section viii.d.5.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\27\\ <a href=\"https://www.facebook.com/help/1701730696756992?helpref=hc_global_nav\">https://www.facebook.com/help/1701730696756992?helpref=hc_global_nav</a>.\n",
      "    \\28\\ <a href=\"https://support.google.com/accounts/answer/3024190?hl=en\">https://support.google.com/accounts/answer/3024190?hl=en</a>.\n",
      "    \\29\\ <a href=\"https://help.twitter.com/en/managing-your-account/how-to-download-your-twitter-archive\">https://help.twitter.com/en/managing-your-account/how-to-download-your-twitter-archive</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "e. initial step to persistent access to all of a patient's ehi\n",
      "    we believe that open, standards-based apis should provide \n",
      "persistent access to patients' ehi over time to achieve the envisioned \n",
      "goals in sec.  170.404. in the meantime, this proposed criterion in \n",
      "sec.  170.315(b)(10) will provide an initial step toward achieving \n",
      "those goals. we clarify that ``persistent'' or ``continuous'' access to \n",
      "ehi is not required to satisfy this criterion's requirements and that \n",
      "the minimum requirement is for a discrete data export capability. \n",
      "similarly, while the criterion requires the timely export of all ehi, \n",
      "such export need not occur instantaneously (or in ``real-time''). \n",
      "however, health it developers are encouraged to consider persistent \n",
      "access and real-time approaches as part of the step-wise progression we \n",
      "see towards open, standards-based apis for a growing number of data \n",
      "elements per the uscdi in the proposed ``standardized api for patient \n",
      "and population services'' criterion (sec.  170.315(g)(10).'' further, \n",
      "we caution that where it is reasonable for a developer to provide \n",
      "persistent or real-time access to electronic health information, the \n",
      "refusal to do so may be inconsistent with the conditions of \n",
      "certification in sec.  170.401 (information blocking) and sec.  170.402 \n",
      "(assurances related to this capability), as well as the information \n",
      "blocking provision, as to which readers should refer to sections vii \n",
      "and viii of this proposed rule. similarly, while this certification \n",
      "criterion would provide a baseline capability for exporting data for \n",
      "the specific use cases described above, health it developers may need \n",
      "to provide other data export and conversion services or support \n",
      "additional export use cases beyond those encompassed by this criterion \n",
      "to facilitate the appropriate access, exchange, and use of electronic \n",
      "health information and to avoid engaging in information blocking.\n",
      "f. timeframes\n",
      "    onc seeks input on ehi export and timeframes. in particular, beyond \n",
      "exporting all the ehi the health it system produces and electronically \n",
      "manages, should this criterion include capabilities to permit health \n",
      "care providers to set timeframes for ehi export, such as only the \n",
      "``past two years'' or ``past month'' of ehi?\n",
      "    for discussion of the required timeframe for developers of \n",
      "certified health it to certify to this proposed criterion and make it \n",
      "available to their customers, please see section vii.b.2, which \n",
      "addresses a health it developer's required assurances regarding the \n",
      "availability and provision of this ehi export capability to its \n",
      "customers.\n",
      "g. replaces the 2015 edition ``data export'' criterion in the 2015 \n",
      "edition base ehr definition\n",
      "    we propose to remove the ``data export'' criterion (sec.  \n",
      "170.315(b)(6)) from the 2015 edition, including the 2015 edition base \n",
      "ehr definition expressed in sec.  170.102. correspondingly, we propose \n",
      "to include the proposed ``ehi export'' criterion (sec.  170.315(b)(10)) \n",
      "in the 2015 edition base ehr definition, which would affect health care \n",
      "providers' compliance responsibilities when it comes to possessing \n",
      "cehrt for associated cms programs. a specific c-cda data export \n",
      "criterion no longer supports advancements in interoperability in the \n",
      "evolving health it industry. the proposed ``ehi export'' certification \n",
      "criterion is standards-agnostic and supports a more open approach to \n",
      "interoperability. more specifically, the proposed ``ehi export'' \n",
      "criterion differs significantly from the ``data export'' certification \n",
      "criterion as the latter is limited to clinical data as specified in the \n",
      "c-cda. also, the proposed ``ehi export'' criterion is not limited to \n",
      "just the scope of the certified capabilities in the certified health it \n",
      "module as it applies to all produced and electronically managed ehi. \n",
      "further, by including this functionality in the 2015 base ehr \n",
      "definition, we can be assured that health care providers participating \n",
      "in the cms programs (e.g., promoting interoperability programs) have \n",
      "functionality to both support patient requests for their ehi and \n",
      "switching health it systems.\n",
      "    we propose to modify the base ehr definition to include the \n",
      "proposed ``ehi export'' criterion 24 months from the effective date of \n",
      "the final rule for this proposed rule (which practically speaking would \n",
      "be 25 months because of the 30-day delayed effective date). we believe \n",
      "this is sufficient time for health it developers to develop, test, \n",
      "certify, and rollout this functionality to health care providers based \n",
      "on the flexible approach offered for meeting this criterion. we also \n",
      "believe this timeframe provides sufficient time for health care \n",
      "providers to adopt and implement the functionality included in the \n",
      "``ehi export'' criterion. to note, we refer readers to the \n",
      "``assurances'' condition and maintenance of certification requirements \n",
      "in section vii.b.2, which propose complementary requirements on health \n",
      "it developers to rollout health it certified ``ehi export'' within 24 \n",
      "months of the effective date of a final rule for this proposed rule. we \n",
      "welcome comments on our proposed compliance timeline.\n",
      "    we note that we do not propose a transition period for the ``data \n",
      "export'' criterion. we propose to remove the criterion from the 2015 \n",
      "edition upon the effective date of a final rule for this proposed rule. \n",
      "unlike the ``application access--data category request'' criterion \n",
      "(which we propose to replace with the new api criterion in this \n",
      "proposed rule), the ``data export'' criterion does not support an \n",
      "objective or measure under the cms promoting interoperability programs. \n",
      "therefore, we do not believe that health it developers and health care \n",
      "providers need to support the functionality in the ``data export'' \n",
      "criterion while they transition to the development, adoption, and \n",
      "implementation of the ehi export criterion. this approach should reduce \n",
      "burden and costs for both health it developers and health care \n",
      "providers. we welcome comments on this approach, including whether this \n",
      "will leave health care providers without an export capability for an \n",
      "inordinate period of time such that we should require health it \n",
      "developers to support the ``data export'' functionality for health care \n",
      "providers until the health it developer attests to providing the new \n",
      "ehi export functionality to all of its customers.\n",
      "    readers are also referred to the regulatory impact analysis in \n",
      "section xiv of this proposed rule for a discussion of the estimated \n",
      "costs and benefits of this proposed criterion, as well as the impact of \n",
      "the proposed removal of the 2015 edition ``data export'' criterion.\n",
      "5. standardized api for patient and population services criterion\n",
      "    to implement the cures act, we propose to adopt a new api criterion \n",
      "in sec.  170.315(g)(10), which would replace the ``application access--\n",
      "data category request'' certification criterion (sec.  170.315(g)(8)) \n",
      "and become part of the 2015 edition base ehr definition. this new \n",
      "certification criterion would require the use of fhir standards, \n",
      "several implementation specifications, and focus on supporting two \n",
      "types of api-enabled services: (1) services for\n",
      "\n",
      "[[page 7450]]\n",
      "\n",
      "which a single patient's data is at focus; and (2) services for which \n",
      "multiple patients' data are at focus. please refer to the ``application \n",
      "programming interfaces'' section (vii.b.4) in this preamble for a more \n",
      "detailed discussion of the ``api'' certification criterion and related \n",
      "conditions and maintenance of certification requirements.\n",
      "6. privacy and security transparency attestations\n",
      "a. background\n",
      "    in 2015, the hit standards committee (hitsc) recommended the \n",
      "adoption of two new certification criteria for the program. the \n",
      "national coordinator endorsed the hitsc recommendations for \n",
      "consideration by the secretary, and the secretary determined that it \n",
      "was appropriate to propose adoption of the two new certification \n",
      "criteria through rulemaking (81 fr 10635). to implement the secretary's \n",
      "determination, we propose to add two new 2015 edition privacy and \n",
      "security ``transparency attestation'' certification criteria for: (1) \n",
      "encrypt authentication credentials; and (2) multi-factor \n",
      "authentication.\n",
      "    in the 2015 edition final rule, we adopted a new, simpler, and \n",
      "straightforward approach to privacy and security (p&s) certification \n",
      "requirements for health it modules certified to the 2015 edition, which \n",
      "we refer to as the 2015 edition privacy and security certification \n",
      "framework (80 fr 62705). in this proposed rule, we propose \n",
      "modifications to the 2015 edition privacy and security certification \n",
      "framework in sec.  170.550(h) and propose to add new criteria to which \n",
      "a health it developer would need to certify pertaining to whether or \n",
      "not its product encrypts authentication credentials (specifically sec.  \n",
      "170.315(d)(12)) and supports multi-factor authentication (specifically \n",
      "sec.  170.315(d)(13)). to be clear, we are not proposing to require \n",
      "that health it have the functionality present to encrypt authentication \n",
      "credentials or support multi-factor authentication. rather, we propose \n",
      "that a health it developer indicate whether or not their certified \n",
      "health it has those capabilities by attesting yes or no.\n",
      "b. encrypt authentication credentials\n",
      "    we propose to adopt an ``encrypt authentication credentials'' \n",
      "certification criterion in sec.  170.315(d)(12) and include it in the \n",
      "p&s certification framework (sec.  170.550(h)). we propose to make the \n",
      "encrypt authentication credentials certification criterion applicable \n",
      "to any health it module currently certified to the 2015 edition and any \n",
      "health it module presented for certification due to the fact that all \n",
      "health it must meet the ``authentication, access control, and \n",
      "authorization'' certification criterion adopted in sec.  170.315(d)(1) \n",
      "as part of current program requirements. while the 2015 edition \n",
      "``authentication, access control, and authorization'' certification \n",
      "criterion criteria requires that patient information saved on end user \n",
      "devices is encrypted, those same protections are not explicitly \n",
      "required through certification for the authentication credentials used \n",
      "to access that same information. as such, we believe that this proposal \n",
      "would address that gap and encourage health it developers to take steps \n",
      "to ensure that authentication credentials are protected consistent with \n",
      "industry best practices.\n",
      "    to provide clarity as to what a ``yes'' attestation for ``encrypt \n",
      "authentication credentials'' would mean, we provide the following \n",
      "explanation. encrypting authentication credentials could include \n",
      "password encryption or cryptographic hashing, which is storing only \n",
      "encrypted or cryptographically hashed passwords. if a developer attests \n",
      "that its health it module encrypts authentication credentials, we \n",
      "propose that the attestation would mean that the health it module is \n",
      "capable of cryptographically protecting stored authentication \n",
      "credentials in accordance with standards adopted in sec.  \n",
      "170.210(a)(2), annex a: federal information processing standards (fips) \n",
      "publication 140-2, approved security functions for fips pub 140-2, \n",
      "security requirements for cryptographic modules. we posit that fips \n",
      "publication 140-2 is the seminal, comprehensive, and most appropriate \n",
      "standard. moreover, in the specified fips 140-2 standard, there is an \n",
      "allowance for various approved encryption methods, and health it \n",
      "developers would have the flexibility to implement any of the approved \n",
      "encryption methods in order to attest yes to this criterion. health it \n",
      "developers should keep apprised of these standards as they evolve and \n",
      "are updated to address vulnerabilities identified in the current \n",
      "standard.\n",
      "    we do not believe it is necessary for a health it module to be \n",
      "required to be tested to this criterion, so long as by attesting yes to \n",
      "this criterion, the health it developer is attesting that if \n",
      "authentication credentials are stored, then the authentication \n",
      "credentials are protected consistent with the requirements above. to be \n",
      "clear, a ``no'' attestation is a sufficient response to address this \n",
      "certification criterion; however, health it developers should be aware \n",
      "that this ``no'' will be made publicly available on the chpl. note that \n",
      "if a developer attested to encrypting authentication credentials, a \n",
      "certified health it module would be subject to onc-acb surveillance for \n",
      "any potential non-conformity with the requirements of this criterion. \n",
      "specifically, if the onc-acb becomes aware of situations where the \n",
      "developer's health it is not meeting the developer's affirmative \n",
      "attestation per the criterion's requirements, the onc-acb may use its \n",
      "corrective action process to bring the product back into conformance.\n",
      "    we propose that, for health it certified prior to a subsequent \n",
      "final rule's effective date, the health it would need to be certified \n",
      "to the ``encrypt authentication credentials'' certification criterion \n",
      "within six months after the final rule's effective date. for health it \n",
      "certified for the first time after the final rule's effective date, we \n",
      "propose that the health it must meet this criterion at the time of \n",
      "certification. this should allow sufficient time for health it \n",
      "developers to assess their health it modules' capabilities and attest \n",
      "``yes'' or ``no'' to the certification criterion.\n",
      "    for an assessment of this proposal's costs and benefits, please \n",
      "refer to the regulatory impact analysis in section xiv of this \n",
      "preamble. we welcome comments on this assessment and this proposal in \n",
      "general. we also note that some health it presented for certification \n",
      "is not designed to store authentication credentials. therefore, we \n",
      "specifically request comment on whether we should include an explicit \n",
      "provision in this criterion to accommodate such health it. this could \n",
      "be similar to the approach we have taken with the 2015 edition ``end-\n",
      "user device encryption'' criterion (sec.  170.315(d)(7)(ii)), where we \n",
      "permit the criterion to be met if the health it developer indicates \n",
      "their technology is designed to prevent electronic health information \n",
      "from being locally stored on end-user devices.\n",
      "c. multi-factor authentication\n",
      "    we propose to adopt a ``multi-factor authentication'' (mfa) \n",
      "criterion in sec.  170.315(d)(13) and include it in the p&s \n",
      "certification framework (sec.  170.550(h)). we propose to make the \n",
      "``multi-factor authentication'' certification criterion applicable to \n",
      "any health it module currently certified to the 2015 edition and any \n",
      "health it module presented for certification. health it developers have \n",
      "already been implementing mfa to meet the electronic prescribing of \n",
      "controlled substances (epcs) requirements set by drug enforcement \n",
      "administration (dea), and if adopted, this certification criterion \n",
      "would be general in that its\n",
      "\n",
      "[[page 7451]]\n",
      "\n",
      "intended outcome would provide more public transparency around the mfa \n",
      "capabilities included in certified health it.\n",
      "    this proposal supports the department of homeland security (dhs) \n",
      "led initiative ``stop, think, connect'' which strongly recommends and \n",
      "runs campaigns to promote stronger authentication, typically related to \n",
      "mfa, going beyond a username and password to log in. mfa is also \n",
      "recommended by numerous organizations and groups. in the ``report on \n",
      "improving cybersecurity in the health care industry,'' \\30\\ the health \n",
      "care industry cybersecurity task force recommended requiring strong \n",
      "authentication to improve identity and access management for health \n",
      "care workers, patients, and medical devices/ehrs. using a single factor \n",
      "approach to accessing information is particularly prone to cyber-attack \n",
      "because one factor passwords can be weak, stolen, and are vulnerable to \n",
      "external phishing attacks, malware, and social engineering threats. in \n",
      "situations where the provider is accessing a health it product or \n",
      "health information exchange external to the hospital or clinical \n",
      "environment, the health care industry cybersecurity task force \n",
      "recommended that the health care industry adopt the nist sp 800-46 \n",
      "guidelines for remote access, including the use of two-factor \n",
      "authentication to ensure a compromised password cannot alone be used to \n",
      "gain access. promoting the use of mfa and leveraging biometrics, mobile \n",
      "phones, and/or wearables can help to establish a trust relationship \n",
      "with the patient. additionally, nist recommends any personal data, \n",
      "whether self-asserted or validated, require mfa.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\30\\ <a href=\"https://www.phe.gov/preparedness/planning/cybertf/documents/report2017.pdf\">https://www.phe.gov/preparedness/planning/cybertf/documents/report2017.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    however, despite the benefits of adopting mfa, we are also aware of \n",
      "some of the challenges. specifically, in health care, many providers \n",
      "are resistant to adopt mfa because of the inconvenience and loss of \n",
      "time of going through another step to access the patient's ehi. also, \n",
      "mfa has not been deployed very long in the health care setting, so it \n",
      "is not clear how much it actually addresses the risk. in most mfa \n",
      "implementations, passwords are still present. in addition to having to \n",
      "manage passwords, users also have to manage an additional layer of \n",
      "security. another usability challenge is that systems often require \n",
      "different types of mfa, which adds to the complexity and also may \n",
      "require providers to keep track of tokens. mfa is often recommended as \n",
      "a solution to password problems, but it is still vulnerable to theft. \n",
      "these alternative forms of authentication have their own set of \n",
      "vulnerability issues. the cost of implementing mfa and ensuring it will \n",
      "be implemented in a way that does not inhibit clinical workflow is also \n",
      "an issue to be considered.\n",
      "    to provide clarity as to what a ``yes'' attestation for ``multi-\n",
      "factor authentication'' attestation would mean, we provide the \n",
      "following explanation. mfa requires users to authenticate using \n",
      "multiple means to confirm they are who they claim to be in order to \n",
      "prove one's identity, under the assumption that it is unlikely that an \n",
      "unauthorized individual or entity will be able to succeed when more \n",
      "than one token is required. mfa includes using two or more of these: \n",
      "(i) something people know, such as a password or a personal \n",
      "identification number (pin); (ii) something people have, such as a \n",
      "phone, badge, card, rsa token or access key; and (iii) something people \n",
      "are, such as fingerprints, retina scan, heartbeat, and other biometric \n",
      "information. thus, in order to be issued a certification, we propose to \n",
      "require that a health it module developer attest to whether or not its \n",
      "certified health it supports mfa consistent with industry recognized \n",
      "standards (e.g., nist special publication 800-63b digital \n",
      "authentication guidelines, iso 27001).\n",
      "    we propose that, for health it certified prior to a subsequent \n",
      "final rule's effective date, the health it would need to be certified \n",
      "to the ``multi-factor authentication'' certification criterion within \n",
      "six months after the final rule's effective date. for health it \n",
      "certified for the first time after the final rule's effective date, we \n",
      "propose that the health it must meet this criterion at the time of \n",
      "certification. this should allow sufficient time for health it \n",
      "developers to assess their health it modules' capabilities and attest \n",
      "``yes'' or ``no'' to the certification criterion.\n",
      "    we generally seek comment on whether there is value in adopting the \n",
      "proposed ``multi- factor authentication'' criterion. we also solicit \n",
      "comment on the method of attestation and, if the health it developer \n",
      "does attest to supporting mfa, whether we should require the health it \n",
      "developer to explain how they support mfa. for example, should the \n",
      "health it developer be required to identify the mfa technique(s) used/\n",
      "supported by submitting specific information on how it is implemented, \n",
      "including identifying the purpose(s)/use(s) to which mfa is applied \n",
      "within their health it module (such as where in the clinical workflow \n",
      "it is required), and, as applicable, whether the mfa solution complies \n",
      "with industry standard? this information could enable the health it \n",
      "developer to highlight their health it's capabilities to support mfa.\n",
      "7. data segmentation for privacy and consent management criteria\n",
      "    we adopted two 2015 edition ``data segmentation for privacy'' \n",
      "(ds4p) certification criteria in the 2015 edition final rule. one \n",
      "criterion (``ds4p-send'' (sec.  170.315(b)(7)) includes capabilities \n",
      "for creating a summary care record formatted to the c-cda 2.1 standard \n",
      "and document-level tagging as restricted (and subject to restrictions \n",
      "on re-disclosure) according to the ds4p standard. the other criterion \n",
      "(``ds4p-receive'' (sec.  170.315(b)(8)) includes capabilities for \n",
      "receiving a summary care record formatted to the c-cda 2.1 standard and \n",
      "document-level tagged as restricted (and subject to restrictions on re-\n",
      "disclosure) according to the ds4p standard. as noted in the 2015 \n",
      "edition final rule (80 fr 62646)), certification to these criteria is \n",
      "not required to meet the cehrt definition for cms ehr incentive \n",
      "programs, now referred to as the promoting interoperability programs. \n",
      "the current 2015 edition ds4p certification criteria specify the \n",
      "technical capabilities that the health it must have to apply and \n",
      "recognize security labels in a summary document (c-cda) such that the \n",
      "recipient of a summary document would be able to recognize the \n",
      "existence of sensitive elements within the summary document (80 fr \n",
      "62646). security labeling provides a way for computer systems to \n",
      "properly handle data passed among systems, to preserve the condition of \n",
      "security, and to enable access control decisions on the information, so \n",
      "that the information is only accessed by the appropriate entities. the \n",
      "hl7 healthcare classification system (hcs) standard provides a common \n",
      "syntax and semantics for interoperable security labels in health care. \n",
      "the ds4p standard makes use of the hcs specification and describes a \n",
      "method for applying security labels to hl7 cda documents to ensure that \n",
      "privacy policies established at a record's source can be understood and \n",
      "enforced by the recipient of the record.\n",
      "    in the 2015 edition final rule, we noted that the ds4p standard is \n",
      "not restricted to data subject to the federal regulations governing the \n",
      "confidentiality of substance use disorder patient records (42 cfr part \n",
      "2) (80 fr 62647). it may be implemented to support other data exchange \n",
      "use cases in which compliance with state or federal legal frameworks \n",
      "require sensitive health information to be tagged\n",
      "\n",
      "[[page 7452]]\n",
      "\n",
      "and segmented (80 fr 62647). we further stated that we offered \n",
      "certification to these criteria as an initial step towards the ability \n",
      "of an interoperable health care system to use technical standards to \n",
      "compute and persist security labels to permit access, use, or \n",
      "disclosure of protected health information in accordance with \n",
      "applicable policies and patient preferences. we understood and \n",
      "acknowledged additional challenges surrounding the prevalence of \n",
      "unstructured data, sensitive images, and potential issues around use of \n",
      "sensitive health information by clinical decision support systems. the \n",
      "adoption of document level data segmentation for structured documents \n",
      "would not solve these issues, but we acknowledged it would help move \n",
      "technology in the direction where these issues could be addressed (80 \n",
      "fr 16841).\n",
      "    adoption of the current 2015 edition ds4p criteria was also \n",
      "consistent with earlier hit policy committee (hitpc) recommendations on \n",
      "the use of ds4p technology to enable the electronic implementation and \n",
      "management of disclosure policies that originate from the patient, the \n",
      "law, or an organization, in an interoperable manner, so that electronic \n",
      "sensitive health information may be appropriately shared.\\31\\ these \n",
      "hitpc recommendations consisted of a glide path for the exchange of 42 \n",
      "cfr part 2-protected data starting with the inclusion of level 1 \n",
      "(document level tagging) send and receive functionality. the hitpc also \n",
      "recommended advancing the exchange of 42 cfr part 2-protected data, by \n",
      "outlining additional capabilities in sharing, viewing and incorporating \n",
      "privacy restricted data at a more granular level, as well as managing \n",
      "computable patient consent for the use of restricted data.\\32\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\31\\ see hit policy committee (hitpc) recommendation letter to \n",
      "onc, july 2014, <a href=\"http://www.healthit.gov/facas/sites/faca/files/pstt_ds4p_transmittal%20letter_2014-07-03.pdf\">http://www.healthit.gov/facas/sites/faca/files/pstt_ds4p_transmittal%20letter_2014-07-03.pdf</a>; see also hitpc's \n",
      "privacy and security tiger team public meeting, transcript, may 12, \n",
      "2014, <a href=\"http://www.healthit.gov/facas/sites/faca/files/pstt_transcript_final_2014-05-12.pdf\">http://www.healthit.gov/facas/sites/faca/files/pstt_transcript_final_2014-05-12.pdf</a>; public meeting, transcript, \n",
      "may 27, 2014, <a href=\"http://www.healthit.gov/facas/sites/faca/files/pstt_transcript_final_2014-05-27.pdf\">http://www.healthit.gov/facas/sites/faca/files/pstt_transcript_final_2014-05-27.pdf</a>.\n",
      "    \\32\\ for more details on the two glide paths for part 2-\n",
      "protected data, see <a href=\"http://www.healthit.gov/facas/sites/faca/files/pstt_ds4p_transmittal%20letter_2014-07-03.pdf\">http://www.healthit.gov/facas/sites/faca/files/pstt_ds4p_transmittal%20letter_2014-07-03.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    since the 2015 edition final rule, the health care industry has \n",
      "engaged in additional field testing and implementation of the ds4p \n",
      "standard. as of the beginning of the third quarter of the 2018 cy, only \n",
      "about 20 products (products with multiple certified versions were \n",
      "counted once) were certified to the current 2015 edition ds4p \n",
      "certification criteria. in addition, stakeholders shared with onc--\n",
      "through public forums, listening sessions, and correspondence--that \n",
      "focusing certification on segmentation to only the document level does \n",
      "not permit providers the flexibility to address more granular \n",
      "segmentation needs. stakeholders noted that certain provider types, \n",
      "such as providers of pediatric care and behavioral health care, are \n",
      "currently using a range of burdensome manual workflows in order to meet \n",
      "complex use cases for ds4p which are also impacted by state and local \n",
      "laws. additionally, stakeholders have expressed interest in onc \n",
      "exploring health it standards that work with ds4p to support the \n",
      "management of consent for sharing documents that include security \n",
      "labels such as through the use of an api.\n",
      "    therefore, in consideration of stakeholder feedback and our stated \n",
      "policy approach to adopt ds4p certification criteria on a glide path, \n",
      "we propose to remove the current 2015 edition ds4p-send (sec.  \n",
      "170.315(b)(7)) and ds4p-receive (sec.  170.315(b)(8)) certification \n",
      "criteria. the proposed effective date of removal of these criteria \n",
      "would be the effective date of a subsequent final rule for this \n",
      "proposed rule. we propose to replace these two criteria with three new \n",
      "2015 edition ds4p certification criteria (two for c-cda and one for a \n",
      "fhir-based api) that would support a more granular approach to privacy \n",
      "tagging data and consent management for health information exchange \n",
      "supported by either the c-cda- or fhir-based exchange standards. our \n",
      "primary purpose for proposing to remove and replace them, in lieu of \n",
      "proposing to revise them, is to provide clarity to stakeholders as to \n",
      "the additional functionality enabled by health it certified to the new \n",
      "criteria. we note resources released by onc and ocr, such as the hhs \n",
      "security risk assessment tool \\33\\ and the guide to privacy and \n",
      "security of electronic health information,\\34\\ as well as the office \n",
      "for civil rights' security risk analysis guidance \\35\\ that entities \n",
      "may employ to make risk-based decisions regarding their implementation \n",
      "of the proposed ds4p criteria. we also note the availability of the \n",
      "electronic consent management landscape assessment, challenges, and \n",
      "technology report.\\36\\ the report includes suggestions for overcoming \n",
      "barriers associated with implementing electronic consent management, \n",
      "which may be considered for further research and discussion.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\33\\ hhs security risk assessment tool: <a href=\"http://www.healthit.gov/providers-professionals/security-risk-assessment\">http://www.healthit.gov/providers-professionals/security-risk-assessment</a>.\n",
      "    \\34\\ onc guide to privacy and security of electronic health \n",
      "information: <a href=\"http://www.healthit.gov/sites/default/files/\">http://www.healthit.gov/sites/default/files/</a> pdf/\n",
      "privacy/privacy-and-security-guide.pdf.\n",
      "    \\35\\ hhs office for civil rights:<a href=\"https://www.hhs.gov/hipaa/for-professionals/security/guidance/index.html\">https://www.hhs.gov/hipaa/for-professionals/security/guidance/index.html</a>; and <a href=\"https://www.hhs.gov/hipaa/for-professionals/security/guidance/guidance-risk-analysis/index.html?language=es\">https://www.hhs.gov/hipaa/for-professionals/security/guidance/guidance-risk-analysis/index.html?language=es</a>.\n",
      "    \\36\\ <a href=\"https://www.healthit.gov/sites/default/files/privacy-security/ecm_finalreport_forrelease62415.pdf\">https://www.healthit.gov/sites/default/files/privacy-security/ecm_finalreport_forrelease62415.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "a. implementation with the consolidated cda release 2.1\n",
      "    in place of the removed 2015 edition ds4p criteria, we propose to \n",
      "adopt new ds4p-send (sec.  [thinsp]170.315(b)(12)) and ds4p-receive \n",
      "(sec.  [thinsp]170.315(b)(13)) criteria that would remain based on the \n",
      "c-cda and the hl7 ds4p standard. these criteria would include \n",
      "capabilities for applying the ds4p standard at the document, section, \n",
      "and entry level. we believe this offers more valuable functionality to \n",
      "providers and patients, especially given the complexities of the \n",
      "landscape of privacy laws for multiple care and specialty settings. we \n",
      "believe health it certified to these criteria could support multiple \n",
      "practice settings and use cases. for example, in section vi.a.2 of this \n",
      "preamble, we explain how the proposed capabilities included in these \n",
      "criteria could support the pediatric health care setting. we believe \n",
      "this proposal could also reduce burden for providers by leveraging \n",
      "health it's ability to recognize and manage sensitive data and patient \n",
      "consent directives, rather than relying on case-by-case manual \n",
      "redaction and subsequent workarounds to transmit redacted documents. we \n",
      "emphasize that health care providers already have processes and \n",
      "workflows to address their existing compliance obligations which could \n",
      "be made more efficient and cost effective through the use of health it. \n",
      "we recognize that more granular privacy markings at the point of data \n",
      "capture would further support existing and future priorities of states \n",
      "for multiple care and specialty settings, including behavioral health \n",
      "and pediatric health care settings.\n",
      "    we welcome public comment on our proposals to replace the current \n",
      "2015 edition ds4p criteria and adopt new 2015 edition ds4p-send (sec.  \n",
      "[thinsp]170.315(b)(12)) and ds4p-receive (sec.  [thinsp]170.315(b)(13)) \n",
      "criteria to support improved options for data segmentation for health \n",
      "care providers engaged in complex use cases such as those identified in \n",
      "pediatric care (see also section vi.a) and behavioral health\n",
      "\n",
      "[[page 7453]]\n",
      "\n",
      "care, including for opioid use disorder (oud) (see also section vi.b).\n",
      "b. implementation with fhir standard\n",
      "    in collaboration with onc, the substance abuse and mental health \n",
      "services administration (samhsa) developed the consent2share \n",
      "application to address the specific privacy protections of patients \n",
      "with substance use disorders who are covered by the federal \n",
      "confidentiality regulation, 42 cfr part 2. consent2share is an open \n",
      "source application for data segmentation and consent management. it is \n",
      "designed to integrate with existing fhir systems. samhsa created a fhir \n",
      "implementation guide (the consent2share consent profile design, \n",
      "hereafter referred to as ``consent implementation guide'') that \n",
      "describes how the consent2share (c2s) application and associated access \n",
      "control solution uses the fhir consent resource to represent and \n",
      "persist patient consent for treatment, research, or disclosure.\\37\\ the \n",
      "implementation guide provides instructions for using the fhir consent \n",
      "resource to capture a record of a health care consumer's privacy \n",
      "preferences.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\37\\ the draft fhir ig titled ``consent2share fhir profile \n",
      "design.docx'' can be accessed through the community- based care and \n",
      "privacy (cbcp) hl7 workgroup, within the package name titled \n",
      "``bhits_fhir_consent_ig,'' at <a href=\"https://gforge.hl7.org/gf/project/cbcc/frs/\">https://gforge.hl7.org/gf/project/cbcc/frs/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    as discussed in section vii.b.4 of this proposed rule, we are \n",
      "proposing policies related to the implementation of a standardized api \n",
      "to support the exchange of health information between providers and \n",
      "patients and among members of a care team. we anticipate that the \n",
      "proposed 2015 edition ``standardized api for patient and population \n",
      "services'' certification criterion (sec.  170.315(g)(10)) will result \n",
      "in a proliferation of apis that will enable a more flexible and less \n",
      "burdensome approach to exchanging ehi. we believe the health care \n",
      "industry can leverage this api infrastructure to share segmented data \n",
      "in a secure and scalable manner. therefore, we propose to adopt a 2015 \n",
      "edition certification criterion ``consent management for apis'' in \n",
      "sec.  170.315(g)(11) to support data segmentation and consent \n",
      "management through an api in accordance with the consent implementation \n",
      "guide. certification to this criterion would be at a health it \n",
      "developer's discretion and would indicate that a system is capable of \n",
      "responding to requests through an api for patient consent directives \n",
      "that include standards-based security labeling.\n",
      "    we acknowledge that our proposed implementation specification, the \n",
      "consent implementation guide, is based on a different version of the \n",
      "fhir standard (fhir standard for trial use 3, also known as fhir \n",
      "release 3) than the proposed ``standardized api for patient and \n",
      "population services'' criteria (sec.  170.315(g)(10)) which is proposed \n",
      "to reference just fhir release 2. furthermore, we acknowledge that this \n",
      "discrepancy may result in additional implementation efforts for \n",
      "developers. in ideal circumstances, we would have proposed a data \n",
      "segmentation and consent management standard for apis that was based on \n",
      "fhir release 2 and aligned with the ``standardized api for patient and \n",
      "population services'' criteria proposed in this proposed rule. however, \n",
      "although samhsa also created a consent implementation guide based on \n",
      "fhir release 2,\\38\\ the guide used the fhir ``contract'' resource to \n",
      "represent patient consent directives. it is our understanding that an \n",
      "approach based on the ``contract'' resource has since been abandoned by \n",
      "the industry in favor of using the ``consent'' resource which was \n",
      "introduced in fhir release 3. moreover, the fhir release 2 version of \n",
      "the consent implementation guide went through relatively little testing \n",
      "and was never formally implemented because samhsa began developing an \n",
      "update to the guide based on the ``consent'' resource in fhir release \n",
      "3. consequently, proposing an implementation specification based on \n",
      "fhir release 2 would not have aligned with the more common \n",
      "implementation of fhir-based consent directives by the health care \n",
      "industry. we do not anticipate that the initial misalignment between \n",
      "the proposed api criterion (sec.  170.315(g)(10)) and the proposed \n",
      "third ds4p criterion (sec.  170.315(g)(11)) will pose a significant \n",
      "burden on health it developers. further, our proposal to permit health \n",
      "it developers to voluntarily implement and use a new version of an \n",
      "adopted standard or implementation specification so long as such \n",
      "version was approved by the national coordinator for use in \n",
      "certification through the standards version advancement process, \n",
      "discussed in section vii.b.5, would enable standards version alignment \n",
      "between these two criteria in the future as the fhir standard matures.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\38\\ the draft behavioral health information technologies and \n",
      "standards (bhits) fhir dstu2 consent implementation guide can be \n",
      "accessed through the community-based care and privacy (cbcp) hl7 \n",
      "workgroup at <a href=\"https://gforge.hl7.org/gf/project/cbcc/frs/?action=frsreleaseview&release_id=1279\">https://gforge.hl7.org/gf/project/cbcc/frs/?action=frsreleaseview&release_id=1279</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    samhsa created the ``consent implementation guide'' to support \n",
      "developers in implementing the fhir consent resource to represent \n",
      "patient consent for treatment, research, and disclosure. the consent \n",
      "implementation guide provides instructions for using the fhir \n",
      "``consent'' resource to capture a record of a health care consumer's \n",
      "privacy preferences. implementing an instance of the fhir consent \n",
      "resource based on this guide allows for a patient consent to permit or \n",
      "deny identified recipient(s) or recipient role(s) to perform one or \n",
      "more actions, regarding the patient's health information for specific \n",
      "purposes and periods of time. for example the consent implementation \n",
      "guide supports consent management for specific use cases to permit or \n",
      "deny disclosure based on a specific law, regulation, or policy under \n",
      "which the patient consented. the implementation guide uses security \n",
      "labels as a mechanism for specifying a patient's preferences (e.g., \n",
      "permit disclosure of ehi labeled ``restricted''). the consent \n",
      "implementation guide provides a much simpler mechanism for representing \n",
      "a patient's consent preferences than the old approach based on fhir \n",
      "release 2 and has undergone implementation and pilot testing by \n",
      "samhsa's consent2share (c2s) application.\n",
      "    our proposal to adopt the version aligned with fhir release 3 and \n",
      "the fhir release 3 standard for this criterion reflects stakeholder \n",
      "interests and efforts to support particular use cases. c2s enables data \n",
      "segmentation and consent management for disclosure of several discrete \n",
      "categories of sensitive health data related to conditions and \n",
      "treatments including: alcohol, tobacco and substance use disorders \n",
      "(including opioid use disorder), behavioral health, hiv/aids, and \n",
      "sexuality and reproductive health. these capabilities support multiple \n",
      "use cases in both primary and specialty care, and specifically address \n",
      "priority needs identified by stakeholders to support pediatric care. we \n",
      "emphasize that health care providers already have processes and \n",
      "workflows to address their existing compliance obligations which could \n",
      "be made more efficient and cost effective through the use of health it. \n",
      "finally, given that the fhir standard is modular in nature, and \n",
      "especially since the ``consent'' resource did not exist in fhir release \n",
      "2, we anticipate that health it developers that elect to certify to \n",
      "this criterion would be able to support the consent implementation \n",
      "guide along with the api requirements specified in ``standardized api \n",
      "for\n",
      "\n",
      "[[page 7454]]\n",
      "\n",
      "patient and population services'' (sec.  170.315(g)(10)) with modest \n",
      "extra effort.\n",
      "    we welcome comments on this proposal. we specifically seek comment \n",
      "on how the availability of this proposed certification criterion might \n",
      "increase the ability to support multiple care coordination and privacy \n",
      "priorities, including those associated with pediatric care; and whether \n",
      "we should consider other similar api based options and resources as \n",
      "standards for certification criteria. we also seek comment on whether \n",
      "the misalignment between the versions of the fhir standard used by our \n",
      "proposed ``consent management for apis'' and ``standardized api for \n",
      "patient and population services'' criteria would create excessive \n",
      "burden for developers and implementers. specifically, we seek comment \n",
      "on if certification to the ``consent management for apis'' should only \n",
      "be available in conjunction with the ``standardized api for patient and \n",
      "population services'' criteria at such a time as the criteria are \n",
      "aligned to one version of the fhir standard or if the option to certify \n",
      "to the ``consent management for apis'' should be allowed for those \n",
      "developers interested in doing so even without current standards \n",
      "alignment. we note that samhsa is currently pursuing additional work to \n",
      "expand use cases related to data segmentation for privacy and fhir \n",
      "compatibility.\n",
      "\n",
      "c. unchanged 2015 edition criteria--program reference alignment\n",
      "\n",
      "    in the fy 2019 ipps/ltch pps proposed rule (83 fr 20516), cms \n",
      "proposed scoring and measurement policies to move beyond the three \n",
      "stages of meaningful use to a new phase of ehr measurement with an \n",
      "increased focus on interoperability and improving patient access to \n",
      "health information. to reflect this focus, cms changed the name of the \n",
      "medicare and medicaid ehr incentive programs, to the medicare and \n",
      "medicaid promoting interoperability (pi) programs. to align with the \n",
      "renaming of the ehr incentive programs, we propose to remove references \n",
      "to the ehr incentive programs and replace them with ``promoting \n",
      "interoperability programs'' in the 2015 edition ``automated numerator \n",
      "recording'' criterion in sec.  170.315(g)(1) and the ``automated \n",
      "measure calculation'' criterion in sec.  170.315(g)(2).\n",
      "\n",
      "v. modifications to the onc health it certification program\n",
      "\n",
      "a. corrections\n",
      "\n",
      "1. auditable events and tamper resistance\n",
      "    currently, sec.  170.315(d)(2), ``auditable events and tamper \n",
      "resistance,'' includes a cross- reference to sec.  170.315(d)(7). \n",
      "however, the cross reference to sec.  170.315(d)(7), ``end-user device \n",
      "encryption,'' does not always apply. we propose to revise sec.  \n",
      "170.550(h)(3) to apply the sec.  170.315(d)(7) cross reference as \n",
      "appropriate and exempt sec.  170.315(d)(7) when the certificate scope \n",
      "does not require sec.  170.315(d)(7) certification (see sec.  \n",
      "170.315(d)(2)(i)(c)). paragraph 170.315(d)(2)(i)(c) is not applicable \n",
      "for the privacy and security testing and certification of a health it \n",
      "module required by sec.  170.550(h)(3)(iii), (v), (vii), and (viii). \n",
      "this specific requirement was intended to be exempted. it would only \n",
      "apply if sec.  170.315(d)(7) was also required for privacy and security \n",
      "testing and certification, which it is not under the aforementioned \n",
      "paragraphs. for example, a developer that is seeking to certify a \n",
      "health it module to sec.  170.315(h) will not necessarily have end-user \n",
      "device encryption features (see sec.  170.315(d)(7)). as such, \n",
      "certification can proceed for the audit log process without the health \n",
      "it module demonstrating that it can record an encryption status as \n",
      "required by sec.  170.315(d)(2)(i)(c). we have previously identified \n",
      "this error in guidance and now propose to codify the correction in \n",
      "regulation.\\39\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\39\\ <a href=\"https://www.healthit.gov/sites/default/files/2015ed_ccg_d2-auditable-events-tamper-resistance.pdf\">https://www.healthit.gov/sites/default/files/2015ed_ccg_d2-auditable-events-tamper-resistance.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "2. amendments\n",
      "    we propose to revise sec.  170.550(h) to remove the ``amendments'' \n",
      "criterion's application to certain non-applicable clinical criteria \n",
      "including: ``drug-drug, drug-allergy interaction checks for \n",
      "computerized provider order entry (cpoe)'' sec.  170.315(a)(4); \n",
      "``clinical decision support'' sec.  170.315(a)(9); ``drug-formulary and \n",
      "preferred drug list checks'' sec.  170.315(a)(10); and ``patient-\n",
      "specific education'' sec.  170.315(a)(13). health it modules presented \n",
      "for certification to these criteria would not have to demonstrate the \n",
      "capabilities required by the 2015 edition ``amendments'' certification \n",
      "criterion (sec.  170.315(d)(4)), unless the health it is presented for \n",
      "certification to another criterion that requires certification to the \n",
      "2015 edition ``amendments'' criterion under the p&s certification \n",
      "framework. this has already been incorporated into sub- regulatory \n",
      "guidance, and we propose to codify this clarification in \n",
      "regulation.\\40\\ the revision was made upon further analysis of the p&s \n",
      "certification framework and the applicability of the ``amendments'' \n",
      "certification criterion sec.  170.315(d)(4) to health it capabilities \n",
      "that would not necessarily have any patient data for which a request \n",
      "for an amendment would be relevant.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\40\\ <a href=\"https://www.healthit.gov/sites/default/files/2015ed_ccg_a4-dd-dai-checks-for-cpoe.pdf\">https://www.healthit.gov/sites/default/files/2015ed_ccg_a4-dd-dai-checks-for-cpoe.pdf</a>, <a href=\"https://www.healthit.gov/sites/default/files/2015ed_ccg_a9-clinical-decision-support.pdf\">https://www.healthit.gov/sites/default/files/2015ed_ccg_a9-clinical-decision-support.pdf</a>, <a href=\"https://www.healthit.gov/sites/default/files/2015ed_ccg_a10-drug-formulary-pdl-checks.pdf\">https://www.healthit.gov/sites/default/files/2015ed_ccg_a10-drug-formulary-pdl-checks.pdf</a>, and <a href=\"https://www.healthit.gov/sites/default/files/2015ed_ccg_a13-patient-specific-ed-resources.pdf\">https://www.healthit.gov/sites/default/files/2015ed_ccg_a13-patient-specific-ed-resources.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "3. view, download, and transmit to 3rd party\n",
      "    we propose to remove sec.  170.315(e)(1)(ii)(b) which includes a \n",
      "cross-reference to sec.  170.315(d)(2). this cross-reference indicates \n",
      "that health it may demonstrate compliance with activity history log \n",
      "requirements if it is also certified to the 2015 edition ``auditable \n",
      "events and tamper-resistance'' certification criterion (sec.  \n",
      "170.315(d)(2)). however, we no longer require testing of activity \n",
      "history log when certifying for sec.  170.315(d)(2). therefore, this \n",
      "cross-reference is no longer applicable to meet certification \n",
      "requirements for the 2015 edition ``view, download, and transmit to 3rd \n",
      "party'' certification criterion (sec.  170.315(e)(1)) activity history \n",
      "log requirements.\n",
      "4. integrating revised and new certification criteria into the 2015 \n",
      "edition privacy and security certification framework\n",
      "    consistent with the 2015 edition privacy and security certification \n",
      "framework, each certification criterion has a set of appropriate p&s \n",
      "``safeguards'' that must be in place. in the 2015 edition, we required \n",
      "that an onc-acb must ensure that a health it module presented for \n",
      "certification to any of the certification criteria that fall into each \n",
      "regulatory text ``first level paragraph'' category of sec.  170.315 \n",
      "(e.g., sec.  170.315(a)) identified below would be certified to either \n",
      "approach 1 (technically demonstrate) or approach 2 (system \n",
      "documentation). in this proposed rule, we propose to require the new \n",
      "criteria (sec.  170.315(d)(12) and (d)(13)) to apply to all sec.  \n",
      "170.315 certification criteria. therefore, given these and the other \n",
      "modifications discussed above, we propose to revise the p&s \n",
      "certification framework as\n",
      "\n",
      "[[page 7455]]\n",
      "\n",
      "noted in the table below. however, the p&s certification framework \n",
      "would need to be further updated depending on finalization of the \n",
      "proposals discussed in section iii.b.4, which propose removal of \n",
      "certain 2015 edition certification criteria.\n",
      "\n",
      "                   table 1--proposed 2015 edition privacy and security certification framework\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                           it will need to be certified to approach 1 or approach 2 for each of\n",
      "    if the health it module includes        the p&s certification criteria listed in the ``approach 1'' column\n",
      "  capabilities for certification listed  -----------------------------------------------------------------------\n",
      "                 under:                            approach 1                          approach 2\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "sec.   170.315(a)(1), through (2), (5),   sec.   170.315(d)(1)         for each applicable p&s certification\n",
      " through (8), (11), and (12).              (authentication, access      criterion not certified using approach\n",
      "                                           control, and                 1, the health it developer submits\n",
      "                                           authorization), (d)(2)       system documentation that is\n",
      "                                           (auditable events and        sufficiently detailed to enable\n",
      "                                           tamper resistance), (d)(3)   integration such that the health it\n",
      "                                           (audit reports), (d)(4)      module has implemented service\n",
      "                                           (amendments), (d)(5)         interfaces for each applicable p&s\n",
      "                                           (automatic log-off),         certification criterion that enable the\n",
      "                                           (d)(6) (emergency access),   health it module to access external\n",
      "                                           and (d)(7) (end-user         services necessary to meet the\n",
      "                                           device encryption).          requirements of the p&s certification\n",
      "                                                                        criterion.\n",
      "sec.   170.315(a)(4), (9), (10), and      sec.   170.315(d)(1)\n",
      " (13).                                     through (d)(3) and (d)(5)\n",
      "                                           through (d)(7).\n",
      "sec.   170.315(b).......................  sec.   170.315(d)(1)\n",
      "                                           through (d)(3) and (d)(5)\n",
      "                                           through (d)(8) (integrity).\n",
      "sec.   170.315(c).......................  sec.   170.315(d)(1)\n",
      "                                           through (d)(3) and (d)(5)\n",
      "                                           *.\n",
      "sec.   170.315(e)(1)....................  sec.   170.315(d)(1)\n",
      "                                           through (d)(3), (d)(5),\n",
      "                                           (d)(7), and (d)(9)(trusted\n",
      "                                           connection).\n",
      "sec.   170.315(e)(2) and (3)............  sec.   170.315(d)(1)\n",
      "                                           through (d)(3), (d)(5),\n",
      "                                           and (d)(9) *.\n",
      "sec.   170.315(f).......................  sec.   170.315(d)(1)\n",
      "                                           through (d)(3) and (d)(7).\n",
      "sec.   170.315(g)(7) through (g)(11)....  sec.   170.315(d)(1) and\n",
      "                                           (d)(9); and (d)(2) or\n",
      "                                           (d)(10) (auditing actions\n",
      "                                           on health information).\n",
      "sec.   170.315(h).......................  sec.   170.315(d)(1)\n",
      "                                           through (d)(3) *.\n",
      "sec.   170.315(b).......................  sec.   170.315(d)(1)\n",
      "                                           through (d)(3) and (d)(5)\n",
      "                                           through (d)(8) (integrity).\n",
      "sec.   170.315(c).......................  sec.   170.315(d)(1)\n",
      "                                           through (d)(3) and (d)(5).\n",
      "sec.   170.315(e)(1)....................  sec.   170.315(d)(1)\n",
      "                                           through (d)(3), (d)(5),\n",
      "                                           (d)(7), and (d)(9)(trusted\n",
      "                                           connection).\n",
      "sec.   170.315(e)(2) and (3)............  sec.   170.315(d)(1)\n",
      "                                           through (d)(3), (d)(5),\n",
      "                                           and (d)(9).\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      " \n",
      " \n",
      "------------------------------------------------------------------------\n",
      "              sec.   170.315(a)-(h) certification criterion\n",
      "------------------------------------------------------------------------\n",
      "sec.   170.315(a) through (h)                 sec.   170.315(d)(12)\n",
      " certification criterion.\n",
      "sec.   170.315(a) through (h)                 sec.   170.315(d)(13)\n",
      " certification criterion.\n",
      "------------------------------------------------------------------------\n",
      "an onc-acb must ensure that a health it module presented for\n",
      " certification to any of the certification criteria that fall into each\n",
      " regulatory text ``first level paragraph'' category of sec.   170.315\n",
      " (e.g. sec.   170.315(a)) identified in the table above is certified to\n",
      " either approach 1 (technically demonstrate) or approach 2\n",
      " (systemdocumentation). in addition, we propose that health it\n",
      " developers seeking certification to any sec.   170.315 certification\n",
      " criterion for their health it modules attest to whether they encrypt\n",
      " authentication credentials (sec.   170.315(d)(12)) and support multi-\n",
      " factor authentication (sec.   170.315(d)(13)).\n",
      "we clarify that of the adopted 2015 edition certification criteria, only\n",
      " the privacy and security criteria specified in sec.   170.315(g)(1)\n",
      " through (6) are exempt from the 2015 edition privacy and security\n",
      " certification framework due to the capabilities included in these\n",
      " criteria, which do not implicate privacy and security concerns..\n",
      "in order to be issued a certification, a health it module would only\n",
      " need to be tested once to each applicable privacy and security\n",
      " criterion identified as part of approach 1 or approach 2 so long as the\n",
      " health it developer attests that such privacy and security capabilities\n",
      " apply to the full scope of capabilities included in the requested\n",
      " certification, except for the certification of a health it module to\n",
      " sec.   170.315(e)(1) ``view, download, and transmit to 3rd party'' and\n",
      " (e)(2) ``secure messaging.'' for each of these criteria, a health it\n",
      " module must be separately tested to sec.   170.315(d)(9) because of the\n",
      " specific capabilities for secure electronic transmission and secure\n",
      " electronic messaging included in each criterion, respectively. we also\n",
      " propose the health it developers seeking certification to any sec.\n",
      " 170.315 certification criterion for their health it modules attest to\n",
      " whether they encrypt authentication credentials (sec.   170.315(d)(12))\n",
      " and support multi-factor authentication (sec.   170.315(d)(13)).\n",
      "------------------------------------------------------------------------\n",
      "* sec.   170.315(d)(2)(i)(c) is not required if the scope of the health\n",
      "  it module does not have end-user device encryption features.\n",
      "\n",
      "\n",
      "[[page 7456]]\n",
      "\n",
      "b. principles of proper conduct for onc-acbs\n",
      "\n",
      "1. records retention\n",
      "    we propose to revise the records retention requirement in sec.  \n",
      "[thinsp]170.523(g) to include the ``life of the edition'' as well as 3 \n",
      "years after the retirement of an edition related to the certification \n",
      "of complete ehrs and health it module(s). in the 2015 edition final \n",
      "rule (80 fr 62602), we adopted a records retention provision that \n",
      "required onc-acbs to retain all records related to the certification of \n",
      "complete ehrs and health it module(s) for the ``life of the edition'' \n",
      "plus an additional 3 years, and the records would be available to hhs \n",
      "upon request during this period of time. in the 2015 edition final \n",
      "rule, the ``life of the edition'' was defined as beginning with the \n",
      "codification of an edition of certification criteria in regulation and \n",
      "ending when the edition is removed from regulation. we now propose to \n",
      "clarify that hhs has the ability to access certification records for \n",
      "the ``life of the edition,'' which begins with the codification of an \n",
      "edition of certification criteria in the code of federal regulations \n",
      "through a minimum of 3 years from the effective date that removes the \n",
      "applicable edition from the code of federal regulations, not solely \n",
      "during the 3-year period after removal from the cfr.\n",
      "2. conformance methods for certification criteria\n",
      "    the principle of proper conduct (popc) in sec.  170.523(h) \n",
      "specifies that onc-acbs may only certify health it that has been tested \n",
      "by onc-atls using tools and test procedures approved by the national \n",
      "coordinator. we propose to revise this popc in three ways. first, we \n",
      "propose to revise this popc to additionally permit onc-acbs to certify \n",
      "health it modules that they have evaluated for conformance with \n",
      "certification criteria without first passing through an onc-atl. \n",
      "however, we propose that such methods to determine conformity must \n",
      "first be approved by the national coordinator. this proposal provides \n",
      "valuable program flexibility and market efficiencies for streamlining \n",
      "health it module certification, acknowledging the broad spectrum of \n",
      "evidence of conformance, from laboratory testing with an onc-atl to \n",
      "developer self-declaration. this program flexibility will also allow us \n",
      "to leverage the success we have seen in implementation of our \n",
      "alternative test method process where any entity can submit a test \n",
      "procedure and/or test tool for approval for use under the program. for \n",
      "example, the national coordinator may, under this provision, approve a \n",
      "conformance method for certification criteria where evidence of a valid \n",
      "declaration of conformity (e.g., certification) granted under an \n",
      "external program can be submitted directly to an onc-acb to meet the \n",
      "requirement of that certification criteria.\n",
      "    second, we propose to revise the popc to clarify that \n",
      "certifications can only be issued to health it modules and not complete \n",
      "ehrs. we are proposing to remove the 2014 edition from the cfr (see \n",
      "section ii.b.2 of this preamble) and complete ehr certifications are no \n",
      "longer available for certification to the 2015 edition (80 fr 62608; 79 \n",
      "fr 54443). we propose to remove the provision that permits the use of \n",
      "test results from national voluntary laboratory accreditation program \n",
      "(nvlap)-accredited testing laboratories under the program because the \n",
      "regulatory transition period from nvlap-accredited testing laboratories \n",
      "to onc-atls has expired (81 fr 72447).\n",
      "    third, we propose to remove the provision that permits the \n",
      "certification of health it previously certified to an edition if the \n",
      "certification criterion or criteria to which the health it module(s) \n",
      "was previously certified have not been revised and no new certification \n",
      "criteria are applicable because the circumstances that this provision \n",
      "seeks to address are no longer feasible with certification to the 2015 \n",
      "edition. any health it module previously certified to the 2014 edition \n",
      "and presented for certification to the 2015 edition would have at least \n",
      "one new or revised 2015 edition certification criteria that would be \n",
      "applicable. for example, the 2015 edition ``accessibility-centered \n",
      "design'' criterion (sec.  170.315(g)(5)) is applicable to any health it \n",
      "module presented for certification to the 2015 edition.\n",
      "3. onc-acbs to accept test results from any onc-atl in good standing\n",
      "    we propose to revise the popc for onc-acbs in order to address \n",
      "business relationships between onc-acbs and onc-atls. to encourage \n",
      "market competition, we propose to require onc-acbs to accept test \n",
      "results from any onc-atl that is in good standing under the program and \n",
      "is compliant with its iso 17025 accreditation requirements. however, if \n",
      "an onc-acb has concerns about accepting test results from a certain \n",
      "onc-atl, the onc-acb would have an opportunity to explain the potential \n",
      "issues to onc and nvlap, and on a case-by-case basis, onc could \n",
      "consider the facts and make the final determination.\n",
      "    onc-atls must be accredited by the nvlap and seek authorization \n",
      "from onc to participate in the onc health it certification program. \n",
      "onc-atls test products against the onc-approved test method for the \n",
      "standards and certification criteria identified by the secretary using \n",
      "onc-approved test methods. onc-acbs make certification determinations \n",
      "and conduct surveillance for health it originally tested by an onc-atl. \n",
      "based on the process that all onc-atls must undergo, we believe that \n",
      "they are capable of providing accurate test results that should be \n",
      "accepted by any onc-acb.\n",
      "    the intent of this proposal is to ensure that onc-atls are not \n",
      "discriminated against and do not suffer injury from onc-acbs not \n",
      "accepting their test results if, in fact, they are in good standing. \n",
      "this proposal may also prevent harm to health it developers, who \n",
      "present their health it to be tested by onc-atls and ultimately seek \n",
      "certification by onc-acbs under the program. these situations may arise \n",
      "if a health it developer's onc-acb leaves the program or goes out of \n",
      "business. this proposal may also prevent situations of preferential \n",
      "business arrangements such as when one organization is both an onc-atl \n",
      "and onc-acb and will not enter into a contract with another \n",
      "organization who is also an onc-atl.\n",
      "4. mandatory disclosures and certifications\n",
      "    we propose to revise the popc in sec.  170.523(k). we propose to \n",
      "remove sec.  170.523(k) (1)(ii)(b) because certifications can only be \n",
      "issued to health it modules and not complete ehrs. we are proposing to \n",
      "remove the 2014 edition from the cfr (see section iii.b.2 of this \n",
      "preamble) and complete ehr certifications are no longer available for \n",
      "certification to the 2015 edition (80 fr 62608; 79 fr 54443). we also \n",
      "propose to revise sec.  170.523(k)(1)(iii) to broaden the section \n",
      "beyond just the medicare and medicaid ehr incentive programs (now \n",
      "referred to as promoting interoperability programs). we propose to \n",
      "revise the section to include a detailed description of all known \n",
      "material information concerning additional types of costs or fees that \n",
      "a user may be required to pay to implement or use the health it \n",
      "module's capabilities, whether to meet provisions of hhs programs \n",
      "requiring the use of certified health it or to achieve any other use \n",
      "within the scope of the health it's certification.\n",
      "\n",
      "[[page 7457]]\n",
      "\n",
      "    we also propose to remove the provision in sec.  170.523(k)(3) that \n",
      "requires a certification issued to a pre-coordinated, integrated bundle \n",
      "of health it modules to be treated the same as a certification issued \n",
      "to a complete ehr for the purposes of sec.  170.523(k)(1), except that \n",
      "the certification must also indicate each health it module that is \n",
      "included in the bundle. we propose to remove this provision because \n",
      "pre-coordinated, integrated bundles are no longer applicable for \n",
      "certification under program.\n",
      "    we propose to revise sec.  170.523(k)(4) to clarify that a \n",
      "certification issued to a health it module based solely on the \n",
      "applicable certification criteria adopted by the onc health it \n",
      "certification program must be separate and distinct from any other \n",
      "certification(s) based on other criteria or requirements. the intent of \n",
      "this provision, as indicated in the establishment of the permanent \n",
      "certification program for health information technology final rule (76 \n",
      "fr 1272), is to ensure that any other certifications an onc-acb may \n",
      "issue, is separately indicated from the applicable certification \n",
      "criteria adopted by the onc health it certification program.\n",
      "    we also propose changes related to transparency attestations and \n",
      "limitations in section iii.b.5. of this preamble. additionally, we \n",
      "propose other new popcs for onc-acbs in sections vii.b.5 and vii.d of \n",
      "this preamble.\n",
      "\n",
      "c. principles of proper conduct for onc-atls--records retention\n",
      "\n",
      "    we propose to revise the records retention requirement in sec.  \n",
      "[thinsp]170.524(f) to include the ``life of the edition'' as well as 3 \n",
      "years after the retirement of an edition related to the certification \n",
      "of health it module(s). the circumstances are the same as in section \n",
      "v.b.1 of this preamble mentioned above, therefore, we propose the same \n",
      "revisions for onc-atls as we did for onc-acbs.\n",
      "\n",
      "vi. health it for the care continuum\n",
      "\n",
      "    onc believes health it should help promote and support patient care \n",
      "when and where it is needed. this means health it should help support \n",
      "patient populations, specialized care, transitions of care, and \n",
      "practice settings across the care continuum. in the permanent \n",
      "certification program final rule, we clarified that section 3001(c)(5) \n",
      "of the phsa provides the national coordinator with the authority to \n",
      "establish a voluntary certification program or programs for other types \n",
      "of health it beyond those which supported the ehr incentive programs \n",
      "(now called the promoting interoperability programs). however, we \n",
      "decided that the initial focus of the program should be on supporting \n",
      "the ehr incentive programs, which focuses on ehr technology for the \n",
      "ambulatory and inpatient settings (76 fr 1294). as the program evolved \n",
      "and the adoption and use of certified health it increased \n",
      "significantly, we modified the program in the 2015 edition final rule \n",
      "to make it more open and accessible to more types of health it, \n",
      "including health it that supports various care and practice settings \n",
      "beyond those included in the ehr incentive programs (80 fr 62604). our \n",
      "goal was then and is now to support the advancement of interoperable \n",
      "health it and to promote health it functionality in care and practice \n",
      "settings across the care continuum (see also 80 fr 62604).\n",
      "    onc's efforts in the 2015 edition to make the program more open and \n",
      "accessible to other care settings also aligned with fall 2013 \n",
      "recommendations from the hit policy committee (hitpc). the hitpc \n",
      "examined the extension of the program to include functionalities that \n",
      "would benefit settings not covered by the ehr incentive programs. the \n",
      "hitpc recommended that considerations regarding functionality should \n",
      "focus on whether the functionality would:\n",
      "\n",
      "<bullet> advance a national priority or legislative mandate\n",
      "<bullet> align with existing federal/state programs\n",
      "<bullet> utilize the existing technology pipeline\n",
      "<bullet> build on existing stakeholder support\n",
      "<bullet> appropriately balance the costs and benefits of a \n",
      "certification program.\n",
      "\n",
      "    taking into consideration the hitpc recommendations, onc's 2015 \n",
      "edition focused on the adoption of certification criteria that are \n",
      "standards-based, applicable to a wide variety of care and practice \n",
      "settings, and that advance the structured recording, access, exchange, \n",
      "and use of health information. onc has also encouraged users--including \n",
      "specialty groups--to continue to work with developers to innovate, \n",
      "develop, and deploy health it in specific clinical settings in ways \n",
      "that promote safety, effectiveness, and efficient health care delivery \n",
      "while also reducing burden.\n",
      "    in the 2015 edition final rule we stated that we did not intend to \n",
      "develop and issue separate regulatory certification ``paths'' or \n",
      "``tracks'' for particular care or practice settings (e.g., a ``long-\n",
      "term and post-acute care (ltpac) certification'') because it would be \n",
      "difficult to independently construct such ``paths'' or ``tracks'' in a \n",
      "manner that would align with other relevant programs and specific \n",
      "stakeholder needs. while we never have had intentions to adopt care- or \n",
      "practice-specific certification tracks, or additional voluntary \n",
      "program(s), in parallel to the existing voluntary onc health it \n",
      "certification program, we stated that we would welcome the opportunity \n",
      "to work with hhs agencies, other agencies, and provider associations in \n",
      "identifying the appropriate functionality and certification criteria in \n",
      "the program to support their stakeholders (80 fr 62704). this approach \n",
      "is consistent with the recommendations by the hitpc.\n",
      "    since the publication of the 2015 edition final rule, onc has \n",
      "explored how we might work with the industry and with specialty \n",
      "organizations to collaboratively advance health it that supports \n",
      "medical specialties and sites of service. as a result, we have gained \n",
      "insight from stakeholders regarding the burdens associated with \n",
      "establishing a specific set of required certification criteria for all \n",
      "users--which may include capabilities not applicable to certain \n",
      "settings of care or specialties. stakeholders have also noted that the \n",
      "adoption of a set of required criteria without also enabling and \n",
      "incentivizing innovation beyond those criteria may have the unintended \n",
      "consequence of stifling progress for that setting. stakeholders noted \n",
      "that the timeline for testing and certifying to required criteria and \n",
      "the subsequent deployment of certification criteria in practice \n",
      "settings is not always aligned with standards updates, the emergence of \n",
      "new standards, or technological innovation. finally, stakeholders have \n",
      "urged onc to leverage multiple means to advance interoperability \n",
      "standards that are widely applicable, to enable and promote innovation \n",
      "that is supported by these standards, and--in collaboration with \n",
      "stakeholders to monitor and support developments in emerging standards \n",
      "and technologies for specialty use cases.\n",
      "    section 4001(b)(i) of the cures act instructs the national \n",
      "coordinator to encourage, keep, or recognize, through existing \n",
      "authorities, the voluntary certification of health it under the program \n",
      "for use in medical specialties and sites of service for which no such \n",
      "technology is available or where more technological advancement or \n",
      "integration is needed. this provision of the cures act closely aligns \n",
      "with onc's ongoing collaborative efforts with both federal partners and \n",
      "stakeholders within the health care and health it community to \n",
      "encourage and support the advancement of health it for a wide\n",
      "\n",
      "[[page 7458]]\n",
      "\n",
      "range of clinical settings. these initiatives have included projects \n",
      "related to clinical priorities beyond those specifically included in \n",
      "the ehr incentive programs (now called the promoting interoperability \n",
      "programs) including efforts in public health, behavioral health, and \n",
      "long-term and post-acute care. we further note that these initiatives \n",
      "often include the development of non-regulatory informational resources \n",
      "to support the specific implementation goal and align with the \n",
      "technical specifications already available in the program for \n",
      "certification. to advance these efforts, we generally consider a range \n",
      "of factors including: stakeholder input and identification of clinical \n",
      "needs and clinical priorities, the evolution and adoption of health it \n",
      "across the care continuum, the costs and benefits associated with any \n",
      "policy or implementation strategy related to care settings and sites of \n",
      "service, and potential regulatory burden and compliance timelines. \n",
      "generally, onc's approach can be summarized in three parts:\n",
      "    <bullet> first, onc analyzes existing certification criteria to \n",
      "identify how such criteria may be applicable for medical specialties \n",
      "and sites of service.\n",
      "    <bullet> second, onc focuses on the real-time evaluation of \n",
      "existing and emerging standards to determine applicability to medical \n",
      "specialties and sites of service as well as to the broader care \n",
      "continuum, including the evaluation of such standards for inclusion in \n",
      "the onc interoperability standards advisory (isa).\\41\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\41\\ <a href=\"https://www.healthit.gov/isa/\">https://www.healthit.gov/isa/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> third, onc may work in collaboration with stakeholders to \n",
      "support the development of informational resources for medical \n",
      "specialties and sites of service for which onc identifies a need to \n",
      "advance the effective implementation of certified health it.\n",
      "    we believe this approach provides an economical, flexible, and \n",
      "responsive option for both health care providers and the health it \n",
      "industry, which is also in alignment with the provisions of the cures \n",
      "act related to burden reduction and promoting interoperability. we are \n",
      "committed to continuing to work with stakeholders in this manner to \n",
      "encourage and advance the adoption of health it to support medical \n",
      "specialties and sites of service, and to help ensure that providers \n",
      "have the tools they need to support patients at the point of care and \n",
      "that essential patient health information is available across a care \n",
      "settings.\n",
      "    this section outlines our approach to implement section 4001(b) of \n",
      "the cures act, which requires that the secretary make recommendations \n",
      "for the voluntary certification of health it for use by pediatric \n",
      "health providers and to adopt certification criteria to support the \n",
      "voluntary certification of health it for use by pediatric health \n",
      "providers to support the health care of children. to be clear, and \n",
      "consistent with past practice, we do not recommend or propose a \n",
      "``pediatric-specific track or program'' under the onc health it \n",
      "certification program. this proposed rule outlines the certification \n",
      "criteria adopted in the 2015 edition which we believe support the \n",
      "certification of health it for pediatric care. finally, it identifies \n",
      "the new and revised criteria proposed in this rule which we believe \n",
      "further support the voluntary certification of health it for pediatric \n",
      "care. we have included in the appendix of this proposed rule a set of \n",
      "technical worksheets that can help inform your comments on the \n",
      "recommendations, the new and revised criteria in the program that would \n",
      "also support pediatric care settings, and the overall approach we have \n",
      "herein described. these worksheets outline the following information:\n",
      "    <bullet> the alignment of each recommendation to the children's \n",
      "model ehr format \\42\\ as identified by stakeholders (see also section \n",
      "vi.a.1 and 2 for further detail on the children's model ehr format and \n",
      "the recommendations).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\42\\ <a href=\"https://healthit.ahrq.gov/health-it-tools-and-resources/pediatric-resources/childrens-electronic-health-record-ehr-format\">https://healthit.ahrq.gov/health-it-tools-and-resources/pediatric-resources/childrens-electronic-health-record-ehr-format</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> the alignment of each recommendation to the 2015 edition \n",
      "certification criteria and new or revised criteria described in this \n",
      "proposed rule (see also section vi.a.2.a and b).\n",
      "    <bullet> potential supplemental items from the children's model ehr \n",
      "format identified by onc which relate to the primary recommendation and \n",
      "the related certification criteria.\n",
      "\n",
      "    we invite readers to use these worksheets to inform public \n",
      "comment on the recommendations and criteria described in section \n",
      "vi.a.2 specifically as they relate to pediatric health care use \n",
      "cases. the comments received on these technical worksheets through \n",
      "this proposed rule will be used to inform the final recommendations \n",
      "for voluntary certification of health it criteria for use in \n",
      "pediatric care. furthermore, these comments, and the detailed \n",
      "insights received through stakeholder outreach, may inform the \n",
      "future development of a non-binding informational guide or resource \n",
      "to provide useful information for health it developers and pediatric \n",
      "care providers seeking to successfully implement these health it \n",
      "solutions in a clinical setting.\n",
      "\n",
      "a. health it for pediatric setting\n",
      "\n",
      "    section 4001(b)(iii) of the cures act--``health information \n",
      "technology for pediatrics'' requires that:\n",
      "    <bullet> first, that the secretary, in consultation with relevant \n",
      "stakeholders, shall make recommendations for the voluntary \n",
      "certification of health it for use by pediatric health providers to \n",
      "support the health care of children, and\n",
      "    <bullet> second, that the secretary shall adopt certification \n",
      "criteria to support the voluntary certification of health it for use by \n",
      "pediatric health providers to support the health care of children.\n",
      "    in this proposed rule, we describe our approach to stakeholder \n",
      "engagement, the analysis used to develop the recommendations, and the \n",
      "specific certification criteria we believe can support each \n",
      "recommendation.\n",
      "1. background and stakeholder convening\n",
      "    over the past ten years, a number of initiatives have focused on \n",
      "the availability and use of effective health it tools and resources for \n",
      "pediatric care. these have included a number of public-private \n",
      "partnerships including efforts between hhs, state agencies, and health \n",
      "systems for innovative projects that range from care coordination \n",
      "enterprise solutions to immunization information systems and to point \n",
      "of care solutions for specialty needs. in order to learn from and build \n",
      "upon these efforts, onc has engaged with stakeholders in both the \n",
      "public and private sector including other federal, state and local \n",
      "government partners, health care providers engaged in the care of \n",
      "children, standards development organizations, charitable foundations \n",
      "engaged in children's health care research, and health it developers \n",
      "supporting pediatric care settings.\n",
      "    for example, significant work has been done by the agency for \n",
      "healthcare research and quality (ahrq), cms, the health resources and \n",
      "services administration (hrsa), and organizations around the children's \n",
      "model ehr format (children's format), which is critical to any \n",
      "discussion of the pediatric health it landscape.\\43\\ the children's \n",
      "format was authorized by the 2009 children's health insurance program \n",
      "reauthorization act (chipra) \\44\\ and developed by ahrq in\n",
      "\n",
      "[[page 7459]]\n",
      "\n",
      "close collaboration with cms. it was developed to bridge the gap \n",
      "between the functionality present in most ehrs currently available and \n",
      "the functionality that could optimally support the care of children. \n",
      "specifically, the children's format provides information to ehr system \n",
      "developers and others about critical functionality and other \n",
      "requirements that are helpful to include in an ehr system to address \n",
      "health care needs specific to the care of children. the final version \n",
      "of the children's format,\\45\\ released in 2015, consists of 47 high \n",
      "priority functional requirements in 19 topic areas that focus on \n",
      "improvements that would better support the safety and quality of care \n",
      "delivered to children. the children's format was intended as a starting \n",
      "point for developers, users, and purchasers for informing an approach \n",
      "for pediatric voluntary certification. we refer to the voluntary \n",
      "edition proposed rule for a description of onc's prior discussion \n",
      "around the children's format (79 fr 10930).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\43\\ agency for health care information and technology. health \n",
      "information technology. <a href=\"http://healthit.ahrq.gov/health-it-tools-and-resources/childrens-electronic-health-record-ehr-format\">http://healthit.ahrq.gov/health-it-tools-and-resources/childrens-electronic-health-record-ehr-format</a> accessed \n",
      "september, 2017.\n",
      "    \\44\\ public law 111-3, section 401.\n",
      "    \\45\\ <a href=\"https://healthit.ahrq.gov/sites/default/files/docs/citation/children-ehr-format-enhancement-final-recommendation-report-abridged.pdf\">https://healthit.ahrq.gov/sites/default/files/docs/citation/children-ehr-format-enhancement-final-recommendation-report-abridged.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in the summer of 2017, the american academy of pediatrics (aap) \n",
      "reviewed the 2015 format using a robust analytical process and \n",
      "engagement with their members. the result was a prioritized list of \n",
      "eight clinical priorities to support pediatric health care (``priority \n",
      "list''). in october 2017, onc held a technical discussion with \n",
      "stakeholders titled ``health it for pediatrics'' with the specific \n",
      "purpose of obtaining input from an array of stakeholders in an effort \n",
      "to draw correlations between the pediatric providers' clinical \n",
      "priorities identified in the priority list with the detailed technical \n",
      "requirements outlined in the children's format and the capabilities and \n",
      "standards that could be included in certified health it. through this \n",
      "collaborative approach, the meeting participants identified a set of \n",
      "priority needs for health it to support pediatric care based upon those \n",
      "identified by the priority list and the primary correlation to the \n",
      "children's format.\n",
      "2. recommendations for the voluntary certification of health it for use \n",
      "in pediatric care\n",
      "    to support the first part of section 4001(b) of the cures act, onc \n",
      "considered the historical efforts on the children's model ehr format, \n",
      "the input from stakeholders, and our own technical analysis and review \n",
      "of health it capabilities and standards to develop a set of \n",
      "recommendations for voluntary certification for health it for pediatric \n",
      "care. these include eight recommendations related to the priority list:\n",
      "    <bullet> recommendation 1: use biometric-specific norms for growth \n",
      "curves and support growth charts for children.\n",
      "    <bullet> recommendation 2: compute weight-based drug dosage.\n",
      "    <bullet> recommendation 3: ability to document all guardians and \n",
      "caregivers.\n",
      "    <bullet> recommendation 4: segmented access to information.\n",
      "    <bullet> recommendation 5: synchronize immunization histories with \n",
      "registries.\n",
      "    <bullet> recommendation 6: age- and weight-specific single-dose \n",
      "range checking.\n",
      "    <bullet> recommendation 7: transferrable access authority.\n",
      "    <bullet> recommendation 8: associate maternal health information \n",
      "and demographics with newborn.\n",
      "    we also developed two additional recommendations beyond the \n",
      "priority list which relate to other items within the children's format \n",
      "that are considered important to pediatric stakeholders. these \n",
      "additional recommendations, which we believe may be supported by \n",
      "certified health it, are as follows:\n",
      "    <bullet> recommendation 9: track incomplete preventative care \n",
      "opportunities.\n",
      "    <bullet> recommendation 10: flag special health care needs.\n",
      "    in order to implement the second part of section 4001(b) of the \n",
      "cures act for the adoption of certification criteria to support the \n",
      "voluntary certification of health it for use by pediatric health care \n",
      "providers, we have identified both the 2015 edition certification \n",
      "criteria and the new or revised criteria in this proposed rule that we \n",
      "believe support these 10 recommendations for health it for pediatric \n",
      "care and sites of service. we direct readers to the appendix of this \n",
      "proposed rule for a set of technical worksheets which include a cross-\n",
      "walk of the various criteria specifically associated with each \n",
      "recommendation. these worksheets outline the following information:\n",
      "    <bullet> the alignment of each recommendation to the primary \n",
      "children's format \\46\\ item identified by stakeholders.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\46\\ <a href=\"https://healthit.ahrq.gov/health-it-tools-and-resources/pediatric-resources/childrens-electronic-health-record-ehr-format\">https://healthit.ahrq.gov/health-it-tools-and-resources/pediatric-resources/childrens-electronic-health-record-ehr-format</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> the alignment of each recommendation to the 2015 edition \n",
      "certification criteria and new or revised criteria described in this \n",
      "proposed rule.\n",
      "    <bullet> supplemental items from the children's format for each \n",
      "recommendation and the related certification criteria.\n",
      "    we invite readers to use these worksheets to inform public comment \n",
      "on the recommendations, the inclusion of specific items from the \n",
      "children's format, and the identified certification criteria as they \n",
      "relate specifically to use cases for pediatric care and sites of \n",
      "service. we also seek comment on the following:\n",
      "    1. relevant gaps, barriers, safety concerns, and resources \n",
      "(including available best practices, activities, and tools) that may \n",
      "impact or support feasibility of the recommendation in practice.\n",
      "    2. effective use of health it itself in support of each \n",
      "recommendation as involves provider training, establishing workflow, \n",
      "and other related safety and usability considerations.\n",
      "    3. if any of the 10 recommendations should not be included in onc's \n",
      "final recommendations for voluntary certification of health it for \n",
      "pediatric care.\n",
      "    4. any certification criteria from the program that is identified \n",
      "for the 10 recommendations that should not be included to support the \n",
      "specific recommendation.\n",
      "    as stated in the worksheets located in the appendix, commenters are \n",
      "encouraged to reference the specific ``recommendation number'' (1-10) \n",
      "with the corresponding technical worksheet question number in their \n",
      "response. for example, ``recommendation 1--question 3''.\n",
      "a. 2015 edition certification criteria\n",
      "    in order to implement the second part of section 4001(b) of the \n",
      "cures act to adopt certification criteria to support the voluntary \n",
      "certification of health it for use by pediatric health providers to \n",
      "support the health care of children, we identified the following 2015 \n",
      "edition certification criteria that support the recommendations. within \n",
      "the technical worksheets in the appendix of this proposed rule, these \n",
      "criteria are noted under each recommendation to which they are \n",
      "correlated. the 2015 edition criteria are as follows:\n",
      "    <bullet> ``api functionality'' criteria (sec.  170.315(g)(7)-\n",
      "(g)(9)) which addresses many of the challenges currently faced by \n",
      "patients and by caregivers such as parents or guardians accessing \n",
      "child's health information, including the ``multiple portal'' problem, \n",
      "by potentially allowing individuals to aggregate health information \n",
      "from multiple sources in a web or mobile application of their choice.\n",
      "    <bullet> ``care plan'' criterion (sec.  170.315(b)(9)) which \n",
      "supports\n",
      "\n",
      "[[page 7460]]\n",
      "\n",
      "pediatric care by facilitating the documentation of electronic health \n",
      "information in a structured format to improve care coordination (80 fr \n",
      "62648-62649).\n",
      "    <bullet> ``clinical decision support'' (cds) criterion (sec.  \n",
      "170.315(a)(9)) which supports pediatric care by enabling interventions \n",
      "based on the capture of biometric data.\n",
      "    <bullet> ``common clinical data set'' (adopted in (sec.  \n",
      "170.315(b)(4) and sec.  170.315(b)(5)) which includes optional \n",
      "pediatric vital sign data elements including as optional the reference \n",
      "range/growth curve for three pediatric vital signs--bmi percent per \n",
      "loinc identifiers for age per sex, weight per length/sex, and head \n",
      "occipital-frontal circumference for children less than three years of \n",
      "age.\n",
      "    <bullet> ``data segmentation for privacy'' send criterion and \n",
      "receive criterion (adopted in sec.  170.315(b)(7) and sec.  \n",
      "170.315(b)(8)) which provides the ability to: create a summary record \n",
      "that is tagged at the document level as restricted and subject to re-\n",
      "disclosure; receive a summary record that is document-level tagged as \n",
      "restricted; separate the document-level tagged document from other \n",
      "documents received; and, view the restricted document without having to \n",
      "incorporate any of the data from the document.\n",
      "    <bullet> ``demographics'' criterion (sec.  170.315(a)(5)) which \n",
      "supports pediatric care through the capture of values and value sets \n",
      "relevant for the pediatric health care setting as well as allowing for \n",
      "improved patient matching which is a key challenge for pediatric care.\n",
      "    <bullet> ``electronic prescribing'' criterion (adopted in sec.  \n",
      "170.315(b)(3)) which includes an optional structured and codified sig \n",
      "format, which has the capability to exchange weight-based dosing \n",
      "calculations within the ncpdp script 10.6 standard and limits the \n",
      "ability to prescribe all oral, liquid medications in only metric \n",
      "standard units of ml (i.e., not cc) important for enabling safe \n",
      "prescribing practices for children.\n",
      "    <bullet> ``family health history'' criterion (sec.  170.315(a)(12)) \n",
      "which supports pediatric care because it leverages concepts or \n",
      "expressions for familial conditions, which are especially clinically \n",
      "relevant when caring for children.\n",
      "    <bullet> ``patient health information capture'' criterion (sec.  \n",
      "170.315(e)(3)) which supports providers' ability to accept health \n",
      "information from a patient or authorized representative. this criterion \n",
      "could support pediatric care through documentation of decision-making \n",
      "authority of a patient representative.\n",
      "    <bullet> ``social, psychological, and behavioral data'' criterion \n",
      "sec.  170.315(a)(15) which supports integration of behavioral health \n",
      "data into a child's record across the care continuum by enabling a user \n",
      "to record, change, and access a patient's social, psychological, and \n",
      "behavioral data based using snomed ct[supreg] and loinc[supreg] codes.\n",
      "    <bullet> ``transitions of care'' criterion (sec.  170.315(b)(1)) \n",
      "which supports structured transition of care summaries and referral \n",
      "summaries that help ensure the coordination and continuity of health \n",
      "care as children transfer between different clinicians at different \n",
      "health care organizations or different levels of care within the same \n",
      "health care organization;\n",
      "    <bullet> ``transmission to immunization registries'' criterion \n",
      "(sec.  170.315(f)(1)) which supports the safe and effective provision \n",
      "of child health care through immunizations and registry linkages. this \n",
      "criterion also provides the ability to request, access, and display the \n",
      "evaluated immunization history and forecast from an immunization \n",
      "registry for a patient. immunization forecasting recommendations allow \n",
      "for providers to access the most complete and up-to-date information on \n",
      "a patient's immunization history to inform discussions about what \n",
      "vaccines a patient may need based on nationally recommended \n",
      "immunization recommendations (80 fr 62662-62664).\n",
      "    <bullet> ``view, download, and transmit to 3rd party'' (vdt) \n",
      "criterion (sec.  170.315(e)(1)) which supports transferrable access \n",
      "authority for the pediatric health care setting and provides the \n",
      "ability for patients (and their authorized representatives) \\47\\ to \n",
      "view, download, and transmit their health information to a 3rd party.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\47\\ the vdt criterion includes a ``patient-authorized \n",
      "representative'' concept that aligns with the use of the term under \n",
      "the ehr incentive program. a ``patient-authorized representative'' \n",
      "is defined as any individual to whom the patient has granted access \n",
      "to their health information (see also 77 fr 13720). however, consent \n",
      "is not needed for minors, for whom existing local, state, or federal \n",
      "law grants their parents or guardians access (see also 77 fr 13720).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we note that some of these criteria may be updated based on \n",
      "proposals contained in this proposed rule; however, we believe that \n",
      "prior to any such updates, technology that is currently available and \n",
      "certified to these 2015 edition criteria can make a significant impact \n",
      "in supporting providers engaged in the health care of children. we \n",
      "invite readers to use the technical worksheets in the appendix to this \n",
      "proposed rule to inform their public comment on the recommendations, \n",
      "the inclusion of specific items from the children's format, and the \n",
      "identified 2015 edition certification criteria as they relate \n",
      "specifically to use cases for pediatric care and sites of service.\n",
      "b. new or revised certification criteria in this proposed rule\n",
      "    in order to implement the second part of section 4001(b)(iii) of \n",
      "the cures act to adopt certification criteria to support the voluntary \n",
      "certification of health information technology for use by pediatric \n",
      "health providers to support the health care of children, we identified \n",
      "new or revised certification criteria in this proposed rule that \n",
      "support the recommendations. these new or revised criteria and \n",
      "standards in this proposed rule that would support pediatric settings \n",
      "include:\n",
      "    <bullet> new api criterion (sec.  170.315(g)(10)) which would serve \n",
      "to implement the cures act requirement to permit health information to \n",
      "be accessed, exchanged, and used from apis without special effort (see \n",
      "section iv.b.5 of this proposed rule).\n",
      "    <bullet> new ``ds4p'' criteria (two for c-cda ((sec.  \n",
      "170.315(b)(12)) and (sec.  170.315(b)(13)) and one for fhir (sec.  \n",
      "170.315(g)(11))) that would support a more granular approach to privacy \n",
      "tagging data for health information exchange supported by either the c-\n",
      "cda- or fhir-based exchange standards (see section vi.a for a \n",
      "discussion of this criteria in relation to pediatric settings and \n",
      "section vi.b for discussion of these criteria in relation to opioid use \n",
      "disorder).\n",
      "    <bullet> new electronic prescribing certification criterion (sec.  \n",
      "170.315(b)(11)), which would supports improved patient safety and \n",
      "prescription accuracy, workflow efficiencies, and increased \n",
      "configurability of systems including functionality that could support \n",
      "pediatric medication management.\n",
      "    <bullet> uscdi (sec.  170.213) which enables the inclusion of \n",
      "pediatric vital sign data elements, including the reference range/scale \n",
      "or growth curve for bmi percentile per age and sex, weight for age per \n",
      "length and sex, and head occipital-frontal circumference (and the \n",
      "criteria that include the uscdi).\n",
      "    each of these proposed criteria are further described in other \n",
      "sections of this proposed rule; however, in this section of this \n",
      "proposed rule we specifically seek comment on the application of these \n",
      "criteria to pediatric use cases in support of our recommendations for \n",
      "the voluntary certification of health it for pediatric care.\n",
      "\n",
      "[[page 7461]]\n",
      "\n",
      "    for example, our proposal for three new 2015 edition ds4p \n",
      "certification criteria (two for c-cda ((sec.  170.315(b)(12)) and \n",
      "(sec.  170.315(b)(13)) and one for fhir (sec.  170.315(g)(11))) could \n",
      "provide functionality to address the concerns of multiple stakeholders \n",
      "in a range of specialty use cases--including pediatric care settings. \n",
      "in this section of this proposed rule, we seek comment specifically \n",
      "related to the inclusion of these criteria in our recommendations. \n",
      "specifically, stakeholders have expressed the need to--based on the \n",
      "intended recipient of the data--to restrict granular pediatric health \n",
      "data at production. we believe these criteria could, for example, help \n",
      "enable providers to:\n",
      "    <bullet> limit the sharing of reproductive and sexual health data \n",
      "from an ehr in order to protect the minor's privacy;\n",
      "    <bullet> prevent disclosure of an emancipated minor's sensitive \n",
      "health information, while also permitting a parent or legal guardian to \n",
      "provide consent for treatment; and\n",
      "    <bullet> segment child abuse information based on jurisdictional \n",
      "laws, which may have varying information sharing requirements for \n",
      "parents, guardians, and/or other possible legal representatives.\n",
      "    while health care providers should already have processes and \n",
      "workflows in place to address their existing compliance obligations, we \n",
      "recognize that more granular privacy markings at the point of data \n",
      "capture would further support existing and future priorities of \n",
      "pediatric health providers, as well as for multiple medical specialties \n",
      "and sites of service. we also recognize that such point of data capture \n",
      "markings can reduce administrative burden through efficiencies gained \n",
      "in streamlined compliance workflows.\n",
      "    we invite readers to use the technical worksheets in the appendix \n",
      "of this proposed rule to support public comment on the recommendations, \n",
      "the inclusion of specific items from the children's format, and the \n",
      "identified proposed new or revised certification criteria as they \n",
      "relate specifically to use cases for pediatric care and sites of \n",
      "service.\n",
      "    however, as discussed, through our experience and engagement with \n",
      "health care providers and health it developers, we believe that in some \n",
      "cases information resources can aid in implementation in clinical \n",
      "settings. in the past, onc has worked collaboratively with federal \n",
      "partners, health it developers, and the health care community to \n",
      "support the development of non-regulatory informational resources that \n",
      "can provide additional support for health it implementation (see, for \n",
      "example, the onc patient engagement playbook). such a resource could \n",
      "include the recommendations and certification criteria here identified \n",
      "and synthesize these technical recommendations with information outside \n",
      "of the program related to patient safety, usability, privacy and \n",
      "security, and other key considerations for successful implementation of \n",
      "a health it system within a clinical setting. we believe that the \n",
      "creation of such a resource, in collaboration with clinical and \n",
      "technical stakeholders, would help support the advancement of health it \n",
      "solutions for use in pediatric care and pediatric settings. we further \n",
      "include additional information on prior onc initiatives related to \n",
      "health it for pediatric settings as available on our website at \n",
      "<a href=\"http://www.healthit.gov/pediatrics\">www.healthit.gov/pediatrics</a>.\n",
      "\n",
      "b. health it and opioid use disorder prevention and treatment--request \n",
      "for information\n",
      "\n",
      "    we have identified a need to explore ways to advance health it \n",
      "across the care continuum to support efforts to fight the opioid \n",
      "epidemic. to that purpose, we seek comment in this proposed rule on a \n",
      "series of questions related to health it functionalities and standards \n",
      "to support the effective prevention and treatment of opioid use \n",
      "disorder (oud) across patient populations and care settings.\n",
      "    we recognize the significance of the opioid epidemic confronting \n",
      "our nation and the importance of helping to support health care \n",
      "providers committed to preventing inappropriate access to prescription \n",
      "opioids and providing safe, appropriate treatment.\n",
      "    hhs has a comprehensive strategy to combat the opioid crisis. it \n",
      "consists of five points that are focused on better: addiction \n",
      "prevention, treatment, and recovery services; data; pain management; \n",
      "targeting of overdose reversing drugs; and research.\\48\\ in support of \n",
      "this strategy, hhs will improve access to prevention, treatment, and \n",
      "recovery support services; target the availability and distribution of \n",
      "overdose-reversing drugs; strengthen public health data reporting and \n",
      "collection; support cutting-edge research; and advance the practice of \n",
      "pain management. to combat the opioid crisis, in october 2018, congress \n",
      "passed the substance use-disorder prevention that promotes opioid \n",
      "recovery and treatment (support) for patients and communities act. it \n",
      "aims to expand treatment, recovery, and prevention initiatives for \n",
      "substance use disorder and also includes interoperability and health it \n",
      "tools as a key part of the response to this crisis.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\48\\ <a href=\"https://www.hhs.gov/opioids/\">https://www.hhs.gov/opioids/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we believe health it offers promising strategies to help medical \n",
      "specialties and sites of service as they combat opioid use disorder \n",
      "(oud). for example, health it has the potential to improve adherence to \n",
      "opioid prescribing guidelines and physician adherence to treatment \n",
      "protocols, to increase the safety of prescribing for controlled \n",
      "substances, to enhance clinician access to pdmps, and to expand access \n",
      "to addiction treatment and recovery support services. additionally, \n",
      "through the program, our goal continues to be to improve access to data \n",
      "from disparate sources and help ensure that key data is consistently \n",
      "available to the right person, at the right place, and at the right \n",
      "time across the care continuum. one component of advancing that goal is \n",
      "through technical standards for exchanging health information that form \n",
      "an essential foundation for interoperability.\n",
      "    onc has heard from stakeholders including policymakers, \n",
      "implementers, health care providers and patient advocacy groups that \n",
      "additional information is needed to assist in planning for the \n",
      "effective use of health it in oud prevention and treatment. we \n",
      "additionally recognize stakeholders' interest in the new opioid \n",
      "measures (query of pdmp measure and verify opioid treatment agreement \n",
      "measure) included in cms's promoting interoperability programs \n",
      "(formerly known as the medicare and medicaid ehr incentive programs). \n",
      "these two measures support hhs initiatives related to the treatment of \n",
      "opioid and substance use disorders by helping health care providers \n",
      "avoid inappropriate prescriptions, improve coordination of prescribing \n",
      "amongst health care providers, and focus on the advanced use of \n",
      "certified health it in care coordination for oud prevention and \n",
      "treatment (83 fr 41644).\n",
      "    in order to support these efforts, in this proposed rule we outline \n",
      "a brief overview of some key areas of health it implementation that \n",
      "could support oud prevention and treatment. these include consideration \n",
      "of current health it certification criteria included in the 2015 \n",
      "edition, revised or new certification criteria as outlined in this \n",
      "proposed rule, and current health it initiatives underway in the health \n",
      "care industry or health it industry which intersect with onc policy \n",
      "goals. in this section of the proposed rule, we request public comment \n",
      "specifically from the perspective of how our existing program\n",
      "\n",
      "[[page 7462]]\n",
      "\n",
      "requirements and proposals in this rulemaking may support use cases \n",
      "related to oud prevention and treatment and if there are additional \n",
      "areas that onc should consider for effective implementation of health \n",
      "it-enabled oud prevention and treatment. we seek comment from this \n",
      "perspective on the identification of 2015 edition certification \n",
      "criteria, the proposals for revised or new certification criteria, and \n",
      "the potential future consideration of emerging technologies described \n",
      "in various initiatives.\n",
      "1. 2015 edition certification criteria\n",
      "    we seek public comment on how the existing 2015 edition \n",
      "certification criteria as well as proposals within this proposed rule \n",
      "for revised or new criteria support oud prevention and treatment. \n",
      "specifically, we seek comment on certification criteria previously \n",
      "adopted in the 2015 edition that can support clinical priorities, \n",
      "advance interoperability for oud (including care coordination and the \n",
      "effective use of health it for the treatment and prevention of oud). in \n",
      "this proposed rule, we summarize some of these 2015 edition \n",
      "certification criteria identified and indicate how they support care \n",
      "coordination, the prevention of oud and overdose, and the detection of \n",
      "opioid misuse, abuse, and diversion.\n",
      "    we have also below identified the proposals for revised or new 2015 \n",
      "edition criteria within this proposed rule that we believe can support \n",
      "clinical priorities, advance interoperability for oud (including care \n",
      "coordination and also the effective use of health it for the treatment \n",
      "and prevention of oud). we welcome input from stakeholders specifically \n",
      "on these criteria within the context of oud prevention and treatment, \n",
      "as well as input on the identification of other criteria included \n",
      "either in the 2015 edition and/or that are proposed in other parts of \n",
      "this rule that may be considered a clinical and interoperability \n",
      "priority for supporting oud treatment and prevention.\n",
      "    we have identified several 2015 edition certification criteria \n",
      "available now for certification in the program which could support care \n",
      "coordination and the prevention and detection of opioid misuse, abuse, \n",
      "and diversion. they are:\n",
      "    <bullet> the ``transitions of care'' criterion (sec.  \n",
      "170.315(b)(1)) supports structured transition of care summaries and \n",
      "referral summaries that help ensure the coordination and continuity of \n",
      "health care as patients transfer between different clinicians at \n",
      "different health care organizations or different levels of care within \n",
      "the same health care organization. this criteria supports the ability \n",
      "to transmit a summary care record to support an individual with oud \n",
      "upon discharge from an inpatient setting or from a primary care \n",
      "provider to another setting for their care.\n",
      "    <bullet> the ``clinical information reconciliation and \n",
      "incorporation'' criterion (sec.  170.315(b)(2)) allows clinicians to \n",
      "reconcile and incorporate patient health information sent from external \n",
      "sources to maintain a more accurate and up-to-date patient record. this \n",
      "process could help--for example--reduce opioid related errors regarding \n",
      "patients who use multiple pharmacies, have co-morbidity factors, and \n",
      "visit multiple clinicians.\n",
      "    <bullet> the ``electronic prescribing'' criterion (sec.  \n",
      "170.315(b)(3)) provides a way to write and transmit prescription \n",
      "information electronically. this criterion facilitates appropriate \n",
      "opioid prescribing by simplifying the review of prescription \n",
      "information during follow-up visits or transitions to other clinicians, \n",
      "by allowing prescribers to communicate prescription-related messages to \n",
      "pharmacies electronically and by capturing and transmitting medication \n",
      "histories that are shared with pdmps. in this proposed rule, we propose \n",
      "to update the existing electronic prescribing certification criterion \n",
      "as described in section iv.b.2 of this proposed rule.\n",
      "    <bullet> the ``patient health information capture'' (sec.  \n",
      "170.315(e)(3)) allows clinicians to incorporate unstructured patient \n",
      "generated health data or data from a non-clinical setting into a \n",
      "patient record. the cms promoting interoperability programs for \n",
      "eligible hospitals includes a new optional measure which is focused on \n",
      "verifying the existence of a signed opioid treatment agreement for \n",
      "certain patients when a controlled substance is prescribed and \n",
      "incorporating it into the record. in the hospital inpatient prospective \n",
      "payment systems final rule, cms recognized this certification \n",
      "criterion's potential to support this goal within a certified health it \n",
      "system (83 fr 41654).\n",
      "    <bullet> the ``social, psychological, and behavioral data'' \n",
      "criterion (sec.  170.315(a)(15)) can help to provide a more complete \n",
      "view of a patient's overall health status. this is important to help \n",
      "provide a ``whole-patient'' approach to the treatment of substance use \n",
      "disorders included as part of medicated-assisted treatment (mat) that \n",
      "involves the use of fda-approved medications, in combination with \n",
      "counseling and behavioral therapies, to treat individuals recovering \n",
      "from oud. this data can help to improve care coordination and lead to \n",
      "the identification of appropriate social supports and community \n",
      "resources.\n",
      "    we seek comment on how these criteria and what additional 2015 \n",
      "edition certification criteria may be considered a clinical and \n",
      "interoperability priority for supporting oud treatment and prevention. \n",
      "we also seek comment on the value of developing a potential future non- \n",
      "binding informational guide or resource to provide useful information \n",
      "for oud providers and sites of service related to specific clinical \n",
      "priorities and use cases of focus.\n",
      "2. revised or new 2015 edition certification criteria in this proposed \n",
      "rule\n",
      "    this proposed rule contains additional proposals to revise or add \n",
      "new criteria to the program to better support care across the \n",
      "continuum. we believe these criteria and standards, highlighted below, \n",
      "can also support treatment and prevention of oud. we seek comment \n",
      "specifically on the applicability of these criteria to the oud use \n",
      "case. they are:\n",
      "    <bullet> uscdi: as detailed in section iv.b.1, we are proposing to \n",
      "adopt the uscdi as a standard (sec.  170.213) which would establish a \n",
      "minimum set of data classes (including structured data fields) that are \n",
      "required to be interoperable nationwide, and is designed to be expanded \n",
      "in an iterative and predictable way over time. the uscdi version 1 \n",
      "(uscdi v1) builds upon the 2015 edition ccds and includes a common set \n",
      "of data classes that can be supported by commonly used standards. it \n",
      "includes the 2015 edition ccds data elements, such as medications. it \n",
      "also includes two new data classes, titled ``clinical notes'' and \n",
      "``provenance,'' which would help facilitate interoperable exchange and \n",
      "the trustworthiness of the data being exchanged. these enhancements to \n",
      "the comprehensiveness and reliability of the data being exchanged could \n",
      "help empower physicians in the prevention and detection of opioid \n",
      "misuse, abuse, and diversion.\n",
      "    in addition, because we propose to adopt the uscdi as a standard, \n",
      "health it developers would be allowed to take advantage of the \n",
      "maintenance of certification requirements described in section vii.b.5 \n",
      "of this proposed rule. therefore, the uscdi would have the potential to \n",
      "further benefit clinical priorities and interoperability for oud, \n",
      "including safe and appropriate opioid prescribing, through the ability \n",
      "to voluntarily implement and use a new version of an adopted standard \n",
      "or\n",
      "\n",
      "[[page 7463]]\n",
      "\n",
      "implementation specification so long as certain conditions are met, \n",
      "including the new version being approved by the national coordinator \n",
      "for use in certification through the standards version advancement \n",
      "process. we seek comment on how this proposal would further support the \n",
      "access, exchange, and use of additional and future data classes \n",
      "(including structured data fields) in more care and practice settings \n",
      "specifically as related to the prevention and treatment of oud.\n",
      "    <bullet> standardized api: we are proposing new api functionality \n",
      "through the adoption of a new api certification criterion (sec.  \n",
      "170.315(g)(10)), which serves to implement the cures act requirement to \n",
      "permit health information to be accessed, exchanged, and used from apis \n",
      "without special effort. this criterion would enable efficient exchange \n",
      "of health information using modern internet technologies and thus \n",
      "enable collaborative, patient-driven, integrated care for individuals \n",
      "recovering from oud.\n",
      "    <bullet> data segmentation for privacy and consent management: as \n",
      "discussed in section iv.b.7, we are also proposing to remove the \n",
      "current 2015 edition ds4p--send (sec.  170.315(b)(7)) and ds4p--receive \n",
      "(sec.  170.315(b)(8)) certification criteria. we propose to replace \n",
      "these two criteria with three new 2015 edition ds4p certification \n",
      "criteria (two for c-cda ((sec.  170.315(b)(12)) and (sec.  \n",
      "170.315(b)(13)) and one for fhir (sec.  170.315(g)(11))) that would \n",
      "support a more granular approach to privacy tagging data for health \n",
      "information exchange supported by either the c-cda- or fhir-based \n",
      "exchange standards. we believe this proposal would offer functionality \n",
      "that is more valuable to providers and patients, especially given the \n",
      "complexities of the privacy law landscape for multiple care and \n",
      "specialty settings. we also believe this proposal could lead to more \n",
      "complete records, contribute to patient safety, and enhance care \n",
      "coordination. additionally, we believe this proposal may support a more \n",
      "usable display of oud information at the request of patients within an \n",
      "ehr and we invite input on best practices, including the processes and \n",
      "methods by which oud information should be displayed.\n",
      "    <bullet> electronic prescribing and pdmps: as discussed in section \n",
      "iv.b.2, we are proposing to remove the current 2015 edition electronic \n",
      "prescribing certification criterion (sec.  170.315(b)(3)) and replace \n",
      "this criterion with a new electronic prescribing certification \n",
      "criterion (sec.  170.315(b)(11)) that would support improved patient \n",
      "safety and prescription accuracy, create workflow efficiencies, reduce \n",
      "testing requirements, and increase configurability of systems. this new \n",
      "proposed criterion includes the addition of risk evaluation and \n",
      "mitigation strategy (rems) messages. we believe this proposal would \n",
      "help address challenges discussed in the cms hospital inpatient \n",
      "prospective payment systems final rule (83 fr 41651) and medicare \n",
      "physician fee schedule proposed rule (83 fr 35704) by strengthening \n",
      "clinical and administrative efficiency, helping move the industry \n",
      "forward by adopting more current standards for electronic prescribing, \n",
      "and harmonizing efforts across federal agencies in the prevention and \n",
      "treatment of oud. in addition, the fda has enacted an opioids \n",
      "medications rems program for opioid analgesics \\49\\ mandating \n",
      "prescriber and patient education to encourage proper patient screening \n",
      "and appropriate monitoring. adoption of the new proposed criterion also \n",
      "supports the efficient and accurate exchange of medication history \n",
      "transactions between providers and pharmacies, and between pharmacies \n",
      "and state pdmps.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\49\\ <a href=\"https://www.fda.gov/drugs/drugsafety/informationbydrugclass/ucm163647.htm\">https://www.fda.gov/drugs/drugsafety/informationbydrugclass/ucm163647.htm</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "3. emerging standards and innovations\n",
      "    in addition to the certification criteria established in the 2015 \n",
      "edition final rule and proposed in this rule, onc is engaged in a \n",
      "number of health it and standards initiatives exploring innovation and \n",
      "emerging standards to inform future health it policy. in some cases, \n",
      "these efforts may not be mature enough or best suited for adoption in \n",
      "the program; however, we seek comment on the potential consideration of \n",
      "these initiatives for future direction of onc policy.\n",
      "    <bullet> cds hooks: improving how opioids are prescribed through \n",
      "evidence-based guidelines can ensure patients have access to safer, \n",
      "more effective chronic pain treatment while reducing the risk of opioid \n",
      "misuse, abuse, or overdose from these drugs. in response to the \n",
      "critical need for consistent and current opioid prescribing guidelines, \n",
      "the centers for disease control and prevention (cdc) released the \n",
      "guideline for prescribing opioids for chronic pain.\\50\\ while progress \n",
      "has been made in training prescribers and fostering the adoption of the \n",
      "cdc guideline, the president's opioid commission \\51\\ acknowledged that \n",
      "``not all states have adopted the guideline, not all physicians are \n",
      "aware of them, and sound opioid prescribing guidelines are far from \n",
      "universally followed.'' clinical decision support (cds) hooks is a \n",
      "health it specification that has the potential to positively affect \n",
      "prescriber adoption of evidence-based prescribing guidelines by \n",
      "invoking patient-specific clinical support from within the clinician's \n",
      "ehr workflow. onc is currently collaborating with cdc on a project to \n",
      "translate the cdc guideline into standardized, shareable, computable \n",
      "decision support artifacts using cds hooks. we recognize that cds hooks \n",
      "is still an emerging technology and seek input on the adoption of the \n",
      "cds hooks specification for opioid prescribing and oud prevention and \n",
      "treatment. we also request public comment on other health it solutions \n",
      "and effective approaches to improve opioid prescription practices and \n",
      "clinical decision support for oud.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\50\\ guideline for prescribing opioids for chronic pain: <a href=\"https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm\">https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm</a>.\n",
      "    \\51\\ president's opioid commission: <a href=\"https://www.whitehouse.gov/sites/whitehouse.gov/files/images/final_report_draft_11-1-2017.pdf\">https://www.whitehouse.gov/sites/whitehouse.gov/files/images/final_report_draft_11-1-2017.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> care plan fhir resource: a shared care plan is a critical \n",
      "concept for managing an individual's health across a continuum that \n",
      "includes both clinical and non-clinical settings \\52\\ and can help \n",
      "enable more informed and useful connections among all the stakeholders \n",
      "engaged in preventing or treating oud. for those in recovery from oud, \n",
      "the care plan can enable patients to access their care plan information \n",
      "and coordinate their care with approved community care providers which \n",
      "is critical and part of evidence-based recovery treatment services. in \n",
      "2015, the onc hitpc recommended that the national coordinator \n",
      "accelerate the implementation of dynamic, shared, longitudinal care \n",
      "plans that incorporate information from both clinical and non-clinical \n",
      "services and empower individuals to manage their own health and \n",
      "care.\\53\\ a consideration for hhs as part of this earlier \n",
      "recommendation included looking at the future standards development \n",
      "needed to transition from the static care plan documentation (document \n",
      "template in c-cda r2.1) to a dynamic shared care plan that supports \n",
      "more robust care coordination.\\54\\ we believe hl7 standards and \n",
      "standardized apis can elevate care coordination and care management \n",
      "across the continuum,\n",
      "\n",
      "[[page 7464]]\n",
      "\n",
      "including for those providers without ehrs, whether for opioid use \n",
      "disorder related treatment, primary health, or other problems. indeed, \n",
      "numerous efforts are underway within hl7 and other collaborations to \n",
      "standardize ``care plans'' and their content using fhir and the c-cda. \n",
      "from a technical perspective and in the context of the proposals \n",
      "focused on the uscdi standard, the arch standard, the new proposed api \n",
      "certification criterion at 170.315(g)(10), and the voluntary standards \n",
      "version advancement process maintenance of certification requirement \n",
      "described in section vii.b.5 of this proposed rule, we can see a future \n",
      "where a (g)(10)-certified api would be capable of supporting care plan \n",
      "data. we request public comment on the current maturity of existing and \n",
      "forthcoming technical specifications to support care plan/care plan \n",
      "data as well as specific information that could be prioritized within a \n",
      "future uscdi data class focused on care plans.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\52\\ <a href=\"https://www.healthit.gov/hitac/events/policy-advanced-health-models-and-meaningful-use-workgroup-8\">https://www.healthit.gov/hitac/events/policy-advanced-health-models-and-meaningful-use-workgroup-8</a>.\n",
      "    \\53\\ <a href=\"https://www.healthit.gov/sites/default/files/facas/hitpc_ahm_hearing_transmittal_08-11-2015_0.pdf\">https://www.healthit.gov/sites/default/files/facas/hitpc_ahm_hearing_transmittal_08-11-2015_0.pdf</a>.\n",
      "    \\54\\ <a href=\"https://www.healthit.gov/hitac/events/policy-advanced-health-models-and-meaningful-use-workgroup-8\">https://www.healthit.gov/hitac/events/policy-advanced-health-models-and-meaningful-use-workgroup-8</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in addition to commenting on the criteria noted in this section, we \n",
      "also encourage stakeholders to participate in the isa process.\\55\\ the \n",
      "isa represents the model by which onc coordinates the identification, \n",
      "assessment, and public awareness of interoperability standards and \n",
      "implementation specifications. onc encourages all stakeholders to \n",
      "implement and use the standards and implementation specifications \n",
      "identified in the isa as applicable to the specific interoperability \n",
      "needs they seek to address and encourages pilot testing and other \n",
      "industry experience adopting standards and implementation \n",
      "specifications identified as ``emerging'' in the isa. the web-based \n",
      "version of the isa documents known limitations, preconditions, and \n",
      "dependencies, and provide suggestions for security best practices in \n",
      "the form of security patterns for referenced standards and \n",
      "implementation specifications when they are used to address a specific \n",
      "clinical health it interoperability need.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\55\\ to learn more about, and/or participate in, the isa \n",
      "process, please visit <a href=\"https://www.healthit.gov/isa/\">https://www.healthit.gov/isa/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    additionally, through the isa process, stakeholders are encouraged \n",
      "to comment on the outlined standards and implementation specifications, \n",
      "as onc updates the isa regularly. onc has developed and has plans to \n",
      "develop further isa content to highlight standards and implementation \n",
      "specifications that support the prevention and treatment of oud/\n",
      "substance use disorder (sud). for example, the ncpdp script standard \n",
      "allows a prescriber to request a patient's medication history from a \n",
      "state pdmp via the rxhistoryrequest and rxhistoryresponse. onc is also \n",
      "working to enhance the isa to make it easier for stakeholders to find \n",
      "standards and implementation specifications related to high-priority \n",
      "use cases, such as oud/sud. the isa has a comment process that occurs \n",
      "each year \\56\\ and we encourage stakeholders to participate in that \n",
      "process to comment on other standards and implementation specifications \n",
      "that currently exist in the isa or that the industry and its \n",
      "stakeholders feel should be added to the isa that support oud/sud \n",
      "prevention, treatment, monitoring, and care coordination.\n",
      "4. additional comment areas\n",
      "    we further seek comment on effective approaches for the successful \n",
      "dissemination and adoption of standards including the ncpdp script \n",
      "2017071 standard (see section iv.b.2) that can support the exchange of \n",
      "pdmp data for integration into ehrs and also enable further adoption \n",
      "and use of electronic prescribing of controlled substances (epcs). \n",
      "regarding integration of health it with pdmps and epcs, we believe \n",
      "there are real and perceived challenges and opportunities that involve \n",
      "policy and technical components. as we explore these issues in \n",
      "collaboration with industry and stakeholders, we seek comment on the \n",
      "priority challenges and opportunities for these topics and on any \n",
      "technical and policy distinctions, as appropriate.\n",
      "    we also note that there are many federal initiatives separate from \n",
      "onc proposed rulemaking and the program that exist within hhs programs \n",
      "including, but not limited to, cms medicaid and medicare programs. for \n",
      "example, medicare now provides separate payment for psychiatric \n",
      "collaborative care model/behavioral health integration and chronic care \n",
      "management services (see 81 fr 80233, and 80247), and medicaid issued \n",
      "guidance on leveraging technology to address the opioid crisis at \n",
      "enhanced funding matches \\56\\ and also includes sud health it in \n",
      "standard terms and conditions as part of 1115 waiver requirements.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\56\\ <a href=\"https://www.medicaid.gov/federal-policy-guidance/downloads/smd18006.pdf\">https://www.medicaid.gov/federal-policy-guidance/downloads/smd18006.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in addition, cms sought comment for consideration through separate \n",
      "rulemaking in both the 2019 physician fee schedule proposed rule (83 fr \n",
      "35923) and hospital inpatient prospective payment systems proposed rule \n",
      "(83 fr 20528) regarding whether they should adopt the ncpdp script \n",
      "2017071 standard to facilitate future reporting of the proposed query \n",
      "of pdmp quality measure. as noted in the hospital inpatient prospective \n",
      "payment systems final rule, a few commenters supported the use of ncpdp \n",
      "script standard implementation guide version 2017071 medication history \n",
      "transactions for pdmp queries and response. additionally, cms \n",
      "encourages advances in standards and their use to deliver innovative, \n",
      "interoperable solutions that will seamlessly integrate pdmp query \n",
      "functionality into clinician-friendly, patient- centered cehrt-enabled \n",
      "workflows that facilitate safer, more informed prescribing practices \n",
      "and improved patient outcomes (83 fr 41651).\n",
      "    we seek comment on how successful implementation of health it that \n",
      "supports oud can aid in the achievement of national and programmatic \n",
      "goals, especially where they may align with initiatives across hhs and \n",
      "with stakeholder and industry led efforts.\n",
      "    finally, we seek comment on a topic that involves health it for \n",
      "both pediatric care and oud prevention and treatment--neonatal \n",
      "abstinence syndrome (or nas). in its september 2018 report, facing \n",
      "addiction in america: the surgeon general's spotlight on opioids, the \n",
      "hhs office of the surgeon general describes how the incidence of \n",
      "neonatal abstinence syndrome (or nas), has increased dramatically in \n",
      "the last decade along with increased opioid misuse. newborns may \n",
      "experience nas, a withdrawal syndrome, following exposure to drugs \n",
      "while in the mother's womb. nas is an expected and treatable condition \n",
      "following repeated maternal substance use and abuse during pregnancy, \n",
      "which may have long-term health consequences for the infant.\n",
      "    immediate newborn nas signs include neurological excitability, \n",
      "gastrointestinal dysfunction, and autonomic dysfunction. newborns with \n",
      "nas are more likely than other babies to have low birthweight and \n",
      "respiratory complications. onc believes the pediatric clinical health \n",
      "it recommendations proposed in this rule (including priority 8, which \n",
      "includes the linkage of health data in records of the mother and \n",
      "newborn) are important for supporting newborns at birth and as they \n",
      "grow and receive care in various settings. as such, we invite comment \n",
      "on:\n",
      "    <bullet> the effective use of health it itself in support of the \n",
      "nas use case as involves provider training, establishing\n",
      "\n",
      "[[page 7465]]\n",
      "\n",
      "workflow, and other related safety and usability considerations.\n",
      "    <bullet> existing and potential tools, such as decision support or \n",
      "clinical quality measurement, for supporting children with nas and on \n",
      "the specific data elements related to the care of these children and \n",
      "use of these tools in practice.\n",
      "    <bullet> identification of any related criteria and the respective \n",
      "corresponding proposed pediatric recommendation for the voluntary \n",
      "certification of health it for use in pediatric care that supports the \n",
      "nas use case including but not limited to recommendation number 8 noted \n",
      "above.\n",
      "    we welcome public comment on these health it policies, \n",
      "functionalities and standards to support providers engaged in the \n",
      "treatment and prevention of oud.\n",
      "\n",
      "vii. conditions and maintenance of certification\n",
      "\n",
      "    section 4002 of the cures act requires the secretary of hhs, \n",
      "through notice and comment rulemaking, to establish conditions and \n",
      "maintenance of certification requirements for the program. \n",
      "specifically, health it developers or entities must adhere to certain \n",
      "conditions and maintenance of certification requirements concerning \n",
      "information blocking; appropriate exchange, access, and use of \n",
      "electronic health information; communications regarding health it; \n",
      "application programming interfaces (apis); real world testing for \n",
      "interoperability; attestations regarding certain conditions and \n",
      "maintenance of certification requirements; and submission of reporting \n",
      "criteria under the ehr reporting program.\n",
      "\n",
      "a. implementation\n",
      "\n",
      "    to implement section 4002 of the cures act, we propose an approach \n",
      "whereby the conditions and maintenance of certification express both \n",
      "initial requirements for health it developers and their certified \n",
      "health it module(s) as well as ongoing requirements that must be met by \n",
      "both health it developers and their certified health it module(s) under \n",
      "the program. if these requirements are not met, then the health it \n",
      "developer may no longer be able to participate in the program and/or \n",
      "its certified health it may have its certification terminated. we \n",
      "propose to implement each cures act condition of certification with \n",
      "further specificity as it applies to the program. we also propose to \n",
      "establish the maintenance of certification requirements for each \n",
      "condition of certification as standalone requirements. this approach \n",
      "would establish clear baseline technical and behavior conditions of \n",
      "certification requirements with evidence that the conditions of \n",
      "certification are continually being met through the maintenance of \n",
      "certification requirements.\n",
      "\n",
      "b. provisions\n",
      "\n",
      "1. information blocking\n",
      "    the cures act requires that a health it developer, as a condition \n",
      "and maintenance of certification under the program, not take any action \n",
      "that constitutes ``information blocking'' as defined in section 3022(a) \n",
      "of the phsa (see 3001(c)(5)(d)(i) of the phsa). we propose to establish \n",
      "this information blocking condition of certification in sec.  170.401. \n",
      "the condition of certification prohibits any health it developer under \n",
      "the program from taking any action that constitutes information \n",
      "blocking as defined by section 3022(a) of the phsa and proposed in \n",
      "sec.  171.103.\n",
      "    we clarify that this proposed ``information blocking'' condition of \n",
      "certification and its requirements would be substantive requirements of \n",
      "the program and would use the definition of ``information blocking'' \n",
      "established by section 3022(a) of the phsa and as also proposed in \n",
      "sec.  171.103, as it relates to health it developers of certified \n",
      "health it. in addition to onc's statutory authority for this condition \n",
      "of certification, the hhs office of the inspector general (oig) has \n",
      "both investigatory and enforcement authority over information blocking \n",
      "and may issue civil money penalties for information blocking conducted \n",
      "by health it developers of certified health it, health information \n",
      "networks and health information exchanges. oig may also investigate \n",
      "health care providers for information blocking for which health care \n",
      "providers could be subject to disincentives.\n",
      "    we refer readers to section vii.d of this proposed rule for \n",
      "additional discussion of onc's enforcement of this and other proposed \n",
      "conditions and maintenance of certification requirements. we also refer \n",
      "readers to section viii of this proposed rule for our proposals to \n",
      "implement the information blocking provisions of the cures act, \n",
      "including proposed sec.  171.103.\n",
      "    we do not, at this time, propose any associated maintenance of \n",
      "certification requirements for this condition of certification.\n",
      "2. assurances\n",
      "    the cures act requires that a health it developer, as a condition \n",
      "and maintenance of certification under the program, provide assurances \n",
      "to the secretary, unless for legitimate purposes specified by the \n",
      "secretary, that it will not take any action that constitutes \n",
      "information blocking as defined in section 3022(a) of the phsa, or any \n",
      "other action that may inhibit the appropriate exchange, access, and use \n",
      "of electronic health information (ehi). we propose to implement this \n",
      "condition of certification and accompanying maintenance of \n",
      "certification requirements in sec.  170.402. as a condition of \n",
      "certification requirement, a health it developer must comply with the \n",
      "condition as recited here and in the cures act. we refer readers to \n",
      "section viii of this proposed rule for the proposed reasonable and \n",
      "necessary activities specified by the secretary, which constitute the \n",
      "exceptions to the information blocking definition.\n",
      "    we also propose to establish more specific conditions and \n",
      "maintenance of certification requirements for a health it developer to \n",
      "provide assurances that it does not take any action that may inhibit \n",
      "the appropriate exchange, access, and use of ehi. these proposed \n",
      "requirements serve to provide further clarity under the program as to \n",
      "how health it developers can provide such broad assurances with more \n",
      "specific actions.\n",
      "a. full compliance and unrestricted implementation of certification \n",
      "criteria capabilities\n",
      "    we propose, as a condition of certification, that a health it \n",
      "developer must ensure that its health it certified under the onc health \n",
      "it certification program (program) conforms to the full scope of the \n",
      "certification criteria to which its health it is certified. this has \n",
      "always been an expectation of onc and users of certified health it and, \n",
      "importantly, a requirement of the program. we believe, however, that by \n",
      "incorporating this expectation and requirement as a condition of \n",
      "certification under the program, there would be assurances, and \n",
      "documentation via the ``attestations'' condition and maintenance of \n",
      "certification requirements proposed in sec.  170.406, that all health \n",
      "it developers fully understand their responsibilities under the \n",
      "program, including not to take any action with their certified health \n",
      "it that may inhibit the appropriate exchange, access, and use of ehi. \n",
      "to this point, certification criteria are designed and issued so that \n",
      "certified health it can support interoperability and the appropriate \n",
      "exchange, access, and use of electronic health information.\n",
      "\n",
      "[[page 7466]]\n",
      "\n",
      "    we propose that, as a complementary condition of certification, \n",
      "health it developers of certified health it must provide an assurance \n",
      "that they have made certified capabilities available in ways that \n",
      "enable them to be implemented and used in production environments for \n",
      "their intended purposes. more specifically, developers would be \n",
      "prohibited from taking any action that could interfere with a user's \n",
      "ability to access or use certified capabilities for any purpose within \n",
      "the scope of the technology's certification. such actions may inhibit \n",
      "the appropriate access, exchange, or use of ehi and are therefore \n",
      "contrary to this proposed condition of certification and the statutory \n",
      "provision that it implements. while such actions are already prohibited \n",
      "under the program (80 fr 62711), making these existing requirements \n",
      "explicit would ensure that health it developers are required to attest \n",
      "to them on a regular basis pursuant to the condition of certification \n",
      "proposed in sec.  170.406, which will in turn provide additional \n",
      "assurances to the secretary that developers of certified health it \n",
      "support and do not inhibit appropriate access, exchange, or use of ehi.\n",
      "    by way of example, actions that would violate this aspect of the \n",
      "proposed condition include failing to fully deploy or enable certified \n",
      "capabilities; imposing limitations (including restrictions) on the use \n",
      "of certified capabilities once deployed; or requiring subsequent \n",
      "developer assistance to enable the use of certified capabilities, \n",
      "contrary to the intended uses and outcomes of those capabilities (see \n",
      "80 fr 62711). the condition would also be violated were a developer to \n",
      "refuse to provide documentation, support, or other assistance \n",
      "reasonably necessary to enable the use of certified capabilities for \n",
      "their intended purposes (see 80 fr 62711). more generally, any action \n",
      "that would be likely to substantially impair the ability of one or more \n",
      "users (or prospective users) to implement or use certified capabilities \n",
      "for any purpose within the scope of applicable certification criteria \n",
      "would be prohibited by this condition (see 80 fr 62711). such actions \n",
      "may include imposing limitations or additional types of costs, \n",
      "especially if these were not disclosed when a customer purchased or \n",
      "licensed the certified health it (see 80 fr 62711).\n",
      "b. certification to the ``electronic health information export'' \n",
      "criterion\n",
      "    we propose, as a condition of certification requirement, that a \n",
      "health it developer that produces and electronically manages ehi must \n",
      "certify health it to the 2015 edition ``electronic health information \n",
      "export'' certification criterion in sec.  170.315(b)(10). we discuss \n",
      "the proposed ``electronic health information (ehi) export'' criterion \n",
      "in section iv.b.4 of this proposed rule. further, as a maintenance of \n",
      "certification requirement, we propose that a health it developer that \n",
      "produces and electronically manages ehi must provide all of its \n",
      "customers of certified health it with health it certified to the \n",
      "functionality included in sec.  170.315(b)(10) within 24 months of a \n",
      "subsequent final rule's effective date or within 12 months of \n",
      "certification for a health it developer that never previously certified \n",
      "health it to the 2015 edition, whichever is longer. consistent with \n",
      "these proposals, we also propose to amend sec.  170.550 to require that \n",
      "onc-acbs certify health it to the proposed 2015 edition ``ehi export'' \n",
      "when the health it developer of the health it presented for \n",
      "certification produces and electronically manages ehi.\n",
      "    as discussed in section iv.c.1 of this proposed rule, the \n",
      "availability of the capabilities in the proposed 2015 edition ``ehi \n",
      "export'' certification criterion to providers and patients would \n",
      "promote access, exchange, and use of ehi to facilitate health care \n",
      "providers in switching practices and health it systems and patients' \n",
      "electronic access to all their health information stored by a provider. \n",
      "as such, health it developers with health it certified to the proposed \n",
      "2015 edition ``ehi export'' certification criterion that is made \n",
      "available to its customers provides assurances that the developer is \n",
      "not taking actions that constitute information blocking or any other \n",
      "action that may inhibit the appropriate exchange, access, and use of \n",
      "ehi.\n",
      "c. records and information retention\n",
      "    we propose that, as a maintenance of certification requirement, a \n",
      "health it developer must, for a period of 10 years beginning from the \n",
      "date of certification, retain all records and information necessary \n",
      "that demonstrate initial and ongoing compliance with the requirements \n",
      "of the onc health it certification program. in other words, records and \n",
      "information should be retained starting from the date a developer first \n",
      "certifies health it under the program and applies separately to each \n",
      "unique health it module (or complete ehr, as applicable) certified \n",
      "under the program. this retention of records is necessary to verify \n",
      "health it developer compliance with program requirements, including \n",
      "certification criteria and conditions of certification. we believe that \n",
      "10 years is an appropriate period of time given that many users of \n",
      "certified health it participate in various cms programs, as well as \n",
      "other programs, that require similar periods of records retention. we \n",
      "also refer readers to section vii.d.3.c of this preamble for additional \n",
      "discussion of records access to information necessary to enforce the \n",
      "conditions and maintenance of certification.\n",
      "    in an effort to reduce administrative burden, we also propose, that \n",
      "in situations where applicable certification criteria are removed from \n",
      "the code of federal regulations before the 10 years have expired, \n",
      "records must only be kept for 3 years from the date of removal for \n",
      "those certification criteria and related program provisions unless that \n",
      "timeframe would exceed the overall 10-year retention period. this ``3-\n",
      "year from the date of removal'' records retention period also aligns \n",
      "with the records retention requirements for onc-acbs and onc-atls under \n",
      "the program.\n",
      "    we encourage comment on these proposals and whether the proposed \n",
      "requirements can provide adequate assurances that certified health it \n",
      "developers are demonstrating initial and ongoing compliance with the \n",
      "requirements of the program; and thereby ensuring that certified health \n",
      "it can support interoperability, and appropriate exchange, access, and \n",
      "use of ehi.\n",
      "d. trusted exchange framework and the common agreement--request for \n",
      "information\n",
      "    the cures act added section 3001(c)(9) to the phsa, which requires \n",
      "the national coordinator to work with stakeholders with the goal of \n",
      "developing or supporting a trusted exchange framework and a common \n",
      "agreement (collectively, ``tefca'') for the purpose of ensuring full \n",
      "network-to-network exchange of health information. section \n",
      "3001(c)(9)(b) outlines a process for establishing a tefca between \n",
      "health information networks (hins)--including provisions for the \n",
      "national coordinator, in collaboration with the nist, to provide \n",
      "technical assistance on implementation and pilot testing of the tefca. \n",
      "in accordance with section 3001(c)(9)(c), the national coordinator \n",
      "shall publish the tefca on its website and in the federal register, as \n",
      "well as annually publish on its website a directory of the hins that \n",
      "have adopted the common agreement and are capable of trusted exchange \n",
      "pursuant to the common agreement. the process, application, and \n",
      "construction of the\n",
      "\n",
      "[[page 7467]]\n",
      "\n",
      "tefca are further outlined in section 3001(c)(9)(d), including \n",
      "requiring that the secretary shall through notice and comment \n",
      "rulemaking, establish a process for hins that voluntarily adopt the \n",
      "tefca to attest to such adoption. we request comment as to whether \n",
      "certain health it developers should be required to participate in the \n",
      "tefca as a means of providing assurances to their customers and onc \n",
      "that they are not taking actions that constitute information blocking \n",
      "or any other action that may inhibit the appropriate exchange, access, \n",
      "and use of ehi. we would expect that such a requirement, if proposed in \n",
      "a subsequent rulemaking, would apply to health it developers that have \n",
      "a health it module(s) certified to any of the certification criteria in \n",
      "sec. sec.  170.315(b)(1), (c)(1) and (c)(2), (e)(1), (f), and (g)(9) \n",
      "through (11); and provide services for connection to health information \n",
      "networks (hins). these services could be routing ehi through a hin or \n",
      "responding to requests for ehi from a hin.\n",
      "    we have identified health it developers that certify health it to \n",
      "the criteria above because the capabilities included in the criteria \n",
      "support access and exchange of ehi. therefore, we believe such health \n",
      "it developers, as opposed to a health it developer that only supports \n",
      "clinical decision support (sec.  170.315(a)(9)) with its certified \n",
      "health it, would be best suited to participate in the trusted exchange \n",
      "framework and adhere to the common agreement. similarly, we believe \n",
      "that many such health it developers with the identified certified \n",
      "health it would be in position, and requested by customers, to provide \n",
      "connection services to hins. when such criteria are met (certified to \n",
      "the identified criteria above and actually providing connection \n",
      "services), participation in the trusted exchange framework and \n",
      "adherence to the common agreement are consistent with this condition \n",
      "and maintenance of certification as specified by the cures act, the \n",
      "intent of congress to establish widespread interoperability and \n",
      "exchange of health information without information blocking, and \n",
      "supports onc's responsibility, as established by the hitech act, to \n",
      "develop and support a nationwide health it infrastructure that allows \n",
      "for the electronic use and exchange of information. more specifically, \n",
      "by participating in the trusted exchange framework and adhering to the \n",
      "common agreement, these health it developers provide assurances that \n",
      "they are not taking actions that constitute information blocking or any \n",
      "other action that may inhibit the appropriate exchange, access, and use \n",
      "of ehi. for more information on the trusted exchange framework and \n",
      "common agreement, please visit: <a href=\"https://www.healthit.gov/topic/interoperability/trusted-exchange-framework-and-common-agreement\">https://www.healthit.gov/topic/interoperability/trusted-exchange-framework-and-common-agreement</a>.\n",
      "    in consideration of this request for comment, we welcome comment on \n",
      "the certification criteria we have identified as the basis for health \n",
      "it developer participation in the trusted exchange framework and \n",
      "adherence to the common agreement, other certification criteria that \n",
      "would serve as a basis for health it developer participation in the \n",
      "trusted exchange framework and adherence to the common agreement, and \n",
      "whether the current structure of the trusted exchange framework and \n",
      "common agreement are conducive to health it developer participation and \n",
      "in what manner.\n",
      "3. communications\n",
      "    the cures act requires that a health it developer, as a condition \n",
      "and maintenance of certification under the program, does not prohibit \n",
      "or restrict communication regarding the following subjects:\n",
      "    <bullet> the usability of the health information technology;\n",
      "    <bullet> the interoperability of the health information technology;\n",
      "    <bullet> the security of the health information technology;\n",
      "    <bullet> relevant information regarding users' experiences when \n",
      "using the health information technology;\n",
      "    <bullet> the business practices of developers of health information \n",
      "technology related to exchanging electronic health information; and\n",
      "    <bullet> the manner in which a user of the health information \n",
      "technology has used such technology.\n",
      "    we propose to implement this condition of certification and its \n",
      "requirements in sec.  170.403. the cures act placed no limitations on \n",
      "the protection of the communications delineated above (referred to \n",
      "hereafter as ``protected communications''). as such, we propose to \n",
      "broadly interpret the subject matter of communications that are \n",
      "protected from developer prohibition or restriction as well as the \n",
      "conduct of developers that implicate the protection afforded to \n",
      "communications by this condition of certification and discuss this \n",
      "proposed approach in detail below. while we propose to implement a \n",
      "broad general prohibition against developers imposing prohibitions and \n",
      "restrictions on protected communications, we also recognize that there \n",
      "are circumstances where it is both legitimate and reasonable for \n",
      "developers to limit the sharing of information about their products. as \n",
      "such, we propose to allow developers to impose prohibitions or \n",
      "restrictions on protected communications in certain narrowly defined \n",
      "circumstances. in order for a prohibition or restriction on a protected \n",
      "communication to be permitted, we propose that it must pass a two-part \n",
      "test. first, the communication that is being prohibited or restricted \n",
      "must not fall within a class of communication about which no \n",
      "restriction or prohibition would ever be legitimate or reasonable--such \n",
      "as communications required by law, made to a government agency, or made \n",
      "to a defined category of safety organizations--and which we refer to \n",
      "hereafter as ``communications with unqualified protection.'' second, to \n",
      "be permitted, a developer's prohibition or restriction must also fall \n",
      "within a prescribed category of circumstances for which we propose it \n",
      "is both legitimate and reasonable for a developer to limit the sharing \n",
      "of information about its products. this would be because of the nature \n",
      "of the relationship between the developer and the communicator or \n",
      "because of the nature of the information that is, or could be, the \n",
      "subject of the communication (referred to hereafter as ``permitted \n",
      "prohibitions and restrictions''). a restriction or prohibition that \n",
      "does not satisfy this two-part test will contravene this condition of \n",
      "certification. as discussed in more detail below, we propose that this \n",
      "two-part test strikes a reasonable balance between the need to promote \n",
      "open communication about health it and related business practices, and \n",
      "the need to protect the legitimate interests of health it developers \n",
      "and other entities.\n",
      "a. background and purpose\n",
      "    this condition of certification addresses industry practices that \n",
      "severely limit the ability and willingness of health it customers, \n",
      "users, researchers, and other stakeholders who use and work with health \n",
      "it to openly discuss and share their experiences and other relevant \n",
      "information about the performance of health it, including the ability \n",
      "of health it to exchange health information electronically. these \n",
      "practices result in a lack of transparency around health it that can \n",
      "contribute to and exacerbate patient safety risks, system security \n",
      "vulnerabilities, and product performance issues. as discussed below, \n",
      "these issues have been documented and reported on over a number of \n",
      "years.\n",
      "    the challenges presented by health it developer actions that \n",
      "prohibit or\n",
      "\n",
      "[[page 7468]]\n",
      "\n",
      "restrict communications have been examined for some time. the problem \n",
      "was identified in a 2012 report by the institute of medicine of the \n",
      "national academies (iom) entitled ``health it and patient safety: \n",
      "building safer systems for better care'' \\57\\ (iom report). the iom \n",
      "report stated that health care providers, researchers, consumer groups \n",
      "other health it users lack information regarding the functionality of \n",
      "health it.\\58\\ the iom report observed, relatedly, that many developers \n",
      "restrict the information that users can communicate about developers' \n",
      "products through nondisclosure clauses, confidentiality clauses, \n",
      "intellectual property protections, hold-harmless clauses, and other \n",
      "boilerplate contract language.\\59\\ importantly, the iom report found \n",
      "that such clauses discourage users from sharing information about \n",
      "patient safety risks related to health it, which significantly limits \n",
      "the ability of health it users to understand how health it impacts \n",
      "patient safety.\\60\\ the report stressed the need for health it \n",
      "developers to enable the free exchange of information regarding the \n",
      "experience of using their health it products, including the sharing of \n",
      "screenshots.\\61\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\57\\ iom (institute of medicine), health it and patient safety: \n",
      "building safer systems for better care (2012). available at <a href=\"http://www.nationalacademies.org/hmd/reports/2011/health-it-and-patient-safety-building-safer-systems-for-better-care.aspx\">http://www.nationalacademies.org/hmd/reports/2011/health-it-and-patient-safety-building-safer-systems-for-better-care.aspx</a>.\n",
      "    \\58\\ id, 195.\n",
      "    \\59\\ ibid.\n",
      "    \\60\\ ibid.\n",
      "    \\61\\ ibid.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    other close observers of health it have similarly noted that broad \n",
      "restrictions on communications can inhibit the communication of \n",
      "information about errors and adverse events.\\62\\ concerns have also \n",
      "been raised by researchers of health it products,\\63\\ who emphasize \n",
      "that confidentiality and intellectual property provisions in contracts \n",
      "often place broad and unclear limits on authorized uses of information \n",
      "related to health it, which in turn seriously impacts the ability of \n",
      "researchers to conduct and publish their research.\\64\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\62\\ see kathy kenyon, overcoming contractual barriers to ehr \n",
      "research, health affairs blog (october 14, 2015). available at \n",
      "<a href=\"http://healthaffairs.org/blog/2015/10/14/overcoming-contractual-barriers-to-ehr-research/\">http://healthaffairs.org/blog/2015/10/14/overcoming-contractual-barriers-to-ehr-research/</a>.\n",
      "    \\63\\ see hardeep singh, david c. classen, and dean f. sittig, \n",
      "creating an oversight infrastructure for electronic health record-\n",
      "related patient safety hazards, 7(4) journal of patient safety 169 \n",
      "(2011). available at <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3677059/\">https://www.ncbi.nlm.nih.gov/pmc/articles/pmc3677059/</a>.\n",
      "    \\64\\ kathy kenyon, overcoming contractual barriers to ehr \n",
      "research, health affairs blog (october 14, 2015). available at \n",
      "<a href=\"http://healthaffairs.org/blog/2015/10/14/overcoming-contractual-barriers-to-ehr-research/\">http://healthaffairs.org/blog/2015/10/14/overcoming-contractual-barriers-to-ehr-research/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the issue of health it developers prohibiting or restricting \n",
      "communications about health it has been the subject of a series of \n",
      "hearings by the senate committee on health, education, labor and \n",
      "pensions (help committee), starting in the spring of 2015. during \n",
      "several hearings, stakeholders emphasized the lack of transparency \n",
      "around the performance of health it in a live environment, noting that \n",
      "this can undermine a competitive marketplace, hinder innovation, and \n",
      "prevent improvements in the safety and usability of the technology.\\65\\ \n",
      "\\66\\ additionally, the help committee indicated serious concerns \n",
      "regarding the reported efforts of health it developers to restrict, by \n",
      "contract and other means, communications regarding user experience, \n",
      "including information relevant to safety and interoperability.\\67\\ when \n",
      "one senator asked a panel of experts--which included a health it \n",
      "developer--if there were any reasons for health it contracts to have \n",
      "confidentiality clauses restricting users of health information \n",
      "technology from discussing their experience of using the health it, all \n",
      "panel members agreed that such clauses should be prohibited.\\68\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\65\\ help 6/10/15 pg 12; available at <a href=\"https://www.gpo.gov/fdsys/pkg/chrg-114shrg25971/pdf/chrg-114shrg25971.pdf\">https://www.gpo.gov/fdsys/pkg/chrg-114shrg25971/pdf/chrg-114shrg25971.pdf</a>.\n",
      "    \\66\\ help 3/17/15 pg 47; available at <a href=\"https://www.gpo.gov/fdsys/pkg/chrg-114shrg93864/pdf/chrg-114shrg93864.pdf\">https://www.gpo.gov/fdsys/pkg/chrg-114shrg93864/pdf/chrg-114shrg93864.pdf</a>.\n",
      "    \\67\\ help 7/23/15 pg 13, pg 27; available at <a href=\"https://www.help.senate.gov/hearings/achieving-the-promise-of-health-information-technology-information-blocking-and-potential-solutions\">https://www.help.senate.gov/hearings/achieving-the-promise-of-health-information-technology-information-blocking-and-potential-solutions</a>.\n",
      "    \\68\\ help 7/23/15 pg 38; available at <a href=\"https://www.help.senate.gov/hearings/achieving-the-promise-of-health-information-technology-information-blocking-and-potential-solutions\">https://www.help.senate.gov/hearings/achieving-the-promise-of-health-information-technology-information-blocking-and-potential-solutions</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    prior to the help committee hearings described above, the issue of \n",
      "developers prohibiting and restricting communications about the \n",
      "performance of their health it was also addressed in house energy and \n",
      "commerce committee hearings when committee members heard testimony and \n",
      "held discussions related to the cures act.\\69\\ commentary by witnesses \n",
      "at the hearings emphasized the need to ensure that health it products \n",
      "are safe and encouraged the availability of information around health \n",
      "it products to improve quality and ensure patient safety.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\69\\ energy and commerce 7/17/14 pg 35; available at <a href=\"http://docs.house.gov/meetings/if/if16/20140717/102509/hhrg-113-if16-20140717-sd008.pdf\">http://docs.house.gov/meetings/if/if16/20140717/102509/hhrg-113-if16-20140717-sd008.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    developer actions that prohibit or restrict communications about \n",
      "health it have also been the subject of investigative reporting.\\70\\ a \n",
      "september 2015 report examined eleven contracts between health systems \n",
      "and major health it developers and found that, with one exception, all \n",
      "of the contracts protected large amounts of information from being \n",
      "disclosed, including information related to safety and performance \n",
      "issues.\\71\\ the report stated that broad confidentiality and \n",
      "intellectual property protection clauses were the greatest barriers to \n",
      "allowing the communication of information regarding potential safety \n",
      "issues and adverse events.\\72\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\70\\ d tahir, politico investigation: ehr gag clauses exist--\n",
      "and, critics say, threaten safety, politico, august 27, 2015.\n",
      "    \\71\\ ibid.\n",
      "    \\72\\ ibid.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    finally, onc has itself been made aware of health it developer \n",
      "contract language that purports to prohibit the disclosure of \n",
      "information about health it, including even a customer's or user's \n",
      "opinions and conclusions about the performance and other aspects of the \n",
      "technology. our extensive interactions with health care providers, \n",
      "researchers, and other stakeholders consistently indicate that such \n",
      "terms are not uncommon and that some developers may actively enforce \n",
      "them and engage in other practices to discourage communications \n",
      "regarding developers' health it products and related business \n",
      "practices.\n",
      "    this proposed condition of certification is needed to significantly \n",
      "improve transparency around the functioning of health it in the field. \n",
      "this will help ensure that the health it ultimately selected and used \n",
      "by health care providers and others functions as expected, is less \n",
      "likely to have safety issues or implementation difficulties, enables \n",
      "greater interoperability of health information, and more fully allows \n",
      "users to reap the benefits of health it utilization, including \n",
      "improvements in care and quality, and reductions in costs.\n",
      "b. condition of certification requirements\n",
      "i. protected communications and communicators\n",
      "    we propose that the protection afforded to communicators under this \n",
      "condition of certification would apply irrespective of the form or \n",
      "medium in which the communication is made. developers must not prohibit \n",
      "or restrict communications whether written, oral, electronic or by any \n",
      "other method if they concern protected communications, unless permitted \n",
      "otherwise by this condition of\n",
      "\n",
      "[[page 7469]]\n",
      "\n",
      "certification. similarly, this condition of certification does not \n",
      "impose any limit on the identity of the communicators that are able to \n",
      "benefit from the protection afforded, except that employees and \n",
      "contractors of a health it developer may be treated differently when \n",
      "making communications that are not afforded unqualified protection \n",
      "under sec.  170.403(a)(2)(i). this condition of certification is not \n",
      "limited to communications by health it customers (e.g., providers) who \n",
      "have contracts with health it developers. entities or individuals who \n",
      "enter into agreements with a developer in connection with the \n",
      "developer's health it--for example, a data analytics vendor who is \n",
      "required to sign a non-disclosure agreement before being granted access \n",
      "to the developer's health it--would also be covered by the protection \n",
      "afforded to communicators under this condition of certification. \n",
      "patients, health it researchers, industry groups, and health \n",
      "information exchanges would be able to make protected communications \n",
      "about the health it free of impermissible prohibitions or restrictions. \n",
      "similarly, the condition of certification would also extend to \n",
      "potential customers of health it who are provided with product or \n",
      "software demonstrations, irrespective of whether they proceed with the \n",
      "acquisition of the technology. examples of other protected \n",
      "communications include, but are not limited to:\n",
      "    <bullet> a post made to an online forum;\n",
      "    <bullet> the sharing of screenshots, subject to certain proposed \n",
      "restrictions on their general publication;\n",
      "    <bullet> an unattributed written review by a health it user;\n",
      "    <bullet> a quote given by a health care executive to a journalist;\n",
      "    <bullet> a presentation given at a trade show;\n",
      "    <bullet> a social media post;\n",
      "    <bullet> a product review posted on a video-sharing service such as \n",
      "youtube;\n",
      "    <bullet> the statements and conclusions made in a peer-reviewed \n",
      "journal; and\n",
      "    <bullet> private communications made between health it customers \n",
      "about the health it.\n",
      "ii. protected subject areas\n",
      "    the cures act (and sec.  170.403(a)(1)) identifies a list of \n",
      "subject areas about which developers cannot prohibit or restrict \n",
      "communications. these subject areas address health it performance and \n",
      "usability, health it security, and the business practices related to \n",
      "exchanging ehi. for the reasons discussed below, we propose that the \n",
      "terms used to describe the subject areas should be construed broadly, \n",
      "consistent with the scope of communications that congress specified in \n",
      "the act. we encourage comment on whether the types of subject matter we \n",
      "identify below are adequate to protect the full range of communications \n",
      "contemplated by the cures act.\n",
      "(a) usability of health information technology\n",
      "    the term ``usability'' is not defined in the cures act nor in any \n",
      "other relevant statutory provisions. in the national institute of \n",
      "standards and technology (nist) usability initiative, nist describes \n",
      "``usability'' of health it by referencing the iso \\73\\ standard, \n",
      "iso9241: usability is ``the extent to which a product can be used by \n",
      "specified users to achieve specified goals with effectiveness, \n",
      "efficiency and satisfaction in a specified context of use.'' \\74\\ \n",
      "separately, himss \\75\\ has recognized the following principles of \n",
      "software usability: simplicity; naturalness; consistency; forgiveness \n",
      "and feedback; effective use of language; efficient interactions; \n",
      "effective information presentation; preservation of context; and \n",
      "minimize cognitive load.\\76\\ as these organizations have expressed, \n",
      "there are a multitude of factors that contribute to any judgment about \n",
      "``usability,'' and any assessment about the usability of health it \n",
      "should appropriately rest on the factors contributing to the \n",
      "effectiveness, efficiency, and performance offered. as such, we propose \n",
      "that the ``usability'' of health it be construed broadly to include \n",
      "both an overall judgment on the ``usability'' of a particular health it \n",
      "product, as well as any factor that contributes to usability. factors \n",
      "of usability that could be the subject of protected communications \n",
      "include, but are not limited to: the user interface (i.e., what a user \n",
      "sees on the screen, such as layout, controls, graphics and navigational \n",
      "elements); ease of use (e.g., how many clicks); how the technology \n",
      "supports users' workflows; the organization of information; cognitive \n",
      "burden; cognitive support; error tolerance; clinical decision support; \n",
      "alerts; error handling; customizability; use of templates; mandatory \n",
      "data elements; the use of text fields; and customer support.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\73\\ the international organization for standardization (iso) is \n",
      "an international standard-setting organization that develops, \n",
      "publishes, and promotes proprietary, industrial, and commercial \n",
      "standards. for more information see <a href=\"https://www.iso.org/home.html\">https://www.iso.org/home.html</a>.\n",
      "    \\74\\ see <a href=\"https://www.nist.gov/programs-projects/health-it-usability\">https://www.nist.gov/programs-projects/health-it-usability</a>.\n",
      "    \\75\\ the healthcare information and management systems society \n",
      "(himss) is a not-for-profit organization that promotes the use of \n",
      "information technology in health care. for more information, see \n",
      "<a href=\"http://www.himss.org/\">http://www.himss.org/</a>.\n",
      "    \\76\\ see <a href=\"http://www.himss.org/what-ehr-usability\">http://www.himss.org/what-ehr-usability</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "(b) interoperability of health information technology\n",
      "    section 3000(9) of the phsa, as amended by the cures act, provides \n",
      "a definition of ``interoperability'' that describes a type of health it \n",
      "that demonstrates the necessary capabilities to be interoperable. for \n",
      "the purposes of this condition of certification, we propose that \n",
      "protected communications regarding the ``interoperability of health \n",
      "it'' would include communications about whether a health it product and \n",
      "associated developer business practices meet the interoperability \n",
      "definition described in section 3000(9) of the phsa, including \n",
      "communications about aspects of the technology or developer that fall \n",
      "short of the expectations found in that definition. this will include \n",
      "communications about the interoperability capabilities of health it and \n",
      "the practices of a health it developer that may inhibit the access, \n",
      "exchange, or use of ehi, including information blocking.\n",
      "(c) security of health it\n",
      "    the security of health information technology is primarily \n",
      "addressed under the hipaa security rule,\\77\\ which establishes national \n",
      "standards to protect individuals' electronic protected health \n",
      "information (ephi) that is created, received, maintained, or \n",
      "transmitted by a covered entity or business associate. covered entities \n",
      "and business associates must ensure the confidentiality, integrity, and \n",
      "availability of all such ephi; protect against any reasonably \n",
      "anticipated threats or hazards to the security or integrity of such \n",
      "information; and protect against any reasonably anticipated uses or \n",
      "disclosures of such information that are not permitted or required \n",
      "under the hipaa privacy rule.\\78\\ hipaa requires that health it \n",
      "developers, to the extent that they are business associates of hipaa-\n",
      "covered entities, implement appropriate administrative, physical, and \n",
      "technical safeguards to ensure the confidentiality, integrity, and \n",
      "security of ephi.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\77\\ 45 cfr part 160 and subparts a and c of part 164.\n",
      "    \\78\\ 45 cfr part 160 and subparts a and e of part 164.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we propose that the matters that fall within the topic of health it \n",
      "security should be broadly construed to include any safeguards, whether \n",
      "or not required by the security rule, that may be implemented (or not \n",
      "implemented) by a developer to ensure the confidentiality,\n",
      "\n",
      "[[page 7470]]\n",
      "\n",
      "integrity, and security of the wider set of ehi (including ephi), \n",
      "together with the health it product's performance regarding security. \n",
      "for example, a developer may not prohibit or restrict a potential \n",
      "communicator from communicating about, without limitation:\n",
      "    <bullet> the approach to security adopted for the health it at \n",
      "issue (e.g., architectural approach or authentication methodology);\n",
      "    <bullet> the resilience of the health it;\n",
      "    <bullet> identified security flaws in the developer's health it; or\n",
      "    <bullet> the response to cyber threats or security breaches by the \n",
      "developer.\n",
      "(d) user experiences\n",
      "    the phrase ``user experience'' is not defined in the cures act nor \n",
      "in any other relevant statutory provisions. we propose to afford these \n",
      "terms their ordinary meaning. to qualify as a ``user experience,'' the \n",
      "experience must be one that is had by a user of health it. however, \n",
      "beyond this, we do not propose to qualify the types of experiences that \n",
      "would receive protection under the condition on the basis of the ``user \n",
      "experience'' subject area. this reflects the great variety of \n",
      "experiences that users may have with health it and the often subjective \n",
      "nature of such experiences. thus, we believe that if the user had the \n",
      "experience, the experience is relevant.\n",
      "    to illustrate the breadth of potential user experiences that would \n",
      "be protected by this condition of certification, we propose that \n",
      "communications about ``relevant information regarding users' \n",
      "experiences when using the health it'' would encompass, for example, \n",
      "communications and information about a person or organization's \n",
      "experience acquiring, implementing, using, or otherwise interacting \n",
      "with health it. this includes experiences associated with the use of \n",
      "the health it in the delivery of health care, together with \n",
      "administrative functions performed using the health it. user \n",
      "experiences would also include the experiences associated with \n",
      "configuring and using the technology throughout implementation, \n",
      "training, and in practice. further, user experiences would include \n",
      "patients' and consumers' user experiences with consumer apps, patient \n",
      "portals, and other consumer-facing technologies. to be clear, a \n",
      "``relevant user experience'' includes any aspect of the health it user \n",
      "experience that could positively or negatively impact the effectiveness \n",
      "or performance of the health it.\n",
      "(e) manner in which a user has used health it\n",
      "    we propose that protected communications regarding the ``manner in \n",
      "which a user has used health it'' would encompass any information \n",
      "related to how the health it has been used in practice. this subject \n",
      "area largely overlaps with the matters covered under the ``user \n",
      "experience'' subject area but may include additional perspectives or \n",
      "details beyond those experienced by a user of health it. types of \n",
      "information that would fall within this subject area include but are \n",
      "not limited to:\n",
      "    <bullet> information about a work-around implemented to overcome an \n",
      "issue in the health it;\n",
      "    <bullet> customizations built on top of core health it \n",
      "functionality;\n",
      "    <bullet> the specific conditions under which a user used the health \n",
      "it, such as information about constraints imposed on health it \n",
      "functionality due to implementation decisions; and\n",
      "    <bullet> information about the ways in which health it could not be \n",
      "used or did not function as was represented by the developer.\n",
      "(f) business practices related to exchange\n",
      "    we propose that the subject matter of ``developer business \n",
      "practices related to exchanging electronic health information'' should \n",
      "be broadly construed to include developer policies and practices that \n",
      "facilitate the exchange of electronic health information, and developer \n",
      "policies and practices that impact the ability of health it to exchange \n",
      "health information. we further propose that the exchange of electronic \n",
      "health information encompasses the appropriate and timely sharing of \n",
      "electronic health information.\n",
      "    we propose that protected communications include, but are not \n",
      "limited to:\n",
      "    <bullet> the costs charged by a developer for products or services \n",
      "that support the exchange of electronic health information (e.g., \n",
      "interface costs, api licensing fees and royalties, maintenance and \n",
      "subscription fees, transaction or usage-based costs for exchanging \n",
      "information);\n",
      "    <bullet> the timeframes and terms on which developers will or will \n",
      "not enable connections and facilitate exchange with other technologies, \n",
      "individuals, or entities, including other health it developers, \n",
      "exchanges, and networks;\n",
      "    <bullet> the developer's approach to participation in health \n",
      "information exchanges and/or networks;\n",
      "    <bullet> the developer's licensing practices and terms as it \n",
      "relates to making available apis and other aspects of its technology \n",
      "that enable the development and deployment of interoperable products \n",
      "and services; and\n",
      "    <bullet> the developer's approach to creating interfaces with \n",
      "third-party products or services, including whether connections are \n",
      "treated as ``one off'' customizations, or whether similar types of \n",
      "connections can be implemented at a reduced cost.\n",
      "    importantly, we further propose that information regarding business \n",
      "practices related to exchanging electronic health information would \n",
      "include information about the switching costs imposed by a developer, \n",
      "as we are aware that the cost of switching health it is a significant \n",
      "factor impacting health care providers adopting the most exchange-\n",
      "friendly health it products that are available.\n",
      "iii. meaning of ``prohibit or restrict''\n",
      "    the terms ``prohibit'' and ``restrict'' are not defined in the \n",
      "cures act or in any other relevant statutory provisions. as discussed \n",
      "in detail below, communications can be prohibited or restricted through \n",
      "contractual terms or agreements (e.g., non-disclosure agreements, non-\n",
      "disparagement clauses) as well as through conduct, including punitive \n",
      "or retaliatory business practices that are designed to create powerful \n",
      "disincentives to engaging in communications about developers or their \n",
      "products. therefore, we propose that this condition of certification \n",
      "would not be limited to only formal prohibitions or restrictions (such \n",
      "as by means of contracts or agreements) and would encompass any conduct \n",
      "by a developer that would be likely to restrict a communication or \n",
      "class of communications protected by this condition, as discussed in \n",
      "detail below.\n",
      "    the conduct in question must have some nexus to the making of a \n",
      "protected communication or an attempted or contemplated protected \n",
      "communication. that is, conduct by a developer that may be perceived as \n",
      "intimidating or punitive would not implicate this condition of \n",
      "certification unless that conduct was designed to directly or \n",
      "indirectly influence the making of a protected communication. \n",
      "similarly, health it contracts may include terms that govern the manner \n",
      "in which the parties conduct themselves, and those terms would not \n",
      "implicate this condition of certification unless the operative effect \n",
      "of a term was to restrict or prohibit a protected communication. for \n",
      "abundant clarity, we note that the fact that a customer's health it \n",
      "product is not performing in the manner the customer expected, or in \n",
      "the manner\n",
      "\n",
      "[[page 7471]]\n",
      "\n",
      "that the developer promised, would not, in itself be evidence that the \n",
      "developer is engaging in conduct that restricts or prohibits a \n",
      "protected communication. rather, a nexus must exist between the alleged \n",
      "poor performance and the making of (or attempting or contemplating to \n",
      "make) a protected communication.\n",
      "    we note that contractual prohibitions or restrictions on \n",
      "communications can, in limited circumstances, be legitimate and serve \n",
      "an important role in protecting proprietary information and \n",
      "intellectual property that are essential for health it developers to \n",
      "innovate and compete. on this basis, we propose to permit certain types \n",
      "of prohibitions and restrictions, subject to strict conditions to \n",
      "ensure that they are narrowly tailored and do not restrict protected \n",
      "communications. these permitted prohibitions and restrictions are \n",
      "discussed in section vii.b.3.b.v below.\n",
      "(a) prohibitions or restrictions arising by way of contract\n",
      "    the principal way that health it developers can control the \n",
      "disclosure of information about their health it is through contractual \n",
      "prohibitions or restrictions. such prohibitions or restrictions can \n",
      "arise in contractual provisions that address, for example, \n",
      "confidentiality obligations, intellectual property protections, hold-\n",
      "harmless requirements, nondisclosure obligations, non-compete \n",
      "obligations, and publicity rights.\n",
      "    there are different ways that contractual prohibitions or \n",
      "restrictions arise. in some instances a contractual prohibition or \n",
      "restriction will be expressed, and the precise nature and scope of the \n",
      "prohibition or restriction will be explicit from the face of the \n",
      "contract or agreement. for example, a contract will say that the health \n",
      "it customer must not disclose screenshots of the health it. however, \n",
      "more often, a contract will impose prohibitions or restrictions in less \n",
      "precise terms. for example, a health it contract might use broad \n",
      "language when describing the information or materials that customers \n",
      "and users are forbidden from disclosing pursuant to a confidentiality \n",
      "clause, casting a vague net over the developer's ``proprietary'' \n",
      "information and purporting to cover information that may be neither \n",
      "confidential, secret, nor protected by law. a contract does not need to \n",
      "expressly prohibit or restrict a protected communication in order to \n",
      "have the effect of prohibiting or restricting that protected \n",
      "communication. the use of broad or vague language that obfuscates the \n",
      "types of communications that can and cannot be made may be treated as a \n",
      "prohibition or restriction if it has the effect of restricting \n",
      "legitimate communications about health it.\n",
      "    restrictions and prohibitions found in contracts used by developers \n",
      "to sell or license their health it products can apply to customers \n",
      "directly and can require that the customer ``flow-down'' obligations \n",
      "onto the customer's employees, contractors, and other individuals or \n",
      "entities that use or work with the developer's health it. such contract \n",
      "provisions would not comply with this condition of certification if \n",
      "they prohibit or restrict protected communications. prohibitions or \n",
      "restrictions on communications can also be found in separate \n",
      "nondisclosure agreements (ndas) that developers require their \n",
      "customers--and in some instances the users of the health it--to enter \n",
      "into in order to receive or access the health it. we propose that such \n",
      "agreements are covered by this condition of certification. finally, \n",
      "health it developers typically may require third-party contractors used \n",
      "by their customers (such as a data analytics vendor engaged by a health \n",
      "care provider to analyze the provider's data) to enter into a nda with \n",
      "the developer before commencing their contract activities. in some \n",
      "extreme cases, the employees of these third-party contractors are \n",
      "required to sign ndas in their personal capacities. these ndas \n",
      "typically include obligations that prohibit or restrict communications \n",
      "about the developer's health it products, and we propose that any such \n",
      "prohibitions or restrictions within the context of protected \n",
      "communications as defined here would be subject to this condition of \n",
      "certification.\n",
      "(b) prohibitions or restrictions that arise by way of conduct\n",
      "    we are aware that some health it developers engage in conduct that \n",
      "has the effect of prohibiting or restricting protected communications. \n",
      "this conduct may arise despite the developer's contract and/or business \n",
      "associate agreement being silent on, or even expressly permitting, the \n",
      "protected communication. the effect of such conduct can be significant, \n",
      "as health care providers are dependent on their health it developer in \n",
      "order to receive critical software updates or other maintenance \n",
      "services, and sometimes have little bargaining power. similarly, a \n",
      "third-party developer is dependent on a health it developer's \n",
      "authorization in order to perform work in connection with the \n",
      "developer's health it.\n",
      "    we propose that conduct that has the effect of prohibiting or \n",
      "restricting a protected communication would be subject to this \n",
      "condition of certification. we emphasize that, as discussed above, the \n",
      "conduct in question must have some nexus to the making of a protected \n",
      "communication or an attempted or contemplated protected communication. \n",
      "as such, developer conduct that was alleged to be intimidating, or \n",
      "health it performance that was perceived to be substandard, would not, \n",
      "in and of itself, implicate this condition of certification unless \n",
      "there was some nexus between the conduct or performance issue and the \n",
      "making of (or attempting or threatening to make) a protected \n",
      "communication. examples of conduct that could implicate this condition \n",
      "of certification include, but are not limited to:\n",
      "    <bullet> taking steps to enforce, including by threatening to \n",
      "enforce, a right arising under contract that contravenes this condition \n",
      "of certification.\n",
      "    <bullet> taking steps to enforce, including by threatening to \n",
      "enforce, a legal right that purports to prohibit or restrict a \n",
      "protected communication. this would include, for example, the making of \n",
      "threats, such as via a cease and desist letter, to a researcher who has \n",
      "made a protected communication.\n",
      "    <bullet> employing a technological measure (within the meaning of \n",
      "17 u.s.c. 1201) that a user would have to circumvent in order to make a \n",
      "protected communication, for example, a technological measure that a \n",
      "health it user would need to circumvent in order to take a screenshot \n",
      "of the developer's health it.\n",
      "    <bullet> discouraging the making of protected communications by:\n",
      "    [cir] making threats against a health care customer (e.g., by \n",
      "threatening to withhold the latest version of the developer's software) \n",
      "in response to the customer making or attempting to make a protected \n",
      "communication.\n",
      "    [cir] taking retaliatory action against a person or entity that has \n",
      "made a protected communication (e.g., withholding support, delaying the \n",
      "provider's adoption of a new software release, or removing a provider \n",
      "from the developer's ``preferred customer'' list).\n",
      "    <bullet> having policies that disadvantage persons or entities that \n",
      "make protected communications (e.g., a policy that bars a provider from \n",
      "qualifying for the developer's ``preferred customer'' list if it shares \n",
      "screenshots in a manner protected by this condition of certification).\n",
      "    <bullet> refusing to publish--or refusing to remove or delete--\n",
      "protected communications made in an online forum that the developer \n",
      "moderates or controls.\n",
      "\n",
      "[[page 7472]]\n",
      "\n",
      "    <bullet> causing the removal or deletion of a protected \n",
      "communication from any publication (e.g., a youtube copyright take-down \n",
      "notice that does not raise a legitimate copyright claim).\n",
      "iv. communications with unqualified protection\n",
      "    we propose, and discuss below, a narrow class of communications--\n",
      "consisting of five specific types of communications--that would receive \n",
      "unqualified protection from developer prohibitions or restrictions. \n",
      "with respect to communications with unqualified protection, a developer \n",
      "would be prohibited from imposing any prohibition or restriction. as \n",
      "discussed below, we propose that this narrow class of communications \n",
      "warrants unqualified protection because of the strength of the public \n",
      "policy interest being advanced by the communication and/or the \n",
      "sensitivity with which the identified recipient treats, and implements \n",
      "safeguards to protect the confidentiality and security of, the \n",
      "information received. a developer that imposes a prohibition or \n",
      "restriction on a communication with unqualified protection would fail \n",
      "the first part of the two-part test for allowable prohibitions or \n",
      "restrictions, and as such would contravene the condition of \n",
      "certification.\n",
      "(a) disclosures required by law\n",
      "    we propose that where a communication relates to subject areas \n",
      "enumerated in sec.  170.403(a)(1) and there are federal, state, or \n",
      "local laws that would require the disclosure of information related to \n",
      "health it, developers must not prohibit or restrict in any way \n",
      "protected communications made in compliance with those laws. we note \n",
      "that we expect that most health it contracts would allow for, or at the \n",
      "very least not prohibit or restrict, any communication or disclosure \n",
      "that is required by law, such as responding to a court or congressional \n",
      "subpoena, or a valid warrant presented by law enforcement. we further \n",
      "propose that if required by law, a potential communicator should not \n",
      "have to delay any protected communication under this condition of \n",
      "certification. furthermore, we propose that the reasonable limitations \n",
      "and prohibitions that are discussed below and permitted by sec.  \n",
      "170.403(a)(2) do not apply to these types of protected communications.\n",
      "(b) communicating information about adverse events, hazards, and other \n",
      "unsafe conditions to government agencies, health care accreditation \n",
      "organizations, and patient safety organizations\n",
      "    it is well established that there is a strong public interest in \n",
      "allowing open communication of information regarding health care \n",
      "hazards, adverse events, and unsafe conditions. given the central role \n",
      "played by health it in the delivery of care, information about health \n",
      "it is a critical component of any investigation into the cause of \n",
      "hazards, adverse events, or unsafe conditions. on the basis of this \n",
      "public policy interest alone, we propose there is an overwhelming \n",
      "interest in ensuring that all communications about health it that are \n",
      "necessary to identify patient safety risks, and to make health it \n",
      "safer, not be encumbered by prohibitions or restrictions imposed by \n",
      "health it developers that may affect the extent or timeliness of \n",
      "communications. in addition to the public policy interest in promoting \n",
      "uninhibited communications about health it safety, the recognized \n",
      "communication channels for adverse events, hazards, and unsafe \n",
      "conditions provide protections that help ensure that any disclosures \n",
      "made are appropriately handled and kept confidential and secure. \n",
      "indeed, the class of recipients to which the information can be \n",
      "communicated under this category of communications with unqualified \n",
      "protection should provide health it developers with comfort that there \n",
      "is very little risk of such communications prejudicing the developer's \n",
      "intellectual property rights. for example, government agencies impose \n",
      "appropriate controls on information they receive, mitigating any risk \n",
      "that developers may feel arises from the disclosure of information \n",
      "about their health it. similarly, accrediting bodies for health care \n",
      "delivery observe strict confidentiality policies for information \n",
      "received or developed during the accreditation process and in \n",
      "connection with complaints received.\n",
      "    finally, the patient safety and quality improvement act of 2005 \n",
      "(psqia) \\79\\ provides for privilege and confidentiality protections for \n",
      "information that meets the definition of patient safety work product \n",
      "(pswp). this means that pswp may only be disclosed as permitted by the \n",
      "psqia and its implementing regulations. we clarify that to the extent \n",
      "activities are conducted in accordance with the psqia, its implementing \n",
      "regulation, and section 4005(c) of the cures act, no such activities \n",
      "shall be construed as constituting restrictions or prohibitions that \n",
      "contravene this condition of certification.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\79\\ patient safety and quality improvement act of 2005, 42 \n",
      "u.s.c. 299b-21-b-26 (pub. l. 109-41).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we understand that the nature of the information about health it \n",
      "that would ordinarily be disclosed by a health care provider when \n",
      "reporting an adverse event, hazard, or unsafe conditions to government \n",
      "agencies, health care accreditation organizations, and patient safety \n",
      "organizations, would not ordinarily contain intellectual property or \n",
      "trade secrets. notwithstanding this, in light of the public policy \n",
      "interest and established reporting mechanisms described above, we do \n",
      "not consider the potential inclusion of intellectual property or trade \n",
      "secrets in the communication should prohibit or restrict a health care \n",
      "provider from making a complete and timely report. for example, \n",
      "proposed sec.  170.403(a)(2)(ii)(d) permits developers to impose \n",
      "certain restrictions on the general publication of screenshots, but we \n",
      "do not consider that such restrictions should be permitted when the \n",
      "communication is made for one of the purposes, and to one of the \n",
      "recipients, identified in sec.  170.403(a)(2)(i)(b).\n",
      "    we seek comment on whether the unqualified protection afforded to \n",
      "communications made to a patient safety organizations about adverse \n",
      "events, hazards, and other unsafe conditions should be limited. \n",
      "specifically, we seek comment on whether the unqualified protection \n",
      "should be limited by the nature of the patient safety organization to \n",
      "which a communication can be made, or the nature of the communication \n",
      "that can made--such as limiting to only material that was created as \n",
      "pswp.\n",
      "(c) communicating information about cybersecurity threats and incidents \n",
      "to government agencies\n",
      "    we propose that if health it developers were to impose prohibitions \n",
      "or restrictions on the ability of any person or entity to communicate \n",
      "information about cybersecurity threats and incidents to government \n",
      "agencies, such conduct would not comply with this condition of \n",
      "certification. government agencies such as the united states computer \n",
      "emergency readiness team (us-cert) respond to and protect both the \n",
      "government and private industry from cyber threats. their work helps \n",
      "protect the entire health care system from cybersecurity threats and \n",
      "relies on the timely reporting of security issues and vulnerabilities \n",
      "by health care\n",
      "\n",
      "[[page 7473]]\n",
      "\n",
      "providers and health it users. these agencies impose appropriate \n",
      "controls on information they receive, which mitigates any risk that \n",
      "developers may feel arises from the disclosure of information about \n",
      "their health it. the us-cert, for example, provides secure forms for \n",
      "such reporting, and we are confident that reporting security incident \n",
      "information to us-cert and other government agencies would be unlikely \n",
      "to pose any threat to health it developer intellectual property or \n",
      "trade secrets. additionally, the information likely reported regarding \n",
      "such an incident would generally not reveal trade secrets. where \n",
      "circumstances may require collection of more sensitive and confidential \n",
      "information related to a developer's intellectual property, we believe \n",
      "that appropriate protections would likely apply and that the public \n",
      "benefit of thoroughly investigating and addressing cybersecurity issues \n",
      "outweighs any potential harm.\n",
      "    communications about security issues related to health it may alert \n",
      "nefarious individuals or entities to the existence of a security \n",
      "vulnerability which could be exploited before a developer has time to \n",
      "fix the vulnerability. however, we propose that this concern must be \n",
      "balanced against the imperative of ensuring that health it customers \n",
      "are aware of security vulnerabilities so that they can respond by \n",
      "deploying reactive measures independent of the developer, such as \n",
      "ceasing health information exchange with a compromised system. we seek \n",
      "comment on whether it would be reasonable to permit health it \n",
      "developers to impose limited restrictions on communications about \n",
      "security issues so as to safeguard the confidentiality, integrity, and \n",
      "security of ehi. for example, should health it developers be permitted \n",
      "to require that health it users notify the developer about the \n",
      "existence of a security vulnerability prior to, or simultaneously with, \n",
      "any communication about the issue to a government agency?\n",
      "(d) communicating information about information blocking and other \n",
      "unlawful practices to a government agency\n",
      "    as in the circumstances described above, we believe that the public \n",
      "benefit associated with the communication of information to government \n",
      "agencies on information blocking, or any other unlawful practice, \n",
      "outweighs any concerns developers might have about the disclosure of \n",
      "information about their health it. we believe that reporting \n",
      "information blocking, as well as other unlawful practices, to a \n",
      "government agency would not cause an undue threat to a health it \n",
      "developer's intellectual property or trade secrets. generally speaking, \n",
      "agencies collecting reports would protect all information received and \n",
      "keep it confidential to the extent permitted by law.\n",
      "(e) communicating information about a health it developer's failure to \n",
      "comply with a condition of certification or other program requirement\n",
      "    we propose that the benefits to the public and to users of health \n",
      "it of communicating information about a health it developer's failure \n",
      "to comply with a condition of certification or other program \n",
      "requirement (45 cfr part 170) justify prohibiting developers of health \n",
      "it from placing any restrictions on such protected communications. \n",
      "information regarding the failure of a health it product to meet any \n",
      "condition of certification or other program requirement is vital to the \n",
      "effective performance and integrity of the program, which certifies \n",
      "that health it functions consistent with its certification. while the \n",
      "current procedures for reporting issues with certified health it \n",
      "encourage providers to contact developers in the first instance to \n",
      "address certification issues, users of health it should not hesitate to \n",
      "contact onc-authorized certification bodies (onc-acbs), or onc itself, \n",
      "if the developer does not provide an appropriate response, or the \n",
      "matter is of a nature that should be immediately reported to an onc-acb \n",
      "or to onc.\n",
      "v. permitted prohibitions and restrictions\n",
      "    we propose that, except for communications with unqualified \n",
      "protection discussed above and enumerated in sec.  170.403(a)(2)(i), \n",
      "health it developers would be permitted to impose certain narrow kinds \n",
      "of prohibitions and restrictions discussed below and specified in sec.  \n",
      "170.403(a)(2)(ii). we believe this policy strikes a reasonable balance \n",
      "between the need to promote open communication about health it and \n",
      "related business practices and the need to protect the legitimate \n",
      "interests of health it developers and other entities. specifically, \n",
      "with the exception of communications with unqualified protection, \n",
      "developers would be permitted to prohibit or restrict the following \n",
      "communications, subject to certain conditions:\n",
      "    <bullet> communications of their own employees;\n",
      "    <bullet> disclosure of non-user-facing aspects of the software;\n",
      "    <bullet> certain communications that would infringe the developer's \n",
      "or another person's intellectual property rights;\n",
      "    <bullet> publication of screenshots in very narrow circumstances; \n",
      "and\n",
      "    <bullet> communications of information that a person or entity \n",
      "knows only because of their participation in developer-led product \n",
      "development and testing.\n",
      "    as discussed in detail in the sections that follow, the proposed \n",
      "condition of certification carefully delineates the circumstances under \n",
      "which these types of prohibitions and restrictions would be permitted, \n",
      "including certain associated conditions that developers would be \n",
      "required to meet. to be clear, any prohibition or restriction not \n",
      "expressly permitted would violate the condition. additionally, it would \n",
      "be the developer's burden to demonstrate to the satisfaction of onc \n",
      "that the developer has met all associated requirements. further, as an \n",
      "additional safeguard, we propose that where a developer seeks to avail \n",
      "itself of one of the permitted types of prohibitions or restrictions, \n",
      "the developer must ensure that potential communicators are clearly and \n",
      "explicitly notified about the information and material that can be \n",
      "communicated, and that which cannot. we propose this would mean that \n",
      "the language of health it contracts must be precise and specific. \n",
      "contractual provisions or public statements that support a permitted \n",
      "prohibition or restriction on communication should be very specific \n",
      "about the rights and obligations of the potential communicator. \n",
      "contract terms that are vague and cannot be readily understood by a \n",
      "reasonable health it customer will not benefit from the qualifications \n",
      "to this condition of certification outlined below.\n",
      "(a) developer employees and contractors\n",
      "    we recognize that health it developer employees, together with the \n",
      "entities and individuals who are contracted by health it developers to \n",
      "deliver products and/or services (such as consultants), may be exposed \n",
      "to highly sensitive, proprietary, and valuable information in the \n",
      "course of performing their duties. we also recognize that the proper \n",
      "functioning of a workforce depends, at least in part, on the ability of \n",
      "an employer to regulate how and when the organization communicates \n",
      "information to the public, and that employees owe confidentiality \n",
      "obligations to their employers. we propose that on this basis, \n",
      "developers are permitted to impose prohibitions or restrictions on the \n",
      "communications of employees and\n",
      "\n",
      "[[page 7474]]\n",
      "\n",
      "contractors to the extent that those communications fall outside of the \n",
      "class of communications with unqualified protection as discussed above.\n",
      "(b) non-user-facing aspects of health it\n",
      "    the purpose of this condition of certification is to ensure that \n",
      "health it users and other potential communicators are not restrained in \n",
      "their ability to communicate--publicly or privately--about certain \n",
      "protected subject areas. we propose that this purpose can generally be \n",
      "achieved without communicators disclosing information about those parts \n",
      "of health it that are legally protected trade secrets. as such, we \n",
      "propose this condition of certification will permit health it \n",
      "developers to impose prohibitions and restrictions on communications \n",
      "that are not communications with unqualified protection to the extent \n",
      "necessary to ensure that communications do not disclose ``non-user-\n",
      "facing aspects of health it.''\n",
      "    a ``non-user-facing aspect of health it'' is, for the purpose of \n",
      "this condition of certification, an aspect of health it that is not a \n",
      "``user-facing aspect of health it.'' a ``user-facing aspect of health \n",
      "it'' means those aspects of health it that that are disclosed and \n",
      "evident to anyone running, using, or observing the operation of health \n",
      "it. that is, a user-facing aspect of health it comprises those aspects \n",
      "of the health it that are manifest in how the health it software works. \n",
      "user-facing aspects of health it include the design concepts and \n",
      "functionality that is readily ascertainable from the health it's user \n",
      "interface and screen display. they do not include those parts of the \n",
      "health it that are not exposed to persons running, using, or observing \n",
      "the operation of the health it. we propose that non-user-facing aspects \n",
      "of health it would include source and object code, software \n",
      "documentation, design specifications, flowcharts, and file and data \n",
      "formats. we welcome comments on whether these and other aspects of \n",
      "health it should be treated as not being user-facing.\n",
      "    for clarity, we note that the terminology of ``user-facing aspects \n",
      "of health it'' is not intended to afford only health it users with \n",
      "specific protections against developer prohibitions or restrictions on \n",
      "communications. rather, the terminology is agnostic as to the identity \n",
      "of the communicator and is instead focused on describing those aspects \n",
      "of health it that are readily ascertainable from the health it's user \n",
      "interface and screen display. numerous other potential communicators \n",
      "will also be exposed to ``user-facing aspects of health it,'' such as \n",
      "third-party contractors, health information exchange organizations, \n",
      "recipients of a software demonstration, and trade groups or researchers \n",
      "that observe the operation of health it in the field.\n",
      "    we propose that this approach reasonably implements the cures act, \n",
      "which, in direct response to strict confidentiality obligations, broad \n",
      "intellectual property clauses, and non-disclosure provisions in ehr \n",
      "contracts, identified a list of protected subject areas for disclosure \n",
      "(enumerated at section 3001(c)(5)(d)(iii) of the phsa) that largely \n",
      "targeted the aspects of health it that are apparent to, and known by, \n",
      "individuals and entities that use or interact with health it. we \n",
      "propose that if a health it user were prohibited from describing the \n",
      "user-facing aspects of their health it product, they could not sensibly \n",
      "communicate useful information about the usability or interoperability \n",
      "of the product, or their experiences as a health it user. these subject \n",
      "areas are fundamentally tied to the way that the health it product \n",
      "works, its design, and its functionality.\n",
      "    protecting the communication of ``user-facing aspects of health \n",
      "it'' is also consistent with the treatment of software products under \n",
      "trade secret law, where the public-facing aspects of software products \n",
      "are not generally considered secret because they are evident to anyone \n",
      "running the software program. moreover, this approach is appropriate \n",
      "given the manner in which health it is deployed and used by health it \n",
      "customers. unlike software products that are deployed and used in a \n",
      "cloistered setting where access to the software is highly restricted, \n",
      "health it is typically deployed in a setting in which the operation of \n",
      "the health it can be readily observed by a wide range of persons. \n",
      "health it used in a physician's consulting room can be observed by the \n",
      "patient. health it deployed in a hospital can be observed by numerous \n",
      "individuals in addition to those who are ``authorized users'' of the \n",
      "health it system, including, for example, the patient, the patient's \n",
      "family, volunteer staff, law enforcement, and clergy. as such, because \n",
      "health it is of a nature that license terms or nondisclosure \n",
      "obligations do not act as a genuine control over the disclosure of \n",
      "those aspects of the software that are ``user-facing,'' communications \n",
      "about such aspects should be afforded protection from developer \n",
      "prohibitions and restrictions under this proposed condition of \n",
      "certification.\n",
      "(c) intellectual property\n",
      "    many aspects of health it--including software and documentation--\n",
      "will contain intellectual property that belongs to the health it \n",
      "developer (or a third party) and is protected by law. health it \n",
      "products may have portions in which copyrighted works exist, or that \n",
      "are subject to patent protection. as in other technology sectors, \n",
      "health it developers place a high value on their intellectual property \n",
      "and go to significant lengths to protect it, including intellectual \n",
      "property provisions in their health it contracts.\n",
      "    this condition of certification is not intended to operate as a de \n",
      "facto license for health it users and others to act in any way that \n",
      "might infringe the legitimate intellectual property rights of \n",
      "developers. indeed, we propose that health it developers are permitted \n",
      "to prohibit or restrict communications that would infringe their \n",
      "intellectual property rights so long as the communication in question \n",
      "is not a communication with unqualified protection. however, any \n",
      "prohibition and restriction imposed by a developer must be no broader \n",
      "than legally permissible and reasonably necessary to protect the \n",
      "developer's legitimate intellectual property interests. we are aware \n",
      "that some health it contracts contain broad intellectual property \n",
      "provisions (and related terms, such as nondisclosure provisions) that \n",
      "purport to prevent health it customers and users from using copyright \n",
      "material in ways that are lawful. on this basis, while we are providing \n",
      "an exception for the protection of intellectual property interests, we \n",
      "want to clarify that under this condition of certification health it \n",
      "developers are not permitted to prohibit or restrict, or purport to \n",
      "prohibit or restrict, communications that would be a ``fair use'' of \n",
      "any copyright work comprised in the developer's health it. that is, a \n",
      "developer is not permitted to prohibit or restrict communications under \n",
      "the guise of copyright protection (or under the guise of a \n",
      "confidentiality or non-disclosure obligation) when the communication in \n",
      "question makes a use of the copyright material in a way that would \n",
      "qualify that use as a ``fair use.'' \\80\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\80\\ see 17 u.s.c. 107.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we welcome comments on whether an appropriate balance has been \n",
      "struck between protecting legitimate intellectual property rights of \n",
      "developers and ensuring that health it customers, users, researchers, \n",
      "and other stakeholders who use and work with health it can openly \n",
      "discuss and share their experiences and other relevant\n",
      "\n",
      "[[page 7475]]\n",
      "\n",
      "information about the performance of health it.\n",
      "(d) faithful reproductions of health it screenshots\n",
      "    we propose that health it developers generally would not be \n",
      "permitted to prohibit or restrict communications that disclose \n",
      "screenshots of the developer's health it. we consider screen displays \n",
      "an essential component of health it performance and usability, and \n",
      "their reproduction may be necessary in order for a health it user or \n",
      "other health it stakeholder to properly make communications about the \n",
      "subject matters enumerated in sec.  170.403(a)(1). we acknowledge that \n",
      "some health it developers have historically and aggressively sought to \n",
      "prohibit the disclosure of such communications. we consider that \n",
      "developers may benefit from screen displays being faithfully reproduced \n",
      "so that health it users and other stakeholders can form an objective \n",
      "opinion on any question raised about usability in communications \n",
      "protected by this proposed condition of certification. moreover, we \n",
      "consider that the reproduction of screenshots in connection with the \n",
      "making of a communication protected by this condition of certification \n",
      "would ordinarily represent a ``fair use'' of any copyright subsisting \n",
      "in the screen display, and developers should not impose prohibitions or \n",
      "restrictions that would limit that fair use.\n",
      "    notwithstanding the above, we propose to permit certain \n",
      "prohibitions and restrictions on the communication of screenshots. \n",
      "except in connection with communications with unqualified protection, \n",
      "developers would be permitted to impose certain restrictions on the \n",
      "disclosure of screenshots, as described below.\n",
      "    in order to ensure that disclosures of screenshots are reasonable \n",
      "and represent a faithful reproduction of the developer's screen design \n",
      "and health it, we propose that developers would be permitted to prevent \n",
      "communicators from altering screenshots, other than to annotate the \n",
      "screenshot or to resize it for the purpose of publication. we consider \n",
      "this a reasonable limitation on the disclosure of screenshots and one \n",
      "that would help developers' health it avoid being misrepresented by \n",
      "communicators seeking to make a communication protected by this \n",
      "proposed condition of certification.\n",
      "    we also propose that health it developers could impose restrictions \n",
      "on the disclosure of a screenshot on the basis that it would infringe \n",
      "third-party intellectual property rights (on their behalf or as \n",
      "required by license). however, to take advantage of this exception, the \n",
      "developer would need to first put all potential communicators on \n",
      "sufficient written notice of those parts of the screen display that \n",
      "contain trade secrets or intellectual property rights and cannot be \n",
      "communicated, and would still need to allow communicators to \n",
      "communicate redacted versions of screenshots that do not reproduce \n",
      "those parts.\n",
      "    finally, we also recognize that health it developers may have \n",
      "obligations under hipaa as a business associate and that it would be \n",
      "reasonable for developers to impose restrictions on the communication \n",
      "of screenshots that contain protected health information, provided that \n",
      "developers permit the communication of screenshots that have been \n",
      "redacted to conceal protected health information, or the relevant \n",
      "individual's consent or authorization had been obtained.\n",
      "(e) testing and development\n",
      "    we are aware that some health it developers expose aspects of their \n",
      "health it to health care providers and others for the purpose of \n",
      "testing and development prior to a product's ``general availability'' \n",
      "release. such disclosures may relate to beta releases that are shared \n",
      "with certain customers for testing prior to the software being made \n",
      "generally available to the market, or may be made as part of a joint-\n",
      "venture or cooperative development process. in these circumstances, we \n",
      "propose that a health it developer would be justified in keeping \n",
      "information about its health it confidential, and we do not intend that \n",
      "the protection afforded to communicators under this condition of \n",
      "certification would allow disclosures of this information. this \n",
      "permitted prohibition or restriction would allow developers to seek \n",
      "appropriate intellectual property protection and freely discuss novel, \n",
      "``unreleased'' product features with their customer base, which has \n",
      "significant public policy benefits for research and innovation in the \n",
      "health it industry.\n",
      "    as with the other allowable restrictions listed above, we propose \n",
      "that this permitted restriction would be limited and does not apply to \n",
      "communications which are communications with unqualified protection as \n",
      "described above and specified in sec.  170.403(a)(2)(i). for example, \n",
      "information that is learned as part of development and testing, such as \n",
      "the hard-coding of test procedure processes that raise serious patient \n",
      "safety concerns, could be communicated for one of the limited purposes \n",
      "specified in sec.  170.403(a)(2)(i) if the software is certified or \n",
      "released to market. we propose that this permitted restriction would \n",
      "also not apply to communications about the released version of the \n",
      "health it once the health it has been released to market or has been \n",
      "certified, provided that the communications otherwise meet all other \n",
      "requirements to be afforded protection under this condition of \n",
      "certification and the information communicated could be discovered by \n",
      "any ordinary user of the health it.\n",
      "    for example, a health it developer and a large health system enter \n",
      "into an agreement for members of the health it developer's engineering \n",
      "team to work with members of the health system's clinical team to \n",
      "develop a customization for the system's use of the developer's ehr. in \n",
      "order to properly protect any intellectual property rights, or \n",
      "proprietary information, arising from this work, the developer and \n",
      "health system enter into a contract which imposes on the system and \n",
      "affected members of its clinical team strict nondisclosure related to \n",
      "testing and development of the health it. this would be reasonable and \n",
      "would not contravene this condition of certification, provided that: \n",
      "(1) the nondisclosure obligations were narrowly targeted toward the \n",
      "work product associated with the testing and development; and (2) the \n",
      "obligations ceased immediately upon any resultant software being \n",
      "deployed in the health system, to the extent that the information fell \n",
      "within one of the subject areas enumerated in sec.  170.403(a)(1) and \n",
      "would be apparent to an ordinary user of the health it.\n",
      "    to ensure that this permitted prohibition/restriction is not \n",
      "abused, such as by maintaining a product in beta release for an \n",
      "indefinite or lengthy period of time, we request comment on whether we \n",
      "should limit the time this protection would apply for testing purposes. \n",
      "this could be no longer than a year after release of a product or \n",
      "update. we also request comment on whether we should set specific \n",
      "parameters for covered testing. for example, we note above our \n",
      "expectations that a product would be shared with certain customers for \n",
      "testing prior to the software being made generally available to the \n",
      "market. as such, for this permitted prohibition/restriction to apply, \n",
      "should we more specifically limit the extent a product can be \n",
      "distributed to customers for testing purposes?\n",
      "\n",
      "[[page 7476]]\n",
      "\n",
      "c. maintenance of certification requirements\n",
      "    we propose that to maintain compliance with this condition of \n",
      "certification a health it developer must not establish or enforce any \n",
      "contract or agreement provision that contravenes this condition of \n",
      "certification. we are aware that some developers currently have in \n",
      "place health it contracts that contain provisions that contravene this \n",
      "proposed condition of certification because they impose impermissible \n",
      "prohibitions or restrictions on communications. in some instances, the \n",
      "provisions in question will be expressly at odds with this condition, \n",
      "imposing obligations on health it customers, or creating rights in \n",
      "favor of the developer, that prohibit or restrict communications that \n",
      "are protected. in other instances, a contract will include a provision \n",
      "that contravenes this condition because it has been drawn in such broad \n",
      "terms--such as an overly-expansive definition of confidential \n",
      "information--that a reasonable reader of the provision would consider \n",
      "the making of a communication protected by this condition a breach of \n",
      "the contract.\n",
      "    health it contracts are typically for a significant duration--e.g., \n",
      "5 years or more--or include an automatic renewal whereby the then \n",
      "current terms roll over for any renewal period. the implementation of \n",
      "this proposed condition of certification cannot therefore wait until \n",
      "health it contracts that contravene this condition expire in the \n",
      "ordinary course. as such, we are requiring that health it developers \n",
      "take immediate steps to become in compliance with this condition of \n",
      "certification.\n",
      "    we propose that a health it developer must notify all customers and \n",
      "those with which it has contracts/agreements, within six months of the \n",
      "effective date of a subsequent final rule for this proposed rule, that \n",
      "any communication or contract/agreement provision that contravenes this \n",
      "condition of certification will not be enforced by the health it \n",
      "developer. further, we propose that this notice would need to be \n",
      "provided annually up to and until the health it developer amends the \n",
      "contract or agreement to remove or make void any contractual provision \n",
      "that contravenes this condition of certification. we further propose as \n",
      "a maintenance of certification requirement in sec.  170.405(b)(2) that \n",
      "health it developers must amend their contracts or agreements to remove \n",
      "or make void any provisions that contravene the condition of \n",
      "certification within a reasonable period of time, but not later than \n",
      "two years from the effective date of a subsequent final rule for this \n",
      "proposed rule.\n",
      "    we believe this is an appropriate approach as we understand that \n",
      "health it developers are in regular contact with their customers, and \n",
      "so the provision of a notice that satisfies this requirement should not \n",
      "present an undue burden for a developer. we would also expect that \n",
      "developers have kept good records of nondisclosure agreements that they \n",
      "have entered into with other organizations or individuals, such as \n",
      "third-party developers, and can communicate with those organizations or \n",
      "individuals as necessary to satisfy this requirement. in the event that \n",
      "a health it developer cannot, despite all reasonable efforts, locate an \n",
      "entity or individual that previously entered into an agreement with the \n",
      "developer that prohibits or restricts communications protected by this \n",
      "condition, the developer would not be in contravention of this \n",
      "condition so long as it takes no step to enforce the prohibition or \n",
      "restriction. for clarity, we do not propose that health it developers \n",
      "be required to furnish to onc or their onc-acb copies of notices made \n",
      "to customers, or copies of contracts or agreements revised, in \n",
      "satisfaction of this maintenance of certification requirement, although \n",
      "those communications may be requested by onc or an onc-acb in the usual \n",
      "course of business. to this point, under the ``enforcement'' section of \n",
      "this proposed rule (vii.d), we describe our general enforcement \n",
      "approach outlining a corrective action process for onc to review \n",
      "instances where conditions and maintenance of certification \n",
      "requirements are not being met by a health it developer under the \n",
      "program.\n",
      "    we note that another approach we considered proposing would have \n",
      "been to require that developers amend their current health it contracts \n",
      "immediately. we have, however, relied on the proposed requirement that \n",
      "developers not enforce contractual terms that contravene this proposed \n",
      "condition of certification until they can amend their contracts in a \n",
      "reasonable period of time, but not later than two years from the \n",
      "effective date of a subsequent final rule for this proposed rule. we \n",
      "seek comment on whether this is an adequate approach to removing \n",
      "prohibitions and restrictions on protected communications and ensuring \n",
      "that health it customers, users, researchers, and other stakeholders \n",
      "are aware of their right to engage in such communications \n",
      "notwithstanding existing contracts or agreements to the contrary.\n",
      "4. application programming interfaces\n",
      "    as a condition of certification (and maintenance thereof) under the \n",
      "program, the cures act requires health it developers to publish apis \n",
      "that allow ``health information from such technology to be accessed, \n",
      "exchanged, and used without special effort through the use of apis or \n",
      "successor technology or standards, as provided for under applicable \n",
      "law.'' the cures act's api condition of certification also states that \n",
      "a developer must, through an api, ``provide access to all data elements \n",
      "of a patient's electronic health record to the extent permissible under \n",
      "applicable privacy laws.''\n",
      "    the cures act's api condition of certification includes several key \n",
      "phrases and requirements for health it developers that go beyond just \n",
      "the technical functionality of the products they present for \n",
      "certification. in this section of the preamble we outline our proposals \n",
      "to implement the cures act's api condition of certification in order to \n",
      "provide compliance clarity for health it developers.\n",
      "    these proposals include new standards, new implementation \n",
      "specifications, and a new certification criterion as well as detailed \n",
      "conditions and maintenance of certification requirements. we also \n",
      "propose to modify the base ehr definition. we note that health it \n",
      "developers should also consider these proposals in the context of what \n",
      "could warrant review from an information blocking perspective in so far \n",
      "as action (or inaction) that would be inconsistent with this proposed \n",
      "rule's api conditions and maintenance of certification requirements.\n",
      "a. statutory interpretation and api policy principles\n",
      "    one of the most significant phrases in the cures act's api \n",
      "condition of certification concerns the deployment and use of apis \n",
      "``without special effort.'' specifically, the cures act requires health \n",
      "it developers to publish apis and allow health information from such \n",
      "technology ``to be accessed, exchanged, and used without special \n",
      "effort.'' in this context, we interpret the ``effort'' exerted (i.e., \n",
      "by whom) to be focused on the api users, which could include third-\n",
      "party software developers, the health care providers that acquired this \n",
      "api technology, and patients, health care providers, and payers that \n",
      "use apps/services that connect to api technology.\n",
      "    as we considered the meaning and context associated with the phrase \n",
      "``without special effort'' and what\n",
      "\n",
      "[[page 7477]]\n",
      "\n",
      "would make apis included in certified health it truly ``open,'' we \n",
      "focused on key attributes that could be used to refine our \n",
      "interpretation and guide our proposals. we interpret ``without special \n",
      "effort'' to require that apis, and the health care ecosystem in which \n",
      "they are deployed, have three attributes: standardized, transparent, \n",
      "and pro-competitive. each of these attributes is briefly described in \n",
      "more detail below and all of our subsequent proposals address one or a \n",
      "combination of these attributes.\n",
      "    <bullet> standardized--meaning that all health it developers \n",
      "seeking certification would have to implement the same technical api \n",
      "capabilities in their products (using modern, computing standards such \n",
      "as restful interfaces and xml/json). technical consistency and \n",
      "implementation predictability are fundamental to scale api-enabled \n",
      "interoperability and reduce the level of custom development and costs \n",
      "necessary to access, exchange, and use health information. further, \n",
      "from a regulatory standpoint, health it developers would gain certainty \n",
      "in regards to pre-certification testing requirements and post-\n",
      "certification ``real world testing'' expectations. equally, from an \n",
      "industry standpoint, a consistent and predictable set of api functions \n",
      "would provide the health it ecosystem with known technical requirements \n",
      "against which ``app'' developers and other innovative services can be \n",
      "built.\n",
      "    <bullet> transparent--meaning that all health it developers seeking \n",
      "certification would need to make the specific business and technical \n",
      "documentation necessary to interact with the apis in production freely \n",
      "and publicly accessible. such transparency and openness is commonplace \n",
      "in many other industries and has fueled innovation, growth, and \n",
      "competition.\n",
      "    <bullet> pro-competitive--meaning that all health it developers \n",
      "seeking certification would need to abide by business practices that \n",
      "promote the efficient access, exchange, and use of ehi to support a \n",
      "competitive marketplace that enhances consumer value and choice. \n",
      "moreover, health care providers should have the sole authority and \n",
      "autonomy to unilaterally permit third-party software developers to \n",
      "connect to the api technology they have acquired. in other words, \n",
      "health it developers must not interfere with a health care provider's \n",
      "use of their acquired api technology in any way, especially ways that \n",
      "would impact its equitable access and use based on (for example) \n",
      "another software developer's size, current client base, or business \n",
      "line. it also means that developers (together with health care \n",
      "providers that deploy apis) are accountable to patients who, as \n",
      "consumers of health care services, have paid for their care and the \n",
      "information generated from such care. thus, patients should be able to \n",
      "access their ehi via any api-enabled app they choose without special \n",
      "effort, including without incurring additional costs and without \n",
      "encountering access requirements that impede their ability to access \n",
      "their information in a persistent manner.\n",
      "b. key terms\n",
      "    to clearly convey the stakeholders on which our proposals focus and \n",
      "are meant to support, we propose to use the following terms to reflect \n",
      "these meanings and/or roles:\n",
      "    <bullet> the term ``api technology'' (with a lowercase ``t'') \n",
      "generally refers to the capabilities of certified health it that \n",
      "fulfill the api-focused certification criteria adopted or proposed for \n",
      "adoption at 45 cfr 170.315(g)(7) through (g)(11).\n",
      "    <bullet> ``api technology supplier'' refers to a health it \n",
      "developer that creates the api technology that is presented for testing \n",
      "and certification to any of the certification criteria adopted or \n",
      "proposed for adoption at 45 cfr 170.315(g)(7) through (g)(11). we \n",
      "propose to adopt this term in sec.  170.102.\n",
      "    <bullet> ``api data provider'' refers to the organization that \n",
      "deploys the api technology created by the ``api technology supplier'' \n",
      "and provides access via the api technology to data it produces and \n",
      "electronically manages. in some cases, the api data provider may \n",
      "contract with the api technology supplier to perform the api deployment \n",
      "service on its behalf. however, in such circumstances, the api data \n",
      "provider retains control of what and how information is disclosed and \n",
      "so for the purposes of this definition is considered to be the entity \n",
      "that deploys the api technology. we propose to adopt this term in sec.  \n",
      "170.102.\n",
      "    <bullet> ``api user''--refers to persons and entities that use or \n",
      "create software applications that interact with the apis developed by \n",
      "the ``api technology supplier'' and deployed by the ``api data \n",
      "provider.'' an api user includes, but is not limited to, third-party \n",
      "software developers, developers of software applications used by api \n",
      "data providers, patients, health care providers, and payers that use \n",
      "apps/services that connect to api technology. we propose to adopt this \n",
      "term in sec.  170.102.\n",
      "    we also use:\n",
      "    <bullet> the term ``(g)(10)-certified api'' for ease of reference \n",
      "throughout the preamble to refer to health it certified to the \n",
      "certification criterion proposed for adoption in 45 cfr 170.315(g)(10).\n",
      "    <bullet> the term ``app'' for ease of reference to describe any \n",
      "type of software application that would be designed to interact with \n",
      "the (g)(10)-certified apis. this generic term is meant to include, but \n",
      "not be limited to, a range of applications from mobile and browser-\n",
      "based to comprehensive business-to-business enterprise applications \n",
      "administered by third parties.\n",
      "c. proposed api standards, implementation specifications, and \n",
      "certification criterion\n",
      "    apis can be thought of as a set of commands, functions, protocols, \n",
      "and/or tools published by one software developer (``software developer \n",
      "a'') that enable other software developers (x, y, and z) to create \n",
      "programs and applications that interact with a's software without \n",
      "needing to know the ``internal'' workings of a's software. apis can \n",
      "facilitate more seamless access to health information and it is \n",
      "important to note for context that onc adopted three 2015 edition \n",
      "certification criteria that specified api capabilities for health it \n",
      "modules (criteria adopted in 45 cfr 170.315(g)(7), (g)(8), and (g)(9)). \n",
      "the following sections detail our proposals to adopt standards, \n",
      "implementation specifications, and a new api certification criterion. \n",
      "together, these proposals account for the technical requirements we \n",
      "propose to associate with the cures act's api condition of \n",
      "certification and are reinforced through the condition's policy \n",
      "proposals.\n",
      "i. proposed adoption of fhir dstu2 standard\n",
      "    overall, and on balance, we have structured our standards and \n",
      "implementation specifications proposals to best meet the health it \n",
      "industry where it is most prepared to comply today. as a result, we \n",
      "propose to adopt the hl7[supreg] fast healthcare interoperability \n",
      "resources (fhir[supreg]) standard as a foundational standard within our \n",
      "suite of proposals. specifically, we propose to adopt fhir draft \n",
      "standard for trial use (dstu) 2 (hereafter referred to as ``fhir \n",
      "release 2'') as a baseline standard conformance requirement. in so \n",
      "doing, we can work with industry to support a conformance testing \n",
      "infrastructure for a full suite of proposals focused on one fhir \n",
      "release (its associated implementation specifications) and \n",
      "complementary\n",
      "\n",
      "[[page 7478]]\n",
      "\n",
      "security and app registration protocols, compared to numerous \n",
      "versions.\\81\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\81\\ in october 2018, onc released a first version of a fhir \n",
      "testing tool visit here for more details: <a href=\"https://inferno.healthit.gov/\">https://inferno.healthit.gov/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the 2015 edition final rule did not include specific standards or \n",
      "implementation specifications to describe the way in which apis needed \n",
      "to be designed to meet sec.  170.315(g)(8). instead, we specified a \n",
      "functional certification criterion and encouraged the industry to \n",
      "coalesce around a standardized specification for its api functionality, \n",
      "such as the fhir standard. we did, however, require health it \n",
      "developers to make their technical api documentation publicly available \n",
      "and we subsequently made such information accessible via the chpl.\n",
      "    upon reviewing health it developers certified to sec.  \n",
      "170.315(g)(8), approximately 32% have published via the chpl that they \n",
      "are using fhir, specifically fhir release 2, as of mid- september 2018. \n",
      "additionally, nearly 51% of health it developers appear to be using a \n",
      "version of fhir and oauth 2.0 together. we also note that when viewed \n",
      "from the perspective of how many providers are served by these fhir \n",
      "implementers, we estimate that approximate 87% of hospitals and 57% of \n",
      "clinicians are served by developers with a fhir release 2 api and 87% \n",
      "of hospitals and 69% of clinicians are served by developers with a fhir \n",
      "api of any version. in the years since the 2015 edition final rule, \n",
      "industry stakeholders have made rapid progress to advance the fhir \n",
      "standard. this includes substantial investments in industry pilots, \n",
      "specification development led through the argonaut project \\82\\ \n",
      "production deployment of apis conformant to fhir release 2 following \n",
      "the argonaut specifications, and the support for fhir release 2 in \n",
      "apple's ios 11.3, which includes a new ``health records'' app for the \n",
      "iphone based on these specifications.\\83\\ therefore, the industry is \n",
      "well prepared and ready to adopt the fhir standard.\n",
      "    thus, we propose to adopt fhir release 2 as the baseline standard \n",
      "in a new api standards section of our rules at 45 cfr 170.215(a)(1). \n",
      "additionally, as discussed in further detail below, we reference fhir \n",
      "release 2 for use in the new api certification criterion proposed for \n",
      "adoption in sec.  170.315(g)(10).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\82\\ <a href=\"http://argonautwiki.hl7.org/index.php?title=main_page\">http://argonautwiki.hl7.org/index.php?title=main_page</a>.\n",
      "    \\83\\ <a href=\"https://www.apple.com/newsroom/2018/01/apple-announces-effortless-solution-bringing-health-records-to-iphone/\">https://www.apple.com/newsroom/2018/01/apple-announces-effortless-solution-bringing-health-records-to-iphone/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    although fhir release 3 is published and some health it developers \n",
      "have included varied support for it in their product(s) at this time, \n",
      "there is limited evidence that its production deployment is as \n",
      "widespread as fhir release 2. thus, we believe that fhir release 2 is \n",
      "the most appropriate version to propose to adopt as part of proposed \n",
      "sec.  170.315(g)(10)'s conformance requirements. this approach would \n",
      "provide a stable and consistent direction in which the industry can go \n",
      "when it comes to deploying (g)(10)-certified apis that support data \n",
      "access to the uscdi. fhir release 2 best reflects the industry's \n",
      "current maturity and implementation readiness, it has been more \n",
      "rigorously tested, and it is largely implemented in most 2015 edition \n",
      "health it systems that have and are being deployed in production. thus, \n",
      "the incremental burden for many health it developers to get certified \n",
      "to the proposed criterion in sec.  170.315(g)(10) would be largely \n",
      "limited to the added security and registration conformance requirements \n",
      "we have proposed to include. we recognize, however, that some health it \n",
      "developers certified to sec.  170.315(g)(8) chose not to use fhir and \n",
      "will have more substantial changes to make in order to meet this \n",
      "proposal.\n",
      "    additionally, fhir release 4 has now been published \\84\\ and \n",
      "updated associated implementation specifications are expected to \n",
      "follow. fhir release 4 has several key improvements, including certain \n",
      "foundational aspects in the standard and ``fhir resources'' designated \n",
      "as ``normative'' for the first time. this will lead to acycle of more \n",
      "mature us fhir core profiles aligned with release 4 and additional \n",
      "implementation guidance that explicitly specifies how to handle \n",
      "populations of patient data (batch exports) via fhir to more \n",
      "efficiently enable population and learning health system-oriented \n",
      "services. likewise, from an industry update trajectory, we believe that \n",
      "fhir release 4's normative resources will be compelling from a maturity \n",
      "and stability perspective such that many health it developers will \n",
      "either rapidly progress to fhir release 4 from release 3 or skip wide-\n",
      "scale production deployment of fhir release 3 altogether, making fhir \n",
      "release 4 the next de facto version the industry would move toward and \n",
      "coalesce behind.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\84\\ <a href=\"http://blog.hl7.org/hl7-publishes-fhir-release-4\">http://blog.hl7.org/hl7-publishes-fhir-release-4</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    given fhir release 4's public release and that the industry will \n",
      "begin to implement release 4 in parallel with this rulemaking, we \n",
      "request comment on the following options we could pursue for a final \n",
      "rule.\n",
      "    option 1 (proposed in regulation text): adopt just fhir release 2 \n",
      "for reference in proposed sec.  170.315(g)(10). this option would \n",
      "require health it developers seeking certification to build, test, and \n",
      "certify systems solely to fhir release 2 and its associated \n",
      "implementation specifications. under this option, if the national \n",
      "coordinator approved the use of fhir release 3 or 4 (pursuant to the \n",
      "standards version advancement process) it would occur, at the earliest, \n",
      "one year after a final rule was issued. given that timing, and the \n",
      "compliance deadlines proposed later in this section, it would mean that \n",
      "health it developers would have no option but to develop to fhir \n",
      "release 2 in order to meet the proposed compliance deadlines.\n",
      "    option 2: adopt fhir release 2 and fhir release 3 in order to \n",
      "introduce optionality into how health it developers are able to \n",
      "demonstrate compliance with proposed sec.  170.315(g)(10). in other \n",
      "words, by adopting and referencing both fhir release 2 and 3 in \n",
      "proposed sec.  170.315(g)(10) it would permit a health it developer to \n",
      "use either one to meet the criterion (i.e., both versions would not be \n",
      "required to be supported and demonstrating only one would be needed to \n",
      "meet certification). similarly, under this option, if the national \n",
      "coordinator approved the use of fhir release 4 (pursuant to the \n",
      "standards version advancement process) it would occur, at the earliest, \n",
      "one year after a final rule was issued. given that timing, and the \n",
      "compliance deadlines proposed later in this section, it would mean that \n",
      "health it developers would have no option but to develop to fhir \n",
      "release 2 or release 3 in order to meet the proposed compliance \n",
      "deadlines.\n",
      "    option 3: adopt fhir release 2 and fhir release 4 in order to \n",
      "introduce flexibility into how health it developers are able to \n",
      "demonstrate compliance with proposed sec.  170.315(g)(10). the full \n",
      "implementation of this option would depend on all applicable \n",
      "corresponding fhir release 2 implementation specifications also being \n",
      "published in their fhir release 4 formats and available prior to the \n",
      "issuance of a final rule. provided these fhir release 4 implementation \n",
      "specifications are published in time for a final rule, this option \n",
      "would appear to be the best near- and long-term option for the \n",
      "industry. we anticipate this being the case because it would let \n",
      "lagging health it developers catch up to the fhir release 2 baseline \n",
      "while at the same time enable leading health it developers to move \n",
      "directly and immediately to fhir release 4 as a means to meet proposed\n",
      "\n",
      "[[page 7479]]\n",
      "\n",
      "sec.  170.315(g)(10)'s compliance timelines. in other words, unlike \n",
      "options 1 and 2, the standards version advancement process would not be \n",
      "necessary and the trajectory of leading health it developers would be \n",
      "well supported by the certification criterion. we also request comment \n",
      "on a variant of option 3 that would include a pre-defined cut-over for \n",
      "the permitted use of and certification to fhir release 2. we note that \n",
      "if this variant were implemented as part of option 3, we would likely \n",
      "also need to add a maintenance of certification requirement in the \n",
      "final rule to establish an upgrade timeline to fhir release 4 for those \n",
      "health it developers who originally sought certification for fhir \n",
      "release 2. such a maintenance requirement would seem necessary in order \n",
      "to bring the industry into closer alignment with respect to a more up-\n",
      "to-date national baseline for fhir.\n",
      "    option 4: adopt solely fhir release 4 in the final rule for \n",
      "reference in proposed sec.  170.315(g)(10). this option would require \n",
      "health it developers seeking certification to build, test, and certify \n",
      "systems solely to fhir release 4 and its associated implementation \n",
      "specifications. again, provided all applicable fhir release 4 \n",
      "implementation specifications are published in time for a final rule, \n",
      "this option would appear to be a close preference to option 3 for \n",
      "industry. we believe this would be the case because by the time a final \n",
      "rule associated with these proposals is issued, it is likely that \n",
      "health it developers would have close to or over a year's worth of \n",
      "development experience with fhir release 4. as a result, many may be \n",
      "poised to introduce their first round of generally available fhir \n",
      "release 4 products into production. if onc were to offer certification \n",
      "to fhir release 2 (as in option 3) this flexibility could \n",
      "unintentionally delay the industry's transition to fhir release 4 and \n",
      "slow progress associated with fhir-based interoperability. the \n",
      "following compliance timeline example attempts to make this point \n",
      "clearer. if, for example, the final rule was effective january 2020, \n",
      "based on other proposals associated with the api conditions of \n",
      "certification, health it developers would have up to 2 years to rollout \n",
      "their (g)(10)-certified api technology, which would mean january 2022. \n",
      "at that point, fhir release 4 would have been published for nearly 3 \n",
      "years and fhir release 2 would have been published for nearly 6 years. \n",
      "without a pre-defined cut-over for fhir release 2 in option 3, that \n",
      "certification approach would permit fhir release 2 apis to be deployed \n",
      "in 2022 and used for an indeterminate period of time.\n",
      "    in preparing your comments, please fully review our proposed \n",
      "certification criterion in sec.  170.315(g)(10) and the accompanying \n",
      "conditions of certification attributed to the api-oriented \n",
      "certification criteria. notably, if we were to adopt another fhir \n",
      "release in a final rule as an alternative to fhir release 2 for the \n",
      "proposed api criterion in sec.  170.315(g)(10), then we would also \n",
      "adopt the applicable implementation specifications and fhir profiles \n",
      "(the us fhir core profiles) associated with the fhir release in order \n",
      "to support uscdi data access. we highly encourage stakeholders to \n",
      "express their perspective and explicitly note their preferred option in \n",
      "comments.\n",
      "ii. proposed adoption of associated fhir release 2 implementation \n",
      "specifications\n",
      "    our proposal to adopt the fhir standard alone, however, is \n",
      "insufficient to provide the level of consistent implementation that \n",
      "will be necessary to realize the ``without special effort'' provision \n",
      "in this condition of certification. fhir, much like other standards \n",
      "that are initially developed to be internationally applicable, requires \n",
      "additional implementation specifications in order to further constrain \n",
      "implementation choices and reflect us-based standards policies (such as \n",
      "the use of rxnorm for representing medications). in fhir, the \n",
      "additional constraints placed on ``base fhir resources'' are expressed \n",
      "through what are called ``fhir profiles.'' fhir profiles typically \n",
      "provide additional rules about which resource elements must be used and \n",
      "what additional elements have been added that are not part of the base \n",
      "fhir resource. this can include, but not be limited to, rules about \n",
      "which api features are used and how as well as rules about which \n",
      "terminologies are used in particular elements. the term ``profile'' is \n",
      "a general term that is used in the fhir standard to describe either an \n",
      "individual fhir resource, or an entire implementation specification \n",
      "consisting of multiple fhir resources. accordingly, we propose to adopt \n",
      "three implementation specifications that will establish a standardized \n",
      "baseline and further constrain api conformance to help assure that apis \n",
      "can be used ``without special effort.''\n",
      "    we propose to adopt in sec.  170.215(a)(2) an implementation \n",
      "specification that would list a set of base fhir resources that health \n",
      "it modules certified to the proposed criterion in sec.  170.315(g)(10) \n",
      "would need to support. we refer to this proposed initial set of fhir \n",
      "resources as the ``api resource collection in health'' or ``the arch.'' \n",
      "the arch would align with and be directed by the data policy specified \n",
      "in the proposed us core data for interoperability (uscdi) standard \n",
      "(discussed in section iv.b.1 of this proposed rule).\n",
      "    as a result, we propose to include 15 fhir resources in the arch's \n",
      "first version. based on prior industry efforts, including the argonaut \n",
      "project to map fhir resources to the previously defined common clinical \n",
      "data set (ccds), we know that the following 13 fhir resources map to \n",
      "and support the equivalent data classes specified in the uscdi: \n",
      "allergyintolerance; careplan; condition; device; diagnosticreport; \n",
      "goal; immunization; medication; medicationorder; medicationstatement; \n",
      "observation; patient; and procedure. we also propose to include, \n",
      "specifically for the patient resource that the ``patient.address'' and \n",
      "``patient.telecom'' elements must be supported as part of the patient \n",
      "resource. these elements are neither required in the base fhir resource \n",
      "or additional implementation specifications; however, they are \n",
      "necessary to align with the uscdi's data requirements. with respect to \n",
      "the device resource, we propose to require that the ``device.udi'' \n",
      "element follow the human readable representation of the unique device \n",
      "identifier (udi) found in the recommendation, guidance, and conformance \n",
      "requirements section of the ``hl7 version 3 cross paradigm \n",
      "implementation guide: medical devices and unique device identification \n",
      "(udi) pattern, release 1,'' a document hosted by hl7.\\85\\ developers \n",
      "would be held responsible only for the recommendation, guidance, and \n",
      "conformance requirements for hl7 fhir in the implementation guide and \n",
      "would not be held responsible for other requirements in the \n",
      "implementation guide specific to other standards, including \n",
      "requirements for hl7 version 2 and hl7 version 3. for clarity, these \n",
      "proposed requirements are part of the arch version 1 standard.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\85\\ <a href=\"http://www.hl7.org/implement/standards/product_brief.cfm?product_id=487\">http://www.hl7.org/implement/standards/product_brief.cfm?product_id=487</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in addition to these 13 fhir resources, we have included two \n",
      "additional fhir resources:\n",
      "    (1) the provenance resource; and (2) the documentreference resource \n",
      "to accommodate clinical notes. these additions would make for a total \n",
      "of 15 fhir resources to reflect the direction of the uscdi v1. with \n",
      "respect to clinical notes, we understand from our own\n",
      "\n",
      "[[page 7480]]\n",
      "\n",
      "analysis and technical discussions within hl7 that the fhir \n",
      "documentreference resource is best capable of handling the exchange of \n",
      "clinical notes. since the ccds was defined over two years ago, we have \n",
      "most frequently heard from provider stakeholders that access to \n",
      "``clinical notes'' is key, impactful, and highly desirable data that \n",
      "should be accessible via the c-cdas they exchange as well as via apis. \n",
      "while we realize the industry may need to develop additional \n",
      "implementation guidance to support clinical notes via fhir, we believe \n",
      "that including fhir resources in arch version 1 directly addresses the \n",
      "steady requests we have received from providers to include a focus on \n",
      "the access, exchange, and use of ``clinical notes'' as part of \n",
      "certification. thus, we propose to include the fhir documentreference \n",
      "resource in the arch to support clinical notes. we also clarify that \n",
      "the clinical note text included in this fhir resource would need to be \n",
      "represented in its ``raw'' text form. in other words, it would be \n",
      "unacceptable for the note text to be converted to another file or \n",
      "format (e.g., .docx, pdf) when it is provided as part of an api \n",
      "response. with respect to the provenance resource, we believe its \n",
      "inclusion in the arch is paramount to the long-term success and use of \n",
      "fhir-based apis. while c-cda's are often critiqued due to their \n",
      "relative ``length,'' the c-cda often represents the output of a \n",
      "clinical event and includes relevant context. the same will not always \n",
      "be true in an api-context. this is due to the fact that fhir-based apis \n",
      "make it significantly easier for apps to request specific data (e.g., \n",
      "just a patient's active medications). thus, it is equally important \n",
      "over the long-term that the industry not lose sight of the metadata \n",
      "(i.e., the who, what, when, where, why, and how) behind the data that \n",
      "was created. as a result, we believe that this early stage of fhir \n",
      "deployment is the best time for the industry to build in support for \n",
      "the provenance resource. otherwise, if we were to expand the arch in \n",
      "future years to include this fhir resource, we estimate that the \n",
      "developer burden and overall industry impact would be greater than \n",
      "building this support in ``from the start.'' specifically, and to \n",
      "remain consistent with the uscdi, we propose to require that the \n",
      "``provenance.recorded'' (for the author's time stamp) and \n",
      "``provenance.agent.actor'' (for the author and author's organization) \n",
      "elements be supported as part of the provenance resource.\n",
      "    over time, and as the uscdi is expanded, we also expect to update \n",
      "this implementation specification to expand the arch beyond these 15 \n",
      "fhir resources. equally, consistent with the maintenance of \n",
      "certification requirements described in section vii.b.5 of this \n",
      "proposed rule (the standards version advancement process proposals), \n",
      "which would permit health it developers to voluntarily implement and \n",
      "use a new version of an adopted standard or implementation \n",
      "specification so long as certain conditions are met including that the \n",
      "new version is approved by the national coordinator for use in \n",
      "certification through the standards version advancement process, health \n",
      "it developers would be able to update their certified health it to \n",
      "include (g)(10)-certified api access to a broader set of data once a \n",
      "new version of the arch is approved.\n",
      "    the next implementation specification for the fhir standard we \n",
      "propose to adopt in sec.  170.215(a)(3) is the argonaut data query \n",
      "implementation guide version 1 (argonaut ig), hosted by hl7.\\86\\ this \n",
      "implementation guide has been pilot tested and is now being implemented \n",
      "for production use by health it developers. notably, it specifies fhir \n",
      "profile constraints for 13 of the associated fhir resources we propose \n",
      "to include in the arch version 1 and these fhir profiles support the \n",
      "data included in the uscdi (v1).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\86\\ <a href=\"http://www.fhir.org/guides/argonaut/r2/\">http://www.fhir.org/guides/argonaut/r2/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the next implementation specification for the fhir standard we \n",
      "propose the secretary adopt in sec.  170.215(a)(4) is the specific \n",
      "portion of the argonaut ig that refers to the ``argonaut data query \n",
      "implementation guide server'' conformance requirements. while it could \n",
      "be implied through our proposed adoption of the argonaut ig that these \n",
      "conformance requirements would be included, we seek to make this an \n",
      "explicit requirement for the api certification criterion proposed in \n",
      "sec.  170.315(g)(10). conformance to this implementation specification \n",
      "is essential in order to ensure that all fhir servers are consistently \n",
      "configured to support the defined data queries and ``supported \n",
      "searches'' associated with each argonaut profiled fhir resource. for \n",
      "clarity, conformance testing would focus on and be limited to the \n",
      "``shall'' requirements. we also note that the argonaut data query \n",
      "implementation guide server includes conformance requirements for the \n",
      "``documentreference profile,'' which defines ``how a provider or \n",
      "patient can retrieve a patient's existing clinical document.'' this \n",
      "particular specification was produced in support of the 2015 edition \n",
      "certification criterion adopted in sec.  170.315(g)(9). as a result, we \n",
      "clarify that this specific portion of the server ig and conformance \n",
      "requirement would be out of scope for the purposes of proposed sec.  \n",
      "170.315(g)(10).\n",
      "    we have separately proposed the fhir standard and each of these \n",
      "implementation specifications so that the national coordinator may \n",
      "evaluate industry progress and make a unique or combined determination \n",
      "as to the appropriate time to approve for voluntary upgrade pursuant to \n",
      "the standards version advancement process discussed in more detail in \n",
      "section vii.b.5 as well as subsequently go through rulemaking to adopt \n",
      "a new version of: the fhir standard, the arch, implementation \n",
      "specifications that ``profile'' the resources in the arch, and \n",
      "implementation specifications for fhir server conformance capabilities. \n",
      "while the proposed implementation specifications relate to one another, \n",
      "they can also be updated independently of each other as time goes on. \n",
      "for instance, the national coordinator could approve a new version of \n",
      "the fhir standard ``release 5'' in the future in accordance with the \n",
      "standards version advancement process. in so doing, the national \n",
      "coordinator could leave the scope of the arch the same and update \n",
      "(necessarily) the implementation specifications for the fhir profiles \n",
      "and fhir server conformance requirements accordingly to align with the \n",
      "new fhir version. as an alternative example, the national coordinator \n",
      "could leave the fhir standard version the same and approve a new \n",
      "version of the arch to include more fhir resources.\n",
      "    we note that other federal agencies may be adopting the fhir \n",
      "standard and additional fhir implementation guides for their program \n",
      "requirements. we plan to coordinate with such other agencies to focus \n",
      "on strategic alignment among the fhir standard versions, applicable \n",
      "implementation guides, and use cases.\n",
      "iii. proposed adoption of standards and implementation specifications \n",
      "to support persistent user authentication and app authorization\n",
      "    to enable and support persistent user authentication and app \n",
      "authorization processes, we propose to adopt a standards and additional \n",
      "implementation specification for the fhir standard. first, we propose \n",
      "to adopt the ``openid connect core 1.0\n",
      "\n",
      "[[page 7481]]\n",
      "\n",
      "incorporating errata set 1'' standard in sec.  170.215(b) as it \n",
      "complements the smart application launch framework implementation guide \n",
      "release 1.0.0 \\87\\ (smart guide). the openid standard is typically \n",
      "paired with oauth 2.0 implementations and focuses on user \n",
      "authentication. second, we propose to adopt the smart guide in sec.  \n",
      "170.215(a)(5) as an additional implementation specification associated \n",
      "with the fhir standard. this guide is referenced by the argonaut ig and \n",
      "is generally being implemented by the health it community as a security \n",
      "layer with which fhir deployment is being combined (from both a fhir \n",
      "server and fhir application perspective). further, while the smart \n",
      "guide includes certain mandatory requirements, we believe three \n",
      "specific aspects are necessary to specifically require in order for \n",
      "certification to enable consistent industry-wide implementation.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\87\\ <a href=\"https://build.fhir.org/ig/hl7/smart-app-\">https://build.fhir.org/ig/hl7/smart-app-</a> launch/.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the smart guide specifies the use of ``refresh tokens'' as \n",
      "optional. we believe that this requirement is necessary in order to \n",
      "enable persistent access by apps, especially in a patient access \n",
      "context. thus, we propose to make their use mandatory with a minimum \n",
      "refresh token life of 3 months. while this technique would need to be \n",
      "supported for both types of api-enabled services we propose be \n",
      "supported through sec.  170.315(g)(10), we wish to emphasize that \n",
      "implementing refresh token support is directly intended to enable a \n",
      "patient's ``persistent access'' to their electronic health information \n",
      "without special effort (i.e., without having to frequently re-\n",
      "authenticate and re-authorize while using their preferred app). this \n",
      "proposal aligns with the industry developed security best practice \n",
      "guidelines for oauth 2.0 implementations, which require support for a \n",
      "short-lived ``access token'' and a long-lived ``refresh token'' that \n",
      "could be subsequently used by the app to obtain a new ``access token'' \n",
      "after the original ``access token'' expires. we believe this approach \n",
      "enhances the seamlessness of a patient's data access and reduces the \n",
      "``friction'' they would otherwise experience having to re-authenticate \n",
      "and re-authorize. at the same time, because the access token is short \n",
      "lived, this minimizes the risk of a patient's information being \n",
      "accessed by unauthorized users if for some reason the access token is \n",
      "compromised. the technical capabilities that we intend to explicitly \n",
      "test are referenced as part of the proposed api certification criterion \n",
      "in sec.  170.315(g)(10).\n",
      "    we also propose to require that the ``standalone launch'' and ``ehr \n",
      "launch'' requirements specified in the smart guide be supported. we \n",
      "believe that requiring api technology suppliers to demonstrate both of \n",
      "these capacities will help ensure greater standardization and ease of \n",
      "use among (g)(10)-certified apis. when a third-party ``app'' first \n",
      "connects to a fhir server, it often requires some contextual data to \n",
      "make the app more ``user friendly.'' this information could include \n",
      "things such as the most recent patient encounter or hospital visit. the \n",
      "contextual information depends on how the ``app'' is launched.\n",
      "    when an app is launched from ``outside of an ehr,'' such as from a \n",
      "patient's smartphone or web browser, then the app is considered to be \n",
      "launched in a ``standalone'' mode. in this mode, the app has to request \n",
      "that the fhir server provide appropriate contextual information, which \n",
      "can then be used to customize the app's display for the patient. the \n",
      "smart guide has standardized the information that such apps can request \n",
      "from fhir servers and defined it as ``standalone launch.''\n",
      "    in other contexts, apps can be launched from ``within the ehr.'' \n",
      "this is typically the case when a third-party app is integrated as part \n",
      "of an ehr technology. in this case, the app is considered to have been \n",
      "launched in the ``ehr'' mode. typically, when such an app is launched \n",
      "from within an ehr, the user (e.g., provider, nurse) has a patient's \n",
      "record ``open'' or ``active'' in the ehr and expects the app to \n",
      "directly open the same patient when it is launched. in order for this \n",
      "to happen, the app has to request that the fhir server provides \n",
      "information about the patient record that is currently ``open'' in the \n",
      "ehr. the smart guide has standardized this interaction and defined it \n",
      "as ``ehr launch.''\n",
      "iv. proposed adoption of a new api certification criterion in sec.  \n",
      "170.315(g)(10)\n",
      "proposal overview\n",
      "    to implement the cures act, we propose to adopt a new criterion in \n",
      "sec.  170.315(g)(10) to replace the certification criterion adopted in \n",
      "sec.  170.315(g)(8). currently, the criterion adopted in sec.  \n",
      "170.315(g)(8) focuses on a health it module's ability to provide api \n",
      "functionality that can respond with data for each of the data \n",
      "categories specified in the common clinical data set. moreover, its \n",
      "focus on read-access/response to requests for specific types of data \n",
      "most directly aligns with the api uses envisioned by industry \n",
      "stakeholders and the cures act, which is why we believe it is necessary \n",
      "and appropriate to replace sec.  170.315(g)(8). in contrast, we do not \n",
      "propose that it is necessary to replace the certification criteria \n",
      "adopted in sec.  170.315(g)(7) and (g)(9) because the former does not \n",
      "prescribe specific technical approaches (and can continue to be met as \n",
      "technology evolves) and the latter supports a discrete use case \n",
      "relative to an api function that responds with a c-cda.\n",
      "    we propose our approach to adopt a replacement for sec.  \n",
      "170.315(g)(8) that will provide clear regulatory compliance \n",
      "requirements for stakeholders because: (1) 2015 edition testing and \n",
      "certification to sec.  170.315(g)(8) will continue throughout this \n",
      "rulemaking; (2) presuming we adopt this (or a modified version of this) \n",
      "proposal in a final rule, it will be easier for the industry to \n",
      "distinguish compliance requirements between two separate certification \n",
      "criteria compared to a time/context-sensitive ``version'' of sec.  \n",
      "170.315(g)(8); and (3) sec.  170.315(g)(8) is currently specified in \n",
      "the base ehr definition so its replacement has compliance effects on \n",
      "health care providers participating in every program that requires the \n",
      "use of certified ehr technology, which references the base ehr \n",
      "definition.\n",
      "    at a high-level, we propose that this new api certification \n",
      "criterion would require fhir servers to support two types of api-\n",
      "enabled services:\n",
      "    <bullet> services for which a single patient's \\88\\ data is at \n",
      "focus; and\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\88\\ we recognize that individuals may not always be in an \n",
      "active role as a ``patient'' when they use an application to access \n",
      "their data. however, we believe it is clearer for the purposes of \n",
      "readability and policy intent to use the term ``patient'' as opposed \n",
      "to ``individual.''\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> services for which multiple patients' data are at focus, \n",
      "which, hereafter, we refer to as ``population-level'' to convey the \n",
      "grouped and cohort scope on which the data associated with these \n",
      "services would be focused (e.g., a specific provider's patient panel, \n",
      "all of the patients covered by a particular health plan, a group of \n",
      "patients cared for through an alternative payment model).\n",
      "    this proposed certification criterion would only require mandatory \n",
      "support for ``read'' access for both identified services, though we \n",
      "envision a future version of this certification criterion that could \n",
      "include specific ``write'' conformance requirements (for example, to \n",
      "aid decision support) once fhir-based apis are widely adopted. in all \n",
      "cases, this proposed criterion will require that the two types of api \n",
      "services have appropriate security controls implemented. these controls\n",
      "\n",
      "[[page 7482]]\n",
      "\n",
      "would ensure a user fully authenticates to the api-enabled data source \n",
      "to which the request is being made and that the user's software \n",
      "application is appropriately authorized to request specified data.\n",
      "    api services that focus on a single patient would include, but not \n",
      "be limited to, those that interact with software applications \n",
      "controlled and used by a patient to access their data as well as \n",
      "software applications implemented by a provider to enhance their own \n",
      "``internal'' clinical care tools and workflow (e.g., a specialized \n",
      "calculation app). most, if not all, of these types of interactions are \n",
      "typically orchestrated in a synchronous, real to near-real-time mode \n",
      "via apis.\n",
      "    conversely, api services that focus on multiple patients would \n",
      "include, but not be limited to, software applications used by a health \n",
      "care provider to manage various internal patient populations as well as \n",
      "external services a health care provider may contract for to support \n",
      "quality improvement, population health management, and cost \n",
      "accountability vis-[agrave]-vis the provider's partners (e.g., health \n",
      "plans). historically, access to this kind of computing has often been \n",
      "cumbersome, opaque, and required one-off scripting and significant \n",
      "engineering labor with no overarching standardized methods. by shifting \n",
      "this paradigm to a fhir-based api, we anticipate that the market will \n",
      "be able to respond with a new slate of innovative solutions.\n",
      "    across this spectrum of population-level uses, the scope or \n",
      "quantity of the data may range from a small group to many hundreds or \n",
      "thousands of patients. moreover, when ``external'' applications and \n",
      "services are provided access to patient data by the provider, we expect \n",
      "that such access and associated privacy and security protocols would be \n",
      "established consistent with existing legal requirements under the hipaa \n",
      "privacy and security rules (including business associate agreements), \n",
      "other data use agreements (as applicable), and any other state or \n",
      "federal applicable law. principally, for the purposes of the proposed \n",
      "certification criterion, we seek to include and ensure through testing \n",
      "and certification that a set of baseline api functionality exists and \n",
      "is deployed for providers to use at their discretion to support their \n",
      "own clinical priorities as well as to use to engage with their \n",
      "partners, such as software developers and developers of third-party \n",
      "applications.\n",
      "    we have explicitly proposed to include support for api services \n",
      "that are population-level focused in this certification criterion \n",
      "because the current certification criterion in sec.  170.315(g)(8) has \n",
      "largely been tested, certified, and deployed to support the ``patient \n",
      "data request'' use case. in comparison, population-level focused api \n",
      "services are envisioned to support fhir-based apps that not only \n",
      "improve clinical workflow and decision support but also help advance a \n",
      "learning health system. in so doing, providers, payers, and other \n",
      "stakeholders will be able to make incrementally better use of fhir's \n",
      "restful api and json payload to apply modern computing techniques, \n",
      "including big data analyses and machine learning, to account for, \n",
      "assess, and inform the quality and effectiveness of care delivered. as \n",
      "noted in the proposed api standards section, fhir release 4 includes \n",
      "technical specifications to enable standardized population-level \n",
      "services via fhir-based apis in a more efficient manner than currently \n",
      "possible. if ``option 3'' or ``option 4'' is preferred by industry in \n",
      "terms of the fhir standards options for this certification criterion, \n",
      "these approaches would be demonstrable. alternatively, if the national \n",
      "coordinator were to approve fhir release 4 for use under this proposed \n",
      "certification criterion (following the standards version advancement \n",
      "process described in section vii.b.5 of this preamble) then it would be \n",
      "able to be used to meet these technical expectations.\n",
      "    lastly, as we considered the necessary oversight responsibilities \n",
      "the cures act adds to the program, we have determined that it would be \n",
      "essential to include a specific population-level api conformance \n",
      "requirement as part of this criterion so that such capabilities could \n",
      "be evaluated post-certification for compliance with (among other \n",
      "requirements) this api condition of certification and the information \n",
      "blocking and real world testing conditions of certification.\n",
      "specific proposals\n",
      "    in general, we have approached framing sec.  170.315(g)(10) in the \n",
      "same way we framed sec.  170.315(g)(8). this new proposed criterion, \n",
      "however, includes some important differences and specificity compared \n",
      "to sec.  170.315(g)(8). taken together, the following proposals are \n",
      "designed to establish a consistent set of api implementation \n",
      "requirements aimed at the api condition of certification's ``without \n",
      "special effort'' requirement. we propose that api technology presented \n",
      "by a health it developer (otherwise considered an api technology \n",
      "supplier in this context) for testing and certification to the proposed \n",
      "certification criterion in sec.  170.315(g)(10) would need to meet the \n",
      "requirements outlined below. we seek comment on all of the following \n",
      "proposals.\n",
      "data response\n",
      "    we propose in sec.  170.315(g)(10)(i) that the health it presented \n",
      "for testing and certification must be capable of responding to requests \n",
      "for data on a single patient and multiple patients associated with each \n",
      "of the fhir resources specified in arch version 1 and consistent with \n",
      "fhir release 2 and the argonaut ig implementation specification. more \n",
      "specifically, we clarify that all data elements indicated as \n",
      "``mandatory'' and ``must support'' by the proposed standards and \n",
      "implementation specifications must be supported and would be in scope \n",
      "for testing. through this approach, certification will provide for a \n",
      "consistent and predictable starting scope of data from which apps and \n",
      "other services can be developed.\n",
      "search support\n",
      "    we propose to require in sec.  170.315(g)(10)(ii) that the health \n",
      "it presented for testing and certification must be capable of \n",
      "responding to all of the ``supported searches'' specified in the \n",
      "argonaut data query implementation guide server, which as a reminder we \n",
      "have proposed for adoption as an implementation specification in sec.  \n",
      "170.215(a)(4).\\89\\ given that there is not yet a consistent, \n",
      "standardized specification for fhir servers to handle searches for \n",
      "multiple patients, we clarify that a health it developer would be \n",
      "permitted to approach searches for multiple patients in the manner it \n",
      "deems most efficient to meet this proposed certification criterion. we \n",
      "note, consistent with the implementation specifications current scope, \n",
      "that conformance would focus on search associated with a single \n",
      "patient's data. however, we reiterate the health it presented for \n",
      "testing and certification and as implemented must support searches for \n",
      "multiple patients independent of a required standard for such searches.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\89\\ <a href=\"http://www.fhir.org/guides/argonaut/r2/conformance-server.html\">http://www.fhir.org/guides/argonaut/r2/conformance-server.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    for the documentreference and provenance resources, which are \n",
      "currently present in the base fhir standard, we request comments on the \n",
      "minimum ``search'' parameters that would need to be supported.\n",
      "\n",
      "[[page 7483]]\n",
      "\n",
      "app registration\n",
      "    we propose in sec.  170.315(g)(10)(iii) that health it presented \n",
      "for testing and certification must be capable of enabling apps to \n",
      "register with an ``authorization server.'' this proposed conformance \n",
      "requirement would require an api technology supplier to demonstrate its \n",
      "registration process, but would not require that it be done according \n",
      "to a specific standard. we considered proposing the oauth 2.0 dynamic \n",
      "client registration protocol (rfc 7591) standard (``dynamic \n",
      "registration'') as the only way to support registration for this \n",
      "certification criterion and request public comment on whether we should \n",
      "require its support as part of a final rule's certification criterion. \n",
      "for clarity, we note that while we have not explicitly required dynamic \n",
      "registration as the only way to demonstrate conformance with this \n",
      "specific portion of the certification criterion, api technology \n",
      "suppliers would still be allowed to use dynamic registration if they so \n",
      "choose.\n",
      "    while requiring dynamic registration could create a more consistent \n",
      "registration experience for health it developers, we did not expressly \n",
      "include this standard because of its relatively low adoption and \n",
      "implementation in the health it ecosystem. notably, while the smart \n",
      "guide covers a majority of technical steps necessary for an app to \n",
      "connect a fhir server, it is neutral on the registration process api \n",
      "technology suppliers could take. much like we did with sec.  \n",
      "170.315(g)(8) in the initial 2015 edition final rule by not requiring \n",
      "fhir, we believe that a prudent approach for registration is to require \n",
      "that it be addressed from a functional perspective while the industry \n",
      "reaches consensus on the best techniques to enable registration.\n",
      "    note, that while this portion of proposed sec.  170.315(g)(10) \n",
      "focuses on the technical standards conformance, we have also included a \n",
      "specific ``maintenance requirement'' associated with the api condition \n",
      "of certification around the timeliness of this registration process in \n",
      "production settings as applicable to api technology suppliers. this \n",
      "proposed requirement will ensure that patients are able to use their \n",
      "apps in a timely manner.\n",
      "    we do not intend to test registration capabilities for apps that \n",
      "would be executed within an api data provider's clinical environment. \n",
      "we believe this discretion is warranted as api technology suppliers and \n",
      "api data providers are best poised to innovate and execute various \n",
      "methods for app registration within a clinical environment. however, we \n",
      "request comment on this perspective.\n",
      "secure connection, authentication and authorization\n",
      "    we propose in sec.  170.315(g)(10)(iv) that the health it presented \n",
      "for testing and certification must be capable of establishing a secure \n",
      "and trusted connection with an application that requests patient data \n",
      "in accordance with the smart guide. in the context of this proposed \n",
      "criterion, this would require that an ``authorization server'' be \n",
      "deployed and support, at a minimum, ``authorize'' and ``token'' \n",
      "endpoints and the publication of the endpoint urls via fhir server's \n",
      "metadata as specified in the smart guide to enable automated discovery \n",
      "by apps. again, we note, consistent with this implementation \n",
      "specification's current scope, that initial conformance would focus on \n",
      "the secure connection parameters with a single patient's data in mind. \n",
      "given that there is not yet a consistent, standardized specification \n",
      "for fhir servers to handle secure connection parameters for multiple \n",
      "patients, we clarify that a health it developer would be permitted to \n",
      "approach secure connections for multiple patients in the manner it \n",
      "deems most efficient to meet this proposed certification criterion.\n",
      "    when an application connects to request data for the first time, we \n",
      "propose in sec.  170.315(g)(10)(v)(a) that health it presented for \n",
      "testing and certification must be capable of demonstrating support for \n",
      "user authentication according to the openid connect core 1.0 \n",
      "incorporating errata set 1 \\90\\ standard. it should be noted that the \n",
      "openid connect standard is agnostic to the actual authentication \n",
      "mechanism used by the health it while providing a standard way for \n",
      "health it to exchange the authentication information to the app. the \n",
      "primary benefit being that it lets apps verify the identity of the end-\n",
      "user based on the authentication performed by the authorization server \n",
      "without having the apps to take additional responsibility for \n",
      "authenticating the user. we also propose in sec.  170.315(g)(10)(v)(b) \n",
      "that health it presented for testing and certification must demonstrate \n",
      "that users can authorize applications (in the appropriate context) to \n",
      "access data in accordance with the smart guide. pursuant to this \n",
      "proposed implementation specification described above, we also intend \n",
      "to test health it in the ``standalone launch'' and ``ehr launch'' \n",
      "modes. additionally, we clarify that for the purposes of testing and \n",
      "certification, we propose to require that health it support only a \n",
      "limited set of capabilities related to the openid connect standard--\n",
      "specifically, only those that are specified in the smart guide.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\90\\ <a href=\"http://openid.net/specs/openid-connect-core-1_0.html\">http://openid.net/specs/openid-connect-core-1_0.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    further, in order to enable patients and providers to get \n",
      "persistent access to health information without having to re-\n",
      "authenticate and re-authorize, we propose to require that a ``refresh \n",
      "token'' must be provided with an expiration period of at least 3 months \n",
      "from the date issued. the ``refresh token'' could be subsequently used \n",
      "by the app to obtain a new ``access token'' after the expiration of the \n",
      "original ``access token.'' note the proposed refresh token requirement \n",
      "is different than providing an ``access token'' with an extended life, \n",
      "which is typically discouraged from a security best practice \n",
      "perspective so as to prevent unauthorized access if for some reason the \n",
      "access token were to be acquired for use by an unauthorized \n",
      "application.\n",
      "    we propose in sec.  170.315(g)(10)(vi) that health it presented for \n",
      "testing and certification must demonstrate that it can support \n",
      "subsequent connections by an app and requests data without requiring \n",
      "the user to re-authorize and re-authenticate when a valid refresh token \n",
      "is supplied. further, we propose that once a valid refresh token has \n",
      "been used to get a new access token that the fhir server must \n",
      "demonstrate that it can issue a new refresh token to the app, which \n",
      "must be for a new period no shorter than three months. for example, if \n",
      "an application were issued a refresh token that was good for three \n",
      "months upon its first-ever connection and then subsequently connected \n",
      "to the fhir server one month later, the fhir server would need to \n",
      "enable that connection to occur without re-authentication and re-\n",
      "authorization, and it would need to issue a new refresh token for a new \n",
      "three-month period from that access date. again, we intend to test \n",
      "health it in the ``standalone launch'' and ``ehr launch'' contexts \n",
      "pursuant to the smart guide.\n",
      "    we have proposed this renewal requirement because industry \n",
      "stakeholders at various meetings and conferences at which we have \n",
      "attended have indicated that a constant need for patients to re-\n",
      "authenticate and re-authorize their apps creates usability challenges \n",
      "and may otherwise contradict the cures act's intent associated with the \n",
      "phrase ``without special effort.'' further, we are not aware of a \n",
      "standard, consistent\n",
      "\n",
      "[[page 7484]]\n",
      "\n",
      "methodology for specifying the lifetime of refresh tokens in published \n",
      "technical specifications. as a result, we believe our approach would \n",
      "improve the current user experience for patients and providers alike. \n",
      "additionally, authorization servers maintain binding between the \n",
      "refresh token and the application to whom it was issued, and hence can \n",
      "protect against misuse by unauthorized applications.\n",
      "    we believe that the three-month period is a reasonable length given \n",
      "the proposal for the re-issuance of a new refresh token. however, we \n",
      "acknowledge that this same policy outcome we discuss above could be \n",
      "achieved by, for example, having a two-month period. accordingly, we \n",
      "seek comment on whether there are available specifications we should \n",
      "review as well as whether there should be a reasonable upper bound from \n",
      "a timing perspective (e.g., one year) after which the user should be \n",
      "required to re-authenticate and re-authorize.\n",
      "    for both the first time connection and subsequent connection \n",
      "proposals, we recognize that there is not yet a consistent, \n",
      "standardized specification for fhir servers to handle data requests for \n",
      "multiple patients. as noted above, we expect that fhir release 4 will \n",
      "have such specificity. however, for the purposes of meeting this \n",
      "proposed certification criterion, we clarify that a health it developer \n",
      "would be permitted to approach requests for multiple patients in the \n",
      "manner it deems most efficient.\n",
      "transparency through the publication of api documentation\n",
      "    in the 2015 edition final rule we included transparent \n",
      "documentation requirements for all three of the api-focused \n",
      "certification criteria adopted in sec.  170.315(g)(7) through (g)(9). \n",
      "these requirements specified that documentation associated with api \n",
      "syntax (and other technical descriptors), the software components and \n",
      "configurations that would be necessary in order for a deployed api to \n",
      "successfully work, and the terms of use for the api be made publicly \n",
      "available. we continue to believe that such a requirement is important \n",
      "for proposed sec.  170.315(g)(10), especially in light of the cures \n",
      "act's ``without special effort'' provision. such transparency and \n",
      "openness is commonplace in many other industries and has fueled \n",
      "innovation, growth, and competition. further, we believe that full \n",
      "transparency is necessary to ensure that software developers building \n",
      "to a health it developer's (g)(10)-certified api have a thorough \n",
      "understanding of any requirements against which their software will \n",
      "need to be designed.\n",
      "    in reconciling the 2015 edition final rule's api documentation \n",
      "requirements with the new expectations set forth by the cures act \n",
      "regarding a health it developer's practices, we have determined that \n",
      "revisions are necessary. accordingly, we propose to revise the \n",
      "documentation provision in the api certification criteria adopted in \n",
      "sec.  170.315(g)(7) through (g)(9) as well as reflect the same revision \n",
      "in proposed sec.  170.315(g)(10) and (11). specifically, we propose to \n",
      "focus the documentation requirement set forth by the certification \n",
      "criteria on solely the technical documentation associated with the api \n",
      "technology. as a result, we propose to remove the provision in sec.  \n",
      "170.315(g)(7) through (g)(9) associated with ``terms of use'' as this \n",
      "type of documentation could be considered more reflective of business \n",
      "practice and better placed with other similar requirements. consistent \n",
      "with the cures act's api condition of certification, we have proposed \n",
      "more detailed condition of certification requirements associated with a \n",
      "health it developer's api terms of use in order to address business \n",
      "practices that could interfere with and create special effort on the \n",
      "part of an api user.\n",
      "    with respect to the technical documentation that would need to be \n",
      "made publicly available, we recognize that our proposed formal adoption \n",
      "of the fhir standard and the associated implementation specifications \n",
      "(for sec.  170.315(g)(10)) would be consistent across all health it \n",
      "presented for certification. as a result there may be minimal \n",
      "additional documentation needed for these capabilities beyond what is \n",
      "already documented in these standards and specifications. however, \n",
      "pursuant to the limited mandatory scope proposed for ``data response'' \n",
      "(for sec.  170.315(g)(10)), we believe that api technology suppliers \n",
      "should disclose any additional data their (g)(10)-certified api \n",
      "supports in the context of fhir resources referenced in arch version1 \n",
      "and associated implementation specifications. for example, the argonaut \n",
      "ig ``patient profile'' includes optional elements for marital status, \n",
      "photo, and contact (as in contact person like a guardian or friend). to \n",
      "the degree that a (g)(10)-certified api supports such optional data an \n",
      "api technology supplier would be required to convey this support in its \n",
      "published technical documentation. additionally, we note that other \n",
      "specifications, like the rfc 7591, provide developers some latitude in \n",
      "terms of the information that could be supplied for the purposes of \n",
      "registration.\n",
      "    thus, we propose in sec.  170.315(g)(10)(vii) that an api \n",
      "technology supplier would need to provide detailed information for all \n",
      "aspects of its (g)(10)-certified api, especially for any unique \n",
      "technical requirements and configurations, such as how the fhir server \n",
      "handles requests for multiple patients (until such time as there is an \n",
      "approved standardized approach that can be cited) as well as app \n",
      "registration requirements. for aspects that are not unique and are \n",
      "fully specified by the fhir standard and associated implementation \n",
      "specifications, the developer could include hyperlinks to this \n",
      "information as part of its overall documentation. further, we propose \n",
      "to include the word ``complete'' in the documentation provision in \n",
      "order to make this point explicit and link this obligation to the \n",
      "associated transparency conditions proposed as part of the overall \n",
      "condition of certification. we note for health it developers that the \n",
      "documentation published must be of the sort and to the level of \n",
      "specificity, precision, and detail that the health it developer \n",
      "customarily provides to its own employees, contractors, and/or partners \n",
      "who develop software applications for production environments.\n",
      "    lastly, we note that all of the documentation referenced by this \n",
      "criterion must be accessible to the public via a hyperlink without \n",
      "additional access requirements, including, without limitation, any form \n",
      "of registration, account creation, ``click-through'' agreements, or \n",
      "requirement to provide contact details or other information prior to \n",
      "accessing the documentation. it would also require that such \n",
      "documentation needs to be submitted as part of testing for this \n",
      "certification criterion and subsequently to onc-acbs for review prior \n",
      "to issuing a certification.\n",
      "d. condition of certification requirements\n",
      "    to implement the cures act, we have designed this api condition of \n",
      "certification in a manner that will complement the technical \n",
      "capabilities described in our other proposals, while addressing the \n",
      "broader technology and business landscape in which these api \n",
      "capabilities will be deployed and used.\n",
      "    consistent with the attributes we have identified for the statutory \n",
      "phrase ``without special effort,'' our overarching vision for this \n",
      "condition of certification is to ensure that (g)(10)- certified apis, \n",
      "among all api\n",
      "\n",
      "[[page 7485]]\n",
      "\n",
      "technology, are deployed in a manner that supports an experience that \n",
      "is as seamless and frictionless as possible. to that end, we seek to \n",
      "promote a standards-based ecosystem that is transparent, scalable, and \n",
      "open to robust competition and innovation.\n",
      "    the specific requirements of this condition of certification are \n",
      "discussed in several sections below. these requirements would address \n",
      "certain implementation, maintenance, and business practices for which \n",
      "clear and consistent parameters are needed to ensure that api \n",
      "technology is deployed in a manner that achieves the policy goals we \n",
      "have described. the proposed requirements would also align this \n",
      "condition of certification with other requirements and policies of the \n",
      "cures act that promote interoperability and deter information blocking, \n",
      "as discussed in more detail in the sections that follow.\n",
      "i. scope and compliance\n",
      "    to start this condition of certification, we propose in sec.  \n",
      "170.404 to apply this condition of certification to health it \n",
      "developers with health it certified to any of the api-focused \n",
      "certification criteria. these criteria include the proposed \n",
      "``standardized api for patient and population services'' (sec.  \n",
      "170.315(g)(10)) and ``consent management for apis'' (sec.  \n",
      "170.315(g)(11)) as well as the current ``application access--patient \n",
      "selection'' (sec.  170.315(g)(7)), ``application access--data category \n",
      "request'' (sec.  170.315(g)(8)), ``application access--all data \n",
      "request'' (sec.  170.315(g)(9)). in other words, this entire condition \n",
      "of certification would not apply to health it developers that do not \n",
      "have technology certified to any of these api-focused certification \n",
      "criteria. similarly, this condition is solely applicable to these api-\n",
      "focused certification criteria. as a result, the proposed policies for \n",
      "this condition of certification would not apply to a health it \n",
      "developer's practices associated with, for example, the immunization \n",
      "reporting certification criterion adopted in sec.  170.315(f)(1) \n",
      "because that criterion is not one of the api-focused criteria. however, \n",
      "health it developers should remain mindful that other proposals in this \n",
      "proposed rule, especially those related to information blocking, could \n",
      "still apply to its practices associated with non-api-focused \n",
      "certification criteria.\n",
      "    given the proposed applicability of this condition to current api-\n",
      "focused criteria and that health it developers with products certified \n",
      "to sec. sec.  170.315(g)(7)-(9) would need to meet new compliance \n",
      "requirements associated with such criteria, we also propose certain \n",
      "compliance timelines associated with this condition of certification \n",
      "that would need to be met.\n",
      "ii. cures act condition and interpretation of access to ``all data \n",
      "elements''\n",
      "    first, we propose to adopt the cures act's api condition of \n",
      "certification in sec.  170.404(a)(1) to fully incorporate the statute's \n",
      "compliance requirements. second, strictly for the scope of the api \n",
      "condition of certification, we propose to interpret the meaning of the \n",
      "phrase ``all data elements of a patient's electronic health record'' as \n",
      "follows.\n",
      "    for the reasons discussed above, the proposed sec.  170.315(g)(10) \n",
      "certification criterion and associated standards and implementation \n",
      "specifications would facilitate api access to a limited set of data \n",
      "elements (i.e., from the fhir resources that arch version 1). \n",
      "accordingly, for the purposes of meeting this portion of the cures \n",
      "act's api condition of certification, we interpret the scope of: the \n",
      "arch; its associated implementation specifications; and the policy \n",
      "expressed around the data elements that must be supported by (g)(10)-\n",
      "certified apis (i.e., fhir servers) to constitute ``all data \n",
      "elements.'' given other proposals related to permitting the use of \n",
      "updated versions of adopted standards and implementation \n",
      "specifications, we expect that (g)(10)-certified apis will be able to \n",
      "support access to more data over time in response to updates to the \n",
      "uscdi and the arch. as these updates occur, the industry would be able \n",
      "to incrementally approach the totality of data that can be \n",
      "electronically accessed, exchanged, and used pursuant to the cures \n",
      "act's reference to ``all data elements.''\n",
      "    again, we reiterate that this specific interpretation does not \n",
      "extend beyond the api condition of certification and cannot be inferred \n",
      "to reduce the scope or applicability of other cures act conditions of \n",
      "certification or the information blocking proposals, which necessarily \n",
      "will include a larger scope of data. for example, other conditions of \n",
      "certification will apply to health it developer behaviors associated \n",
      "with data that are not part of the uscdi or arch, such as the proposals \n",
      "at 45 cfr 170.402 and the proposals in part 171, which apply across \n",
      "several stakeholders including health information networks and health \n",
      "care providers.\n",
      "iii. transparency conditions\n",
      "    we propose as part of this condition of certification that api \n",
      "technology suppliers be required to make specific business and \n",
      "technical documentation freely and publicly accessible. thus, we \n",
      "propose to adopt several transparency conditions as part of sec.  \n",
      "170.404(a)(2).\n",
      "    similar to our policy associated with the api-focused certification \n",
      "criteria, we propose in sec.  170.404(a)(2)(i) that all published \n",
      "documentation be complete and available via a publicly accessible \n",
      "hyperlink that allows any person to directly access the information \n",
      "without any preconditions or additional steps. for example, the api \n",
      "technology supplier cannot impose any access requirements, including, \n",
      "without limitation, any form of registration, account creation, \n",
      "``click-through'' agreements, or requirement to provide contact details \n",
      "or other information prior to accessing the documentation.\n",
      "terms and conditions transparency\n",
      "    in addition to technical documentation, we propose in sec.  \n",
      "170.404(a)(2)(ii)(a) to require api technology suppliers to publish all \n",
      "terms and conditions for use of its api technology. we believe that it \n",
      "is important to make this information readily accessible to api data \n",
      "providers, api users, app developers, and other persons. this \n",
      "transparency would ensure that these stakeholders do not experience \n",
      "``special effort'' in the form of unnecessary costs or delays to obtain \n",
      "the terms and conditions for api technology. further, we believe that \n",
      "full transparency is necessary to ensure that app developers have a \n",
      "thorough understanding in advance of any terms or conditions that might \n",
      "apply to them and do not encounter unanticipated hurdles once they have \n",
      "committed to developing software or attempt to implement or deploy such \n",
      "software in production.\n",
      "    we note that this requirement would apply to all terms and \n",
      "conditions that apply to the api technology and its use. as noted \n",
      "above, and for the purposes of this proposal's scope, ``api \n",
      "technology'' refers to the specified api capabilities for health it \n",
      "modules certified to sec.  170.315(g)(7) through (11) under the \n",
      "program. we consider ``terms and conditions'' to include any fees, \n",
      "restrictions, limitations, obligations, registration process \n",
      "requirements, and other terms or conditions that would be material and \n",
      "needed to:\n",
      "    <bullet> develop software applications to interact with the api \n",
      "technology;\n",
      "    <bullet> distribute, deploy, and enable the use of software \n",
      "applications in production environments that use the api technology;\n",
      "    <bullet> use software applications, including to access, exchange, \n",
      "and use ehi by means of the api technology;\n",
      "\n",
      "[[page 7486]]\n",
      "\n",
      "    <bullet> use any ehi obtained by means of the api technology; and\n",
      "    <bullet> register software applications (as discussed in more \n",
      "below).\n",
      "    in addition, we propose in sec.  170.404(a)(2)(ii)(b) that any and \n",
      "all permitted fees charged by an api technology supplier for the use of \n",
      "its api technology must be published and described in detailed, plain \n",
      "language as part of its publicly available terms and conditions. the \n",
      "description of the fees must include all material information, \n",
      "including, but not limited to, the persons or classes of persons to \n",
      "whom the fee applies; the circumstances in which the fee applies; and \n",
      "the amount of the fee, which for variable fees must include the \n",
      "specific variable(s) and methodology(ies) that will be used to \n",
      "calculate the fee.\n",
      "    for the purposes of the specific transparency conditions proposed \n",
      "in sec.  170.404(a)(2) and their relationship and applicability to api \n",
      "technology suppliers with products already certified to sec.  \n",
      "170.315(g)(7), (8), or (9), we propose to establish a compliance date \n",
      "of six months from the final rule's effective date (which would give \n",
      "developers approximately eight months from the final rule's publication \n",
      "date) to revise their existing api documentation to come into \n",
      "compliance with the final rule. we also recognize that api technology \n",
      "suppliers will need to update the proposed publicly available \n",
      "information from time to time. thus, for the purposes of and with \n",
      "respect to subsequent updates to this information, we expect api \n",
      "technology suppliers to make clear to the public the timing information \n",
      "applicable to their disclosures (e.g., effective/as of date or last \n",
      "updated date) in order to prevent out of sync discrepancies in what an \n",
      "api technology supplier's public documentation states and what it may \n",
      "be communicating directly to its customers (e.g., a change in fees is \n",
      "directly communicated to customers but not reflected at the publicly \n",
      "available hyperlink pursuant to its responsibilities under this \n",
      "proposal). if an api technology supplier's actions are out of sync with \n",
      "its publicly provided documentation, the api technology supplier would \n",
      "be at risk of violating this condition of certification. we request \n",
      "public comment on whether this expectation should be formally specified \n",
      "in regulation text or if these ``effective date'' approaches for \n",
      "changes to transparency documentation are common place such that it \n",
      "would be a standard practice as part of making this documentation \n",
      "available.\n",
      "    we also note that api technology suppliers would be expected to \n",
      "revise and/or construct terms and conditions for its api technology \n",
      "that account for and reflect the proposals associated with this api \n",
      "condition of certification and information blocking policies. in so far \n",
      "as an api technology supplier would find it necessary to enforce its \n",
      "published terms and conditions, we caution api technology suppliers to \n",
      "be mindful of whether such terms and conditions would be acceptable and \n",
      "consistent with the aforementioned policies in the first place--as an \n",
      "impermissible term or condition would be problematic regardless of \n",
      "whether it was actively enforced.\n",
      "    we propose in sec.  170.404(a)(2)(ii)(c) a final transparency \n",
      "condition associated with api technology suppliers' application \n",
      "developer verification processes that takes into account the fact that \n",
      "we did not propose to adopt the dynamic registration standard as part \n",
      "of proposed sec.  170.315(g)(10). had we proposed requiring dynamic \n",
      "registration, we would have also proposed a specific condition of \n",
      "certification that would have outright prohibited api technology \n",
      "suppliers from identity proofing or verifying authenticity of an app \n",
      "developer when it came to apps that were designed to enable patient \n",
      "access.\n",
      "    on balance, however, we believe that permitting api technology \n",
      "suppliers to institute a process to verify the authenticity of \n",
      "application developers will foster additional trust in the growing api \n",
      "ecosystem. we seek comments and recommendations on factors that would \n",
      "enable registration with minimal barriers. for example, permitting api \n",
      "technology suppliers to do one- time verification of the app developers \n",
      "(or even rely on centralized vetting by a trusted third party), which \n",
      "would allow the developer's future apps to automatically register \n",
      "without case-by- case checks (or checks for each api technology \n",
      "supplier with which the app developer interacts). one risk to consider \n",
      "with dynamic registration plus a prohibition on vetting, for instance, \n",
      "is that it would be much easier for a malicious app developer to spoof \n",
      "another legitimate app developer's app. such an action could ultimately \n",
      "lead to confusion and distrust in the market. however, the dynamic \n",
      "registration option would minimize barriers to registration especially \n",
      "for third-party apps designed to enable patient access. we seek \n",
      "comments on options and trade-offs we should consider.\n",
      "    accordingly, and weighing those concerns with the cures act's \n",
      "``without special effort'' provision and our proposed information \n",
      "blocking policies, we specifically propose to permit api technology \n",
      "suppliers to institute a process to verify the authenticity of \n",
      "application developers so long as such process is completed within five \n",
      "business days \\91\\ of receipt of an application developer's request to \n",
      "register their software application with the api technology's \n",
      "authorization server. to clarify, this verification process would need \n",
      "to focus specifically on the application developer--not its software \n",
      "application(s). we also clarify that api technology suppliers would \n",
      "have the discretion to establish their verification process so long as \n",
      "the process is objective and the same for all application developers \n",
      "and it can reasonably be completed within the five business days--\n",
      "otherwise such a process could risk implicating/violating other \n",
      "elements of this proposed api condition of certification as well as \n",
      "information blocking behaviors. the following includes a few non-\n",
      "exhaustive examples of verification techniques that could be used by an \n",
      "api technology supplier to have additional certainty about the \n",
      "application developer with whom they are interacting: instituting a \n",
      "``penny verification'' process, requiring some form of corporate \n",
      "documentation, or requesting other forms of authenticating \n",
      "documentation or transactions.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\91\\ we consider a ``business day'' to include the normal work \n",
      "days and hours of operation during a week (monday through friday), \n",
      "excluding federal holidays and weekends.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we believe that five business days is sufficient time for api \n",
      "technology suppliers to weed out malicious developers seeking to \n",
      "deceive the api technology supplier, api data providers or api users, \n",
      "but request public comment on other timing considerations. moreover, we \n",
      "clarify that this proposed condition of certification is meant to set \n",
      "the upper bound for a verification process an api technology supplier \n",
      "would be permitted to take and should not be interpreted as compelling \n",
      "api technology suppliers to institute such a process (i.e., api \n",
      "technology suppliers would not be required to institute a verification \n",
      "process). rather, for those api technology suppliers that see it in \n",
      "their (as well as their customers and patients) best interests to \n",
      "institute such a process, we have laid out the rules that we believe \n",
      "meet the cures act's without special effort expectations. if an api \n",
      "technology supplier chooses not to institute an app developer \n",
      "verification process prior to enabling the production use of an app, it \n",
      "would solely need to meet the maintenance of certification\n",
      "\n",
      "[[page 7487]]\n",
      "\n",
      "requirement associated with enabling apps for production use discussed \n",
      "in more detail below.\n",
      "    we remind stakeholders that even in the case where an api \n",
      "technology supplier chooses not to vet app developers, the apps would \n",
      "not have carte blanche access to a health care provider's data. to the \n",
      "contrary, such apps will still be registered and thus be identifiable \n",
      "and able to have their access deactivated by an api technology supplier \n",
      "or health care provider (api data provider) if they behave in anomalous \n",
      "or malicious ways (e.g., denial of service attack). and a patient \n",
      "seeking access to their data using the app will need to authenticate \n",
      "themselves (using previously issued credentials by a health care \n",
      "provider or trusted source) and authorize: (1) the app to connect to \n",
      "the fhir server; and (2) specify the scope of the data the app may \n",
      "access.\n",
      "    as a separate matter, we also recognize that in order to assure \n",
      "health care providers that the apps they use within their health it \n",
      "will operate appropriately, will fully integrate into workflow, and \n",
      "will not degrade overall system performance, that api technology \n",
      "suppliers may establish additional mechanisms to vet app developers. \n",
      "such mechanisms could fit into the ``value-added services'' permitted \n",
      "fee and result in the app being acknowledged or listed by the health it \n",
      "developer in some special manner (e.g., in an ``app store,'' ``verified \n",
      "app'' list). while our proposals do not specify any explicit limits to \n",
      "the nature and governance of these approaches, we wish to caution \n",
      "health it developers that even though such processes have a reasoned \n",
      "basis in providing an added layer of trust above and beyond the basic \n",
      "production-readiness of an app, they can equally be used as a means to \n",
      "prevent, limit, and otherwise frustrate innovation, competition, and \n",
      "access to the market. such an outcome would be inconsistent with the \n",
      "cures act, could directly violate the specific condition of \n",
      "certification associated with fees permitted for value-added services, \n",
      "and could constitute information blocking.\n",
      "iv. permitted fees conditions\n",
      "general proposals involving fees\n",
      "    as part of this api condition of certification, we propose to adopt \n",
      "specific conditions that would set boundaries for the fees api \n",
      "technology suppliers would be permitted to charge and to whom those \n",
      "permitted fees could be charged. as a reminder, these proposals would \n",
      "only apply to a health it developer's business practices associated \n",
      "with its ``api technology'' (i.e., the capabilities certified to sec.  \n",
      "170.315(g)(7) through (11)). we seek comment on all of the following \n",
      "proposals.\n",
      "    in sec.  170.404(a)(3)(i)(a), we propose to establish a general \n",
      "prohibition on api technology suppliers imposing fees associated with \n",
      "api technology. this general prohibition is meant to ensure that api \n",
      "technology suppliers do not engage in pricing practices that create \n",
      "barriers to entry and competition for apps and api-based services that \n",
      "health care providers seek to use. these outcomes would be inconsistent \n",
      "with the goal of enabling api-based access, exchange, and use of ehi by \n",
      "patients and other stakeholders without special effort.\n",
      "    in establishing this general prohibition, we have been mindful of \n",
      "the need for api technology suppliers to recover their costs and to \n",
      "earn a reasonable return on their investments in providing api \n",
      "technology that has been certified under the program. accordingly, we \n",
      "have identified categories of ``permitted fees'' that api technology \n",
      "suppliers would be permitted to charge and still be compliant with the \n",
      "condition of certification and program requirements, and discuss these \n",
      "proposals below. we emphasize, however, and propose in detail below, \n",
      "that api technology suppliers would not be permitted in any way \n",
      "whatsoever to impose fees on any person in connection with an api \n",
      "technology supplier's work to support the use of api technology to \n",
      "facilitate a patient's ability to access, exchange, or use their ehi.\n",
      "    we note that other than for fees charged for ``value-added \n",
      "services'' (proposed in sec.  170.404(a)(3)(iv)), the fees permitted \n",
      "under this condition of certification must arise between an api \n",
      "technology supplier and an api data provider. any fee that arises in \n",
      "connection with an api user's use of api technology would need to exist \n",
      "solely between the api data provider and the api user. this policy \n",
      "reinforces the autonomy that we believe api data providers should have \n",
      "to establish relationships with api users. however, as discussed in \n",
      "detail below, api technology suppliers would be permitted to charge api \n",
      "data providers based on the usage activities of api users.\n",
      "    we also seek to clarify that while the proposed permitted fees set \n",
      "the boundaries for the fees api technology suppliers would be permitted \n",
      "to charge and to whom those permitted fees could be charged, they do \n",
      "not prohibit who may pay the api technology supplier's permitted fee. \n",
      "in other words, these conditions limit the party from which an api \n",
      "technology supplier may require payment, but they do not speak to who \n",
      "may pay the fee. for example, if through some type of relationship/\n",
      "agreement an api user or other party offered to pay the fee an api data \n",
      "provider owed to an api technology supplier, that practice would be \n",
      "allowed and unaffected under these conditions. this is an acceptable \n",
      "practice because the fee is first arrived at between the api technology \n",
      "supplier and api data provider, and then api technology supplier \n",
      "receives payment from another party via the api data provider or \n",
      "directly on behalf of the api data provider. as a general matter, we \n",
      "note that stakeholders should be mindful of other federal and state \n",
      "laws and regulations that could prohibit or limit certain types of \n",
      "relationships involving remuneration.\n",
      "    we note that the proposed ``permitted fees conditions'' align with \n",
      "the requirements of the information blocking exceptions proposed in 45 \n",
      "cfr 171.204 and 171.206. any fee that would not be covered by those \n",
      "exceptions, and that would, therefore, be suspect under the information \n",
      "blocking provision, would equally not be permitted by this api \n",
      "condition of certification. we strongly encourage readers to review our \n",
      "proposals associated with those exceptions, which are contained in \n",
      "sections viii.d.4 and viii.d.6 of this preamble, respectively.\n",
      "permitted fees--general conditions\n",
      "    we propose in sec.  170.404(a)(3)(i)(b) general conditions that an \n",
      "api technology supplier's fee must satisfy in order for such fee to be \n",
      "expressly permitted and thus not contravene the proposed condition of \n",
      "certification. first, we propose in sec.  170.404(a)(3)(i)(b)(1) that \n",
      "in order to be a permitted fee, a fee imposed by an api technology \n",
      "supplier must be based on objective and verifiable criteria that are \n",
      "uniformly applied for all substantially similar or similarly situated \n",
      "classes of persons and requests. this would require an api technology \n",
      "supplier to apply fee criteria that, among other things, would lead an \n",
      "api technology supplier to come to the same conclusion with respect to \n",
      "the permitted fee's amount each time it interacted with a class of \n",
      "persons or responded to a request. accordingly, the fee could not be \n",
      "based on the api technology supplier's subjective judgment or \n",
      "discretion.\n",
      "    moreover, in order to be permitted, the fee must not be based in \n",
      "any part on\n",
      "\n",
      "[[page 7488]]\n",
      "\n",
      "whether the api user is a competitor or potential competitor, or on \n",
      "whether the api data provider or api user will be using the data \n",
      "accessed via the api technology in a way that facilitates competition \n",
      "with the api technology supplier. this condition is intended to ensure \n",
      "that any fee charged by an api technology supplier does not have the \n",
      "purpose or effect of excluding or creating impediments for competitors, \n",
      "business rivals, or other persons engaged in developing or enabling the \n",
      "use of api technology. we believe these fee limitations are necessary \n",
      "in light of the potential for api technology suppliers to use their \n",
      "control over api technology to engage in discriminatory practices that \n",
      "create barriers to api technology. these principles are consistent with \n",
      "the approach described in section viii of this preamble (``information \n",
      "blocking'').\n",
      "    second, we propose in sec.  170.404(a)(3)(i)(b)(2) that in order to \n",
      "be a permitted fee, a fee imposed by an api technology supplier must be \n",
      "reasonably related to the api technology supplier's costs of supplying \n",
      "and, if applicable, supporting the api technology to, or at the request \n",
      "of, the api data provider to whom the fee is charged. for example, the \n",
      "api technology supplier would not be permitted to charge a fee when the \n",
      "underlying costs relevant to the supply or service have already been \n",
      "accounted for or recovered through other fees (regardless of whether \n",
      "such fees were charged to the api data provider or to other persons). \n",
      "moreover, an api technology supplier that conditioned access to its api \n",
      "technology on revenue-sharing or the entry into a royalty agreement \n",
      "would be at significant risk of imposing a fee that bore no plausible \n",
      "relation to the costs incurred by the api technology supplier to \n",
      "develop the api technology or support its use by api users.\n",
      "    third, we propose in sec.  170.404(a)(3)(i)(b)(3) to require that \n",
      "in order to be a permitted fee, the costs of supplying, and if \n",
      "applicable, supporting the api technology upon which the fee is based \n",
      "must be reasonably allocated among all customers to whom the api \n",
      "technology is supplied or for whom it is supported. a reasonable \n",
      "allocation of costs would require that the api technology supplier \n",
      "allocate its costs in accordance with criteria that are reasonable and \n",
      "between only those api data providers that either cause the costs to be \n",
      "incurred or benefit from the associated supply or support of the api \n",
      "technology. if an api technology supplier developed api technology that \n",
      "could be supplied to multiple customers with minimal tailoring, the \n",
      "core costs of developing its api technology should be allocated among \n",
      "those customers when recovered as a fee. the api technology supplier \n",
      "would not be permitted to recover the total of its core costs from each \n",
      "customer. similarly, when an api technology supplier uses shared \n",
      "facilities and resources to support the usage of api technology, it \n",
      "would need to ensure that those shared costs were reasonably allocated \n",
      "between all of the customers that benefited from them. however, \n",
      "whenever an api technology supplier is required to provide services and \n",
      "incur costs that are unique to a particular customer, it would not need \n",
      "to distribute those costs among other customers that had deployed its \n",
      "api technology.\n",
      "    last, we propose in sec.  170.404(a)(3)(i)(b)(4) to require that in \n",
      "order to be a permitted fee, the api technology supplier must ensure \n",
      "that fees are not be based in any part on whether the requestor or \n",
      "other person is a competitor, potential competitor, or will be using \n",
      "the api technology in a way that facilitates competition with the api \n",
      "technology supplier. the use of such criteria would be suspect because \n",
      "it suggests the fee the api technology supplier is charging is not \n",
      "based on its reasonable costs to provide the api technology or services \n",
      "and may have the purpose or effect of excluding or creating impediments \n",
      "for competitors, business rivals, or other persons engaged in \n",
      "developing or enabling the use of api technologies and services.\n",
      "    we request comments on these general conditions for permitted fees \n",
      "and whether commenters believe we have created effective guardrails to \n",
      "ensure that fees do not prevent ehi from being accessed, exchanged, and \n",
      "used through the use of apis without special effort.\n",
      "specific proposed permitted fees\n",
      "    as noted above, we propose that api technology suppliers would be \n",
      "prohibited from charging fees associated with api technology unless \n",
      "such fees are expressly permitted. additionally, as a reminder, the \n",
      "scope of ``api technology'' subject to these proposals would only \n",
      "include certified health it that fulfill the api-focused certification \n",
      "criteria adopted or proposed for adoption at 45 cfr 170.315(g)(7) \n",
      "through (g)(11). thus, all other api functionality provided by a health \n",
      "it developer with its product(s) that have no link to these certified \n",
      "capabilities would not be subject to this condition of certification.\n",
      "    the following proposals outline the specific circumstances in which \n",
      "an api technology supplier would be permitted to charge fees associated \n",
      "with api technology certified under the program. a fee that satisfies \n",
      "one of the permitted fees in sec. sec.  170.404(a)(3)(ii)-(iv) must \n",
      "also satisfy each of the general conditions in sec.  170.404(a)(3)(i) \n",
      "in order to be permitted and for its recovery compliant with this \n",
      "condition of certification.\n",
      "permitted fee for developing, deploying, and upgrading api technology\n",
      "    in sec.  170.404(a)(3)(ii), we propose to permit an api technology \n",
      "supplier to charge api data providers reasonable fees for developing, \n",
      "deploying, and upgrading api technology. fees for ``developing'' api \n",
      "technology comprise the api technology supplier's costs of designing, \n",
      "developing, and testing api technology to specifications that fulfill \n",
      "the requirements of the api-focused certification criteria adopted or \n",
      "proposed for adoption at 45 cfr 170.315(g)(7) through (g)(11). fees for \n",
      "developing api technology must not include the api technology \n",
      "supplier's costs of updating the non-api related capabilities of the \n",
      "api technology supplier's existing health it, including its databases, \n",
      "as part of its development of the api technology. these costs would be \n",
      "connected to past business decisions made by the api technology \n",
      "supplier and typically arise due to health it being designed or \n",
      "implemented in nonstandard ways that unnecessarily increase the \n",
      "complexity, difficulty or burden of accessing, exchanging, or using \n",
      "ehi. the recovery of the costs associated with updating an api \n",
      "technology supplier's health it generally would be inconsistent with \n",
      "the cures act requirement that api technology be deployed ``without \n",
      "special effort.''\n",
      "    the api technology supplier's fees for ``deploying'' api technology \n",
      "comprise the api technology supplier's costs of operationalizing api \n",
      "technology in a production environment. such fees include, but are not \n",
      "limited to, standing up hosting infrastructure, software installation \n",
      "and configuration, and the creation and maintenance of api data \n",
      "provider administrative functions. an api technology supplier's fees \n",
      "for ``deploying'' api technology does not include the costs associated \n",
      "with managing the traffic of api calls that access the api technology, \n",
      "which an api technology supplier can only recover under the permitted \n",
      "fee for usage support costs under sec.  170.404(a)(3)(iii). for \n",
      "clarity, we reiterate that for the purpose of this condition of \n",
      "certification, we consider\n",
      "\n",
      "[[page 7489]]\n",
      "\n",
      "that api technology is ``deployed'' by the customer--the api data \n",
      "provider--that purchased or licensed it.\n",
      "    the api technology supplier's fees for ``upgrading'' api technology \n",
      "comprise the api technology supplier's costs of supplying an api data \n",
      "provider with an updated version of api technology. such costs would \n",
      "include the costs required to bring api technology into conformity with \n",
      "new requirements of the program, upgrades to implement general software \n",
      "updates (not otherwise covered by development fees or under warranty), \n",
      "or developing and releasing newer versions of the api technology at the \n",
      "request of an api data provider.\n",
      "    the nature of the costs that can be charged under this category of \n",
      "permitted fees will depend on the scope of the work to be undertaken by \n",
      "an api technology supplier (i.e., how much or how little labor an api \n",
      "data provider requires of the api technology supplier to deploy and \n",
      "upgrade the api technology being supplied). for example, where an api \n",
      "data provider decides to fully outsource the deployment of its api \n",
      "technology to its api technology supplier, the api technology \n",
      "supplier's costs will include the work associated with the development \n",
      "of the api technology, the work deploying the api technology, and any \n",
      "work upgrading the api technology.\n",
      "    we propose that any fees that an api technology supplier charges \n",
      "for developing, deploying, or upgrading api technology must be charged \n",
      "solely to the api data provider(s) for whom the capabilities are \n",
      "deployed. we propose this limitation because we believe that these \n",
      "costs should be negotiated between the api technology supplier that \n",
      "supplies the capabilities and the api data provider (i.e., health care \n",
      "provider) that implements them in its production environment. in our \n",
      "view, it is inappropriate to pass these costs on to api users as doing \n",
      "so would impose considerable costs on the api data provider's current \n",
      "or potential partners, such as those offering third-party applications \n",
      "and services, as well as the end-users of api technology and would \n",
      "amount to the kind of ``special effort'' that the cures act's api \n",
      "condition of certification seeks to prevent.\n",
      "    subject to the general conditions proposed in sec.  \n",
      "170.404(a)(3)(i) and discussed above, api technology suppliers can \n",
      "recover the full range of reasonable costs associated with developing, \n",
      "deploying, and upgrading api technology over time. we believe it is \n",
      "important that api technology suppliers be able to recover these costs \n",
      "and earn a reasonable return on their investments so that they have \n",
      "adequate incentives to make continued investments in these \n",
      "technologies. in particular, we anticipate that api technology \n",
      "suppliers will need to continually expand the data elements and upgrade \n",
      "the capabilities associated with certified apis as the fhir standard \n",
      "and its implementation specifications mature, and the national \n",
      "coordinator expands the uscdi and arch.\n",
      "permitted fee to recover costs of supporting api usage for purposes \n",
      "other than patient access, exchange, and use\n",
      "    in sec.  170.404(a)(3)(iii) we propose to permit an api technology \n",
      "supplier to charge usage-based fees to api data providers to the extent \n",
      "that the api technology is used for purposes other than facilitating \n",
      "access, exchange, or use of ehi by patients or their applications, \n",
      "technologies, or services.\n",
      "    we consider ``usage-based'' fees to be the fees imposed by an api \n",
      "technology supplier to recover the costs that would typically be \n",
      "incurred supporting api interactions at increasing volumes and scale \n",
      "within established service levels. that is, ``usage-based'' fees \n",
      "recover costs incurred by an api technology supplier due to the actual \n",
      "use of the api technology once it has been deployed (e.g., costs to \n",
      "support a higher volume of traffic, data, or number of apps via the api \n",
      "technology). we acknowledge that api technology suppliers could adopt a \n",
      "range of pricing methodologies when charging for the support of api \n",
      "usage. we expect that api usage support fees would only come into play \n",
      "when the api technology supplier acts on behalf of the api data \n",
      "provider to deploy its api technology. thus, the costs recovered under \n",
      "``usage-based'' fees would only be able to reflect ``post-deployment'' \n",
      "costs. as such, ``usage-based'' fees would not be allowed to include \n",
      "any costs necessary to prepare and ``get the api technology up, \n",
      "running, and ready for use,'' which are costs that we propose should be \n",
      "recovered as part of the deployment services delivered by the api \n",
      "technology supplier if permitted under sec.  170.404(a)(3)(ii). we \n",
      "believe this condition of certification offers the flexibility \n",
      "necessary to accommodate reasonable pricing methodologies and will \n",
      "allow api technology suppliers to explore innovative approaches to \n",
      "recovering the costs associated with supporting api use as a permitted \n",
      "fee.\n",
      "    as discussed above, we expect that api usage support fees would \n",
      "only come into play when the api technology supplier acts on behalf of \n",
      "the api data provider to deploy its api technology. conversely, in \n",
      "scenarios where the api data provider, such as a large hospital system, \n",
      "assumes full responsibility for the technical infrastructure necessary \n",
      "to deploy and host the api technology it has acquired, the volume and \n",
      "scale of its usage would be the api data provider's sole \n",
      "responsibility. as a result, in this scenario and under our proposal's \n",
      "structure, an api technology supplier would not be permitted to charge \n",
      "usage-based fees. instead, the api technology supplier would be limited \n",
      "to the fees it would be permitted to recover through the ``development, \n",
      "deployment, upgrade'' permitted fee discussed above.\n",
      "    we reiterate, that ``usage-based'' fees would need to be settled \n",
      "between an api technology supplier and api data provider. the api \n",
      "technology supplier would have no standing to go around or through the \n",
      "api data provider to issue fees to, for example, a population health \n",
      "analytics company engaged by an api data provider who accesses the api \n",
      "data provider's data via the api technology.\n",
      "    we propose that any usage-based fees associated with api technology \n",
      "be limited to the recovery of the api technology supplier's \n",
      "``incremental costs.'' an api technology supplier's ``incremental \n",
      "costs'' comprise the api technology supplier's costs that are directly \n",
      "attributable to supporting api interactions at increasing volumes and \n",
      "scale within established service levels. we propose than an api \n",
      "technology supplier should ``price'' its costs of supporting access to \n",
      "the api technology by reference to the additional costs that the api \n",
      "technology supplier would incur in supporting certain volumes of api \n",
      "use. in practice, we expect that this means that api technology \n",
      "suppliers will offer a certain number of ``free'' api calls based on \n",
      "the fact that, up to a certain threshold, the api technology supplier \n",
      "will not incur any material costs in supporting api technology in \n",
      "addition to the costs recovered for deployment services. however, after \n",
      "this threshold is exceeded, we expect that the api technology supplier \n",
      "will impose usage-based costs commensurate to the additional costs that \n",
      "the api technology supplier must incur to support api technology use at \n",
      "increasing volumes and scale.\n",
      "    we expect that api technology suppliers would charge fees that are \n",
      "correlated to the incremental ratchetting up of the cost required to \n",
      "meet increased demand. for example, if, at a certain volume of api \n",
      "calls, the api technology supplier needed to deploy\n",
      "\n",
      "[[page 7490]]\n",
      "\n",
      "additional server capacity, the associated incremental cost of bringing \n",
      "an additional server online could be passed on to the api data provider \n",
      "because the api technology deployed on behalf of the api data provider \n",
      "was the subject of the higher usage. up until the point that the \n",
      "threshold is reached, the additional server capacity was not required \n",
      "and so the api technology supplier would not be permitted to recover \n",
      "the cost associated with it. moreover, the additional server capacity \n",
      "would support ongoing demand up to a certain additional volume, and so \n",
      "the api technology supplier would not be permitted to recover the costs \n",
      "of further additional server capacity until the then current capacity \n",
      "was exhausted.\n",
      "    notwithstanding the above, we note that api technology suppliers \n",
      "may choose to charge for their api usage support services on a ``pay as \n",
      "you go'' basis, such as a fee-per-call pricing structure. this approach \n",
      "could be consistent with the requirement that the api technology \n",
      "supplier only impose its incremental costs, and the requirements of \n",
      "this condition of certification more generally. however, depending on \n",
      "the amount being charged, this pricing model is open to abuse, with api \n",
      "data providers at risk of paying unreasonably high fees if the volume \n",
      "of api use is high and when the api data provider does not share in the \n",
      "benefits enjoyed by the api technology supplier when delivering a \n",
      "service at scale. as such, the api technology supplier would need to be \n",
      "careful to ensure that the total fees paid by an api data provider were \n",
      "reasonably related to the api technology supplier's costs of supporting \n",
      "the api technology. where the fees paid over a reasonable measuring \n",
      "period were not reasonably related to the api technology supplier's \n",
      "costs, they would not be permitted.\n",
      "    we are also aware that api technology suppliers may offer a pricing \n",
      "structure for api usage support based on unlimited api calls. that is, \n",
      "the api technology supplier may charge a flat-fee irrespective of the \n",
      "volume of traffic accessing the api technology. such a pricing model \n",
      "would be allowed under the proposed condition provided that the api \n",
      "technology supplier's fee for api usage support was reasonably related \n",
      "to the cost of the services that it had agreed to provide. this would \n",
      "mean that the api technology supplier would need to make a realistic \n",
      "estimate of the volume of api calls that it would need to support to \n",
      "fulfill any service level promised, and calculate its fee based on the \n",
      "costs of supporting that call volume. so long as the api technology \n",
      "supplier made a realistic estimate of the anticipated volume and \n",
      "support level, the legitimacy of the api technology supplier's fees, \n",
      "and its ability to recover them as permitted fees, would be unaffected \n",
      "by api users making lower than expected use of api technology.\n",
      "    in the context of this proposed permitted fee's scope and the \n",
      "proposed general prohibition on fees, we seek to make clear that api \n",
      "technology suppliers would be prohibited from charging (or including in \n",
      "their contracts and agreements with api data providers) any usage-based \n",
      "fees for api uses that are associated with the access, exchange, and \n",
      "use of ehi by patients or their applications, technologies, or \n",
      "services. this would include, among other things, api calls or other \n",
      "transactions initiated by or on behalf of a patient, including third \n",
      "parties (e.g., an application or any other technology or service) \n",
      "authorized by the patient or their representative to request data on \n",
      "their behalf.\n",
      "    usage fees associated with the access, exchange, and use of ehi by \n",
      "patients is a specific example of a prohibited fee that would fit under \n",
      "the general prohibition of a ``fee not otherwise permitted'' and is \n",
      "based on several considerations. first, such fees between an api \n",
      "technology supplier and api data provider would likely be passed on \n",
      "directly to patients, creating a significant impediment to their \n",
      "ability to access, exchange, and use their ehi, without special effort, \n",
      "through applications and technologies of their choice. more \n",
      "fundamentally, most of the information contained in a patient's \n",
      "electronic record has been documented during the practice of medicine \n",
      "or has otherwise been captured in the course of providing health care \n",
      "services to patients. in our view, patients have effectively paid for \n",
      "this information, either directly or through their employers, health \n",
      "plans, and other entities that negotiate and purchase health care items \n",
      "and services on their behalf. thus, our proposal reflects our belief \n",
      "that it is inappropriate to charge patients additional costs to access \n",
      "this information, whether those costs are charged directly to patients \n",
      "or passed on as a result of fees charged to persons that provide apps, \n",
      "technologies, and services on a patient's behalf.\n",
      "    to be clear, if an api data provider sought to employ api \n",
      "technology for the limited purpose of making ehi available to patients \n",
      "and their apps, the api data provider's api technology supplier would \n",
      "have no legitimate basis to charge the api data provider, or any other \n",
      "person, for the ``patient access'' usage-based costs associated with \n",
      "the api technology.\n",
      "    any unreasonable fees associated with a patient's access to their \n",
      "ehi may be suspect under the information blocking provision. such fees \n",
      "may also be inconsistent with an individual's right of access to their \n",
      "phi under the hipaa privacy rule (45 cfr 164.524).)\n",
      "    in addition to our proposal in sec.  170.404(a)(3)(iii)(a) and \n",
      "detailed above that this permitted fee would not include any costs \n",
      "incurred by the api technology supplier to support uses of the api \n",
      "technology that facilitate a patient's ability to access, exchange, or \n",
      "use their electronic health information, we also propose to explicitly \n",
      "exclude two additional costs from this permitted fee. in sec.  \n",
      "170.404(a)(3)(iii)(b), we propose that this permitted fee would not \n",
      "include costs associated with intangible assets (including depreciation \n",
      "or loss of value), except the actual development or acquisition costs \n",
      "of such assets. for instance, an api technology supplier could not \n",
      "charge an api data provider a fee based on the purported ``cost'' of \n",
      "allowing the api data provider to use the api technology supplier's \n",
      "patented api technology. as discussed in more detail in section \n",
      "viii.d.4 (information blocking), we believe it would be inappropriate \n",
      "to permit an actor to charge a fee based on these considerations, which \n",
      "are inherently subjective and could invite the kinds of rent-seeking \n",
      "and opportunistic pricing practices that create barriers to access, \n",
      "use, and exchange of ehi and impede interoperability.\n",
      "    in sec.  170.404(a)(3)(iii)(c), we propose that this permitted fee \n",
      "would not include opportunity costs, except for the reasonable forward-\n",
      "looking cost of capital. these speculative costs could include revenues \n",
      "that an api technology supplier could have earned had it not provided \n",
      "the api technology. we clarify that the exclusion of opportunity costs \n",
      "would not preclude an api technology supplier from recovering its \n",
      "reasonable forward-looking cost of capital. we believe these costs are \n",
      "relatively concrete and that permitting their recovery will protect \n",
      "incentives for api technology suppliers to invest in developing and \n",
      "providing interoperability elements (as described in section viii.d.4).\n",
      "permitted fee for value-added services\n",
      "    in sec.  170.404(a)(3)(iv) we propose to permit an api technology \n",
      "supplier to charge fees to api users \\92\\ for value-\n",
      "\n",
      "[[page 7491]]\n",
      "\n",
      "added services supplied in connection with software that can interact \n",
      "with the api technology. these ``value-added services'' would need to \n",
      "be provided in connection with and supplemental to the development, \n",
      "testing, and deployment of software applications that interact with api \n",
      "technology. critically, fees would not be permitted if they interfere \n",
      "with an api user's ability to efficiently and effectively develop and \n",
      "deploy production-ready software. this means that in order to be \n",
      "permitted, an api user could not be required to incur the fee in order \n",
      "to develop and deploy a production-ready software application that \n",
      "interacts with the api technology acquired by the api data provider. \n",
      "rather, a fee will only be permitted if it relates to a service that a \n",
      "software developer can elect to purchase, but is not required to \n",
      "purchase in order to develop and deploy production-ready apps.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\92\\ in this context a health care provider, which could \n",
      "otherwise be an ``api data provider'' in one context, may equally be \n",
      "an api user in a different context. given this potential dual role \n",
      "for health care providers, we have focused on api users as the party \n",
      "to whom a fee may be charged for the purposes of this permitted fee.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we believe it appropriate to permit this type of fee because api \n",
      "technology suppliers may offer a wide-range of market differentiating \n",
      "services to make it attractive for api users to develop software \n",
      "applications that can interact with the api technology supplied by an \n",
      "api technology supplier. such services could include advanced training, \n",
      "premium development tools and distribution channels, and enhanced \n",
      "compatibility/integration testing assessments. for example, an api \n",
      "technology supplier would be permitted to charge fees for value-added \n",
      "services that would be associated with but go beyond the scope set by \n",
      "the (g)(10)-certified api, such as write access, co-branded integration \n",
      "into the api technology supplier's product(s) workflow, co-marketing \n",
      "arrangements, and promoted placement in an api technology supplier's \n",
      "app store. that said, we caution api technology suppliers that value-\n",
      "added services would have to be made available in a manner that \n",
      "complies with other requirements of this condition of certification and \n",
      "with the information blocking provision.\n",
      "    to illustrate the scope of the fees permitted under this proposal, \n",
      "we clarify that the permitted value-added services fee would enable an \n",
      "api technology supplier to recover certain costs associated with \n",
      "operating an ``app store.'' however, those fees cannot interfere with \n",
      "an api user's ability to efficiently and effectively develop and deploy \n",
      "production-ready apps without special effort. we are aware that api \n",
      "technology suppliers offer services associated with the listing and \n",
      "promotion of apps beyond basic app placement. such fees would be \n",
      "permitted, so long as the api technology supplier ensured that basic \n",
      "access and listing in the app store was provided free of charge if an \n",
      "app developer depended on such listing to efficiently and effectively \n",
      "develop and deploy production-ready apps without special effort. fees \n",
      "charged for additional/specialized technical support or promotion of \n",
      "the api user's app beyond these basic access and listing services would \n",
      "also be permitted. in contrast, if an api technology supplier required, \n",
      "for example, a software developer's app to go through a paid listing \n",
      "process as a dependency/precondition to be able to be deployed (and \n",
      "generally accessible) to the api technology supplier's health care \n",
      "provider customers to use, this would not be a permitted fee under this \n",
      "condition of certification, would constitute special effort, and could \n",
      "raise information blocking concerns.\n",
      "prohibited fees\n",
      "    as discussed above, we proposed that any api-related fee imposed by \n",
      "an api technology supplier that is not expressly permitted is \n",
      "prohibited. this approach is necessary because, as discussed in section \n",
      "viii.c.5.c of this proposed rule, we continue to receive evidence that \n",
      "some health it developers are engaging in practices that create special \n",
      "effort when it comes to api technology. these practices include fees \n",
      "that create barriers to entry or competition as well as rent-seeking \n",
      "and other opportunistic behaviors. for example, some health it \n",
      "developers are conditioning access to technical interoperability \n",
      "documentation on revenue-sharing or royalty agreements that bear no \n",
      "plausible relation to the costs incurred by the health it developer to \n",
      "provide or enable its use. we are also aware of discriminatory pricing \n",
      "policies that have the purpose or effect of excluding competitors from \n",
      "the use of apis and other interoperability elements. these practices \n",
      "close off the market to innovative applications and services that could \n",
      "empower patients and enable providers to deliver greater value and \n",
      "choice to health care consumers and additional service providers.\n",
      "    to address these concerns we provide the following non-exhaustive \n",
      "examples of fees for services that api technology suppliers would be \n",
      "prohibited from charging:\n",
      "    <bullet> any fee for access to the documentation that an api \n",
      "technology supplier is required to publish or make available under this \n",
      "condition of certification.\n",
      "    <bullet> any fee for access to other types of documentation or \n",
      "information that a software developer may reasonably require to make \n",
      "effective use of api technology for any legally permissible purpose.\n",
      "    <bullet> any fee in connection with any services that would be \n",
      "essential to a developer or other person's ability to develop and \n",
      "commercially distribute production-ready applications that use api \n",
      "technology. these services could include, for example, access to ``test \n",
      "environments'' and other resources that an app developer would need to \n",
      "efficiently design and develop apps. the services could also include \n",
      "access to distribution channels if they are necessary to deploy \n",
      "production-ready software and to production resources, such as the \n",
      "information needed to connect to fhir servers (endpoints) or the \n",
      "ability to dynamically register with an authorization server.\n",
      "permitted fees request for comment\n",
      "    we request comment on any additional specific ``permitted fees'' \n",
      "not addressed above that api technology suppliers should be able to \n",
      "recover in order to assure a reasonable return on investment. \n",
      "furthermore, we request comment on whether it would be prudent to adopt \n",
      "specific, or more granular, cost methodologies for the calculation of \n",
      "the permitted fees. commenters are encouraged to consider, in \n",
      "particular, whether the approach we have described will be \n",
      "administrable and appropriately balance the need to ensure that \n",
      "patients, providers, app developers, and other stakeholders do not \n",
      "encounter unnecessary costs and other special effort with the need to \n",
      "provide adequate assurance to api technology suppliers, investors, and \n",
      "innovators that they will be able to earn a reasonable return on their \n",
      "investments in api technology. we welcome comments on whether the \n",
      "approach adequately balances these concerns or would achieve our stated \n",
      "policy goals, and we welcome comments on potential revisions or \n",
      "alternative approaches. we encourage detailed comments that include, \n",
      "where possible, economic justifications for suggested revisions or \n",
      "alternative approaches.\n",
      "record-keeping requirements\n",
      "    to provide appropriate accountability, we propose in sec.  \n",
      "170.404(a)(3)(v) that api technology suppliers must keep for inspection\n",
      "\n",
      "[[page 7492]]\n",
      "\n",
      "detailed records of all fees charged with respect to api technology and \n",
      "all costs that it claims to have incurred to provide api technology to \n",
      "api data providers. to provide assurance that the api technology \n",
      "supplier's fees are reasonably related to the api technology supplier's \n",
      "costs, the api technology supplier would need to document, with the \n",
      "same level of detail, any fees charged and associated costs incurred to \n",
      "provide other services to which any portion of the costs could \n",
      "reasonably be attributed. for example, if the api technology supplier \n",
      "charges a fee that reflects its costs for internet servers used to \n",
      "provide the api technology, the api technology supplier would need to \n",
      "document the costs of any other internet-based services it provides, as \n",
      "well as any other purposes for which the internet servers are used.\n",
      "    separately, an api technology supplier would need to document the \n",
      "criteria it used to allocate any costs across relevant customers, \n",
      "requestors, or other persons. the criteria must be documented in a \n",
      "level of detail that would enable determination as to whether the api \n",
      "technology supplier's cost allocations are objectively reasonable and \n",
      "comply with the cost accountability requirements, including whether \n",
      "fees reflect the api technology supplier's actual costs reasonably \n",
      "incurred, were allocated reasonably and between only those api data \n",
      "providers that either cause the costs to be incurred or benefit from \n",
      "the associated supply or support of the api technology, and were \n",
      "distributed across customers and other relevant persons in a \n",
      "permissible manner, as described above.\n",
      "    we note that an api technology supplier must retain its accounting \n",
      "records consistent with the retention requirement proposed for adoption \n",
      "as part of the assurances condition of certification (proposed for \n",
      "adoption in sec.  170.402). in the event that a potential violation of \n",
      "this condition and maintenance of certification creates a conformance \n",
      "fact-finding scenario by onc or information blocking is investigated, \n",
      "we believe that this period of time would provide onc with appropriate \n",
      "visibility into the api technology supplier's business practices.\n",
      "    we request comment on whether these requirements provide adequate \n",
      "traceability and accountability for costs permitted under this api \n",
      "condition of certification. we also seek comment on whether to require \n",
      "more detailed accounting records or to prescribe specific accounting \n",
      "standards.\n",
      "iv. openness and pro-competitive conditions\n",
      "    we propose that api technology suppliers would have to comply with \n",
      "certain requirements to promote an open and competitive marketplace. as \n",
      "a general condition, we propose in sec.  170.404(a)(4) that api \n",
      "technology suppliers must grant api data providers (i.e., health care \n",
      "providers who purchase or license api technology) the sole authority \n",
      "and autonomy to permit api users to interact with the api technology \n",
      "deployed by the api data provider. we reinforce this general condition \n",
      "through more specific proposed conditions proposals discussed below \n",
      "that would require api technology suppliers to provide equitable access \n",
      "to api technology, which would include granting the rights and \n",
      "providing the cooperation necessary to enable apps to be deployed that \n",
      "use the api technology to access, exchange, and use ehi in production \n",
      "environments.\n",
      "    as important context for these proposals, we note that the api \n",
      "technology required by this condition of certification falls squarely \n",
      "within the concept of ``essential interoperability elements'' described \n",
      "in section viii.c.4.b of this preamble and, as such, are subject to \n",
      "strict protections under the information blocking provision. as a \n",
      "corollary, to the extent that api technology suppliers claim an \n",
      "intellectual property right or other proprietary interest in the api \n",
      "technology, they must take care not to impose any fees, require any \n",
      "license terms, or engage in any other practices that could add \n",
      "unnecessary cost, difficulty, or other burden that could impede the \n",
      "effective use of the api technology for the purpose of enabling or \n",
      "facilitating access, exchange, or use of ehi. moreover, even apart from \n",
      "these information blocking considerations, we believe that, as \n",
      "developers of technology certified under the program, api technology \n",
      "suppliers owe a special responsibility to patients, providers, and \n",
      "other stakeholders to make api technology available in a manner that is \n",
      "truly ``open'' and minimizes any costs or other burdens that could \n",
      "result in special effort. the proposed conditions set forth below are \n",
      "intended to provide clear rules and expectations for api technology \n",
      "suppliers so that they can meet these obligations.\n",
      "non-discrimination\n",
      "    we propose in sec.  170.404(a)(4)(i) that an api technology \n",
      "supplier must adhere to a strictly non-discriminatory policy regarding \n",
      "the provision of api technology. as a starting point, we propose to \n",
      "require in sec.  170.404(a)(4)(i)(a) that api technology suppliers \n",
      "comply with all of the requirements discussed in section viii.c.4.b of \n",
      "this proposed rule regarding the non-discriminatory provision of \n",
      "interoperability elements. accordingly, and consistent with developers' \n",
      "obligations under the program and our expectation that api technology \n",
      "be truly ``open,'' we propose to require that api technology suppliers \n",
      "must provide api technology to api data providers on terms that are no \n",
      "less favorable than they would provide to themselves and their \n",
      "customers, suppliers, partners, and other persons with whom they have a \n",
      "business relationship. this requirement would apply to both price and \n",
      "non-price terms and thus would apply to any fees that the api \n",
      "technology supplier is permitted to charge under the ``permitted \n",
      "charges conditions'' of this condition of certification. we believe \n",
      "this requirement would ensure that api data providers (i.e., health \n",
      "care providers) who purchase or license api technology have sole \n",
      "authority and autonomy to permit third-party software developers to \n",
      "connect to and use the api technology they have acquired.\n",
      "    next, we propose in sec.  170.404(a)(4)(i)(b) that any terms and \n",
      "conditions associated with api technology would have to be based on \n",
      "objective and verifiable criteria that are uniformly applied for all \n",
      "substantially similar or similarly situated classes of persons and \n",
      "requests. for example, if the api technology supplier applied an ``app \n",
      "store'' entry/listing process unequally and added arbitrary criteria \n",
      "based on the use case(s) an app was focused on, such business practices \n",
      "would not comply with this specific condition and could also be in \n",
      "violation of the information blocking provision.\n",
      "    moreover, we propose in sec.  170.404(a)(4)(i)(c) that an api \n",
      "technology supplier would be prohibited from offering or varying such \n",
      "terms or conditions on the basis of impermissible criteria, such as \n",
      "whether the api user with whom the api data provider has a relationship \n",
      "is a competitor, potential competitor, or will be using ehi obtained \n",
      "via the api technology in a way that facilitates competition with the \n",
      "api technology supplier. the api technology supplier would also be \n",
      "prohibited from taking into consideration the revenue or other value \n",
      "the api user with whom the api data provider has a relationship may \n",
      "derive from access, exchange, or use of ehi obtained by means of the \n",
      "api technology. we believe these proposals\n",
      "\n",
      "[[page 7493]]\n",
      "\n",
      "will help promote greater equity and competition in market as well as \n",
      "prevent discriminatory business practices by api technology suppliers.\n",
      "rights to access and use api technology\n",
      "    we propose in sec.  170.404(a)(4)(ii)(a) that an api technology \n",
      "supplier would have to make api technology available in a manner that \n",
      "enables api data providers and api users to develop and deploy apps to \n",
      "access, exchange, and use ehi in production environments. to this end, \n",
      "we propose that an api technology supplier must have and, upon request, \n",
      "must grant to api data providers and their api users all rights that \n",
      "may be reasonably necessary to access and use api technology in a \n",
      "production environment. in other words, this proposal is focused on the \n",
      "provision of rights reasonably necessary to access and use api \n",
      "technology and does not extend to other intellectual property \n",
      "maintained by the api technology supplier, especially intellectual \n",
      "property that has no nexus with the access and use of api technology. \n",
      "in situations where such a nexus exists, even partially, the api \n",
      "technology supplier would have the duty to determine a method to grant \n",
      "the applicable rights reasonably necessary to access and use the api \n",
      "technology. and if practicable, under these partial cases, we note that \n",
      "it would be possible for the api technology supplier to exclude the \n",
      "intellectual property that would have no impact on the access and use \n",
      "of the api technology.\n",
      "    accordingly, following our proposal, api technology suppliers would \n",
      "need to grant api data providers and their api users with rights that \n",
      "could include but not be limited to the following in order to \n",
      "sufficiently support the use of the api technology:\n",
      "    <bullet> for the purposes of developing products or services that \n",
      "are designed to be interoperable with the api technology supplier's \n",
      "health it or with health it under the api technology supplier's \n",
      "control.\n",
      "    <bullet> any marketing, offering, and distribution of interoperable \n",
      "products and services to potential customers and users that would be \n",
      "needed for the api technology to be used in a production environment. \n",
      "note, api technology suppliers, pursuant to the ``value-added \n",
      "services'' permitted fee, would be able to offer and charge for \n",
      "services such as preferential marketing agreements, co-marketing \n",
      "agreements, and other business arrangements so long as such services \n",
      "are beyond what is necessary for the api technology to be put into use \n",
      "in a production environment.\n",
      "    <bullet> enabling the use of the interoperable products or services \n",
      "in production environments, including accessing and enabling the \n",
      "exchange and use of electronic health information.\n",
      "    relatedly, in sec.  170.404(a)(4)(ii)(b) we propose to prohibit an \n",
      "api technology supplier from imposing any collateral terms or \n",
      "agreements that could interfere with or lead to special effort in the \n",
      "use of api technology for any of the above purposes. we note that these \n",
      "collateral terms or agreements may also implicate the information \n",
      "blocking provision for the reasons described in section viii.d.3.c of \n",
      "this preamble. these specific proposed conditions would expressly \n",
      "prohibit an api technology supplier from conditioning any of the rights \n",
      "described above on the requirement that the recipient of the rights do, \n",
      "or agree to do, any of the following:\n",
      "    <bullet> pay a fee to license the rights described above, including \n",
      "but not limited to a license fee, royalty, or revenue-sharing \n",
      "arrangement.\n",
      "    <bullet> not compete with the api technology supplier in any \n",
      "product, service, or market.\n",
      "    <bullet> deal exclusively with the api technology supplier in any \n",
      "product, service, or market.\n",
      "    <bullet> obtain additional licenses, products, or services that are \n",
      "not related to or can be unbundled from the api technology.\n",
      "    <bullet> license, grant, assign, or transfer any intellectual \n",
      "property to the api technology supplier.\n",
      "    <bullet> meet additional developer or product certification \n",
      "requirements.\n",
      "    <bullet> provide the api technology supplier or its technology with \n",
      "reciprocal access to application data.\n",
      "    these prohibitions largely mirror those proposed under the \n",
      "exception to the information blocking definition in sec.  171.206 and \n",
      "reflect the same concerns expressed in that context in section \n",
      "viii.d.3.c of this preamble. however, we note the following important \n",
      "distinction: whereas proposed sec.  171.206 would permit a developer to \n",
      "charge a reasonable royalty to license interoperability elements, this \n",
      "api condition of certification would not permit any such royalty, \n",
      "license fee, or other type of fee of any kind whatsoever pursuant to \n",
      "the general fee prohibition proposed in the ``permitted charges \n",
      "condition.'' this additional limitation reflects the more exacting \n",
      "standards that apply to api technology suppliers with respect to the \n",
      "provision of api technology under this condition of certification. \n",
      "while we believe that, for the reasons described in section viii.d.3.c \n",
      "of this preamble, health it developers should generally be permitted to \n",
      "charge reasonable royalties for the use of their intellectual property, \n",
      "we consider api technology to be a special case. certified health it \n",
      "developers (i.e., api technology suppliers) are required to provide \n",
      "these capabilities as part of their statutory duty to facilitate the \n",
      "access, exchange, and use of patient health information from ehrs \n",
      "``without special effort.'' we believe the language requiring that \n",
      "these capabilities be ``open'' precludes an api technology supplier \n",
      "from conditioning access to api technology on the payment of a royalty \n",
      "or other fee, however ``reasonable'' the fee might otherwise be.\n",
      "    we clarify that the prohibitions explained above against additional \n",
      "developer or health it module certification requirements and, \n",
      "separately, against requirements for reciprocal access to application \n",
      "data, are within the scope of the collateral terms prohibited by \n",
      "proposed sec.  171.206 even though these additional api technology \n",
      "supplier requirements are not explicitly referenced by that exception \n",
      "because they are not generally applicable to all types of \n",
      "interoperability elements. nevertheless, permitting an api technology \n",
      "supplier to impose these kinds of additional requirements would be \n",
      "inconsistent with the cures act's expectation that api technology be \n",
      "made available openly and in a manner that promotes competition. for \n",
      "the same reason such practices may raise information blocking concerns.\n",
      "api technology suppliers--additional obligations\n",
      "    to support the use of api technology in production environments, we \n",
      "propose in sec.  170.404(a)(4)(iii) that an api technology supplier \n",
      "must provide all support and other services that are reasonably \n",
      "necessary to enable the effective development, deployment, and use of \n",
      "api technology by api data providers and its api users in production \n",
      "environments. in general, the precise nature of these obligations will \n",
      "depend on the specifics of the api technology supplier's technology and \n",
      "the manner in which it is implemented and made available for specific \n",
      "customers. therefore, with the following exceptions, we do not \n",
      "delineate the api technology supplier's specific support obligations \n",
      "and instead propose a general requirement to this effect in sec.  \n",
      "170.404(a)(4)(iii).\n",
      "\n",
      "[[page 7494]]\n",
      "\n",
      "changes and updates to api technology and terms and conditions\n",
      "    we propose to require in sec.  170.404(a)(4)(iii)(a) that api \n",
      "technology suppliers must make reasonable efforts to maintain the \n",
      "compatibility of the api technology they develop and assist api data \n",
      "providers to deploy in order to avoid disrupting the use of api \n",
      "technology. similarly, we propose in sec.  170.404(a)(4)(iii)(b) that \n",
      "prior to making changes or updates to its api technology or to the \n",
      "terms or conditions thereof, an api technology supplier would need to \n",
      "provide notice and a reasonable opportunity for its api data provider \n",
      "customers and registered application developers to update their \n",
      "applications to preserve compatibility with its api technology or to \n",
      "comply with any revised terms or conditions. without this opportunity, \n",
      "clinical and patient applications could be rendered inoperable or \n",
      "operate in unexpected ways unbeknownst to the users or software \n",
      "developers.\n",
      "    further, we note that this proposal aligns with the exception to \n",
      "the information blocking definition proposed in sec.  171.206. as \n",
      "explained in section viii.d.3.c of this preamble, the information \n",
      "blocking definition would be implicated were an api technology supplier \n",
      "to make changes to its api technology that ``break'' compatibility or \n",
      "otherwise degrade the performance or interoperability of the licensee's \n",
      "products or services that incorporate the licensed api technology. we \n",
      "propose these additional safeguards are important in light of the ease \n",
      "with which an api technology supplier could make subtle ``tweaks'' to \n",
      "its technology or related services, which could disrupt the use of the \n",
      "licensee's compatible technologies or services and result in \n",
      "substantial competitive and consumer injury.\n",
      "    we clarify that this requirement would in no way prevent an api \n",
      "technology supplier from making improvements to its technology or \n",
      "responding to the needs of its own customers or users. however, the api \n",
      "technology supplier would need to demonstrate that whatever actions it \n",
      "took were necessary to accomplish these purposes and that it afforded \n",
      "the licensee a reasonable opportunity under the circumstances to update \n",
      "its technology to maintain interoperability. relatedly, we recognize \n",
      "that an api technology supplier may have to suspend access or make \n",
      "other changes immediately and without prior notice in response to \n",
      "legitimate privacy, security, or patient safety-related exigencies. \n",
      "such practices would be permitted by this condition of certification \n",
      "provided they are tailored and do not unnecessarily interfere with the \n",
      "use of api technology. from an information blocking standpoint, if such \n",
      "practices interfered with access, exchange, or use of ehi, the api \n",
      "technology supplier could seek coverage under the exceptions to the \n",
      "information blocking provision described in section viii.d of this \n",
      "preamble. for instance, if the suspended access was in response to a \n",
      "privacy exigency, the api technology supplier may be able to seek \n",
      "coverage under the exception for promoting the privacy of ehi at \n",
      "proposed sec.  171.202.\n",
      "e. maintenance of certification requirements\n",
      "    we propose to adopt maintenance requirements for this condition of \n",
      "certification. these maintenance requirements would be duties that we \n",
      "believe the cures act expected api technology suppliers (i.e., health \n",
      "it developers) would need to comply with in the course of maintaining \n",
      "their health it module(s)' certification.\n",
      "i. app registration timeliness\n",
      "    in the specific context of application registration, we wish to \n",
      "underscore that to provide a frictionless experience for developers of \n",
      "these applications and individuals that use them, an api technology \n",
      "supplier would be required to provide all services and other support \n",
      "necessary to ensure that such apps can be deployed and used in \n",
      "production without any additional assistance or intervention by the api \n",
      "technology supplier. for this reason, we propose in sec.  170.404(b)(1) \n",
      "a specific requirement for api technology suppliers that they would \n",
      "need to ``register'' (in connection with the api technology \n",
      "functionality proposed in sec.  170.315(g)(10)(iii)) and enable all \n",
      "applications for production use within one business day of completing \n",
      "its verification of an application developer's authenticity as \n",
      "described in proposed sec.  170.404(a)(2)(ii)(c). we propose this \n",
      "explicit requirement is necessary in order to ensure that a patient's \n",
      "ability to use an app of their choice is not artificially or \n",
      "intentionally slowed by an api technology supplier, causing special \n",
      "effort on the part of the patient to gain access to their ehi. we also \n",
      "emphasize that this is specific duty for api technology suppliers in \n",
      "the course of maintaining the health it module(s)' certificate to which \n",
      "their api technology is associated. in instances where an api \n",
      "technology supplier chooses not to perform app developer verification \n",
      "processes described in proposed sec.  170.404(a)(2)(ii)(c), it would \n",
      "need to solely meet this one business day requirement from the point of \n",
      "having received a request for registration.\n",
      "ii. publication of fhir endpoints\n",
      "    in order to interact with a fhir restful api, an app needs to know \n",
      "the ``fhir service base url,'' which is often referred to colloquially \n",
      "as a ``fhir server's endpoint.'' \\93\\ the public availability and easy \n",
      "accessibility of this information is a central necessity to assuring \n",
      "the use of fhir-based apis without special effort, especially for \n",
      "patient access apps. accordingly, we propose to adopt in sec.  \n",
      "170.404(b)(2) a specific requirement that an api technology supplier \n",
      "must support the publication of service base urls for all of its \n",
      "customers, regardless of those that are centrally managed by the api \n",
      "technology supplier or locally deployed, and make such information \n",
      "publicly available (in a computable format) at no charge. in instances \n",
      "where an api technology supplier is contracted by an api data provider \n",
      "to manage its fhir server, we expect that this administrative duty will \n",
      "be relatively easy to manage. in instances where an api data provider \n",
      "assumes full responsibility to ``locally manage'' its fhir server, the \n",
      "api technology supplier would be required, pursuant to this proposed \n",
      "maintenance requirement, to obtain this information from its customers. \n",
      "we strongly encourage api technology suppliers, health care providers, \n",
      "hins and patient advocacy organizations to coalesce around the \n",
      "development of a public resource or service from which all stakeholders \n",
      "could benefit. we believe this would help scale and enhance the ease \n",
      "with which service base urls could be obtained and used.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\93\\ <a href=\"http://hl7.org/fhir/http.html#general\">http://hl7.org/fhir/http.html#general</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "iii. providing (g)(10)-certified apis to api data providers\n",
      "    we propose in sec.  170.404(b)(3) that an api technology supplier \n",
      "with api technology previously certified to the certification criterion \n",
      "in sec.  170.315(g)(8) must provide all api data providers with such \n",
      "api technology deployed with api technology certified to the \n",
      "certification criterion in sec.  170.315(g)(10) within 24 months of \n",
      "this final rule's effective date. we believe this maintenance of \n",
      "certification requirement will permit onc to monitor and facilitate the \n",
      "rollout to health care providers of this important functionality. this \n",
      "is of particular relevance as we propose below to include this \n",
      "functionality in the 2015 base ehr definition in place of the\n",
      "\n",
      "[[page 7495]]\n",
      "\n",
      "current ``application access--data category request'' certification \n",
      "criterion (sec.  170.315(g)(8)), which means health care providers will \n",
      "need this functionality to meet the certified ehr technology (cehrt) \n",
      "for associated centers for medicare & medicaid services (cms) programs.\n",
      "f. 2015 edition base ehr definition\n",
      "    as described in detail above, we have propose to adopt a new \n",
      "certification criterion in sec.  170.315(g)(10) that would replace the \n",
      "current criterion adopted in sec.  170.315(g)(8) and as referenced in \n",
      "the 2015 edition base ehr definition expressed in sec.  170.102. this \n",
      "change is necessary to fully implement the cures act and ensure that \n",
      "api technology suppliers have the requisite incentive to deploy \n",
      "standardized apis that can be used ``without special effort'' and api \n",
      "data providers have added incentive to adopt such functionality. as \n",
      "result, we propose to create a phase-in for the proposed api \n",
      "certification criterion in sec.  170.315(g)(10) from the issuance of a \n",
      "subsequent final rule. this phase-in period includes separate and \n",
      "sequential time for api technology suppliers and api data providers.\n",
      "    consistent with our proposed compliance timing for the \n",
      "certification criterion proposed for adoption in sec.  170.315(b)(10), \n",
      "we propose to add compliance timeline language to the 2015 edition base \n",
      "ehr definition for the transition from sec.  170.315(g)(8) to sec.  \n",
      "170.315(g)(10) that would reflect a total of 24 months from the final \n",
      "rule's effective date (which practically speaking would be 25 months \n",
      "because of the 30-day delayed effective date). we believe this approach \n",
      "is best because it identifies a single, specific date for both api \n",
      "technology suppliers and api data providers by which upgraded api \n",
      "technology needs to be deployed in production. we also believe that 24 \n",
      "months is sufficient for this upgrade because the scope and nature of \n",
      "our proposals intersect and reflect a large portion of capabilities api \n",
      "technology suppliers have already developed and deployed to meet sec.  \n",
      "170.315(g)(8). moreover, this single date enables api technology \n",
      "suppliers (based on their client base and it architecture) to determine \n",
      "the most appropriate timeline for development, testing, certification, \n",
      "and product release cycles in comparison to having to meet an arbitrary \n",
      "``must be certified by this date'' requirement.\n",
      "5. real world testing\n",
      "    the cures act requires, as a condition and maintenance of \n",
      "certification under the program, that health it developers have \n",
      "successfully tested the real world use of the technology for \n",
      "interoperability in the type of setting in which such technology would \n",
      "be marketed. the cures act defines interoperability as ``health \n",
      "information technology that enables the secure exchange of electronic \n",
      "health information with, and use of electronic health information from, \n",
      "other health information technology without special effort on the part \n",
      "of the user; allows for complete access, exchange, and use of all \n",
      "electronically accessible health information for authorized use under \n",
      "applicable state or federal law; and does not constitute information \n",
      "blocking as also defined by the cures act.'' \\94\\ we propose to codify \n",
      "this interoperability definition in sec.  170.102. we further note that \n",
      "we propose in section viii of this proposed rule to codify the \n",
      "definition of information blocking included in the cures act in sec.  \n",
      "171.103.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\94\\ defined in section 3022 of the cures act.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the program issues, and will continue to issue under our real world \n",
      "testing approach, certifications to health it through a process whereby \n",
      "health it is assessed against the testing requirements established by \n",
      "onc. often, this means health it is tested by an onc-atl in a \n",
      "laboratory environment through methods that include a testing proctor's \n",
      "visual inspection of functions, review of developer-provided \n",
      "documentation of functions, and testing tools with simulation test \n",
      "data. an onc-acb evaluates the results of testing and makes a \n",
      "determination, based on these test results and an assessment of \n",
      "compliance with other program requirements, to issue the health it a \n",
      "certificate. over the course of the program's existence, onc has \n",
      "emphasized the continued conformance of certified health it products \n",
      "post-certification in real world and clinical settings. for example, \n",
      "onc expanded the responsibilities of onc-acbs in the 2015 edition final \n",
      "rule to require that they perform in-the-field surveillance. we did \n",
      "this to affirm the program's long-standing expectations that certified \n",
      "health it continue to operate in accordance with certification \n",
      "requirements when implemented in the field (80 fr 62707-62719). these \n",
      "efforts are also in line with the cures act's real world testing \n",
      "condition of certification through their focus on system \n",
      "interoperability and exchange of information as deployed and used in \n",
      "care environments--that is to say, in the ``real world.''\n",
      "    the objective of real world testing is to verify the extent to \n",
      "which certified health it deployed in operational production settings \n",
      "is demonstrating continued compliance to certification criteria and \n",
      "functioning with the intended use cases as part of the overall \n",
      "maintenance of a health it's certification. real world testing should \n",
      "ensure certified health it has the ability to share electronic health \n",
      "information with other systems. real world testing should assess that \n",
      "the certified health it is meeting the intended use case(s) of the \n",
      "certification criteria to which it is certified within the workflow, \n",
      "health it architecture, and care/practice setting in which the health \n",
      "it is implemented. accordingly, we propose that successful real world \n",
      "testing means for the purpose of this condition of certification that:\n",
      "    <bullet> the certified health it continues to be compliant to the \n",
      "certification criteria to which it is certified, including the required \n",
      "technical standards and vocabulary codes sets;\n",
      "    <bullet> the certified health it is exchanging electronic health \n",
      "information in the care and practice settings for which it is intended \n",
      "for use; and\n",
      "    <bullet> electronic health information is received by and used in \n",
      "the certified health it.\n",
      "    we propose to limit the applicability of this condition of \n",
      "certification to health it developers with health it modules certified \n",
      "to one or more 2015 edition certification criteria focused on \n",
      "interoperability and data exchange, which are:\n",
      "    <bullet> the care coordination criteria in sec.  170.315(b);\n",
      "    <bullet> the clinical quality measures (cqms) criteria in sec.  \n",
      "170.315(c)(1) through (c)(3);\n",
      "    <bullet> the ``view, download, and transmit to 3rd party'' \n",
      "criterion in sec.  170.315(e)(1);\n",
      "    <bullet> the public health criteria in sec.  170.315(f);\n",
      "    <bullet> the application programming interface criteria in sec.  \n",
      "170.315(g)(7) through (g)(11); and\n",
      "    <bullet> the transport methods and other protocols criteria in \n",
      "sec.  170.315(h).\n",
      "    the 2015 edition certification criteria that are not included in \n",
      "the proposed list include many functionality-based criteria, \n",
      "administrative criteria, and, overall, criteria that do not focus on \n",
      "interoperability and exchange of data. in particular, we do not propose \n",
      "to include the 2015 edition paragraph (a) ``clinical'' certification \n",
      "criteria in this list because they do not focus on interoperability and \n",
      "exchange of data. however, the data in the paragraph (a) criteria \n",
      "largely will be covered through the uscdi as a minimum data set \n",
      "expected for exchange; the uscdi is included in such criteria as \n",
      "``transitions\n",
      "\n",
      "[[page 7496]]\n",
      "\n",
      "of care'' (sec.  170.315(b)(1)), ``view, download, and transmit to 3rd \n",
      "party'' (sec.  170.315(e)(1)), and the api criteria (i.e., sec.  \n",
      "170.315(g)(9) and (10)).\n",
      "    we solicit comment on whether to include the ``patient health \n",
      "information capture'' certification criteria in sec.  170.315(e)(3), \n",
      "including the value of real world testing these functionalities \n",
      "compared to the benefit for interoperability and exchange. we also \n",
      "solicit comment on whether any other 2015 edition certification \n",
      "criteria should be included or removed from the applicability list for \n",
      "this condition of certification.\n",
      "    to fully implement the real world testing condition of \n",
      "certification as described above, we propose maintenance of \n",
      "certification requirements that would require health it developers to \n",
      "submit publicly available prospective annual real world testing plans \n",
      "and retrospective annual real world testing results for its certified \n",
      "health it that include certification criteria focused on \n",
      "interoperability. as we considered the various approaches to implement \n",
      "this cures act requirement on health it developers, we determined that \n",
      "health it developers would be best positioned to construct how their \n",
      "certified health it could be tested in the real world. moreover, by \n",
      "requiring health it developers to be responsible for facilitating their \n",
      "certified health it testing in production settings and being held \n",
      "accountable to publicly publish their results, we would balance the \n",
      "respective burden of this statutory requirement with its intended \n",
      "assurances for health care providers. additionally, onc is not \n",
      "adequately resourced to centrally administer a real world testing \n",
      "regime among each health it developer and its customers, nor do we have \n",
      "the specific relationships with health care providers that health it \n",
      "developers do. lastly, even if onc were positioned to support and scale \n",
      "a real world testing regime, we would run the risk of having one-size-\n",
      "fits-all tools that would not necessarily get to the level of detail \n",
      "and granularity necessary and reflective of different health care \n",
      "settings and different scopes of practice that use certified health it.\n",
      "    given these considerations, we propose that a health it developer \n",
      "must submit an annual real world testing plan to its onc-acb via a \n",
      "publicly accessible hyperlink no later than december 15, of each \n",
      "calendar year for each of its certified 2015 edition health it modules \n",
      "that include certification criteria specified for this condition of \n",
      "certification. prior to submission to the onc-acb, the plan would need \n",
      "to be approved by a health it developer authorized representative \n",
      "capable of binding the health it developer for execution of the plan \n",
      "and include the representative's contact information. the plan would \n",
      "need to include all health it certified to the 2015 edition through \n",
      "august 31 of the preceding year. the plan would also need to address \n",
      "the health it developer's real world testing for the upcoming calendar \n",
      "year and include, for each of the certification criteria in scope:\n",
      "    <bullet> the testing method(s)/methodology(ies) that will be used \n",
      "to demonstrate real world interoperability, including a mandatory focus \n",
      "on scenario- and use case-focused testing;\n",
      "    <bullet> the care and practice setting(s) that will be tested for \n",
      "real world interoperability, including conformance to certification \n",
      "criteria requirements, and an explanation for the health it developer's \n",
      "choice of care setting(s) to test; \\95\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\95\\ we do not propose to specifically define or limit the care \n",
      "settings and leave it to the health it developer to determine. as an \n",
      "example, health it developers can consider categories, including but \n",
      "not limited to, those used in the ehr incentive programs (<a href=\"https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/october2017_medicareehrincentivepayments.pdf\">https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/downloads/october2017_medicareehrincentivepayments.pdf</a>); long-term and post-\n",
      "acute care; pediatrics; behavioral health; and small, rural, and \n",
      "underserved settings.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> the timeline and plans for voluntary updates to standards \n",
      "and implementation specifications that onc has approved (further \n",
      "discussed below);\n",
      "    <bullet> a schedule of key real world testing milestones;\n",
      "    <bullet> a description of the expected outcomes of real world \n",
      "testing;\n",
      "    <bullet> at least one measurement/metric associated with the real \n",
      "world testing; and\n",
      "    <bullet> a justification for the health it developer's real world \n",
      "testing approach.\n",
      "    the intended testing methods/methodologies would need to address \n",
      "testing scenarios, use cases, and workflows associated with \n",
      "interoperability. testing may occur in the operational setting using \n",
      "real patient data, in an environment that mirrors the clinical setting \n",
      "using synthetic or real patient data, or in the clinical setting with \n",
      "synthetic data intermixed. note that when health it developers who are \n",
      "hipaa business associates are conducting testing using ephi, such \n",
      "testing must be conducted consistent with their business associate \n",
      "agreements and other compliance responsibilities. the health it \n",
      "developer may also partner with other health it developers to perform \n",
      "real world testing. we would expect developers to consider such factors \n",
      "as the size of the organization that production systems support, the \n",
      "type of organization and setting, the number of patient records and \n",
      "users, system components and integrations, and the volume and types of \n",
      "data exchange in planning for real world testing. we would also expect \n",
      "developers to explain how they will incorporate voluntary standards \n",
      "updates in their real world testing as discussed further below. while \n",
      "we are not proposing a minimum proportion of the customer base that \n",
      "must be covered in real world testing, we highly encourage developers \n",
      "to find ways to ensure, to the extent practical, proportionate coverage \n",
      "of their customer base that balances the goals of real world testing \n",
      "with burden to providers. health it developers would not be required to \n",
      "test the certified health it in each and every setting in which it is \n",
      "intended for use as this would likely not be feasible due to the \n",
      "associated burden; however, developers must address their choice of \n",
      "care and/or practice settings to test and onc encourages developers \n",
      "test in as many settings as feasible. additionally, health it \n",
      "developers would be required to provide a justification for their \n",
      "chosen approach. because our approach provides great flexibility for \n",
      "health it developers with respect to demonstrating compliance, we \n",
      "believe it is imperative that they provide a justification to explain \n",
      "their methodology. through the transparent reporting of their real \n",
      "world testing plans, the public will have an opportunity to consider a \n",
      "health it developer's chosen approach(es) and whether it is \n",
      "sufficiently comprehensive to provide assurance that the certified \n",
      "health it has satisfactorily demonstrated its satisfaction of program \n",
      "requirements including interoperability in real world settings relevant \n",
      "to their needs.\n",
      "    health it developers should consider existing testing tools and \n",
      "approaches that may be used to assess real world interoperability. for \n",
      "example, we encourage health it developers to consider metrics of use \n",
      "and exchange from existing networks, communities, and tools including, \n",
      "but not limited to, surescripts, carequality, commonwell health \n",
      "alliance, the c-cda one-click scorecard, and directtrust. we do not \n",
      "believe that testing through the onc-approved test procedures is \n",
      "sufficient to demonstrate real world use as the test procedures \n",
      "developed for initial laboratory testing and certification are \n",
      "generally setting agnostic, focused on standards conformance, and do \n",
      "not always test the full scope of the certification criteria's intended \n",
      "functionality. we also clarify that the\n",
      "\n",
      "[[page 7497]]\n",
      "\n",
      "onc-approved test procedures are not intended for use in in-the-field \n",
      "surveillance or for real world testing. further, we do not believe \n",
      "connect-a-thons are a valid approach to testing real world use of \n",
      "health it because they do not necessarily assess interoperability and \n",
      "functionality in live settings, but rather test developer/vendor \n",
      "connectivity in a closed test environment. health it developers may \n",
      "consider working with an onc-acb to have the onc-acb oversee the \n",
      "execution of the health it developer's real world testing plans, which \n",
      "could include in-the-field surveillance per sec.  170.556, as an \n",
      "acceptable approach to meet the requirements of the real world testing \n",
      "condition of certification.\n",
      "    we propose that health it developers with multiple certified health \n",
      "it products that may include the same interoperability-focused \n",
      "certification criteria intended to be implemented in the same settings \n",
      "have the discretion to design their real world testing plans in a way \n",
      "that efficiently tests a combination of products. likewise, health it \n",
      "developers may find portions of their real world testing plans are \n",
      "transferrable to their other certified products; thus a health it \n",
      "developer could choose to submit a real world testing plan that covers \n",
      "multiple certified products as appropriate and as long as there is \n",
      "traceability to the specific certified health it modules. to be clear, \n",
      "developers of health it products deployed through the cloud who offer \n",
      "their products for multiple types of settings would be required to test \n",
      "the same capability for those different settings. however, we solicit \n",
      "comment on whether we should offer an exemption for services that truly \n",
      "support all of a developer's customers through a single interface/\n",
      "engine and whether this would be sufficient to meet the intent of the \n",
      "real world testing condition of certification. additionally, while the \n",
      "developers' plans must address each of the interoperability-focused \n",
      "certification criteria in their certified health it, developers can and \n",
      "should design scenario-based test cases that incorporate multiple \n",
      "functionalities as appropriate for the real world workflow and setting.\n",
      "    we propose that a health it developer would submit annual real \n",
      "world testing results to their onc-acbs via a publicly accessible \n",
      "hyperlink no later than january 31, of each calendar year for the \n",
      "preceding calendar year's real world testing. real world testing \n",
      "results for each interoperability-focused certification criterion must \n",
      "address the elements required in the previous year's testing plan, \n",
      "describe the outcomes of real world testing with any challenges \n",
      "encountered, and provide at least one measurement or metric associated \n",
      "with the real world testing. as noted above, developers are encouraged \n",
      "to use metrics demonstrating real world use from existing networks and \n",
      "communities. we seek comment on whether onc should require developers \n",
      "submit real world testing results for a minimum ``core'' set of general \n",
      "metrics/measurements and examples of suggested metrics/measurements. we \n",
      "also invite comment on the proposed annual frequency and timing of \n",
      "required real world testing results reporting.\n",
      "    we acknowledge that a subsequent final rule for this proposed rule \n",
      "may not provide sufficient time for health it developers to develop and \n",
      "submit plans for a full year of real world testing in 2020. if such a \n",
      "situation comes to fruition, we expect to provide an appropriate period \n",
      "of time for developers to submit their plans and potentially treat 2020 \n",
      "as a ``pilot'' year for real world testing. we would expect that such \n",
      "pilot testing conform to our proposed real world testing to the extent \n",
      "practical and feasible (e.g., same criteria but for a shorter duration \n",
      "and without the same consequences for non-compliance). we welcome \n",
      "comments on this potential approach.\n",
      "    we clarify, and propose, that even if a health it developer does \n",
      "not have customers or has not deployed their certified health it module \n",
      "at the time the real world testing plan is due, the health it developer \n",
      "would still need to submit a plan that addresses its prospective \n",
      "testing for the coming year for any health it certified prior to august \n",
      "31 of the preceding calendar year. if a health it developer does not \n",
      "have customers or has not deployed their certified health it module \n",
      "when the annual real world testing results are due, we propose that the \n",
      "developer would need to report as such to meet the proposed maintenance \n",
      "of certification requirement. for further clarity, a developer would \n",
      "not need to report on any health it certified after august 31, in the \n",
      "preceding year.\n",
      "standards version advancement process\n",
      "    as new and more advanced versions \\96\\ become available for adopted \n",
      "standards and implementation specifications applicable to criteria \n",
      "subject to the real world testing condition and maintenance of \n",
      "certification requirements, we believe that a health it developer's \n",
      "ability to conduct ongoing maintenance on its certified health it \n",
      "module(s) to incorporate these new versions is essential to support \n",
      "interoperability in the real world. updated versions of standards \n",
      "reflect insights gained from real-world implementation and use. they \n",
      "also reflect industry stakeholders' interests to improve the capacity, \n",
      "capability, and clarity of such standards to meet new, innovative \n",
      "business needs, which earlier standards versions cannot support. \n",
      "therefore, as part of the real world testing condition of \n",
      "certification, we propose a maintenance of certification flexibility \n",
      "that we refer to as the standards version advancement process. the \n",
      "standards version advancement process would permit health it developers \n",
      "to voluntarily use in their certified health it modules newer versions \n",
      "of adopted standards so long as certain conditions are met, not limited \n",
      "to but notably including successful real world testing of the health it \n",
      "module using the new version(s).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\96\\ we note that standards development organizations and \n",
      "consensus standards bodies use various nomenclature, such as \n",
      "``versions,'' to identify updates to standards and implementation \n",
      "specifications.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we propose to establish the standards version advancement \n",
      "processnot only to meet the cures act's goals for interoperability, but \n",
      "also in response to the continuous stakeholder feedback that onc has \n",
      "received through prior rulemakings and engagements, which requested \n",
      "that onc establish a predictable and timely approach within the program \n",
      "to keep pace with the industry's standards development efforts. \n",
      "rulemaking has not kept up with the pace of standards development and \n",
      "deployment in the health care market. there is no better evidence of \n",
      "this reality than by example from our 2015 edition rulemaking finalized \n",
      "approximately three years ago and before the cures act added conditions \n",
      "and maintenance of certification provisions to the phsa. two version \n",
      "updates of the national health care survey standard (versions 1.1 and \n",
      "1.2) have been issued since we adopted version 1.0 in the 2015 edition \n",
      "final rule (october 16, 2015). health it developer and health care \n",
      "provider compliance and use of these versions has and will be necessary \n",
      "for submission to centers for disease control and prevention (cdc) even \n",
      "though the certification criterion adopted in sec.  170.315(f)(7) \n",
      "continues to require conformance to version 1.0. similarly, many other \n",
      "adopted standards have seen multiple newer versions introduced to the \n",
      "market since we issued the 2015 edition final rule, such as for ecqm \n",
      "reporting or e-prescribing. the proposed standards\n",
      "\n",
      "[[page 7498]]\n",
      "\n",
      "version advancement process flexibility gives health it developers the \n",
      "option to avoid such unnecessary costs and can help reduce market \n",
      "confusion by enabling certified health it modules keep pace with \n",
      "standards advancement and market needs including but not limited to \n",
      "those related to emerging public health concerns.\n",
      "    we have also been informed by stakeholders that, in other cases, \n",
      "onc's inability to more nimbly identify and incorporate newer versions \n",
      "to standards and implementation specifications that were already \n",
      "adopted by the secretary into the program has perversely impacted \n",
      "standards developing organization (sdo) processes. although sdos can \n",
      "rapidly iterate version updates to standards and implementation \n",
      "specifications to address ambiguities and implementation challenges \n",
      "reported from the field and to particularly address matters that \n",
      "adversely impact interoperability, the lack of a clear path for that \n",
      "work effort to be timely realized as part of the program's \n",
      "certification requirements has had a chilling effect on the pace of \n",
      "change. it can also affect the willingness of volunteers at these sdos \n",
      "to devote their time to make updates that would be outdated by the time \n",
      "onc goes through a rulemaking, which can be years. stakeholders have \n",
      "indicated that certified health it developers, customers and users of \n",
      "certified health it, and the sdo industry have been technologically \n",
      "restricted and innovation-stunted as a result of our prior regulatory \n",
      "approach, which focused on certification assuring compliance only to \n",
      "the version of a standard adopted in regulation and did not provide an \n",
      "avenue for the program to accommodate iterative updates to standards \n",
      "during the time between rulemakings. with the passage of the \n",
      "``maintenance of certification'' provision in sec.  4002 of the cures \n",
      "act, we believe the approach proposed here is in line with our new \n",
      "statutory authority regarding conditions of certification and \n",
      "maintenance of certification and would better and more timely support \n",
      "market demands for widespread interoperability.\n",
      "    in supporting more rapid advancement of interoperability, we \n",
      "believe the proposed standards version advancement process approach \n",
      "will benefit patient care, improve competition, and spur additional \n",
      "engagement in standards development. to this point, currently, if the \n",
      "uscdi v1 were adopted as currently proposed in sec.  170.213 and then \n",
      "needed to be updated to add just one data class or data element (e.g., \n",
      "a new demographic element), we would need to initiate notice and \n",
      "comment rulemaking to incorporate that uscdi version change into the \n",
      "program. likewise, similar updates to standards included in our 2015 \n",
      "edition final rule are made annually (or more frequently) by sdos. in \n",
      "order to attempt to keep pace with such updates, which are published at \n",
      "different times of the year, onc would need to continuously engage in \n",
      "rulemaking cycles, perhaps even more than once per year. we believe \n",
      "that the proposed standards version advancement process would allow for \n",
      "more advanced versions of standards and implementation specifications \n",
      "to be approved for use under the program in a more timely and flexible \n",
      "manner that helps to ease the concerns stakeholders have reported. \n",
      "stakeholder input throughout the program's existence has informed onc \n",
      "that updating large groupings of standards' versions while also \n",
      "adopting new standards through rulemakings that only occur about once \n",
      "every three years can create an artificial market impact in a number of \n",
      "ways. such ``all-in-one'' updates affect all health it developers and \n",
      "the vast majority of health care providers at the same time across all \n",
      "sectors rather than enabling a more incremental and market-based \n",
      "upgrade cycle in response to interoperability, business, and clinical \n",
      "needs.\n",
      "    the standards version advancement process and corresponding \n",
      "proposed revisions to sec. sec.  170.550 and 170.555 would introduce \n",
      "two types of administrative flexibility for health it developers \n",
      "participating in the program. first, for those health it developers \n",
      "with an existing certified health it module, the health it modules \n",
      "would be permitted to be upgraded (in the course of ongoing \n",
      "maintenance) to a new version of an adopted standard within the scope \n",
      "of the certification (without having to retest or recertify) so long as \n",
      "such version was approved by the national coordinator for use in \n",
      "certification through the standards version advancement process. \n",
      "second, for those health it developers seeking to have a health it \n",
      "module's initial certificate issued, the health it module would be \n",
      "permitted to be presented for certification to a new version of an \n",
      "adopted standard so long as such version was approved by the national \n",
      "coordinator through the standards version advancement process. this \n",
      "policy flexibility is similar to the flexibility we introduced several \n",
      "years ago for ``minimum standards'' code sets, but we would require \n",
      "onc-acbs to offer certification under the standards version advancement \n",
      "process to national-coordinator-approved newer versions of all \n",
      "standards to which real world testing requirements apply.\\97\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\97\\ for purposes of clarity, we note that the standards version \n",
      "advancement process would not affect the established minimum \n",
      "standards code sets flexibility. consistent with sec.  170.555, \n",
      "under the program, health it could continue to be certified or \n",
      "upgraded to a newer version of identified minimum standards code \n",
      "sets (see 80 fr 62612) than even the most recent one the national \n",
      "coordinator had approved for use in the program via the standards \n",
      "version advancement process unless the secretary prohibits the use \n",
      "of the newer version for certification.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in order to ensure equitable treatment under the program and in \n",
      "order for onc to maintain the program's overall integrity, each \n",
      "developer that chooses to leverage the proposed standards version \n",
      "advancement process maintenance of certification program flexibilities \n",
      "would need to satisfy the following.\n",
      "health it developers updating already certified health it\n",
      "    in instances where a health it developer has certified a health it \n",
      "module, including but not limited to instances where its customers are \n",
      "already using the certified health it module, if the developer intends \n",
      "to update pursuant to the standards version advancement process \n",
      "election, the developer would be required to provide advance notice to \n",
      "all affected customers and its onc-acb: (a) expressing its intent to \n",
      "update the software to the more advanced version of the standard \n",
      "approved by the national coordinator through the standards version \n",
      "advancement process; (b) the developer's expectations for how the \n",
      "update will affect interoperability of the affected health it module as \n",
      "it is used in the real world; and (c) whether the developer intends to \n",
      "continue to support the certificate for the existing health it module \n",
      "version for some period of time and how long, or if the existing \n",
      "version of the health it module certified to prior version(s) of \n",
      "applicable standards will be deprecated (e.g., that the developer will \n",
      "stop supporting the earlier version of the module and request to have \n",
      "the certificate withdrawn). the notice would be required to be provided \n",
      "sufficiently in advance of the developer establishing its planned \n",
      "timeframe for implementation of the upgrade to the more advanced \n",
      "standard(s) version(s) in order to offer customers reasonable \n",
      "opportunity to ask questions and plan for the update. we request public \n",
      "comment on the minimum time prior to an anticipated implementation of \n",
      "an updated standard or implementation\n",
      "\n",
      "[[page 7499]]\n",
      "\n",
      "specification version update that should be considered reasonable for \n",
      "purposes of allowing customers, especially health care providers using \n",
      "the health it module in their health care delivery operations, to \n",
      "adequately plan for potential implications of the update for their \n",
      "operations and their exchange relationships. we would also be \n",
      "interested to know if commenters believe that there are specific \n",
      "certification criteria, standards, characteristics of the certified \n",
      "health it module or its implementation (such as locally hosted by the \n",
      "customer using it versus software-as-a-service type of implementation), \n",
      "or specific types or characteristics of customers that could affect the \n",
      "minimum advance notice that should be considered reasonable across \n",
      "variations in these factors.\n",
      "    we anticipate providing onc-acbs (and/or health it developers) with \n",
      "a means to attribute this updated information to the listings on the \n",
      "chpl for the health it modules the onc-acb has certified, and propose \n",
      "to require in the principles of proper conduct for onc-acbs that they \n",
      "are ultimately responsible for this information being made publicly \n",
      "available on the chpl. we request public comment on any additional \n",
      "information about updated standards versions that may be beneficial to \n",
      "have listed with certified health it modules on the chpl.\n",
      "    we clarify that a health it developer would be able to choose which \n",
      "of the updated standards versions approved by the national coordinator \n",
      "for use in certification through the standards version advancement \n",
      "process the developer seeks to include in its updated certified health \n",
      "it module and would be able to do so on an itemized basis. in other \n",
      "words, if the national coordinator were to approve for use through the \n",
      "standards version advancement process several different new versions of \n",
      "adopted standards that affected different certification criteria within \n",
      "the scope of a certified health it module, the developer would be able \n",
      "to just update one certification criterion to one or more of the \n",
      "applicable new standards and would not have to update its health it \n",
      "module to all of the national coordinator-approved new versions all at \n",
      "once in order to be able to take advantage of this proposed \n",
      "flexibility.\n",
      "health it developers presenting a new health it module for \n",
      "certification and leveraging the standards version advancement process\n",
      "    in instances where a health it developer presents a health it \n",
      "module for certification for which no prior certificate can serve as \n",
      "the basis for using the standards version advancement process, we \n",
      "propose that the health it developer would be permitted to use and \n",
      "implement any and all of the newer versions of adopted standards the \n",
      "national coordinator approves through the standards version advancement \n",
      "process. we have implemented this proposed policy through necessary \n",
      "adjustments to the way in which onc-acbs process certifications in \n",
      "sec.  170.550. we recognize that this proposed flexibility reflects \n",
      "certain programmatic and policy trade-offs. on one hand, a health it \n",
      "developer would be permitted to use the most recent version of \n",
      "standards approved by the national coordinator instead of having to \n",
      "build in potentially ``outdated'' standards just to get certified. on \n",
      "the other hand, the program's testing infrastructure (which is now \n",
      "inclusive of government-developed and non-government-developed tools) \n",
      "may experience certain lag times in terms of when updated test tools to \n",
      "support the approved version advancements would be available to test \n",
      "health it modules for certification purposes. as a result, we propose \n",
      "to provide the ability for onc-acbs to accept a developer self-\n",
      "declaration of conformity as to the use, implementation, and \n",
      "conformance to a newer version of a standard (including but not limited \n",
      "to implementation specifications) as sufficient demonstration of \n",
      "conformance in circumstances where the national coordinator has \n",
      "approved a version update of a standard for use in certification \n",
      "through the standards version advancement process but an associated \n",
      "testing tool is not yet updated to test to the newer version. again, we \n",
      "clarify that a health it developer would be able to choose which \n",
      "national coordinator-approved standard version(s) it seeks to include \n",
      "in a new or updated certified health it module and would be able to do \n",
      "so on an itemized basis.\n",
      "    on balance, we believe that this programmatic flexibility and the \n",
      "potential interoperability improvements from the use of newer versions \n",
      "of standards outweighs the subsequent oversight challenges. moreover, \n",
      "these oversight challenges can be mitigated by the standards version \n",
      "advancement process itself (i.e., the national coordinator not \n",
      "approving a new version if the program or industry is not ready) and \n",
      "the corresponding conditions of certification that continue with the \n",
      "use of national coordinator-approved new versions of adopted standards. \n",
      "we also believe that this approach will continue to hold developers \n",
      "accountable for, and shift the focus of health it module performance \n",
      "demonstration to, real world testing for interoperability for deployed \n",
      "health it modules. as described above, we understand the limitations of \n",
      "test methods used prior to certification and further emphasize the \n",
      "importance of continued conformance of health it modules in the field. \n",
      "however, we request comment on specific program impacts we should \n",
      "consider.\n",
      "general requirements associated with health it modules certified using \n",
      "the standards version advancement process\n",
      "    in all cases, regardless of whether a health it developer is \n",
      "updating an existing certified health it module or presenting a new \n",
      "health it module for certification to new versions of adopted standards \n",
      "approved by the national coordinator through the standards version \n",
      "advancement process, it would need to adhere to the following once it \n",
      "elects to takes advantage of this proposed flexibility:\n",
      "    <bullet> the developer would need to ensure its mandatory \n",
      "disclosures in sec.  170.523(k)(1) appropriately reflect its use of any \n",
      "national coordinator-approved newer versions of standards.\n",
      "    <bullet> the developer would need to address and adhere to all \n",
      "conditions of certification and maintenance of certification \n",
      "requirements proposed that are otherwise be applicable to its certified \n",
      "health it modules regardless of whether those health it modules were \n",
      "certified to the exact same versions of adopted standards that are \n",
      "listed in the text of 45 cfr part 170 or national coordinator-approved \n",
      "newer version(s) of the standard(s). for instance, the developer would \n",
      "need to ensure that its real world testing plan and performance \n",
      "included the national coordinator-approved standards versions to which \n",
      "it is claiming conformance.\n",
      "    in terms of compliance with the real world testing condition and \n",
      "maintenance of certification requirements, the attestations condition \n",
      "and maintenance of certification requirements proposed in sec.  \n",
      "170.406, and for the purposes of onc-acb surveillance, we note that \n",
      "health it developers would be accountable for maintaining all \n",
      "applicable certified health it modules in accordance with approved \n",
      "versions of standards and implementation specifications that they \n",
      "voluntarily elect to use in their certified health it. if, at any point \n",
      "after initial certification or updated certification for\n",
      "\n",
      "[[page 7500]]\n",
      "\n",
      "a health it module using the national coordinator approved advanced \n",
      "versions of standards or implementation specifications, real world \n",
      "testing results do not demonstrate the health it module's conformance \n",
      "to each applicable certification criterion had been achieved and \n",
      "maintained using the national coordinator approved advanced version \n",
      "update of any applicable standard(s) and implementation \n",
      "specification(s), then the developer would not be allowed to claim or \n",
      "characterize the health it module as conformant to the criterion using \n",
      "such standard version, and the standard or implementation specification \n",
      "version could not be indicated in the health it module's chpl record as \n",
      "supported by any version release of the health it module, until such \n",
      "time as they could demonstrate through onc-atl or results of real world \n",
      "testing that they had successfully upgraded the health it module to \n",
      "fully conform to applicable certification criteria while incorporating \n",
      "the more advanced version of the standard. non-conformities associated \n",
      "with the use of new versions of national coordinator-approved standards \n",
      "would be found and enforced through the same program rules just like \n",
      "they would be for non-conformities with the versions of adopted \n",
      "standards that are codified in regulation text. further, we remind \n",
      "health it developers that they would be required to make an attestation \n",
      "to their real world testing results, including (though not limited to) \n",
      "those that would be used to support use of new versions of national \n",
      "coordinator-approved standards.\n",
      "advanced version approval approach\n",
      "    once a standard has been adopted for use in the program through \n",
      "notice and comment rulemaking, onc would undertake an annual, open and \n",
      "transparent process, including opportunity for public comment, to \n",
      "timely ascertain whether a more recent version of that standard or \n",
      "implementation specification should be approved for developers' \n",
      "voluntary use. onc would identify updated versions of previously \n",
      "adopted standards and implementation specifications based on our own \n",
      "monitoring of market trends and interoperability needs, as well as \n",
      "input received from external stakeholders. such external input may \n",
      "include, but would not be limited to, recommendations made by the \n",
      "health information technology advisory committee as well as input \n",
      "received from sdos.\n",
      "    onc expects to use an expanded section of the interoperability \n",
      "standards advisory (isa) web platform to facilitate the public \n",
      "transparency and engagement process. at a particular time of the year \n",
      "(e.g., early fall), onc would post a list of new versions of adopted \n",
      "standards and implementation specifications that appear timely and \n",
      "appropriate for use within the program (for the subsequent calendar \n",
      "year) along with accompanying descriptive context (e.g., the types/\n",
      "nature of updates in the new version of a standard). onc would then \n",
      "widely communicate to all members of the public that the list was \n",
      "available and make a general solicitation of comments to any and all \n",
      "interested parties for a period of 30 to 60 days. we would generally \n",
      "expect to receive comments on a range of issues related to the version \n",
      "of the standard under consideration, including its availability, \n",
      "testing tools, maturity, implementation burden, and overall impact on \n",
      "interoperability. health it developers, health information networks \n",
      "(hins), and the health care organizations that purchase and use health \n",
      "it are already familiar with the process of commenting through our \n",
      "existing isa resource and we believe this process is well suited to \n",
      "support widespread engagement by all stakeholders. similar to the isa, \n",
      "we would expect to be open to receiving comments on newer versions of \n",
      "adopted standards throughout the year leading up to the formal comment \n",
      "period.\n",
      "    once the formal comment period closes, onc would review the \n",
      "comments and consider the potential impacts of a new version an adopted \n",
      "standard or implementation specification. we anticipate approving newer \n",
      "versions of adopted standards and implementation specifications based \n",
      "on several interdependent program and market factors, such as its \n",
      "ability to enhance interoperability and overall compatibility with \n",
      "other adopted versions, how burdensome it would be to update to the \n",
      "newer version and the scope and scale of the changes, whether the new \n",
      "version would be required for reporting by a corresponding program \n",
      "(e.g., cms or cdc), the availability of test tools for the new version, \n",
      "and the new version's relationship to other adopted standards and any \n",
      "dependencies. upon concluding our review and analysis, onc would \n",
      "publish in this new isa section a final list of national coordinator-\n",
      "approved advanced versions that health it developers could electively \n",
      "use consistent with the standards version advancement process.\n",
      "    within this proposed approach, we expect that when it comes to a \n",
      "standard, the national coordinator would identify version updates to an \n",
      "adopted standard consistent with that standard's name and version \n",
      "track. this method would provide long-term consistency for health it \n",
      "developers in terms of the overall technical conformance requirements \n",
      "on which they will be focused.\n",
      "    with respect to adopted implementation specifications, we believe \n",
      "that more flexibility about the precise name and version track \n",
      "identifiers would be warranted given that implementation specifications \n",
      "are developed by market-driven industry consortia (e.g., argonaut \n",
      "project and direct project stakeholders) as well as traditional sdos. \n",
      "similarly, authors of implementation specifications sometimes develop \n",
      "supplemental documents to the ``parent'' implementation specification \n",
      "or split the implementation specification to form newly titled \n",
      "materials. in any of these cases, the resulting implementation \n",
      "specification may--on its face--initially appear to bear no relation to \n",
      "a previously adopted implementation specification because of changes to \n",
      "its title, version naming, or numbering presentation. in reality, in \n",
      "many of these cases, the implementation specification retains \n",
      "substantially the same purpose(s) and thus represents a versioning \n",
      "update rather than amounting to a novel specification. accordingly, \n",
      "regardless of its title and author, the national coordinator would take \n",
      "into account whether any ``new'' implementation specification under \n",
      "consideration is more accurately characterized as novel to the program \n",
      "or instead is a derivative work that is substantially a more advanced \n",
      "version of a previously adopted implementation specification(s). \n",
      "stakeholders would also be able to comment on the same during the \n",
      "advanced version approval process described here.\n",
      "    the public listing of these national coordinator determinations to \n",
      "approve version updates to already adopted standards and implementation \n",
      "specifications would serve as the single, comprehensive, and \n",
      "authoritative index of the versions of adopted standards and \n",
      "implementation specifications available for use under the program. we \n",
      "note, however, that certain program administration steps would need to \n",
      "occur (such as onc-acbs expanding the scope of their accreditations) \n",
      "after the national coordinator has approved newer versions of adopted \n",
      "standards. as a result, there would likely be a temporary delay between \n",
      "the national coordinator's approval decision and when certification to \n",
      "new standards versions under the program would start.\n",
      "    we welcome comments on any and all aspects of our proposed \n",
      "standards\n",
      "\n",
      "[[page 7501]]\n",
      "\n",
      "version approval process as an option available to developers through \n",
      "maintenance requirements as part of the real world testing condition \n",
      "and maintenance of certification. this includes all aspects of our \n",
      "described approach to standards and implementation specification \n",
      "advanced version approval processes. we also invite comments on our \n",
      "proposal to allow in conjunction with this maintenance flexibility the \n",
      "opportunity for developers to elect to present health it for initial \n",
      "testing and certification either to more advanced versions or the prior \n",
      "versions included in regulatory text as of the date the technology is \n",
      "presented.\n",
      "principle of proper conduct for onc-acb for all real world testing \n",
      "proposals\n",
      "    we propose to include a new principle of proper conduct for onc-\n",
      "acbs in sec.  170.523(p) that would require onc-acbs to review and \n",
      "confirm that applicable health it developers submit real world testing \n",
      "plans and results in accordance with our proposals. we expect that onc-\n",
      "acbs would review the plans for completeness. once completeness is \n",
      "confirmed, onc-acbs would provide the plans to onc by december 15 and \n",
      "results to onc by april 1. the december 15 date is the same date as the \n",
      "health it developer requirement for submission of the real world \n",
      "testing plan. for purposes of the program, this treats both regulated \n",
      "entities equally and permits them to work out a process that ensures \n",
      "all real world testing plans are submitted to the chpl by december 15. \n",
      "for example, a health it developer that is confident in its plan and \n",
      "does not anticipate any further certification, may submit its plan in \n",
      "july of the preceding year.\n",
      "    the submission of results, however, does not present the same \n",
      "dynamic of the potential need to work together to ensure the plan is \n",
      "complete. as such, we have proposed different dates. we would expect \n",
      "the developers to submit their results by january 31. we believe this \n",
      "would provide sufficient time for onc-acbs to review all plans and post \n",
      "them to the chpl by april 1, including notifying onc when the results \n",
      "were not in compliance with requirements. onc would make both the plans \n",
      "and results publicly available via the chpl. we note that onc-acbs will \n",
      "continue to be required to perform in-the-field surveillance of \n",
      "certified health it modules and results of real world testing could be \n",
      "considered information to inform onc-acb surveillance activities.\n",
      "    because we are proposing to allow health it developers to implement \n",
      "national coordinator-approved advanced versions of standards and \n",
      "implementation specifications in certified health it modules through a \n",
      "developer self-declaration of conformity presented for certification if \n",
      "an associated testing tool is not yet updated to test to the newer \n",
      "version for the standards and implementation specification version \n",
      "updates they have chosen to use in the program, we propose two \n",
      "requirements to ensure the public and onc-acbs have knowledge of the \n",
      "version of a standard that certified health it meets. first, we propose \n",
      "to revise the principle of proper conduct in sec.  170.523(m) to \n",
      "require onc-acbs to collect, no less than quarterly, all version \n",
      "updates made to standards successfully included in certified health it \n",
      "per the requirements within the real world testing condition of \n",
      "certification standards version advancement process. this would ensure \n",
      "that onc-acbs are aware of the version of a standard that certified \n",
      "health it meets for the purposes of surveillance and program \n",
      "administration. second, we propose (as discussed above), that a \n",
      "developer that chooses to avail itself of the standards version \n",
      "advancement process flexibility must address in its real world testing \n",
      "plans and results submissions the timeline and rollout of applicable \n",
      "version updates for standards and implementation specifications. this \n",
      "addition to sec.  170.523(m) along with existing requirements for \n",
      "weekly onc-acb chpl reporting to versions of standards per sec.  \n",
      "170.523(f)(1)(xvii) would allow for timely updates to health it module \n",
      "certificate information in the chpl. together with the requirements \n",
      "(discussed above) for developers' communication with their current and \n",
      "potential customers, we intend to ensure that the public and end-users \n",
      "have transparency into planned and actual standards and implementation \n",
      "specifications updates for their certified health it.\n",
      "    in complement to the above requirements to ensure transparency for \n",
      "the public and end users, we propose in sec.  170.523(t) a new \n",
      "principle of proper conduct for onc-acbs requiring them to ensure that \n",
      "developers seeking to take advantage of the standards version \n",
      "advancement process flexibility in sec.  170.405(b)(5) comply with the \n",
      "applicable requirements, and that the onc-acb both retain records of \n",
      "the timing and content of developers' sec.  170.405(b)(5) notices and \n",
      "timely post each notice's content publicly on the chpl attributed to \n",
      "the certified health it modules to which it applies.\n",
      "    we seek comment on the proposed additions to the principles of \n",
      "proper conduct for onc-acbs. more specifically, we seek comment on \n",
      "whether onc-acbs should be required to perform an evaluation beyond a \n",
      "completeness check for the real world testing plans and results and the \n",
      "value versus the burden of such an endeavor.\n",
      "6. attestations\n",
      "    the cures act requires that a health it developer, as a condition \n",
      "and maintenance of certification under the program, provide to the \n",
      "secretary an attestation to all the conditions of certification \n",
      "specified in the cures act, except for the ``ehr reporting criteria \n",
      "submission'' condition of certification. we propose to implement the \n",
      "cures act ``attestations'' requirements condition of certification in \n",
      "sec.  170.406. we also propose that, as part of the implementation of \n",
      "this statutory provision, health it developers would attest, as \n",
      "applicable, to compliance with the conditions and maintenance of \n",
      "certification requirements described in this section of the preamble \n",
      "and proposed in sec. sec.  170.401 through 170.405.\n",
      "    we propose that, as a maintenance of certification requirement for \n",
      "the ``attestations'' condition of certification, health it developers \n",
      "must submit their attestations every 6 months (i.e., semiannually). we \n",
      "believe this would provide an appropriate ``attestation period'' to \n",
      "base any enforcement actions, such as by onc under the program or by \n",
      "the office of the inspector general under its cures act authority. we \n",
      "also believe this 6-month attestation period properly balances the need \n",
      "to support appropriate enforcement actions with the attestation burden \n",
      "placed on developers. we will determine when the first attestation will \n",
      "be due depending on when the final rule is published. we require \n",
      "attestations to be due twice a year, likely in the middle and end of \n",
      "the calendar year.\n",
      "    the process we plan to implement for providing attestations should \n",
      "minimize burden on health it developers. first, we propose to provide a \n",
      "14-day attestation period twice a year. for health it developers \n",
      "presenting health it for certification for the first time under the \n",
      "program, we propose that they would be required to submit an \n",
      "attestation at the time of certification and then also comply with the \n",
      "semiannual attestation periods. second, we would publicize and prompt \n",
      "developers to complete their attestation\n",
      "\n",
      "[[page 7502]]\n",
      "\n",
      "during the required attestation periods. third, we propose to provide a \n",
      "method for health it developers to indicate their compliance, non-\n",
      "compliance with, or the inapplicability of each condition and \n",
      "maintenance of certification requirement as it applies to all of their \n",
      "health it certified under the program for each attestation period. \n",
      "last, we propose to provide health it developers the flexibility to \n",
      "specify non-compliance per certified health it module, if necessary. we \n",
      "note, however, that any non-compliance with the proposed conditions and \n",
      "maintenance of certification requirements, including the \n",
      "``attestations'' conditions and maintenance of certification \n",
      "requirements, would be subject to onc direct review, corrective action, \n",
      "and enforcement procedures under the program. we refer readers to \n",
      "section vii.d of this preamble for discussion of proposed onc direct \n",
      "review, corrective action, and enforcement procedures for the \n",
      "conditions and maintenance of certification requirements under the \n",
      "program.\n",
      "    we propose that attestations would be submitted to onc-acbs on \n",
      "behalf of onc and the secretary. we propose that onc-acbs would have \n",
      "two responsibilities related to attestations. one responsibility we \n",
      "propose in sec.  170.523(q) is that an onc-acb must review and submit \n",
      "the health it developers' attestations to onc. onc would then make the \n",
      "attestations publicly available through the chpl. the other \n",
      "responsibility we propose in sec.  170.550(l) is that before issuing a \n",
      "certification, an onc-acb would need to ensure that the health it \n",
      "developer of the health it module has met its responsibilities related \n",
      "to the conditions and maintenance of certification requirements as \n",
      "solely evidenced by its attestation. for example, if a health it \n",
      "developer with an active certification under the program indicated non-\n",
      "compliant designations in their attestation but is already \n",
      "participating in a corrective action plan under onc direct review to \n",
      "resolve the non-compliance, certification would be able to proceed \n",
      "while the issue is being resolved.\n",
      "    we welcome comments on the proposed attestations condition and \n",
      "maintenance of certification requirements, including the appropriate \n",
      "frequency and timing of attestations. we also welcome comments on the \n",
      "proposed responsibilities for onc-acbs related to the attestations of \n",
      "condition and maintenance of certification requirements.\n",
      "7. ehr reporting criteria submission\n",
      "    the cures act specifies that health it developers be required, as a \n",
      "condition and maintenance of certification under the program, to submit \n",
      "reporting criteria on certified health it in accordance with the ehr \n",
      "reporting program established under section 3009a of the phsa, as added \n",
      "by the cures act. we have not yet established an ehr reporting program. \n",
      "once onc establishes such program, we will undertake future rulemaking \n",
      "to propose and implement the associated condition and maintenance of \n",
      "certification requirement(s) for health it developers.\n",
      "\n",
      "c. compliance\n",
      "\n",
      "    the proposed maintenance of certification requirements discussed \n",
      "above do not necessarily define all the outcomes necessary to meet the \n",
      "conditions of certification. rather, they provide preliminary or \n",
      "baseline evidence toward measuring whether a condition is being met. \n",
      "thus, onc could determine that a condition of certification is not \n",
      "being met through reasons other than the maintenance of certification \n",
      "requirements. for example, meeting the proposed maintenance of \n",
      "certification requirement that requires a health it developer to not \n",
      "establish or enforce any contract or agreement that contravenes the \n",
      "communications condition of certification does not excuse a health it \n",
      "developer from meeting all the requirements specified in the proposed \n",
      "communications condition of certification. this is analogous to \n",
      "clarifications onc has previously provided about certification criteria \n",
      "requirements whereby testing prior to certification sometimes only \n",
      "tests a subset of the full criterion's intended functions and scope. \n",
      "however, for compliance and surveillance purposes, we have stated that \n",
      "onc and its onc-acbs will examine whether the certified health it meets \n",
      "the full scope of the certification criterion rather than the subset of \n",
      "functions it was tested against (80 fr 62709-10).\n",
      "\n",
      "d. enforcement\n",
      "\n",
      "    the cures act affirms onc's role in using certification to improve \n",
      "health it's capabilities for the access, use, and exchange of \n",
      "electronic health information. the cures act provides this affirmation \n",
      "through expanded certification authority for onc to establish \n",
      "conditions and maintenance of certification requirements for health it \n",
      "developers that go beyond the certified health it itself. the new \n",
      "conditions and maintenance of certification provisions in section 4002 \n",
      "of the cures act focus on the actions and business practices of health \n",
      "it developers (e.g., information blocking and appropriate access, use, \n",
      "and exchange of electronic health information) as well as technical \n",
      "interoperability of health it (e.g., apis and real world testing). \n",
      "furthermore and equally important, section 4002 of the cures act \n",
      "provides that the secretary of hhs may encourage compliance with the \n",
      "conditions and maintenance of certification requirements and take \n",
      "action to discourage noncompliance. as discussed in the 2015 edition \n",
      "final rule, onc is not limited to enforcing program compliance solely \n",
      "through those requirements expressed in certification criteria adopted \n",
      "under the program (80 fr 62710; see also 81 fr 72412). certification \n",
      "under the program also relies on a health it developer's compliance \n",
      "with program requirements that ensure the basic integrity and \n",
      "effectiveness of the program, which is further stressed through the \n",
      "addition of the conditions and maintenance of certification \n",
      "requirements in the cures act (referred to jointly as the ``conditions \n",
      "and maintenance of certification'' in this section of the preamble).\n",
      "    given these considerations, we propose a general enforcement \n",
      "approach outlining a corrective action process for onc to review \n",
      "potential or known instances where a condition or maintenance of \n",
      "certification requirement has not been or is not being met by a health \n",
      "it developer under the program, including the requirement for a health \n",
      "it developer to attest to meeting the conditions and maintenance of \n",
      "certification. table 2 below provides an overview of the proposed \n",
      "approach to onc enforcement of the conditions and maintenance of \n",
      "certification. we provide more specific proposals following table 2.\n",
      "\n",
      "[[page 7503]]\n",
      "\n",
      "\n",
      "\n",
      "          table 2--proposed approach for enforcement of the conditions and maintenance of certification\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                                             opportunity for\n",
      "proposed regulatory    condition of    opportunity for developer   consequences of not   developer to appeal onc\n",
      "        text           certification   to take corrective action   taking appropriate       determination to\n",
      "                                                                    corrective action       terminate or ban\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "sec.   170.401.....  information       yes......................  certification ban of  yes.\n",
      "sec.   170.402.....   blocking.                                    all of a\n",
      "                     assurances......                              developer's\n",
      "                                                                   certified health it\n",
      "                                                                   modules.\n",
      "sec.   170.403.....  communications.   .........................  onc may also\n",
      "sec.   170.404.....  apis............                              consider\n",
      "sec.   170.405.....  real world                                    termination of\n",
      "sec.   170.406.....   testing..                                    health it module\n",
      "                     attestations....                              certificates if\n",
      "                                                                   there is a nexus\n",
      "                                                                   between the\n",
      "                                                                   developer's\n",
      "                                                                   practices and a\n",
      "                                                                   certified health it\n",
      "                                                                   module.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "1. onc direct review of the conditions and maintenance of certification \n",
      "requirements\n",
      "    we propose to utilize the processes previously established for onc \n",
      "direct review of certified health it in the eoa final rule (81 fr \n",
      "72404) and codified in sec. sec.  170.580 and 170.581 for the \n",
      "enforcement of the conditions and maintenance of certification. we \n",
      "propose this approach for multiple reasons. first, these processes were \n",
      "established to address non-conformities with program requirements. \n",
      "conditions and maintenance of certification are proposed to be adopted \n",
      "as program requirements and, as such, any noncompliance with the \n",
      "conditions and maintenance of certification would constitute a program \n",
      "non-conformity. second, health it developers are familiar with the onc \n",
      "direct review provisions as they were established in october 2016. \n",
      "third, sec. sec.  170.580 and 170.581 provide thorough and transparent \n",
      "processes for working with health it developers through notice and \n",
      "corrective action to remedy program non-conformities. last, the direct \n",
      "review framework provides equitable opportunities for health it \n",
      "developers to respond to onc actions and appeal certain onc \n",
      "determinations.\n",
      "2. review and enforcement only by onc\n",
      "    we propose to retain use of the term ``direct review'' as \n",
      "previously adopted in the eoa final rule to continue to distinguish \n",
      "actions onc takes to directly review certified health it or health it \n",
      "developers' actions in comparison to an onc-acb's review of certified \n",
      "health it under surveillance. we propose, however, that onc would be \n",
      "the sole party responsible for enforcing compliance with the conditions \n",
      "and maintenance of certification. the conditions and maintenance of \n",
      "certification focus on health it developer behavior and actions in \n",
      "addition to the certified health it module. onc is more familiar with \n",
      "the behavioral requirements based on its expertise and experience. \n",
      "conversely, onc-acbs are generally more suited, based on their \n",
      "accreditation and current responsibilities, to address non-conformities \n",
      "with technical and other program requirements. onc also has the \n",
      "necessary resources and the ability to coordinate with other agencies \n",
      "to enforce the conditions and maintenance of certification, such as \n",
      "with the ``information blocking'' condition of certification (proposed \n",
      "sec.  170.401). further, onc enforcement would provide more \n",
      "predictability and consistency, which would likely benefit stakeholders \n",
      "in matters related to api fees and information blocking. we do, \n",
      "however, discuss below the scope of onc-acb surveillance as it relates \n",
      "to onc's proposed enforcement of the conditions and maintenance of \n",
      "certification.\n",
      "3. review processes\n",
      "    we propose to substantially adopt the processes as they are \n",
      "currently codified in sec. sec.  170.580 and 170.581 for onc's review \n",
      "and enforcement of the conditions and maintenance of certification, but \n",
      "propose certain revisions and additions to the processes to properly \n",
      "incorporate the proposed conditions and maintenance of certification \n",
      "and effectuate congressional intent. these revisions and additions \n",
      "include renaming and restructuring headings for clarity, which we do \n",
      "not discuss below.\n",
      "a. initiating review and health it developer notice\n",
      "    we propose to fully incorporate the review of the conditions and \n",
      "maintenance of certification into the provisions of sec.  170.580(a) \n",
      "and (b). we propose in sec.  170.580(a)(iii) that if onc has a \n",
      "reasonable belief that a health it developer has not complied with a \n",
      "condition of certification, then it may initiate direct review. \n",
      "similarly, we propose in sec.  170.580(b)(1) and (2) that onc may issue \n",
      "the health it developer a notice of potential non-conformity or notice \n",
      "of non-conformity and provide the health it developer an opportunity to \n",
      "respond with an explanation and written documentation, including any \n",
      "information onc requests. these processes, including relevant \n",
      "timeframes, are specified in sec.  170.580(b).\n",
      "i. complaint resolution\n",
      "    we note and recommend that customers and end-users first work with \n",
      "their health it developers to resolve any issues of potential non-\n",
      "compliance with the conditions and maintenance of certification as \n",
      "prior program experience has shown that many issues can be resolved at \n",
      "this step. if the issue cannot be resolved, we then recommend the end-\n",
      "user contact the onc-acb. however, as discussed above and in section \n",
      "vii.d.5 below, the onc-acb purview for certified health it generally \n",
      "applies to certified capabilities and limited requirements of developer \n",
      "business practices. if neither of these pathways resolves the issue, \n",
      "end-users may provide feedback to onc via the health it feedback \n",
      "form.\\98\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\98\\ <a href=\"https://www.healthit.gov/form/healthit-feedback-form\">https://www.healthit.gov/form/healthit-feedback-form</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "ii. method of correspondence with health it developers\n",
      "    section 170.505 states that correspondence and communication with \n",
      "onc or the national coordinator shall be conducted by email, unless \n",
      "otherwise necessary or specified. in the eoa final rule, we signaled \n",
      "our intent to send notices of potential non-conformity, non-conformity, \n",
      "suspension, proposed termination, and termination via certified mail \n",
      "(81 fr 72429). however, in accordance with sec.  170.505, we propose \n",
      "that email should be the default mode of correspondence for direct \n",
      "review of non-compliance with the conditions and maintenance of \n",
      "certification.\n",
      "\n",
      "[[page 7504]]\n",
      "\n",
      "    under the eoa final rule, onc can initiate direct review of \n",
      "certified health it in limited circumstances, namely when there is a \n",
      "reasonable belief that the certified health it may be causing or \n",
      "contributing to serious risks to public health or safety or suspected \n",
      "non-conformities present practical challenges that may prevent an onc-\n",
      "acb from effectively investigating or responding to the suspected non-\n",
      "conformity. in contrast, we propose in this proposed rule to enable onc \n",
      "to initiate direct review to address a health it developer's conduct \n",
      "under the conditions and maintenance of certification requirements in \n",
      "addition to non-conformities in certified health it. this proposal \n",
      "would create an expanded set of circumstances for onc to conduct direct \n",
      "review. accordingly, the type and extent of review by onc could vary \n",
      "significantly based on the complexity and severity of each fact \n",
      "pattern. for instance, onc may be able to address certain non-\n",
      "conformities under the conditions and maintenance of certification \n",
      "quickly and with minimal effort (e.g., failure to make public a \n",
      "documentation hyperlink), while others may be more complex and require \n",
      "additional time and effort (e.g., violation of api fee prohibitions). \n",
      "considering this wide range of potential non-conformities under the \n",
      "conditions and maintenance of certification, we believe it is \n",
      "appropriate for onc to retain discretion to decide, on a case-by-case \n",
      "basis, when to go beyond the provisions of sec.  170.505 in providing \n",
      "notices and correspondence for non-compliance with the conditions and \n",
      "maintenance of certification.\n",
      "    we solicit comment on the nature and types of non-conformities with \n",
      "the conditions and maintenance of certification requirements that onc \n",
      "should consider in determining the method of correspondence. we also \n",
      "solicit comment on whether the type of notice should affect the method \n",
      "of correspondence and whether certain types of notices under direct \n",
      "review should be considered more critical than others, thus requiring a \n",
      "specific method of correspondence.\n",
      "b. relationship with onc-acbs and onc-atls\n",
      "    section 170.580(a)(3) outlines onc direct review in relation to the \n",
      "roles of onc-acbs and onc-atls, which we propose to revise to \n",
      "incorporate conditions and maintenance of certification. we note that \n",
      "we provide situational examples below in section vii.d.5 ``effect on \n",
      "existing program requirements and processes'' regarding onc direct \n",
      "review and the role of an onc-acb. as finalized in the eoa final rule \n",
      "and per sec.  170.580(a)(3)(v), we remind readers that onc may refer \n",
      "the applicable part of its review of certified health it to the \n",
      "relevant onc-acb(s) if onc determines this would serve the effective \n",
      "administration or oversight of the program (81 fr 72427-72428).\n",
      "c. records access\n",
      "    we propose to revise sec.  170.580(b)(3) to ensure that onc, or \n",
      "third parties acting on its behalf, has access to the information \n",
      "necessary to enforce the conditions and maintenance of certification. \n",
      "as specified in sec.  170.580(b)(1)(ii)(a)(2), (b)(2)(ii)(a)(2) and \n",
      "(b)(3), in response to a notice of potential non-conformity or notice \n",
      "of non-conformity, onc must be granted access to, and have the ability \n",
      "to share within hhs, with other federal agencies, and with appropriate \n",
      "entities, all of a health it developers' records and technology related \n",
      "to the development, testing, certification, implementation, \n",
      "maintenance, and use of a health it developers' certified health it; \n",
      "and any complaint records related to the certified health it. \n",
      "``complaint records'' include, but are not limited to issue logs and \n",
      "help desk tickets (81 fr 72431). we propose to supplement these \n",
      "requirements with a requirement that a health it developer make \n",
      "available to onc, and third parties acting on its behalf, records \n",
      "related to marketing and distribution, communications, contracts, and \n",
      "any other information relevant to compliance with any of the conditions \n",
      "and maintenance of certification or other program requirements. this \n",
      "information would assist in reviewing allegations that a health it \n",
      "developer violated, for example, the ``prohibit and restrict \n",
      "communications'' condition of certification. further, it is possible \n",
      "that multiple conditions and maintenance of certification may be \n",
      "implicated under a review, and thus onc believes it is appropriate to \n",
      "require a developer make available to onc all records and other \n",
      "relevant information concerning all the conditions and maintenance of \n",
      "certification and program requirements to which it and its health it \n",
      "modules are subject.\n",
      "    if onc determined that a health it developer was not cooperative \n",
      "with the fact-finding process, we propose onc would have the ability to \n",
      "issue a certification ban and/or terminate a certificate (see proposed \n",
      "sec.  170.581 discussed below and sec.  170.580(f)(1)(iii)(a)(1)).\n",
      "    we understand that health it developers may have concerns regarding \n",
      "the disclosure of proprietary, trade secret, competitively sensitive, \n",
      "or other confidential information. as we stated in the eoa final rule \n",
      "(81 fr 72429), onc would implement appropriate safeguards to ensure, to \n",
      "the extent permissible with federal law, that any proprietary business \n",
      "information or trade secrets onc may encounter by accessing the health \n",
      "it developer's records, other information, or technology, would be kept \n",
      "confidential by onc or any third parties working on behalf of onc. \n",
      "however, a health it developer would not be able to avoid providing onc \n",
      "access to relevant records by asserting that such access would require \n",
      "it to disclose trade secrets or other proprietary or confidential \n",
      "information. therefore, health it developers must clearly mark, as \n",
      "described in hhs freedom of information act regulations at 45 cfr \n",
      "5.65(c), any information they regard as trade secret or confidential \n",
      "commercial or financial information which they seek to keep \n",
      "confidential prior to disclosing the information to onc or any third \n",
      "party working on behalf of onc.\n",
      "d. corrective action\n",
      "    we propose that if onc determines that a health it developer is \n",
      "noncompliant with a condition of certification (i.e., a non-\n",
      "conformity), onc would work with the health it developer to establish a \n",
      "corrective action plan (cap) to remedy the issue through the processes \n",
      "specified in sec.  170.580(b)(2)(ii)(a)(4) and (c). we note that a \n",
      "health it developer may be in noncompliance with more than one \n",
      "condition of certification. in such cases, onc will follow the proposed \n",
      "compliance enforcement process for each condition of certification \n",
      "accordingly, but may also require the health it developer to address \n",
      "all violations in one cap for efficiency of process. we also propose, \n",
      "as we currently do with caps for certified health it, to list health it \n",
      "developers under a cap on onc's website.\n",
      "e. certification ban and termination\n",
      "    we propose in sec.  170.581 that if a health it developer under onc \n",
      "direct review for non-compliance with a condition of certification \n",
      "failed to work with onc or was otherwise noncompliant with the \n",
      "requirements of the cap and/or cap process, onc could issue a \n",
      "certification ban for the health it developer (and its subsidiaries and \n",
      "successors). a certification ban, as it currently does for other \n",
      "matters under sec.  170.581, would prohibit prospective certification \n",
      "activity by the health it developer.\n",
      "\n",
      "[[page 7505]]\n",
      "\n",
      "    onc would also consider termination \\99\\ of the certificate(s) of \n",
      "the affected health it module(s) should the health it developer fail to \n",
      "work with onc or is otherwise noncompliant with the requirements of the \n",
      "cap and/or cap process (see proposed sec.  170.580(f)(1)(iii)). onc may \n",
      "consider termination if there is a nexus between the developer's \n",
      "actions or business practices and certified health it module(s) (see \n",
      "proposed sec.  170.580(f)(1)(iii)). for example, onc may determine that \n",
      "a health it developer is violating a condition of certification due to \n",
      "a clause in its contracts that prevents its users from sharing or \n",
      "discussing technological impediments to information exchange. in this \n",
      "example, the health it developer's conduct would violate the \n",
      "``prohibiting or restricting communication'' condition of certification \n",
      "proposed in sec.  170.403. if the same conduct were also found to \n",
      "impair the functionality of the certified health it module (such as by \n",
      "preventing the proper use of certified capabilities for the exchange of \n",
      "ehi), onc may determine that a nexus exists between the developer's \n",
      "business practices and the functionality of the certified health it \n",
      "module, and may consider termination of the certificates of that \n",
      "particular health it module under the proposed approach.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\99\\ as noted in the eoa final rule, ``termination'' means an \n",
      "onc action to ``terminate'' or ``revoke'' the certification status \n",
      "of a complete ehr or health it module. (81 fr 72443).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we propose this approach, which allows onc to initiate a \n",
      "certification ban and/or certificate termination under certain \n",
      "circumstances, to ensure that health it developers are acting in \n",
      "accordance with the conditions and maintenance of certification. \n",
      "however, we stress that our first and foremost priority is to work with \n",
      "health it developers to remedy any noncompliance with conditions and \n",
      "maintenance of certification through a corrective action process before \n",
      "taking further action. this emphasizes onc's desire to promote and \n",
      "support health it developer compliance with the conditions and \n",
      "maintenance of certification and ensure that certified health it is \n",
      "compliant with program requirements in order to foster an environment \n",
      "where ehi is exchanged in an interoperable way.\n",
      "    onc does not believe that noncompliance with a condition of \n",
      "certification should always result in the termination of the \n",
      "certificate of one or more of a developer's health it modules for a few \n",
      "reasons. a violation of a condition of certification may relate solely \n",
      "to health it developer business practices or actions that do not affect \n",
      "the health it module's conformance to the requirements of the \n",
      "certification criteria. in this case, termination of the certification \n",
      "could unfairly and negatively affect a provider's ability to use the \n",
      "health it module for participation in cms programs that require \n",
      "certification because the health it module itself is functioning in \n",
      "accordance with the technical requirements of its certificate.\\100\\ as \n",
      "such, onc would carefully consider on a case-by-case basis the \n",
      "appropriateness of termination of a health it module's certification(s) \n",
      "based on the specific circumstances of the noncompliance with the \n",
      "condition of certification. the proposed enforcement approach balances \n",
      "the above stated goals and provides an outlined process that can be \n",
      "consistently followed.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\100\\ note that, in this example, an onc-acb may investigate the \n",
      "technical functionalities of the health it module against its \n",
      "certificate and perform surveillance under sec.  170.556 separate \n",
      "from onc's process to enforce compliance with the conditions of \n",
      "certification. if under onc-acb surveillance, a health it developer \n",
      "does not adequately or timely fulfill a corrective action plan, the \n",
      "onc-acb may suspend and withdraw the health it module's certificate. \n",
      "the expectations of onc-acb duties as relates to onc's enforcement \n",
      "of the conditions of certification are described further in the \n",
      "preamble.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in considering whether termination of a health it module's \n",
      "certificate(s) and/or a certification ban is appropriate, onc will \n",
      "consider factors including, but not limited to: whether the health it \n",
      "developer has previously been found in noncompliance with the \n",
      "conditions and maintenance of certification or other program \n",
      "requirements; the severity and pervasiveness of the noncompliance, \n",
      "including the effect of the noncompliance on widespread \n",
      "interoperability and health information exchange; the extent to which \n",
      "the health it developer cooperates with onc to review the \n",
      "noncompliance; the extent of potential negative impact on providers who \n",
      "may seek to use the certified health it to participate in cms programs; \n",
      "and whether termination and/or a certification ban is necessary to \n",
      "ensure the integrity of the certification process.\n",
      "    as under sec.  170.580(f)(2), onc would provide notice of the \n",
      "termination to the health it developer, including providing reasons \n",
      "for, and information supporting, the termination and instructions for \n",
      "appealing the termination. we propose to add similar notice provisions \n",
      "to sec.  170.581 for certification bans issued under onc direct review \n",
      "for non-compliance with the conditions and maintenance of \n",
      "certification, which would also include instructions for requesting \n",
      "reinstatement. in this regard, we propose to apply the current \n",
      "reinstatement procedures under sec.  170.581 to conditions and \n",
      "maintenance of certification bans, but with an additional requirement \n",
      "that the health it developer has resolved the non-compliance with the \n",
      "condition of certification. in sum, a health it developer could seek \n",
      "onc's approval to re-enter the program and have the certification ban \n",
      "lifted if it demonstrates it has resolved the noncompliance with the \n",
      "condition of certification and onc is satisfied that all affected \n",
      "customers have been provided appropriate remediation.\n",
      "    for clarity, a health it developer would have an opportunity to \n",
      "appeal an onc determination to issue a certification ban and/or \n",
      "termination it resulting from a non-conformity with a condition of \n",
      "certification as discussed below and/or seek reinstatement in the \n",
      "program and have the certification ban lifted. to note, we propose to \n",
      "make terminations effective consistent with current sec.  \n",
      "170.580(f)(2)(iii) and similarly for certification bans (see proposed \n",
      "sec.  170.581(c)). we seek comment on whether onc should:\n",
      "    <bullet> impose a minimum certification ban length before a health \n",
      "it developer can request onc remove the ban for health it developers \n",
      "who are noncompliant with a condition of certification more than once \n",
      "(e.g., a minimum six months for two instances, a minimum of one year \n",
      "for three instances).\n",
      "    <bullet> consider additional factors for a certification ban and/or \n",
      "the termination of a health it developer's certified health it \n",
      "resulting from a non-conformity with a condition of certification.\n",
      "f. appeal\n",
      "    we propose to provide a health it developer an opportunity to \n",
      "appeal an onc determination to issue a certification ban and/or \n",
      "termination resulting from a non-conformity with a condition of \n",
      "certification and would follow the processes specified in sec.  \n",
      "170.580(g). as such, we propose to revise sec.  170.580(g) to include \n",
      "onc direct review of the conditions and maintenance of certification.\n",
      "g. suspension\n",
      "    section 170.580 includes a process for suspending the certification \n",
      "of a health it module at any time if onc has a reasonable belief that \n",
      "the certified health it may present a serious risk to public health and \n",
      "safety. while this will\n",
      "\n",
      "[[page 7506]]\n",
      "\n",
      "remain the case for certified health it under onc direct review (i.e., \n",
      "suspension of certification is always available under onc direct review \n",
      "when the certified health it presents a serious risk to public health \n",
      "and safety), we do not believe such circumstances would apply to \n",
      "noncompliance with the conditions of certification. further, we believe \n",
      "the more streamlined processes proposed for addressing noncompliance \n",
      "with conditions and maintenance of certification alleviates the need to \n",
      "proceed through a suspension process. therefore, we do not propose to \n",
      "apply the suspension processes under sec.  170.580 to our review of the \n",
      "conditions of certification. we welcome comments on this proposal, \n",
      "including reasons for why we should apply suspension processes to the \n",
      "conditions of certification as part of a subsequent final rule.\n",
      "h. proposed termination\n",
      "    section 170.580 includes an intermediate step between a developer \n",
      "failing to take appropriate and timely corrective action and \n",
      "termination of a certified health it module's certificate, called \n",
      "``proposed termination'' (see sec.  170.580(e) and 81 fr 72437)). we \n",
      "propose to not include this step when a health it developer fails to \n",
      "take appropriate and timely corrective action for noncompliance with a \n",
      "condition of certification. rather, as discussed above, onc may proceed \n",
      "directly to issuing a certification ban or notice of termination if it \n",
      "determines a certification ban and/or termination are appropriate per \n",
      "the considerations discussed above. the conditions and maintenance of \n",
      "certification include requirements of developer business practices and \n",
      "actions for which, as previously discussed, noncompliance with the \n",
      "conditions and maintenance of certification in these arenas are likely \n",
      "to undermine the integrity of the program and impede widespread \n",
      "interoperability and information exchange. as such, onc believes it is \n",
      "appropriate and consistent with the cures act to proceed immediately to \n",
      "a certification ban and/or termination of the affected certified health \n",
      "it modules' certificates if a developer does not take appropriate and \n",
      "timely corrective action. a certification ban and/or termination are \n",
      "appropriate disincentives for noncompliance with the conditions and \n",
      "maintenance of certification.\n",
      "4. public listing of certification ban and terminations\n",
      "    we propose to publicly list health it developers and certified \n",
      "health it modules on onc's website that are subject to a certification \n",
      "ban and/or have been terminated, respectively, for noncompliance with a \n",
      "condition of certification or for reasons already specified in sec.  \n",
      "170.581. we currently take this same approach for health it with \n",
      "terminated certifications (see 81 fr 72438). public listing serves to \n",
      "discourage noncompliance with conditions and maintenance of \n",
      "certification, other program requirements, remediation of non-\n",
      "conformities, and cooperation with onc and the onc-acbs. it also serves \n",
      "to provide notice to all onc-atls, onc-acbs, public and private \n",
      "programs requiring the use of certified health it, and consumers of \n",
      "certified health it of the status of certified health it and health it \n",
      "developers operating under the program.\n",
      "    we seek comment on this proposal, including input on the \n",
      "appropriate period of time to list health it developers and affected \n",
      "certified health it modules on <a href=\"http://healthit.gov\">healthit.gov</a>. for example, if a \n",
      "developer sought and received reinstatement under the program (and \n",
      "lifting of the certification ban), should the health it developer no \n",
      "longer be listed on the onc website? alternatively, should we list \n",
      "health it developers who have been subject to the certification ban \n",
      "under sec.  170.581 for a certain period of time beyond the active ban, \n",
      "including indefinitely (e.g., with the timeframe when the ban was \n",
      "active)?\n",
      "5. effect on existing program requirements and processes\n",
      "    the cures act introduces new conditions and maintenance of \n",
      "certification that encompass technical and functional requirements of \n",
      "health it and new actions and business practice requirements for health \n",
      "it developers, which onc proposes to adopt in subpart d of part 170. \n",
      "the pre-cures act structure and requirements of the program provide \n",
      "processes to enforce compliance with technical and functional \n",
      "requirements of certified health it, and to a more limited extent, \n",
      "requirements for the business practices of health it developers (see, \n",
      "e.g., 45 cfr 170.523(k)(1)) under subparts c (certification criteria \n",
      "for health information technology) and e (onc health it certification \n",
      "program) of part 170. onc-acbs are required to perform surveillance on \n",
      "certified health it modules and may investigate reported alleged non-\n",
      "conformities with program requirements under subparts a, b, c, and e \n",
      "with the ultimate goal to work with the health it developer to correct \n",
      "the non-conformity. under certain situations, such as unsafe conditions \n",
      "or impediments to onc-acb oversight, onc may directly review certified \n",
      "health it to determine whether it conforms to the requirements of the \n",
      "program (see sec.  170.580 and the eoa final rule at 81 fr 72404). \n",
      "these avenues for investigating non-conformities with certified health \n",
      "it modules will continue to exist under the program and generally focus \n",
      "on functionality and performance of certified health it or more limited \n",
      "requirements of business practices of health it developers found in \n",
      "subparts a, b, c and e of part 170, respectively. thus, there may be \n",
      "instances where one or more conditions and maintenance of certification \n",
      "are not being or have not been met that also relate to certified health \n",
      "it modules non-conformities under subparts a, b, c and e. under these \n",
      "situations, onc could in parallel implement both sets of processes--\n",
      "existing processes to investigate health it module non-conformities and \n",
      "the proposed process to enforce compliance with the conditions and \n",
      "maintenance of certification.\n",
      "    we again note that under the proposed enforcement approach, only \n",
      "onc would have the ability to determine whether a condition or \n",
      "maintenance of certification requirement per subpart d has been or is \n",
      "being met. we propose to delineate the scope of an onc-acb's \n",
      "requirements to perform surveillance on certified health it modules as \n",
      "related only to the requirements of subparts a, b, c and e of part 170. \n",
      "table 3 below further illustrates the proposed difference in scope of \n",
      "review activities between onc-acbs and onc. given our proposed approach \n",
      "that would authorize solely onc to determine whether a condition or \n",
      "maintenance of certification requirement per subpart d has been or is \n",
      "being met, we propose to add a new principle of proper conduct for onc-\n",
      "acbs in sec.  170.523(s) that would require onc-acbs to report to onc, \n",
      "no later than a week after becoming aware, any information that could \n",
      "inform whether onc should exercise direct review for noncompliance with \n",
      "a condition of certification or any matter within the scope of onc \n",
      "direct review. we believe this is appropriate because onc-acbs receive \n",
      "complaints and other information about certified health it modules \n",
      "through their own channels; as this information may relate to potential \n",
      "noncompliance with the conditions and maintenance of certification or \n",
      "other matters within the scope of onc direct review, onc should be made \n",
      "aware of this information.\n",
      "\n",
      "[[page 7507]]\n",
      "\n",
      "\n",
      "\n",
      "  table 3--scope of onc-acb surveillance and onc direct review for proposed enforcement approach for conditions\n",
      "                                        and maintenance of certification\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                           onc-acb purview for surveillance    onc purview for enforcement per\n",
      "        condition of certification                    per 170.556                    170.580 and 170.581\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "170.401: information blocking............  only as it relates to subparts    all of 170.401.\n",
      "                                            a, b, c and e of part 170.\n",
      "170.402: assurances......................  only as it relates to subparts    all of 170.402.\n",
      "                                            a, b, c and e of part 170,\n",
      "                                            including the certification\n",
      "                                            criterion in sec.\n",
      "                                            170.315(b)(10) ``ehi export''.\n",
      "170.403: communications..................  only as it relates to subparts    all of 170.403.\n",
      "                                            a, b, c and e of part 170.\n",
      "170.404: apis............................  only as it relates to subparts    all of 170.404.\n",
      "                                            a, b, c and e of part 170,\n",
      "                                            including the certification\n",
      "                                            criterion in sec.\n",
      "                                            170.315(g)(10).\n",
      "170.405: real world testing..............  only as it relates to subparts    all of 170.405.\n",
      "                                            a, b, c and e of part 170.\n",
      "170.406: attestations....................  only as it relates to subparts    all of 170.406.\n",
      "                                            a, b, c and e of part 170.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    for example and further illustration purposes, onc may receive a \n",
      "complaint of information blocking alleging that a health it developer \n",
      "has limited the ability to receive secure direct messages from users of \n",
      "a competing developer's ehr. the complaint alleges the certified health \n",
      "it drops the incoming message without alerting the user that a message \n",
      "was ever received. onc would consider the information blocking concerns \n",
      "(proposed sec.  170.401) as well as the potential safety concerns \n",
      "presented by dropped messages associated with certified functionality \n",
      "of the 2015 edition ``transitions of care'' certification criterion \n",
      "(sec.  170.315(b)(1)) and standards for the secure direct messaging in \n",
      "its review. for the potential safety concerns, onc would be exercising \n",
      "its authority to review certified health it that may be causing or \n",
      "contributing to conditions that present a serious risk to public health \n",
      "or safety under sec.  170.580(a)(2)(i). in contrast, the onc-acb would \n",
      "not be responsible for reviewing the information blocking or safety \n",
      "concerns directly, but it would be responsible for assessing whether \n",
      "surveillance needs to be performed on the certified health it for the \n",
      "functionality in the 2015 edition ``transitions of care'' certification \n",
      "criterion (sec.  170.315(b)(1)) and the 2015 edition ``direct project'' \n",
      "certification criterion (sec.  170.315(h)(1)), as these requirements \n",
      "are found within subpart c of part 170 and could be implicated based on \n",
      "the complaint.\n",
      "    to provide another example, an onc-acb could receive complaints \n",
      "from users that a developer's certified health it does not support the \n",
      "fhir dstu 2 standard and associated api resource collection in health \n",
      "(arch version 1) as required in the proposed new 2015 edition \n",
      "certification criterion sec.  170.315(g)(10) (proposed under subparts b \n",
      "and c).the respective onc-acb(s) responsible for the certification of \n",
      "the certified health it could surveil this health it under the \n",
      "requirements of sec.  170.556 (under subpart e). additionally, onc \n",
      "could follow the cap process under sec.  170.580(c) to enforce the \n",
      "associated ``api'' condition of certification proposed in sec.  \n",
      "170.404(a)(2). during the course of the onc-acb surveillance, the onc-\n",
      "acb subsequently discovers the developer has implemented the fhir dstu \n",
      "2 standard and associated resources in such as a way that the patient's \n",
      "historical medications are being accessed, but not the patient's \n",
      "current medications. the onc-acb would notify onc of its findings as it \n",
      "relates to a condition of certification under subpart d and pursue its \n",
      "own corrective action process under the surveillance requirements of \n",
      "sec.  170.556. once onc receives information regarding the complaints \n",
      "from the onc-acb, we could consider the potential safety risks for \n",
      "providers using the developer's api to access new or referred patients' \n",
      "medical information for diagnostic and treatment purposes. in this \n",
      "example, onc could review both the certified health it and the \n",
      "developer action under sec.  170.580, which is proposed to be expanded \n",
      "to account for developer actions under the conditions and maintenance \n",
      "of certification (see proposed sec.  170.580(a)(2)(iii)) in addition to \n",
      "onc's direct investigation of certified health it for potential safety \n",
      "risks (see sec.  170.580(a)(2)(i)).\n",
      "6. concurrent enforcement by the office of inspector general\n",
      "    we clarify that the enforcement approach described in this proposal \n",
      "would apply to onc's administration of the conditions and maintenance \n",
      "of certification and other requirements under the program but would not \n",
      "apply to other agencies or offices that have independent authority to \n",
      "investigate and take enforcement action against a health it developer \n",
      "of certified health it. notably, section 3022(b)(1)(a)(ii) of the phsa, \n",
      "as added by the cures act, authorizes the oig to investigate claims \n",
      "that a health it developer of certified health it has engaged in \n",
      "information blocking, which is defined by section 3022(a)(1) of the \n",
      "phsa subject to reasonable and necessary activities identified by the \n",
      "secretary as exceptions to the definition as proposed at part 171 (see \n",
      "section viii. of this proposed rule). additionally, section \n",
      "3022(b)(1)(a)(i) authorizes oig to investigate claims that a health it \n",
      "developer of certified health it has submitted a false attestation \n",
      "under the condition of certification described at section \n",
      "3001(c)(5)(d)(vii). we emphasize that onc's and oig's respective \n",
      "authorities under the cures act (and in general) are independent and \n",
      "that either or both offices may exercise those authorities at any time.\n",
      "    we anticipate, however, that onc and oig may coordinate their \n",
      "respective enforcement activities, as appropriate, such as by sharing \n",
      "information about claims or suggestions of possible information \n",
      "blocking or false attestations (including violations of conditions and \n",
      "maintenance of certification that may indicate that a developer has \n",
      "falsely attested to meeting a condition). therefore, we propose that we \n",
      "may coordinate our review of a claim of information blocking with the \n",
      "oig or defer to the oig to lead a review of a claim of information \n",
      "blocking. in addition, we propose that we may rely on oig findings to \n",
      "form the basis of a direct review action.\n",
      "7. applicability of conditions and maintenance of certification \n",
      "requirements for self-developers\n",
      "    the final rule establishing onc's permanent certification program, \n",
      "``establishment of the permanent certification for health information'' \n",
      "(76 fr 1261), addresses self-developers. the language in the final rule \n",
      "describes the concept of ``self-developed'' as referring to a complete \n",
      "ehr or ehr module designed, created, or modified by an entity that \n",
      "assumed the total costs for\n",
      "\n",
      "[[page 7508]]\n",
      "\n",
      "testing and certification and that will be the primary user of the \n",
      "health it (76 fr 1300). therefore, self-developers differ from other \n",
      "health it developers in that their products are not made commercially \n",
      "available and they do not have customers. while we propose that all \n",
      "general conditions and maintenance of certification requirements apply \n",
      "to such developers, we also seek comment on which aspects of the \n",
      "conditions and maintenance of certification requirements may not be \n",
      "applicable to self-developers. for example, when considering the \n",
      "communications condition of certification, a self-developer of health \n",
      "it may not have customer contracts, but could have other agreements in \n",
      "place, such as ndas, that would be subject to the condition of \n",
      "certification.\n",
      "\n",
      "viii. information blocking\n",
      "\n",
      "a. statutory basis\n",
      "\n",
      "    section 4004 of the cures act added section 3022 of the phsa (42 \n",
      "u.s.c. 300jj-52, ``the information blocking provision''). section \n",
      "3022(a)(1) of the phsa defines practices that constitute information \n",
      "blocking when engaged in by a health care provider, or a health \n",
      "information technology developer, exchange, or network. section \n",
      "3022(a)(3) authorizes the secretary to identify, through notice and \n",
      "comment rulemaking, reasonable and necessary activities that do not \n",
      "constitute information blocking for purposes of the definition set \n",
      "forth in section 3022(a)(1). we propose to establish seven exceptions \n",
      "to the information blocking definition, each of which would define \n",
      "certain activities that would not constitute information blocking for \n",
      "purposes of section 3022(a)(1) of the phsa because they are reasonable \n",
      "and necessary to further the ultimate policy goals of the information \n",
      "blocking provision. we also propose to interpret or define certain \n",
      "statutory terms and concepts that are ambiguous, incomplete, or provide \n",
      "the secretary with discretion, and that we believe are necessary to \n",
      "carry out the secretary's rulemaking responsibilities under section \n",
      "3022(a)(3).\n",
      "\n",
      "b. legislative background and policy considerations\n",
      "\n",
      "    in this section, we outline the purpose of the information blocking \n",
      "provision and related policy and practical considerations that we \n",
      "considered in identifying the reasonable and necessary activities that \n",
      "are proposed as exceptions to the definition of information blocking \n",
      "described subsequently in section viii.d of this preamble.\n",
      "1. purpose of the information blocking provision\n",
      "    the information blocking provision was enacted in response to \n",
      "concerns that some individuals and entities are engaging in practices \n",
      "that unreasonably limit the availability and use of electronic health \n",
      "information (ehi) for authorized and permitted purposes. these \n",
      "practices undermine public and private sector investments in the \n",
      "nation's health it infrastructure and frustrate efforts to use modern \n",
      "technologies to improve health care quality and efficiency, accelerate \n",
      "research and innovation, and provide greater value and choice to health \n",
      "care consumers.\n",
      "    the nature and extent of information blocking has come into sharp \n",
      "focus in recent years. in 2015, at the request of congress, we \n",
      "submitted a report on health information blocking \\101\\ (``information \n",
      "blocking congressional report''), in which we commented on the then \n",
      "current state of technology and of health it and health care markets. \n",
      "notably, we observed that prevailing market conditions create \n",
      "incentives for some individuals and entities to exercise their control \n",
      "over ehi in ways that limit its availability and use.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\101\\ onc, report to congress on health information blocking \n",
      "(apr. 2015), <a href=\"https://www.healthit.gov/sites/default/files/reports/info_blocking_040915.pdf\">https://www.healthit.gov/sites/default/files/reports/info_blocking_040915.pdf</a> [hereinafter ``information blocking \n",
      "congressional report''].\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    since that time, we have continued to receive complaints and \n",
      "reports of information blocking from patients, clinicians, health care \n",
      "executives, payers, app developers and other technology companies, \n",
      "registries and health information exchanges, professional and trade \n",
      "associations, and many other stakeholders. onc has listened to and \n",
      "reviewed these complaints and reports, consulted with stakeholders, and \n",
      "solicited input from our federal partners in order to inform our \n",
      "proposed information blocking policies. stakeholders described \n",
      "discriminatory pricing policies that have the obvious purpose and \n",
      "effect of excluding competitors from the use of interoperability \n",
      "elements. many of the industry stakeholders who shared their \n",
      "perspectives with us in listening sessions, including several health it \n",
      "developers of certified health it, condemned these practices and urged \n",
      "us to swiftly address them. our engagement with stakeholders confirms \n",
      "that, despite significant public and private sector efforts to improve \n",
      "interoperability and data accessibility, adverse incentives remain and \n",
      "continue to undermine progress toward a more connected health system.\n",
      "    based on these economic realities and our first-hand experience \n",
      "working with the health it industry and stakeholders, in the \n",
      "information blocking congressional report, we concluded that \n",
      "information blocking is a serious problem and recommended that congress \n",
      "prohibit information blocking and provide penalties and enforcement \n",
      "mechanisms to deter these harmful practices.\n",
      "    recent empirical and economic research further underscores the \n",
      "intractability of this problem and its harmful effects. in a national \n",
      "survey of health information organizations, half of respondents \n",
      "reported that ehr developers routinely engage in information blocking, \n",
      "and a quarter of respondents reported that hospitals and health systems \n",
      "routinely do so. the survey reported that perceived motivations for \n",
      "such conduct included, for ehr vendors, maximizing short-term revenue \n",
      "and competing for new clients, and for hospitals and health systems, \n",
      "strengthening their competitive position relative to other hospitals \n",
      "and health systems.\\102\\ other research suggests that these practices \n",
      "weaken competition among health care providers by limiting patient \n",
      "mobility, encouraging consolidation, and creating barriers to entry for \n",
      "developers of new and innovative applications and technologies that \n",
      "enable more effective uses of clinical data to improve population \n",
      "health and the patient experience.\\103\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\102\\ see, e.g., julia adler-milstein and eric pfeifer, \n",
      "information blocking: is it occurring and what policy strategies can \n",
      "address it?, 95 milbank quarterly 117, 124-25 (mar. 2017), available \n",
      "at <a href=\"http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12247/full\">http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12247/full</a>.\n",
      "    \\103\\ see, e.g., martin gaynor, farzad mostashari, and paul b. \n",
      "ginsberg, making health care markets work: competition policy for \n",
      "health care, 16-17 (apr. 2017), available at <a href=\"http://heinz.cmu.edu/news/news-detail/index.aspx?nid=3930\">http://heinz.cmu.edu/news/news-detail/index.aspx?nid=3930</a>; diego a. martinez et al., a \n",
      "strategic gaming model for health information exchange markets, \n",
      "health care mgmt. science (sept. 2016). (``[s]ome healthcare \n",
      "provider entities may be interfering with hie across disparate and \n",
      "unaffiliated providers to gain market advantage.'') niam yaraghi, a \n",
      "sustainable business model for health information exchange \n",
      "platforms: the solution to interoperability in healthcare it (2015), \n",
      "available at <a href=\"http://www.brookings.edu/research/papers/2015/01/30-sustainable-business-model-health-information-exchange-yaraghi\">http://www.brookings.edu/research/papers/2015/01/30-sustainable-business-model-health-information-exchange-yaraghi</a>; \n",
      "thomas c. tsai & ashish k. jha, hospital consolidation, competition, \n",
      "and quality: is bigger necessarily better?, 312 j. am. med. assoc. \n",
      "29, 29 (2014).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the information blocking provision provides a comprehensive \n",
      "response to these concerns. the information blocking provision defines \n",
      "and creates possible penalties and disincentives for\n",
      "\n",
      "[[page 7509]]\n",
      "\n",
      "information blocking in broad terms, while working to deter the entire \n",
      "spectrum of practices that unnecessarily impede the flow of ehi or its \n",
      "use to improve health and the delivery of care. the information \n",
      "blocking provision applies to the conduct of health care providers, and \n",
      "to health it developers of certified health it, exchanges, and \n",
      "networks, and seeks to deter it with substantial penalties, including \n",
      "civil money penalties, and disincentives for violations. additionally, \n",
      "developers of health it certified under the program are prohibited from \n",
      "information blocking under 3001(c)(5)(d)(i) of the phsa. to promote \n",
      "effective enforcement, the information blocking provision empowers the \n",
      "hhs office of inspector general (oig) to investigate claims of \n",
      "information blocking and provides referral processes to facilitate \n",
      "coordination with other relevant agencies, including onc, the hhs \n",
      "office for civil rights (ocr), and the federal trade commission (ftc). \n",
      "the information blocking provision also provides for a complaint \n",
      "process and corresponding confidentiality protections to encourage and \n",
      "facilitate the reporting of information blocking. enforcement of the \n",
      "information blocking provision is buttressed by section \n",
      "3001(c)(5)(d)(i) and (vi) of the phsa, which prohibits information \n",
      "blocking by developers of certified health it as a condition and \n",
      "maintenance of certification requirement under the program and requires \n",
      "them to attest that they have not engaged in such practices.\n",
      "2. policy considerations and approach to the information blocking \n",
      "provision\n",
      "    to ensure that individuals and entities that engage in information \n",
      "blocking are held accountable, the information blocking provision \n",
      "encompasses a relatively broad range of potential practices. for \n",
      "example, it is possible that some activities that are innocuous, or \n",
      "even beneficial, could technically implicate the information blocking \n",
      "provision. given the possibility of these practices, congress \n",
      "authorized the secretary to identify reasonable and necessary \n",
      "activities that do not constitute information blocking (see section \n",
      "3022(a)(3) of the phsa) (in this proposed rule, we refer to such \n",
      "reasonable and necessary activities identified by the secretary as \n",
      "``exceptions'' to the information blocking provision). the information \n",
      "blocking provision also excludes from the definition of information \n",
      "blocking practices that are required by law (section 3022(a)(1) of the \n",
      "phsa) and clarifies certain other practices that would not be penalized \n",
      "(sections 3022(a)(6) and (7) of the phsa).\n",
      "    in considering potential exceptions to the information blocking \n",
      "provision, we must balance a number of policy and practical \n",
      "considerations. to minimize compliance and other burdens for \n",
      "stakeholders, we seek to promote policies that are clear, predictable, \n",
      "and administrable. in addition, we seek to implement the information \n",
      "blocking provision in a way that is sensitive to legitimate practical \n",
      "challenges that may prevent access, exchange, or use of ehi in certain \n",
      "situations. we must also accommodate practices that, while they may \n",
      "inhibit access, exchange, or use of ehi, are reasonable and necessary \n",
      "to advance other compelling policy interests, such as preventing harm \n",
      "to patients and others, promoting the privacy and security of ehi, and \n",
      "promoting competition and consumer welfare.\n",
      "    at the same time, while pursuing these objectives, we must adhere \n",
      "to congress's plainly expressed intent to provide a comprehensive \n",
      "response to the information blocking problem. information blocking can \n",
      "occur through a variety of business, technical, and organizational \n",
      "practices that can be difficult to detect and that are constantly \n",
      "changing as technology and industry conditions evolve. the statute \n",
      "responds to these challenges by defining information blocking broadly \n",
      "and in a manner that allows for careful consideration of relevant facts \n",
      "and circumstances in individual cases.\n",
      "    accordingly, we propose to establish certain defined exceptions to \n",
      "the information blocking provision. these exceptions would be subject \n",
      "to strict conditions that balance the considerations described above. \n",
      "based on those considerations, in developing the proposed exceptions, \n",
      "we applied three overarching policy criteria. first, each exception \n",
      "would be limited to certain activities that are both reasonable and \n",
      "necessary to advance the aims of the information blocking provision. \n",
      "these reasonable and necessary activities include: promoting public \n",
      "confidence in the health it infrastructure by supporting the privacy \n",
      "and security of ehi, and protecting patient safety; and promoting \n",
      "competition and innovation in health it and its use to provide health \n",
      "care services to consumers. second, we believe that each exception \n",
      "addresses a significant risk that regulated individuals and entities \n",
      "will not engage in these reasonable and necessary activities because of \n",
      "uncertainty regarding the breadth or applicability of the information \n",
      "blocking provision. third, and last, each exception is intended to be \n",
      "tailored, through appropriate conditions, so that it is limited to the \n",
      "reasonable and necessary activities that it is designed to protect and \n",
      "does not extend protection to other activities or practices that could \n",
      "raise information blocking concerns.\n",
      "    we discuss these policy considerations in more detail in the \n",
      "context of each of the exceptions proposed in section viii.d of this \n",
      "preamble.\n",
      "\n",
      "c. relevant statutory terms and provisions\n",
      "\n",
      "    in this section of the preamble, we discuss how we propose to \n",
      "interpret certain aspects of the information blocking provision that we \n",
      "believe are ambiguous, incomplete, or that provide the secretary with \n",
      "discretion. we propose to define or interpret certain terms or concepts \n",
      "that are present in the statute and, in a few instances, to establish \n",
      "new regulatory terms or definitions that we believe are necessary to \n",
      "implement the secretary's authority under section 3022(a)(3) to \n",
      "identify reasonable and necessary activities that do not constitute \n",
      "information blocking. our goal in interpreting the statute and defining \n",
      "relevant terms is to provide greater clarity concerning the types of \n",
      "practices that could implicate the information blocking provision and, \n",
      "relatedly, to more effectively communicate the applicability and scope \n",
      "of the proposed exceptions outlined in this proposed rule. we believe \n",
      "that these proposals will provide a more meaningful opportunity for the \n",
      "public to comment on the proposed exceptions and our overall approach \n",
      "to interpreting and administering the information blocking provision. \n",
      "additionally, we believe additional interpretive clarity will assist \n",
      "regulated actors to comply with the requirements of the information \n",
      "blocking provision.\n",
      "1. ``required by law''\n",
      "    with regard to the statute's exclusion of practices that are \n",
      "``required by law'' from the definition of information blocking, we \n",
      "emphasize that ``required by law'' refers specifically to interferences \n",
      "with access, exchange, or use of ehi that are explicitly required by \n",
      "state or federal law. by carving out practices that are ``required by \n",
      "law,'' the statute acknowledged that there are state and federal laws \n",
      "that advance important policy interests and objectives by restricting \n",
      "access, exchange, and use of their ehi, and that practices that follow \n",
      "such laws should not be considered information blocking.\n",
      "\n",
      "[[page 7510]]\n",
      "\n",
      "    we note that for the purpose of developing an exception for \n",
      "reasonable and necessary privacy-protective practices, we have \n",
      "distinguished between interferences that are ``required by law'' and \n",
      "those engaged in pursuant to a privacy law, but which are not \n",
      "``required by law.'' the former does not fall within the definition of \n",
      "information blocking, but the latter may implicate the information \n",
      "blocking provision and an exception may be necessary. for a detailed \n",
      "discussion of this topic, please see section viii.d.2 of this preamble.\n",
      "2. health care providers, health it developers, exchanges, and networks\n",
      "    section 3022(a)(1) of the phsa, in defining information blocking, \n",
      "refers to four classes of individuals and entities that may engage in \n",
      "information blocking and which include: health care providers, health \n",
      "it developers of certified health it, networks, and exchanges. we \n",
      "propose to adopt definitions of these terms to provide clarity \n",
      "regarding the types of individuals and entities to whom the information \n",
      "blocking provision applies. we note that, for convenience and to avoid \n",
      "repetition in this preamble, we typically refer to these individuals \n",
      "and entities covered by the information blocking provision as \n",
      "``actors'' unless it is relevant or useful to refer to the specific \n",
      "type of individual or entity. that is, when the term ``actor'' appears \n",
      "in this preamble, it means an individual or entity that is a health \n",
      "care provider, health it developer, exchange, or network. for the same \n",
      "reasons, we propose to define ``actor'' in sec.  171.102.\n",
      "a. health care providers\n",
      "    the term ``health care provider'' is defined in section 3000(3) of \n",
      "the phsa. we propose to adopt this definition for purposes of section \n",
      "3022 of the phsa when defining ``health care provider'' in sec.  \n",
      "171.102. we note that this definition is different from the definition \n",
      "of ``health care provider'' under the hipaa privacy and security rules. \n",
      "we are considering adjusting the information blocking definition of \n",
      "``health care provider'' to cover all individuals and entities covered \n",
      "by the hipaa ``health care provider'' definition. we seek comment on \n",
      "whether this approach would be justified, and commenters are encouraged \n",
      "to specify reasons why doing so might be necessary to ensure that the \n",
      "information blocking provision applies to all health care providers \n",
      "that might engage in information blocking.\n",
      "b. health it developers of certified health it\n",
      "    section 3022(a)(1)(b) of the phsa defines information blocking, in \n",
      "part, by reference to the conduct of ``health information technology \n",
      "developers.'' because title xxx of the phsa does not define ``health \n",
      "information technology developer,'' we interpret section 3022(a)(1)(b) \n",
      "in light of the specific authority provided to oig in section \n",
      "3022(b)(1)(a) and (b)(2). section 3022(b)(2) discusses developers, \n",
      "networks, and exchanges in terms of an ``individual or entity,'' \n",
      "specifically cross-referencing section 3022(b)(1)(a). sections \n",
      "3002(b)(1) and (b)(1)(a) state, in relevant part, that the oig may \n",
      "investigate information blocking claims regarding a health information \n",
      "technology developer of certified health information technology or \n",
      "other entity offering certified health information technology. \n",
      "together, these sections make clear that the information blocking \n",
      "provisions and oig's authority extend to individuals or entities that \n",
      "develop or offer certified health it. that the individual or entity \n",
      "must develop or offer certified health it is further supported by \n",
      "section 3022(a)(7) of the phsa--which refers to developers' \n",
      "responsibilities to meet the requirements of certification--and section \n",
      "4002 of the cures act--which identifies information blocking as a \n",
      "condition of certification.\n",
      "    notwithstanding this, the cures act does not prescribe that conduct \n",
      "that may implicate the information blocking provisions be limited to \n",
      "practices related to only certified health it. rather, the information \n",
      "blocking provisions would be implicated by any practice engaged in by \n",
      "an individual or entity that develops or offers certified health it \n",
      "that is likely to interfere with the access, exchange, or use of ehi, \n",
      "including practices associated with any of the developer or offeror's \n",
      "health it products that have not been certified under the program. this \n",
      "interpretation is based primarily on section 3022(b)(1) of the phsa. if \n",
      "congress had intended that the enforcement of the information blocking \n",
      "provisions were limited to practices connected to certified health it, \n",
      "we believe the cures act would have included language that tied \n",
      "enforcement to the operation or performance of a product certified \n",
      "under the program. rather, the description of the practices that oig \n",
      "can investigate in section 3022(b)(1)(a)(ii) of the phsa are not tied \n",
      "to the certification status of the health it at issue, omitting any \n",
      "express reference to a health it developer's practice needing to be \n",
      "related to ``certified health information technology.'' that the scope \n",
      "of the information blocking provision should not be limited to \n",
      "practices that involve only certified health it is further evidenced by \n",
      "no such limitation applying to health care providers, health \n",
      "information exchanges (hies), and health information networks (hins) as \n",
      "listed in sections 3022(b)(1) of the phsa.\n",
      "    additionally, the ``practice described'' in section 3022(a)(2) of \n",
      "the phsa refers to ``certified health information technologies'' when \n",
      "illustrating practices that restrict authorized access, exchange, or \n",
      "use of ehi under applicable state or federal laws (section \n",
      "3022(a)(2)(a) of the phsa), but omits any reference to certification \n",
      "when describing ``health information technology'' in the practices \n",
      "described in sections 3022(a)(2)(b) and (c) of the phsa. importantly, \n",
      "sections 3022(a)(2)(b) and (c) of the phsa address practices that are \n",
      "particularly relevant to health it developers and offerors, although \n",
      "they could be engaged in by other types of actors. we interpret this \n",
      "drafting as a deliberate decision not to link the information blocking \n",
      "provisions with only the performance or use of certified health it.\n",
      "    finally, we note that the cures act does not impose a temporal \n",
      "nexus that would require that information blocking be carried out at a \n",
      "time when an individual or entity had health it certified under the \n",
      "program. ostensibly, then, once an individual or entity has health it \n",
      "certified, or otherwise maintains the certification of health it, the \n",
      "individual or entity becomes forever subject to the information \n",
      "blocking provision. we do not believe that, understood in context, the \n",
      "cures act supports such a broad interpretation. noting the above \n",
      "discussion concerning oig's scope of authority under section \n",
      "3022(b)(1)(a) and (b)(2) of the phsa, we believe that to make \n",
      "developers and offerors of certified health it subject to the \n",
      "information blocking provision in perpetuity would be inconsistent with \n",
      "the voluntary nature of the program. however, we also believe that the \n",
      "cures act does not provide any basis for interpreting the information \n",
      "blocking provision so narrowly that a developer or offeror of certified \n",
      "health it could escape penalty as a consequence of having its \n",
      "certification terminated or by withdrawing all of its extant \n",
      "certifications.\n",
      "    we consider that in the circumstances where a health it developer \n",
      "has its certification terminated, or withdraws its certification, such \n",
      "that it no longer has any health it certified under the\n",
      "\n",
      "[[page 7511]]\n",
      "\n",
      "program, it should nonetheless be subject to penalties for information \n",
      "blocking engaged in during the time that it did have health it \n",
      "certified under the program. accordingly, we propose to adopt a \n",
      "definition of ``heath information technology (it) developer of \n",
      "certified health it'' for the purposes of interpretation and \n",
      "enforcement of the information blocking provisions, including those \n",
      "regulatory provisions proposed under title 45, part 171, of the code of \n",
      "federal regulations, that would capture such developers or offerors. we \n",
      "propose, in sec.  171.102, that ``health it developer of certified \n",
      "health it'' means an individual or entity that develops or offers \n",
      "health information technology (as that term is defined in 42 u.s.c. \n",
      "300jj(5)) and which had, at the time it engaged in a practice that is \n",
      "the subject of an information blocking claim, health it (one or more) \n",
      "certified under the program. to note, we propose that the term \n",
      "``information blocking claim'' within this definition should be read \n",
      "broadly to encompass any statement of information blocking or potential \n",
      "information blocking. ``claims'' of information blocking within this \n",
      "definition would not be limited, in any way, to a specific form, \n",
      "format, or submission approach or process.\n",
      "    we are also considering additional approaches to help ensure that \n",
      "developers and offerors of certified health it remain subject to the \n",
      "information blocking provision for an appropriate period of time after \n",
      "leaving the program. the rationale for this approach would be that a \n",
      "developer or offeror of certified health it should be subject to \n",
      "penalties if, following the termination or withdrawal of certification, \n",
      "it refused to provide its customers with access to the ehi stored in \n",
      "the decertified health it, provided that such interference was not \n",
      "required by law and did not qualify for one of the information blocking \n",
      "exceptions. adopting this broader approach would help avoid the risk \n",
      "that a developer would be able to engage in the practices described in \n",
      "section 3022(a)(2) of the phsa in respect to ehi that was collected on \n",
      "behalf of a health care provider when that health care provider would \n",
      "reasonably expect that the information blocking provision would protect \n",
      "against unreasonable and unnecessary interferences with that ehi. if \n",
      "the information blocking provision did not extend to capture such \n",
      "conduct, the protection afforded by the information blocking provision \n",
      "could become illusory, and providers would need to consider securing \n",
      "contractual rights to prevent interference, which we are aware they \n",
      "typically have great difficulty doing.\\104\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\104\\ see onc, ehr contracts untangled selecting wisely, \n",
      "negotiating terms, and understanding the fine print, <a href=\"https://www.healthit.gov/sites/default/files/ehr_contracts_untangled.pdf\">https://www.healthit.gov/sites/default/files/ehr_contracts_untangled.pdf</a> \n",
      "(september 2016).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    one way that this could be achieved would be to define ``health it \n",
      "developer of certified health it'' as including developers and offerors \n",
      "of certified health it that continue to store ehi that was previously \n",
      "stored in health it certified in the program. alternatively, we are \n",
      "considering whether developers and offerors of certified health it \n",
      "should remain subject to the information blocking provision for an \n",
      "appropriate period of time after leaving the program. namely, that the \n",
      "information blocking provision should apply for a specific time period, \n",
      "say one year, after the developer or offeror no longer has any health \n",
      "it certified in the program. this second approach has the attraction of \n",
      "providing a more certain basis for understanding which developers are \n",
      "subject to the information blocking provision. however, it also \n",
      "potentially captures developers and offerors who have fully removed \n",
      "themselves from the program and, for example, no longer exercise \n",
      "control over ehi that was stored in their certified health it.\n",
      "    we seek comment on which of these two models best achieves our \n",
      "policy goal of ensuring that health it developers of certified health \n",
      "it will face consequences under the information blocking provision if \n",
      "they engage in information blocking in connection with ehi that was \n",
      "stored or controlled by the developer or offeror whilst they were \n",
      "participating in the program. commenters are also encouraged to \n",
      "identify alternative models and approaches for identifying when a \n",
      "developer or offeror should, and should no longer, be subject to the \n",
      "information blocking provision.\n",
      "    we note that a developer or offeror of a single health it product \n",
      "that has had its certification suspended would be considered to have \n",
      "certified health it for the purpose of the definition. we also note \n",
      "that we interpret the requirement that the health it developer of \n",
      "certified health it ``exercise control'' over ehi broadly. a developer \n",
      "would not necessarily need to have access to the ehi in order to \n",
      "exercise control. for example, a developer that implemented a ``kill-\n",
      "switch'' for a decertified software product that was locally hosted by \n",
      "a health care provider, preventing that provider from accessing its \n",
      "records, would be exercising control over the ehi for the purpose of \n",
      "this definition.\n",
      "    we clarify that we interpret ``individual or entity that develops \n",
      "the certified health it'' as the individual or entity that is legally \n",
      "responsible for the certification status of the health it, which would \n",
      "be the individual or entity that entered into a binding agreement that \n",
      "resulted in the certification status of the health it under the program \n",
      "or, if such rights are transferred, the individual or entity that holds \n",
      "the rights to the certified health it. we also clarify that an \n",
      "``individual or entity that offers certified health it'' would include \n",
      "an individual or entity that under any arrangement makes certified \n",
      "health it available for purchase or license. we seek comment on both of \n",
      "our interpretations. more specifically, we seek comment on whether \n",
      "there are particular types of arrangements under which certified health \n",
      "it is ``offered'' in which the offeror should not be considered a \n",
      "``health it developer of certified health it'' for the purposes of the \n",
      "information blocking provisions.\n",
      "    we also clarify that the proposed definition of ``health it \n",
      "developer of certified health it'' and our interpretation of the use of \n",
      "``health information technology developer'' applies to part 171 only \n",
      "and does not apply to the implementation of any other section of the \n",
      "phsa or the cures act, including section 4005(c)(1) of the cures act.\n",
      "    we clarify that api technology suppliers, as described in section \n",
      "vii.4 of this preamble and defined in sec.  170.102, would be \n",
      "considered health it developers of certified health it subject to the \n",
      "conditions described above.\n",
      "    last, we clarify that a ``self-developer'' of certified health it, \n",
      "as the term has been used in the onc health it certification program \n",
      "(program) and described in this rulemaking (section vii.d.7) and \n",
      "previous rulemaking,\\105\\ would be treated as a health care provider \n",
      "for the purposes of information blocking. this is because of our \n",
      "description of a self-developer for program purposes \\106\\ would \n",
      "essentially mean that such developers would not be supplying or \n",
      "offering their certified health it to other entities. to be clear, \n",
      "self-developers would still be subject to the proposed conditions and\n",
      "\n",
      "[[page 7512]]\n",
      "\n",
      "maintenance of certification requirements because they have health it \n",
      "certified under the program (see also section vii.d.7). we welcome \n",
      "comments on our determination regarding ``self-developers'' for \n",
      "information blocking purposes and whether there are other factors we \n",
      "should consider in how we treat ``self-developers'' of certified health \n",
      "it for the purposes of information blocking.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\105\\ the final rule establishing onc's permanent certification \n",
      "program, ``establishment of the permanent certification for health \n",
      "information'' (76 fr 1261), addresses self-developers.\n",
      "    \\106\\ the language in the final rule describes the concept of \n",
      "``self-developed'' as referring to a complete ehr or ehr module \n",
      "designed, created, or modified by an entity that assumed the total \n",
      "costs for testing and certification and that will be the primary \n",
      "user of the health it (76 fr 1300).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we also seek comment generally on the definition proposed for \n",
      "``health it developer of certified health it.''\n",
      "c. networks and exchanges\n",
      "    the terms ``network'' and ``exchange'' are not defined in the \n",
      "information blocking provision or in any other relevant statutory \n",
      "provisions. we propose to define these terms so that these individuals \n",
      "and entities that are covered by the information blocking provision \n",
      "understand that they must comply with its provisions. in accordance \n",
      "with the meaning and intent of the information blocking provision, we \n",
      "believe it is necessary to define these terms in a way that does not \n",
      "assume the application or use of certain technologies and is flexible \n",
      "enough to apply to the full range and diversity of exchanges and \n",
      "networks that exist today and may arise in the future. we note that in \n",
      "the past few years alone many new types of exchanges and networks that \n",
      "transmit ehi have emerged, and we expect this trend to accelerate with \n",
      "continued advancements in technology and renewed efforts to advance \n",
      "trusted exchange among networks and other entities under the trusted \n",
      "exchange framework and common agreement provided for by section 4003(b) \n",
      "of the cures act.\n",
      "    in considering the most appropriate way to define these terms, we \n",
      "examined how they are used throughout the cures act and the hitech act. \n",
      "additionally, we considered dictionary and industry definitions of \n",
      "``network'' and ``exchange.'' while these terms have varied usage and \n",
      "meaning in different industry contexts, certain concepts are common and \n",
      "have been incorporated into the proposed definitions below.\n",
      "i. health information network\n",
      "    we propose a functional definition of ``health information \n",
      "network'' (hin) that focuses on the role of these actors in the health \n",
      "information ecosystem. we believe the defining attribute of a hin is \n",
      "that it enables, facilitates, or controls the movement of information \n",
      "between or among different individuals or entities that are \n",
      "unaffiliated. for this purpose, we propose that two parties are \n",
      "affiliated if one has the power to control the other, or if both \n",
      "parties are under the common control or ownership of a common owner. we \n",
      "note that a significant implication of this definition is that a health \n",
      "care provider or other entity that enables, facilitates, or controls \n",
      "the movement of ehi within its own organization, or between or among \n",
      "its affiliated entities, is not a hin in connection with that movement \n",
      "of information for the purposes of this proposed rule.\n",
      "    more affirmatively, we propose that an actor could be considered a \n",
      "hin if it performs any or any combination of the following activities. \n",
      "first, the actor would be a hin if it were to determine, oversee, \n",
      "administer, control, or substantially influence policies or agreements \n",
      "that define the business, operational, technical, or other conditions \n",
      "or requirements that enable or facilitate the access, exchange, or use \n",
      "of ehi between or among two or more unaffiliated individuals or \n",
      "entities. second, an actor would be a hin if it were to provide, \n",
      "manage, control, or substantially influence any technology or service \n",
      "that enables or facilitates the access, exchange, or use of ehi between \n",
      "or among two or more unaffiliated individuals or entities.\n",
      "    typically, a hin will influence the sharing of ehi between many \n",
      "unaffiliated individuals or entities. however, we do not propose to \n",
      "establish any minimum number of parties or ``nodes'' beyond the \n",
      "requirement that there be some actual or contemplated access, exchange, \n",
      "or use of information between or among at least two unaffiliated \n",
      "individuals or entities that is enabled, facilitated, or controlled by \n",
      "the hin. we believe such a limitation would be artificial and would not \n",
      "capture the full range of entities that should be considered networks \n",
      "under the information blocking provision. to be clear, any individual \n",
      "or entity that enables, facilitates, or controls the access, exchange, \n",
      "or use of ehi between or among only itself and another unaffiliated \n",
      "individual or entity would not be considered a hin in connection with \n",
      "the movement of that ehi (although that movement of ehi may still be \n",
      "regulated under the information blocking provision on the basis that \n",
      "the individual or entity is a health care provider or health it \n",
      "developer of certified health it). to be a hin, the individual or \n",
      "entity would need to be enabling, facilitating, or controlling the \n",
      "access, exchange, or use of ehi between or among two or more other \n",
      "individuals or entities that were not affiliated with it.\n",
      "    to illustrate how the proposed definition would operate, we note \n",
      "the following examples. an entity is established within a state for the \n",
      "purpose of improving the movement of ehi between the health care \n",
      "providers operating in that state. the entity identifies standards \n",
      "relating to security and offers terms and conditions to be entered into \n",
      "by health care providers wishing to participate in the network. the \n",
      "entity offering (and then overseeing and administering) the terms and \n",
      "conditions for participation in the network would be considered a hin \n",
      "for the purpose of the information blocking provision. we note that \n",
      "there is no need for a separate entity to be created in order that an \n",
      "entity be considered a hin. for instance, a health system that \n",
      "administers business and operational agreements for facilitating the \n",
      "exchange of ehi that are adhered to by unaffiliated family practices \n",
      "and specialist clinicians in order to streamline referrals between \n",
      "those practices and specialists would likely be considered a hin.\n",
      "    we note that the proposed definition would also encompass an \n",
      "individual or entity that does not directly enable, facilitate, or \n",
      "control the movement of information, but nonetheless exercises control \n",
      "or substantial influence over the policies, technology, or services of \n",
      "a network. in particular, there may be an individual or entity that \n",
      "relies on another entity--such as an entity specifically created for \n",
      "the purpose of managing a network--for policies and technology, but \n",
      "nevertheless dictates the movement of ehi over that network. for \n",
      "example, a large health care provider may decide to lead an effort to \n",
      "establish a network that facilitates the movement of ehi between a \n",
      "group of smaller health care providers (as well as the large health \n",
      "care provider) and through the technology of health it developers. to \n",
      "achieve this outcome, the large health care provider, together with \n",
      "some of the participants, creates a new entity that administers the \n",
      "network's policies and technology. in this scenario, the large health \n",
      "care provider would come within the functional definition of a hin and \n",
      "could be held accountable for the conduct of the network if the large \n",
      "health care provider used its control or substantial influence over the \n",
      "new entity--either in a legal sense, such as via its control over the \n",
      "governance or management of the entity, or in a less formal sense, such \n",
      "as if the large health care provider prescribed a policy to be \n",
      "adopted--to interfere with the access, exchange, or use of ehi. we note \n",
      "that the large health care provider in this example would be treated as \n",
      "a health care provider when utilizing the\n",
      "\n",
      "[[page 7513]]\n",
      "\n",
      "network to move ehi via the network's policies, technology, or \n",
      "services, but would be considered a hin in connection with the \n",
      "practices of the network over which the large health care provider \n",
      "exercises control or substantial influence.\n",
      "    we seek comment on the proposed definition of a hin. in particular, \n",
      "we request comment on whether the proposed definition is broad enough \n",
      "(or too broad) to cover the full range of individuals and entities that \n",
      "could be considered health information networks within the meaning of \n",
      "the information blocking provision. additionally, we specifically \n",
      "request comment on whether the proposed definition would effectuate our \n",
      "policy goal of defining this term in a way that does not assume \n",
      "particular technologies or arrangements and is flexible enough to \n",
      "accommodate changes in these and other conditions.\n",
      "ii. health information exchange\n",
      "    we propose to define a ``health information exchange'' (hie) as an \n",
      "individual or entity that enables access, exchange, or use of ehi \n",
      "primarily between or among a particular class of individuals or \n",
      "entities or for a limited set of purposes. our research and experience \n",
      "in working with exchanges drove the proposed definition of this term. \n",
      "hies include but are not limited to regional health information \n",
      "organizations (rhios), state health information exchanges (state hies), \n",
      "and other types of organizations, entities, or arrangements that enable \n",
      "ehi to be accessed, exchanged, or used between or among particular \n",
      "types of parties or for particular purposes. for example, an hie might \n",
      "facilitate or enable the access, exchange, or use of ehi exclusively \n",
      "within a regional area (such as a rhio), or for a limited scope of \n",
      "participants and purposes (such as a clinical data registry or an \n",
      "exchange established by a hospital-physician organization to facilitate \n",
      "admission, discharge, and transfer (adt) alerting). we note that hies \n",
      "may be established under federal or state laws or regulations but may \n",
      "also be established for specific health care or business purposes or \n",
      "use cases. additionally, we note that if an hie facilitates the access, \n",
      "exchange, or use of ehi for more than a narrowly defined set of \n",
      "purposes, then it may be both an hie and a hin.\n",
      "    we seek comment on this proposed definition of an hie. again, we \n",
      "encourage commenters to consider whether this proposed definition is \n",
      "broad enough (or too broad) to cover the full range of individuals and \n",
      "entities that could be considered exchanges within the meaning of the \n",
      "information blocking provision, and whether the proposed definition is \n",
      "sufficiently flexible to accommodate changing technological and other \n",
      "conditions.\n",
      "3. electronic health information\n",
      "    the definition of information blocking applies to electronic health \n",
      "information (ehi) (section 3022(a)(1) of the phsa). while section \n",
      "3000(4) of the phsa by reference to section 1171(4) of the social \n",
      "security act defines ``health information,'' ehi is not specifically \n",
      "defined in the cures act, hitech act, or other relevant statutes. we \n",
      "propose to define ehi to mean:\n",
      "    (i) electronic protected health information; and\n",
      "    (ii) any other information that--\n",
      "    <bullet> is transmitted by or maintained in electronic media, as \n",
      "defined in 45 cfr 160.103;\n",
      "    <bullet> identifies the individual, or with respect to which there \n",
      "is a reasonable basis to believe the information can be used to \n",
      "identify the individual; and\n",
      "    <bullet> relates to the past, present, or future health or \n",
      "condition of an individual; the provision of health care to an \n",
      "individual; or the past, present, or future payment for the provision \n",
      "of health care to an individual.\n",
      "    this definition of ehi includes, but is not limited to, electronic \n",
      "protected health information and health information that is created or \n",
      "received by a health care provider and those operating on their behalf; \n",
      "health plan; health care clearinghouse; public health authority; \n",
      "employer; life insurer; school; or university. in addition, we clarify \n",
      "that under our proposed definition, ehi includes, but is not limited \n",
      "to, electronic protected health information (ephi) as defined in 45 cfr \n",
      "160.103. in particular, unlike ephi and health information, ehi is not \n",
      "limited to information that is created or received by a health care \n",
      "provider, health plan, health care clearinghouse, public health \n",
      "authority, employer, life insurer, school, or university. ehi may be \n",
      "provided, directly from an individual, or from technology that the \n",
      "individual has elected to use, to an actor covered by the information \n",
      "blocking provisions. we propose that ehi does not include health \n",
      "information that is de-identified consistent with the requirements of \n",
      "45 cfr 164.514(b). we generally request comment on this proposed \n",
      "definition as well as on whether the exclusion of health information \n",
      "that is de-identified is consistent with the requirements of 45 cfr \n",
      "164.514(b).\n",
      "    to be clear, this definition provides for an expansive set of ehi, \n",
      "which could include information on an individual's health insurance \n",
      "eligibility and benefits, billing for health care services, and payment \n",
      "information for services to be provided or already provided, which may \n",
      "include price information.\n",
      "price information\n",
      "    the fragmented and complex nature of pricing within the health care \n",
      "system has decreased the efficiency of the health care system and has \n",
      "had negative impacts on patients, health care providers, health \n",
      "systems, plans, plan sponsors and other key health care stakeholders. \n",
      "patients and plan sponsors have trouble anticipating or planning for \n",
      "costs, are not sure how they can lower their costs, are not able to \n",
      "compare costs, and have no practical way to measure the quality of the \n",
      "care or coverage they receive relative to the price they pay. pricing \n",
      "information continues to grow in importance with the increase of high \n",
      "deductible health plans and surprise billing, which have resulted in an \n",
      "increase in out-of-pocket health care spending. transparency in the \n",
      "price and cost of health care would help address the concerns outlined \n",
      "above by empowering patients to make informed health care decisions. \n",
      "further, the availability of price information could help increase \n",
      "competition that is based on the quality and value of the services \n",
      "patients receive. consistent with its statutory authority, the \n",
      "department is considering subsequent rulemaking to expand access to \n",
      "price information for the public, prospective patients, plan sponsors, \n",
      "and health care providers.\n",
      "    increased consumer demand, aligned incentives, more accessible and \n",
      "digestible information, and the evolution of price transparency tools \n",
      "are critical components to moving to a health care system that pays for \n",
      "value. however, the complex and decentralized nature of how price \n",
      "information is created, structured, formatted, and stored presents many \n",
      "challenges to achieving price transparency. to this point, pricing \n",
      "within health care demands a market-based approach whereby, for \n",
      "example, platforms are created that utilize raw data to provide \n",
      "consumers with digestible price information through their preferred \n",
      "medium.\n",
      "    onc has a unique role in setting the stage for such future actions \n",
      "by establishing the framework to prevent the blocking of price \n",
      "information. given that price information impacts the ability of \n",
      "patients to shop for and make decisions about their care, we seek \n",
      "comment on the parameters and implications of including price \n",
      "information within the scope of ehi for purposes of information \n",
      "blocking. in\n",
      "\n",
      "[[page 7514]]\n",
      "\n",
      "addition, the overall department seeks comment on the technical, \n",
      "operational, legal, cultural, environmental and other challenges to \n",
      "creating price transparency within health care.\n",
      "    <bullet> should prices that are included in ehi:\n",
      "    [cir] reflect the amount to be charged to and paid for by the \n",
      "patient's health plan (if the patient is insured) and the amount to be \n",
      "charged to and collected from the patient (as permitted by the \n",
      "provider's agreement with the patient's health plan), including for \n",
      "drugs or medical devices;\n",
      "    [cir] include various pricing information such as charge master \n",
      "price, negotiated prices, pricing based on cpt codes or drgs, bundled \n",
      "prices, and price to payer;\n",
      "    [cir] be reasonably available in advance and at the point of sale;\n",
      "    [cir] reflect all out-of-pocket costs such as deductibles, \n",
      "copayments and coinsurance (for insured patients); and/or\n",
      "    [cir] include a reference price as a comparison tool such as the \n",
      "medicare rate and, if so, what is the most meaningful reference?\n",
      "    <bullet> for the purpose of informing referrals for additional care \n",
      "and prescriptions, should future rulemaking by the department require \n",
      "health it developers to include in their platforms a mechanism for \n",
      "patients to see price information, and for health care providers to \n",
      "have access to price information, tailored to an individual patient, \n",
      "integrated into the practice or clinical workflow through apis?\n",
      "    <bullet> to the extent that patients have a right to price \n",
      "information within a reasonable time in advance of care, how would such \n",
      "reasonableness be defined for:\n",
      "    [cir] scheduled care, including how far in advance should such \n",
      "pricing be available for patients still shopping for care, in addition \n",
      "to those who have already scheduled care;\n",
      "    [cir] emergency care, including how and when transparent prices \n",
      "should be disclosed to patients and what sort of exceptions might be \n",
      "appropriate, such as for patients in need of immediate stabilization;\n",
      "    [cir] ambulance services, including air ambulance services; and\n",
      "    [cir] unscheduled inpatient care, such as admissions subsequent to \n",
      "an emergency visit?\n",
      "    <bullet> how would price information vary based on the type of \n",
      "health insurance and/or payment structure being utilized, and what, if \n",
      "any, challenges would such variation create to identifying the price \n",
      "information that should be made available for access, exchange, or use?\n",
      "    <bullet> are there electronic mechanisms/processes available for \n",
      "providing price information to patients who are not registered (i.e., \n",
      "not in the provider system) when they try to get price information?\n",
      "    <bullet> should price information be made available on public \n",
      "websites so that patients can shop for care without having to contact \n",
      "individual providers, and if so, who should be responsible for posting \n",
      "such information? additionally, how would the public posting of pricing \n",
      "information through api technology help advance market competition and \n",
      "the ability of patients to shop for care?\n",
      "    <bullet> if price information that includes a provider's negotiated \n",
      "rates for all plans and the rates for the uninsured were to be required \n",
      "to be posted on a public website, is there technology currently \n",
      "available or that could be easily developed to translate that data into \n",
      "a useful format for individuals? are there existing standards and code \n",
      "sets that would facilitate such transmission and translation? to the \n",
      "extent that some data standards are lacking in this regard, could \n",
      "developers make use of unstandardized data?\n",
      "    <bullet> what technical standards currently exist or may be needed \n",
      "to represent price information electronically for purposes of access, \n",
      "exchange, and use?\n",
      "    <bullet> are there technical impediments experienced by \n",
      "stakeholders regarding price information flowing electronically?\n",
      "    <bullet> would updates to the cms-managed hipaa transactions \n",
      "standards and code sets be necessary to address the movement of price \n",
      "information in a standardized way?\n",
      "    <bullet> how can price transparency be achieved for care delivered \n",
      "through value based arrangements, including at accountable care \n",
      "organizations, demonstrations and other risk-sharing arrangements?\n",
      "    <bullet> what future requirements should the department consider \n",
      "regarding the inclusion of price information in a patient's ehi, \n",
      "particularly as it relates to the amount paid to a health care provider \n",
      "by a patient (or on behalf of a patient) as well as payment \n",
      "calculations for the future provision of health care to such patient?\n",
      "    <bullet> if price information is included in ehi, could that \n",
      "information be useful in subsequent rulemaking that the department may \n",
      "consider in order to reduce or prevent surprise medical billing, such \n",
      "as requirements relating to:\n",
      "    [cir] the provision of a single bill that includes all health care \n",
      "providers involved in a health care service, including their network \n",
      "status;\n",
      "    [cir] the provision of a binding quote reasonably in advance of \n",
      "scheduled care (that is, non-emergent care) or some subset of scheduled \n",
      "care, such as for the most ``shoppable'' services;\n",
      "    [cir] ensuring that all health care providers in an in-network \n",
      "facility charge the in-network rate; and\n",
      "    [cir] notification of billing policies such as timely invoice dates \n",
      "for all providers and facilities, notwithstanding network status, due \n",
      "date for invoice payments by the prospective patient's payers and out-\n",
      "of-pocket obligations, date when unpaid balances are referred for \n",
      "collections, and appeals rights and procedures for patients wishing to \n",
      "contest an invoice?\n",
      "4. interests promoted by the information blocking provision\n",
      "a. access, exchange, and use of ehi\n",
      "    the information blocking provision promotes the ability to access, \n",
      "exchange, and use ehi, consistent with the requirements of applicable \n",
      "law. we interpret the terms ``access,'' ``exchange,'' and ``use'' \n",
      "broadly, consistent with their generally understood meaning in the \n",
      "health it industry and their function and context in the information \n",
      "blocking provision.\n",
      "    the concepts of access, exchange, and use are closely related: ehi \n",
      "cannot be used unless it can be accessed, and this often requires that \n",
      "the ehi be exchanged among different individuals or entities and \n",
      "through various technological means. moreover, the technological and \n",
      "other means necessary to facilitate appropriate access and exchange of \n",
      "ehi vary significantly depending on the purpose for which the \n",
      "information will be used. for example, the technologies and services \n",
      "that support a payer's access to ehi to assess clinical value will \n",
      "likely differ from those that support a patient's access to ehi via a \n",
      "smartphone app. that is, to deter information blocking in these and \n",
      "many other potential uses of ehi--and, by extension, the many and \n",
      "diverse means of access and exchange that support such uses.\n",
      "    this is consistent with the way these terms are employed in the \n",
      "information blocking provision and in other relevant statutory \n",
      "provisions. for example, section 3022(a)(2) of the phsa contemplates a \n",
      "broad range of purposes for which ehi may be accessed, exchanged, and \n",
      "used--from treatment, care delivery, and other permitted purposes, to \n",
      "exporting complete information sets and transitioning between health it \n",
      "systems, to supporting innovations and advancements in health \n",
      "information access, exchange, and use. separately,\n",
      "\n",
      "[[page 7515]]\n",
      "\n",
      "the cures act and the hitech act contemplate many different purposes \n",
      "for and means of accessing, exchanging, and using ehi, which include, \n",
      "but are not limited to, quality improvement, guiding medical decisions \n",
      "at the time and place of care, reducing medical errors and health \n",
      "disparities, delivering patient-centered care, and supporting public \n",
      "health and clinical research activities.\\107\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\107\\ see section 3001(b) of the phsa; see also section \n",
      "3009(a)(3) of the phsa (enumerating reporting criteria relating to \n",
      "access, exchange, and use of ehi for a broad and diverse range of \n",
      "purposes).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in addition to these statutory provisions, we have considered how \n",
      "the terms access, exchange, and use have been defined or used in \n",
      "existing regulations and other relevant health it industry contexts. \n",
      "while those definitions have specialized meanings and are not \n",
      "controlling here, they are instructive insofar as they illustrate the \n",
      "breadth with which these terms have been understood in other contexts. \n",
      "for example, the hipaa privacy rule defines an individual's right of \n",
      "access to include the right to have a copy of all or part of their phi \n",
      "transmitted directly to them or any person or entity he or she \n",
      "designates, in any form and format (including electronically) that the \n",
      "individual requests and that the covered entity holding the information \n",
      "can readily produce (45 cfr 164.524). in a different context, the hipaa \n",
      "security rule defines ``access'' as the ability or the means necessary \n",
      "to read, write, modify, or communicate data/information or otherwise \n",
      "use any system resource (45 cfr 164.304). the hipaa rules also define \n",
      "the term ``use,'' which includes the sharing, employment, application, \n",
      "utilization, examination, or analysis of individually identifiable \n",
      "health information within an entity that maintains the information (45 \n",
      "cfr 160.103).\n",
      "    as the examples and discussion above demonstrate, the concepts of \n",
      "access, exchange, and use are used in a variety of contexts to refer to \n",
      "a broad spectrum of activities. we believe that the types of access, \n",
      "exchange, and use described above would be promoted under the \n",
      "information blocking provision, as would other types of access, \n",
      "exchange, or use not specifically contemplated in these or other \n",
      "regulations. further, we note that the information blocking provision \n",
      "would also extend to innovations and advancements in health information \n",
      "access, exchange, and use that may occur in the future (see section \n",
      "3022(a)(2) of the phsa).\n",
      "    consistent with the above, and to convey the full breadth of \n",
      "activities that may implicate the information blocking provision, we \n",
      "propose definitions of access, exchange, and use in sec.  171.102. we \n",
      "emphasize the interrelated nature of the definitions. for example, the \n",
      "definition of ``use'' includes the ability to read, write, modify, \n",
      "manipulate, or apply ehi to accomplish a desired outcome or to achieve \n",
      "a desired purpose, while ``access'' is defined as the ability or means \n",
      "necessary to make ehi available for use. as such, interference with \n",
      "``access'' would include, for example, an interference that prevented a \n",
      "health care provider from writing ehi to its health it or from \n",
      "modifying ehi stored in health it, whether by the provider itself or \n",
      "by, or via, a third-party app. we encourage comment on these \n",
      "definitions. in particular, commenters may wish to consider whether \n",
      "these definitions are broad enough to cover all of the potential \n",
      "purposes for which ehi may be needed and ways in which it could \n",
      "conceivably be used, now and in the future.\n",
      "b. interoperability elements\n",
      "    in this proposed rule, we use the term ``interoperability element'' \n",
      "to refer to any means by which ehi can be accessed, exchanged, or used. \n",
      "we clarify that the means of accessing, exchanging, and using ehi are \n",
      "not limited to functional elements and technical information but also \n",
      "encompass technologies, services, policies, and other conditions \\108\\ \n",
      "necessary to support the many potential uses of ehi as described above. \n",
      "because of the evolving nature of technology and the diversity of \n",
      "privacy laws and regulations, institutional arrangements, and policies \n",
      "that govern the sharing of ehi, we will not provide an exhaustive list \n",
      "of interoperability elements. however, we believe that it is useful to \n",
      "define this term, both because of its importance for analyzing the \n",
      "likelihood of interference under the information blocking provision, \n",
      "and because some of the proposed exceptions to the provision contain \n",
      "conditions concerning the availability and provision of \n",
      "interoperability elements. therefore, we propose to define \n",
      "``interoperability element'' in sec.  171.102. as noted, our intent is \n",
      "to capture all of the potential means by which ehi may be accessed, \n",
      "exchanged, or used for any relevant purposes; both now and as \n",
      "technology and other conditions evolve. we seek comment on whether the \n",
      "proposed definition realizes that intent and, if not, any changes we \n",
      "should consider.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\108\\ see onc, connecting health and care for the nation: a \n",
      "shared nationwide interoperability roadmap at x-xi, <a href=\"https://www.healthit.gov/topic/interoperability/interoperability-roadmap\">https://www.healthit.gov/topic/interoperability/interoperability-roadmap</a> \n",
      "(oct. 2015) [hereinafter ``interoperability roadmap''].\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "5. practices that may implicate the information blocking provision\n",
      "    to meet the definition of information blocking, a practice must be \n",
      "likely to interfere with, prevent, or materially discourage access, \n",
      "exchange, or use of ehi. in this section and elsewhere in this \n",
      "preamble, we discuss various types of hypothetical practices that could \n",
      "implicate the provision. we do this to illustrate the scope of the \n",
      "information blocking provision and to explain our interpretation of \n",
      "various statutory concepts. however, we stress that the types of \n",
      "practices discussed in this preamble are illustrative, not exhaustive, \n",
      "and that many other types of practices could also implicate the \n",
      "provision. nor does the fact that we have not identified or discussed a \n",
      "particular type of practice imply that it is less serious than those \n",
      "that are discussed in this preamble. indeed, because information \n",
      "blocking may take many forms, it is not possible--and we do not \n",
      "attempt--to anticipate or catalog the many potential types of practices \n",
      "that may raise information blocking concerns.\n",
      "    we emphasize that any analysis of information blocking necessarily \n",
      "requires a careful consideration of the individual facts and \n",
      "circumstances, including whether the practice was required by law, \n",
      "whether the actor had the requisite statutory knowledge, and whether an \n",
      "exception applies. when we state that a practice would implicate the \n",
      "provision or could violate the provision, we are expressing a \n",
      "conclusion that the type of practice is one that would be likely to \n",
      "interfere with, prevent, or materially discourage access, exchange, or \n",
      "use of ehi, and that further analysis of these and other statutory \n",
      "elements would therefore be warranted to determine whether a violation \n",
      "has occurred. we highlight this distinction because to implicate the \n",
      "information blocking provision is not necessarily to violate it, and \n",
      "that each case will turn on its own unique facts. for example, a \n",
      "practice that seemingly meets the statutory definition of information \n",
      "blocking would not be information blocking if it was required by law, \n",
      "if one or more elements of the definition were not met, or if was \n",
      "covered by one of the proposed exceptions.\n",
      "    we propose in section viii.d of this preamble to establish seven \n",
      "exceptions to the information blocking provision for certain reasonable \n",
      "and necessary activities. if an actor can establish that an exception \n",
      "applies to each practice for which a claim of information blocking\n",
      "\n",
      "[[page 7516]]\n",
      "\n",
      "has been made, including that the actor satisfied all applicable \n",
      "conditions of the exception at all relevant times, then the practice \n",
      "would not constitute information blocking.\n",
      "    based on early discussions with stakeholders during the development \n",
      "of this proposed rule, we are aware that the generality with which the \n",
      "information blocking provision describes practices that are likely to \n",
      "interfere with, prevent, or materially discourage access, exchange, or \n",
      "use of ehi may leave some uncertainty as to the scope of the \n",
      "information blocking provision and the types of practices that will \n",
      "implicate enforcement by onc and/or oig. to provide additional clarity \n",
      "on this point, we elaborate our understanding of these important \n",
      "statutory concepts below.\n",
      "a. prevention, material discouragement, and other interference\n",
      "    the information blocking provision and its enforcement subsection \n",
      "do not define the terms ``interfere with,'' ``prevent,'' and \n",
      "``materially discourage,'' and use these terms collectively and without \n",
      "differentiation. based on our interpretation of the information \n",
      "blocking provision and the ordinary meanings of these terms in the \n",
      "context of ehi, we do not believe they are mutually exclusive, but that \n",
      "prevention and material discouragement are best understood as types of \n",
      "interference, and that use of these terms in the statute to define \n",
      "information blocking illustrates the desire to reach all practices that \n",
      "an actor knows, or should know, are likely to prevent, materially \n",
      "discourage, or otherwise interfere with the access, exchange, or use of \n",
      "ehi. consistent with this understanding, in this preamble to the \n",
      "proposed rule, we use the terms ``interfere with'' and ``interference'' \n",
      "as inclusive of prevention, material discouragement, and other forms of \n",
      "interference that implicate the information blocking provision.\n",
      "    we believe that interference could take many forms. in addition to \n",
      "the prevention or material discouragement of access, exchange, or use, \n",
      "we propose that interference could include practices that increase the \n",
      "cost, complexity, or other burden associated with accessing, \n",
      "exchanging, or using ehi. additionally, interference could include \n",
      "practices that limit the utility, efficacy, or value of ehi that is \n",
      "accessed, exchanged, or used, such as by diminishing the integrity, \n",
      "quality, completeness, or timeliness of the data. we refer readers to \n",
      "section viii.c.5.c of this preamble below for a discussion of these and \n",
      "other potential practices that could interfere with access, exchange, \n",
      "or use and thereby implicate the information blocking provision.\n",
      "    relatedly, to avoid potential ambiguity and clearly communicate the \n",
      "full range of potential practices that could implicate the information \n",
      "blocking provision, we propose to codify a definition of ``interfere \n",
      "with'' in sec.  171.102, consistent with our interpretation set forth \n",
      "above.\n",
      "b. likelihood of interference\n",
      "    the information blocking provision is preventative in nature. that \n",
      "is, the information blocking provision proscribes practices that are \n",
      "likely to interfere with (including preventing or materially \n",
      "discouraging) access, exchange, or use of ehi--whether or not such harm \n",
      "actually materializes. by including both the likely and the actual \n",
      "effects of a practice, the information blocking provision encourages \n",
      "individuals and entities to avoid engaging in practices that undermine \n",
      "interoperability, and to proactively promote access, exchange, and use \n",
      "of ehi.\n",
      "    we believe that a practice would satisfy the information blocking \n",
      "provision's ``likelihood'' requirement if, under the circumstances, \n",
      "there is a reasonably foreseeable risk that the practice will interfere \n",
      "with access, exchange, or use of ehi. for example, where an actor \n",
      "refuses to share ehi or to provide access to certain interoperability \n",
      "elements, it is reasonably foreseeable that such actions will interfere \n",
      "with access, exchange, or use of ehi. as another example, it is \n",
      "reasonably foreseeable that a health care provider may need to access \n",
      "information recorded in a patient's electronic record that could be \n",
      "relevant to the treatment of that patient. for this reason, a policy or \n",
      "practice that limits timely access to such information in an \n",
      "appropriate electronic format creates a reasonably foreseeable \n",
      "likelihood of interfering with the use of the information for these \n",
      "treatment purposes.\n",
      "    whether the risk of interference is reasonably foreseeable will \n",
      "depend on the particular facts and circumstances attending the practice \n",
      "or practices at issue. because of the number and diversity of potential \n",
      "practices, and the fact that different practices will present varying \n",
      "risks of interfering with access, exchange, or use of ehi, we do not \n",
      "attempt to anticipate all of the potential ways in which the \n",
      "information blocking provision could be implicated. nevertheless, to \n",
      "assist with compliance, we clarify certain circumstances in which, \n",
      "based on our experience, a practice will almost always be likely to \n",
      "interfere with access, exchange, or use of ehi. we caution that these \n",
      "situations are not exhaustive and that other circumstances may also \n",
      "give rise to a very high likelihood of interference under the \n",
      "information blocking provision. in each case, onc will consider the \n",
      "totality of the circumstances in evaluating whether a practice is \n",
      "likely to implicate the statute and to give rise to a violation.\n",
      "i. observational health information\n",
      "    although the information blocking provision applies to all ehi, we \n",
      "believe that information blocking concerns are especially pronounced \n",
      "when the conduct at issue has the potential to interfere with the \n",
      "access, exchange, or use of ehi that is created or maintained during \n",
      "the practice of medicine or the delivery of health care services to \n",
      "patients. we refer to such information in this section of the preamble \n",
      "collectively as ``observational health information.'' such information \n",
      "includes, but is not limited to, health information about a patient \n",
      "that could be captured in a patient record within an ehr and other \n",
      "clinical information management systems; as well as information \n",
      "maintained in administrative and other it systems when the information \n",
      "is clinically relevant, directly supports patient care, or facilitates \n",
      "the delivery of health care services to consumers. we note that there \n",
      "is a special need for timely, electronic access to this information and \n",
      "that, moreover, the clinical and operational utility of this \n",
      "information is often highly dependent on multiple actors exercising \n",
      "varying forms and degrees of control over the information itself or the \n",
      "technological, contractual, or other means by which it can be accessed, \n",
      "exchanged, and used. against these indications, practices that \n",
      "adversely impact the access, exchange, or use of observational health \n",
      "information will almost always implicate the information blocking \n",
      "provision.\n",
      "    we note that observational health information may be technically \n",
      "structured or unstructured (such as ``free text''). therefore, in \n",
      "general, clinicians' notes would constitute observational health \n",
      "information, at least insofar as the notes contain observations or \n",
      "conclusions about a patient or the patient's care. in contrast, we \n",
      "believe certain types of ehi are qualitatively distinct from \n",
      "observational health information, such as ehi that is created through \n",
      "aggregation, algorithms, and other techniques that transform \n",
      "observational health information into fundamentally new data or \n",
      "insights that are not obvious from the observational\n",
      "\n",
      "[[page 7517]]\n",
      "\n",
      "information alone. this could include, for example, population-level \n",
      "trends, predictive analytics, risk scores, and ehi used for comparisons \n",
      "and benchmarking activities. similarly, internally developed quality \n",
      "measures and care protocols are generally distinct from observational \n",
      "health information. in general, we believe that practices that pertain \n",
      "solely to the creation or use of these transformative data and insights \n",
      "would not usually present the very high likelihood of interference \n",
      "described above. however, we emphasize that, depending on the specific \n",
      "facts at issue, practices related to electronic non-observational \n",
      "health information (a type of ehi), such as price information, could \n",
      "still be subject to the information blocking provision. we seek comment \n",
      "on this proposed approach and encourage commenters to identify \n",
      "potential practices related to non-observational health information \n",
      "that could raise information blocking concerns.\n",
      "    finally, we clarify that merely collecting, organizing, formatting, \n",
      "or processing observational health information maintained in ehrs and \n",
      "other source systems does not change the fundamental nature of that ehi \n",
      "or obligations under the information blocking provisions. likewise, the \n",
      "mere fact that ehi is stored in a proprietary format or has been \n",
      "combined with confidential or proprietary information does not alter \n",
      "the actor's obligations under the information blocking provisions to \n",
      "facilitate access, exchange, and use of the ehi in response to a \n",
      "request. for example, the information blocking provision would be \n",
      "implicated if an actor were to assert proprietary rights in medical \n",
      "vocabularies or code sets in a way that was likely to interfere with \n",
      "the access, exchange, or use of observational health information stored \n",
      "in such formats. however, as noted in section viii.d.6 of this \n",
      "preamble, under the exception for licensing of interoperability \n",
      "elements on reasonable and non-discriminatory terms, an actor could \n",
      "charge a royalty for access to proprietary data or data coded in a \n",
      "proprietary manner so long as that royalty were offered on reasonable \n",
      "and non-discriminatory terms pursuant to the conditions outlined in the \n",
      "exception.\n",
      "ii. purposes for which information may be needed\n",
      "    we believe the information blocking provision will almost always be \n",
      "implicated when a practice interferes with access, exchange, or use of \n",
      "ehi for certain purposes, including but not limited to:\n",
      "    <bullet> providing patients with access to their ehi and the \n",
      "ability to exchange and use it without special effort (see section \n",
      "vii.b.4).\n",
      "    <bullet> ensuring that health care professionals, care givers, and \n",
      "other authorized persons have the ehi they need, when and where they \n",
      "need it, to make treatment decisions and effectively coordinate and \n",
      "manage patient care and can use the ehi they may receive from other \n",
      "sources.\n",
      "    <bullet> ensuring that payers and other entities that purchase \n",
      "health care services can obtain the information they need to \n",
      "effectively assess clinical value and promote transparency concerning \n",
      "the quality and costs of health care services.\n",
      "    <bullet> ensuring that health care providers can access, exchange, \n",
      "and use ehi for quality improvement and population health management \n",
      "activities.\n",
      "    <bullet> supporting access, exchange, and use of ehi for patient \n",
      "safety and public health purposes.\n",
      "    the need to ensure that ehi is readily available and usable for \n",
      "these purposes is paramount. therefore, practices that increase the \n",
      "cost, difficulty, or other burden of accessing, exchanging, or using \n",
      "ehi for these purposes would almost always implicate the information \n",
      "blocking provision. individuals and entities that develop health it or \n",
      "have a role in making these technologies and services available should \n",
      "consider the impact of their actions and take steps to support \n",
      "interoperability and avoid impeding the availability or use of ehi.\n",
      "iii. control over essential interoperability elements; other \n",
      "circumstances of reliance or dependence\n",
      "    an actor may have substantial control over one or more \n",
      "interoperability elements that provide the only reasonable means of \n",
      "accessing, exchanging, or using ehi for a particular purpose. in these \n",
      "circumstances, any practice by the actor that could impede the use of \n",
      "the interoperability elements--or that could unnecessarily increase the \n",
      "cost or other burden of using the elements--would almost always \n",
      "implicate the information blocking provision.\n",
      "    the situation described above is most likely when customers or \n",
      "users are dependent on an actor's technology or services, which can \n",
      "occur for any number of reasons. for example, technological dependence \n",
      "may arise from legal or commercial relations, such as a health care \n",
      "provider's reliance on its ehr developer to ensure that ehi managed on \n",
      "its behalf is accessible and usable when it is needed. relatedly, most \n",
      "ehi is currently stored in ehrs and other source systems that use \n",
      "proprietary data models or formats. knowledge of the data models, \n",
      "formats, or other relevant technical information (e.g., proprietary \n",
      "apis) is necessary to understand the data and make efficient use of it \n",
      "in other applications and technologies. because this information is \n",
      "routinely treated as confidential or proprietary, the developer's \n",
      "cooperation is required to enable uses of the ehi that go beyond the \n",
      "capabilities provided by the developer's technology. this includes the \n",
      "capability to export complete information sets and to migrate data in \n",
      "the event that a user decides to switch to a different technology.\n",
      "    separate from these contractual and intellectual property issues, \n",
      "users may become ``locked in'' to a particular technology, hie, or hin \n",
      "for financial or business reasons. for example, many health care \n",
      "providers have invested significant resources to adopt ehr \n",
      "technologies--including costs for deployment, customization, data \n",
      "migration, and training--and have tightly integrated these technologies \n",
      "into their information management strategies, clinical workflows, and \n",
      "business operations. as a result, they may be reluctant to switch to \n",
      "other technologies due to the significant cost and disruption this \n",
      "would entail.\n",
      "    another important driver of technological dependence is the \n",
      "``network effects'' of health it adoption, which are amplified by a \n",
      "reliance on technologies and approaches that are not standardized and \n",
      "do not enable seamless interoperability. consequently, health care \n",
      "providers and other health it users may gravitate towards and become \n",
      "reliant on the proprietary technologies, hies, or hins that have been \n",
      "adopted by other individuals and entities with whom they have the \n",
      "greatest need to exchange ehi. these effects may be especially \n",
      "pronounced within particular product or geographic areas. for example, \n",
      "a hin that facilitates certain types of exchange or transactions may be \n",
      "so widely adopted that it is a de facto industry standard. a similar \n",
      "phenomenon may occur within a particular geographic area once a \n",
      "critical mass of hospitals, physicians, or other providers adopt a \n",
      "particular ehr technology, hie, or hin.\n",
      "    in these and other analogous circumstances of reliance or \n",
      "dependence, there is a heightened risk that an actor's conduct will \n",
      "interfere with access, exchange, or use of ehi. to assist with \n",
      "compliance, we highlight the following common scenarios, based on our \n",
      "outreach to stakeholders, in which\n",
      "\n",
      "[[page 7518]]\n",
      "\n",
      "actors exercise control over key interoperability elements.\\109\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\109\\ as an important clarification, we note that control over \n",
      "interoperability elements may exist with or without the actor's \n",
      "ability to manipulate the price of the interoperability elements in \n",
      "the market.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> health it developers of certified health it that provide \n",
      "ehr systems or other technologies used to capture ehi at the point of \n",
      "care are in a unique position to control subsequent access to and use \n",
      "of that information.\n",
      "    <bullet> hins and hies may be in a unique position to control the \n",
      "flow of information among particular persons or for particular \n",
      "purposes, especially if the hin or hie has achieved significant \n",
      "adoption in a particular geographic area or for a particular type of \n",
      "health information use case.\n",
      "    <bullet> similar control over ehi may be exercised by other \n",
      "entities, such as health it developers of certified health it, that \n",
      "supply or control proprietary technologies, platforms, or services that \n",
      "are widely adopted by a class of users or that are a ``de facto \n",
      "standard'' for certain types of ehi exchanges or transactions.\n",
      "    <bullet> health care providers within health systems and other \n",
      "entities that provide health it platforms, infrastructure, or \n",
      "information sharing policies may have a degree of control over \n",
      "interoperability or the movement of data within a geographic area that \n",
      "is functionally equivalent to the control exercised by a dominant \n",
      "health it developer, hin, or hie.\n",
      "    to avoid violating the information blocking provision, actors with \n",
      "control over interoperability elements should be careful not to engage \n",
      "in practices that exclude persons from the use of those elements or \n",
      "create artificial costs or other impediments to their use.\n",
      "    we encourage comment on these and other circumstances that may \n",
      "present an especially high likelihood that a practice will interfere \n",
      "with access, exchange, or use of ehi within the meaning of the \n",
      "information blocking provision.\n",
      "c. examples of practices likely to interfere with access, exchange, or \n",
      "use of ehi\n",
      "    to further clarify the scope of the information blocking provision, \n",
      "below we describe several types of practices that would be likely to \n",
      "interfere with access, exchange, or use of ehi. these examples clarify \n",
      "and expand on those set forth in section 3022(a)(2) of the phsa.\n",
      "    because information blocking can take many forms, we emphasize that \n",
      "the categories of practices described below are illustrative only and \n",
      "do not provide an exhaustive list or comprehensive description of \n",
      "practices that may implicate the information blocking provision and its \n",
      "penalties. we also reiterate that to implicate the provision is not \n",
      "necessarily to violate it, and that each case will turn on its own \n",
      "unique facts. for instance, a practice that seemingly meets the \n",
      "statutory definition of information blocking would not be information \n",
      "blocking if it was required by law, if one or more elements of the \n",
      "definition were not met, or if it was covered by one of the proposed \n",
      "exceptions for certain reasonable and necessary activities detailed in \n",
      "section viii.d of this preamble. for the purposes of the following \n",
      "discussion, we do not consider the applicability of any exceptions \n",
      "proposed in section viii.d of this preamble; we therefore strongly \n",
      "encourage readers to review that section in conjunction with the \n",
      "discussion of practices in this section below.\n",
      "i. restrictions on access, exchange, or use\n",
      "    the information blocking provision establishes penalties, including \n",
      "civil monetary penalties, or requires appropriate disincentives, for \n",
      "practices that restrict access, exchange, or use of ehi for permissible \n",
      "purposes. for example, section 3022(a)(2)(a) of the phsa states that \n",
      "information blocking may include practices that restrict authorized \n",
      "access, exchange, or use for treatment and other permitted purposes \n",
      "under applicable law. section 3022(a)(2)(c)(i) of the phsa states that \n",
      "information blocking may include implementing health it in ways that \n",
      "are likely to restrict the access, exchange, or use of ehi with respect \n",
      "to exporting complete information sets or in transitioning between \n",
      "health it systems.\n",
      "    one means by which actors may restrict access, exchange, or use of \n",
      "ehi is through formal restrictions. these may be expressed in contract \n",
      "or license terms, ehi sharing policies, organizational policies or \n",
      "procedures, or other instruments or documents that set forth \n",
      "requirements related to ehi or health it. additionally, in the absence \n",
      "of an express contractual restriction, an actor may achieve the same \n",
      "result by exercising intellectual property or other rights in ways that \n",
      "restrict access, exchange, or use. as an illustration, the following \n",
      "non-exhaustive examples illustrate types of formal restrictions that \n",
      "would likely implicate the information blocking provision. as stated \n",
      "above, the examples throughout this section viii.c.5.c. are presented \n",
      "without consideration to whether a proposed exception applies, and \n",
      "readers are encouraged to familiarize themselves with section viii.d of \n",
      "this preamble.\n",
      "    <bullet> a health system's internal policies or procedures require \n",
      "staff to obtain an individual's written consent before sharing any of a \n",
      "patient's ehi with unaffiliated providers for treatment purposes even \n",
      "though obtaining an individual's consent is not required by state or \n",
      "federal law.\n",
      "    <bullet> an ehr developer's software license agreement prohibits a \n",
      "customer from disclosing to its it contractors certain technical \n",
      "interoperability information without which the customer and its it \n",
      "contractors cannot efficiently export and convert ehi for use in other \n",
      "applications.\n",
      "    <bullet> a hin's participation agreement prohibits entities that \n",
      "receive ehi through the hin from transmitting that ehi to entities who \n",
      "are not participants of the hin.\n",
      "    <bullet> an ehr developer sues to prevent a clinical data registry \n",
      "from providing interfaces to physicians who use the developer's ehr \n",
      "technology and wish to submit ehi to the registry. the ehr developer \n",
      "claims that the registry is infringing the developer's copyright in its \n",
      "database because the interface incorporates data mapping that \n",
      "references the table headings and rows of the ehr database in which the \n",
      "ehi is stored.\n",
      "    access, exchange, or use of ehi can also be restricted in less \n",
      "formal ways. the information blocking provision would be implicated, \n",
      "for example, where an actor simply refuses to exchange or to facilitate \n",
      "the access or use of ehi, either as a general practice or in isolated \n",
      "instances. the refusal may be expressly stated, or it may be implied \n",
      "from the actor's conduct, as where the actor ignores requests to share \n",
      "ehi or provide interoperability elements; gives implausible reasons for \n",
      "not doing so; or insists on terms or conditions that are so objectively \n",
      "unreasonable that they amount to a refusal to provide access, exchange, \n",
      "or use of the ehi. some examples of informal restrictions include, but \n",
      "are not limited to:\n",
      "    <bullet> a health it developer of certified health it refuses to \n",
      "license interoperability elements that are reasonably necessary for the \n",
      "developer's customers, their it contractors, and other health it \n",
      "developers to develop and deploy software that will work with the \n",
      "certified health it.\n",
      "    <bullet> a health system incorrectly claims that the hipaa rules or \n",
      "other legal requirements preclude it from exchanging ehi with \n",
      "unaffiliated providers.\n",
      "\n",
      "[[page 7519]]\n",
      "\n",
      "    <bullet> an ehr developer ostensibly allows third-party developers \n",
      "to deploy apps that are interoperable with its ehr system. however, as \n",
      "a condition of doing so, the third-party developers must provide their \n",
      "source code and grant the ehr developer the right to use it for its own \n",
      "purposes--terms that almost no developer would willingly accept.\n",
      "    <bullet> a provider notifies its ehr developer of its intent to \n",
      "switch to another ehr system and requests a complete export of its ehi. \n",
      "the developer will provide only the ehi in a pdf format, even though it \n",
      "already can and does produce the data in a commercially reasonable \n",
      "structured format.\n",
      "    we emphasize that restrictions on access, exchange, or use that are \n",
      "required by law would not implicate the information blocking provision. \n",
      "moreover, we recognize that some restrictions, while not required by \n",
      "law, may be reasonable and necessary for the privacy and security of \n",
      "individuals' ehi; such practices may qualify for protection under the \n",
      "exceptions proposed in section viii.d.2 and 3 of this preamble.\n",
      "ii. limiting or restricting the interoperability of health it\n",
      "    the information blocking provision includes practices that restrict \n",
      "the access, exchange, or use of ehi in various ways (see section \n",
      "3022(a)(2) of the phsa). these practices could include, for example, \n",
      "disabling or restricting the use of a capability that enables users to \n",
      "share ehi with users of other systems or to provide access to ehi to \n",
      "certain types of persons or for certain purposes that are legally \n",
      "permissible. in addition, the information blocking provision would be \n",
      "implicated where an actor configures or otherwise implements technology \n",
      "in ways that limit the types of data elements that can be exported or \n",
      "used from the technology. other practices that would be suspect include \n",
      "configuring capabilities in a way that removes important context, \n",
      "structure, or meaning from the ehi, or that makes the data less \n",
      "accurate, complete, or usable for important purposes for which it may \n",
      "be needed. likewise, implementing capabilities in ways that create \n",
      "unnecessary delays or response times, or that otherwise limit the \n",
      "timeliness of ehi accessed or exchanged, would interfere with the \n",
      "access, exchange, and use of that information and would therefore \n",
      "implicate the information blocking provision. we note that any \n",
      "conclusions regarding such interference would be based on fact-finding \n",
      "specific to each case and would need to consider the applicability of \n",
      "an exception.\n",
      "    we propose that the information blocking provision would be \n",
      "implicated if an actor were to deploy technological measures that limit \n",
      "or restrict the ability to reverse engineer the functional aspects of \n",
      "technology in order to develop means for extracting and using ehi \n",
      "maintained in the technology. this may include, for example, employing \n",
      "technological protection measures that, if circumvented, would trigger \n",
      "liability under the digital millennium copyright act (see 17 u.s.c. \n",
      "1201) or other laws.\n",
      "    the following hypothetical situations illustrate some (though not \n",
      "all) of the types of practices described above and which would \n",
      "implicate the information blocking provision.\n",
      "    <bullet> a health system implements locally-hosted ehr technology \n",
      "certified to proposed sec.  170.315(g)(10) (the health system acts as \n",
      "an api data provider as defined by sec.  170.102). as required by \n",
      "proposed sec.  170.404(b)(2), the technology developer provides the \n",
      "health system with the capability to automatically publish its \n",
      "production endpoints (i.e., the internet servers that an app must \n",
      "``call'' and interact with in order to request and exchange patient \n",
      "data). the health system chooses not to enable this capability, \n",
      "however, and provides the production endpoint information only to apps \n",
      "it specifically approves. this prevents other applications--and \n",
      "patients that use them--from accessing data that should be made readily \n",
      "accessible via standardized apis.\n",
      "    <bullet> a hospital directs its ehr developer to configure its \n",
      "technology so that users cannot easily send electronic patient \n",
      "referrals and associated ehi to unaffiliated providers, even when the \n",
      "user knows the direct address and/or identity (i.e., national provider \n",
      "identifier) of the unaffiliated provider.\n",
      "    <bullet> an ehr developer that prevents (such as by way of imposing \n",
      "exorbitant fees unrelated to the developer's costs, or by some \n",
      "technological means) a third-party clinical decision support (cds) app \n",
      "from writing ehi to the records maintained by the ehr developer on \n",
      "behalf of a health care provider (despite the provider authorizing the \n",
      "third-party app developer's use of ehi) because the ehr developer: (1) \n",
      "offers a competing cds software to the third-party app; and (2) \n",
      "includes functionality (e.g., apis) in its health it that would provide \n",
      "the third party with the technical capability to modify those records \n",
      "as desired by the health care provider.\n",
      "    <bullet> although an ehr developer's patient portal offers the \n",
      "capability for patients to directly transmit or request for direct \n",
      "transmission of their ehi to a third party, the developer's customers \n",
      "(e.g., health care providers) choose not to enable this capability.\n",
      "    <bullet> a health care provider has the capability to provide same-\n",
      "day access to ehi in a form and format requested by a patient or a \n",
      "patient's health care provider, but takes several days to respond.\n",
      "iii. impeding innovations and advancements in access, exchange, or use \n",
      "or health it-enabled care delivery\n",
      "    the information blocking provision encompasses practices that \n",
      "create impediments to innovations and advancements to the access, \n",
      "exchange, and use of ehi, including care delivery enabled by health it \n",
      "(section 3022(a)(2)(c)(ii) of the phsa). importantly, the information \n",
      "blocking provision would be implicated and penalties may apply if an \n",
      "actor were to engage in exclusionary, discriminatory, or other \n",
      "practices that impede the development, dissemination, or use of \n",
      "interoperable technologies and services that enhance access, exchange, \n",
      "or use of ehi.\n",
      "    most acutely, the information blocking provision would be \n",
      "implicated if an actor were to refuse to license or allow the \n",
      "disclosure of interoperability elements to persons who require those \n",
      "elements to develop and provide interoperable technologies or \n",
      "services--including those that might complement or compete with the \n",
      "actor's own technology or services. the same would be true if the actor \n",
      "were to allow access to interoperability elements but were to restrict \n",
      "their use for these purposes. the following examples, which are not \n",
      "exhaustive, illustrate practices that would likely implicate the \n",
      "information blocking provision by interfering with access, exchange, or \n",
      "use of ehi:\n",
      "    <bullet> a health it developer of certified health it refuses to \n",
      "license an api's interoperability elements, to grant the rights \n",
      "necessary to commercially distribute applications that use the api's \n",
      "interoperability elements, or to provide the related services necessary \n",
      "to enable the use of such applications in production environments.\n",
      "    <bullet> an ehr developer of certified health it requires third-\n",
      "party applications to be ``vetted'' for security before use but does \n",
      "not promptly conduct the vetting or conducts the vetting in a \n",
      "discriminatory or exclusionary manner.\n",
      "    <bullet> a health it developer of certified health it refuses to \n",
      "license interoperability elements that other software applications \n",
      "require to efficiently access, exchange, and use\n",
      "\n",
      "[[page 7520]]\n",
      "\n",
      "ehi maintained in the developer's technology.\n",
      "    rather than restricting interoperability elements, an actor may \n",
      "insist on terms or conditions that are burdensome and discourage their \n",
      "use. these practices would implicate the information blocking provision \n",
      "for the reasons described above. consider the following non-exhaustive \n",
      "examples:\n",
      "    <bullet> an ehr developer of certified health it maintains an ``app \n",
      "store'' through which other developers can have ``apps'' listed that \n",
      "run natively on the ehr developer's platform. however, if an app \n",
      "``competes'' with the ehr developer's apps or apps it plans to develop, \n",
      "the developer requires that the app developer grant the developer the \n",
      "right to use the app's source code.\n",
      "    <bullet> a health care provider engages a systems integrator to \n",
      "develop an interface engine. however, the provider's license agreement \n",
      "with its ehr developer prohibits it from disclosing technical \n",
      "documentation that the systems integrator needs to perform the work. \n",
      "the ehr developer states that it will only permit the systems \n",
      "integrator to access the documentation if all of its employees sign a \n",
      "broad non-compete agreement that would effectively bar them from \n",
      "working for any other health it companies.\n",
      "    the information blocking provision would be implicated also if an \n",
      "actor were to discourage efforts to develop or use interoperable \n",
      "technologies or services by exercising its influence over customers, \n",
      "users, or other persons, as in the following non-exhaustive examples:\n",
      "    <bullet> an ehr developer of certified health it maintains an ``app \n",
      "store'' through which other developers can have ``apps'' listed that \n",
      "run natively on the ehr developer's platform. the ehr developer charges \n",
      "app developers a substantial fee for this service unless an app \n",
      "developer agrees not to deploy the app in any other ehr developers' app \n",
      "stores.\n",
      "    <bullet> a hospital is working with several health it developers to \n",
      "develop an application that will enable ambulatory providers who use \n",
      "different ehr systems to access and update patient data in the \n",
      "hospital's ehr system from within their ambulatory ehr workflows. the \n",
      "inpatient ehr developer, being a health it developer of certified \n",
      "health it, pressures the hospital to abandon this project, stating that \n",
      "if it does not it will no longer receive the latest updates and \n",
      "features for its inpatient ehr system.\n",
      "    <bullet> a health it developer of certified health it discourages \n",
      "customers from procuring data integration capabilities from a third-\n",
      "party developer, claiming that it will be providing such capabilities \n",
      "free of charge in the next release of its product. in reality, the \n",
      "capabilities it is developing are more limited in scope and are still \n",
      "12-18 months from being production-ready.\n",
      "    <bullet> a health system insists that local physicians adopt its \n",
      "ehr platform, which provides limited connectivity with competing \n",
      "hospitals and facilities. the health system threatens to revoke \n",
      "admitting privileges for physicians that do not comply.\n",
      "    similar concerns would arise were an actor to engage in \n",
      "discriminatory practices--such as imposing unnecessary and burdensome \n",
      "administrative, technical, contractual, or other requirements on \n",
      "certain persons or classes of persons--that interfere with access and \n",
      "exchange or ehi by frustrating or discouraging efforts to enable \n",
      "interoperability. the following non-exhaustive examples illustrate some \n",
      "ways this could occur:\n",
      "    <bullet> an hin charges additional fees, requires more stringent \n",
      "testing or certification requirements, or imposes additional terms for \n",
      "participants that are competitors, are potential competitors, or may \n",
      "use ehi obtained via the hin in a way that facilitates competition with \n",
      "the hin.\n",
      "    <bullet> a health care provider imposes one set of fees and terms \n",
      "to establish interfaces or data sharing arrangements with several \n",
      "registries and exchanges, but offers another more costly or \n",
      "significantly onerous set of terms to establish substantially similar \n",
      "interfaces and arrangements with an hie or hin that is used primarily \n",
      "by health plans that purchase health care services from the provider at \n",
      "negotiated reduced rates.\n",
      "    <bullet> a health it developer of certified health it charges \n",
      "customers fees, throttles speeds, or limits the number of records they \n",
      "can export when exchanging ehi with a regional hie that supports \n",
      "exchange among users of competing health it products, but does not \n",
      "impose like fees or limitations when its customers exchange ehi with \n",
      "enterprise hies that primarily serve users of the developer's own \n",
      "technology.\n",
      "    <bullet> as a condition of disclosing interoperability elements to \n",
      "third-party developers, an ehr developer requires third-party \n",
      "developers to enter into business associate agreements with all of the \n",
      "ehr developer's covered entity customers, even if the work being done \n",
      "is not for the benefit of the covered entities.\n",
      "    <bullet> a health it developer of certified health it takes \n",
      "significantly longer to provide or update interfaces that facilitate \n",
      "the exchange of ehi with users of competing technologies or services.\n",
      "    we clarify that not all instances of differential treatment would \n",
      "necessarily constitute a discriminatory practice that implicates the \n",
      "information blocking provision. for example, different fee structures \n",
      "or other terms may reflect genuine differences in the cost, quality, or \n",
      "value of the ehi and the effort required to provide access, exchange, \n",
      "or use. we also note that, in certain circumstances, it may be \n",
      "reasonable and necessary for an actor to restrict or impose reasonable \n",
      "and non-discriminatory terms or conditions on the use of \n",
      "interoperability elements, even though such practices could implicate \n",
      "the information blocking provision. for this reason, we propose in \n",
      "section viii.d.6 of this preamble to establish a narrow exception that \n",
      "would apply to these types of practices.\n",
      "iv. rent-seeking and other opportunistic pricing practices\n",
      "    certain practices that artificially increase the cost and expense \n",
      "associated with accessing, exchanging, and using ehi will implicate the \n",
      "information blocking provision. such practices are plainly contrary to \n",
      "the information blocking provision and the concerns that motivated its \n",
      "enactment.\n",
      "    an actor may seek to extract profits or capture revenue streams \n",
      "that would be unobtainable without control of a technology or other \n",
      "interoperability elements that are necessary to enable or facilitate \n",
      "access, exchange, or use of ehi. as discussed in section viii.c.5.b.iii \n",
      "of this proposed rule, most ehi is currently stored in ehrs and other \n",
      "source systems that use proprietary data models or formats; this puts \n",
      "ehr developers (and other actors that control data models or standards) \n",
      "in a unique position to block access to (including the export and \n",
      "portability of) ehi for use in competing systems or applications, or to \n",
      "charge rents for access to the basic technical information needed to \n",
      "accomplish the access, exchange, or use of ehi for these purposes. \n",
      "these information blocking concerns may be compounded to the extent \n",
      "that ehr developers do not disclose, in advance, the fees they will \n",
      "charge for interfaces, data export, data portability, and other \n",
      "interoperability-related services (see 80 fr 62719; 80 fr 16880-81). we \n",
      "note that these concerns are not limited to ehr developers. other \n",
      "actors who exercise substantial control over ehi or essential \n",
      "interoperability elements may engage in analogous behaviors that would \n",
      "implicate the information blocking provision.\n",
      "\n",
      "[[page 7521]]\n",
      "\n",
      "    to illustrate, we provide the following non-exhaustive examples, \n",
      "which reflect some of the more common types of rent-seeking and \n",
      "opportunistic behaviors of which we are aware and that are likely to \n",
      "interfere with access, exchange, or use of ehi:\n",
      "    <bullet> an ehr developer of certified health it charges customers \n",
      "a fee to provide interfaces, connections, data export, data conversion \n",
      "or migration, or other interoperability services, where the amount of \n",
      "the fee exceeds the actual costs that the developer reasonably incurred \n",
      "to provide the services to the particular customer(s).\n",
      "    <bullet> an ehr developer of certified health it charges a fee to \n",
      "perform an export using the ehi export capability proposed in sec.  \n",
      "170.315(b)(10) for the purposes of switching health it systems or to \n",
      "provide patients access to ehi.\n",
      "    <bullet> an ehr developer of certified health it charges more to \n",
      "export or use ehi in certain situations or for certain purposes, such \n",
      "as when a customer is transitioning to a competing technology or \n",
      "attempting to export data for use with a hie, third-party application, \n",
      "or other technology or service that competes with the revenue \n",
      "opportunities associated with the ehr developer's own suite of products \n",
      "and services.\n",
      "    <bullet> an ehr developer of certified health it interposes itself \n",
      "between a customer and a third-party developer, insisting that the \n",
      "developer pay a licensing fee, royalty, or other payment in exchange \n",
      "for permission to access the ehr system or related documentation, where \n",
      "the fee is not reasonably necessary to cover any additional costs the \n",
      "ehr developer incurs from the third-party developer's activities.\n",
      "    <bullet> an analytics company provides services to the customers of \n",
      "an ehr developer of certified health it, including de-identifying \n",
      "customer ehi and combining it with other data to identify areas for \n",
      "quality improvement. the ehr developer insists on a revenue sharing \n",
      "arrangement whereby it would receive a percentage of the revenue \n",
      "generated from these activities in return for facilitating access to \n",
      "its customers' ehi, which turns out to be disadvantageous to customers. \n",
      "the revenue the ehr developer would receive exceeds its reasonable \n",
      "costs of facilitating the access to ehi.\n",
      "    the information blocking provision would clearly be implicated by \n",
      "these and other practices by which an actor profits from its \n",
      "unreasonable control over ehi or interoperability elements without \n",
      "adding any efficiency to the health care system or serving any other \n",
      "procompetitive purpose. but the reach of the information blocking \n",
      "provision is not limited to these types of practices. we interpret the \n",
      "definition of information blocking to encompass any fee that materially \n",
      "discourages or otherwise imposes a material impediment to access, \n",
      "exchange, or use of ehi. we use the term ``fee'' in the broadest \n",
      "possible sense to refer to any present or future obligation to pay \n",
      "money or provide any other thing of value and propose to include this \n",
      "definition in sec.  171.102. we believe this scope may be broader than \n",
      "necessary to address genuine information blocking concerns and could \n",
      "unnecessarily diminish investment and innovation in interoperable \n",
      "technologies and services. therefore, as discussed in section viii.d.4 \n",
      "of this preamble, we propose to create an exception that, subject to \n",
      "certain conditions, would permit the recovery of costs that are \n",
      "reasonably incurred to provide access, exchange, and use of ehi. we \n",
      "refer readers to that section for additional details regarding this \n",
      "proposal.\n",
      "v. non-standard implementation practices\n",
      "    section 3022(a)(2)(b) of the phsa states that information blocking \n",
      "may include implementing health it in non-standard ways that \n",
      "substantially increase the complexity or burden of accessing, \n",
      "exchanging, or using ehi. in general, this type of interference is \n",
      "likely to occur when, despite the availability of generally accepted \n",
      "technical, policy, or other approaches that are suitable for achieving \n",
      "a particular implementation objective, an actor does not implement the \n",
      "standard, does not implement updates to the standard, or implements the \n",
      "standard in a way that materially deviates from its formal \n",
      "specifications. these practices lead to unnecessary complexity and \n",
      "burden, such as the additional cost and effort required to implement \n",
      "and maintain ``point-to-point'' connections, custom-built interfaces, \n",
      "and one-off trust agreements.\n",
      "    while each case will necessarily depend on its individual facts, \n",
      "and while we recognize that the development and adoption of standards \n",
      "across the health it industry is an ongoing process, we propose that \n",
      "the information blocking provision would be implicated in at least two \n",
      "distinct sets of circumstances. first, information blocking may arise \n",
      "where an actor chooses not to adopt, or to materially deviate from, \n",
      "relevant standards, implementation specifications, and certification \n",
      "criteria adopted by the secretary under section 3004 of the phsa. \n",
      "second, even where no federally adopted or identified standard exists, \n",
      "if a particular implementation approach has been broadly adopted in a \n",
      "relevant industry segment, deviations from that approach would be \n",
      "suspect unless strictly necessary to achieve substantial efficiencies.\n",
      "    to further illustrate these types of practices that would implicate \n",
      "the information blocking provision, we provide the following non-\n",
      "exhaustive examples of conduct that would be likely to interfere with \n",
      "access, exchange, or use of ehi:\n",
      "    <bullet> an ehr developer of certified health it implements the c-\n",
      "cda for receiving transitions of care summaries but only sends \n",
      "transitions of care summaries in a proprietary or outmoded format.\n",
      "    <bullet> a health it developer of certified health it adheres to \n",
      "the ``required'' portions of a widely adopted industry standard but \n",
      "chooses to implement proprietary approaches for ``optional'' parts of \n",
      "the standard when other interoperable means are readily available.\n",
      "    even where no standards exist for a particular purpose, actors \n",
      "should not design or implement health it in non-standard ways that \n",
      "unnecessarily increase the costs, complexity, and other burden of \n",
      "accessing, exchanging, or using ehi. for example, an ehr developer of \n",
      "certified health it designs its database tables in a way that is \n",
      "unreasonably difficult to ``map'' to a non-proprietary format, which is \n",
      "a necessary prerequisite to converting the ehi to a format that can be \n",
      "used in other software applications. when a customer requests the \n",
      "capability to export ehi to a clinical data registry, the ehr developer \n",
      "quotes substantial costs resulting from the need to write custom code \n",
      "to enable this functionality. based on these facts, the fees do not \n",
      "reflect costs that are reasonably incurred to provide the service and \n",
      "are instead the result of the developer's impractical design choices. \n",
      "we are aware that some actors attribute certain non-standard \n",
      "implementations on legacy systems that the actor did not themselves \n",
      "design but which have to be integrated into the actor's health it. such \n",
      "instances will be considered on a case by case basis.\n",
      "    again, we reiterate that information blocking can take many forms \n",
      "and that the practices (and categories of practices) described above do \n",
      "not provide an exhaustive list or comprehensive description of \n",
      "practices that may implicate the information blocking provision.\n",
      "\n",
      "[[page 7522]]\n",
      "\n",
      "6. applicability of exceptions\n",
      "a. reasonable and necessary activities\n",
      "    as discussed above, section 3022(a)(3) authorizes the secretary to \n",
      "identify, through notice and comment rulemaking, reasonable and \n",
      "necessary activities that do not constitute information blocking for \n",
      "purposes of the definition set forth in section 3022(a)(1). separately, \n",
      "the cures act identifies at section 3022(a)(1) practices that \n",
      "contravene the definition of information blocking. following this cures \n",
      "act terminology, conduct that implicates the information blocking \n",
      "provision and that does not fall within one of the exceptions described \n",
      "in section viii.d of this preamble, or does not meet all conditions for \n",
      "an exception, would be considered a ``practice.'' conduct that falls \n",
      "within an exception and meets all the applicable conditions for that \n",
      "exception would be considered an ``activity.'' the challenge with this \n",
      "distinction is that when examining conduct that is the subject of an \n",
      "information blocking claim-- an actor's actions that likely interfered \n",
      "with access, exchange, or use of ehi--it can be illusory to \n",
      "distinguish, on its face, conduct that is a practice and conduct that \n",
      "is an activity. indeed, conduct that implicates the information \n",
      "blocking provision but falls within an exception could nonetheless be \n",
      "considered information blocking in the event that the actor has not \n",
      "satisfied the conditions applicable to that exception.\n",
      "    while we acknowledge the terminology used in the cures act, we \n",
      "propose to use the term ``practice'' throughout this proposed rule when \n",
      "we describe conduct that is likely to interfere with, prevent, or \n",
      "materially discourage access, exchange, or use of electronic health \n",
      "information, regardless of whether that conduct meets the conditions \n",
      "for an exception to the information blocking provision. consistent with \n",
      "this approach, when identifying reasonable and necessary activities in \n",
      "sec. sec.  171.200 through 171.206, we describe practices that, if all \n",
      "the applicable conditions are met, are reasonable and necessary and not \n",
      "information blocking. we have taken this approach, in part, because we \n",
      "believe that to adopt the terminology of activity to describe conduct \n",
      "that may or may not be information blocking would confuse the reader \n",
      "and obfuscate our intent in certain circumstances. as an illustration, \n",
      "a health care provider may implement an organizational security policy \n",
      "that limits access, exchange, or use of certain information to certain \n",
      "users (e.g., role-based access). prior to determining whether the \n",
      "implementation of the security policy is reasonable and necessary under \n",
      "the circumstances, such conduct would be considered a ``practice'' that \n",
      "implicates the information blocking provision. however, it may later be \n",
      "determined that such conduct is reasonable and necessary and would then \n",
      "be considered an ``activity.'' due to these types of scenarios, we \n",
      "contend that the better approach is to use one term--practice--\n",
      "throughout the proposed rule and clarify when describing the conduct at \n",
      "issue whether it is a practice that is information blocking, a practice \n",
      "that implicates the information blocking provision, or a practice that \n",
      "is reasonable and necessary and not information blocking.\n",
      "b. treatment of different types of actors\n",
      "    the proposed exceptions would apply to health care providers, \n",
      "health it developers of certified health it, hies, and hins who engage \n",
      "in certain practices covered by an exception, provided that all \n",
      "applicable conditions of the exception are satisfied at all relevant \n",
      "times and for each practice for which the exception is sought. the \n",
      "exceptions are generally applicable to all actors. however, in some \n",
      "instances we propose conditions within an exception that apply to a \n",
      "particular type of actor.\n",
      "c. establishing that activities and practices meet the conditions of an \n",
      "exception\n",
      "    we propose that, in the event of an investigation of an information \n",
      "blocking complaint, an actor must demonstrate that an exception is \n",
      "applicable and that the actor met all relevant conditions of the \n",
      "exception at all relevant times and for each practice for which the \n",
      "exception is sought. we consider this allocation of proof to be a \n",
      "substantive condition of the proposed exceptions. as a practical \n",
      "matter, we propose that actors are in the best position to demonstrate \n",
      "compliance with the conditions of the proposed exceptions and to \n",
      "produce the detailed evidence necessary to demonstrate that compliance. \n",
      "we request comment about the types of documentation and/or standardized \n",
      "methods that an actor may use to demonstrate compliance with the \n",
      "exception conditions.\n",
      "\n",
      "d. proposed exceptions to the information blocking provision\n",
      "\n",
      "    we propose to establish seven exceptions to the information \n",
      "blocking provision. the exceptions would apply to certain activities \n",
      "that may technically meet the definition of information blocking but \n",
      "that are reasonable and necessary to further the underlying public \n",
      "policies of the information blocking provision.\n",
      "    the seven proposed exceptions are based on three related policy \n",
      "considerations. first, each exception is limited to certain activities \n",
      "that clearly advance the aims of the information blocking provision. \n",
      "these reasonable and necessary activities include providing appropriate \n",
      "protections to prevent harm to patients and others; promoting the \n",
      "privacy and security of ehi; promoting competition and innovation in \n",
      "health it and its use to provide health care services to consumers, and \n",
      "to develop more efficient means of health care delivery; and allowing \n",
      "system downtime in order to implement upgrades, repairs, and other \n",
      "changes to health it. second, each exception addresses a significant \n",
      "risk that regulated actors will not engage in these beneficial \n",
      "activities because of uncertainty concerning the breadth or \n",
      "applicability of the information blocking provision. finally, each \n",
      "exception is subject to strict conditions to ensure that it is limited \n",
      "to activities that are reasonable and necessary.\n",
      "    the first three exceptions, set forth in viii.d.1-d.3, extend to \n",
      "certain activities that are reasonable and necessary to prevent harm to \n",
      "patients and others; promote the privacy of ehi; and promote the \n",
      "security of ehi, subject to strict conditions to prevent the exceptions \n",
      "from being misused. we believe that without these exceptions, actors \n",
      "may be reluctant to engage in the types of reasonable and necessary \n",
      "activities described below, and that this could erode trust in the \n",
      "health it ecosystem and undermine efforts to provide access and \n",
      "facilitate the exchange and use of ehi for important purposes. such a \n",
      "result would be contrary to the purpose of the information blocking \n",
      "provision and the broader policies of the cures act.\n",
      "    the next three exceptions, set forth in viii.d.4-d.6, address \n",
      "activities that are reasonable and necessary to promote competition and \n",
      "consumer welfare. first, we propose to permit the recovery of certain \n",
      "types of reasonable costs incurred to provide technology and services \n",
      "that enable access to ehi and facilitate the exchange and use of that \n",
      "information, provided certain conditions are met. second, we propose to \n",
      "permit an actor to decline to provide access, exchange, or use of ehi \n",
      "in a manner that is infeasible, subject to a duty to provide a \n",
      "reasonable alternative. and, third, we propose an exception that would \n",
      "permit an actor to license interoperability elements on reasonable\n",
      "\n",
      "[[page 7523]]\n",
      "\n",
      "and non-discriminatory terms. these exceptions would be subject to \n",
      "strict conditions to ensure that they do not extend protection to \n",
      "practices that raise information blocking concerns.\n",
      "    the last exception, set forth in viii.d.7, recognizes that it may \n",
      "be reasonable and necessary for actors to make health it temporarily \n",
      "unavailable for the benefit of the overall performance of health it. \n",
      "this exception would permit an actor to make the operation of health it \n",
      "unavailable in order to implement upgrades, repairs, and other changes.\n",
      "    as context for the exceptions proposed below in viii.d.4-d.6, we \n",
      "note that addressing information blocking is critical for promoting \n",
      "competition and innovation in health it and for the delivery of health \n",
      "care services to consumers. indeed, the information blocking provision \n",
      "itself expressly addresses practices that impede innovations and \n",
      "advancements in health information access, exchange, and use, including \n",
      "care delivery enabled by health it (section 3022(a)(2)(c)(ii) of the \n",
      "phsa). as discussed in section viii.c.5.b.iii of this preamble, health \n",
      "it developers of certified health it, hies, hins, and, in some \n",
      "instances, health care providers may exploit their control over \n",
      "interoperability elements to create barriers to entry for competing \n",
      "technologies and services that offer greater value for health it \n",
      "customers and users, provide new or improved capabilities, and enable \n",
      "more robust access, exchange, and use of ehi.\\110\\ more than this, \n",
      "information blocking may harm competition not just in health it \n",
      "markets, but also in markets for health care services.\\111\\ dominant \n",
      "providers in these markets may leverage their control over technology \n",
      "to limit patient mobility and choice.\\112\\ they may also pressure \n",
      "independent providers to adopt expensive, hospital-centric technologies \n",
      "that do not suit their workflows, limit their ability to share \n",
      "information with unaffiliated providers, and make it difficult to adopt \n",
      "or use alternative technologies that could offer greater efficiency and \n",
      "other benefits.\\113\\ the technological dependence resulting from these \n",
      "practices can be a barrier to entry by would-be competitors. it can \n",
      "also make independent providers vulnerable to acquisition or induce \n",
      "them into exclusive arrangements that enhance the market power of \n",
      "incumbent providers, while preventing the formation of clinically-\n",
      "integrated products and networks that offer more choice and better \n",
      "value to consumers and purchasers of health care services.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\110\\ see also martin gaynor, farzad mostashari, and paul b. \n",
      "ginsberg, making health care markets work: competition policy for \n",
      "health care, 16-17 (apr. 2017), available at <a href=\"http://heinz.cmu.edu/news/news-detail/index.aspx?nid=3930\">http://heinz.cmu.edu/news/news-detail/index.aspx?nid=3930</a>.\n",
      "    \\111\\ see, e.g., keynote address of ftc chairwoman edith \n",
      "ramirez, antitrust in healthcare conference arlington, va (may 12, \n",
      "2016), available at <a href=\"https://www.ftc.gov/system/files/documents/public_statements/950143/160519antitrusthealthcarekeynote.pdf\">https://www.ftc.gov/system/files/documents/public_statements/950143/160519antitrusthealthcarekeynote.pdf</a>.\n",
      "    \\112\\ see, e.g., martin gaynor, farzad mostashari, and paul b. \n",
      "ginsberg, making health care markets work: competition policy for \n",
      "health care, 16-17 (apr. 2017), available at <a href=\"http://heinz.cmu.edu/news/news-detail/index.aspx?nid=3930\">http://heinz.cmu.edu/news/news-detail/index.aspx?nid=3930</a>.\n",
      "    \\113\\ see, e.g., healthcare research firm toughens survey \n",
      "standards as more cios reap the profits of reselling vendor \n",
      "software, black book, available at <a href=\"http://www.prweb.com/releases/2015/02/prweb12530856.htm\">http://www.prweb.com/releases/2015/02/prweb12530856.htm</a>; arthur allen, connecticut law bans ehr-\n",
      "linked information blocking, <a href=\"http://politico.com\">politico.com</a> (oct. 29, 2015).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    section 3022(a)(5) of the phsa provides that the secretary may \n",
      "consult with the federal trade commission (ftc) in defining practices \n",
      "that do not constitute information blocking because they are necessary \n",
      "to promote competition and consumer welfare. we appreciate the \n",
      "expertise and informal technical assistance of ftc staff, which we have \n",
      "taken into consideration in developing the exceptions described in \n",
      "viii.d.4-d.6 of this preamble. we note that the language in the cures \n",
      "act regarding information blocking is substantively and substantially \n",
      "different from the language and goals in the antitrust laws enforced by \n",
      "the ftc. we view the cures act as authorizing onc and oig to regulate \n",
      "conduct that may be considered permissible under the antitrust laws. on \n",
      "this basis, this proposed rule requires that actors who control \n",
      "interoperability elements cooperate with individuals and entities that \n",
      "require those elements for the purpose of developing, disseminating, \n",
      "and enabling technologies and services that can interoperate with the \n",
      "actor's technology.\n",
      "    we emphasize that onc is taking this approach because we view \n",
      "patients as having an overwhelming interest in ehi about themselves, \n",
      "and particularly observational health information (see the discussion \n",
      "in section viii.c.4.b of this preamble). as such, access to ehi, and \n",
      "the ehi itself, should not be traded or sold by those actors who are \n",
      "custodians of ehi or who control its access, exchange, or use. we \n",
      "emphasize that such actors should not be able to charge fees for \n",
      "providing electronic access, exchange, or use of patients' ehi. we \n",
      "propose that actors should be required to share ehi unless they are \n",
      "prohibited from doing so under an existing law or are covered by one of \n",
      "the exceptions detailed in this preamble. in addition, any remedy \n",
      "sought or action taken by hhs under the information blocking provision \n",
      "would be independent from the antitrust laws and would not prevent ftc \n",
      "or doj from taking action with regard to the same actor or conduct.\n",
      "    we request comment on the following seven proposed exceptions, \n",
      "including whether they will achieve our stated policy goals.\n",
      "1. preventing harm\n",
      "    we propose to establish an exception to the information blocking \n",
      "provision for practices that are reasonable and necessary to prevent \n",
      "harm to a patient or another person, provided certain conditions are \n",
      "met. the exception and corresponding conditions are set forth in the \n",
      "proposed regulation text in sec.  171.201.\n",
      "    this proposed exception would acknowledge the public interest in \n",
      "protecting patients and other persons against unreasonable risks of \n",
      "harm that, in certain narrowly defined circumstances described below, \n",
      "justify practices that are likely to interfere with access, exchange, \n",
      "or use of ehi and that would implicate the information blocking \n",
      "provision in the absence of an exception.\n",
      "    the exception would be subject to strict conditions, which we \n",
      "believe are necessary to prevent patient safety from being used as a \n",
      "pretext for information blocking or as a post hoc rationalization for \n",
      "practices that are not reasonable and necessary to address material \n",
      "risks of harm to a patient or another person.\n",
      "    we have adopted the terminology of ``patient'' to denote the \n",
      "context in which the threat of harm arises. that is, this proposed \n",
      "exception has been designed to recognize certain practices taken for \n",
      "the benefit of recipients of health care--those individuals whose ehi \n",
      "is at issue--and other persons whose information may be recorded in \n",
      "that ehi or who may be at risk of harm because of the access, use, or \n",
      "exchange of ehi. the use of the term ``patient'' does not require, \n",
      "other than in the context of the risk of harm determined by a licensed \n",
      "health care professional (see sec.  171.201(a)(3)), that an actor \n",
      "seeking to benefit from this exception needs to have a clinician-\n",
      "patient relationship with the individual (or individuals) at risk of \n",
      "harm. indeed, a health it developer of certified health it would be \n",
      "able to benefit from this exception in connection with practices \n",
      "undertaken for the benefit of individuals receiving (or having \n",
      "received, or expected to receive) care from a health care provider that \n",
      "uses the developer's health it. similarly, an hie or hin that exchanges \n",
      "or facilitates the exchange of ehi would\n",
      "\n",
      "[[page 7524]]\n",
      "\n",
      "be able to benefit from this exception in connection with the \n",
      "activities carried out by the hie or hin for or at the direction of a \n",
      "health care provider.\n",
      "patient harm risks that would be cognizable under this exception\n",
      "    consistent with the definition of information blocking, we have \n",
      "identified certain risks to patient harm that arise in the context of \n",
      "access, exchange, or use of ehi. to qualify for this proposed \n",
      "exception, an actor's practice must respond to a risk that is \n",
      "cognizable under this exception.\n",
      "risk of corrupt or inaccurate data being recorded or incorporated in a \n",
      "patient's electronic health record\n",
      "    the exception may apply to practices that prevent harm arising from \n",
      "corrupted or inaccurate ehi being recorded or incorporated in a \n",
      "patient's electronic health record. users of health it systems strive \n",
      "to maintain accurate electronic health records by carefully inputting \n",
      "ehi and verifying existing ehi. occasionally a clinician or other user \n",
      "of health it is presented with ehi that, due to a failure of the \n",
      "technology, is either entirely incorrect or contains inaccurate \n",
      "information. at other times, ehi could become corrupted. in these \n",
      "cases, the sharing or integration of such ehi could lead to \n",
      "inaccuracies in the patient's electronic health record that then run \n",
      "the risk of being propagated further. we note, however, that known \n",
      "inaccuracies in some data within a record may not be sufficient \n",
      "justification to withhold the entire record if the remainder of the \n",
      "patient's ehi could be effectively shared without also presenting the \n",
      "known incorrect or corrupted information as if it were trustworthy. \n",
      "also, we would expect that once information is known to be inaccurate \n",
      "or corrupted, a health care provider holding that record would, for \n",
      "example, take action to cure the inaccuracy or corruption. we \n",
      "understand that in the ordinary course of practice, and consistent with \n",
      "professional and legal standards for clinical record keeping, health \n",
      "care providers take appropriate action to remediate known problems with \n",
      "ehi and restore a record as a whole to be safely usable, and therefore \n",
      "safely sharable.\n",
      "    this recognized risk is limited to corruption and inaccuracies \n",
      "caused by performance and technical issues affecting health it. for \n",
      "example, this exception may be relevant if certified health it were to \n",
      "incorrectly present an old and superseded version of a medication list, \n",
      "or when only partial copies of laboratory tests are being linked to a \n",
      "patient when the patient's record is exchanged. however, this \n",
      "recognized risk does not extend to purported accuracy issues arising \n",
      "from the incompleteness of a patient's electronic health record \n",
      "generally. electronic health records, like the paper charts they \n",
      "replaced, are inevitably imperfect records. many patients see multiple \n",
      "health care providers and so it is unlikely that any single health care \n",
      "provider's record will provide a complete picture of a patient's \n",
      "health. some patients intentionally keep certain information secret \n",
      "even from their health care providers, and others fail to share \n",
      "potentially critical information with their health care providers \n",
      "because they forget to, or simply do not understand its clinical \n",
      "significance.\n",
      "\n",
      "    while the access, exchange, or use of ehi in these situations could \n",
      "give rise to the risk of harm if the ehi was relied on without \n",
      "qualification, such reliance does not accord with our understanding of \n",
      "clinical practice, as the risk of incompleteness resulting from \n",
      "patients having multiple providers, or from errors of omission by \n",
      "patients and their care providers, is not unique to electronic health \n",
      "records or their interoperable exchange. therefore, the risk that the \n",
      "ehi a given health care provider holds for a given patient may not be a \n",
      "perfectly complete record of that patient's health or care will not be \n",
      "recognized as being sufficient to support an actor qualifying for this \n",
      "exception in the face of a claim of information blocking.\n",
      "    we also acknowledge that certain federal and state laws, such as 42 \n",
      "cfr part 2 and state medical record laws, require an actor to obtain an \n",
      "individual's written consent before sharing health information. \n",
      "however, we propose that an actor would not be able to benefit from \n",
      "this exception on the basis of a perceived risk arising from exchanging \n",
      "or providing access to ehi when the ehi exchanged or made accessible \n",
      "does not include certain information due to a patient's decision not to \n",
      "consent to its disclosure. for example, this exception would not \n",
      "recognize an actor's conduct in not providing access, exchange, or use \n",
      "of a patient's electronic health record on the basis that the patient's \n",
      "failure to consent to the disclosure of substance abuse treatment \n",
      "information made the patient's record incomplete and thus inaccurate.\n",
      "risk of misidentifying a patient or patient's electronic health \n",
      "information\n",
      "    the exception may apply to practices that are designed to promote \n",
      "data quality and integrity and support health it applications properly \n",
      "identifying and matching patient records or ehi. accurately identifying \n",
      "patients and correctly attributing their ehi to them is a complex task \n",
      "and involves layers of safeguards, including verification of a \n",
      "patient's identity, proper registration in health it systems, physical \n",
      "identification such as wristbands, and usability and implementation \n",
      "decisions such as ensuring the display of a patient's name and date of \n",
      "birth on every screen of the patient's electronic chart. when a \n",
      "clinician or other health it user may know or reasonably suspect that \n",
      "specific ehi in a patient's record is or may be misattributed, either \n",
      "within a local record or as received through ehi exchange, it would be \n",
      "reasonable for them to avoid sharing or incorporating the ehi that they \n",
      "know would, or reasonably suspect could, propagate errors in the \n",
      "patient's records and thus pose the attendant risks to the patient. as \n",
      "discussed below, an actor's response to this risk would need to be no \n",
      "broader than necessary to mitigate the risk of harm arising from the \n",
      "potentially misidentified record or misattributed data. a health it \n",
      "developer of certified health it could not, for example, refuse to \n",
      "provide a batch export on the basis that the exported records may \n",
      "contain a misidentified record. similarly, a health care provider that \n",
      "identified that a particular piece of information had been \n",
      "misattributed to a patient would not be excused from exchanging or \n",
      "providing access to all other ehi about the patient that had not been \n",
      "misattributed.\n",
      "determination by a licensed health care professional that the \n",
      "disclosure of ehi is reasonably likely to endanger life or physical \n",
      "safety\n",
      "    the exception may permit certain restrictions on the disclosure of \n",
      "an individual's ehi in circumstances where a licensed health care \n",
      "professional has determined, in the exercise of professional judgment, \n",
      "that the disclosure is reasonably likely to endanger the life or \n",
      "physical safety of the patient or another person. this would include \n",
      "the situation where a covered entity elected not to treat a person as \n",
      "the personal representative of an individual in situations of potential \n",
      "abuse or endangerment, including in accordance with 45 cfr \n",
      "164.502(g)(5). in certain cases, the clinician may have individualized \n",
      "knowledge stemming from the clinician-patient relationship that, for a \n",
      "particular patient and for that patient's circumstances, harm could \n",
      "result if certain ehi were shared or transmitted electronically. \n",
      "consistent with the hipaa privacy rule, a\n",
      "\n",
      "[[page 7525]]\n",
      "\n",
      "decision not to provide access, exchange, or use of ehi on this basis \n",
      "would be subject to any right that an affected individual is afforded \n",
      "under applicable federal or state laws to have the determination \n",
      "reviewed and potentially reversed.\n",
      "    we request comment on whether the categories of harm described \n",
      "above capture the full range of safety risks that might arise directly \n",
      "from accessing, exchanging, or using ehi. we also request comment on \n",
      "whether we should consider other types of patient safety risks related \n",
      "to data quality and integrity concerns, or that may have a less \n",
      "proximate connection to ehi but that could provide a reasonable and \n",
      "necessary basis for an actor to restrict or otherwise impede access, \n",
      "exchange, or use of ehi in appropriate circumstances. we ask that \n",
      "commenters provide detailed rationale for any suggested revisions to \n",
      "these categories, including additional conditions that may be necessary \n",
      "to ensure that the exception is tailored and does not extend protection \n",
      "to practices that are not reasonable and necessary to promote patient \n",
      "safety and that could present information blocking concerns.\n",
      "reasonable belief that practice was necessary to directly and \n",
      "substantially reduce the likelihood of harm\n",
      "    to qualify for this exception, an actor must have had a reasonable \n",
      "belief that the practice or practices will directly and substantially \n",
      "reduce the likelihood of harm to a patient or another person. as \n",
      "discussed above, the type of risk must also be cognizable under this \n",
      "exception.\n",
      "    an actor could meet this condition in two ways.\n",
      "qualifying organizational policy\n",
      "    in most cases, we anticipate that the actor would demonstrate that \n",
      "the practices it engaged in were consistent with an organizational \n",
      "policy that was objectively reasonable and no broader than necessary \n",
      "for the type of patient safety risks at issue. in these circumstances, \n",
      "we propose that an actor's policy would need to satisfy the following \n",
      "requirements.\n",
      "    first, we propose that the policy must be in writing.\n",
      "    second, it must have been developed with meaningful input from \n",
      "clinical, technical, and other appropriate staff or others who have \n",
      "expertise or insight relevant to the risk of harm that the policy \n",
      "addresses. this condition would not be met if, for example, a hospital \n",
      "imposed top-down information sharing policies or workflows established \n",
      "by the hospital's ehr developer and approved by hospital administrators \n",
      "without meaningful input from the medical staff, it department, and \n",
      "front-line clinicians who would implement, and thus be affected by, the \n",
      "policy and are in the best position to gauge how effective it will be \n",
      "at mitigating patient safety risks.\n",
      "    third, we propose that the policy must have been implemented in a \n",
      "consistent and non-discriminatory manner. as part of this condition, \n",
      "the actor must have taken reasonable steps to educate its directors, \n",
      "officers, employees, contractors, and authorized personnel on how to \n",
      "apply the policy and to provide appropriate oversight to ensure that \n",
      "the policy is not applied in an arbitrary, discriminatory, or otherwise \n",
      "inappropriate manner. this condition would not be met if, for example, \n",
      "a policy or practice were based on factors that lacked a direct and \n",
      "substantial correlation with the particular risk of harm at issue.\n",
      "    last, we propose that the policy must have been be no broader than \n",
      "necessary for the specific risk or type of risk at issue. for example, \n",
      "as evidence that the policy is no broader than necessary, the policy \n",
      "would need to identify the relevant risks and follow an approach to \n",
      "mitigating those risks that is based on current patient safety evidence \n",
      "and best practices, supplemented by input from clinical, technical, and \n",
      "other staff or others who are in the best position to make judgments \n",
      "about the policy's effectiveness, as discussed above. further evidence \n",
      "that the policy was no broader than necessary would be whether the \n",
      "actor considered alternative approaches and reasonably concluded that, \n",
      "under the circumstances, those approaches were either inadequate to \n",
      "address the identified risks of harm or would not have reduced the \n",
      "likelihood of interference with access, exchange, or use of ehi. for \n",
      "example, a tailored response to the existence of corrupted data would \n",
      "necessarily permit all uncorrupted ehi to continue to be accessed, \n",
      "used, and exchanged. this condition would not be met, for example, if \n",
      "an actor's policy imposed a blanket ban on the sharing of ehi with \n",
      "users of different technologies or with health care providers who are \n",
      "not part of a particular health system, hie, or hin.\n",
      "qualifying individualized finding\n",
      "    we recognize that some health care providers (such as small \n",
      "practices) may not have comprehensive and formal policies governing all \n",
      "aspects of ehi and patient safety. additionally, even if an \n",
      "organizational policy exists, it may not anticipate all of the \n",
      "potential risks of harm that could arise in real-world clinical or \n",
      "production environments of health it. in these circumstances, in lieu \n",
      "of demonstrating that a practice conformed to the actor's policies and \n",
      "that the policies met the conditions described above, the actor could \n",
      "justify the practice or practices directly by making a finding in each \n",
      "case, based on the particularized facts and circumstances, that the \n",
      "practice is necessary and no broader than necessary to mitigate the \n",
      "risk of harm. to do so, we propose that the actor would need to show \n",
      "that the practices were approved on a case-by-case basis by an \n",
      "individual with direct knowledge of the relevant facts and \n",
      "circumstances and who had relevant clinical, technical, or other \n",
      "appropriate expertise. such an individual would need to reasonably \n",
      "conclude, on the basis of those particularized facts and circumstances \n",
      "and his/her expertise and best professional judgment, that the practice \n",
      "was necessary, and no broader than necessary, to mitigate the risk of \n",
      "harm to a patient or other persons.\n",
      "    we propose that a licensed health care professional's independent \n",
      "and individualized judgment about the safety of the actor's patients or \n",
      "other persons would be entitled to substantial deference under this \n",
      "proposed exception. so long as the clinician actually considered all of \n",
      "the relevant facts and determined that, under the particular \n",
      "circumstances, the practice was necessary to protect the safety of the \n",
      "clinician's patient or other person, we would not second-guess the \n",
      "clinician's judgment. to provide further clarity on this point, we \n",
      "provide the following illustration.\n",
      "    a clinician suspects that a patient is at risk of domestic abuse. \n",
      "the patient has recently visited the clinic for a pregnancy test, and \n",
      "tells the clinician that the potential father is not her current \n",
      "partner. the test returns a positive result. the clinician notes that \n",
      "in the patient's electronic health record, her partner has been given \n",
      "access to view her test results. the clinician, considering all factors \n",
      "for this particular situation and particular patient, and aware of the \n",
      "clinic's policy towards the restriction of electronic health \n",
      "information sharing, concludes that releasing this result \n",
      "electronically could place the patient at risk of harm. the clinician \n",
      "thus chooses not to release the test result electronically and plans to \n",
      "deliver the result to the patient in a safe manner. the exception would \n",
      "apply in this case because the clinician reasonably believes, based on \n",
      "the relationship with this particular patient and the clinician's best \n",
      "clinical judgment, that the restriction is\n",
      "\n",
      "[[page 7526]]\n",
      "\n",
      "necessary to prevent harm to the patient.\n",
      "    we seek public comment on whether this proposed exception is \n",
      "appropriate and adequately balances the interest of promoting access, \n",
      "exchange, and use of ehi with legitimate concerns about the risk of \n",
      "harm to patients and others. in addition to any other relevant issues, \n",
      "we specifically request feedback on whether the exception is broad \n",
      "enough to prevent harm to patients and others and, if not, what \n",
      "additional risks we should address should we finalize this proposal; \n",
      "and whether there are additional safeguards the secretary should adopt \n",
      "in order to prevent practices that attempt to undermine the policy goal \n",
      "of the exception. we also seek comment on whether there are customary \n",
      "practices (e.g., standards of care) that advance patient safety \n",
      "concerns but which actors do not, as a matter of practice, record in \n",
      "documented policies, and which should be taken into account when \n",
      "assessing the reasonableness of a practice under this exception.\n",
      "2. promoting the privacy of ehi\n",
      "    we propose to establish an exception to the information blocking \n",
      "provision for practices that are reasonable and necessary to protect \n",
      "the privacy of an individual's ehi, provided certain conditions are \n",
      "met. the exception and corresponding conditions are set forth in the \n",
      "proposed regulation text in sec.  171.202. we note that any practice \n",
      "engaged in to protect the privacy of an individual's ehi must be \n",
      "consistent with applicable laws related to health information privacy, \n",
      "including the hipaa privacy rule as applicable, as well as with other \n",
      "applicable laws and regulations, such as the hitech act, 42 cfr part 2, \n",
      "and state laws. this exception to the information blocking provision \n",
      "does not alter an actor's obligation to comply with these and other \n",
      "applicable laws.\n",
      "    we believe this exception is necessary to support basic trust and \n",
      "confidence in health it infrastructure. without this exception, there \n",
      "would be a significant risk that actors would share ehi in \n",
      "inappropriate circumstances, such as when an individual has taken \n",
      "affirmative steps to request that the ehi not be shared, or when an \n",
      "actor has been unable to obtain reasonable assurances as to an \n",
      "individual's identity.\n",
      "    in contrast to the other exceptions defined in this proposed rule, \n",
      "this proposed exception has been structured with discrete ``sub-\n",
      "exceptions.'' an actor's practice must qualify for a sub-exception in \n",
      "order to be covered by this exception. the sub-exceptions have, to a \n",
      "large extent, been crafted to closely mirror privacy-protective \n",
      "practices that are recognized under state and federal privacy laws. in \n",
      "this way, the privacy sub-exceptions to the information blocking \n",
      "provision would recognize as reasonable and necessary practices that \n",
      "are engaged in by actors consistent with privacy laws, provided that \n",
      "certain conditions are met. we have proposed four sub-exceptions that \n",
      "address the following privacy protective practices: (1) not providing \n",
      "access, exchange, or use of ehi when a state or federal law requires \n",
      "that a condition be satisfied before an actor provides access, \n",
      "exchange, or use of ehi, and the condition is not satisfied (proposed \n",
      "in sec.  171.202(b)); (2) not providing access, exchange, or use of ehi \n",
      "when the actor is a health it developer of certified health it that is \n",
      "not covered by the hipaa privacy rule in respect to a practice \n",
      "(proposed in sec.  171.202(c)); (3) a covered entity, or a business \n",
      "associate on behalf of a covered entity, denying an individual's \n",
      "request for access to their electronic phi in the circumstances \n",
      "provided in 45 cfr 164.524(a)(1), (2), or (3) (proposed at sec.  \n",
      "171.202(d)); and (4) not providing access, exchange, or use of ehi \n",
      "pursuant to an individual's request, in certain situations (proposed in \n",
      "sec.  171.202(e)). the rationale for each sub-exception is described in \n",
      "detail below.\n",
      "    an actor would need to satisfy at least one sub-exception in order \n",
      "that a purportedly privacy-protective practice that interferes with \n",
      "access, exchange, or use of ehi not be subject to the information \n",
      "blocking provision. each sub-exception has conditions that must be met \n",
      "in order that an actor's practice qualifies for protection under the \n",
      "sub-exception.\n",
      "specific terminology used for the purposes of this proposed exception\n",
      "    we note that this proposed exception and our discussion below uses \n",
      "certain terms that are defined by the hipaa rules \\114\\ but that, for \n",
      "purposes of this exception, may have a broader meaning in the context \n",
      "of the information blocking provision and its implementing regulations \n",
      "as set forth in this proposed rule. in general, the terms ``access,'' \n",
      "``exchange,'' and ``use'' have the meaning explained in section \n",
      "viii.c.4.a of this preamble. however, in some instances we refer to \n",
      "``use'' in the context of a disclosure or use of ephi under the hipaa \n",
      "privacy rule, in which case we have explicitly stated that the term \n",
      "``use'' has the meaning defined in 45 cfr 160.103. similarly, we refer \n",
      "in a few cases to an individual's right of access under 45 cfr 164.524, \n",
      "in which case the term ``access'' should be understood in that hipaa \n",
      "privacy rule context. for purposes of section 3022 of the phsa, \n",
      "however, the term ``access'' includes, but is broader than, an \n",
      "individual's access to their phi as provided for by the hipaa privacy \n",
      "rule (see section viii.c.4.a of this preamble).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\114\\ 45 cfr part 160 and subparts a, c, and e of part 164.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    finally, the term ``individual'' is defined by the hipaa rules at \n",
      "45 cfr 160.103. separately, under the information blocking enforcement \n",
      "provision, the term ``individual'' is used to refer to actors that are \n",
      "health it developers of certified health it, hins, or hies, (see \n",
      "section 3022(b)(2)(a) of the phsa). for purposes of this exception (and \n",
      "only this exception), we use neither of these definitions. instead, the \n",
      "term ``individual'' encompasses any or all of the following: (1) an \n",
      "individual defined by 45 cfr 160.103; (2) a person who is the subject \n",
      "of ehi that is being accessed, exchanged or used; (3) a person who \n",
      "legally acts on behalf of an individual or person described in (1) or \n",
      "(2), including as a personal representative, in accordance with 45 cfr \n",
      "164.502(g); or (4) a legal representative authorized to make health \n",
      "care decisions on behalf of a person or an executor or administrator \n",
      "who can act on behalf of the deceased's estate under state or other \n",
      "law.\n",
      "    we clarify that (2) varies from (1) because there could be \n",
      "individuals who could be the subject of ehi that is being accessed, \n",
      "exchanged, or used under (2), but who would not be the subject of phi \n",
      "under (1). the purpose of (2) is to include ehi that would be accessed, \n",
      "exchanged or used by entities that are not subject to hipaa (e.g., non-\n",
      "covered entities and non-business associates). these entities could \n",
      "include, for example, health it developers or data analytics companies \n",
      "that have access to ehi, but are not business associates.\n",
      "    we also clarify that (3) encompasses a person with legal authority \n",
      "to act on behalf of the individual, which includes a person who is a \n",
      "personal representative as defined under the hipaa privacy rule. we \n",
      "included the component of legal authority to act in (3) because the \n",
      "hipaa privacy rule gives rights to parents or legal guardians in \n",
      "certain circumstances where they are not the ``personal \n",
      "representative'' for their child(ren). for instance, a non-custodial \n",
      "parent who has requested a minor child's medical records under a court-\n",
      "ordered divorce decree may have legal authority to act on behalf of the\n",
      "\n",
      "[[page 7527]]\n",
      "\n",
      "child even if he or she is not the child's ``personal representative.'' \n",
      "further, in limited circumstances and if permitted under state law, a \n",
      "family member may have legal authority to act on behalf of a patient to \n",
      "make health care decisions in emergency situations even if that family \n",
      "member may not be the ``legal representative'' or ``personal \n",
      "representative'' of the patient.\n",
      "    we have adopted this specialized usage to ensure that this privacy \n",
      "exception extends protection to information about, and respects the \n",
      "privacy preferences of, all individuals, not only those individuals \n",
      "whose ehi is protected as ephi by hipaa covered entities and business \n",
      "associates.\n",
      "interaction between information blocking, the exception for promoting \n",
      "the privacy of ehi, and the hipaa privacy rule\n",
      "    having consulted extensively with the hhs office for civil rights \n",
      "(ocr), who enforce the hipaa privacy, security and breach notification \n",
      "rules, we have developed the information blocking provision to advance \n",
      "our shared goals of preventing information blocking for nefarious or \n",
      "self-interested purposes while maintaining and upholding existing \n",
      "privacy rights and protections for individuals. the proposed exception \n",
      "for promoting the privacy of ehi (also referred to as ``the privacy \n",
      "exception'') operates in a manner consistent with the framework of the \n",
      "hipaa privacy rule. we designed these exceptions to ensure that \n",
      "individual privacy rights are not diminished as a consequence of the \n",
      "information blocking provision, and to ensure that the information \n",
      "blocking provision does not require the use or disclosure of ehi in a \n",
      "way that would not be permitted under the hipaa privacy rule. our \n",
      "intent is that the information blocking provision does not conflict \n",
      "with the hipaa privacy rule. indeed, the sub-exception proposed in \n",
      "sec.  171.202(d) reflects a policy judgment that an actor's denial of \n",
      "access to an individual consistent with the limited conditions for such \n",
      "denials that are described in the hipaa privacy rule at 45 cfr \n",
      "164.524(a)(1), (2), and (3) is reasonable under the circumstances. we \n",
      "believe this resolves any potential conflict between limitations on an \n",
      "individual's right of access under the hipaa privacy rule and the \n",
      "information blocking provision.\n",
      "    we note that the information blocking provision may operate to \n",
      "require that actors provide access, exchange, or use of ehi in \n",
      "situations that hipaa does not. this is because the hipaa privacy rule \n",
      "permits, but does not require, covered entities to use and disclose \n",
      "ephi in most circumstances. the information blocking provision, on the \n",
      "other hand, requires that an actor provide access to, exchange, or use \n",
      "of ehi unless they are prohibited from doing so under an existing law \n",
      "or are covered by one of the exceptions detailed in this preamble. to \n",
      "illustrate, the hipaa privacy rule permits health care providers to \n",
      "exchange ephi for treatment purposes, but does not require them to do \n",
      "so. under the information blocking provision, unless an exception to \n",
      "information blocking applies, or the interference is required by law, a \n",
      "primary care provider would be required to exchange ephi with a \n",
      "specialist who requests it to treat an individual who was a common \n",
      "patient of the provider and the specialist, even if the primary care \n",
      "provider offered patient care services in competition with the \n",
      "specialist's practice, or would usually refer its patients to another \n",
      "specialist due to an existing business relationship.\n",
      "promoting patient privacy rights\n",
      "    as discussed above, the information blocking provision would not \n",
      "require that actors provide access, exchange, or use of ehi in a manner \n",
      "that is not permitted under the hipaa privacy rule or other privacy \n",
      "laws. as such, the privacy-protective controls existing under hipaa \n",
      "would not be weakened by the information blocking provision. moreover, \n",
      "we have structured the privacy exception to ensure that actors can \n",
      "engage in reasonable and necessary practices that advance the privacy \n",
      "interests of individuals.\n",
      "    for example, we believe that, unless required by law, actors should \n",
      "not be compelled to share ehi against patients' wishes or without \n",
      "adequate safeguards out of a concern that restricting the access, \n",
      "exchange, or use of the ehi would constitute information blocking. this \n",
      "could seriously undermine patients' trust and confidence in the privacy \n",
      "of their ehi and diminish the willingness of patients, providers, and \n",
      "other entities to provide or maintain health information electronically \n",
      "in the first place. in addition, such outcomes would undermine and not \n",
      "advance the goals of the information blocking provision and be \n",
      "inconsistent with the broader policy goal of the cures act to \n",
      "facilitate trusted exchange of ehi. trusted exchange requires not only \n",
      "that ehi be shared in accordance with applicable law, but also that it \n",
      "be shared in a manner that effectuates individuals' expressed privacy \n",
      "preferences. we note and discuss below that an individual's expressed \n",
      "privacy preferences will not be controlling in all cases. an actor will \n",
      "not be able to rely on an individual's expressed privacy preference in \n",
      "circumstances where the access, exchange, or use is required by law.\n",
      "    for these reasons, we propose that the proposed sub-exception in \n",
      "sec.  171.202(e) would generally permit an actor to give effect to \n",
      "individuals' expressed privacy preferences, including their desire not \n",
      "to permit access, exchange, or use of their ehi. for example, provided \n",
      "that corresponding conditions have been met, a health care provider \n",
      "could honor a patient's request not to share their ehi in circumstances \n",
      "in which the hipaa privacy rule would permit (though not require) the \n",
      "provider to disclose the information, such as for treatment purposes. \n",
      "at the same time, however, we believe that the privacy exception must \n",
      "be tailored to ensure that protection of an individual's privacy is not \n",
      "used as a pretext for information blocking. accordingly, we propose \n",
      "that this exception, which is discussed more fully below, would be \n",
      "subject to strict conditions.\n",
      "privacy practices required by law\n",
      "    because the information blocking provision excludes from the \n",
      "definition of information blocking practices that are required by law \n",
      "(section 3022(a)(1) of the phsa), privacy-protective practices that are \n",
      "required by law do not implicate the information blocking provision and \n",
      "do not require coverage from an exception. for example, the hipaa \n",
      "privacy rule requires that a covered entity must agree to the request \n",
      "of an individual to restrict disclosure of protected health information \n",
      "(phi) about the individual to a health plan if the disclosure is for \n",
      "the purpose of carrying out payment or health care operations and not \n",
      "otherwise required by law and the phi pertains solely to a health care \n",
      "item or service for which the individual, or person other than the \n",
      "health plan on behalf of the individual, has paid the covered entity in \n",
      "full.\\115\\ if an individual made such a request and met all \n",
      "requirements of the hipaa privacy rule, the actor would be required by \n",
      "law not to exchange the individual's ehi to a health plan. in this \n",
      "situation, the actor's interference with access, exchange, or use would \n",
      "not be information blocking and as such, the actor would not need to \n",
      "benefit from this exception.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\115\\ 45 cfr 164.522(a)(1)(vi).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    practices that are ``required by law'' can be distinguished from \n",
      "other practices that an actor engages in pursuant to a privacy law, but \n",
      "which are not ``required by law.'' such privacy laws are typically \n",
      "framed in a way that\n",
      "\n",
      "[[page 7528]]\n",
      "\n",
      "conditions the making of a ``disclosure'' on the satisfying of specific \n",
      "conditions, but does not expressly require that the actor engage in a \n",
      "practice that interferes with access, exchange, or use of ehi. for \n",
      "example, the hipaa privacy rule provides that a covered entity may use \n",
      "or disclose phi in certain circumstances where the individual concerned \n",
      "has authorized the disclosure.\\116\\ the effect of this requirement is \n",
      "that the covered entity should not use or disclose the phi in the \n",
      "absence of an individual's authorization. however, because the \n",
      "requirement does not prohibit the actor from exchanging the ehi in all \n",
      "circumstances, the actor would be at risk of engaging in a practice \n",
      "that was information blocking unless an exception applied. for this \n",
      "reason, we have included a sub-exception, addressed in sec.  171.202(b) \n",
      "and discussed below, that provides that an actor will not be engaging \n",
      "in information blocking if a state or federal privacy law imposes a \n",
      "precondition to the provision of access, exchange, or use, and that \n",
      "precondition has not been satisfied.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\116\\ 45 cfr 164.508 (uses and disclosures for which an \n",
      "authorization is required).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "sub-exception to proposed privacy exception: precondition not satisfied\n",
      "    state and federal privacy laws that permit the disclosure of phi \n",
      "often impose conditions that must be satisfied prior to a disclosure \n",
      "being made. we propose to establish a sub-exception to the information \n",
      "blocking provision that recognizes that an actor will not be engaging \n",
      "in information blocking if an actor does not provide access, exchange, \n",
      "or use of ehi because a necessary precondition required by law has not \n",
      "been satisfied. this exception will apply to all instances where an \n",
      "actor's ability to provide access, exchange, or use is ``controlled'' \n",
      "by a legal obligation to satisfy a condition, or multiple conditions, \n",
      "prior to providing that access, exchange, or use. to be covered by this \n",
      "exception, the actor must comply with conditions, which are discussed \n",
      "below.\n",
      "    the nature of the preconditions that an actor must satisfy in order \n",
      "to provide access, exchange, or use of ehi will depend on the privacy \n",
      "laws that regulate the actor. an actor that is regulated by a \n",
      "restrictive state privacy law may need to satisfy more conditions than \n",
      "an actor regulated by a less restrictive state privacy law, before \n",
      "providing access, exchange, or use. similarly, certain state privacy \n",
      "laws may impose standards for meeting preconditions that are more \n",
      "rigorous than the laws in force elsewhere.\n",
      "    to illustrate how we propose this sub-exception would operate, we \n",
      "provide the following examples. we note that this list of examples is \n",
      "not exhaustive and that preconditions required by law that control \n",
      "access, exchange, or use of ehi that are not listed below would still \n",
      "qualify under this proposed sub-exception so long as all conditions are \n",
      "met.\n",
      "    <bullet> certain federal and state laws require that a person \n",
      "provide consent before his or her ehi can be accessed, exchanged, or \n",
      "used for specific purposes. although the hipaa privacy rule does not \n",
      "have consent requirements for an individual (as that term is defined in \n",
      "the hipaa privacy rule) when a covered entity or business associate is \n",
      "using or disclosing ephi for treatment, payment or health care \n",
      "operations, some state laws and federal laws and regulations do require \n",
      "that a person's consent be obtained by the disclosing party/entity \n",
      "before disclosing certain health information. for example, for some \n",
      "sensitive health conditions such as hiv/aids, mental health, or genetic \n",
      "testing, state laws may impose a higher standard for disclosure of such \n",
      "information (i.e., require consent) than is required under the hipaa \n",
      "privacy rule. additionally, under 42 cfr part 2, federally-assisted \n",
      "``part 2 programs'' generally are required to obtain a person's consent \n",
      "to disclose or re-disclose patient-identifying information related to \n",
      "the person's substance use disorder, such as treatment for addiction. \n",
      "the exception would operate to clarify an actor's compliance \n",
      "obligations in these situations. it would not be considered information \n",
      "blocking to refuse to provide access, exchange, or use of ehi if the \n",
      "actor has not received the person's consent, subject to conditions \n",
      "discussed herein.\n",
      "    <bullet> if an actor is required by law to obtain an individual's \n",
      "hipaa authorization before providing access, exchange, or use of the \n",
      "individual's ehi, then the individual's refusal to provide an \n",
      "authorization would justify the actor's refusal to provide access, \n",
      "exchange, or use of ehi. the actor's refusal would, subject to \n",
      "conditions discussed herein, be protected under this exception.\n",
      "    <bullet> the hipaa privacy rule, and many state privacy laws, \n",
      "authorize the disclosure of phi in certain circumstances only once the \n",
      "identity and authority of the person requesting the information has \n",
      "been verified. we acknowledge that it is reasonable and necessary that \n",
      "actors take appropriate steps, consistent with federal and state laws, \n",
      "to ensure that ehi is not disclosed to the wrong person or to a person \n",
      "who is not authorized to receive it. where an actor cannot verify the \n",
      "identity or authority of a person requesting access to ehi, and such \n",
      "verification is required by law before the actor can provide access, \n",
      "exchange, or use of the ehi, the actor's refusal to provide access, \n",
      "exchange, or use will, subject to the conditions discussed herein, be \n",
      "reasonable and necessary and will not be information blocking.\n",
      "    <bullet> under the hipaa privacy rule, a health care provider may \n",
      "share information with another health care provider for a quality \n",
      "improvement project if it has verified that the requesting entity has a \n",
      "relationship with the person whose information is being requested. \n",
      "where the actor could not establish if the relationship existed, it \n",
      "would not be information blocking for the actor to refuse to provide \n",
      "access, exchange, or use, subject to the conditions discussed herein.\n",
      "    we seek comments generally on this proposed sub-exception. more \n",
      "specifically, we seek comment on how this proposed sub-exception would \n",
      "be exercised by actors in the context of state laws. we are aware that \n",
      "actors that operate across state lines or in multiple jurisdictions \n",
      "sometimes adopt organization-wide privacy practices that conform with \n",
      "the most restrictive privacy laws regulating their business. in order \n",
      "to ensure that the information blocking provision does not diminish the \n",
      "privacy rights of individuals being serviced by such actors, we are \n",
      "considering the inclusion of an accommodation in this sub-exception \n",
      "that would recognize an actor's observance of a legal precondition that \n",
      "the actor is required by law to satisfy in at least one state in which \n",
      "it operates. we believe this approach would be consistent with \n",
      "practices already in place for multi-state health care systems. for \n",
      "example, some states require specific consent requirements before \n",
      "exchanging sensitive health information such as a patient's mental \n",
      "health condition. as a result, the health care system will utilize one \n",
      "consent form for multi-jurisdiction purposes in order to meet various \n",
      "federal and state law requirements. however, in the event that we did \n",
      "adopt such an accommodation, we would also need to carefully consider \n",
      "how to ensure that before the use of the most stringent restriction is \n",
      "applied in all jurisdictions, the actor has provided all privacy \n",
      "protections afforded by that law across its entire business. this type \n",
      "of approach would ensure that an actor cannot take advantage of a more-\n",
      "restrictive privacy law for the benefit of this exception while not \n",
      "also fulfilling\n",
      "\n",
      "[[page 7529]]\n",
      "\n",
      "the privacy-protective obligations of the law being relied on. we seek \n",
      "comment on whether there is a need for onc to adopt such an \n",
      "accommodation for actors operating in multiple states, and encourage \n",
      "commenters to identify any additional conditions that should attach to \n",
      "the provision of such an accommodation. we also request comment on our \n",
      "proposed approach to dealing with varying state privacy laws throughout \n",
      "this proposed sub-exception.\n",
      "    we also recognize that under the patchwork of state privacy laws, \n",
      "some states have enacted laws that more comprehensively identify the \n",
      "circumstance in which an individual or entity can and cannot provide \n",
      "access, exchange, or use of ehi. we are considering to what extent \n",
      "health care providers that are not regulated by the hipaa privacy rule, \n",
      "and would rely instead on state laws for this sub-exception, would be \n",
      "able to benefit from this sub-exception when engaging in practices that \n",
      "interfere with access, exchange, or use of ehi for the purpose of \n",
      "promoting patient privacy. we seek comment on any challenges that may \n",
      "be encountered by health care providers that are not regulated as \n",
      "covered entities under the hipaa privacy rule when seeking to take \n",
      "advantage of this proposed sub-exception. we also seek comment on \n",
      "whether there exists a class of health care provider that is not \n",
      "regulated by any federal or state privacy law that prescribes \n",
      "preconditions that must be satisfied in connection with the disclosure \n",
      "of ehi, and whether any such class of health care provider would \n",
      "benefit from a sub-exception similar to that proposed in sec.  \n",
      "171.202(c) for health it developers of certified health it.\n",
      "conditions to be met to qualify for the sub-exception\n",
      "    in most circumstances, an actor would be in a position to influence \n",
      "whether a precondition is satisfied. for example, an actor could \n",
      "deprive a person of the opportunity to take some step that is a \n",
      "prerequisite for the exchange of their ehi, could assume the existence \n",
      "of a fact prejudicial to the granting of access without seeking to \n",
      "discover the truth or otherwise of the fact, or could make a \n",
      "determination that a precondition was not satisfied without properly \n",
      "informing itself of all relevant information. as such, we propose that \n",
      "this exception would be subject to conditions that ensure that the \n",
      "protection of an individual's privacy is not used as a pretext for \n",
      "information blocking.\n",
      "    we propose that an actor can qualify, in part, for this sub-\n",
      "exception by implementing and conforming to organizational policies and \n",
      "procedures that identify the criteria to be used by the actor and, as \n",
      "applicable, the steps that the actor will take, in order to satisfy the \n",
      "precondition. most actors are covered entities or business associates \n",
      "for the purposes of the hipaa privacy rule, and are already required to \n",
      "have policies and procedures and training programs in place that \n",
      "address how phi and ephi is used (as that term is defined in 45 cfr \n",
      "160.103, as amended) and disclosed. as such, we expect that the \n",
      "overwhelming majority of actors will already be in a position to meet \n",
      "this condition, or would be able to meet this condition with modest \n",
      "additional effort. however, we acknowledge that some actors may not, \n",
      "for whatever reason, have privacy policies and practices in place, or \n",
      "may have implemented privacy policies and practices that do not \n",
      "sufficiently address the criteria to be used, and steps to be taken, to \n",
      "satisfy a precondition relied on by the actor. as such, we propose to \n",
      "provide an alternative basis on which to qualify, in part, for this \n",
      "sub-exception. we propose to permit actors to instead document, on a \n",
      "case-by-case basis, the criteria used by the actor to determine when \n",
      "the precondition will be satisfied, any criteria that were not met, and \n",
      "the reason why the criteria were not met. these alternative conditions, \n",
      "which are discussed in detail below, ensure that this sub-exception \n",
      "does not protect practices that are post hoc rationalizations used to \n",
      "justify improper practices, whilst also ensuring that actors do not \n",
      "face any pressure to disclose ehi in the situation where they do not \n",
      "have privacy policies and practices in place, or where their privacy \n",
      "policies and practices do not respond to the requirements of this \n",
      "condition.\n",
      "    separately, we propose that if the precondition that an actor \n",
      "purports to have been satisfied relies on the provision of a consent or \n",
      "authorization from an individual, it is a condition of this sub-\n",
      "exception that the actor must have done all things reasonably necessary \n",
      "within its control to provide the individual with a meaningful \n",
      "opportunity to provide that consent or authorization.\n",
      "    we reiterate, again, that the information blocking provision does \n",
      "not require the provision of access, exchange, or use of ehi in a \n",
      "manner that would not be permitted under the hipaa privacy rule.\n",
      "organizational policies and procedures\n",
      "    if an actor seeks to qualify for this sub-exception, in part, by \n",
      "implementing and conforming to organizational policies and procedures, \n",
      "such policies and procedures must be in writing, and specify the \n",
      "criteria to be used by the actor, and, if applicable, the steps that \n",
      "the actor will take, in order to satisfy the precondition relied on by \n",
      "the actor not to provide access, exchange, or use of ehi. it would not \n",
      "be sufficient for an actor to simply identify the existence of the \n",
      "precondition in their organizational policies and procedures.\n",
      "    we acknowledge that certain preconditions may be outside the direct \n",
      "control of the actor. for example, the requirement that an actor \n",
      "receive a valid authorization before releasing ehi in certain \n",
      "circumstances would be a precondition to be satisfied by the \n",
      "individual, and the actor may have little ability to influence the \n",
      "nature of the authorization that it receives. for preconditions of this \n",
      "nature, the actor's policies and procedures would only need to identify \n",
      "the criteria that the actor will apply and the steps that the actor \n",
      "will take to facilitate the satisfaction of the precondition, such as \n",
      "identifying the requirements for a valid authorization and the follow \n",
      "up steps (if any) to be taken in response to receipt of an \n",
      "authorization that does not meet those requirements. in contrast, where \n",
      "the satisfaction of a precondition relies solely on an actor, such as \n",
      "the ``minimum necessary'' determination made by hipaa covered entities \n",
      "(or their business associates) when exchanging ehi that is ephi, the \n",
      "actor's policies and procedures would need to particularize the steps \n",
      "that the actor will take in order to ensure that it satisfies the \n",
      "precondition. where the precondition falls somewhere in between and \n",
      "relies on actions taken by both the actor and an individual, the \n",
      "actor's policies and procedures would need to address how the actor \n",
      "would do the things necessary within its control, which would include \n",
      "the steps it should take to facilitate all actions needed to be taken \n",
      "by an individual.\n",
      "    take, for example, the situation where an actor needed to determine \n",
      "whether the subject individual had a relationship with a requesting \n",
      "entity as a precondition to exchanging ehi. the actor's policies and \n",
      "practices should, at minimum, identify the criteria to be applied, \n",
      "being the evidence that the actor would need in order to satisfy itself \n",
      "of the existence of a relationship, such as receipt of a medicare or \n",
      "other insurance number, or other indicia of a relationship such as the \n",
      "establishment of a doctor-patient relationship.\n",
      "    an actor would only be eligible to benefit from this sub-exception \n",
      "if it has followed its processes and policies. continuing the above \n",
      "example, an actor\n",
      "\n",
      "[[page 7530]]\n",
      "\n",
      "that chose not to provide access to ehi on the basis that insufficient \n",
      "evidence had been provided to establish the existence of the \n",
      "relationship, would need to show that its decision was based on the \n",
      "applicable criteria specified in the actor's policy and practices.\n",
      "    using a different example, and as discussed above, the hipaa \n",
      "privacy rule generally requires covered entities (and their business \n",
      "associates) to take reasonable steps to limit the use or disclosure of, \n",
      "and requests for, phi to the minimum necessary to accomplish the \n",
      "intended purpose.\\117\\ satisfying the ``minimum necessary'' requirement \n",
      "is a precondition to be met under the hipaa privacy rule before an \n",
      "actor exchanges ephi for many purposes. the determination of what \n",
      "constitutes the ``minimum necessary'' is a fact based judgment made by \n",
      "an actor. to allow covered entities the flexibility to address their \n",
      "unique circumstances, the hipaa privacy rule requires covered entities \n",
      "(and their business associates) to make their own assessment of what \n",
      "ephi is reasonably necessary for a particular purpose, given the \n",
      "characteristics of their business and workforce. to qualify for this \n",
      "proposed sub-exception, the actor's privacy policies and procedures \n",
      "would need to identify criteria for making a ``minimum necessary'' \n",
      "determination for both routine and non-routine disclosures and \n",
      "requests, including identifying the circumstances under which \n",
      "disclosing the entire medical record is reasonably necessary. for \n",
      "actors that are covered entities or business associates, the \n",
      "development of policies and procedures for the making of minimum \n",
      "necessary determinations for requesting, using and disclosing phi is \n",
      "already a requirement of the hipaa privacy rule, so we expect that \n",
      "actors will already have such policies and procedures in place. if an \n",
      "actor implemented its organizational policies and procedures for making \n",
      "``minimum necessary'' determinations consistent with the hipaa privacy \n",
      "rule, and otherwise met the other conditions of this exception, a \n",
      "decision to exchange the minimum necessary information but less \n",
      "information than requested by another entity would satisfy this sub-\n",
      "exception and not be considered information blocking.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\117\\ 45 cfr 164.502(b).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    finally, an actor's policies and procedures must be implemented. \n",
      "this ensures that an actor can only satisfy this condition by reference \n",
      "to privacy policies and practices that individuals in fact benefit \n",
      "from, and not by policies and procedures that have been documented but \n",
      "not applied. proper implementation would involve making the policies \n",
      "and processes available to all decision makers, and facilitating \n",
      "workforce and contractor understanding and consistent implementation of \n",
      "the actor's policies and procedures such as by providing training. this \n",
      "condition ensures that this sub-exception does not protect practices \n",
      "that are post hoc rationalizations used to justify improper practices.\n",
      "    as discussed above, to the extent existing state and federal laws \n",
      "apply to a given actor, we expect an actor to already have procedures \n",
      "in place to address those legal requirements. indeed, the hipaa privacy \n",
      "rule requires that covered entities have policies and procedures and \n",
      "training programs in place that address how phi and ephi are used (as \n",
      "those terms are defined in 45 cfr 160.103) and disclosed. moreover, \n",
      "this exception is only enlivened when an actor asserts that its conduct \n",
      "was carried out to satisfy a precondition, and we expect that such \n",
      "conduct should be considered and deliberate.\n",
      "    we seek comment on this proposed condition generally, and \n",
      "specifically, on whether an actor's organizational policies and \n",
      "procedures provide a sufficiently robust and reliable basis for \n",
      "evaluating the bona fides, reasonableness, and necessity of practices \n",
      "engaged in to satisfy preconditions required by state or federal \n",
      "privacy laws.\n",
      "documenting criteria and rationale\n",
      "    if an actor's practice does not conform to an actor's \n",
      "organizational policies and procedures as required by sec.  \n",
      "171.202(b)(1), we propose that that an actor can seek to qualify for \n",
      "this sub-exception, in part, by documenting how it reached its decision \n",
      "that it would not provide access, use, or exchange of ehi on the basis \n",
      "that a precondition had not been satisfied. such documentation must be \n",
      "created on a case-by-case basis. an actor will not satisfy this \n",
      "condition if, for instance, it sought to document a general practice \n",
      "that it had applied to all instances where the precondition had not \n",
      "been satisfied. rather, the record created by the actor must address \n",
      "the specific circumstances of the specific practice (or interference) \n",
      "at issue.\n",
      "    the record created by the actor must identify the criteria used by \n",
      "the actor to determine when the precondition is satisfied. that is, it \n",
      "must identify the objective criteria that the actor applied to \n",
      "determine whether the precondition had been satisfied. consistent with \n",
      "the condition to this sub-exception that the practice must be tailored \n",
      "to the privacy interest at issue (discussed below), those criteria \n",
      "would need to be directly relevant to satisfying the precondition. for \n",
      "example, if the precondition at issue was the provision of a valid \n",
      "hipaa authorization, the actor's documented record should reflect, at \n",
      "minimum, that the authorization would need to meet each of the \n",
      "requirements specified for a valid authorization at 45 cfr 164.508(c). \n",
      "the record would then need to document the criteria that had not been \n",
      "met, and the reason so. continuing the example, the actor could record \n",
      "that the authorization did not contain the name or other specific \n",
      "identification of the person making the request because the \n",
      "authorization only disclosed the person's first initial rather than \n",
      "first name, and the actor had records about multiple people with that \n",
      "same initial and last name.\n",
      "    we believe that this condition will provide the transparency \n",
      "necessary to demonstrate whether the actor has satisfied the conditions \n",
      "applicable to this exception. moreover, it will ensure that a decision \n",
      "to not provide access, exchange, or use of ehi is considered and \n",
      "deliberate, and therefore reasonable and necessary.\n",
      "    we seek comment on this proposed condition.\n",
      "meaningful opportunity to provide consent or authorization\n",
      "    if the precondition that an actor purports to have satisfied relies \n",
      "on the provision of a consent or authorization from an individual, it \n",
      "is a condition of this sub-exception that the actor must have done all \n",
      "things reasonably necessary within its control to provide the \n",
      "individual with a meaningful opportunity to provide that consent or \n",
      "authorization. this condition will be relevant when, for example, a \n",
      "state privacy law or the hipaa privacy rule requires an individual to \n",
      "provide their consent and/or hipaa authorization before identifiable \n",
      "information can be accessed, exchanged, or used for specific purposes. \n",
      "for instance, a state law may require that an individual provide \n",
      "consent before a hospital can share her treatment information \n",
      "electronically with another treating health care provider. under this \n",
      "scenario, the hospital's refusal to exchange the ehi in the absence of \n",
      "the individual's consent would be reasonable and necessary and would \n",
      "not be information blocking, so long as the hospital had provided the \n",
      "individual with a meaningful opportunity to provide that consent and \n",
      "where the criteria and other conditions of this proposed exception were \n",
      "met.\n",
      "\n",
      "[[page 7531]]\n",
      "\n",
      "    in the context of the provision of consent, a meaningful \n",
      "opportunity would ordinarily require that an actor provide the \n",
      "individual with a legally compliant consent form; make a reasonable \n",
      "effort to inform an individual that she has the right to consent to the \n",
      "disclosure of her ehi; and provide the individual with sufficient \n",
      "information and educational material (commensurate with the \n",
      "circumstances of the disclosure). it would be best practice for an \n",
      "actor to also inform the individual about the revocability of any \n",
      "consent given, if and as provided in the relevant state or federal \n",
      "privacy law, and the actor's processes for acting on any revocation.\n",
      "    we are considering addressing this condition in further detail, \n",
      "whether by way of additional guidance or in regulation text. to this \n",
      "end, we seek comments regarding what actions an actor should take, \n",
      "within the actor's control, to provide an individual with a meaningful \n",
      "opportunity to provide a required consent or authorization, and whether \n",
      "different expectations should arise in the context of a consent versus \n",
      "a hipaa authorization. for example, commenters may wish to provide \n",
      "comment on the actions to be taken to ensure that an individual has a \n",
      "meaningful opportunity to satisfy a precondition that the individual \n",
      "provide a hipaa authorization. specifically, in the context of a \n",
      "requirement that the authorization be signed, what effort should be \n",
      "expected from actors in seeking signatures from: (i) persons acting for \n",
      "the patient where the patient is unable to sign a form; (ii) former \n",
      "patients whose ehi is being requested from third parties; or (iii) \n",
      "patients that are not in a facility, such as patients of individual \n",
      "physicians?\n",
      "    we clarify that after providing the individual with a meaningful \n",
      "opportunity to consent or provide authorization, we believe that it is \n",
      "the individual's responsibility to complete any required documentation \n",
      "before an actor is able to access, exchange, or use the individual's \n",
      "ehi. we do not expect the actor to ``chase'' the individual despite \n",
      "using its best efforts provide the individual with an opportunity to \n",
      "sign a consent or authorization form. so long as the actor has provided \n",
      "the individual with a meaningful opportunity to consent, the actor will \n",
      "have fulfilled this aspect of the eligibility requirements of this sub-\n",
      "exception.\n",
      "    separately, to qualify for this sub-exception, to the extent that \n",
      "the precondition at issue was the provision of a consent or \n",
      "authorization by an individual, the actor must not have improperly \n",
      "encouraged or induced the individual to not provide the consent or \n",
      "authorization. this does not mean that the hospital cannot inform an \n",
      "individual about the advantages and disadvantages of exchanging ehi and \n",
      "any associated risks, so long as the information communicated is \n",
      "accurate and legitimate. however, an actor would not meet this \n",
      "condition in the event that it misled an individual about the nature of \n",
      "the consent to be provided, dissuaded individuals from providing \n",
      "consent in respect of disclosures to the actor's competitors, or \n",
      "imposed onerous requirements to effectuate consent that were \n",
      "unnecessary and not required by law.\n",
      "    we seek comment on whether the proposed condition requiring the \n",
      "provision of a meaningful opportunity and prohibiting improper \n",
      "encouragement or inducement should apply to preconditions beyond the \n",
      "precondition that an individual provide consent or authorization. we \n",
      "seek comment on whether the conditions specified for this sub-\n",
      "exception, when taken in total, are sufficiently particularized and \n",
      "sufficiently strict to ensure that actors that are in a position to \n",
      "influence whether a precondition is satisfied will not be able to take \n",
      "advantage of this sub-exception and seek protection for practices that \n",
      "do not promote the privacy of ehi. we also seek comment on whether we \n",
      "should adopt a more tailored approach to conditioning the availability \n",
      "of this exception. for example, we are considering whether different \n",
      "conditions should apply depending on: (i) the nature of the ehi at \n",
      "issue; (ii) the circumstances in which the ehi is being access, \n",
      "exchanged, or used; (iii) the interest being protected by the \n",
      "precondition; or (iv) the nature of the precondition to be satisfied. \n",
      "commenters are encouraged to identify scenarios in which the \n",
      "application of the conditions applicable to this sub-exception, as \n",
      "proposed, give rise to unnecessary burden, or would require activities \n",
      "that do not advance the dual policy interests of preventing information \n",
      "blocking and promoting privacy and security.\n",
      "practice must be tailored to the specific privacy risk or interest \n",
      "being addressed\n",
      "    to qualify for this sub-exception, an actor's privacy-protective \n",
      "practice must be tailored to the specific privacy risks that the \n",
      "practice actually addresses. this condition necessarily presupposes \n",
      "that an actor has carefully evaluated the privacy requirements imposed \n",
      "on the actor, the privacy interests to be managed by the actor, and has \n",
      "developed a considered response that is tailored to protecting and \n",
      "promoting the privacy of ehi. for example, the hipaa privacy rule at 45 \n",
      "cfr 164.514(h) requires that, in certain circumstances, the disclosure \n",
      "of phi is only authorized once the identity and authority of the person \n",
      "requesting the information has been verified. the privacy issue to be \n",
      "addressed in this instance is the risk that phi will be disclosed to \n",
      "the wrong individual, or an unauthorized person. if an actor chooses \n",
      "not to provide access, exchange, or use of ehi on the basis that the \n",
      "actor's identity verification requirements have not been satisfied, the \n",
      "actor's practice must be tailored to the specific privacy risks at \n",
      "issue. this would require that the actor ensure that it does not impose \n",
      "identity verification requirements that are unreasonably onerous under \n",
      "the circumstances.\n",
      "    to illustrate, a policy where a driver's license was the only \n",
      "accepted government-issued form of identification would not be a \n",
      "practice that is tailored to the privacy risk at issue because the \n",
      "provider's preference for one form of government-issued identification \n",
      "over another does not meaningfully manage the privacy risk. similarly, \n",
      "it may be unreasonable for an actor to require the production of \n",
      "documentation demonstrating the parent-child relationship unless the \n",
      "actor was in possession of information that suggested that an adult \n",
      "might not have authority to be the child's legal representative. to do \n",
      "otherwise would be to apply an onerous requirement in all instances of \n",
      "parent-child relationships, which is insufficiently tailored to the \n",
      "privacy risk being managed. finally, it may be unreasonable for an \n",
      "actor to insist that the individual produce original identification if \n",
      "the individual was able to furnish a scanned copy of their form of \n",
      "identification that the actor could reasonably rely on.\n",
      "    for the purposes of this sub-exception, we clarify that engaging in \n",
      "an interference on the basis that a precondition has not been satisfied \n",
      "would be a practice that addresses a privacy risk or interest, and so \n",
      "tailoring that interference to satisfy a precondition can satisfy this \n",
      "condition. controls on access, exchange, or use arising under privacy \n",
      "laws serve a privacy interest and so this condition will be met so long \n",
      "as the actor's practice is tailored to the risk or interest being \n",
      "addressed.\n",
      "    we seek comment on this proposed condition.\n",
      "\n",
      "[[page 7532]]\n",
      "\n",
      "practice must be implemented in a consistent and non-discriminatory \n",
      "manner\n",
      "    we propose that in order for a practice to qualify for this sub-\n",
      "exception, the practice must be implemented in a consistent and non-\n",
      "discriminatory manner. this condition would provide basic assurance \n",
      "that the purported privacy practice is directly related to a specific \n",
      "privacy risk and is not being used to interfere with access, exchange, \n",
      "or use of ehi for other purposes to which this exception does not \n",
      "apply.\n",
      "    this condition requires that the actor's privacy-protective \n",
      "practices must be based on objective criteria that apply uniformly for \n",
      "all substantially similar privacy risks. an actor could not, for \n",
      "example, implement an organizational privacy policy that imposed \n",
      "unreasonably onerous requirements on a certain class of individuals or \n",
      "entities without a legitimate justification for doing so. for example, \n",
      "an actor that offered a patient-facing software application (app) would \n",
      "not be able to benefit from this exception if it refused to exchange \n",
      "ehi with a competitor app on the basis of an individual's failure to \n",
      "meet onerous authorization requirements that applied only to health \n",
      "information exchange with the competitor app and did not apply to, for \n",
      "example, the exchange of ehi with health care providers. this condition \n",
      "provides basic assurance that the purported privacy-protective practice \n",
      "is not being used to interfere with access, exchange, or use of ehi for \n",
      "other purposes to which this proposed exception does not apply.\n",
      "    we request comment on this proposed condition.\n",
      "sub-exception to proposed privacy exception: health it developer of \n",
      "certified health it not covered by hipaa\n",
      "    the sub-exception proposed in sec.  171.202(b) recognizes as \n",
      "reasonable and necessary the activities engaged in by actors consistent \n",
      "with the controls placed on access, exchange, or use of ehi by federal \n",
      "and state privacy laws. importantly, that sub-exception is limited to \n",
      "actors that are subject to those federal and state privacy laws; an \n",
      "actor that is not regulated by hipaa or a state privacy law cannot \n",
      "benefit from the exception proposed in sec.  171.202(b).\n",
      "    we propose to establish a sub-exception to the information blocking \n",
      "provision that would apply to actors that are health it developers of \n",
      "certified health it but not regulated by the hipaa privacy rule in \n",
      "respect to the operation of the actor's health it product or service \n",
      "(referred to hereafter as ``non-covered actors''). we expect that the \n",
      "class of actors to which this proposed sub-exception applies will be \n",
      "very small. the vast majority of health it developers of certified \n",
      "health it operate as business associates to health care providers or \n",
      "health plans, are regulated by the hipaa privacy rule, and will be able \n",
      "to benefit from the exception proposed in sec.  171.202(b) to the \n",
      "extent that the hipaa privacy rule (or applicable state privacy law) \n",
      "imposes preconditions to the provision of access, exchange, or use of \n",
      "ehi. however, we recognize that direct-to-consumer health it products \n",
      "and services are a growing sector of the health it market. this class \n",
      "of health it is often not regulated by the hipaa privacy rule, but \n",
      "could be certified under the program. we note that the privacy \n",
      "practices of consumer-facing health it products and services are \n",
      "typically regulated by the federal trade commission act (ftc act). \n",
      "however, the ftc act applies to acts and practices that are unfair and \n",
      "deceptive (15 u.s.c. 45(a)(1)), and does not prescribe privacy \n",
      "requirements to be adopted or followed that can be leveraged for the \n",
      "purpose of recognizing reasonable and necessary privacy-protective \n",
      "practices in this proposed rule.\\118\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\118\\ see hhs, examining oversight of the privacy & security of \n",
      "health data collected by entities not regulated by hipaa, <a href=\"https://www.healthit.gov/sites/default/files/non-covered_entities_report_june_17_2016.pdf\">https://www.healthit.gov/sites/default/files/non-covered_entities_report_june_17_2016.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    as discussed in section viii.c.2.b, where a health it developer of \n",
      "certified health it offers a health it product or service not regulated \n",
      "by the hipaa privacy rule, such product or service is subject to the \n",
      "information blocking provision. we want to ensure that non-covered \n",
      "actors that engage in reasonable and necessary privacy-protective \n",
      "practices that interfere with the access, exchange, or use of ehi can \n",
      "seek coverage under this proposed sub-exception. as such, we propose \n",
      "that a non-covered actor will not engage in information blocking if the \n",
      "actor does not provide access, exchange, or use of ehi where the \n",
      "practice implements a process that is described in the actor's \n",
      "organizational privacy policy and has been disclosed to any individual \n",
      "or entity that uses the actor's health it. this proposed sub-exception \n",
      "is proposed in sec.  171.202(c).\n",
      "    as a threshold requirement of this sub-exception, the actor's \n",
      "practice of interfering with access, exchange, or use of ehi must \n",
      "comply with any applicable state or federal privacy laws. while we have \n",
      "developed this sub-exception for the express purpose of addressing \n",
      "privacy-protective practices that are not regulated by the hipaa \n",
      "privacy rule, we acknowledge that there may be other privacy laws \n",
      "implicated by the practice in question. if the actor's practice \n",
      "contravenes a state or federal privacy law, but otherwise satisfies \n",
      "this proposed sub-exception, the actor would not be entitled to benefit \n",
      "from this sub-exception.\n",
      "practice must implement privacy policy\n",
      "    in order to qualify for this sub-exception, the practice engaged in \n",
      "by the non-covered actor--the interference with access, exchange, or \n",
      "use of ehi--must also implement a process described in the actor's \n",
      "organizational privacy policy. this requires that a non-covered actor \n",
      "must have documented in detail in its organizational privacy policy the \n",
      "processes and procedures that the actor will use to determine when the \n",
      "actor will not provide access, exchange, or use of ehi. for example, a \n",
      "non-covered actor that proposed to require the provision of written \n",
      "consent for the use or disclosure of ehi would need to describe in its \n",
      "organizational privacy policy the processes and procedures to be \n",
      "utilized by the actor to implement that privacy-protective practice in \n",
      "order that the practice be considered reasonable and necessary and \n",
      "qualify for this sub- exception. a privacy policy that was prepared at \n",
      "a high level--for example, that simply stated that written consent was \n",
      "required--would not qualify. to build on this example, a non-covered \n",
      "actor's consent policy would need to describe the specific requirements \n",
      "that are imposed on individuals when giving consent, together with the \n",
      "processes and procedures to be followed by the non-covered actor to \n",
      "ensure that the individual has a meaningful choice over whether to \n",
      "consent. compliance with this condition ensures that this sub-exception \n",
      "recognizes only legitimate practices that have been tailored to the \n",
      "privacy needs of the individuals that use the non-covered actor's \n",
      "health it, and does not recognize practices that are a pretext or \n",
      "after-the-fact rationalization for actions that interfere with access, \n",
      "exchange, or use of ehi.\n",
      "    it necessarily follows that the non-covered actor's practice must \n",
      "implement its documented organizational privacy policy. for example, if \n",
      "a non-covered actor chose not to provide access, exchange, or use of \n",
      "ehi on the basis that it could not verify the identity of the \n",
      "individual requesting the ehi, the non-covered actor would need to be \n",
      "able to demonstrate that it implemented the\n",
      "\n",
      "[[page 7533]]\n",
      "\n",
      "part of its organizational privacy policy that dealt with identity \n",
      "verification. practices that diverge from an actor's documented \n",
      "policies or practices, or which are not addressed in an actor's \n",
      "organizational privacy policy, would not qualify for this proposed sub- \n",
      "exception.\n",
      "practice must have been disclosed to users\n",
      "    a non-covered actor that seeks to benefit from this proposed sub-\n",
      "exception must also ensure that it has previously disclosed the \n",
      "privacy-protective practice to the individuals and entities that use, \n",
      "or will use, the health it. these users are affected by the practices \n",
      "engaged in by a non-covered actor but may otherwise have no visibility \n",
      "of the non-covered actor's approach to protecting the privacy of ehi. \n",
      "we expect that non-covered actors will seek to satisfy this condition \n",
      "by using a privacy notice.\\119\\ we emphasize that the disclosure must \n",
      "be meaningful. in assessing whether a non-covered actor's disclosure \n",
      "was meaningful, regard will be paid to whether the disclosure was in \n",
      "plain language and conspicuous, including whether the disclosure was \n",
      "located in a place, and presented in a manner, that is accessible and \n",
      "obvious to the individuals and entities that use, or will use, the \n",
      "health it.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\119\\ onc has provided a model privacy notice (mpn) that is a \n",
      "voluntary, openly available resource designed to help developers \n",
      "clearly convey information about their privacy and security policies \n",
      "to their users. similar to the fda nutrition facts label, the mpn \n",
      "provides a snapshot of a company's existing privacy practices \n",
      "encouraging transparency and helping consumers make informed choices \n",
      "when selecting products. the mpn does not mandate specific policies \n",
      "or substitute for more comprehensive or detailed privacy policies. \n",
      "see <a href=\"https://www.healthit.gov/topic/privacy-security-and-hipaa/model-privacy-notice-mpn\">https://www.healthit.gov/topic/privacy-security-and-hipaa/model-privacy-notice-mpn</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    to qualify for this sub-exception, a non-covered actor would not be \n",
      "required to disclose its organizational privacy policy to its customers \n",
      "or to the public generally. rather, the non- covered actor need only \n",
      "describe, with sufficient detail and precision to be readily understood \n",
      "by users of the non-covered actor's health it, the privacy-protective \n",
      "practices that the non-covered actor has adopted and will observe. this \n",
      "is necessary because a non-covered actor that is not subject to \n",
      "prescribed privacy standards in connection with the provision of health \n",
      "it will have significant flexibility in the privacy-protective \n",
      "practices that it adopts. if an actor is not required to inform the \n",
      "individuals and entities that use, or will use, the health it, about \n",
      "the privacy- protective practices that it will implement in its \n",
      "product, or when providing its service, there is a risk that this \n",
      "proposed sub-exception will give deference to policies and processes \n",
      "that are post hoc rationalizations used to justify improper practices. \n",
      "this condition also serves as a check on the nature of the \n",
      "interferences that a non-covered actor writes into its organizational \n",
      "privacy policies; transparency will help to ensure that a non-covered \n",
      "actor takes a balanced approach to protecting privacy interests on one \n",
      "hand, and pursuing business interests that might be inconsistent with \n",
      "the information blocking provision, on the other hand. we hope that \n",
      "this requirement will foster a quasi-market based measure of when a \n",
      "privacy-protective practice is ``reasonable and necessary,'' and ensure \n",
      "that any departure made by a non-covered actor from privacy practices \n",
      "that are recognized by state or federal law is transparent and open.\n",
      "    it will be a matter for non-covered actors to determine the most \n",
      "appropriate way to communicate its privacy practices to users. we \n",
      "believe that it would be reasonable that non- covered actors would, at \n",
      "minimum, post their privacy notices, or otherwise describe their \n",
      "privacy-protective practices, on their websites.\n",
      "practice must be tailored to privacy risk and implemented in a non-\n",
      "discriminatory manner\n",
      "    finally, we propose that in order for a practice to qualify for \n",
      "this sub-exception, an actor's practice must be tailored to the \n",
      "specific privacy risks that the practice actually addresses, and must \n",
      "be implemented in a consistent and non-discriminatory manner. these \n",
      "conditions also apply to the exception proposed in sec.  171.202(b), \n",
      "and the discussion above addressing these conditions in connection with \n",
      "sec.  171.202(b) applies to this proposed exception in sec.  \n",
      "171.202(c). we refer readers to the above discussion and invite \n",
      "comments on these proposed conditions.\n",
      "    we seek comment on this proposed sub-exception generally. \n",
      "specifically, we seek comment on whether hies or hins would benefit \n",
      "from a similar sub-exception. we also seek comment on whether the \n",
      "conditions applicable to this sub-exception are sufficient to ensure \n",
      "that non-covered actors cannot take advantage of this exception by \n",
      "engaging in practices that are inconsistent with the promotion of \n",
      "individual privacy. we also seek comment on the level of detail that \n",
      "non-covered actors should be required to use when describing their \n",
      "privacy practices and processes to user of health it.\n",
      "sub-exception to proposed privacy exception: denial of an individual's \n",
      "request for their electronic protected health information in the \n",
      "circumstances provided in 45 cfr 164.524(a)(1), (2), and (3)\n",
      "    we propose a limited sub-exception to the information blocking \n",
      "provision that would permit a covered entity or business associate to \n",
      "deny an individual's request for access to their phi in the \n",
      "circumstances provided under 45 cfr 164.524(a)(1), (2), and (3). we \n",
      "believe this exception would avoid a potential conflict between the \n",
      "hipaa privacy rule and the information blocking provision. \n",
      "specifically, the hipaa privacy rule contemplates circumstances under \n",
      "which covered entities, and in some instances business associates, may \n",
      "deny an individual access to phi and distinguishes those grounds for \n",
      "denial which are reviewable from those which are not. this exception \n",
      "applies to both the ``unreviewable grounds'' and ``reviewable grounds'' \n",
      "of access. the ``unreviewable grounds'' for denial for individuals \n",
      "include situations involving: (1) certain requests that are made by \n",
      "inmates of correctional institutions; (2) information created or \n",
      "obtained during research that includes treatment, if certain conditions \n",
      "are met; (3) denials permitted by the privacy act; and (4) information \n",
      "obtained from non-health care providers pursuant to promises of \n",
      "confidentiality. in addition, two categories of information are \n",
      "expressly excluded from the individual right of access: (1) \n",
      "psychotherapy notes, which are the personal notes of a mental health \n",
      "care provider documenting or analyzing the contents of a counseling \n",
      "session that are maintained separate from the rest of the patient's \n",
      "medical record (see 45 cfr 164.524(a)(1)); and (2) information compiled \n",
      "in reasonable anticipation of, or for use in, a civil, criminal, or \n",
      "administrative action or proceeding (see 45 cfr 164.501).\n",
      "    the ``reviewable grounds'' of access as described in sec.  \n",
      "164.524(a)(3), which provides that a covered entity may deny access \n",
      "provided that the individual is given a right to have such denials \n",
      "reviewed under certain circumstances. one such circumstance is when a \n",
      "licensed health care professional, in the exercise of professional \n",
      "judgment, determines that the access requested is reasonably likely to \n",
      "endanger the life or physical safety of the individual or another \n",
      "person. in addition, if access is denied, then the individual has the \n",
      "right to have the denial reviewed by a\n",
      "\n",
      "[[page 7534]]\n",
      "\n",
      "licensed health professional who is to act as a reviewing official and \n",
      "did not participate in the original decision to deny access (see \n",
      "generally 45 cfr 164.524(a)(3)).\n",
      "    we propose that if an actor who is a covered entity or business \n",
      "associate denies an individual's request for access to their phi on the \n",
      "basis of these unreviewable and reviewable grounds, and provided the \n",
      "denial of access complies with the requirements of the hipaa privacy \n",
      "rule in each case, then the actor would qualify for this exception and \n",
      "these practices would not constitute information blocking.\n",
      "    the following example illustrates this proposed sub-exception. an \n",
      "individual is a patient of a psychiatrist who is a hipaa covered \n",
      "entity. the patient has requested all of his electronic health files \n",
      "from the psychiatrist. the psychiatrist maintains separately from the \n",
      "electronic health record a file containing psychotherapy notes \n",
      "regarding the patient. the psychiatrist grants access to the patient by \n",
      "providing a copy of the information in his electronic health record, \n",
      "but does not provide the patient's psychotherapy notes. under this \n",
      "example, the psychiatrist would meet the requirements of this proposed \n",
      "exception since the hipaa privacy rule provides that covered entities \n",
      "can deny individuals access to their psychotherapy notes and provides \n",
      "that this is an unreviewable grounds for denial.\n",
      "    we seek comment on this proposed sub-exception.\n",
      "sub-exception to proposed privacy exception: respecting an individual's \n",
      "request not to share information\n",
      "    we propose to establish an exception to the information blocking \n",
      "provision that would, in certain circumstances, permit an actor not to \n",
      "provide access, exchange, or use of ehi if an individual has \n",
      "specifically requested that the actor not do so. this sub-exception is \n",
      "proposed in sec.  171.202(e). we believe this sub-exception is \n",
      "necessary to ensure that actors are confident that they can respect \n",
      "individuals' privacy choices without engaging in information blocking, \n",
      "and to promote public confidence in the health it infrastructure by \n",
      "effectuating patients' preference about how and under what \n",
      "circumstances their ehi will be accessed, exchanged, and used. we \n",
      "recognize that individuals may have concerns about permitting their ehi \n",
      "to be accessed, exchanged, or used electronically under certain \n",
      "circumstances. as a matter of public policy, we think that these \n",
      "privacy concerns, if expressed by an individual and agreed to by an \n",
      "actor, would be reasonable and necessary, and an actor's conduct in \n",
      "abiding by its agreement would, if all conditions are met, be an \n",
      "exception to the information blocking provision.\n",
      "    this proposed sub-exception would not apply under circumstances \n",
      "where an actor interferes with a use or disclosure of ehi that is \n",
      "required by law, including when ehi is required by the secretary to \n",
      "enforce hipaa under 45 cfr 164.502(a)(2)(ii) and 45 cfr \n",
      "164.502(a)(4)(i). stated differently, this sub-exception would not \n",
      "operate to permit an actor to refuse to provide access, exchange, or \n",
      "use of ehi when that access, exchange, or use is required by law. this \n",
      "sub-exception recognizes and supports the public policy objective of \n",
      "the hipaa privacy rule, which identifies uses and disclosures of ehi \n",
      "for which the public interest in the disclosure of the individual's \n",
      "information outweighs the individual's interests in controlling the \n",
      "information.\n",
      "    this sub-exception would permit an actor not to share ehi if the \n",
      "following conditions are met: (1) the individual made the request to \n",
      "the actor not to have his or her ehi accessed, exchanged, or used; (2) \n",
      "the individual's request was initiated by the individual without any \n",
      "improper encouragement or inducement by the actor; and (3) the actor or \n",
      "its agent documents the request within a reasonable time period.\n",
      "    to qualify for this sub-exception, the request that the \n",
      "individual's ehi not be accessed, exchanged, or used must come from the \n",
      "individual. moreover, the individual must have made the request \n",
      "independently and without any improper encouragement or inducement by \n",
      "the actor. for example, it would be improper to encourage individuals \n",
      "not to share information with unaffiliated providers on the basis of \n",
      "generalized or speculative risks of unauthorized disclosure. on the \n",
      "other hand, if the actor was aware of a specific privacy or security \n",
      "risk, it would not be improper to inform individuals of that risk. \n",
      "likewise, an actor would be permitted to provide an individual with \n",
      "general information about her privacy rights and options, including for \n",
      "example, the option to not provide consent, provided the information is \n",
      "presented accurately, does not omit important information, and is not \n",
      "presented in a way that is likely to improperly influence the \n",
      "individual's decision about how to exercise their rights.\n",
      "    if an individual submits a request to an actor not to disclose her \n",
      "ehi, and the actor agrees with and documents the request, the request \n",
      "would be valid for purposes of this sub-exception unless and until it \n",
      "is subsequently revoked by the individual. we believe this approach \n",
      "would minimize compliance burdens for actors while also respecting \n",
      "individuals' requests. we propose that once the individual makes the \n",
      "request, she should not, subject to the requirements of applicable \n",
      "federal or state laws and regulations, have to continually reiterate \n",
      "her privacy preferences, such as having to re-submit a request every \n",
      "year. likewise, we propose that once the actor has documented an \n",
      "individual's request, the actor should not have to repeatedly reconfirm \n",
      "and re-document the request. we seek comment, however, regarding \n",
      "whether this approach is too permissive and could result in unintended \n",
      "consequences. we also seek comment on this proposed sub-exception \n",
      "generally, including on effective ways for an individual to revoke his \n",
      "or her privacy request for purposes of this sub-exception.\n",
      "    we also propose that in order for a practice to qualify for this \n",
      "sub-exception, an actor's practice must be implemented in a consistent \n",
      "and non-discriminatory manner. this condition would provide basic \n",
      "assurance that the purported privacy practice is directly related to \n",
      "the risk of disclosing ehi contrary to the wishes of an individual, and \n",
      "is not being used to interfere with access, exchange, or use of ehi for \n",
      "other purposes to which this exception does not apply. this condition \n",
      "requires that the actor's privacy-protective practice must be based on \n",
      "objective criteria that apply uniformly for all substantially similar \n",
      "privacy risks.\n",
      "    we note that under the hipaa privacy rule, individuals have the \n",
      "right to request restrictions on how a covered entity will use (as that \n",
      "term is defined in 45 cfr160.103) and disclose phi about them for \n",
      "treatment, payment, and health care operations pursuant to 45 cfr \n",
      "164.522(a)(1). under sec.  164.522(a), a covered entity is not required \n",
      "to agree to an individual's request for a restriction (other than in \n",
      "the case of a disclosure to a health plan under sec.  \n",
      "164.522(a)(1)(vi)), but is bound by any restrictions to which it \n",
      "agrees.\n",
      "    we wish to clarify that, for the purposes of this proposed sub-\n",
      "exception, the actor may give effect to an individual's request not to \n",
      "have an actor disclose ehi even if state or federal laws would allow \n",
      "the actor not to follow the individual's request. this is consistent \n",
      "with our position that, absent improper encouragement or inducement, \n",
      "and subject to appropriate conditions, it should not be considered \n",
      "information blocking to give effect to\n",
      "\n",
      "[[page 7535]]\n",
      "\n",
      "patients' individual preferences about how their ehi will be shared or \n",
      "not. as an illustration, if an individual requests that her ehi not be \n",
      "accessed, exchanged, or used by a physician to help train new staff at \n",
      "a hospital, the physician may agree not to use the individual's ehi for \n",
      "this purpose despite the fact it would not be required by law to agree \n",
      "to such a restriction. provided the physician has not encouraged or \n",
      "induced the individual to make this request, this sub-exception would \n",
      "apply to the physician's refusal to disclose the information to staff \n",
      "for training purposes.\n",
      "    we seek comments on this sub-exception generally. specifically, we \n",
      "seek comment on what would be considered a reasonable time frame for \n",
      "documentation. in addition, we also seek comment on how this sub-\n",
      "exception would affect public health disclosures and health care \n",
      "research, if an actor did not share a patient's ehi due to a privacy \n",
      "preference, including any effects on preventing or controlling \n",
      "diseases, injury, or disability, and the reporting of disease, injury, \n",
      "and vital events such as births or deaths, and the conduct of public \n",
      "health surveillance and health care research.\n",
      "3. promoting the security of ehi\n",
      "    we propose to establish an exception to the information blocking \n",
      "provision that would permit actors to engage in practices that are \n",
      "reasonable and necessary to promote the security of ehi, subject to \n",
      "certain conditions. without this exception, actors may be reluctant to \n",
      "implement security measures or engage in other activities that are \n",
      "reasonable and necessary for safeguarding the confidentiality, \n",
      "integrity, and availability of ehi. this could undermine the ultimate \n",
      "goals of the information blocking provision by discouraging best \n",
      "practice security protocols and diminishing the reliability of the \n",
      "health it ecosystem.\n",
      "    robust security protections are critical to promoting patients' and \n",
      "other stakeholders' trust and confidence that ehi will be collected, \n",
      "used, and shared in a manner that protects individuals' privacy and \n",
      "complies with applicable legal requirements. public confidence in the \n",
      "security of their ehi has been challenged, however, by the growing \n",
      "incidence of cyber-attacks in the health care sector. more than ever, \n",
      "health care providers, health it developers, hies and hins must be \n",
      "vigilant to mitigate security risks and implement appropriate \n",
      "safeguards to secure the ehi they collect, maintain, access, use, and \n",
      "exchange.\n",
      "    the cures act directs the national coordinator, in consultation \n",
      "with the hhs office for civil rights (ocr), to issue guidance on common \n",
      "``security barriers'' that prevent the trusted exchange of ehi (section \n",
      "3022(c)(2) of the phsa). however, the cures act also seeks to promote \n",
      "the security of ehi, which it defines as an element of interoperability \n",
      "(section 3000(9)(a) of the phsa) and a target area for the policy \n",
      "development to be undertaken by the health information technology \n",
      "advisory committee (section 3002(b)(2)(b)(ii) of the phsa). the \n",
      "inclusion of these provisions promote broader access, exchange, and use \n",
      "of ehi while at the same time continuing to promote the \n",
      "confidentiality, integrity, and availability of ehi through security \n",
      "practices that are appropriate and tailored to identified \n",
      "vulnerabilities and risks.\n",
      "    to qualify for this exception, we propose that an actor's conduct \n",
      "must satisfy threshold conditions. as discussed in detail below, the \n",
      "particular security-related practice must be directly related to \n",
      "safeguarding the confidentiality, integrity, and availability of ehi, \n",
      "implemented consistently and in a non-discriminatory manner, and \n",
      "tailored to identified security risks.\n",
      "    while the importance of security practices cannot be overstated, \n",
      "this proposed exception would not apply to all practices that purport \n",
      "to secure ehi. rather, this exception will only be available when the \n",
      "actor's security-based practice satisfies the conditions applicable to \n",
      "this exception. we do not believe it would be appropriate to prescribe \n",
      "a ``maximum'' level of security or to dictate a one-size-fits-all \n",
      "approach for all actors that may not be appropriate in all \n",
      "circumstances and may not accommodate new threats, countermeasures, and \n",
      "best practices in a rapidly changing security landscape. indeed, \n",
      "security infrastructure varies from organization to organization, and \n",
      "there exist diverse approaches and technology solutions to managing \n",
      "security risks. we do not intend for this proposed exception to dictate \n",
      "a specific security approach when an actor's security posture must be \n",
      "agile and its practices iterative. moreover, effective security best \n",
      "practices focus on the mitigation and remediation of risks to a \n",
      "reasonable and acceptable level, and not the elimination of all \n",
      "vulnerabilities, so organizations should have the flexibility to assess \n",
      "what vulnerabilities to address and how best to address them while \n",
      "ensuring the confidentiality, integrity, and availability of ehi.\n",
      "    as such, we propose that actors would be able to satisfy this \n",
      "exception through practices that implement either security policies and \n",
      "practices developed by the actor, or case-by-case determinations made \n",
      "by the actor. whether a security-motivated practice meets this \n",
      "exception would be determined on a case-by-case basis using a fact-\n",
      "based analysis of the conditions set forth below. this approach offers \n",
      "the most appropriate framework for analyzing security practices, which \n",
      "are necessarily driven by and must be tailored to actors' individual \n",
      "circumstances.\n",
      "    we wish to emphasize that the security-based practices implemented \n",
      "by a single physician office with limited technology resources, for \n",
      "example, will be different to those implemented by a large health \n",
      "system, and that this difference does not affect an actor's ability to \n",
      "qualify for this exception. the fact-based approach we propose will \n",
      "allow each actor to implement policies, procedures, and technologies \n",
      "that are appropriate for its particular size, organizational structure, \n",
      "and risks to individuals' ehi.\n",
      "    a fact-based analysis also aligns with the hipaa security rule \n",
      "\\120\\ concerning the security of ephi. the hipaa security rule does not \n",
      "dictate the security measures that a covered entity or business \n",
      "associate must implement, but instead requires the entity to develop \n",
      "security practices and implement administrative, physical, and \n",
      "technical safeguards that take into account the entity's size, \n",
      "complexity, and capabilities; technical, hardware, and software \n",
      "infrastructure; the costs of security measures; and the likelihood and \n",
      "possible impact of potential risks to ephi. under the hipaa security \n",
      "rule, covered entities and business associates are required to conduct \n",
      "an accurate and thorough assessment of the potential risks and \n",
      "vulnerabilities to the confidentiality, integrity, and availability of \n",
      "ephi held by the covered entity or business associate. once covered \n",
      "entities and business associates have completed the risk assessment, \n",
      "they must take security measures sufficient to reduce identified risks \n",
      "and vulnerabilities to reasonable and appropriate levels (45 cfr \n",
      "164.308(a)(1)(ii)). we note, however, that while our approach is \n",
      "consistent with the regulation of security practices under the hipaa \n",
      "security rule, the fact that a practice complies with the hipaa \n",
      "security rule does not establish that it\n",
      "\n",
      "[[page 7536]]\n",
      "\n",
      "meets the conditions of this proposed exception to the information \n",
      "blocking provision. the hipaa security rule and this proposed exception \n",
      "have different focuses. the hipaa security rule establishes a baseline \n",
      "by requiring certain entities to ensure the confidentiality, integrity, \n",
      "and availability of ephi by implementing security measures, among other \n",
      "safeguards, that the entities determine are sufficient to reduce risks \n",
      "and vulnerabilities to a reasonable and appropriate level. in contrast, \n",
      "the purpose of this exception to the information blocking provision is \n",
      "to provide flexibility for reasonable and necessary security practices \n",
      "while screening out practices that purport to promote the security of \n",
      "ehi but that are unreasonably broad, onerous on those seeking access to \n",
      "the ehi, are not applied consistently across/within an organization, or \n",
      "otherwise may unreasonably interfere with access, exchange, or use of \n",
      "ehi.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\120\\ the hipaa security rule is located at 45 cfr part 160 and \n",
      "subparts a and c of part 164 and 68 fr 8333.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we propose the following conditions that must be met for an \n",
      "activity or practice to qualify for this exception.\n",
      "the practice must be directly related to safeguarding the \n",
      "confidentiality, integrity, and availability of ehi\n",
      "    as a threshold condition, the proposed exception would not apply to \n",
      "any practices that are not directly related to safeguarding the \n",
      "security of ehi. in assessing the practice, we would consider whether \n",
      "and to what extent the practice directly addressed specific security \n",
      "risks or concerns. we would also consider whether the practice served \n",
      "any other purposes and, if so, whether those purposes were merely \n",
      "incidental to the overriding security purpose or provided an \n",
      "objectively distinct, non-security-related rationale for engaging in \n",
      "the practice.\n",
      "    we note that it should not be particularly difficult or onerous for \n",
      "an actor to demonstrate, as contemplated above, that its practice was \n",
      "directly related to a specific security risk or concern. for example, \n",
      "the actor may show that the practice was a direct response to a known \n",
      "security incident or threat; or that the practice directly related to \n",
      "the need to verify a person's identity before granting access to ehi; \n",
      "or that the practice was directly related to ensuring the integrity of \n",
      "ehi.\n",
      "    the salient issue under this condition, therefore, would be whether \n",
      "the security practice was actually necessary and directly related to \n",
      "safeguarding ehi. to that end, we would consider the actor's purported \n",
      "basis for adopting the particular security practice, which could be \n",
      "evidenced by the actor's organizational security policy, risk \n",
      "assessments, and other relevant documentation, which most actors are \n",
      "already required to develop pursuant to requirements under the hipaa \n",
      "rules.\\121\\ however, we propose that the documentation of an actor's \n",
      "decision-making would not necessarily be dispositive. for example, if \n",
      "the practice had the practical effect of disadvantaging competitors or \n",
      "steering referrals, this could be evidence that the practice was not \n",
      "directly related to the safeguarding the confidentiality, integrity, \n",
      "and availability of ehi. we propose that such an inference would also \n",
      "not be warranted where the actor has not met the other conditions of \n",
      "this exception proposed below, as where the actor's policies were not \n",
      "developed or implemented in a reasonable manner; its security policies \n",
      "or practices were not tailored to specific risks; or it applied its \n",
      "security policies or practices in an inconsistent or discriminatory \n",
      "manner.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\121\\ 45 cfr 164.306(d)(3)(ii)(b)(1); 45 cfr 164.316(b)(1).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "the practice must be tailored to the specific security risk being \n",
      "addressed\n",
      "    to qualify for this exception, we propose that an actor's security-\n",
      "related practice must be tailored to specific security risks that the \n",
      "practice actually addressed. this condition necessarily presupposes \n",
      "that an actor has carefully evaluated the risk posed by the security \n",
      "threat and developed a considered response that is tailored to \n",
      "mitigating the vulnerabilities of the actor's health it or other \n",
      "related systems. for example, the awareness of a security vulnerability \n",
      "in a particular hie's technology may justify a health care provider's \n",
      "suspending access to ehi from that organization or by participants of \n",
      "that hie, but only for the period in which the threat persists. in \n",
      "contrast, a response that suspended access by all hies or that \n",
      "persisted even after the hie had addressed the security vulnerability \n",
      "in its technology would not be tailored to address specific risks and \n",
      "would not meet this condition.\n",
      "    as another example, it may be reasonable for a health care provider \n",
      "to refuse to grant access to ehi when an individual has been unable to \n",
      "prove her identity. however, the actor's identity proofing practice \n",
      "would have to be tailored to address risks specifically associated with \n",
      "the disclosure of ehi to unauthorized individuals. for example, \n",
      "identity proofing requirements might be tailored if the practice is \n",
      "based on a risk assessment and best practice policies and procedures \n",
      "and is applied consistently and in a non-discriminatory manner. \n",
      "however, we believe an identity proofing requirement would not be \n",
      "tailored if it were not based on an objectively reasonable security \n",
      "risk assessment and a careful consideration of alternative approaches \n",
      "that could adequately address the specific risk of patient \n",
      "misidentification in a less restrictive fashion.\n",
      "    as a final example, an actor's decision to deny access to the ehi \n",
      "it maintains may be reasonable if the practice responds to a request \n",
      "for ehi from a patient-facing website or application that causes the \n",
      "actor's system to raise a malicious software detection alert or if the \n",
      "request comes from a website or application listed on a security \n",
      "``blacklist.'' however, we propose that the actor's response must be \n",
      "tailored to the specific threat. among other things, the denial of \n",
      "access must be limited to the patient and/or their personal software. \n",
      "so as to ensure that the response is properly tailored, it would be \n",
      "best practice for actors to ensure that they communicate to those \n",
      "persons whose access was denied the reason for the denial of access, \n",
      "and communicate objective timeframes (if feasible to do so) and other \n",
      "parameters for when access would be granted or restored. moreover, we \n",
      "propose that, to the extent that the practice implements an \n",
      "organizational security policy, the policy must align with applicable \n",
      "consensus-based standards or best practices for responding to these \n",
      "types of incidents. disagreement with the individual about the \n",
      "worthiness of the third party as a recipient of ehi, or even concerns \n",
      "about what the third party might do with the ehi, except for reasons \n",
      "such as those listed in the ``preventing harm'' exception, are not \n",
      "acceptable reasons to deny an individual's request.\n",
      "practice must be implemented in a consistent and non-discriminatory \n",
      "manner\n",
      "    we propose that in order for a practice to qualify for this \n",
      "proposed exception, the actor's practice must have been implemented in \n",
      "a consistent and non-discriminatory manner. this condition would \n",
      "provide basic assurance that the purported security practice is \n",
      "directly related to a specific security risk and is not being used to \n",
      "interfere with access, exchange, or use of ehi for other purposes to \n",
      "which this exception does not apply.\n",
      "    as an illustration solely of the non-discriminatory manner \n",
      "condition, consider a health it developer of certified health it that \n",
      "offers apps to its customers via an app marketplace. if the\n",
      "\n",
      "[[page 7537]]\n",
      "\n",
      "developer requires that third-party apps sold (or made available) via \n",
      "the developer's app marketplace meet certain security requirements, \n",
      "those security requirements must be imposed in a non-discriminatory \n",
      "manner. this would mean, for example, that if a developer imposed a \n",
      "requirement that third-party apps include two-factor authentication for \n",
      "patient access, the developer would need to ensure that the same \n",
      "requirement was imposed on, and met by, all other apps, including any \n",
      "apps made available by the developer itself. to note, such a developer \n",
      "requirement must also meet the other conditions of this exception \n",
      "(e.g., the condition that the practice be tailored to the specific \n",
      "security risk being addressed).\n",
      "practices that implement an organizational security policy\n",
      "    as discussed above, an actor's approach to information security \n",
      "management will reflect the actor's particular size, organizational \n",
      "structure, and risk posture. because of this, it is important that \n",
      "actors develop and implement organizational policies that secure ehi. \n",
      "we propose that, where an actor has documented security policies that \n",
      "align with applicable consensus-based standards, and where the policies \n",
      "are implemented in a consistent and non-discriminatory manner, a \n",
      "practice's conformity with such policies would provide a degree of \n",
      "assurance that the practice was reasonable and necessary to address \n",
      "specific security risks and thus should not constitute information \n",
      "blocking. conversely, a practice that went beyond an actor's \n",
      "established policies or practices by imposing security controls that \n",
      "were not documented, would not qualify for this exception under this \n",
      "condition (although the actor may be able to qualify under the \n",
      "alternative basis for practices that do not implement a security \n",
      "policy). further, such practices would be suspect under the information \n",
      "blocking provision if there were indications that the actor's security-\n",
      "related justifications were a pretext or after-the-fact \n",
      "rationalizations for its actions or was otherwise unreasonable under \n",
      "the circumstances.\n",
      "    we reiterate that, to the extent that an actor seeks to justify a \n",
      "practice on the basis of its organizational security policies, such \n",
      "policies must be in writing and implemented in a consistent and non-\n",
      "discriminatory manner. as noted above, what a policy requires will \n",
      "depend on the facts and circumstances. however, we propose that to \n",
      "support a presumption that a practice conducted pursuant to the actor's \n",
      "security policy was reasonable, the policy would have to meet the \n",
      "following conditions.\n",
      "    <bullet> risks identified and assessed. the actor's security policy \n",
      "must be informed by an assessment of the security risks facing the \n",
      "actor. while we do not propose any requirements as to a risk \n",
      "assessment, we note that a good risk assessment would use an approach \n",
      "consistent with industry standards,\\122\\ and would incorporate elements \n",
      "such as threat and vulnerability analysis, data collection, security \n",
      "measures, likelihood of occurrence, impact, level of risk, and final \n",
      "reporting.\\123\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\122\\ see ocr, guidance on risk analysis, <a href=\"https://www.hhs.gov/hipaa/for-professionals/security/guidance/guidance-risk-analysis/index.html?language=es\">https://www.hhs.gov/hipaa/for-professionals/security/guidance/guidance-risk-analysis/index.html?language=es</a>.\n",
      "    \\123\\ onc and ocr have jointly launched the hhs hipaa security \n",
      "risk assessment (sra) tool, <a href=\"https://www.healthit.gov/providers-professionals/security-risk-assessment-tool\">https://www.healthit.gov/providers-professionals/security-risk-assessment-tool</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> consensus-based standards or best practice guidance. the \n",
      "actor's policy must align with one or more applicable consensus-based \n",
      "standards or best practice guidance. at present, examples of relevant \n",
      "best practices for development of security policies include, but are \n",
      "not limited to: nist-800-53 rev. 5; the nist cybersecurity framework; \n",
      "and nist sp 800-100, sp 800-37 rev. 2, sp 800-39, as updated and as \n",
      "interpreted through formal guidance. best practice guidance on security \n",
      "policies is also developed by consensus standards bodies such as iso, \n",
      "ietf, or iec. hipaa covered entities and business associates may be \n",
      "able to leverage their hipaa security rule compliance activities and \n",
      "can, if they choose, align their security policy with those parts of \n",
      "the nist cybersecurity framework that are referenced in the hipaa \n",
      "security rule crosswalk to nist cybersecurity framework to satisfy this \n",
      "condition. relevant consensus-based standards and frameworks provide \n",
      "actors of varying size and resources with the flexibility needed to \n",
      "apply the right security controls to the right information systems at \n",
      "the right time to adequately address risk.\n",
      "    <bullet> objective timeframes and other parameters. we propose that \n",
      "the actor's security policy must provide objective timeframes and \n",
      "common terminology used for identifying, responding to, and addressing \n",
      "security incidents. examples of acceptable sources for development of a \n",
      "security response plan include: nist incident response procedure \n",
      "(<a href=\"https://csrc.nist.gov/publications/detail/sp/800-61/rev-2/final\">https://csrc.nist.gov/publications/detail/sp/800-61/rev-2/final</a>), us-\n",
      "cert for interactions with government systems (<a href=\"https://www.us-cert.gov/government-users/reporting-requirements\">https://www.us-cert.gov/government-users/reporting-requirements</a>), and isc-cert for critical \n",
      "infrastructure (<a href=\"https://ics-cert.us-cert.gov/\">https://ics-cert.us-cert.gov/</a>).\n",
      "    as a point of clarification, we note that an actor's compliance \n",
      "with the hipaa security rule (if applicable to the actor) would be \n",
      "relevant to, but not dispositive of, whether the actor's policies and \n",
      "procedures were objectively reasonable for the purpose of this \n",
      "exception. an actor's documentation of its security policies and \n",
      "procedures for compliance with the security rule may not offer a basis \n",
      "to evaluate whether the actor's security practices unnecessarily \n",
      "interfere with access, use, or exchange of ehi. for example, it could \n",
      "be difficult to determine whether a practice unnecessary interferes \n",
      "with exchange of ehi based on a review of the customized phi data flow \n",
      "diagram the actor prepared as part of its security rule risk analysis. \n",
      "we believe that a documented policy that provides explicit references \n",
      "to consensus-based standards and best practice guidance (such as the \n",
      "nist cybersecurity framework) offer an objective and robust means for \n",
      "onc and the oig to evaluate the reasonableness of a particular security \n",
      "control for the purpose of this exception.\n",
      "    we recognize that, as a practical matter, some actors (such as \n",
      "small health care providers or those with limited resources) may have \n",
      "organizational security policies that are less robust or that otherwise \n",
      "fall short of the minimum conditions proposed above. as discussed \n",
      "immediately below, we propose that in these circumstances an actor \n",
      "could still benefit from this proposed exception by demonstrating that \n",
      "the practice at issue was objectively reasonable under the \n",
      "circumstances, without regard to a formal policy.\n",
      "practices that do not implement an organizational security policy\n",
      "    while we expect that most security practices engaged in by an actor \n",
      "will implement an organizational policy, we recognize that ehi security \n",
      "may present novel and unexpected threats that even a best-practice risk \n",
      "assessment and security policy cannot anticipate. if a practice that \n",
      "does not implement an organizational policy is to qualify for this \n",
      "exception, however, it must meet certain conditions. the actor's \n",
      "practice must, based on the particularized facts and circumstances, be \n",
      "necessary to mitigate the security risk. importantly, we propose that \n",
      "the actor would have to demonstrate that it considered reasonable and \n",
      "appropriate alternatives that could have reduced the likelihood of \n",
      "interference with access, exchange, or use of ehi, and that there were \n",
      "no reasonable and appropriate alternatives\n",
      "\n",
      "[[page 7538]]\n",
      "\n",
      "that were less likely to interfere with access, exchange or use of ehi.\n",
      "    we note that an actor's consideration of reasonable and appropriate \n",
      "alternatives will depend on the urgency and nature of the security \n",
      "threat in question. we anticipate that an actor's qualification for \n",
      "this exception would accommodate exigent circumstances. for example, we \n",
      "would not expect an actor to delay the implementation of a security \n",
      "measure in response to an emergency on the basis that it has not yet \n",
      "been able to initiate a fully realized risk assessment process. \n",
      "however, we expect that in these exigent circumstances, where the actor \n",
      "has implemented a security practice without first considering whether \n",
      "there were reasonable and appropriate alternatives that were less \n",
      "likely to interfere with access, exchange or use of ehi, the actor \n",
      "would expeditiously make any necessary changes to the practice based on \n",
      "the actor's consideration of reasonable and appropriate alternatives \n",
      "that are less likely to interfere with access, exchange or use of ehi. \n",
      "we propose that the exception would apply in these instances so long as \n",
      "an actor takes these steps and complies with all other applicable \n",
      "conditions.\n",
      "    we encourage comment on these conditions and our overall approach \n",
      "to this proposed exception, including whether our proposal provides \n",
      "adequate flexibility for actors to implement measures that are \n",
      "commensurate to the threats they face, the technology infrastructure \n",
      "they possess, and their overall security profiles and, equally \n",
      "important, whether this exception adequately mitigates the risk that \n",
      "actors will adopt security policies that are unnecessarily restrictive \n",
      "or engage in practices that unreasonably interfere with access, \n",
      "exchange, or use of ehi. commenters are encouraged to propose \n",
      "additional conditions that may be necessary to ensure that the \n",
      "exception is tailored and does not extend protection to practices that \n",
      "are not reasonable and necessary to promote the security of ehi and \n",
      "that could present information blocking concerns. we also seek comment \n",
      "on whether the use of consensus-based standards and guidance provides \n",
      "an appropriate reference point for the development of security \n",
      "policies. finally, commenters may wish to offer an alternative basis \n",
      "for identifying practices that do not offer a security benefit \n",
      "(compared with available alternatives) but that cause an information \n",
      "blocking harm by interfering with access, exchange, or use of ehi.\n",
      "4. recovering costs reasonably incurred\n",
      "    we propose to establish an exception to the information blocking \n",
      "provision that would permit the recovery of certain costs reasonably \n",
      "incurred to provide access, exchange, or use of ehi. the exception and \n",
      "corresponding conditions are set forth in the proposed regulation text \n",
      "in sec.  171.204. we interpret the definition of information blocking \n",
      "to include any fee that is likely to interfere with the access, \n",
      "exchange, or use of ehi (see discussion in section viii.c.4.c.iv). we \n",
      "anticipate that this interpretation may be broader than necessary to \n",
      "address genuine information blocking concerns and could have unintended \n",
      "consequences on innovation and competition. specifically, unless we \n",
      "establish an exception, actors may be unable to recover costs that they \n",
      "reasonably incur to develop technologies and provide services that \n",
      "enhance interoperability. this could undermine the ultimate goals of \n",
      "the information blocking provision by diminishing incentives to invest \n",
      "in, develop, and disseminate interoperable technologies and services \n",
      "that enable more robust access, exchange, and use of ehi. therefore, we \n",
      "propose to establish an exception that would permit the recovery of \n",
      "certain costs that we believe are unlikely to present information \n",
      "blocking concerns and would generally promote innovation, competition, \n",
      "and consumer welfare, provided certain conditions are met. we note that \n",
      "complying with the requirements of this exception would not prevent an \n",
      "actor from making a profit in connection with the provision of access, \n",
      "exchange, or use of ehi. indeed, the costs recoverable under this \n",
      "proposed exception could include a reasonable profit, provided that all \n",
      "applicable conditions were met.\n",
      "    the exception would be subject to strict conditions to prevent its \n",
      "potential misuse. specifically, we are concerned that a broad or \n",
      "insufficiently tailored exception for the recovery of costs could \n",
      "protect rent-seeking, opportunistic fees, and exclusionary practices \n",
      "that interfere with the access, exchange, and use of ehi. these \n",
      "practices fall within the definition of information blocking and \n",
      "reflect some of the most serious concerns that motivated its enactment \n",
      "(see section viii.b of this preamble). for example, in the information \n",
      "blocking congressional report, we cited evidence of wide variation in \n",
      "fees charged for health it products and services. while we cautioned \n",
      "that the issue of fees is nuanced, and that variations in fees could be \n",
      "attributable in part to different technology architectures, service \n",
      "models, capabilities, service levels, and other factors, we concluded \n",
      "that these factors alone could not adequately explain all of the \n",
      "variation in prices that we had observed. based on these and other \n",
      "indications, we concluded that some actors were engaging in \n",
      "opportunistic pricing practices or, in some cases, charging prices \n",
      "designed to deter connectivity or exchange with competing technologies \n",
      "or services.\n",
      "    in the time since we published the information blocking \n",
      "congressional report, these practices have persisted and, in certain \n",
      "respects, become more pronounced. in a national survey of hie \n",
      "executives published in 2017, 47% of respondents reported that ehr \n",
      "developers ``often/routinely'' charge high fees for exchange that are \n",
      "unrelated to cost, and another 40% reported that they ``sometimes'' \n",
      "do.\\124\\ meanwhile, we have continued to receive credible evidence of \n",
      "rent-seeking and other opportunistic behaviors, such as fees for data \n",
      "export and data portability that are not plausibly related to any \n",
      "reasonable time, materials, or other costs that a developer would \n",
      "reasonably incur to provide these services. and, while some practices \n",
      "described in the information blocking congressional report have become \n",
      "less prevalent (such as the charging of per-transaction fees), other \n",
      "practices have emerged that are equally concerning.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\124\\ julia adler-milstein and eric pfeifer, information \n",
      "blocking: is it occurring and what policy strategies can address \n",
      "it?, 95 milbank quarterly 117, 124-25 (mar. 2017), available at \n",
      "<a href=\"http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12247/full\">http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12247/full</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    as just one illustration, some ehr developers have begun \n",
      "conditioning access or use of customer ehi on revenue-sharing or \n",
      "royalty agreements that bear no plausible relation to the costs \n",
      "incurred by the ehr developer to grant access to the ehi. we have also \n",
      "heard of discriminatory pricing policies that have the obvious purpose \n",
      "and effect of excluding competitors from the use of interoperability \n",
      "elements. many of the industry stakeholders who shared their \n",
      "perspectives with us in listening sessions prior to this proposed rule, \n",
      "including several health it developers of certified health it, \n",
      "condemned these practices and urged us to swiftly address them.\n",
      "    in light of these concerns, we propose that this exception would \n",
      "apply only to the recovery of certain costs and only when the actor's \n",
      "methods for recovering such costs comply with certain conditions at all \n",
      "relevant times. as discussed in more detail below, these conditions \n",
      "would require that the costs the actor recovered were reasonably\n",
      "\n",
      "[[page 7539]]\n",
      "\n",
      "incurred and did not reflect costs that are speculative or subjective. \n",
      "actors would also be required to allocate costs in an appropriate \n",
      "manner and to use objective and permissible criteria when charging fees \n",
      "to recover those costs. further, the exception would not apply to \n",
      "certain fees, such as those based on the profit or revenue associated \n",
      "with the use of ehi (either being earned by the actor, or that could be \n",
      "realized by another individual or entity) that exceed the actor's \n",
      "reasonable costs for providing access, exchange, or use of the ehi. we \n",
      "specify certain prohibited fees below.\n",
      "    finally, the exception would provide additional conditions \n",
      "applicable to fees charged in connection with: (1) the certified apis \n",
      "described in sec.  170.404; and (2) the ehi export capability proposed \n",
      "in sec.  170.315(b)(10) for the purposes of switching health it or to \n",
      "provide patients their electronic health information. we emphasize that \n",
      "access to ehi that is provisioned by supplying some form of physical \n",
      "media, such as paper copies (where the ehi is printed out), or where \n",
      "ehi is copied onto a cd or flash-drive, would not be a practice that \n",
      "implicated the information blocking provision provided that the fee(s) \n",
      "charged for that access complied with hipaa (45 cfr 164.524(c)(4)).\n",
      "    our intention with this exception is not to set any particular cost \n",
      "that would be considered ``reasonably incurred,'' but rather to allow \n",
      "the market to define the appropriate price so long as certain methods \n",
      "are followed and certain criteria are met.\n",
      "requirement that costs be reasonably incurred\n",
      "    regardless of the type of cost at issue, a basic condition of this \n",
      "proposed exception is that any costs the actor seeks to recover must \n",
      "have been reasonably incurred to provide the relevant interoperability \n",
      "elements to enable access, exchange, or use of ehi. ultimately, whether \n",
      "a cost was reasonably incurred will depend on the particular facts and \n",
      "circumstances. we believe this fact-based approach is appropriate in \n",
      "light of the considerable diversity in the types of costs that actors \n",
      "might incur and the range of factors that could bear on the \n",
      "reasonableness of those costs. for example, the costs of developing \n",
      "software may vary with the purposes it is intended to serve, the \n",
      "settings in which it will be deployed, the types and scope of \n",
      "capabilities included, and the extent to which these development \n",
      "efforts build on existing development efforts and know-how. \n",
      "additionally, the costs of providing services, including the \n",
      "implementation of technology in production environments, may vary based \n",
      "on the technology design or architecture, individual customer needs, \n",
      "local implementation conditions, and other factors. an analysis of \n",
      "costs would also account for different distribution and service models \n",
      "under which the costs are calculated. we seek comment on these and \n",
      "other considerations that may be relevant to assessing the \n",
      "reasonableness of costs incurred for purposes of this exception.\n",
      "method for recovering costs\n",
      "    to qualify for the exception, we propose that the method by which \n",
      "the actor seeks to recover its costs must be reasonable and non-\n",
      "discriminatory. this would require that the actor base its recovery of \n",
      "costs on objective and verifiable criteria that are uniformly applied \n",
      "for all substantially similar or similarly situated classes of persons \n",
      "and requests. we emphasize that this proposal does not mean that the \n",
      "actor must apply the same prices or price terms for all persons or \n",
      "classes of persons to whom it provides the services. however, any \n",
      "differences in prices or price terms would have to be based on actual \n",
      "differences in the costs that the actor incurred or other reasonable \n",
      "and non-discriminatory criteria. we further propose to require that the \n",
      "method by which the actor recovers its costs must be reasonably related \n",
      "to the actor's costs of providing the type of access, exchange, or use \n",
      "to, or at the request of, the person or entity to whom the fee is \n",
      "charged.\n",
      "    we also propose that the method by which the actor recovers its \n",
      "costs must be reasonably allocated among all customers to whom the \n",
      "technology or service is supplied, or for whom the technology is \n",
      "supported. a reasonable allocation of costs would require that the \n",
      "actor allocate its costs in accordance with criteria that are \n",
      "reasonable and between only those customers that either cause the costs \n",
      "to be incurred or benefit from the associated supply or support of the \n",
      "technology. if an actor developed technology that could be supplied to \n",
      "multiple customers with minimal tailoring, the core costs of developing \n",
      "its technology should be allocated between those customers when \n",
      "recovered as a fee. the actor would not be permitted to recover the \n",
      "total of its core costs from each customer. similarly, when an actor \n",
      "uses shared facilities and resources to support the usage of \n",
      "technology, it would need to ensure that those shared costs were \n",
      "reasonably allocated between all of the customers that benefited from \n",
      "them. however, whenever an actor is required to provide services and \n",
      "incur costs that are unique to a particular customer, it would not need \n",
      "to distribute those costs among other customers that had deployed \n",
      "technology.\n",
      "    in addition, the exception would not apply if the method by which \n",
      "the actor recovers its costs is based, in any part, on whether the \n",
      "requestor or other person is a competitor, potential competitor, or \n",
      "will be using the ehi in a way that facilitates competition with the \n",
      "actor. the use of such criteria would be suspect because it suggests \n",
      "the fee the actor is charging is not based on its reasonable costs to \n",
      "provide the services and may have the purpose or effect of excluding or \n",
      "creating impediments for competitors, business rivals, or other persons \n",
      "engaged in developing or enabling the use of interoperable technologies \n",
      "and services.\n",
      "    last, we propose that the method by which the actor recovers its \n",
      "costs must not be based on the sales, profit, revenue, or other value \n",
      "that the requestor or other persons derive or may derive from the \n",
      "access to, exchange of, or use of electronic health information, \n",
      "including the secondary use of such information, that exceeds the \n",
      "actor's reasonable costs for providing access, exchange, or use of \n",
      "electronic health information. we emphasize that such revenue-sharing \n",
      "or profit-sharing arrangements would only be acceptable and covered by \n",
      "the exception if such arrangements are designed to provide an \n",
      "alternative way to recover the costs reasonably incurred for providing \n",
      "services.\n",
      "    we seek comment on these conditions and other issues we should \n",
      "consider in assessing whether the methodology by which an actor \n",
      "distributes costs and charges fees should be considered reasonable and \n",
      "necessary for purposes of this exception. in particular we are \n",
      "considering whether to introduce specific factors and methods for \n",
      "assessing when profit will be reasonable. for example, should the pro-\n",
      "competitive or efficiency-adding aspect of an actor's approach to \n",
      "providing access, exchange, or use of ehi be taken into account when \n",
      "assessing the reasonableness of the profit recovered by an actor? we \n",
      "also ask commenters to consider whether there are specific use cases \n",
      "for which actors' profits should be limited or prohibited. we request \n",
      "that commenters provide as much detail as possible when describing \n",
      "methods for quantifying profits and evaluating their reasonableness.\n",
      "\n",
      "[[page 7540]]\n",
      "\n",
      "costs specifically excluded\n",
      "    we propose that certain costs should be explicitly excluded from \n",
      "this exception regardless of the method for recovering the costs. we \n",
      "have proposed these excluded costs, which are detailed below, in an \n",
      "effort to provide additional clarity about the scope of this exception \n",
      "and to create guardrails for preventing potential misuse of the \n",
      "exception.\n",
      "costs due to non-standard design or implementation choices\n",
      "    we propose that this exception would not permit the recovery of any \n",
      "cost that the actor incurred due to the health it being designed or \n",
      "implemented in non-standard ways that unnecessarily increase the \n",
      "complexity, difficulty or burden of accessing, exchanging, or using \n",
      "ehi. to the extent that such costs can be reasonably avoided, we \n",
      "believe that actors should internalize the costs of such behaviors, \n",
      "which do not benefit consumers, and which create unnecessary \n",
      "impediments to access, exchange, and use of ehi. as an illustration, if \n",
      "a health it developer of certified health it designed its database \n",
      "tables or other aspects of its technology in ways that make exporting \n",
      "or converting ehi to other formats difficult, the developer could not \n",
      "claim that its costs to provide data conversion services to customers \n",
      "are reasonably incurred. such costs would not be eligible under this \n",
      "exception (and might implicate the information blocking provision for \n",
      "the reasons noted in section viii.c.4.c.v of this preamble).\n",
      "    we welcome comments on the exclusion of these types of costs.\n",
      "subjective or speculative costs\n",
      "    we propose to limit this exception to the recovery of costs that an \n",
      "actor actually incurred to provide the relevant interoperability \n",
      "element or group of elements (which may comprise either products or \n",
      "services). we propose that this exception would not permit the recovery \n",
      "of certain types of costs that are subjective or speculative. we note \n",
      "two important examples of this limitation.\n",
      "    first, an actor would not be permitted to recover any costs \n",
      "associated with intangible assets (including depreciation or loss of \n",
      "value), other than the actual development or acquisition costs of such \n",
      "assets. for example, an actor could not charge a customer a fee based \n",
      "on the purported ``cost'' of allowing the customer to use the actor's \n",
      "patented technology, computer software, databases, trade secrets, \n",
      "copyrighted works, and the like. we understand that the customer's use \n",
      "of the asset could be considered a ``cost'' in the sense that, were it \n",
      "not for the information blocking provision, the actor could charge a \n",
      "royalty or other fee for the use of its intangible assets. for this \n",
      "reason, in section viii.d.6, we propose to permit an actor to license \n",
      "most interoperability elements on reasonable and non-discriminatory \n",
      "terms, subject to certain conditions. for purposes of this more general \n",
      "exception, however, we believe it would be inappropriate to permit an \n",
      "actor to charge a fee based on these considerations, which are \n",
      "inherently subjective and could invite the kinds of rent-seeking and \n",
      "opportunistic pricing practices that fall squarely within the \n",
      "definition of information blocking. we clarify that an actor's \n",
      "practices could qualify for both this exception (recovering costs \n",
      "reasonably incurred) and the exception for licensing of \n",
      "interoperability elements on reasonable and non-discriminatory terms in \n",
      "section viii.d.6. in that case, the actor could recover costs under \n",
      "both exceptions.\n",
      "    second, and for similar reasons, an actor would not be permitted to \n",
      "recover costs that are speculative. the exception would not apply to \n",
      "``opportunity costs,'' such as the revenues that an actor could have \n",
      "earned had it not provided the interoperability elements. we clarify \n",
      "that the exclusion of opportunity costs would not preclude an actor \n",
      "from recovering its reasonable forward-looking cost of capital. we \n",
      "believe these costs are relatively concrete and that permitting their \n",
      "recovery will protect incentives for actors to invest in developing and \n",
      "providing interoperability elements.\n",
      "fee prohibited by 45 cfr 164.524(c)(4)\n",
      "    we also propose that the exception would not apply to fees \n",
      "prohibited by 45 cfr 164.524(c)(4). the hipaa privacy rule permits a \n",
      "covered entity to impose a reasonable, cost-based fee if the individual \n",
      "requests a copy of the phi (or agrees to receive a summary or \n",
      "explanation of the information). the fee may include only the cost of: \n",
      "(1) labor for copying the phi requested by the individual, whether in \n",
      "paper or electronic form; (2) supplies for creating the paper copy or \n",
      "electronic media (e.g., cd or usb drive) if the individual requests \n",
      "that the electronic copy be provided on portable media; (3) postage, \n",
      "when the individual requests that the copy, or the summary or \n",
      "explanation, be mailed; and (4) preparation of an explanation or \n",
      "summary of the phi, if agreed to by the individual (45 cfr \n",
      "164.524(c)(4)). the fee may not include costs associated with \n",
      "verification; documentation; searching for and retrieving the phi; \n",
      "maintaining systems; recouping capital for data access, storage, or \n",
      "infrastructure; or other costs not listed above even if such costs are \n",
      "authorized by state law.\n",
      "individual electronic access\n",
      "    we propose that this exception would not apply if the actor charged \n",
      "a fee based in any part on the electronic access by an individual or \n",
      "their personal representative, agent, or designee to the individual's \n",
      "ehi. such fees are distinguished from the cost-based fees that a \n",
      "covered entity is permitted to charge individuals for the provision of \n",
      "copies of ephi under hipaa (45 cfr 164.524(c)(4)), and similar \n",
      "allowable costs under state privacy laws, which would not be excluded \n",
      "from the costs recoverable under this exception. to be clear, access to \n",
      "ehi that is provisioned by supplying some form of physical media, such \n",
      "as paper copies (where the ehi is printed out), or where ehi is copied \n",
      "onto a cd or flash-drive, would not be a practice that implicated the \n",
      "information blocking provision provided that the fee(s) charged for \n",
      "that access complied with hipaa (45 cfr 164.524(c)(4)).\n",
      "    a fee based on electronic access by an individual or their personal \n",
      "representative, agent, or designee to the individual's ehi, in \n",
      "contrast, would arise if an actor sought to impose on individuals, or \n",
      "their personal representatives, agents, or designees, a fee that \n",
      "operated as a toll for the provision of electronic access. for example, \n",
      "a health care provider that charges individuals a fee in order that the \n",
      "individuals be given access to their ehi via the health care provider's \n",
      "patient portal or another mode of web-based delivery, would not be able \n",
      "to benefit from this exception. similarly, where an individual \n",
      "authorizes a consumer-facing app to retrieve ehi on the individual's \n",
      "behalf, it would be impermissible for an actor to charge the app or its \n",
      "developer a fee to access or use apis that enable access to the \n",
      "individual's ehi. this would be true whether the actor is a supplier of \n",
      "the api technology or an individual or entity that has deployed the api \n",
      "technology, such as a health care provider.\n",
      "export and portability of ehi maintained in ehr systems\n",
      "    the definition of information blocking specifically mentions \n",
      "transitions between health it systems and the export of complete \n",
      "information sets as protected forms of access, exchange, and use (see \n",
      "section 3022(a)(2)(c)(i) of the phsa). in our experience, health care \n",
      "providers\n",
      "\n",
      "[[page 7541]]\n",
      "\n",
      "frequently encounter rent-seeking and opportunistic pricing practices \n",
      "in these and other contexts in which they are attempting to export ehi \n",
      "from their systems for use in connection with other technologies or \n",
      "services that compete with or could reduce the revenue opportunities \n",
      "associated with an ehr developer's own suite of products and services. \n",
      "as discussed in section viii.c.5.b.iii of this preamble, most ehi is \n",
      "currently maintained in ehrs and other source systems that use \n",
      "proprietary data models or formats; this puts ehr developers in a \n",
      "unique position to block the export and portability of ehi for use in \n",
      "competing systems or applications, or to charge rents for access to the \n",
      "basic technical information needed to facilitate the conversion or \n",
      "migration of data for these purposes. the concerns are compounded by \n",
      "the fact that ehr developers rarely disclose in advance the fees they \n",
      "will charge for data export and data portability services (see 80 fr \n",
      "62719; 80 fr 16880-81).\n",
      "    for the reasons above, we propose that fees charged for the export, \n",
      "conversion, or migration of data from an ehr technology would not \n",
      "qualify for the exception unless they also meet two additional \n",
      "conditions.\n",
      "    first, we propose that health it developers of certified health it \n",
      "would, for purposes of this exception, be precluded from charging a fee \n",
      "to perform an export of ehi via the capability of health it certified \n",
      "to the proposed 2015 edition ``ehi export'' certification criterion \n",
      "(sec.  170.315(b)(10)) for the purposes of switching health it systems \n",
      "or to provide patients their ehi. as part of the ``assurances'' \n",
      "condition of certification, health it developers that produce and \n",
      "electronically manage ehi would need to be certified to the ``ehi \n",
      "export'' criterion and provider the functionality to its customers (see \n",
      "sec.  170.402(a)(4) and section vii.b.2.b of this preamble). as \n",
      "described in section iv.c.1 of this preamble, the ``ehi export'' \n",
      "certification criterion is intended to provide a baseline capability to \n",
      "export ehi from certified health it in a commercially reasonable format \n",
      "in support of transitioning of ehi between health it systems and \n",
      "patient access. fees or limitations associated with the use of this \n",
      "capability (as distinguished from deployment or other costs reasonably \n",
      "incurred by the developer) would not receive protection under the \n",
      "exception and may be suspect under the information blocking provision. \n",
      "we clarify that this condition would not preclude a developer from \n",
      "charging a fee to deploy the ehi export capability in a health care \n",
      "provider's production environment, or to provide additional services in \n",
      "connection with this capability other than those reasonably necessary \n",
      "to enable its intended use. for example, this condition would not \n",
      "preclude a developer from charging a fee to perform an export of ehi \n",
      "via the capability of health it certified to the proposed sec.  \n",
      "170.315(b)(10) for a third-party analytics company. we emphasize once \n",
      "again that these excluded fees are distinguished from the cost-based \n",
      "fees that a covered entity is permitted to charge individuals for the \n",
      "provision of copies of ephi under hipaa (45 cfr 164.524(c)(4)), and \n",
      "similar allowable costs under state privacy laws, which would not be \n",
      "excluded from the costs recoverable under this exception.\n",
      "    we note that, because this certification criterion provides only a \n",
      "baseline capability for exporting data, we anticipate that health it \n",
      "developers of certified health it will need to provide other data \n",
      "portability services to facilitate the smooth transition of health care \n",
      "providers between different health it systems. we propose that such \n",
      "fees may qualify for protection under the exception, but only if they \n",
      "meet the other conditions described above and in proposed sec.  \n",
      "171.205(a).\n",
      "    second, we propose that the exception would not apply to a fee to \n",
      "export or convert data from an ehr technology unless such fee was \n",
      "agreed to in writing at the time the technology was acquired, meaning \n",
      "when the ehr developer and the customer entered into a contract or \n",
      "license agreement for the ehr technology. this condition is designed to \n",
      "promote the disclosure of fees upfront and thereby reduce the potential \n",
      "for actors to engage in installed-base opportunism or attempting to use \n",
      "fees to discourage data portability.\n",
      "compliance with the condition of certification specific to api \n",
      "technology suppliers and api data providers\n",
      "    we note that health it developers of certified health it subject to \n",
      "the api condition of certification proposed in sec.  170.404 may not \n",
      "charge certain types of fees and are subject to more specific cost \n",
      "accountability provisions than apply generally under this proposed \n",
      "exception. we believe that the failure of developers to comply with \n",
      "these additional requirements would impose impediments to consumer and \n",
      "other stakeholder access to ehi without special effort and would be \n",
      "suspect under the information blocking provision. we propose, \n",
      "therefore, that a health it developer of certified health it subject to \n",
      "the api condition of certification must comply with all requirements of \n",
      "that condition for all practices and at all relevant times in order to \n",
      "qualify for this exception.\n",
      "    we also believe that a health care provider that acts as an api \n",
      "data provider, should be subject to the same constraints. for example, \n",
      "the api condition of certification prohibits a health it developer from \n",
      "charging a usage fee to patient-oriented apps. we believe information \n",
      "blocking concerns would arise if a provider were to charge such a fee, \n",
      "notwithstanding the fact that the provider is not subject to the \n",
      "certification requirements. for this reason, we propose that, if the \n",
      "actor is an api data provider, the actor is only permitted to charge \n",
      "the same fees that an api technology supplier is permitted to charge to \n",
      "recover costs consistent with the permitted fees specified in the \n",
      "condition of certification in sec.  170.404. in other words, to the \n",
      "extent that a provider is an api data provider, the provider will not \n",
      "qualify for this exception if it charges any fee that a health it \n",
      "developer of certified health it would be prohibited from charging \n",
      "under the api condition of certification.\n",
      "application of the exception to individual practices\n",
      "    we clarify that the conditions of this exception, including those \n",
      "governing the methodology and criteria by which an actor calculates and \n",
      "distributes its costs, must be satisfied for each and every fee that an \n",
      "actor charges to a customer, requestor, or other person. for example, \n",
      "if an actor uses a cost allocation methodology that does not meet the \n",
      "requirements of the exception, each fee charged on the basis of that \n",
      "methodology would be a suspect practice under the information blocking \n",
      "provision. all applicable conditions of the exception must be met at \n",
      "all relevant times for each practice.\n",
      "    we request comment on this proposed exception. specifically, we ask \n",
      "commenters to consider alternate approaches to the exception that would \n",
      "also achieve the goal of allowing actors to recover certain types of \n",
      "costs that would promote innovation, competition and consumer welfare \n",
      "and that are unlikely to present information blocking concerns. in \n",
      "assessing other potential approaches to this exception, we encourage \n",
      "commenters to contemplate such considerations as enforceability, \n",
      "potential burden on the parties, and overall effectiveness in meeting \n",
      "the above stated goals.\n",
      "\n",
      "[[page 7542]]\n",
      "\n",
      "5. responding to requests that are infeasible\n",
      "    we propose to establish an exception to the information blocking \n",
      "provision that would permit an actor to decline to provide access, \n",
      "exchange, or use of ehi in a manner that is infeasible, provided \n",
      "certain conditions are met. the exception and corresponding conditions \n",
      "are set forth in the proposed regulation text in sec.  171.205. we \n",
      "propose that this exception would not apply when a response is required \n",
      "by law. as discussed in section viii.c.5 of this preamble, we propose \n",
      "that the information blocking provision would be implicated if an actor \n",
      "were to refuse to facilitate access, exchange, or use of ehi, either as \n",
      "a general practice or in isolated instances. however, we believe that \n",
      "in certain circumstances legitimate practical challenges beyond an \n",
      "actor's control may limit its ability to comply with requests for \n",
      "access, exchange, or use. in some cases, the actor may not have--and \n",
      "may be unable to obtain--the requisite technological capabilities, \n",
      "legal rights, financial resources, or other means necessary to provide \n",
      "a particular form of access, exchange, or use. in other cases, the \n",
      "actor may be able to comply with the request, but only by incurring \n",
      "costs or other burdens that are clearly unreasonable under the \n",
      "circumstances.\n",
      "    actors confronted with these types of practical challenges may be \n",
      "concerned about their exposure under the information blocking \n",
      "provision, which could lead to inefficient outcomes. for example, \n",
      "health care providers may feel compelled to entertain requests to \n",
      "enable or support means of exchange or use that would be disruptive to \n",
      "health care operations or that are not financially sustainable. in some \n",
      "of these instances, the actor may be able, but reluctant, to offer \n",
      "alternative means that would meet the requestor's needs while reducing \n",
      "the burden on the actor, leading to more efficient outcomes overall. \n",
      "actors could also be forced into a ``reactive'' posture that limits \n",
      "their ability to make holistic decisions and to implement health it in \n",
      "a considered, scalable way that facilitates robust interoperability and \n",
      "information sharing. these outcomes would be counterproductive to the \n",
      "policies the information blocking provision encompasses.\n",
      "    the proposed exception would alleviate some of these concerns while \n",
      "safeguarding against pretextual and other unreasonable refusals to \n",
      "provide access, exchange, or use of ehi. the exception would permit an \n",
      "actor to decline a request in certain narrowly-defined circumstances \n",
      "when doing so would be infeasible (or impossible) and when the actor \n",
      "otherwise did all that it reasonably could do under the circumstances \n",
      "to facilitate alternative means of accessing, exchanging, and using the \n",
      "ehi. we believe this approach is principled and tailored in a manner \n",
      "that will promote basic fairness and encourage parties to work \n",
      "cooperatively to implement efficient solutions to interoperability \n",
      "challenges. importantly, to ensure that the exception is not used \n",
      "inappropriately, we propose a structured, fact-based approach for \n",
      "determining whether a request was in fact ``infeasible'' within the \n",
      "meaning of this exception. this approach would be limited to a \n",
      "consideration of factors specifically delineated in the exception and \n",
      "that focus the infeasibility inquiry on the immediate and direct \n",
      "financial and operational challenges of facilitating access, exchange, \n",
      "and use, as distinguished from more remote, indirect, or speculative \n",
      "types of injuries.\n",
      "    we encourage comment on these and other aspects of this proposal, \n",
      "which are described in more detail below.\n",
      "i. infeasibility of request\n",
      "    to qualify for this proposed exception, in addition to meeting \n",
      "other conditions, we propose that compliance with the request for \n",
      "access, exchange, or use must be infeasible. we propose a two-step test \n",
      "that an actor would need to meet in order to demonstrate that a request \n",
      "was infeasible.\n",
      "complying with the request would impose a substantial burden on the \n",
      "actor\n",
      "    under the first step of the infeasibility test, the actor would \n",
      "need to show that complying with the particular request in the manner \n",
      "requested would impose a substantial burden on the actor that is \n",
      "unreasonable under the circumstances. we anticipate that in most cases \n",
      "an actor would meet this requirement by showing that it did not have, \n",
      "and could not readily obtain, the requisite technological capabilities, \n",
      "legal rights, or other means necessary to facilitate the particular \n",
      "type of access, exchange, or use requested. additionally, the \n",
      "requirement could be met by showing that, had it complied with the \n",
      "request, the actor would have experienced a significant disruption to \n",
      "its health care or business activities or would have incurred \n",
      "significant unbudgeted costs. we would also consider other analogous \n",
      "outcomes that impact the actor's health care or business activities in \n",
      "a direct and substantial way. we seek comment on what those outcomes \n",
      "might be and encourage commenters to be as detailed and specific as \n",
      "possible.\n",
      "    in determining whether these or other types of burdens are \n",
      "substantial, we would consider the actor's particular circumstances, \n",
      "including the type of actor; the nature and purpose of its business or \n",
      "other activities; and the financial, technical, and other resources and \n",
      "expertise at its disposal. in addition, we would also consider any \n",
      "offsetting benefits to the actor of providing the requested access, \n",
      "exchange, or use, such as facilitating the actor's compliance with \n",
      "statutory and regulatory requirements. due to the variability of \n",
      "circumstances, onc would take a fact-specific approach to these \n",
      "analyses.\n",
      "    as an illustration, a small physician practice with limited \n",
      "financial and technical resources may find it burdensome to accommodate \n",
      "requests from other providers to establish and maintain outbound \n",
      "interfaces from the practice's ehr system that it neither needs for its \n",
      "own health care activities nor to comply with any regulatory \n",
      "requirements. in contrast, a large health system with a well-resourced \n",
      "it department may be in a position to accommodate such requests without \n",
      "significant disruption to its business and at relatively minimal \n",
      "additional expense relative to its overall it budget. similarly, custom \n",
      "development or other activities that might be burdensome for a health \n",
      "care provider with limited technical expertise may not result in a \n",
      "substantial burden for a health it developer, exchange, or network \n",
      "whose business is to develop and provide technological solutions.\n",
      "    we clarify that the exception focuses solely on the immediate and \n",
      "direct financial and operational challenges of facilitating access, \n",
      "exchange, or use. the exception does not apply--and we would give no \n",
      "weight--to any putative burdens that an actor experiences that relate \n",
      "primarily to the actor's pursuit of an economic advantage, such as its \n",
      "ability to charge higher prices, capture additional revenue streams, \n",
      "maintain or increase its market share, or otherwise pursue its own \n",
      "economic interests. to the extent that these interests merit an \n",
      "exception under the information blocking provision, they are addressed \n",
      "under the exceptions proposed in sec. sec.  171.204 and 171.206. in the \n",
      "same way, the exception would not apply to any putative burdens that \n",
      "are more appropriately examined under another proposed exception. for \n",
      "example, an actor could not claim that it is burdensome to implement a \n",
      "tailored organizational patient safety policy under proposed sec.  \n",
      "171.201(b) or to\n",
      "\n",
      "[[page 7543]]\n",
      "\n",
      "develop and implement policies and procedures for satisfying \n",
      "preconditions imposed by state or federal privacy laws for the \n",
      "provision of access, exchange, or use of ehi under proposed sec.  \n",
      "171.202(b).\n",
      "the burden imposed on the actor would be plainly unreasonable under the \n",
      "circumstances\n",
      "    to show that a request for access, exchange, or use was infeasible, \n",
      "the actor must not only demonstrate that complying with the request \n",
      "would have resulted in a substantial burden, as described above; the \n",
      "actor must also demonstrate that requiring it to comply with the \n",
      "request--and thus to assume the substantial burden demonstrated under \n",
      "the first part of the test--would have been plainly unreasonable under \n",
      "the circumstances. whether it would have been plainly unreasonable for \n",
      "the actor to assume the burden of providing access, exchange, or use \n",
      "will be highly dependent on the particular facts and circumstances. \n",
      "while for this reason we do not believe that bright-line rules would be \n",
      "appropriate, we do propose to rely primarily on the following key \n",
      "factors enumerated in proposed sec.  171.205(a)(1):\n",
      "    <bullet> the type of ehi and the purposes for which it may be \n",
      "needed;\n",
      "    <bullet> the cost to the actor of complying with the request in the \n",
      "manner requested;\n",
      "    <bullet> the financial, technical, and other resources available to \n",
      "the actor;\n",
      "    <bullet> whether the actor provides comparable access, exchange, or \n",
      "use to itself or to its customers, suppliers, partners, and other \n",
      "persons with whom it has a business relationship;\n",
      "    <bullet> whether the actor owns or has control over a predominant \n",
      "technology, platform, health information exchange, or health \n",
      "information network through which ehi is accessed or exchanged;\n",
      "    <bullet> whether the actor maintains ephi on behalf of a covered \n",
      "entity, as defined in 45 cfr 160.103, or maintains ehi on behalf of the \n",
      "requestor or another person whose access, exchange, or use of ehi will \n",
      "be enabled or facilitated by the actor's compliance with the request;\n",
      "    <bullet> whether the requestor and other relevant persons can \n",
      "reasonably access, exchange, or use the information from other sources \n",
      "or through other means; and\n",
      "    <bullet> the additional cost and burden to the requestor and other \n",
      "relevant persons of relying on alternative means of access, exchange, \n",
      "or use.\n",
      "    as these factors suggest, the starting point for our inquiry would \n",
      "be to identify the type of ehi at issue and the purposes for which it \n",
      "may be needed. as explained in section viii.c.5.b.i. of this preamble, \n",
      "certain types of ehi--namely, observational health information--give \n",
      "rise to a heightened risk of interference under the information \n",
      "blocking provision. for purposes of this exception and the information \n",
      "blocking provision more generally, the actor has a strong duty to \n",
      "facilitate the availability and use of this information, which may be \n",
      "needed for important activities for which timely and complete access to \n",
      "ehi is essential, such as providing patients with their ehi; enabling \n",
      "the use of ehi for treatment and care coordination; and making ehi \n",
      "available for quality improvement and population health management \n",
      "activities.\n",
      "    next, we would consider the severity of the burdens that the actor \n",
      "would have experienced to provide the access, exchange, or use of ehi \n",
      "in the manner requested. for this purpose, we would consider both the \n",
      "burden on the actor of complying with the specific request at issue as \n",
      "well as the burden the actor would experience if it was required to \n",
      "comply with similar types of requests. we would also consider the \n",
      "observed or likely frequency of such requests. as already discussed, we \n",
      "anticipate that the extent of any burden would depend in part on the \n",
      "particular circumstances of the actor. in addition, in considering the \n",
      "burden to the actor, we would also consider any offsetting benefits to \n",
      "the actor of providing the requested access, exchange, or use.\n",
      "    having ascertained the nature and severity of any burdens that the \n",
      "actor would assume to provide the requested access, exchange, or use, \n",
      "we would balance these burdens against the countervailing costs to the \n",
      "requestor and other persons (including consumers) who would be harmed \n",
      "by the actor's refusal to provide the requested access, exchange, or \n",
      "use. importantly, we would consider whether the requestor and other \n",
      "persons could have obtained the ehi from other sources or through other \n",
      "means, including those made available by the actor as an accommodation \n",
      "to the requestor, as discussed in more detail below. if alternative \n",
      "means were available, we would examine the extent to which they would \n",
      "have been appropriate for the purposes for which the ehi or \n",
      "interoperability elements were needed and the extent to which requiring \n",
      "the requestor to pursue these alternative means would impose additional \n",
      "costs or burdens on the requestor and other persons. for example, if \n",
      "the ehi was readily available through other means that were equally \n",
      "efficacious, the actor's refusal to provide yet one more means of \n",
      "access, exchange, or use might impose only a minimal burden on the \n",
      "requestor and other persons' use of the ehi. in contrast, if the actor \n",
      "conditions critical technology or infrastructure for accessing, \n",
      "exchanging, or using ehi, or if its control over other interoperability \n",
      "elements means that ehi cannot be efficiently accessed, exchanged, or \n",
      "used without the actor's cooperation, requiring the requestor to pursue \n",
      "other means of access, exchange, or use would likely be unrealistic and \n",
      "represent an insurmountable burden.\n",
      "    one final consideration would inform our analysis. we would \n",
      "consider the balancing of relative burdens in conjunction with the \n",
      "actor's control over interoperability elements. as an example, a \n",
      "dominant health it developer of certified health it or network that \n",
      "refuses to facilitate a particular form of access, exchange, or use \n",
      "with other entities would have to demonstrate an extreme burden \n",
      "relative to the need for access, exchange, or use in order to qualify \n",
      "for this exception. this exacting standard would also apply in other \n",
      "circumstances of dependence or reliance on the actor to facilitate \n",
      "access, exchange, or use. for example, a dominant health system that \n",
      "provides local health it infrastructure would have to demonstrate an \n",
      "extreme hardship to justify denying interconnection requests or access \n",
      "to interoperability elements. likewise, where the actor is a business \n",
      "associate of a covered entity, or owes some other special duty to the \n",
      "requestor, the actor could not qualify for this exception unless the \n",
      "cost or burden it would have borne was so extreme in comparison to the \n",
      "marginal benefits to the requestor that the request was clearly \n",
      "unreasonable by any objective measure.\n",
      "    we acknowledge that there may be situations when complying with a \n",
      "request for access, exchange, or use would be considered infeasible \n",
      "because an actor is unable to provide such access, exchange, or use due \n",
      "to unforeseeable or unavoidable circumstances that are outside the \n",
      "actor's control. for example, an actor could seek coverage under this \n",
      "exception if it is unable to provide access, exchange, or use of ehi \n",
      "due to a natural disaster (such as a hurricane, tornado or earthquake) \n",
      "or war. these are just a couple examples of such circumstances and are \n",
      "by no means an exhaustive list.\n",
      "    we emphasize that, consistent with the requirements for \n",
      "demonstrating that activities and practices meet the conditions of an \n",
      "exception proposed in section viii.c.6.c of this preamble, the actor \n",
      "would need to produce evidence and ultimately prove that complying\n",
      "\n",
      "[[page 7544]]\n",
      "\n",
      "with the request for access, exchange, or use in the manner requested \n",
      "would have imposed a clearly unreasonable burden on the actor under the \n",
      "circumstances.\n",
      "    we note that there are certain circumstances that we propose would \n",
      "not constitute a burden to the actor for purposes of this exception and \n",
      "shall not be considered in determining whether complying with a request \n",
      "would have been infeasible. we propose that it would not be considered \n",
      "a burden if providing the requested access, exchange, or use in the \n",
      "manner requested would have (1) facilitated competition with the actor; \n",
      "or (2) prevented the actor from charging a fee. throughout this \n",
      "proposed rule, we have highlighted that one of the goals of the \n",
      "information blocking section is to promote competition, and allowing \n",
      "the argument that a request is infeasible because it facilitates \n",
      "competition with the actor would be antithetical to this goal. \n",
      "similarly, an argument that a request is infeasible because it prevents \n",
      "the actor from charging a fee would also be outside the scope of this \n",
      "exception because such a result would not constitute a substantial, \n",
      "unreasonable burden that this exception seeks to address.\n",
      "    we request comment on the structured, fact-based approach we have \n",
      "proposed for determining whether a request was in fact ``infeasible'' \n",
      "within the meaning of this exception. we encourage comment on, among \n",
      "other issues, whether the factors we have specifically delineated above \n",
      "properly focus the infeasibility inquiry; whether our approach to \n",
      "weighing these factors is appropriate; and whether there are additional \n",
      "burdens, distinct from the immediate and direct financial and \n",
      "operational challenges contemplated above, that are similarly concrete \n",
      "and should be considered under the fact-based rubric of this exception.\n",
      "ii. duty to timely respond and provide reasonable cooperation\n",
      "    in addition to demonstrating that a particular request or class of \n",
      "requests was infeasible, we propose that an actor would have to show \n",
      "that it satisfied several additional conditions. specifically, to \n",
      "qualify for this exception, the actor must have timely responded to all \n",
      "requests relating to access, exchange, and use of ehi, including but \n",
      "not limited to requests to establish connections and to provide \n",
      "interoperability elements. further, for any request that the actor \n",
      "claims was infeasible, the actor must have provided the requestor with \n",
      "a detailed written explanation of the reasons why the actor could not \n",
      "accommodate the request. finally, the actor must have worked with the \n",
      "requesting party in a timely manner to identify and provide a \n",
      "reasonable alternative means of accessing, exchanging, or using the \n",
      "ehi, as applicable. the actor's failure to meet any of these conditions \n",
      "would disqualify the actor from the exception and could also be \n",
      "evidence that the actor knew that it was engaging in practices that \n",
      "contravened the information blocking provision.\n",
      "    we clarify that the duty to timely respond and provide reasonable \n",
      "cooperation would necessarily be assessed from the standpoint of what \n",
      "is objectively reasonable for an individual or entity in the actor's \n",
      "position. for example, we would not expect a small physician practice \n",
      "to provide the same level of engagement and technical assistance to \n",
      "third parties as a large hospital or health system with considerable \n",
      "health it resources and expertise at its disposal. in some \n",
      "circumstances, it may even be difficult for a small practice to comply \n",
      "with any request for access, exchange, and use that is more complicated \n",
      "than a simple request for a patient's personal health information. if \n",
      "there are such requests--and there could be--then small practices may \n",
      "be both unable to comply with such requests and poorly situated to \n",
      "assist requesting parties with alternatives. we provide these examples \n",
      "to emphasize that we will look at the specific facts and circumstances \n",
      "of each case to determine what is objectively reasonable.\n",
      "    we believe that these conditions will minimize the risk that this \n",
      "exception could protect improper refusals to provide interoperability \n",
      "elements, including naked refusals to deal as well as other practices, \n",
      "such as improper delays in access or exchange that would present \n",
      "information blocking concerns. additionally, the requirements for an \n",
      "actor to timely respond and document its justifications for declining a \n",
      "request in writing would prevent an actor from using post hoc \n",
      "rationalizations to justify these and other improper practices. \n",
      "finally, we believe that establishing a clear duty under the exception \n",
      "for actors to deal on reasonable terms with parties seeking to access, \n",
      "exchange, or use ehi will encourage parties to cooperate to identify \n",
      "and implement efficient solutions to interoperability challenges, \n",
      "thereby avoiding disputes that could lead to information blocking.\n",
      "    we encourage comment on the additional conditions and related \n",
      "considerations described above. specifically, we request comment \n",
      "regarding potential obstacles to satisfying these conditions and \n",
      "improvements we could make to the proposed process.\n",
      "6. licensing of interoperability elements on reasonable and non-\n",
      "discriminatory terms\n",
      "    we propose to establish an exception to the information blocking \n",
      "provision that would permit actors to license interoperability elements \n",
      "on reasonable and non-discriminatory (rand) terms, provided that \n",
      "certain conditions are met. the exception and corresponding conditions \n",
      "are set forth in the proposed regulation text in sec.  171.206. as \n",
      "discussed in section viii.c.5.a of this preamble, the information \n",
      "blocking provision would be implicated if an actor were to refuse to \n",
      "license or allow the disclosure of interoperability elements to persons \n",
      "who require those elements to develop and provide interoperable \n",
      "technologies or services--including those that might complement or \n",
      "compete with the actor's own technology or services. moreover, the \n",
      "information blocking provision would be implicated if the actor \n",
      "licensed such interoperability elements subject to terms or conditions \n",
      "that have the purpose or effect of excluding or discouraging \n",
      "competitors, rivals, or other persons from engaging in these pro-\n",
      "competitive and interoperability-enhancing activities. thus, this \n",
      "licensing requirement would apply in both vertical and horizontal \n",
      "relationships. for instance, it would apply when a developer in a \n",
      "vertical relationship to the actor--a network in this example--wants to \n",
      "use interoperability elements in order to access the ehi maintained in \n",
      "the actor's network. the requirement would also apply when a rival \n",
      "network in a horizontal relationship to the actor (network) wants to \n",
      "use interoperability elements so that its network can be compatible \n",
      "with the applications that have already been developed for use with the \n",
      "actor's network.\n",
      "    we note that some licensees do not require the interoperability \n",
      "elements to develop products or services that can be interoperable with \n",
      "the actor's health it. for instance, there may be firms that simply \n",
      "want to license the actor's technology for use in developing their own \n",
      "interoperability elements. their interest would be for access to the \n",
      "technology itself--not for the use of the technology to interoperate \n",
      "with either the actor or its customers. this may be the case, for \n",
      "example, if the relevant intellectual property included patents that \n",
      "were applicable to other information technology applications outside of \n",
      "health it. in such cases, the actor's licensing of its patents in such \n",
      "a\n",
      "\n",
      "[[page 7545]]\n",
      "\n",
      "context would not implicate the information blocking provision.\n",
      "    below are examples of situations that would implicate the \n",
      "information blocking provision (these examples are not exhaustive):\n",
      "    <bullet> an actor refuses to negotiate a license after receiving a \n",
      "request from a developer.\n",
      "    <bullet> an actor offers a license at the request of a developer, \n",
      "but only at a royalty rate that exceeds a rand rate.\n",
      "    <bullet> an actor offers a license to a competitor at a royalty \n",
      "rate significantly higher than was offered to a party not in direct \n",
      "competition with the actor.\n",
      "    <bullet> an actor files a patent infringement lawsuit against a \n",
      "developer without first offering to negotiate a license on rand terms.\n",
      "    there are compelling reasons for this prohibition. in our \n",
      "experience, contractual and intellectual property rights are frequently \n",
      "used to extract rents for access to ehi or to prevent competition from \n",
      "developers of interoperable technologies and services (see section \n",
      "viii.c.5.c.iv. of this preamble). these practices frustrate access, \n",
      "exchange, and use of ehi and stifle competition and innovation in the \n",
      "health it sector. as a case in point, even following the enactment of \n",
      "the cures act, some ehr developers are selectively prohibiting--whether \n",
      "expressly or through commercially unreasonable terms--the disclosure or \n",
      "use of technical interoperability information required for third-party \n",
      "applications to be able to access, exchange, and use ehi maintained in \n",
      "ehr systems. this limits health care providers' use of the ehi \n",
      "maintained on their behalf to the particular capabilities and use cases \n",
      "that their ehr developer happens to support. more than this, by \n",
      "limiting the ability of providers to choose what applications and \n",
      "technologies they can use with their ehr systems, these practices close \n",
      "off the market to innovative applications and services that providers \n",
      "and other stakeholders need to deliver greater value and choice to \n",
      "health care purchasers and consumers.\n",
      "    despite these serious concerns, we recognize that the definition of \n",
      "information blocking may be broader than necessary and could have \n",
      "unintended consequences. in contrast to the practices described above, \n",
      "we believe it is generally appropriate for actors to license their \n",
      "intellectual property (ip) on rand terms that do not block \n",
      "interoperability. provided certain conditions are met, we believe that \n",
      "these practices would further the goals of the information blocking \n",
      "provision by allowing actors to protect the value of their innovations \n",
      "and earn returns on the investments they have made to develop, \n",
      "maintain, and update those innovations. this in turn will protect \n",
      "future incentives to invest in, develop, and disseminate interoperable \n",
      "technologies and services. conversely, if actors cannot (or believe \n",
      "they cannot) protect and commercialize their innovations, they may not \n",
      "engage in these productive activities that improve access, exchange, \n",
      "and use of ehi.\n",
      "    while we believe this exception is necessary to promote competition \n",
      "and consumer welfare, we are highly sensitive to the danger that actors \n",
      "will continue to use their contractual and ip rights to interfere with \n",
      "access, exchange, and use of ehi, undermining the information blocking \n",
      "provision's fundamental objectives. for this reason, the exception \n",
      "would be subject to strict conditions to ensure, among other things, \n",
      "that actors license interoperability elements on rand terms and that \n",
      "they do not impose collateral terms or engage in other practices that \n",
      "would impede the use of the interoperability elements or otherwise \n",
      "undermine the intent of this exception.\n",
      "    we acknowledge that preventing intellectual property holders from \n",
      "extracting rents for access to ehi may differ from standard \n",
      "intellectual property policy. absent specific circumstances, ip holders \n",
      "are generally free to negotiate with prospective licensees to determine \n",
      "the royalty to practice their ip, and this negotiated royalty \n",
      "frequently reflects the value the licensee would obtain from exercising \n",
      "those rights. however, in the context of ehi, we propose that a \n",
      "limitation on rents is essential due to the likelihood that rents will \n",
      "frustrate access, exchange, and use of ehi, particularly because of the \n",
      "power dynamics that exist in the health it market.\n",
      "    we remind readers that actors are not required to seek the \n",
      "protection of this (or any other) exception. if an actor does not want \n",
      "to license a particular technology, it may choose to comply with the \n",
      "information blocking provision in another way, such as by developing \n",
      "and providing alternative means of accessing, exchanging, and using ehi \n",
      "that are similarly efficient and efficacious. the purpose of this \n",
      "exception is not to dictate a licensing scheme for all, or even most, \n",
      "health it, but rather to provide a tailored ``safe harbor'' that will \n",
      "provide clear expectations for those who desire it.\n",
      "i. reasonable and non-discriminatory (rand) terms\n",
      "    we propose to require, as a condition of this exception, that any \n",
      "terms upon which an actor licenses interoperability elements must be \n",
      "reasonable and non-discriminatory (rand). as discussed below, \n",
      "commitments to license technology on rand terms are frequently required \n",
      "in the context of standards development organizations (sdos), and we \n",
      "believe that the practical and policy considerations that have led sdos \n",
      "to adopt these policies are related in many respects to the information \n",
      "blocking concerns presented when an actor exploits control over \n",
      "interoperability elements to extract economic rents or impede the \n",
      "development or use of interoperable technologies and services.\n",
      "    we recognize that strong legal protections for ip rights can \n",
      "promote competition and innovation.\\125\\ nevertheless, ip rights can \n",
      "also be misused in ways that undermine these goals.\\126\\ we believe \n",
      "this potential for abuse is heightened when the ip rights pertain to \n",
      "functional aspects of technology that are essential to enabling \n",
      "interoperability. as an important example, a technology developer may \n",
      "encourage the inclusion of its technology in an industry standard \n",
      "created by an sdo while not disclosing that it has ip rights in that \n",
      "technology. after the sdo incorporates the technology into its \n",
      "standard, and industry begins to make investments tied to the standard, \n",
      "the ip-holder may then assert its ip rights and demand royalties or \n",
      "license terms that it could not have achieved before the standard was \n",
      "adopted because companies would incur substantial switching costs to \n",
      "abandon initial designs or adopt different products.\\127\\ to address \n",
      "these\n",
      "\n",
      "[[page 7546]]\n",
      "\n",
      "types of concerns, while balancing the legitimate interests and \n",
      "incentives of ip owners, many sdos now have policies requiring members \n",
      "who contribute technologies to a standard to voluntarily commit to \n",
      "license that technology on rand terms and will consider whether firms \n",
      "have made voluntary rand commitments when weighing whether to include \n",
      "their technology in standards.\\128\\ while this commitment to license on \n",
      "rand terms is voluntary as compared to our proposed requirement to use \n",
      "rand terms, it serves to illustrate how rand terms can be used to \n",
      "address such concerns.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\125\\ see ftc and doj antitrust guidelines for the licensing of \n",
      "intellectual property, at 2 (2017), <a href=\"https://www.ftc.gov/system/files/documents/public_statements/1049793/ip_guidelines_2017.pdf\">https://www.ftc.gov/system/files/documents/public_statements/1049793/ip_guidelines_2017.pdf</a>.\n",
      "    \\126\\ see assessment techs. of wi, llc v. wiredata, inc., 350 \n",
      "f.3d 640, 644-45 (7th cir. 2003); sega enterprises ltd. v. accolade, \n",
      "inc., 977 f.2d 1510, 1520-28 (9th cir. 1992); sony computer \n",
      "entertainment, inc. v. connectix corp., 203 f.3d 596, 602-08 (9th \n",
      "cir. 2000); bateman v. mnemonics, inc., 79 f.3d 1532, 1539-40 n. 18 \n",
      "(11th cir. 1996); atari games corp. v. nintendo of america, inc., \n",
      "975 f.2d 832, 842-44 (fed. cir. 1992).\n",
      "    \\127\\ see doj and ftc, antitrust enforcement and intellectual \n",
      "property rights: promoting innovation and competition, at 37-40 \n",
      "(apr. 2017), <a href=\"https://www.ftc.gov/sites/default/files/documents/reports/antitrust-enforcement-and-intellectual-property-rights-promoting-innovation-and-competition-report.s.department-justice-and-federal-trade-commission/p040101promotinginnovationandcompetitionrpt0704.pdf\">https://www.ftc.gov/sites/default/files/documents/reports/antitrust-enforcement-and-intellectual-property-rights-promoting-innovation-and-competition-report.s.department-justice-and-federal-trade-commission/p040101promotinginnovationandcompetitionrpt0704.pdf</a>.\n",
      "    \\128\\ see, e.g., microsoft corp. v. motorola, inc., no. c10-\n",
      "1823jlr, 2013 wl 2111217, at *6 (w.d. wash. apr. 25, 2013).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    similar concerns arise when actors who control proprietary \n",
      "interoperability elements demand royalties or license terms from \n",
      "competitors or other persons who are technologically dependent on the \n",
      "use of those interoperability elements. as discussed in section \n",
      "viii.c.5 of this preamble, to the extent that the interoperability \n",
      "elements are essential to enable the efficient access, exchange, or use \n",
      "of ehi by particular persons or for particular purposes, any practice \n",
      "by the actor that could impede the use of the interoperability elements \n",
      "for that purpose--or that could unnecessarily increase the cost or \n",
      "other burden of using the elements for that purpose--would give rise to \n",
      "an obvious risk of interference with access, exchange, or use of ehi \n",
      "under the information blocking provision.\n",
      "    we believe that a rand requirement would balance the need for \n",
      "robust ip protections with the need to ensure that this proposed \n",
      "exception does not permit actors to exercise their ip or other \n",
      "proprietary rights in inappropriate ways that block the development, \n",
      "adoption, or use of interoperable technologies and services. the \n",
      "exercise of ip rights in these ways is incompatible with the \n",
      "information blocking provision, which protects the investments that \n",
      "taxpayers and the health care industry have made to adopt technologies \n",
      "that will enable the efficient sharing of ehi to benefit consumers and \n",
      "the health care system. while actors are entitled to protect and \n",
      "exercise their ip rights, to benefit from this exception to the \n",
      "information blocking provision they must do so in a reasonable and non-\n",
      "discriminatory manner that does not undermine these efforts and impede \n",
      "the appropriate flow of ehi.\n",
      "    accordingly, we propose that, to qualify for this exception, an \n",
      "actor must license requested interoperability elements on rand terms. \n",
      "to comply with this condition, any terms or conditions under which the \n",
      "actor discloses or allows the use of interoperability elements must \n",
      "meet several requirements set forth below. these requirements apply to \n",
      "both price terms (such as royalties and license fees) and other terms, \n",
      "such as conditions or limitations on access to interoperability \n",
      "elements or the purposes for which they can be used.\n",
      "responding to requests\n",
      "    we propose that, upon receiving a request to license or use \n",
      "interoperability elements, an actor would be required to respond to the \n",
      "requestor within 10 business days from receipt of the request. we note \n",
      "that the request could be made to ``license'' or ``use'' the \n",
      "interoperability elements because a requestor may not always know that \n",
      "``license'' is the legal mechanism for ``use'' when making the request. \n",
      "this provision is intended to ensure that a requestor is given an \n",
      "opportunity to license and use interoperability elements. as such, the \n",
      "requirement for responding to requests should not be limited to \n",
      "requests to ``license.''\n",
      "    in order to meet this requirement, the actor would be required to \n",
      "respond to the requestor within 10 business days from the receipt of \n",
      "the request by: (1) negotiating with the requestor in a rand fashion to \n",
      "identify the interoperability elements that are needed; and (2) \n",
      "offering an appropriate license with rand terms, consistent with its \n",
      "other obligations under this exception. we emphasize that, in order to \n",
      "qualify for this proposed exception, the actor is only required to \n",
      "negotiate with the requestor in a rand fashion and to offer a license \n",
      "with rand terms. the actor is not required to grant a license in all \n",
      "instances. for example, the actor would not be required to grant a \n",
      "license if the requestor refuses an actor's offer to license \n",
      "interoperability elements on rand terms.\n",
      "    we emphasize that there would be circumstances under which the \n",
      "actor could pursue legal action against parties that infringe its \n",
      "intellectual property whilst complying with this exception. for \n",
      "instance, an actor could bring legal action if a firm appropriates the \n",
      "actor's intellectual property without requesting a license or after \n",
      "refusing to accept a license on rand terms.\n",
      "    we do not propose a set timeframe for when the negotiations must be \n",
      "resolved because it is difficult to predict the duration of such \n",
      "negotiations. for instance, there could be situations when the actor \n",
      "and requestor meet once and the actor makes a rand offer that is \n",
      "immediately accepted by the requestor. however, there could be other \n",
      "situations when the requestor and actor each make counteroffers, which \n",
      "would extend the negotiations.\n",
      "    we request comment on whether 10 business days is an appropriate \n",
      "amount of time for the actor to respond to the requestor. in proposing \n",
      "this timeframe, we considered the urgency of certain requests to \n",
      "license interoperability elements and our expectation that developers \n",
      "would have standard licenses at their disposal that could be adapted in \n",
      "these situations. we considered proposing response timeframes ranging \n",
      "from 5 business days to 15 business days. we also considered proposing \n",
      "two separate timeframes for: (1) negotiating with the requestor; and \n",
      "(2) offering the license. if commenters prefer a different response \n",
      "timeframe or approach than proposed, we request that commenters explain \n",
      "their rationale with as much detail as possible.\n",
      "    in addition, we query whether we should create set limits for: (1) \n",
      "the amount of time the requestor has to accept the actor's initial \n",
      "offer or make a counteroffer; (2) if the requestor makes a \n",
      "counteroffer, the amount of time the actor has to accept the \n",
      "requestor's counteroffer or make its own counteroffer; and (3) an \n",
      "allowable number of counteroffers in negotiations.\n",
      "scope of rights\n",
      "    to qualify for this proposed exception, we propose that the actor \n",
      "must license the requested interoperability elements with all rights \n",
      "necessary to access and use the interoperability elements for the \n",
      "following purposes, as applicable:\n",
      "    <bullet> all rights necessary to access and use the \n",
      "interoperability elements for the purpose of developing products or \n",
      "services that are interoperable with the actor's health it or with \n",
      "health it under the actor's control and/or any third party who \n",
      "currently uses the actor's interoperability elements to interoperate \n",
      "with the actor's health it or health it under the actor's control. \n",
      "these rights would include the right to incorporate and use the \n",
      "interoperability elements in the licensee's own technology to the \n",
      "extent necessary to accomplish this purpose.\n",
      "    <bullet> all rights necessary to market, offer, and distribute the \n",
      "interoperable products and services described above to potential \n",
      "customers and users, including the right to copy or disclose the \n",
      "interoperability elements as necessary to accomplish this purpose.\n",
      "    <bullet> all rights necessary to enable the use of the \n",
      "interoperable products or services in production environments,\n",
      "\n",
      "[[page 7547]]\n",
      "\n",
      "including using the interoperability elements to access and enable the \n",
      "exchange and use of electronic health information.\n",
      "    we request comment on whether these rights are sufficiently \n",
      "inclusive to support licensees in developing interoperable \n",
      "technologies, bringing them to market, and deploying them for use in \n",
      "production environments. we also request comment on the breadth of \n",
      "these required rights and if they should be subject to any limitations \n",
      "that would not interfere with the uses we have described above.\n",
      "reasonable royalty\n",
      "    as a condition of this exception, we propose that if an actor \n",
      "charges a royalty for the use of interoperability elements, the royalty \n",
      "base and rate must be reasonable. consistent with the requirements for \n",
      "demonstrating that activities and practices meet the conditions of an \n",
      "exception proposed in section viii.c.6.c, the actor would need to show \n",
      "that the royalty base was reasonable and that the royalty was within a \n",
      "reasonable range for the interoperability elements at issue. \n",
      "importantly, we note that the reasonableness of any royalties would be \n",
      "assessed solely on basis of the independent value of the actor's \n",
      "technology to the licensee's product,\\129\\ not on any strategic value \n",
      "stemming from the actor's control over essential means of accessing, \n",
      "exchanging, or using electronic health information. for instance, the \n",
      "reasonableness of royalties could not be assessed based on the \n",
      "strategic value stemming from the adoption of the technology by \n",
      "customers or users, the switching costs associated with the technology, \n",
      "or other circumstances of technological dependence described elsewhere \n",
      "in this preamble (see section viii.c.5). we note that ``strategic \n",
      "value'' would stem from the actor's control over essential means of \n",
      "accessing, exchanging, or using electronic health information. limiting \n",
      "a reasonable royalty to the value of the technology isolated from \n",
      "strategic value is similar in concept to apportionment of reasonable \n",
      "royalties for the infringement of standard essential patents \n",
      "(seps).\\130\\ in our context, permitting an actor to charge a royalty on \n",
      "the basis of these considerations would effectively allow the actor to \n",
      "extract rents on access, exchange, and use of ehi, which is contrary to \n",
      "the goals of the information blocking provision.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\129\\ see ericsson, inc. v. d-link systems, inc., 773 f.3d 1201, \n",
      "1226; 1232 (fed. cir. 2014).\n",
      "    \\130\\ see, e.g., georgia-pacific corp. v. united states plywood \n",
      "corp., 318 f. supp 1116 (s.d.n.y. 1970) (utilizing the more common \n",
      "approach).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in evaluating the actor's assertions and evidence that the royalty \n",
      "was reasonable, we propose that onc may consider the following factors:\n",
      "    <bullet> the royalties received by the actor for the licensing of \n",
      "the proprietary elements in other circumstances comparable to rand-\n",
      "licensing circumstances.\n",
      "    <bullet> the rates paid by the licensee for the use of other \n",
      "comparable proprietary elements.\n",
      "    <bullet> the nature and scope of the license.\n",
      "    <bullet> the effect of the proprietary elements in promoting sales \n",
      "of other products of the licensee and the licensor, taking into account \n",
      "only the contribution of the elements themselves and not of the \n",
      "enhanced interoperability that they enable.\n",
      "    <bullet> the utility and advantages of the actor's interoperability \n",
      "element over the existing technology, if any, that had been used to \n",
      "achieve a similar level of access, exchange, or use of ehi.\n",
      "    <bullet> the contribution of the elements to the technical \n",
      "capabilities of the licensee's products, taking into account only the \n",
      "value of the elements themselves and not the enhanced interoperability \n",
      "that they enable.\n",
      "    <bullet> the portion of the profit or of the selling price that may \n",
      "be customary in the particular business or in comparable businesses to \n",
      "allow for the use of the proprietary elements or analogous elements \n",
      "that are also covered by rand commitments.\n",
      "    <bullet> the portion of the realizable profit that should be \n",
      "credited to the proprietary elements as distinguished from non-\n",
      "proprietary elements, the manufacturing process, business risks, \n",
      "significant features or improvements added by the licensee, or the \n",
      "strategic value resulting from the network effects, switching costs, or \n",
      "other effects of the adoption of the actor's technology.\n",
      "    <bullet> the opinion testimony of qualified experts.\n",
      "    <bullet> the amount that a licensor and a licensee would have \n",
      "agreed upon (at the time the licensee began using the elements) if both \n",
      "were considering the rand obligation under this exception and its \n",
      "purposes, and had been reasonably and voluntarily trying to reach an \n",
      "agreement.\n",
      "    these factors mirror those used by courts that have examined the \n",
      "reasonableness of royalties charged pursuant to a commitment to an sdo \n",
      "to license standard-essential technologies on rand terms (see microsoft \n",
      "corp. v. motorola, inc.; \\131\\ in re innovatio ip ventures, llc patent \n",
      "litig.; \\132\\ and realtek semiconductor corp. v. lsi corp \\133\\). \n",
      "however, we have adapted the factors to the information blocking \n",
      "context as follows. in the sdo context, the rand requirement mitigates \n",
      "the risk that patent-holders will engage in ``hold up''--that is, \n",
      "charging excessive royalties that do not reflect the value of their \n",
      "contributions to the standard, but rather reflect the costs associated \n",
      "with switching to alternative technologies after a standard is \n",
      "adopted--and that the cumulative effect of such royalties will make the \n",
      "standard too expensive to implement--a problem called ``royalty \n",
      "stacking.'' \\134\\ to address the risks of hold-up and royalty stacking \n",
      "in the standards development context, a rand license should compensate \n",
      "a patentee for their technical contribution to the technology embodied \n",
      "in a standard, but should not compensate them for mere inclusion in the \n",
      "standard.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\131\\ case no. 10-cv-1823 jlr, 2013 wl 2111217 (w.d.wash. apr. \n",
      "25, 2013).\n",
      "    \\132\\ mdl 2303, 2013 wl 5593609 (n.d.ill. oct. 3, 2013).\n",
      "    \\133\\ case no. 5:12-cv-03451-rmw, 2014 wl 46997 (n.d.cal. jan. \n",
      "6, 2014).\n",
      "    \\134\\ microsoft corp. v. motorola, inc., 864 f.supp.2d 1023, \n",
      "1027 (w.d.wash. 2012).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    similarly, in the context of information blocking, we propose the \n",
      "rand inquiry focuses on whether the royalty demanded by the actor \n",
      "represents the independent value of the actor's proprietary technology. \n",
      "we propose that if the actor has licensed the interoperability element \n",
      "through a standards development organization in accordance with such \n",
      "organization's policies regarding the licensing of standards-essential \n",
      "technologies on reasonable and non-discriminatory terms, the actor may \n",
      "charge a royalty that is consistent with such policies. rather than \n",
      "asking whether the royalty inappropriately captures additional value \n",
      "derived from the technology's inclusion in the industry standard, we \n",
      "would ask whether the actor is charging a royalty that is not based on \n",
      "the value of its technology (embodied in the interoperability elements) \n",
      "but rather includes the strategic value stemming from the adoption of \n",
      "that technology by customers or users. thus, under this proposed \n",
      "approach and the factors set forth above, we would consider the \n",
      "technical contribution of the actor's interoperability elements to the \n",
      "licensee's products--such as any proprietary capabilities or features \n",
      "that the licensee uses in its product--but would screen out any \n",
      "functional aspects of the actor's technology that are used only to \n",
      "establish interoperability and enable ehi to be accessed, exchanged, \n",
      "and used. additionally, we propose that\n",
      "\n",
      "[[page 7548]]\n",
      "\n",
      "to address the potential risk of royalty stacking we would need to \n",
      "consider the aggregate royalties that would apply if owners of other \n",
      "essential interoperability elements made royalty demands of the \n",
      "implementer. specifically, we propose that, to qualify for this \n",
      "exception, the actor must grant licenses on terms that are objectively \n",
      "commercially reasonable taking into account the overall licensing \n",
      "situation, including the cost to the licensee of obtaining other \n",
      "interoperability elements that are important for the viability of the \n",
      "products for which it is seeking to license interoperability elements \n",
      "from the actor.\n",
      "    we clarify that, as proposed, this condition would not preclude an \n",
      "actor from licensing its interoperability elements pursuant to an \n",
      "existing rand commitment to an sdo. we also note that, in addition to \n",
      "complying with the requirements described above, to meet this proposed \n",
      "condition any royalties charged must meet the condition, proposed \n",
      "separately below, that any license terms be non-discriminatory.\n",
      "    we request comment on these aspects of the proposed exception. \n",
      "commenters are encouraged to consider, in particular, whether the \n",
      "factors and approach we have described will be administrable and \n",
      "appropriately balance the unreasonable blocking by actors of the use of \n",
      "essential interoperability elements with the need to provide adequate \n",
      "assurance to investors and innovators that they will be able to earn a \n",
      "reasonable return on their investments in interoperable technologies. \n",
      "if our proposed approach does not adequately balance these concerns or \n",
      "would not achieve our stated policy goals, we ask that commenters \n",
      "suggest revisions or alternative approaches. we ask that such comments \n",
      "be as detailed as possible and provide rigorous economic justifications \n",
      "for any suggested revisions or alternative approaches.\n",
      "non-discriminatory terms\n",
      "    we propose that for this exception to apply the terms on which an \n",
      "actor licenses and otherwise provides interoperability elements must be \n",
      "non-discriminatory. this requirement would apply to both price and non-\n",
      "price terms, and thus would apply to the royalty terms discussed \n",
      "immediately above as well as other types of terms that may be included \n",
      "in licensing agreements or other agreements related to the provision or \n",
      "use of interoperability elements.\n",
      "    to comply with this condition, the terms on which the actor \n",
      "licensed the interoperability elements must be based on criteria that \n",
      "the actor applied uniformly for all substantially similar or similarly \n",
      "situated classes of persons and requests. this requirement addresses a \n",
      "root cause of information blocking. in order to be considered non-\n",
      "discriminatory, such criteria would have to be objective and \n",
      "verifiable, not based on the actor's subjective judgment or discretion. \n",
      "we emphasize that this proposal does not mean that the actor must apply \n",
      "the same terms for all persons or classes of persons requesting a \n",
      "license. however, any differences in terms would have to be based on \n",
      "actual differences in the costs that the actor incurred or other \n",
      "reasonable and non-discriminatory criteria. moreover, we propose that \n",
      "any criteria upon which an actor varies its terms or conditions would \n",
      "have to be both competitively neutral--meaning that the criteria are \n",
      "not based in any part on whether the requestor or other person is a \n",
      "competitor, potential competitor, or will be using ehi obtained via the \n",
      "interoperability elements in a way that facilitates competition with \n",
      "the actor--and neutral as to the revenue or other value that the \n",
      "requestor may be derived from access, exchange, or use of the ehi \n",
      "obtained via the interoperability elements, including any secondary use \n",
      "of such ehi. we believe these limitations are necessary in light of the \n",
      "potential for actors to use their control over interoperability \n",
      "elements to engage in discriminatory practices that create unreasonable \n",
      "barriers or costs for persons seeking to develop, offer, or use \n",
      "interoperable technologies to expand access and enhance the exchange \n",
      "and use of ehi.\n",
      "    to clarify our expectations for this proposed condition, we provide \n",
      "the following illustration. consider an ehr developer that establishes \n",
      "an ``app store'' through which third-party developers can license the \n",
      "ehr developer's proprietary apis, which we assume are separate from the \n",
      "apis required by the api condition of certification proposed in sec.  \n",
      "170.404. the ehr developer could charge a reasonable royalty and impose \n",
      "other reasonable terms to license these interoperability elements. the \n",
      "terms and conditions could vary based on neutral, objectively \n",
      "verifiable, and uniformly applied criteria. these might include, for \n",
      "example, significantly greater resources consumed by certain types of \n",
      "apps, such as those that export large volumes of data on a continuous \n",
      "basis, or the heightened risks associated with apps designed to \n",
      "``write'' data to the ehr database or to run natively within the ehr's \n",
      "user interface. in contrast, the ehr developer could not vary its terms \n",
      "and conditions based on subjective criteria, such as whether it thinks \n",
      "an app will be ``popular'' or is a ``good fit'' for its ecosystem. nor \n",
      "could it offer different terms or conditions on the basis of objective \n",
      "criteria that are not competitively neutral, such as whether an app \n",
      "``connects to'' other technologies or services, provides capabilities \n",
      "that the ehr developer plans to incorporate in a future release of its \n",
      "technology, or enables an efficient means for customers to export data \n",
      "for use in other databases or technologies that compete directly with \n",
      "the ehr developer. similarly, the ehr developer could not set different \n",
      "terms or conditions based on how much revenue or other value the app \n",
      "might generate from the information it collects through the apis, such \n",
      "as by introducing a revenue-sharing requirement for apps that use data \n",
      "for secondary purposes that are very lucrative and for which the ehr \n",
      "developer would like a ``piece of the pie.'' such practices would \n",
      "disqualify the actor from this exception and would implicate the \n",
      "information blocking provision.\n",
      "    the foregoing conditions are not intended to limit an actor's \n",
      "flexibility to set different terms based on legitimate differences in \n",
      "the costs to different classes of persons or in response to different \n",
      "classes of requests, so long as any such classification was in fact \n",
      "based on neutral criteria (in the sense described above) that are \n",
      "objectively verifiable and were applied in a consistent manner for \n",
      "persons and/or requests within each class. as an important example, the \n",
      "proposed condition would not preclude a covered actor from pursuing \n",
      "strategic partnerships, joint ventures, co-marketing agreements, cross-\n",
      "licensing agreements, and other similar types of commercial \n",
      "arrangements under which it provides more favorable terms than for \n",
      "other persons with whom it has a more arms-length relationship. in \n",
      "these instances the actor should have no difficulty identifying \n",
      "substantial and verifiable efficiencies that demonstrate that any \n",
      "variations in its terms and conditions were based on objective and \n",
      "neutral criteria. we do note an important caveat, however, specifically \n",
      "that a health it developer of certified health it who is an ``api \n",
      "technology supplier'' under the condition of certification proposed in \n",
      "sec.  170.404 would not be permitted to offer different terms in \n",
      "connection with the apis required by that condition of certification. \n",
      "as discussed in section vii.b.4 of this preamble, we propose that api \n",
      "technology suppliers are\n",
      "\n",
      "[[page 7549]]\n",
      "\n",
      "required to make these apis available on terms that are no less \n",
      "favorable than provided to their own customers, suppliers, partners, \n",
      "and other persons with whom they have a business relationship. as noted \n",
      "below towards the end of our discussion of this exception to the \n",
      "information blocking provision, the exception incorporates the api \n",
      "condition of certification's requirements in full for all health it \n",
      "developers subject to that condition.\n",
      "    we welcome comments on the foregoing condition and requirements.\n",
      "collateral terms\n",
      "    we propose five additional conditions that would reinforce the \n",
      "requirements of this exception discussed above. these additional \n",
      "conditions would provide bright-line prohibitions for certain types of \n",
      "collateral terms or agreements that we believe are inherently likely to \n",
      "interfere with access, exchange, or use of ehi. we propose that any \n",
      "attempt to require a licensee or its agents or contractors to do or \n",
      "agree to do any of the following would disqualify the actor from this \n",
      "exception and would be suspect under the information blocking \n",
      "provision.\n",
      "    first, the actor must not require the licensee or its agents or \n",
      "contractors to not compete with the actor in any product, service, or \n",
      "market, including markets for goods and services, technologies, and \n",
      "research and development. we are aware that such agreements have been \n",
      "used to either directly exclude suppliers of interoperable technologies \n",
      "and services from the market or to create exclusivity that reduces the \n",
      "range of technologies and options available to health care providers \n",
      "and other health it customers and users.\n",
      "    second, and for similar reasons, the actor must not require the \n",
      "licensee or its agents or contractors to deal exclusively with the \n",
      "actor in any product, service, or market, including markets for goods \n",
      "and services, technologies, and research and development.\n",
      "    third, the actor must not require the licensee or its agents or \n",
      "contractors to obtain additional licenses, products, or services that \n",
      "are not related to or can be unbundled from the requested \n",
      "interoperability elements. this condition reinforces the condition \n",
      "described earlier requiring that any royalties charged by the actor for \n",
      "the use of interoperability elements be reasonable. without this \n",
      "condition, we believe that an actor could require a licensee to take a \n",
      "license to additional interoperability elements that the licensee does \n",
      "not need or want, which could enable the actor to extract royalties \n",
      "that are inconsistent with its rand obligations under this exception. \n",
      "we clarify that this condition would not preclude an actor and a \n",
      "willing licensee from agreeing to such an arrangement, so long as the \n",
      "arrangement was not required.\n",
      "    fourth, the actor must not condition the use of interoperability \n",
      "elements on a requirement or agreement to license, grant, assign, or \n",
      "transfer the licensee's own ip to the actor. we believe it is \n",
      "inconsistent with the actor's rand licensing obligations under this \n",
      "exception, and would raise information blocking concerns, for an actor \n",
      "to use its control over interoperability elements as leverage to obtain \n",
      "a ``grant back'' of ip rights or other consideration whose value may \n",
      "exceed that of a reasonable royalty. consistent with our approach under \n",
      "other conditions of this exception, this condition would not preclude \n",
      "an actor and a willing licensee from agreeing to a cross-licensing, co-\n",
      "marketing, or other agreement if they so choose. however, the actor \n",
      "cannot require the licensee to enter into such an agreement. the actor \n",
      "must offer the option of licensing the interoperability elements \n",
      "without a promise to provide consideration beyond a reasonable royalty. \n",
      "we note that in the sdo context, it can sometimes be consistent with \n",
      "rand terms to require that an sep licensee also grant a cross-license \n",
      "to any seps that it holds, provided that the cross-license is limited \n",
      "to patents essential to the licensed standard. in this way, this \n",
      "condition differs from licensing in the sdo context.\n",
      "    finally, the actor must not condition the use of interoperability \n",
      "elements on a requirement or agreement to pay a fee of any kind \n",
      "whatsoever unless the fee meets either the narrowly crafted condition \n",
      "to this exception for a reasonable royalty, or, alternatively, the fee \n",
      "satisfies the separate exception proposed in sec.  171.204, which \n",
      "permits the recovery of certain costs reasonably incurred. as noted in \n",
      "section viii.d.4, that exception generally does not allow for the \n",
      "recovery of royalties or other fees associated with intangible assets. \n",
      "however, the exception does allow for the reasonable and actual \n",
      "development and acquisition costs of such assets.\n",
      "    we request comment on the categorical exclusions outlined above. in \n",
      "particular, we encourage commenters to weigh in on our assumption that \n",
      "these practices are inherently likely to interfere with access, \n",
      "exchange, or use of ehi. we also encourage commenters to suggest any \n",
      "conceivable benefits that these practices might offer for \n",
      "interoperability or for competition and consumers that we might have \n",
      "overlooked. again, we ask that to the extent possible commenters \n",
      "provide detailed economic rationale in support of their comments.\n",
      "non-disclosure agreement\n",
      "    we propose that an actor would be permitted under this exception to \n",
      "require a licensee to agree to a confidentiality or non-disclosure \n",
      "agreement (nda) to protect the actor's trade secrets, provided that the \n",
      "nda is no broader than necessary to prevent the unauthorized disclosure \n",
      "of the actor's trade secrets. further, we propose that the actor would \n",
      "have to identify (in the nda) the specific information that it claims \n",
      "as trade secrets, and that such information would have to meet \n",
      "definition of a trade secret under applicable law. we believe these \n",
      "safeguards are necessary to ensure that the nda is not used to impose \n",
      "restrictions or burdensome requirements that are not actually necessary \n",
      "to protect the actor's trade secrets and that impede the use of the \n",
      "interoperability elements. the use of an nda for such purposes would \n",
      "preclude an actor from qualifying for this exception and would \n",
      "implicate the information blocking provision. we note that if the actor \n",
      "is a health it developer of certified health it, it may be subject to \n",
      "the condition of certification proposed in sec.  170.403, which \n",
      "prohibits certain health it developer prohibitions and restrictions on \n",
      "communications about a health it developer's technology and business \n",
      "practices. this exception would not in any way abrogate the developer's \n",
      "obligations to comply with that condition.\n",
      "    we encourage comment on this condition of the proposed exception.\n",
      "ii. additional requirements relating to the provision of \n",
      "interoperability elements\n",
      "    in addition to the conditions described above, we propose that an \n",
      "actor's practice would need to comply with additional conditions that \n",
      "ensure that actors who license interoperability elements on rand terms \n",
      "do not engage in separate practices that impede the use of those \n",
      "elements or otherwise undermine the intent of this exception. these \n",
      "conditions are analogous to the conditions described in our proposal \n",
      "above concerning collateral terms but address a broader range of \n",
      "practices that may not be effected through the license agreements \n",
      "themselves or that occur separately from the licensing negotiations and \n",
      "other dealings between the actor and the licensee. specifically, we \n",
      "propose that an actor would not qualify for this exception if it \n",
      "engaged in a practice that had the purpose or\n",
      "\n",
      "[[page 7550]]\n",
      "\n",
      "effect of impeding the efficient use of the interoperability elements \n",
      "to access, exchange, or use ehi for any permissible purpose; or the \n",
      "efficient development, distribution, deployment, or use of an \n",
      "interoperable product or service for which there is actual or potential \n",
      "demand. as an illustration, the exception would not apply if the \n",
      "developer licensed its proprietary apis for use by third-party apps but \n",
      "then prevented or delayed the use of those apps in production \n",
      "environments by, for example, restricting or discouraging customers \n",
      "from enabling the use of the apps, or engaging in ``gate keeping'' \n",
      "practices, such as requiring apps to go through a vetting process and \n",
      "then applying that process in a discriminatory or unreasonable manner.\n",
      "    finally, to ensure the actor's commitments under this exception are \n",
      "durable, we propose one additional safeguard: an actor cannot avail \n",
      "itself of this exception if, having licensed the interoperability \n",
      "elements, the actor makes changes to the elements or its technology \n",
      "that ``break'' compatibility or otherwise degrade the performance or \n",
      "interoperability of the licensee's products or services. we believe \n",
      "this condition is crucial given the ease with which an actor could make \n",
      "subtle ``tweaks'' to its technology or related services that could \n",
      "disrupt the use of the licensee's compatible technologies or services \n",
      "and result in substantial competitive and consumer injury.\n",
      "    we clarify and emphasize that this proposed condition would in no \n",
      "way prevent an actor from making improvements to its technology or \n",
      "responding to the needs of its own customers or users. however, to \n",
      "benefit from the exception, the actor's practice would need to be \n",
      "necessary to accomplish these purposes and the actor must have afforded \n",
      "the licensee a reasonable opportunity under the circumstances to update \n",
      "its technology to maintain interoperability. we also recognize that an \n",
      "actor may have to suspend access or make other changes immediately and \n",
      "without prior notice in response to legitimate privacy, security, or \n",
      "patient safety-related exigencies. such practices would be governed by \n",
      "the exceptions proposed in section viii.d of this preamble and thus \n",
      "would not need to qualify for this exception.\n",
      "iii. compliance with conditions of certification\n",
      "    as a final condition of this proposed exception, we propose that \n",
      "health it developers of certified health it who are subject to the \n",
      "conditions of certification proposed in sec. sec.  170.402, 170.403, \n",
      "and 170.404 must comply with all requirements of those conditions of \n",
      "certification for all practices and at all relevant times. several of \n",
      "the requirements of these conditions mirror those of this exception. \n",
      "however, in some instances the conditions of certification provide \n",
      "additional or more specific requirements that apply to the provision of \n",
      "interoperability elements by developers of certified health it. for \n",
      "example, developers subject to the api condition of certification must \n",
      "make certain public apis available on terms that are royalty free and \n",
      "no less favorable than provided to themselves and their customers, \n",
      "suppliers, partners, and other persons with whom they have a business \n",
      "relationship. these more prescriptive requirements reflect the specific \n",
      "obligations of health it developers under the program, including the \n",
      "duty to facilitate the access, exchange, and use of information from \n",
      "patients' electronic health records without special effort. a health it \n",
      "developer of certified health it's failure to comply with these and \n",
      "other certification requirements that specifically support \n",
      "interoperability would, in addition to precluding the developer from \n",
      "invoking this exception, be significant evidence of information \n",
      "blocking.\n",
      "7. maintaining and improving health it performance\n",
      "    we propose to establish an exception to the information blocking \n",
      "provision for certain practices that are reasonable and necessary to \n",
      "maintain and improve the overall performance of health it, provided \n",
      "certain conditions are met. the proposed exception would recognize as \n",
      "reasonable and necessary the practice of an actor making health it \n",
      "under its control temporarily unavailable to maintain or improve the \n",
      "health it. the exception and corresponding conditions are set forth in \n",
      "the proposed regulation text in sec.  171.207.\n",
      "    ehi should be accessible and usable on demand by those that need \n",
      "it. however, in order for this to happen, the health it through which \n",
      "ehi is accessed, exchanged, or used must perform properly and \n",
      "efficiently. this requires that health it be maintained and in some \n",
      "instances improved. the performance of such maintenance and \n",
      "improvements sometimes requires that health it is temporarily taken \n",
      "offline, which can interfere with the access, exchange, and use of ehi. \n",
      "we believe this exception is necessary to ensure that actors are not \n",
      "deterred from maintaining and improving the overall performance of \n",
      "health it because temporary unavailability of ehi may cause \n",
      "interference with its access, exchange, and use. without this specific \n",
      "exception, there could be a significant risk that actors may refrain \n",
      "from conducting maintenance and improvements of health it out of fear \n",
      "that if the purpose was not for preventing harm, promoting security, or \n",
      "for another reason covered by the other exceptions, then their actions \n",
      "might contravene the information blocking provision.\n",
      "    this exception would apply to the unavailability of health it \n",
      "occasioned by both planned and unplanned maintenance and improvements. \n",
      "planned maintenance or improvements are typically carried out at \n",
      "regular intervals and address routine repairs, updates, or new \n",
      "releases. unplanned maintenance or improvements respond to urgent or \n",
      "time-sensitive issues, which cannot wait for the occurrence of a pre-\n",
      "planned time period to implement the required maintenance or \n",
      "improvements.\n",
      "    this proposed exception acknowledges that the performance of health \n",
      "it is often measured by service level agreements that provide \n",
      "flexibility to ensure that system availability is balanced with \n",
      "essential maintenance and improvements. where the provision of health \n",
      "it is subject to an allowance for maintenance or improvement that has \n",
      "been agreed to by the recipient of that health it, we propose that \n",
      "neither that agreement, nor the performance of it, should constitute \n",
      "information blocking, provided that certain conditions are met.\n",
      "    to ensure that the actor's practice of making health it, and in \n",
      "turn ehi, unavailable for the purpose of carrying out maintenance or \n",
      "improvements is reasonable and necessary, we have identified conditions \n",
      "that must be satisfied at all relevant times to qualify for this \n",
      "exception.\n",
      "unavailability of health it must be for no longer than necessary to \n",
      "achieve the maintenance or improvements for which the health it was \n",
      "made unavailable\n",
      "    any unavailability of health it must be for a period of time no \n",
      "longer than necessary to achieve the maintenance or improvement purpose \n",
      "for which the health it is made unavailable. this condition recognizes \n",
      "the critical importance of access to ehi and ensures that health it is \n",
      "not made unavailable for longer than needed. for example, a health it \n",
      "developer of certified health it that has the right under its contract \n",
      "with a large health system to take its system offline for four hours \n",
      "each month to conduct routine maintenance would not qualify for this \n",
      "exception if\n",
      "\n",
      "[[page 7551]]\n",
      "\n",
      "an information blocking claim was made about a period of unavailability \n",
      "during which no maintenance was performed.\n",
      "    making this evaluation for unplanned maintenance or improvements \n",
      "will be more difficult, because unplanned maintenance or improvements \n",
      "are typically initiated in response to a threat or risk that needs to \n",
      "be responded to on an urgent basis and for so long as the threat or \n",
      "risk persists. however, if, for example, an hie identified a software \n",
      "failure (not identified as a safety or security risk) that required \n",
      "immediate remediation necessitating the actor take its health it \n",
      "offline, the actor would be expected to bring the health it back online \n",
      "as soon as possible after the issue was resolved.\n",
      "unavailability of health it for maintenance or improvements must be \n",
      "implemented in a consistent and non-discriminatory manner\n",
      "    we propose that any unavailability of health it occasioned by the \n",
      "conduct of maintenance or improvements must be implemented in a \n",
      "consistent and non-discriminatory manner. this condition provides a \n",
      "basic assurance that when health it is made unavailable for the purpose \n",
      "of performing maintenance or improvements that the unavailability is \n",
      "not abused by the actor that controls the health it. for example, a \n",
      "health it developer of certified health it would not qualify for this \n",
      "exception if the developer, using a standard contract that provided a \n",
      "flexible allowance for planned maintenance or improvements, initiated \n",
      "planned maintenance or improvements for a customer with an expiring \n",
      "health it contract during a time when users might reasonably be \n",
      "expected to access ehi, but conducted planned maintenance or \n",
      "improvements for new customers in the middle of the night. however, \n",
      "this condition does not require that actors conduct planned maintenance \n",
      "or improvements simultaneously, or require that every health it \n",
      "contract provide the same promises in regard to planned maintenance or \n",
      "improvements. indeed, a recipient of health it may agree to a longer \n",
      "window for unavailability in exchange for a reduced fee for system \n",
      "maintenance, which would not contravene this condition.\n",
      "unavailability of health it for maintenance or improvements must be \n",
      "agreed\n",
      "    in order to benefit from this exception, we propose that the \n",
      "unavailability of health it due to maintenance or improvements \n",
      "initiated by a health it developer of certified health it, hie, or hin, \n",
      "must be agreed to by the individual or entity to whom the health it is \n",
      "supplied. the availability of health it is typically addressed in a \n",
      "written contract or other written agreements, that puts the recipient \n",
      "of the health it on notice about the level of ehi and health it \n",
      "unavailability that can be expected for users of the health it. by such \n",
      "agreements, the recipient of the health it willfully agrees to that \n",
      "level of planned and unplanned unavailability (typically referred to in \n",
      "health it contracts as ``downtime''). some health it contracts address \n",
      "the question of system availability by way of an ``uptime warranty'' \n",
      "that specifies the maximum amount of unavailability for a specified \n",
      "period and the timing of any planned unavailability.\n",
      "    we acknowledge that in some cases, health it needs to be taken \n",
      "offline or maintenance or improvements on an urgent basis and in a way \n",
      "that is not expressly permitted under a health it contract. an actor \n",
      "may still satisfy this proposed condition so long as the maintenance or \n",
      "improvements are agreed to by the recipient of the health it. this \n",
      "could be achieved by way of an oral agreement reached between the \n",
      "parties by telephone, but we note that because an actor must \n",
      "demonstrate that it satisfies the requirements of this exception, it \n",
      "would be best practice for an actor to ensure the agreement was in \n",
      "writing or, at minimum, contemporaneously documented.\n",
      "    this proposed condition of this exception only applies when the \n",
      "unavailability of health it is caused by a health it developer of \n",
      "certified health it, hie, or hin. in these circumstances, it is the \n",
      "supplier of the health it that controls if and when health it is \n",
      "intentionally taken offline for maintenance or improvements. this \n",
      "condition does not apply when health it is made unavailable for \n",
      "maintenance or improvements at the initiative of a recipient (or \n",
      "customer) of health it, because in that case, the unavailability has, \n",
      "for the purpose of this exception, nothing to do with the supplier. \n",
      "when it is a customer of health it that initiates unavailability, the \n",
      "unavailability would not need to be the subject of an agreement with \n",
      "the supplier of that health it, nor anyone else, in order for the \n",
      "customer of health it to benefit from this exception. for example, a \n",
      "health care provider that locally hosts and maintains its health it \n",
      "(being software supplied by a health it developer) would not need to \n",
      "satisfy this condition if it interfered with access to ehi by taking \n",
      "the health it offline temporarily to conduct maintenance. however, if \n",
      "the same health care provider was to receive a new release of the \n",
      "health it developer's software, which was to be implemented by the \n",
      "developer and which required that the health it be taken offline by the \n",
      "developer for 6 hours, then that unavailability, or an allowance for \n",
      "it, would need to be the subject of prior agreement. unavailability of \n",
      "health it initiated by a recipient of health it (rather than the \n",
      "supplier of the health it) would still need to satisfy the other \n",
      "conditions of this exception, including that the unavailability be for \n",
      "a period of time no longer than necessary to achieve the maintenance or \n",
      "improvements for which the health it was made unavailable.\n",
      "    we note that this condition would need to be satisfied by any hie \n",
      "or hin that sought to benefit from this exception in connection with \n",
      "any interference with access, exchange, or use occasioned by an hie or \n",
      "hin making its health it unavailable for the purposes of conducting \n",
      "maintenance or improvements. an hie would need to have secured the \n",
      "agreement of those individuals or entities that use its exchange \n",
      "services, and a hin would need to have obtained the agreement of the \n",
      "network's participants.\n",
      "interaction with preventing harm and promoting security exceptions\n",
      "    when health it is made unavailable for maintenance or improvements \n",
      "aimed at preventing harm to a patient or other person, or securing ehi, \n",
      "an actor must comply with the conditions specified in proposed sec.  \n",
      "171.201 or sec.  171.203 respectively, in order to qualify for an \n",
      "exception to the information blocking provision. this condition ensures \n",
      "that this exception cannot be used to avoid compliance with conditions \n",
      "applicable under other exceptions. for example, if part of an ehr \n",
      "system was taken offline in response to a health it developer of \n",
      "certified health it being alerted to the risk of corrupt or inaccurate \n",
      "data being recorded or incorporated in a patient's health record, any \n",
      "decision to make the ehr unavailable on this basis to conduct unplanned \n",
      "maintenance or improvements would need to accord with the conditions of \n",
      "the proposed exception for preventing harm (see sec.  171.201 and \n",
      "section viii.d.1 of this proposed rule). similarly, unavailability \n",
      "occasioned by maintenance or improvements initiated to secure ehi in \n",
      "response to a suspected malware attack would need to either be \n",
      "implemented in accordance with the actor's organizational security \n",
      "policy that satisfied the requirements of the proposed exception for \n",
      "promoting the\n",
      "\n",
      "[[page 7552]]\n",
      "\n",
      "security of ehi or if the practice did not implement an organizational \n",
      "security policy, the actor must have made a determination in each case, \n",
      "based on the particularized facts and circumstances, consistent with \n",
      "the requirements of the exception (see sec.  171.203(d) and section \n",
      "viii.d.3 of this proposed rule).\n",
      "request for comment\n",
      "    we seek comment on this exception generally. specifically, we seek \n",
      "comment on whether the proposed conditions impose appropriate \n",
      "limitations on actor-initiated health it maintenance or improvements \n",
      "that lead to ehi unavailability. our goal is to ensure that the \n",
      "exception is not abused, while at the same time recognizing reasonable \n",
      "commercial arrangements entered into by parties for the proper \n",
      "maintenance and improvement of health it.\n",
      "    we are also considering whether to expand this exception to capture \n",
      "a broader class of practices that are the subject of reasonable \n",
      "commercial agreements and which, in the absence of an exception, may be \n",
      "considered information blocking. that is, to extend this exception or \n",
      "create new exceptions for additional types of practices that interfere \n",
      "with access, exchange, or use of ehi, but that are the subject of free \n",
      "agreement and which are reasonable and necessary. for example, we are \n",
      "considering whether a practice taken by an actor to throttle or meter \n",
      "the availability or performance of health it, where agreed to by the \n",
      "recipient of that health it, could ever be a practice that we recognize \n",
      "as not being information blocking if such practice does not otherwise \n",
      "qualify under an existing exception.\n",
      "    as discussed in section viii.c.5 of this preamble, we are aware \n",
      "that actors can use commercial agreements to materially discourage, and \n",
      "in some instances outright prohibit, certain instances of access, \n",
      "exchange, or use of ehi. for example, a hin might use a participation \n",
      "agreement to prohibit entities that receive ehi through the hin from \n",
      "transmitting that ehi to entities who are not participants of the hin. \n",
      "such an arrangement would not be reasonable or necessary because there \n",
      "is no legitimate justification for it. however, we are also aware of \n",
      "commercial arrangements that are not motivated by anti-competitive \n",
      "considerations but that nonetheless have the effect of interfering with \n",
      "the access, exchange, or use of ehi. for example, a health it developer \n",
      "of certified health it may agree to commercial terms with a customer \n",
      "that have the effect of interfering with access, exchange, or use of \n",
      "ehi, but which are designed to appropriately accommodate the customer's \n",
      "limited resources, or to assure the performance of certain health it \n",
      "functionality.\n",
      "    we expect that most reasonable and necessary commercial \n",
      "arrangements that affect access, exchange, or use of ehi could be \n",
      "recognized under one or more of the existing exceptions. however, we \n",
      "seek comment on whether there exists a class of legitimate commercial \n",
      "arrangements that could implicate the information blocking provision, \n",
      "but which would not benefit from the existing proposed exceptions.\n",
      "\n",
      "e. additional exceptions--request for information\n",
      "\n",
      "1. exception for complying with common agreement for trusted exchange\n",
      "    to support full network-to-network exchange of ehi, section \n",
      "3001(c)(9)(a) of the phsa, added by section 4003 of the cures act, \n",
      "directs the national coordinator to convene public-private partnerships \n",
      "to develop or support a trusted exchange framework (trusted exchange \n",
      "framework), including a common agreement for a common set of rules for \n",
      "trusted exchange between hins (common agreement). the most recent draft \n",
      "trusted exchange framework was released for public comment on january \n",
      "5, 2018,\\135\\ however, a new draft will be released in the coming \n",
      "months.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\135\\ onc, draft trusted exchange framework, <a href=\"https://www.healthit.gov/sites/default/files/draft-trusted-exchange-framework.pdf\">https://www.healthit.gov/sites/default/files/draft-trusted-exchange-framework.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we are considering whether we would should propose, in a future \n",
      "rulemaking, a narrow exception to the information blocking provision \n",
      "for practices that are necessary to comply with the requirements of the \n",
      "common agreement. such an exception may support adoption of the common \n",
      "agreement and encourage other entities to participate in trusted \n",
      "exchange through hins that enter into the common agreement. it would do \n",
      "so by providing protection if there are practices that are expressly \n",
      "required by the common agreement, or that are necessary to implement \n",
      "such requirements, that might implicate the information blocking \n",
      "provision and would not qualify for another exception. we note that \n",
      "such an exception would be consistent with the complementary roles of \n",
      "the information blocking provision and other provisions of the cures \n",
      "act that support interoperability and enhance the trusted exchange of \n",
      "ehi (including the interoperable network exchange provisions at section \n",
      "3001(c)(9) of the phsa, the definition of interoperability at section \n",
      "3000(10) of the phsa, and the conditions of certification required by \n",
      "section 3001(c)(5)(d) of the phsa).\n",
      "    we expect that any proposal would be narrowly framed such that \n",
      "contract terms, policies, or other practices that are not strictly \n",
      "necessary to comply with the common agreement would not qualify for the \n",
      "exception. similarly, we expect that the proposal would provide that an \n",
      "actor could benefit from this exception only if the practice or \n",
      "practices that the actor pursued were no broader than necessary under \n",
      "the circumstances. these limitations would ensure that the exception is \n",
      "narrowly tailored to practices that are most likely to promote trusted \n",
      "exchange without unnecessarily impeding access, exchange, or use of \n",
      "ehi.\n",
      "    we ask commenters to provide feedback on this potential exception \n",
      "to the information blocking provision to be considered for inclusion in \n",
      "future rulemaking. commenters should consider whether such an exception \n",
      "is necessary, given the scope of the other exceptions proposed in this \n",
      "nprm, and whether there could be any negative effects of such an \n",
      "exception. we ask commenters to consider the appropriate scope of this \n",
      "exception, which could include which actors could benefit from the \n",
      "exception and the conditions that should apply in order to qualify for \n",
      "the exception.\n",
      "2. new exceptions\n",
      "    we welcome comment on any potential new exceptions we should \n",
      "consider for future rulemaking. commenters should consider the policy \n",
      "goals and structure of the proposed exceptions in this proposed rule \n",
      "when providing comment. we ask that commenters provide rationale for \n",
      "any proffered exceptions to the information blocking provisions and any \n",
      "conditions an actor would need to meet to qualify for the proffered \n",
      "exception.\n",
      "\n",
      "f. complaint process\n",
      "\n",
      "    section 3022(d)(3)(a) of the phsa directs the national coordinator \n",
      "to implement a standardized process for the public to submit reports on \n",
      "claims of health information blocking. such reports could be submitted \n",
      "regarding any practice by health care providers, health it developers, \n",
      "exchanges, or networks that may constitute information blocking under \n",
      "section 3022(a). these practices include, but are not limited to, \n",
      "health it products or developers of such products (or other entities \n",
      "offering such products to health care providers) not being \n",
      "interoperable or resulting in information blocking;\n",
      "\n",
      "[[page 7553]]\n",
      "\n",
      "and false statements by developers of certified health it that they \n",
      "have not engaged in information blocking. section 3022(d)(3)(b) further \n",
      "requires that this complaint process provide for the collection of such \n",
      "information as the originating institution, location, type of \n",
      "transaction, system and version, timestamp, terminating institution, \n",
      "locations, system and version, failure notice, and other related \n",
      "information.\n",
      "    we intend to implement and evolve this complaint process by \n",
      "building on existing mechanisms, including the complaint process \n",
      "currently available at <a href=\"https://www.healthit.gov/healthit-feedback\">https://www.healthit.gov/healthit-feedback</a>. \n",
      "however, we request comment on this approach and any alternative \n",
      "approaches that would best effectuate this aspect of the cures act. in \n",
      "addition to any other comments that the public may wish to submit, we \n",
      "specifically request comment on the following issues:\n",
      "    <bullet> what types of information are most important to collect in \n",
      "order to identify potential instances of information blocking?\n",
      "    <bullet> what types of information are contemplated by the \n",
      "following categories delineated in section 3022(d)(3)(b): the \n",
      "originating institution; location; type of transaction; system and \n",
      "version; timestamp; terminating institution; locations; system and \n",
      "version; failure notice; and other related information?\n",
      "    <bullet> what types of information or data elements should be \n",
      "collected under each of the above categories?\n",
      "    <bullet> what additional types of information beyond the above may \n",
      "be relevant to complaints and allegations of information blocking, \n",
      "especially practices that involve contractual or other business \n",
      "practices for which some of the categories of technical or \n",
      "transactional information above may not apply?\n",
      "    <bullet> how can onc encourage and streamline the collection of \n",
      "such information so as to minimize burden and encourage the submission \n",
      "of complaints, especially complaints about practices that raise the \n",
      "types of information blocking concerns described in this proposed rule?\n",
      "    <bullet> how can onc facilitate the inclusion of sufficient detail \n",
      "and granularity in complaints to enable effective investigations?\n",
      "    <bullet> what safeguards should be provided to support adequate \n",
      "confidentiality and handling of information that could: (1) identify \n",
      "the source of the complaint or allegation; (2) contain other \n",
      "individually identifiable information; and (3) contain confidential or \n",
      "proprietary business information?\n",
      "\n",
      "g. disincentives for health care providers--request for information\n",
      "\n",
      "    section 3022(b)(2)(b) of the phsa provides that any health care \n",
      "provider determined by the oig to have committed information blocking \n",
      "shall be referred to the appropriate agency to be subject to \n",
      "appropriate disincentives using authorities under applicable federal \n",
      "law, as the secretary sets forth through notice and comment rulemaking. \n",
      "however, we note that these disincentives may not cover the full range \n",
      "of conduct within the scope of section 3022(a)(1). we request \n",
      "information on disincentives or if modifying disincentives already \n",
      "available under existing hhs programs and regulations would provide for \n",
      "more effective deterrents.\n",
      "    we also seek information on the implementation of section \n",
      "3022(d)(4) of the phsa, which provides that in carrying out section \n",
      "3022(d) of the phsa, the secretary shall, to the extent possible, not \n",
      "duplicate penalty structures that would otherwise apply with respect to \n",
      "information blocking and the type of individual or entity involved as \n",
      "of the day before december 13, 2016--enactment of the cures act.\n",
      "\n",
      "ix. registries request for information\n",
      "\n",
      "    section 4005 (a) and (b) of the cures act focuses on \n",
      "interoperability and bidirectional exchange between ehrs and \n",
      "registries, including clinician-led clinical data registries. onc is \n",
      "approaching these provisions from several angles to address the \n",
      "technical capability of ehrs to exchange data with registries in \n",
      "accordance with applicable recognized standards. based on stakeholder \n",
      "engagement and public comments on prior onc regulations, we have \n",
      "identified a wide range of areas where the use of standards could \n",
      "significantly improve bidirectional exchange with registries for a \n",
      "range of purposes, including public health, quality reporting, and care \n",
      "quality improvement.\n",
      "    as discussed in the ``strategy on reducing regulatory and \n",
      "administrative burden relating to the use of health it and ehrs'' draft \n",
      "report released by onc for public comment in december of 2018,\\136\\ \n",
      "health care providers are faced with a myriad of federal public health \n",
      "reporting requirements and options that rely on both bidirectional \n",
      "exchange and aggregation of clinical data. cdc, samhsa, fda, hrsa, and \n",
      "usda also fund state and local public health jurisdictions to collect \n",
      "clinical data from health care providers. as noted in the cures act, \n",
      "there are also a wide range of clinician-led quality and specialty \n",
      "clinical data registries. compounding these reporting requirements and \n",
      "options is, as reported by health care providers, a lack of \n",
      "standardization across electronic infrastructure that has led to a \n",
      "comparatively slow adoption of health it systems among registries. this \n",
      "lack of interoperability impacts not only data exchange between health \n",
      "care providers, but is a significant barrier to the integration and \n",
      "potential use of clinical data received from a registry for quality \n",
      "improvement or clinical care.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\136\\ <a href=\"https://www.healthit.gov/topic/usability-and-provider-burden/strategy-reducing-burden-relating-use-health-it-and-ehrs\">https://www.healthit.gov/topic/usability-and-provider-burden/strategy-reducing-burden-relating-use-health-it-and-ehrs</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    for these reasons outlined above, we believe it is appropriate to \n",
      "explore multiple approaches to advancing health it interoperability for \n",
      "bidirectional exchange with registries in order to mitigate risks based \n",
      "on factors like feasibility and readiness, potential unintended burden \n",
      "on health care providers, and the need to focus on priority clinical \n",
      "use cases. onc is in the process of conducting research and analysis to \n",
      "determine what evidence-based use cases should be supported and what \n",
      "standards are available to support such use cases. we are also \n",
      "considering the overall maturity of technology adoption within the \n",
      "market to support identified standards and the use of certified ehrs \n",
      "and clinical data registries for these identified use cases in the near \n",
      "term, as well as identifying glide paths for the potential future \n",
      "development of enterprise solutions.\n",
      "    in the 2015 edition final rule, we included certification criteria \n",
      "and standards that are applicable for specific use cases for \n",
      "bidirectional exchange such as immunization information systems. in \n",
      "this proposed rule, we have proposed processes for updating standards \n",
      "as well as new policies related to real world testing that would help \n",
      "ensure that functionalities are implemented in a manner that is \n",
      "technically feasible in a practice setting. in addition, we have worked \n",
      "with federal partners to advance health it policies related to \n",
      "bidirectional exchange with registries in a manner that supports and \n",
      "reflects the current market place while encouraging innovation and \n",
      "increased adoption. for example, we have worked with cms to enhance \n",
      "guidance for qcdrs under the mips to support health it innovation and \n",
      "partnership with health it organizations. we are also working with the \n",
      "cdc and states to support enhancements to pdmp integration as a\n",
      "\n",
      "[[page 7554]]\n",
      "\n",
      "priority use case for standards-based health it solutions. we believe \n",
      "these efforts can help to address the near term need to support high \n",
      "priority use cases for bidirectional exchange between health care \n",
      "providers and registries.\n",
      "    in this proposed rule, we propose to adopt new standards and \n",
      "capabilities for certified apis that have the potential to change how \n",
      "certain types of information exchange are done, including the potential \n",
      "to exchange information with clinical data and public health \n",
      "registries. in this request for information (rfi), we are seeking \n",
      "information on how health it solutions and the proposals throughout \n",
      "this rule can aid bidirectional exchange with registries for a wide \n",
      "range public health, quality reporting, and clinical quality \n",
      "improvement initiatives. for example, in december of 2018, in the \n",
      "``strategy on reducing regulatory and administrative burden relating to \n",
      "the use of health it and ehrs'' draft report, we noted that hl7 was \n",
      "working on an update to the fhir standard to support api access to \n",
      "request data on populations of patients, which could potentially \n",
      "address additional use cases, including supporting payer needs, public \n",
      "health and quality improvement efforts, and health research \n",
      "organizations. as discussed in section vii.4, fhir release 4 has now \n",
      "been published \\85\\ and updated associated implementation \n",
      "specifications are expected to follow. fhir release 4 has several key \n",
      "improvements, including certain foundational aspects in the standard \n",
      "and ``fhir resources'' designated as ``normative'' for the first time. \n",
      "this will lead to a cycle of more mature us fhir core profiles aligned \n",
      "with release 4 and additional implementation guidance that explicitly \n",
      "specifies how to handle populations of patient data (batch exports) via \n",
      "fhir to more efficiently enable population and learning health system-\n",
      "oriented services.\n",
      "    we seek comment on use cases where an api using fhir release 4 \n",
      "might support improved exchange between a provider and a registry. \n",
      "specifically, we seek comment on how the use of this standard might:\n",
      "    <bullet> reduce the burden of implementing multiple solutions for \n",
      "various types of exchange, while still supporting the variability \n",
      "needed to exchange information with registries devoted to the care of a \n",
      "population defined by a particular disease, condition, exposure, or \n",
      "therapy;\n",
      "    <bullet> allow for the collection of detailed, standardized data on \n",
      "an ongoing basis for medical procedures, services, or therapies for \n",
      "particular diseases, conditions, or exposures;\n",
      "    <bullet> support an overall approach to data quality, including the \n",
      "systematic collection of clinical and other health care data, using \n",
      "standardized data elements and procedures to verify the completeness \n",
      "and validity of those data;\n",
      "    <bullet> improve and enhance the ability of providers to leverage \n",
      "feedback from a registry to improve patient care; and\n",
      "    <bullet> address a sufficiently wide range of use cases to warrant \n",
      "the prioritization of technical innovation on api-based options over \n",
      "the continued development of use-case-specific solutions in future \n",
      "rulemaking.\n",
      "    we also welcome any other comments stakeholders may have on \n",
      "implementation of the registries provisions under section 4005 of the \n",
      "cures act.\n",
      "\n",
      "x. patient matching request for information\n",
      "\n",
      "    patient matching is a critical component to interoperability and \n",
      "the nation's health information technology infrastructure. accurate \n",
      "patient matching helps health care providers access and share the right \n",
      "information on the right patient when and where it is needed.\n",
      "    inaccurate patient matching can compromise safety, privacy, and \n",
      "lead to increased health care costs, as acknowledged in the departments \n",
      "of labor, health and human services, and education, and related \n",
      "agencies appropriation bill, 2017: \\137\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\137\\ <a href=\"https://www.congress.gov/114/crpt/hrpt699/crpt-114hrpt699.pdf\">https://www.congress.gov/114/crpt/hrpt699/crpt-114hrpt699.pdf</a>.\n",
      "\n",
      "    the committee is aware that one of the most significant \n",
      "challenges inhibiting the safe and secure electronic exchange of \n",
      "health information is the lack of a consistent patient data matching \n",
      "strategy. with the passage of the hitech act, a clear mandate was \n",
      "placed on the nation's healthcare community to adopt electronic \n",
      "health records and health exchange capability. although the \n",
      "committee continues to carry a prohibition against hhs using funds \n",
      "to promulgate or adopt any final standard providing for the \n",
      "assignment of a unique health identifier for an individual until \n",
      "such activity is authorized, the committee notes that this \n",
      "limitation does not prohibit hhs from examining the issues around \n",
      "patient matching. accordingly, the committee encourages the \n",
      "secretary, acting through the office of the national coordinator for \n",
      "health information technology and cms, to provide technical \n",
      "assistance to private-sector led initiatives to develop a \n",
      "coordinated national strategy that will promote patient safety by \n",
      "---------------------------------------------------------------------------\n",
      "accurately identifying patients to their health information.\n",
      "\n",
      "    similarly, the fiscal year 2018 appropriations bill \\138\\ also \n",
      "included language regarding patient matching.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\138\\ <a href=\"https://appropriations.house.gov/uploadedfiles/23920.pdf\">https://appropriations.house.gov/uploadedfiles/23920.pdf</a>.\n",
      "\n",
      "    the committee is aware that a challenge inhibiting the safe and \n",
      "secure electronic exchange of health information is the lack of a \n",
      "consistent approach to matching patient data. the committee \n",
      "encourages onc to engage with stakeholders on private-sector led \n",
      "initiatives to develop a coordinated strategy that will promote \n",
      "patient safety by accurately identifying patients to their health \n",
      "---------------------------------------------------------------------------\n",
      "information.\n",
      "\n",
      "    section 4007 of the 21st century cures act (pub. l. 114-255) \n",
      "directs the government accountability office (gao) to conduct a study \n",
      "on patient matching. specifically, the gao was charged to review the \n",
      "policies and activities of the office of the national coordinator for \n",
      "health information technology (onc) and other relevant stakeholders, \n",
      "including standards development organizations, developers, providers, \n",
      "suppliers, payers, quality organizations, states, health information \n",
      "technology policy and technical experts, and other appropriate \n",
      "entities. the gao report, approaches and challenges to electronically \n",
      "matching patients' records across providers, was released in january \n",
      "2019.\\139\\ in this report, gao describes (1) stakeholders' patient \n",
      "record matching approaches and related challenges; and (2) efforts to \n",
      "improve patient record matching identified by stakeholders. \n",
      "stakeholders said more could be done to improve patient record \n",
      "matching, and identified several efforts that could improve matching. \n",
      "for example, some said that implementing common standards for recording \n",
      "demographic data; sharing best practices and other resources; and \n",
      "developing a public-private collaboration effort could each improve \n",
      "matching. stakeholders' views varied on the roles onc and others should \n",
      "play in these efforts and the extent to which the efforts would improve \n",
      "matching. multiple stakeholders emphasized that no single effort would \n",
      "solve the challenge of patient record matching.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\139\\ u.s. government accountability office, approaches and \n",
      "challenges to electronically matching patients' records across \n",
      "providers, gao-19-197, <a href=\"https://www.gao.gov/assets/700/696426.pdf\">https://www.gao.gov/assets/700/696426.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    patient matching may be defined as the linking of one patient's \n",
      "data within and across health care providers in order to obtain a \n",
      "comprehensive and longitudinal view of that patient's health care. at a \n",
      "minimum, this is accomplished by linking multiple demographic data \n",
      "fields such as name, birth date, sex, phone number, and\n",
      "\n",
      "[[page 7555]]\n",
      "\n",
      "address. for this reason, accurate and standardized data capture and \n",
      "exchange and optimized algorithm performance are critical components to \n",
      "the accurate patient matching. with this in mind, onc has taken several \n",
      "steps to better understand the patient matching landscape and to \n",
      "identify areas where onc can assist in standards and technical \n",
      "development, coordination, and innovation. for example, in 2017, onc \n",
      "launched the patient matching algorithm challenge, where six winners \n",
      "were awarded total prize winnings of $75,000.\\140\\ the goals of this \n",
      "challenge were to bring about greater transparency and data on the \n",
      "performance of existing patient matching algorithms, spur the adoption \n",
      "of performance metrics for patient matching algorithm developers, and \n",
      "positively impact other aspects of patient matching such as \n",
      "deduplication and linking. in addition, in 2018, onc showcased \n",
      "innovative technical and non-technical approaches to matching through \n",
      "hosting a patient matching track at onc's second interoperability \n",
      "forum.\\141\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\140\\ <a href=\"https://www.hhs.gov/about/news/2017/11/08/hhs-names-patient-matching-algorithm-challenge-winners.html\">https://www.hhs.gov/about/news/2017/11/08/hhs-names-patient-matching-algorithm-challenge-winners.html</a>.\n",
      "    \\141\\ <a href=\"https://www.healthit.gov/news/events/oncs-2nd-interoperability-forum\">https://www.healthit.gov/news/events/oncs-2nd-interoperability-forum</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in this request for information (rfi), we seek comment on \n",
      "additional opportunities that may exist in the patient matching space \n",
      "and ways that onc can lead and contribute to coordination efforts with \n",
      "respect to patient matching. onc and cms collaborated to jointly issue \n",
      "complementary requests for information regarding patient matching. onc \n",
      "is particularly interested in ways that patient matching can facilitate \n",
      "improved patient safety, better care coordination, and advanced \n",
      "interoperability. inaccurate patient matching can lead to inappropriate \n",
      "and unnecessary care; unnecessary burden on both patients and providers \n",
      "to correct misidentification, time consuming and expensive burden on \n",
      "health systems to detect and reconcile duplicate patient records and \n",
      "improper record merges; and poor oversite into fraud and abuse. per a \n",
      "survey by the college of healthcare information management executives, \n",
      "one in five providers named lack of an appropriate patient matching \n",
      "strategy as the primary reason for inadvertent illness or injury.\\142\\ \n",
      "we consider this a quality of care and patient safety issue and seek \n",
      "stakeholder input on creative, innovative, and effective approaches to \n",
      "patient matching within and across providers. we also intend to review \n",
      "the responses to this rfi in concert with the gao report once \n",
      "published.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\142\\ <a href=\"https://chimecentral.org/wp-content/uploads/2014/11/summary_of_chime_survey_on_patient_data.pdf\">https://chimecentral.org/wp-content/uploads/2014/11/summary_of_chime_survey_on_patient_data.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we specifically seek input on the following:\n",
      "    <bullet> it is a common misconception that technology alone can \n",
      "solve the problem of poor data quality, but even the most advanced, \n",
      "innovative technical approaches are unable to overcome data quality \n",
      "issues. thus, we seek input on the potential effect that data \n",
      "collection standards may have on the quality of health data that is \n",
      "captured and stored and the impact that such standards may have on \n",
      "accurate patient matching. we also seek input on other solutions that \n",
      "may increase the likelihood of accurate data capture, including the \n",
      "implementation of technology that supports the verification and \n",
      "authentication of certain demographic data elements such as mailing \n",
      "address, as well as other efforts that support ongoing data quality \n",
      "improvement efforts.\n",
      "    <bullet> in concert with the gao study referenced above, we seek \n",
      "input on what additional data elements could be defined to assist in \n",
      "patient matching as well as input on a required minimum set of elements \n",
      "that need to be collected and exchanged. we encourage stakeholders to \n",
      "review the patient demographic record matching section of the \n",
      "interoperability standards advisory \\143\\ and comment on the standards \n",
      "and implementation specifications outlined. public comments and subject \n",
      "matter feedback on all sections of the interoperability standards \n",
      "advisory are accepted year round.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\143\\ <a href=\"https://www.healthit.gov/isa/patient-demographic-record-matching\">https://www.healthit.gov/isa/patient-demographic-record-matching</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> also in alignment with the gao study, we seek input on \n",
      "whether and what requirements for electronic health records could be \n",
      "established to assure data used for patient matching is collected \n",
      "accurately and completely for every patient. for instance, the adopted \n",
      "2015 edition ``transitions of care'' certification criterion (sec.  \n",
      "170.315(b)(1)) currently includes patient matching requirements for \n",
      "first name, last name, previous name, middle name, suffix, date of \n",
      "birth, address, phone number, and sex. these requirement also include \n",
      "format constraints for some of the data.\n",
      "    <bullet> there are unique matching issues related to pediatrics and \n",
      "we seek comment on innovative and effective technical or non-technical \n",
      "approaches that could support accurate pediatric record matching.\n",
      "    <bullet> recent research suggests that involving patients in \n",
      "patient matching may be a viable and effective solution to increase the \n",
      "accuracy of matching, and giving patients access to their own clinical \n",
      "information empowers engagements and improved health outcomes. we seek \n",
      "comment on potential solutions that include patients through a variety \n",
      "of methods and technical platforms in the capture, update and \n",
      "maintenance of their own demographic and health data, including privacy \n",
      "criteria and the role of providers as educators and advocates.\n",
      "    <bullet> in addition, we seek input on standardized metrics for the \n",
      "performance evaluation of available patient matching algorithms. health \n",
      "it developers are each relying on a number of patient matching \n",
      "algorithms, however, without the adoption of agreed upon metrics for \n",
      "the evaluation of algorithm performance across the industry, existing \n",
      "matching approaches cannot be accurately evaluated or compared across \n",
      "systems or over time.\n",
      "    <bullet> at the same time, we seek input on transparent patient \n",
      "matching indicators such as database duplicate rate, duplicate creation \n",
      "rate, and true match rate, for example, that are necessary for \n",
      "assessment and reporting. the current lack of consensus, adoption, and \n",
      "transparency of such indicators makes communication, reporting, and \n",
      "cross-provider or cross-organizational comparisons impossible, impedes \n",
      "a full and accurate assessment of the extent of the problem, prohibits \n",
      "informed decision making, limits research on complementary matching \n",
      "methods, and inhibits progress and innovation in this area.\n",
      "    <bullet> there are a number of emerging private-sector led \n",
      "approaches in patient matching that may prove to be effective, and we \n",
      "seek input on these approaches, in general. a number of matching \n",
      "services that leverage referential matching technology have emerged in \n",
      "the market recently, yet evaluations of this type of approach has \n",
      "either not been conducted or has not been made public. other innovative \n",
      "technical approaches such as biometrics, machine learning and \n",
      "artificial intelligence, or locally developed unique identifier \n",
      "efforts, when used in combination with non-technical approaches such as \n",
      "patient engagement, supportive policies, data governance, and ongoing \n",
      "data quality improvement efforts may enhance capacity for matching.\n",
      "    <bullet> finally, onc seeks input on new data that could be added \n",
      "to the united states core data for interoperability (uscdi) or further \n",
      "constrained within it in order to support patient matching.\n",
      "\n",
      "[[page 7556]]\n",
      "\n",
      "xi. incorporation by reference\n",
      "\n",
      "    the office of the federal register has established requirements for \n",
      "materials (e.g., standards and implementation specifications) that \n",
      "agencies propose to incorporate by reference in the code of federal \n",
      "regulations (79 fr 66267; 1 cfr 51.5(a)). specifically, sec.  51.5(a) \n",
      "requires agencies to discuss, in the preamble of a proposed rule, the \n",
      "ways that the materials it proposes to incorporate by reference are \n",
      "reasonably available to interested parties or how it worked to make \n",
      "those materials reasonably available to interested parties; and \n",
      "summarize, in the preamble of the proposed rule, the material it \n",
      "proposes to incorporate by reference.\n",
      "    to make the materials we intend to incorporate by reference \n",
      "reasonably available, we provide a uniform resource locator (url) for \n",
      "the standards and implementation specifications. in many cases, these \n",
      "standards and implementation specifications are directly accessible \n",
      "through the urls provided. in instances where they are not directly \n",
      "available, we note the steps and requirements necessary to gain access \n",
      "to the standard or implementation specification. in most of these \n",
      "instances, access to the standard or implementation specification can \n",
      "be gained through no-cost (monetary) participation, subscription, or \n",
      "membership with the applicable standards developing organization (sdo) \n",
      "or custodial organization. in certain instances, where noted, access \n",
      "requires a fee or paid membership. as an alternative, a copy of the \n",
      "standards may be viewed for free at the u.s. department of health and \n",
      "human services, office of the national coordinator for health \n",
      "information technology, 330 c street sw, washington, dc 20201. please \n",
      "call (202) 690-7171 in advance to arrange inspection.\n",
      "    the national technology transfer and advancement act (nttaa) of \n",
      "1995 (15 u.s.c. 3701 et seq.) and the office of management and budget \n",
      "(omb) circular a-119 require the use of, wherever practical, technical \n",
      "standards that are developed or adopted by voluntary consensus \n",
      "standards bodies to carry out policy objectives or activities, with \n",
      "certain exceptions. the nttaa and omb circular a-119 provide exceptions \n",
      "to selecting only standards developed or adopted by voluntary consensus \n",
      "standards bodies, namely when doing so would be inconsistent with \n",
      "applicable law or otherwise impractical. as discussed in section iv of \n",
      "this preamble, we have followed the nttaa and omb circular a-119 in \n",
      "proposing standards and implementation specifications for adoption, \n",
      "including describing any exceptions in the proposed adoption of \n",
      "standards and implementation specifications. over the years of adopting \n",
      "standards and implementation specifications for certification, we have \n",
      "worked with sdos, such as hl7, to make the standards we propose to \n",
      "adopt, and subsequently adopt and incorporate by reference in the \n",
      "federal register, available to interested stakeholders. as described \n",
      "above, this includes making the standards and implementation \n",
      "specifications available through no-cost memberships and no-cost \n",
      "subscriptions.\n",
      "    as required by sec.  51.5(a), we provide summaries of the standards \n",
      "we propose to adopt and subsequently incorporate by reference in the \n",
      "code of federal regulations. we also provide relevant information about \n",
      "these standards and implementation specifications throughout the \n",
      "preamble.\n",
      "    we have organized the following standards and implementation \n",
      "specifications that we propose to adopt through this rulemaking \n",
      "according to the sections of the code of federal regulation (cfr) in \n",
      "which they would be codified and cross-referenced for associated \n",
      "certification criteria and requirements that we propose to adopt. we \n",
      "note, in certain instances, that we request comment in this proposed \n",
      "rule on multiple standards or implementation specifications that we are \n",
      "considering for adoption and incorporation by reference for particular \n",
      "use cases. we include all of these standards and implementation \n",
      "specifications in this section of the preamble.\n",
      "\n",
      "content exchange standards and implementation specifications for \n",
      "exchanging electronic health information--45 cfr 170.205\n",
      "\n",
      "<bullet> cms implementation guide for quality reporting document \n",
      "architecture category i hospital quality reporting implementation guide \n",
      "for 2019, may 4, 2018\n",
      "    url: <a href=\"https://ecqi.healthit.gov/system/files/qrda_hqr_2019_cms_ig_final_508.pdf\">https://ecqi.healthit.gov/system/files/qrda_hqr_2019_cms_ig_final_508.pdf</a>.\n",
      "    this is a direct access link.\n",
      "    summary: this guide is a cms quality reporting document \n",
      "architecture category i (qrda i) implementation guide to the hl7 \n",
      "implementation guide for cda release 2: quality reporting document \n",
      "architecture category i, release 1, stu release 5 (published december \n",
      "2017), referred to as the hl7 qrda i stu r5 in this guide. this guide \n",
      "describes additional conformance statements and constraints for ehr \n",
      "data submissions that are required for reporting information to the cms \n",
      "for the hospital inpatient quality reporting program 2019 reporting \n",
      "period. the purpose of this guide is to serve as a companion to the \n",
      "base hl7 qrda i stu r5 for entities such as eligible hospitals (eh), \n",
      "critical access hospitals (cah), and vendors to submit qrda i data for \n",
      "consumption by cms systems including for hospital quality reporting \n",
      "(hqr).\n",
      "<bullet> cms implementation guide for quality reporting document \n",
      "architecture category iii eligible clinicians and eligible \n",
      "professionals programs implementation guide for 2019, october 8, 2018\n",
      "    url: <a href=\"https://ecqi.healthit.gov/system/files/2019_cms_qrda_iii_eligible_clinicians_and_ep_ig-508.pdf\">https://ecqi.healthit.gov/system/files/2019_cms_qrda_iii_eligible_clinicians_and_ep_ig-508.pdf</a>.\n",
      "    this is a direct access link.\n",
      "    summary: the health level seven international (hl7) quality \n",
      "reporting document architecture (qrda) defines constraints on the hl7 \n",
      "clinical document architecture release 2 (cda r2). qrda is a standard \n",
      "document format for the exchange of electronic clinical quality measure \n",
      "(ecqm) data. qrda reports contain data extracted from electronic health \n",
      "records (ehrs) and other information technology systems. the reports \n",
      "are used for the exchange of ecqm data between systems for quality \n",
      "measurement and reporting programs. this qrda guide contains the \n",
      "centers for medicare & medicaid services (cms) supplemental \n",
      "implementation guide to the hl7 implementation guide for cda release 2: \n",
      "quality reporting document architecture, category iii, stu release 2.1 \n",
      "(june, 2017) for the 2019 performance period. this hl7 base standard is \n",
      "referred to as the hl7 qrda-iii stu r2.1.\n",
      "<bullet> health level 7 (hl7[supreg]) cda r2 ig: c-cda templates for \n",
      "clinical notes r1 companion guide, release 1 (c-cda 2.1 companion \n",
      "guide), march 2017\n",
      "    url: <a href=\"http://www.hl7.org/implement/standards/product_brief.cfm?product_id=447\">http://www.hl7.org/implement/standards/product_brief.cfm?product_id=447</a>.\n",
      "    access requires a ``user account'' and a license agreement. there \n",
      "is no monetary cost for a user account and license agreement.\n",
      "    summary: the companion guide to consolidated clinical document \n",
      "architecture (c-cda) provides supplemental guidance to the health level \n",
      "seven (hl7) cda[supreg] r2 ig: c-cda templates for clinical notes stu \n",
      "release 2.1 in support of the onc 2015\n",
      "\n",
      "[[page 7557]]\n",
      "\n",
      "edition health it certification criteria (2015 edition) certified \n",
      "electronic health record technology requirements. this guide provides \n",
      "additional technical clarification and practical guidance to assist \n",
      "implementers to support best practice implementations of the 2015 \n",
      "edition health information technology (health it) certification \n",
      "criteria, 2015 edition base electronic health record (ehr) definition, \n",
      "and onc health it certification.\n",
      "<bullet> health level 7(hl7[supreg]) cda r2 implementation guide: c-cda \n",
      "supplemental templates for unique device identification (udi) for \n",
      "implantable medical devices, release 1-us realm\n",
      "    url: <a href=\"http://www.hl7.org/implement/standards/product_brief.cfm?product_id=486\">http://www.hl7.org/implement/standards/product_brief.cfm?product_id=486</a>.\n",
      "    access requires a ``user account'' and a license agreement. there \n",
      "is no monetary cost for a user account and license agreement.\n",
      "    summary: the implementation guide contains guidance, supporting \n",
      "material and new templates to implement support for unique device \n",
      "identifiers (udis) for implantable medical devices. the ig identifies \n",
      "changes needed to the c-cda to better facilitate the exchange of the \n",
      "individual udi components in the health care system when devices are \n",
      "implanted in a patient. the udi components include the device \n",
      "identifier (di) and the following individual production identifiers \n",
      "(pi): the lot or batch number, serial number, manufacturing date, \n",
      "expiration date, and distinct identification code.\n",
      "<bullet> national council for prescription drug programs (ncpdp), \n",
      "script standard implementation guide, version 2017071 (approval date \n",
      "for ansi: july 28, 2017)\n",
      "    url: <a href=\"http://www.ncpdp.org/standards/standards-info\">http://www.ncpdp.org/standards/standards-info</a>.\n",
      "    access requires registration, membership fee, a user account, and \n",
      "license agreement to obtain a copy of the standard.\n",
      "    summary: script standards are developed for transmitting \n",
      "prescription information electronically between prescribers, \n",
      "pharmacies, payers, and other entities for new prescriptions, changes \n",
      "of prescriptions, prescription refill requests, prescription fill \n",
      "status notifications, cancellation notifications, relaying of \n",
      "medication history, transactions for long-term care, electronic prior \n",
      "authorization and other transactions. new transactions in this update \n",
      "include prescription drug administration message, new prescription \n",
      "requests, new prescription response denials, prescription transfer \n",
      "message, prescription fill indicator change, prescription \n",
      "recertification, risk evaluation and mitigation strategy (rems) \n",
      "initiation request, rems initiation response, rems request, and rems \n",
      "response.\n",
      "\n",
      "united states core data for interoperability--45 cfr 170.213\n",
      "\n",
      "<bullet> the united states core data for interoperability (uscdi), \n",
      "version 1 (v1)\n",
      "    url: <a href=\"https://www.healthit.gov/uscdi\">https://www.healthit.gov/uscdi</a>.\n",
      "    this is a direct access link.\n",
      "    summary: the united states core data for interoperability (uscdi) \n",
      "establishes a minimum set of data classes that are required to be \n",
      "interoperable nationwide and is designed to be expanded in an iterative \n",
      "and predictable way over time. data classes listed in the uscdi are \n",
      "represented in a technically agnostic manner.\n",
      "\n",
      "application programming interface standards--45 cfr 170.215\n",
      "\n",
      "<bullet> hl7[supreg] fhir[supreg] foundation, argonaut data query \n",
      "implementation guide server, version 1.0.2, december 15, 2016\n",
      "    url: <a href=\"http://www.fhir.org/guides/argonaut/r2/conformance-server.html\">http://www.fhir.org/guides/argonaut/r2/conformance-server.html</a>.\n",
      "    this is a direct access link.\n",
      "    summary: this profile defines the expected capabilities of an \n",
      "argonaut data query server when conforming to the argonaut data query \n",
      "ig. the conformance resource includes the complete list of actual \n",
      "profiles, restful operations, and search parameters supported by \n",
      "argonaut data query servers. servers have the option of choosing from \n",
      "this list to access necessary data based on their local use cases and \n",
      "other contextual requirements.\n",
      "<bullet> hl7[supreg] fhir[supreg] foundation, argonaut data query \n",
      "implementation guide, version 1.0.0, december 23, 2016\n",
      "    url: <a href=\"http://www.fhir.org/guides/argonaut/r2/\">http://www.fhir.org/guides/argonaut/r2/</a>.\n",
      "    this is a direct access link.\n",
      "    summary: the argonaut data query implementation guide is based upon \n",
      "the core fhir dstu release 2.0 api and documents security and \n",
      "authorization, data element query of the onc common clinical data set, \n",
      "and document query of static documents. this specification describes \n",
      "four use cases and sets search expectations for each. argonaut uses the \n",
      "smart guide for apps that connect to ehr data.\n",
      "<bullet> health level 7 (hl7[supreg]) fast healthcare interoperability \n",
      "resources (fhir[supreg]) release 2.0 draft standard for trial use \n",
      "(dstu), version 1.0.2-7202, october 24, 2015\n",
      "    url: <a href=\"http://hl7.org/fhir/dstu2/index.html\">http://hl7.org/fhir/dstu2/index.html</a>.\n",
      "    this is a direct access link.\n",
      "    summary: the fast healthcare interoperability resources (fhir) \n",
      "draft standard for trial use (dstu) release 2.0, version 1.0.2 is \n",
      "designed to enable information exchange to support the provision of \n",
      "health care in a wide variety of settings. the specification builds on \n",
      "and adapts modern, widely used, restful practices to enable the \n",
      "provision of integrated health care across a wide range of teams and \n",
      "organizations. hl7 fhir solutions are built from a set of modular \n",
      "components called ``resources''. these resources can easily be \n",
      "assembled into working systems that solve real world clinical and \n",
      "administrative problems at a fraction of the price of existing \n",
      "alternatives. hl7 fhir is suitable for use in a wide variety of \n",
      "contexts (e.g., mobile phone apps, cloud communications, ehr-based data \n",
      "sharing, and server communication in large institutional health care \n",
      "providers). all resources have the following features in common: a url \n",
      "that identifies it; common metadata; a human-readable xhtml summary; a \n",
      "set of defined common data elements; and an extensibility framework to \n",
      "support variation in health care.\n",
      "<bullet> health level 7 (hl7[supreg]) version 3.0.1 fast healthcare \n",
      "interoperability resources specification (fhir[supreg]) release 3 \n",
      "standard for trial use (stu), april 19, 2017\n",
      "    url: <a href=\"http://hl7.org/fhir/stu3/index.html\">http://hl7.org/fhir/stu3/index.html</a>.\n",
      "    this is a direct access link.\n",
      "    summary: the fast healthcare interoperability resources \n",
      "(fhir[supreg]) standard for trial use (stu) release 3 leverages the \n",
      "latest web standards and applies a tight focus on implementation. fhir \n",
      "solutions are built from a set of modular components called \n",
      "``resources''. these resources can easily be assembled into working \n",
      "systems that solve real world clinical and administrative problems at a \n",
      "fraction of the price of existing alternatives. fhir is suitable for \n",
      "use in a wide variety of contexts--mobile phone apps, cloud \n",
      "communications, ehr-based data sharing, server communication in large \n",
      "institutional health care providers, and much more. this third stu \n",
      "release includes a significant increase in the number of supported \n",
      "resources as well\n",
      "\n",
      "[[page 7558]]\n",
      "\n",
      "as revisions to previously published resources reflecting implementer \n",
      "feedback and increased maturity and stability.\n",
      "<bullet> health level 7 (hl7[supreg]) version 4.0.0 fast healthcare \n",
      "interoperability resources specification (fhir[supreg]) release 4, \n",
      "december 27, 2018\n",
      "    url: <a href=\"http://hl7.org/fhir/r4/\">http://hl7.org/fhir/r4/</a>.\n",
      "    this is a direct access link.\n",
      "    summary: the fast healthcare interoperability resources \n",
      "(fhir[supreg]) release 4 provides the first set of normative fhir \n",
      "resources. this normative designation means that the future changes \n",
      "will be backward compatible for the first time. these resources define \n",
      "the content and structure of core health data which can be used by \n",
      "developers to build standardized applications. release 4 provides new \n",
      "standard operation on how to obtain data from multiple patients via \n",
      "fhir. api services that focus on multiple patients would enable health \n",
      "care providers to manage various internal patient populations as well \n",
      "as external services a health care provider may contract for to support \n",
      "quality improvement, population health management, and cost \n",
      "accountability vis-[agrave]-vis the provider's partners (e.g., health \n",
      "plans).\n",
      "<bullet> health level 7 (hl7[supreg]) implementation specification--\n",
      "fhir profile: consent2share fhir consent profile design, december 11, \n",
      "2017\n",
      "    url: <a href=\"https://gforge.hl7.org/gf/project/cbcc/frs/?action=frsreleaseview&release_id=1259\">https://gforge.hl7.org/gf/project/cbcc/frs/?action=frsreleaseview&release_id=1259</a>.\n",
      "    the standard can be accessed through this link.\n",
      "    summary: the consent2share fhir consent profile design provides \n",
      "instructions for using the fhir ``consent'' resource to capture a \n",
      "record of a health care consumer's privacy preferences. implementing an \n",
      "instance of the fhir consent resource based on this guide allows for a \n",
      "patient consent to permit or deny identified recipient(s) or recipient \n",
      "role(s) to perform one or more actions regarding a patient's health \n",
      "information for specific purposes and periods of time.\n",
      "<bullet> api resource collection in health (arch) version 1\n",
      "    url: <a href=\"https://www.healthit.gov/arch\">https://www.healthit.gov/arch</a>.\n",
      "    this is a direct access link.\n",
      "    summary: the api resource collection in health (arch) is an \n",
      "implementation specification that list a set of base fhir resources \n",
      "that health it modules would need to support. the arch aligns with, and \n",
      "is directed by, the data policy specified in the us core data for \n",
      "interoperability (uscdi) standard.\n",
      "<bullet> smart application launch framework implementation guide \n",
      "release 1.0.0, november 13, 2018\n",
      "    url: <a href=\"http://hl7.org/fhir/smart-app-launch/\">http://hl7.org/fhir/smart-app-launch/</a>.\n",
      "    this is a direct access link.\n",
      "    summary: smart on fhir provides reliable, secure authorization for \n",
      "a variety of app architectures through the use of the oauth 2.0 \n",
      "standard. this authorization guide supports the four uses cases defined \n",
      "for phase 1 of the argonaut project. this profile is intended to be \n",
      "used by developers of apps that need to access fhir resources by \n",
      "requesting access tokens from oauth 2.0 compliant authorization \n",
      "servers. the profile defines a method through which an app requests \n",
      "authorization to access a fhir resource, and then uses that \n",
      "authorization to retrieve the resource. other health insurance \n",
      "portability and accountability act (hipaa)-mandated security \n",
      "mechanisms, such as end-user authentication, session time-out, security \n",
      "auditing, and accounting of disclosures, are outside the scope of this \n",
      "profile.\n",
      "<bullet> ietf oauth 2.0 dynamic client registration protocol (rfc \n",
      "7591), july 2015\n",
      "    url: <a href=\"https://tools.ietf.org/html/rfc7591\">https://tools.ietf.org/html/rfc7591</a>.\n",
      "    this is a direct access link.\n",
      "    summary: this specification defines mechanisms for dynamically \n",
      "registering oauth 2.0 clients with authorization servers. registration \n",
      "requests send a set of desired client metadata values to the \n",
      "authorization server. the resulting registration responses return a \n",
      "client identifier to use at the authorization server and the client \n",
      "metadata values registered for the client. the client can then use this \n",
      "registration information to communicate with the authorization server \n",
      "using the oauth 2.1 protocol. this specification also defines a set of \n",
      "common client metadata fields and values for clients to use during \n",
      "registration.\n",
      "<bullet> openid connect core 1.0 incorporating errata set 1, november \n",
      "8, 2014\n",
      "    url: <a href=\"http://openid.net/specs/openid-connect-core-1_0.html\">http://openid.net/specs/openid-connect-core-1_0.html</a>.\n",
      "    this is a direct access link.\n",
      "    summary: openid connect 1.0 is a simple identity layer on top of \n",
      "the oauth 2.0 protocol. it enables clients to verify the identity of \n",
      "the end-user based on the authentication performed by an authorization \n",
      "server, as well as to obtain basic profile information about the end-\n",
      "user in an interoperable and rest-like manner. this specification \n",
      "defines the core openid connect functionality: authentication built on \n",
      "top of oauth 2.0 and the use of claims to communicate information about \n",
      "the end-user. it also describes the security and privacy considerations \n",
      "for using openid connect.\n",
      "\n",
      "xii. response to comments\n",
      "\n",
      "    because of the large number of public comments normally received in \n",
      "response to federal register documents, we are not able to acknowledge \n",
      "or respond to them individually. we will consider all comments we \n",
      "receive by the date and time specified in the dates section of this \n",
      "preamble, and, when we proceed with a subsequent document, we will \n",
      "respond to the comments in the preamble of that document.\n",
      "    we note that, throughout this proposed rule, we identified areas \n",
      "where we need more information before making a proposal (i.e., requests \n",
      "for information). we note that comments we receive in response to these \n",
      "requests for information will not necessarily be addressed in the final \n",
      "rule, but will be used to inform future rulemaking.\n",
      "\n",
      "xiii. collection of information requirements\n",
      "\n",
      "    the paperwork reduction act of 1995 (pra) requires agencies to \n",
      "provide a 60-day notice in the federal register and solicit public \n",
      "comment on a proposed collection of information before it is submitted \n",
      "to the office of management and budget for review and approval. in \n",
      "order to fairly evaluate whether an information collection should be \n",
      "approved by the omb, section 3506(c)(2)(a) of the pra requires that we \n",
      "solicit comment on the following issues:\n",
      "    1. whether the information collection is necessary and useful to \n",
      "carry out the proper functions of the agency;\n",
      "    2. the accuracy of the agency's estimate of the information \n",
      "collection burden;\n",
      "    3. the quality, utility, and clarity of the information to be \n",
      "collected; and\n",
      "    4. recommendations to minimize the information collection burden on \n",
      "the affected public, including automated collection techniques.\n",
      "    under the pra, the time, effort, and financial resources necessary \n",
      "to meet the information collection requirements referenced in this \n",
      "section are to be considered. we explicitly seek, and will consider, \n",
      "public comment on our assumptions as they relate to the pra \n",
      "requirements summarized in this section. to comment on the collection\n",
      "\n",
      "[[page 7559]]\n",
      "\n",
      "of information or to obtain copies of the supporting statements and any \n",
      "related forms for the proposed paperwork collections referenced in this \n",
      "section, email your comment or request, including your address and \n",
      "phone number to <a href=\"mailto:sherrette.funn@hhs.gov\">sherrette.funn@hhs.gov</a>, or call the reports clearance \n",
      "office at (202) 690-6162. written comments and recommendations for the \n",
      "proposed information collections must be directed to the os paperwork \n",
      "clearance officer at the above email address within 60 days.\n",
      "\n",
      "a. onc-acbs\n",
      "\n",
      "    we propose to add new onc-acb collection and reporting requirements \n",
      "for the certification of health it to the 2015 edition (and any \n",
      "subsequent edition certification) in sec.  170.523(p), (q), (t), and \n",
      "sec.  170.550(1).\n",
      "    as proposed for sec. sec.  170.550(l), onc-acbs would not be able \n",
      "to certify health it until they review and verify health it developers' \n",
      "attestations confirming that the developers are compliant with \n",
      "conditions and maintenance of certification requirements. onc-acbs \n",
      "would also submit the health it developer attestations to onc as \n",
      "proposed by sec.  170.523(q). we believe this will require minimal \n",
      "effort on behalf of onc-acbs as the onc submission part will be \n",
      "electronically facilitated via the chpl.\n",
      "    as proposed for sec.  170.523(p)(3), onc-acbs would be required to \n",
      "collect and report certain information to onc related to real world \n",
      "testing plans and results. onc-acbs would be required to verify that \n",
      "the health it developer submits an annual, publicly available real \n",
      "world testing plan and perform a completeness check for both real world \n",
      "testing plans and results. we believe onc-acbs will face minimum burden \n",
      "in complying with these new proposed requirements.\n",
      "    as proposed for sec.  170.523(t), onc-acbs would ensure health it \n",
      "developers opting to take advantage of the standard version advancement \n",
      "process flexibility per sec.  170.405(b)(5) provide timely advance \n",
      "written notice to the onc-acb and all affected customers. onc-acbs \n",
      "would maintain a record of the date of issuance and the content of \n",
      "developers' notices, and timely post content of each notice received \n",
      "publicly on the chpl attributed to the certified health it module(s) to \n",
      "which it applies. we believe this will require minimal effort on behalf \n",
      "of onc-acbs as the submission part will be electronically facilitated \n",
      "via the chpl.\n",
      "    in the 2015 edition proposed rule (80 fr 16894), we estimated fewer \n",
      "than ten annual respondents for all of the regulatory ``collection of \n",
      "information'' requirements that applied to the onc-aa and onc-acbs, \n",
      "including those previously approved by omb. in the 2015 edition final \n",
      "rule (80 fr 62733), we concluded that the regulatory ``collection of \n",
      "information'' requirements for the onc-aa and the onc-acbs were not \n",
      "subject to the pra under 5 cfr 1320.3(c). we continue to estimate less \n",
      "than ten annual respondents for all of the proposed regulatory \n",
      "``collection of information'' requirements for onc-acbs under part 170 \n",
      "of title 45, including those previously approved by omb and proposed in \n",
      "this proposed rule. accordingly, the regulatory ``collection of \n",
      "information'' requirements under the program described in this section \n",
      "are not subject to the pra under 5 cfr 1320.3(c). we welcome comments \n",
      "on these conclusions and the supporting rationale on which they are \n",
      "based. for costs estimates of these proposed new regulatory \n",
      "requirements, we refer readers to section xiv. (regulatory impact \n",
      "analysis) of this proposed rule.\n",
      "\n",
      "b. health it developers\n",
      "\n",
      "    we propose in 45 cfr 170.580(a)(2)(iii) that onc may take action \n",
      "against a health it developer for failure to comply with conditions and \n",
      "maintenance of certification requirements. we proposed to generally use \n",
      "the same processes previously codified in regulation (sec. sec.  \n",
      "170.580 and 170.581) to take administrative enforcement action. these \n",
      "processes would require health it developers to submit information to \n",
      "onc to facilitate and conclude its review. the pra, however, exempts \n",
      "these information collections. specifically, 44 u.s.c. \n",
      "3518(c)(1)(b)(ii) excludes collection activities during the conduct of \n",
      "administrative actions or investigations involving the agency against \n",
      "specific individuals or entities.\n",
      "    we propose in 45 cfr 170.402(b)(1) that a health it developer must, \n",
      "for a period of 10 years beginning from the date each of a developer's \n",
      "health it is first certified under the onc health it certification \n",
      "program, retain all records and information necessary to demonstrate \n",
      "initial and ongoing compliance with the requirements of the onc health \n",
      "it certification program. we believe it will take approximately two \n",
      "hours per week on average to comply with our proposed record retention \n",
      "requirement. we welcome comments if stakeholders believe more or less \n",
      "time should be included in our estimate.\n",
      "\n",
      "   table 4--estimated annualized total burden hours for health it developers to comply with records retention\n",
      "                                                  requirements\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                     number of\n",
      "               code of federal regulations section                   health it    average burden       total\n",
      "                                                                    developers         hours\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "45 cfr 170.402(b)(1)............................................             458             104          47,632\n",
      "rrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrr\n",
      "    total burden hours..........................................  ..............  ..............          47,632\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "xiv. regulatory impact analysis\n",
      "\n",
      "a. statement of need\n",
      "\n",
      "    this proposed rule is necessary to meet our statutory \n",
      "responsibilities under the 21st century cures act (cures act) and to \n",
      "advance hhs policy goals to promote interoperability and mitigate \n",
      "burden for stakeholders. proposals that could result in monetary costs \n",
      "for stakeholders include the: (1) proposals to update the 2015 edition \n",
      "health it certification criteria; (2) proposals related to conditions \n",
      "and maintenance of certification for a health it developer; (3) \n",
      "proposals related to oversight for the conditions and maintenance of \n",
      "certification; and (4) proposals related to information blocking.\n",
      "    while much of the costs of this proposed rule will fall on health \n",
      "it developers that seek to certify health it under the onc health it \n",
      "certification program (program), we believe the implementation and use \n",
      "of health it certified to the 2015 edition (including the new criteria \n",
      "in this proposed rule), compliance with the conditions and maintenance \n",
      "of certification, and the\n",
      "\n",
      "[[page 7560]]\n",
      "\n",
      "limited exceptions to information blocking proposed would ultimately \n",
      "result in significant benefits for health care providers and patients. \n",
      "we outline some of these benefits below. we emphasize in this \n",
      "regulatory impact analysis (ria) that we believe this proposed rule \n",
      "would create opportunities for new market entrants and would remove \n",
      "barriers to interoperability and electronic health information \n",
      "exchange, which would greatly benefit health care providers and \n",
      "patients.\n",
      "    we note in this ria that there were instances in which we had \n",
      "difficulty quantifying certain benefits due to a lack of applicable \n",
      "studies and/or data. however, in such instances, we highlight the \n",
      "significant qualitative benefits of our proposals to advance an \n",
      "interoperable health system that empowers individuals to use their \n",
      "electronic health information (ehi) to the fullest extent and enables \n",
      "health care providers and communities to deliver smarter, safer, and \n",
      "more efficient care.\n",
      "\n",
      "b. alternatives considered\n",
      "\n",
      "    we assessed whether there are alternatives to our proposals, \n",
      "specifically our proposals concerning ehi export, application \n",
      "programming interfaces (apis), and real world testing. we have been \n",
      "unable to identify alternatives that would appropriately implement our \n",
      "responsibilities under the cures act and support interoperability. we \n",
      "believe our proposals take the necessary steps to fulfill the mandates \n",
      "specified in the public health service act (phsa), as amended by the \n",
      "health information technology for economic and clinical health (hitech) \n",
      "act and the cures act, in the least burdensome way. we are, however, \n",
      "open to less burdensome alternatives that meet statutory requirements \n",
      "and our goals. accordingly, we welcome comments on our assessment and \n",
      "any alternatives we should consider.\n",
      "\n",
      "c. overall impact\n",
      "\n",
      "    we have examined the impact of this proposed rule as required by \n",
      "executive order 12866 on regulatory planning and review (september 30, \n",
      "1993), executive order 13563 on improving regulation and regulatory \n",
      "review (february 2, 2011), executive order 13771 on reducing regulation \n",
      "and controlling regulatory costs, the regulatory flexibility act (5 \n",
      "u.s.c. 601 et seq.), section 202 of the unfunded mandates reform act of \n",
      "1995 (2 u.s.c. 1532), and executive order 13132 on federalism (august \n",
      "4, 1999).\n",
      "1. executive orders 12866 and 13563--regulatory planning and review \n",
      "analysis\n",
      "    executive orders 12866 on regulatory planning and review and 13563 \n",
      "on improving regulation and regulatory review direct agencies to assess \n",
      "all costs and benefits of available regulatory alternatives and, if \n",
      "regulation is necessary, to select regulatory approaches that maximize \n",
      "net benefits (including potential economic, environmental, public \n",
      "health and safety effects, distributive impacts, and equity). a \n",
      "regulatory impact analysis (ria) must be prepared for major rules with \n",
      "economically significant effects ($100 million or more in any one \n",
      "year). omb has determined that this proposed rule is an economically \n",
      "significant rule as the potential costs associated with this proposed \n",
      "rule could be greater than $100 million per year. accordingly, we have \n",
      "prepared an ria that to the best of our ability presents the costs and \n",
      "benefits of this proposed rule.\n",
      "2. executive order 13771--reducing regulation and controlling \n",
      "regulatory costs\n",
      "    executive order 13771 on reducing regulation and controlling \n",
      "regulatory costs was issued on january 30, 2017 and directs agencies to \n",
      "repeal two existing regulations for each new regulation issued in \n",
      "fiscal year (fy) 2017 and thereafter. it further directs agencies, via \n",
      "guidance issued by the office of management and budget (omb), that the \n",
      "total incremental costs of all regulations should be no greater than \n",
      "zero in fy 2018. the analysis required by executive order 13771, as \n",
      "supplemented by executive order 13777, adds additional requirements for \n",
      "analysis of regulatory actions. the new requirements under executive \n",
      "orders 13771 and 13777 do not change or reduce existing requirements \n",
      "under executive orders 12866 or 13563.\n",
      "a. costs and benefits\n",
      "    we have estimated the potential monetary costs and benefits of this \n",
      "proposed rule for health it developers, health care providers, \n",
      "patients, onc-authorized certification bodies (onc-acbs), onc-\n",
      "authorized testing laboratories (onc-atls), and the federal government \n",
      "(i.e., onc), and have broken those costs and benefits out into the \n",
      "following categories: (1) deregulatory actions (no associated costs); \n",
      "(2) updates the 2015 edition health it certification criteria; (3) \n",
      "conditions and maintenance of certification for a health it developer; \n",
      "(4) oversight for the conditions and maintenance of certification; and \n",
      "(5) information blocking.\n",
      "    in accordance with executive order 12866, we have included the ria \n",
      "summary table as table 25. in addition, we have included a summary to \n",
      "meet the regulatory reform analysis requirements under executive order \n",
      "13771.\n",
      "    we note that we have rounded all estimates to the nearest dollar \n",
      "and that all estimates are expressed in 2016 dollars as it is the most \n",
      "recent data available to address all cost and benefit estimates \n",
      "consistently. we also note that estimates presented in the following \n",
      "``employee assumptions and hourly wage,'' ``quantifying the estimated \n",
      "number of health it developers and products,'' and ``number of end \n",
      "users that might be impacted by onc's proposed regulations'' sections \n",
      "are used throughout this ria.\n",
      "    for proposals where research supported direct estimates of impact, \n",
      "we estimated the benefits. for proposals where no such research was \n",
      "identified to be available, we developed estimates based on a \n",
      "reasonable proxy.\n",
      "    we note that interoperability can positively impact patient safety, \n",
      "care coordination, and improve health care processes and health \n",
      "outcomes.\\144\\ however, achieving interoperability is a function of a \n",
      "number of factors including the capability of the technology used by \n",
      "health care providers. therefore, to assess the benefits of our \n",
      "proposals, we must first consider how to assess their respective \n",
      "effects on interoperability holding other factors constant.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\144\\ <a href=\"https://www.qualityforum.org/publications/2017/09/interoperability_2016-2017_final_report.aspx\">https://www.qualityforum.org/publications/2017/09/interoperability_2016-2017_final_report.aspx</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    for the purpose of this analysis, we used regression analysis to \n",
      "calculate the impact of our real world testing and api proposals on \n",
      "interoperability. we assumed that the real world testing and api \n",
      "proposals would collectively have the same impact on interoperability \n",
      "as health it certified to the 2014 edition. therefore, we estimated \n",
      "linear probability models that identified the impact of 2014 edition \n",
      "certified health it on hospitals' interoperability.\\145\\ we used data \n",
      "from the 2014 and 2015 american hospital association (aha) annual \n",
      "survey information technology supplement (it supplement), which \n",
      "consists of an analytic sample of 4,866 observations of non-federal \n",
      "acute care\n",
      "\n",
      "[[page 7561]]\n",
      "\n",
      "hospitals that responded to the it supplement.\\146\\ we controlled for \n",
      "additional factors such as participation in a health information \n",
      "exchange organization, hospital characteristics, and urban/rural \n",
      "status. more specifically, we used the following explanatory variables:\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\145\\ the interoperability dependent variable is a binary \n",
      "indicator for whether a hospital routinely sends, receives, and \n",
      "integrates summary of care records electronically outside of its \n",
      "system and finds any health information electronically outside of \n",
      "its system.\n",
      "    \\146\\ american hospital association health it supplement survey, \n",
      "<a href=\"http://www.ahadata.com/aha-healthcare-database/\">http://www.ahadata.com/aha-healthcare-database/</a>.\n",
      "\n",
      "edition = 1 if a hospital adopted 2014 edition ehr, 0 otherwise\n",
      "rhio = 1 if a hospital participates in health information exchange \n",
      "organization, 0 otherwise\n",
      "government = 1 if a hospital is publically owned, 0 otherwise\n",
      "alt_teaching = 1 if a hospital is teaching, 0 otherwise\n",
      "nonprofit = 1 if a hospital is not for profit, 0 otherwise\n",
      "largebed = 1 if a hospital has more than 399 beds, 0 otherwise\n",
      "medbed = 1 if a hospital's number of beds is between 100 and 399, 0 \n",
      "otherwise\n",
      "urban_rural = 1 if a hospital is urban, 0 otherwise\n",
      "cah = 1 if a hospital is critical access, 0 otherwise\n",
      "year = year of the data (2014 and 2015)\n",
      "s = state fixed effects\n",
      "\n",
      "we found a statistically significant marginal effect of using 2014 \n",
      "edition certified health it associated with a five percentage point \n",
      "increase in interoperability.\\147\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\147\\ results were similar when we used logit or probit \n",
      "specifications.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while we acknowledge that there might be shared benefits across \n",
      "proposals, we have taken steps to ensure that the benefits attributed \n",
      "to each proposal is unique to the proposal referenced. we assumed that \n",
      "this marginal effect is true for our proposals and distributed the 5% \n",
      "benefit across our real world testing and api proposals at (.1-1%) to \n",
      "(1-4%) respectively. moreover, the number of providers impacted is \n",
      "proposal specific. given data limitations, we believe this approach \n",
      "allows us to estimate the benefits of our proposals without double \n",
      "counting the impact each proposal might have on interoperability.\n",
      "employee assumptions and hourly wage\n",
      "    we have made employee assumptions about the level of expertise \n",
      "needed to complete the proposed requirements in this section. for wage \n",
      "calculations for federal employees and onc-acbs, we have correlated the \n",
      "employee's expertise with the corresponding grade and step of an \n",
      "employee classified under the general schedule (gs) federal salary \n",
      "classification, relying on the associated employee hourly rates for the \n",
      "washington, dc locality pay area as published by the office of \n",
      "personnel management for 2016.\\148\\ we have assumed that overhead costs \n",
      "(including benefits) are equal to 100% of pre-tax wages. therefore, we \n",
      "have doubled the employee's hourly wage to account for overhead costs. \n",
      "we have concluded that a 100% expenditure on benefits is an appropriate \n",
      "estimate based on research conducted by hhs.\\149\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\148\\ <a href=\"https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/salary-tables/pdf/2016/dcb_h.pdf\">https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/salary-tables/pdf/2016/dcb_h.pdf</a>.\n",
      "    \\149\\ see u.s. department of health and human services, office \n",
      "of the assistant secretary for planning and evaluation (aspe), \n",
      "guidelines for regulatory impact analysis, at 28-30 (2016), \n",
      "available at <a href=\"https://aspe.hhs.gov/system/files/pdf/242926/hhs_riaguidance.pdf\">https://aspe.hhs.gov/system/files/pdf/242926/hhs_riaguidance.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we have used bureau of labor statistics (bls) data to calculate \n",
      "private sector employee wage estimates (e.g., health it developers, \n",
      "health care providers, hins, attorneys, etc.), as we believe bls \n",
      "provides the most accurate and comprehensive wage data for private \n",
      "sector positions. just as with the general schedule federal salary \n",
      "classification calculations, we have assumed that overhead costs \n",
      "(including benefits) are equal to 100% of pre-tax wages.\n",
      "    all wage estimates (gs and bls) have been calculated in 2016 \n",
      "dollars because omb requested that agencies generate cost and benefit \n",
      "estimates in 2016 dollars under executive order 13771. if we were to \n",
      "represent wage estimates in 2017 dollars, then costs and benefits, \n",
      "including net benefits, would increase by 4%. for our final rule, we \n",
      "will consider using 2017 and even 2018 dollars, if available, for our \n",
      "cost and benefit estimates.\n",
      "    we welcome comments on our methodology for estimating labor costs.\n",
      "quantifying the estimated number of health it developers and products\n",
      "    in this section, we describe the methodology used to assess the \n",
      "potential impact of new 2015 edition certification criteria on the \n",
      "availability of certified products in the health it market. this \n",
      "analysis is based on the number of certified health it products (i.e., \n",
      "health it modules), product capability, and the number of health it \n",
      "developers that left, merged, and/or entered the health it market \n",
      "between the establishment of the program and implementation of the 2011 \n",
      "edition and the implementation of the 2014 edition.\\150\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\150\\ availability of 2014 cehrt for meaningful users providers, \n",
      "health it policy committee data update (sept. 9, 2015), available at \n",
      "<a href=\"http://www.healthit.gov/facas/sites/faca/files/hitpc_data_update_presentation_final_2015-09-09.pdf\">http://www.healthit.gov/facas/sites/faca/files/hitpc_data_update_presentation_final_2015-09-09.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    market consolidation may occur as a result of a natural evolvement \n",
      "of a new industry.\\151\\ we account for this factor in our analysis. in \n",
      "table 5 below, we quantify the extent to which the certified health it \n",
      "market consolidated between the 2011 edition and 2014 edition. we found \n",
      "that the number of health it developers certifying products between the \n",
      "2011 edition and 2014 edition decreased by 22.1% and the number of \n",
      "products available decreased by 23.2%.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\151\\ see graeme k. deans, fritz kroeger, and stefan zeisel, the \n",
      "consolidation curve (dec. 2002); j. david cummins and maria rubio-\n",
      "misas, deregulation, consolidation, and efficiency: evidence from \n",
      "the spanish insurance industry, journal of money, credit and \n",
      "banking, vol. 38, no. 2 (mar. 2006), at 323-55; martin gaynor and \n",
      "deborah haas-wilson, change, consolidation, and competition in \n",
      "health care markets, the journal of economic perspectives, vol. 13, \n",
      "no. 1 (winter 1999), at 141-64.\n",
      "\n",
      "          table 5--certified health it market consolidation from the 2011 edition to the 2014 edition a\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                                                      market\n",
      "                                                                   2011 edition    2014 edition    consolidation\n",
      "                                                                                                        (%)\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "health it developers............................................           1,017             792           -22.1\n",
      "products........................................................           1,408           1,081           -23.2\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\\a\\ for the purposes of these market consolidation calculations, we included the total number of active or\n",
      "  suspended health it products and their developers. withdrawn products and their developers were excluded from\n",
      "  this total.\n",
      "\n",
      "    not all products are certified to all of the edition's \n",
      "certification criteria available in the program. modular certification \n",
      "allows a health it developer to present a product for certification to \n",
      "a narrower scope of\n",
      "\n",
      "[[page 7562]]\n",
      "\n",
      "specific use cases, which may be impacted at differing levels or may \n",
      "not be impacted by the proposals in this proposed rule. therefore, we \n",
      "have estimated the number of 2015 edition certified health it products \n",
      "and health it developers impacted by each proposal using proxies from \n",
      "historical data. using the rates identified in table 5, we then applied \n",
      "our estimate for market consolidation to estimate the number 2015 \n",
      "edition certified health it products and health it developers that \n",
      "would be impacted by our policies in this proposed rule. specifically, \n",
      "to estimate the number of 2015 edition products and health it \n",
      "developers in the market, we have assumed:\n",
      "    1. products capable of recording ehi will include new certification \n",
      "criteria. we assume that products capable of recording patient health \n",
      "data will be the types of products most likely to be impacted by and \n",
      "include the new proposed certification criteria.\n",
      "    2. products capable of recording ehi data available in 2015 equal \n",
      "the number of products available in 2014. in 2014, there were 710 \n",
      "products by 588 developers capable of recording ehi. since the new \n",
      "criteria involve the access to and movement and exchange of ehi, we \n",
      "used only products that record ehi as a basis for our estimates. we \n",
      "believe the 2014 totals reflect a realistic estimate of the currently \n",
      "available products and their developers that could include the new 2015 \n",
      "certification criteria.\n",
      "    3. market consolidation rates denoted in table 5 hold constant. we \n",
      "assume that the rate of market consolidation for products (-23.2%) and \n",
      "health it developers (-22.1%) from the 2011 edition to the 2014 edition \n",
      "holds constant for the 2015 edition.\n",
      "    as shown in table 6 below, based on the assumptions 1-3 above, we \n",
      "have estimated the total number of 2015 products (545) and their \n",
      "developers (458).\n",
      "\n",
      " table 6--total number of health it developers and products by scenario\n",
      "------------------------------------------------------------------------\n",
      "                                             number of\n",
      "                scenario                     health it       number of\n",
      "                                            developers       products\n",
      "------------------------------------------------------------------------\n",
      "2015 edition projection--all products...             617             830\n",
      "2015 edition projection--products                    458             545\n",
      " capable of recording ehi...............\n",
      "------------------------------------------------------------------------\n",
      "\n",
      "number of end users that might be impacted by onc's proposed \n",
      "regulations\n",
      "    for the purpose of this analysis, the population of end users \n",
      "differs according to the regulatory action proposed. in many cases, the \n",
      "end user population impacted is the number of hospitals and health care \n",
      "providers that possess certified health it. due to data limitations, \n",
      "our analysis regarding the number of hospitals and health care \n",
      "providers impacted by the regulatory action is based on the number of \n",
      "hospitals and health care providers that have historically participated \n",
      "in the centers for medicare & medicaid services (cms) ehr incentive \n",
      "programs. although there are limitations to this approach, participants \n",
      "in the cms ehr incentive programs represent an adequate sample on which \n",
      "to base our estimates.\\152\\ we estimate 439,187 health care providers \n",
      "\\153\\ in 95,470 clinical practices \\154\\ and 4,519 hospitals \\155\\ will \n",
      "be impacted.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\152\\ see office of the national coordinator for health \n",
      "information technology, office-based health care professionals \n",
      "participating in the cms ehr incentive programs (aug. 2017), \n",
      "<a href=\"http://dashboard.healthit.gov/quickstats/pages/fig-health-care-professionals-ehr-incentive-programs.php\">dashboard.healthit.gov/quickstats/pages/fig-health-care-professionals-ehr-incentive-programs.php</a>; office of the national \n",
      "coordinator for health information technology, hospitals \n",
      "participating in the cms ehr incentive programs (aug. 2017), \n",
      "<a href=\"http://dashboard.healthit.gov/quickstats/pages/fig-hospitals-ehr-incentive-programs.php\">dashboard.healthit.gov/quickstats/pages/fig-hospitals-ehr-incentive-programs.php</a>.\n",
      "    \\153\\ this estimate is the total number of eligible providers \n",
      "that ever participated in the cms medicare and medicaid electronic \n",
      "health record incentive program.\n",
      "    \\154\\ this number was estimated based on the de-duplicated \n",
      "number of practices that had at least one clinician participate in \n",
      "the cms medicare electronic health record incentive program.\n",
      "    \\155\\ this estimate is the total number of eligible hospitals \n",
      "that ever participated in the cms medicare electronic health record \n",
      "incentive program.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "(1) deregulatory actions\n",
      "costs\n",
      "    we do not expect costs to be associated with the deregulatory \n",
      "action proposals.\n",
      "benefits\n",
      "    we expect the proposals for deregulatory actions to result in \n",
      "significant benefits for health it developers, providers, onc-acbs, \n",
      "onc-atls, and onc. these expected benefits are detailed below.\n",
      "1.1 removal of the randomized surveillance minimum threshold \n",
      "requirements\n",
      "    we have proposed to revise sec.  [thinsp]170.556(c) by revising the \n",
      "requirement that onc-acbs must conduct in-the-field, randomized \n",
      "surveillance and in its place specify that onc-acbs may conduct in-the-\n",
      "field, randomized surveillance. we have further proposed to remove \n",
      "sec.  [thinsp]170.556(c)(2), which specifies that onc-acbs must conduct \n",
      "randomized surveillance for a minimum of 2% of certified health it \n",
      "products per year. we have also proposed to remove the requirement that \n",
      "onc-acbs make a good faith effort to complete randomized surveillance \n",
      "and the circumstances permitted for exclusion from this requirement \n",
      "found in sec.  [thinsp]170.556(c)(5).\n",
      "    these proposals would reduce burden on health care providers by \n",
      "reducing their exposure to randomized in-the-field surveillance of \n",
      "their health it products. health care providers expressed concern about \n",
      "the time commitment to support onc-acb randomized surveillance of \n",
      "health it products, particularly if no non-conformities with certified \n",
      "health it were found. providers have generally stated that reactive \n",
      "surveillance (e.g., complaint-based surveillance) is a more logical and \n",
      "economical approach to surveillance of health it products implemented \n",
      "in a health care setting. the proposal in this proposed rule would \n",
      "provide health it developers more time to focus on interoperability. it \n",
      "would also provide onc-acbs more time to respond to reactive \n",
      "surveillance, including health care provider complaints about certified \n",
      "health it. in the 2015 edition final rule, we did not independently \n",
      "estimate the costs for randomized surveillance. rather, we relied on \n",
      "prior regulatory cost estimates for all surveillance actions. one of \n",
      "our onc-acbs charges a $3,000 annual fee per product for surveillance \n",
      "due to the new randomized surveillance requirements and to help \n",
      "normalize their revenue stream during down cycles between certification \n",
      "editions. using this fee as a cost basis and\n",
      "\n",
      "[[page 7563]]\n",
      "\n",
      "assuming it would apply to all certified health it (as opposed to the \n",
      "market-adjusted universe of health it that is used in other \n",
      "calculations in this ria), we estimate that our proposal to remove the \n",
      "randomized surveillance ``2% minimum threshold'' requirements would \n",
      "result in cost savings between $6.8 and $13.7 million for all \n",
      "stakeholders. to arrive at this estimate, we multiplied the $3,000 \n",
      "annual fee per product for surveillance by the total number of products \n",
      "certified to the 2014 edition which was 4,559 products at the time \n",
      "($3,000 * 4,559 = $13.7 million). we anticipate the number of products \n",
      "certified for 2014 to decrease to a little as half of the original \n",
      "count over time. therefore, we estimated the low end to be half of the \n",
      "$13.7 million (.5 * $13.7 million = $6.8 million). this estimate is \n",
      "based on feedback we received from our onc-atl and onc-acb \n",
      "stakeholders. onc-acbs performed randomized surveillance an average of \n",
      "22 times the first year the requirement was in effect. the following \n",
      "year surveillance was performed an average of 2 times. we cannot \n",
      "predict how many randomized surveillance events the onc-acbs will \n",
      "perform now that we are not enforcing the requirement. it will be \n",
      "completely at the discretion of the onc-acbs.\n",
      "    we note that we considered other potential benefits that we were \n",
      "unable to quantify. we considered that health care provider burden may \n",
      "decrease from the elimination of the 2% minimum threshold requirements \n",
      "because a provider would previously aid the onc-acb in software \n",
      "demonstrations. however, we acknowledge that in the long term and \n",
      "moving forward, providers will likely be the party reporting more of \n",
      "the complaints that could result in reactive surveillance. we also \n",
      "considered that an additional benefit of the proposal would be reduced \n",
      "burden on onc-acbs. feedback from onc-acbs indicates that having to \n",
      "meet a set number of surveillance activities in 12 months can be quite \n",
      "burdensome, especially when factoring in the active engagement \n",
      "necessary from provider participants. last, we considered the potential \n",
      "benefit to health it developers in having more surveillance focused on \n",
      "situations dealing with actual end-user concerns and/or difficulties. \n",
      "health it developers have indicated that they benefit from such \n",
      "surveillance, as feedback about conformance and capability can improve \n",
      "their products.\n",
      "    we welcome comments on potential means, methods, and relevant \n",
      "comparative studies and data that we could use to better quantify these \n",
      "benefits.\n",
      "1.2 removal of the 2014 edition from the code of federal regulations\n",
      "    we have proposed to remove the 2014 edition certification criteria \n",
      "from the code of federal regulations, which would directly benefit \n",
      "health it developers, onc-acbs, onc-atls, and onc and indirectly \n",
      "benefit health care providers. when looking at the cost savings for \n",
      "removing the 2014 edition certification criteria, we considered the \n",
      "current costs for maintaining those certifications and their \n",
      "surveillance (reactive), as well as the maintenance and administrative \n",
      "costs associated with supporting customer use of certified health it \n",
      "for cms ehr incentive program participation. the estimates below \n",
      "consider onc analysis of the financial sustainability of onc-acbs and \n",
      "reflect data from as late as 2015.\n",
      "    we estimate that health it developers would realize monetary \n",
      "savings from no longer supporting the 2014 edition certification \n",
      "criteria due to a reduction in activities related to maintaining \n",
      "certification and surveillance. we are aware that one of our onc-acbs \n",
      "charges an inherited certified status (ics) fee of $1,000. this fee has \n",
      "been applied over the last calendar year. over that time period, the \n",
      "number of new, unique 2014 edition products has been declining (24 \n",
      "products in the last calendar year, and no new products in the last \n",
      "four months) compared to the number of ics certifications (569). just \n",
      "assuming the cost of continued ics certification, health it developers \n",
      "would be paying approximately $569,000 each year to keep their 2014 \n",
      "edition products up-to-date.\n",
      "    we are not aware of comparable fees charged by onc-atls; however, \n",
      "based on our experience with the program, we expect health it \n",
      "developers would realize similar cost savings associated with onc-atl \n",
      "maintenance of the testing component associated with ics. thus, we \n",
      "estimate an additional $569,000 cost savings for health it developers \n",
      "due to the reduced testing requirements.\n",
      "    a recent study conducted by onc indicates that 2014 edition ics \n",
      "certification is not profitable for onc-acbs, which is why one onc-acb \n",
      "charged an additional $3,000 annual fee per product for surveillance \n",
      "for 2015 edition certifications. in 2015, the net income for onc-acbs \n",
      "dropped 99% from about $5,310,000 in 2014 to $67,000 due to a decline \n",
      "in revenue from a drop in new 2014 edition certified health it products \n",
      "without a significant drop in expenses. we do not have enough \n",
      "information to calculate what percentage of onc-acb expenses are the \n",
      "direct result of 2014 edition certification maintenance; however, our \n",
      "research indicates that it is significantly less profitable for onc-\n",
      "acbs to maintain 2014 edition certification criteria (e.g., through ics \n",
      "attestation and reactive surveillance) than to certify new 2014 edition \n",
      "certified health it products.\n",
      "    we also attempted to identify a potential reduction in maintenance \n",
      "and administrative costs as a result of removing 2014 edition \n",
      "certification criteria. we could not obtain data to conduct a full \n",
      "quantitative analysis specific to the reduction of health it developer \n",
      "and health care provider costs related to supporting and maintaining \n",
      "the 2014 edition. we seek comment on methods to quantify potential \n",
      "costs for maintaining and supporting products to previous editions.\n",
      "    we did conduct a review of academic literature and qualitative \n",
      "analysis regarding potential savings from no longer supporting the 2014 \n",
      "edition. we looked at data in it industry systems as whole, which \n",
      "showed that upgrading outdated legacy systems saves resources otherwise \n",
      "spent on maintaining compatibilities to multiple systems and also \n",
      "increases quality and efficiency.\\156\\ furthermore, as technology \n",
      "evolves, newer software and products allow for smoother updates \n",
      "compared to their predecessors. newer products provide better security \n",
      "features that are able to address both new and existing issues. in \n",
      "addition, older software has an increased risk of failure, which, in \n",
      "the health it industry, increases risk to patient safety.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\156\\ james crotty and ivan horrocks, managing legacy system \n",
      "costs: a case study of a meta-assessment model to identify solutions \n",
      "in a large financial services company, applied computing and \n",
      "informatics (2017), at 1-9.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    from the implementer's perspective, the research indicates that \n",
      "retaining legacy systems tends to inhibit scalability and growth for \n",
      "businesses. the perpetuity of outdated legacy systems increases \n",
      "connection and system integration costs and limits the ability to \n",
      "realize increased efficiency through it implementation. newer products \n",
      "are developed to current specifications and updated standards, which \n",
      "decreases barriers and marginal cost of ancillary product \n",
      "implementation and increases the accessibility of data in ancillary \n",
      "systems--including via mobile devices and the latest applications. \n",
      "finally, office staff in a health care setting would no longer need to \n",
      "be trained to accommodate differing data access\n",
      "\n",
      "[[page 7564]]\n",
      "\n",
      "needs or workarounds required to integrate to the legacy product.\\157\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\157\\ id.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the research also indicates that retaining legacy software would \n",
      "not be beneficial or profitable to the health it market. prolonging \n",
      "backwards compatibility of newer products to legacy systems encourages \n",
      "market fragmentation.\\158\\ limiting fragmentation encourages innovation \n",
      "and attracts more developers by reducing barriers and the marginal cost \n",
      "of development to multiple platforms. health it stakeholders have \n",
      "expressed that system fragmentation increases the cost to develop and \n",
      "maintain health it connectivity for data exchange and to integrate \n",
      "software supporting administrative and clinical processes, as well as \n",
      "limiting the feasibility of developing products to support specialty \n",
      "clinical care. this direct feedback suggests that fragmentation is \n",
      "having a negative impact on the interoperability and usability of \n",
      "health it systems for health care providers. we intend to encourage the \n",
      "health it market to keep progressing with a baseline expectation of \n",
      "functionalities that evolve over time. this requires limiting \n",
      "fragmentation by no longer supporting outdated or obsolete legacy \n",
      "software.\\159\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\158\\ il-horn hann, byungwan koh, and marius f. niculescu, the \n",
      "double-edged sword of backward compatibility: the adoption of \n",
      "multigenerational platforms in the presence of intergenerational \n",
      "services, inform. systems res. (2016), at 112-30.\n",
      "    \\159\\ id.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we also estimate that additional savings could be realized by \n",
      "reducing regulatory complexity and burden caused by having two \n",
      "certification editions. for example, in the 2015 edition final rule, we \n",
      "added new requirements, such as disclosure and transparency \n",
      "requirements, that applied to all certified product editions. this \n",
      "required significant effort by health it developers and onc-acbs to \n",
      "execute the requirements, and both groups found it challenging to \n",
      "complete the task in the original timeframe provided by onc. we have \n",
      "observed that the task of managing two different editions within \n",
      "different rules increases complexity and burden for onc staff, \n",
      "contractors, onc-acbs, cms programs referencing the certification \n",
      "criteria, and other stakeholders, as compared to our proposal to remove \n",
      "the 2014 edition certification criteria. however, we are unable to \n",
      "estimate these benefits because we have no means for quantifying the \n",
      "benefits gained from only using the 2015 edition. we welcome comments \n",
      "on potential means, methods, and relevant comparative studies and data \n",
      "that we could use to quantify these benefits.\n",
      "    we also expect that health care providers would benefit from this \n",
      "proposal because such action would likely motivate health it developers \n",
      "to certify health it products to the 2015 edition, thus enabling \n",
      "providers to use the most up-to-date and supported systems to care for \n",
      "patients. the 2015 edition certification criteria facilitates greater \n",
      "interoperability for several clinical health information purposes and \n",
      "enables health information exchange, including apis, through new and \n",
      "enhanced certification criteria, standards, and implementation \n",
      "specifications. the certification criteria also allow for updates to \n",
      "documents and data standards and focus on the establishment of an \n",
      "interoperable health information infrastructure. we welcome comments on \n",
      "potential means, methods, and relevant comparative studies and data \n",
      "that we could use to quantify these benefits.\n",
      "1.3 removal of the onc-approved accreditor from the onc health it \n",
      "certification program\n",
      "    we expect onc to realize monetary cost savings from the proposal to \n",
      "remove the onc- approved accreditor (onc-aa) from the program. we \n",
      "expect onc to realize costs savings from no longer: (1) developing and \n",
      "publishing a federal register notice and listserv; (2) monitoring the \n",
      "open application period and reviewing and making decisions regarding \n",
      "applications; and (3) oversight and enforcement of the onc-aa. we have \n",
      "calculated the estimated annual cost savings for this proposal, taking \n",
      "into consideration that the onc-aa renewed its status every three \n",
      "years.\n",
      "    the onc-aa's expertise is in the iso/iec 17065 standard. therefore, \n",
      "to effectively collaborate with the onc-aa for program activities, onc \n",
      "allocates resources for working with the onc-aa and informing the onc-\n",
      "aa of scheme requirements and applicable policy interpretations, which \n",
      "we have and can provide directly to the onc-acbs. the amount of onc \n",
      "resources allocated depends on current program activities and need. for \n",
      "our calculations, we used the estimated hours for collaborating with \n",
      "and informing an onc-aa in 2017 (using 2016 wage estimates). we \n",
      "estimate that onc spent approximately 110 hours collaborating with the \n",
      "onc-aa in 2017, which includes (all at the gs-13, step 1 level): annual \n",
      "assessments; providing appropriate guidance; implementing new \n",
      "requirements and initiatives; and consultations as necessary. the \n",
      "hourly wage with benefits for a gs-13, step 1 employee located in \n",
      "washington, dc is approximately $88.30. therefore, we estimate the \n",
      "annual cost savings to be $3,238.\n",
      "    we estimate that onc would commit approximately eight hours of \n",
      "staff time to develop the federal register notice, which would include \n",
      "approximately: four hours for drafting and review by an analyst at the \n",
      "gs-13, step 1 level; two hours for review and analysis by senior \n",
      "certification staff at the gs-14, step 1 level; and two hours for \n",
      "review and submittal for publication by immediate office staff at the \n",
      "gs-15, step 1 level. the hourly wage with benefits for a gs-13, step 1 \n",
      "employee located in washington, dc is approximately $88.30. the hourly \n",
      "wage with benefits for a gs-14, step 1 employee located in washington, \n",
      "dc is approximately $104.34. the hourly wage with benefits for a gs-15, \n",
      "step 1 employee located in washington, dc is approximately $122.74. \n",
      "therefore, we estimate the annual cost savings to be $269. \n",
      "additionally, we estimate a cost of $477 to publish each page in the \n",
      "federal register, which includes operational costs. the federal \n",
      "register notice for onc-aas requires, on average, one page in the \n",
      "federal register (every three years), so we estimate an additional \n",
      "annual cost savings of $159.\n",
      "    we estimate that onc would commit approximately two hours of staff \n",
      "time by an analyst at the gs-13, step 1 level to draft, review, and \n",
      "publish the listserv to announce the federal register notice. the \n",
      "hourly wage with benefits for a gs-13, step 1 employee located in \n",
      "washington, dc is approximately $88.30. therefore, we estimate the \n",
      "annual cost savings to be $59.\n",
      "    we estimate that onc would commit approximately 25 hours of staff \n",
      "time to manage the open application process, review applications and \n",
      "reach application decisions, which would include approximately: 20 \n",
      "hours by an analyst at the gs-13, step 1 level; three hours by senior \n",
      "certification staff at the gs-14, step 1 level; and two hours for \n",
      "review and approval by immediate office staff at the gs-15, step 1 \n",
      "level. the hourly wage with benefits for a gs-13, step 1 employee \n",
      "located in washington, dc is approximately $88.30. the hourly wage with \n",
      "benefits for a gs-14, step 1 employee located in washington, dc is \n",
      "approximately $104.34. the hourly wage with benefits for a gs-15, step \n",
      "1 employee located in washington, dc is approximately $122.74. \n",
      "therefore, we estimate the annual cost savings to be $775.\n",
      "    taking all of these potential costs savings into consideration, we \n",
      "estimate\n",
      "\n",
      "[[page 7565]]\n",
      "\n",
      "the overall annual costs savings for our proposal to remove the onc-aa \n",
      "from the program to be $4,500.\n",
      "1.4 removal of certain 2015 edition certification criteria\n",
      "    in section iii.b.4 of this proposed rule, we propose to remove the \n",
      "following certification criteria from the 2015 edition: sec.  \n",
      "170.315(b)(4) ``common clinical data set summary--create;'' (b)(5) \n",
      "``common clinical data set summary--receive'', sec.  170.315(a)(10) \n",
      "``drug formulary and preferred drug list checks,'' sec.  170.315(a)(11) \n",
      "``smoking status,''sec.  170.315(a)(13) ``patient-specific education \n",
      "resources'' and sec.  170.315(e)(2) ``secure messaging.''\n",
      "    for determining calculations for the majority of the proposed \n",
      "removal of certain 2015 edition certification criteria, we used the \n",
      "assumptions below. for the proposed removal of sec.  170.315(b)(4) \n",
      "common clinical data set summary--create and (b)(5) common clinical \n",
      "data set summary--receive, we took a slightly different approach \n",
      "discussed in section 1.4.1.\n",
      "    in the 2015 edition final rule, we estimated the costs for \n",
      "developing and preparing health it to meet the 2015 edition \n",
      "certification criteria. the development and preparation costs we \n",
      "estimated were derived through a health it developer per criterion \n",
      "cost. we estimated the development and preparation costs over a four-\n",
      "year period and we projected the costs would be unevenly distributed. \n",
      "in figuring out the cost savings for the deregulatory actions, we \n",
      "initially used the distribution from the 2015 edition, but then \n",
      "adjusted the percentages of development and preparation costs due to \n",
      "current empirical and anecdotal evidence. the distribution was \n",
      "reevaluated to account for 2019 and we estimate the actual development \n",
      "and preparation distribution for 2018 to be 35% and for 2019 to be 15%. \n",
      "we took the average development and preparation cost estimates (low and \n",
      "high) per criterion from table 14 of the 2015 edition final rule (80 fr \n",
      "62737). we then used our new distribution to figure out the cost per \n",
      "year for years 2018 and 2019. we took the total estimated costs for \n",
      "2018 and 2019 and divided that by 12 to determine the cost savings per \n",
      "month and took a range of 6-12 months.\n",
      "    to determine the testing costs of the deregulatory actions, we took \n",
      "the number of health it developers who develop products for \n",
      "certification for the identified criteria from the 2015 edition final \n",
      "rule and then figured out the average cost per criterion. based on the \n",
      "costs that one of the onc-atls charges for testing, we estimated the \n",
      "average cost for testing per criterion and determined subsequent cost \n",
      "savings. in 2017, only about five to ten percent of products have been \n",
      "tested and certified compared to the number of certified 2014 edition \n",
      "products. therefore, up to 90 to 95 percent of products remain to be \n",
      "tested and certified to the 2015 edition.\n",
      "    we estimate the total cost savings by multiplying the number of \n",
      "health it developers who developed products for certification to a \n",
      "certain criterion by the estimated cost per criterion, $475. we then \n",
      "took five percent of that number to figure out the high end for the \n",
      "cost savings. we then took 10 percent to figure out the low end. the \n",
      "five percent was derived from looking at the number of unique \n",
      "developers who have at least one active 2014 edition product and the \n",
      "number of unique developers who have at least one active 2015 edition. \n",
      "the denominator is the number of unique developers who have at least \n",
      "one active 2014 edition product, which is 793. the numerator is the \n",
      "number of unique developers who have at least one active 2015 edition \n",
      "product and one active 2014 edition product, which is 41. (41/793 = \n",
      "0.0517024 or 5 percent).\n",
      "1.4.1 common clinical data set summary record criteria\n",
      "    we propose to remove the common clinical data set summary--create \n",
      "(sec.  170.315(b)(4)) and common clinical data set summary--receive \n",
      "(sec.  170.315(b)(5)) criteria.\n",
      "    we expect onc to realize cost savings associated with internal \n",
      "infrastructure support and maintenance, which would include actions \n",
      "such as (1) developing and maintaining information regarding these \n",
      "criteria on the onc website; (2) creating documents related to these \n",
      "criteria and making those documents 508 compliant; (3) updating, \n",
      "revising, and supporting certification companion guides, test \n",
      "procedures, and test tools; and (4) responding to inquiries concerning \n",
      "these criteria. based on onc data on the number of inquiries received \n",
      "since early 2016, we estimate approximately 12 annual inquiries about \n",
      "sec.  170.315(b)(4) and (5) respectively (24 total inquiries for two \n",
      "criteria). we estimate it will take an analyst at the gs-13, step 1 \n",
      "level an average of two hours to conduct all tasks associated with each \n",
      "inquiry. the hourly wage with benefits for a gs-13, step 1 employee \n",
      "located in washington, dc is approximately $88.30. therefore, we \n",
      "estimate the annual cost savings to be $4,238.\n",
      "    we do not expect cost savings associated with software maintenance \n",
      "because both of these criteria incorporate the common clinical data set \n",
      "and essentially the same data input and validation requirements as the \n",
      "transitions of care criterion (sec.  170.315(b)(1)). the removal of \n",
      "these two criteria would not affect the test data and software \n",
      "maintenance costs, as the same test data and software validation \n",
      "elements remain in sec.  170.315(b)(1) and the common clinical data set \n",
      "used in other criteria.\n",
      "    onc-acbs could realize minimal savings, as they would need to \n",
      "conduct slightly less surveillance based on the two products that are \n",
      "currently certified to these criteria. we expect these potential cost \n",
      "savings to be de minimis and have therefore not estimated them.\n",
      "    taking all these potential costs savings into consideration, we \n",
      "estimate the overall annual costs savings for our proposal to remove \n",
      "the common clinical data set summary record certification criteria from \n",
      "the 2015 edition to be $4,238. we welcome comments on the above \n",
      "estimates and methods we could use to better quantify these benefits.\n",
      "1.4.2 drug formulary and preferred drug list checks\n",
      "    we propose to remove the 2015 edition ``drug formulary and \n",
      "preferred drug list checks'' criterion in sec.  170.315(a)(10)). to \n",
      "calculate the cost savings for removing this criterion, we used the \n",
      "2015 edition estimated costs for development and preparation for this \n",
      "criterion which were between $15,750 and $31,500. we believe that 35% \n",
      "of developers would be still newly certifying in 2018 and 15% in 2019 \n",
      "and applied the proportions respectively. we estimated the cost of \n",
      "development and preparation costs to be between $5,512.50 and $11,025 \n",
      "for 2018 and $2,362.50 and $4,725 for 2019. we calculated the cost per \n",
      "month for years 2018 and 2019 and using the high point estimates, \n",
      "estimated the development and preparation costs over a 6 to 12 month \n",
      "period between august 2018 to august 2019 to be between $4,068.75 and \n",
      "$6,825.\n",
      "    to calculate the cost for testing for this criterion, we multiplied \n",
      "the 5 developers that we estimated in the 2015 edition to develop \n",
      "products to this criterion by our estimated cost to test per criterion \n",
      "of $475. the estimated cost per criterion was based on what one onc-atl \n",
      "charged for testing and averaged per criterion. to be conservative in \n",
      "our calculations, we reduced the number by 10% and 5% respectively \n",
      "resulting in $2,137.50 and $2,256.25.\n",
      "    taking these estimated costs into account we expect cost savings to\n",
      "\n",
      "[[page 7566]]\n",
      "\n",
      "remove the 2015 edition ``drug formulary and preferred drug list \n",
      "checks'' criterion to be between $8,962.50 and $9,081.25.\n",
      "1.4.3 smoking status\n",
      "    we propose to remove the 2015 edition ``smoking status'' criterion \n",
      "(sec.  170.315(a)(11)), which would include removing it from the 2015 \n",
      "edition base ehr definition. to calculate the cost savings for removing \n",
      "this criterion, we used the 2015 edition estimated costs of developing \n",
      "and preparing the criterion to the 2015 edition, between $15,750 and \n",
      "$31,500 and estimated that 35% of developers would be newly certified \n",
      "in 2018 and 15% in 2019. we estimated the cost of development and \n",
      "preparation costs to be between $5,512.50 and $11,025 for 2018 and \n",
      "$2,362.50 and $4,725 for 2019. we calculated the cost per month for \n",
      "years 2018 and 2019 and using the high point estimates, estimated the \n",
      "development and preparation costs over a 6 to 12 month period between \n",
      "august 2018 and august 2019. we estimated the costs to be between \n",
      "$4,068.75 at 6 months and $6,825 at 12 months.\n",
      "    to calculate the cost for testing for this criterion, 5 developers \n",
      "were estimated in the 2015 edition to develop products to this \n",
      "criterion. we multiplied the 5 developers by our estimated cost to test \n",
      "per criterion of $475. this estimated cost per criterion was based on \n",
      "what one onc-atl charged for testing and averaged per criterion. to be \n",
      "conservative, we reduced the number by 10% and 5% respectively \n",
      "resulting in $2,137.50 and $2,256.25.\n",
      "    taking these estimated costs into account we expect cost savings to \n",
      "remove the 2015 edition ``smoking status'' criterion to be between \n",
      "$8,962.50 and $9,081.25.\n",
      "1.4.4 patient-specific education resources\n",
      "    we propose to remove the 2015 edition ``patient-specific education \n",
      "resources'' certification criterion (sec.  170.315(a)(13)). to estimate \n",
      "the cost of removing this criterion, we used the 2015 edition estimated \n",
      "costs for development and preparation which is between $4,709,880 and \n",
      "$6,279,840. we believe that 35% of developers would be still newly \n",
      "certifying in 2018 and 15% in 2019 and applied the proportions \n",
      "respectively. we estimated the cost of development and preparation to \n",
      "be between $1,648,458 and $2,197,944 for 2018 and $706,482 and $941,976 \n",
      "for 2019. we calculated the cost per month for years 2018 and 2019 and \n",
      "using the high point estimates, estimated the development and \n",
      "preparation costs over a 6 to 12 month period, within august 2018 to \n",
      "august 2019. we estimated the costs to be between $850,395 at 6 months \n",
      "and $1,360,632 at 12 months. to calculate the testing cost for this \n",
      "criterion, we multiplied the estimates from the 2015 edition of 249 \n",
      "developers that we estimated would develop products to this criterion \n",
      "by our estimated cost to test per criterion of $475. the estimated cost \n",
      "per criterion was based on what one onc-atl charged for testing and \n",
      "averaged per criterion. to be conservative, we reduced the number by \n",
      "10% and 5% respectively resulting in $106,447.50 and $112,361.25. \n",
      "taking these estimated costs into account, we expect the cost savings \n",
      "of removing the 2015 edition ``patient-specific education resources'' \n",
      "criterion to be between $1,467,079.50 and $1,472,993.25.\n",
      "1.4.5 secure messaging\n",
      "    we propose to remove the 2015 edition ``secure messaging'' \n",
      "criterion (sec.  170.315(e)(2)). to estimate the cost savings of \n",
      "removing this criterion, we used the estimates from the 2015 edition \n",
      "final rule for development and preparation costs which is between \n",
      "$1,552,320 and $3,104,640. we estimated that 35% of developers would be \n",
      "still newly certifying in 2018 and 15% in 2019 and applied the \n",
      "proportions respectively. we estimated the cost of development and \n",
      "preparation costs to be between $543,312 and $1,086,624 for 2018 and \n",
      "$232,848 and $465,696 for 2019. we then calculated the cost per month \n",
      "for years 2018 and 2019 and using the high point estimates, estimated \n",
      "the development and preparation costs over a 6 to 12 month period, \n",
      "between august 2018 to august 2019 to be between $401,016 at 6 months \n",
      "and $672,672 at 12 months. to calculate the cost for testing this \n",
      "criterion, we multiplied the 246 developers that we estimated in the \n",
      "2015 edition would develop products to this criterion by our estimated \n",
      "cost to test per criterion of $475. the estimated cost per criterion \n",
      "was based on what one onc-atl charged for testing and averaged per \n",
      "criterion. to be conservative, we reduced the number by 10% and 5%, \n",
      "respectively, resulting in $105,165 and $111,007.50. taking these \n",
      "estimated costs into account, we estimate the cost savings of removing \n",
      "the 2015 edition ``secure messaging'' criterion to be between $777,837 \n",
      "and $783,678.50.\n",
      "1.5 removal of certain certification requirements\n",
      "    we propose to remove sec.  170.523(k)(1)(iii)(b), which requires \n",
      "onc-acbs to ensure that certified health it includes a detailed \n",
      "description of all known material information concerning limitations \n",
      "that a user may encounter in the course of implementing and using the \n",
      "certified health it, whether to meet ``meaningful use'' objectives and \n",
      "measures or to achieve any other use within the scope of the health \n",
      "it's certification. we also propose to remove sec.  \n",
      "170.523(k)(1)(iv)(b) and (c), which state that the types of information \n",
      "required to be disclosed include but are not limited to: (b) \n",
      "limitations, whether by contract or otherwise, on the use of any \n",
      "capability to which technology is certified for any purpose within the \n",
      "scope of the technology's certification; or in connection with any data \n",
      "generated in the course of using any capability to which health it is \n",
      "certified; (c) limitations, including but not limited to technical or \n",
      "practical limitations of technology or its capabilities, that could \n",
      "prevent or impair the successful implementation, configuration, \n",
      "customization, maintenance, support, or use of any capabilities to \n",
      "which technology is certified; or that could prevent or limit the use, \n",
      "exchange, or portability of any data generated in the course of using \n",
      "any capability to which technology is certified.\n",
      "    to calculate the savings related to removing these two disclosure \n",
      "requirements, we estimated 830 products certified to the 2015 edition. \n",
      "we did so by applying the market consolidation rate of -23.2% which was \n",
      "the rate observed between 2011 and 2014 editions. assuming that an onc-\n",
      "acb spends 1 hour on average reviewing costs, limitations and mandatory \n",
      "disclosures, we estimate the time saved by no longer having to review \n",
      "the limitations to be two-thirds of an hour. the hourly wage with \n",
      "benefits for a gs-13, step 1 employee located in washington, dc is \n",
      "approximately $88.30 and we assume this to be the hourly rate for an \n",
      "onc-acb reviewer. we multiplied 830, the projected number of certified \n",
      "products, by two- thirds of an hour and the assumed hourly rate and \n",
      "calculated the cost savings to be $48,859.\n",
      "(2) updates to the 2015 edition certification criteria\n",
      "    the following section details the costs and benefits for updates to \n",
      "the 2015 edition health it certification criteria, which includes (1) \n",
      "costs and benefits to update certain 2015 edition criteria to due to \n",
      "the adoption of the united states core data for interoperability \n",
      "(uscdi) as a standard and (2) costs for new 2015 edition criteria for \n",
      "electronic health\n",
      "\n",
      "[[page 7567]]\n",
      "\n",
      "information export, api, privacy and security, and data segmentation \n",
      "for privacy (ds4p)-send and data segmentation for privacy-receive, and \n",
      "consent management for apis.\n",
      "2.1 united states core data for interoperability\n",
      "    in order to advance interoperability by ensuring compliance with \n",
      "new structured data and code sets that support the data, we propose in \n",
      "this proposed rule to remove the ``common clinical data set'' \n",
      "definition and its references from the 2015 edition and replace it with \n",
      "the ``united states core data for interoperability'' (uscdi) standard, \n",
      "naming version 1 (v1) in sec.  170.213 and incorporating it by \n",
      "reference in sec.  170.299. the uscdi v1 establishes a minimum set of \n",
      "data classes (including structured data) that are required for health \n",
      "it to be interoperable nationwide and is designed to be expanded in an \n",
      "iterative and predictable way over time.\n",
      "    the uscdi v1 adds 2 new data classes, ``clinical notes'' and \n",
      "``provenance'' that were not defined in the ccds, which will require \n",
      "updates to the consolidated clinical document architecture (c-cda) \n",
      "standard and updates to the following certification criteria: sec.  \n",
      "170.315(b)(1) (transitions of care); (e)(1) (view, download, and \n",
      "transmit to 3rd party); (g)(6) (consolidated cda creation performance); \n",
      "(f)(5) (transmission to public health agencies--electronic case \n",
      "reporting); and (g)(9) (application access--all data request). from our \n",
      "analysis of the c-cda standard, we conclude that the requirements of \n",
      "``provenance'' data class are already met by the existing c-cda \n",
      "standard, and will not require any new development. therefore, we have \n",
      "estimated the proposed cost to health it developers to add support for \n",
      "``clinical notes'' data class in c-cda, and the necessary updates to \n",
      "the affected certification criteria. these estimates are detailed in \n",
      "table 7 below and are based on the following assumptions:\n",
      "    1. health it developers will use the same labor costs and data \n",
      "models. table 7 shows the estimated labor costs per product for a \n",
      "health it developer to develop support for the additional uscdi data \n",
      "element in the c-cda standard and affected certification criteria. we \n",
      "recognize that health it developer costs will vary; however, our \n",
      "estimates in this section assume all health it developers will incur \n",
      "the costs noted in table 7.\n",
      "    2. a proxy is needed to project the number of 2015 edition \n",
      "certified health it products. we estimate that 545 products from 458 \n",
      "developers will be affected by our proposal. our proxy is based on the \n",
      "number of 2014 edition certified health it products that are capable of \n",
      "recording patient data.\\160\\ there were 710 products by 588 developers \n",
      "with at least one 2014 edition product capable of recording patient \n",
      "data. we then multiplied these numbers by our certified health it \n",
      "market consolidation estimates of -22.1% and -23.2% to project the \n",
      "number of 2015 developers and products, respectively.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\160\\ we defined ``products capable of recording patient data'' \n",
      "as any 2014 edition health it product that was certified for at \n",
      "least one of the following criteria: demographics ((a)(5)), \n",
      "medication list ((a)(7)), medication allergy list ((a)(8)), problem \n",
      "list ((a)(6)), and family health history ((a)(12)).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    3. according to the may 2016 bls occupational employment \n",
      "statistics, the mean hourly wage for a ``software developer'' is \n",
      "$50.14.\\161\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\161\\ <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "\n",
      "    table 7--costs to health it developers to develop support for the additional uscdi data element in c-cda\n",
      "                                  standard and affected certification criteria\n",
      "                                                 [2016 dollars]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                             lower bound     upper bound\n",
      "               tasks                       details              hours           hours             remarks\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "update c-cda creation)............  new development to                800           1,800  (1) lower bound\n",
      "                                     support ``clinical                                     assumes health it\n",
      "                                     notes'' for c-cda                                      already has\n",
      "                                     and c-cda 2.1                                          developed c-cda r2.1\n",
      "                                     companion guide.                                       into their system\n",
      "                                                                                            and only needs to be\n",
      "                                                                                            updated for new data\n",
      "                                                                                            class.\n",
      "                                                                                           (2) upper bound\n",
      "                                                                                            estimates effort for\n",
      "                                                                                            organizations that\n",
      "                                                                                            are on older\n",
      "                                                                                            versions of c-cda\n",
      "                                                                                            standard, for\n",
      "                                                                                            example c-cda r1.1.\n",
      "sec.   170.315(b)(1) (transitions   new development to                200             600  necessary updates to\n",
      " of care).                           support ``clinical                                     health it to support\n",
      "                                     notes'' for c-cda                                      the new data class\n",
      "                                     and c-cda                                              to meet the criteria\n",
      "                                     2.1companion guide.                                    requirements.\n",
      "sec.   170.315(b)(6) (data export)  new development to                300             800  necessary updates to\n",
      "                                     support ``clinical                                     health it to support\n",
      "                                     notes'' for c-cda                                      the new data class\n",
      "                                     and c-cda 2.1                                          to meet the criteria\n",
      "                                     companion guide.                                       requirements.\n",
      "sec.   170.315(e)(1) (view,         new development to                400           1,000  necessary updates to\n",
      " download, and transmit to 3rd       support ``clinical                                     health it to support\n",
      " party).                             notes'' for c-cda                                      the new data class\n",
      "                                     and c-cda                                              to meet the criteria\n",
      "                                     2.1companion guide.                                    requirements.\n",
      "sec.   170.315(g)(6) (consolidated  new development to                200             600  170.315(b)(1) and\n",
      " cda creation performance).          support ``clinical                                     sec.   170.315(g)(6)\n",
      "                                     notes'' for c-cda                                      are related and may\n",
      "                                     and c-cda 2.1                                          be developed\n",
      "                                     companion guide.                                       together.\n",
      "                                                          --------------------------------\n",
      "    total hours...................  .....................           1,900           4,800  .....................\n",
      "                                                          --------------------------------\n",
      "    hourly rate...................  .....................              $100.28\n",
      "                                                          --------------------------------\n",
      "    cost per product..............  .....................        $190,532        $481,344  .....................\n",
      "                                                          --------------------------------\n",
      "    total cost (545 products).....  .....................         $103.8m         $262.3m  .....................\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "[[page 7568]]\n",
      "\n",
      "    we estimate that the cost to a health it developer to develop \n",
      "support for the additional uscdi data element would range from $190,532 \n",
      "to $481,344. therefore, assuming 545 products, we estimate that the \n",
      "total annual cost to all health it developers would, on average, range \n",
      "from $103.8 million to $262.3 million. this would be a one-time cost to \n",
      "developers per product that is certified to the specified certification \n",
      "criteria and would not be perpetual.\n",
      "    we believe this proposal would benefit health care providers, \n",
      "patients, and the industry as a whole. clinical notes and provenance \n",
      "were included in the draft uscdi v1 based on significant feedback from \n",
      "the industry, which highly regarded their desirability as part of \n",
      "interoperable exchanges. the free text portion of the clinical notes \n",
      "was most often relayed by clinicians as the data they sought, but were \n",
      "often missing during electronic health information exchange. similarly, \n",
      "the provenance of data was also referenced by stakeholders as a \n",
      "fundamental need to improve the trustworthiness and reliability of the \n",
      "data being exchanged. we expect improvements to interoperable exchange \n",
      "of information and data provenance to significantly benefit providers \n",
      "and patients. however, we are not aware of an approach for quantifying \n",
      "these benefits and welcome comments on potential approaches to \n",
      "quantifying these benefits.\n",
      "2.2 electronic health information export\n",
      "    we have proposed a new 2015 edition certification criterion for \n",
      "``electronic health information export'' in sec.  170.315(b)(10). the \n",
      "intent of this criterion is to provide patients and health it users a \n",
      "means to efficiently export the entire electronic record for a single \n",
      "patient or all patients in a computable, electronic format. further, it \n",
      "would facilitate the receiving health it system's interpretation and \n",
      "use of the ehi to the extent reasonably practicable using the health it \n",
      "developer's existing technology. this outcome would promote exchange, \n",
      "access, and use of electronic health information. it would also \n",
      "facilitate health care providers' ability to switch health it systems \n",
      "or migrate electronic health information for use in other technologies. \n",
      "this proposed criterion supports two specific use cases. first, it \n",
      "supports the export for a single patient that would need to be enabled \n",
      "upon valid request from a user or a patient. second, the ehi export \n",
      "functionality for all patients' data would support a health care \n",
      "provider or health system in switching health it systems.\n",
      "costs\n",
      "    this section describes the estimated costs of the ``electronic \n",
      "health information export'' certification criterion. the cost estimates \n",
      "are based on the following assumptions:\n",
      "    1. health it developers will use the same labor costs and data \n",
      "models. table 8 shows the estimated labor costs per product for a \n",
      "health it developer to develop and maintain the electronic health \n",
      "information export functionality. we recognize that health it developer \n",
      "costs will vary; however, our estimates in this section assume all \n",
      "health it developers will incur the costs noted in table 8.\n",
      "    2. a proxy is needed to project the number of 2015 edition \n",
      "certified health it products containing the ``electronic health \n",
      "information export'' certification criterion. we estimate that 545 \n",
      "products from 458 developers will contain the ``electronic health \n",
      "information export'' criterion. to develop these estimates we first \n",
      "identified a proxy for the number of health it developers that may \n",
      "create a 2015 edition certified health it product containing the \n",
      "``electronic health information export'' criterion. our proxy is based \n",
      "on the number of 2014 edition certified health it products that are \n",
      "capable of recording patient data.\\162\\ we based our estimates on these \n",
      "products because data must be captured to be exported under the \n",
      "proposed criterion. there were 710 products by 588 developers with at \n",
      "least one 2014 edition product capable of recording patient data. we \n",
      "then multiplied these numbers by our certified health it market \n",
      "consolidation estimates of -22.1% and -23.2% to project the number of \n",
      "2015 developers and products, respectively.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\162\\ we defined ``products capable of recording patient data'' \n",
      "as any 2014 edition product that was certified for at least one of \n",
      "the following criteria: demographics ((a)(5)), medication list \n",
      "((a)(7)), medication allergy list ((a)(8)), problem list ((a)(6)), \n",
      "and family health history ((a)(12)).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    3. according to the may 2016 bls occupational employment \n",
      "statistics, the mean hourly wage for a ``software developer'' is \n",
      "$50.14.\\163\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\163\\ <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "\n",
      "  table 8--estimated labor costs to develop and maintain the electronic health information export criterion per\n",
      "                                                     product\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                               lower bound     upper bound\n",
      "                  activity                        hours           hours                    remarks\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "task 1: developing the data dictionary and              160           1,600  this is the effort to document all\n",
      " exporting the ehi in a developer format                                      the data exported by the product\n",
      " (per product).                                                               for a single patient and for all\n",
      "                                                                              patients. the lower bound assumes\n",
      "                                                                              that the health it developer\n",
      "                                                                              already has a standard format in\n",
      "                                                                              which they are exporting the data\n",
      "                                                                              for either case (e.g., c-cda for\n",
      "                                                                              single patient, csv file or\n",
      "                                                                              database dump for all data) and\n",
      "                                                                              the effort is merely to publish it\n",
      "                                                                              to the users. on the other hand,\n",
      "                                                                              the upper bound reflects the case\n",
      "                                                                              where the health it has to develop\n",
      "                                                                              the export capability de novo into\n",
      "                                                                              their product, and document the\n",
      "                                                                              data output. this still assumes\n",
      "                                                                              that the developer will be able to\n",
      "                                                                              use the format of their choice.\n",
      "                                                                             note: this is a one-time cost to\n",
      "                                                                              develop the export capability.\n",
      "task 2: maintaining the data dictionary and              80             800  this is the annual maintenance cost\n",
      " performing export when requested (per                                        charged by health it developers to\n",
      " product).                                                                    provide c-cda feed to providers.\n",
      "                                                                              this is a yearly update to\n",
      "                                                                              products that are typically\n",
      "                                                                              modest. the lower bound estimate\n",
      "                                                                              assumes the effort when there are\n",
      "                                                                              only minor changes to the product.\n",
      "                                                                              the upper bound estimate assumes\n",
      "                                                                              the effort when the product\n",
      "                                                                              supports a substantial number of\n",
      "                                                                              new data classes.\n",
      "\n",
      "[[page 7569]]\n",
      "\n",
      " \n",
      "task 3: maintaining the software to perform              80             800  this is the annual cost to update\n",
      " the electronic health information export                                     the software that would generate\n",
      " (per product).                                                               the data access files. the lower\n",
      "                                                                              bound estimates the cost to\n",
      "                                                                              maintain the software when there\n",
      "                                                                              are minor changes to the product,\n",
      "                                                                              including updates to underlying\n",
      "                                                                              software (e.g., database versions,\n",
      "                                                                              operating systems, etc.). the\n",
      "                                                                              upper bound estimate accounts for\n",
      "                                                                              substantial reworking of the\n",
      "                                                                              export software program to support\n",
      "                                                                              new data classes or new data\n",
      "                                                                              formats.\n",
      "                                            --------------------------------\n",
      "    total labor hours......................             320           3,200  ...................................\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "  table 9--example calculation for the lower bound estimated cost to health it developers to perform task 1 for\n",
      "                               the electronic health information export criterion\n",
      "                                                 [2016 dollars]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                               estimated labor     developer\n",
      "                                                                 hours lower      salary (per       projected\n",
      "                                                                    bound            hour)           products\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "task 1.......................................................             160          $100.28              545\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "example calculation:\n",
      "    160 hours x $100.28 x 545 products = $8,744,416.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "   table 10--total cost to develop and maintain the electronic health\n",
      "                      information export criterion\n",
      "                             [2016 dollars]\n",
      "------------------------------------------------------------------------\n",
      "                                                  estimated cost\n",
      "                activity                 -------------------------------\n",
      "                                            lower bound     upper bound\n",
      "------------------------------------------------------------------------\n",
      "task 1 (545 products)...................      $8,744,416     $87,444,160\n",
      "task 2 (545 products)...................       4,372,208      43,722,080\n",
      "task 3 (545 products)...................       4,372,208      43,722,080\n",
      "                                         -------------------------------\n",
      "    total (545 products)................      17,488,832     174,888,320\n",
      "------------------------------------------------------------------------\n",
      "\n",
      "    based on the stated assumptions and costs outlined in table 8, the \n",
      "total estimated cost for health it developers to develop products to \n",
      "the electronic health information export certification criterion will \n",
      "range from $17.5 million to $174.9 million. assuming 458 health it \n",
      "developers, there would be an average cost per health it developer \n",
      "ranging from $38,185 to $381,852. the midpoint of ranges stated is used \n",
      "as the primary estimate of costs and benefits. we note that the \n",
      "development costs, which equal half of the total, would be a one-time \n",
      "cost and would not be perpetual.\n",
      "benefits\n",
      "    there are a number of benefits to the electronic health information \n",
      "export functionality. in our analysis, we have calculated the benefits \n",
      "in terms of the reduced costs of the electronic health information \n",
      "export functionality compared to performing data export without the \n",
      "electronic health information export functionality. the benefit \n",
      "calculations below are based on the following assumptions:\n",
      "    1. on average, 5% of providers and hospitals switch their health it \n",
      "annually. using cms medicare ehr incentive program data from years \n",
      "2013-2016, we estimate the rate of providers (hospitals and eligible \n",
      "professionals) that changed their health it developer. we believe that \n",
      "the electronic health information export functionality would help \n",
      "alleviate the burden of switching between health it systems by making \n",
      "data more portable. thus, the benefit calculations are based on \n",
      "assumptions regarding the number of clinical practices (n = 4,774) and \n",
      "hospitals (n = 226) that are projected to switch products in a year.\n",
      "    2. health it consultants \\164\\ will use the same labor costs and \n",
      "data models. table 11 shows the estimated labor costs per product for a \n",
      "hospital or health care provider to hire a health it consultant to \n",
      "perform data export without the electronic health information export \n",
      "functionality. we recognize that these costs will vary based on the \n",
      "size of the hospital or clinical practice.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\164\\ ``health it consultant'' refers to a technical expert that \n",
      "a hospital or provider will hire to migrate their data from a legacy \n",
      "system to a new ehr.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    3. according to the may 2016 bls occupational employment \n",
      "statistics, the mean hourly wage for a ``software developer'' is \n",
      "$50.14.\\165\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\165\\ <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "\n",
      "[[page 7570]]\n",
      "\n",
      "\n",
      "\n",
      "  table 11--cost per provider to perform data export without electronic health information export functionality\n",
      "                                        when switching health it products\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                             estimated cost  estimated cost\n",
      "                                              per health it   per health it\n",
      "                  activity                    switch (lower   switch (upper                remarks\n",
      "                                              bound) (hour)   bound) (hour)\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "task 1: understanding and mapping the data              320           3,200  the lower bound is an estimate for\n",
      " in health it database into standard terms.                                   a small provider practice using\n",
      "                                                                              the standard instance of a\n",
      "                                                                              certified health it product with\n",
      "                                                                              no customization and use of\n",
      "                                                                              nationally recognized content\n",
      "                                                                              standards. the upper bound\n",
      "                                                                              estimates a medium to large\n",
      "                                                                              practice with substantial local\n",
      "                                                                              customization of content.\n",
      "task 2: exporting the data from the health              160           1,600  the lower bound assumes that the\n",
      " it into a format that can be subsequently                                    certified health it product is\n",
      " used to import.                                                              capable of exporting most of the\n",
      "                                                                              data into standard output format\n",
      "                                                                              such as c-cda. the upper bound\n",
      "                                                                              estimates the case where a large\n",
      "                                                                              amount of data is not easily\n",
      "                                                                              exported by the certified health\n",
      "                                                                              it product and therefore\n",
      "                                                                              substantial one-off software needs\n",
      "                                                                              to be written to export the data\n",
      "                                                                              into a custom (de novo) format\n",
      "                                                                              developed for the transition.\n",
      "                                            --------------------------------\n",
      "    total labor hours......................             480           4,800  ...................................\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    table 12 provides an example calculation for how we calculated our \n",
      "total costs presented in table 13.\n",
      "\n",
      " table 12--example calculation for the lower bound estimated cost to providers to hire a health it consultant to\n",
      "                     perform task 1 without the electronic health information functionality\n",
      "                                                 [2016 dollars]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                                                    estimated\n",
      "                                                               estimated labor     developer      annual number\n",
      "                                                                 hours lower      salary (per      of health it\n",
      "                                                                    bound            hour)           switches\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "task 1.......................................................             320          $100.28            5,000\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "example calculation\n",
      "    320 hours x $100.28 x 5,000 switches = $160,448,000\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "    table 13--total cost to providers to perform data export without the electronic health information export\n",
      "                                 functionality when switching health it products\n",
      "                                                 [2016 dollars]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                                                        estimated cost\n",
      "                                  activity                                   -----------------------------------\n",
      "                                                                                lower bound       upper bound\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "task 1......................................................................    $160,448,000      $1,604,480,000\n",
      "task 2......................................................................      80,224,000         802,240,000\n",
      "                                                                             -----------------------------------\n",
      "    total cost savings (5,000 switches).....................................     240,672,000       2,406,720,000\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    we multiplied the costs to switch health it by the estimated number \n",
      "of hospitals and clinical practices affected. thus the estimated annual \n",
      "benefit, in terms of cost savings to hospitals and clinical practices \n",
      "would range from $240.7 million to $2.4 billion. if we assume, based on \n",
      "our upper bound estimates above, that the total cost to health it \n",
      "developers is $174.9 million and that increased developer costs are \n",
      "passed to customers, then the net benefit to hospitals and clinical \n",
      "practices would range from $65.8 million to $2.2 billion. the midpoint \n",
      "of ranges stated is used as the primary estimate of costs and benefits.\n",
      "2.3 application programming interfaces\n",
      "    our proposals regarding apis in this proposed rule reflect the full \n",
      "depth and scope of what we believe is necessary to implement the api \n",
      "condition of certification. we propose to include new standards, new \n",
      "implementation specifications, and a new certification criterion. our \n",
      "proposal also includes a detailed condition of certification and \n",
      "associated maintenance of certification requirements, as well as a \n",
      "proposal to modify the base ehr definition.\n",
      "costs\n",
      "    this section describes the potential costs of the api certification \n",
      "criterion. the cost estimates below are based on the following \n",
      "assumptions:\n",
      "    1. health it developers will use the same labor costs and data \n",
      "models. table 14 shows the estimated labor costs per\n",
      "\n",
      "[[page 7571]]\n",
      "\n",
      "product for a health it developer to develop and maintain an api. we \n",
      "recognize that health it developer costs will vary; however, we have \n",
      "assumed in our calculations that all health it developers will incur \n",
      "the costs noted in table 14.\n",
      "    2. a proxy is needed to project number of 2015 edition certified \n",
      "health it products containing the api certification criterion. we \n",
      "estimate that 459 products from 394 developers will contain the api \n",
      "criterion. we used a proxy to determine the number of health it \n",
      "developers that may develop an api for the certification to the 2015 \n",
      "edition. there were 598 products and 506 developers with at least one \n",
      "2014 edition certified health it product that could perform transitions \n",
      "of care. we then multiplied this number by our certified health it \n",
      "market consolidation estimates of -22.1% and -23.2% to project the \n",
      "number of 2015 developers and products, respectively. we believe this \n",
      "estimate serves as a reasonable proxy for products capability of \n",
      "sending patient data. the 2015 edition required api functionality \n",
      "achieves a similar end by allowing providers to retrieve patient data \n",
      "from secure data servers hosted by other developers, as well as \n",
      "providing patients access to their medical records through third-party \n",
      "applications connected to these same secure servers.\n",
      "    3. according to the may 2016 bls occupational employment \n",
      "statistics, the mean hourly wage for a ``software developer'' is \n",
      "$50.14.\\166\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\166\\ <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "\n",
      "                           table 14--estimated labor hours to develop and maintain api\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                               estimated labor hours\n",
      "             tasks                       details         --------------------------------         remarks\n",
      "                                                            lower bound     upper bound\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "task 1: develop support for      (1) new development to            1,500           3,500  (1) lower bound\n",
      " fast healthcare                  support ``clinical                                       assumes health it\n",
      " interoperability resources       notes'',                                                 already has developed\n",
      " (fhir[supreg]) api and arch      ``provenance'',                                          fhir dstu2 and smart\n",
      " 1.0 (per product).               ``address'' and                                          for 2015 and only\n",
      "                                  ``telecon''. (2) only                                    needs to be updated\n",
      "                                  ``mandatory'' and                                        for additional\n",
      "                                  ``must support''                                         resources. (2) upper\n",
      "                                  elements are required                                    bound assumes new\n",
      "                                  for each of the arch                                     development for all\n",
      "                                  resources.                                               resources.\n",
      "task 2: development of app       (1) new registration              1,000           2,500  (1) lower bound\n",
      " registration server and portal   server development (or                                   assumes that the\n",
      " (per developer).                 updates to existing                                      developer already has\n",
      "                                  server) to support                                       existing application\n",
      "                                  registration                                             registration\n",
      "                                  timeliness and                                           infrastructure in\n",
      "                                  publication of fhir                                      place, and only needs\n",
      "                                  endpoints. (2)                                           to update it to\n",
      "                                  development of portal                                    support the api\n",
      "                                  and managing the                                         maintenance of\n",
      "                                  application                                              certification\n",
      "                                  registration system.                                     requirements. (2)\n",
      "                                                                                           upper bound is new\n",
      "                                                                                           development of an\n",
      "                                                                                           application\n",
      "                                                                                           registration service\n",
      "                                                                                           and portal.\n",
      "task 3: update arch and fhir     (1) this is an estimate           1,200           2,000  (1) lower bound\n",
      " standards as part of regular     for adding one or two                                    assumes developers\n",
      " api maintenance (per product).   new data elements to                                     are already\n",
      "                                  uscdi and making it a                                    supporting the\n",
      "                                  requirement. (2)                                         elements and also\n",
      "                                  support for api-                                         have been testing api-\n",
      "                                  enabled services for                                     enabled services for\n",
      "                                  data on a single                                         data on a single\n",
      "                                  patient and multiple                                     patient and multiple\n",
      "                                  patients, as well as                                     patients. (2) upper\n",
      "                                  smart backend services                                   bound assumes new\n",
      "                                  as part of fhir 4.                                       development for uscdi\n",
      "                                                                                           updates and api-\n",
      "                                                                                           enabled services for\n",
      "                                                                                           data on a single\n",
      "                                                                                           patient and multiple\n",
      "                                                                                           patients.\n",
      "task 4: update application       this would be yearly                400           1,300  (1) lower bound\n",
      " registration server and portal   updates and                                              estimates hours to\n",
      " (per developer).                 maintenance of the                                       keep it running with\n",
      "                                  portal to keep it                                        junior staff. (2)\n",
      "                                  running. we do not                                       upper bound estimates\n",
      "                                  anticipate any major                                     small updates and\n",
      "                                  changes to the                                           adds in developer and\n",
      "                                  standard and will be                                     quality assurance\n",
      "                                  primarily driven by                                      resources.\n",
      "                                  usage and developer\n",
      "                                  interest.\n",
      "other costs (50% per product,    (1) server costs. (2)            $5,000         $25,000  (1) estimated as\n",
      " 50% per developer).              software costs (e.g.,                                    monetized costs and\n",
      "                                  databases, application                                   not as hours; most of\n",
      "                                  servers, portal                                          the costs would be\n",
      "                                  technology).                                             one-time procurement\n",
      "                                                                                           costs plus yearly\n",
      "                                                                                           maintenance.\n",
      "                                                                                          note: one-time cost.\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    table 15 provides an example calculation for how we calculated our \n",
      "total costs presented in table 16.\n",
      "\n",
      "[[page 7572]]\n",
      "\n",
      "\n",
      "\n",
      " table 15--example calculation for the lower bound estimated cost to developers to perform task 1 to develop api\n",
      "                                                 [2016 dollars]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                                               estimated labor     developer\n",
      "                                                                 hours lower      salary (per       projected\n",
      "                                                                    bound            hour)           products\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "task 1.......................................................           1,500          $100.28              459\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "example calculation:\n",
      "    1,500 hours x $100.28 x 459 products = $69,042,780\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "\n",
      "            table 16--total cost to develop and maintain api\n",
      "                             [2016 dollars]\n",
      "------------------------------------------------------------------------\n",
      "                                                  estimated cost\n",
      "                activity                 -------------------------------\n",
      "                                            lower bound     upper bound\n",
      "------------------------------------------------------------------------\n",
      "task 1 (459 products)...................     $69,042,780    $161,099,820\n",
      "task 2 (394 developers).................      39,510,320      98,775,800\n",
      "task 3 (459 products)...................      55,234,224      92,057,040\n",
      "task 4 (394 developers).................      15,804,128      51,363,416\n",
      "other costs (394 developers)............         985,000       4,925,000\n",
      "other costs (459 products)..............       1,147,500       5,737,500\n",
      "                                         -------------------------------\n",
      "    total (459 products and 394              181,723,952     413,958,576\n",
      "     developers)........................\n",
      "------------------------------------------------------------------------\n",
      "\n",
      "    we note that we have proposed to adopt in sec.  170.404(b)(3) a \n",
      "specific requirement that an api technology supplier must support the \n",
      "publication of service base urls for all of its customers regardless of \n",
      "whether they are centrally managed by the api technology supplier or \n",
      "locally deployed. the api technology supplier must make such \n",
      "information publicly available at no charge. thus, we are placing the \n",
      "responsibility of publishing the urls on health it developers and those \n",
      "costs are captured in the registration portal cost estimation in this \n",
      "ria.\n",
      "    based on the stated assumptions and costs outlined in table 16, the \n",
      "total estimated costs for health it developers to develop and maintain \n",
      "a product to the api criterion would range from $181.7 million to \n",
      "$414.0 million with an average cost per developer ranging from $461,228 \n",
      "to $1,050,656. we note that the ``other costs,'' which account for $2.1 \n",
      "million to $10.7 million of this total are one-time costs and are not \n",
      "perpetual. the midpoint of ranges stated is used as the primary \n",
      "estimate of costs and benefits.\n",
      "benefits\n",
      "    the medicare access and chip reauthorization act (macra) tasks onc \n",
      "with measuring interoperability in the health it industry.\\167\\ the \n",
      "measurement concepts developed include a multi-part approach analyzing \n",
      "not only adoption of health it functionalities supporting information \n",
      "exchange but the downstream impact of these technologies on data \n",
      "completeness, data integration, and supports for core functions of \n",
      "patient care. the benefits of our api proposal are similarly \n",
      "multifaceted. in the analysis below, we quantify benefits in the \n",
      "following three areas:\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\167\\ health it buzz blog, measuring interoperability: listening \n",
      "and learning, <a href=\"https://www.healthit.gov/buzz-blog/electronic-health-and-medical-records/interoperability-electronic-health-and-medical-records/measuring-interoperability-listening-learning/\">https://www.healthit.gov/buzz-blog/electronic-health-and-medical-records/interoperability-electronic-health-and-medical-records/measuring-interoperability-listening-learning/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> reduction in provider burden associated with locating \n",
      "patient data;\n",
      "    <bullet> reduced costs related to reductions in duplicate lab \n",
      "tests, readmissions, emergency room (er) visits, and adverse drug \n",
      "events due to increased interoperability. we focused on these outcomes \n",
      "for two reasons: (i) evidence in literature indicates that health \n",
      "information exchange impacts the chosen measures; and (ii) cost of care \n",
      "associated with these measures is high and the impact of health \n",
      "information exchange is likely to result in significant benefits in the \n",
      "form of cost reduction.\n",
      "    <bullet> increase in the number of individuals with access to their \n",
      "health information.\n",
      "    the benefit calculations are based on the following assumptions:\n",
      "    1. benefits noted in academic literature are assumed accurate. \n",
      "estimates of the benefits are based on estimates obtained from peer \n",
      "reviewed academic literature. onc reviewed academic articles for \n",
      "validity; however, models were not replicated.\n",
      "    2. hospitals and eligible professionals that have participated in \n",
      "the cms ehr incentive programs will be impacted: estimates are based on \n",
      "the assumption that 439,187 health care providers and/or 4,519 \n",
      "hospitals would be affected by this regulatory action.\n",
      "    3. estimates on the impact of apis on rates of interoperability (1% \n",
      "to 4%) are based on onc analysis. to identify the impact of the api \n",
      "proposal on interoperability, we used regression analysis. \n",
      "specifically, we estimated linear probability models that identified \n",
      "the impact of 2014 edition certified ehr on hospitals' interoperability \n",
      "(whether a hospital sends, receives, finds, and integrates summary of \n",
      "care records). using data from the american hospital association (aha) \n",
      "from years 2014 to 2015 in the model, we controlled for hospital size, \n",
      "profit status, participation in a health information organization, and \n",
      "state and year fixed effects. the marginal effect of using a 2014 \n",
      "edition certified health it equated to a 5% increase in \n",
      "interoperability. this is an upper bound estimate. for the purpose\n",
      "\n",
      "[[page 7573]]\n",
      "\n",
      "of this analysis, we assume that one to four percentage points would be \n",
      "a reasonable range for api's marginal impact on interoperability.\n",
      "    as noted previously, there might be shared benefits across certain \n",
      "proposals and we have taken steps to ensure that the benefits \n",
      "attributed to each proposal are unique to the proposal referenced. \n",
      "specifically, we used regression analysis to calculate the impact of \n",
      "our real world testing and api proposals on interoperability. we \n",
      "assumed that the collective impact of real world testing and api \n",
      "proposals on interoperability would not exceed the impact of 2014 \n",
      "edition certified health it. therefore, we estimated linear probability \n",
      "models that identified the impact of 2014 edition certified health it \n",
      "on hospitals' interoperability.\\168\\ we controlled for additional \n",
      "factors such as participation in a health information exchange \n",
      "organization, hospital characteristics, and urban/rural status. we \n",
      "found the marginal effect of using 2014 edition certified health it was \n",
      "a five percentage point increase in interoperability.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\168\\ american hospital association health it supplement survey, \n",
      "<a href=\"http://www.ahadata.com/aha-healthcare-database/\">http://www.ahadata.com/aha-healthcare-database/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while we acknowledge that there might be shared benefits across \n",
      "proposals, we have taken steps to ensure that the benefits attributed \n",
      "to each proposal is unique to the proposal referenced. we assumed that \n",
      "this marginal effect is true for our proposals and distributed the 5% \n",
      "benefit across our real world testing and api proposals at (.1-1%) to \n",
      "(1-4%) respectively. moreover, the number of providers impacted is \n",
      "proposal specific. given data limitations, we believe this approach \n",
      "allows us to estimate the benefits of our proposals without double \n",
      "counting the impact each proposal might have on interoperability.\n",
      "    the first table below shows benefits of apis for providers where we \n",
      "monetize the impact of apis as total amount saved by reducing provider \n",
      "time spent with the health it. sinsky et al found physicians spend 27% \n",
      "of their total time on direct clinical face time with patients, and \n",
      "49.2% of their time on ehr and desk work.\\169\\ outside office hours, \n",
      "physicians spend another 1 to 2 hours of personal time each night doing \n",
      "additional computer and other clerical work. based on this study, we \n",
      "assume that providers spend, on average, 6 hours per day with their ehr \n",
      "(4 hours of an 8 hour work day and 2 hours outside of office hours). \n",
      "despite the number of hours providers spend in their ehr, there is \n",
      "evidence that the introduction of ehrs is associated with time saved. \n",
      "amusan et al found that ehr and computerized provider order entry \n",
      "(cpoe) implementation was associated with 3.69 minutes of time saved \n",
      "five months post implementation.\\170\\ additionally, adler-milstein et \n",
      "al found that an increase in ehr use resulted in a 5.3% increase in \n",
      "work relative value units per clinician work day.\\171\\ using this \n",
      "evidence, we estimate the potential impact of apis on providers' time \n",
      "ranges from 1%-5%.\\172\\ because the benefit of time saved is not \n",
      "limited to interoperable exchange of health information among providers \n",
      "but includes additional benefits such as increased patient knowledge, \n",
      "we used evidence from the literature to calculate the time saved \n",
      "benefit. thus, the impact of apis on provider time is expected to \n",
      "represent a larger impact (5%) than the impact of apis on health \n",
      "outcomes (1%-4%) and cost. this is primarily because provider behavior \n",
      "is more directly affected by this improvement.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\169\\ christine sinsky et al., allocation of physician time in \n",
      "ambulatory practice: a time and motion study in 4 specialties, ann \n",
      "intern med. (dec. 6, 2016), at 753-60.\n",
      "    \\170\\ amusan, tongen, speedie, and mellin, a time-motion study \n",
      "to evaluate the impact of emr and cpoe implementation on physician \n",
      "efficiency, j. healthcare inf. manag. (fall 2008), at 31-7.\n",
      "    \\171\\ julia adler-milstein and robert s. huckman, the impact of \n",
      "electronic health record use on physician productivity, am j manag \n",
      "care (nov. 19, 2013).\n",
      "    \\172\\ the calculation for these estimates are as follows: 1% \n",
      "leverages amusan et al.'s lower bound estimate of 3.69 minutes. \n",
      "assuming 6 hours (or 360 minutes) per day, this amounts to \n",
      "approximately 1% of time saved. the upper bound estimate of 5% \n",
      "leverages adler-milstein's estimate of a 5.3% estimate (rounded to \n",
      "5%).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "benefits of apis\n",
      "\n",
      "                                                                               table 17--benefit of api providers\n",
      "                                                                                         [2016 dollars]\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                                                hours saved (percent) a b                         number of        total benefit c (per year)\n",
      "             benefit type                        number affected             hourly wage   ----------------------------------  hours per day   working days in ---------------------------------\n",
      "                                                                                                  min              max            with ehr          a year            min              max\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "reduction in provider time spent in     439,187 providers................              95                1                5              d 6              260            $651m            $3.3b\n",
      " health it by improving usability and\n",
      " interoperability.\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "a julia adler-milstein and robert s. huckman, the impact of electronic health record use on physician productivity, am j manag care (nov. 19, 2013).\n",
      "b amusan, tongen, speedie, and mellin, a time-motion study to evaluate the impact of emr and cpoe implementation on physician efficiency, j. healthcare inf. manag. (fall 2008), at 31-7.\n",
      "c total benefit is a product of number affected physicians, hourly wage, hours saved from ehr improvements, hours worked with ehr, and number of working days in a year.\n",
      "d christine sinsky et al., allocation of physician time in ambulatory practice: a time and motion study in 4 specialties, ann intern med. (dec. 6, 2016), at 753-60.\n",
      "\n",
      "\n",
      "                                                                        table 18--benefit of api for patients and payers\n",
      "                                                                                         [2016 dollars]\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                             overall              impact of api                                                     total benefit a (per year)\n",
      "                                                                         interop impact --------------------------------                            % of total   -------------------------------\n",
      "             benefit type                       number affected             (marginal                                           total cost         cost impacted\n",
      "                                                                             effect)           min             max                                                      min             max\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "duplicate testing....................  439,187 providers...............          b 0.09            0.01            0.04  c 200 billion..........             100           $180m           $720m\n",
      "avoidable hospitalizations and         4,519 hospitals.................          b 0.09            0.01            0.04  d $41b.................             100             37m            148m\n",
      " readmissions.\n",
      "\n",
      "[[page 7574]]\n",
      "\n",
      " \n",
      "e visits.............................  100% of visits affected.........          b 0.09            0.01            0.04  e cost per er visit                 100             48m            194m\n",
      "                                                                                                                          $1,233, 131m visits.\n",
      "adverse drug events..................  20% of events affected..........           f 22%            0.01            0.04  g $30 billion..........              20             13m             53m\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "a total benefit is a product of total cost, % of total cost impacted, overall impact of interoperability, and impact of api.\n",
      "b stephen e. ross, tiffany a. radcliff, william g. leblanc, l. miriam dickinson, anne m. libby, and donald e. nease jr., effects of health information exchange adoption on ambulatory testing\n",
      "  rates, j. am. med. inform. assoc. (2013), at 1137-1142; bridget a. stewart, susan fernandes, elizabeth rodriguez-huertas, and michael landzberg, a preliminary look at duplicate testing\n",
      "  associated with lack of electronic health record interoperability for transferred patients, j. of the am. med. informatics assoc. (2010), at 341-344; sezgin ayabakan, indranil r. bardhan,\n",
      "  zhiqiang (eric) zheng, and kirk kirksey value of health information sharing in reducing healthcare waste: an analysis of duplicate testing across hospitals, mis quarterly (jan. 1, 2017);\n",
      "  eric j. lammers, julia adler-milstein, and keith e. kocher, does health information exchange reduce redundant imaging? evidence from emergency departments, med care (mar. 2014), at 227-34.\n",
      "c national academy of medicine. (2016), <a href=\"http://money.cnn.com/2017/05/20/news/economy/medical-tests/index.html\">http://money.cnn.com/2017/05/20/news/economy/medical-tests/index.html</a>.\n",
      "d agency for healthcare research and quality (ahrq) statistical brief #199 (dec. 2015), <a href=\"https://www.hcup-us.ahrq.gov/reports/statbriefs/sb199-readmissions-payer-age.pdf\">https://www.hcup-us.ahrq.gov/reports/statbriefs/sb199-readmissions-payer-age.pdf</a>; ahrq statistical brief\n",
      "  #72, nationwide frequency and costs of potentially preventable hospitalizations (apr. 2009), <a href=\"https://www.hcup-us.ahrq.gov/reports/statbriefs/sb72.pdf\">https://www.hcup-us.ahrq.gov/reports/statbriefs/sb72.pdf</a>.\n",
      "e national center for health statistics (nchs) data brief no. 252 (june 2016), <a href=\"https://www.cdc.gov/nchs/data/databriefs/db252.pdf\">https://www.cdc.gov/nchs/data/databriefs/db252.pdf</a>; nolan caldwell, tanja srebotnjak, tiffany wang, and renee\n",
      "  hsia, ``how much will i get charged for this?'' patient charges for top ten diagnoses in the emergency department (2013), <a href=\"https://doi.org/10.1371/journal.pone.0055491\">https://doi.org/10.1371/journal.pone.0055491</a>.\n",
      "f m.f. furukawa, w.d. spector, m.r. limcangco, and w.e. encinosa, meaningful use of health information technology and declines in in-hospital adverse drug events, j. of the am. med.\n",
      "  informatics assoc. (2017).\n",
      "g janet sultana, paola cutroneo, and gianluca trifir[ograve], clinical and economic burden of adverse drug reactions.\n",
      "\n",
      "    based on the above calculations, we estimate the annual benefit to \n",
      "health care providers for the use of the proposed api capabilities \n",
      "would, on average, range from $651 million to $3.3 billion. we estimate \n",
      "the annual benefit for patients and payers would, on average, range \n",
      "from $278 million to million to $1.1 billion. therefore, we estimate \n",
      "the total annual benefit of apis to, on average, range from $929 \n",
      "million to $4.4 billion. if we assume, based on our cost estimates, an \n",
      "annual cost to health it developers of $414 million and that increased \n",
      "developer costs are passed to customers, then the net benefit to \n",
      "hospitals/providers would range from $515 million to $3.3 billion. the \n",
      "midpoint of ranges stated is used as the primary estimate of benefits.\n",
      "    as we stated above, for table 17, we assume apis provide both \n",
      "patients and clinicians with increased access to ehi, which will have a \n",
      "direct impact on physicians by making their work more efficient. \n",
      "extrapolating the numbers from literature, we assume this technology \n",
      "will improve physicians' time by 1%-5%. also as stated above, for table \n",
      "18, we assume apis affect utilization through marginal improvements in \n",
      "interoperability. for this reason, in addition to apis, we needed to \n",
      "incorporate the impact of interoperability on each of the outcomes. we \n",
      "request comment on these assumptions. specifically, whether they are \n",
      "appropriate and whether there are alternative assumptions or bases upon \n",
      "which we should make our assumptions.\n",
      "    we expect additional benefits from the use of apis could be derived \n",
      "from increased patient, and eventually payer, access to ehi. apis make \n",
      "it easier for patients to transmit data to and from different sources. \n",
      "according to the health information national trends survey,\\173\\ half \n",
      "of americans were offered access to an online medical record by a \n",
      "provider or insurer in 2017. however, among those who were offered \n",
      "access, only 53% accessed their record at least once within the last \n",
      "year, and only 3.6% of individuals who accessed their record reported \n",
      "transmitting their data to a service or application. the proportion of \n",
      "individuals accessing their online health information and transmitting \n",
      "their information to third parties is expected to grow as apis become \n",
      "more widespread and make more data available in a computable format. \n",
      "growing evidence suggests that patients who have access to their ehi \n",
      "are more likely to adhere to medical orders including screening \n",
      "recommendations.\\174\\ thus, we expect such patients would ultimately \n",
      "realize improved health outcomes.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\173\\ these estimates were derived from health information \n",
      "national trends survey 5, cycle 1 (2017).\n",
      "    \\174\\ see <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5391175/\">https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5391175/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in addition, the use of apis to support the exchange and analysis \n",
      "of payment related data (including price information) would improve \n",
      "cost transparency in the market, increase the availability of valuable \n",
      "information for payers and patients, and likely drive down health care \n",
      "prices. for instance, a recent study by the minnesota department of \n",
      "health showed that the pricing for knee replacement surgery, which is a \n",
      "standard procedure in many hospitals, can vary significantly across \n",
      "practices in the same locality. the minnesota study showed that \n",
      "minnesota insurers paid as much as $47,000 for a patient's total knee \n",
      "replacement and as little as $6,200--a nearly eight-fold price \n",
      "difference. in addition to total knee replacements, the study found \n",
      "that total hip replacement costs ranged from $6,700 to $44,000, a 6\\1/\n",
      "2\\-fold difference. typical vaginal baby delivery ranged from $2,900 to \n",
      "$12,300, while c-section deliveries ranged from $4,700 to $22,800. \n",
      "another study by premier in conjunction with wake forest university \n",
      "medical center found similar results. among 350 hospitals, the average \n",
      "cost of primary knee implants was $4,464. yet, 50% of the hospitals \n",
      "paid between $4,066 and $5,609 on the devices. further, the same group \n",
      "of hospitals paid an average of $5,252 for primary hip implants, but \n",
      "50% of the hospitals paid between $4,759 and $6,463. the studies \n",
      "illustrated the secretive nature of pricing in the health care market, \n",
      "as well as the extreme variations in price that can exist for the same \n",
      "procedure within the same locality.\\175\\ \\176\\ while this study was the\n",
      "\n",
      "[[page 7575]]\n",
      "\n",
      "first-ever local study of insurance company payments to hospitals for \n",
      "those four common procedures, similar pricing variations have been well \n",
      "documented in other, broader studies in recent years.\\177\\ we expect \n",
      "that making such price information available to insurers through apis \n",
      "would drive health care prices down, which could lead to significant \n",
      "benefits across the health care continuum.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\175\\ glenn howatt, that surgery will cost you $6,200. or maybe \n",
      "$47,000, star tribune (jan. 3, 2018), available at <a href=\"http://www.startribune.com/that-surgery-will-cost-you-6-200-or-maybe-47-000/467894173/\">http://www.startribune.com/that-surgery-will-cost-you-6-200-or-maybe-47-000/467894173/</a>.\n",
      "    \\176\\ bakalar, catherine and czajka, robin (2018) margin of \n",
      "excellence: total joint replacements [white paper] may 24, 2018, \n",
      "<a href=\"http://offers.premierinc.com/rs/381-nbb-525/images/wc_cm_totaljoint_2018_05_04.pdf\">http://offers.premierinc.com/rs/381-nbb-525/images/wc_cm_totaljoint_2018_05_04.pdf</a>.\n",
      "    \\177\\ see e.g., elisabeth rosenthal, the $2.7 trillion medical \n",
      "bill; colonoscopies explains why u.s. leads the world in health \n",
      "expenditures, the new york times (june 1, 2013), available at <a href=\"http://www.nytimes.com/2013/06/02/health/colonoscopies-explain-why-us-leads-the-world-in-health-expenditures.html?pagewanted=all\">http://www.nytimes.com/2013/06/02/health/colonoscopies-explain-why-us-leads-the-world-in-health-expenditures.html?pagewanted=all</a>; steve \n",
      "twedt, hospitals' charges can vary greatly for similar services, \n",
      "pittsburgh post-gazette (may 9, 2013), available at <a href=\"http://www.post-gazette.com/business/businessnews/2013/05/09/hospitals-charges-can-vary-greatly-for-similar-services/stories/201305090300\">http://www.post-gazette.com/business/businessnews/2013/05/09/hospitals-charges-can-vary-greatly-for-similar-services/stories/201305090300</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while the examples above emphasize procedures that tend to have \n",
      "defined end points, the eventual population health queries would more \n",
      "broadly allow payers and analytics firms working for employers to \n",
      "computationally examine the care providers render. not only is price \n",
      "transparency currently missing from the marketplace, but for most \n",
      "inpatient care, the actual details of care are largely unobtainable \n",
      "through any apis. however, we are not aware of an approach for \n",
      "quantifying these types of benefits and welcome comments on potential \n",
      "approaches to quantifying these benefits.\n",
      "2.4 new privacy and security certification criteria\n",
      "    to be certified to the new privacy and security certification \n",
      "criteria, encrypt authentication credentials (sec.  170.315(d)(12)) and \n",
      "multi-factor authentication (mfa) (sec.  170.315(d)(13)), we are \n",
      "proposing to require health it developers to assess their health it \n",
      "modules' capabilities and attest ``yes'' or ``no'' to the certification \n",
      "criteria. as specified in section iv.c.3 of this proposed rule, we are \n",
      "proposing to make these certification criteria applicable to all health \n",
      "it modules under the program. for encrypt authentication credentials \n",
      "and multi-factor authentication, we are proposing to require a simple \n",
      "attestation. for mfa, we are also proposing to require that if the \n",
      "health it developer attests to supporting mfa, the health it developer \n",
      "would need to explain how it supports mfa. we also request public \n",
      "comment on whether there is value in adopting an mfa criterion and \n",
      "whether the health it developer should explain how it supports mfa.\n",
      "costs\n",
      "    these criteria are not intended to place additional burden on \n",
      "health it developers as they do not require new development or \n",
      "implementation. rather, a health it developer is only required to \n",
      "attest to whether they encrypt authentication credentials or support \n",
      "mfa. we expect the costs associated with attesting to these criteria to \n",
      "be de minimis because we do not expect additional forms to be required \n",
      "and expect minimal effort would be required to complete the \n",
      "attestation. we welcome comments on these expectations. the midpoint of \n",
      "ranges stated is used as the primary estimate of costs and benefits.\n",
      "benefits\n",
      "    as stated previously, we are not requiring health it developers to \n",
      "encrypt authentication credentials or support mfa. instead, we are \n",
      "requiring they attest to whether they support the certification \n",
      "criteria or not. by requiring an attestation, we are promoting \n",
      "transparency, which might motivate some health it developers that do \n",
      "not currently encrypt authentication credentials or support mfa to do \n",
      "so. if health it developers are motivated by this criteria and \n",
      "ultimately do encrypt authentication credentials and/or support mfa, we \n",
      "acknowledge that there would be costs to do so; however, we assume that \n",
      "the benefits would substantially exceed the costs. encrypting \n",
      "authentication credentials and adopting mfa would reduce the likelihood \n",
      "that authentication credentials would be compromised and would \n",
      "eliminate an unnecessary use of it resources. encrypting authentication \n",
      "credentials and adopting mfa could directly reduce providers' \n",
      "operating/support costs, which would reduce their administrative and \n",
      "financial burden. encrypting authentication credentials would also help \n",
      "decrease costs and burden by reducing the number of password resets due \n",
      "to possible phishing or other vulnerabilities.\n",
      "    according to verizon's 2017 data breach investigations report, 81% \n",
      "of hacking-related breaches leveraged either stolen and/or weak \n",
      "passwords.\\178\\ the verizon report encourages customers to vary their \n",
      "passwords and use two-factor authentication. also, nist special \n",
      "publication 800-63b: digital identity guidelines, authentication and \n",
      "lifecycle management,\\179\\ recommends the use of and provides the \n",
      "requirements for using multi-factor authenticators. based on these \n",
      "reports and other anecdotal evidence, we believe encrypting \n",
      "authentication credentials and supporting mfa are established best \n",
      "practices among industry developers, including health it developers. as \n",
      "described above, we propose to require health it developers to attest \n",
      "to whether they encrypt authentication credentials. we do not have \n",
      "access to published literature that details how health it developers \n",
      "are already encrypting authentication credentials and supporting mfa \n",
      "industry-wide, but we believe the majority of health it developers, or \n",
      "around 80%, are taking such actions. we assume that building this \n",
      "functionality is in the future project plans for the remaining 20% \n",
      "because, as noted previously, adopting these capabilities is an \n",
      "industry best practice. health it developers that have not yet adopted \n",
      "these capabilities are likely already making financial investments to \n",
      "get up to speed with industry standards. we believe our proposal may \n",
      "motivate these health it developers to speed their implementation \n",
      "process, but we have not attributed a monetary estimate to this \n",
      "potential benefit because our rule is not a direct cause of health it \n",
      "developers adopting these capabilities. by the time we release the \n",
      "final rule, many more, or perhaps all, health it developers will likely \n",
      "already be encrypting authentication credentials and supporting mfa. we \n",
      "welcome comments on this expectation and any means or methods we could \n",
      "use to quantify these benefits.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\178\\ <a href=\"http://www.verizonenterprise.com/verizon-insights-lab/dbir/2017/\">http://www.verizonenterprise.com/verizon-insights-lab/dbir/2017/</a>.\n",
      "    \\179\\ <a href=\"https://pages.nist.gov/800-63-3/sp800-63b.html\">https://pages.nist.gov/800-63-3/sp800-63b.html</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "2.5 data segmentation for privacy-send and data segmentation for \n",
      "privacy-receive; and consent management for apis\n",
      "    we propose to remove the current 2015 edition data segmentation for \n",
      "privacy (ds4p)-send (sec.  170.315(b)(7)) and ds4p-receive (sec.  \n",
      "170.315(b)(8)) certification criteria which apply the ds4p standard at \n",
      "the document level. we propose to replace these two criteria with three \n",
      "new 2015 edition ds4p certification criteria (two for c-cda and one for \n",
      "fhir) that would support a more granular approach to privacy tagging \n",
      "data for health information exchange supported by either the c-cda- or \n",
      "fhir-based exchange standards. in place of the removed 2015 edition \n",
      "ds4p criteria, we propose to adopt new ds4p-send (sec.  \n",
      "[thinsp]170.315(b)(12)) and ds4p-receive (sec.  [thinsp]170.315(b)(13))\n",
      "\n",
      "[[page 7576]]\n",
      "\n",
      "criteria that would remain based on the c-cda and the hl7 ds4p \n",
      "standard. these criteria would include capabilities for applying the \n",
      "ds4p standard at the document, section, and entry level. we also \n",
      "propose to adopt a third 2015 edition ds4p certification criterion \n",
      "``consent management for apis'' (sec.  170.315(g)(11)) that requires \n",
      "health it to be capable of responding to requests for data through an \n",
      "api in accordance with the consent implementation guide. our primary \n",
      "purpose for proposing to remove and replace them, in lieu of proposing \n",
      "to revise them, is to provide clarity to stakeholders as to the \n",
      "additional functionality enabled by health it certified to the new \n",
      "criteria.\n",
      "costs\n",
      "    we anticipate this proposal could result in up-front costs to \n",
      "health it developers as this new criteria would require the health it \n",
      "to support all three levels--document, section, and entry--as specified \n",
      "in the current ds4p standard. however, we note that these criteria are \n",
      "not being required in any program at this time. as of the beginning of \n",
      "the third quarter of the 2018 cy, only about 20 products (products with \n",
      "multiple certified versions were counted once) were certified to the \n",
      "current 2015 edition ds4p certification criteria. we estimate that 10-\n",
      "15 products will implement the new ds4p criteria. developers may need \n",
      "to perform fairly extensive health it upgrades to support the more \n",
      "complex and granular data tagging requirements under these criteria. we \n",
      "anticipate developers will need approximately 1,500-2,500 hours to \n",
      "upgrade databases and/or other backend infrastructure to appropriately \n",
      "apply security labels to data and/or develop access control \n",
      "capabilities. moreover, developers will likely incur costs to upgrade \n",
      "health it to generate a security-labeled c-cda conforming to the ds4p \n",
      "standard. we estimate developers will need 400-600 hours per criterion \n",
      "to make these upgrades on systems that had previously certified to the \n",
      "document-level ds4p criteria, or 720-1,220 hours per criterion for \n",
      "systems that are implementing these criteria for the first time. we \n",
      "believe this work would be performed by a ``software developer.'' \n",
      "according to the may 2016 bls occupational employment statistics, the \n",
      "mean hourly wage for software developer is $50.14. as noted previously, \n",
      "we have assumed that overhead costs (including benefits) are equal to \n",
      "100% of pre-tax wages, so the hourly wage including overhead costs is \n",
      "$100.28. therefore, we estimate the total cost to developers could \n",
      "range from $2,306,440 to $7,430,748. we note that this would be a one-\n",
      "time cost. the midpoint of ranges stated is used as the primary \n",
      "estimate of costs and benefits.\n",
      "    additionally, our proposal supports the capability to respond to \n",
      "requests for patient consent information through an api compatible with \n",
      "fhir release 3. in order to meet the ``consent management for apis'' \n",
      "criteria, developers would demonstrate compatibility with the standards \n",
      "framework used for the consent implementation guide. we have estimated \n",
      "costs associated with this aspect of our proposal using the following \n",
      "assumptions:\n",
      "    1. we estimate developers will require 1,500-3,500 hours to upgrade \n",
      "health it to align with the fhir stu3 data model and develop a stu3 \n",
      "compatible fhir server.\n",
      "    2. as with the two ds4p criteria, we anticipate developers will \n",
      "need approximately 1,500-2,500 hours to upgrade databases and/or other \n",
      "backend infrastructure to appropriately apply security labels to data \n",
      "and/or develop access control capabilities. we expect that this would \n",
      "be a one-time cost.\n",
      "    3. because certification to this criterion is voluntary and because \n",
      "supporting this criterion requires implementation of a version of fhir \n",
      "(stu3) that does not align with the other api criterion in this rule \n",
      "(based on dstu2), we estimate the number of products that will support \n",
      "this criterion is approximately 5% of the total number of 2015 \n",
      "certified products. we used a proxy to determine the number of health \n",
      "it developers that may develop an api for the 2015 edition. there were \n",
      "598 products and 506 developers with at least one 2014 edition \n",
      "certified product that could perform transitions of care. we then \n",
      "multiplied this number by our certified health it market consolidation \n",
      "estimates of -22.1% and -23.2% to project the number of 2015 developers \n",
      "and products, respectively; we estimate that 459 products from 394 \n",
      "developers will contain the api criterion. therefore, we anticipate 23 \n",
      "products from 20 developers will certify to the ``consent management \n",
      "for apis'' criterion. we believe this work would be performed by a \n",
      "``software developer.''\n",
      "    4. according to the may 2016 bls occupational employment \n",
      "statistics, the mean hourly wage for a ``software developer'' is \n",
      "$50.14.\n",
      "    our cost estimates are explained in the table below.\n",
      "\n",
      "                                           table 19--costs related to data segmentation for privacy using api\n",
      "                                                                     [2016 dollars]\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                                lower bound     upper bound\n",
      "                  tasks                                 details                    hours           hours       assumptions             remarks\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "task 1: enhance health it to align with    enhance health it to align with             1,500           3,500  ............  this is a one-time cost for\n",
      " the fhir stu3 data model and develop a     the fhir stu3 data model and                                                     health it systems to align\n",
      " stu3 compatible fhir server.               develop a stu3 compatible fhir                                                   with the fhir stu3 data\n",
      "                                            server.                                                                          model and develop a stu3\n",
      "                                                                                                                             compatible fhir server.\n",
      "task 2: enhancements to health it to       enhancements to health it to                1,500           2,500  ............  this is a one-time cost for\n",
      " upgrade databases and/or other backend     upgrade databases and/or other                                                   health it systems to\n",
      " infrastructure to appropriately apply      backend infrastructure to                                                        support data segmentation\n",
      " security labels to data and/or develop     appropriately apply security                                                     for discrete data.\n",
      " access control capabilities.               labels to data and/or develop\n",
      "                                            access control capabilities.\n",
      "                                                                             --------------------------------\n",
      "    total labor hours....................  .................................           3,000           6,000\n",
      "                                                                             --------------------------------\n",
      "    hourly rate..........................  .................................              $100.28\n",
      "                                                                             --------------------------------\n",
      "\n",
      "[[page 7577]]\n",
      "\n",
      " \n",
      "    cost per product.....................  .................................        $300,840        $601,680\n",
      "                                                                             --------------------------------\n",
      "    total cost (23 products).............  .................................      $6,919,320     $13,838,640\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    we believe this proposal involving standardized apis, as well as \n",
      "the voluntary nature of the proposal, would significantly mitigate \n",
      "health it developer costs. we also expect developers to see a return on \n",
      "their investment in developing and preparing their health it for these \n",
      "certification criteria given the benefits to interoperable exchange. we \n",
      "welcome comments on this analysis.\n",
      "    we anticipate potential costs for onc related to this proposal \n",
      "associated with: (1) developing and maintaining information regarding \n",
      "these new criteria on the onc website; (2) creating documents related \n",
      "to these new criteria and making those documents 508 compliant; (3) \n",
      "updating, revising, and supporting certification companion guides, test \n",
      "procedures, and test tools; and (4) responding to inquiries concerning \n",
      "these criteria. we estimate an onc analyst at the gs-13, step 1 level \n",
      "staff would devote, on average, 200 hours to the above tasks annually. \n",
      "the hourly wage with benefits for a gs-13, step 1 employee located in \n",
      "washington, dc is approximately $88.30. therefore, we estimate the \n",
      "annual costs to be $17,660.\n",
      "benefits\n",
      "    we believe leveraging the ds4p standard's ability to allow for both \n",
      "document level and more granular tagging would offer functionality that \n",
      "is more valuable to providers and patients, especially given the \n",
      "complexities of the privacy landscape for multiple care and specialty \n",
      "settings. we also believe this proposal would benefit providers, \n",
      "patients, and onc because it would support more complete records, \n",
      "contribute to patient safety, and enhance care coordination. we believe \n",
      "this proposal could also reduce burden for providers by enabling an \n",
      "automated option, rather relying on case-by-case manual redaction and \n",
      "subsequent workarounds to transmit redacted documents. we emphasize \n",
      "that health care providers already have processes and workflows to \n",
      "address their existing compliance obligations, which could be made more \n",
      "efficient and cost effective through the use of health it. we expect \n",
      "these benefits for providers, patients, and onc to be significant; \n",
      "however, we are unable to quantify these benefits at this time because \n",
      "we do not have adequate information to support quantitative estimates. \n",
      "we welcome comments regarding potential approaches for quantifying \n",
      "these benefits.\n",
      "(3) conditions and maintenance of certification\n",
      "3.1 information blocking\n",
      "    for a discussion of the costs and benefits of the exceptions to \n",
      "information blocking proposed in this rule, please see section (5) of \n",
      "this ria.\n",
      "3.2 assurances\n",
      "    we are proposing that health it developers must make certain \n",
      "assurances as conditions and maintenance of certification: (1) \n",
      "assurances regarding the electronic health information export \n",
      "certification criterion in sec.  170.315(b)(10) and (2) assurances \n",
      "regarding retaining records and information.\n",
      "3.2.1 electronic health information export\n",
      "    we propose, as a condition of certification requirement, that a \n",
      "health it system that produces and electronically manages electronic \n",
      "health information must be certified to the 2015 edition ``electronic \n",
      "health information export'' certification criterion in sec.  \n",
      "170.315(b)(10). further, as a maintenance of certification requirement, \n",
      "health it developers must comply with this proposed condition of \n",
      "certification requirement within 24 months of a subsequent final rule's \n",
      "effective date or at the time of certification if the health it \n",
      "developer never previously certified health it to the 2015 edition. as \n",
      "another maintenance of certification requirement, we propose that \n",
      "health it developers must provide all of their customers with the \n",
      "functionality included in sec.  170.315(b)(10).\n",
      "    for a detailed discussion of the costs and benefits of the \n",
      "assurances regarding the electronic health information export \n",
      "certification criterion in sec.  170.315(b)(10), please see section 2.2 \n",
      "of this ria above.\n",
      "3.2.2 records and information retention\n",
      "    we propose that, as a maintenance of certification requirement, a \n",
      "health it developer must, for a period of 10 years beginning from the \n",
      "date of certification, retain all records and information necessary \n",
      "that demonstrate initial and ongoing compliance with the requirements \n",
      "of the onc health it certification program. in an effort to reduce \n",
      "administrative burden, we also propose, that in situations where \n",
      "applicable certification criteria are removed from the code of federal \n",
      "regulations before the 10 years have expired, records must only be kept \n",
      "for 3 years from the date of removal for those certification criteria \n",
      "and related program provisions unless that timeframe would exceed the \n",
      "overall 10-year retention period. this ``3-year from the date of \n",
      "removal'' records retention period also aligns with the records \n",
      "retention requirements for onc-acbs and onc-atls under the program.\n",
      "    currently, there are no existing regulatory requirements regarding \n",
      "record and information retention by health it developers. we expect the \n",
      "costs to developers to retain the records and information described \n",
      "above to be mitigated due to the following factors. first, we expect \n",
      "that health it developers are already keeping the majority of their \n",
      "records and information in an electronic format. second, we expect that \n",
      "health it developers already have systems in place for retaining \n",
      "records and information. last, we expect that some developers may \n",
      "already be retaining records and information for extended periods of \n",
      "time due to existing requirements of other programs, including for \n",
      "those programs their customers participate in. for instance, medicaid \n",
      "managed care companies are required to keep records for ten years from \n",
      "the effective date of a contract.\n",
      "    we estimate that each health it developer will, on average, spend \n",
      "two hours each week to comply with our proposed record retention \n",
      "requirement. we expect that a health it developer's office clerk could \n",
      "complete the record retention responsibilities. according to\n",
      "\n",
      "[[page 7578]]\n",
      "\n",
      "the may 2016 bls occupational employment statistics, the mean hourly \n",
      "wage for an office clerk is $15.87.\\180\\ as noted previously, we have \n",
      "assumed that overhead costs (including benefits) are equal to 100% of \n",
      "pre-tax wages, so the hourly wage including overhead costs is $31.74. \n",
      "therefore, we estimate the annual cost per developer would, on average, \n",
      "be $3,301 and the total annual cost for all health it developers (458 \n",
      "health it developers have products certified to the 2015 edition that \n",
      "are capable of recording patient health data) would, on average, be \n",
      "$1.5 million. we note that this is a perpetual cost. we welcome \n",
      "comments on these cost estimates.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\180\\ see <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "3.3 prohibition or restriction of communications costs\n",
      "    health it developers would need to notify their customers about the \n",
      "unenforceability of communications and contract provisions that violate \n",
      "this condition of certification. generally, health it developers should \n",
      "already have mechanisms in place, whether via online postings, email, \n",
      "mail, or phone, for alerting customers to changes in their policies and \n",
      "procedures. such alerts should be standard practice. however, we have \n",
      "estimated the potential costs for health it developers to draft the \n",
      "notice and mail the notice as appropriate. we estimate that a health it \n",
      "developer's office clerk will commit (overall) approximately 40 hours \n",
      "to drafting and mailing notices when necessary. according to the may \n",
      "2016 bls occupational employment statistics, the mean hourly wage for \n",
      "an office clerk is $15.87.\\181\\ as noted previously, we have assumed \n",
      "that overhead costs (including benefits) are equal to 100% of pre-tax \n",
      "wages, so the hourly wage including overhead costs is $31.74. \n",
      "therefore, we estimate the annual cost per developer to be $1,270 and \n",
      "the total cost for all health it developers (792 health it developers \n",
      "certified to the 2014 edition) to be $1 million. we note that this is a \n",
      "one-time cost and would not be perpetual.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\181\\ see <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we also note that mailing is one option for delivery, along with \n",
      "other means such as email. we do not have information concerning how \n",
      "health it developers will deliver their notices. we have estimated a \n",
      "total cost for all developers to mail the notices (including postage) \n",
      "to be $80,000. again, we note that this is a one-time cost. we welcome \n",
      "comments on these cost estimates.\n",
      "    in order to meet the cures act requirement that health it \n",
      "developers do not prohibit or restrict communication regarding health \n",
      "it, some health it developers would eventually need to amend their \n",
      "contracts to reflect such a change. many standard form health it \n",
      "contracts limit the ability of users to voluntarily discuss problems or \n",
      "report usability and safety concerns that they experience when using \n",
      "their health it. this type of discussion or reporting is typically \n",
      "prohibited through broad confidentiality, nondisclosure, and \n",
      "intellectual property provisions in the vendor's standard form health \n",
      "it contract. some standard form health it contracts may also include \n",
      "non- disparagement clauses that prohibit customers from making \n",
      "statements that could reflect negatively on the health it developer. \n",
      "these practices are often referred to colloquially in the industry as \n",
      "``gag clauses.'' we expect amendments to these clauses to be \n",
      "accomplished in the normal course of business, such as when \n",
      "renegotiating contracts or updating them for hipaa or other compliance \n",
      "requirements. as such, we do not estimate any direct or indirect costs \n",
      "for health it developers to amend their contracts to comply with this \n",
      "condition of certification.\n",
      "benefits\n",
      "    we expect health care providers to benefit from this proposal. \n",
      "there is growing recognition that these practices of prohibiting or \n",
      "restricting communication do not promote health it safety or good \n",
      "security hygiene and that health it contracts should support and \n",
      "facilitate the transparent exchange of information relating to patient \n",
      "care. we are unable to estimate these benefits because we do not have \n",
      "adequate information to determine the prevalence of gag clauses and \n",
      "other such restrictive practices, nor do we have a means to quantify \n",
      "the value to providers of being able to freely communicate and share \n",
      "information. we welcome comments on approaches to quantify these \n",
      "benefits.\n",
      "3.4 application programming interfaces\n",
      "    for a discussion of the costs and benefits of the new api \n",
      "criterion, please see section 2.3 of this ria.\n",
      "3.5 transparency requirements for application programming interfaces\n",
      "    we propose as part of the conditions and maintenance of \n",
      "certification that api technology suppliers be required to make \n",
      "specific business and technical documentation necessary to interact \n",
      "with the apis in production freely and publicly accessible. we expect \n",
      "that the api technology suppliers would perform the following tasks \n",
      "related to transparency of business and technical documentation and \n",
      "would devote the following number of hours annually to such task: (1) \n",
      "health level 7's (hl7[supreg]) fast healthcare interoperability \n",
      "resources (fhir[supreg]) api documentation (the vendor would most \n",
      "likely point to the hl7 fhir standard for api documentation) (estimated \n",
      "eight hours); (2) patient application registration documentation, which \n",
      "would include a development effort to create a website that manages the \n",
      "application registration activity (estimated 40 hours); (3) publication \n",
      "of the fhir endpoint--base urls for all centrally managed providers \n",
      "(estimated 40 hours); (4) publication of fhir endpoints for provider-\n",
      "managed apis (estimated 160 hours); and (5) api cost information \n",
      "documentation, which would typically be documented as a tiered rate \n",
      "based on usage or some form of monthly rate (estimated 40 hours).\n",
      "    we believe each of the above tasks would be performed by a \n",
      "``software developer.'' according to the may 2016 bls occupational \n",
      "employment statistics, the mean hourly wage for software developer is \n",
      "$50.14 \\182\\ as noted previously, we have assumed that overhead costs \n",
      "(including benefits) are equal to 100% of pre-tax wages, so the hourly \n",
      "wage including overhead costs is $100.28. therefore, we estimate the \n",
      "cost per developer to be $28,881. as noted in section 2.3 of this ria, \n",
      "we estimate that 459 products from 394 developers will contain the api \n",
      "criterion. therefore, we estimate the total developer total would be \n",
      "$11.4 million. we note that this is a one-time cost and would not be \n",
      "perpetual.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\182\\ see <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "3.6 real world testing\n",
      "    the objective of real world testing is to verify the extent to \n",
      "which deployed health it products in operational production settings \n",
      "are demonstrating compliance to certification criteria and functioning \n",
      "with the intended use cases for continued maintenance of certification. \n",
      "real world testing should ensure certified health it products have the \n",
      "ability to share electronic health information between other systems. \n",
      "real world testing should assess that the certified health it is \n",
      "meeting the intended use case(s) of the certification criteria to which \n",
      "it is certified within the workflow, health it architecture,\n",
      "\n",
      "[[page 7579]]\n",
      "\n",
      "and care/practice setting in which the health it is implemented. we \n",
      "note that we expect real world testing would take about three months of \n",
      "the year to perform.\n",
      "costs\n",
      "    this section describes the potential costs of the real world \n",
      "testing requirements in this proposed rule. the costs estimates are \n",
      "based on the following assumptions:\n",
      "    1. health it developers will use the same labor costs. table 20 \n",
      "shows the estimated labor costs for a health it developer to perform \n",
      "real world testing. we recognize that health it developer costs will \n",
      "vary; however, our estimates in this section assume all developers will \n",
      "incur the costs noted in table 20.\n",
      "    2. proxy needed to project the number of 2015 edition products \n",
      "impacted by real world testing. we estimate that 523 products from 429 \n",
      "developers will be impacted by real world testing. we used a proxy to \n",
      "determine developers that would be subject to real world testing there \n",
      "were 681 products and 551 developers with at least one of its 2014 \n",
      "edition certified products that could perform either (or both) \n",
      "transitions of care and/or send any type of public health data. we then \n",
      "multiplied these numbers by our estimates for certified health it \n",
      "market consolidation by -22.1% and -23.2% to project number of 2015 \n",
      "developers and products, respectively. we believe this estimate serves \n",
      "as a reasonable proxy for products impacted by real world testing, as \n",
      "these products primarily focus on interoperability.\n",
      "    the tables below describe the various costs to health it developers \n",
      "to perform real world testing by task.\n",
      "\n",
      "                table 20--estimated cost to health it developers to perform real world testing a\n",
      "                                                 [2016 dollars]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                    tasks and labor category                           hours           rate            total\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "task 1: design real world testing approach and submit plan (per   ..............  ..............         $33,817\n",
      " developer).....................................................\n",
      "    15-1133 software developers, systems software...............              80          106.34        8,507.20\n",
      "    15-1143 computer network architects.........................             120          100.24       12,028.80\n",
      "    15-1121 computer systems analysts...........................              80           88.10        7,048.00\n",
      "    15-1199 computer occupations, all other.....................              40           85.46        3,418.40\n",
      "    27-3042 technical writers...................................              40           70.36        2,814.40\n",
      "task 2: prepare staff and environments (per developer)..........  ..............  ..............          14,646\n",
      "    15-1121 computer systems analysts...........................              40           88.10        3,524.00\n",
      "    15-1142 network and computer systems administrators.........              40           81.26        3,250.40\n",
      "    15-1152 computer network support specialists................              40           65.16        2,606.40\n",
      "    15-1199 computer occupations, all other.....................              40           85.46        3,418.40\n",
      "    15-1122 information security analysts.......................              20           92.34        1,846.80\n",
      "task 3: perform testing (per product)...........................  ..............  ..............          31,577\n",
      "    15-1121 computer systems analysts...........................              80           88.10        7,048.00\n",
      "    15-1133 software developers, systems software...............              40          106.34        4,253.60\n",
      "    15-1199 computer occupations, all other.....................             160           85.46       13,673.60\n",
      "    15-1142 network and computer systems administrators.........              40           81.26        3,250.40\n",
      "    15-1141 database administrators.............................              40           83.78        3,351.20\n",
      "task 4: collect results and prepare-submit report (per            ..............  ..............          20,118\n",
      " developer).....................................................\n",
      "    15-1199 computer occupations, all other.....................             120           85.46       10,255.20\n",
      "    15-1121 computer systems analysts...........................              80           88.10        7,048.00\n",
      "    27-3042 technical writers...................................              40           70.36        2,814.40\n",
      "                                                                 -----------------------------------------------\n",
      "        total labor hours.......................................           1,140\n",
      "        other direct costs--printing, publishing (per product)..  ..............  ..............          150.00\n",
      "                                                                 -----------------------------------------------\n",
      "            total cost..........................................  ..............  ..............         100,307\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\\a\\ labor rates in this chart are from the bls. see <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "\n",
      "\n",
      "                                 table 21--real world testing total annual cost\n",
      "                                                 [2016 dollars]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                      task                                         calculation                      total cost\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "task 1.........................................  $33,817 x 429 developers.......................     $14,507,407\n",
      "task 2.........................................  $14,646 x 429 developers.......................       6,283,134\n",
      "task 3.........................................  $31,577 x 523 products.........................      16,514,666\n",
      "task 4.........................................  $20,118 x 429 developers.......................       8,630,450\n",
      "other direct costs.............................  $150 x 429 developers..........................          78,450\n",
      "                                                                                                 ---------------\n",
      "    total cost.................................  ...............................................      46,014,108\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "    based on the stated assumptions and costs outlined in the above \n",
      "tables, we estimate the total annual cost for real world testing would, \n",
      "on average, be $46 million with an average cost per developer of \n",
      "$107,259.\n",
      "benefits\n",
      "    there are a number of benefits that can be attributed to real world \n",
      "testing. real world testing may impact the effective integration of \n",
      "varied health it systems, including integration of certified health it \n",
      "with non-certified and ancillary technologies such as picture archiving \n",
      "and communications systems (pacs) or specialty specific interfaces. \n",
      "real world testing might also have an effect on the effective \n",
      "implementation of workflows in a clinical setting. in this analysis, we \n",
      "have\n",
      "\n",
      "[[page 7580]]\n",
      "\n",
      "calculated the benefits in the following categories:\n",
      "    1. provider time saved documenting in their ehr due to improved \n",
      "usability.\n",
      "    2. increased provider satisfaction with their ehr resulting in \n",
      "fewer providers incurring the costs of switching products.\n",
      "    3. benefits related to reductions in duplicate lab tests, \n",
      "readmissions, er visits, and adverse drug events due to increased \n",
      "interoperability. we focused on these outcomes for two reasons: (i) \n",
      "evidence in literature indicate that health information exchange \n",
      "impacts the chosen measures; and (ii) cost of care associated with \n",
      "these measures is high and the impact of health information exchange is \n",
      "likely to result in significant benefits in the form of reduced costs.\n",
      "    the benefit calculations are based on the following assumptions:\n",
      "    1. benefits noted in academic literature are assumed accurate and \n",
      "results were not externally validated. estimates of the benefits \n",
      "associated with the benefits are based on estimates obtained from the \n",
      "academic literature. staff reviewed the academic articles for validity, \n",
      "but estimates were not replicated to confirm accuracy.\n",
      "    2. hospitals and eligible professionals that participate in the cms \n",
      "ehr incentive program will be impacted. estimates are based on the \n",
      "assumption that 439,187 health care providers and/or 4,519 hospitals \n",
      "will be affected by this regulatory action.\n",
      "    3. estimates of the impact of real world testing on rates of \n",
      "interoperability (0.1 to 1%) are based on onc analysis. to identify the \n",
      "impact of real world testing on interoperability, we used regression \n",
      "analysis. specifically, we estimated linear probability models that \n",
      "identified impact of 2014 edition certified ehr on hospitals' \n",
      "interoperability (whether a hospital sends, receives, finds, and \n",
      "integrates summary of care records). using data from the aha from years \n",
      "2014-2015 in the model, we controlled for hospital size, profit status, \n",
      "participation in a health information organization, and state and year \n",
      "fixed effects. the marginal effect of using a 2014 edition was a five \n",
      "percentage point increase in interoperability. this is an upper bound \n",
      "estimate. for the purpose of this analysis, we assume 0.1% to 1% would \n",
      "be a reasonable range for real world testing to impact \n",
      "interoperability.\n",
      "    4. impact of real world testing is also based on the estimated \n",
      "number of providers that switch health it developers (rate = 5%). using \n",
      "cms medicare ehr incentive program data from years 2013-2016, we \n",
      "estimate the rate of providers (hospitals and eligible professionals) \n",
      "that changed their health it developer.\n",
      "    5. estimates of the rate of eligible professionals (10%) and \n",
      "hospitals (5%) that will be impacted by real world testing are based on \n",
      "onc complaint data. because real world testing is designed to improve \n",
      "usability and interoperability of products, we assume that those \n",
      "eligible professionals and hospitals most likely to be impacted are \n",
      "those who currently use products by health it developers with \n",
      "complaints.\n",
      "    as noted previously in this analysis, we acknowledge that there \n",
      "might be shared benefits across certain proposals and have taken steps \n",
      "to ensure that the benefits attributed to each proposal are unique to \n",
      "the proposal referenced. specifically, we used regression analysis to \n",
      "calculate the impact of our real world testing and api proposals on \n",
      "interoperability. we assumed that the real world testing and api \n",
      "proposals would collectively have the same impact on interoperability \n",
      "as use of 2014 edition certified health it. therefore, we estimated \n",
      "linear probability models that identified the impact of 2014 edition \n",
      "certified health it on hospitals' interoperability.\\183\\ we controlled \n",
      "for additional factors such as participation in a health information \n",
      "exchange organization, hospital characteristics, and urban/rural \n",
      "status. we found the marginal effect of using 2014 edition certified \n",
      "health it was a five percentage point increase in interoperability.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\183\\ american hospital association health it supplement survey, \n",
      "<a href=\"http://www.ahadata.com/aha-healthcare-database/\">http://www.ahadata.com/aha-healthcare-database/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while we acknowledge that there might be shared benefits across \n",
      "proposals, we have taken steps to ensure that the benefits attributed \n",
      "to each proposal is unique to the proposal referenced. we assumed that \n",
      "this marginal effect is true for our proposals and distributed the 5% \n",
      "benefit across our real world testing and api proposals at (.1-1%) to \n",
      "(1-4%) respectively. moreover, the number of providers impacted is \n",
      "proposal specific. given data limitations, we believe this approach \n",
      "allows us to estimate the benefits of our proposals without double \n",
      "counting the impact each proposal might have on interoperability.\n",
      "    the first table below shows benefits of real world testing for \n",
      "providers where we monetize the impact of real world testing as total \n",
      "amount saved by reducing provider time spent with the health it. the \n",
      "impact of real world testing on provider time is expected to represent \n",
      "a larger impact (5%) than the impact of real world testing on health \n",
      "outcomes (1%-4%) and cost. this is primarily because provider behavior \n",
      "is more directly affected by improvements in interoperability.\n",
      "benefits of real world testing\n",
      "\n",
      "                                                                      table 22--benefit of real world testing for providers\n",
      "                                                                                         [2016 dollars]\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                                                     hours saved (percent) a b                                      total benefit c  (per year)\n",
      "                                                                                                 --------------------------------  hours per day     number of\n",
      "                 benefit type                            number affected            hourly wage                                      with ehr      working days  -------------------------------\n",
      "                                                                                                        min             max                          in a year          min             max\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "reduction in provider time spent in health it   43,919 providers or 10% d (based              95               1               5             e 6             260            $65m           $325m\n",
      " by improving usability and interoperability.    on complaint data).\n",
      "administrative time spent in health it by       using a rule of 0.75                       14.52               1               5             e 6             260              7m             37m\n",
      " improving billing, patient matching, product    administrative staff per\n",
      " integration.                                    provider,f 32,939 personnel.\n",
      "\n",
      "[[page 7581]]\n",
      "\n",
      " \n",
      "number of providers switching health it g.....  number 2,195; cost of switching   ..............  ..............  ..............  ..............  ..............             33m            154m\n",
      "                                                 min = $15,000, max = $70,000.\n",
      "                                                                                 ---------------------------------------------------------------------------------------------------------------\n",
      "    total benefit.............................  ................................  ..............  ..............  ..............  ..............  ..............            105m            516m\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\\a\\ julia adler-milstein and robert s. huckman, the impact of electronic health record use on physician productivity, am j manag care (nov. 19, 2013).\n",
      "\\b\\ amusan, tongen, speedie, and mellin, a time-motion study to evaluate the impact of emr and cpoe implementation on physician efficiency, j. healthcare inf. manag. (fall 2008), at 31-7.\n",
      "\\c\\ total benefits for the provider and administrative time spent in health it by improving usability and interoperability. total benefits from switching ehr vendor is a product of number\n",
      "  providers switching and cost of ehr.\n",
      "\\d\\ the estimate is based on the number of providers that currently possess products with complaints. this is identified by flagging health it developers and products about whom/which\n",
      "  complaints are logged on onc's database. these health it developers are then matched to physicians using the meaningful use database.\n",
      "\\e\\ christine sinsky et al., allocation of physician time in ambulatory practice: a time and motion study in 4 specialties, ann intern med. (dec. 6, 2016), at 753-60.\n",
      "\\f\\ physician practice, calculating the right number of staff for your medical practice, available at <a href=\"http://www.physicianspractice.com/blog/calculating-right-number-staff-your-medical-practice\">http://www.physicianspractice.com/blog/calculating-right-number-staff-your-medical-practice</a> practice.\n",
      "\\g\\ this estimate was obtained from meaningful use data from years 2013-2016. ``switching'' is defined as an annual change in all health it developers by providers/hospitals.\n",
      "\n",
      "\n",
      "                                                                 table 23--benefit of real world testing for patients and payers\n",
      "                                                                                         [2016 dollars]\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                          overall      impact of real world testing                                                 total benefit a  (per year)\n",
      "                                                                      interop impact --------------------------------                               percent of\n",
      "              benefit type                    population affected        (marginal                                            total cost            total cost   -------------------------------\n",
      "                                                                          effect)           min             max                                      impacted           min             max\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "duplicate testing.......................  35,607 providers..........          b 0.09           0.001            0.01  200 billion c.............              10            $18m           $180m\n",
      "avoidable hospitalizations and            5% of hospitals (n = 226).          b 0.09           0.001            0.01  $41b d....................               5            0.2m            1.8m\n",
      " readmissions.\n",
      "er visits...............................  5% of visits affected.....          b 0.03           0.001            0.01  cost per er visit $1,233,                5              2m            2.4m\n",
      "                                                                                                                       131m visits e.\n",
      "adverse drug events.....................  5% of events affected.....          f 0.22           0.001            0.01  $30 billion g.............               5           0.33m            3.3m\n",
      "                                                                     ---------------------------------------------------------------------------------------------------------------------------\n",
      "    total benefit.......................  ..........................  ..............  ..............  ..............  ..........................  ..............            2.6m           25.6m\n",
      "------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\\a\\ total benefit is a product of total cost, % of total cost impacted, overall impact of interoperability, and impact of real world testing.\n",
      "\\b\\ stephen e. ross, tiffany a. radcliff, william g. leblanc, l. miriam dickinson, anne m. libby, and donald e. nease jr., effects of health information exchange adoption on ambulatory testing\n",
      "  rates, j. am. med. inform. assoc. (2013), at 1137-1142; bridget a. stewart, susan fernandes, elizabeth rodriguez-huertas, and michael landzberg, a preliminary look at duplicate testing\n",
      "  associated with lack of electronic health record interoperability for transferred patients, j. of the am. med. informatics assoc. (2010), at 341-344; sezgin ayabakan, indranil r. bardhan,\n",
      "  zhiqiang (eric) zheng, and kirk kirksey value of health information sharing in reducing healthcare waste: an analysis of duplicate testing across hospitals, mis quarterly (jan. 1, 2017);\n",
      "  eric j. lammers, julia adler-milstein, and keith e. kocher, does health information exchange reduce redundant imaging? evidence from emergency departments, med care (mar. 2014), at 227-34.\n",
      "\\c\\ national academy of medicine. (2016), <a href=\"http://money.cnn.com/2017/05/20/news/economy/medical-tests/index.html\">http://money.cnn.com/2017/05/20/news/economy/medical-tests/index.html</a>.\n",
      "\\d\\ agency for healthcare research and quality (ahrq) statistical brief #199 (dec. 2015), <a href=\"https://www.hcup-us.ahrq.gov/reports/statbriefs/sb199-readmissions-payer-age.pdf\">https://www.hcup-us.ahrq.gov/reports/statbriefs/sb199-readmissions-payer-age.pdf</a>; ahrq statistical\n",
      "  brief #72, nationwide frequency and costs of potentially preventable hospitalizations (apr. 2009), <a href=\"https://www.hcup-us.ahrq.gov/reports/statbriefs/sb72.pdf\">https://www.hcup-us.ahrq.gov/reports/statbriefs/sb72.pdf</a>.\n",
      "\\e\\ national center for health statistics (nchs) data brief no. 252 (june 2016), <a href=\"https://www.cdc.gov/nchs/data/databriefs/db252.pdf\">https://www.cdc.gov/nchs/data/databriefs/db252.pdf</a>; nolan caldwell, tanja srebotnjak, tiffany wang, and renee\n",
      "  hsia, ``how much will i get charged for this?'' patient charges for top ten diagnoses in the emergency department (2013), <a href=\"https://doi.org/10.1371/journal.pone.0055491\">https://doi.org/10.1371/journal.pone.0055491</a>.\n",
      "\\f\\m.f. furukawa, w.d. spector, m.r. limcangco, and w.e. encinosa, meaningful use of health information technology and declines in in-hospital adverse drug events, j. of the am. med.\n",
      "  informatics assoc. (2017).\n",
      "\\g\\ janet sultana, paola cutroneo, and gianluca trifir[ograve], clinical and economic burden of adverse drug reactions (dec. 2013).\n",
      "\n",
      "    based on the stated assumptions and benefits outlined in table 22 \n",
      "above, we estimate the total annual benefit for real world testing to \n",
      "providers would, on average, range from $105 million to $516 million. \n",
      "based on the stated assumptions and benefits outlined in table 23 \n",
      "above, we estimate the total annual benefit for patients and payers \n",
      "would, on average, range from $4.3 million to $25.5 million. therefore, \n",
      "we estimate the total benefit of real world testing would, on average, \n",
      "range from $109.3 million to $541.5 million. if we assume, based on our \n",
      "cost estimates, the average annual costs to health it developers would \n",
      "be $46 million and that increased health it developer costs are passed \n",
      "to customers, then the net benefit to hospitals/providers would range \n",
      "from $63.3 million to $495.5 million.\n",
      "    we recognize that health it developers may deploy their systems in \n",
      "a number of ways, including cloud-based deployments, and seek comment \n",
      "on whether our cost estimates of real world testing should factor in \n",
      "such methods of system deployment. for example, we request feedback \n",
      "about whether health it developers would incur reduced real world \n",
      "testing costs through cloud-based deployments as opposed to other \n",
      "deployment methods. we specifically solicit comment on the general \n",
      "ratio of cloud-based to non-cloud-based deployments within the health \n",
      "care ecosystem and specific cost variations in performing real world \n",
      "testing based on the type of deployment. we also request comment on our \n",
      "assumptions about the burden to providers in time spent assisting \n",
      "health it developers since we encourage health it developers to come up \n",
      "with ways to perform real world testing that mitigate provider \n",
      "disruption.\n",
      "\n",
      "[[page 7582]]\n",
      "\n",
      "3.6.1 real world testing maintenance requirements\n",
      "    we propose to revise the principle of proper conduct in sec.  \n",
      "170.523(m) to require onc-acbs to collect, no less than quarterly, all \n",
      "updates successfully made to standards in certified health it pursuant \n",
      "to the developers having opted to avail themselves of the standards \n",
      "version advancement process flexibility under the real world testing \n",
      "condition of certification. under sec.  170.523(p), onc-acbs will be \n",
      "responsible for: (1) reviewing and confirming that applicable health it \n",
      "developers submit real world testing plans in accordance with sec.  \n",
      "170.405(b)(1); (2) reviewing and confirming that applicable health it \n",
      "developers submit real world testing results in accordance with sec.  \n",
      "170.405(b)(2); and (3) submitting real world testing plans by december \n",
      "15 and results by april 1 of each calendar year to onc for public \n",
      "availability. in addition, under sec.  170.523(t), onc-acbs will be \n",
      "required to: (1) maintain a record of the date of issuance and the \n",
      "content of developers' notices; and (2) timely post content of each \n",
      "notice on the chpl.\n",
      "    using the information from the ``real world testing'' section of \n",
      "this ria, we estimate that 429 developers will be impacted by real \n",
      "world testing. we estimate that, on average, it will take an onc-acb \n",
      "employee at the gs-13, step 1 level approximately 30 minutes to collect \n",
      "all updates made to standards in health it modules in accordance with \n",
      "sec.  170.523(m). the hourly wage with benefits for a gs-13, step 1 \n",
      "employee located in washington, dc is approximately $88.30. since the \n",
      "collection must occur no less than quarterly, we assume it occurs, on \n",
      "average, four times per year. therefore, we estimate the annual cost to \n",
      "onc-acbs to comply with the collection requirements under sec.  \n",
      "170.523(m) to be $139,867.\n",
      "    we estimate that, on average, it will take an onc-acb employee at \n",
      "the gs-13, step 1 level approximately 1 hour to review and confirm that \n",
      "applicable health it developers submit real world testing plans in \n",
      "accordance with sec.  170.405(b)(1). we estimate that, on average, it \n",
      "will take an onc-acb employee at the gs-13, step 1 level approximately \n",
      "30 minutes to review and confirm that applicable health it developers \n",
      "submit real world testing results in accordance with sec.  \n",
      "170.405(b)(2). we estimate that, on average, it will take an onc-acb \n",
      "employee at the gs-13, step 1 level approximately 30 minutes to submit \n",
      "real world testing plans and results to onc for public availability. \n",
      "the hourly wage with benefits for a gs-13, step 1 employee located in \n",
      "washington, dc is approximately $88.30. therefore, we estimate the \n",
      "annual cost to onc-acbs to comply with the submission and reporting \n",
      "requirements under sec. sec.  170.523(m) and 170.550(l) to be $143,891.\n",
      "    throughout the ria we have used 830 products as our 2015 edition \n",
      "projection. we came up with this projection by multiplying a -23.2% \n",
      "market consolidation rate from the total number of products certified \n",
      "to 2014 edition. this assumption was based on the market consolidation \n",
      "rate observed between the 2011 and 2014 editions. we have estimated the \n",
      "number of 2015 edition products that will certify each criteria \n",
      "included in the real world testing condition of certification. we \n",
      "assume that there will be a cost associated with a notice for each \n",
      "certified criteria (even if an individual product were to update the \n",
      "same standard across multiple criteria that use that standard). this \n",
      "estimation was calculated by multiplying the current percent of 2015 \n",
      "edition products that certify a criteria by the estimated number of \n",
      "total 2015 edition products (830).\n",
      "    we assume that the amount of time for an onc-acb staff person to \n",
      "(1) maintain a record of the date of issuance and the content of \n",
      "developers' notices; and (2) to timely post content of each notice on \n",
      "the chpl can be anywhere from 30 minutes to 1 hour.\n",
      "    the hourly wage with benefits for a gs-13, step 1 employee located \n",
      "in washington, dc is approximately $88.30. this was the hourly rate we \n",
      "used for the ria, so it's consistent with prior calculations. this wage \n",
      "is used to determine the onc-acb time cost to complete this requirement \n",
      "under sec.  170.523(t). our minimum estimate for the amount of time to \n",
      "comply is 30 minutes per notice. if 25% of certified products update \n",
      "any of the applicable standards, we estimate it will cost $58,807. if \n",
      "all products update any of the applicable standards, we estimate it \n",
      "will cost $235,231. our maximum estimate for the amount of time to \n",
      "comply is 1 hour per notice. if 25% of certified products update any of \n",
      "the applicable standards, we estimate it will cost $117,615. if all \n",
      "products update any of the applicable standards, we estimate it will \n",
      "cost $470,462. our lower bound estimate for the cost of this \n",
      "requirement is $58,807. our upper bound estimate for the cost of this \n",
      "requirement is $470,462.\n",
      "3.8 attestations\n",
      "    the cures act requires that a health it developer, as a condition \n",
      "and maintenance of certification under the program, provide to the \n",
      "secretary an attestation to all the conditions and maintenance of \n",
      "certification specified in the cures act, except for the ``ehr \n",
      "reporting program'' condition of certification. it also requires that a \n",
      "health it developer attest to ensuring that its health it allows for \n",
      "health information to be exchanged, accessed, and used in the manner \n",
      "described by the api condition of certification. we propose to \n",
      "implement the cures act ``attestations'' condition of certification in \n",
      "sec.  170.406 by requiring health it developers to attest to the \n",
      "aforementioned conditions. for the purposes of estimating the potential \n",
      "burden of these attestations on health it developers, onc-acbs, and \n",
      "onc, we are estimating that all health it developers under the program \n",
      "will submit an attestation biannually. as noted previously in this ria, \n",
      "there are 792 health it developers certified to the 2014 edition.\n",
      "    we estimate it will take a health it developer employee \n",
      "approximately one hour on average to prepare and submit each \n",
      "attestation to the onc-acb. according to the may 2016 bls occupational \n",
      "employment statistics, the mean hourly wage for a software developer is \n",
      "$50.14 \\184\\ therefore, we estimate the annual cost including overhead \n",
      "costs to be $79,422.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\184\\ see <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we propose that attestations would be submitted to onc-acbs on \n",
      "behalf of onc and the secretary. we assume there will be three onc-acbs \n",
      "as this is the current number of onc-acbs, and we also assume an equal \n",
      "distribution in responsibilities among onc-acbs. onc-acbs would have \n",
      "two responsibilities related to attestations. one responsibility we \n",
      "propose in sec.  170.523(q) is that an onc-acb must review and submit \n",
      "the health it developers' attestations to onc. we estimate it will take \n",
      "an onc-acb employee at the gs-13, step 1 level approximately 30 minutes \n",
      "on average to review and submit each attestation to onc. the other \n",
      "responsibility we propose in sec.  170.550(l) is that before issuing a \n",
      "certification, an onc-acb would need to ensure that the health it \n",
      "developer of the health it module has met its responsibilities related \n",
      "to the conditions and maintenance of certification requirements as \n",
      "solely evidenced by its attestation. we estimate it will take an onc-\n",
      "acb\n",
      "\n",
      "[[page 7583]]\n",
      "\n",
      "employee at the gs-13, step 1 level approximately one hour on average \n",
      "to complete this task. the hourly wage with benefits for a gs-13, step \n",
      "1 employee located in washington, dc is approximately $88.30. \n",
      "therefore, we estimate the annual cost to onc-acbs to be $209,801.\n",
      "    we propose that onc would make the attestations publicly available \n",
      "on the chpl once they are submitted by the onc-acbs. onc posts \n",
      "information regularly to the chpl and we estimate the added costs to \n",
      "post the attestation will be de minimis. we welcome comments if \n",
      "stakeholders believe more or less networks should be included in our \n",
      "estimate.\n",
      "(4) oversight for the conditions and maintenance of certification\n",
      "    onc's processes for overseeing the conditions and maintenance of \n",
      "certification will, for the most part, mirror onc's processes for \n",
      "direct review of non-conformities in certified health it as described \n",
      "in current sec.  170.580. we have proposed that onc may directly review \n",
      "a health it developer's actions to determine whether they conform to \n",
      "the conditions and maintenance of certification requirements proposed \n",
      "in this proposed rule. the estimated costs and benefits for such \n",
      "oversight and review are detailed below.\n",
      "costs\n",
      "    we estimated the potential monetary costs of our proposal to allow \n",
      "onc to directly review a health it developer's actions to determine \n",
      "whether the actions conform to the requirements of the program as \n",
      "follows: (1) costs for health it developers to correct non-conforming \n",
      "actions identified by onc; (2) costs for health it developers and onc \n",
      "related to onc review and inquiry into non-conforming actions by the \n",
      "health it developer; and (3) costs for onc-acbs related to the new \n",
      "proposed reporting requirement in the principles of proper conduct in \n",
      "sec.  170.523(s).\n",
      "costs for health it developers to correct non-conforming actions \n",
      "identified by onc\n",
      "    we do not believe health it developers face additional direct costs \n",
      "for the proposed onc direct review of health it developer actions (see \n",
      "cost estimates for the conditions and maintenance of certification \n",
      "requirements). however, we acknowledge that this proposed rule may \n",
      "eventually require health it developers to correct certain actions or \n",
      "non-conformities with their health it that do not conform to the \n",
      "conditions and maintenance of certification.\n",
      "    if onc identifies a non-conforming action by a health it developer, \n",
      "the costs incurred by the health it developer to bring its actions into \n",
      "conformance would be determined on a case-by-case basis. factors that \n",
      "would be considered include, but are not limited to: (1) the extent of \n",
      "customers and/or business affected; (2) how pervasive the action(s) is \n",
      "across the health it developer's business; (3) the period of time that \n",
      "the health it developer was taking the action(s) in question; and (4) \n",
      "the corrective action required to resolve the issue. we are unable to \n",
      "reliably estimate these costs as we do not have cost estimates for a \n",
      "comparable situation. we request comment on existing relevant data and \n",
      "methods we could use to estimate these costs.\n",
      "costs for health it developers and onc related to onc review and \n",
      "inquiry into health it developer actions\n",
      "    in order to calculate the potential costs to health it developers \n",
      "and onc related to onc review and inquiry into health it developer \n",
      "actions, we have created the following categories for potential costs: \n",
      "(1) onc review and inquiry prior to the issuance of a notice of non-\n",
      "conformity; (2) onc review and inquiry following the issuance of a \n",
      "notice of non-conformity and the health it developer does not contest \n",
      "onc's findings (i.e., no appeal); and (3) onc review and inquiry \n",
      "following the issuance of a notice of non-conformity and the health it \n",
      "developer contests onc's findings (i.e., appeal).\n",
      "onc review and inquiry prior to the issuance of a notice of non-\n",
      "conformity\n",
      "    we anticipate that onc will receive, on average, between 100 and \n",
      "200 complaints per year concerning the conditions and maintenance of \n",
      "certification that will warrant review and inquiry by onc. we estimate \n",
      "that such initial review and inquiry by onc would require, on average, \n",
      "two to three analysts at the gs-13 level working one to two hours each \n",
      "per complaint. the hourly wage with benefits for a gs-13, step 1 \n",
      "employee located in washington, dc is approximately $88.30. therefore, \n",
      "we estimate each review and inquiry would cost onc, on average, between \n",
      "$177 and $529. we estimate the total annual cost to onc would, on \n",
      "average, range from $17,700 and $105,800. this range takes into account \n",
      "both the low end of reviews that are resolved quickly and the high end \n",
      "in which staff would need to discuss issues with onc leadership or in \n",
      "some cases, hhs senior leadership including the office of general \n",
      "counsel. we have not estimated health it developer costs associated \n",
      "with onc review prior to the issuance of a notice of non-conformity \n",
      "because, in most cases, health it developers are not required to take \n",
      "action prior to the notice of non-conformity.\n",
      "onc review and inquiry following the issuance of a notice of non-\n",
      "conformity and the health it developer does not contest onc's findings\n",
      "    this category would capture cases that require review and inquiry \n",
      "following onc's issuance of a notice of non-conformity, but that would \n",
      "not proceed to the appeals process. examples of such situations would \n",
      "include, but not be limited to: (1) a health it developer violates a \n",
      "condition of certification and does not contest onc's finding that it \n",
      "is in violation of the condition of certification; or (2) a health it \n",
      "developer fails to meet a deadline, such as for its corrective action \n",
      "plan (cap). we estimate that onc will, on average, conduct between 12 \n",
      "and 18 of these reviews annually.\n",
      "    we estimate that a health it developer may commit, on average and \n",
      "depending on complexity, between 10 and 40 hours of staff time per case \n",
      "to provide onc with all requested records and documentation that onc \n",
      "would use to review and conduct an inquiry into health it developer \n",
      "actions, and, when necessary, make a certification ban and/or \n",
      "termination determination. we assumed that the work would be performed \n",
      "by a ``computer systems analyst.'' according to the may 2016 bls \n",
      "occupational employment statistics, the mean hourly wage for computer \n",
      "systems analyst is $44.05.\\185\\ as noted previously, we have assumed \n",
      "that overhead costs (including benefits) are equal to 100% of pre-tax \n",
      "wages, so the hourly wage including overhead costs would be $88.10. \n",
      "therefore, we estimate the average annual cost for health it developers \n",
      "would range from $10,572 to $63,432. we note that some health it \n",
      "developers' costs are expected to be less and some health it \n",
      "developers' costs are expected to be more than this estimated cost \n",
      "range. further, we note that these costs would be perpetual.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\185\\ <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we estimate that onc may commit, on average and depending on \n",
      "complexity, between 8 and 80 hours of staff time to complete a review \n",
      "and inquiry into health it developer actions. we assume that the \n",
      "expertise of a gs-15, step 1 federal employee(s) would be\n",
      "\n",
      "[[page 7584]]\n",
      "\n",
      "necessary. the hourly wage with benefits for a gs-15, step 1 employee \n",
      "located in washington, dc is approximately $122.74. therefore, based on \n",
      "the estimate of between 12 and 18 cases each year, we estimate onc's \n",
      "annual costs would on, average range, from $11,783 to $176,745. we note \n",
      "that some reviews and inquiries may cost less and some may cost more \n",
      "than this estimated cost range. further, we note that these costs would \n",
      "be perpetual.\n",
      "    we welcome comments on our estimated costs and any comparable \n",
      "processes and costs that we could use to improve our cost estimates.\n",
      "onc review and inquiry following the issuance of a notice of non-\n",
      "conformity and the health it developer contests onc's findings\n",
      "    as discussed in section vii.c of this preamble, we propose to \n",
      "permit a health it developer to appeal an onc determination to issue a \n",
      "certification ban and/or terminate a certification under sec.  \n",
      "170.581(a)(2)(iii). this category of cost calculations captures cases \n",
      "that require review and inquiry following onc's issuance of a notice of \n",
      "non-conformity and where the health it developer contests onc's finding \n",
      "and files an appeal. we estimate that onc will, on average, conduct \n",
      "between three and five of these reviews annually.\n",
      "    we estimate that a ``computer systems analyst'' for the health it \n",
      "developer may commit, on average and depending on complexity, between \n",
      "20 and 80 hours to provide the required information to appeal a \n",
      "certification ban and/or termination under sec.  170.581(a)(2)(iii) and \n",
      "respond to any requests from the hearing officer. according to the may \n",
      "2016 bls occupational employment statistics, the mean hourly wage for a \n",
      "computer systems analyst is $44.05.\\186\\ assuming that overhead costs \n",
      "(including benefits) are equal to 100% of pre-tax wages, the hourly \n",
      "wage including overhead costs is $88.10. therefore, we estimate the \n",
      "annual cost, including overhead costs, for a health it developer to \n",
      "appeal a certification ban and/or termination under sec.  \n",
      "170.581(a)(2)(iii) would, on average, range from $5,286 to $35,240. we \n",
      "note that some health it developers' costs are expected to be less and \n",
      "some health it developers' costs are expected to be more than this \n",
      "estimated cost range. further, we note that these costs would be \n",
      "perpetual.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\186\\ see <a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>. \n",
      "<a href=\"https://www.bls.gov/oes/2016/may/oes439061.htm\">https://www.bls.gov/oes/2016/may/oes439061.htm</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we estimate that onc would commit, on average and depending on \n",
      "complexity, between 40 and 160 hours of staff time to conduct each \n",
      "appeal. this would include the time to represent onc in the appeal and \n",
      "support the costs for the hearing officer. we assume that the expertise \n",
      "of a gs-15, step 1 federal employee(s) would be necessary. the hourly \n",
      "wage with benefits for a gs-15, step 1 employee located in washington, \n",
      "dc is approximately $122.74. therefore, based on the estimate on \n",
      "between three and five cases each year, we estimate the cost for onc to \n",
      "conduct an appeal would, on average, range from $14,729 to $98,192. we \n",
      "note that some appeals may cost less and some may cost more than this \n",
      "estimated cost range. further, we note that these costs would be \n",
      "perpetual.\n",
      "    based on the above estimates, we estimate the total annual costs \n",
      "for health it developers related to onc review and inquiry into health \n",
      "it developer actions would, on average, range from $15,858 to $98,672. \n",
      "we estimate the total annual costs for onc related to onc review and \n",
      "inquiry into health it developer actions would, on average, range from \n",
      "$44,212 to $380,737.\n",
      "    we welcome comments on our estimated costs and any comparable \n",
      "processes and costs that we could use to improve our cost estimates.\n",
      "costs for onc-acbs\n",
      "    we also note that onc-acbs could realize costs associated with the \n",
      "new proposed reporting requirement in the principles of proper conduct \n",
      "in sec.  170.523(s) that they report, at a minimum, on a weekly basis \n",
      "to the national coordinator any circumstances that could trigger onc \n",
      "direct review per sec.  170.580(a)(2). we estimate that, on average, it \n",
      "will take an onc-acb employee at the gs-13, step 1 level approximately \n",
      "30 minutes to prepare the report. the hourly wage with benefits for a \n",
      "gs-13, step 1 employee located in washington, dc is approximately \n",
      "$88.30. since the collection must occur no less than weekly, we will \n",
      "assume it occurs, on average, 52 times per year. therefore, given that \n",
      "there are currently three onc-acbs, we estimate the annual cost to onc-\n",
      "acbs to comply with the reporting requirement under sec.  170.523(s) \n",
      "would, on average, be $6,889.\n",
      "benefits\n",
      "    this proposed rule's provisions for onc direct review of the \n",
      "conditions and maintenance of certification requirements would promote \n",
      "health it developers' accountability for their actions and ensure that \n",
      "health it developers' actions conform with the requirements of the \n",
      "cures act and conditions and maintenance of certification requirements \n",
      "in sec. sec.  170.400-406. specifically, onc's direct review of health \n",
      "it developer actions will facilitate onc's ability to require \n",
      "comprehensive corrective action by health it developers to address non-\n",
      "conforming actions determined by onc. if onc ultimately implements a \n",
      "certification ban and/or terminates a certification(s), such action \n",
      "will serve to protect the integrity of the program and users of health \n",
      "it. while we do not have available means to quantify the benefits of \n",
      "onc direct review of health it developer actions, we note that onc \n",
      "direct review supports and enables the national coordinator to fulfill \n",
      "his responsibilities under the hitech act and cures act, instills \n",
      "public confidence in the program, and protects public health and \n",
      "safety.\n",
      "(5) information blocking\n",
      "costs\n",
      "    we expect onc to incur an annual cost for issuing guidance related \n",
      "to the information blocking ``reasonable and necessary'' exceptions. we \n",
      "assume that the guidance would be provided by onc staff with the \n",
      "expertise of a gs-15, step 1 federal employee(s). the hourly wage with \n",
      "benefits for a gs-15, step 1 employee located in washington, dc is \n",
      "approximately $122.74. we estimate it would take onc staff between 200 \n",
      "and 400 hours to develop the guidance. therefore, we estimate the \n",
      "annual cost to onc would, on average, range from $98,192 to $196,384.\n",
      "benefits\n",
      "    information blocking not only interferes with effective health \n",
      "information exchange, but also negatively impacts many important \n",
      "aspects of health and health care. to make informed health care \n",
      "decisions, providers and individuals must have timely access to \n",
      "information in a form that is usable. when health information is \n",
      "unavailable, decisions can be impaired--and so too the safety, quality, \n",
      "and effectiveness of care provided to patients. information blocking \n",
      "impedes progress towards reforming health care delivery and payment \n",
      "because sharing information seamlessly across the care continuum is \n",
      "fundamental to moving to a person-centered, high-performing health care \n",
      "system. information blocking can undermine consumers' confidence in \n",
      "their health care providers by preventing individuals from accessing \n",
      "their health information and using it to make informed decisions\n",
      "\n",
      "[[page 7585]]\n",
      "\n",
      "about their health and health care. information blocking also prevents \n",
      "advances in biomedical and public health research, which require the \n",
      "ability to analyze information from many sources in order to identify \n",
      "public health risks, develop new treatments and cures, and enable \n",
      "precision medicine.\n",
      "    in addition, information blocking is a practice that is profoundly \n",
      "anti-consumer and anti-competition. information blocking can be used to \n",
      "increase revenue, escalate prices, and prevent market competition both \n",
      "for current and future competitors and for new services. for instance, \n",
      "a study released in 2017 about the prevalence of information blocking \n",
      "and how to address it assessed the perceived motivations for \n",
      "information blocking. the study found that respondents perceived that \n",
      "information-blocking practices by health it developers were often \n",
      "motivated by a desire to maximize short-term revenue and to increase \n",
      "the likelihood that providers will select their health it instead of a \n",
      "competitor's health it. among hospitals and health systems, the most \n",
      "frequent perceived motivation was also related to improving revenue, \n",
      "namely to strengthen their competitive position in the market, followed \n",
      "by accommodating more important internal priorities than health \n",
      "information exchange.\\187\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\187\\ julia adler-milstein and eric pfeifer, information \n",
      "blocking: is it occurring and what policy strategies can address \n",
      "it?, 95 milbank quarterly 117 (mar. 2017) at 124-5, available at \n",
      "<a href=\"http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12247/full\">http://onlinelibrary.wiley.com/doi/10.1111/1468-0009.12247/full</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    according to leaders of health information exchange efforts, \n",
      "information blocking is relatively widespread.\\188\\ half of leaders of \n",
      "health information exchange efforts (n = 60) nationwide reported that \n",
      "they routinely encountered information blocking by health it \n",
      "developers. the top three types of information blocking practices they \n",
      "encountered on a routine basis included:\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\188\\ id.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> deployment of products with limited interoperability \n",
      "(49%);\n",
      "    <bullet> high fees for health information exchange unrelated to \n",
      "cost (47%); and\n",
      "    <bullet> making third-party access to standardized data difficult \n",
      "(42%).\n",
      "    many hospitals have experienced the negative impacts of health it \n",
      "developer information blocking practices. in 2015, almost half of \n",
      "hospitals (46%) nationwide reported difficulty exchanging data with \n",
      "providers whose health it system differed from theirs and one-quarter \n",
      "of hospitals reported paying additional costs to exchange electronic \n",
      "health information with providers outside their hospital system.\\189\\ \n",
      "there is also emerging evidence related to the negative impacts of \n",
      "information blocking at the market level on hospitals' health \n",
      "information exchange activity.\\190\\ health information exchange \n",
      "activity among hospitals who are using a dominant health it developer \n",
      "within a given hospital referral region was found to be significantly \n",
      "higher compared to those that are using a non-dominant health it \n",
      "developer, particularly in more competitive markets where dominant \n",
      "health it developers had a smaller share of the market. as information \n",
      "blocking diminishes and information blocking becomes less prevalent, \n",
      "such gaps in rates of exchange and barriers to exchange of health \n",
      "information should diminish. considering the above motivations for and \n",
      "consequences of information blocking, we believe health care providers \n",
      "and patients will benefit greatly from compliance with the information \n",
      "blocking definition. our proposal would promote the free flow of \n",
      "electronic health information when and where it is needed.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\189\\ vaishali patel, jawanna henry, yuriy pylypchuk, and \n",
      "talisha searcy, interoperability among u.s. non-federal acute care \n",
      "hospitals in 2015, onc data brief, no.36 (may 2016).\n",
      "    \\190\\ jordan everson and julia adler-milstein, engagement in \n",
      "hospital health information exchange is associated with vendor \n",
      "marketplace dominance, health affairs. 35, no. 7 (2016), at 1286-93.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we have also included provisions in this proposed rule that would \n",
      "establish exceptions to the definition of information blocking, which \n",
      "we estimate will generate significant net benefits. as noted above, \n",
      "section 3022 of the phsa defines information blocking broadly section \n",
      "3022(a)(3) instructs authorizes the secretary to identify reasonable \n",
      "and necessary activities that would be considered establish exceptions \n",
      "to the definition of information blocking. in this rule, we propose to \n",
      "establish several exceptions. the exceptions, if finalized, would \n",
      "create clear guidelines for industry regarding pro-competitive and \n",
      "other beneficial activities and would enable stakeholders to determine \n",
      "more easily and with greater certainty whether their activities are \n",
      "excepted from the information blocking definition. the additional \n",
      "clarity provided by the exceptions would make it easier for these \n",
      "regulated entities to comply with the statute--resulting in reduced \n",
      "compliance costs--and would result in increased predictability, which \n",
      "would allow regulated entities to more effectively plan and invest \n",
      "resources in developing and using interoperable technologies and \n",
      "services to improve health care efficiency and value. overall, the \n",
      "proposed exceptions are accommodating to legitimate industry practices \n",
      "for health it developers, hospitals, and health care providers and, we \n",
      "believe, would ease the burden and compliance costs for these parties.\n",
      "    due to limited data and research available, we have only estimated \n",
      "the benefits of our information blocking proposals for payers, \n",
      "specifically patients and insurers. in order to quantify the magnitude \n",
      "of information blocking and the benefits of restricting information \n",
      "blocking, we estimated the following expression, which gives us the \n",
      "imposed cost of information blocking for each health outcome: [% \n",
      "providers that engage in cross-vendor exchange] x [marginal effect (me) \n",
      "of information blocking] x [me effect of interoperability] x [total \n",
      "cost of health outcome].\n",
      "    we extracted the ``me effect of interoperability'' and ``cost of \n",
      "health outcomes'' from academic literature (see citations in table 24). \n",
      "we used a proxy of the ``percent of providers engaged in cross-vendor \n",
      "exchange'' with the ``percent of hospitals engaged in cross-vendor \n",
      "referral of patients outside their system'' (82% in 2015).\n",
      "    we estimated the ``me of information blocking'' through the \n",
      "following research design. we looked at hospitals that switched vendors \n",
      "and examined their referral patterns before and after the switch. if \n",
      "hospitals that switched vendors also had to change their referral \n",
      "patterns, this could be evidence of information blocking. to \n",
      "operationalize this experiment, we estimated the following equation:\n",
      "\n",
      "y = b * s + r + h + e.\n",
      "\n",
      "    in this equation, the variables are as follows:\n",
      "\n",
      "<bullet> y = percent of referrals to providers using a vendor to \n",
      "which the hospital switched\n",
      "<bullet> b = estimate of interest, which reflects the change in \n",
      "referral to the vendors after the switch relative to hospitals that \n",
      "did not switch. after controlling for hospital and year fixed, this \n",
      "is essentially an interaction effect of the year with the switch.\n",
      "<bullet> s = indicator for whether hospital switched vendor\n",
      "<bullet> r = year\n",
      "<bullet> h = hospital fixed effects\n",
      "<bullet> e = error term (every regression has an error term)\n",
      "\n",
      "    we used cms referral data and linked it with healthcare information \n",
      "and management systems society (himss) and aha data for information on \n",
      "hospitals' vendors and other characteristics. our estimate for ``b'' is \n",
      "0.4 percentage points, meaning if a\n",
      "\n",
      "[[page 7586]]\n",
      "\n",
      "hospital switches to vendor x, the referrals to hospitals with that \n",
      "vendor increases by a rate of 0.4 percentage points. this number we \n",
      "interpret as a proxy for the extent to which difficulties in cross \n",
      "vendor exchange hinder patient care. however, our finding does not \n",
      "imply that difficulties in cross vendor exchange can be entirely \n",
      "attributed to information blocking. one source of difficulties could be \n",
      "explained by technological challenges where inherent software \n",
      "differences among vendors hinder cross vendor exchange. an additional \n",
      "reason for this result could be attributed to contractual agreements \n",
      "where vendors may incentivize their clients to exchange with other \n",
      "clients having the same vendor. nevertheless, to keep our estimates \n",
      "conservative, we reduced our estimates by a factor of five. hence, we \n",
      "use 0.08 percentage points as the ``me of information blocking.''\n",
      "    our estimates are detailed in the table below.\n",
      "\n",
      "                                         table 24--benefits of prohibiting and/or deterring information blocking\n",
      "                                                                     [2016 dollars]\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                                                            percent of\n",
      "                                              percent of                                      overall        providers       marginal\n",
      "               benefit type                   total cost             total cost           interop impact  susceptible to     effect of      benefit \\a\\\n",
      "                                               impacted                                      (marginal      information     information\n",
      "                                                                                              effect)        blocking        blocking\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "duplicate testing.........................             100  200 billion \\b\\.............        \\c\\ 0.09              82            0.08           $1.1b\n",
      "avoidable hospitalizations and                         100  $41b \\d\\....................            0.09              82            0.08            242m\n",
      " readmissions.\n",
      "er visits.................................             100  cost per er visit $1,233,               0.03              82            0.08            317m\n",
      "                                                             131m visits \\e\\.\n",
      "adverse drug events.......................             100  $30 billion \\f\\.............            0.22              82            0.08             86m\n",
      "                                           -------------------------------------------------------------------------------------------------------------\n",
      "    total benefit per year................  ..............  ............................  ..............  ..............  ..............            1.8b\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\\a\\ total benefit is a product of % of total cost impacted, total cost, overall interop impact, percent of providers susceptible to information\n",
      "  blocking, and marginal effect of information blocking.\n",
      "\\b\\ national academy of medicine (2016), <a href=\"http://money.cnn.com/2017/05/20/news/economy/medical-tests/index.html\">http://money.cnn.com/2017/05/20/news/economy/medical-tests/index.html</a>.\n",
      "\\c\\ stephen e. ross, tiffany a. radcliff, william g. leblanc, l. miriam dickinson, anne m. libby, and donald e. nease jr., effects of health information\n",
      "  exchange adoption on ambulatory testing rates, j. am. med. inform. assoc. (2013), at 1137-1142; bridget a. stewart, susan fernandes, elizabeth\n",
      "  rodriguez-huertas, and michael landzberg, a preliminary look at duplicate testing associated with lack of electronic health record interoperability\n",
      "  for transferred patients, j. of the am. med. informatics assoc. (2010), at 341-344; sezgin ayabakan, indranil r. bardhan, zhiqiang (eric) zheng, and\n",
      "  kirk kirksey value of health information sharing in reducing healthcare waste: an analysis of duplicate testing across hospitals, mis quarterly (jan.\n",
      "  1, 2017); eric j. lammers, julia adler-milstein, and keith e. kocher, does health information exchange reduce redundant imaging? evidence from\n",
      "  emergency departments, med care (mar. 2014), at 227-34.\n",
      "\\d\\ agency for healthcare research and quality (ahrq) statistical brief #199 (dec. 2015), <a href=\"https://www.hcup-us.ahrq.gov/reports/statbriefs/sb199-readmissions-payer-age.pdf\">https://www.hcup-us.ahrq.gov/reports/statbriefs/sb199-readmissions-payer-age.pdf</a>; ahrq statistical brief #72, nationwide frequency and costs of potentially preventable hospitalizations (apr. 2009), <a href=\"https://www.hcup-us.ahrq.gov/reports/statbriefs/sb72.pdf\">https://www.hcup-us.ahrq.gov/reports/statbriefs/sb72.pdf</a>.\n",
      "\\e\\ national center for health statistics (nchs) data brief no. 252 (june 2016), <a href=\"https://www.cdc.gov/nchs/data/databriefs/db252.pdf\">https://www.cdc.gov/nchs/data/databriefs/db252.pdf</a>; nolan caldwell,\n",
      "  tanja srebotnjak, tiffany wang, and renee hsia, ``how much will i get charged for this?'' patient charges for top ten diagnoses in the emergency\n",
      "  department (2013), <a href=\"https://doi.org/10.1371/journal.pone.0055491\">https://doi.org/10.1371/journal.pone.0055491</a>.\n",
      "\\f\\ janet sultana, paola cutroneo, and gianluca trifir[ograve], clinical and economic burden of adverse drug reactions.\n",
      "\n",
      "    we request comment on our approach to estimating these benefits, as \n",
      "well as the benefit estimates in the table above.\n",
      "(6) total annual cost estimate\n",
      "    we estimate that the total annual cost for this proposed rule for \n",
      "the first year after it is finalized (including one-time costs), based \n",
      "on the cost estimates outlined above and throughout this ria, would, on \n",
      "average, range from $365 million to $919 million with an average annual \n",
      "cost of $642 million. we estimate that the total perpetual cost for \n",
      "this proposed rule (starting in year two), based on the cost estimates \n",
      "outlined above, would, on average, range from $228 million to $452 \n",
      "million with an average annual cost of $340 million. we also include \n",
      "estimates based on the stakeholder group affected. we estimate the \n",
      "total costs to health it developers to be between $373 million and $933 \n",
      "million (including one-time and perpetual costs) with $569,000 in cost \n",
      "savings. we estimate the total costs to onc-acbs to be between $213,000 \n",
      "and $311,000. we estimate the government (onc) costs to be between \n",
      "$44,800 and $269,000 while saving $4,500. in addition, to the above \n",
      "mentioned cost savings that are attributable to specific stakeholder \n",
      "groups, we estimate to an additional cost savings of $6.8 million to \n",
      "$13.7 million to all stakeholders affected by this proposal. we are \n",
      "unable to attribute these amounts to specific stakeholder groups.\n",
      "(7) total annual benefit estimate\n",
      "    we estimate the total annual benefit for this proposed rule, based \n",
      "on the benefit estimates outlined above, would range from $3.08 billion \n",
      "to $9.15 billion with an average annual benefit of $6.1 billion. we \n",
      "attribute between $756 million and $3.8 billion in benefits to \n",
      "hospitals and clinicians. we attribute between $2.1 billion and $2.9 \n",
      "billion to payers and patients. our estimates include benefits \n",
      "attributed to the whole health care system, not just to the \n",
      "stakeholders mentioned above.\n",
      "(8) total annual net benefit\n",
      "    we estimate the total annual net benefit for this proposed rule for \n",
      "the first year after it is finalized (including one-time costs), based \n",
      "on the estimates outlined above, would range from $2.7 billion to $8.2 \n",
      "billion with an average net benefit of $5.5 billion. we estimate the \n",
      "total perpetual annual net benefit for this proposed rule (starting in \n",
      "year two), based on the estimates outlined above, would range from $2.9 \n",
      "billion to $8.7 billion with an average net benefit of $5.8 billion.\n",
      "b. accounting statement and table\n",
      "    when a rule is considered an economically significant rule under \n",
      "executive order 12866, we are required to develop an accounting \n",
      "statement indicating the classification of the expenditures associated \n",
      "with the provisions of the proposed rule. monetary annual benefits are \n",
      "presented as discounted flows using 3% and 7% factors in table 25 \n",
      "below. we are not able to explicitly define the universe of\n",
      "\n",
      "[[page 7587]]\n",
      "\n",
      "all costs, but have provided an average of likely costs of this \n",
      "proposed rule as well as a high and low range of likely costs. this \n",
      "proposed rule requires no federal annual monetized transfers.\n",
      "\n",
      "                                                           table 25--e.o. 12866 summary table\n",
      "                                                            [in $ millions, 2016 time period]\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "                                                                            lower bound     upper bound                     lower bound     upper bound\n",
      "                                                           primary (3%)        (3%)            (3%)        primary (7%)        (7%)            (7%)\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "present value of quantified costs.......................           1,557           1,043           2,070           1,394             934           1,853\n",
      "non-quantified costs....................................            text  ..............  ..............  ..............  ..............  ..............\n",
      "present value of quantified benefits....................          27,998          14,100          41,896          25,067          12,624          37,509\n",
      "non-quantified benefits.................................            text  ..............  ..............  ..............  ..............  ..............\n",
      "present value of net benefits...........................           2,456           1,129          37,620           2,190           1,011          33,681\n",
      "annualized quantified costs.............................             330             355             433             318             365             422\n",
      "non-quantified costs....................................            text  ..............  ..............  ..............  ..............  ..............\n",
      "annualized quantified benefits..........................           5,935           2,989           8,881           5,714           2,878           8,550\n",
      "non-quantified benefits.................................            text  ..............  ..............  ..............  ..............  ..............\n",
      "annualized net quantified benefits......................           5,184           2,304           7,975           4,991           2,838           8,128\n",
      "--------------------------------------------------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "\n",
      "                             table 26--e.o. 12866 summary table non-discounted flows\n",
      "                                                 [2016 dollars]\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                      year 1          year 2          year 3          year 4          year 5\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "costs...........................    $641,853,087    $339,870,993    $339,870,993    $339,870,993    $339,870,993\n",
      "net benefits....................   5,471,742,914   5,773,725,008   5,773,725,008   5,773,725,008   5,773,725,008\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "                                      year 6          year 7          year 8          year 9          year 10\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "costs...........................    $339,870,993    $339,870,993    $339,870,993    $339,870,993    $339,870,993\n",
      "net benefits....................   5,773,725,008   5,773,725,008   5,773,725,008   5,773,725,008   5,773,725,008\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "3. regulatory flexibility act\n",
      "    the regulatory flexibility act (rfa) requires agencies to analyze \n",
      "options for regulatory relief of small businesses if a rule has a \n",
      "significant impact on a substantial number of small entities. the small \n",
      "business administration (sba) establishes the size of small businesses \n",
      "for federal government programs based on average annual receipts or the \n",
      "average employment of a firm.\\191\\ the entities that are likely to be \n",
      "directly affected by the requirements in this proposed rule \n",
      "requirements are health it developers. we note that the proposed \n",
      "reasonable and necessary activities that do not constitute information \n",
      "blocking provide flexibilities and relief for health it developers of \n",
      "certified health it, health information networks, health information \n",
      "exchanges, and health care providers in relation to the information \n",
      "blocking provision of the cures act. these proposed reasonable and \n",
      "necessary activities also take into account the potential burden on \n",
      "small entities to meet these ``exceptions'' to information blocking, \n",
      "such as with considering the size and resources of small entities when \n",
      "meeting security requirements to qualify for the ``promoting the \n",
      "security of electronic health information'' exception. we refer readers \n",
      "to section viii for our information blocking-related proposals and \n",
      "welcome comments on their impacts on small entities.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\191\\ the sba references that annual receipts means ``total \n",
      "income'' (or in the case of a sole proprietorship, ``gross income'') \n",
      "plus ``cost of goods sold'' as these terms are defined and reported \n",
      "on internal revenue service tax return forms.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    while health it developers that pursue certification of their \n",
      "health it under the program represent a small segment of the overall \n",
      "information technology industry, we believe that many health it \n",
      "developers impacted by the requirements proposed in this proposed rule \n",
      "most likely fall under the north american industry classification \n",
      "system (naics) code 541511 ``custom computer programming services.'' \n",
      "\\192\\ the sba size standard associated with this naics code is set at \n",
      "$27.5 million annual receipts or less. there is enough data generally \n",
      "available to establish that between 75% and 90% of entities that are \n",
      "categorized under the naics code 541511 are under the sba size \n",
      "standard. we also note that with the exception of aggregate business \n",
      "information available through the u.s. census bureau and the sba \n",
      "related to naics code 541511, it appears that many health it developers \n",
      "that pursue certification of their health it under the program are \n",
      "privately held or owned and do not regularly, if at all, make their \n",
      "specific annual receipts publicly available. as a result, it is \n",
      "difficult to locate empirical data related to many of these health it \n",
      "developers to correlate to the sba size standard. however, although not \n",
      "perfectly correlated to the size standard for naics code 541511, we do \n",
      "have information indicating that over 60% of health it developers that \n",
      "have had complete ehrs and/or health it modules certified to the 2011 \n",
      "edition have less than 51 employees.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\192\\ <a href=\"https://www.sba.gov/sites/default/files/files/size_standards_table_2017.pdf\">https://www.sba.gov/sites/default/files/files/size_standards_table_2017.pdf</a>. <a href=\"https://www.sba.gov/sites/default/files/files/size_standards_table_2017.pdf\">https://www.sba.gov/sites/default/files/files/size_standards_table_2017.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we estimate that the proposed requirements in this proposed rule \n",
      "would have effects on health it developers, some of which may be small \n",
      "entities, that have certified health it or are likely to pursue \n",
      "certification of their health it under the program. we believe, \n",
      "however, that we have proposed the minimum amount of requirements \n",
      "necessary to accomplish our primary policy goal of enhancing \n",
      "interoperability. further, as discussed in section xiv.b of this ria \n",
      "above, there are no appropriate regulatory or non-regulatory \n",
      "alternatives that could be developed to lessen the compliance burden \n",
      "associated with this proposed\n",
      "\n",
      "[[page 7588]]\n",
      "\n",
      "rule because many of the proposals are derived directly form \n",
      "legislative mandates in the cures act. additionally, we have attempted \n",
      "to offset some of the burden imposed on health it developers in this \n",
      "proposed rule with cost saving proposals through deregulatory actions \n",
      "(see proposed section iii).\n",
      "    we do not believe that the proposed requirements of this proposed \n",
      "rule would create a significant impact on a substantial number of small \n",
      "entities, but request comment on whether there are small entities that \n",
      "we have not identified that may be affected in a significant way by \n",
      "this proposed rule. additionally, the secretary proposes to certify \n",
      "that this proposed rule would not have a significant impact on a \n",
      "substantial number of small entities.\n",
      "4. executive order 13132--federalism\n",
      "    executive order 13132 establishes certain requirements that an \n",
      "agency must meet when it promulgates a proposed rule (and subsequent \n",
      "final rule) that imposes substantial direct requirement costs on state \n",
      "and local governments, preempts state law, or otherwise has federalism \n",
      "implications. nothing in this proposed rule imposes substantial direct \n",
      "compliance costs on state and local governments, preempts state law, or \n",
      "otherwise has federalism implications. we are not aware of any state \n",
      "laws or regulations that are contradicted or impeded by any of the \n",
      "proposals in this proposed rule. we welcome comments on this \n",
      "assessment.\n",
      "5. unfunded mandates reform act of 1995\n",
      "    section 202 of the unfunded mandates reform act of 1995 requires \n",
      "that agencies assess anticipated costs and benefits before issuing any \n",
      "rule that imposes unfunded mandates on state, local, and tribal \n",
      "governments or the private sector requiring spending in any one year of \n",
      "$100 million in 1995 dollars, updated annually for inflation. the \n",
      "current inflation-adjusted statutory threshold is approximately $150 \n",
      "million. while the estimated potential cost effects of this proposed \n",
      "rule reach the statutory threshold, we do not believe this proposed \n",
      "rule imposes unfunded mandates on state, local, and tribal governments \n",
      "or the private sector. we welcome comments on these conclusions.\n",
      "6. executive order 13771 reducing regulation and controlling regulatory \n",
      "costs\n",
      "    executive order 13771 (january 30, 2017) requires that the costs \n",
      "associated with significant new regulations ``to the extent permitted \n",
      "by law, be offset by the elimination of existing costs associated with \n",
      "at least two prior regulations.'' the department believes that this \n",
      "rule is a significant regulatory action as defined by executive order \n",
      "12866 which imposes costs, and therefore is considered a regulatory \n",
      "action under executive order 13771. the department estimates that this \n",
      "rule generates $275 million in annualized costs at a 7% discount rate, \n",
      "discounted relative to 2016, over a perpetual time horizon.\n",
      "    omb reviewed this proposed rule.\n",
      "\n",
      "list of subjects\n",
      "\n",
      "45 cfr part 170\n",
      "\n",
      "    computer technology, electronic health record, electronic \n",
      "information system, electronic transactions, health, health care, \n",
      "health information technology, health insurance, health records, \n",
      "hospitals, incorporation by reference, laboratories, medicaid, \n",
      "medicare, privacy, reporting and recordkeeping requirements, public \n",
      "health, security.\n",
      "\n",
      "45 cfr part 171\n",
      "\n",
      "    computer technology, electronic health record, electronic \n",
      "information system, electronic transactions, health, health care, \n",
      "health care provider, health information exchange, health information \n",
      "technology, health information network, health insurance, health \n",
      "records, hospitals, privacy, reporting and recordkeeping requirements, \n",
      "public health, security.\n",
      "\n",
      "    for the reasons set forth in the preamble, 45 cfr subtitle a, \n",
      "subchapter d, is proposed to be amended as follows:\n",
      "\n",
      "part 170--health information technology standards, implementation \n",
      "specifications, and certification criteria and certification \n",
      "programs for health information technology\n",
      "\n",
      "0\n",
      "1. the authority citation for part 170 continues to read as follows:\n",
      "\n",
      "    authority: 42 u.s.c. 300jj-11; 42 u.s.c 300jj-14; 5 u.s.c. 552.\n",
      "\n",
      "0\n",
      "2. revise sec.  170.101 to read as follows:\n",
      "\n",
      "\n",
      "sec.  170.101  applicability.\n",
      "\n",
      "    the standards, implementation specifications, and certification \n",
      "criteria adopted in this part apply to health it modules and the \n",
      "testing and certification of such health it modules.\n",
      "0\n",
      "3. amend sec.  170.102 as follows:\n",
      "0\n",
      "a. remove the definitions of ``2014 edition base ehr'', and ``2014 \n",
      "edition ehr certification criteria'';\n",
      "0\n",
      "b. amend the definition of ``2015 edition base ehr'' by revising \n",
      "paragraph (3);\n",
      "0\n",
      "c. add, in alphabetical order, the definitions for ``api data \n",
      "provider'', ``api technology supplier'', and ``api user'';\n",
      "0\n",
      "d. remove the definitions of ``common clinical data set'', and \n",
      "``complete ehr, 2014 edition''; and\n",
      "0\n",
      "e. add, in alphabetical order, the definitions for ``fee'', \n",
      "``interoperability'', and ``interoperability element''.\n",
      "    the revisions and additions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.102  definitions.\n",
      "\n",
      "* * * * *\n",
      "\n",
      "2015 edition base ehr * * *\n",
      "\n",
      "    (3) has been certified to the certification criteria adopted by the \n",
      "secretary in--\n",
      "    (i) section 170.315(a)(1), (2), or (3); (5); (9); (14); (b)(1); \n",
      "(c)(1); (g)(7) and (9); and (h)(1) or (2);\n",
      "    (ii) section 170.315(g)(8) or (10) until [24 months from the final \n",
      "rule's effective date]; and\n",
      "    (iii) section 170.315(b)(10) and (g)(10) on and after [24 months \n",
      "from the final rule's effective date].\n",
      "* * * * *\n",
      "    api data provider refers to the organization that deploys the api \n",
      "technology created by the ``api technology supplier'' and provides \n",
      "access via the api technology to data it produces and electronically \n",
      "manages. in some cases, the api data provider may contract with the api \n",
      "technology supplier to perform the api deployment service on its \n",
      "behalf. however, in such circumstances, the api data provider retains \n",
      "control of what and how information is disclosed and so for the \n",
      "purposes of this definition is considered to be the entity that deploys \n",
      "the api technology.\n",
      "    api technology supplier refers to a health it developer that \n",
      "creates the api technology that is presented for testing and \n",
      "certification to any of the certification criteria adopted or proposed \n",
      "for adoption at sec.  170.315(g)(7) through (11).\n",
      "    api user refers to persons and entities that use or create software \n",
      "applications that interact with the apis developed by the ``api \n",
      "technology supplier'' and deployed by the ``api data provider.'' an api \n",
      "user includes, but is not limited to, third-party software developers, \n",
      "developers of software applications used by api data providers, and \n",
      "patients and health care providers that use apps that connect to api \n",
      "technology on their behalf.\n",
      "* * * * *\n",
      "\n",
      "[[page 7589]]\n",
      "\n",
      "    fee is defined as it is in sec.  171.102 of this subchapter.\n",
      "* * * * *\n",
      "    interoperability is, with respect to health information technology, \n",
      "such health information technology that--\n",
      "    (i) enables the secure exchange of electronic health information \n",
      "with, and use of electronic health information from, other health \n",
      "information technology without special effort on the part of the user;\n",
      "    (ii) allows for complete access, exchange, and use of all \n",
      "electronically accessible health information for authorized use under \n",
      "applicable state or federal law; and\n",
      "    (iii) does not constitute information blocking as defined in sec.  \n",
      "171.103 of this subchapter.\n",
      "    interoperability element is defined as it is in sec.  171.102 of \n",
      "this subchapter.\n",
      "* * * * *\n",
      "\n",
      "\n",
      "sec.  170.200   [amended]\n",
      "\n",
      "0\n",
      "4. amend sec.  170.200 by removing the phrase ``complete ehrs and.''\n",
      "\n",
      "\n",
      "sec.  170.202   [amended]\n",
      "\n",
      "0\n",
      "5. amend sec.  170.202 by removing and reserving paragraph (a)(1).\n",
      "\n",
      "\n",
      "sec.  170.204   [amended]\n",
      "\n",
      "0\n",
      "6. amend sec.  170.204 by removing and reserving paragraphs (b)(1) and \n",
      "(2), and by removing paragraph (c).\n",
      "0\n",
      "7. amend sec.  170.205 as follows:\n",
      "0\n",
      "a. remove and reserve paragraphs (a)(1) and (2);\n",
      "0\n",
      "b. add paragraph (a)(4)(i) and add and reserve paragraph (a)(4)(ii);\n",
      "0\n",
      "c. add paragraph (b)(1);\n",
      "0\n",
      "d. remove and reserve paragraphs (d)(2), (d)(3), (e)(3), (h)(1), \n",
      "(i)(1), and (j); and\n",
      "0\n",
      "e. add paragraphs (h)(3) and (k)(3).\n",
      "    the revisions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.205  content exchange standards and implementation \n",
      "specifications for exchanging electronic health information.\n",
      "\n",
      "    (a) * * *\n",
      "    (4) * * *\n",
      "    (i) standard. hl7 cda[supreg] r2 implementation guide: c-cda \n",
      "templates for clinical notes r1 companion guide, release 1 \n",
      "(incorporated by reference in sec.  170.299).\n",
      "    (ii) [reserved]\n",
      "* * * * *\n",
      "    (b) * * *\n",
      "    (1) standard. national council for prescription drug programs \n",
      "(ncpdp), script standard implementation guide, version 2017071 \n",
      "(incorporated by reference in sec.  170.299).\n",
      "* * * * *\n",
      "    (h) * * *\n",
      "    (3) cms implementation guide for quality reporting document \n",
      "architecture category i hospital quality reporting implementation guide \n",
      "for 2019 (incorporated by reference in sec.  170.299).\n",
      "* * * * *\n",
      "    (k) * * *\n",
      "    (3) cms implementation guide for quality reporting document \n",
      "architecture category iii eligible clinicians and eligible \n",
      "professionals programs implementation guide for 2019 (incorporated by \n",
      "reference in sec.  170.299).\n",
      "* * * * *\n",
      "\n",
      "\n",
      "sec.  170.207   [amended]\n",
      "\n",
      "0\n",
      "8. amend sec.  170.207 by removing and reserving paragraphs (d)(2), \n",
      "(e)(2), (g)(1), (h), and (j).\n",
      "\n",
      "\n",
      "sec.  170.210   [amended]\n",
      "\n",
      "0\n",
      "9. amend sec.  170.210 by removing and reserving paragraphs (a)(1) and \n",
      "(c)(1).\n",
      "0\n",
      "10. add sec.  170.213 to read as follows:\n",
      "\n",
      "\n",
      "sec.  170.213  united states core data for interoperability\n",
      "\n",
      "    standard. united states core data for interoperability (uscdi), \n",
      "version 1 (v1) (incorporated by reference in sec.  170.299).\n",
      "0\n",
      "11. add sec.  170.215 to read as follows:\n",
      "\n",
      "\n",
      "sec.  170.215  application programming interface standards.\n",
      "\n",
      "    the secretary adopts the following application programming \n",
      "interface (api) standards and associated implementation specifications:\n",
      "    (a)(1) standard. hl7 fast healthcare interoperability resources \n",
      "(fhir) draft standard for trial use (dstu) 2 (v1.0.2-7202) \n",
      "(incorporated by reference in sec.  170.299).\n",
      "    (2) implementation specifications. api resource collection in \n",
      "health (arch) version 1 (incorporated by reference in sec.  170.299).\n",
      "    (3) implementation specifications--fhir profiles. argonaut data \n",
      "query implementation guide version 1.0.0 (incorporated by reference in \n",
      "sec.  170.299).\n",
      "    (4) implementation specifications--fhir server conformance. \n",
      "argonaut data query implementation guide server (incorporated by \n",
      "reference in sec.  170.299).\n",
      "    (5) implementation specification--application authorization. hl7 \n",
      "smart application launch framework implementation guide release 1.0.0, \n",
      "including mandatory support for ``refresh tokens,'' ``standalone \n",
      "launch,'' and ``ehr launch'' requirements (incorporated by reference in \n",
      "sec.  170.299).\n",
      "    (b) application authentication. standard. openid connect core 1.0 \n",
      "incorporating errata set 1 (incorporated by reference in sec.  \n",
      "170.299).\n",
      "    (c)(1) standard. hl7 fast healthcare interoperability resources \n",
      "(fhir) release 3 standard for trial use (stu) 3 (v3.0.1) (incorporated \n",
      "by reference in sec.  170.299).\n",
      "    (2) implementation specification--fhir consent resources. hl7 \n",
      "consent2share fhir consent profile design (incorporated by reference in \n",
      "sec.  170.299).\n",
      "0\n",
      "12. amend sec.  170.299 as follows:\n",
      "0\n",
      "a. remove and reserve paragraphs (c)(2), (3), (d)(2), (7), and (8);\n",
      "0\n",
      "b. add paragraphs (e)(4) and (5);\n",
      "0\n",
      "c. remove and reserve paragraphs (f)(3), (6), (7), (10), and (11);\n",
      "0\n",
      "d. add paragraphs (f)(30) through (36);\n",
      "0\n",
      "e. redesignate paragraphs (o) through (r) and (g) through (n) as \n",
      "paragraphs (q) through (t) and (h) through (o), respectively;\n",
      "0\n",
      "f. add new paragraph (g) and paragraph (i)(4);\n",
      "0\n",
      "g. remove and reserve newly redesignated paragraph (k)(1);\n",
      "0\n",
      "h. add paragraph (l)(3);\n",
      "0\n",
      "i. remove and reserve newly redesignated paragraph (m)(3);\n",
      "0\n",
      "j. add paragraphs (n)(5) and (6);\n",
      "0\n",
      "k. add new paragraph (p); and\n",
      "0\n",
      "l. remove and reserve newly redesignated paragraphs (s)(4), and (5).\n",
      "    the additions and revisions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.299  incorporation by reference.\n",
      "\n",
      "* * * * *\n",
      "    (e) * * *\n",
      "    (4) cms implementation guide for quality reporting document \n",
      "architecture category i hospital quality reporting implementation guide \n",
      "for 2019, may 4, 2018, ibr approved for sec.  170.205(h).\n",
      "    (5) cms implementation guide for quality reporting document \n",
      "architecture category iii eligible clinicians and eligible \n",
      "professionals programs implementation guide for 2019, october 8, 2018, \n",
      "ibr approved for sec.  170.205(k).\n",
      "    (f) * * *\n",
      "    (30) hl7 cda release 2 implementation guide: c-cda templates for \n",
      "clinical notes r1 companion guide, release 1, march 2017, ibr approved \n",
      "for sec.  170.205(a).\n",
      "    (31) hl7 fast healthcare interoperability resources (fhir[supreg]) \n",
      "release 2.0, draft standard for trial use (dstu) version 1.0.2-7202, \n",
      "october 24, 2015, ibr approved for sec.  170.215(a).\n",
      "    (32) hl7 fast healthcare interoperability resource specification \n",
      "(fhir[supreg]) release 3 standard for trial use (stu), version 3.0.1, \n",
      "february 21, 2017, ibr approved for sec.  170.215(c).\n",
      "    (33) hl7 fast healthcare interoperability resources specification \n",
      "(fhir[supreg]) release 4, version 4.0.0,\n",
      "\n",
      "[[page 7590]]\n",
      "\n",
      "december 27, 2018, ibr approved for sec.  170.215.\n",
      "    (34) hl7 implementation specification--fhir profile: consent2share \n",
      "fhir consent profile design, december 11, 2017, ibr approved for sec.  \n",
      "170.215(c).\n",
      "    (35) hl7 cda r2 implementation guide: c-cda supplemental templates \n",
      "for unique device identification (udi) for implantable medical devices, \n",
      "release 1--us realm, november 15, 2018, ibr approved for sec.  170.205.\n",
      "    (36) hl7 smart application launch framework implementation guide \n",
      "release 1.0.0, november 13, 2018, ibr approved for sec.  170.215(a).\n",
      "    (g) hl7[supreg] fhir[supreg] foundation. 3300 washtenaw avenue, \n",
      "suite 227, ann arbor, mi 48104; telephone (734) 677-7777 or <a href=\"https://www.fhir.org/\">https://www.fhir.org/</a>.\n",
      "    (1) argonaut data query implementation guide. version 1.0.0, \n",
      "december 23, 2016, ibr approved for sec.  170.215(a).\n",
      "    (2) argonaut data query implementation guide server, version 1.0.2, \n",
      "december 15, 2016, ibr approved for sec.  170.215(a).\n",
      "* * * * *\n",
      "    (i) * * *\n",
      "    (4) oauth 2.0 dynamic client registration protocol (rfc 7591), july \n",
      "2015, ibr approved for sec.  170.215.\n",
      "* * * * *\n",
      "    (l) * * *\n",
      "    (3) national council for prescription drug programs (ncpdp), script \n",
      "standard implementation guide, version 2017071 (approval date for ansi: \n",
      "july 28, 2017), ibr approved for sec.  170.205(b).\n",
      "* * * * *\n",
      "    (n) * * *\n",
      "    (5) onc united states core data for interoperability (uscdi), \n",
      "version 1 (v1), february 11, 2019, ibr approved for sec.  170.213; \n",
      "available at <a href=\"https://www.healthit.gov/uscdi\">https://www.healthit.gov/uscdi</a>.\n",
      "    (6) api resource collection in health (arch) version 1, february 1, \n",
      "2019, ibr approved for sec.  170.215(a); available at <a href=\"https://www.healthit.gov/arch\">https://www.healthit.gov/arch</a>.\n",
      "* * * * *\n",
      "    (p) openid foundation, 2400 camino ramon, suite 375, san ramon, ca \n",
      "94583, telephone +1 925-275-6639, <a href=\"http://openid.net/\">http://openid.net/</a>.\n",
      "    (1) openid connect core 1.0 incorporating errata set 1, november 8, \n",
      "2014, ibr approved for sec.  170.215(b).\n",
      "    (2) [reserved]\n",
      "* * * * *\n",
      "\n",
      "\n",
      "sec.  170.300   [amended]\n",
      "\n",
      "0\n",
      "14. amend sec.  170.300 in paragraphs (a) and (c) by removing the \n",
      "phrase ``complete ehrs and''.\n",
      "\n",
      "\n",
      "sec.  170.314   [removed and reserved]\n",
      "\n",
      "0\n",
      "15. remove and reserve sec.  170.314.\n",
      "0\n",
      "16. amend sec.  170.315 as follows:\n",
      "0\n",
      "a. remove and reserve paragraphs (a)(6) through (8), (10); (11); and \n",
      "(13);\n",
      "0\n",
      "b. in paragraphs (b)(1)(ii)(a) introductory text, (b)(1)(ii)(a)(2), \n",
      "(3), (b)(1)(ii)(b) and (c), remove the reference ``sec.  170.205(a)(3) \n",
      "and sec.  170.205(a)(4)'' and add in its place the reference ``sec.  \n",
      "170.205(a)(3), (a)(4), and (a)(4)(i)'';\n",
      "0\n",
      "c. in paragraph (b)(1)(iii) introductory text, remove the reference \n",
      "``sec.  170.205(a)(4)'' and add in its place the reference ``sec.  \n",
      "170.205(a)(3), (a)(4), and (a)(4)(i)'';\n",
      "0\n",
      "d. revise paragraph (b)(1)(iii)(a);\n",
      "0\n",
      "e. in paragraph (b)(2)(i) and (ii), remove the reference ``sec.  \n",
      "170.205(a)(3) and sec.  170.205(a)(4)'' and add in its place the \n",
      "reference ``sec.  170.205(a)(3), (a)(4), and (a)(4)(i)'';\n",
      "0\n",
      "f. remove and reserve paragraphs (b)(4) through (8);\n",
      "0\n",
      "g. revise paragraph (b)(9);\n",
      "0\n",
      "h. add paragraphs (b)(10), (11), (12), (13),\n",
      "0\n",
      "i. revise paragraph (c)(3);\n",
      "0\n",
      "j. add paragraphs (d)(12), and (13);\n",
      "0\n",
      "k. revise paragraph (e)(1)(i)(a)(1);\n",
      "0\n",
      "l. in paragraph (e)(1)(i)(b)(1)(ii) and (e)(1)(i)(b)(2) introductory \n",
      "text, remove the reference ``sec.  170.205(a)(4)'' and add in its place \n",
      "the reference ``sec.  170.205(a)(4) and (a)(4)(i)'';\n",
      "0\n",
      "m. remove and reserve paragraph (e)(1)(ii)(b);\n",
      "0\n",
      "n. remove and reserve paragraph (e)(2);\n",
      "0\n",
      "o. revise paragraphs (f)(5)(iii)(b)(1), (g)(6) introductory text, \n",
      "(g)(6)(i) and (iv);\n",
      "0\n",
      "p. revise paragraphs (g)(1) and (g)(2) by removing ``ehr incentive \n",
      "programs'' and adding in its place ``promoting interoperability \n",
      "programs'';\n",
      "0\n",
      "q. revising paragraph (g)(3)(i);\n",
      "0\n",
      "r. in paragraphs (g)(6)(ii) and (iii), remove the reference ``sec.  \n",
      "170.205(a)(4)'' and add in its place the reference ``sec.  \n",
      "170.205(a)(4) and (a)(4)(i)'';\n",
      "0\n",
      "s. revise paragraph (g)(6)(iv);\n",
      "0\n",
      "t. remove paragraphs (g)(7)(ii)(a)(3);\n",
      "0\n",
      "u. revise paragraph (g)(9)(i)(a);\n",
      "0\n",
      "v. remove paragraph (g)(9)(ii)(a)(3); and\n",
      "0\n",
      "w. add paragraphs (g)(10) and (g)(11).\n",
      "    the revisions and additions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.315   2015 edition health it certification criteria.\n",
      "\n",
      "* * * * *\n",
      "    (b) * * *\n",
      "    (1) * * *\n",
      "    (iii) * * *\n",
      "    (a) the data classes expressed in the standard in sec.  170.213 \n",
      "and, including as specified for the following data:\n",
      "    (1) assessment and plan of treatment. in accordance with the \n",
      "``assessment and plan section (v2)'' of the standard specified in sec.  \n",
      "170.205(a)(4) and (a)(4)(i); or in accordance with the ``assessment \n",
      "section (v2)'' and ``plan of treatment section (v2)'' of the standard \n",
      "specified in sec.  170.205(a)(4) and (a)(4)(i).\n",
      "    (2) goals. in accordance with the ``goals section'' of the standard \n",
      "specified in sec.  170.205(a)(4) and (a)(4)(i).\n",
      "    (3) health concerns. in accordance with the ``health concerns \n",
      "section'' of the standard specified in sec.  170.205(a)(4) and \n",
      "(a)(4)(i).\n",
      "    (4) unique device identifier(s) for a patient's implantable \n",
      "device(s). in accordance with the ``product instance'' in the \n",
      "``procedure activity procedure section'' of the standard specified in \n",
      "sec.  170.205(a)(4) and (a)(4)(i).\n",
      "* * * * *\n",
      "    (4) [reserved]\n",
      "    (5) [reserved]\n",
      "    (6) [reserved]\n",
      "    (7) [reserved]\n",
      "    (8) [reserved]\n",
      "    (9) care plan. enable a user to record, change, access, create, and \n",
      "receive care plan information in accordance with:\n",
      "    (i) the care plan document template, including the health status \n",
      "evaluations and outcomes section and interventions section (v2), in the \n",
      "standard specified in sec.  170.205(a)(4); and\n",
      "    (ii) the standard in sec.  170.205(a)(4)(i).\n",
      "    (10) electronic health information export. (i) single patient \n",
      "electronic health information export.\n",
      "    (a) enable a user to timely create an export file(s) with all of a \n",
      "single patient's electronic health information the health it produces \n",
      "and electronically manages on that patient.\n",
      "    (b) a user must be able to execute this capability at any time the \n",
      "user chooses and without subsequent developer assistance to operate.\n",
      "    (c) limit the ability of users who can create such export file(s) \n",
      "in at least one of these two ways:\n",
      "    (1) to a specific set of identified users.\n",
      "    (2) as a system administrative function.\n",
      "    (d) the export file(s) created must be electronic and in a \n",
      "computable format.\n",
      "    (e) the export file(s) format, including its structure and syntax, \n",
      "must be included with the exported file(s).\n",
      "    (ii) database export. create an export of all the electronic health \n",
      "information the health it produces and electronically manages.\n",
      "    (a) the export created must be electronic and in a computable \n",
      "format.\n",
      "    (b) the export's format, including its structure and syntax must be \n",
      "included with the export.\n",
      "\n",
      "[[page 7591]]\n",
      "\n",
      "    (iii) documentation. the export format(s) used to support single \n",
      "patient electronic health information export as specified in paragraph \n",
      "(b)(10)(i) of this section and database export as specified in \n",
      "paragraph (b)(10)(ii) of this section must be made available via a \n",
      "publicly accessible hyperlink.\n",
      "    (11) electronic prescribing. (i) enable a user to perform all of \n",
      "the following prescription-related electronic transactions in \n",
      "accordance with the standard specified in sec.  170.205(b)(1) and, at a \n",
      "minimum, the version of the standard specified in sec.  170.207(d)(3) \n",
      "as follows:\n",
      "    (a) ask mailbox (getmessage).\n",
      "    (b) relay acceptance of transaction (status).\n",
      "    (c) error response (error).\n",
      "    (d) create new prescriptions (newrx, newrxrequest, \n",
      "newrxresponsedenied).\n",
      "    (e) change prescriptions (rxchangerequest, rxchangeresponse).\n",
      "    (f) renew prescriptions (rxrenewalrequest, rxrenewalresponse).\n",
      "    (g) resupply (resupply).\n",
      "    (h) return receipt (verify).\n",
      "    (i) cancel prescriptions (cancelrx, cancelrxresponse).\n",
      "    (j) receive fill status notifications (rxfill, \n",
      "rxfillindicatorchange).\n",
      "    (k) drug administration (drugadministration).\n",
      "    (l) transfer (rxtransferrequest, rxtransferresponse, \n",
      "rxtransferconfirm).\n",
      "    (m) recertify (recertification).\n",
      "    (n) request and receive medication history (rxhistoryrequest, \n",
      "rxhistoryresponse).\n",
      "    (o) complete risk evaluation and mitigation strategy transactions \n",
      "(remsinitiationrequest, remsinitiationresponse, remsrequest, and \n",
      "remsresponse).\n",
      "    (ii) for each transaction listed in paragraph (b)(11)(i) of this \n",
      "section, the technology must be able to receive and transmit the reason \n",
      "for the prescription using the diagnosis elements in dru segment.\n",
      "    (iii) optional. for each transaction listed in paragraph (b)(11)(i) \n",
      "of this section, the technology must be able to receive and transmit \n",
      "the reason for the prescription using the indication elements in the \n",
      "sig segment.\n",
      "    (iv) limit a user's ability to prescribe all oral liquid \n",
      "medications in only metric standard units of ml (i.e., not cc).\n",
      "    (v) always insert leading zeroes before the decimal point for \n",
      "amounts less than one and must not allow trailing zeroes after a \n",
      "decimal point when a user prescribes medications.\n",
      "    (12) data segmentation for privacy--send. enable a user to create a \n",
      "summary record formatted in accordance with the standard adopted in \n",
      "sec.  170.205(a)(4) and (a)(4)(i) that is tagged as restricted at the \n",
      "document, section, and entry (data element) level and subject to \n",
      "restrictions on re-disclosure according to the standard adopted in \n",
      "sec.  170.205(o)(1).\n",
      "    (13) data segmentation for privacy--receive. enable a user to:\n",
      "    (i) receive a summary record that is formatted in accordance with \n",
      "the standard adopted in sec.  170.205(a)(4) and (a)(4)(i) that is \n",
      "tagged as restricted at the document, section, and entry (data element) \n",
      "level and subject to restrictions on re-disclosure according to the \n",
      "standard adopted in sec.  170.205(o)(1); and\n",
      "    (ii) preserve privacy markings to ensure fidelity to the tagging \n",
      "based on consent and with respect to sharing and re-disclosure \n",
      "restrictions.\n",
      "    (c) * * *\n",
      "    (3) clinical quality measures--report. enable a user to \n",
      "electronically create a data file for transmission of clinical quality \n",
      "measurement data in accordance with the implementation specifications \n",
      "specified in sec.  170.205(h)(3) and (k)(3).\n",
      "* * * * *\n",
      "    (d) * * *\n",
      "* * * * *\n",
      "    (12) encrypt authentication credentials. health it developers must \n",
      "assess their health it modules' capabilities and make one of the \n",
      "following attestations:\n",
      "    (i) ``yes.'' health it module encrypts stored authentication \n",
      "credentials in accordance with standards adopted in sec.  \n",
      "170.210(a)(2).\n",
      "    (ii) ``no.'' health it module does not encrypt stored \n",
      "authentication credentials.\n",
      "    (13) multi-factor authentication. health it developers must assess \n",
      "their health it modules' capabilities and make one of the following \n",
      "attestations:\n",
      "    (i) ``yes.'' health it module supports authentication through \n",
      "multiple elements the identity of the user with industry recognized \n",
      "standards.\n",
      "    (ii) ``no.'' health it module does not support authentication \n",
      "through multiple elements the identity of the user with industry \n",
      "recognized standards.\n",
      "    (e) * * *\n",
      "    (1) * * *\n",
      "    (i) * * *\n",
      "    (a) * * *\n",
      "    (1) the data classes expressed in the standard in sec.  170.213 \n",
      "(which should be in their english (i.e., non-coded) representation if \n",
      "they associate with a vocabulary/code set), including as specified for \n",
      "the following data:\n",
      "    (i) assessment and plan of treatment. in accordance with the \n",
      "``assessment and plan section (v2)'' of the standard specified in sec.  \n",
      "170.205(a)(4) and (a)(4)(i); or in accordance with the ``assessment \n",
      "section (v2)'' and ``plan of treatment section (v2)'' of the standard \n",
      "specified in sec.  170.205(a)(4) and (a)(4)(i).\n",
      "    (ii) goals. in accordance with the ``goals section'' of the \n",
      "standard specified in sec.  170.205(a)(4) and (a)(4)(i).\n",
      "    (iii) health concerns. in accordance with the ``health concerns \n",
      "section'' of the standard specified in sec.  170.205(a)(4) and \n",
      "(a)(4)(i).\n",
      "    (iv) unique device identifier(s) for a patient's implantable \n",
      "device(s). in accordance with the ``product instance'' in the \n",
      "``procedure activity procedure section'' of the standard specified in \n",
      "sec.  170.205(a)(4) and (a)(4)(i).\n",
      "* * * * *\n",
      "    (ii) * * *\n",
      "    (b) [reserved]\n",
      "* * * * *\n",
      "    (f) * * *\n",
      "    (5) * * *\n",
      "    (iii) * * *\n",
      "    (b) * * *\n",
      "    (1) the data classes expressed in the standard in sec.  170.213.\n",
      "* * * * *\n",
      "    (g) design and performance--(1) automated numerator recording. for \n",
      "each promoting interoperability programs percentage-based measure, \n",
      "technology must be able to create a report or file that enables a user \n",
      "to review the patients or actions that would make the patient or action \n",
      "eligible to be included in the measure's numerator. the information in \n",
      "the report or file created must be of sufficient detail such that it \n",
      "enables a user to match those patients or actions to meet the measure's \n",
      "denominator limitations when necessary to generate an accurate \n",
      "percentage.\n",
      "    (2) automated measure calculation. for each promoting \n",
      "interoperability programs percentage-based measure that is supported by \n",
      "a capability included in a technology, record the numerator and \n",
      "denominator and create a report including the numerator, denominator, \n",
      "and resulting percentage associated with each applicable measure.\n",
      "    (3) * * *\n",
      "    (i) user-centered design processes must be applied to each \n",
      "capability technology includes that is specified in the following \n",
      "certification criteria: paragraphs (a)(1) through (5), (9), and (14); \n",
      "and (b)(2), (3), and (11).\n",
      "* * * * *\n",
      "    (6) consolidated cda creation performance. the following technical \n",
      "and performance outcomes must be demonstrated related to consolidated \n",
      "cda creation. the capabilities required under paragraphs (g)(6)(i) \n",
      "through (iv) of\n",
      "\n",
      "[[page 7592]]\n",
      "\n",
      "this section can be demonstrated in tandem and do not need to be \n",
      "individually addressed in isolation or sequentially. this certification \n",
      "criterion's scope includes only the data classes expressed in the \n",
      "standard in sec.  170.213.\n",
      "    (i) reference c-cda match. create a data file formatted in \n",
      "accordance with the standard adopted in sec.  170.205(a)(4) and \n",
      "(a)(4)(i) that matches a gold-standard, reference data file, including \n",
      "as specified for the following data:\n",
      "    (a) assessment and plan of treatment. in accordance with the \n",
      "``assessment and plan section (v2)'' of the standard specified in sec.  \n",
      "170.205(a)(4) and (a)(4)(i); or in accordance with the ``assessment \n",
      "section (v2)'' and ``plan of treatment section (v2)'' of the standard \n",
      "specified in sec.  170.205(a)(4) and (a)(4)(i).\n",
      "    (b) goals. in accordance with the ``goals section'' of the standard \n",
      "specified in sec.  170.205(a)(4) and (a)(4)(i).\n",
      "    (c) health concerns. in accordance with the ``health concerns \n",
      "section'' of the standard specified in sec.  170.205(a)(4) and \n",
      "(a)(4)(i).\n",
      "    (d) unique device identifier(s) for a patient's implantable \n",
      "device(s). in accordance with the ``product instance'' in the \n",
      "``procedure activity procedure section'' of the standard specified in \n",
      "sec.  170.205(a)(4) and (a)(4)(i).\n",
      "* * * * *\n",
      "    (iv) completeness verification. create a data file for each of the \n",
      "applicable document templates referenced in paragraph (g)(6)(ii) of \n",
      "this section without the omission of any of the data classes expressed \n",
      "in the standard in sec.  170.213.\n",
      "* * * * *\n",
      "    (8) [reserved]\n",
      "    (9) * * *\n",
      "    (i) * * *\n",
      "    (a) respond to requests for patient data (based on an id or other \n",
      "token) for all of the data classes expressed in the standard in sec.  \n",
      "170.213 at one time and return such data (according to the specified \n",
      "standards, where applicable) in a summary record formatted according to \n",
      "the standard specified in sec.  170.205(a)(4) and (a)(4)(i) following \n",
      "the ccd document template, including as specified for the following \n",
      "data:\n",
      "    (1) assessment and plan of treatment. in accordance with the \n",
      "``assessment and plan section (v2)'' of the standard specified in sec.  \n",
      "170.205(a)(4) and (a)(4)(i); or in accordance with the ``assessment \n",
      "section (v2)'' and ``plan of treatment section (v2)'' of the standard \n",
      "specified in sec.  170.205(a)(4) and (a)(4)(i).\n",
      "    (2) goals. in accordance with the ``goals section'' of the standard \n",
      "specified in sec.  170.205(a)(4) and (a)(4)(i).\n",
      "    (3) health concerns. in accordance with the ``health concerns \n",
      "section'' of the standard specified in sec.  170.205(a)(4) and \n",
      "(a)(4)(i).\n",
      "    (4) unique device identifier(s) for a patient's implantable \n",
      "device(s). in accordance with the ``product instance'' in the \n",
      "``procedure activity procedure section'' of the standard specified in \n",
      "sec.  170.205(a)(4) and (a)(4)(i).\n",
      "    (10) standardized api for patient and population services. the \n",
      "following technical outcomes and conditions must be met through the \n",
      "demonstration of application programming interface technology.\n",
      "    (i) data response. respond to requests for data (based on an id or \n",
      "other token) for each of the resources referenced by the standard \n",
      "adopted in sec.  170.215(a)(1) and implementation specifications \n",
      "adopted in sec.  170.215(a)(2) and (3).\n",
      "    (ii) search support. respond to search requests for data consistent \n",
      "with the search criteria included in the implementation specification \n",
      "adopted in sec.  170.215(a)(4).\n",
      "    (iii) app registration. enable an application to register with the \n",
      "technology's ``authorization server.''\n",
      "    (iv) secure connection. establish a secure and trusted connection \n",
      "with an application that requests data in accordance with the standard \n",
      "adopted in sec.  170.215(a)(5).\n",
      "    (v) authentication and app authorization--1st time connection. the \n",
      "first time an application connects to request data the technology:\n",
      "    (a) authentication. demonstrates that user authentication occurs \n",
      "during the process of authorizing the application to access fhir \n",
      "resources in accordance with the standard adopted in sec.  170.215(b).\n",
      "    (b) app authorization. demonstrates that a user can authorize \n",
      "applications to access a single patient's data as well as multiple \n",
      "patients data in accordance with the implementation specification \n",
      "adopted in sec.  170.215(a)(5) and issue a refresh token that is valid \n",
      "for a period of at least 3 months.\n",
      "    (vi) authentication and app authorization--subsequent connections. \n",
      "demonstrates that an application can access a single patient's data as \n",
      "well as multiple patients data in accordance with the implementation \n",
      "specification adopted in sec.  170.215(a)(5) without requiring re-\n",
      "authorization and re-authentication when a valid refresh token is \n",
      "supplied and issue a new refresh token for new period no shorter than 3 \n",
      "months.\n",
      "    (vii) documentation. (a) the api(s) must include complete \n",
      "accompanying documentation that contains, at a minimum:\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return variables and their types/\n",
      "structures, exceptions and exception handling methods and their \n",
      "returns.\n",
      "    (2) the software components and configurations that would be \n",
      "necessary for an application to implement in order to be able to \n",
      "successfully interact with the api and process its response(s).\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with an authorization server.\n",
      "    (b) the documentation used to meet paragraph (g)(10)(vii)(a) of \n",
      "this section must be available via a publicly accessible hyperlink.\n",
      "    (11) consent management for apis. (i) respond to requests for data \n",
      "in accordance with:\n",
      "    (a) the standard adopted in sec.  170.215(c)(1); and\n",
      "    (b) the implementation specification adopted in sec.  \n",
      "170.215(c)(2).\n",
      "    (ii) documentation. (a) the api(s) must include complete \n",
      "accompanying documentation that contains, at a minimum:\n",
      "    (1) api syntax, function names, required and optional parameters \n",
      "supported and their data types, return variables and their types/\n",
      "structures, exceptions and exception handling methods and their \n",
      "returns.\n",
      "    (2) the software components and configurations that would be \n",
      "necessary for an application to implement in order to be able to \n",
      "successfully interact with the api and process its response(s).\n",
      "    (3) all applicable technical requirements and attributes necessary \n",
      "for an application to be registered with an authorization server.\n",
      "    (b) the documentation used to meet paragraph (g)(11)(ii)(a) of this \n",
      "section must be available via a publicly accessible hyperlink.\n",
      "* * * * *\n",
      "0\n",
      "17. add subpart d to part 170 to read as follows:\n",
      "subpart d--conditions and maintenance of certification for health it \n",
      "developers\n",
      "sec.\n",
      "170.400 basis and scope.\n",
      "170.401 information blocking.\n",
      "170.402 assurances.\n",
      "170.403 communications.\n",
      "170.404 application programming interfaces.\n",
      "170.405 real world testing.\n",
      "170.406 attestations.\n",
      "\n",
      "[[page 7593]]\n",
      "\n",
      "subpart d--conditions and maintenance of certification for health \n",
      "it developers\n",
      "\n",
      "\n",
      "sec.  170.400  basis and scope.\n",
      "\n",
      "    this subpart implements section 3001(c)(5)(d) of the public health \n",
      "service act by setting forth certain conditions and maintenance of \n",
      "certification requirements for health it developers participating in \n",
      "the onc health it certification program.\n",
      "\n",
      "\n",
      "sec.  170.401  information blocking.\n",
      "\n",
      "    (a) condition of certification. a health it developer must not take \n",
      "any action that constitutes information blocking as defined in 42 \n",
      "u.s.c. 300jj-52 and sec.  171.103.\n",
      "    (b) maintenance of certification. [reserved]\n",
      "\n",
      "\n",
      "sec.  170.402  assurances.\n",
      "\n",
      "    (a) condition of certification. (1) a health it developer must \n",
      "provide assurances satisfactory to the secretary that the health it \n",
      "developer will not take any action that constitutes information \n",
      "blocking as defined in 42 u.s.c. 300jj-52 and sec.  171.103, unless for \n",
      "legitimate purposes specified by the secretary; or any other action \n",
      "that may inhibit the appropriate exchange, access, and use of \n",
      "electronic health information.\n",
      "    (2) a health it developer must ensure that its health it certified \n",
      "under the onc health it certification program conforms to the full \n",
      "scope of the certification criteria.\n",
      "    (3) a health it developer must not take any action that could \n",
      "interfere with a user's ability to access or use certified capabilities \n",
      "for any purpose within the scope of the technology's certification.\n",
      "    (4) a health it developer that manages electronic health \n",
      "information must certify health it to the certification criterion in \n",
      "sec.  170.315(b)(10).\n",
      "    (b) maintenance of certification. (1) a health it developer must \n",
      "retain all records and information necessary to demonstrate initial and \n",
      "ongoing compliance with the requirements of the onc health it \n",
      "certification program for:\n",
      "    (i) a period of 10 years beginning from the date each of a \n",
      "developer's health it is first certified under the program; or\n",
      "    (ii) if for a shorter period of time, a period of 3 years from the \n",
      "effective date that removes all of the certification criteria to which \n",
      "the developer's health it is certified from the code of federal \n",
      "regulations.\n",
      "    (2) a health it developer that must comply with the requirements of \n",
      "paragraph (a)(4) of this section must provide all of its customers of \n",
      "certified health it with the health it certified to the certification \n",
      "criterion in sec.  170.315(b)(10) within 24 months of this final rule's \n",
      "effective date or within 12 months of certification for a health it \n",
      "developer that never previously certified health it to the 2015 \n",
      "edition, whichever is longer.\n",
      "\n",
      "\n",
      "sec.  170.403  communications.\n",
      "\n",
      "    (a) condition of certification. (1) a health it developer may not \n",
      "prohibit or restrict the communication regarding--\n",
      "    (i) the usability of its health it;\n",
      "    (ii) the interoperability of its health it;\n",
      "    (iii) the security of its health it;\n",
      "    (iv) relevant information regarding users' experiences when using \n",
      "its health it;\n",
      "    (v) the business practices of developers of health it related to \n",
      "exchanging electronic health information; and\n",
      "    (vi) the manner in which a user of the health it has used such \n",
      "technology.\n",
      "    (2) a health it developer must not engage in any practice that \n",
      "prohibits or restricts a communication regarding the subject matters \n",
      "enumerated in paragraph (a)(1) of this section, unless the practice is \n",
      "specifically permitted by this paragraph and complies with all \n",
      "applicable requirements of this paragraph.\n",
      "    (i) unqualified protection for certain communications. a health it \n",
      "developer must not prohibit or restrict any person or entity from \n",
      "communicating any information or materials whatsoever (including \n",
      "proprietary information, confidential information, and intellectual \n",
      "property) when the communication is about one or more of the subject \n",
      "matters enumerated in paragraph (a)(1) of this section and is made for \n",
      "any of the following purposes--\n",
      "    (a) making a disclosure required by law;\n",
      "    (b) communicating information about adverse events, hazards, and \n",
      "other unsafe conditions to government agencies, health care \n",
      "accreditation organizations, and patient safety organizations;\n",
      "    (c) communicating information about cybersecurity threats and \n",
      "incidents to government agencies;\n",
      "    (d) communicating information about information blocking and other \n",
      "unlawful practices to government agencies; or\n",
      "    (e) communicating information about a health it developer's failure \n",
      "to comply with a condition of certification, or with any other \n",
      "requirement of this part, to onc or an onc-acb.\n",
      "    (ii) permitted prohibitions and restrictions. for communications \n",
      "about one or more of the subject matters enumerated in paragraph (a)(1) \n",
      "of this section that is not entitled to unqualified protection under \n",
      "paragraph (a)(2)(i) of this section, a health it developer may prohibit \n",
      "or restrict communications only as expressly permitted by paragraphs \n",
      "(a)(2)(ii)(a) through (f) of this section.\n",
      "    (a) developer employees and contractors. a health it developer may \n",
      "prohibit or restrict the communications of the developer's employees or \n",
      "contractors.\n",
      "    (b) non-user-facing aspects of health it. a health it developer may \n",
      "prohibit or restrict communications that disclose information about \n",
      "non-user-facing aspects of the developer's health it.\n",
      "    (c) intellectual property. a health it developer may prohibit or \n",
      "restrict communications that would infringe the intellectual property \n",
      "rights existing in the developer's health it (including third-party \n",
      "rights), provided that--\n",
      "    (1) a health it developer does not prohibit or restrict, or purport \n",
      "to prohibit or restrict, communications that would be a fair use of a \n",
      "copyright work; and\n",
      "    (2) a health it developer does not prohibit the communication of \n",
      "screenshots of the developer's health it, subject to the limited \n",
      "restrictions described in paragraph (a)(2)(ii)(d) of this section.\n",
      "    (d) screenshots. a health it developer may require persons who \n",
      "communicate screenshots to--\n",
      "    (1) not alter screenshots, except to annotate the screenshot, \n",
      "resize it, or to redact the screenshot in accordance with sec.  \n",
      "170.403(a)(2)(ii)(d)(3) or to conceal protected health information;\n",
      "    (2) not infringe the intellectual property rights of any third \n",
      "parties, provided that--\n",
      "    (i) the developer has used all reasonable endeavors to secure a \n",
      "license (including the right to sublicense) in respect to the use of \n",
      "the third-party rights by communicators for purposes of the \n",
      "communications protected by this condition of certification;\n",
      "    (ii) the developer does not prohibit or restrict, or purport to \n",
      "prohibit or restrict, communications that would be a fair use of a \n",
      "copyright work;\n",
      "    (iii) the developer has put all potential communicators on \n",
      "sufficient written notice of each aspect of its screen display that \n",
      "contains third-party content that cannot be communicated because the \n",
      "reproduction would infringe the third-party's intellectual property \n",
      "rights; and\n",
      "\n",
      "[[page 7594]]\n",
      "\n",
      "    (iv) communicators are permitted to communicate screenshots that \n",
      "have been redacted to not disclose third-party content; and\n",
      "    (3) redact protected health information, unless the individual has \n",
      "provided all necessary consents or authorizations or the communicator \n",
      "is otherwise authorized, permitted, or required by law to disclose the \n",
      "protected health information.\n",
      "    (e) pre-market testing and development. a health it developer may \n",
      "prohibit or restrict communications that disclose information or \n",
      "knowledge solely acquired in the course of participating in pre-market \n",
      "product development and testing activities carried out for the benefit \n",
      "of the developer or for the joint benefit of the developer and \n",
      "communicator. a developer must not, once the subject health it is \n",
      "released or marketed for purposes other than product development and \n",
      "testing, and subject to the permitted prohibitions and restrictions \n",
      "described in paragraph (a)(2)(ii) of this section, prohibit or restrict \n",
      "communications about matters enumerated in paragraph (a)(1) of this \n",
      "section.\n",
      "    (b) maintenance of certification. (1) notice. health it developers \n",
      "must issue a written notice to all customers and those with which it \n",
      "has agreements containing provisions that contravene paragraph (a) of \n",
      "this section:\n",
      "    (i) within six months of the effective date of the final rule that \n",
      "any communication or contract provision that contravenes paragraph (a) \n",
      "of this section will not be enforced by the health it developer.\n",
      "    (ii) within one year of the final rule, and annually thereafter \n",
      "until paragraph (b)(2)(ii) of this section is fulfilled, that any \n",
      "communication or contract provision that contravenes paragraph (a) of \n",
      "this section will not be enforced by the health it developer.\n",
      "    (2) contracts and agreements. (i) a health it developer must not \n",
      "establish or enforce any contract or agreement that contravenes \n",
      "paragraph (a) of this section.\n",
      "    (ii) if a health it developer has a contract or agreement in \n",
      "existence at the time of the effective date of this final rule that \n",
      "contravenes paragraph (a) of this section, then the developer must in a \n",
      "reasonable period of time, but not later than two years from the \n",
      "effective date of this rule, amend the contract or agreement to remove \n",
      "or void the contractual provision that contravenes paragraph (a) of \n",
      "this section.\n",
      "\n",
      "\n",
      "sec.  170.404  application programming interfaces.\n",
      "\n",
      "    the following condition of certification applies to developers of \n",
      "health it modules certified to any of the certification criteria \n",
      "adopted in sec.  170.315(g)(7) through (11).\n",
      "    (a) condition of certification. (1) general. an api technology \n",
      "supplier must publish apis and must allow health information from such \n",
      "technology to be accessed, exchanged, and used without special effort \n",
      "through the use of apis or successor technology or standards, as \n",
      "provided for under applicable law, including providing access to all \n",
      "data elements of a patient's electronic health record to the extent \n",
      "permissible under applicable privacy laws.\n",
      "    (2) transparency conditions. (i) general. the business and \n",
      "technical documentation published by an api technology supplier must be \n",
      "complete. all documentation published pursuant to paragraph (a)(2)(ii) \n",
      "of this section must be published via a publicly accessible hyperlink \n",
      "that allows any person to directly access the information without any \n",
      "preconditions or additional steps.\n",
      "    (ii) terms and conditions. (a) material information. the api \n",
      "technology supplier must publish all terms and conditions for its api \n",
      "technology, including any fees, restrictions, limitations, obligations, \n",
      "registration process requirements, or other similar requirements that \n",
      "would be needed to:\n",
      "    (1) develop software applications to interact with the api \n",
      "technology;\n",
      "    (2) distribute, deploy, and enable the use of software applications \n",
      "in production environments that use the api technology;\n",
      "    (3) use software applications, including to access, exchange, and \n",
      "use electronic health information by means of the api technology;\n",
      "    (4) use any electronic health information obtained by means of the \n",
      "api technology; and\n",
      "    (5) register software applications.\n",
      "    (b) api fees. any and all fees charged by an api technology \n",
      "supplier for the use of its api technology must be described in \n",
      "detailed, plain language. the description of the fees must include all \n",
      "material information, including but not limited to:\n",
      "    (1) the persons or classes of persons to whom the fee applies;\n",
      "    (2) the circumstances in which the fee applies; and\n",
      "    (3) the amount of the fee, which for variable fees must include the \n",
      "specific variable(s) and methodology(ies) that will be used to \n",
      "calculate the fee.\n",
      "    (c) application developer verification. an api technology supplier \n",
      "is permitted to institute a process to verify the authenticity of \n",
      "application developers so long as such process is objective and the \n",
      "same for all application developers and completed within 5 business \n",
      "days of receipt of an application developer's request to register their \n",
      "software application for use with the api technology supplier's api \n",
      "technology.\n",
      "    (3) permitted fees conditions. (i) general conditions. (a) all fees \n",
      "related to api technology not otherwise permitted by this section are \n",
      "prohibited from being imposed by an api technology supplier.\n",
      "    (b) for all permitted fees, an api technology supplier must:\n",
      "    (1) ensure that fees are based on objective and verifiable criteria \n",
      "that are uniformly applied for all substantially similar or similarly \n",
      "situated classes of persons and requests.\n",
      "    (2) ensure that fees imposed on api data providers are reasonably \n",
      "related to the api technology supplier's costs of supplying and, if \n",
      "applicable, supporting api technology to, or at the request of, the api \n",
      "data provider to whom the fee is charged.\n",
      "    (3) ensure that the costs of supplying and, if applicable, \n",
      "supporting the api technology upon which the fee is based are \n",
      "reasonably allocated among all customers to whom the api technology is \n",
      "supplied, or for whom the api technology is supported.\n",
      "    (4) ensure that fees are not based in any part on whether the \n",
      "requestor or other person is a competitor, potential competitor, or \n",
      "will be using the api technology in a way that facilitates competition \n",
      "with the api technology supplier.\n",
      "    (ii) permitted fee--development, deployment, and upgrades. an api \n",
      "technology supplier is permitted to charge fees to an api data provider \n",
      "to recover the costs reasonably incurred by the api technology supplier \n",
      "to develop, deploy, and upgrade api technology for the api data \n",
      "provider.\n",
      "    (iii) permitted fee--supporting api uses for purposes other than \n",
      "patient access. an api technology supplier is permitted to charge fees \n",
      "to an api data provider to recover the incremental costs reasonably \n",
      "incurred by the api technology supplier to support the use of api \n",
      "technology deployed by or on behalf of the api data provider. this \n",
      "permitted fee does not include:\n",
      "    (a) any costs incurred by the api technology supplier to support \n",
      "uses of the api technology that facilitate a patient's ability to \n",
      "access, exchange, or use their electronic health information;\n",
      "\n",
      "[[page 7595]]\n",
      "\n",
      "    (b) costs associated with intangible assets (including depreciation \n",
      "or loss of value), except the actual development or acquisition costs \n",
      "of such assets; or\n",
      "    (c) opportunity costs, except for the reasonable forward-looking \n",
      "cost of capital.\n",
      "    (iv) permitted fee--value-added services. an api technology \n",
      "supplier is permitted to charge fees to an api user for value-added \n",
      "services supplied in connection with software that can interact with \n",
      "the api technology, provided that such services are not necessary to \n",
      "efficiently and effectively develop and deploy such software.\n",
      "    (v) record-keeping requirements. an api technology supplier must \n",
      "keep for inspection detailed records of any fees charged with respect \n",
      "to the api technology, the methodology(ies) used to calculate such \n",
      "fees, and the specific costs to which such fees are attributed.\n",
      "    (4) openness and pro-competitive conditions. general condition. an \n",
      "api technology supplier must grant an api data provider the sole \n",
      "authority and autonomy to permit api users to interact with the api \n",
      "technology deployed by the api data provider.\n",
      "    (i) non-discrimination. (a) an api technology suppler must provide \n",
      "api technology to api data providers on terms that are no less \n",
      "favorable than it provides to itself and its own customers, suppliers, \n",
      "partners, and other persons with whom it has a business relationship.\n",
      "    (b) the terms on which an api technology supplier provides api \n",
      "technology must be based on objective and verifiable criteria that are \n",
      "uniformly applied for all substantially similar or similarly situated \n",
      "classes of persons and requests.\n",
      "    (c) an api technology supplier must not offer different terms or \n",
      "service on the basis of:\n",
      "    (1) whether the api user with whom an api data provider has a \n",
      "relationship is a competitor, potential competitor, or will be using \n",
      "electronic health information obtained via the api technology in a way \n",
      "that facilitates competition with the api technology supplier.\n",
      "    (2) the revenue or other value the api user with whom an api data \n",
      "provider has a relationship may derive from access, exchange, or use of \n",
      "electronic health information obtained by means of api technology.\n",
      "    (ii) rights to access and use api technology. (a) an api technology \n",
      "supplier must have and, upon request, must grant to api data providers \n",
      "and their api users all rights that may be reasonably necessary to \n",
      "access and use api technology in a production environment, including:\n",
      "    (1) for the purposes of developing products or services that are \n",
      "designed to be interoperable with the api technology supplier's health \n",
      "information technology or with health information technology under the \n",
      "api technology supplier's control;\n",
      "    (2) any marketing, offering, and distribution of interoperable \n",
      "products and services to potential customers and users that would be \n",
      "needed for the api technology to be used in a production environment; \n",
      "and\n",
      "    (3) enabling the use of the interoperable products or services in \n",
      "production environments, including accessing and enabling the exchange \n",
      "and use of electronic health information.\n",
      "    (b) an api technology supplier must not condition any of the rights \n",
      "described in paragraph (a)(4)(ii)(a) of this section on the requirement \n",
      "that the recipient of the rights do, or agree to do, any of the \n",
      "following:\n",
      "    (1) pay a fee to license such rights, including but not limited to \n",
      "a license fee, royalty, or revenue-sharing arrangement.\n",
      "    (2) not compete with the api technology supplier in any product, \n",
      "service, or market.\n",
      "    (3) deal exclusively with the api technology supplier in any \n",
      "product, service, or market.\n",
      "    (4) obtain additional licenses, products, or services that are not \n",
      "related to or can be unbundled from the api technology.\n",
      "    (5) license, grant, assign, or transfer any intellectual property \n",
      "to the api technology supplier.\n",
      "    (6) meet additional developer or product certification \n",
      "requirements.\n",
      "    (7) provide the api technology supplier or its technology with \n",
      "reciprocal access to application data.\n",
      "    (iii) service and support obligations. an api technology supplier \n",
      "must provide all support and other services reasonably necessary to \n",
      "enable the effective development, deployment, and use of api technology \n",
      "by api data providers and their api users in production environments.\n",
      "    (a) changes and updates to api technology. an api technology \n",
      "supplier must make reasonable efforts to maintain the compatibility of \n",
      "its api technology and to otherwise avoid disrupting the use of api \n",
      "technology in production environments.\n",
      "    (b) changes to terms and conditions. except as exigent \n",
      "circumstances require, prior to making changes or updates to its api \n",
      "technology or to the terms and conditions thereof, an api technology \n",
      "supplier must provide notice and a reasonable opportunity for its api \n",
      "data provider customers and registered application developers to update \n",
      "their applications to preserve compatibility with api technology and to \n",
      "comply with applicable terms and conditions.\n",
      "    (b) maintenance of certification. (1) registration for production \n",
      "use. an api technology supplier with health it certified to the \n",
      "certification criterion adopted in sec.  170.315(g)(10) must register \n",
      "and enable all applications for production use within 1 business day of \n",
      "completing its verification of an application developer's authenticity, \n",
      "pursuant to paragraph (a)(2)(ii)(c) of this section.\n",
      "    (2) service base url publication. api technology supplier must \n",
      "support the publication of service base urls for all of its customers, \n",
      "regardless of those that are centrally managed by the api technology \n",
      "supplier or locally deployed by an api data provider, and make such \n",
      "information publicly available (in a computable format) at no charge.\n",
      "    (3) rollout of (g)(10)-certified apis. an api technology supplier \n",
      "with api technology previously certified to the certification criterion \n",
      "in sec.  170.315(g)(8) must provide all api data providers with such \n",
      "api technology deployed with api technology certified to the \n",
      "certification criterion in sec.  170.315(g)(10) within 24 months of \n",
      "this final rule's effective date.\n",
      "\n",
      "\n",
      "sec.  170.405  real world testing.\n",
      "\n",
      "    (a) condition of certification. a health it developer with health \n",
      "it modules to be certified to any one or more 2015 edition \n",
      "certification criteria in sec.  170.315(b), (c)(1) through (3), (e)(1), \n",
      "(f), (g)(7) through (11), and (h) must successfully test the real world \n",
      "use of those health it module(s) for interoperability (as defined in 42 \n",
      "u.s.c. 300jj(9) and sec.  170.102) in the type of setting in which such \n",
      "health it module(s) would be/is marketed.\n",
      "    (b) maintenance of certification. (1) real world testing plan \n",
      "submission. a health it developer must submit an annual real world \n",
      "testing plan to its onc-acb via a publicly accessible hyperlink no \n",
      "later than december 15 of each calendar year for each of its certified \n",
      "2015 edition health it modules that include certification criteria \n",
      "referenced in paragraph (a) of this section.\n",
      "    (i) the plan must be approved by a health it developer authorized \n",
      "representative capable of binding the health it developer for execution \n",
      "of the plan and include the representative's contact information.\n",
      "\n",
      "[[page 7596]]\n",
      "\n",
      "    (ii) the plan must include all health it certified to the 2015 \n",
      "edition through august 31st of the preceding year.\n",
      "    (iii) the plan must address the following for each of the \n",
      "certification criteria identified in paragraph (a) of this section that \n",
      "are included in the health it module's scope of certification:\n",
      "    (a) the testing method(s)/methodology(ies) that will be used to \n",
      "demonstrate real world interoperability and conformance to the \n",
      "certification criteria's requirements, including scenario- and use \n",
      "case-focused testing;\n",
      "    (b) the care setting(s) that will be tested for real world \n",
      "interoperability and an explanation for the health it developer's \n",
      "choice of care setting(s) to test;\n",
      "    (c) the timeline and plans for any voluntary updates to standards \n",
      "and implementation specifications that the national coordinator has \n",
      "approved through the standards version advancement process.\n",
      "    (d) a schedule of key real world testing milestones;\n",
      "    (e) a description of the expected outcomes of real world testing;\n",
      "    (f) at least one measurement/metric associated with the real world \n",
      "testing; and\n",
      "    (g) a justification for the health it developer's real world \n",
      "testing approach.\n",
      "    (2) real world testing results reporting. a health it developer \n",
      "must submit real world testing results to its onc-acb via a publicly \n",
      "accessible hyperlink no later than january 31 each calendar year for \n",
      "each of its certified 2015 edition health it modules that include \n",
      "certification criteria referenced in paragraph (a) of this section. the \n",
      "real world testing results must report the following for each of the \n",
      "certification criteria identified in paragraph (a) of this section that \n",
      "are included in the health it module's scope of certification:\n",
      "    (i) the method(s) that was used to demonstrate real world \n",
      "interoperability;\n",
      "    (ii) the care setting(s) that was tested for real world \n",
      "interoperability;\n",
      "    (iii) the voluntary updates to standards and implementation \n",
      "specifications that the national coordinator has approved through the \n",
      "standards version advancement process.\n",
      "    (iv) a list of the key milestones met during real world testing;\n",
      "    (v) the outcomes of real world testing including a description of \n",
      "any challenges encountered during real world testing; and\n",
      "    (vi) at least one measurement/metric associated with the real world \n",
      "testing.\n",
      "    (3) uscdi updates for c-cda. a health it developer with health it \n",
      "certified to sec.  170.315(b)(1), (e)(1), (g)(6), (f)(5), and/or (g)(9) \n",
      "prior to the effective date of this final rule must:\n",
      "    (i) update their certified health it to be compliant with the \n",
      "revised versions of these criteria adopted in this final rule; and\n",
      "    (ii) provide its customers of the previously certified health it \n",
      "with certified health it that meets paragraph (b)(3)(i) of this section \n",
      "within 24 months of the effective date of this final rule.\n",
      "    (4) c-cda companion guide updates. a health it developer with \n",
      "health it certified to sec.  170.315(b)(1), (b)(2), (b)(9), (e)(1), \n",
      "(g)(6), and/or (g)(9) prior to the effective date of this final rule \n",
      "must:\n",
      "    (i) update their certified health it to be compliant with the \n",
      "revised versions of these criteria adopted in this final rule; and\n",
      "    (ii) provide its customers of the previously certified health it \n",
      "with certified health it that meets paragraph (b)(4)(i) of this section \n",
      "within 24 months of the effective date of this final rule.\n",
      "    (5) voluntary standards and implementation specifications updates. \n",
      "a health it developer subject to paragraph (a) of this section that \n",
      "voluntary updates its certified health it to a new version of an \n",
      "adopted standard that is approved by the national coordinator through \n",
      "the standards version advancement process must:\n",
      "    (i) provide advance notice to all affected customers and its onc-\n",
      "acb--\n",
      "    (a) expressing its intent to update the software to the more \n",
      "advanced version of the standard approved by the national coordinator;\n",
      "    (b) the developer's expectations for how the update will affect \n",
      "interoperability of the affected health it module as it is used in the \n",
      "real world;\n",
      "    (c) whether the developer intends to continue to support the \n",
      "certificate for the existing certified health it module version for \n",
      "some period of time and how long or if the existing certified health it \n",
      "module version will be deprecated; and\n",
      "    (ii) successfully demonstrate conformance with approved more recent \n",
      "versions of the standard(s) or implementation specification(s) included \n",
      "in applicable 2015 edition certification criterion specified in \n",
      "paragraph (a) of this section.\n",
      "\n",
      "\n",
      "sec.  170.406  attestations.\n",
      "\n",
      "    (a) condition of certification. a health it developer must provide \n",
      "the secretary with an attestation of compliance with the conditions and \n",
      "maintenance of certification requirements specified in sec. sec.  \n",
      "170.401 through 170.405 at the time of certification. specifically, a \n",
      "health it developer must attest to:\n",
      "    (1) having not taken any action that constitutes information \n",
      "blocking as defined in 42 u.s.c. 300jj-52 and sec.  171.103;\n",
      "    (2) having provided assurances satisfactory to the secretary that \n",
      "they will not take any action that constitutes information blocking as \n",
      "defined in 42 u.s.c. 300jj-52 and sec.  171.103, unless for legitimate \n",
      "purposes specified by the secretary; or any other action that may \n",
      "inhibit the appropriate exchange, access, and use of electronic health \n",
      "information;\n",
      "    (3) not prohibiting or restricting the communications regarding--\n",
      "    (i) the usability of its health it;\n",
      "    (ii) the interoperability of its health it;\n",
      "    (iii) the security of its health it;\n",
      "    (iv) relevant information regarding users' experiences when using \n",
      "its health it;\n",
      "    (v) the business practices of developers of health it related to \n",
      "exchanging electronic health information; and\n",
      "    (vi) the manner in which a user of the health it has used such \n",
      "technology; and\n",
      "    (4) having published application programming interfaces (apis) and \n",
      "allowing health information from such technology to be accessed, \n",
      "exchanged, and used without special effort through the use of \n",
      "application programming interfaces or successor technology or \n",
      "standards, as provided for under applicable law, including providing \n",
      "access to all data elements of a patient's electronic health record to \n",
      "the extent permissible under applicable privacy laws;\n",
      "    (5) ensuring that its health it allows for health information to be \n",
      "exchanged, accessed, and used, in the manner described in paragraph \n",
      "(a)(4) of this section; and\n",
      "    (6) having undertaken real world testing of its health it module(s) \n",
      "for interoperability (as defined in 42 u.s.c. 300jj(9)) in the type of \n",
      "setting in which such health it module(s) will be/is marketed.\n",
      "    (b) maintenance of certification. (1) a health it developer must \n",
      "attest to compliance with sec. sec.  170.401 through 170.405 at the \n",
      "time of certification.\n",
      "    (2) a health it developer must attest semiannually to compliance \n",
      "with sec. sec.  170.401 through 170.405 for all its health it that had \n",
      "an active certification at any time under the onc health it \n",
      "certification program during the prior six months.\n",
      "\n",
      "\n",
      "sec.  170.501   [amended]\n",
      "\n",
      "0\n",
      "18. amend sec.  170.501 as follows:\n",
      "0\n",
      "a. in paragraph (a) remove the phrase ``complete ehrs'';\n",
      "\n",
      "[[page 7597]]\n",
      "\n",
      "0\n",
      "b. in paragraph (b) remove the phrase ``complete ehrs and''; and\n",
      "0\n",
      "c. remove and reserve paragraph (c).\n",
      "\n",
      "\n",
      "sec.  170.502   [amended]\n",
      "\n",
      "0\n",
      "19. amend sec.  170.502 as follows:\n",
      "0\n",
      "a. in the definition of ``deployment site'', remove the phrase \n",
      "``complete ehr,'';\n",
      "0\n",
      "b. in the definition of ``development site'', remove the phrase \n",
      "``complete ehr,'';\n",
      "0\n",
      "c. in the definition of ``gap certification'', remove the phrase \n",
      "``complete ehr or'';\n",
      "0\n",
      "d. remove the definition of ``onc-approved accreditor or onc-aa'';\n",
      "0\n",
      "e. in the definition of ``onc-authorized certification body or onc-\n",
      "acb'', remove the phrase ``complete ehrs,''; and\n",
      "0\n",
      "f. in the definition of ``onc-authorized testing lab or onc-atl'', \n",
      "remove the phrase ``complete ehrs and''.\n",
      "\n",
      "\n",
      "sec.  170.503   [removed and reserved]\n",
      "\n",
      "0\n",
      "20. remove and reserve sec.  170.503.\n",
      "\n",
      "\n",
      "sec.  170.504   [removed and reserved]\n",
      "\n",
      "0\n",
      "21. remove and reserve sec.  170.504.\n",
      "0\n",
      "22. revise sec.  170.505 to read as follows:\n",
      "\n",
      "\n",
      "sec.  170.505  correspondence.\n",
      "\n",
      "    (a) correspondence and communication with onc or the national \n",
      "coordinator shall be conducted by email, unless otherwise necessary or \n",
      "specified. the official date of receipt of any email between onc or the \n",
      "national coordinator and an applicant for onc-acb status, an applicant \n",
      "for onc-atl status, an onc-acb, an onc-atl, health it developer, or a \n",
      "party to any proceeding under this subpart is the date on which the \n",
      "email was sent.\n",
      "    (b) in circumstances where it is necessary for an applicant for \n",
      "onc-acb status, an applicant for onc-atl status, an onc-acb, an onc-\n",
      "atl, health it developer, or a party to any proceeding under this \n",
      "subpart to correspond or communicate with onc or the national \n",
      "coordinator by regular, express, or certified mail, the official date \n",
      "of receipt for all parties will be the date of the delivery \n",
      "confirmation to the address on record.\n",
      "\n",
      "\n",
      "sec.  170.510   [amended]\n",
      "\n",
      "0\n",
      "23. amend sec.  170.510 by removing paragraph (a) and redesignating \n",
      "paragraphs (b) and (c) as paragraphs (a) and (b).\n",
      "0\n",
      "24. amend sec.  170.520 by revising paragraph (a)(3) to read as \n",
      "follows:\n",
      "\n",
      "\n",
      "sec.  170.520  application.\n",
      "\n",
      "    (a) * * *\n",
      "    (3) documentation that confirms that the applicant has been \n",
      "accredited to iso/iec 17065, with an appropriate scope, by any \n",
      "accreditation body that is a signatory to the multilateral recognition \n",
      "arrangement (mla) with the international accreditation forum (iaf) \n",
      "(incorporated by reference in sec.  170.599).\n",
      "* * * * *\n",
      "0\n",
      "25. amend sec.  170.523 as follows:\n",
      "0\n",
      "a. revise paragraph (a);\n",
      "0\n",
      "b. in paragraph (f) introductory text, add a header and remove the \n",
      "phrase, ``complete ehrs,'';\n",
      "0\n",
      "c. removing and reserve paragraph (f)(2);\n",
      "0\n",
      "d. revise paragraphs (g) and (h);\n",
      "0\n",
      "e. in paragraph (k) introductory text, remove the phrase ``complete \n",
      "ehrs and'';\n",
      "0\n",
      "f. in paragraph (k)(1) introductory text, add a header and remove the \n",
      "phrase ``complete ehr or'';\n",
      "0\n",
      "g. remove paragraphs (k)(1)(ii)(b), and (k)(1)(iii)(b);\n",
      "0\n",
      "h. revise paragraph (k)(1)(iii)(a);\n",
      "0\n",
      "i. remove paragraphs (k)(1)(iv)(b) and (c);\n",
      "0\n",
      "j. remove and reserve paragraphs (k)(2) and (3);\n",
      "0\n",
      "k. revise paragraph (k)(4);\n",
      "0\n",
      "l. revise paragraphs (m)(1) and (2);\n",
      "0\n",
      "m. add paragraphs (m)(3) and (4));\n",
      "0\n",
      "n. in paragraph (o), remove the phrase ``complete ehr or''; and\n",
      "0\n",
      "o. add paragraphs (p) through (t).\n",
      "    the revisions and additions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.523  principles of proper conduct for onc-acbs.\n",
      "\n",
      "* * * * *\n",
      "    (a) accreditation. maintain its accreditation in good standing to \n",
      "iso/iec 17065 (incorporated by reference in sec.  170.599).\n",
      "* * * * *\n",
      "    (f) reporting. * * *\n",
      "    (2) [reserved]\n",
      "    (g) records retention. (1) retain all records related to the \n",
      "certification of complete ehrs and health it modules to an edition of \n",
      "certification criteria beginning with the codification of an edition of \n",
      "certification criteria in the code of federal regulations through a \n",
      "minimum of 3 years from the effective date that removes the applicable \n",
      "edition from the code of federal regulations; and\n",
      "    (2) make the records available to hhs upon request during the \n",
      "retention period described in paragraph (g)(1) of this section;\n",
      "    (h) testing. only certify health it modules that have been:\n",
      "    (1) tested, using test tools and test procedures approved by the \n",
      "national coordinator, by an:\n",
      "    (i) onc-atl;\n",
      "    (ii) onc-atl, nvlap-accredited testing laboratory under the onc \n",
      "health it certification program, and/or an onc-atcb for the purposes of \n",
      "performing gap certification; or\n",
      "    (2) evaluated by it for compliance with a conformance method \n",
      "approved by the national coordinator.\n",
      "* * * * *\n",
      "    (k) disclosures. * * *\n",
      "    (1) * * *\n",
      "    (ii) for a health it module certified to 2015 edition health it \n",
      "certification criteria, the information specified by paragraphs \n",
      "(f)(1)(i), (vi) through (viii), (xv), and (xvi) of this section as \n",
      "applicable for the specific health it module.\n",
      "    (iii) in plain language, a detailed description of all known \n",
      "material information concerning additional types of costs or fees that \n",
      "a user may be required to pay to implement or use the health it \n",
      "module's capabilities, whether to meet provisions of hhs programs \n",
      "requiring the use of certified health it or to achieve any other use \n",
      "within the scope of the health it's certification. the additional types \n",
      "of costs or fees required to be disclosed include but are not limited \n",
      "to costs or fees (whether fixed, recurring, transaction-based, or \n",
      "otherwise) imposed by a health it developer (or any third party from \n",
      "whom the developer purchases, licenses, or obtains any technology, \n",
      "products, or services in connection with its certified health it) to \n",
      "purchase, license, implement, maintain, upgrade, use, or otherwise \n",
      "enable and support the use of capabilities to which health it is \n",
      "certified; or in connection with any data generated in the course of \n",
      "using any capability to which health it is certified.\n",
      "* * * * *\n",
      "    (2) [reserved]\n",
      "    (3) [reserved]\n",
      "    (4) a certification issued to a health it module based solely on \n",
      "the applicable certification criteria adopted by the onc health it \n",
      "certification program must be separate and distinct from any other \n",
      "certification(s) based on other criteria or requirements.\n",
      "* * * * *\n",
      "    (m) * * *\n",
      "    (1) all adaptations of certified health it modules;\n",
      "    (2) all updates made to certified health it modules affecting the \n",
      "capabilities in certification criteria to which the ``safety-enhanced \n",
      "design'' criteria apply;\n",
      "    (3) all updates made to certified health it modules in compliance \n",
      "with sec.  170.405(b)(3) and (4); and;\n",
      "\n",
      "[[page 7598]]\n",
      "\n",
      "    (4) all voluntary standards updates successfully made to certified \n",
      "health it modules per sec.  170.405(b)(5).\n",
      "* * * * *\n",
      "    (p) real world testing. (1) review and confirm that applicable \n",
      "health it developers submit real world testing plans in accordance with \n",
      "sec.  170.405(b)(1).\n",
      "    (2) review and confirm that applicable health it developers submit \n",
      "real world testing results in accordance with sec.  170.405(b)(2).\n",
      "    (3) submit real world testing plans by december 15 of each calendar \n",
      "year and results by april 1 of each calendar year to onc for public \n",
      "availability.\n",
      "    (q) attestations. review and submit health it developer conditions \n",
      "and maintenance of certification attestations made in accordance with \n",
      "sec.  170.406 to onc for public availability.\n",
      "    (r) test results from onc-atls. accept test results from any onc-\n",
      "atl that is:\n",
      "    (1) in good standing under the onc health it certification program, \n",
      "and\n",
      "    (2) compliant with its iso 17025 accreditation requirements.\n",
      "    (s) information for direct review. report to onc, no later than a \n",
      "week after becoming aware of, any information that could inform whether \n",
      "onc should exercise direct review under sec.  170.580(a).\n",
      "    (t) standards voluntary advancement process module updates notices. \n",
      "ensure health it developers opting to take advantage of the standards \n",
      "version advancement process flexibility per sec.  170.405(b)(5) provide \n",
      "timely advance written notice to the onc-acb and all affected \n",
      "customers.\n",
      "    (1) maintain a record of the date of issuance and the content of \n",
      "developers' sec.  170.405(b)(5) notices; and\n",
      "    (2) timely post content of each sec.  170.405(b)(5) notice received \n",
      "publicly on the chpl attributed to the certified health it module(s) to \n",
      "which it applies.\n",
      "0\n",
      "26. amend sec.  170.524 as follows:\n",
      "0\n",
      "a. revise paragraph (f); and\n",
      "0\n",
      "b. in paragraph (h)(3), remove the phrase ``complete ehrs and/or''. the \n",
      "revisions and additions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.524  principles of proper conduct for onc-atls.\n",
      "\n",
      "* * * * *\n",
      "    (f) records retention. (1) retain all records related to the \n",
      "testing of complete ehrs and/or health it modules to an edition of \n",
      "certification criteria beginning with the codification of an edition of \n",
      "certification criteria in the code of federal regulations through a \n",
      "minimum of 3 years from the effective date that removes the applicable \n",
      "edition from the code of federal regulations; and\n",
      "    (2) make the records available to hhs upon request during the \n",
      "retention period described in paragraph (f)(1) of this section;\n",
      "* * * * *\n",
      "\n",
      "\n",
      "sec.  170.545   [removed and reserved]\n",
      "\n",
      "0\n",
      "27. remove and reserve sec.  170.545.\n",
      "0\n",
      "28. amend sec.  170.550 as follows:\n",
      "0\n",
      "a. add paragraph (e);\n",
      "0\n",
      "b. remove and reserve paragraph (f);\n",
      "0\n",
      "c. add paragraph (g)(5);\n",
      "0\n",
      "d. revise paragraphs (h)(3)(i), (iii), (v), (vii); and\n",
      "0\n",
      "e. add paragraphs (h)(3)(ix) and (l).\n",
      "    the additions and revisions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.550  health it module certification.\n",
      "\n",
      "* * * * *\n",
      "    (e) onc-acbs must provide an option for certification of health it \n",
      "modules to any one or more of the criteria referenced in sec.  \n",
      "170.405(a) based on newer versions of standards included in the \n",
      "criteria which have been approved by the national coordinator for use \n",
      "in certification through the standards version advancement process.\n",
      "    (f) [reserved]\n",
      "    (g) * * *\n",
      "    (5) section 170.315(b)(10) when the health it developer of the \n",
      "health it presented for certification produces and electronically \n",
      "manages electronic health information.\n",
      "    (h) * * *\n",
      "    (3) * * *\n",
      "    (i) section 170.315(a)(1) through (3), (5) through (8), (11), and \n",
      "(12) are also certified to the certification criteria specified in \n",
      "sec.  170.315(d)(1) through (7). section 170.315(a)(4), (9), (10), and \n",
      "(13) are also certified to the certification criteria specified in \n",
      "sec.  170.315(d)(1) through (3), and (5) through (7).\n",
      "* * * * *\n",
      "    (iii) section 170.315(c) is also certified to the certification \n",
      "criteria specified in sec.  170.315(d)(1), (2)(i)(a), (b), (ii) through \n",
      "(v), (3), and (5);\n",
      "* * * * *\n",
      "    (v) section 170.315(e)(2) and (3) is also certified to the \n",
      "certification criteria specified in sec.  170.315(d)(1), (d)(2)(i)(a), \n",
      "(b), (ii) through (v), (3), (5), and (9);\n",
      "* * * * *\n",
      "    (vii) section 170.315(g)(7) through (11) is also certified to the \n",
      "certification criteria specified in sec.  170.315(d)(1) and (9); and \n",
      "(d)(2)(i)(a), (2)(i)(b), 2(ii) through (v), or (10);\n",
      "    (viii) section 170.315(h) is also certified to the certification \n",
      "criteria specified in sec.  170.315(d)(1), (2)(i)(a), (2)(i)(b), \n",
      "(2)(ii) through (v), and (3); and\n",
      "* * * * *\n",
      "    (ix) if applicable, any criterion adopted in sec.  170.315 is also \n",
      "certified to the certification criteria specified in sec.  \n",
      "170.315(d)(12) and/or (13).\n",
      "* * * * *\n",
      "    (l) conditions of certification attestations. before issuing a \n",
      "certification, ensure that the health it developer of the health it \n",
      "module has met its responsibilities under subpart d of this part.\n",
      "\n",
      "\n",
      "sec.  170.555   [amended]\n",
      "\n",
      "0\n",
      "29. amend sec.  170.555 as follows:\n",
      "0\n",
      "a. in paragraph (a), remove the reference ``complete ehrs and/or'';\n",
      "0\n",
      "b. revise paragraph (b)(1); and\n",
      "0\n",
      "c. in paragraph (b)(2), remove the reference ``certified complete ehr \n",
      "or''. the revisions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.555  certification to newer versions of certain standards.\n",
      "\n",
      "* * * * *\n",
      "    (b) * * *\n",
      "    (1) onc-acbs are not required to certify complete ehrs and/or \n",
      "health it module(s) according to newer versions of standards adopted \n",
      "and named in subpart b of this part, unless:\n",
      "    (i) the national coordinator identifies a new version through the \n",
      "standards version advancement process and a health it developer \n",
      "voluntarily elects to update its certified health it to the new version \n",
      "in accordance with sec.  170.405(b)(5); or\n",
      "    (ii) the new version is incorporated by reference in sec.  170.299.\n",
      "* * * * *\n",
      "0\n",
      "30. amend sec.  170.556 as follows:\n",
      "0\n",
      "a. revise paragraph (a) introductory text;\n",
      "0\n",
      "b. in paragraph (b) introductory text, remove the phrase ``certified \n",
      "complete ehr or'';\n",
      "0\n",
      "c. revise paragraph (c) introductory text;\n",
      "0\n",
      "d. in paragraph (c)(1), remove the phrases ``certified complete ehr \n",
      "or'' and ``complete ehr or'';\n",
      "0\n",
      "e. remove and reserve paragraph (c)(2);\n",
      "0\n",
      "f. in paragraph (c)(3), remove the phrase ``certified complete ehrs \n",
      "and'';\n",
      "0\n",
      "g. in paragraphs (c)(4)(i) and (ii), remove the phrase ``certified \n",
      "complete ehr or'';\n",
      "0\n",
      "h. remove paragraphs (c)(5) and (6);\n",
      "0\n",
      "i. in paragraph (d)(1), remove the phrase ``complete ehr or'';\n",
      "0\n",
      "j. in paragraph (d)(3)(ii), remove the phrase ``certified complete ehr \n",
      "or'';\n",
      "0\n",
      "k. in paragraph (d)(5) introductory text, remove the phrase ``complete \n",
      "ehr or'';\n",
      "0\n",
      "l. in paragraph (d)(6), remove the phrases ``certified complete ehr \n",
      "or'' and ``complete ehr or'';\n",
      "\n",
      "[[page 7599]]\n",
      "\n",
      "0\n",
      "m. in paragraph (e)(3), remove the phrase ``complete ehr or''; and\n",
      "0\n",
      "n. in paragraph (f), remove the phrase ``certified complete ehr or''. \n",
      "the revisions and additions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.556  in-the-field surveillance and maintenance of \n",
      "certification for health it.\n",
      "\n",
      "    (a) in-the-field surveillance. consistent with its accreditation to \n",
      "iso/iec 17065 and the requirements of this subpart, an onc-acb must \n",
      "initiate surveillance ``in the field'' as necessary to assess whether a \n",
      "certified health it module continues to conform to the requirements in \n",
      "subparts a, b, c and e of this part once the certified health it module \n",
      "has been implemented and is in use in a production environment.\n",
      "* * * * *\n",
      "    (c) randomized surveillance. during each calendar year surveillance \n",
      "period, an onc-acb may conduct in-the-field surveillance for certain \n",
      "randomly selected health it modules to which it has issued a \n",
      "certification.\n",
      "* * * * *\n",
      "    (2) [reserved]\n",
      "* * * * *\n",
      "\n",
      "\n",
      "sec. sec.  170.560, 170.565, and 170.570   [amended]\n",
      "\n",
      "0\n",
      "31. in the table below, for each section and paragraph indicated in the \n",
      "first two columns, remove the phrase indicated in the third column:\n",
      "\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "               section                         paragraphs                              remove\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "sec.   170.560......................  (a)(2)......................  ``complete ehrs and/or''.\n",
      "sec.   170.565......................  (d)(ii) and (d)(iii)........  ``complete ehrs or''.\n",
      "sec.   170.565......................  (h)(2)(iii).................  ``complete ehrs and''.\n",
      "sec.   170.570......................  (a), (b)(2), (c)              ``complete ehrs and/or''.\n",
      "                                       introductory text, (c)(1),\n",
      "                                       and (c)(2).\n",
      "----------------------------------------------------------------------------------------------------------------\n",
      "\n",
      "sec.  170.575   [removed and reserved]\n",
      "\n",
      "0\n",
      "32. remove and reserve sec.  170.575.\n",
      "0\n",
      "33. amend sec.  170.580 as follows:\n",
      "0\n",
      "a. revise paragraph (a)(1) and the headings of paragraphs (a)(2)(i) and \n",
      "(ii);\n",
      "0\n",
      "b. add paragraph (a)(2)(iii);\n",
      "0\n",
      "c. revise paragraphs (a)(3)(i), (iv), and (v);\n",
      "0\n",
      "d. add paragraph (a)(4);\n",
      "0\n",
      "e. revise paragraphs (b)(1)(i) and (iii)(d);\n",
      "0\n",
      "f. revise paragraphs (b)(2)(i);\n",
      "0\n",
      "g. revise paragraphs (b)(3)(i) and (ii);\n",
      "0\n",
      "h. add paragraphs (b)(3)(iii) and (iv);\n",
      "0\n",
      "i. revise paragraph (c)(1);\n",
      "0\n",
      "j. in paragraphs (d)(1), (d)(2)(i)(c), and (d)(4), remove the phrase \n",
      "``complete ehr or'';\n",
      "0\n",
      "k. in paragraph (d)(5), remove the phrase ``complete ehrs or'';\n",
      "0\n",
      "l. revise paragraph (e)(1) introductory text;\n",
      "0\n",
      "m. revise paragraph (f)(1);\n",
      "0\n",
      "n. in paragraph (f)(2)(i)(c) by removing the reference ``complete ehr \n",
      "or'';\n",
      "0\n",
      "o. revise paragraphs (g)(1) introductory text, (g)(1)(i), (g)(2), \n",
      "(g)(3)(i), (g)(4), (g)(5)(i), and (g)(6)(v).\n",
      "    the additions and revisions read as follows:\n",
      "\n",
      "\n",
      "sec.  170.580  onc review of certified health it or a health it \n",
      "developer's actions.\n",
      "\n",
      "    (a) * * *\n",
      "    (1) purpose. onc may directly review certified health it or a \n",
      "health it developer's actions or practices to determine whether either \n",
      "conform to the requirements of the onc health it certification program.\n",
      "    (2) * * *\n",
      "    (i) certified health it causing or contributing to unsafe \n",
      "conditions. * * *\n",
      "* * * * *\n",
      "    (ii) impediments to onc-acb oversight of certified health it. * * *\n",
      "* * * * *\n",
      "    (iii) noncompliance with conditions and maintenance of \n",
      "certification. onc may initiate direct review under this section if it \n",
      "has a reasonable belief that a health it developer has not complied \n",
      "with a condition or maintenance of certification requirement under \n",
      "subpart d of this part.\n",
      "    (3) * * *\n",
      "    (i) onc's review of certified health it or a health it developer's \n",
      "actions or practices is independent of, and may be in addition to, any \n",
      "surveillance of certified health it conducted by an onc-acb.\n",
      "    (4) coordination with the office of inspector general. (i) onc may \n",
      "coordinate its review of a claim of information blocking with the \n",
      "office of inspector general or defer to the office of inspector general \n",
      "to lead a review of a claim of information blocking.\n",
      "    (ii) onc may rely on office of inspector general findings to form \n",
      "the basis of a direct review action.\n",
      "* * * * *\n",
      "    (iv) an onc-acb and onc-atl shall provide onc with any available \n",
      "information that onc deems relevant to its review of certified health \n",
      "it or a health it developer's actions or practices.\n",
      "    (v) onc may end all or any part of its review of certified health \n",
      "it or a health it developer's actions or practices under this section \n",
      "at any time and refer the applicable part of the review to the relevant \n",
      "onc-acb(s) if onc determines that doing so would serve the effective \n",
      "administration or oversight of the onc health it certification program.\n",
      "    (b) * * *\n",
      "    (1) * * *\n",
      "    (i) circumstances that may trigger notice of potential non-\n",
      "conformity. at any time during its review of certified health it or a \n",
      "health it developer's actions or practices under paragraph (a) of this \n",
      "section, onc may send a notice of potential non-conformity if it has a \n",
      "reasonable belief that certified health it or a health it developer may \n",
      "not conform to the requirements of the onc health it certification \n",
      "program.\n",
      "* * * * *\n",
      "    (iii) * * *\n",
      "    (d) issue a notice of proposed termination if the health it is \n",
      "under review in accordance with paragraphs (a)(2)(i) or (ii) of this \n",
      "section.\n",
      "    (2) * * *\n",
      "    (i) circumstances that may trigger notice non-conformity. at any \n",
      "time during its review of certified health it or a health it \n",
      "developer's actions or practices under paragraph (a) of this section, \n",
      "onc may send a notice of non-conformity to the health it developer if \n",
      "it determines that certified health it or a health it developer's \n",
      "actions or practices does not conform to the requirements of the onc \n",
      "health it certification program.\n",
      "* * * * *\n",
      "    (3) * * *\n",
      "    (i) all records related to the development, testing, certification, \n",
      "implementation, maintenance and use of its certified health it;\n",
      "    (ii) any complaint records related to the certified health it;\n",
      "    (iii) all records related to the condition(s) and maintenance of \n",
      "certification requirements, including marketing and distribution \n",
      "records, communications, and contracts; and\n",
      "    (iv) any other relevant information.\n",
      "    (c) * * *\n",
      "    (1) applicability. if onc determines that certified health it or a \n",
      "health it developer's action or practice does not conform to \n",
      "requirements of the onc health it certification program, onc shall \n",
      "notify the health it developer of its determination and require the \n",
      "health\n",
      "\n",
      "[[page 7600]]\n",
      "\n",
      "it developer to submit a proposed corrective action plan.\n",
      "* * * * *\n",
      "    (e) * * *\n",
      "    (1) applicability. excluding situations of noncompliance with a \n",
      "condition or maintenance of certification requirement under subpart d \n",
      "of this part, onc may propose to terminate a certification issued to a \n",
      "health it module if:\n",
      "* * * * *\n",
      "    (f) * * *\n",
      "    (1) applicability. the national coordinator may terminate a \n",
      "certification if:\n",
      "    (i) a determination is made that termination is appropriate after \n",
      "considering the information provided by the health it developer in \n",
      "response to the proposed termination notice;\n",
      "    (ii) the health it developer does not respond in writing to a \n",
      "proposed termination notice within the timeframe specified in paragraph \n",
      "(e)(3) of this section; or\n",
      "    (iii) a determination is made that the health it developer is \n",
      "noncompliant with a condition or maintenance of certification \n",
      "requirement under subpart d of this part or for the following \n",
      "circumstances when onc exercises direct review under paragraph \n",
      "(a)(2)(iii) of this section:\n",
      "    (a) the health it developer fails to timely respond to any \n",
      "communication from onc, including, but not limited to:\n",
      "    (1) fact-finding;\n",
      "    (2) a notice of potential non-conformity within the timeframe \n",
      "established in accordance with paragraph (b)(1)(ii)(a)(3) of this \n",
      "section; or\n",
      "    (3) a notice of non-conformity within the timeframe established in \n",
      "accordance with paragraph (b)(2)(ii)(a)(3) of this section.\n",
      "    (b) the information or access provided by the health it developer \n",
      "in response to any onc communication, including, but not limited to: \n",
      "fact-finding, a notice of potential non-conformity, or a notice of non-\n",
      "conformity is insufficient or incomplete;\n",
      "    (c) the health it developer fails to cooperate with onc and/or a \n",
      "third party acting on behalf of onc;\n",
      "    (d) the health it developer fails to timely submit in writing a \n",
      "proposed corrective action plan;\n",
      "    (e) the health it developer fails to timely submit a corrective \n",
      "action plan that adequately addresses the elements required by onc as \n",
      "described in paragraph (c) of this section;\n",
      "    (f) the health it developer does not fulfill its obligations under \n",
      "the corrective action plan developed in accordance with paragraph (c) \n",
      "of this section; or\n",
      "    (g) onc concludes that the non-conformity(ies) cannot be cured.\n",
      "* * * * *\n",
      "    (g) * * *\n",
      "    (1) basis for appeal. a health it developer may appeal an onc \n",
      "determination to suspend or terminate a certification issued to a \n",
      "health it module and/or an onc determination to issue a certification \n",
      "ban under sec.  170.581(a)(2) if the health it developer asserts:\n",
      "    (i) onc incorrectly applied onc health it certification program \n",
      "requirements for a\n",
      "    (a) suspension;\n",
      "    (b) termination; or\n",
      "    (c) certification ban under sec.  170.581(a)(2); or\n",
      "* * * * *\n",
      "    (2) method and place for filing an appeal. a statement of intent to \n",
      "appeal followed by a request for appeal must be submitted to onc in \n",
      "writing by an authorized representative of the health it developer \n",
      "subject to the determination being appealed. the statement of intent to \n",
      "appeal and request for appeal must be filed in accordance with the \n",
      "requirements specified in the notice of:\n",
      "    (i) termination;\n",
      "    (ii) suspension; or\n",
      "    (iii) certification ban under sec.  170.581(a)(2).\n",
      "    (3) * * *\n",
      "    (i) a statement of intent to appeal must be filed within 10 days of \n",
      "a health it developer's receipt of the notice of:\n",
      "    (a) suspension;\n",
      "    (b) termination; or\n",
      "    (c) certification ban under sec.  170.581(a)(2).\n",
      "* * * * *\n",
      "    (4) effect of appeal. (i) a request for appeal stays the \n",
      "termination of a certification issued to a health it module, but the \n",
      "health it module is prohibited from being marketed, licensed, or sold \n",
      "as ``certified'' during the stay.\n",
      "    (ii) a request for appeal does not stay the suspension of a health \n",
      "it module.\n",
      "    (iii) a request for appeal stays a certification ban issued under \n",
      "sec.  170.581(a)(2).\n",
      "    (5) * * *\n",
      "    (i) the hearing officer may not review an appeal in which he or she \n",
      "participated in the initial suspension, termination, or certification \n",
      "ban determination or has a conflict of interest in the pending matter.\n",
      "* * * * *\n",
      "    (6) * * *\n",
      "    (v) onc will have an opportunity to provide the hearing officer \n",
      "with a written statement and supporting documentation on its behalf \n",
      "that clarifies, as necessary, its determination to suspend or terminate \n",
      "the certification or issue a certification ban.\n",
      "* * * * *\n",
      "0\n",
      "34. revise sec.  170.581 to read as follows:\n",
      "\n",
      "\n",
      "sec.  170.581  certification ban.\n",
      "\n",
      "    (a) circumstances trigger a certification ban. the certification of \n",
      "any of a health it developer's health it is prohibited when:\n",
      "    (1) the certification of one or more of the health it developer's \n",
      "complete ehrs or health it modules is:\n",
      "    (i) terminated by onc under the onc health it certification \n",
      "program;\n",
      "    (ii) withdrawn from the onc health it certification program by an \n",
      "onc-acb because the health it developer requested it to be withdrawn \n",
      "when the health it developer's health it was the subject of a potential \n",
      "non-conformity or non-conformity as determined by onc;\n",
      "    (iii) withdrawn by an onc-acb because of a non-conformity with any \n",
      "of the certification criteria adopted by the secretary under subpart c \n",
      "of this part;\n",
      "    (iv) withdrawn by an onc-acb because the health it developer \n",
      "requested it to be withdrawn when the health it developer's health it \n",
      "was the subject of surveillance for a certification criterion or \n",
      "criteria adopted by the secretary under subpart c of this part, \n",
      "including notice of pending surveillance; or\n",
      "    (2) onc determines a certification ban is appropriate per its \n",
      "review under sec.  170.580(a)(2)(iii).\n",
      "    (b) notice of certification ban. when onc decides to issue a \n",
      "certification ban to a health it developer, onc will notify the health \n",
      "it developer of the certification ban through a notice of certification \n",
      "ban. the notice of certification ban will include, but may not be \n",
      "limited to:\n",
      "    (1) an explanation of the certification ban;\n",
      "    (2) information supporting the certification ban;\n",
      "    (3) instructions for appealing the certification ban if banned in \n",
      "accordance with paragraph (a)(2) of this section; and\n",
      "    (4) instructions for requesting reinstatement into the onc health \n",
      "it certification program, which would lift the certification ban.\n",
      "    (c) effective date of certification ban. (1) a certification ban \n",
      "will be effective immediately if banned under paragraphs (a)(1) of this \n",
      "section.\n",
      "    (2) for certification bans issued under paragraph (a)(2) of this \n",
      "section, the ban\n",
      "\n",
      "[[page 7601]]\n",
      "\n",
      "will be effective immediately after the following applicable \n",
      "occurrence:\n",
      "    (i) the expiration of the 10-day period for filing a statement of \n",
      "intent to appeal in sec.  170.580(g)(3)(i) if the health it developer \n",
      "does not file a statement of intent to appeal.\n",
      "    (ii) the expiration of the 30-day period for filing an appeal in \n",
      "sec.  170.580(g)(3)(ii) if the health it developer files a statement of \n",
      "intent to appeal, but does not file a timely appeal.\n",
      "    (iii) a final determination to issue a certification ban per sec.  \n",
      "170.580(g)(7) if a health it developer files an appeal timely.\n",
      "    (d) reinstatement. the certification of a health it developer's \n",
      "health it subject to the prohibition in paragraph (a) of this section \n",
      "may commence once the following conditions are met.\n",
      "    (1) a health it developer must request onc's permission in writing \n",
      "to participate in the onc health it certification program.\n",
      "    (2) the request must demonstrate that the customers affected by the \n",
      "certificate termination, certificate withdrawal, or non-compliance with \n",
      "a condition or maintenance of certification have been provided \n",
      "appropriate remediation.\n",
      "    (3) for non-compliance with a condition or maintenance of \n",
      "certification requirement, the non-compliance must be resolved.\n",
      "    (4) onc is satisfied with the health it developer's demonstration \n",
      "under paragraph (d)(2) of this section that all affected customers have \n",
      "been provided with appropriate remediation and grants reinstatement \n",
      "into the onc health it certification program.\n",
      "0\n",
      "35. add part 171 to read as follows:\n",
      "\n",
      "part 171--information blocking\n",
      "\n",
      "subpart a--general provisions\n",
      "sec.\n",
      "171.100 basis and purpose.\n",
      "171.101 applicability.\n",
      "171.102 definitions.\n",
      "171.103 information blocking.\n",
      "subpart b--exceptions for reasonable and necessary activities that do \n",
      "not constitute information blocking\n",
      "171.200 availability and effect of exceptions.\n",
      "171.201 exception--preventing harm.\n",
      "171.202 exception--promoting the privacy of electronic health \n",
      "information.\n",
      "171.203 exception--promoting the security of electronic health \n",
      "information.\n",
      "171.204 exception--recovering costs reasonably incurred.\n",
      "171.205 exception--responding to requests that are infeasible.\n",
      "171.206 exception--licensing of interoperability elements on \n",
      "reasonable and non-discriminatory terms.\n",
      "sec.  171.207 exception--maintaining and improving health it \n",
      "performance.\n",
      "\n",
      "    authority:  42 u.s.c. 300jj-52; 5 u.s.c. 552.\n",
      "\n",
      "subpart a--general provisions\n",
      "\n",
      "\n",
      "sec.  171.100  statutory basis and purpose.\n",
      "\n",
      "    (a) basis. this part implements section 3022 of the public health \n",
      "service act, 42 u.s.c. 300jj-52.\n",
      "    (b) purpose. the purpose of this part is to establish exceptions \n",
      "for reasonable and necessary activities that do not constitute \n",
      "``information blocking,'' as defined by section 3022(a)(1) of the \n",
      "public health service act, 42 u.s.c. 300jj-52.\n",
      "\n",
      "\n",
      "sec.  171.101  applicability.\n",
      "\n",
      "    this part applies to health care providers, health it developers of \n",
      "certified health it, health information exchanges, and health \n",
      "information networks, as those terms are defined in sec.  171.102.\n",
      "\n",
      "\n",
      "sec.  171.102   definitions.\n",
      "\n",
      "    for purposes of this part:\n",
      "    access means the ability or means necessary to make electronic \n",
      "health information available for use, including the ability to securely \n",
      "and efficiently locate and retrieve information from any and all source \n",
      "systems in which the information may be recorded or maintained.\n",
      "    actor means a health care provider, health it developer of \n",
      "certified health it, health information exchange, or health information \n",
      "network.\n",
      "    api data provider is defined as it is in sec.  170.102.\n",
      "    api technology supplier is defined as it is in sec.  170.102.\n",
      "    electronic health information (ehi) means--\n",
      "    (1) electronic protected health information; and\n",
      "    (2) any other information that identifies the individual, or with \n",
      "respect to which there is a reasonable basis to believe the information \n",
      "can be used to identify the individual and is transmitted by or \n",
      "maintained in electronic media, as defined in 45 cfr 160.103, that \n",
      "relates to the past, present, or future health or condition of an \n",
      "individual; the provision of health care to an individual; or the past, \n",
      "present, or future payment for the provision of health care to an \n",
      "individual.\n",
      "    electronic media is defined as it is in 45 cfr 160.103.\n",
      "    electronic protected health information (ephi) is defined as it is \n",
      "in 45 cfr 160.103.\n",
      "    exchange means the ability for electronic health information to be \n",
      "transmitted securely and efficiently between and among different \n",
      "technologies, systems, platforms, or networks in a manner that allows \n",
      "the information to be accessed and used.\n",
      "    fee means any present or future obligation to pay money or provide \n",
      "any other thing of value.\n",
      "    health care provider has the same meaning as ``health care \n",
      "provider'' at 42 u.s.c. 300jj.\n",
      "    health information exchange or hie means an individual or entity \n",
      "that enables access, exchange, or use of electronic health information \n",
      "primarily between or among a particular class of individuals or \n",
      "entities or for a limited set of purposes.\n",
      "    health information network or hin means an individual or entity \n",
      "that satisfies one or both of the following--\n",
      "    (1) determines, oversees, administers, controls, or substantially \n",
      "influences policies or agreements that define business, operational, \n",
      "technical, or other conditions or requirements for enabling or \n",
      "facilitating access, exchange, or use of electronic health information \n",
      "between or among two or more unaffiliated individuals or entities.\n",
      "    (2) provides, manages, controls, or substantially influences any \n",
      "technology or service that enables or facilitates the access, exchange, \n",
      "or use of electronic health information between or among two or more \n",
      "unaffiliated individuals or entities.\n",
      "    health it developer of certified health it means an individual or \n",
      "entity that develops or offers health information technology (as that \n",
      "term is defined in 42 u.s.c. 300jj(5)) and which had, at the time it \n",
      "engaged in a practice that is the subject of an information blocking \n",
      "claim, health information technology (one or more) certified under the \n",
      "onc health it certification program.\n",
      "    information blocking is defined as it is in sec.  171.103 and 42 \n",
      "u.s.c. 300jj-52(a).\n",
      "    interfere with means to prevent, materially discourage, or \n",
      "otherwise inhibit access, exchange, or use of electronic health \n",
      "information.\n",
      "    interoperability element means--\n",
      "    (1) any functional element of a health information technology, \n",
      "whether hardware or software, that could be used to access, exchange, \n",
      "or use electronic health information for any purpose, including \n",
      "information transmitted by or maintained in disparate media, \n",
      "information systems, health information exchanges, or health \n",
      "information networks.\n",
      "    (2) any technical information that describes the functional \n",
      "elements of technology (such as a standard, specification, protocol, \n",
      "data model, or schema) and that a person of ordinary skill in the art \n",
      "may require to use the functional elements of the technology,\n",
      "\n",
      "[[page 7602]]\n",
      "\n",
      "including for the purpose of developing compatible technologies that \n",
      "incorporate or use the functional elements.\n",
      "    (3) any technology or service that may be required to enable the \n",
      "use of a compatible technology in production environments, including \n",
      "but not limited to any system resource, technical infrastructure, or \n",
      "health information exchange or health information network element.\n",
      "    (4) any license, right, or privilege that may be required to \n",
      "commercially offer and distribute compatible technologies and make them \n",
      "available for use in production environments.\n",
      "    (5) any other means by which electronic health information may be \n",
      "accessed, exchanged, or used.\n",
      "    permissible purpose means a purpose for which a person is \n",
      "authorized, permitted, or required to access, exchange, or use \n",
      "electronic health information under applicable law.\n",
      "    person is defined as it is in 45 cfr 160.103.\n",
      "    protected health information is defined as it is in 45 cfr 160.103.\n",
      "    practice means one or more related acts or omissions by an actor.\n",
      "    use means the ability of health it or a user of health it to access \n",
      "relevant electronic health information; to comprehend the structure, \n",
      "content, and meaning of the information; and to read, write, modify, \n",
      "manipulate, or apply the information to accomplish a desired outcome or \n",
      "to achieve a desired purpose.\n",
      "\n",
      "\n",
      "sec.  171.103  information blocking.\n",
      "\n",
      "    information blocking means a practice that--\n",
      "    (a) except as required by law or covered by an exception set forth \n",
      "in subpart b of this part, is likely to interfere with, prevent, or \n",
      "materially discourage access, exchange, or use of electronic health \n",
      "information; and\n",
      "    (b) if conducted by a health information technology developer, \n",
      "health information exchange, or health information network, such \n",
      "developer, exchange, or network knows, or should know, that such \n",
      "practice is likely to interfere with, prevent, or materially discourage \n",
      "the access, exchange, or use of electronic health information; or\n",
      "    (c) if conducted by a health care provider, such provider knows \n",
      "that such practice is unreasonable and is likely to interfere with, \n",
      "prevent, or materially discourage access, exchange, or use of \n",
      "electronic health information.\n",
      "\n",
      "subpart b--exceptions for reasonable and necessary activities that \n",
      "do not constitute information blocking\n",
      "\n",
      "\n",
      "sec.  171.200  availability and effect of exceptions.\n",
      "\n",
      "    a practice shall not be treated as information blocking if the \n",
      "actor satisfies an exception to the information blocking provision by \n",
      "meeting all applicable requirements and conditions of the exception at \n",
      "all relevant times.\n",
      "\n",
      "\n",
      "sec.  171.201  exception--preventing harm.\n",
      "\n",
      "    to qualify for this exception, each practice by an actor must meet \n",
      "the following conditions at all relevant times.\n",
      "    (a) the actor must have a reasonable belief that the practice will \n",
      "directly and substantially reduce the likelihood of harm to a patient \n",
      "or another person arising from--\n",
      "    (1) corrupt or inaccurate data being recorded or incorporated in a \n",
      "patient's electronic health record;\n",
      "    (2) misidentification of a patient or patient's electronic health \n",
      "information; or\n",
      "    (3) disclosure of a patient's electronic health information in \n",
      "circumstances where a licensed health care professional has determined, \n",
      "in the exercise of professional judgment, that the disclosure is \n",
      "reasonably likely to endanger the life or physical safety of the \n",
      "patient or another person, provided that, if required by applicable \n",
      "federal or state law, the patient has been afforded any right of review \n",
      "of that determination.\n",
      "    (b) if the practice implements an organizational policy, the policy \n",
      "must be--\n",
      "    (1) in writing;\n",
      "    (2) based on relevant clinical, technical, and other appropriate \n",
      "expertise;\n",
      "    (3) implemented in a consistent and non-discriminatory manner; and\n",
      "    (4) no broader than necessary to mitigate the risk of harm.\n",
      "    (c) if the practice does not implement an organizational policy, an \n",
      "actor must make a finding in each case, based on the particularized \n",
      "facts and circumstances, and based on, as applicable, relevant \n",
      "clinical, technical, and other appropriate expertise, that the practice \n",
      "is necessary and no broader than necessary to mitigate the risk of \n",
      "harm.\n",
      "\n",
      "\n",
      "sec.  171.202  exception--promoting the privacy of electronic health \n",
      "information.\n",
      "\n",
      "    to qualify for this exception, each practice by an actor must \n",
      "satisfy at least one of the sub-exceptions in paragraphs (b) through \n",
      "(e) of this section at all relevant times.\n",
      "    (a) meaning of ``individual'' in this section. the term \n",
      "``individual'' as used in this section means one or more of the \n",
      "following--\n",
      "    (1) an individual as defined by 45 cfr 160.103.\n",
      "    (2) any other natural person who is the subject of the electronic \n",
      "health information being accessed, exchanged, or used.\n",
      "    (3) a person who legally acts on behalf of a person described in \n",
      "paragraph (a)(1) or (2) of this section, including as a personal \n",
      "representative, in accordance with 45 cfr 164.502(g).\n",
      "    (4) a person who is a legal representative of and can make health \n",
      "care decisions on behalf of any person described in paragraph (a)(1) or \n",
      "(2) of this section.\n",
      "    (5) an executor, administrator or other person having authority to \n",
      "act on behalf of a deceased person described in paragraph (a)(1) or (2) \n",
      "of this section or the individual's estate under state or other law.\n",
      "    (b) precondition not satisfied. if the actor is required by a state \n",
      "or federal privacy law to satisfy a condition prior to providing \n",
      "access, exchange, or use of electronic health information, the actor \n",
      "may choose not to provide access, exchange, or use of such electronic \n",
      "health information if the precondition has not been satisfied, provided \n",
      "that--\n",
      "    (1) the actor's practice--\n",
      "    (i) conforms to the actor's organizational policies and procedures \n",
      "that:\n",
      "    (a) are in writing;\n",
      "    (b) specify the criteria to be used by the actor and, as \n",
      "applicable, the steps that the actor will take, in order that the \n",
      "precondition can be satisfied; and\n",
      "    (c) have been implemented, including by taking reasonable steps to \n",
      "ensure that its workforce members and its agents understand and \n",
      "consistently apply the policies and procedures; or\n",
      "    (ii) has been documented by the actor, on a case-by-case basis, \n",
      "identifying the criteria used by the actor to determine when the \n",
      "precondition would be satisfied, any criteria that were not met, and \n",
      "the reason why the criteria were not met; and\n",
      "    (2) if the precondition relies on the provision of consent or \n",
      "authorization from an individual, the actor:\n",
      "    (i) did all things reasonably necessary within its control to \n",
      "provide the individual with a meaningful opportunity to provide the \n",
      "consent or authorization; and\n",
      "    (ii) did not improperly encourage or induce the individual to not \n",
      "provide the consent or authorization.\n",
      "    (3) the actor's practice is--\n",
      "    (i) tailored to the specific privacy risk or interest being \n",
      "addressed; and\n",
      "\n",
      "[[page 7603]]\n",
      "\n",
      "    (ii) implemented in a consistent and non-discriminatory manner.\n",
      "    (c) health it developer of certified health it not covered by \n",
      "hipaa. if the actor is a health it developer of certified health it \n",
      "that is not required to comply with the hipaa privacy rule when \n",
      "engaging in a practice that promotes the privacy interests of an \n",
      "individual, the actor may choose not to provide access, exchange, or \n",
      "use of electronic health information provided that the actor's \n",
      "practice--\n",
      "    (1) complies with applicable state or federal privacy laws;\n",
      "    (2) implements a process that is described in the actor's \n",
      "organizational privacy policy;\n",
      "    (3) had previously been meaningfully disclosed to the persons and \n",
      "entities that use the actor's product or service;\n",
      "    (4) is tailored to the specific privacy risk or interest being \n",
      "addressed; and\n",
      "    (5) is implemented in a consistent and non-discriminatory manner.\n",
      "    (d) denial of an individual's request for their electronic \n",
      "protected health information in the circumstances provided in 45 cfr \n",
      "164.524(a)(1), (2), and (3). if an individual requests their electronic \n",
      "protected health information under 45 cfr 164.502(a)(1)(i) or 45 cfr \n",
      "164.524, the actor may deny the request in the circumstances provided \n",
      "in 45 cfr 164.524(a)(1), (2), or (3).\n",
      "    (e) respecting an individual's request not to share information. in \n",
      "circumstances where not required or prohibited by law, an actor may \n",
      "choose not to provide access, exchange, or use of an individual's \n",
      "electronic health information if--\n",
      "    (1) the individual requests that the actor not provide such access, \n",
      "exchange, or use;\n",
      "    (2) such request is initiated by the individual without any \n",
      "improper encouragement or inducement by the actor;\n",
      "    (3) the actor or its agent documents the request within a \n",
      "reasonable time period; and\n",
      "    (4) the actor's practice is implemented in a consistent and non-\n",
      "discriminatory manner.\n",
      "\n",
      "\n",
      "sec.  171.203  exception--promoting the security of electronic health \n",
      "information.\n",
      "\n",
      "    to qualify for this exception, each practice by an actor must meet \n",
      "the following conditions at all relevant times.\n",
      "    (a) the practice must be directly related to safeguarding the \n",
      "confidentiality, integrity, and availability of electronic health \n",
      "information.\n",
      "    (b) the practice must be tailored to the specific security risk \n",
      "being addressed.\n",
      "    (c) the practice must be implemented in a consistent and non-\n",
      "discriminatory manner.\n",
      "    (d) if the practice implements an organizational security policy, \n",
      "the policy must--\n",
      "    (1) be in writing;\n",
      "    (2) have been prepared on the basis of, and directly respond to, \n",
      "security risks identified and assessed by or on behalf of the actor;\n",
      "    (3) align with one or more applicable consensus-based standards or \n",
      "best practice guidance; and\n",
      "    (4) provide objective timeframes and other parameters for \n",
      "identifying, responding to, and addressing security incidents.\n",
      "    (e) if the practice does not implement an organizational security \n",
      "policy, the actor must have made a determination in each case, based on \n",
      "the particularized facts and circumstances, that:\n",
      "    (1) the practice is necessary to mitigate the security risk to the \n",
      "electronic health information; and\n",
      "    (2) there are no reasonable and appropriate alternatives to the \n",
      "practice that address the security risk that are less likely to \n",
      "interfere with, prevent, or materially discourage access, exchange or \n",
      "use of electronic health information.\n",
      "\n",
      "\n",
      "sec.  171.204  exception--recovering costs reasonably incurred.\n",
      "\n",
      "    to qualify for this exception, each practice by an actor must meet \n",
      "the following conditions at all relevant times.\n",
      "    (a) types of costs to which this exception applies. this exception \n",
      "is limited to the actor's costs reasonably incurred to provide access, \n",
      "exchange, or use of electronic health information.\n",
      "    (b) method for recovering costs. the method by which the actor \n",
      "recovers its costs--\n",
      "    (1) must be based on objective and verifiable criteria that are \n",
      "uniformly applied for all substantially similar or similarly situated \n",
      "classes of persons and requests;\n",
      "    (2) must be reasonably related to the actor's costs of providing \n",
      "the type of access, exchange, or use to, or at the request of, the \n",
      "person or entity to whom the fee is charged;\n",
      "    (3) must be reasonably allocated among all customers to whom the \n",
      "technology or service is supplied, or for whom the technology is \n",
      "supported;\n",
      "    (4) must not be based in any part on whether the requestor or other \n",
      "person is a competitor, potential competitor, or will be using the \n",
      "electronic health information in a way that facilitates competition \n",
      "with the actor; and\n",
      "    (5) must not be based on the sales, profit, revenue, or other value \n",
      "that the requestor or other persons derive or may derive from the \n",
      "access to, exchange of, or use of electronic health information, \n",
      "including the secondary use of such information, that exceeds the \n",
      "actor's reasonable costs for providing access, exchange, or use of \n",
      "electronic health information.\n",
      "    (c) costs specifically excluded. this exception does not apply to--\n",
      "    (1) costs that the actor incurred due to the health it being \n",
      "designed or implemented in non-standard ways that unnecessarily \n",
      "increase the complexity, difficulty or burden of accessing, exchanging, \n",
      "or using electronic health information;\n",
      "    (2) costs associated with intangible assets (including depreciation \n",
      "or loss of value), other than the actual development or acquisition \n",
      "costs of such assets;\n",
      "    (3) opportunity costs, except for the reasonable forward-looking \n",
      "cost of capital;\n",
      "    (4) a fee prohibited by 45 cfr 164.524(c)(4);\n",
      "    (5) a fee based in any part on the electronic access by an \n",
      "individual or their personal representative, agent, or designee to the \n",
      "individual's electronic health information;\n",
      "    (6) a fee to perform an export of electronic health information via \n",
      "the capability of health it certified to sec.  170.315(b)(10) of this \n",
      "subchapter for the purposes of switching health it or to provide \n",
      "patients their electronic health information; or\n",
      "    (7) a fee to export or convert data from an ehr technology, unless \n",
      "such fee was agreed to in writing at the time the technology was \n",
      "acquired.\n",
      "    (d) compliance with the conditions of certification. (1) \n",
      "notwithstanding any other provision of this exception, if the actor is \n",
      "a health it developer subject to the conditions of certification in \n",
      "sec.  170.402(a)(4) or sec.  170.404 of this subchapter, the actor must \n",
      "comply with all requirements of such conditions for all practices and \n",
      "at all relevant times.\n",
      "    (2) if the actor is an api data provider, the actor is only \n",
      "permitted to charge the same fees that an api technology supplier is \n",
      "permitted to charge to recover costs consistent with the permitted fees \n",
      "specified in the condition of certification in sec.  170.404 of this \n",
      "subchapter.\n",
      "\n",
      "\n",
      "sec.  171.205  exception--responding to requests that are infeasible.\n",
      "\n",
      "    to qualify for this exception, each practice by an actor must meet \n",
      "the following conditions at all relevant times.\n",
      "    (a) request is infeasible. (1) the actor must demonstrate, in \n",
      "accordance with\n",
      "\n",
      "[[page 7604]]\n",
      "\n",
      "paragraph (a)(2) of this section, that complying with the request in \n",
      "the manner requested would impose a substantial burden on the actor \n",
      "that is unreasonable under the circumstances, taking into \n",
      "consideration--\n",
      "    (i) the type of electronic health information and the purposes for \n",
      "which it may be needed;\n",
      "    (ii) the cost to the actor of complying with the request in the \n",
      "manner requested;\n",
      "    (iii) the financial, technical, and other resources available to \n",
      "the actor;\n",
      "    (iv) whether the actor provides comparable access, exchange, or use \n",
      "to itself or to its customers, suppliers, partners, and other persons \n",
      "with whom it has a business relationship;\n",
      "    (v) whether the actor owns or has control over a predominant \n",
      "technology, platform, health information exchange, or health \n",
      "information network through which electronic health information is \n",
      "accessed or exchanged;\n",
      "    (vi) whether the actor maintains electronic protected health \n",
      "information on behalf of a covered entity, as defined in 45 cfr \n",
      "160.103, or maintains electronic health information on behalf of the \n",
      "requestor or another person whose access, exchange, or use of \n",
      "electronic health information will be enabled or facilitated by the \n",
      "actor's compliance with the request;\n",
      "    (vii) whether the requestor and other relevant persons can \n",
      "reasonably access, exchange, or use the electronic health information \n",
      "from other sources or through other means; and\n",
      "    (viii) the additional cost and burden to the requestor and other \n",
      "relevant persons of relying on alternative means of access, exchange, \n",
      "or use.\n",
      "    (2) the following circumstances do not constitute a burden to the \n",
      "actor for purposes of this exception and shall not be considered in \n",
      "determining whether the actor has demonstrated that complying with a \n",
      "request would have been infeasible.\n",
      "    (i) providing the requested access, exchange, or use in the manner \n",
      "requested would have facilitated competition with the actor.\n",
      "    (ii) providing the requested access, exchange, or use in the manner \n",
      "requested would have prevented the actor from charging a fee.\n",
      "    (b) responding to requests. the actor must timely respond to all \n",
      "requests relating to access, exchange, or use of electronic health \n",
      "information, including but not limited to requests to establish \n",
      "connections and to provide interoperability elements.\n",
      "    (c) written explanation. the actor must provide the requestor with \n",
      "a detailed written explanation of the reasons why the actor cannot \n",
      "accommodate the request.\n",
      "    (d) provision of a reasonable alternative. the actor must work with \n",
      "the requestor in a timely manner to identify and provide a reasonable \n",
      "alternative means of accessing, exchanging, or using the electronic \n",
      "health information.\n",
      "\n",
      "\n",
      "sec.  171.206  exception--licensing of interoperability elements on \n",
      "reasonable and non-discriminatory terms.\n",
      "\n",
      "    to qualify for this exception, each practice by an actor must meet \n",
      "the following conditions at all relevant times.\n",
      "    (a) responding to requests. upon receiving a request to license or \n",
      "use interoperability elements, the actor must respond to the requestor \n",
      "within 10 business days from receipt of the request by:\n",
      "    (1) negotiating with the requestor in a reasonable and non-\n",
      "discriminatory fashion to identify the interoperability elements that \n",
      "are needed; and\n",
      "    (2) offering an appropriate license with reasonable and non-\n",
      "discriminatory terms.\n",
      "    (b) reasonable and non-discriminatory terms. the actor must license \n",
      "the interoperability elements described in paragraph (a) of this \n",
      "section on terms that are reasonable and non-discriminatory.\n",
      "    (1) scope of rights. the license must provide all rights necessary \n",
      "to access and use the interoperability elements for the following \n",
      "purposes, as applicable.\n",
      "    (i) developing products or services that are interoperable with the \n",
      "actor's health it, health it under the actor's control, or any third \n",
      "party who currently uses the actor's interoperability elements to \n",
      "interoperate with the actor's health it or health it under the actor's \n",
      "control.\n",
      "    (ii) marketing, offering, and distributing the interoperable \n",
      "products and/or services to potential customers and users.\n",
      "    (iii) enabling the use of the interoperable products or services in \n",
      "production environments, including accessing and enabling the exchange \n",
      "and use of electronic health information.\n",
      "    (2) reasonable royalty. if the actor charges a royalty for the use \n",
      "of the interoperability elements described in paragraph (a) of this \n",
      "section, the royalty must be reasonable and comply with the following \n",
      "requirements.\n",
      "    (i) the royalty must be non-discriminatory, consistent with \n",
      "paragraph (b)(3) of this section.\n",
      "    (ii) the royalty must be based solely on the independent value of \n",
      "the actor's technology to the licensee's products, not on any strategic \n",
      "value stemming from the actor's control over essential means of \n",
      "accessing, exchanging, or using electronic health information.\n",
      "    (iii) if the actor has licensed the interoperability element \n",
      "through a standards development organization in accordance with such \n",
      "organization's policies regarding the licensing of standards-essential \n",
      "technologies on reasonable and non-discriminatory terms, the actor may \n",
      "charge a royalty that is consistent with such policies.\n",
      "    (3) non-discriminatory terms. the terms (including royalty terms) \n",
      "on which the actor licenses and otherwise provides the interoperability \n",
      "elements must be non-discriminatory and comply with the following \n",
      "requirements.\n",
      "    (i) the terms must be based on objective and verifiable criteria \n",
      "that are uniformly applied for all substantially similar or similarly \n",
      "situated classes of persons and requests.\n",
      "    (ii) the terms must not be based in any part on--\n",
      "    (a) whether the requestor or other person is a competitor, \n",
      "potential competitor, or will be using electronic health information \n",
      "obtained via the interoperability elements in a way that facilitates \n",
      "competition with the actor; or\n",
      "    (b) the revenue or other value the requestor may derive from \n",
      "access, exchange, or use of electronic health information obtained via \n",
      "the interoperability elements, including the secondary use of such \n",
      "electronic health information.\n",
      "    (4) collateral terms. the actor must not require the licensee or \n",
      "its agents or contractors to do, or to agree to do, any of the \n",
      "following.\n",
      "    (i) not compete with the actor in any product, service, or market.\n",
      "    (ii) deal exclusively with the actor in any product, service, or \n",
      "market.\n",
      "    (iii) obtain additional licenses, products, or services that are \n",
      "not related to or can be unbundled from the requested interoperability \n",
      "elements.\n",
      "    (iv) license, grant, assign, or transfer to the actor any \n",
      "intellectual property of the licensee.\n",
      "    (v) pay a fee of any kind whatsoever, except as described in \n",
      "paragraph (b)(2) of this section, unless the practice meets the \n",
      "requirements of the exception in sec.  171.204.\n",
      "    (5) non-disclosure agreement. the actor may require a reasonable \n",
      "non-disclosure agreement that is no broader than necessary to prevent \n",
      "unauthorized disclosure of the actor's trade secrets, provided--\n",
      "    (i) the agreement states with particularity all information the \n",
      "actor claims as trade secrets; and\n",
      "\n",
      "[[page 7605]]\n",
      "\n",
      "    (ii) such information meets the definition of a trade secret under \n",
      "applicable law.\n",
      "    (c) additional requirements relating to the provision of \n",
      "interoperability elements. the actor must not engage in any practice \n",
      "that has any of the following purposes or effects.\n",
      "    (1) impeding the efficient use of the interoperability elements to \n",
      "access, exchange, or use electronic health information for any \n",
      "permissible purpose.\n",
      "    (2) impeding the efficient development, distribution, deployment, \n",
      "or use of an interoperable product or service for which there is actual \n",
      "or potential demand.\n",
      "    (3) degrading the performance or interoperability of the licensee's \n",
      "products or services, unless necessary to improve the actor's \n",
      "technology and after affording the licensee a reasonable opportunity to \n",
      "update its technology to maintain interoperability.\n",
      "    (d) compliance with conditions of certification. notwithstanding \n",
      "any other provision of this exception, if the actor is a health it \n",
      "developer subject to the conditions of certification in sec. sec.  \n",
      "170.402, 170.403, or 170.404 of this subchapter, the actor must comply \n",
      "with all requirements of such conditions for all practices and at all \n",
      "relevant times.\n",
      "\n",
      "\n",
      "sec.  171.207  exception--maintaining and improving health it \n",
      "performance.\n",
      "\n",
      "    to qualify for this exception, each practice by an actor must meet \n",
      "the following conditions at all relevant times.\n",
      "    (a) maintenance and improvements to health it. an actor may make \n",
      "health it under its control temporarily unavailable in order to perform \n",
      "maintenance or improvements to the health it, provided that the actor's \n",
      "practice is--\n",
      "    (1) for a period of time no longer than necessary to achieve the \n",
      "maintenance or improvements for which the health it was made \n",
      "unavailable;\n",
      "    (2) implemented in a consistent and non-discriminatory manner; and\n",
      "    (3) if the unavailability is initiated by a health it developer of \n",
      "certified health it, hie, or hin, agreed to by the individual or entity \n",
      "to whom the health it developer of certified health it, hie, or hin \n",
      "supplied the health it.\n",
      "    (b) practices that prevent harm. if the unavailability of health it \n",
      "for maintenance or improvements is initiated by an actor in response to \n",
      "a risk of harm to a patient or another person, the actor does not need \n",
      "to satisfy the requirements of this section, but must comply with all \n",
      "requirements of sec.  171.201 at all relevant times to qualify for an \n",
      "exception.\n",
      "    (c) security-related practices. if the unavailability of health it \n",
      "for maintenance or improvements is initiated by an actor in response to \n",
      "a security risk to electronic health information, the actor does not \n",
      "need to satisfy the requirements of this section, but must comply with \n",
      "all requirements of sec.  171.203 at all relevant times to qualify for \n",
      "an exception.\n",
      "\n",
      "    dated: january 22, 2019.\n",
      "alex m. azar ii,\n",
      "secretary, department of health and human services.\n",
      "\n",
      "    note: the following appendix will not appear in the code of \n",
      "federal regulations.\n",
      "\n",
      "appendix: pediatric technical worksheets\n",
      "\n",
      "    these worksheets contain information on how each recommendation \n",
      "corresponds to the children's ehr format and to the existing or \n",
      "proposed new onc certification criteria. we invite readers to use \n",
      "these worksheets to inform public comment on the recommendations, \n",
      "the inclusion of specific items from the children's ehr format,\\193\\ \n",
      "and the identified certification criteria as they relate \n",
      "specifically to use cases for pediatric care and sites of service.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\193\\ <a href=\"https://healthit.ahrq.gov/health-it-tools-and-resources/pediatric-resources/childrens-electronic-health-record-ehr-format\">https://healthit.ahrq.gov/health-it-tools-and-resources/pediatric-resources/childrens-electronic-health-record-ehr-format</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we welcome public comment on the identified certification \n",
      "criteria for each recommendation. specifically, we seek comment for \n",
      "each recommendation on the following four broad questions:\n",
      "    <bullet> q1. what relevant gaps, barriers, safety concerns, and/\n",
      "or resources (including available best practices, activities, and \n",
      "tools) may impact or support feasibility of the recommendation in \n",
      "practice?\n",
      "    <bullet> q2. how can the effective use of it support each \n",
      "recommendation as involves provider training, establishing workflow, \n",
      "and other related safety and usability considerations?\n",
      "    <bullet> q3. should any of the recommendations not be included?\n",
      "    <bullet> q4. should any of the functional criteria listed under \n",
      "the ``alignment with 2015 edition certification criteria'' and the \n",
      "``alignment with proposed new or updated certification criteria'' be \n",
      "removed as a correlated item to support any of the recommendations?\n",
      "    commenters are encouraged to reference the specific \n",
      "recommendation number (110) with the corresponding question number \n",
      "in their response. for example, ``recommendation 1. q3.'' commenters \n",
      "are highly encouraged to use the template onc has created to support \n",
      "public comment on the proposed rule.\n",
      "\n",
      "recommendation 1: use biometric-specific norms for growth curves and \n",
      "support growth charts for children\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirement as follows:\n",
      "    title: use biometric-specific norms for growth curves.\n",
      "    children's ehr format: req-2044--release package 2015 priority \n",
      "list.\n",
      "    topic(s): primary care management, well child/preventive care.\n",
      "    description: the system shall include the ability to use \n",
      "pediatric age-specific norms for weight, height/length, head \n",
      "circumference, and bmi to calculate and display growth percentiles \n",
      "and plot them over time on standardized centers for disease control \n",
      "and prevention/world health organizations (cdc/who) growth curves as \n",
      "appropriate.\n",
      "\n",
      "alignment with 2015 edition certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition definition and criteria listed below:\n",
      "    common clinical data set* (ccds) including optional pediatric \n",
      "vital sign data elements with the reference range/scale or growth \n",
      "curve for bmi percentile per age and sex for youth 2-20 years of \n",
      "age, weight for age per length and sex for children less than three \n",
      "years of age, and head occipital-frontal circumference for children \n",
      "less than three years of age.\n",
      "    demographic criterion requires the ability to record birth sex \n",
      "in accordance with hl7 version 3 (``administrative gender'') and a \n",
      "null flavor value attributed as follows: male (m); female (f); and \n",
      "unknown (unk).\n",
      "    clinical decision support (cds) can be used to develop a variety \n",
      "of tools to enhance decision-making in the pediatric clinical \n",
      "workflow including contextually relevant reference information, \n",
      "clinical guidelines, condition-specific order sets, alerts, and \n",
      "reminders, among other tools.\n",
      "    application programming interfaces criteria including the \n",
      "``application access--patient selection'', ``application access--\n",
      "data category request'', and ``application access--all data \n",
      "request'' which can help address many of the challenges currently \n",
      "faced by caregivers accessing pediatric health data.\n",
      "\n",
      "alignment with proposed new or updated certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the proposed \n",
      "new and updated certification criteria in this proposed rule:\n",
      "    united states core data for interoperability (uscdi): the uscdi \n",
      "(sec.  170.213) which enables the inclusion of pediatric vital sign \n",
      "data elements, including the reference range/scale or growth curve \n",
      "for bmi percentile per age and sex, weight for age per length and \n",
      "sex, and head occipital-frontal circumference.\n",
      "    application programming interfaces (apis): sec.  170.315(g)(10), \n",
      "would require the use of health level 7 (hl7[supreg]) fast \n",
      "healthcare interoperability resources (fhir[supreg]) standards and \n",
      "several implementation specifications to establish standardized \n",
      "application programming interfaces (apis) for\n",
      "\n",
      "[[page 7606]]\n",
      "\n",
      "interoperability purposes and to permit 3rd party software \n",
      "developers to connect to the electronic health record (ehr) through \n",
      "the certified api technology.\n",
      "\n",
      "supplemental children's format requirements for recommendation 1\n",
      "\n",
      "    we seek feedback about the relevance of the following potential \n",
      "supplemental children's ehr format requirements and their \n",
      "correlation to recommendation 1.\n",
      "    1. title: allow unknown patient sex.\n",
      "    children's ehr format: req-2009--release package 2015 priority \n",
      "list.\n",
      "    topic(s): prenatal screening, birth information, genetic \n",
      "information.\n",
      "    description: the system shall provide the ability to record a \n",
      "patient's sex as male, female, or unknown, and shall allow it to be \n",
      "updated.\n",
      "    2015 edition criterion alignment: demographics.\n",
      "    new or updated criterion alignment: uscdi.\n",
      "    2. title: record gestational age assessment and persist in the \n",
      "ehr.\n",
      "    children's ehr format: requirement req-2019--release package \n",
      "2015 priority list.\n",
      "    topic(s): well child/preventive care, growth data.\n",
      "    description: the system shall capture and display assigned \n",
      "gestational age as well as the diagnosis of sga (small for \n",
      "gestational age) or lga (large for gestational age) when \n",
      "appropriate.\n",
      "    2015 edition criterion alignment: common clinical data set \n",
      "(ccds).\n",
      "    new or updated criterion alignment: uscdi.\n",
      "    3. title: support growth charts for children.\n",
      "    children's ehr format: requirement req-2042--release package: \n",
      "2015 priority list.\n",
      "    topic(s): growth data.\n",
      "    description: the system shall support display of growth charts \n",
      "that plot selected growth parameters such as height, weight, head \n",
      "circumference, and bmi (entered with appropriate precision or \n",
      "computed as described in req-2019) along with appropriate sets of \n",
      "norms provided by the cdc or in a compatible tabular format \n",
      "(typically based on lambda-mu-sigma [lms] curve fitting \n",
      "computational method).\n",
      "    2015 edition criterion alignment: common clinical data set \n",
      "(ccds), clinical decision support (cds).\n",
      "    new or updated criterion alignment: uscdi, api.\n",
      "    title: provide alerts for out-of-range biometric data.\n",
      "    children's ehr format: requirement req-2045--release package \n",
      "2015 priority list.\n",
      "    topic(s): primary care management, well child/preventive care.\n",
      "    description: the system shall include the ability to provide \n",
      "alerts for weight, length/height, head circumference, and bmi data \n",
      "points that fall outside two standard deviations of cdc/who \n",
      "pediatric data.\n",
      "    2015 edition criterion alignment: clinical decision support \n",
      "(cds).\n",
      "    new or updated criterion alignment: uscdi, api.\n",
      "\n",
      "recommendation 2: compute weight-based drug dosage\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirement as follows:\n",
      "    title: compute weight-based drug dosage.\n",
      "    children's ehr format: req-2012--release package 2015 priority \n",
      "list.\n",
      "    topic(s): medication management.\n",
      "    description: the system shall compute drug dose, based on \n",
      "appropriate dosage ranges, using the patient's body weight and body \n",
      "surface area, and shall display the dosing weight and weight-based \n",
      "dosing strategy (when applicable) on the prescription.\n",
      "\n",
      "alignment with 2015 edition certification criterion\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition criterion listed below:\n",
      "    <bullet> electronic prescribing criterion:\n",
      "\n",
      "--provides the ability to send and receive the specified \n",
      "prescription transactions electronically per the ncpdp script \n",
      "version 10.6 standard implementation recommendations and using \n",
      "rxnorm vocabulary codes\n",
      "--limits the ability to prescribe all oral, liquid medications in \n",
      "only metric standard units of ml (i.e., not cc)\n",
      "\n",
      "    includes an optional structured and codified sig format, which \n",
      "has the capability to exchange weight-based dosing calculations \n",
      "within the ncpdp script 10.6 standard.\n",
      "\n",
      "alignment with proposed new or updated certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the proposed \n",
      "new and updated certification criteria in this proposed rule:\n",
      "    <bullet> united states core data for interoperability (uscdi): \n",
      "the uscdi (sec.  170.213) which enables the inclusion of pediatric \n",
      "vital sign data elements, including the reference range/scale or \n",
      "growth curve for bmi percentile per age and sex, weight for age per \n",
      "length and sex, and head occipital-frontal circumference.\n",
      "    <bullet> electronic prescribing: (sec.  170.315(b)(11)) which \n",
      "supports improved patient safety and prescription accuracy, workflow \n",
      "efficiencies, and increase configurability of systems including \n",
      "functionality that would support pediatric medication management.\n",
      "\n",
      "supplemental children's format requirements for recommendation 2\n",
      "\n",
      "    we seek feedback about the relevance of the following potential \n",
      "children's ehr format requirements and their correlation to \n",
      "recommendation 2.\n",
      "    1. title: rounding for administrable doses.\n",
      "    children's ehr format: req-2035--release package 2015 priority \n",
      "list.\n",
      "    topic(s): medication management.\n",
      "    description: the system shall enable calculated doses (e.g., \n",
      "weight-based) to be rounded to optimize administration convenience.\n",
      "    2015 edition criterion alignment: electronic prescribing.\n",
      "    new or updated criterion alignment: electronic prescribing.\n",
      "    2. title: alert based on age-specific norms.\n",
      "    children's ehr format: req-2013--release package 2015 priority \n",
      "list.\n",
      "    topic(s): primary care management, well child/preventive care.\n",
      "    description: the system shall provide the ability to present \n",
      "alerts for lab results outside of pediatric-specific normal value \n",
      "ranges.\n",
      "    2015 edition criterion alignment: clinical decision support \n",
      "(cds).\n",
      "    new or updated criterion alignment: api.\n",
      "\n",
      "recommendation 3: ability to document all guardians and caregivers\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirement as follows:\n",
      "    title: ability to access family history, including all guardians \n",
      "and caregivers.\n",
      "    children's ehr format: req-2006--release package 2015 priority \n",
      "list.\n",
      "    topic(s): child abuse reporting, primary care management, \n",
      "parents and guardians, and family relationship data.\n",
      "    description: the system shall provide the ability to record \n",
      "information about all guardians and caregivers (biological parents, \n",
      "foster parents, adoptive parents, guardians, surrogates, and \n",
      "custodians), siblings, and case workers, with contact information \n",
      "for each.\n",
      "\n",
      "alignment with 2015 edition certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition criteria listed below, and onc believes this priority also \n",
      "is supported by health it beyond what is included in the \n",
      "certification program.\n",
      "    <bullet> care plan: criteria includes the ability to record, \n",
      "change, access, create, and receive care plan information according \n",
      "to the care plan document template in the hl7 implementation guide \n",
      "for cda[supreg] release 2: consolidated cda templates for clinical \n",
      "notes (us realm), draft standard for trial use release 2.1 \n",
      "(including the sections for health status evaluations and outcomes \n",
      "and for interventions (v2)).\n",
      "    <bullet> transitions of care: criteria includes the ability to \n",
      "create, receive, and properly consumer interoperable documents using \n",
      "a common content and transport standard that include key health data \n",
      "that should be accessible and available for exchange.\n",
      "    <bullet> application programming interfaces criteria including \n",
      "the ``application access--patient selection'', ``application \n",
      "access--data category request'', and ``application access--all data \n",
      "request'' which can help address many of the challenges currently \n",
      "faced by caregivers accessing pediatric health data.\n",
      "    <bullet> transitions of care criteria includes the ability to \n",
      "create and to receive interoperable documents using a comment \n",
      "content standard that include key health data that should be \n",
      "accessible and available for exchange to support the care of \n",
      "children across care settings.\n",
      "    <bullet> demographic criterion requires the ability to record \n",
      "various demographic information for a patient including potential \n",
      "supports for patient and parental matching.\n",
      "\n",
      "[[page 7607]]\n",
      "\n",
      "alignment with proposed new or updated certification criteria\n",
      "\n",
      "    onc believes tis priority is supported by the proposed new and \n",
      "updated certification criteria in this proposed rule:\n",
      "    <bullet> united states core data for interoperability (uscdi): \n",
      "the uscdi (sec.  170.213) which enables the inclusion of pediatric \n",
      "vital sign data elements, including the reference range/scale or \n",
      "growth curve for bmi percentile per age and sex, weight for age per \n",
      "length and sex, and head occipital-frontal circumference.\n",
      "    <bullet> data segmentation for privacy: (two for c-cda ((sec.  \n",
      "170.315(b)(12)) and (sec.  170.315(b)(13)) and one for fhir (sec.  \n",
      "170.315(g)(11))) could provide functionality to address the concerns \n",
      "multiple stakeholders expressed regarding the need to restrict \n",
      "granular pediatric health data at production based on the intended \n",
      "recipient of the data.\n",
      "    <bullet> application programming interfaces (apis): sec.  \n",
      "170.315(g)(10), would require the use of health level 7 \n",
      "(hl7[supreg]) fast healthcare interoperability resources \n",
      "(fhir[supreg]) standards and several implementation specifications \n",
      "to establish standardized application programming interfaces (apis) \n",
      "for interoperability purposes and to permit 3rd party software \n",
      "developers to connect to the electronic health record (ehr) through \n",
      "the certified api technology.\n",
      "\n",
      "supplemental children's ehr format requirements for recommendation 3\n",
      "\n",
      "    we seek feedback about the relevance of the following potential \n",
      "supplemental children's ehr format requirements and their \n",
      "correlation to recommendation 3.\n",
      "    1. title: ability to document parental (guardian) notification \n",
      "or permission.\n",
      "    children's ehr format: req-2008: release package: 2015 priority \n",
      "list.\n",
      "    topic(s): security and confidentiality, parents and guardians, \n",
      "and family relationship data.\n",
      "    description: the system shall provide the ability to document \n",
      "parental (guardian) notification or permission for consenting minors \n",
      "to receive some treatments as required by institutional policy or \n",
      "jurisdictional law.\n",
      "    2015 edition criterion alignment: data segmentation for \n",
      "privacy--send criterion, data segmentation for privacy--receive \n",
      "criterion, and/or the patient health information capture criterion, \n",
      "view, download, and transmit (vdt) to third-party, and application \n",
      "programming interface (api).\n",
      "    new or updated criterion alignment: data segmentation for \n",
      "privacy.\n",
      "    2. title: record parental notification of newborn screening \n",
      "diagnosis.\n",
      "    children's ehr format: req-2016: release package: 2015 priority \n",
      "list.\n",
      "    topic(s): newborn screening.\n",
      "    description: the system shall be able to track that the child's \n",
      "legal guardians were notified of any newborn screening-related \n",
      "diagnosis.\n",
      "    2015 edition criterion alignment: question: view, download, and \n",
      "transmit (vdt) to third-party, secure messaging, application \n",
      "programming interface (api).\n",
      "    new or updated criterion alignment: api.\n",
      "    3. title: authorized non-clinician viewers of ehr data.\n",
      "    children's ehr format: req-2032--release package 2015 priority \n",
      "list.\n",
      "    topic(s): child welfare, patient portals (phr).\n",
      "    description: the system shall have the ability to identify \n",
      "members of the care team (including professional and nonprofessional \n",
      "members) and indicate their roles/relationships to the child.\n",
      "    2015 edition criterion alignment: care plan criterion, \n",
      "authentication, access control, and authorization.\n",
      "    new or updated criterion alignment: api.\n",
      "    4. title: document decision-making authority of patient \n",
      "representative.\n",
      "    children's ehr format: req-2030: release package: 2015 priority \n",
      "list.\n",
      "    topic(s): security and confidentiality.\n",
      "    description: the system shall have the ability to store, \n",
      "retrieve, and display information about an individual's right to \n",
      "authorize care, to release information, and to authorize payment for \n",
      "care on behalf of the patient, including time restrictions or other \n",
      "limitations. this includes storing copies of the relevant consent \n",
      "and authorization forms in compliance with state and federal rules, \n",
      "and also includes cases of child foster care, state social services \n",
      "agencies, guardians, guarantors, and those recognized to have full \n",
      "or partial authority. the system shall allow for multiple \n",
      "individuals.\n",
      "    2015 edition criterion alignment: patient health information \n",
      "capture.\n",
      "    new or updated criterion alignment: data segmentation.\n",
      "\n",
      "recommendation 4: segmented access to information\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirement as follows:\n",
      "    title: segmented access to information.\n",
      "    children's ehr format: req-2041: release package: 2015 priority \n",
      "list.\n",
      "    topic(s): security and confidentiality.\n",
      "    description: the system shall provide users the ability to \n",
      "segment health care data in order to keep information about minor \n",
      "consent services private and distinct from other content of the \n",
      "record, such that it is not exposed to parents/guardians without the \n",
      "minor's authorization.\n",
      "\n",
      "alignment with 2015 edition certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition criteria listed below, and onc believes this recommendation \n",
      "is supported by health it beyond what is included in the \n",
      "certification program\n",
      "    <bullet> data segmentation for privacy criteria:\n",
      "    [cir] data segmentation for privacy--send criterion provides the \n",
      "ability to create a summary record (formatted to consolidated cda \n",
      "(c-cda) release 2.1) that is tagged at the document level as \n",
      "restricted and subject to re-disclosure restrictions using the hl7 \n",
      "implementation guide: data segmentation for privacy (ds4p), release \n",
      "1.\n",
      "    [cir] data segmentation for privacy--receive criterion requires \n",
      "the ability to receive a summary record (formatted to consolidated \n",
      "cda release 2.1) that is document--level tagged as restricted and \n",
      "subject to re-disclosure restrictions using the hl7 implementation \n",
      "guide: data segmentation for privacy (ds4p), release 1. requires the \n",
      "ability to separate the document-level tagged document from other \n",
      "documents received. requires the ability to view the restricted \n",
      "document without having to incorporate any of the data from the \n",
      "document.\n",
      "    <bullet> transitions of care criteria includes the ability to \n",
      "create, receive, and properly consumer interoperable documents using \n",
      "a common content and transport standard that include key health data \n",
      "that should be accessible and available for exchange.\n",
      "\n",
      "alignment with proposed new or updated certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the proposed \n",
      "new and updated certification criteria in this proposed rule:\n",
      "    <bullet> united states core data for interoperability (uscdi): \n",
      "the uscdi (sec.  170.213) which enables the inclusion of pediatric \n",
      "vital sign data elements, including the reference range/scale or \n",
      "growth curve for bmi percentile per age and sex, weight for age per \n",
      "length and sex, and head occipital-frontal circumference.\n",
      "    <bullet> data segmentation for privacy: (two for c-cda ((sec.  \n",
      "170.315(b)(12)) and (sec.  170.315(b)(13)) and one for fhir (sec.  \n",
      "170.315(g)(11))) would provide functionality to address the concerns \n",
      "multiple stakeholders expressed regarding the need to restrict \n",
      "granular pediatric health data at production based on the intended \n",
      "recipient of the data.\n",
      "    <bullet> application programming interfaces (apis): sec.  \n",
      "170.315(g)(10), would require the use of health level 7 \n",
      "(hl7[supreg]) fast healthcare interoperability resources \n",
      "(fhir[supreg]) standards and several implementation specifications \n",
      "to establish standardized application programming interfaces (apis) \n",
      "for interoperability purposes and to permit 3rd party software \n",
      "developers to connect to the electronic health record (ehr) through \n",
      "the certified api technology.\n",
      "\n",
      "supplemental children's format requirements for recommendation 4\n",
      "\n",
      "    we seek feedback about the relevance of the following potential \n",
      "children's ehr format requirements and their correlation to \n",
      "recommendation 4.\n",
      "    1. title: problem-specific age of consent.\n",
      "    children's ehr format: req-2039: release package: 2015 priority \n",
      "list.\n",
      "    topic(s): security and confidentiality.\n",
      "    description: the system shall provide the ability to access \n",
      "legal guidelines on consent requirements for reference, where \n",
      "available, and to record the age of consent for a specific treatment \n",
      "when these differ based on legal guidelines.\n",
      "    2015 edition criterion alignment: demographics, care plan \n",
      "criterion, data segmentation for privacy--send, data segmentation \n",
      "for privacy--receive.\n",
      "    new or updated criterion alignment: uscdi, data segmentation.\n",
      "\n",
      "[[page 7608]]\n",
      "\n",
      "recommendation 5: synchronize immunization histories with registries\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirement as follows:\n",
      "    title: synchronize immunization histories with registry.\n",
      "    children's ehr format: req-2011*: release package: 2015 priority \n",
      "list.\n",
      "    topic(s): registry linkages, immunizations.\n",
      "    description: the system shall support updating and reconciling a \n",
      "child's immunization record with information received from \n",
      "immunization information systems or other health information \n",
      "exchanges (hies).\n",
      "    title: use established immunization messaging standards.\n",
      "    children's ehr format: req-2028 release package: 2015 priority \n",
      "list.\n",
      "    topic(s): registry linkages, immunizations.\n",
      "    description: (a) the system shall use the messaging standards \n",
      "established through meaningful use requirements to send data to \n",
      "immunization information systems or other hies. (b) the system shall \n",
      "use the messaging standards established through meaningful use \n",
      "requirements to receive data from immunization information systems \n",
      "or other hies.\n",
      "\n",
      "alignment with 2015 edition certification criterion\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition criterion listed below:\n",
      "    <bullet> transmission to immunization registries criterion, \n",
      "which:\n",
      "    [cir] provides the ability to create immunization information \n",
      "according to the implementation guide for immunization messaging \n",
      "release 1.5, and the july 2015 addendum, using cvx codes for \n",
      "historical vaccines and ndc codes for newly administered vaccines.\n",
      "    [cir] provides the ability to request, access, and display the \n",
      "evaluated immunization history and forecast from an immunization \n",
      "registry for a patient in accordance with the hl7 2.5.1 standard, \n",
      "the hl7 2.5.1. ig for immunization messaging, release 1.5, and july \n",
      "2015 addendum.\n",
      "    <bullet> view, download, and transmit to third party (vdt) \n",
      "criterion, which:\n",
      "    [cir] provides the ability for patients (and their authorized \n",
      "representatives) to view, download, and transmit their health \n",
      "information to a third party via internet-based technology \n",
      "consistent with one of the web content accessibility guidelines \n",
      "(wcag) 2.0 levels a or aa.\n",
      "    [cir] requires the ability for patients (and their authorized \n",
      "representatives) to view, at a minimum, the common clinical data \n",
      "set, laboratory test report(s), and diagnostic image reports.\n",
      "\n",
      "alignment with proposed new or updated certification criteria\n",
      "\n",
      "    <bullet> united states core data for interoperability (uscdi): \n",
      "the uscdi (sec.  170.213) which enables the inclusion of pediatric \n",
      "vital sign data elements, including the reference range/scale or \n",
      "growth curve for bmi percentile per age and sex, weight for age per \n",
      "length and sex, and head occipital-frontal circumference.\n",
      "    <bullet> application programming interfaces (apis): sec.  \n",
      "170.315(g)(10), would require the use of health level 7 \n",
      "(hl7[supreg]) fast healthcare interoperability resources \n",
      "(fhir[supreg]) standards and several implementation specifications \n",
      "to establish standardized application programming interfaces (apis) \n",
      "for interoperability purposes and to permit 3rd party software \n",
      "developers to connect to the electronic health record (ehr) through \n",
      "the certified api technology.\n",
      "\n",
      "supplemental children's format requirements for recommendation 5\n",
      "\n",
      "    we seek feedback about the relevance of the following potential \n",
      "children's ehr format requirements and their correlation to \n",
      "recommendation 5.\n",
      "    1. title: produce completed forms from ehr data.\n",
      "    the children's ehr format: req-2027 release package: 2015 \n",
      "priority list.\n",
      "    topic(s): well child/preventive care, immunizations.\n",
      "    description: the system shall produce reports (e.g., for camp, \n",
      "school, or child care) of a child's immunization history, including \n",
      "the following elements: child's name, date of birth and sex, date \n",
      "the report was produced, antigen administered, date administered, \n",
      "route of administration (when available), and an indication of \n",
      "whether a vaccine was refused or contraindicated.\n",
      "    2015 edition certification alignment: transmission to \n",
      "immunization registries, view, download and transmit (vdt), \n",
      "application programming interface (api).\n",
      "    new or updated criterion alignment: api.\n",
      "\n",
      "recommendation 6: age- and weight-specific single-dose range checking\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirements as follows:\n",
      "    title: age- and weight-specific single-dose range checking.\n",
      "    children's ehr format: req-2037: release package: 2015 priority \n",
      "list.\n",
      "    topic(s): medication management.\n",
      "    description: the system shall provide medication dosing decision \n",
      "support that detects a drug dose that falls outside the minimum-\n",
      "maximum range based on the patient's age, weight, and maximum \n",
      "recommended adult dose (if known) or maximum recommended pediatric \n",
      "dose (if known), for a single dose of the medication.\n",
      "\n",
      "alignment with 2015 edition certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition criterion listed below:\n",
      "    clinical decision support (cds) can be used to develop a variety \n",
      "of tools to enhance decision-making in the pediatric clinical \n",
      "workflow including contextually relevant reference information, \n",
      "clinical guidelines, condition-specific order sets, alerts, and \n",
      "reminders, among other tools.\n",
      "    application programming interfaces criteria including the \n",
      "``application access--patient selection'', ``application access--\n",
      "data category request'', and ``application access--all data \n",
      "request'' which can help address many of the challenges currently \n",
      "faced by caregivers accessing pediatric health data.\n",
      "    onc believes this priority could also be supported by health it \n",
      "beyond what is included in the certification program.\n",
      "    onc notes that per the national council for prescription drug \n",
      "programs (ncpdp), dose-range checking should be based on industry \n",
      "drug database products and are not intrinsic to script.\n",
      "\n",
      "alignment with proposed new or updated certification criteria\n",
      "\n",
      "    <bullet> united states core data for interoperability (uscdi): \n",
      "the uscdi (sec.  170.213) which enables the inclusion of pediatric \n",
      "vital sign data elements, including the reference range/scale or \n",
      "growth curve for bmi percentile per age and sex, weight for age per \n",
      "length and sex, and head occipital-frontal circumference.\n",
      "    <bullet> application programming interfaces (apis): sec.  \n",
      "170.315(g)(10), would require the use of health level 7 \n",
      "(hl7[supreg]) fast healthcare interoperability resources \n",
      "(fhir[supreg]) standards and several implementation specifications \n",
      "to establish standardized application programming interfaces (apis) \n",
      "for interoperability purposes and to permit 3rd party software \n",
      "developers to connect to the electronic health record (ehr) through \n",
      "the certified api technology.\n",
      "\n",
      "recommendation 7: transferrable access authority\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirement as follows:\n",
      "    title: transferrable access authority.\n",
      "    children's ehr format: req-2026: release package: 2015 priority \n",
      "list.\n",
      "    topic(s): school-based linkages, security and confidentiality, \n",
      "patient portals and patient health records (phr).\n",
      "    description: the system shall provide a mechanism to enable \n",
      "access control that allows a transferrable access authority (e.g., \n",
      "to address change in guardian, child reaching age of maturity, \n",
      "etc.).\n",
      "\n",
      "alignment with 2015 edition certification criterion\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition criterion below.\n",
      "    <bullet> view, download, and transmit to third party (vdt) \n",
      "criterion, which:\n",
      "    [cir] provides the ability for patients (and their authorized \n",
      "representatives) to view, download, and transmit their health \n",
      "information to a third party via internet-based technology \n",
      "consistent with one of the web content accessibility guidelines \n",
      "(wcag) 2.0 levels a or aa.\n",
      "    [cir] requires the ability for patients (and their authorized \n",
      "representatives) to view, at a minimum, the common clinical data \n",
      "set, laboratory test report(s), and diagnostic image reports.\n",
      "    application programming interfaces criteria including the \n",
      "``application access--patient selection'', ``application access--\n",
      "data\n",
      "\n",
      "[[page 7609]]\n",
      "\n",
      "category request'', and ``application access--all data request'' \n",
      "which can help address many of the challenges currently faced by \n",
      "caregivers accessing pediatric health data.\n",
      "\n",
      "alignment with proposed new or updated certification criterion\n",
      "\n",
      "    <bullet> data segmentation for privacy: (two for c-cda ((sec.  \n",
      "170.315(b)(12)) and (sec.  170.315(b)(13)) and one for fhir (sec.  \n",
      "170.315(g)(11))) would provide functionality to address the concerns \n",
      "multiple stakeholders expressed regarding the need to restrict \n",
      "granular pediatric health data at production based on the intended \n",
      "recipient of the data.\n",
      "    <bullet> application programming interfaces (apis): sec.  \n",
      "170.315(g)(10), would require the use of health level 7 \n",
      "(hl7[supreg]) fast healthcare interoperability resources \n",
      "(fhir[supreg]) standards and several implementation specifications \n",
      "to establish standardized application programming interfaces (apis) \n",
      "for interoperability purposes and to permit 3rd party software \n",
      "developers to connect to the electronic health record (ehr) through \n",
      "the certified api technology.\n",
      "\n",
      "supplemental children's format requirements for recommendation 7\n",
      "\n",
      "    we seek feedback about the relevance of the following potential \n",
      "children's ehr format requirements and their correlation to \n",
      "recommendation 7.\n",
      "    1. title: age of emancipation.\n",
      "    the children's ehr format: requirement req-2040 release package: \n",
      "2015 priority list.\n",
      "    topic(s): security and confidentiality.\n",
      "    description: the system shall provide the ability to record the \n",
      "patient's emancipated minor status.\n",
      "    2015 edition criterion alignment: demographic.\n",
      "    new or updated criterion alignment: data segmentation.\n",
      "\n",
      "recommendation 8: associate maternal health information and \n",
      "demographics with newborn\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirement as follows:\n",
      "    title: associate mother's demographics with newborn.\n",
      "    children's ehr format: req-2021: release package: 2015 priority \n",
      "list\n",
      "    topic(s): patient identifier, parents and guardians and family \n",
      "relationship data.\n",
      "    description: the system shall provide the ability to associate \n",
      "identifying parent or guardian demographic information, such as \n",
      "relationship to child, street address, telephone number, and/or \n",
      "email address for each individual child.\n",
      "\n",
      "alignment with the 2015 edition certification criterion\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition criterion below:\n",
      "    <bullet> care plan: criteria includes the ability to record, \n",
      "change, access, create, and receive care plan information according \n",
      "to the care plan document template in the hl7 implementation guide \n",
      "for cda[supreg] release 2: consolidated cda templates for clinical \n",
      "notes (us realm), draft standard for trial use release 2.1 \n",
      "(including the sections for health status evaluations and outcomes \n",
      "and for interventions (v2)).\n",
      "    <bullet> transitions of care criteria includes the ability to \n",
      "create and to receive interoperable documents using a comment \n",
      "content standard that include key health data that should be \n",
      "accessible and available for exchange to support the care of \n",
      "children across care settings.\n",
      "    <bullet> demographic criterion requires the ability to record \n",
      "various demographic information for a patient including potential \n",
      "supports for patient and parental matching.\n",
      "    <bullet> family health history criterion permits the ability to \n",
      "record, change, and access a patient's family health history \n",
      "(according to the september 2015 release of snomed ct[supreg], u.s. \n",
      "edition).\n",
      "    <bullet> social, psychological, and behavioral data criteria \n",
      "capture information (also known as social determinants of health) \n",
      "that can help to provide a more complete view of a mother's overall \n",
      "health status.\n",
      "\n",
      "alignment with proposed new or updated certification criteria\n",
      "\n",
      "    <bullet> united states core data for interoperability (uscdi): \n",
      "the uscdi (sec.  170.213) which enables the inclusion of pediatric \n",
      "vital sign data elements, including the reference range/scale or \n",
      "growth curve for bmi percentile per age and sex, weight for age per \n",
      "length and sex, and head occipital-frontal circumference.\n",
      "    <bullet> application programming interfaces (apis): sec.  \n",
      "170.315(g)(10), would require the use of health level 7 \n",
      "(hl7[supreg]) fast healthcare interoperability resources \n",
      "(fhir[supreg]) standards and several implementation specifications \n",
      "to establish standardized application programming interfaces (apis) \n",
      "for interoperability purposes and to permit 3rd party software \n",
      "developers to connect to the electronic health record (ehr) through \n",
      "the certified api technology.\n",
      "\n",
      "recommendation 9: track incomplete preventative care opportunities\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirement as follows:\n",
      "    title: track incomplete preventive care opportunities.\n",
      "    children's ehr format: req-2024: release package: 2015 priority \n",
      "list.\n",
      "    topic(s): well child/preventive care.\n",
      "    description: the system shall generate a list on demand for any \n",
      "children who have missed recommended health supervision visits \n",
      "(e.g., preventive opportunities), according to the frequency of \n",
      "visits recommended in bright futures\\tm\\.\n",
      "\n",
      "alignment with 2015 edition certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition criterion below:\n",
      "    clinical decision support (cds) criterion includes configuration \n",
      "that enables interventions based on various ccds data elements, \n",
      "including vital signs.\n",
      "    <bullet> clinical quality measures criteria for record and \n",
      "export, import and calculate, and filter criteria:\n",
      "    [cir] record and export criterion ensures that health it systems \n",
      "can record and export cqm data electronically; the export \n",
      "functionality gives clinicians the ability to export their results \n",
      "to multiple programs.\n",
      "    [cir] import and calculate criterion supports streamlined \n",
      "clinician processes through the importing of cqm data in a \n",
      "standardized format and ensures that health it systems can correctly \n",
      "calculate ecqm results using a standardized format.\n",
      "    [cir] filter criterion supports the capability for a clinician \n",
      "to make a query for ecqm results using or a combination of data \n",
      "captured by the certified health it for quality improvement and \n",
      "quality reporting purposes.\n",
      "    <bullet> application programming interfaces criteria including \n",
      "the ``application access--patient selection'', ``application \n",
      "access--data category request'', and ``application access--all data \n",
      "request'' which can help address many of the challenges currently \n",
      "faced by caregivers accessing pediatric health data.\n",
      "\n",
      "alignment with proposed new or updated certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the proposed \n",
      "new and updated certification criteria in this proposed rule:\n",
      "    <bullet> application programming interfaces (apis): sec.  \n",
      "170.315(g)(10), would require the use of health level 7 \n",
      "(hl7[supreg]) fast healthcare interoperability resources \n",
      "(fhir[supreg]) standards and several implementation specifications \n",
      "to establish standardized application programming interfaces (apis) \n",
      "for interoperability purposes and to permit 3rd party software \n",
      "developers to connect to the electronic health record (ehr) through \n",
      "the certified api technology.\n",
      "\n",
      "recommendation 10: flag special health care needs\n",
      "\n",
      "alignment with children's ehr format\n",
      "\n",
      "    stakeholders identified alignment with the children's ehr format \n",
      "requirement as follows:\n",
      "    title: flag special health care needs.\n",
      "    the children's ehr format: req-2014: release package: 2015 \n",
      "priority list.\n",
      "    topic(s): children with special health care needs.\n",
      "    description: the system shall support the ability for providers \n",
      "to flag or un-flag individuals with special health care needs or \n",
      "complex conditions who may benefit from care management, decision \n",
      "support, and care planning, and shall support reporting.\n",
      "\n",
      "alignment with 2015 edition certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the 2015 \n",
      "edition criterion below.\n",
      "    <bullet> problem list criterion contains the patient's current \n",
      "health problems, injuries, chronic conditions, and other factors \n",
      "that affect the overall health and well-being of the patient.\n",
      "    <bullet> clinical decision support (cds) can be used to develop \n",
      "a variety of tools to enhance decision-making in the pediatric \n",
      "clinical workflow including contextually relevant\n",
      "\n",
      "[[page 7610]]\n",
      "\n",
      "reference information, clinical guidelines, condition-specific order \n",
      "sets, alerts, and reminders, among other tools.\n",
      "    <bullet> clinical quality measures criteria for record and \n",
      "export, import and calculate, and filter criteria:\n",
      "    [cir] record and export criterion ensures that health it systems \n",
      "can record and export cqm data electronically; the export \n",
      "functionality gives clinicians the ability to export their results \n",
      "to multiple programs.\n",
      "    [cir] import and calculate criterion supports streamlined \n",
      "clinician processes through the importing of cqm data in a \n",
      "standardized format and ensures that health it systems can correctly \n",
      "calculate ecqm results using a standardized format.\n",
      "    [cir] filter criterion supports the capability for a clinician \n",
      "to make a query for ecqm results using or a combination of data \n",
      "captured by the certified health it for quality improvement and \n",
      "quality reporting purposes.\n",
      "\n",
      "alignment with proposed new or updated certification criteria\n",
      "\n",
      "    onc believes this recommendation is supported by the proposed \n",
      "new and updated certification criteria in this proposed rule:\n",
      "    <bullet> united states core data for interoperability (uscdi): \n",
      "the uscdi (sec.  170.213) which enables the inclusion of pediatric \n",
      "vital sign data elements, including the reference range/scale or \n",
      "growth curve for bmi percentile per age and sex, weight for age per \n",
      "length and sex, and head occipital-frontal circumference.\n",
      "    <bullet> application programming interfaces (apis): sec.  \n",
      "170.315(g)(10), would require the use of health level 7 \n",
      "(hl7[supreg]) fast healthcare interoperability resources \n",
      "(fhir[supreg]) standards and several implementation specifications \n",
      "to establish standardized application programming interfaces (apis) \n",
      "for interoperability purposes and to permit 3rd party software \n",
      "developers to connect to the electronic health record (ehr) through \n",
      "the certified api technology.\n",
      "\n",
      "[fr doc. 2019-02224 filed 2-22-19; 4:15 pm]\n",
      " billing code 4150-45-p[fedreg][vol]*[/vol][no]*[/no][date]*[/\n",
      "date][prorules]?>\n",
      "\n",
      "\n",
      "</pre></body>\n",
      "</html>\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in HHS-ONC-2019-0002: 100%|██████████| 2/2 [00:00<00:00,  2.85it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Added /Users/ha/Downloads/mirrulations/specific/HHS-ONC-2019-0002/raw-data/documents/HHS-ONC-2019-0002-0001_content.htm to vector store.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Processing files in CMS-2025-0050: 0it [00:00, ?it/s]\n",
      "Processing files in CMS-2022-0163: 100%|██████████| 1/1 [00:00<00:00, 14.07it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html>\n",
      "<head>\n",
      "<title>federal register, volume 87 issue 194 (friday, october 7, 2022)</title>\n",
      "</head>\n",
      "<body><pre>[federal register volume 87, number 194 (friday, october 7, 2022)]\n",
      "[notices]\n",
      "[pages 61018-61029]\n",
      "from the federal register online via the government publishing office [<a href=\"http://www.gpo.gov\">www.gpo.gov</a>]\n",
      "[fr doc no: 2022-21904]\n",
      "\n",
      "\n",
      "=======================================================================\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "department of health and human services\n",
      "\n",
      "centers for medicare & medicaid services\n",
      "\n",
      "[cms-0058-nc]\n",
      "rin 0938-zb72\n",
      "\n",
      "\n",
      "request for information; national directory of healthcare \n",
      "providers & services\n",
      "\n",
      "agency: centers for medicare & medicaid services (cms), health and \n",
      "human services (hhs).\n",
      "\n",
      "action: request for information.\n",
      "\n",
      "-----------------------------------------------------------------------\n",
      "\n",
      "summary: this request for information solicits public comments on \n",
      "establishing a national directory of healthcare providers & services \n",
      "(ndh) that could serve as a ``centralized data hub'' for healthcare \n",
      "provider, facility, and entity directory information nationwide.\n",
      "\n",
      "dates: to be assured consideration, comments must be received at one of \n",
      "the addresses provided below, no later than 5 p.m. on december 6, 2022.\n",
      "\n",
      "addresses: in commenting, please refer to file code cms-0058-nc.\n",
      "    comments, including mass comment submissions, must be submitted in \n",
      "one of the following three ways (please choose only one of the ways \n",
      "listed):\n",
      "    1. electronically. you may submit electronic comments on this \n",
      "regulation to <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a>. follow the ``submit a \n",
      "comment'' instructions.\n",
      "    2. by regular mail. you may mail written comments to the following \n",
      "address only: centers for medicare & medicaid services, department of \n",
      "health and human services, attention: cms-0058-nc, p.o. box 8013, \n",
      "baltimore, md 21244-8013.\n",
      "    please allow sufficient time for mailed comments to be received \n",
      "before the close of the comment period.\n",
      "    3. by express or overnight mail. you may send written comments to \n",
      "the following address only: centers for medicare & medicaid services, \n",
      "department of health and human services, attention: cms-0058-nc, mail \n",
      "stop c4-26-05, 7500 security boulevard, baltimore, md 21244-1850.\n",
      "    for information on viewing public comments, see the beginning of \n",
      "the supplementary information section.\n",
      "\n",
      "for further information contact:\n",
      "alexandra mugge, (410) 786-4457.\n",
      "david koppel, (303) 844-2883.\n",
      "\n",
      "supplementary information: inspection of public comments: all comments \n",
      "received before the close of the comment period are available for \n",
      "viewing by the public, including any personally identifiable or \n",
      "confidential business information that is included in a comment. we \n",
      "post all comments received before the close of the comment period on \n",
      "the following website as soon as possible after they have been \n",
      "received: <a href=\"http://www.regulations.gov\">http://www.regulations.gov</a>. follow the search instructions on \n",
      "that website to view public comments. cms will not post on \n",
      "<a href=\"http://regulations.gov\">regulations.gov</a> public comments that make threats to individuals or \n",
      "institutions or suggest that the individual will take actions to harm \n",
      "the individual. cms continues to encourage individuals not to submit \n",
      "duplicative comments. we will post acceptable comments from multiple \n",
      "unique commenters even if the content is identical or nearly identical \n",
      "to other comments.\n",
      "\n",
      "i. introduction\n",
      "\n",
      "    healthcare directories that contain aggregated information about \n",
      "healthcare providers, facilities, and other entities involved in \n",
      "patient care are crucial resources for consumers and the healthcare \n",
      "industry. contemporary and comprehensive directories can support a \n",
      "variety of use cases, such as helping consumers choose a provider, \n",
      "comparing health plan networks, auditing network adequacy, and \n",
      "coordinating patients' care.\\1\\ today, consumers use provider \n",
      "directories and online searches more than any other resource (such as \n",
      "word-of-mouth or physician referrals) to research healthcare providers. \n",
      "in a 2020 consumer preference report, a majority of the consumers \n",
      "surveyed indicated that the online availability of accurate directory \n",
      "information (address, insurance, specialty, hours, etc.) has affected \n",
      "their decisions when choosing a doctor.\\2\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\1\\ onc health it. (2016, february). strategic implementation \n",
      "guide: provider directories. see page 4. retrieved from <a href=\"https://www.healthit.gov/sites/default/files/statestrategicimplementationguide-providerdirectories-v1-final.pdf\">https://www.healthit.gov/sites/default/files/statestrategicimplementationguide-providerdirectories-v1-final.pdf</a>.\n",
      "    \\2\\ <a href=\"http://doctor.com\">doctor.com</a>. (2020). customer experience trends in \n",
      "healthcare. retrieved from <a href=\"https://cms.doctor.com/wp-content/uploads/2020/03/cxtrends2020-report-final.pdf\">https://cms.doctor.com/wp-content/uploads/2020/03/cxtrends2020-report-final.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    although these are important resources, the fragmentation of \n",
      "current provider directories requires inefficient, redundant reporting \n",
      "from providers.\\3\\ directories often contain inaccurate information, \n",
      "rarely support interoperable data exchange or public health reporting, \n",
      "and are overall costly to the healthcare industry. according to one \n",
      "estimate from a provider survey completed in 2019 by the council for \n",
      "affordable quality healthcare (caqh), physician practices collectively \n",
      "spend $2.76 billion annually on directory maintenance, which is \n",
      "equivalent to approximately $998.84 per month per practice, or one \n",
      "staff member workday per week.\\4\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\3\\ we use the term ``providers'' generally in this rfi to refer \n",
      "to healthcare facilities and practitioners and do not intend that to \n",
      "include or exclude any specific category of individuals or entities.\n",
      "    \\4\\ caqh. (2019). the hidden causes of inaccurate provider \n",
      "directories. retrieved from <a href=\"https://www.caqh.org/sites/default/files/explorations/caqh-hidden-causes-provider-directories-whitepaper.pdf\">https://www.caqh.org/sites/default/files/explorations/caqh-hidden-causes-provider-directories-whitepaper.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the caqh estimated that transitioning directory data collection to \n",
      "a single streamlined platform could save the average physician practice \n",
      "an estimated $4,746 annually, or an approximated $1.1 billion in \n",
      "collective annual savings across the nation. directory maintenance \n",
      "costs for physician practices vary based on many factors including \n",
      "practice size, the number of payers with which they are contracted, \n",
      "number of practice locations, and importantly, how often and timely \n",
      "they verify or update their information in directories. furthermore, \n",
      "providers reported that they must submit directory information in \n",
      "various ways, including by fax, credentialing software, provider \n",
      "management and enrollment software, phone, and physical mail. this \n",
      "disjointed system results in barriers to patient care, administrative \n",
      "burden on providers and their staff, and increased cost for the entire \n",
      "healthcare industry.\\5\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\5\\ ibid.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    one driver of inaccuracy is the varying frequencies and levels of \n",
      "detail at which different directories require information. some track \n",
      "directory information at the practice level, and others include \n",
      "directory information for each physical location. without processes or \n",
      "internal audits for data accuracy, different practice staff may provide \n",
      "inconsistent information across\n",
      "\n",
      "[[page 61019]]\n",
      "\n",
      "directories. administrative complexity and unclear accountability for \n",
      "data accuracy also contributes to data quality and accuracy challenges. \n",
      "even when payers have legal obligations to maintain an accurate \n",
      "directory, as discussed in section ii. of this document, they generally \n",
      "must rely on providers to update the information within their \n",
      "directories and are left with few options if a provider does not do so \n",
      "in a timely manner. this also puts a burden on provider staff, who must \n",
      "update their directory information for an average of 20 different \n",
      "payers per practice.\\6\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\6\\ caqh. (2019). the hidden causes of inaccurate provider \n",
      "directories, see page 2. retrieved from <a href=\"https://www.caqh.org/sites/default/files/explorations/caqh-hidden-causes-provider-directories-whitepaper.pdf\">https://www.caqh.org/sites/default/files/explorations/caqh-hidden-causes-provider-directories-whitepaper.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we believe that cms may have an opportunity to alleviate some of \n",
      "these burdens and improve the state of provider directories through a \n",
      "cms-developed and maintained, application programming interface (api)-\n",
      "enabled, national directory. a national directory of healthcare \n",
      "providers & services (ndh) could serve as a ``centralized data hub'' \n",
      "for directory and digital contact information containing the most \n",
      "accurate, up-to-date, and validated (that is, data that is verified by \n",
      "cms against primary sources) data in a publicly accessible index.\\7\\ an \n",
      "ndh could both streamline existing data across cms systems and publish \n",
      "information in an easier-to-use format than is available today. more \n",
      "useful public data could help patients find providers, facilitate \n",
      "interoperable provider data exchange, and help payers improve the \n",
      "accuracy of their own directories. we use the term ``centralized data \n",
      "hub'' to describe the practice of aggregating data from many existing \n",
      "systems into a single location, which is a best practice within any \n",
      "industry, including healthcare. establishing a ``centralized data hub'' \n",
      "breaks down technological barriers between various data sets and allows \n",
      "other databases to reference the source of the information without \n",
      "duplicating data. this aggregation and standardization of data could \n",
      "help avoid errors and inaccuracies in directories that reference data \n",
      "in an ndh. cms could use an ndh as a mechanism to collect and maintain \n",
      "directory information in a standardized, interoperable, and sharable \n",
      "format that allows widespread access while maintaining privacy and \n",
      "security protocols to safeguard access to sensitive information.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\7\\ to address digital contact information, section 4003(c)(1) \n",
      "of the 21st century cures act requires the secretary of health and \n",
      "human services to ``establish a provider digital contact information \n",
      "index to provide digital contact information for health \n",
      "professionals and health facilities.''\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    to align with national standards for interoperability, an ndh could \n",
      "be built on the standards established by the office of the national \n",
      "coordinator for health information technology (onc) at 45 cfr part 170, \n",
      "subpart b. specifically, an ndh could use hl7[supreg] fast healthcare \n",
      "interoperability resources (fhir[supreg]) apis, the latest standard for \n",
      "which is codified at 45 cfr 170.215(a)(1), to enable data exchange. \n",
      "fhir is a standard for exchanging healthcare information electronically \n",
      "that enables rapid and efficient data transactions through an \n",
      "api.<sup>8 9</sup> systems with different data architecture can use \n",
      "fhir apis to exchange health data in a consistent manner, which gives \n",
      "providers, payers, and other relevant entities a fast and secure way to \n",
      "send and receive healthcare data. fhir is a widely adopted standard \n",
      "that we already require for specific types of health data exchange.\\10\\ \n",
      "we expect onc to periodically update the standards at 45 cfr part 170, \n",
      "subpart b through notice and comment rulemaking, and an ndh could use \n",
      "the most up-to-date standards, as appropriate.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\8\\ hl7. (2022, may 28). welcome to fhir. retrieved from <a href=\"http://hl7.org/fhir/\">http://hl7.org/fhir/</a>.\n",
      "    \\9\\ health it. (2021, june 16). fhir fact sheets. retrieved from \n",
      "https://www.healthit.gov/topic/standards-technology/standards/fhir-\n",
      "fact-\n",
      "sheets#:~:text=what%20is%20hl7%c2%ae%20fhir,be%20quickly%20and%20effi\n",
      "ciently%20exchanged.\n",
      "    \\10\\ cms. (2020, may 1). 85 fr 25510. see page 25521-22, 25530. \n",
      "retrieved from <a href=\"https://www.federalregister.gov/d/2020-05050\">https://www.federalregister.gov/d/2020-05050</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    onc and the federal health architecture (fha), a former federal \n",
      "agency collaboration created to enhance interoperability among federal \n",
      "health information technology (it) systems,\\11\\ developed the validated \n",
      "healthcare directory (vhdir) fhir implementation guide (ig), which \n",
      "describes the technical design considerations for collecting, \n",
      "validating, verifying, and exchanging data from a central source of \n",
      "provider data using fhir standards. that ig is currently a ``standard \n",
      "for trial use,'' meaning it has been deemed ``ready to implement'' by \n",
      "the sponsoring work group, but there has not yet been significant \n",
      "implementation experience.\\12\\ testing and development processes are \n",
      "ongoing toward establishing the ig as a normative standard through the \n",
      "american national standards institute (ansi)-approved process. cms will \n",
      "continue to monitor and work with the appropriate standards development \n",
      "organizations on this effort.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\11\\ health it. (2020, january 17). federal health architecture \n",
      "(fha). retrieved from <a href=\"https://www.healthit.gov/archive/topic/onc-hitech-programs/federal-health-architecture-fha\">https://www.healthit.gov/archive/topic/onc-hitech-programs/federal-health-architecture-fha</a>.\n",
      "    \\12\\ mckenzie, l. & peters, m. (2021, march 3). hl7 balloting. \n",
      "retrieved from <a href=\"https://confluence.hl7.org/display/hl7/hl7+balloting\">https://confluence.hl7.org/display/hl7/hl7+balloting</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    previous healthcare directory technical efforts, described in \n",
      "section ii. of this document, have identified cms as the appropriate \n",
      "owner of a validated directory, such as an ndh.\\13\\ we agree that cms, \n",
      "with collaborative input from industry and federal partners, is \n",
      "positioned to develop an ndh in a manner that serves all stakeholders, \n",
      "builds and maintains trust in the data, advances public health goals, \n",
      "improves data exchange, streamlines administrative processes, and \n",
      "promotes interoperability.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\13\\ fast. (2020, december 17). proposed solutions working \n",
      "document: directory (v3). retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    through this rfi, we seek input on the current state of healthcare \n",
      "provider directories and steps that we could or should take if cms \n",
      "concludes that adequate legal authority exists to establish an ndh and \n",
      "proceeds to do so.\n",
      "    we believe a modern healthcare provider directory should serve \n",
      "multiple purposes for end users. in addition to helping patients locate \n",
      "providers that meet their individual needs and preferences, a modern \n",
      "healthcare directory should enable healthcare providers, payers, and \n",
      "others involved in patient care to identify one another's digital \n",
      "contact information, also referred to as digital endpoints,\\14\\ for \n",
      "interoperable electronic data exchange. we are collecting feedback from \n",
      "the public regarding the topics and questions in the discussion that \n",
      "follows. we pose questions throughout this document; a response to \n",
      "every question is not required in order to submit comments.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\14\\ cms. (2022, february 11). obrhi faqs. retrieved from \n",
      "<a href=\"https://www.cms.gov/about-cms/obrhi/faqs\">https://www.cms.gov/about-cms/obrhi/faqs</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "ii. background\n",
      "\n",
      "    provider directories have long been a focus of federal healthcare \n",
      "improvement efforts. on several occasions, congress has acted to \n",
      "address the challenges of directory data availability and accuracy. \n",
      "federal executive branch departments and agencies have also taken \n",
      "considerable steps to implement regulatory requirements aimed at \n",
      "addressing these challenges.\n",
      "    section 4001 of the balanced budget act of 1997 (bba) (pub. l. 105-\n",
      "33) established a new medicare part c (now also known as medicare \n",
      "advantage) program, and under section\n",
      "\n",
      "[[page 61020]]\n",
      "\n",
      "1852(c)(1)(c) of the social security act (the act) required that \n",
      "medicare advantage organizations (ma organizations) annually disclose \n",
      "in a clear, accurate, and standardized form to each ma plan enrollee, \n",
      "the number, mix, and distribution of plan providers, among other \n",
      "information.\n",
      "    this requirement was implemented in regulations at 42 cfr \n",
      "422.111(b)(3), which requires ma organizations to disclose a \n",
      "description of the number, mix, and distribution (addresses) of \n",
      "providers from whom enrollees may reasonably be expected to obtain \n",
      "services. cms has issued updated guidance over several years regarding \n",
      "the responsibilities of ma organizations to have accurate provider \n",
      "directories, with guidance appearing in the medicare marketing \n",
      "guidelines and medicare communications and marketing guidelines \n",
      "<sup>15 16</sup> and section 110 of chapter 4 of the medicare managed \n",
      "care manual.<sup>17 18</sup>\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\15\\ cms. (2022, february 9). medicare communications and \n",
      "marketing guidelines (mcmg). retrieved from <a href=\"https://www.cms.gov/files/document/medicare-communications-marketing-guidelines-2-9-2022.pdf\">https://www.cms.gov/files/document/medicare-communications-marketing-guidelines-2-9-2022.pdf</a>.\n",
      "    \\16\\ prior to 2020, cms issued the medicare marketing guidelines \n",
      "(historical versions are available through the hhs guidance portal, \n",
      "available online here: <a href=\"https://www.hhs.gov/guidance/\">https://www.hhs.gov/guidance/</a>) but replaced \n",
      "that document with the medicare communications and marketing \n",
      "guidelines when the applicable regulations were revised in a final \n",
      "rule that appeared in the federal register on april 16, 2018 (83 fr \n",
      "16440, 16624 through 16633).\n",
      "    \\17\\ cms. (2015, april 22). medicare managed care manual \n",
      "publication # 100-16: chapter 4--benefits and beneficiary \n",
      "protections. retrieved from <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/manuals/internet-only-manuals-ioms-items/cms019326\">https://www.cms.gov/regulations-and-guidance/guidance/manuals/internet-only-manuals-ioms-items/cms019326</a>.\n",
      "    \\18\\ cms. (2016, april 22). medicare managed care manual: \n",
      "benefits and beneficiary protections. retrieved from <a href=\"https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/mc86c04.pdf\">https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/mc86c04.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    similarly, in section 4701 of the bba, congress added section \n",
      "1932(a)(5)(b)(i) of the act, which requires that the medicaid managed \n",
      "care organizations that are specified in the statute make available, \n",
      "upon request, the identity, locations, qualifications, and availability \n",
      "of providers that participate with that entity. these same requirements \n",
      "were applied to children's health insurance program (chip) managed care \n",
      "entities via section 403 of the children's health insurance program \n",
      "reauthorization act (chipra) of 2009 (pub. l. 111-3), at section \n",
      "2103(f)(3) of the act.\n",
      "    in 2015, in the ``patient protection and affordable care act; hhs \n",
      "notice of benefit and payment parameters for 2016'' final rule (80 fr \n",
      "10829), we established a requirement, at 45 cfr 156.230(b), that \n",
      "qualified health plan (qhp) issuers on the federally-facilitated \n",
      "exchanges publish online an easily-accessible, up-to-date, accurate, \n",
      "and complete provider directory. those directories must include \n",
      "information on which providers are accepting new patients, the \n",
      "provider's location, contact information, specialty, medical group, and \n",
      "any institutional affiliations. cms also requires issuers to make this \n",
      "information publicly available on their own websites in a machine-\n",
      "readable file and format to allow third parties to create resources \n",
      "that aggregate information on different plans.<sup>19 20</sup> cms \n",
      "conducts annual reviews to assess the accuracy of issuers' machine-\n",
      "readable provider data files, comparing the data files to the issuers' \n",
      "online provider directories and other data sources, such as the \n",
      "national plan and provider enumeration system (nppes) and the united \n",
      "states postal service (usps) address verification database. over five \n",
      "plan years beginning in plan year (py) 2017 through py2021, cms found \n",
      "that no more than 47 percent of the provider entries we reviewed from \n",
      "the machine-readable provider data files included a complete set of \n",
      "accurate telephone numbers, addresses, specialties, plan affiliations, \n",
      "and whether the provider is accepting new patients.\\21\\ furthermore, \n",
      "only 73 percent of the providers reviewed could be fully matched to the \n",
      "published directories on the payer's website. finally, when we compared \n",
      "provider information from the machine-readable data files to the nppes \n",
      "national provider identifier (npi) registry, only 28 percent of the \n",
      "provider names, addresses, and specialties matched.\\22\\ in addition to \n",
      "accuracy issues, we note that a machine-readable file is a static data \n",
      "source that must be entirely recreated to provide a snapshot of the \n",
      "dataset at any point in time. conversely, the apis that we discuss here \n",
      "could allow data to be accessed in real-time and with the most up-to-\n",
      "date information at the moment the system is queried.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\19\\ cms. (2022, january 7). 2023 letter to issuers in the \n",
      "federally-facilitated exchanges, chapter 3, section 1. retrieved \n",
      "from <a href=\"https://www.cms.gov/files/document/2023-draft-letter-issuers-508.pdf\">https://www.cms.gov/files/document/2023-draft-letter-issuers-508.pdf</a>.\n",
      "    \\20\\ cms. (2017, february 17). addendum to 2018 letter to \n",
      "issuers in the federally-facilitated marketplaces. retrieved from \n",
      "<a href=\"https://www.cms.gov/cciio/resources/regulations-and-guidance/downloads/final-2018-letter-to-issuers-in-the-federally-facilitated-marketplaces-and-february-17-addendum.pdf\">https://www.cms.gov/cciio/resources/regulations-and-guidance/downloads/final-2018-letter-to-issuers-in-the-federally-facilitated-marketplaces-and-february-17-addendum.pdf</a>.\n",
      "    \\21\\ cms selected a sample of 25 providers from 45 qhp and 5 \n",
      "sadp issuers, for each issuer, the target sample was selected to \n",
      "equally distribute primary care physician (pcp), obstetrics/\n",
      "gynecology (ob/gyn), pediatrics, and specialty providers for qhps, \n",
      "and general dentists, pediatric dentists, and specialty dentists for \n",
      "sadps. the provider's national provider identification number (npi) \n",
      "was used to ensure providers were not chosen more than once during \n",
      "each plan year review. one sadp in the sample had only 15 unique \n",
      "npis from which a sample could be selected; this resulted in the \n",
      "final sample size of 1,235 unique npis.\n",
      "    \\22\\ cms. (2022, march 22). machine-readable provider directory \n",
      "review summary report plan years 2017-2021. retrieved from <a href=\"https://www.cms.gov/files/document/2017-2021mrpdsummaryreportfinal508.pdf\">https://www.cms.gov/files/document/2017-2021mrpdsummaryreportfinal508.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in the contract year 2016 call letter for part c (medicare \n",
      "advantage) and part d plans, cms announced it was initiating a \n",
      "monitoring effort of the accuracy of online provider directories for \n",
      "plans offered by ma organizations.\\23\\ beginning in february 2016, cms \n",
      "studied the accuracy of information in ma organizations' online \n",
      "directories. we released findings in july 2018 from three review rounds \n",
      "in which we identified at least one deficiency in 45 percent, 55 \n",
      "percent, and 49 percent of listed locations.\\24\\ significant types of \n",
      "identified inaccuracies included providers who did not practice at the \n",
      "listed location, providers who did not accept the plan at the listed \n",
      "location, incorrect phone numbers or addresses, and mistaken \n",
      "``accepting new patients'' flags. in that report, we identified a \n",
      "centralized database as a possible long-term solution.\\25\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\23\\ cms. (2015, april 6). announcement of calendar year (cy) \n",
      "2016 medicare advantage capitation rates and medicare advantage and \n",
      "part d payment policies and final call letter. retrieved from \n",
      "<a href=\"https://www.cms.gov/medicare/health-plans/medicareadvtgspecratestats/downloads/announcement2016.pdf\">https://www.cms.gov/medicare/health-plans/medicareadvtgspecratestats/downloads/announcement2016.pdf</a>.\n",
      "    \\24\\ cms. (2018, november 28). online provider directory review \n",
      "report. retrieved from <a href=\"https://www.cms.gov/medicare/health-plans/managedcaremarketing/downloads/provider_directory_review_industry_report_round_3_11-28-2018.pdf\">https://www.cms.gov/medicare/health-plans/managedcaremarketing/downloads/provider_directory_review_industry_report_round_3_11-28-2018.pdf</a>.\n",
      "    \\25\\ ibid.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    on january 3, 2020, as a follow-up to the ma provider directory \n",
      "monitoring study conducted from 2016 to 2018, cms issued a health plan \n",
      "management system (hpms) memo encouraging ma organizations to work with \n",
      "their contracted providers and to urge those providers to review and \n",
      "update their nppes data. cms announced that it would exercise \n",
      "enforcement discretion with regard to potential violations of sec.  \n",
      "422.111(b)(3) should cms uncover errors in an ma organization's \n",
      "provider directory where the errors are consistent with nppes data that \n",
      "were updated or certified between january 1 and april 30, 2020, \n",
      "provided the ma organization corrected any identified errors within 30 \n",
      "days.\\26\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\26\\ cms. (2020, january). hpms memo. retrieved from <a href=\"https://www.cms.gov/httpseditcmsgovresearch-statistics-data-and-systemscomputer-data-and-systemshpmshpms-memos-archive/hpms-memo-3\">https://www.cms.gov/httpseditcmsgovresearch-statistics-data-and-systemscomputer-data-and-systemshpmshpms-memos-archive/hpms-memo-3</a>.\n",
      "\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "[[page 61021]]\n",
      "\n",
      "    in 2016, congress enacted the 21st century cures act (cures act) \n",
      "(pub. l. 114-255). section 4003(c) of the cures act requires the \n",
      "secretary of hhs (the secretary), directly or through a partnership \n",
      "with a private entity, to establish a provider digital contact \n",
      "information index to provide digital contact information for health \n",
      "professionals and health facilities. to implement that requirement of \n",
      "section 4003(c) of the cures act, in june 2018 we updated nppes,\\27\\ a \n",
      "system authorized by section 1173(b) of the act and that we administer, \n",
      "to be able to capture digital contact information, also referred to as \n",
      "digital endpoints,\\28\\ for both healthcare professionals and \n",
      "facilities. nppes currently supplies npi numbers to healthcare \n",
      "providers (both individuals and facilities), maintains their npi \n",
      "record, and publishes the records online. nppes has been updated to \n",
      "include the capability to capture one or more fields of digital contact \n",
      "information that can be used to facilitate secure health information \n",
      "exchange. for instance, providers can submit a type of digital endpoint \n",
      "such as a direct address, which functions similar to a regular email \n",
      "address, but includes additional security measures to ensure that \n",
      "messages are only accessible by the intended recipient in order to keep \n",
      "the information confidential and secure.\\29\\ as nppes is publicly \n",
      "searchable on cms' website, many other entities use the data included \n",
      "in the nppes downloadable file for other business and research purposes \n",
      "(for example, the kaiser family foundation completed a 2020 report on \n",
      "the availability of active critical care physicians and nurses in a \n",
      "state-by-state analysis, relating to covid-19).\\30\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\27\\ cms. nppes npi registry. retrieved from <a href=\"https://npiregistry.cms.hhs.gov/\">https://npiregistry.cms.hhs.gov/</a>.\n",
      "    \\28\\ cms. (2022, february 11). obrhi faqs. retrieved from \n",
      "<a href=\"https://www.cms.gov/about-cms/obrhi/faqs\">https://www.cms.gov/about-cms/obrhi/faqs</a>.\n",
      "    \\29\\ health it. (2014, may). direct basics: q&a for providers. \n",
      "retrieved from <a href=\"https://www.healthit.gov/sites/default/files/directbasicsforprovidersqa_05092014.pdf\">https://www.healthit.gov/sites/default/files/directbasicsforprovidersqa_05092014.pdf</a>.\n",
      "    \\30\\ lopez, e. (2020, july 30). the critical care workforce and \n",
      "covid-19. retrieved from <a href=\"https://www.kff.org/report-section/the-critical-care-workforce-and-covid-19-a-state-by-state-analysis-data-note/\">https://www.kff.org/report-section/the-critical-care-workforce-and-covid-19-a-state-by-state-analysis-data-note/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    additionally, section 4003(b) of the cures act amended section \n",
      "3001(c) of the public health service act (phsa) to add a new paragraph \n",
      "(9)(a) that directed the national coordinator to ``develop or support a \n",
      "trusted exchange framework, including a common agreement among health \n",
      "information networks nationally.'' the overall goal of the trusted \n",
      "exchange framework and common agreement (tefca) is to establish a \n",
      "universal floor for interoperability across the country. paragraph \n",
      "(9)(d) of section 3001(c) of the phsa requires the national coordinator \n",
      "to create and publish on onc's website, ``a list of the health \n",
      "information networks that have adopted the common agreement and are \n",
      "capable of trusted exchange pursuant to the common agreement.'' on \n",
      "january 18, 2022, onc released the common agreement for nationwide \n",
      "health information interoperability version 1 (common agreement).\\31\\ \n",
      "the common agreement and the incorporated by reference qualified health \n",
      "information network (qhin) technical framework version 1 (qtf) \\32\\ \n",
      "establish a technical infrastructure model and governing approach for \n",
      "different health information networks and their users to securely share \n",
      "clinical information with each other. the common agreement and the qtf \n",
      "do not require fhir-based exchange because network enablement of fhir \n",
      "is still maturing in key areas. however, the onc recognized \n",
      "coordinating entity (rce),\\33\\ a private-sector entity that implements \n",
      "the common agreement, released a 3-year fhir roadmap for tefca \n",
      "exchange, which lays out a deliberate strategy to add fhir-based \n",
      "exchange under tefca in the near future.\\34\\ the common agreement also \n",
      "includes requirements for maintaining a directory of exchange \n",
      "participants' digital endpoints.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\31\\ onc. (2022, january). common agreement for national health \n",
      "information interoperability, version 1. retrieved from <a href=\"https://www.healthit.gov/sites/default/files/page/2022-01/common_agreement_for_nationwide_health_information_interoperability_version_1.pdf\">https://www.healthit.gov/sites/default/files/page/2022-01/common_agreement_for_nationwide_health_information_interoperability_version_1.pdf</a>.\n",
      "    \\32\\ onc tefca recognized coordinating entity. (2022, january). \n",
      "qualified health information network (qhin) technical framework \n",
      "(qtf) version 1.0. retrieved from <a href=\"https://rce.sequoiaproject.org/wp-content/uploads/2022/01/qtf_0122.pdf\">https://rce.sequoiaproject.org/wp-content/uploads/2022/01/qtf_0122.pdf</a>.\n",
      "    \\33\\ in august 2019, onc awarded a cooperative agreement to the \n",
      "sequoia project to serve as the initial rce. the rce will \n",
      "operationalize and enforce the common agreement, oversee qhin-\n",
      "facilitated network operations, and ensure compliance by \n",
      "participating qhins. the rce will also engage stakeholders to create \n",
      "a roadmap for expanding interoperability over time. see the sequoia \n",
      "project. (2019, september 4). onc awards the sequoia project a \n",
      "cooperative agreement for the trusted exchange framework and common \n",
      "agreement to support advancing nationwide interoperability of \n",
      "electronic health information. retrieved from <a href=\"https://sequoiaproject.org/onc-awards-the-sequoia-project-a-cooperative-agreement-for-the-trusted-exchange-framework-and-common-agreement-to-support-advancing-nationwide-interoperability-of-electronic-health-information\">https://sequoiaproject.org/onc-awards-the-sequoia-project-a-cooperative-agreement-for-the-trusted-exchange-framework-and-common-agreement-to-support-advancing-nationwide-interoperability-of-electronic-health-information</a>.\n",
      "    \\34\\ onc tefca recognized coordinating entity. (2022, january). \n",
      "fhir roadmap for tefca exchange, version 1. retrieved from <a href=\"https://rce.sequoiaproject.org/wp-content/uploads/2022/01/fhir-roadmap-v1.0_updated.pdf\">https://rce.sequoiaproject.org/wp-content/uploads/2022/01/fhir-roadmap-v1.0_updated.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    section 5006 of the cures act requires medicaid agencies to publish \n",
      "online a directory of certain physicians who participate in the state's \n",
      "fee-for-service (ffs) program. medicaid agencies must update these \n",
      "directories at least annually and include providers' names, \n",
      "specialties, addresses, and telephone numbers. for physicians \n",
      "participating in a primary care case-management system, the directory \n",
      "must also indicate whether they are accepting medicaid beneficiaries as \n",
      "new patients and the physician's cultural and linguistic capabilities. \n",
      "other providers may be included at the state's option, as may certain \n",
      "additional information such as the physician's or provider's internet \n",
      "website.\n",
      "    in 2016, onc and fha hosted a provider directory workshop to \n",
      "convene public and private stakeholders, including health it \n",
      "developers, organizations, and vendors involved in directory solutions, \n",
      "to discuss provider directory issues and challenges.<sup>35 36</sup> \n",
      "the workshop highlighted widely held concerns about provider directory \n",
      "data quality, administrative burden, and consumer satisfaction. to \n",
      "address these concerns, onc and fha launched the healthcare directory \n",
      "initiative. this group developed the vhdir fhir ig to define the \n",
      "underlying architecture for a proposed national directory of validated \n",
      "healthcare data and to provide technical specifications for the \n",
      "exchange of such information.\\37\\ fhir standards and igs, including the \n",
      "vhdir ig, are developed through an industry-led, consensus-based public \n",
      "process. onc, hhs, and cms are all engaged in work to promote the \n",
      "adoption and use of the fhir standards for interoperability beyond the \n",
      "provider directory domain.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\35\\ onc. (2016, june 24). onc/fha provider directory workshop. \n",
      "retrieved from <a href=\"https://www.ca-hie.org/site-content/cahie-knowledge-network-2016-06-24-healthcare-directory.pdf\">https://www.ca-hie.org/site-content/cahie-knowledge-network-2016-06-24-healthcare-directory.pdf</a>.\n",
      "    \\36\\ health <a href=\"http://it.gov\">it.gov</a>. (2020, january 17). federal health \n",
      "architecture (fha). retrieved from <a href=\"https://www.healthit.gov/archive/topic/onc-hitech-programs/federal-health-architecture-fha\">https://www.healthit.gov/archive/topic/onc-hitech-programs/federal-health-architecture-fha</a>.\n",
      "    \\37\\ onc tech lab standards coordination. (2019, june 25). \n",
      "healthcare directory. retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/healthcare+directory\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/healthcare+directory</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    building on that work, in 2020, onc, through the fhir at scale \n",
      "taskforce (fast),\\38\\ identified numerous technical challenges \n",
      "associated with directories, particularly related to digital \n",
      "endpoints.<sup>39 40</sup> specifically, fast\n",
      "\n",
      "[[page 61022]]\n",
      "\n",
      "determined that there is neither an authoritative source for digital \n",
      "contact information nor a consistent method for locating such \n",
      "information. onc conducted research, stakeholder engagement, and key \n",
      "technical development activities to establish the technical framework \n",
      "and capabilities for an adaptable and scalable ndh.<sup>41 42</sup>\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\38\\ fast. (2022, march 16), fast home. retrieved from <a href=\"https://confluence.hl7.org/display/fast/fhir+at+scale+taskforce+%28fast%29+home\">https://confluence.hl7.org/display/fast/fhir+at+scale+taskforce+%28fast%29+home</a>.\n",
      "    \\39\\ fast. (2020, december 17). proposed solutions working \n",
      "document: directory (v3). retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx</a>.\n",
      "    \\40\\ endpoints provide a simple, secure, scalable, and \n",
      "standards-based way for participants to send authenticated, \n",
      "encrypted health information directly to known, trusted recipients \n",
      "over the internet. see cms. (2016). health information exchange \n",
      "(hie) page. retrieved from <a href=\"https://nppes.cms.hhs.gov/webhelp/nppeshelp/health%20information%20exchange.html\">https://nppes.cms.hhs.gov/webhelp/nppeshelp/health%20information%20exchange.html</a>.\n",
      "    \\41\\ onc tech lab standards coordination. (2019, june 27). \n",
      "healthcare directory workshop--2019. retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/provider+directory+workshop+-+2016\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/provider+directory+workshop+-+2016</a>.\n",
      "    \\42\\ onc tech lab standards coordination. (2019, june 27). day 1 \n",
      "agenda presentations. retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/day+1-+agenda-presentations\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/day+1-+agenda-presentations</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the fast analysis concluded that a more robust directory is the \n",
      "needed long-term solution to overcome the technical barriers of using \n",
      "nppes as a digital endpoint repository. the taskforce noted that nppes \n",
      "was not originally designed to hold, validate, and maintain digital \n",
      "contact information required to ``appropriately describe the endpoints \n",
      "for fhir.'' \\43\\ they described that nppes cannot sufficiently capture \n",
      "the data complexity necessary to fully facilitate electronic data \n",
      "exchange. for instance, provider-organization relationship information \n",
      "may be necessary to determine which endpoints are relevant for \n",
      "particular use cases. the taskforce noted that other organizations that \n",
      "are not currently included in nppes, such as payers, are vital to \n",
      "capture in a directory to effectively utilize digital endpoint \n",
      "information.\\44\\ these challenges to using nppes as a digital endpoint \n",
      "directory are evidenced by the low rate of provider digital endpoint \n",
      "submission. in 2021, cms determined that 2.9 million providers still \n",
      "had missing digital endpoints in nppes.\\45\\ additionally, the taskforce \n",
      "found that the majority of the direct addresses and fhir endpoints that \n",
      "providers had submitted were invalid, a strong indication of the issues \n",
      "associated with using nppes as an endpoint repository. the taskforce \n",
      "described that there has ``historically [been a] low rate of \n",
      "publication of valid direct addresses in nppes,'' and ``that only 4.3 \n",
      "percent of fhir endpoints \\46\\ were valid as of 8/20/2020.'' \\47\\ the \n",
      "fast report concluded that for a digital endpoint directory to be \n",
      "effective, the directory ``needs to be based on a broader set of \n",
      "validated healthcare participants and relationships.'' \\48\\ this means \n",
      "that such a directory must be designed to adapt to industry or market \n",
      "demands for its use. fast proposed a ``national repository for \n",
      "validated information related to healthcare endpoints,'' which \n",
      "described the development of a centralized directory as a critical next \n",
      "step in promoting digital contact information discovery, and therefore \n",
      "interoperability, across the healthcare system.\\49\\ fast described that \n",
      "``one authoritative national source of truth'' is needed to help \n",
      "address the issues with current directory systems and identified cms as \n",
      "the potential owner of this asset.<sup>50 51</sup>\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\43\\ fast. (2020, december 17). proposed solutions working \n",
      "document: directory (v3). retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx</a>.\n",
      "    \\44\\ ibid.\n",
      "    \\45\\ cms. (2021, december 11). public reporting of missing \n",
      "digital contact information. retrieved from <a href=\"https://data.cms.gov/provider-compliance/public-reporting-of-missing-digital-contact-information\">https://data.cms.gov/provider-compliance/public-reporting-of-missing-digital-contact-information</a>.\n",
      "    \\46\\ fhir endpoints are just one type of endpoint collected in \n",
      "nppes and refer to a fhir-compatible endpoint such as a fhir url. \n",
      "other types of endpoints used by providers are not necessarily fhir-\n",
      "compatible, such as a direct address.\n",
      "    \\47\\ fast. (2020, december 17). proposed solutions working \n",
      "document: directory (v3). retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx</a>.\n",
      "    \\48\\ ibid.\n",
      "    \\49\\ ibid.\n",
      "    \\50\\ ibid.\n",
      "    \\51\\ note, the fast initiative will transition from an onc-\n",
      "convened initiative into an official hl7 fhir accelerator in 2022.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in may 2020, cms published a final rule, ``medicare and medicaid \n",
      "programs; patient protection and affordable care act; interoperability \n",
      "and patient access for medicare advantage organization and medicaid \n",
      "managed care plans, state medicaid agencies, chip agencies and chip \n",
      "managed care entities, issuers of qualified health plans on the \n",
      "federally-facilitated exchanges, and healthcare providers'' (cms \n",
      "interoperability and patient access final rule),\\52\\ in which we \n",
      "required that, by january 1, 2021, ma organizations, medicaid \\53\\ and \n",
      "chip ffs \\54\\ programs, medicaid managed care plans,\\55\\ and chip \n",
      "managed care entities \\56\\ make standardized information about their \n",
      "provider networks available through a provider directory api that is \n",
      "conformant with technical standards finalized by onc.<sup>57 58</sup> \n",
      "those provider directory apis are required to be accessible via a \n",
      "public-facing digital endpoint on the payer's website to ensure public \n",
      "discovery and access. payers must make all directory information \n",
      "available to current and prospective enrollees and the public through \n",
      "the provider directory api within 30 calendar days of receiving new or \n",
      "updated provider directory data.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\52\\ cms. (2020, may 1). 85 fr 25510, see page 25513. retrieved \n",
      "from <a href=\"https://www.federalregister.gov/d/2020-05050\">https://www.federalregister.gov/d/2020-05050</a>.\n",
      "    \\53\\ we note 42 cfr 431.70 as the current regulation requiring \n",
      "provider directory apis.\n",
      "    \\54\\ we note 42 cfr 457.760 as the current regulation requiring \n",
      "provider directory apis.\n",
      "    \\55\\ we note 42 cfr 438.242(b)(6) as the current regulation \n",
      "requiring provider directory apis.\n",
      "    \\56\\ we note 42 cfr 457.1233(d), through cross-reference to \n",
      "sec.  438.242, as the current regulation requiring provider \n",
      "directory apis.\n",
      "    \\57\\ while other aspects of that rule applied to issuers of qhps \n",
      "on the ffes, this requirement did not.\n",
      "    \\58\\ onc. (2020, may 1). 45 cfr 170.215. retrieved from <a href=\"https://www.federalregister.gov/documents/2020/05/01/2020-07419/21st-century-cures-act-interoperability-information-blocking-and-the-onc-health-it-certification\">https://www.federalregister.gov/documents/2020/05/01/2020-07419/21st-century-cures-act-interoperability-information-blocking-and-the-onc-health-it-certification</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in the same final rule, cms finalized a policy to publicly report \n",
      "the names and npis of those providers who do not have digital contact \n",
      "information included in nppes.\\59\\ in december 2021, cms published a \n",
      "report of approximately 2.9 million npis associated with providers and \n",
      "clinicians without digital contact information in nppes,\\60\\ an \n",
      "initiative cms has undertaken to improve provider engagement. cms noted \n",
      "that the nppes missing digital contact information report will be \n",
      "updated quarterly. the most recent data for the second quarter of 2022, \n",
      "reported july 25, 2022, do not show any significant improvements in the \n",
      "number of providers with missing digital contact information compared \n",
      "to the december 2021 report.\\61\\ these data underscore fast's call for \n",
      "a more robust long-term digital endpoint directory solution.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\59\\ cms. (2020, may 1). 85 fr 25510. see page 25584. retrieved \n",
      "from <a href=\"https://www.federalregister.gov/d/2020-05050/p-767\">https://www.federalregister.gov/d/2020-05050/p-767</a>.\n",
      "    \\60\\ cms. (2021, december 11). public reporting of missing \n",
      "digital contact information. retrieved from <a href=\"https://data.cms.gov/provider-compliance/public-reporting-of-missing-digital-contact-information\">https://data.cms.gov/provider-compliance/public-reporting-of-missing-digital-contact-information</a>.\n",
      "    \\61\\ cms. (2021, july 25). public reporting of missing digital \n",
      "contact information. retrieved from <a href=\"https://data.cms.gov/provider-compliance/public-reporting-of-missing-digital-contact-information\">https://data.cms.gov/provider-compliance/public-reporting-of-missing-digital-contact-information</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in 2020, the consolidated appropriations act, 2021 (caa) (pub. l. \n",
      "116-260), division bb, section 116 added a new section 2799a-5 to the \n",
      "phsa, section 720 to the employee retirement income security act of \n",
      "1974 (erisa), and section 9820 to the internal revenue code of 1986. \n",
      "these\n",
      "\n",
      "[[page 61023]]\n",
      "\n",
      "provisions require group health plans and health insurance issuers \n",
      "offering group or individual health insurance coverage to publish a \n",
      "provider directory and to establish a process to verify data in the \n",
      "directory at least every 90 days, beginning with plan years that start \n",
      "on or after january 1, 2022. those directories must include names, \n",
      "addresses, specialty, telephone numbers, and digital contact \n",
      "information for healthcare providers and healthcare facilities. in \n",
      "addition, the caa added a new section 2799b-9 to the phsa, which \n",
      "requires each healthcare provider and healthcare facility to have in \n",
      "place business processes to ensure the timely provision of provider \n",
      "directory information to those payers.\n",
      "    to address part of the issue of inaccurate directory information, \n",
      "the caa established consumer protections for incorrect provider \n",
      "directory information identifying a provider or facility as in-network \n",
      "for an item or service. if a patient receives provider directory \n",
      "information identifying a provider or healthcare facility as in-network \n",
      "with regard to an item or service, and receives that item or service \n",
      "from that provider or healthcare facility, and that provider or \n",
      "healthcare facility is actually out-of-network, their plan or issuer \n",
      "must limit cost-sharing to in-network terms that would apply to items \n",
      "or services that were furnished by an in-network provider or facility, \n",
      "and apply the deductible or out-of-pocket maximums as if the provider \n",
      "or facility were in-network. we note that further rulemaking is \n",
      "forthcoming for the provider directory requirements of that law, as \n",
      "discussed in the ``requirements related to surprise billing; part i'' \n",
      "interim final rule (86 fr 36872).<sup>62 63</sup>\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\62\\ ``requirements related to surprise billing; part i (86 fr \n",
      "36872, 36876).\n",
      "    \\63\\ interim guidance can be found at p. 7-8 of ``faqs about \n",
      "affordable care act and consolidated appropriations act, 2021 \n",
      "implementation part 49'' at <a href=\"https://www.cms.gov/cciio/resources/fact-sheets-and-faqs/downloads/faqs-part-49.pdf\">https://www.cms.gov/cciio/resources/fact-sheets-and-faqs/downloads/faqs-part-49.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    in addition to these efforts, industry stakeholders have stepped in \n",
      "to try and fill this directory gap by developing large commercial \n",
      "digital endpoint directories.<sup>64 65</sup> although industry-\n",
      "developed directories have helped facilitate communication among users, \n",
      "access to their data is often fee-based, which inherently creates \n",
      "barriers to use and inequity for healthcare entities that do not have \n",
      "the resources or funds to buy access to these privately-owned endpoint \n",
      "directories. a free and publicly available cms-sponsored ndh could \n",
      "minimize and may even eliminate this cost barrier associated with \n",
      "private industry created digital endpoint directories, and ensure all \n",
      "stakeholders have equal access to the relevant digital contact \n",
      "information they may need to securely exchange health data. \n",
      "additionally, competing directories can lead to fragmentation and still \n",
      "require providers to submit similar information to multiple directories \n",
      "if information is not shared among directories. the fast team concluded \n",
      "there should be one directory that acts as a centralized data hub to \n",
      "build trust, improve accuracy, and reduce the administrative burden on \n",
      "providers that submit data to multiple directories.\\66\\ as discussed in \n",
      "section iii, industry stakeholders could utilize the data contained in \n",
      "an ndh to populate their own directories, supplementing it with \n",
      "additional data that could be beneficial for end users.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\64\\ caqh. (2022). caqh endpoint directory. retrieved from \n",
      "<a href=\"https://www.caqh.org/solutions/caqh-endpoint-directory\">https://www.caqh.org/solutions/caqh-endpoint-directory</a>.\n",
      "    \\65\\ globenewswire. (2022, march 10). caremesh launches \n",
      "developer portal and apis for its national provider directory. \n",
      "retrieved from <a href=\"https://www.globenewswire.com/news-release/2022/03/10/2401103/0/en/caremesh-launches-developer-portal-and-apis-for-its-national-provider-directory.html\">https://www.globenewswire.com/news-release/2022/03/10/2401103/0/en/caremesh-launches-developer-portal-and-apis-for-its-national-provider-directory.html</a>.\n",
      "    \\66\\ fhir at scale taskforce (fast). (2020, june 1 & 15). sme \n",
      "session summary report. retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/fast+proposed+solutions+-+subject+matter+expert+%28sme%29+panel+sessions?preview=/149848177/181174490/fast-directory%20sme%20session%20summary%20report.pdf\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/fast+proposed+solutions+-+subject+matter+expert+%28sme%29+panel+sessions?preview=/149848177/181174490/fast-directory%20sme%20session%20summary%20report.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    the efforts noted previously have continued to drive improvements \n",
      "to provider directories and lead the discussion on how to improve \n",
      "patient access to information about healthcare services. however, the \n",
      "effort required to update and maintain these numerous and varied \n",
      "directories presents a significant burden across the healthcare \n",
      "industry, and we continue to see challenges with data availability and \n",
      "accuracy. we believe that cms could build upon the previous work in \n",
      "nppes to help address some of these challenges by streamlining our own \n",
      "data and making that data available in an enhanced form for public \n",
      "use.\\67\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\67\\ cms. (2022, february 11). obrhi faqs. retrieved from \n",
      "https://www.cms.gov/about-cms/obrhi/\n",
      "faqs#:~:text=digital%20contact%20information%2c%20also%20known,truste\n",
      "d%20recipients%20over%20the%20internet.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "iii. national directory of healthcare providers & services concept and \n",
      "perceived benefits\n",
      "\n",
      "a. national directory of healthcare providers & services concept and \n",
      "perceived benefits\n",
      "\n",
      "    a centralized, validated ndh could help to alleviate current \n",
      "directory challenges by acting as a ``centralized data hub'' for \n",
      "healthcare directory information. by consolidating data into one source \n",
      "and reducing the number of places directory information must be \n",
      "maintained, an ndh could reduce the overall burden of keeping \n",
      "healthcare directory data up-to-date and accurate. for example, \n",
      "currently, when a provider changes their office location, that provider \n",
      "must update at least two separate cms systems, nppes and the medicare \n",
      "provider enrollment, chain, and ownership system (pecos), as well as an \n",
      "average of 20 separate payers' directories per physician practice.\\68\\ \n",
      "with the establishment of an ndh, that provider may be able to update \n",
      "their information one time, through a single point of entry in an ndh, \n",
      "which would make that data available not only to cms, but also publicly \n",
      "available for other payers and developers to utilize in their own \n",
      "directories. we believe that providers and their staff would be more \n",
      "likely to keep a single ndh updated, and verify it more frequently, \n",
      "thus improving accuracy within an ndh, cms systems, and in payers' \n",
      "directories.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\68\\ caqh. (2019, november 13). caqh survey: maintaining \n",
      "provider directories costs us physician practices 2.76 billion \n",
      "annually. retrieved from <a href=\"https://www.caqh.org/about/press-release/caqh-survey-maintaining-provider-directories-costs-us-physician-practices-276\">https://www.caqh.org/about/press-release/caqh-survey-maintaining-provider-directories-costs-us-physician-practices-276</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    a core requirement of an ndh would be the capability to validate \n",
      "and verify submitted information. in the context of an ndh, validation \n",
      "and verification can refer to separate but related processes. first, it \n",
      "is important to validate that the format of submitted data meets the \n",
      "required standards. this could be done, for example, by checking for \n",
      "the existence of required data elements, that those data elements are \n",
      "in the appropriate format, that references to existing resources are \n",
      "correct, and that any codes are from appropriate value sets. second, it \n",
      "is important to verify the accuracy of data against a primary source. \n",
      "for example, a digital endpoint could be verified by sending a secure \n",
      "message to that endpoint asking the provider to complete verification \n",
      "through some action. we do not expect that all data elements would \n",
      "require the same level of validation and verification. as part of \n",
      "initial phases of ndh planning and development, cms would assess \n",
      "possible verification methods and sources. through this rfi, we hope to \n",
      "receive comments on this topic that could inform that assessment.\n",
      "    to support the ``centralized data hub'' concept, and improve \n",
      "directory function, cms seeks feedback on potentially establishing an \n",
      "ndh that would overlay existing cms systems that have directory-like \n",
      "functions,\n",
      "\n",
      "[[page 61024]]\n",
      "\n",
      "consolidate the data within them, and provide a single point of entry \n",
      "for providers to streamline workflows. we also believe that cms could \n",
      "reduce the burden on providers and payers by building this directory \n",
      "using the most up-to-date technology, leveraging fhir apis. fhir apis \n",
      "would allow external stakeholders to pull data from an ndh to use as a \n",
      "data source for their own directories, thus avoiding duplicative data \n",
      "collection efforts. we note that in this use case example, the payers \n",
      "pulling provider data from an ndh would be responsible for verifying \n",
      "their own list of network providers.\n",
      "    using a fhir api, stakeholders could access and use ndh data to \n",
      "support a variety of use cases. industry would be able to transform the \n",
      "data for purposes beyond what a public-facing cms portal would be able \n",
      "to provide, and present it in a customized format for consumers, \n",
      "commercial, or operational use. we envision the following as other \n",
      "potential use cases for a fhir api-enabled ndh:\n",
      "    <bullet> a patient or consumer could use an ndh directly, or \n",
      "through an app of their choosing that connects to an ndh via a fhir \n",
      "api, to locate a provider.\n",
      "    <bullet> to support interoperability, a provider could connect to \n",
      "an ndh through the fhir api to request the digital endpoint a \n",
      "particular payer uses to receive prior authorization requests. once \n",
      "returned by an ndh, the provider's electronic health record (ehr) or \n",
      "practice management system could use that digital contact information \n",
      "to direct a prior authorization request to the appropriate payer.\n",
      "    <bullet> a payer (such as an ma organization, a private insurer, or \n",
      "state medicaid agency) could use an ndh, via a fhir api, to update its \n",
      "own provider directory with the latest information. this would allow \n",
      "the payer to present a provider directory without having to bear the \n",
      "burden of collecting data that is already available through an ndh from \n",
      "individual providers. the providers would also experience less burden \n",
      "because they would only need to update data in an ndh, and not multiple \n",
      "payer-specific directories. we note that payers would still be required \n",
      "to verify the accuracy of their network information to ensure that the \n",
      "provider directory is accurate.\n",
      "    we recognize that widespread adoption of, and trust in, an ndh \n",
      "would be necessary to fulfill this role as a ``centralized data hub'' \n",
      "for directory data. without up-to-date, useful, and comprehensive \n",
      "directory data, an ndh would not be able to address existing healthcare \n",
      "directory challenges. we seek feedback on both positive and negative \n",
      "incentives that could be put into place to encourage widespread ndh \n",
      "use. these incentives may be for providers to update and maintain data \n",
      "and/or for payers to use the data from an ndh rather than requiring \n",
      "duplicative submissions from providers. we want to understand what \n",
      "incentives, programs, or policies might promote timely and accurate \n",
      "data reporting, as well as robust ndh usage by stakeholders.\n",
      "    we note that we previously requested comments, summarized in the \n",
      "2020 cms interoperability and patient access final rule,\\69\\ regarding \n",
      "policies that we could implement to encourage providers to update their \n",
      "digital contact information in nppes. several commenters suggested \n",
      "incorporating a requirement to have up-to-date digital contact \n",
      "information in nppes into the merit-based incentive payment system \n",
      "(mips) program. we acknowledge a logical relationship with the \n",
      "promoting interoperability category of mips and continue to explore \n",
      "that avenue. however, we also realize the limitations of that \n",
      "possibility, as only certain types of clinicians who see medicare \n",
      "patients are eligible to participate in mips and many medicare \n",
      "providers participate in alternative programs.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\69\\ cms. (2020, may 1). 85 fr 25510. see pages 25581-84. \n",
      "retrieved from <a href=\"https://www.federalregister.gov/d/2020-05050\">https://www.federalregister.gov/d/2020-05050</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    we understand that it would be critical to allow listed entities, \n",
      "particularly providers, to delegate or authorize other individuals, \n",
      "either in their organization or intermediary organizations, to submit \n",
      "directory data on their behalf to reduce burden and ensure that data \n",
      "submission is feasible, timely, and accurate. we are using the term \n",
      "``listed entities'' to refer to individuals and groups whose data could \n",
      "be available in an ndh. we want to understand current industry best \n",
      "practices for delegating authority and aspects of this functionality \n",
      "that could be used with an ndh.\n",
      "\n",
      "b. interactions with current cms data systems and impacts to business \n",
      "processes\n",
      "\n",
      "    integrating an ndh with current cms-maintained systems, such as \n",
      "nppes, pecos, and care compare, could streamline data collection by \n",
      "acting as the single entry-point for listed entities to update their \n",
      "data across multiple cms systems. such data interactions could address \n",
      "provider data accuracy and consistency issues among cms systems.\\70\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\70\\ levinson, d. r. (2013, may). improvements needed to ensure \n",
      "provider enumeration and medicare enrollment data are accurate, \n",
      "complete, and consistent. retrieved from <a href=\"https://oig.hhs.gov/oei/reports/oei-07-09-00440.pdf\">https://oig.hhs.gov/oei/reports/oei-07-09-00440.pdf</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    examples of existing cms data collection and reporting systems that \n",
      "an ndh could interface with to streamline data processes include:\n",
      "    <bullet> nppes: developed to assign npis to healthcare \n",
      "providers.\\71\\ once an npi is assigned, cms, through nppes, publishes \n",
      "the parts of the npi record that have public relevance, including the \n",
      "provider's name, location, phone number, gender, specialty (taxonomy), \n",
      "practice address, and other identifiers for public use.\\72\\ authorized \n",
      "under the health insurance portability and accountability act of 1996 \n",
      "(hipaa) (section 1173(b) of the act and at 45 cfr 160.103, 162.402, and \n",
      "162.408 of the regulations).\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\71\\ cms. nppes. retrieved from <a href=\"https://nppes.cms.hhs.gov/#/\">https://nppes.cms.hhs.gov/#/</a>.\n",
      "    \\72\\ cms. nppes npi registry. retrieved from <a href=\"https://npiregistry.cms.hhs.gov/\">https://npiregistry.cms.hhs.gov/</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    <bullet> pecos: supports the medicare provider and supplier \n",
      "enrollment process. registered providers and suppliers use pecos to \n",
      "securely submit and manage their medicare enrollment and revalidation \n",
      "processes. this system and its information attestation workflows are \n",
      "integral to program integrity prevention, investigation, and \n",
      "enforcement activities. we note that pecos data are not publicly \n",
      "available. rather, the system only contains information on medicare \n",
      "providers and suppliers, and updates are limited by medicare enrollment \n",
      "requirements. authorized under sections 1102(a), 1128, 1814(a), \n",
      "1815(a), 1833(e), 1871, and 1886(d)(5)(f) of the act; 1842(r); section \n",
      "1124(a)(1), and 1124a, section 4313, as amended, of the bba of 1997; \n",
      "and section 31001(i) (31 u.s.c. 7701) of the debt collection \n",
      "improvement act of 1996 (dcia) (pub. l. 104-134), as amended.\n",
      "    <bullet> medicare care compare: public, consumer-facing directory \n",
      "containing contact and quality information on certain types of medicare \n",
      "providers, suppliers, and provider organizations, including doctors, \n",
      "clinicians, hospitals, nursing homes, home health and hospice care, \n",
      "inpatient rehabilitation facilities, long-term care hospitals, and \n",
      "dialysis facilities. care compare data are populated from several data \n",
      "sources, including pecos, nppes and cms quality reporting programs. \n",
      "care compare allows for comparison of medicare providers and suppliers. \n",
      "we are authorized to collect and publicly report the following:\n",
      "    ++ certain physician quality data, in part, by section 10331(a)(1) \n",
      "of the affordable care act, section 104(e) of the medicare access and \n",
      "chip\n",
      "\n",
      "[[page 61025]]\n",
      "\n",
      "reauthorization act of 2015 (macra) and section 1848 of the act.\n",
      "    ++ certain hospital quality data under section 501(b) of mma of \n",
      "2003 and section 5001(a) of the deficit reduction act of 2005 and \n",
      "section 1886 of the act.\n",
      "    ++ certain hospice quality data under section 3004 of the \n",
      "affordable care act and section 1814 of the act.\n",
      "    ++ certain long-term care hospital quality data under section 3004 \n",
      "of the affordable care act and section 1886(m)(5) of the act.\n",
      "    ++ certain inpatient rehabilitation facility quality data under \n",
      "section 3004 of the affordable care act and section 1886(j)(7) of the \n",
      "act.\n",
      "    ++ certain home health quality data under section 1895(b)(3)(b)(v) \n",
      "of the act.\n",
      "    ++ certain dialysis facility quality data under section 1881 of the \n",
      "act and required by 42 cfr 405.2100 through 405.2171 (now at 42 cfr \n",
      "414.330, 488.60, and 494.100 through 494.180).\n",
      "    ++ certain skilled nursing home quality data under section \n",
      "1888(e)(6) of the act, modified under the improving medicare post-acute \n",
      "care transformation (impact) act of 2014.\n",
      "    we note that we are not specifically requesting comment on \n",
      "replacing any of these or other cms systems with an ndh. rather, we \n",
      "believe that an ndh could be a tool that works in combination with \n",
      "these systems to streamline and improve the processes for collecting, \n",
      "maintaining, and presenting information in a more user-friendly manner. \n",
      "as discussed earlier, we envision that an ndh would create efficiencies \n",
      "by serving as a ``centralized data hub'' that would feed data to these \n",
      "other systems to use within their intended functions. an ndh built with \n",
      "modern data exchange capabilities, such as apis, could share data with \n",
      "other cms systems in real-time, improving data accuracy across cms \n",
      "while eliminating the need for stakeholders to update information in \n",
      "multiple places.\n",
      "    within these systems, cms collects various demographic, contact, \n",
      "and healthcare practice data from or about many provider types and \n",
      "payer entities. these systems, in combination with other data systems \n",
      "that cms maintains, have been established over time to perform their \n",
      "specific roles and in total contain a significant breadth of provider \n",
      "and payer data. by strengthening current efforts to streamline data \n",
      "processes, cms could further improve the value and usability of its \n",
      "data. for example, linking provider contact information and quality \n",
      "data into one streamlined cms resource could help consumers identify, \n",
      "compare, and locate providers who meet their specific needs and \n",
      "preferences. we also note that linking this information may be valuable \n",
      "for providers and payers participating in value-based payment models. \n",
      "we seek feedback on how we could combine these datasets into a single \n",
      "interface to be able to display more complex information, such as a \n",
      "clinician's relationship with hospitals or nursing facilities. this \n",
      "data aggregation may better support patients when choosing a healthcare \n",
      "facility or help providers locate one another for improved data \n",
      "exchange and care coordination.\n",
      "    we have increasingly emphasized improving the interoperability of \n",
      "data collected across our systems. as we have discussed, we believe \n",
      "existing directory-like information within cms' systems could benefit \n",
      "from the operational efficiencies and streamlined effort of an ndh. we \n",
      "seek comment, prompted by the questions below, on various aspects that \n",
      "we should consider as we evaluate the feasibility, scope, and \n",
      "functionality of an ndh.\n",
      "\n",
      "c. comment solicitation\n",
      "\n",
      "    we solicit comments on the following topics related to the \n",
      "establishment of an ndh:\n",
      "    <bullet> what benefits and challenges might arise while integrating \n",
      "data from cms systems (such as nppes, pecos, and medicare care compare) \n",
      "into an ndh? what data elements from each of these systems would be \n",
      "important to include in an ndh versus only being available directly \n",
      "from the system in question?\n",
      "    <bullet> are there other cms, hhs (for example, hpms, title x \n",
      "family planning clinic locator, acl's eldercare resource locator, \n",
      "samhsa's behavioral health resource locator, hrsa's national \n",
      "practitioner data bank, or hrsa's get health care), or federal systems \n",
      "with which an ndh could or should interface to exchange directory data?\n",
      "    ++ what are these systems, how should an ndh interact with these \n",
      "systems, and for what purpose?\n",
      "    ++ what data elements from each of these systems would be important \n",
      "to include in an ndh?\n",
      "    <bullet> are there systems at the state or local level that would \n",
      "be beneficial for an ndh to interact with, such as those for licensing, \n",
      "credentialing, medicaid provider enrollment, emergency response (for \n",
      "example, the patient unified lookup system for emergencies (pulse) \n",
      "\\73\\) or public health?\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\73\\ onc. (2022, march 4). patient unified lookup system for \n",
      "emergencies (pulse). retrieved from <a href=\"https://www.healthit.gov/topic/health-it-health-care-settings/public-health/patient-unified-lookup-system-for-emergencies-pulse\">https://www.healthit.gov/topic/health-it-health-care-settings/public-health/patient-unified-lookup-system-for-emergencies-pulse</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    ++ what data elements would be beneficial to include in an ndh for \n",
      "interaction with state or local systems, including state-based \n",
      "exchanges or existing state-level provider directories?\n",
      "    <bullet> added by the cures act, section 3001(c)(9)(d)(i) of the \n",
      "phsa requires onc to create, annually update, and publish on its \n",
      "website a ``list of the health information networks that have adopted \n",
      "the common agreement and are capable of trusted exchange pursuant to \n",
      "the common agreement.'' are there beneficial ways an ndh could \n",
      "interface with such a list or provide additional information that may \n",
      "be useful, such as a directory of services? are there use cases for \n",
      "integrating such health information network data in an ndh?\n",
      "    <bullet> what types of data should be publicly accessible from an \n",
      "ndh (either from a consumer-facing cms website or via an api) and what \n",
      "types of data would be helpful for cms to collect for only internal use \n",
      "(such as for program integrity purposes or for provider privacy)?\n",
      "    <bullet> are there particular data elements that cms currently \n",
      "collects or should collect as part of an ndh that we should not make \n",
      "publicly available, regardless of usefulness to consumers, due to its \n",
      "proprietary nature? to the extent that an ndh might collect proprietary \n",
      "data from various entities, what privacy protections should be in place \n",
      "for these data?\n",
      "    <bullet> we want an ndh to support health equity goals throughout \n",
      "the healthcare system. what listed entities, data elements, or ndh \n",
      "functionalities would help underserved populations receive healthcare \n",
      "services? what considerations would be relevant to address equity \n",
      "issues during the planning, development, or implementation of an ndh?\n",
      "    <bullet> how could ndh use within the healthcare industry be \n",
      "incentivized? how could cms incentivize other organizations, such as \n",
      "payers, health systems, and public health entities to engage with an \n",
      "ndh?\n",
      "    <bullet> how could cms evaluate whether an ndh achieves the \n",
      "targeted outcomes for its end users (for example, that it saves \n",
      "providers time or that it simplifies patients' ability to find care)? \n",
      "we solicit comments on an ndh concept and high-level functionality:\n",
      "    <bullet> would an ndh as described provide the benefits outlined \n",
      "previously?\n",
      "    <bullet> would an ndh as described reduce the directory data \n",
      "submission burden on providers?\n",
      "\n",
      "[[page 61026]]\n",
      "\n",
      "    <bullet> how could a centralized source for digital contact \n",
      "information benefit providers, payers, and other stakeholders?\n",
      "    <bullet> we have heard interest in including additional healthcare-\n",
      "related entities and provider types beyond physicians in an ndh-type \n",
      "directory beyond those providers included in current cms systems or \n",
      "typical payers' directories? for example, should an ndh include allied \n",
      "health professionals, post-acute care providers, dentists, emergency \n",
      "medical services, nurse practitioners, physician assistants, certified \n",
      "nurse midwives, providers of dental, vision, and hearing care, \n",
      "behavioral health providers (psychiatrists, clinical psychologists, \n",
      "licensed professional counselors, licensed clinical social workers, \n",
      "etc.), suppliers, pharmacies, public health entities, community \n",
      "organizations, nursing facilities, suppliers of durable medical \n",
      "equipment or health information networks? we specifically request \n",
      "comment on entities that may not currently be included in cms systems.\n",
      "    ++ for what use cases should these various entities be included?\n",
      "    <bullet> are there ndh use cases to address social drivers and/or \n",
      "determinants of health? if so, what are they? are there other entities, \n",
      "relationships, or data elements that would be helpful to include in an \n",
      "ndh to help address the social drivers and/or determinants of health \n",
      "(for example, community-based organizations that provide housing-\n",
      "related services and supports, non-medical transportation, home-\n",
      "delivered meals, educational services, employment, community \n",
      "integration and social supports, or case management)? what types of \n",
      "entities or data elements relating to social drivers and/or \n",
      "determinants of health should not be included in an ndh?\n",
      "    <bullet> what provider or entity data elements would be helpful to \n",
      "include in an ndh for use cases relating to patient access and consumer \n",
      "choice (for example, finding providers or comparing networks)?\n",
      "    ++ what data elements would be useful to include in an ndh to help \n",
      "patients locate providers who meet their specific needs and \n",
      "preferences?\n",
      "    ++ would it be helpful to include data elements such as provider \n",
      "languages spoken other than english, specific office accessibility \n",
      "features for patients with disabilities and/or limited mobility, \n",
      "accessible examination or medical diagnostic equipment, or a provider's \n",
      "cultural competencies, such as the national committee for quality \n",
      "assurance's health equity accreditation (though we note that these data \n",
      "elements may be difficult to verify in some cases)?\n",
      "    <bullet> what provider or entity data elements would be helpful to \n",
      "include in an ndh for use cases relating to care coordination and \n",
      "essential business transactions (for example, prior authorization \n",
      "requests, referrals, public health reporting)?\n",
      "    ++ what specific health information exchange or use cases would be \n",
      "important for an ndh to support?\n",
      "    ++ are there other types of data transactions or use cases beyond \n",
      "those already discussed that would be helpful for an ndh to support?\n",
      "    ++ are there additional data elements beyond those already \n",
      "discussed that would be useful for these use cases?\n",
      "    ++ beyond using fhir apis, what strategic approaches should be \n",
      "taken to ensure that directory data are interoperable?\n",
      "    <bullet> the covid-19 pandemic has highlighted a need for public \n",
      "health systems to be better connected to providers and with each other. \n",
      "would there be benefits to including public health entities in an ndh?\n",
      "    ++ what public health use cases would it be helpful for an ndh to \n",
      "support (for example, facilitating digital contact endpoint discovery \n",
      "for public health reporting, or to provide additional data for public \n",
      "health entities' analytics)?\n",
      "    ++ what data elements would be useful to collect from these \n",
      "entities to advance public health goals?\n",
      "    <bullet> understanding that individuals often move between public \n",
      "and commercial health insurance coverage, what strategies could cms \n",
      "pursue to ensure that an ndh is comprehensive both nationwide and \n",
      "market-wide?\n",
      "    ++ are there specific strategies, technical solutions, or policies \n",
      "cms could pursue to encourage participation in an ndh by group health \n",
      "plans and health insurance issuers offering group or individual health \n",
      "insurance coverage for programs or product lines not currently under \n",
      "cms' purview?\n",
      "    <bullet> are there use cases for which it would be helpful for an \n",
      "ndh to support state and local governments? for example, are there \n",
      "specific types of providers, data elements, or technical requirements \n",
      "that would allow for infrastructure planning support, resource \n",
      "allocation, policy analysis, research, evaluation, emergency \n",
      "preparedness and response (such as pulse), care coordination, planning, \n",
      "establishing partnerships, and determining service gaps?\n",
      "    ++ how should cms work with states to align federal and state \n",
      "policies to allow all parties to effectively use an ndh?\n",
      "    <bullet> are there use cases for which an ndh could be used to help \n",
      "prevent fraud, waste, abuse, improper payments, or privacy breaches? \n",
      "conversely, are there any concerns that an ndh, as described, could \n",
      "increase the possibility of those outcomes, and, if so, what actions \n",
      "could be taken to mitigate that risk?\n",
      "    <bullet> what specific functionality or use cases, including any \n",
      "not discussed here, would it be helpful for cms to consider developing \n",
      "within an ndh? what types of data elements would need to be included \n",
      "(or excluded) to support these use cases (for example, licensing, \n",
      "certification, and credentialing)?\n",
      "    <bullet> beyond identifying providers associated with specific \n",
      "organizations, and organizations that may be under the umbrella of a \n",
      "single health system, what other relationships would be important to \n",
      "capture and why?\n",
      "    <bullet> we have received feedback that individual providers may \n",
      "not use their individual digital endpoints in many cases where the \n",
      "communications involve patients receiving institutional care. how can \n",
      "we associate group- or practice-level digital contact information with \n",
      "appropriate providers to ensure that data get to the right place?\n",
      "    <bullet> what types of entities should be encouraged to use data \n",
      "from an ndh? for what purposes and why?\n",
      "    <bullet> what are some of the functions or features of current \n",
      "provider directories that work particularly well?\n",
      "    <bullet> what are some of the lessons learned or mistakes to avoid \n",
      "from current provider directories of which we should be aware?\n",
      "    we solicit comments on key considerations related to data \n",
      "submission and maintenance for potential ndh development:\n",
      "    <bullet> what policy or operational factors should be considered \n",
      "for new data collection interfaces as part of a single point of entry?\n",
      "    <bullet> how can data be collected, updated, verified, and \n",
      "maintained without creating or increasing burden on providers and \n",
      "others who could contribute data to an ndh, especially for under-\n",
      "resourced or understaffed facilities?\n",
      "    <bullet> what are barriers to updating directory data in current \n",
      "systems that could be addressed with an ndh?\n",
      "    <bullet> what are current and potential best practices regarding \n",
      "the frequency of directory data updates?\n",
      "    <bullet> what specific strategies, technical solutions, or policies \n",
      "could cms implement to facilitate timely and accurate directory data \n",
      "updates? how\n",
      "\n",
      "[[page 61027]]\n",
      "\n",
      "could consistent and accurate ndh data submission be incentivized \n",
      "within the healthcare industry?\n",
      "    <bullet> how should duplicate information or conflicting \n",
      "information reported from different sources be resolved to balance the \n",
      "reporting burden versus confidence in data accuracy?\n",
      "    <bullet> the healthcare directory initiative and fast both \n",
      "identified validation and verification as important functions of a \n",
      "centralized directory. what data types or data sources are important to \n",
      "verify (for example, provider endpoint information, provider \n",
      "credentialing) versus relying on self-reported information? are there \n",
      "specific recommendations for verifying specific data elements?\n",
      "    <bullet> what use cases would benefit from data being verified and \n",
      "what sort of assurances would be necessary for trust and reliance on \n",
      "those data?\n",
      "    <bullet> are there use cases where an ndh could provide data that \n",
      "has already been verified to reduce that burden on payers or other \n",
      "entities and, if so, how could that be achieved?\n",
      "    <bullet> what concerns might listed entities have about submitting \n",
      "data to an ndh? we solicit comments on provider delegation of authority \n",
      "to submit data on a provider's behalf:\n",
      "    <bullet> outside of cms, what mechanisms, standards, or processes \n",
      "are currently used to enable provider delegation of authority to submit \n",
      "data?\n",
      "    <bullet> what challenges, if any, occur in the processes for \n",
      "delegating authority to submit data on behalf of providers or in the \n",
      "processes for submitting directory data on behalf of providers?\n",
      "    <bullet> what specific strategies, technical solutions, or policies \n",
      "could be implemented to enable delegation of authority to submit data \n",
      "to an ndh?\n",
      "    <bullet> should cms consider including role-based access management \n",
      "to submit provider data to an ndh, and, if so, what kind of role-based \n",
      "access management?\n",
      "    <bullet> are there entities that currently exist that would be \n",
      "helpful to serve as intermediaries for bulk data verification and \n",
      "upload or submission to an ndh? if so, are there existing models that \n",
      "demonstrate how this can be done (for instance, the verifications \n",
      "performed through the federal data services hub)?\n",
      "    <bullet> how do intermediaries currently perform bulk data \n",
      "verification and upload or submission to provider directories?\n",
      "\n",
      "iv. technical framework for an ndh\n",
      "\n",
      "a. overview\n",
      "\n",
      "    the technical approach to establishing an ndh could leverage the \n",
      "extensive work the federal government has already done, in \n",
      "collaboration with industry stakeholders and standards development \n",
      "organizations, to develop healthcare directory information exchange \n",
      "standards. cms could build on existing work to develop fhir-based \n",
      "standards for healthcare directories. for years, onc has collaborated \n",
      "with hl7, an ansi-accredited standards development organization, to \n",
      "support the scalability and industry adoption of fhir standards for use \n",
      "in a healthcare directory.\\74\\ \\75\\ through an industry-led and \n",
      "consensus-based workgroup process, hl7 publishes various technical \n",
      "architecture standards, known as implementation guides (igs). in 2016, \n",
      "hl7, in cooperation with the onc and fha healthcare directory \n",
      "initiative, developed and published the validated healthcare directory \n",
      "(vhdir) ig. the vhdir ig was developed to describe the technical design \n",
      "considerations for collecting, validating, verifying, and exchanging \n",
      "data from a healthcare directory. the ig also provides technical \n",
      "guidance for a fhir api for accessing data from a validated healthcare \n",
      "directory and could be used, for example, for provider credentialing \n",
      "and privileging.\\76\\ \\77\\ building on this initial work, fast has \n",
      "collaborated with hl7's patient administration work group to develop \n",
      "and maintain new fhir igs to further describe data attestation and \n",
      "verification processes, as well as a standard api for local directories \n",
      "to make verified data available to stakeholders: the national directory \n",
      "endpoint query ig, the national directory exchange ig, and the national \n",
      "directory attestation and validation ig.\\78\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\74\\ onc. (2021, april). what is hl7 fhir? retrieved from \n",
      "<a href=\"https://www.healthit.gov/topic/standards-technology/standards/fhir-fact-sheets\">https://www.healthit.gov/topic/standards-technology/standards/fhir-fact-sheets</a>.\n",
      "    \\75\\ hadassah, g. & marcelonis, d. (2022, may 20). national \n",
      "healthcare directory. retrieved from <a href=\"https://confluence.hl7.org/display/pa/national+healthcare+directory\">https://confluence.hl7.org/display/pa/national+healthcare+directory</a>.\n",
      "    \\76\\ onc tech lab standards coordination. (2019, june 25). \n",
      "healthcare directory. retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/healthcare+directory\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/healthcare+directory</a>.\n",
      "    \\77\\ hl7. (2022). validated healthcare directory. retrieved from \n",
      "<a href=\"http://build.fhir.org/ig/hl7/vhdir/index.html\">http://build.fhir.org/ig/hl7/vhdir/index.html</a>.\n",
      "    \\78\\ hadassah, g. & marcelonis, d. (2022, may 20). national \n",
      "healthcare directory. retrieved from <a href=\"https://confluence.hl7.org/display/pa/national+healthcare+directory\">https://confluence.hl7.org/display/pa/national+healthcare+directory</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    additionally, cms could build on work done by fast. fast identified \n",
      "numerous technical challenges associated with directories, particularly \n",
      "related to digital contact information, and conducted research, \n",
      "stakeholder engagement, and key technical development activities to \n",
      "establish the framework and capabilities needed for a scalable ndh.\\79\\ \n",
      "\\80\\ in their proposed directory technical solutions document, fast \n",
      "also identified cms as the appropriate potential maintainer of an \n",
      "ndh.\\81\\\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    \\79\\ fast. (2020, december 17). proposed solutions working \n",
      "document: directory (v3). retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx</a>.\n",
      "    \\80\\ onc tech lab standards coordination. (2022, april 1). fhir \n",
      "at scale taskforce (fast). retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/pages/viewpage.action?pageid=43614268\">https://oncprojectracking.healthit.gov/wiki/pages/viewpage.action?pageid=43614268</a>.\n",
      "    \\81\\ fast. (2020, december 17). proposed solutions working \n",
      "document: directory (v3). page 13. retrieved from <a href=\"https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx\">https://oncprojectracking.healthit.gov/wiki/display/techlabsc/directory%2c+versions+and+scale+tiger+team?preview=/46301216/183107855/fast-ps-directory%20v3_122320.docx</a>.\n",
      "---------------------------------------------------------------------------\n",
      "\n",
      "    given these existing efforts to establish fhir-based standards for \n",
      "healthcare directory information exchange, cms could leverage this work \n",
      "to serve as the technical foundation on which to develop a fhir api-\n",
      "enabled ndh. additionally, using fhir standards would help align an ndh \n",
      "with the technical standards at 45 cfr 170.215 finalized by onc in the \n",
      "21st century cures act: interoperability, information blocking, and the \n",
      "onc health it certification program final rule (85 fr 25642).\n",
      "\n",
      "b. comment solicitation\n",
      "\n",
      "    we are soliciting comments on technical considerations for a \n",
      "potential ndh:\n",
      "    <bullet> in addition to fhir, what technical standards are \n",
      "currently used or show promise to exchange directory data?\n",
      "    <bullet> what technical standards should an ndh support?\n",
      "    <bullet> what work related to developing fhir standards for an ndh, \n",
      "such as building and refining igs, still needs to be completed?\n",
      "    <bullet> how could cms and onc ensure that an ndh improves \n",
      "interoperability by promoting the adoption of tefca and supporting \n",
      "participating health information networks and healthcare entities? what \n",
      "are key opportunities for an ndh and tefca to work together in a \n",
      "mutually beneficial fashion?\n",
      "    <bullet> are there use cases for providers accessing an ndh through \n",
      "their ehrs and, if so, what are the technical requirements?\n",
      "    <bullet> are there use cases for individuals accessing an ndh \n",
      "through a patient-facing health app and, if so, what are the technical \n",
      "requirements?\n",
      "    <bullet> what security standards should be used to support an ndh?\n",
      "    <bullet> how should authentication and access to an ndh be managed \n",
      "for data\n",
      "\n",
      "[[page 61028]]\n",
      "\n",
      "submission? should authentication and access processes vary based on \n",
      "the type of data being submitted, and if so, how?\n",
      "    <bullet> what other technical considerations should cms be aware \n",
      "of?\n",
      "\n",
      "v. phased approach to implementation\n",
      "\n",
      "a. overview\n",
      "\n",
      "    the primary goal of an ndh would be to serve as a ``centralized \n",
      "data hub'' for accurate directory information in the healthcare market. \n",
      "to achieve that goal, cms is seeking comments on a potential phased \n",
      "approach to establishing an ndh, in alignment with it industry best \n",
      "practices. we would assess our statutory authorities to establish an \n",
      "ndh and take appropriate action. the initial phases of implementation \n",
      "would focus on consolidating and verifying existing data, building \n",
      "trust, and gaining industry buy-in. subsequent phases would build on \n",
      "that foundation by incorporating additional data elements, listed \n",
      "entity types, and functionality while maintaining trust in the \n",
      "integrity of the system and data. this phased approach would allow cms \n",
      "to gather consumer and industry input while focusing on scalability, \n",
      "data validity and governance, ethics, and equity for needed agency \n",
      "action or ndh development.\n",
      "\n",
      "b. comment solicitation\n",
      "\n",
      "    we are soliciting comments on the feasibility of a phased approach \n",
      "to implementation and potential opportunities to build stakeholder \n",
      "trust and adoption along the way:\n",
      "    <bullet> what entities or stakeholders should participate in the \n",
      "development of an ndh, and what involvement should they have?\n",
      "    <bullet> what stakeholders could have valuable feedback in the \n",
      "scoping and early implementation processes to ensure viability of an \n",
      "ndh and sufficient uptake across the healthcare industry?\n",
      "    <bullet> what functionality would constitute a minimum viable \n",
      "product?\n",
      "    <bullet> what specific strategies, technical solutions, or policies \n",
      "could cms employ to best engage stakeholders and build trust throughout \n",
      "the development process?\n",
      "    <bullet> what use cases should be prioritized in a phased \n",
      "development and implementation process for immediate impact and burden \n",
      "reduction?\n",
      "    <bullet> what types of entities and data categories should be \n",
      "prioritized in a phased development and implementation process for \n",
      "immediate impact and burden reduction?\n",
      "    <bullet> how could human-centered design, including equity-centered \n",
      "design, principles be used to optimize the usability of an ndh?\n",
      "    <bullet> what issues should cms anticipate throughout an ndh system \n",
      "development life cycle?\n",
      "    ++ development (for example: timelines, technologies).\n",
      "    ++ implementation (for example: phased roll out, obtaining buy-in).\n",
      "    ++ operations (for example: updating content, access, and \n",
      "security).\n",
      "    ++ maintenance (for example: updating technologies, ensuring data \n",
      "accuracy).\n",
      "\n",
      "vi. prerequisites and cms actions to address challenges and risks\n",
      "\n",
      "a. overview\n",
      "\n",
      "    we are aware of the many prerequisites, risks, and challenges \n",
      "associated with the implementation of such a directory and would \n",
      "consider these throughout the development process. as noted previously, \n",
      "the federal government has led numerous technical efforts that would \n",
      "help inform the planning and development of an ndh. challenges \n",
      "associated with establishing an ndh include, but are not limited to, \n",
      "project planning and scoping, stakeholder and collaborator engagement, \n",
      "development risks, use of existing identifiers (for example, npi or \n",
      "tin), data publication, system maintenance, and stakeholder adoption.\n",
      "\n",
      "b. comment solicitation\n",
      "\n",
      "    we are soliciting comments on risks, challenges, and prerequisites \n",
      "associated with implementing such a directory:\n",
      "    <bullet> what technical or policy prerequisites would need to be \n",
      "met prior to developing an ndh?\n",
      "    <bullet> what specific risks or challenges should be anticipated \n",
      "throughout the system development life cycle of an ndh? how can these \n",
      "risks and challenges be minimized?\n",
      "    <bullet> what are the most promising efforts that exist to date in \n",
      "resolving healthcare directory challenges? how could cms best \n",
      "incorporate outputs from these efforts into the requirements for an \n",
      "ndh? which gaps remain that are not being addressed by existing \n",
      "efforts?\n",
      "\n",
      "vii. information collection requirements\n",
      "\n",
      "    please note, this is a request for information (rfi) only. in \n",
      "accordance with the implementing regulations of the paperwork reduction \n",
      "act of 1995 (pra), specifically 5 cfr 1320.3(h)(4), this general \n",
      "solicitation is exempt from the pra. facts or opinions submitted in \n",
      "response to general solicitations of comments from the public, \n",
      "published in the federal register or other publications, regardless of \n",
      "the form or format thereof, provided that no person is required to \n",
      "supply specific information pertaining to the commenter, other than \n",
      "that necessary for self-identification, as a condition of the agency's \n",
      "full consideration, are not generally considered information \n",
      "collections and therefore not subject to the pra.\n",
      "    this rfi is issued solely for information and planning purposes; it \n",
      "does not constitute a request for proposal (rfp), applications, \n",
      "proposal abstracts, or quotations. this rfi does not commit the u.s. \n",
      "government to contract for any supplies or services or make a grant \n",
      "award. further, cms is not seeking proposals through this rfi and will \n",
      "not accept unsolicited proposals. responders are advised that the u.s. \n",
      "government will not pay for any information or administrative costs \n",
      "incurred in response to this rfi; all costs associated with responding \n",
      "to this rfi will be solely at the interested party's expense. not \n",
      "responding to this rfi does not preclude participation in any future \n",
      "procurement, if conducted. it is the responsibility of the potential \n",
      "responders to monitor this rfi announcement for additional information \n",
      "pertaining to this request. please note that cms will not respond to \n",
      "questions about the policy issues raised in this rfi. cms may or may \n",
      "not choose to contact individual responders. such communications would \n",
      "only serve to further clarify written responses. contractor support \n",
      "personnel may be used to review rfi responses. responses to this notice \n",
      "are not offers and cannot be accepted by the u.s. government to form a \n",
      "binding contract or issue a grant. information obtained as a result of \n",
      "this rfi may be used by the u.s. government for program planning on a \n",
      "non-attribution basis. respondents should not include any information \n",
      "that might be considered proprietary or confidential. this rfi should \n",
      "not be construed as a commitment or authorization to incur cost for \n",
      "which reimbursement would be required or sought. all submissions become \n",
      "u.s. government property and will not be returned. cms may publicly \n",
      "post the comments received, or a summary thereof.\n",
      "    chiquita brooks-lasure, administrator of the centers for medicare & \n",
      "medicaid services, approved this document on september 28, 2022.\n",
      "\n",
      "\n",
      "[[page 61029]]\n",
      "\n",
      "\n",
      "    dated: october 3, 2022.\n",
      "xavier becerra,\n",
      "secretary, department of health and human services.\n",
      "[fr doc. 2022-21904 filed 10-5-22; 8:45 am]\n",
      "billing code 4120-01-p\n",
      "\n",
      "\n",
      "</pre></body>\n",
      "</html>\n",
      "Added /Users/ha/Downloads/mirrulations/specific/CMS-2022-0163/raw-data/documents/CMS-2022-0163-0001_content.htm to vector store.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "from uuid import uuid4\n",
    "\n",
    "from langchain_core.documents import Document\n",
    "\n",
    "index = faiss.IndexFlatL2(len(embeddings.embed_query(\"hello world\")))\n",
    "\n",
    "vector_store = FAISS(\n",
    "    embedding_function=embeddings,\n",
    "    index=index,\n",
    "    docstore=InMemoryDocstore(),\n",
    "    index_to_docstore_id={},\n",
    ")\n",
    "\n",
    "for fold in folders:\n",
    "    for com_file in tqdm(glob(folder_path + fold + \"/**/raw-data/documents/*htm\", recursive=True), desc=f\"Processing files in {fold}\"):\n",
    "        with open(com_file, \"r\") as file:\n",
    "            text = file.read().lower()\n",
    "            print(text)\n",
    "            vector_store.add_documents(\n",
    "                documents=[Document(page_content=text, metadata={\"source\": com_file})],\n",
    "                ids=[str(uuid4())],\n",
    "            )\n",
    "            print(f\"Added {com_file} to vector store.\")\n",
    "            \n",
    "            \n",
    "vector_store.save_local(\"vector_store\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "b7e1cb02",
   "metadata": {},
   "outputs": [],
   "source": [
    "results = vector_store.similarity_search(\n",
    "    \"chocolate chip pancakes\",\n",
    "    k=2,\n",
    "    filter={\"source\": \"tweet\"},\n",
    ")\n",
    "for res in results:\n",
    "    print(f\"* {res.page_content} [{res.metadata}]\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fa2fc4a7",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3979ac66",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
